PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Basten, S; Verropoulou, G				Basten, Stuart; Verropoulou, Georgia			A Re-Interpretation of the 'Two-child Norm' in Post-Transitional Demographic Systems: Fertility Intentions in Taiwan	PLOS ONE			English	Article							SON PREFERENCE; EAST-ASIA; GENDER; POPULATION; EXPERIENCE; COUNTRIES; EMERGENCE; BEHAVIOR; DECLINE; RISE	Taiwan currently has one of the lowest fertility rates in the world, leading to projections of rapid population ageing and decline. In common with other territories in Pacific Asia, policies designed to support childbearing have recently been introduced. Some optimism for the future success of these policies has been drawn from the fact that the 'ideal' number of children stated in Taiwanese surveys is over two. In this way, Taiwan appears to fit the 'two-child norm' model identified for Europe and North America. Furthermore, this feature has led commentators to state that Taiwan is not in a 'low fertility trap'-where positive feedback mechanisms emanating from the normalisation of small families, slow economic growth and ageing/declining population mean attempts to increase fertility become ever less likely to succeed. Using a recent national representative survey, and arguing that 'intentions' are a more reliable guide to understanding the circumstances of family formation, this paper explores fertility intentions in Taiwan with a special focus on women at parity one and parity two. This will form the first full-length examination of fertility intentions in Taiwan published in English and one of the few studies of Pacific Asia that reports a micro-level analysis. We argue that using intentions should provide a better 'barometer' of attitudes towards child-bearing in Taiwan, and that through micro-level analysis, we can better identify the predictors of intentions that could, in turn, provide useful clues both for projections as well as shaping policy responses. While we found some evidence for a 'two-child norm' among childless women, this could be an unrealistic ideal. This is supported by the fact that a majority of women with one child do not intend to have another.	[Basten, Stuart] Univ Oxford, Dept Social Policy & Intervent, Oxford, England; [Verropoulou, Georgia] Univ Piraeus, Dept Stat & Insurance Sci, Piraeus, Greece	University of Oxford; University of Piraeus	Basten, S (corresponding author), Univ Oxford, Dept Social Policy & Intervent, Oxford, England.	stuart.basten@spi.ox.ac.uk	Gietel-Basten, Stuart A/I-8513-2015	Gietel-Basten, Stuart A/0000-0002-5818-8283; Verropoulou, Georgia/0000-0001-6544-2086	Economic and Social Research Council (UK): The gap between fertility ideals and reality in East Asia: a mixed-method comparative study of Beijing Municipality and Taiwan [ES/K001434/1]; Economic and Social Research Council [ES/K001434/1] Funding Source: researchfish; ESRC [ES/K001434/1] Funding Source: UKRI	Economic and Social Research Council (UK): The gap between fertility ideals and reality in East Asia: a mixed-method comparative study of Beijing Municipality and Taiwan; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funded by Economic and Social Research Council (UK): The gap between fertility ideals and reality in East Asia: a mixed-method comparative study of Beijing Municipality and Taiwan (http://www.esrc.ac.uk/my-esrc/grants/ES.K001434.1/read) Grant No. ES/K001434/1.	[Anonymous], 2005, AGEING PENSION REFOR; Basten S., 2014, WORLD POPULATION HUM, P39, DOI DOI 10.1093/ACPROF:OSO/9780198703167.003.0003; Basten S, 2013, REEXAMINING FERTILIT; Basten S., 2010, FINNISH YB POPULATIO, P67; Basten SA, 2015, POP ASS AM ANN M APR; Basten S, 2013, ASIAN SOC WORK POLIC, V7, P242, DOI 10.1111/aswp.12015; Basten S, 2013, ASIAN POPUL STUD, V9, P322, DOI 10.1080/17441730.2013.836394; Basten S, 2013, PALGR MAC STUD FAM, P185; Basten Stuart., 2013, CHILDBEARING PREFERE; Becker G.S., 1993, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; BECKER GS, 1973, J POLIT ECON, V81, pS279, DOI 10.1086/260166; Bongaarts J, 2012, POPUL DEV REV, V38, P83, DOI 10.1111/j.1728-4457.2012.00473.x; Bongaarts J, 2001, POPUL DEV REV, V27, P260; BUTZ WP, 1979, AM ECON REV, V69, P318; Cernada G, 2007, INT Q COMMUNITY HEAL, V27, P99, DOI 10.2190/IQ.27.2.b; Chen Y.-H., 2012, JAPANESE J POPULATIO, V10, P78; Cheng CY, 2007, J CHINESE PHILOS, V34, P1, DOI 10.1111/j.1540-6253.2007.00397.x; Choe MK, 2004, ANN M POP ASS AM BOS; Chuang H-L, 2008, AM J ECON SOCIOL, V62, P435, DOI [10.1111/1536-7150.00221, DOI 10.1111/1536-7150.00221]; Coleman D, 2011, POPUL DEV REV, V37, P217, DOI 10.1111/j.1728-4457.2011.00385.x; Commission of the European Communities, 2005, COM200594 COMM EUR C; Davis D. S., 2014, WIVES HUSBANDS LOVER, P1; Easterlin RA, 1980, BIRTH AND FORTUNE TH; Esping-Andersen G., 2009, INCOMPLETE REVOLUTIO; Frejka T, 2010, POPUL DEV REV, V36, P579, DOI 10.1111/j.1728-4457.2010.00347.x; Goldstein J, 2003, POPUL RES POLICY REV, V22, P479, DOI 10.1023/B:POPU.0000020962.80895.4a; Hayford SR, 2009, DEMOGRAPHY, V46, P765, DOI 10.1353/dem.0.0073; Heiland F, 2008, EUR J POPUL, V24, P129, DOI 10.1007/s10680-008-9162-x; HERMALIN AI, 1979, STUD FAMILY PLANN, V10, P75, DOI 10.2307/1965677; Ho H.-Z., 2013, FATHER INVOLVEMENT Y, P329; Ho H-Z, 2011, INT J PARENTS ED, V5, P35; Hou JW., 2014, SOCIAL SCI CHINA, V35, P78; Jeon Y, 2005, J POPUL ECON, V18, P1, DOI 10.1007/s00148-004-0190-5; Lee M., 2009, JAPANESE J POPULATIO, V7, P71; LEE RD, 1980, POP STUD-J DEMOG, V34, P205, DOI 10.1080/00324728.1980.10410385; Lesthaeghe R, 2014, P NATL ACAD SCI USA, V111, P18112, DOI 10.1073/pnas.1420441111; Lin MH, 2010, AGEING RES REV, V9, pS23, DOI 10.1016/j.arr.2010.07.004; Lin TC, 2009, DEMOGR RES, V20, P377, DOI 10.4054/DemRes.2009.20.16; Lin WI, 2009, ASIAN SOC WORK POLIC, V3, P95, DOI 10.1111/j.1753-1411.2009.00027.x; Lutz Wolfgang, 2006, VIENNA YB POPULATION, V4, P167, DOI DOI 10.1553/POPULATIONYEARBOOK2006S167; Mason Andrew, 2006, Genus, V62, P11; McDonald P, 2013, DEMOGR RES, V28, P981, DOI 10.4054/DemRes.2013.28.34; McDonald P, 2009, ROUT RES PUB SOC POL, P23; McDonald Peter, 2000, J POPULATION RES, V17, P1, DOI DOI 10.1007/BF03029445; Merli M Giovanna, 2011, Population (Engl Ed), V66, P519; Miettinen A, 2011, DEMOGR RES, V24, P469, DOI 10.4054/DemRes.2011.24.20; Mills M, 2008, DEMOGR RES, V18, DOI 10.4054/DemRes.2008.18.1; Morgan SP, 2010, POPUL DEV REV, V36, P91, DOI 10.1111/j.1728-4457.2010.00319.x; Myrskyla M, 2013, POPUL DEV REV, V39, P31, DOI 10.1111/j.1728-4457.2013.00572.x; NAIR NK, 1980, STUD FAMILY PLANN, V11, P255, DOI 10.2307/1966243; NAMBOODIRI NK, 1972, POP STUD-J DEMOG, V26, P185, DOI 10.1080/00324728.1972.10405545; Poston D. L. J., 2014, FAMILY SOCIAL CHANGE, P265; Pradhan I, 2012, DEMOGR INDIA, V41, P53; Pradhan I, 2014, ASIAN POPUL STUD, V10, P163, DOI 10.1080/17441730.2014.909962; Quesnel-Vallee A, 2003, POPUL RES POLICY REV, V22, P497, DOI 10.1023/B:POPU.0000021074.33415.c1; Retherford RD, 1996, POP STUD-J DEMOG, V50, P5, DOI 10.1080/0032472031000149016; Roy R. N., 2014, TRANSITION PARENTHOO; Schoen R, 1999, J MARRIAGE FAM, V61, P790, DOI 10.2307/353578; Sobotka T, 2014, POPUL DEV REV, V40, P391, DOI 10.1111/j.1728-4457.2014.00691.x; Sobotka T, 2011, POPUL DEV REV, V37, P267, DOI 10.1111/j.1728-4457.2011.00411.x; Straughan P., 2008, ULTRALOW FERTILITY P; Testa MR, 2014, ADV LIFE COURSE RES, V21, P28, DOI 10.1016/j.alcr.2014.01.005; Testa MR, 2014, DEMOGR RES, V31, P687, DOI 10.4054/DemRes.2014.31.23; Tu E. J.-C., 2007, TRANSITION CHALLENGE, P71; UNFPA, 2011, IMP DEM CHANG THAIL; United Nations Population Division (UNPD), 2013, WORLD POP PROSP 2012; Wang L.-R., 2014, CONT SOCIAL ISSUES E, P235; Yap Mui Teng, 2003, J POPULATION SOCIAL, V1, P643; Yu W-H., 2009, GENDERED TRAJECTORIE; Yu WH, 2006, J MARRIAGE FAM, V68, P1057, DOI 10.1111/j.1741-3737.2006.00313.x; Zheng ZhenZhen, 2009, Asian Population Studies, V5, P329, DOI 10.1080/17441730903351701	72	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135105	10.1371/journal.pone.0135105	http://dx.doi.org/10.1371/journal.pone.0135105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291083	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900014
J	Kenzaka, T; Kato, K; Kitao, A; Kosami, K; Minami, K; Yahata, S; Fukui, M; Okayama, M				Kenzaka, Tsuneaki; Kato, Ken; Kitao, Akihito; Kosami, Koki; Minami, Kensuke; Yahata, Shinsuke; Fukui, Miho; Okayama, Masanobu			Hyperammonemia in Urinary Tract Infections	PLOS ONE			English	Article							ENCEPHALOPATHY; DIVERSION; COMA	Objectives The present study investigated the incidence of hyperammonemia in urinary tract infections and explored the utility of urinary obstruction relief and antimicrobial administration to improve hyperammonemia. Methods This was an observational study. Subjects were patients who were diagnosed with urinary tract infection and hospitalized between June 2008 and June 2009. We measured plasma ammonia levels on admission in patients who were clinically diagnosed with urinary tract infection and hospitalized. We assessed each patient's level of consciousness on admission using the Glasgow Coma Scale (GCS) and performed urine and blood cultures. We also assessed hearing prior to hospitalization using the Eastern Cooperative Oncology Group performance status (ECOG-PS). In cases with high ammonia levels on admission, plasma ammonia and GCS were measured 24 hours and 5-7 days later. Results Sixty-seven candidates were enrolled; of these, 60 cases (89.6%) with bacterial cell counts >= 10(4) CFU/mL were studied. Five cases (8.3%) presented with high plasma ammonia levels. Cases with hyperammonemia were significantly more likely to present with low GCS scores and urinary retention rate. All five cases received antimicrobial therapy with an indwelling bladder catheter to relieve urinary retention. The case 5 patient died shortly after admission due to complicated aspiration pneumonia; in the remaining cases, plasma ammonia levels were rapidly normalized and the level of consciousness improved. Conclusions The occurrence of hyperammonemia in urinary tract infections is not rare. The cause of hyperammonemia is urinary retention obstruction. Therefore, along with antimicrobial administration, relief of obstruction is important for the treatment of hyperammonemia caused by this mechanism.	[Kenzaka, Tsuneaki; Kosami, Koki; Minami, Kensuke] Jichi Med Univ, Sch Med, Ctr Community Med, Div Gen Med, Shimotsuke, Japan; [Kato, Ken; Kitao, Akihito; Yahata, Shinsuke; Fukui, Miho] Toyooka Publ Hosp, Dept Gen Med, Toyooka, Japan; [Okayama, Masanobu] Kobe Univ, Grad Sch Med, Div Community Med & Med Educ, Kobe, Hyogo 657, Japan; [Kenzaka, Tsuneaki] Kobe Univ, Grad Sch Med, Div Community Med & Career Dev, Kobe, Hyogo 657, Japan	Jichi Medical University; Kobe University; Kobe University	Kenzaka, T (corresponding author), Jichi Med Univ, Sch Med, Ctr Community Med, Div Gen Med, Shimotsuke, Japan.	smile.kenzaka@jichi.ac.jp	OKAYAMA, MASANOBU/U-5542-2019; Kosami, Koki/AAE-8873-2019	Kosami, Koki/0000-0003-1050-2699				Albersen M, 2007, NAT CLIN PRACT UROL, V4, P455, DOI 10.1038/ncpuro0877; Arai Y, 1989, Hinyokika Kiyo, V35, P277; De Jonghe B, 2002, LANCET, V360, P996, DOI 10.1016/S0140-6736(02)11084-1; Hawkes ND, 2001, POSTGRAD MED J, V77, P717, DOI 10.1136/pmj.77.913.717; KAVEGGIA FF, 1990, ARCH INTERN MED, V150, P2389, DOI 10.1001/archinte.150.11.2389; Kenzaka T, 2013, CENT EUR J MED, V8, P597, DOI 10.2478/s11536-013-0202-5; OLIVER RM, 1989, POSTGRAD MED J, V65, P502, DOI 10.1136/pgmj.65.765.502; SAMTOY B, 1980, PEDIATRICS, V65, P294, DOI 10.1542/peds.65.2.294; UTI Subcommittee of the Clinical Evaluation Committee Japan Society of Chemotherapy, 2000, JPN J ANTIBIOT, V53, P453	9	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136220	10.1371/journal.pone.0136220	http://dx.doi.org/10.1371/journal.pone.0136220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292215	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900067
J	Patai, AV; Valcz, G; Hollosi, P; Kalmar, A; Peterfia, B; Patai, A; Wichmann, B; Spisak, S; Bartak, BK; Leiszter, K; Toth, K; Sipos, F; Kovalszky, I; Peter, Z; Miheller, P; Tulassay, Z; Molnar, B				Patai, Arpad V.; Valcz, Gabor; Hollosi, Peter; Kalmar, Alexandra; Peterfia, Balint; Patai, Arpad; Wichmann, Barnabas; Spisak, Sandor; Bartak, Barbara Kinga; Leiszter, Katalin; Toth, Kinga; Sipos, Ferenc; Kovalszky, Ilona; Peter, Zoltan; Miheller, Pal; Tulassay, Zsolt; Molnar, Bela			Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas	PLOS ONE			English	Article							FREQUENT EPIGENETIC INACTIVATION; CANCER; GENE; COLON; MARKER; HYPERMETHYLATION; IDENTIFICATION; PROGRESSION; MUTATIONS; PHENOTYPE	Microarray analysis of promoter hypermethylation provides insight into the role and extent of DNA methylation in the development of colorectal cancer (CRC) and may be co-monitored with the appearance of driver mutations. Colonic biopsy samples were obtained endoscopically from 10 normal, 23 adenoma (17 low-grade (LGD) and 6 high-grade dysplasia (HGD)), and 8 ulcerative colitis (UC) patients (4 active and 4 inactive). CRC samples were obtained from 24 patients (17 primary, 7 metastatic (MCRC)), 7 of them with synchronous LGD. Field effects were analyzed in tissues 1 cm (n = 5) and 10 cm (n = 5) from the margin of CRC. Tissue materials were studied for DNA methylation status using a 96 gene panel and for KRAS and BRAF mutations. Expression levels were assayed using whole genomic mRNA arrays. SFRP1 was further examined by immunohistochemistry. HT29 cells were treated with 5-aza-2' deoxycytidine to analyze the reversal possibility of DNA methylation. More than 85% of tumor samples showed hypermethylation in 10 genes (SFRP1, SST, BNC1, MAL, SLIT2, SFRP2, SLIT3, ALDH1A3, TMEFF2, WIF1), whereas the frequency of examined mutations were below 25%. These genes distinguished precancerous and cancerous lesions from inflamed and healthy tissue. The mRNA alterations that might be caused by systematic methylation could be partly reversed by demethylation treatment. Systematic changes in methylation patterns were observed early in CRC carcinogenesis, occuring in precursor lesions and CRC. Thus we conclude that DNA hypermethylation is an early and systematic event in colorectal carcinogenesis, and it could be potentially reversed by systematic demethylation therapy, but it would need more in vitro and in vivo experiments to support this theory.	[Patai, Arpad V.; Kalmar, Alexandra; Bartak, Barbara Kinga; Leiszter, Katalin; Toth, Kinga; Sipos, Ferenc; Peter, Zoltan; Miheller, Pal; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Med 2, H-1085 Budapest, Hungary; [Valcz, Gabor; Peterfia, Balint; Wichmann, Barnabas; Spisak, Sandor; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary; [Hollosi, Peter; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Hollosi, Peter] Hungarian Acad Sci, Tumor Progress Res Grp, Budapest, Hungary; [Patai, Arpad] Markusovszky Univ Teaching Hosp, Dept Gastroenterol & Med, Szombathely, Hungary; [Spisak, Sandor] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Patai, AV (corresponding author), Semmelweis Univ, Dept Med 2, H-1085 Budapest, Hungary.	arpad.patai@gmail.com	Kovalszky, Ilona/ABH-2832-2020; Sipos, Ferenc/GYV-6182-2022	Kovalszky, Ilona/0000-0002-0179-3378; Miheller, Pal/0000-0002-7396-3145	National Office for Research and Technology, Hungary [TECH_08-A1/2-2008-0114]; Hungarian Scientific Research Fund (OTKA) [K 111743]	National Office for Research and Technology, Hungary(National Office for Research and Technology); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by the National Office for Research and Technology, Hungary, (Grant number: TECH_08-A1/2-2008-0114) and by the Hungarian Scientific Research Fund (OTKA, Grant number: K 111743, www.magzrt.hu and www.otka.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; An B, 2010, INT J CANCER, V127, P2095, DOI 10.1002/ijc.25225; Belshaw NJ, 2010, CARCINOGENESIS, V31, P1158, DOI 10.1093/carcin/bgq077; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Dallol A, 2003, CANCER RES, V63, P1054; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Ebert MPA, 2005, NEOPLASIA, V7, P771, DOI 10.1593/neo.05235; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Hatzaki A, 2001, MOL CELL PROBE, V15, P243, DOI 10.1006/mcpr.2001.0367; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Holemon H, 2007, BIOTECHNIQUES, V43, P683, DOI 10.2144/000112597; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ju HX, 2011, AM J PATHOL, V178, P1835, DOI 10.1016/j.ajpath.2010.12.045; Kann L, 2006, CLIN CHEM, V52, P2299, DOI 10.1373/clinchem.2007.070896; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lind GE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-13; Luo YX, 2014, GASTROENTEROLOGY, V147, P418, DOI 10.1053/j.gastro.2014.04.039; Mizukami H, 2008, ANTICANCER RES, V28, P2697; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Niwa T, 2010, ADV GENET, V71, P41, DOI [10.1016/S0065-2660(10)71002-6, 10.1016/B978-0-12-380864-6.00002-X]; Oh T, 2013, J MOL DIAGN, V15, P498, DOI 10.1016/j.jmoldx.2013.03.004; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Patai AV, 2013, WORLD J GASTROENTERO, V19, P607, DOI 10.3748/wjg.v19.i5.607; Patai AV, 2012, DIGEST DIS, V30, P310, DOI 10.1159/000337004; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; R Core Team, 2021, R LANGUAGE ENV STAT; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Sipos F, 2013, EPIGENOMICS-UK, V5, P569, DOI 10.2217/epi.13.52; Spisak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046215; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taniguchi H, 2005, ONCOGENE, V24, P7946, DOI 10.1038/sj.onc.1208910; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Valcz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106143; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Whitehall VLJ, 2001, CANCER RES, V61, P827; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Zhong X, 2013, J CANCER RES CLIN, V139, P485, DOI 10.1007/s00432-012-1353-5	50	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0133836	10.1371/journal.pone.0133836	http://dx.doi.org/10.1371/journal.pone.0133836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291085	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900003
J	Zheng, YN; Tang, L; Huang, WH; Yan, RY; Ren, FF; Luo, L; Zhang, L				Zheng, Yaning; Tang, Lin; Huang, Wenhan; Yan, Ruyu; Ren, Feifeng; Luo, Lei; Zhang, Ling			Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway	PLOS ONE			English	Article							HEPATIC STEATOSIS; LIPID-METABOLISM; ANGIOTENSIN 1-7; INFLAMMATION; OBESITY; MICE; RECEPTOR; DAMAGE; MAS; RATS	The angiotensin converting enzyme 2-angiotensin-(1-7)-Mas axis (ACE2-Ang-(1-7)-Mas axis) is reported to participate in lipid metabolism in kidney, but its precise effects and underlying mechanisms remain unknown. We hypothesized that Ang-(1-7) reduces lipid accumulation and improves renal injury through the low density lipoprotein receptor-sterol regulatory element binding proteins 2-SREBP cleavage activating protein (LDLr-SREBP2-SCAP) system by suppressing inflammation in high fat diet (HFD)-fed mice. In this study, male C57BL/6 mice were randomized into four groups: STD (standard diet)+saline, HFD+saline, HFD+Ang-(1-7) and STD+Ang-(1-7). After 10 weeks of feeding, mice were administered Ang-(1-7) or saline for two weeks. We found that high inflammation status induced by HFD disrupted the LDLr-SREBP2-SCAP feedback system. Treatment of mice fed a high-fat diet with Ang-(1-7) induced significant improvement in inflammatory status, following the downregulation of LDLr, SREBP2 and SCAP, and then, decreased lipid deposition in kidney and improved renal injury. In conclusion, the anti-inflammatory effect of Ang-(1-7) alleviates renal injury triggered by lipid metabolic disorders through a LDLr-SREBP2-SCAP pathway.	[Zheng, Yaning; Tang, Lin; Huang, Wenhan; Yan, Ruyu; Ren, Feifeng; Luo, Lei; Zhang, Ling] Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400010, Peoples R China	Chongqing Medical University	Tang, L (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400010, Peoples R China.	hopetang@163.com			National Natural Science Youth Foundation of China [81200519]	National Natural Science Youth Foundation of China(National Natural Science Foundation of China (NSFC))	This work was conducted using grants from the National Natural Science Youth Foundation of China (NO. 81200519, Lin Tang). The funder was the main study designer and participated in preparation of the manuscript.	Alfie J, 2011, REV RECENT CLIN TRIA, V6, P134, DOI 10.2174/157488711795177912; Boini KM, 2010, J PHARMACOL EXP THER, V334, P839, DOI 10.1124/jpet.110.168815; Bosnyak S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/192567; Chen Y, 2007, AM J PHYSIOL-RENAL, V293, pF680, DOI 10.1152/ajprenal.00209.2007; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; da Silveira KD, 2010, J IMMUNOL, V185, P5569, DOI 10.4049/jimmunol.1000314; Decleves AE, 2011, J AM SOC NEPHROL, V22, P1846, DOI 10.1681/ASN.2011010026; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Felizardo Raphael Jose Ferreira, 2014, World J Nephrol, V3, P50, DOI 10.5527/wjn.v3.i3.50; Feltenberger JD, 2013, HYPERTENSION, V62, P324, DOI 10.1161/HYPERTENSIONAHA.111.00919; Fraga-Silva RA, 2011, CLINICS, V66, P837, DOI 10.1590/S1807-59322011000500021; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Gariballa S, 2014, NUTRIENTS, V6, P4872, DOI 10.3390/nu6114872; Giani JF, 2012, AM J PHYSIOL-RENAL, V302, pF1606, DOI 10.1152/ajprenal.00063.2012; Giani JF, 2011, AM J PHYSIOL-RENAL, V300, pF272, DOI 10.1152/ajprenal.00278.2010; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; Grobe N, 2012, AM J PHYSIOL-ENDOC M, V302, pE1016, DOI 10.1152/ajpendo.00515.2011; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Harcourt BE, 2012, NEPHROLOGY, V17, P257, DOI 10.1111/j.1440-1797.2011.01547.x; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Huang WH, 2014, BIOCHEM BIOPH RES CO, V450, P1051, DOI 10.1016/j.bbrc.2014.06.107; Joyner J, 2007, AM J PHYSIOL-REG I, V293, pR169, DOI 10.1152/ajpregu.00387.2006; KASISKE BL, 1990, KIDNEY INT, V37, P880, DOI 10.1038/ki.1990.62; Lai YH, 2013, HORM METAB RES, V45, P38, DOI 10.1055/s-0032-1321871; Lee HS, 1997, KIDNEY INT, V51, P1151, DOI 10.1038/ki.1997.158; Lee W, 2012, AM J CHINESE MED, V40, P1217, DOI 10.1142/S0192415X12500905; Mangge H, 2014, WORLD J CARDIOL, V6, P462, DOI 10.4330/wjc.v6.i6.462; Mercadel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099781; Meune C, 2011, J CARDIOVASC PHARM T, V16, P368, DOI 10.1177/1074248410391667; Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Ruan XZ, 2001, KIDNEY INT, V60, P1716, DOI 10.1046/j.1523-1755.2001.00025.x; Santos EL, 2009, BIOCHEM PHARMACOL, V78, P951, DOI 10.1016/j.bcp.2009.06.018; Santos RAS, 2007, CURR OPIN NEPHROL HY, V16, P122, DOI 10.1097/MNH.0b013e328031f362; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; Santos SHS, 2010, ARTERIOSCL THROM VAS, V30, P953, DOI 10.1161/ATVBAHA.109.200493; Santos SHS, 2014, PEPTIDES, V59, P34, DOI 10.1016/j.peptides.2014.07.002; Santos SHS, 2013, PEPTIDES, V46, P47, DOI 10.1016/j.peptides.2013.05.010; Stemmer K, 2012, DIS MODEL MECH, V5, P627, DOI 10.1242/dmm.009407; Sun H, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/592576; Tomiyama-Hanayama M, 2009, AM J PHYSIOL-RENAL, V297, pF679, DOI 10.1152/ajprenal.90680.2008; van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075; Wang XQ, 2014, CHINESE MED J-PEKING, V127, P2953, DOI 10.3760/cma.j.issn.0366-6999.20133011; Xu ZE, 2011, AM J PHYSIOL-RENAL, V301, pF713, DOI 10.1152/ajprenal.00341.2010; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746; Zhang JD, 2010, AM J PHYSIOL-RENAL, V298, pF579, DOI 10.1152/ajprenal.00548.2009; Zhang Kun, 2014, P 14THWORKSHOP DOMAI, P1, DOI DOI 10.1038/KI.2014.274	48	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136187	10.1371/journal.pone.0136187	http://dx.doi.org/10.1371/journal.pone.0136187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291618	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900062
J	Cop, U; Drieghe, D; Duyck, W				Cop, Uschi; Drieghe, Denis; Duyck, Wouter			Eye Movement Patterns in Natural Reading: A Comparison of Monolingual and Bilingual Reading of a Novel	PLOS ONE			English	Article							E-Z-READER; VISUAL WORD RECOGNITION; LANGUAGE LEXICAL ACTIVATION; SPANISH-ENGLISH BILINGUALS; EVENT-RELATED POTENTIALS; SENTENCE CONTEXT; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; MODEL; FREQUENCY	Introduction and Method This paper presents a corpus of sentence level eye movement parameters for unbalanced bilingual first language (L1) and second-language (L2) reading and monolingual reading of a complete novel (56 000 words). We present important sentence-level basic eye movement parameters of both bilingual and monolingual natural reading extracted from this large data corpus. Results and Conclusion Bilingual L2 reading patterns show longer sentence reading times (20%), more fixations (21%), shorter saccades (12%) and less word skipping (4.6%), than L1 reading patterns. Regression rates are the same for L1 and L2 reading. These results could indicate, analogous to a previous simulation with the E-Z reader model in the literature, that it is primarily the speeding up of lexical access that drives both L1 and L2 reading development. Bilingual L1 reading does not differ in any major way from monolingual reading. This contrasts with predictions made by the weaker links account, which predicts a bilingual disadvantage in language processing caused by divided exposure between languages.	[Cop, Uschi; Duyck, Wouter] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Drieghe, Denis] Univ Southampton, Sch Psychol, Southampton, Hants, England	Ghent University; University of Southampton	Cop, U (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	uschi.cop@ugent.be		Duyck, Wouter/0000-0003-2114-6212; Drieghe, Denis/0000-0001-9630-8410	Fonds voor Wetenscappelijk Onderzoek Vlaanderen (FWO) [11J0214N]; special research fund of Ghent University, GOA-Concerted Research Action [BOF13/GOA/032]	Fonds voor Wetenscappelijk Onderzoek Vlaanderen (FWO); special research fund of Ghent University, GOA-Concerted Research Action	This work was supported by Fonds voor Wetenscappelijk Onderzoek Vlaanderen (FWO, www.fwo.be Grant number: 11J0214N, received by UC) and the special research fund of Ghent University, GOA-Concerted Research Action with grant number: BOF13/GOA/032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarriba J, 1996, MEM COGNITION, V24, P477, DOI 10.3758/BF03200936; [Anonymous], 2014, R LANG ENV STAT COMP; Balling LW, 2013, BILING-LANG COGN, V16, P637, DOI 10.1017/S1366728911000733; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Binder KS, 2001, J MEM LANG, V44, P297, DOI 10.1006/jmla.2000.2754; Blythe H. I., 2011, OXFORD HDB EYE MOVEM, P643, DOI [10.1093/oxfordhb/9780199539789.013.0036, DOI 10.1093/OXFORDHB/9780199539789.013.0036]; Blythe HI, 2011, VISION RES, V51, P84, DOI 10.1016/j.visres.2010.10.003; Blythe HI, 2009, VISION RES, V49, P1583, DOI 10.1016/j.visres.2009.03.015; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brenders P, 2011, J EXP CHILD PSYCHOL, V109, P383, DOI 10.1016/j.jecp.2011.03.012; Brysbaert M., 1998, EYE GUIDANCE READING, P125, DOI DOI 10.1016/B978-008043361-5/50007-9; Brysbaert M, 2010, BILING-LANG COGN, V13, P359, DOI 10.1017/S1366728909990344; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Bultena S, 2014, Q J EXP PSYCHOL, V67, P1214, DOI 10.1080/17470218.2013.853090; Buswell G. T., 1922, FUNDAMENTAL READING; CARAMAZZA A, 1979, B PSYCHONOMIC SOC, V13, P212, DOI 10.3758/BF03335062; Cop U, 2015, PSYCHON B REV, DOI [10.3758/s13423-015-0819-2i, DOI 10.3758/S13423-015-0819-2I]; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Cover T. M., 1991, ELEMENTS INFORM THEO; CRISTOFFANINI P, 1986, Q J EXP PSYCHOL-A, V38, P367, DOI 10.1080/14640748608401604; Davis C, 2010, BILING-LANG COGN, V13, P137, DOI 10.1017/S1366728909990393; De Pessemier P., 2009, GL SCHR; Dempster F.N., 1985, BASIC PROCESSES MEMO, P209, DOI DOI 10.1007/978-1-4613-9541-6_5; Dijkstra T, 1999, J MEM LANG, V41, P496, DOI 10.1006/jmla.1999.2654; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; Dijkstra T, 2010, J MEM LANG, V62, P284, DOI 10.1016/j.jml.2009.12.003; Dussias PE, 2008, ACTA PSYCHOL, V128, P501, DOI 10.1016/j.actpsy.2007.09.004; Dussias PE, 2007, BILING-LANG COGN, V10, P101, DOI 10.1017/S1366728906002847; Dussias PE, 2010, ANNU REV APPL LINGUI, V30, P149, DOI 10.1017/S026719051000005X; Duyck W, 2008, PSYCHON B REV, V15, P850, DOI 10.3758/PBR.15.4.850; Duyck W, 2007, J EXP PSYCHOL LEARN, V33, P663, DOI 10.1037/0278-7393.33.4.663; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Gollan T.H., 2001, BILING-LANG COGN, V4, P63, DOI [10.1017/S136672890100013X, DOI 10.1017/S136672890100013X]; Gollan TH, 2008, J MEM LANG, V58, P787, DOI 10.1016/j.jml.2007.07.001; Gollan TH, 2011, J EXP PSYCHOL GEN, V140, P186, DOI 10.1037/a0022256; Gollan TH, 2005, MEM COGNITION, V33, P1220, DOI 10.3758/BF03193224; Gollan TH, 2004, J EXP PSYCHOL LEARN, V30, P246, DOI 10.1037/0278-7393.30.1.246; Gollan TH, 1997, J EXP PSYCHOL LEARN, V23, P1122, DOI 10.1037/0278-7393.23.5.1122; Grosjean F, 1982, LIFE 2 LANG INTRO BI, pviii; Gullifer JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00278; Haikio T, 2009, J EXP CHILD PSYCHOL, V102, P167, DOI 10.1016/j.jecp.2008.04.002; Huestegge L, 2009, VISION RES, V49, P2948, DOI 10.1016/j.visres.2009.09.012; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1430, DOI 10.1037/0278-7393.21.6.1430; Inhoff A, 2003, Q J EXP PSYCHOL-A, V56, P803, DOI 10.1080/02724980244000639; Ivanova I, 2008, ACTA PSYCHOL, V127, P277, DOI 10.1016/j.actpsy.2007.06.003; Joseph HSSL, 2009, VISION RES, V49, P2078, DOI 10.1016/j.visres.2009.05.015; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kennedy A, 2005, VISION RES, V45, P153, DOI 10.1016/j.visres.2004.07.037; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Kliegl R, 2005, PSYCHON B REV, V12, P132, DOI 10.3758/BF03196358; Kliegl R, 2004, EUR J COGN PSYCHOL, V16, P262, DOI 10.1080/09541440340000213; Kroll J., 1999, P 11 C EUR SOC C PSY, P92; Kuperman V, 2013, Q J EXP PSYCHOL, V66, P563, DOI 10.1080/17470218.2012.658820; Lehtonen M, 2012, NEUROPSYCHOLOGIA, V50, P1362, DOI 10.1016/j.neuropsychologia.2012.02.021; Lemhofer K, 2008, J EXP PSYCHOL LEARN, V34, P12, DOI 10.1037/0278-7393.34.1.12; Lemhofer K, 2012, BEHAV RES METHODS, V44, P325, DOI 10.3758/s13428-011-0146-0; Libben MR, 2009, J EXP PSYCHOL LEARN, V35, P381, DOI 10.1037/a0014875; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; McConkie G.W., 1991, VISION VISUAL DYSLEX; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Nation K, 2009, PHILOS T R SOC B, V364, P3665, DOI 10.1098/rstb.2009.0119; Peeters D, 2013, J MEM LANG, V68, P315, DOI 10.1016/j.jml.2012.12.003; Pellegrino F, 2011, LANGUAGE, V87, P539; Perfetti C.A, 1985, READING ABILITY; Perfetti CA, 2005, J EXP PSYCHOL LEARN, V31, P1281, DOI 10.1037/0278-7393.31.6.1281; Pivneva I, 2014, J EXP PSYCHOL LEARN, V40, P787, DOI 10.1037/a0035583; Pollatsek A, 2006, COGNITIVE PSYCHOL, V52, P1, DOI 10.1016/j.cogpsych.2005.06.001; POULISSE N, 1994, APPL LINGUIST, V15, P36, DOI 10.1093/applin/15.1.36; Radach R, 2008, PSYCHOL RES-PSYCH FO, V72, P675, DOI 10.1007/s00426-008-0173-3; RANSDELL SE, 1987, J MEM LANG, V26, P392, DOI 10.1016/0749-596X(87)90098-2; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; Rayner K, 2004, J EXP PSYCHOL HUMAN, V30, P720, DOI 10.1037/0096-1523.30.4.720; Rayner K, 2007, COGNITIVE SCI, V31, P1021, DOI 10.1080/03640210701703824; Rayner K, 2006, PSYCHOL AGING, V21, P448, DOI 10.1037/0882-7974.21.3.448; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reichle E. D., 2011, OXFORD HDB EYE MOVEM, P767, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0042; Reichle ED, 1999, VISION RES, V39, P4403, DOI 10.1016/S0042-6989(99)00152-2; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Reichle ED, 2013, DEV REV, V33, P110, DOI 10.1016/j.dr.2013.03.001; Reichle ED, 2011, PSYCHOPHYSIOLOGY, V48, P993, DOI 10.1111/j.1469-8986.2011.01169.x; Reichle ED, 2009, PSYCHON B REV, V16, P1, DOI 10.3758/PBR.16.1.1; Robertson G, 2006, WIDE RANGE ACHIEVEME; Roelofs A., 2003, PHONETICS PHONOLOGY, P115, DOI [10.1515/9783110895094.115, DOI 10.1515/9783110895094.115]; SANCHEZCASAS RM, 1992, EUR J COGN PSYCHOL, V4, P293; Schwartz AI, 2006, J MEM LANG, V55, P197, DOI 10.1016/j.jml.2006.03.004; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; SIEGEL LS, 1994, INT J BEHAV DEV, P109; TAYLOR SE, 1965, AM EDUC RES J, V2, P187, DOI 10.2307/1161646; Titone D, 2011, J EXP PSYCHOL LEARN, V37, P1412, DOI 10.1037/a0024492; Van Assche E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00174; Van Assche E, 2011, J MEM LANG, V64, P88, DOI 10.1016/j.jml.2010.08.006; Van Assche E, 2009, PSYCHOL SCI, V20, P923, DOI 10.1111/j.1467-9280.2009.02389.x; van Hell JG, 2008, ACTA PSYCHOL, V128, P431, DOI 10.1016/j.actpsy.2008.03.010; van Hell JG, 2012, LANG LEARN, V62, P148, DOI 10.1111/j.1467-9922.2012.00710.x; van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335; Whitford V, 2012, PSYCHON B REV, V19, P73, DOI 10.3758/s13423-011-0179-5; Winskel H, 2009, J MEM LANG, V61, P339, DOI 10.1016/j.jml.2009.07.002; Zwitserlood P., 2003, PHONETICS PHONOLOGY, P79, DOI DOI 10.1515/9783110895094.79	103	46	47	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134008	10.1371/journal.pone.0134008	http://dx.doi.org/10.1371/journal.pone.0134008			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287379	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000360018600015
J	De Blasio, MJ; Boije, M; Vaughan, OR; Bernstein, BS; Davies, KL; Plein, A; Kempster, SL; Smith, GCS; Charnock-Jones, DS; Blache, D; Wooding, FBP; Giussani, DA; Fowden, AL; Forhead, AJ				De Blasio, Miles J.; Boije, Maria; Vaughan, Owen R.; Bernstein, Brett S.; Davies, Katie L.; Plein, Alice; Kempster, Sarah L.; Smith, Gordon C. S.; Charnock-Jones, D. Stephen; Blache, Dominique; Wooding, F. B. Peter; Giussani, Dino A.; Fowden, Abigail L.; Forhead, Alison J.			Developmental Expression and Glucocorticoid Control of the Leptin Receptor in Fetal Ovine Lung	PLOS ONE			English	Article							LATE-GESTATION; PROTEIN EXPRESSION; PLASMA LEPTIN; FETUS; DEXAMETHASONE; SHEEP; LONG; GENE; IDENTIFICATION; METABOLISM	The effects of endogenous and synthetic glucocorticoids on fetal lung maturation are well-established, although the role of leptin in lung development before birth is unclear. This study examined mRNA and protein levels of the signalling long-form leptin receptor (Ob-Rb) in fetal ovine lungs towards term, and after experimental manipulation of glucocorticoid levels in utero by fetal cortisol infusion or maternal dexamethasone treatment. In fetal ovine lungs, Ob-Rb protein was localised to bronchiolar epithelium, bronchial cartilage, vascular endothelium, alveolar macrophages and type II pneumocytes. Pulmonary Ob-Rb mRNA abundance increased between 100 (0.69 fractional gestational age) and 144 days (0.99) of gestation, and by 2-4-fold in response to fetal cortisol infusion and maternal dexamethasone treatment. In contrast, pulmonary Ob-Rb protein levels decreased near term and were halved by glucocorticoid treatment, without any significant change in phosphorylated signal transducer and activator of transcription-3 (pSTAT3) at Ser727, total STAT3 or the pulmonary pSTAT3: STAT3 ratio. Leptin mRNA was undetectable in fetal ovine lungs at the gestational ages studied. These findings demonstrate differential control of pulmonary Ob-Rb transcript abundance and protein translation, and/or post-translational processing, by glucocorticoids in utero. Localisation of Ob-Rb in the fetal ovine lungs, including alveolar type II pneumocytes, suggests a role for leptin signalling in the control of lung growth and maturation before birth.	[De Blasio, Miles J.; Boije, Maria; Vaughan, Owen R.; Bernstein, Brett S.; Davies, Katie L.; Plein, Alice; Wooding, F. B. Peter; Giussani, Dino A.; Fowden, Abigail L.; Forhead, Alison J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England; [Kempster, Sarah L.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Kempster, Sarah L.; Smith, Gordon C. S.; Charnock-Jones, D. Stephen] Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge, England; [Blache, Dominique] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Forhead, Alison J.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Western Australia; Oxford Brookes University	Forhead, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England.	ajf1005@cam.ac.uk	Bernstein, Brett Sydney/AAW-5807-2020; Blache, Dominique/H-4991-2014; De Blasio, Miles/AAB-7234-2019; Charnock-Jones, D. Stephen/B-3743-2009; Charnock-Jones, D. Stephen/AAE-3391-2020; Smith, Gordon/A-8070-2008; De Blasio, Miles J/GQB-1536-2022	Bernstein, Brett Sydney/0000-0001-7225-3793; Blache, Dominique/0000-0003-3476-3068; De Blasio, Miles/0000-0002-4797-5193; Charnock-Jones, D. Stephen/0000-0002-2936-4890; Charnock-Jones, D. Stephen/0000-0002-2936-4890; Smith, Gordon/0000-0003-2124-0997; De Blasio, Miles J/0000-0002-4797-5193; kempster, sarah/0000-0002-4309-1489; Giussani, Dino/0000-0002-1308-1204; Forhead, Alison/0000-0003-2125-4811	Biotechnology and Biological Sciences Research Council [S18103, BB/H01697X/1]; BBSRC [BB/H01697X/1, BB/E002668/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002668/1] Funding Source: researchfish; British Heart Foundation [RG/06/006/22028, RG/11/16/29260] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by the Biotechnology and Biological Sciences Research Council (grant numbers S18103 and BB/H01697X/1).	Bergen HT, 2002, AM J RESP CELL MOL, V27, P71, DOI 10.1165/ajrcmb.27.1.4540; Blache D, 2000, J ENDOCRINOL, V165, P625, DOI 10.1677/joe.0.1650625; Bolt RJ, 2001, PEDIATR PULM, V32, P76, DOI 10.1002/ppul.1092; Byerly MS, 2009, AM J PHYSIOL-REG I, V296, pR1180, DOI 10.1152/ajpregu.90813.2008; Caperna TJ, 2005, DOMEST ANIM ENDOCRIN, V29, P582, DOI 10.1016/j.domaniend.2005.03.005; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069297; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; De Blasio MJ, 2013, J DEV ORIG HLTH DIS, V4, pS51; Figenschau Y, 2001, BIOCHEM BIOPH RES CO, V287, P190, DOI 10.1006/bbrc.2001.5543; Forhead AJ, 2002, ENDOCRINOLOGY, V143, P1166, DOI 10.1210/en.143.4.1166; Forhead AJ, 2007, ENDOCRINOLOGY, V148, P800, DOI 10.1210/en.2006-1194; Forhead AJ, 2006, ENDOCRINOLOGY, V147, P5988, DOI 10.1210/en.2006-0712; Forhead AJ, 2009, J PHYSIOL-LONDON, V587, P1145, DOI 10.1113/jphysiol.2008.167072; FOWDEN AL, 1995, J PHYSIOL-LONDON, V482, P203, DOI 10.1113/jphysiol.1995.sp020510; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Franko KL, 2007, J ENDOCRINOL, V192, P67, DOI 10.1677/joe.1.07063; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garcia-Crespo David, 2005, BMC Vet Res, V1, P3, DOI 10.1186/1746-6148-1-3; Henson MC, 2004, REPRODUCTION, V127, P87, DOI 10.1530/rep.1.00037; Hikita M, 2000, BIOCHEM BIOPH RES CO, V271, P703, DOI 10.1006/bbrc.2000.2692; Hoggard N, 1997, P NATL ACAD SCI USA, V94, P11073, DOI 10.1073/pnas.94.20.11073; Hooper SB, 2001, FETAL GROWTH AND DEVELOPMENT, P114; Huang K, 2008, J APPL PHYSIOL, V105, P249, DOI 10.1152/japplphysiol.00052.2007; Kirwin SM, 2006, PEDIATR RES, V60, P200, DOI 10.1203/01.pdr.0000227478.29271.52; Ladenburger A, 2010, AM J PHYSIOL-LUNG C, V299, pL578, DOI 10.1152/ajplung.00055.2010; Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002; Liu ZJ, 2004, PEDIATR INT, V46, P561, DOI 10.1111/j.1442-200x.2004.01945.x; Lollmann B, 1997, BIOCHEM BIOPH RES CO, V238, P648, DOI 10.1006/bbrc.1997.7205; Mancuso P, 2004, AM J PHYSIOL-LUNG C, V287, pL497, DOI 10.1152/ajplung.00010.2004; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; O'Connor DM, 2007, ENDOCRINOLOGY, V148, P3750, DOI 10.1210/en.2007-0310; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; ROBINSON PM, 1983, Q J EXP PHYSIOL CMS, V68, P15, DOI 10.1113/expphysiol.1983.sp002697; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Royal College of Obstetricians and Gynaecologists, 2010, GREEN TOP GUIDELINE; Sato A, 2011, AM J PHYSIOL-LUNG C, V300, pL498, DOI 10.1152/ajplung.00418.2010; Shekhawat PS, 1998, PEDIATR RES, V43, P338, DOI 10.1203/00006450-199803000-00005; Smolinska N, 2009, ANIM REPROD SCI, V113, P125, DOI 10.1016/j.anireprosci.2008.06.001; Su YX, 2013, AM J PHYSIOL-ENDOC M, V304, pE1404, DOI 10.1152/ajpendo.00013.2013; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wyrwoll CS, 2005, MOL CELL ENDOCRINOL, V241, P73, DOI 10.1016/j.mce.2005.05.003; Xu D, 2012, TOXICOL LETT, V209, P282, DOI 10.1016/j.toxlet.2012.01.006; Yuen BSJ, 1999, J ENDOCRINOL, V163, pR11, DOI 10.1677/joe.0.163R011; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136115	10.1371/journal.pone.0136115	http://dx.doi.org/10.1371/journal.pone.0136115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287800	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600111
J	Gomez, DL; O'Driscoll, M; Sheets, TP; Hruban, RH; Oberholzer, J; McGarrigle, JJ; Shamblott, MJ				Gomez, Danielle L.; O'Driscoll, Marci; Sheets, Timothy P.; Hruban, Ralph H.; Oberholzer, Jose; McGarrigle, James J.; Shamblott, Michael J.			Neurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate	PLOS ONE			English	Article							ADULT-MOUSE PANCREAS; BETA-CELLS; IN-VITRO; PROGENITOR CELLS; ACINAR-CELL; DUCTAL CELLS; TRANSCRIPTION FACTOR; HEMATOPOIETIC STEM; EPITHELIAL-CELLS; DIFFERENTIATION	Neurogenin 3 (NGN3) is necessary and sufficient for endocrine differentiation during pancreatic development and is expressed by a population of progenitor cells that give rise exclusively to hormone-secreting cells within islets. NGN3 protein can be detected in the adult rodent pancreas only following certain types of injury, when it is transiently expressed by exocrine cells undergoing reprogramming to an endocrine cell fate. Here, NGN3 protein can be detected in 2% of acinar and duct cells in living biopsies of histologically normal adult human pancreata and 10% in cadaveric biopsies of organ donor pancreata. The percentage and total number of NGN3+ cells increase during culture without evidence of proliferation or selective cell death. Isolation of highly purified and viable NGN3+ cell populations can be achieved based on coexpression of the cell surface glycoprotein CD133. Transcriptome and targeted expression analyses of isolated CD133+/NGN3+ cells indicate that they are distinct from surrounding exocrine tissue with respect to expression phenotype and Notch signaling activity, but retain high level mRNA expression of genes indicative of acinar and duct cell function. NGN3+ cells have an mRNA expression profile that resembles that of mouse early endocrine progenitor cells. During in vitro differentiation, NGN3+ cells express genes in a pattern characteristic of endocrine development and result in cells that resemble beta cells on the basis of coexpression of insulin C-peptide, chromogranin A and pancreatic and duodenal homeobox 1. NGN3 expression in the adult human exocrine pancreas marks a dedifferentiating cell population with the capacity to take on an endocrine cell fate. These cells represent a potential source for the treatment of diabetes either through ex vivo manipulation, or in vivo by targeting mechanisms controlling their population size and endocrine cell fate commitment.	[Gomez, Danielle L.; O'Driscoll, Marci; Shamblott, Michael J.] Univ S Florida, Dept Pediat, Childrens Res Inst, Morsani Coll Med, St Petersburg, FL 33701 USA; [Sheets, Timothy P.; Shamblott, Michael J.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA; [Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Dept Pathol & Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Oberholzer, Jose; McGarrigle, James J.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Oberholzer, Jose] Univ Illinois, Dept Bioengn, Chicago, IL USA	State University System of Florida; University of South Florida; Johns Hopkins University; Johns Hopkins University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shamblott, MJ (corresponding author), Univ S Florida, Dept Pediat, Childrens Res Inst, Morsani Coll Med, St Petersburg, FL 33701 USA.	mshamblo@health.usf.edu			University of South Florida/All Children's Foundation Sam's Club/Walmart Chair of Pediatrics; Juvenile Diabetes Research Foundation [2-2008-65]	University of South Florida/All Children's Foundation Sam's Club/Walmart Chair of Pediatrics; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The main source of funding for this work came from The University of South Florida/All Children's Foundation Sam's Club/Walmart Chair of Pediatrics (MJS). These funds were given as a gift by associate and customers of Sam's Club and Walmart. It did not involve any additional employment, consultancy, intellectual property licensing, product development or marketing. Additional funding was from the Juvenile Diabetes Research Foundation www.jdrf.org grant number 2-2008-65 (M.J.S.) and gifts from the Mayhew Family (M.J.S), Chicago Diabetes Project (M.J.S) and John Horst (M.J.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afelik S, 2012, DEVELOPMENT, V139, P1744, DOI 10.1242/dev.075804; Anderson KR, 2009, J BIOL CHEM, V284, P31236, DOI 10.1074/jbc.M109.048694; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Bauman M, 2008, HUMAN EMBRYONI UNPUB; Bhanot UK, 2009, LAB INVEST, V89, P489, DOI 10.1038/labinvest.2009.19; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Clark GO, 2007, BIOCHEM BIOPH RES CO, V356, P587, DOI 10.1016/j.bbrc.2007.03.017; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Corbeil D, 2014, P NATL ACAD SCI USA, V111, pE1451, DOI 10.1073/pnas.1400195111; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280; Figeac F, 2012, MOL THER, V20, P1944, DOI 10.1038/mt.2012.112; Fukuda A, 2006, J CLIN INVEST, V116, P1484, DOI 10.1172/JCI27704; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hald J, 2003, DEV BIOL, V260, P426, DOI 10.1016/S0012-1606(03)00326-9; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; KerrConte J, 1996, DIABETES, V45, P1108, DOI 10.2337/diabetes.45.8.1108; Kim HS, 2013, J ENDOCRINOL, V217, P241, DOI 10.1530/JOE-12-0474; Koblas T, 2008, TRANSPL P, V40, P415, DOI 10.1016/j.transproceed.2008.02.017; Landsman L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001143; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Lemper M, 2015, CELL DEATH DIFFER, V22, P1117, DOI 10.1038/cdd.2014.193; Li WC, J CELL SCI 16, V123, P2792; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Mak AB, 2011, J BIOL CHEM, V286, P41046, DOI 10.1074/jbc.M111.261545; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; PARSA I, 1985, CANCER RES, V45, P1285; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Qu XL, 2013, DEV BIOL, V376, P1, DOI 10.1016/j.ydbio.2013.01.021; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Rovira M, 2011, P NATL ACAD SCI USA, V108, P19264, DOI 10.1073/pnas.1113081108; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sancho R, 2014, CELL STEM CELL, V15, P139, DOI 10.1016/j.stem.2014.06.019; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Xiao XW, 2013, J BIOL CHEM, V288, P25297, DOI 10.1074/jbc.M113.484022; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	94	36	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133862	10.1371/journal.pone.0133862	http://dx.doi.org/10.1371/journal.pone.0133862			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288179	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600011
J	Kaneko, F; Blanchard, C; Lebar, N; Nazarian, B; Kavounoudias, A; Romaiguere, P				Kaneko, Fuminari; Blanchard, Caroline; Lebar, Nicolas; Nazarian, Bruno; Kavounoudias, Anne; Romaiguere, Patricia			Brain Regions Associated to a Kinesthetic Illusion Evoked by Watching a Video of One's Own Moving Hand	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; RUBBER HAND; SELF-MOTION; TENDON VIBRATION; MUSCLE VIBRATION; BODY OWNERSHIP; VISUAL-MOTION; AREAS; PERCEPTION; MOVEMENT	It is well known that kinesthetic illusions can be induced by stimulation of several sensory systems (proprioception, touch, vision...). In this study we investigated the cerebral network underlying a kinesthetic illusion induced by visual stimulation by using functionalmagnetic resonance imaging (fMRI) in humans. Participants were instructed to keep their hand still while watching the video of their own moving hand (Self Hand) or that of someone else's moving hand (Other Hand). In the Self Hand condition they experienced an illusory sensation that their hand was moving whereas the Other Hand condition did not induce any kinesthetic illusion. The contrast between the Self Hand and Other Hand conditions showed significant activation in the left dorsal and ventral premotor cortices, in the left Superior and Inferior Parietal lobules, at the right Occipito-Temporal junction as well as in bilateral Insula and Putamen. Most strikingly, there was no activation in the primary motor and somatosensory cortices, whilst previous studies have reported significant activation in these regions for vibrationinduced kinesthetic illusions. To our knowledge, this is the first study that indicates that humans can experience kinesthetic perception without activation in the primarymotor and somatosensory areas. We conclude that under some conditions watching a video of one's ownmoving hand could lead to activation of a network that is usually involved in processing copies of efference, thus leading to the illusory perception that the real hand is indeed moving.	[Kaneko, Fuminari; Blanchard, Caroline; Lebar, Nicolas; Kavounoudias, Anne; Romaiguere, Patricia] Aix Marseille Univ, CNRS, Lab Neurosci Integrat & Adaptat, NIA UMR 7260,FR3C FR3512, Marseille, France; [Nazarian, Bruno] Aix Marseille Univ, CNRS, Inst Neurosci Timone, INT UMR 7289,IRMf Ctr, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Romaiguere, P (corresponding author), Aix Marseille Univ, CNRS, Lab Neurosci Integrat & Adaptat, NIA UMR 7260,FR3C FR3512, Marseille, France.	Patricia.Romaiguere@univ-amu.fr	BLANCHARD, Caroline/N-6392-2014	BLANCHARD, Caroline/0000-0002-3055-1511; Kaneko, Fuminari/0000-0001-7125-0689	Japan Society for the Promotion of Science (JSPS Excellent Young Researcher Overseas Visit Program); JSPS KAKENHI [23300202]	Japan Society for the Promotion of Science (JSPS Excellent Young Researcher Overseas Visit Program); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	FK was supported by the Japan Society for the Promotion of Science (JSPS Excellent Young Researcher Overseas Visit Program) and JSPS KAKENHI (Grant-in-Aid for Scientific Research (B) 23300202).	Aoyama T, 2012, NEUROSCI LETT, V514, P106, DOI 10.1016/j.neulet.2012.02.069; Beer J, 2002, EXP BRAIN RES, V143, P78, DOI 10.1007/s00221-001-0947-y; Blanchard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062475; BONNET M, 1973, ELECTROEN CLIN NEURO, V34, P810; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BRANDT T, 1972, PFLUG ARCH EUR J PHY, pR98; Brett M., 2002, 8 INT C FUNCT MAPP H; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Caetano G, 2007, P NATL ACAD SCI USA, V104, P9058, DOI 10.1073/pnas.0702453104; Casini L, 2006, BRAIN RES, V1121, P200, DOI 10.1016/j.brainres.2006.08.124; Christensen MS, 2007, NAT NEUROSCI, V10, P417, DOI 10.1038/nn1873; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; Confalonieri L., 2012, ISRN NEUROL, V2012, DOI DOI 10.5402/2012/613595; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Deutschlander A, 2004, HUM BRAIN MAPP, V21, P143, DOI 10.1002/hbm.10155; Dohle C, 2009, NEUROREHAB NEURAL RE, V23, P209, DOI 10.1177/1545968308324786; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duclos C, 2007, NEUROIMAGE, V34, P774, DOI 10.1016/j.neuroimage.2006.06.050; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; EKLUND G, 1972, J NEUROL NEUROSUR PS, V35, P606, DOI 10.1136/jnnp.35.5.606; Ferri S, 2013, NEUROIMAGE, V66, P412, DOI 10.1016/j.neuroimage.2012.10.060; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; GILHODES JC, 1986, EXP BRAIN RES, V61, P395; Goble DJ, 2011, J NEUROSCI, V31, P16344, DOI 10.1523/JNEUROSCI.4159-11.2011; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Indovina I, 2013, NEUROIMAGE, V71, P114, DOI 10.1016/j.neuroimage.2013.01.005; Kalckert A, 2014, CONSCIOUS COGN, V30, P118, DOI 10.1016/j.concog.2014.08.022; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kaneko F, 2007, NEUROSCIENCE, V149, P976, DOI 10.1016/j.neuroscience.2007.07.028; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Kavounoudias A, 2008, NEUROPSYCHOLOGIA, V46, P567, DOI 10.1016/j.neuropsychologia.2007.10.002; Kleinschmidt A, 2002, NEUROIMAGE, V16, P873, DOI 10.1006/nimg.2002.1181; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Longo MR, 2009, PERCEPTION, V38, P69, DOI 10.1068/p6045; Metral M, 2014, NEUROPSYCHOLOGIA, V52, P11, DOI 10.1016/j.neuropsychologia.2013.10.027; Moseley GL, 2011, CURR BIOL, V21, pR583, DOI 10.1016/j.cub.2011.06.031; Myers A, 2008, NEUROIMAGE, V42, P1669, DOI 10.1016/j.neuroimage.2008.05.045; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Naito E, 2005, J NEUROPHYSIOL, V93, P1020, DOI 10.1152/jn.00637.2004; Naito E, 2007, EUR J NEUROSCI, V25, P3476, DOI 10.1111/j.1460-9568.2007.05587.x; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmisano S, 1998, PERCEPTION, V27, P1067, DOI 10.1068/p271067; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Radovanovic S, 2002, EXP BRAIN RES, V143, P276, DOI 10.1007/s00221-001-0994-4; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Raos V, 2004, NEUROIMAGE, V23, P193, DOI 10.1016/j.neuroimage.2004.04.024; Raos V, 2007, J NEUROSCI, V27, P12675, DOI 10.1523/JNEUROSCI.2988-07.2007; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Romaiguere P, 2005, NEUROREPORT, V16, P693, DOI 10.1097/00001756-200505120-00008; Romaiguere P, 2003, COGNITIVE BRAIN RES, V16, P74, DOI 10.1016/S0926-6410(02)00221-5; Rothgangel AS, 2011, INT J REHABIL RES, V34, P1, DOI 10.1097/MRR.0b013e3283441e98; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vocks S, 2010, COGN AFFECT BEHAV NE, V10, P422, DOI 10.3758/CABN.10.3.422	83	39	39	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0131970	10.1371/journal.pone.0131970	http://dx.doi.org/10.1371/journal.pone.0131970			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287488	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600002
J	Katsumi, H; Sano, J; Nishikawa, M; Hanzawa, K; Sakane, T; Yamamoto, A				Katsumi, Hidemasa; Sano, Jun-ichi; Nishikawa, Makiya; Hanzawa, Keiko; Sakane, Toshiyasu; Yamamoto, Akira			Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo	PLOS ONE			English	Article							NITROSATED SERUM-ALBUMIN; POLYETHYLENE-GLYCOL; DISPOSITION CHARACTERISTICS; PHARMACOKINETIC ANALYSIS; CHEMICAL-MODIFICATION; CHARGE-DENSITY; NITRIC-OXIDE; DELIVERY; METASTASIS; DRUG	To establish a rational molecular design for bisphosphonate (BP)-modified proteins for efficient bone targeting, a pharmacokinetic study was performed using a series of alendronate (ALN), a nitrogen-containing BP, modified proteins with various molecular weights and varying degrees of modification. Four proteins with different molecular weight-yeast glutathione reductase (GR; MW: 112,000 Da), bovine serum albumin (BSA; MW: 67,000 Da), recombinant human superoxide dismutase (SOD; MW: 32,000 Da), and chicken egg white lysozyme (LZM; MW: 14,000 Da)-were modified with ALN to obtain ALN-modified proteins. Pharmacokinetic analysis of the tissue distribution of the ALN-modified and unmodified proteins was performed after radiolabeling them with indium-111 (In-111) by using a bifunctional chelating agent. Calculation of tissue uptake clearances revealed that the bone uptake clearances of In-111-ALN-modified proteins were proportional to the degree of ALN modification. In-111-GR-ALN and BSA-ALN, the two high-molecular-weight proteins, efficiently accumulated in bones, regardless of the degree of ALN modification. Approximately 36 and 34% of the dose, respectively, was calculated to be delivered to the bones. In contrast, the maximum amounts taken up by bone were 18 and 13% of the dose for In-111-SOD-ALN(32) and LZM-ALN(9), respectively, because of their high renal clearance. In-111-SOD modified with both polyethylene glycol (PEG) and ALN (In-111-PEG-SOD-ALN) was efficiently delivered to the bone. Approximately 36% of the dose was estimated to be delivered to the bones. In an experimental bone metastasis mouse model, treatment with PEG-SOD-ALN significantly reduced the number of tumor cells in the bone of the mice. These results indicate that the combination of PEG and ALN modification is a promising approach for efficient bone targeting of proteins with a high total-body clearance.	[Katsumi, Hidemasa; Sano, Jun-ichi; Hanzawa, Keiko; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Kyoto 607, Japan; [Nishikawa, Makiya] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut & Drug Metab, Kyoto, Japan	Kyoto Pharmaceutical University; Kyoto University	Katsumi, H (corresponding author), Kyoto Pharmaceut Univ, Dept Biopharmaceut, Kyoto 607, Japan.	hkatsumi@mb.kyoto-phu.ac.jp			Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Kyoto Pharmaceutical University	Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Kyoto Pharmaceutical University	This work was supported by the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research. HK recieved the funding from Kyoto Pharmaceutical University (internal to our organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Azim H, 2013, EXPERT REV ANTICANC, V13, P195, DOI [10.1586/era.12.177, 10.1586/ERA.12.177]; Doschak MR, 2009, MOL PHARMACEUT, V6, P634, DOI 10.1021/mp8002368; El-Mabhouh A, 2004, CANCER BIOTHER RADIO, V19, P627, DOI 10.1089/cbr.2004.19.627; FLEISCH H, 1987, CLIN ORTHOP RELAT R, P72; Futami J, 2001, BIOCHEMISTRY-US, V40, P7518, DOI 10.1021/bi010248g; GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003; Gittens SA, 2005, ADV DRUG DELIVER REV, V57, P1011, DOI 10.1016/j.addr.2004.12.015; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Hirabayashi H, 2003, CLIN PHARMACOKINET, V42, P1319, DOI 10.2165/00003088-200342150-00002; HNATOWICH DJ, 1982, INT J APPL RADIAT IS, V33, P327, DOI 10.1016/0020-708X(82)90144-2; Hyoudou K, 2004, CLIN CANCER RES, V10, P7685, DOI 10.1158/1078-0432.CCR-04-1020; Katsumi H, 2005, J PHARMACOL EXP THER, V314, P1117, DOI 10.1124/jpet.105.087429; Katsumi H, 2004, J PHARM SCI-US, V93, P2343, DOI 10.1002/jps.20147; Katsumi H, 2014, FREE RADICAL BIO MED, V69, P318, DOI 10.1016/j.freeradbiomed.2014.01.036; Lambrinoudaki I, 2006, ANN NY ACAD SCI, V1092, P397, DOI 10.1196/annals.1365.036; Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9; Low SA, 2012, ADV DRUG DELIVER REV, V64, P1189, DOI 10.1016/j.addr.2012.01.012; Ma SF, 2005, J CONTROL RELEASE, V102, P583, DOI 10.1016/j.jconrel.2004.11.006; Mihara K, 1993, PHARM RES, V10, P23; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; NISHIDA K, 1991, PHARMACEUT RES, V8, P437, DOI 10.1023/A:1015886708598; NISHIKAWA M, 1995, PHARMACEUT RES, V12, P209, DOI 10.1023/A:1016222808484; Nishikawa M, 2006, EXPERT OPIN DRUG DEL, V3, P355, DOI 10.1517/17425247.3.3.355; Porras AG, 1999, CLIN PHARMACOKINET, V36, P315, DOI 10.2165/00003088-199936050-00002; Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14; TAKAKURA Y, 1990, PHARMACEUT RES, V7, P339, DOI 10.1023/A:1015807119753; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; TAKAKURA Y, 1987, PHARMACEUT RES, V4, P293, DOI 10.1023/A:1016489002393; TALMAGE RV, 1970, AM J ANAT, V129, P467, DOI 10.1002/aja.1001290408; Tu SM, 2008, CANCER J, V14, P35, DOI 10.1097/PPO.0b013e318161d32d; Uludag H, 2002, BIOTECHNOL PROGR, V18, P604, DOI 10.1021/bp0200447; Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Yamasaki Y, 2002, J PHARMACOL EXP THER, V301, P467, DOI 10.1124/jpet.301.2.467; Yamasaki Y, 2003, EUR J PHARM SCI, V18, P305, DOI 10.1016/S0928-0987(03)00021-6; Zheng YL, 2012, J PHARM SCI-US, V101, P552, DOI 10.1002/jps.22773; Zojer N, 1999, DRUG SAFETY, V21, P389, DOI 10.2165/00002018-199921050-00004	39	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135966	10.1371/journal.pone.0135966	http://dx.doi.org/10.1371/journal.pone.0135966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287482	gold, Green Submitted, Green Published			2022-12-27	WOS:000360018600091
J	Gagnaire, V; Jardin, J; Rabah, H; Briard-Bion, V; Jan, G				Gagnaire, Valerie; Jardin, Julien; Rabah, Houem; Briard-Bion, Valerie; Jan, Gwenael			Emmental Cheese Environment Enhances Propionibacterium freudenreichii Stress Tolerance	PLOS ONE			English	Article							IN-VITRO; PROTEOMIC ANALYSIS; PROTEIN-SYNTHESIS; ACID ADAPTATION; INDUCED COLITIS; BILE-SALTS; METABOLISM; APOPTOSIS; SUSCEPTIBILITY; IDENTIFICATION	Dairy propionibacteria are actinomycetales found in various fermented food products. The main species, Propionibacterium freudenreichii, is generally recognized as safe and used both as probiotic and as cheese starter. Its probiotic efficacy tightly depends on its tolerance towards digestive stresses, which can be largely modulated by the ingested delivery vehicle. Indeed, tolerance of this bacterium is enhanced when it is consumed within a fermented dairy product, compared to a dried probiotic preparation. We investigated both stress tolerance and protein neosynthesis upon growth in i) chemically defined or ii) aqueous phase of Emmental cheeses. Although the same final population level was reached in both media, a slower growth and an enhanced survival of CIRM BIA 1 strain of P. freudenreichii subsp. shermanii was observed in Emmental juice, compared to chemically defined medium. This was accompanied by differences in substrates used and products released as well as overexpression of various early stress adaptation proteins in Emmental juice, compared to chemically defined medium, implied in protein folding, in aspartate catabolism, in biosynthesis of valine, leucine and isoleucine, in pyruvate metabolism in citrate cycle, in the propionate metabolism, as well as in oxidoreductases. All these changes led to a higher digestive stress tolerance after growth in Emmental juice. Mechanisms of stress adaptation were induced in this environment, in accordance with enhanced survival. This opens perspectives for the use of hard and semi-hard cheeses as delivery vehicle for probiotics with enhanced efficacy.	[Gagnaire, Valerie; Jardin, Julien; Rabah, Houem; Briard-Bion, Valerie; Jan, Gwenael] INRA, STLO UMR1253, Sci & Technol Lait & Oeuf, F-35042 Rennes, France; [Gagnaire, Valerie; Jardin, Julien; Rabah, Houem; Briard-Bion, Valerie; Jan, Gwenael] AGROCAMPUS OUEST, STLO UMR1253, Rennes, France	INRAE; Institut Agro; Agrocampus Ouest	Gagnaire, V (corresponding author), INRA, STLO UMR1253, Sci & Technol Lait & Oeuf, F-35042 Rennes, France.	valerie.gagnaire@rennes.inra.fr	JARDIN, Julien/A-3241-2012; Gagnaire, Valérie/V-1338-2017	JARDIN, Julien/0000-0003-0520-9391; Gagnaire, Valérie/0000-0003-3186-0620	French National Agency for Research [ANR-2010-ALIA-016]	French National Agency for Research(French National Research Agency (ANR))	GJ received funding from the French National Agency for Research (http://www.anr-surfing.eu): ANR-2010-ALIA-016 project, called Starter SURFace against INflammation of the Gut (SURFING). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou R, 2006, INT J FOOD MICROBIOL, V108, P301, DOI 10.1016/j.ijfoodmicro.2005.11.015; Begley M, 2002, APPL ENVIRON MICROB, V68, P6005, DOI 10.1128/AEM.68.12.6005-6012.2002; Bougle D, 1999, SCAND J GASTROENTERO, V34, P144, DOI 10.1080/00365529950172998; Boyaval P, 1999, LAIT, V79, P59, DOI 10.1051/lait:199914; Castro JM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/723056; Cousin FJ, 2012, FOOD MICROBIOL, V32, P135, DOI 10.1016/j.fm.2012.05.003; Cousin FJ, 2011, DAIRY SCI TECHNOL, V91, P1, DOI 10.1051/dst/2010032; CROW VL, 1986, APPL ENVIRON MICROB, V52, P359, DOI 10.1128/AEM.52.2.359-365.1986; Dalmasso M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029083; Falentin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011748; Fitz A., 1878, BER DTSCH CHEM GES, V11, P1890, DOI [10.1002/cber.187801102180, DOI 10.1002/CBER.187801102180]; Flahaut S, 1996, FEMS MICROBIOL LETT, V138, P49, DOI 10.1016/0378-1097(96)00080-8; Foligne B, 2013, GUT, V62, P1227, DOI 10.1136/gutjnl-2012-304393; Foligne B, 2010, APPL ENVIRON MICROB, V76, P8259, DOI 10.1128/AEM.01976-10; FROHLICHWYDER MT, 2004, CHEESE CHEM PHYS MIC, V2, P141, DOI DOI 10.1016/S1874-558X(04)80042-3; Gagnaire V, 1998, J DAIRY RES, V65, P119, DOI 10.1017/S0022029997002525; Gagnaire V, 2001, LAIT, V81, P339, DOI 10.1051/lait:2001136; Havenaar R, 2011, BENEF MICROBES, V2, P103, DOI 10.3920/BM2011.0003; Herve C, 2007, INT J FOOD MICROBIOL, V113, P303, DOI 10.1016/j.ijfoodmicro.2006.08.013; Hu YB, 2010, FEBS LETT, V584, P2311, DOI 10.1016/j.febslet.2010.03.045; Hugenholtz J, 2002, LAIT, V82, P103, DOI 10.1051/lait:2001009; Isawa K, 2002, BIOSCI BIOTECH BIOCH, V66, P679, DOI 10.1271/bbb.66.679; Jan G, 2007, WOODHEAD PUBL FOOD S, P165, DOI 10.1533/9781845693107.2.165; Jan G, 2002, LAIT, V82, P131, DOI 10.1051/lait:2001012; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Jan G, 2001, APPL ENVIRON MICROB, V67, P2029, DOI 10.1128/AEM.67.5.2029-2036.2001; Jan G, 2000, LAIT, V80, P325, DOI 10.1051/lait:2000128; Lan A, 2008, BRIT J NUTR, V100, P1251, DOI 10.1017/S0007114508978284; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Le Boucher C, 2013, FOOD CHEM, V141, P1032, DOI 10.1016/j.foodchem.2013.03.094; Le Marechal C, 2015, J PROTEOMICS, V113, P447, DOI 10.1016/j.jprot.2014.07.018; Lee S, 2014, J FOOD PROTECT, V77, P1794, DOI 10.4315/0362-028X.JFP-14-070; Leverrier P, 2005, FOOD MICROBIOL, V22, P11, DOI 10.1016/j.fm.2004.05.003; Leverrier P, 2004, ARCH MICROBIOL, V181, P215, DOI 10.1007/s00203-003-0646-0; Leverrier P, 2003, APPL ENVIRON MICROB, V69, P3809, DOI 10.1128/AEM.69.7.3809-3818.2003; Morris JS, 2010, J PROTEOME RES, V9, P595, DOI 10.1021/pr9005603; Okada Y, 2006, GUT, V55, P681, DOI 10.1136/gut.2005.070490; Okada Y, 2006, GASTROENTEROLOGY, V130, pA313; R Core Team, 2014, LANG ENV STAT COMP; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; SALVATBRUNAUD D, 1995, LAIT, V75, P239, DOI 10.1051/lait:1995316; SalvatBrunaud D, 1997, J DAIRY RES, V64, P573, DOI 10.1017/S0022029997002410; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; Thierry A, 2002, LAIT, V82, P17, DOI 10.1051/lait:2001002; Thierry A., 2011, ENCY DAIRY SCI, P403; Thierry A, 2011, INT J FOOD MICROBIOL, V149, P19, DOI 10.1016/j.ijfoodmicro.2011.04.026; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wu RN, 2011, INT J FOOD MICROBIOL, V147, P181, DOI 10.1016/j.ijfoodmicro.2011.04.003	48	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135780	10.1371/journal.pone.0135780	http://dx.doi.org/10.1371/journal.pone.0135780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275229	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600110
J	Sorensen, BS; Busk, M; Overgaard, J; Horsman, MR; Alsner, J				Sorensen, Brita Singers; Busk, Morten; Overgaard, Jens; Horsman, Michael R.; Alsner, Jan			Simultaneous Hypoxia and Low Extracellular pH Suppress Overall Metabolic Rate and Protein Synthesis In Vitro	PLOS ONE			English	Article							GENE-EXPRESSION; AEROBIC GLYCOLYSIS; TUMOR HYPOXIA; BLOOD-FLOW; OXYGEN; CANCERS; MARKERS; CELLS; MICROENVIRONMENT; RELEVANCE	Background The tumor microenvironment is characterized by regions of hypoxia and acidosis which are linked to poor prognosis. This occurs due to an aberrant vasculature as well as high rates of glycolysis and lactate production in tumor cells even in the presence of oxygen (the Warburg effect), which weakens the spatial linkage between hypoxia and acidosis. Methods Five different human squamous cell carcinoma cell lines (SiHa, FaDuDD, UTSCC5, UTSCC14 and UTSCC15) were treated with hypoxia, acidosis (pH 6.3), or a combination, and gene expression analyzed using microarray. SiHa and FaDuDD were chosen for further characterization of cell energetics and protein synthesis. Total cellular ATP turnover and relative glycolytic dependency was determined by simultaneous measurements of oxygen consumption and lactate synthesis rates and total protein synthesis was determined by autoradiographic quantification of the incorporation of 35S-labelled methionine and cysteine into protein. Results Microarray analysis allowed differentiation between genes induced at low oxygen only at normal extracellular pH (pHe), genes induced at low oxygen at both normal and low pHe, and genes induced at low pHe independent of oxygen concentration. Several genes were found to be upregulated by acidosis independent of oxygenation. Acidosis resulted in a more wide-scale change in gene expression profiles than hypoxia including upregulation of genes involved in the translation process, for example Eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2), and Ribosomal protein L37 (RPL37). Acidosis suppressed overall ATP turnover and protein synthesis by 50%. Protein synthesis, but not total ATP production, was also suppressed under hypoxic conditions. A dramatic decrease in ATP turnover (SiHa) and protein synthesis (both cell lines) was observed when hypoxia and low pHe were combined. Conclusions We demonstrate here that the influence of hypoxia and acidosis causes different responses, both in gene expression and in de novo protein synthesis, depending on whether the two factors induced alone or overlapping, and as such it is important for in vivo studies to take this into account.	[Sorensen, Brita Singers; Busk, Morten; Overgaard, Jens; Horsman, Michael R.; Alsner, Jan] Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark	Aarhus University	Sorensen, BS (corresponding author), Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark.	bsin@oncology.au.dk		Horsman, Michael/0000-0003-1578-5691; Sorensen, Brita Singers/0000-0002-3955-4735; Alsner, Jan/0000-0002-5395-3193	Danish Cancer Society [R72-A4448-13-S2]; EC FP7 project METOXIA [222741]; CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology [R25-A2703]; Danish Council for Strategic Research [0603-00136B]; The Danish Cancer Society [R72-A4448] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); EC FP7 project METOXIA; CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); The Danish Cancer Society(Danish Cancer Society)	Financial support was received from the Danish Cancer Society (R72-A4448-13-S2), EC FP7 project METOXIA (project no. 222741), CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology (R25-A2703) and The Danish Council for Strategic Research (0603-00136B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett JA, 2000, YEAST, V16, P755, DOI 10.1002/1097-0061(20000615)16:8<755::AID-YEA587>3.0.CO;2-4; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Bumke MA, 2003, PROTEOMICS, V3, P675, DOI 10.1002/pmic.200300395; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Crean D, 2013, EXP CELL RES, V319, P3116, DOI 10.1016/j.yexcr.2013.07.017; Dregoesc D, 2009, DNA REPAIR, V8, P370, DOI 10.1016/j.dnarep.2008.11.016; Eicheler W, 2002, J HISTOCHEM CYTOCHEM, V50, P197, DOI 10.1177/002215540205000207; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Justus CR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00354; Kato Y, 2005, J BIOL CHEM, V280, P10938, DOI 10.1074/jbc.M411313200; Khacho M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4550; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Matsubara T, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00199; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Raghunand N, 2003, BRIT J RADIOL, V76, pS11, DOI 10.1259/bjr/12913493; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sorensen BS, 2007, RADIOTHER ONCOL, V83, P362, DOI 10.1016/j.radonc.2007.04.028; Sorensen BS, 2010, ACTA ONCOL, V49, P895, DOI 10.3109/02841861003614343; Sorensen BS, 2005, RADIOTHER ONCOL, V76, P187, DOI 10.1016/j.radonc.2005.06.037; Toustrup K, 2011, CANCER RES, V71, P5923, DOI 10.1158/0008-5472.CAN-11-1182; Vantelon N, 2007, EUR J NEUROSCI, V26, P689, DOI 10.1111/j.1460-9568.2007.05698.x; Vaupel P, 2000, INT J ONCOL, V17, P869; VAUPEL P, 1989, CANCER RES, V49, P6449; Weljie AM, 2011, INT J BIOCHEM CELL B, V43, P981, DOI 10.1016/j.biocel.2010.08.009; Wojtkowiak JW, 2012, CANCER RES, V72, P3938, DOI 10.1158/0008-5472.CAN-11-3881; Wouters BG, 2005, SEMIN CELL DEV BIOL	32	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134955	10.1371/journal.pone.0134955	http://dx.doi.org/10.1371/journal.pone.0134955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274822	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600046
J	Wang, HY; Yue, ZH; Wu, JL; Liu, T; Mo, Y; Jiang, XY; Sun, LZ				Wang, Haiyan; Yue, Zhihui; Wu, Jinlang; Liu, Ting; Mo, Ying; Jiang, Xiaoyun; Sun, Liangzhong			The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FILTRATION BARRIER; KIDNEY PODOCYTES; AUTOCRINE; PHOSPHORYLATION; OVEREXPRESSION; RECRUITMENT; ACTIVATION; RECEPTORS; INDUCTION	The pathogenesis of proteinuria in Alport syndrome (AS) remains unclear. Vascular endothelial growth factor A (VEGFA) is a key regulator of the glomerular filtration barrier (GFB). This study explored the expression of VEGFA in the glomeruli and its accumulation in the glomerular basement membrane (GBM) and their relationship with podocyte injury and proteinuria in Alport syndrome (AS). Clinical data and renal tissues of control patients (11 cases) and AS patients (25 cases) were included. AS patients were further divided into 2 groups according to the quantities of their urinary protein: mild to moderate proteinuria group (proteinuria <50 mg/kg/d, 15 cases) and heavy proteinuria group (proteinuria >= 50 mg/kg/d, 10 cases). The expression and distribution of VEGFA and VEGF receptor 2 (VEGFR2) in the GFB, the phosphorylation of VEGFR2 (p-VEGFR2) and nephrin (p-nephrin), and the expression of synaptopodin and nephrin in the glomeruli were detected by immune electron microscopy and/or immunofluorescence, and their relationships to proteinuria in AS patients were analyzed. The accumulation of VEGFA in the GBM was increased in AS patients. The expression of VEGFA and the levels of p-VEGFR2 and p-nephrin in glomeruli were increased and were positively correlated with the degree of proteinuria in AS patients. The expression of synaptopodin and nephrin were decreased and were negatively correlated with the degree of proteinuria in AS patients. The over expressed VEGFA in the glomeruli and its accumulation in the GBM may activate the VEGFA-VEGFR2 and nephrin signaling pathways and lead to podocyte injury and occurrence of proteinuria in AS.	[Wang, Haiyan; Yue, Zhihui; Liu, Ting; Mo, Ying; Jiang, Xiaoyun; Sun, Liangzhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat, Childrens Kidney Dis Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Haiyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jinlang] Sun Yat Sen Univ, Dept Electron Microscopy, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Sun, LZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat, Childrens Kidney Dis Ctr, Guangzhou 510275, Guangdong, Peoples R China.	sunlzh@mail.sysu.edu.cn	Sun, Liangzhong/GQH-9346-2022	Sun, Liangzhong/0000-0003-1962-8626	National Natural Science Foundation of China [81470913]; Guangdong Natural Science Foundation [S2012010009405, S2013010015536]; Guangdong Science and Technology Planning Project [2011B031800126, 2013B021800117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Science and Technology Planning Project	The study was supported by the National Natural Science Foundation of China (Grant No. 81470913), Guangdong Natural Science Foundation (Grant Nos. S2012010009405 and S2013010015536) and Guangdong Science and Technology Planning Project (Grant Nos. 2011B031800126 and 2013B021800117).	Bertuccio C, 2011, J BIOL CHEM, V286, P39933, DOI 10.1074/jbc.M111.241620; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Fan LY, 2002, NEPHRON, V90, P95, DOI 10.1159/000046320; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flinter F, 1997, J MED GENET, V34, P326, DOI 10.1136/jmg.34.4.326; Gagliardini E, 2010, J AM SOC NEPHROL, V21, P2081, DOI 10.1681/ASN.2010020199; Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; Guan N, 2010, ZHONGHUA SHEN ZANG B, V26, P748; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Heidet L, 2009, J AM SOC NEPHROL, V20, P1210, DOI 10.1681/ASN.2008090984; Hohenstein B, 2010, NEPHROL DIAL TRANSPL, V25, P3170, DOI 10.1093/ndt/gfq200; Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649; Karki P, 2009, NEPAL J OPHTHALMOL, V1, P139; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Muller-Deile J, 2009, AM J PHYSIOL-RENAL, V297, pF1656, DOI 10.1152/ajprenal.00275.2009; Schliehe C, 2011, J CONTROL RELEASE, V151, P278, DOI 10.1016/j.jconrel.2011.01.005; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; SIMON M, 1995, AM J PHYSIOL-RENAL, V268, pF240, DOI 10.1152/ajprenal.1995.268.2.F240; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Veron D, 2010, AM J PATHOL, V177, P2225, DOI 10.2353/ajpath.2010.091146; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wang HY, 2013, ZHONGGUO BING LI SHE, V29, P361; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075	26	13	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135648	10.1371/journal.pone.0135648	http://dx.doi.org/10.1371/journal.pone.0135648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274923	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600087
J	Wang, Y; McGivern, DR; Cheng, L; Li, GM; Lemon, SM; Niu, JQ; Su, LS; Reszka-Blanco, NJ				Wang, Yang; McGivern, David R.; Cheng, Liang; Li, Guangming; Lemon, Stanley M.; Niu, Junqi; Su, Lishan; Reszka-Blanco, Natalia J.			Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; CHRONIC HCV INFECTION; COMBINATION ANTIVIRAL THERAPY; INTERFERON-PRODUCING CELLS; PEGYLATED INTERFERON; PROTEASE INHIBITOR; VIRAL-INFECTION; PLUS RIBAVIRIN	Ribavirin is used as a component of combination therapies for the treatment of chronic hepatitis C virus (HCV) infection together with pegylated interferon and/or direct-acting antiviral drugs. Its mechanism of action, however, is not clear. Direct antiviral activity and immunomodulatory functions have been implicated. Plasmacytoid dendritic cells (pDCs) are the principal source of type 1 interferon during viral infection. The interaction of pDCs with HCV-infected hepatocytes is the subject of intense recent investigation, but the effect of ribavirin on pDC activation has not been evaluated. In this study we showed that ribavirin augments toll-like receptors 7 and 9-mediated IFN alpha/beta expression from pDCs and up-regulated numerous interferon-stimulated genes. Using the H77S.3 HCV infection and replication system, we showed that ribavirin enhanced the ability of activated pDCs to inhibit HCV replication, correlated with elevated induction of IFN alpha. Our findings provide novel evidence that ribavirin contributes to HCV inhibition by augmenting pDCs-derived type 1 IFN production.	[Wang, Yang; Niu, Junqi] Jilin Univ, Dept Translat Med, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Wang, Yang; Niu, Junqi] Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Wang, Yang; McGivern, David R.; Cheng, Liang; Li, Guangming; Lemon, Stanley M.; Su, Lishan; Reszka-Blanco, Natalia J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lemon, Stanley M.; Su, Lishan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [McGivern, David R.; Lemon, Stanley M.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA	Jilin University; Jilin University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Niu, JQ (corresponding author), Jilin Univ, Dept Translat Med, Hosp 1, Changchun 130023, Jilin, Peoples R China.	junqiniu@aliyun.com; lishan_su@med.unc.edu; reszka@email.unc.edu	Mcgivern, David/H-6210-2019	Mcgivern, David/0000-0003-3497-5087	National Institutes of Health [CA164029, AI095097, AI080432, AI115207]; National Science and Technology [2013ZX10002008]; China Scholarship Council [201306170128]; NATIONAL CANCER INSTITUTE [R01CA164029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115207, R01AI095097, R01AI080432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health: CA164029, AI095097, AI080432, AI115207; and National Science and Technology Major Project 2013ZX10002008. Yang Wang was supported by a fellowship from the China Scholarship Council, File No. 201306170128. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Baiocchi L, 2010, ANTIVIR THER, V15, P633, DOI 10.3851/IMP1560; Bao MS, 2013, PROTEIN CELL, V4, P40, DOI 10.1007/s13238-012-2104-8; Bodeau S, 2015, J CLIN PHARMACOL, V55, P517, DOI 10.1002/jcph.454; Body-Malapel M, 2008, LAB INVEST, V88, P318, DOI 10.1038/labinvest.3700716; Bougie I, 2003, J BIOL CHEM, V278, P52471, DOI 10.1074/jbc.M308917200; Brillanti S, 1995, J HEPATOL, V23, P13; Chaperot L, 2001, BLOOD, V97, P3210, DOI 10.1182/blood.V97.10.3210; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Chaperot L, 2004, EUR J IMMUNOL, V34, P418, DOI 10.1002/eji.200324531; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Feld JJ, 2015, J HEPATOL, V62, P294, DOI 10.1016/j.jhep.2014.09.013; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Feld JJ, 2012, BEST PRACT RES CL GA, V26, P429, DOI 10.1016/j.bpg.2012.09.013; Feld JJ, 2010, GASTROENTEROLOGY, V139, P154, DOI 10.1053/j.gastro.2010.03.037; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Ferreiros N, 2014, J SEP SCI, V37, P476, DOI 10.1002/jssc.201301173; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fried MW, 2002, HEPATOLOGY, V36, P967, DOI 10.1053/jhep.2002.35529; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; HALL CB, 1983, JAMA-J AM MED ASSOC, V249, P2666, DOI 10.1001/jama.249.19.2666; Hayden F G, 1996, Antivir Ther, V1, P51; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Ibarra KD, 2009, J VIROL, V83, P4538, DOI 10.1128/JVI.02280-08; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Jain MK, 2010, EXPERT OPIN PHARMACO, V11, P673, DOI 10.1517/14656560903580001; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Larrat S, 2003, ANTIMICROB AGENTS CH, V47, P124, DOI 10.1128/AAC.47.1.124-129.2003; Lau DTY, 2013, GASTROENTEROLOGY, V144, P402, DOI 10.1053/j.gastro.2012.10.044; Lawitz E, 2013, ANTIVIR RES, V99, P214, DOI 10.1016/j.antiviral.2013.05.015; Lawitz E, 2013, J HEPATOL, V59, P11, DOI 10.1016/j.jhep.2013.02.008; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Maynard M, 2008, ANTIVIR THER, V13, P607; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; McGivern DR, 2014, GASTROENTEROLOGY, V147, P453, DOI 10.1053/j.gastro.2014.04.021; McHutchison J, 1998, J HEPATOL, V29, P362, DOI 10.1016/S0168-8278(98)80052-4; Meissner EG, 2014, J CLIN INVEST, V124, P3352, DOI 10.1172/JCI75938; Nicot F, 2008, J MED VIROL, V80, P1523, DOI 10.1002/jmv.21227; Ning Q, 1998, J IMMUNOL, V160, P3487; Pawlotsky JM, 2004, GASTROENTEROLOGY, V126, P703, DOI 10.1053/j.gastro.2003.12.002; Pedersen C, 2011, J VIRAL HEPATITIS, V18, P245, DOI 10.1111/j.1365-2893.2010.01303.x; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rotman Y, 2014, GUT, V63, P161, DOI 10.1136/gutjnl-2012-303852; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shiffman ML, 2009, GASTROENTEROLOGY, V137, P1986, DOI 10.1053/j.gastro.2009.08.067; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Singh R, 2011, J VIROL, V85, P208, DOI 10.1128/JVI.01810-10; Stevenson NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027866; Stone AEL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095627; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Tam RC, 1999, J HEPATOL, V30, P376, DOI 10.1016/S0168-8278(99)80093-2; Thomas Emmanuel, 2012, Antiviral Chemistry & Chemotherapy, V23, P1, DOI 10.3851/IMP2125; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Toyoda H, 2008, J VIRAL HEPATITIS, V15, P651, DOI 10.1111/j.1365-2893.2008.01004.x; WITKOWSKI JT, 1972, J MED CHEM, V15, P1150, DOI 10.1021/jm00281a014; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Zeuzem S, 2012, J VIRAL HEPATITIS, V19, P766, DOI 10.1111/j.1365-2893.2012.01624.x; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	71	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135232	10.1371/journal.pone.0135232	http://dx.doi.org/10.1371/journal.pone.0135232			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274905	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600057
J	Castiglioni, L; Colazzo, F; Fontana, L; Colombo, GI; Piacentini, L; Bono, E; Milano, G; Paleari, S; Palermo, A; Guerrini, U; Tremoli, E; Sironi, L				Castiglioni, Laura; Colazzo, Francesca; Fontana, Lucia; Colombo, Gualtiero I.; Piacentini, Luca; Bono, Elisa; Milano, Giuseppina; Paleari, Serena; Palermo, Annamaria; Guerrini, Uliano; Tremoli, Elena; Sironi, Luigi			Evaluation of Left Ventricle Function by Regional Fractional Area Change (RFAC) in a Mouse Model of Myocardial Infarction Secondary to Valsartan Treatment	PLOS ONE			English	Article							CARDIOVASCULAR-MAGNETIC-RESONANCE; LEFT ATRIAL VOLUME; HEART-FAILURE; MATRIX METALLOPROTEINASES; DIASTOLIC DYSFUNCTION; ANGIOTENSIN-II; POSTMYOCARDIAL INFARCTION; TISSUE INHIBITORS; EXPRESSION; FIBROSIS	Aim Left ventricle (LV) regional fractional area change (RFAC) measured by cardiac magnetic resonance (CMR) allows the non-invasive localization and quantification of the degree of myocardial infarction (MI), and could be applied to assess the effectiveness of pharmacological or regenerative therapies. Here we investigate the ability of RFAC to identify regional dysfunction and discriminate the effect of pharmacological treatment with valsartan, a selective antagonist of angiotensin II type 1 receptor, in a model of MI. Methods and Results C57BL/6N mice, undergoing coronary artery ligation, were divided into two groups: untreated (MI) or treated with valsartan (MI+Val). Sham-operated mice were used as a control. Cardiac dimensions and function were assessed at baseline, 24 hours, 1 and 4 weeks post surgery by CMR and echocardiography. At sacrifice histology and whole-genome gene expression profiling were performed. RFAC was able to detect significant differences between treatment groups whereas the global ejection fraction was not. RFAC showed greater loss of regional contraction in remote non-infarcted myocardium in MI group than in MI+Val group. Consistently, in the same region MI+Val mice showed reduced myocyte hypertrophy, fibroblast proliferation, and fibrosis and modulation of target genes; in addition, left atrium volumes, appendage length and duct contraction were preserved. Conclusion In this study, RFAC effectively estimated the degree of systolic dysfunction and discriminated the regions preserved by pharmacological treatment. RFAC index is a promising tool to monitor changes in LV contraction and to assess the effectiveness of therapeutic regimens in clinical settings.	[Castiglioni, Laura; Paleari, Serena; Palermo, Annamaria; Guerrini, Uliano; Tremoli, Elena; Sironi, Luigi] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Colazzo, Francesca; Fontana, Lucia; Colombo, Gualtiero I.; Piacentini, Luca; Bono, Elisa; Milano, Giuseppina; Tremoli, Elena; Sironi, Luigi] Ctr Cardiol Monzino IRCCS, Milan, Italy	University of Milan; IRCCS Centro Cardiologico Monzino	Sironi, L (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	luigi.sironi@unimi.it	Piacentini, Luca/K-8908-2016; Bono, Elisa/AAN-3108-2020; Colombo, Gualtiero I./B-4737-2010; Sironi, Luigi/S-8174-2016; Fontana, Lucia/J-8778-2015; TREMOLI, ELENA/I-8126-2018	Piacentini, Luca/0000-0003-1022-4481; Bono, Elisa/0000-0002-5212-3446; Colombo, Gualtiero I./0000-0002-7348-1939; castiglioni, laura/0000-0002-0772-3231; Fontana, Lucia/0000-0001-9564-2310; Milano, Giuseppina/0000-0002-5560-4667; TREMOLI, ELENA/0000-0002-0929-6106; COLAZZO, FRANCESCA/0000-0002-5782-1606; SIRONI, LUIGI/0000-0002-4738-3454	University of Milan Fellowship; Centro Cardiologico Monzino, IRCCS	University of Milan Fellowship; Centro Cardiologico Monzino, IRCCS	This work was supported by funding from Centro Cardiologico Monzino, IRCCS (Ricerca Corrente-RC2013) and University of Milan Fellowship (to L. Castiglioni).	Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Boixel C, 2003, J AM COLL CARDIOL, V42, P336, DOI 10.1016/S0735-1097(03)00578-3; Cacciapuoti Fulvio, 2012, J Cardiovasc Ultrasound, V20, P25, DOI 10.4250/jcu.2012.20.1.25; Caiani EG, 2006, J CARDIOVASC MAGN R, V8, P427, DOI 10.1080/10976640600599486; Colazzo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125541; Constantine G, 2004, LANCET, V363, P2162, DOI 10.1016/S0140-6736(04)16509-4; de Gasparo M, 2000, J Renin Angiotensin Aldosterone Syst, V1, pS3; Douglas PS, 2003, J AM COLL CARDIOL, V42, P1206, DOI 10.1016/S0735-1097(03)00956-2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fassler R, 1996, EXP CELL RES, V222, P111, DOI 10.1006/excr.1996.0014; Franzosi M, 2011, COMPUT BIOL MED, V41, P829, DOI 10.1016/j.compbiomed.2011.06.021; Friedrich MG, 2008, JACC-CARDIOVASC IMAG, V1, P652, DOI 10.1016/j.jcmg.2008.07.011; GREENBERG B, 1979, AM HEART J, V98, P742, DOI 10.1016/0002-8703(79)90473-3; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Kim S, 2000, PHARMACOL REV, V52, P11; Kramer CM, 1997, J AM COLL CARDIOL, V30, P1625, DOI 10.1016/S0735-1097(97)00406-3; Kwong RY, 2008, CIRCULATION, V118, P1011, DOI 10.1161/CIRCULATIONAHA.107.727826; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; LEW WYW, 1985, CIRC RES, V56, P351, DOI 10.1161/01.RES.56.3.351; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Mahrholdt H, 2002, CIRCULATION, V106, P2322, DOI 10.1161/01.CIR.0000036368.63317.1C; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Oishi Y, 2006, LIFE SCI, V80, P82, DOI 10.1016/j.lfs.2006.08.033; Okayama S, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-87; Pennell DJ, 2004, EUR HEART J, V25, P1940, DOI 10.1016/j.ehj.2004.06.040; Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054; Ramirez TA, 2014, J MOL CELL CARDIOL, V72, P326, DOI 10.1016/j.yjmcc.2014.04.007; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; UNGER T, 2002, AM J CARDIOL, V89, P3; VAZIRI SM, 1995, HYPERTENSION, V25, P1155, DOI 10.1161/01.HYP.25.6.1155; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wong M, 2002, J AM COLL CARDIOL, V40, P970, DOI 10.1016/S0735-1097(02)02063-6; Wu L, 2001, CIRCULATION, V104, P2716, DOI 10.1161/hc4601.099404; Zhao QW, 2004, HYPERTENSION, V44, P264, DOI 10.1161/01.HYP.0000138688.78906.6b	42	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135778	10.1371/journal.pone.0135778	http://dx.doi.org/10.1371/journal.pone.0135778			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291973	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900032
J	Pacholewska, A; Jagannathan, V; Drogemuller, M; Klukowska-Rotzler, J; Lanz, S; Hamza, E; Dermitzakis, ET; Marti, E; Leeb, T; Gerber, V				Pacholewska, Alicja; Jagannathan, Vidhya; Droegemueller, Michaela; Klukowska-Roetzler, Jolanta; Lanz, Simone; Hamza, Eman; Dermitzakis, Emmanouil T.; Marti, Eliane; Leeb, Tosso; Gerber, Vincent			Impaired Cell Cycle Regulation in a Natural Equine Model of Asthma	PLOS ONE			English	Article							RECURRENT AIRWAY-OBSTRUCTION; NF-KAPPA-B; DIFFERENTIAL EXPRESSION ANALYSIS; ANAPHASE-PROMOTING COMPLEX; MESSENGER-RNA EXPRESSION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; BRONCHOALVEOLAR LAVAGE FLUID; EXPERIMENTAL ALLERGIC-ASTHMA; CANCER THERAPEUTIC TARGET; DELTA T-CELLS	Recurrent airway obstruction (RAO) is a common and potentially debilitating lower airway disease in horses, which shares many similarities with human asthma. In susceptible horses RAO exacerbation is caused by environmental allergens and irritants present in hay dust. The objective of this study was the identification of genes and pathways involved in the pathology of RAO by global transcriptome analyses in stimulated peripheral blood mononuclear cells (PBMCs). We performed RNA-seq on PBMCs derived from 40 RAO affected and 45 control horses belonging to three cohorts of Warmblood horses: two half-sib families and one group of unrelated horses. PBMCs were stimulated with hay dust extract, lipopolysaccharides, a recombinant parasite antigen, or left unstimulated. The total dataset consisted of 561 individual samples. We detected significant differences in the expression profiles between RAO and control horses. Differential expression (DE) was most marked upon stimulation with hay dust extract. An important novel finding was a strong upregulation of CXCL13 together with many genes involved in cell cycle regulation in stimulated samples from RAO affected horses, in addition to changes in the expression of several HIF-1 transcription factor target genes. The RAO condition alters systemic changes observed as differential expression profiles of PBMCs. Those changes also depended on the cohort and stimulation of the samples and were dominated by genes involved in immune cell trafficking, development, and cell cycle regulation. Our findings indicate an important role of CXCL13, likely macrophage or Th17 derived, and the cell cycle regulator CDC20 in the immune response in RAO.	[Pacholewska, Alicja; Klukowska-Roetzler, Jolanta; Lanz, Simone; Gerber, Vincent] Univ Bern, Swiss Inst Equine Med, Vetsuisse Fac, Bern, Switzerland; [Pacholewska, Alicja; Klukowska-Roetzler, Jolanta; Lanz, Simone; Gerber, Vincent] Agroscope, Bern, Switzerland; [Pacholewska, Alicja; Jagannathan, Vidhya; Droegemueller, Michaela; Klukowska-Roetzler, Jolanta; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Klukowska-Roetzler, Jolanta] Univ Hosp Bern, Dept Pediat, Div Pediat Hematol Oncol, CH-3010 Bern, Switzerland; [Hamza, Eman; Marti, Eliane] Univ Bern, Dept Clin Res & Vet Publ Hlth, Clin Immunol Grp, Bern, Switzerland; [Hamza, Eman] Cairo Univ, Dept Zoonoses, Fac Vet Med, Cairo, Egypt; [Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Inst Genet & Genom Geneva, Geneva, Switzerland	University of Bern; Swiss Federal Research Station Agroscope; University of Bern; University of Bern; University Hospital of Bern; University of Bern; Egyptian Knowledge Bank (EKB); Cairo University; University of Geneva; Swiss Institute of Bioinformatics	Pacholewska, A (corresponding author), Univ Bern, Swiss Inst Equine Med, Vetsuisse Fac, Bern, Switzerland.	alicja.pacholewska@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Pacholewska, Alicja/A-3267-2015; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Pacholewska, Alicja/0000-0002-4888-4883; Jagannathan, Vidhya/0000-0002-8155-0041; Hamza, Eman/0000-0001-9798-842X	Swiss National Science Foundation [310030-138295, 310000-116803/1]; Swiss Institute of Equine Medicine Research (ismequine.ch)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Institute of Equine Medicine Research (ismequine.ch)	The presented study was funded by Swiss National Science Foundation (www.snf.ch): grant No. 310030-138295 and 310000-116803/1; and Swiss Institute of Equine Medicine Research (ismequine.ch). VG and EM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2012, AM J RESP CELL MOL, V47, P1, DOI 10.1165/rcmb.2011-0203OC; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansotegui I, 2013, WHITE BOOK ON ALLERG; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Baek KJ, 2013, CLIN IMMUNOL, V147, P27, DOI 10.1016/j.clim.2013.02.004; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Boldman K. G., 1993, MANUAL USE MTDFREML; Brundler P, 2011, Vet J, V190, pe12, DOI 10.1016/j.tvjl.2010.12.029; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carlsen HS, 2004, BLOOD, V104, P3021, DOI 10.1182/blood-2004-02-0701; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cordeau ME, 2004, VET IMMUNOL IMMUNOP, V97, P87, DOI 10.1016/j.vetimm.2003.08.013; Dalton JE, 2004, J IMMUNOL, V173, P3660, DOI 10.4049/jimmunol.173.6.3660; Dalton JE, 2003, J IMMUNOL, V171, P6488, DOI 10.4049/jimmunol.171.12.6488; Debrue M, 2005, VET IMMUNOL IMMUNOP, V105, P25, DOI 10.1016/j.vetimm.2004.12.013; Deifl S, 2014, ALLERGY, V69, P1602, DOI 10.1111/all.12501; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; EDFORSLUBS ML, 1971, ACTA ALLERGOL, V26, P249, DOI 10.1111/j.1398-9995.1971.tb01300.x; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fehr AR, 2013, J VIROL, V87, P8818, DOI 10.1128/JVI.00088-13; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Gerard NP, 2002, CURR OPIN IMMUNOL, V14, P705, DOI 10.1016/S0952-7915(02)00410-7; Gerber V, 2009, J VET INTERN MED, V23, P626, DOI 10.1111/j.1939-1676.2009.0292.x; GREEN JA, 1969, SCIENCE, V164, P1415, DOI 10.1126/science.164.3886.1415; Guo J, 2009, INT ARCH ALLERGY IMM, V149, P98, DOI 10.1159/000189191; Hamza E, 2008, VET IMMUNOL IMMUNOP, V122, P65, DOI 10.1016/j.vetimm.2007.10.018; Hansen S, 2014, VET IMMUNOL IMMUNOP, V158, P238, DOI 10.1016/j.vetimm.2014.02.001; Henriquez C, 2014, VET IMMUNOL IMMUNOP, V158, P128, DOI 10.1016/j.vetimm.2013.12.005; Horohov DW, 2005, VET IMMUNOL IMMUNOP, V108, P237, DOI 10.1016/j.vetimm.2005.07.013; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Jiang JH, 2011, BIOCHEM BIOPH RES CO, V415, P325, DOI 10.1016/j.bbrc.2011.10.055; Jost U, 2007, EQUINE VET J, V39, P236, DOI 10.2746/042516407X171110; Baay-Guzman GJ, 2012, CHEST, V141, P886, DOI 10.1378/chest.11-0633; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Karnati HK, 2015, VET RES COMMUN, V39, P73, DOI 10.1007/s11259-014-9621-2; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kato T, 2012, J SURG ONCOL, V106, P423, DOI 10.1002/jso.23109; Kehrli D, 2015, J VET INTERN MED, V29, P320, DOI 10.1111/jvim.12473; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kleiber C, 2005, VET IMMUNOL IMMUNOP, V104, P91, DOI 10.1016/j.vetimm.2004.10.002; Klier J, 2011, VET IMMUNOL IMMUNOP, V144, P79, DOI 10.1016/j.vetimm.2011.07.009; Klukowska-Rotzler J, 2012, ANIM GENET, V43, P450, DOI 10.1111/j.1365-2052.2011.02277.x; Kohl J, 2007, CURR OPIN PHARMACOL, V7, P283, DOI 10.1016/j.coph.2007.01.005; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lanz S, 2013, VET IMMUNOL IMMUNOP, V155, P229, DOI 10.1016/j.vetimm.2013.07.005; Laumen E, 2010, EQUINE VET J, V42, P142, DOI 10.2746/042516409X479586; Lavoie JP, 2001, AM J RESP CRIT CARE, V164, P1410, DOI 10.1164/ajrccm.164.8.2012091; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Lindberg A, 2004, AM J VET RES, V65, P289, DOI 10.2460/ajvr.2004.65.289; MARTI E, 1991, EQUINE VET J, V23, P457, DOI 10.1111/j.2042-3306.1991.tb03761.x; Masteller EL, 2014, DRUG DISCOV TODAY, V19, P1212, DOI 10.1016/j.drudis.2014.05.016; MCFADDEN ER, 1968, NEW ENGL J MED, V278, P1027, DOI 10.1056/NEJM196805092781901; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Meraouna A, 2006, BLOOD, V108, P432, DOI 10.1182/blood-2005-06-2383; Mo JH, 2014, AM J RHINOL ALLERGY, V28, pE100, DOI 10.2500/ajra.2014.28.4025; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Moran G, 2011, VET MED-CZECH, V56, P1, DOI 10.17221/1566-VETMED; Mullane K, 2014, BIOCHEM PHARMACOL, V87, P131, DOI 10.1016/j.bcp.2013.06.026; NAKAYAMA T, 1983, INFECT IMMUN, V40, P486, DOI 10.1128/IAI.40.2.486-492.1983; Neuhaus S, 2010, J VET INTERN MED, V24, P407, DOI 10.1111/j.1939-1676.2009.0465.x; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Niedzwiedz A, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-29; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; OBEL NJ, 1948, ACTA PHARMACOL TOX, V4, P71; Pacholewska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122011; Pirie RS, 2003, CLIN EXP ALLERGY, V33, P1289, DOI 10.1046/j.1365-2745.2003.01651.x; Pirie RS, 2003, CLIN EXP ALLERGY, V33, P676, DOI 10.1046/j.1365-2222.2003.01640.x; Pirie RS, 2002, EQUINE VET J, V34, P343, DOI 10.2746/042516402776249236; Portales-Casamar E, 2009, NUCLEIC ACIDS RES, V37, pD54, DOI 10.1093/nar/gkn783; Poynter ME, 2004, J IMMUNOL, V173, P7003, DOI 10.4049/jimmunol.173.11.7003; Pu D, 2014, EXP THER MED, V8, P1914, DOI 10.3892/etm.2014.2025; Ramseyer A, 2007, J VET INTERN MED, V21, P149, DOI 10.1892/0891-6640(2007)21[149:EOGAEF]2.0.CO;2; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarmiento J, 2013, VET RES COMMUN, V37, P333, DOI 10.1007/s11259-013-9571-0; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schott J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004368; SchulzKnappe P, 1996, J EXP MED, V183, P295, DOI 10.1084/jem.183.1.295; SIMPSON H, 1968, BRIT MED J, V3, P460, DOI 10.1136/bmj.3.5616.460; Singh RP, 2014, AUTOIMMUN REV, V13, P1174, DOI 10.1016/j.autrev.2014.08.019; Sood A, 2012, CHEST, V142, P425, DOI 10.1378/chest.11-2519; Strina A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-5; Swinburne JE, 2009, MAMM GENOME, V20, P504, DOI 10.1007/s00335-009-9214-5; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Tang MLK, 2006, PHARMACOL THERAPEUT, V112, P474, DOI 10.1016/j.pharmthera.2006.05.001; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Temesi G, 2014, ALLERGY ASTHMA IMMUN, V6, P496, DOI 10.4168/aair.2014.6.6.496; Toussaint M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-64; Turlej RK, 2001, THORAX, V56, P696, DOI 10.1136/thorax.56.9.696; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Voelkel NF, 2009, IMMUNOL CELL BIOL, V87, P601, DOI 10.1038/icb.2009.45; WADDELL JA, 1967, BRIT MED J, V2, P402, DOI 10.1136/bmj.2.5549.402; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wan LX, 2014, DEV CELL, V29, P377, DOI 10.1016/j.devcel.2014.04.022; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wang Q, 2010, J IMMUNOL, V185, P834, DOI 10.4049/jimmunol.0901490; Wang YM, 2014, EUR J IMMUNOL, V44, P1575, DOI 10.1002/eji.201344365; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84	120	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136103	10.1371/journal.pone.0136103	http://dx.doi.org/10.1371/journal.pone.0136103			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292153	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900055
J	Smith, M; Berdel, D; Nowak, D; Heinrich, J; Schulz, H				Smith, Maia; Berdel, Dietrich; Nowak, Dennis; Heinrich, Joachim; Schulz, Holger			Sport Engagement by Accelerometry under Field Conditions in German Adolescents: Results from GINIPlus	PLOS ONE			English	Article							VIGOROUS PHYSICAL-ACTIVITY; CHILDREN; SEDENTARY; CHILDHOOD; PATTERNS; SUCCESS; WOMEN; AGE	Introduction Sporting activities differ in their ability to promote moderate-to-vigorous physical activity (MVPA). To assess adolescents' engagement in sport under field conditions we used accelerometers to measure their MVPA levels during sport. We pay special attention to differences between team and individual sport and between common sports. Methods Diary data and 7-day accelerometry from 1054 Germans ages 15-17 were combined to measure physical activity. 1373 diaried episodes of more than 40 common sports were identified from 626 participants and grouped into team and individual sport. We modeled the effect of team and individual sport, and described levels of MVPA and episodes of no MVPA for all recorded sports. Results German boys and girls averaged 43 (SD 21) and 37 (SD 24) minutes MVPA per day. Boys got 2.2 times as much MVPA per minute during team compared to individual sport (p< 0.0001) but there was no significant difference for girls. Percent of time spent in MVPA during sport ranged from6% for weight training to 74% for jogging, with individual sports averaging 10-30% and team sports 30-50%. 11% of sport episodes had no MVPA: half of episodes of cycling, 5% of jogging, and none for tennis or badminton. An episode of individual sport was 17 times more likely to have no MVPA than an episode of team sport (p< 0.0001). Conclusion Under field condition, adolescents were active for only a fraction of diaried sporting time. As measured by accelerometry, individual sport often produced no MVPA. Characteristics of the sport, such as team vs. individual, were more predictive of MVPA than were characteristics of the participant, such as background activity levels.	[Smith, Maia; Heinrich, Joachim; Schulz, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Munich, Germany; [Berdel, Dietrich] Marien Hosp Wesel, Dept Pediat, Wesel, Germany; [Nowak, Dennis; Heinrich, Joachim; Schulz, Holger] German Ctr Lung Res, CPC M, Munich, Germany; [Nowak, Dennis] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; St. Marien Hospital; University of Munich	Schulz, H (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Munich, Germany.	schulz@helmholtz-muenchen.de	Schulz, Holger/J-5643-2015; Heinrich, Joachim/N-1720-2013	Schulz, Holger/0000-0002-1157-200X; Heinrich, Joachim/0000-0002-9620-1629; Smith, Maia Phillips/0000-0002-1154-1158	Mead Johnson; Nestle; Comprehensive Pneumology Center Munich (CPC-M)	Mead Johnson; Nestle(Nestle SA); Comprehensive Pneumology Center Munich (CPC-M)	The 15 year follow up of the GINIplus study was mainly covered from the respective budgets of the initial 4 study centres (Wesel, LMU Munich, Deutsche Rentenversicherung (DRV) Bayern Sud, Helmholtz Centre Munich), partly by the Federal Ministry for the Environment, and by the budget of the IUF - Leibniz Research Institute for Environmental Medicine at the University of Dusseldorf. Further support was obtained from the companies Mead Johnson and Nestle and by cooperation in European Studies (e.g Medall, ESCAPE). In addition, this work was supported by the Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnes A, 2014, GENDER DIFFERENCES E; Chung AE, 2012, CLIN PEDIATR, V51, P122, DOI 10.1177/0009922811417291; Colley Rachel C, 2011, Health Rep, V22, P7; Deaner RO, 2015, PEERJ, V3, DOI 10.7717/peerj.884; DiLorenzo TM, 1998, PREV MED, V27, P470, DOI 10.1006/pmed.1998.0307; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Fairclough S, 2004, HLTH ED RES THEORY P, V20, P14; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gill D, 1988, SPORT PSYCHOL, V2, P212, DOI DOI 10.1123/TSP.2.3.212; Guinhouya BC, 2013, PUBLIC HEALTH, V127, P301, DOI 10.1016/j.puhe.2013.01.020; Heilman ME, 2007, J APPL PSYCHOL, V92, P81, DOI 10.1037/0021-9010.92.1.81; Heilman ME, 2004, J APPL PSYCHOL, V89, P416, DOI 10.1037/0021-9010.89.3.416; Heinrich J, GERMAN INTERVENTIONA; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; LeBlanc AGW, 2010, PEDIATR EXERC SCI, V22, P523, DOI 10.1123/pes.22.4.523; Malina RM, 2001, QUEST, V53, P346, DOI 10.1080/00336297.2001.10491751; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Morales J, 2013, AM ALL HLTH PHYS ED; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Pfitzner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065192; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Ridgers ND, 2005, PREV MED, V41, P102, DOI 10.1016/j.ypmed.2004.10.023; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; Sheehan D, 2014, CAN C LEIS RES 2014; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Smith M, 2014, HDB PHYS ED RES ROLE, P203; Steele RM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-88; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; US Department of Health & Human Services, 2008, PHYS ACT GUID AM, DOI DOI 10.4085/1062-6050-44.1.5; USCDC, 2010, STRAT IMPR QUAL PHYS; Verloigne M., 2012, INT J BEHAV NUTR PHY, V31, P9; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; Wann DL, 1999, J SPORT BEHAV, V22; Weber B, 2008, J PERS SOC PSYCHOL, V93, P973; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178	36	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135630	10.1371/journal.pone.0135630	http://dx.doi.org/10.1371/journal.pone.0135630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291984	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900021
J	Marin, I				Marin, Ignacio			Origin and Diversification of Meprin Proteases	PLOS ONE			English	Article							CIONA-INTESTINALIS; ASTACIN FAMILY; ALPHA-SUBUNIT; BETA-SUBUNIT; GENE; METALLOPROTEASES; EXPRESSION; EVOLUTION; ENDOPEPTIDASES; LOCALIZATION	Meprins are astacin metalloproteases with a characteristic, easily recognizable structure, given that they are the only proteases with both MAM and MATH domains plus a transmembrane region. So far assumed to be vertebrate-specific, it is shown here, using a combination of evolutionary and genomic analyses, that meprins originated before the urochordates/vertebrates split. In particular, three genes encoding structurally typical meprin proteins are arranged in tandem in the genome of the urochordate Ciona intestinalis. Phylogenetic analyses showed that the protease and MATH domains present in the meprin-like proteins encoded by the Ciona genes are very similar in sequence to the domains found in vertebrate meprins, which supports them having a common origin. While many vertebrates have the two canonical meprin-encoding genes orthologous to human MEP1A and MEP1B (which respectively encode for the proteins known as meprin a and meprin beta), a single gene has been found so far in the genome of the chondrichthyan fish Callorhinchus milii, and additional meprin-encoding genes are present in some species. Particularly, a group of bony fish species have genes encoding highly divergent meprins, here named meprin-F. Genes encoding meprin-F proteins, derived from MEP1B genes, are abundant in some species, as the Amazon molly, Poecilia formosa, which has 7 of them. Finally, it is confirmed that the MATH domains of meprins are very similar to the ones in TRAF ubiquitin ligases, which suggests that meprins originated when protease and TRAF E3-encoding sequences were combined.	CSIC, IBV, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Marin, I (corresponding author), CSIC, IBV, Valencia, Spain.	imarin@ibv.csic.es	Marin, Ignacio/A-9524-2009	Marin, Ignacio/0000-0002-1315-8961	Ministerio de Economia y Competitividad (Spanish Government) [BFU2011-30063]	Ministerio de Economia y Competitividad (Spanish Government)(Spanish Government)	This study was supported by Ministerio de Economia y Competitividad (Spanish Government) Grant BFU2011-30063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; BARNES K, 1989, BIOCHEM J, V264, P335, DOI 10.1042/bj2640335; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Becker-Pauly C, 2009, J MOL BIOL, V385, P236, DOI 10.1016/j.jmb.2008.10.062; BECKMANN G, 1993, TRENDS BIOCHEM SCI, V18, P40, DOI 10.1016/0968-0004(93)90049-S; Bertenshaw GP, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P900, DOI 10.1016/B978-0-12-382219-2.00189-7; Bertenshaw GP, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P910, DOI 10.1016/B978-0-12-382219-2.00190-3; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; Biasin V, 2014, J PATHOL, V233, P7, DOI 10.1002/path.4303; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; BUTLER PE, 1988, J BIOL CHEM, V263, P13419; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Eagle ARR, 2005, HUM GENET, V118, P12, DOI 10.1007/s00439-005-0019-7; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; GORBEA CM, 1993, J BIOL CHEM, V268, P21035; Huxley-Jones J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-63; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; JIANG WP, 1992, J BIOL CHEM, V267, P9185; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kaushal GP, 2013, AM J PHYSIOL-RENAL, V304, pF1150, DOI 10.1152/ajprenal.00014.2013; KOUNNAS MZ, 1991, J BIOL CHEM, V266, P17350; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Lam UDP, 2014, GENE, V537, P245, DOI 10.1016/j.gene.2013.12.055; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Marin I, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-63; Marin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068536; Marin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050030; Mohrlen F, 2003, EUR J BIOCHEM, V270, P4909, DOI 10.1046/j.1432-1033.2003.03891.x; Mohrlen F, 2006, EVOL DEV, V8, P223, DOI 10.1111/j.1525-142X.2006.00092.x; Nicholas KB, 1997, GENEDOC A TOOL FOR E; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rawlins ND, 2013, HDB PROTEOLYTIC ENZY, V1, P325; Satou Y, 2005, ZOOL SCI, V22, P837, DOI 10.2108/zsj.22.837; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schutte A, 2007, BIOL CHEM, V388, P523, DOI 10.1515/BC.2007.060; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Stocker W., 2013, PROTEASES STRUCTURE, P235, DOI DOI 10.1007/978-3-7091-0885-7; Sun Q, 2009, EXP HEMATOL, V37, P346, DOI 10.1016/j.exphem.2008.10.016; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uren AG, 1996, TRENDS BIOCHEM SCI, V21, P244, DOI 10.1016/S0968-0004(96)30022-4; Gomis-Ruth FX, 2012, BIOL CHEM, V393, P1027, DOI 10.1515/hsz-2012-0149; Yan L, 2000, DEVELOPMENT, V127, P129; Zapata JM, 2007, ADV EXP MED BIOL, V597, P1; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	52	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135924	10.1371/journal.pone.0135924	http://dx.doi.org/10.1371/journal.pone.0135924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288188	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600086
J	Oudman, T; Hin, V; Dekinga, A; van Gils, JA				Oudman, Thomas; Hin, Vincent; Dekinga, Anne; van Gils, Jan A.			The Effect of Digestive Capacity on the Intake Rate of Toxic and Non-Toxic Prey in an Ecological Context	PLOS ONE			English	Article							KNOTS CALIDRIS-CANUTUS; RED KNOTS; ANNUAL CYCLE; ORGAN SIZE; BEHAVIOR; MOLLUSCIVORE; PREDICTIONS; ADAPTATIONS; SHOREBIRDS; HERBIVORES	Digestive capacity often limits food intake rate in animals. Many species can flexibly adjust digestive organ mass, enabling them to increase intake rate in times of increased energy requirement and/or scarcity of high-quality prey. However, some prey species are defended by secondary compounds, thereby forcing a toxin limitation on the forager's intake rate, a constraint that potentially cannot be alleviated by enlarging digestive capacity. Hence, physiological flexibility may have a differential effect on intake of different prey types, and consequently on dietary preferences. We tested this effect in red knots (Calidris canutus canutus), medium-sized migratory shorebirds that feed on hard-shelled, usually mollusc, prey. Because they ingest their prey whole and crush the shell in their gizzard, the intake rate of red knots is generally constrained by digestive capacity. However, one of their main prey, the bivalve Loripes lucinalis, imposes a toxin constraint due to its symbiosis with sulphide-oxidizing bacteria. We manipulated gizzard sizes of red knots through prolonged exposure to hard-shelled or soft foods. We then measured maximum intake rates of toxic Loripes versus a non-toxic bivalve, Dosinia isocardia. We found that intake of Dosinia exponentially increased with gizzard mass, confirming earlier results with nontoxic prey, whereas intake of Loripes was independent of gizzard mass. Using linear programming, we show that this leads to markedly different expected diet preferences in red knots that try to maximize energy intake rate with a small versus a large gizzard. Intra-and inter-individual variation in digestive capacity is found in many animal species. Hence, the here proposed functional link with individual differences in foraging decisions may be general. We emphasize the potential relevance of individual variation in physiology when studying trophic interactions.	[Oudman, Thomas; Hin, Vincent; Dekinga, Anne; van Gils, Jan A.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Texel, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Oudman, T (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Texel, Netherlands.	Thomas.Oudman@nioz.nl	van Gils, Jan/B-5544-2008	van Gils, Jan/0000-0002-4132-8243; Hin, Vincent/0000-0002-9497-1224	Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO) [864.09.002]	Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO) (grant number: 864.09.002; URL: www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedou Salem MV, 2014, ESTUAR COAST SHELF S, V136, P26, DOI 10.1016/j.ecss.2013.11.009; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Battley PF, 2005, J AVIAN BIOL, V36, P494, DOI 10.1111/j.0908-8857.2005.03730.x; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; BELOVSKY GE, 1994, J MAMMAL, V75, P816, DOI 10.2307/1382464; Berenbaum MR, 1992, HERBIVORES THEIR INT, VII; Bijleveld AI, 2015, ECOLOGY, V96, P1943, DOI 10.1890/14-1845.1; Bijleveld AI, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3135; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Curley EAM, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0152; Dekinga A, 2001, J EXP BIOL, V204, P2167; DEKINGA A, 1993, BIRD STUDY, V40, P144, DOI 10.1080/00063659309477140; Dietz MW, 1999, PHYSIOL BIOCHEM ZOOL, V72, P28, DOI 10.1086/316648; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Hall JO, 2007, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, P465; HAMMOND KA, 1994, PHYSIOL ZOOL, V67, P1479, DOI 10.1086/physzool.67.6.30163908; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; JOHNSON M, 1994, SYMBIOSIS, V17, P1; Leyrer J, 2013, J ORNITHOL, V154, P933, DOI 10.1007/s10336-013-0959-y; Leyrer J, 2012, BEHAV ECOL, V23, P1226, DOI 10.1093/beheco/ars106; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McWilliams SR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0308; Olsson J, 2007, BIOL J LINN SOC, V90, P517, DOI 10.1111/j.1095-8312.2007.00742.x; Onrust J, 2013, BIRD STUDY, V60, P298, DOI 10.1080/00063657.2013.811213; Oudman T, 2014, AM NAT, V183, P650, DOI 10.1086/675759; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; PIERSMA T, 1993, AUK, V110, P552, DOI 10.2307/4088419; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; SECOR SM, 1995, J EXP BIOL, V198, P1313; Starck JM, 1999, ZOOL ANZ, V238, P87; van den Hout PJ, 2014, ANIM BEHAV, V88, P137, DOI 10.1016/j.anbehav.2013.11.020; van der Geest M, 2014, MAR ECOL PROG SER, V501, P113, DOI 10.3354/meps10702; van der Geest M, 2011, J EXP MAR BIOL ECOL, V399, P1, DOI 10.1016/j.jembe.2011.01.003; van der Heide T, 2012, SCIENCE, V336, P1432, DOI 10.1126/science.1219973; van Gils JA, 2005, P ROY SOC B-BIOL SCI, V272, P2609, DOI 10.1098/rspb.2005.3245; Van Gils JA, 2005, J ANIM ECOL, V74, P105, DOI 10.1111/j.1365-2656.2004.00903.x; van Gils JA, 2003, J EXP BIOL, V206, P3369, DOI 10.1242/jeb.00546; van Gils JA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0861; van Gils JA, 2012, ECOLOGY, V93, P1143, DOI 10.1890/11-1282.1; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; Yang HY, 2013, J EXP BIOL, V216, P3627, DOI 10.1242/jeb.083576	43	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136144	10.1371/journal.pone.0136144	http://dx.doi.org/10.1371/journal.pone.0136144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287951	Green Published, gold			2022-12-27	WOS:000360018600112
J	Schwemmer, MA; Feng, SF; Holmes, PJ; Gottlieb, J; Cohen, JD				Schwemmer, Michael A.; Feng, Samuel F.; Holmes, Philip J.; Gottlieb, Jacqueline; Cohen, Jonathan D.			A Multi-Area Stochastic Model for a Covert Visual Search Task	PLOS ONE			English	Article							PERCEPTUAL DECISION; SUPERIOR COLLICULUS; AREA LIP; PARIETAL; INFORMATION; REPRESENTATION; ACCUMULATOR; MECHANISM; ATTENTION; CHOICE	Decisions typically comprise several elements. For example, attention must be directed towards specific objects, their identities recognized, and a choice made among alternatives. Pairs of competing accumulators and drift-diffusion processes provide good models of evidence integration in two-alternative perceptual choices, but more complex tasks requiring the coordination of attention and decision making involve multistage processing and multiple brain areas. Here we consider a task in which a target is located among distractors and its identity reported by lever release. The data comprise reaction times, accuracies, and single unit recordings from two monkeys' lateral interparietal area (LIP) neurons. LIP firing rates distinguish between targets and distractors, exhibit stimulus set size effects, and show response-hemifield congruence effects. These data motivate our model, which uses coupled sets of leaky competing accumulators to represent processes hypothesized to occur in feature-selective areas and limb motor and pre-motor areas, together with the visual selection process occurring in LIP. Model simulations capture the electrophysiological and behavioral data, and fitted parameters suggest that different connection weights between LIP and the other cortical areas may account for the observed behavioral differences between the animals.	[Schwemmer, Michael A.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Feng, Samuel F.] Khalifa Univ, Dept Appl Math & Sci, Abu Dhabi, U Arab Emirates; [Holmes, Philip J.] Princeton Univ, Program Appl & Computat Math, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Holmes, Philip J.; Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Gottlieb, Jacqueline] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	University System of Ohio; Ohio State University; Khalifa University of Science & Technology; Princeton University; Princeton University; Columbia University; Princeton University	Schwemmer, MA (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	schwemmer.2@mbi.osu.edu		Feng, Samuel/0000-0001-9046-2601	Air Force Office of Scientific Research [FA9550-07-1-0537, FA9550-07-1-0528]; National Institutes of Health [P50 MH62196, T32MH065214]; National Eye Institute; Alfred P. Sloan Foundation; Keck Foundation; Klingenstein Fund; McKnight Endowment Fund for Neuroscience; Mathematical Biosciences Institute; National Science Foundation [DMS-0931642]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065214, P50MH062196] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Keck Foundation(W.M. Keck Foundation); Klingenstein Fund(Klingenstein Philanthropies); McKnight Endowment Fund for Neuroscience; Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Air Force Office of Scientific Research grants FA9550-07-1-0537 (SF, PH, and JC) and FA9550-07-1-0528 (PH and JC) and the National Institutes of Health grant P50 MH62196 (PH and JC). SF and MS benefitted from postdoctoral fellowships supplied by National Institutes of Health grant T32MH065214. JG acknowledges support from the National Eye Institute, the Alfred P. Sloan Foundation, the Keck Foundation, the Klingenstein Fund, and the McKnight Endowment Fund for Neuroscience. MS is currently supported in part by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS-0931642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Balan PF, 2008, PLOS BIOL, V6, P1443, DOI 10.1371/journal.pbio.0060158; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, Q J EXP PSYCHOL, V63, P863, DOI 10.1080/17470210903091643; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Borra E, 2014, CEREB CORTEX, V24, P1054, DOI 10.1093/cercor/bhs392; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; COHEN JD, 1994, J COGNITIVE NEUROSCI, V6, P377, DOI 10.1162/jocn.1994.6.4.377; Deco G, 2013, PROG NEUROBIOL, V103, P194, DOI 10.1016/j.pneurobio.2012.01.010; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; DErrico J, 2022, FMINSEARCHBND FMINSE; Ding L, 2012, NEURON, V75, P865, DOI 10.1016/j.neuron.2012.07.021; Eckhoff P, 2011, SIAM J APPL DYN SYST, V10, P148, DOI 10.1137/090770096; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Feng S., 2012, THESIS PRINCETON U; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Gamberini M, 2009, J COMP NEUROL, V513, P622, DOI 10.1002/cne.21980; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb J, 2004, SCIENCE, V303, P317, DOI 10.1126/science.1093922; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Gross CG, 2008, NEUROPSYCHOLOGIA, V46, P841, DOI 10.1016/j.neuropsychologia.2007.11.009; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Lehmann SJ, 2013, J NEUROSCI, V33, P7038, DOI 10.1523/JNEUROSCI.5568-12.2013; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Miller KD, 2012, NEURAL COMPUT, V24, P25, DOI 10.1162/NECO_a_00221; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; Plantenga T., 2009, HOPSPACK 2 0 USER MA; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sawaki R, 2012, J NEUROSCI, V32, P10725, DOI 10.1523/JNEUROSCI.1864-12.2012; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simen P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00183; Simen P, 2009, J EXP PSYCHOL HUMAN, V35, P1865, DOI 10.1037/a0016926; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Vandekerckhove J., 2008, GEN SIMULATED ANNEAL; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Yates J, 2014, COSYNE 2014 MAIN M	52	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136097	10.1371/journal.pone.0136097	http://dx.doi.org/10.1371/journal.pone.0136097			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287613	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600108
J	Trend, S; de Jong, E; Lloyd, ML; Kok, CH; Richmond, P; Doherty, DA; Simmer, K; Kakulas, F; Strunk, T; Currie, A				Trend, Stephanie; de Jong, Emma; Lloyd, Megan L.; Kok, Chooi Heen; Richmond, Peter; Doherty, Dorota A.; Simmer, Karen; Kakulas, Foteini; Strunk, Tobias; Currie, Andrew			Leukocyte Populations in Human Preterm and Term Breast Milk Identified by Multicolour Flow Cytometry	PLOS ONE			English	Article							MOTHERS DELIVERING PRETERM; NEONATAL IMMUNE-SYSTEM; COLOSTRAL LEUKOCYTES; LYMPHOCYTE SUBSETS; PROMOTES DEVELOPMENT; T-CELLS; BLOOD; MACROPHAGES; MECHANISMS; PROTEINS	Background Extremely preterm infants are highly susceptible to bacterial infections but breast milk provides some protection. It is unknown if leukocyte numbers and subsets in milk differ between term and preterm breast milk. This study serially characterised leukocyte populations in breast milk of mothers of preterm and term infants using multicolour flow cytometry methods for extended differential leukocyte counts in blood. Methods Sixty mothers of extremely preterm (<28 weeks gestational age), very preterm (28-31 wk), and moderately preterm (32-36 wk), as well as term (37-41 wk) infants were recruited. Colostrum (d2-5), transitional (d8-12) and mature milk (d26-30) samples were collected, cells isolated, and leukocyte subsets analysed using flow cytometry. Results The major CD45+ leukocyte populations circulating in blood were also detectable in breast milk but at different frequencies. Progression of lactation was associated with decreasing CD45+ leukocyte concentration, as well as increases in the relative frequencies of neutrophils and immature granulocytes, and decreases in the relative frequencies of eosinophils, myeloid and B cell precursors, and CD16-monocytes. No differences were observed between preterm and term breast milk in leukocyte concentration, though minor differences between preterm groups in some leukocyte frequencies were observed. Conclusions Flow cytometry is a useful tool to identify and quantify leukocyte subsets in breast milk. The stage of lactation is associated with major changes in milk leukocyte composition in this population. Fresh preterm breast milk is not deficient in leukocytes, but shorter gestation may be associated with minor differences in leukocyte subset frequencies in preterm compared to term breast milk.	[Trend, Stephanie; de Jong, Emma; Lloyd, Megan L.; Kok, Chooi Heen; Simmer, Karen; Strunk, Tobias; Currie, Andrew] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia; [Trend, Stephanie; de Jong, Emma; Richmond, Peter; Currie, Andrew] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [de Jong, Emma; Currie, Andrew] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Lloyd, Megan L.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Kok, Chooi Heen; Simmer, Karen; Strunk, Tobias] King Edward Mem Hosp Women, Neonatal Clin Care Unit, Perth, WA, Australia; [Doherty, Dorota A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Kakulas, Foteini] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; Murdoch University; University of Western Australia; King Edward Memorial Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Currie, A (corresponding author), Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia.	a.currie@murdoch.edu.au	Strunk, Tobias/AIE-3407-2022; Lloyd, Megan/B-5690-2008; Currie, Andrew/C-2778-2015; Richmond, Peter C/G-3379-2012; de Jong, Emma/AHC-9300-2022	Strunk, Tobias/0000-0001-7079-2339; Lloyd, Megan/0000-0002-0140-1215; Richmond, Peter C/0000-0001-7562-7228; de Jong, Emma/0000-0002-2501-6119; Simmer, Karen/0000-0003-4777-9069; Trend, Stephanie/0000-0003-0210-3452; Currie, Andrew/0000-0002-5193-3404	Centre for Neonatal Research and Education, Women and Infants Research Foundation (WIRF); Princess Margaret Hospital (PMH) foundation; WIRF; Medela AG (Switzerland)	Centre for Neonatal Research and Education, Women and Infants Research Foundation (WIRF); Princess Margaret Hospital (PMH) foundation; WIRF; Medela AG (Switzerland)	Funding: ST received postgraduate scholarships from the Centre for Neonatal Research and Education, Women and Infants Research Foundation (WIRF), and the Princess Margaret Hospital (PMH) foundation. TS and ST received an early career grant from WIRF for this work. FH was the recipient of an unrestricted research grant by Medela AG (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; Bjornsson S, 2008, CYTOM PART B-CLIN CY, V74B, P91, DOI 10.1002/cyto.b.20382; Castellote C, 2011, J NUTR, V141, P1181, DOI 10.3945/jn.110.133652; Chatterton DEW, 2013, INT J BIOCHEM CELL B, V45, P1730, DOI 10.1016/j.biocel.2013.04.028; Cossey V, 2013, NEONATOLOGY, V103, P170, DOI 10.1159/000345419; Currie AJ, 2011, INFECT IMMUN, V79, P1588, DOI 10.1128/IAI.00535-10; DAWARKADAS AM, 1991, J TROP PEDIATRICS, V37, P214, DOI 10.1093/tropej/37.5.214; EGLINTON BA, 1994, IMMUNOL CELL BIOL, V72, P306, DOI 10.1038/icb.1994.46; Faucher JL, 2007, CYTOM PART A, V71A, P934, DOI 10.1002/cyto.a.20457; GOLDMAN AS, 1982, J PEDIATR-US, V101, P901, DOI 10.1016/S0022-3476(82)80007-3; Harrington AM, 2012, AM J CLIN PATHOL, V137, P800, DOI 10.1309/AJCPN4G1IZPABRLH; Hassiotou F, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.1; Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242; Hawkes JS, 1999, PEDIATR RES, V45, P648, DOI 10.1203/00006450-199905010-00006; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; JAIN N, 1991, ACTA PAEDIATR SCAND, V80, P395, DOI 10.1111/j.1651-2227.1991.tb11872.x; Jo Y, 2011, KOREAN J LAB MED, V31, P131, DOI 10.3343/kjlm.2011.31.3.131; JOHNSON DF, 1980, INFECT IMMUN, V28, P314; Lavoie PM, 2010, J INFECT DIS, V202, P1754, DOI 10.1086/657143; Lay JC, 2011, INHAL TOXICOL, V23, P392, DOI 10.3109/08958378.2011.575568; LIEBHABER M, 1977, J PEDIATR-US, V91, P897, DOI 10.1016/S0022-3476(77)80885-8; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Marchant EA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/586076; Melville JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00079; Njemini R, 2014, SCAND J IMMUNOL, V79, P75, DOI 10.1111/sji.12142; O'Connell FP, 2004, AM J CLIN PATHOL, V121, P254, DOI 10.1309/617DWB5GNFWXHW4L; OZKARAGOZ F, 1988, PEDIATR RES, V23, P449, DOI 10.1203/00006450-198805000-00001; Park SH, 2014, CYTOM PART B-CLIN CY, V86, P244, DOI [10.1002/cyto.b.21123, 10.1002/cytob.21123]; Patel AL, 2013, J PERINATOL, V33, P514, DOI 10.1038/jp.2013.2; Peroni DG, 2013, J MATERN-FETAL NEO M, V26, P137, DOI 10.3109/14767058.2012.733744; Reber AJ, 2008, VET IMMUNOL IMMUNOP, V123, P305, DOI 10.1016/j.vetimm.2008.02.009; Reber AJ, 2008, VET IMMUNOL IMMUNOP, V123, P186, DOI 10.1016/j.vetimm.2008.01.034; Reber AJ, 2006, VET IMMUNOL IMMUNOP, V109, P139, DOI 10.1016/j.vetimm.2005.08.014; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Riskin A, 2012, PEDIATR RES, V71, P220, DOI 10.1038/pr.2011.34; RODRIGUEZ C, 1989, ACTA PAEDIATR SCAND, V78, P337, DOI 10.1111/j.1651-2227.1989.tb11088.x; Roussel M, 2010, CYTOM PART A, V77A, P552, DOI 10.1002/cyto.a.20893; SCHLESINGER L, 1989, J PEDIATR GASTR NUTR, V8, P89, DOI 10.1097/00005176-198901000-00017; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; Tarcan A, 2004, BIOL NEONATE, V86, P22, DOI 10.1159/000076918; Trend S, 2015, ANTIBACTERIAL DEFENC; Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107; van de Geijn GJ, 2011, CYTOM PART A, V79A, P694, DOI 10.1002/cyto.a.21105; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; World Health Organization March of Dimes The Partnership for Maternal NCH Save the Children, 2012, PARTN MAT NCH SAV CH	46	51	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135580	10.1371/journal.pone.0135580	http://dx.doi.org/10.1371/journal.pone.0135580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288195	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600056
J	Sun, QH; Chou, GX				Sun, Qinhu; Chou, Guixin			Isoflavonoids from Crotalaria albida Inhibit Adipocyte Differentiation and Lipid Accumulation in 3T3-L1 Cells via Suppression of PPAR-gamma Pathway	PLOS ONE			English	Article							PHYTOESTROGEN GENISTEIN; FLAVONOIDS; RATS; ROOTS	Two 2 ''-isopropenyl dihydrofuran isoflavonoids (1 and 3), one 2 ''-isopropenyl dihydrofuran chromone (2), as well as 13 known compounds were isolated from the herbs of Crotalaria albida. Their structures and relative configurations were elucidated via NMR and HRESIMS analyses. The 2 '' S absolute configuration of 1 and 2 were deduced by comparing their NOESY spectra with that of 3, which was determined via single crystal X-ray diffraction (CuK alpha). The 3R absolute configuration of 1 was determined by CD. Compounds 1, 2, and 3 inhibit the adipocyte differentiation and lipid accumulation of 3T3-L1 through down-regulation of PPAR-gamma activity.	[Sun, Qinhu; Chou, Guixin] Shanghai Univ Tradit Chinese Med, MOE Key Lab Standardizat Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Sun, Qinhu; Chou, Guixin] Shanghai R&D Ctr Standardizat Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Chou, GX (corresponding author), Shanghai Univ Tradit Chinese Med, MOE Key Lab Standardizat Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China.	chouguixinzyb@126.com			National Nature Science Foundation of China [21272159]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by http://www.nsfc.gov.cn/, National Nature Science Foundation of China, Guixin Chou, No. 21272159.	Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; Babu UV, 1998, PHYTOCHEMISTRY, V48, P1457, DOI 10.1016/S0031-9422(97)00876-5; Deodato B, 1999, BRIT J PHARMACOL, V128, P1683, DOI 10.1038/sj.bjp.0702973; Djiogue S, 2009, J NAT PROD, V72, P1603, DOI 10.1021/np900271m; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fanti P, 1998, OSTEOPOROSIS INT, V8, P274, DOI 10.1007/s001980050065; Gong ZW, 2009, ENDOCRINOLOGY, V150, P104, DOI 10.1210/en.2008-0322; Harbourne JB, 1992, THE FLAVONOIDS ADVAN; Hu HB, 2011, CHEM PHARM BULL, V59, P135, DOI 10.1248/cpb.59.135; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; HUTCHINS AM, 1995, J AM DIET ASSOC, V95, P769, DOI 10.1016/S0002-8223(95)00214-6; JURD L, 1972, PHYTOCHEMISTRY, V11, P2535, DOI 10.1016/S0031-9422(00)88532-5; Kaplan F, 2001, J CARDIOVASC RISK, V8, P211, DOI 10.1097/00043798-200108000-00005; LAMARTINIERE CA, 1995, CARCINOGENESIS, V16, P2833, DOI 10.1093/carcin/16.11.2833; Lawson MA, 2006, TETRAHEDRON LETT, V47, P451, DOI 10.1016/j.tetlet.2005.11.069; [李云志 LI Yun-zhi], 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P1195; MARKHAM KR, 1978, TETRAHEDRON, V34, P1389, DOI 10.1016/0040-4020(78)88336-7; Matsuura N, 2005, BIOSCI BIOTECH BIOCH, V69, P2470, DOI 10.1271/bbb.69.2470; Meng QH, 1999, BBA-MOL CELL BIOL L, V1438, P369, DOI 10.1016/S1388-1981(99)00062-1; Mezei O, 2003, J NUTR, V133, P1238; Ngadjui BT, 1999, PHYTOCHEMISTRY, V51, P119, DOI 10.1016/S0031-9422(98)00621-9; Pakala Rajbabu, 2004, Cardiovasc Radiat Med, V5, P97, DOI 10.1016/j.carrad.2004.03.006; Priyarega S, 2003, DES MONOMERS POLYM, V6, P187, DOI 10.1163/156855503768338241; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sciences CAo, 1993, FLORA CHINA; Sun Q-H, 2012, THE 10TH NATIONAL SY, P481; Sun QH, 2013, PHYTOCHEM LETT, V6, P449, DOI 10.1016/j.phytol.2013.05.011; Toebes AHW, 2005, J AGR FOOD CHEM, V53, P4660, DOI 10.1021/jf047995f; Ubukata M, 2007, BIOORG MED CHEM LETT, V17, P4767, DOI 10.1016/j.bmcl.2007.06.059; WAGNER H, 1976, TETRAHEDRON LETT, P1799; Weng JR, 2002, HELV CHIM ACTA, V85, P847, DOI 10.1002/1522-2675(200203)85:3<847::AID-HLCA847>3.0.CO;2-6; Zhang GP, 2009, J NAT PROD, V72, P1265, DOI 10.1021/np900144c; Zhang PC, 2003, J ASIAN NAT PROD RES, V5, P131, DOI 10.1080/1028602021000054982; Zhang S, 2010, ACTA CHIM SINICA, V68, P2227; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07375; Zhang Y, 2012, PPAR RES, V2012, DOI 10.1155/2012/374936	37	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135893	10.1371/journal.pone.0135893	http://dx.doi.org/10.1371/journal.pone.0135893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285147	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100086
J	Sun, WC; Song, H; Yao, XL; Ishidaira, H; Xu, ZX				Sun, Wenchao; Song, Hao; Yao, Xiaolei; Ishidaira, Hiroshi; Xu, Zongxue			Changes in Remotely Sensed Vegetation Growth Trend in the Heihe Basin of Arid Northwestern China	PLOS ONE			English	Article							RIVER-BASIN; CLIMATE-CHANGE; TIME-SERIES; NDVI; DYNAMICS; COVER; PATTERNS	The Heihe River Basin (HRB) is the second largest inland river basin in China, characterized by high diversity in geomorphology and irrigated agriculture in middle reaches. To improve the knowledge about the relationship between biotic and hydrological processes, this study used Global Inventory Modeling and Mapping Studies Normalized Difference Vegetation Index (NDVI) data (1982-2006) to analyze spatiotemporal variations in vegetation growth by using the Mann-Kendall test together with Sen's slope estimator. The results indicate that 10.1% and 1.6% of basin area exhibit statistically significant (p < 0.05) upward and downward trends, and maximum magnitude is 0.066/10a and 0.026/10a, respectively. More specifically, an increasing trend was observed in the Qilian Mountains and Hexi Corridor and a decreasing trend detected in the transitional region between them. Increases in precipitation and temperature may be one possible reason for the changes of vegetation growth in the Qilian Mountains. And decreasing trend in transitional region may be driven by the changes in precipitation. Increases of irrigation contribute to the upward trend of NDVI for cropland in the Hexi Corridor, reflecting that agricultural development becomes more intensive. Our study demonstrates the complexity of the response of vegetation growth in the HRB to climate change and anthropogenic activities and correspondingly adopting mechanistic ecological models capable of describing both factors is favorable for reasonable predictions of future vegetation growth. It is also indicated that improving irrigation water use efficiency is one practical strategy to balance water demand between human and natural ecosystems in the HRB.	[Sun, Wenchao; Song, Hao; Yao, Xiaolei; Xu, Zongxue] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Sun, Wenchao; Song, Hao; Yao, Xiaolei; Xu, Zongxue] JCGCS, Beijing, Peoples R China; [Ishidaira, Hiroshi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan	Beijing Normal University; University of Yamanashi	Sun, WC (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	sunny@bnu.edu.cn	Sun, Wenchao/C-7019-2012		National Natural Science Foundation of China [91125015, 41201018]; National Key Technology R&D Program of China [2013BAB05B04]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (Grant No. 91125015, 41201018), National Key Technology R&D Program of China (Grant No. 2013BAB05B04), and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, J CHINA HYDRO, V33, P85; ASRAR G, 1984, AGRON J, V76, P300, DOI 10.2134/agronj1984.00021962007600020029x; Baudena M, 2007, ADV WATER RESOUR, V30, P1320, DOI 10.1016/j.advwatres.2006.11.006; Cao L, 2013, ECOHYDROLOGY, V6, P917, DOI 10.1002/eco.1245; Dai C, 2008, RESOUR SCI, V44, P182; Dai C, 2008, RESOUR SCI, V44, P177; de Beurs KM, 2005, GLOBAL CHANGE BIOL, V11, P779, DOI 10.1111/j.1365-2486.2005.00949.x; DOdorico P., 2006, DRYLAND ECOHYDROLOGY; Dregne H.E., 1992, DEGRADATION RESTORAT; [凡炳文 Fan Bingwen], 2012, [干旱地区农业研究, Agricultural Research in the Arid Areas], V30, P101; Hashimoto H, 2010, GLOBAL CHANGE BIOL, V16, P255, DOI 10.1111/j.1365-2486.2009.01921.x; Hess T, 1996, J ENVIRON MANAGE, V48, P249, DOI 10.1006/jema.1996.0076; Ji XB, 2006, ENVIRON GEOL, V50, P793, DOI 10.1007/s00254-006-0251-z; Kendall M. G., 1975, RANK CORRELATION MET; Li ZL, 2014, STOCH ENV RES RISK A, V28, P1709, DOI 10.1007/s00477-013-0828-5; [李占玲 Li Zhanling], 2011, [资源科学, Resources Science], V33, P1877; Li Z, 2013, REMOTE SENS ENVIRON, V138, P232, DOI 10.1016/j.rse.2013.07.020; [刘敏 Liu Min], 2004, [中国沙漠, Journal of Desert Research], V24, P162; Los SO, 2013, GLOBAL BIOGEOCHEM CY, V27, P318, DOI 10.1002/gbc.20027; Lu L, 2003, J ARID ENVIRON, V53, P395, DOI 10.1006/jare.2002.1032; Ma MG, 2006, INT J REMOTE SENS, V27, P3473, DOI 10.1080/01431160600593031; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Matthews HD, 2004, CLIM DYNAM, V22, P461, DOI 10.1007/s00382-004-0392-2; Neeti N, 2012, REMOTE SENS LETT, V3, P433, DOI 10.1080/01431161.2011.616238; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Pouliot D, 2009, INT J REMOTE SENS, V30, P149, DOI 10.1080/01431160802302090; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Slaymaker O., 1998, PHYS GEOGRAPHY GLOBA; Strengers BJ, 2010, INT J CLIMATOL, V30, P2055, DOI 10.1002/joc.2132; Tan K, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003530; Wu DH, 2014, REMOTE SENS-BASEL, V6, P4217, DOI 10.3390/rs6054217; Xi HY, 2010, HYDROGEOL J, V18, P791, DOI 10.1007/s10040-009-0562-8; Yue S, 2004, WATER RESOUR MANAG, V18, P201, DOI 10.1023/B:WARM.0000043140.61082.60; Zhang YL, 2013, GLOBAL PLANET CHANGE, V108, P139, DOI 10.1016/j.gloplacha.2013.06.012; Zheng S, 2009, S TO N WATER TRANSFE, V7, P77; [郑世泽 ZHENG Shi-ze], 2009, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V7, P45; Zhu JT, 2012, ECOHYDROLOGY, V5, P628, DOI 10.1002/eco.249	40	10	10	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135376	10.1371/journal.pone.0135376	http://dx.doi.org/10.1371/journal.pone.0135376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284656	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100034
J	Yokoyama, A; Yokoyama, T; Matsui, T; Mizukami, T; Kimura, M; Matsushita, S; Higuchi, S; Maruyama, K				Yokoyama, Akira; Yokoyama, Tetsuji; Matsui, Toshifumi; Mizukami, Takeshi; Kimura, Mitsuru; Matsushita, Sachio; Higuchi, Susumu; Maruyama, Katsuya			Alcohol Dehydrogenase-1B (rs1229984) and Aldehyde Dehydrogenase-2 (rs671) Genotypes Are Strong Determinants of the Serum Triglyceride and Cholesterol Levels of Japanese Alcoholic Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INDUCED FATTY LIVER; MIDDLE-AGED MEN; GENETIC POLYMORPHISMS; ADIPONECTIN LEVELS; LIPID-METABOLISM; ALDH2 GENOTYPES; ETHANOL; CONSUMPTION; RISK	Background Elevated serum triglyceride (TG) and high-density-lipoprotein cholesterol (HDL-C) levels are common in drinkers. The fast-metabolizing alcohol dehydrogenase-1B encoded by the ADH1B*2 allele (vs. ADH1B*1/*1 genotype) and inactive aldehyde dehydrogenase-2 encoded by the ALDH2*2 allele (vs. ALDH2*1/*1 genotype) modify ethanol metabolism and are prevalent (approximate to 90% and approximate to 40%, respectively) in East Asians. We attempted to evaluate the associations between the ADH1B and ALDH2 genotypes and lipid levels in alcoholics. Methods The population consisted of 1806 Japanese alcoholic men (>= 40 years) who had undergone ADH1B and ALDH2 genotyping and whose serum TG, total cholesterol, and HDL-C levels in the fasting state had been measured within 3 days after admission. Results High serum levels of TG (>= 150 mg/dl), HDL-C (>80 mg/dl), and low-density-lipoprotein cholesterol (LDL-C calculated by the Friedewald formula >= 140 mg/dl) were observed in 24.3%, 16.8%, and 15.6%, respectively, of the subjects. Diabetes, cirrhosis, smoking, and body mass index (BMI) affected the serum lipid levels. Multivariate analysis revealed that the presence of the ADH1B* 2 allele and the active ALDH2*1/*1 genotype increased the odds ratio (OR; 95% confidence interval) for a high TG level (2.22[1.67-2.94] and 1.39[0.99-1.96], respectively), and decreased the OR for a high HDL-C level (0.37[0.28-0.49] and 0.51 [0.37-0.69], respectively). The presence of the ADH1B*2 allele decreased the OR for a high LDL-C level (0.60[0.45-0.80]). The ADH1B*2 plus ALDH2*1/*1 combination yielded the highest ORs for high TG levels and lowest OR for a high HDL-C level. The genotype effects were more prominent in relation to the higher levels of TG (>= 220 mg/dl) and HDL-C (>= 100 mg/dl). Conclusions The fast-metabolizing ADH1B and active ALDH2, and especially a combination of the two were strongly associated with higher serum TG levels and lower serum HDL-C levels of alcoholics. The fast-metabolizing ADH1B was associated with lower serum LDL-C levels.	[Yokoyama, Akira; Matsui, Toshifumi; Mizukami, Takeshi; Kimura, Mitsuru; Matsushita, Sachio; Higuchi, Susumu; Maruyama, Katsuya] Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa 2390841, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama 3510104, Japan; [Matsui, Toshifumi] Kyorin Univ Hosp, Dept Geriatr Med, Tokyo 1818611, Japan	National Institute of Public Health - Japan; Kyorin University	Yokoyama, A (corresponding author), Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa 2390841, Japan.	a_yokoyama@kurihama1.hosp.go.jp		Matsui, Toshifumi/0000-0002-8478-2809				[Anonymous], HIMAN KENKYU; [Anonymous], 1994, ALCOHOL CLIN EXP RES, V34, P1246, DOI [10.1111/j.1530-0277.2010.01202.x, DOI 10.1111/J.1530-0277.2010.01202.X]; BARAONA E, 1979, J LIPID RES, V20, P289; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Chen XT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-776; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Galli A, 2001, J BIOL CHEM, V276, P68, DOI 10.1074/jbc.M008791200; GOEDDE HW, 1992, HUM GENET, V88, P344; Hao PP, 2010, ATHEROSCLEROSIS, V212, P213, DOI 10.1016/j.atherosclerosis.2010.05.024; Hashimoto Y, 2002, CLIN CHEM, V48, P1043; HIGUCHI S, 1995, AM J PSYCHIAT, V152, P1219; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Husemoen LLN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011735; Ikehara S, 2008, STROKE, V39, P2936, DOI 10.1161/STROKEAHA.108.520288; Iso H, 2004, STROKE, V35, P1124, DOI 10.1161/01.STR.0000124459.33597.00; Japan Atherosclerosis Society, 2007, JAP ATH SOC JAS GUID; Kawamoto R, 2010, J ATHEROSCLER THROMB, V17, P953, DOI 10.5551/jat.4879; Kloner RA, 2007, CIRCULATION, V116, P1306, DOI 10.1161/CIRCULATIONAHA.106.678375; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Maeda S, 2014, ALCOHOL CLIN EXP RES, V38, P1559, DOI 10.1111/acer.12406; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; Nishida M, 2007, MED MOL MORPHOL, V40, P55, DOI 10.1007/s00795-007-0366-7; Nishise Y, 2010, J CLIN ENDOCR METAB, V95, P3828, DOI 10.1210/jc.2009-1862; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; POWNALL HJ, 1994, J LIPID RES, V35, P2105; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Wakabayashi I, 2008, ALCOHOL ALCOHOLISM, V43, P274, DOI 10.1093/alcalc/agn005; Wang X, 2013, STROKE, V44, P1833, DOI 10.1161/STROKEAHA.113.001326; Yokoyama A, 2014, ALCOHOL ALCOHOL; Yokoyama A, 2014, ALCOHOL CLIN EXP RES, V38, P1237, DOI 10.1111/acer.12372; Yokoyama A, 2014, ALCOHOL ALCOHOLISM, V49, P31, DOI 10.1093/alcalc/agt136; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1391, DOI 10.1111/acer.12108; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1123, DOI 10.1111/acer.12069; Yokoyama A, 2012, INT J CANCER, V130, P2949, DOI 10.1002/ijc.26296; Yokoyama A, 2010, ALCOHOL CLIN EXP RES, V34, P1246, DOI 10.1111/j.1530-0277.2010.01202.x; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	41	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0133460	10.1371/journal.pone.0133460	http://dx.doi.org/10.1371/journal.pone.0133460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284938	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100004
J	Carayol, M; Licaj, I; Achaintre, D; Sacerdote, C; Vineis, P; Key, TJ; Moret, NCO; Scalbert, A; Rinaldi, S; Ferrari, P				Carayol, Marion; Licaj, Idlir; Achaintre, David; Sacerdote, Carlotta; Vineis, Paolo; Key, Timothy J.; Moret, N. Charlotte Onland; Scalbert, Augustin; Rinaldi, Sabina; Ferrari, Pietro			Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC	PLOS ONE			English	Article							CANCER; RISK; PARTICIPANTS; PROFILES	Objective Although metabolic profiles have been associated with chronic disease risk, lack of temporal stability of metabolite levels could limit their use in epidemiological investigations. The present study aims to evaluate the reliability over a two-year period of 158 metabolites and compare reliability over time in fasting and non-fasting serum samples. Methods Metabolites were measured with the AbsolueIDQp180 kit (Biocrates, Innsbruck, Austria) by mass spectrometry and included acylcarnitines, amino acids, biogenic amines, hexoses, phosphatidylcholines and sphingomyelins. Measurements were performed on repeat serum samples collected two years apart in 27 fasting men from Turin, Italy, and 39 non-fasting women from Utrecht, The Netherlands, all participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Reproducibility was assessed by estimating intraclass correlation coefficients (ICCs) in multivariable mixed models. Results In fasting samples, a median ICC of 0.70 was observed. ICC values were <0.50 for 48% of amino acids, 27% of acylcarnitines, 18% of lysophosphatidylcholines and 4% of phosphatidylcholines. In non-fasting samples, the median ICC was 0.54. ICC values were <0.50 for 71% of acylcarnitines, 48% of amino acids, 44% of biogenic amines, 36% of sphingomyelins, 34% of phosphatidylcholines and 33% of lysophosphatidylcholines. Overall, reproducibility was lower in non-fasting as compared to fasting samples, with a statistically significant difference for 19-36% of acylcarnitines, phosphatidylcholines and sphingomyelins. Conclusion A single measurement per individual may be sufficient for the study of 73% and 52% of the metabolites showing ICCs >0.50 in fasting and non-fasting samples, respectively. ICCs were higher in fasting samples that are preferable to non-fasting.	[Carayol, Marion; Licaj, Idlir; Achaintre, David; Scalbert, Augustin; Rinaldi, Sabina; Ferrari, Pietro] Int Agcy Res Canc, F-69372 Lyon, France; [Licaj, Idlir] Univ Tromso, Inst Community Med, Fac Hlth Sci, Tromso, Norway; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, AO Citta Salute & Sci, Turin, Italy; [Sacerdote, Carlotta] Ctr Canc Prevent CPO Piemonte, Turin, Italy; [Vineis, Paolo] Human Genet Fdn HuGeF, Turin, Italy; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Key, Timothy J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Moret, N. Charlotte Onland] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands	World Health Organization; International Agency for Research on Cancer (IARC); UiT The Arctic University of Tromso; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Imperial College London; University of Oxford; Utrecht University; Utrecht University Medical Center	Ferrari, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	ferrarip@iarc.fr	Licaj, Idlir/AAC-2772-2021; Scalbert, Augustin/AAX-8160-2021; Onland-Moret, N. Charlotte/G-9185-2011	Scalbert, Augustin/0000-0001-6651-6710; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Sacerdote, Carlotta/0000-0002-8008-5096; Carayol, Marion/0000-0002-4847-5780; Licaj, Idlir/0000-0003-3389-0735	European Union [260791, FP7-KBBE-2010.2.4.1-2]; International Agency for Research on Cancer; Cancer Research UK [16491] Funding Source: researchfish	European Union(European Commission); International Agency for Research on Cancer; Cancer Research UK(Cancer Research UK)	This work was supported by the European Union (EUROCAN FP7-KBBE-2010.2.4.1-2 grant #260791). AS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work reported in this paper was undertaken during the tenure of MC's postdoctoral fellowship awarded by the International Agency for Research on Cancer.	Breier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089728; Cross AJ, 2014, CANCER-AM CANCER SOC, V120, P3049, DOI 10.1002/cncr.28799; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dunn G., 1989, DESIGN ANAL RELIABIL; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Efron B., 1994, INTRO BOOTSTRAP; Fleiss JL., 1999, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923, DOI 10.1002/9781118032923, DOI 10.1002/9781118032923.CHL]; Floegel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021103; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Jenab M, 2009, HUM GENET, V125, P507, DOI 10.1007/s00439-009-0662-5; Leenders M, 2013, NUTR CANCER, V65, P17, DOI 10.1080/01635581.2013.741754; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; McBride KL, 2007, MOL GENET METAB, V90, P217, DOI 10.1016/j.ymgme.2006.08.010; Medina S, 2013, TRAC-TREND ANAL CHEM, V52, P88, DOI 10.1016/j.trac.2013.08.002; Moore SC, 2014, METABOLOMICS, V10, P259, DOI 10.1007/s11306-013-0574-1; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Rappaport S. M., 2008, QUANTITATIVE EXPOSUR; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Sampson JN, 2013, CANCER EPIDEM BIOMAR, V22, P631, DOI 10.1158/1055-9965.EPI-12-1109; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Yu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021230	26	82	83	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135437	10.1371/journal.pone.0135437	http://dx.doi.org/10.1371/journal.pone.0135437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274920	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600067
J	Kastner, B; Behre, S; Lutz, N; Burger, F; Luntz, S; Hinderhofer, K; Bendszus, M; Hoffmann, GF; Ries, M				Kaestner, Baerbel; Behre, Simone; Lutz, Nadine; Buerger, Friederike; Luntz, Steffen; Hinderhofer, Katrin; Bendszus, Martin; Hoffmann, Georg F.; Ries, Markus			Clinical Research in Vulnerable Populations: Variability and Focus of Institutional Review Boards' Responses	PLOS ONE			English	Review							PROTOCOL; STANDARD	Background Children and patients with cognitive deficits may find it difficult to understand the implication of research. In the European Union (EU), clinical studies outside the EU directives concerning medicinal products or medical devices, i.e., "miscellaneous clinical studies", have no legally mandated timelines for institutional review boards' (IRB) decisions. Goal To evaluate the review process of IRBs for two different "miscellaneous" multicenter clinical research protocols involving vulnerable subjects (children and adult stroke patients). Methods Descriptive and comparative statistics. Protocol 1 is a prospective, multicenter, cross-sectional screening study of a symptomatic pediatric population at risk for Fabry disease involving genetic testing (NCT02152189). Protocol 2 is a prospective, multicenter, randomized, controlled, open-label, blinded endpoint post-market study to evaluate the effectiveness of stent retrievers (NCT02135926). After having obtained positive initial IRB votes at the main study site, both protocols were subsequently submitted to the remaining IRBs. Results Protocol 1 was submitted to 19 IRBs. No IRB objected to the study. Median time-to-final vote was 34 (IQR 10-65; range 0 to 130) days. Two IRBs accepted the coordinating center's IRB votes without re-evaluation. Changes to the informed consent documents were asked by 7/19 IRBs, amendments to the protocol by 2. Protocol 2 was submitted to 16 IRBs. Fifteen decisions were made. No IRB objected to the study. Median time-to final vote was 59 (IQR 10 to 65; range 0 to 128) days, which was not statistically significantly different compared with protocol 1 (Wilcoxon test). Two IRBs accepted a previous IRB decision and did not conduct an independent review. Eight/16 IRBs required changes to the informed consent documents; two IRBs recommended an amendment of the protocol. Conclusion Both clinical research protocols involving vulnerable populations were well accepted. IRB workflows and decision times varied substantially. Some IRBs accepted a previous IRB decision without the necessity of another reevaluation process. Requested changes were focused on the informed consent documents. A more standardized approach across jurisdictions is desirable.	[Kaestner, Baerbel; Behre, Simone; Luntz, Steffen] Univ Heidelberg Hosp, Coordinat Ctr Clin Trials KKS, Heidelberg, Germany; [Lutz, Nadine; Buerger, Friederike; Hoffmann, Georg F.; Ries, Markus] Univ Heidelberg Hosp, Ctr Rare Dis, Ctr Pediat & Adolescent Med, Pediat Neurol & Metab Med, Heidelberg, Germany; [Hinderhofer, Katrin] Univ Heidelberg Hosp, Inst Human Genet, Heidelberg, Germany; [Bendszus, Martin] Univ Heidelberg Hosp, Dept Neurol, Neuroradiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Ries, M (corresponding author), Univ Heidelberg Hosp, Ctr Rare Dis, Ctr Pediat & Adolescent Med, Pediat Neurol & Metab Med, Heidelberg, Germany.	markus.ries@uni-heidelberg.de	Ries, Markus/AAE-4934-2020	Ries, Markus/0000-0002-5054-5741	Shire; Stryker; Covidien; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Shire; Stryker; Covidien; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Study 1 was supported by Shire. Study 2 was supported by Stryker and Covidien. We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ICH HARM TRIP GUID G; Commission E, 2015, ETH CONS CLIN TRIALS; DuBois JM, 2012, AM J PUBLIC HEALTH, V102, P2220, DOI 10.2105/AJPH.2012.300757; European Commission, 2015, EUDRALEX; Food and Drug Administration, 2014, INF CONS INF SHEET G; Green LA, 2006, HEALTH SERV RES, V41, P214, DOI 10.1111/j.1475-6773.2005.00458.x; hhs, 1979, BELM REP ETH PRINC G; Mansbach J, 2007, ACAD EMERG MED, V14, P377, DOI 10.1197/j.aem.2006.11.031; McWilliams R, 2003, JAMA-J AM MED ASSOC, V290, P360, DOI 10.1001/jama.290.3.360; National Bioethics Advisory Commission, 2001, REP REC ETH POL ISS; Stair TO, 2001, ACAD EMERG MED, V8, P636, DOI 10.1111/j.1553-2712.2001.tb00177.x; World Medical Association, 2013, DECL HELS ETH PRINC	12	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135997	10.1371/journal.pone.0135997	http://dx.doi.org/10.1371/journal.pone.0135997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275228	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600140
J	Katsanos, K; Spiliopoulos, S; Saha, P; Diamantopoulos, A; Karunanithy, N; Krokidis, M; Modarai, B; Karnabatidis, D				Katsanos, Konstantinos; Spiliopoulos, Stavros; Saha, Prakash; Diamantopoulos, Athanasios; Karunanithy, Narayan; Krokidis, Miltiadis; Modarai, Bijan; Karnabatidis, Dimitris			Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							HEART-ASSOCIATION; ASPIRIN; PROGRESSION; MANAGEMENT; CILOSTAZOL; PAIRWISE; STROKE; TRIALS	There is a lack of consensus regarding which type of antiplatelet agent should be used in patients with peripheral arterial disease (PAD) and little is known on the advantages and disadvantages of dual antiplatelet therapy. We conducted a systematic review and network meta-analysis of available randomized controlled trials (RCT) comparing different antiplatelet drugs (Aspirin, Ticlopidine, Clopidogrel, Ticagrelor, Cilostazol, Picotamide and Vorapaxar as monotherapies or in combination with aspirin) in PAD patients (PROSPERO public database; CRD42014010299). We collated evidence from previous relevant meta-analyses and searched online databases. Primary efficacy endpoints were: (1) the composite rate of major adverse cardiovascular events (MACE; including vascular deaths, non-fatal myocardial infarction and non-fatal stroke), and (2) the rate of major leg amputations. The primary safety endpoint was the rate of severe bleeding events. Bayesian models were employed for multiple treatment comparisons and risk-stratified hierarchies of comparative efficacy were produced to aid medical decision making. Number-Needed-to-Treat (NNT) and Number-Needed-to-Harm (NNH) are reported in case of significant results. We analyzed 49 RCTs comprising 34,518 patients with 88,358 person-years of follow-up with placebo as reference treatment. Aspirin, Cilostazol, Vorapaxar and Picotamide were ineffective in reducing MACE. A significant MACE reduction was noted with Ticagrelor plus aspirin (RR: 0.67; 95% CrI: 0.46-0.96, NNT = 66), Clopidogrel (RR: 0.72; 95% CrI: 0.58-0.91, NNT = 80), Ticlopidine (RR: 0.75; 95% CrI: 0.58-0.96, NNT = 87), and Clopidogrel plus aspirin (RR: 0.78; 95% CrI: 0.61-0.99, NNT = 98). Dual antiplatelet therapy with Clopidogrel plus aspirin significantly reduced major amputations following leg revascularization (RR: 0.68; 95% CrI: 0.46-0.99 compared to aspirin, NNT = 94). The risk of severe bleeding was significantly higher with Ticlopidine (RR: 5.03; 95% CrI: 1.23-39.6, NNH = 25), Vorapaxar (RR: 1.80; 95% CrI: 1.22-2.69, NNH = 130), and Clopidogrel plus aspirin (RR: 1.48; 95% CrI: 1.05-2.10, NNH = 215). Clopidogrel monotherapy showed the most favourable benefit-harm profile (79% cumulative rank probability best and 77% cumulative rank probability safest). In conclusion, Clopidogrel should be the indicated antiplatelet agent in PAD patients. Dual antiplatelet therapy with aspirin and Clopidogrel can reduce the rate of major leg amputations following revascularization, but carries a slightly higher risk of severe bleeding.	[Katsanos, Konstantinos; Diamantopoulos, Athanasios; Karunanithy, Narayan] Kings Hlth Partners, NHS Fdn Trust, Guys Hosp, Dept Intervent Radiol, London, England; [Katsanos, Konstantinos; Diamantopoulos, Athanasios; Karunanithy, Narayan] Kings Hlth Partners, NHS Fdn Trust, St Thomas Hosp, Dept Intervent Radiol, London, England; [Katsanos, Konstantinos; Spiliopoulos, Stavros; Karnabatidis, Dimitris] Patras Univ Hosp, Sch Med, Dept Intervent Radiol, Rion, Greece; [Saha, Prakash; Modarai, Bijan] Kings Coll London, Acad Dept Surg, Cardiovasc Div, BHF Ctr Res Excellence, London WC2R 2LS, England; [Saha, Prakash; Modarai, Bijan] Kings Hlth Partners, St Thomas Hosp, NIHR Biomed Res Ctr, London, England; [Krokidis, Miltiadis] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Intervent Radiol, Cambridge, England	Guy's & St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of London; King's College London; University of Patras; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Katsanos, K (corresponding author), Kings Hlth Partners, NHS Fdn Trust, Guys Hosp, Dept Intervent Radiol, London, England.	konstantinos.katsanos@gstt.nhs.uk	Krokidis, Miltiadis/AAE-8369-2019; Spiliopoulos, Stavros/I-9280-2019	Krokidis, Miltiadis/0000-0002-2191-240X; Spiliopoulos, Stavros/0000-0003-1860-0568; saha, prakash/0000-0002-9591-1063; Diamantopoulos, Athanasios/0000-0001-9970-0522; Karunanithy, Narayan/0000-0003-0213-1402; Modarai, Bijan/0000-0003-4460-5768	British Heart Foundation [FS/11/37/28819] Funding Source: researchfish; National Institute for Health Research [CL-2011-17-006] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))		Achana FA, 2013, STAT MED, V32, P752, DOI 10.1002/sim.5539; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Belch JJF, 2010, J VASC SURG, V52, P825, DOI 10.1016/j.jvs.2010.04.027; Berger JS, 2011, AM HEART J, V162, P115, DOI 10.1016/j.ahj.2011.04.006; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cacoub PP, 2009, EUR HEART J, V30, P192, DOI 10.1093/eurheartj/ehn534; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Katsanos K, 2014, CARDIOVASC INTER RAD, V37, P592, DOI 10.1007/s00270-014-0876-3; Katsanos K, 2014, J VASC SURG, V59, P1123, DOI 10.1016/j.jvs.2014.01.041; Makowsky MJ, 2008, AM HEART J, V155, P348, DOI 10.1016/j.ahj.2007.09.005; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Muhlestein JB, 2013, J AM COLL CARDIOL, V61, pE1155, DOI 10.1016/j.jacc.2013.01.004; Narins CR, 2004, ARCH INTERN MED, V164, P440, DOI 10.1001/archinte.164.4.440; NICE, 2012, CLINICAL GUIDELINE 1; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Patel MR, 2015, EUR J PREV CARDIOL, V22, P734, DOI 10.1177/2047487314533215; Patel MR, 2011, CIRCULATION, V124; Pignone M, 2010, CIRCULATION, V121, P2694, DOI 10.1161/CIR.0b013e3181e3b133; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Rooke TW, 2011, J VASC SURG, V54, pE32, DOI 10.1016/j.jvs.2011.09.001; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Serneri GGN, 2004, EUR HEART J, V25, P1845, DOI 10.1016/j.ehj.2004.07.013; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Tepe G, 2012, EUR RADIOL, V22, P1998, DOI 10.1007/s00330-012-2441-2; Thompson PD, 2002, AM J CARDIOL, V90, P1314, DOI 10.1016/S0002-9149(02)02869-2; Uchiyama S, 2009, J STROKE CEREBROVASC, V18, P482, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.010; Wijeyeratne YD, 2011, BRIT J CLIN PHARMACO, V72, P647, DOI 10.1111/j.1365-2125.2011.03999.x	40	63	66	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135692	10.1371/journal.pone.0135692	http://dx.doi.org/10.1371/journal.pone.0135692			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274912	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600097
J	Nishikawa, Y; Furukawa, A; Shiga, I; Muroi, Y; Ishii, T; Hongo, Y; Takahashi, S; Sugawara, T; Koshino, H; Ohnishi, M				Nishikawa, Yoshifumi; Furukawa, Ayumi; Shiga, Ikumi; Muroi, Yoshikage; Ishii, Toshiaki; Hongo, Yayoi; Takahashi, Shunya; Sugawara, Tatsuya; Koshino, Hiroyuki; Ohnishi, Masao			Cytoprotective Effects of Lysophospholipids from Sea Cucumber Holothuria atra	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; STICHOPUS-JAPONICUS SELENKA; ANTIFUNGAL GLYCOSIDES; HOLOTOXIN-A; CELLS; LYSOPHOSPHATIDYLCHOLINES; INVERTEBRATES; BIOSYNTHESIS; SAPOGENOL; EXTRACTS	Lysophospholipids are important signaling molecules in animals and metazoan cells. They are widely distributed among marine invertebrates, where their physiological roles are unknown. Sea cucumbers produce unique lysophospholipids. In this study, two lysophospholipids were detected in Holothuria atra for the first time, lyso-platelet activating factor and lysophosphatidylcholine, with nuclear magnetic resonance and liquid chromatography-time-of-flight mass spectrometric analyses. The lipid fraction of H. atra contained lyso-platelet activating factor and lysophosphatidylcholine, and inhibited H2O2-induced apoptosis in the macrophage cell line J774A. 1. The antioxidant activity of the lysophospholipid-containing lipid fraction of H. atra was confirmed with the oxygen radical absorbance capacity method. Our results suggest that the lysophospholipids from H. atra are potential therapeutic agents for the inflammation induced by oxidative stress.	[Nishikawa, Yoshifumi; Furukawa, Ayumi; Shiga, Ikumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Muroi, Yoshikage; Ishii, Toshiaki] Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Obihiro, Hokkaido 080, Japan; [Hongo, Yayoi; Takahashi, Shunya; Koshino, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Sugawara, Tatsuya] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto, Japan; [Ohnishi, Masao] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 080, Japan	Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine; RIKEN; Kyoto University; Obihiro University of Agriculture & Veterinary Medicine	Nishikawa, Y (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 080, Japan.	nisikawa@obihiro.ac.jp	Koshino, Hiroyuki/N-7948-2015; Koshino, Hiroyuki/ABF-4899-2021	Koshino, Hiroyuki/0000-0002-0954-9839; Koshino, Hiroyuki/0000-0002-0954-9839; Sugawara, Tatsuya/0000-0002-1203-5521	MEXT, Japan; Lipid Dynamics Program of RIKEN; Grants-in-Aid for Scientific Research [15K07421] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Lipid Dynamics Program of RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Global COE Program "Frontier Program for Animal Global Health and Hygiene", MEXT, Japan. This work was also supported in part by the Lipid Dynamics Program of RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althunibat O.Y., 2009, EUR J SCI RES, V37, P376; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356; Bin Hashim Ridzwan, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P614, DOI 10.12980/APJTB.4.201414B154; BRACHWITZ H, 1995, PHARMACOL THERAPEUT, V66, P39, DOI 10.1016/0163-7258(95)00001-W; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Butler AJ, 1996, J CHEM ECOL, V22, P2041, DOI 10.1007/BF02040094; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; CONVERT O, 1984, BIOCHIM BIOPHYS ACTA, V794, P320, DOI 10.1016/0005-2760(84)90162-0; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Esmat AY, 2013, NUTRITION, V29, P258, DOI 10.1016/j.nut.2012.06.004; Hamel Jean-Francois, 2004, FAO Fisheries Technical Paper, V463, P359; Herencia F, 1998, LIFE SCI, V62, pPL115, DOI 10.1016/S0024-3205(97)01188-0; Ibrahim CO, 1995, BIOSCI PENANG, V6, P40; KITAGAWA I, 1976, CHEM PHARM BULL, V24, P266; KITAGAWA I, 1976, CHEM PHARM BULL, V24, P275; MANGOLD HK, 1987, LIPIDS, V22, P789, DOI 10.1007/BF02535533; Ogushi M, 2005, FOOD SCI TECHNOL RES, V11, P202, DOI 10.3136/fstr.11.202; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shin BA, 1999, J NAT PROD, V62, P1554, DOI 10.1021/np990303a; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Steel HC, 2002, APMIS, V110, P158, DOI 10.1034/j.1600-0463.2002.100206.x; Sugawara T, 2006, BIOSCI BIOTECH BIOCH, V70, P2906, DOI 10.1271/bbb.60318; SUGIURA T, 1992, BIOCHIM BIOPHYS ACTA, V1126, P298, DOI 10.1016/0005-2760(92)90244-P; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Welch EJ, 2009, MOL PHARMACOL, V75, P227, DOI 10.1124/mol.108.051003; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Yamada K, 2002, YAKUGAKU ZASSHI, V122, P1133, DOI 10.1248/yakushi.122.1133; YAYLI N, 1994, J NAT PROD, V57, P84, DOI 10.1021/np50103a012; Zhang P, 2014, DEV COMP IMMUNOL, V44, P370, DOI 10.1016/j.dci.2014.01.013	31	8	9	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135701	10.1371/journal.pone.0135701	http://dx.doi.org/10.1371/journal.pone.0135701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275144	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600099
J	Taubel, J; Ferber, G; Lorch, U; Wang, DL; Sust, M; Camm, AJ				Taeubel, Joerg; Ferber, Georg; Lorch, Ulrike; Wang, Duolao; Sust, Mariano; Camm, A. John			Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval - A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity	PLOS ONE			English	Article							THOROUGH QT/QTC; HEALTHY-SUBJECTS	Background E-52862 is a Sigma-1 receptor antagonist (S1RA) currently under investigation as a potential analgesic medicine. We successfully applied a concentration-effect model retrospectively to a four-way crossover Phase I single ascending dose study and utilized the QTc shortening effects of a meal to demonstrate assay sensitivity by establishing the time course effects from baseline in all four periods, independently from any potential drug effects. Methods Thirty two healthy male and female subjects were included in four treatment periods to receive single ascending doses of 500 mg, 600 mg or 800 mg of E-52862 or placebo. PK was linear over the dose range investigated and doses up to 600 mg were well tolerated. The baseline electrocardiography (ECG) measurements on Day-1 were time-matched with ECG and pharmacokinetic (PK) samples on Day 1 (dosing day). Results In this conventional mean change to time-matched placebo analysis, the largest time-matched difference to placebo QTcI was 1.44 ms (90% CI: -4.04, 6.93 ms) for 500 mg; -0.39 ms (90% CI: -3.91, 3.13 ms) for 600 mg and 1.32 ms (90% CI: -1.89, 4.53 ms) for 800 mg of E-52862, thereby showing the absence of any QTc prolonging effect at the doses tested. In addition concentration-effect models, one based on the placebo corrected change from baseline and one for the change of QTcI from average baseline with time as fixed effect were fitted to the data confirming the results of the time course analysis. Conclusion The sensitivity of this study to detect small changes in the QTc interval was confirmed by demonstrating a shortening of QTcF of -8.1 (90% CI: -10.4, -5.9) one hour and -7.2 (90% CI: -9.4, -5.0) three hours after a standardised meal.	[Taeubel, Joerg; Lorch, Ulrike] St Georges Univ London, Richmond Pharmacol Ltd, London, England; [Ferber, Georg] Stat Georg Ferber GmbH, Riehen, Switzerland; [Wang, Duolao] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Sust, Mariano] ESTEVE Res & Dev, Dept Clin Invest, Barcelona, Spain; [Taeubel, Joerg; Camm, A. John] St Georges Univ London, Cardiovasc & Cell Sci Res Inst, London, England	St Georges University London; Liverpool School of Tropical Medicine; University of Liverpool; Esteve; St Georges University London	Taubel, J (corresponding author), St Georges Univ London, Richmond Pharmacol Ltd, Cranmer Terrace, London, England.	j.taubel@sgul.ac.uk	Taubel, Jorg/I-1286-2019	Taubel, Jorg/0000-0002-0010-207X; Sust, Mariano/0000-0003-1908-9271; Wang, Duolao/0000-0003-2788-2464	Esteve [E-52862]; Richmond Pharmacology	Esteve; Richmond Pharmacology	Esteve funded a clinical trial investigating E-52862 which is in development as a potential an analgesic substance; Esteve and Richmond Pharmacology as an academic rather than commercial entity funded this supplementary analysis and publication of this manuscript. Richmond Pharmacology Ltd., Statistik Georg Ferber GmbH and Esteve played no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript, beyond the provision of funding. The individual authors' contributions are specified in the submission online form.	Abadias M, 2013, BRIT J CLIN PHARMACO, V75, P103, DOI 10.1111/j.1365-2125.2012.04333.x; [Anonymous], 2014, R LANG ENV STAT COMP; Darpo B, 2010, BRIT J PHARMACOL, V159, P49, DOI 10.1111/j.1476-5381.2009.00487.x; Darpo B, 2014, ANN NONINVAS ELECTRO, V19, P70, DOI 10.1111/anec.12128; Das S, 2014, J CLIN PHARMACOL, V54, P331, DOI 10.1002/jcph.199; Dixon R, 2008, BRIT J CLIN PHARMACO, V66, P396, DOI 10.1111/j.1365-2125.2008.03250.x; Ferber G, 2014, J CLIN PHARM; Florian JA, 2011, J CLIN PHARMACOL, V51, P1152, DOI 10.1177/0091270010381498; GALEAZZI RL, 1976, CLIN PHARMACOL THER, V20, P278; Garnett C, 2011, EXPOSURE RESPONSE MO; Garnett CE, 2008, J CLIN PHARMACOL, V48, P13, DOI 10.1177/0091270007307881; Hnatkova K, 2014, J ELECTROCARDIOL; Hug B, 2010, CLIN CANCER RES, V16, P4016, DOI 10.1158/1078-0432.CCR-10-0280; ICH E14, 2005, INT C HARM STEP 4 GU; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; Pinheiro J., 2014, NLME LINEAR NONLINEA, V3, P1; Piotrovsky V, 2005, AAPS J, V7, pE609, DOI 10.1208/aapsj070363; Spyker DA, 2014, J CLIN PHARMACOL, V54, P665, DOI 10.1002/jcph.257; Taubel J, 2014, J ELECTROCARDIOL; Taubel J, 2013, BRIT J CLIN PHARMACO, V75, P392, DOI 10.1111/j.1365-2125.2012.04376.x; Taubel J, 2012, J CLIN PHARMACOL, V52, P1558, DOI 10.1177/0091270011419851; Zhang J, 2008, J BIOPHARM STAT, V18, P451, DOI 10.1080/10543400802020938	22	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136369	10.1371/journal.pone.0136369	http://dx.doi.org/10.1371/journal.pone.0136369			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291080	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900080
J	von Wowern, E; Ostling, G; Nilsson, PM; Olofsson, P				von Wowern, Emma; Ostling, Gerd; Nilsson, Peter M.; Olofsson, Per			Digital Photoplethysmography for Assessment of Arterial Stiffness: Repeatability and Comparison with Applanation Tonometry	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; AORTIC AUGMENTATION INDEX; VENTRICULAR EJECTION TIME; FINGER PHOTOPLETHYSMOGRAM; HYPERTENSIVE PATIENTS; CARDIOVASCULAR RISK; VOLUME PULSE; HEART-RATE; PLETHYSMOGRAPHY; REPRODUCIBILITY	Introduction Arterial stiffness is an independent risk factor for cardiovascular morbidity and can be assessed by applanation tonometry by measuring pulse wave velocity (PWV) and augmentation index (AIX) by pressure pulse wave analysis (PWA). As an inexpensive and operator independent alternative, photoelectric plethysmography (PPG) has been introduced with analysis of the digital volume pulse wave (DPA) and its second derivatives of wave reflections. Objective The objective was to investigate the repeatability of arterial stiffness parameters measured by digital pulse wave analysis (DPA) and the associations to applanation tonometry parameters. Methods and Results 112 pregnant and non-pregnant individuals of different ages and genders were examined with SphygmoCor arterial wall tonometry and Meridian DPA finger photoplethysmography. Coefficients of repeatability, Bland-Altman plots, intraclass correlation coefficients and correlations to heart rate (HR) and body height were calculated for DPA variables, and the DPA variables were compared to tonometry variables left ventricular ejection time (LVET), PWV and AIX. No DPA variable showed any systematic measurement error or excellent repeatability, but dicrotic index (DI), dicrotic dilatation index (DDI), cardiac ejection elasticity index (EEI), aging index (AI) and second derivatives of the crude pulse wave curve, b/a and e/a, showed good repeatability. Overall, the correlations to AIX were better than to PWV, with correlations coefficients >0.70 for EEI, AI and b/a. Considering the level of repeatability and the correlations to tonometry, the overall best DPA parameters were EEI, AI and b/a. The two pansystolic time parameters, ejection time compensated ( ETc) by DPA and LVET by tonometry, showed a significant but weak correlation. Conclusion For estimation of the LV function, ETc, EEI and b/a are suitable, for large artery stiffness EEI, and for small arteries DI and DDI. The only global parameter, AI, showed a high repeatability and the overall best correlations with AIX and PWV.	[von Wowern, Emma; Olofsson, Per] Lund Univ, Skane Univ Hosp, Inst Clin Sci, Dept Obstet & Gynecol, Malmo, Sweden; [Ostling, Gerd; Nilsson, Peter M.] Lund Univ, Skane Univ Hosp, Inst Clin Sci, Med Res Unit,Dept Internal Med, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	von Wowern, E (corresponding author), Lund Univ, Skane Univ Hosp, Inst Clin Sci, Dept Obstet & Gynecol, Malmo, Sweden.	emma.von_wowern@med.lu.se		Venkatasubramanian, Siddharth/0000-0002-5860-0768	Lund University Medical Faculty; Region Skane	Lund University Medical Faculty; Region Skane	The study was supported by grants from the Lund University Medical Faculty and Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONELLI L, 1994, PROCEEDINGS OF THE 16TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY - ENGINEERING ADVANCES: NEW OPPORTUNITIES FOR BIOMEDICAL ENGINEERS, PTS 1&2, P1216, DOI 10.1109/IEMBS.1994.415400; Avolio A, 2002, J HYPERTENS, V20, P2341, DOI 10.1097/00004872-200212000-00007; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bazett H. C., 1920, HEART, V7, P35; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bortolotto LA, 2000, AM J HYPERTENS, V13, P165, DOI 10.1016/S0895-7061(99)00192-2; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; CHIRIFE R, 1971, AM HEART J, V82, P222, DOI 10.1016/0002-8703(71)90269-9; Davies JI, 2003, J HYPERTENS, V21, P463, DOI 10.1097/00004872-200303000-00004; DORLAS JC, 1985, BRIT J ANAESTH, V57, P524, DOI 10.1093/bja/57.5.524; Elgendi M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-139; Elgendi M, 2014, COMPUT METH PROG BIO, V117, P125, DOI 10.1016/j.cmpb.2014.08.001; Elgendi M, 2012, CURR CARDIOL REV, V8, P215, DOI 10.2174/157340312803217184; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Gonzalez R, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P177, DOI 10.1109/CIC.2008.4749006; Hashimoto J, 2002, J HYPERTENS, V20, P2415, DOI 10.1097/00004872-200212000-00021; Hyun Jae Baek, 2007, 6th International Special Topic Conference on Information Technology Applications in Biomedicine, 2007, P70; Imanaga I, 1998, JPN HEART J, V39, P775; ISHIKAWA H, 1975, JPN CIRC J, V39, P133, DOI 10.1253/jcj.39.133; Jang DG, 2015, IEEE J BIOMED HEALTH, V19, P256, DOI 10.1109/JBHI.2014.2306679; Jang DG, 2010, INT CONF SIGN PROCES, P1742, DOI 10.1109/ICOSP.2010.5656481; Jang DG, 2010, INT CONF SIGN PROCES, P1734, DOI 10.1109/ICOSP.2010.5656472; Janner JH, 2012, J HUM HYPERTENS, V26, P476, DOI 10.1038/jhh.2011.59; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; Kelly RP, 2001, HYPERTENSION, V37, P1429, DOI 10.1161/01.HYP.37.6.1429; Korhonen I, 2009, ACTA ANAESTH SCAND, V53, P975, DOI 10.1111/j.1399-6576.2009.02026.x; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; LEWIS RP, 1977, CIRCULATION, V56, P146, DOI 10.1161/01.CIR.56.2.146; Millasseau SC, 2006, J HYPERTENS, V24, P1449, DOI 10.1097/01.hjh.0000239277.05068.87; Millasseau SC, 2002, CLIN SCI, V103, P371, DOI 10.1042/cs1030371; Millasseau SC, 2000, HYPERTENSION, V36, P952, DOI 10.1161/01.HYP.36.6.952; Murray WB, 1996, J CLIN MONITOR, V12, P365, DOI 10.1007/BF02077634; Nichols W, 1998, MCDONALDS BLOOD FLOW; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Nurnberger J, 2002, J HYPERTENS, V20, P2407, DOI 10.1097/00004872-200212000-00020; Otsuka T, 2006, CIRC J, V70, P304, DOI 10.1253/circj.70.304; Ozawa T., 1978, MYAKUHA, V8, P22; Patvardhan E, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/253758; PORTNEY LG, 1993, FDN CLIN RES APPL PR, P509; Quan H, 1996, BIOMETRICS, V52, P1195, DOI 10.2307/2532835; Salvi V, 2010, BRIT J PHARMACOL, V159, P34, DOI 10.1111/j.1476-5381.2009.00427.x; Sharma T., 2012, THESIS THAPAR U PATI; Skinner SL, CLIN GUIDE PULSE WAV; Takada H, 1996, MED PROG TECHNOL, V21, P205, DOI 10.1023/A:1016936206694; Takazawa K, 1998, HYPERTENSION, V32, P365, DOI 10.1161/01.HYP.32.2.365; Vas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059809, 10.1371/journal.pone.0073990]; WEISSLER AM, 1961, AM HEART J, V62, P367, DOI 10.1016/0002-8703(61)90403-3; Wilkinson IB, 2002, AM J HYPERTENS, V15, P24, DOI 10.1016/S0895-7061(01)02252-X; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595	51	54	57	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135659	10.1371/journal.pone.0135659	http://dx.doi.org/10.1371/journal.pone.0135659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291079	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900025
J	Liu, Y; Wang, L; Cai, ZF; Zhao, P; Peng, CJ; Zhao, LJ; Wan, CD				Liu, Yao; Wang, Ling; Cai, Zhifang; Zhao, Peng; Peng, Cijun; Zhao, Lijin; Wan, Chidan			The Decrease of Peripheral Blood CD4+T Cells Indicates Abdominal Compartment Syndrome in Severe Acute Pancreatitis	PLOS ONE			English	Article							INTRAABDOMINAL HYPERTENSION; PRACTICE GUIDELINES; LYMPHOCYTE SUBSETS; PROSPECTIVE COHORT; REDUCTION	Objective Few data are available on the role of T lymphocytes and inflammatory cytokines in abdominal compartment syndrome (ACS) in severe acute pancreatitis (SAP). We conducted a retrospective study to assess the risk factors associated with ACS in SAP. Methods A total of 76 SAP patients who were admitted within 24 hours after symptom onset in our study. There were 36 patients suffering from ACS and 40 from intra-abdominal hypertension (IAH). On the 1st, 3rd and 7th days after hospital admission, the following variables were assessed: serum value of C-reactive protein (CRP), and the proportions of peripheral CD4(+) and CD8(+) T lymphocytes. Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and computed tomography severity index (CTSI) score were assessed on days 1 and 7 after hospitalization. Results Compared with the patients with IAH, ACS patients showed statistically higher CRP value on 7th day after hospital admission, proportions of CD4(+) T cells on days 1, 3, 7 and CD4(+)/CD8(+) ratio on day 1 were significantly lower (P < 0.05, respectively). A CD4(+) T cell proportion of 30.3% on the 1st day indicated ACS with an area under the curve (AUC) of 0.774, a sensitivity with 82.5% and specificity with 72.0%, respectively. Sensitivity/specificity for predicting ACS in SAP patients on day 1 was 70.0%/68.0% for CD4(+)/CD8(+) ratio, 72.2%/65.0% for APACHE II score. Conclusions The reduction of peripheral blood CD4(+) T lymphocytes is associated with ACS in SAP, and may act as a potential predictor of ACS in SAP.	[Liu, Yao; Wan, Chidan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Hepatobiliary Surg, Wuhan 430074, Hubei Province, Peoples R China; [Liu, Yao; Wang, Ling; Cai, Zhifang; Zhao, Peng; Peng, Cijun; Zhao, Lijin] Zunyi Med Coll, Affiliated Hosp, Dept Hepatobiliary & Pancreat Surg, Zunyi, Guizhou Provinc, Peoples R China	Huazhong University of Science & Technology; Zunyi Medical University	Peng, CJ (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Hepatobiliary & Pancreat Surg, Zunyi, Guizhou Provinc, Peoples R China.	cijunpeng@163.com; chidanwan@126.com						Al-Bahrani AZ, 2008, PANCREAS, V36, P39, DOI 10.1097/mpa.0b013e318149f5bf; [Anonymous], 2005, GUT, V54, pi1; Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Banks PA, 1997, AM J GASTROENTEROL, V92, P377; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Carroll JK, 2007, AM FAM PHYSICIAN, V75, P1513; CURLEY PJ, 1993, BRIT J SURG, V80, P1312, DOI 10.1002/bjs.1800801031; De Waele JJ, 2005, CRIT CARE, V9, pR452, DOI 10.1186/cc3754; Demols A, 2000, GASTROENTEROLOGY, V118, P582, DOI 10.1016/S0016-5085(00)70265-4; Deng ZG, 2011, WORLD J GASTROENTERO, V17, P4911, DOI 10.3748/wjg.v17.i44.4911; Group of Pancreas Surgery Chinese Society of Surgery Chinese Medical Association, 2007, Zhonghua Wai Ke Za Zhi, V45, P727; Gurleyik G, 2005, J PANCREAS, V6, P562; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Ke L, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000108; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Nakayama S, 2014, PANCREAS, V43, P28, DOI 10.1097/MPA.0b013e3182a7c76b; Nawaz H, 2013, AM J GASTROENTEROL, V108, P1911, DOI 10.1038/ajg.2013.348; Oiva J, 2010, CRIT CARE, V14, DOI 10.1186/cc9329; Patel A, 2007, AM J ROENTGENOL, V189, P1037, DOI 10.2214/AJR.07.2092; PEZZILLI R, 1995, PANCREAS, V11, P95, DOI 10.1097/00006676-199507000-00010; Pietruczuk M, 2006, WORLD J GASTROENTERO, V12, P5344, DOI 10.3748/wjg.v12.i33.5344; Takeyama Y, 2000, J GASTROINTEST SURG, V4, P379, DOI 10.1016/S1091-255X(00)80016-5; Werner J, 2003, PANCREATOLOGY, V3, P115, DOI 10.1159/000070079; Wu BU, 2008, GUT, V57, P1698, DOI 10.1136/gut.2008.152702	28	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135768	10.1371/journal.pone.0135768	http://dx.doi.org/10.1371/journal.pone.0135768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287969	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600067
J	Reimers, AC				Reimers, Arne C.			Obstructions to Sampling Qualitative Properties	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; METABOLIC NETWORK; THERMODYNAMIC CONSTRAINTS; VOLUME; DISTRIBUTIONS; MODELS; STATES; SPACE	Background Sampling methods have proven to be a very efficient and intuitive method to understand properties of complicated spaces that cannot easily be computed using deterministic methods. Therefore, sampling methods became a popular tool in the applied sciences. Results Here, we show that sampling methods are not an appropriate tool to analyze qualitative properties of complicated spaces unless RP = NP. We illustrate these results on the example of the thermodynamically feasible flux space of genome-scale metabolic networks and show that with artificial centering hit and run (ACHR) not all reactions that can have variable flux rates are sampled with variables flux rates. In particular a uniform sample of the flux space would not sample the flux variabilities completely. Conclusion We conclude that unless theoretical convergence results exist, qualitative results obtained from sampling methods should be considered with caution and if possible double checked using a deterministic method.	Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands		Reimers, AC (corresponding author), Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands.	arne.c.reimers@gmail.com			Berlin Mathematical School; European Research Consortium for Informatics and Mathematics	Berlin Mathematical School; European Research Consortium for Informatics and Mathematics	Funding: This work was supported by Berlin Mathematical School (PhD-stipend) (www.math-berlin.de) and European Research Consortium for Informatics and Mathematics ("Alain Bensoussan Fellowship Programme") (https://fellowship.ercim.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARANY I, 1987, DISCRETE COMPUT GEOM, V2, P319, DOI 10.1007/BF02187886; Beard DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE633, DOI 10.1152/ajpendo.00239.2004; Beard DA, 2004, J THEOR BIOL, V228, P327, DOI 10.1016/j.jtbi.2004.01.008; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Binns M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0476-5; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Braunstein A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-240; Cogne G, 2011, BIOTECHNOL PROGR, V27, P631, DOI 10.1002/btpr.596; De Martino D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122670; DYER M, 1991, J ACM, V38, P1, DOI 10.1145/102782.102783; ELEKES G, 1986, DISCRETE COMPUT GEOM, V1, P289, DOI 10.1007/BF02187701; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fleming RMT, 2009, BIOPHYS CHEM, V145, P47, DOI 10.1016/j.bpc.2009.08.007; Font-Clos F, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11003; Gudmundsson S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-489; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Jol SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002415; Kaleta C., 2009, LECT NOTES INFORM P, VP-157, P179; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Kelk SM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00580; Kummel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-512; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Lovasz L, 2006, J COMPUT SYST SCI, V72, P392, DOI 10.1016/j.jcss.2005.08.004; Lovasz L, 1999, MATH PROGRAM, V86, P443, DOI 10.1007/s101070050099; Machado D, 2012, BIOINFORMATICS, V28, pI515, DOI 10.1093/bioinformatics/bts401; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Muller AC, 2013, BIOINFORMATICS, V29, P903, DOI 10.1093/bioinformatics/btt059; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Papadimitrou CH, 1994, COMPUTATIONAL COMPLE; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Price ND, 2006, BIOPHYS J, V90, P3919, DOI 10.1529/biophysj.105.072645; Sariyar B, 2006, J THEOR BIOL, V242, P389, DOI 10.1016/j.jtbi.2006.03.007; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2011, BIOPHYS J, V100, P544, DOI 10.1016/j.bpj.2010.12.3707; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Singh A, 2011, METAB ENG, V13, P76, DOI 10.1016/j.ymben.2010.10.006; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Xi YP, 2011, BRIEF BIOINFORM, V12, P132, DOI 10.1093/bib/bbp068; [No title captured], DOI DOI 10.1142/S0218339094000131	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135636	10.1371/journal.pone.0135636	http://dx.doi.org/10.1371/journal.pone.0135636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287384	gold, Green Submitted, Green Published			2022-12-27	WOS:000360018600060
J	Vieira, FG; Ping, QG; Moreno, AJ; Kidd, JD; Thompson, K; Jiang, BB; Lincecum, JM; Wang, MZ; De Zutter, GS; Tassinari, VR; Levine, B; Hatzipetros, T; Gill, A; Perrin, S				Vieira, Fernando G.; Ping, Qinggong; Moreno, Andy J.; Kidd, Joshua D.; Thompson, Kenneth; Jiang, Bingbing; Lincecum, John M.; Wang, Monica Z.; De Zutter, Gerard S.; Tassinari, Valerie R.; Levine, Beth; Hatzipetros, Theo; Gill, Alan; Perrin, Steven			Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SUBUNIT	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by loss of motor neurons. The mechanisms leading to motor neuron degeneration in ALS are unclear. However, there is evidence for involvement of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) in ALS, notably in mutant SOD1 mediated models of ALS. Stress induced phosphorylation of the eIF2 alpha subunit by eukaryotic translation initiation factor 2-alpha kinase 3 Perk activates the UPR. Guanabenz is a centrally acting alpha2 adrenergic receptor agonist shown to interact with a regulatory subunit of the protein phosphatase, Pp1/Gadd34, and selectively disrupt the dephosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eif2alpha). Here we demonstrate that guanabenz is protective in fibroblasts expressing G93A mutant SOD1 when they are exposed to tunicamycin mediated ER stress. However, in contrast to other reports, guanabenz treatment accelerated ALS-like disease progression in a strain of mutant SOD1 transgenic ALS mice. This study highlights challenges of pharmacological interventions of cellular stress responses in whole animal models of ALS.	[Vieira, Fernando G.; Ping, Qinggong; Moreno, Andy J.; Kidd, Joshua D.; Thompson, Kenneth; Jiang, Bingbing; Lincecum, John M.; Wang, Monica Z.; De Zutter, Gerard S.; Tassinari, Valerie R.; Levine, Beth; Hatzipetros, Theo; Gill, Alan; Perrin, Steven] ALS Therapy Dev Inst, Cambridge, MA 02139 USA		Vieira, FG (corresponding author), ALS Therapy Dev Inst, Cambridge, MA 02139 USA.	fvieira@als.net	Vieira, Fernando/L-6246-2013; Vieira, Fernando/ABG-9082-2020	Vieira, Fernando/0000-0003-2996-6418; Vieira, Fernando/0000-0003-2996-6418	ALS Therapy Development Institute	ALS Therapy Development Institute	Funding: The authors received no specific funding for this work. The ALS Therapy Development Institute is a not-for-profit independent 503c organization funded primarily by private donations. The private donations come from 10's of thousands of ALS patients and their families and friends. These revenues are disclosed yearly in the authors' organization's audited financials (http://www.als.net/About-ALS-TDI/ALS-TDI-Annual-Reports.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Division on Earth and Life Studies Institute for Laboratory Animal Research, 2010, GUIDE CARE USE LAB A, V8th; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Huang BS, 1998, HYPERTENSION, V32, P1028, DOI 10.1161/01.HYP.32.6.1028; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Ito Y, 2009, NEUROBIOL DIS, V36, P470, DOI 10.1016/j.nbd.2009.08.013; Jiang HQ, 2014, NEUROSCIENCE, V277, P132, DOI 10.1016/j.neuroscience.2014.03.047; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Matus Soledad, 2013, Int J Cell Biol, V2013, P674751, DOI 10.1155/2013/674751; Mitsumoto H, 2014, LANCET NEUROL, V13, P1127, DOI 10.1016/S1474-4422(14)70129-2; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Rowland LP, 1998, J NEUROL SCI, V160, pS6, DOI 10.1016/S0022-510X(98)00193-2; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2013, FEBS J, V280, P766, DOI 10.1111/j.1742-4658.2012.08535.x; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091608; Wang LJ, 2014, NEUROBIOL DIS, V71, P317, DOI 10.1016/j.nbd.2014.08.010; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Wang LJ, 2011, HUM MOL GENET, V20, P1008, DOI 10.1093/hmg/ddq546; Zhu H, 2003, BRAIN RES, V964, P9, DOI 10.1016/S0006-8993(02)03754-X; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	32	56	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135570	10.1371/journal.pone.0135570	http://dx.doi.org/10.1371/journal.pone.0135570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288094	gold, Green Submitted, Green Published			2022-12-27	WOS:000360018600054
J	Brunsch, M; Schubert, D; Gube, M; Ring, C; Hanisch, L; Linde, J; Krause, K; Kothe, E				Brunsch, Melanie; Schubert, Daniela; Gube, Matthias; Ring, Christiane; Hanisch, Lisa; Linde, Joerg; Krause, Katrin; Kothe, Erika			Dynein Heavy Chain, Encoded by Two Genes in Agaricomycetes, Is Required for Nuclear Migration in Schizophyllum commune	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MICROTUBULE PLUS-END; SEQUENCE COUNT DATA; MATING-TYPE GENES; CYTOPLASMIC DYNEIN; ASPERGILLUS-NIDULANS; FILAMENTOUS FUNGI; PHEROMONE GENES; MOTOR PROTEINS; MIXED MODELS	The white-rot fungus Schizophyllum commune (Agaricomycetes) was used to study the cell biology of microtubular trafficking during mating interactions, when the two partners exchange nuclei, which are transported along microtubule tracks. For this transport activity, the motor protein dynein is required. In S. commune, the dynein heavy chain is encoded in two parts by two separate genes, dhc1 and dhc2. The N-terminal protein Dhc1 supplies the dimerization domain, while Dhc2 encodes the motor machinery and the microtubule binding domain. This split motor protein is unique to Basidiomycota, where three different sequence patterns suggest independent split events during evolution. To investigate the function of the dynein heavy chain, the gene dhc1 and the motor domain in dhc2 were deleted. Both resulting mutants were viable, but revealed phenotypes in hyphal growth morphology and mating behavior as well as in sexual development. Viability of strain Delta dhc2 is due to the higher expression of kinesin-2 and kinesin-14, which was proven via RNA sequencing.	[Brunsch, Melanie; Schubert, Daniela; Gube, Matthias; Ring, Christiane; Hanisch, Lisa; Krause, Katrin; Kothe, Erika] Univ Jena, Inst Microbiol, Microbial Commun, D-07743 Jena, Germany; [Linde, Joerg] Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoll Inst, Res Grp Syst Biol & Bioinformat, D-07745 Jena, Germany	Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Kothe, E (corresponding author), Univ Jena, Inst Microbiol, Microbial Commun, Neugasse 25, D-07743 Jena, Germany.	erika.kothe@uni-jena.de		Gube, Matthias/0000-0001-5101-3096	DFG - GSC [24]	DFG - GSC	This work was supported by DFG - GSC 24, http://dfg.de/Leibniz Association ILRS, http://www.ilrs.hki-jena.de/BMBF, http://www.bmbf.de/.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 1966, GENETICS SEXUALITY H; Asai DJ, 2004, J EUKARYOT MICROBIOL, V51, P23, DOI 10.1111/j.1550-7408.2004.tb00157.x; Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Bruno KS, 1996, P NATL ACAD SCI USA, V93, P4775, DOI 10.1073/pnas.93.10.4775; COOKE WB, 1961, MYCOLOGIA, V53, P575, DOI 10.2307/3756459; de Jong JF, 2010, FEMS MICROBIOL LETT, V310, P91, DOI 10.1111/j.1574-6968.2010.02052.x; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Falnikar A, 2011, MOL BIOL CELL, V22, P1561, DOI 10.1091/mbc.E10-11-0905; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; FISCHER R, 1995, J CELL BIOL, V128, P485, DOI 10.1083/jcb.128.4.485; Gola S, 2003, J BASIC MICROB, V43, P104, DOI 10.1002/jobm.200390010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hirakawa E, 2000, P NATL ACAD SCI USA, V97, P2533, DOI 10.1073/pnas.050585297; Hjelm RP, 2010, ACTA CRYSTALLOGR D, V66, P1218, DOI 10.1107/S0907444910021323; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Hoyt MA, 1997, P NATL ACAD SCI USA, V94, P12747, DOI 10.1073/pnas.94.24.12747; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King SM, 2000, J CELL SCI, V113, P2521; KOLTIN Y, 1968, SCIENCE, V160, P85, DOI 10.1126/science.160.3823.85; Kothe E, 1996, FEMS MICROBIOL REV, V18, P65, DOI 10.1016/0168-6445(96)00003-4; Markus SM, 2011, CYTOSKELETON, V68, P157, DOI 10.1002/cm.20502; Matheny PB, 2006, CAN J BOT, V84, P1794, DOI 10.1139/B06-128; Miller MA, 2010, CREATING CIPRES SCI; MUNOZRIVAS A, 1986, MOL GEN GENET, V205, P103, DOI 10.1007/BF02428038; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Palmer GE, 2006, FEMS MICROBIOL LETT, V262, P1, DOI 10.1111/j.1574-6968.2006.00341.x; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; RAJU TR, 1982, BRAIN RES, V248, P196, DOI 10.1016/0006-8993(82)91165-9; Ramakrishnan C, 2002, PROTEIN ENG, V15, P783, DOI 10.1093/protein/15.10.783; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, 2009, TRACER V1 5; RAPER JR, 1958, GENETICS, V43, P530; RAPER JR, 1974, HDB GENETICS, V1, P597; RAUDASKOSKI M, 1982, T BRIT MYCOL SOC, V78, P475, DOI 10.1016/S0007-1536(82)80154-X; Raudaskoski M, 1998, FUNGAL GENET BIOL, V24, P207, DOI 10.1006/fgbi.1998.1069; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuster M, 2011, EMBO J, V30, P652, DOI 10.1038/emboj.2010.360; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinberg G, 2007, TRENDS MICROBIOL, V15, P14, DOI 10.1016/j.tim.2006.11.007; Straube A, 2001, EMBO J, V20, P5091, DOI 10.1093/emboj/20.18.5091; Suelmann R, 2000, RES MICROBIOL, V151, P247, DOI 10.1016/S0923-2508(00)00151-0; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WENDLAND J, 1995, EMBO J, V14, P5271, DOI 10.1002/j.1460-2075.1995.tb00211.x; WESSELS JGH, 1991, J GEN MICROBIOL, V137, P2439, DOI 10.1099/00221287-137-10-2439; Xiang X, 2003, CURR OPIN MICROBIOL, V6, P628, DOI 10.1016/j.mib.2003.10.009; Xiang X, 2003, J CELL BIOL, V160, P289, DOI 10.1083/jcb.200212168; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Yamamoto A, 2003, J CELL SCI, V116, P4501, DOI 10.1242/jcs.00835; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259	65	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135616	10.1371/journal.pone.0135616	http://dx.doi.org/10.1371/journal.pone.0135616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284622	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100050
J	Ferguson, TW; Zacharias, J; Walker, SR; Collister, D; Rigatto, C; Tangri, N; Komenda, P				Ferguson, Thomas W.; Zacharias, James; Walker, Simon R.; Collister, David; Rigatto, Claudio; Tangri, Navdeep; Komenda, Paul			An Economic Assessment Model of Rural and Remote Satellite Hemodialysis Units	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PERITONEAL-DIALYSIS; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; HOME HEMODIALYSIS; TECHNIQUE FAILURE; MORTALITY; CARE; MODALITY; DELIVERY	Background Kidney Failure is epidemic in many remote communities in Canada. In-centre hemodialysis is provided within these settings in satellite hemodialysis units. The key cost drivers of this program have not been fully described. Such information is important in informing the design of programs aimed at optimizing efficiency in providing dialysis and preventative chronic kidney disease care in remote communities. Design, Setting, Participants, and Measurements We constructed a cost model based on data derived from 16 of Manitoba, Canada's remote satellite units. We included all costs for operation of the unit, transportation, treatment, and capital costs. All costs were presented in 2013 Canadian dollars. Results The annual per-patient cost of providing hemodialysis in the satellite units ranged from $80,372 to $215,918 per patient, per year. The median per patient, per year cost was $99,888 (IQR $89,057-$122,640). Primary cost drivers were capital costs related to construction, human resource expenses, and expenses for return to tertiary care centres for health care. Costs related to transport considerably increased estimates in units that required plane or helicopter transfers. Conclusions Satellite hemodialysis units in remote areas are more expensive on a per-patient basis than hospital hemodialysis and satellite hemodialysis available in urban areas. In some rural, remote locations, better value for money may reside in local surveillance and prevention programs in addition support for home dialysis therapies over construction of new satellite hemodialysis units.	[Zacharias, James; Walker, Simon R.; Collister, David; Rigatto, Claudio; Tangri, Navdeep; Komenda, Paul] Univ Manitoba, Dept Med, Nephrol Sect, Winnipeg, MB, Canada; [Ferguson, Thomas W.; Zacharias, James; Tangri, Navdeep] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba	Komenda, P (corresponding author), Univ Manitoba, Dept Med, Nephrol Sect, Winnipeg, MB, Canada.	paulkomenda@yahoo.com		Tangri, Navdeep/0000-0002-5075-6370; Zacharias, James/0000-0002-4887-5338	Research Manitoba; KRESCENT New Investigator Award; MHRC Establishment Award	Research Manitoba; KRESCENT New Investigator Award(Canadian Institutes of Health Research (CIHR)); MHRC Establishment Award	TF receives funding from a Graduate Studentship from the University of Manitoba through the Manitoba Health Research Council (now Research Manitoba). (http://researchmanitoba.ca)-Research Manitoba, formerly Manitoba Health Research Council. NT is supported by the KRESCENT New Investigator Award and the MHRC Establishment Award. The KRESCENT New investigator award is a joint initiative of the Kidney Foundation of Canada, Canadian Institute of Health Research and the Canadian Society of Nephrology. None of the other authors have any declarations. (http://researchmanitoba.ca)-Research Manitoba, formerly Manitoba Health Research Council (http://www.krescent.ca/Page.aspx?pid=444)-KRESCENT New investigator award. The funders had no role in study design, data collection and analysis, decision to published, or preparation of the manuscript.	Bello AK, 2012, NEPHROL DIAL TRANSPL, V27, P3849, DOI 10.1093/ndt/gfs267; Bernstein K, 2010, CLIN J AM SOC NEPHRO, V5, P645, DOI 10.2215/CJN.04550709; BILINSKY RT, 1971, J AMER MED ASSOC, V218, P1809; Brundisini F, 2013, Ont Health Technol Assess Ser, V13, P1; CAMBI V, 1971, LANCET, V2, P1158; Canadian Institute for Health Information, 2014, CAN ORG REPL REG ANN; Chui BK, 2013, AM J KIDNEY DIS, V61, P104, DOI 10.1053/j.ajkd.2012.07.010; de Wit GA, 1998, HEALTH POLICY, V44, P215, DOI 10.1016/S0168-8510(98)00017-7; Diamant MJ, 2011, CLIN J AM SOC NEPHRO, V6, P1692, DOI 10.2215/CJN.07650810; Diamant MJ, 2010, CLIN J AM SOC NEPHRO, V5, P268, DOI 10.2215/CJN.05190709; Foley RN, 1998, J NEPHROL, V11, P239; Goeree R, 1995, CLIN INVEST MED, V18, P455; Gonzalez-Perez JG, 2005, INT J TECHNOL ASSESS, V21, P32, DOI 10.1017/S026646230505004X; Klarenbach S, 2014, J AM SOC NEPHROL, V25, P587, DOI 10.1681/ASN.2013040360; Komenda P, 2014, CMAJ OPEN IN PRESS; Komenda P, 2012, KIDNEY INT, V81, P307, DOI 10.1038/ki.2011.338; Lee H, 2002, AM J KIDNEY DIS, V40, P611, DOI 10.1053/ajkd.2002.34924; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levin A, 2000, AM J KIDNEY DIS, V36, pS24, DOI 10.1053/ajkd.2000.19928; Lim WH, 2011, NEPHROL DIAL TRANSPL, V26, P3366, DOI 10.1093/ndt/gfr070; Manitoba Health, 2013, MAN PHYS MAN; Manitoba Renal Program, 2014, EL KIDN HLTH REC; Maripuri S, 2012, CLIN J AM SOC NEPHRO, V7, P1121, DOI 10.2215/CJN.10831011; May S., 2013, NEPHROLOGY CARLTON; McFarlane P, 2011, SEMIN DIALYSIS, V24, P678, DOI 10.1111/j.1525-139X.2011.01007.x; Moist LM, 2008, AM J KIDNEY DIS, V51, P641, DOI 10.1053/j.ajkd.2007.12.021; Mowatt G, 2003, Health Technol Assess, V7, P1; O'Hare AM, 2006, KIDNEY INT, V69, P343, DOI 10.1038/sj.ki.5000044; Prakash S, 2007, NEPHROL DIAL TRANSPL, V22, P2297, DOI 10.1093/ndt/gfm176; Roderick P, 2004, AM J KIDNEY DIS, V44, P121, DOI 10.1053/j.ajkd.2004.03.031; Sennfalt K, 2002, PERITON DIALYSIS INT, V22, P39; SHAPIRO FL, 1968, ANN INTERN MED, V69, P673, DOI 10.7326/0003-4819-69-4-673; Smith KB, 2008, AUST J RURAL HEALTH, V16, P56, DOI 10.1111/j.1440-1584.2008.00953.x; Soroka Steven D, 2005, Hemodial Int, V9, P196, DOI 10.1111/j.1492-7535.2005.01132.x; Statistics Canada, 2014, CONS PRIC IND HLTH P; Tonelli M, 2007, KIDNEY INT, V72, P1023, DOI 10.1038/sj.ki.5002443; Tonelli M, 2007, CAN MED ASSOC J, V177, P1039, DOI 10.1503/cmaj.070343; Walker R, 2014, NEPHROLOGY, V19, P459, DOI 10.1111/nep.12269; WILSON R, 1994, CAN FAM PHYSICIAN, V40, P1934; Zacharias J, 2011, SEMIN DIALYSIS, V24, P653, DOI 10.1111/j.1525-139X.2011.01004.x; Zacharias JM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-290	41	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135587	10.1371/journal.pone.0135587	http://dx.doi.org/10.1371/journal.pone.0135587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284357	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100048
J	Kentish, SJ; Frisby, CL; Kritas, S; Li, H; Hatzinikolas, G; O'Donnell, TA; Wittert, GA; Page, AJ				Kentish, Stephen J.; Frisby, Claudine L.; Kritas, Stamatiki; Li, Hui; Hatzinikolas, George; O'Donnell, Tracey A.; Wittert, Gary A.; Page, Amanda J.			TRPV1 Channels and Gastric Vagal Afferent Signalling in Lean and High Fat Diet Induced Obese Mice	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; GASTROINTESTINAL SATIETY SIGNALS; SENSORY NEURONS; ION CHANNELS; FOOD-INTAKE; CAPSAICIN; NUCLEUS; MECHANOSENSITIVITY; MECHANORECEPTORS; MODULATION	Aim Within the gastrointestinal tract vagal afferents play a role in control of food intake and satiety signalling. Activation of mechanosensitive gastric vagal afferents induces satiety. However, gastric vagal afferent responses to mechanical stretch are reduced in high fat diet mice. Transient receptor potential vanilloid 1 channels (TRPV1) are expressed in vagal afferents and knockout of TRPV1 reduces gastro-oesophageal vagal afferent responses to stretch. We aimed to determine the role of TRPV1 on gastric vagal afferent mechanosensitivity and food intake in lean and HFD-induced obese mice. Methods TRPV1+/+ and -/- mice were fed either a standard laboratory diet or high fat diet for 20wks. Gastric emptying of a solid meal and gastric vagal afferent mechanosensitivity was determined. Results Gastric emptying was delayed in high fat diet mice but there was no difference between TRPV1+/+ and -/- mice on either diet. TRPV1 mRNA expression in whole nodose ganglia of TRPV1+/+ mice was similar in both dietary groups. The TRPV1 agonist N-oleoyldopamine potentiated the response of tension receptors in standard laboratory diet but not high fat diet mice. Food intake was greater in the standard laboratory diet TRPV1-/- compared to TRPV1+/+ mice. This was associated with reduced response of tension receptors to stretch in standard laboratory diet TRPV1-/- mice. Tension receptor responses to stretch were decreased in high fat diet compared to standard laboratory diet TRPV1+/+ mice; an effect not observed in TRPV1-/- mice. Disruption of TRPV1 had no effect on the response of mucosal receptors to mucosal stroking in mice on either diet. Conclusion TRPV1 channels selectively modulate gastric vagal afferent tension receptor mechanosensitivity and may mediate the reduction in gastric vagal afferent mechanosensitivity in high fat diet-induced obesity.	[Kentish, Stephen J.; Frisby, Claudine L.; Li, Hui; Hatzinikolas, George; O'Donnell, Tracey A.; Wittert, Gary A.; Page, Amanda J.] Univ Adelaide, Discipline Med, Ctr Nutr & Gastrointestinal Dis, Adelaide, SA, Australia; [Kentish, Stephen J.; Frisby, Claudine L.; Li, Hui; Hatzinikolas, George; O'Donnell, Tracey A.; Wittert, Gary A.; Page, Amanda J.] SAHMRI, Adelaide, SA, Australia; [Wittert, Gary A.; Page, Amanda J.] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Kritas, Stamatiki] Womens & Childrens Hosp, Adelaide, SA, Australia	University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Royal Adelaide Hospital; Womens & Childrens Hospital Australia	Page, AJ (corresponding author), Univ Adelaide, Discipline Med, Ctr Nutr & Gastrointestinal Dis, Adelaide, SA, Australia.	Amanda.page@adelaide.edu.au	wittert, gary/AAE-2398-2019	Page, Amanda/0000-0002-7086-5865; Li, Hui/0000-0002-1010-516X; Wittert, Gary/0000-0001-6818-6065	Royal Adelaide Hospital Gum Bequest	Royal Adelaide Hospital Gum Bequest	This work was supported by Royal Adelaide Hospital Gum Bequest. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; BECKER JM, 1983, AM J PHYSIOL, V245, pG334, DOI 10.1152/ajpgi.1983.245.3.G334; Beglinger C, 2006, PHYSIOL BEHAV, V89, P460, DOI 10.1016/j.physbeh.2006.05.048; Bielefeldt K, 2008, AM J PHYSIOL-GASTR L, V294, pG130, DOI 10.1152/ajpgi.00388.2007; Bielefeldt K, 2006, AM J PHYSIOL-GASTR L, V291, pG987, DOI 10.1152/ajpgi.00080.2006; BLACKSHAW LA, 1987, J AUTONOM NERV SYST, V18, P19; Cioffi DL, 2007, CIRC RES, V100, P934, DOI 10.1161/01.RES.0000265139.10277.62; Daly DM, 2011, J PHYSIOL-LONDON, V589, P2857, DOI 10.1113/jphysiol.2010.204594; Derbenev AV, 2006, J NEUROSCI, V26, P9666, DOI 10.1523/JNEUROSCI.1591-06.2006; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Doyle MW, 2002, J NEUROSCI, V22, P8222; Faussone-Pellegrini MS, 2005, HISTOCHEM CELL BIOL, V124, P61, DOI 10.1007/s00418-005-0025-9; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; HEDDLE R, 1989, J GASTROEN HEPATOL, V4, P437, DOI 10.1111/j.1440-1746.1989.tb01741.x; Jin YH, 2004, J NEUROSCI, V24, P4709, DOI 10.1523/JNEUROSCI.0753-04.2004; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kentish SJ, 2013, INT J OBESITY, DOI [10.1038/ijo.2013, DOI 10.1038/IJ0.2013.138]; Kentish S, 2012, J PHYSIOL-LONDON, V590, P209, DOI 10.1113/jphysiol.2011.222158; Kentish SJ, 2013, J PHYSIOL-LONDON, V591, P1921, DOI 10.1113/jphysiol.2012.247577; Lee E, 2015, FASEB J, V29, P3182, DOI 10.1096/fj.14-268300; Lee KJ, 2004, ALIMENT PHARM THER, V19, P415, DOI 10.1046/j.1365-2036.2004.01823.x; Li H, 2013, ACTA PHYSIOL, V209, P179, DOI 10.1111/apha.12154; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Little TJ, 2011, PHYSIOL BEHAV, V104, P613, DOI 10.1016/j.physbeh.2011.04.038; Liu DY, 2008, HYPERTENS RES, V31, P1989, DOI 10.1291/hypres.31.1989; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; Marshall NJ, 2013, HYPERTENSION, V61, P246, DOI 10.1161/HYPERTENSIONAHA.112.201434; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; O'Neil RG, 2003, NEWS PHYSIOL SCI, V18, P226, DOI 10.1152/nips.01468.2003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Page AJ, 2002, J NEUROPHYSIOL, V87, P2095, DOI 10.1152/jn.00785.2001; Powley TL, 2004, PHYSIOL BEHAV, V82, P69, DOI 10.1016/j.physbeh.2004.04.037; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Rong WF, 2004, J PHYSIOL-LONDON, V560, P867, DOI 10.1113/jphysiol.2004.071746; Symonds E, 2003, EUR J PHARMACOL, V470, P95, DOI 10.1016/S0014-2999(03)01779-5; Toth A, 2009, VITAM HORM, V81, P389, DOI 10.1016/S0083-6729(09)81015-7; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wang XB, 2005, J PHYSIOL-LONDON, V564, P541, DOI 10.1113/jphysiol.2004.081844; Wanner SP, 2011, AGING-US, V3, P450, DOI 10.18632/aging.100306; Ward SM, 2003, J COMP NEUROL, V465, P121, DOI 10.1002/cne.10801; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003; Yao XQ, 2005, NEUROSIGNALS, V14, P273, DOI 10.1159/000093042; Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269; Young RL, 2008, NEUROGASTROENT MOTIL, V20, P708, DOI 10.1111/j.1365-2982.2007.01071.x; Zhang L, 2004, AM J PHYSIOL-GASTR L, V286, pG983, DOI 10.1152/ajpgi.00441.2003; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zhao H, 2010, AM J PHYSIOL-GASTR L, V298, pG212, DOI 10.1152/ajpgi.00396.2009; Zsombok A, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12160	51	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135892	10.1371/journal.pone.0135892	http://dx.doi.org/10.1371/journal.pone.0135892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285043	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100085
J	Kolbe, T; Palme, R; Tichy, A; Rullcke, T				Kolbe, Thomas; Palme, Rupert; Tichy, Alexander; Ruellcke, Thomas			Lifetime Dependent Variation of Stress Hormone Metabolites in Feces of Two Laboratory Mouse Strains	PLOS ONE			English	Article							CORTICOSTERONE METABOLITES; RECEPTOR EXPRESSION; SEASONAL-VARIATION; BONE-MARROW; MICE; CORTISOL; SEX; GLUCOCORTICOIDS; EXCRETION; RESPONSES	Non-invasive measurement of stress hormone metabolites in feces has become routine practice for the evaluation of distress and pain in animal experiments. Since metabolism and excretion of glucocorticoids may be variable, awareness and adequate consideration of influencing factors are essential for accurate monitoring of adrenocortical activity. Reference values are usually provided by baselines compiled prior to the experiment and by age matched controls. The comparison of stress hormone levels between animals of different ages or between studies looking at hormone levels at the beginning and at the end of a long term study might be biased by age-related effects. In this study we analyzed fecal corticosterone metabolites (FCM) during the lifetime of untreated female mice of the strains C57BL/6NCrl and Crl:CD1. For this purpose feces for each individual mouse were collected every two months over a period of 24 hours, at intervals of four hours, until the age of 26 months. Results of the study revealed that age of the animals had a significant impact on the level and circadian rhythm of stress hormone metabolites. Furthermore, long-term observation of mice revealed a strain specific excretion profile of FCM influenced by strong seasonal variability.	[Kolbe, Thomas] Univ Vet Med Vienna, Biomodels Austria, Vienna, Austria; [Kolbe, Thomas] Univ Nat Resources & Life Sci, IFA Tulln, Tulln, Austria; [Palme, Rupert] Univ Vet Med Vienna, Unit Physiol Pathophysiol & Expt Endocrinol, Vienna, Austria; [Tichy, Alexander] Univ Vet Med Vienna, Bioinformat & Biostat Platform, Vienna, Austria; [Ruellcke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria	University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Rullcke, T (corresponding author), Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria.	thomas.ruelicke@vetmeduni.ac.at	Palme, Rupert/A-3499-2008; Kolbe, Thomas/H-8215-2018	Palme, Rupert/0000-0001-9466-3662; Kolbe, Thomas/0000-0003-2974-8066				Bizon JL, 2001, EUR J NEUROSCI, V14, P1739, DOI 10.1046/j.0953-816x.2001.01781.x; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Bundgaard CJ, 2012, IN VIVO, V26, P883; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; Dmitrieva NO, 2013, PSYCHONEUROENDOCRINO, V38, P2354, DOI 10.1016/j.psyneuen.2013.05.003; Douglas AJ, 2003, ENDOCRINOLOGY, V144, P5268, DOI 10.1210/en.2003-0461; DRICKAMER LC, 1990, LAB ANIM SCI, V40, P284; Figueiredo HF, 2007, AM J PHYSIOL-ENDOC M, V292, pE1173, DOI 10.1152/ajpendo.00102.2006; Gold PW, 2015, MOL PSYCHIATR, V20, P32, DOI 10.1038/mp.2014.163; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Haus E, 1997, CHRONOBIOL INT, V14, P347, DOI 10.3109/07420529709001456; Heaney JLJ, 2012, PSYCHONEUROENDOCRINO, V37, P341, DOI 10.1016/j.psyneuen.2011.07.001; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jones BC, 1998, PSYCHONEUROENDOCRINO, V23, P505; Kalliokoski O, 2015, GEN COMP ENDOCR, V211, P147, DOI 10.1016/j.ygcen.2014.12.008; Kalliokoski O, 2012, IN VIVO, V26, P213; Kolbe T, 2016, REPROD FERT DEVELOP, V28, P969, DOI 10.1071/RD14372; Kolbe T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092445; LINKOWSKI P, 1985, J CLIN ENDOCR METAB, V61, P429, DOI 10.1210/jcem-61-3-429; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Meyer L, 2006, BEHAV BRAIN RES, V167, P342, DOI 10.1016/j.bbr.2005.09.023; Mizoguchi K, 2009, NEUROSCIENCE, V159, P259, DOI 10.1016/j.neuroscience.2008.12.020; Nagayama H, 1998, PSYCHOPHARMACOLOGY, V135, P279, DOI 10.1007/s002130050510; NELSON JF, 1995, NEUROBIOL AGING, V16, P837, DOI 10.1016/0197-4580(95)00072-M; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2012, ANIM WELFARE, V21, P331, DOI 10.7120/09627286.21.3.331; Pfeiffenberger U, 2015, LAB ANIM-UK, V49, P121, DOI 10.1177/0023677214559627; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Roberts AJ, 1995, BEHAV NEUROSCI, V109, P1199, DOI 10.1037/0735-7044.109.6.1199; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Sollars PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111944; SPACKMAN DH, 1978, SCIENCE, V200, P87, DOI 10.1126/science.635580; Spani D, 2003, LAB ANIM-UK, V37, P54, DOI 10.1258/002367703762226692; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; TAKAHASHI H, 1987, JPN J PHARMACOL, V43, P441, DOI 10.1254/jjp.43.441; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Touma C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004325; Voigtlander T, 2006, EUR J NEUROSCI, V23, P2723, DOI 10.1111/j.1460-9568.2006.04801.x; Walker MK, 2012, TOXICOL APPL PHARM, V260, P65, DOI 10.1016/j.taap.2012.01.025; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Wright-Williams S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075948	47	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136112	10.1371/journal.pone.0136112	http://dx.doi.org/10.1371/journal.pone.0136112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284365	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100104
J	Levy, GV; Banuelos, CP; Nittolo, AG; Ortiz, GE; Mendiondo, N; Moretti, G; Tekiel, VS; Sanchez, DO				Levy, Gabriela V.; Banuelos, Carolina P.; Nittolo, Analia G.; Ortiz, Gaston E.; Mendiondo, Nicolas; Moretti, Georgina; Tekiel, Valeria S.; Sanchez, Daniel O.			Depletion of the SR-Related Protein TbRRM1 Leads to Cell Cycle Arrest and Apoptosis-Like Death in Trypanosoma brucei	PLOS ONE			English	Article							TARGETING ESSENTIAL PATHWAYS; GENE-EXPRESSION; PROTOZOAN MECHANISMS; PROCYCLIC FORM; CCCH PROTEIN; CYTOKINESIS; DIFFERENTIATION; SEGREGATION; PROGRESSION; HOMOLOGY	Arginine-Serine (RS) domain-containing proteins are RNA binding proteins with multiple functions in RNA metabolism. In mammalian cells this group of proteins is also implicated in regulation and coordination of cell cycle and apoptosis. In trypanosomes, an early branching group within the eukaryotic lineage, this group of proteins is represented by 3 members, two of them are SR proteins and have been recently shown to be involved in rRNA processing as well as in pre-mRNA splicing and stability. Here we report our findings on the 3rd member, the SR-related protein TbRRM1. In the present study, we showed that TbRRM1 ablation by RNA-interference in T. brucei procyclic cells leads to cell-cycle block, abnormal cell elongation compatible with the nozzle phenotype and cell death by an apoptosis-like mechanism. Our results expand the role of the trypanosomal RS-domain containing proteins in key cellular processes such as cell cycle and apoptosis-like death, roles also carried out by the mammalian SR proteins, and thus suggesting a conserved function in this phylo-genetically conserved protein family.	[Levy, Gabriela V.; Banuelos, Carolina P.; Nittolo, Analia G.; Ortiz, Gaston E.; Mendiondo, Nicolas; Moretti, Georgina; Tekiel, Valeria S.; Sanchez, Daniel O.] Univ Nacl San Martin IIB UNSAM, Inst Invest Biotecnol, Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Levy, GV (corresponding author), Univ Nacl San Martin IIB UNSAM, Inst Invest Biotecnol, Consejo Nacl Invest Cient & Tecn CONICET, 25 Mayo & Francia Gral San Martin, Buenos Aires, DF, Argentina.	gvlevy@gmail.com		Tekiel, Valeria/0000-0003-2981-2312; sanchez, daniel/0000-0002-5427-7764; Ortiz, Gaston/0000-0002-5073-3355; Levy, Gabriela Vanesa/0000-0002-7638-3509	National Agency for promotion of Science and Technology, (ANPCyT, Argentina) [PICT 2012-1419]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina) [112 201101 00837]; Fogarty International Center of the U.S. National Institutes of Health [TW007888]	National Agency for promotion of Science and Technology, (ANPCyT, Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fogarty International Center of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	National Agency for promotion of Science and Technology, (ANPCyT, Argentina. PICT 2012-1419 to DOS). Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina. PIP 2012 nro 112 201101 00837 to DOS). GM was supported in part by a Training Grant from the Fogarty International Center of the U.S. National Institutes of Health (grant TW007888).	Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Boucher N, 2007, J BIOL CHEM, V282, P13780, DOI 10.1074/jbc.M700780200; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Gupta SK, 2014, RNA BIOL, V11, P715, DOI 10.4161/rna.29143; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hendriks EF, 2001, EMBO J, V20, P6700, DOI 10.1093/emboj/20.23.6700; Ismaili N, 1999, MOL BIOCHEM PARASIT, V102, P103, DOI 10.1016/S0166-6851(99)00091-2; Ismaili N, 2000, MOL BIOCHEM PARASIT, V106, P109, DOI 10.1016/S0166-6851(99)00205-4; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li ZY, 2012, EUKARYOT CELL, V11, P1180, DOI 10.1128/EC.00145-12; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Manger ID, 2001, MOL BIOCHEM PARASIT, V116, P239, DOI 10.1016/S0166-6851(01)00322-X; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; May SF, 2012, MOL MICROBIOL, V84, P77, DOI 10.1111/j.1365-2958.2012.08008.x; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Montagna GN, 2006, J BIOL CHEM, V281, P33949, DOI 10.1074/jbc.M604951200; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Naguleswaran A, 2015, MBIO, V6, DOI 10.1128/mBio.00114-15; Nazer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043715; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024184; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Palfi Z, 2000, P NATL ACAD SCI USA, V97, P8967, DOI 10.1073/pnas.150236097; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Palfi Z, 2009, GENE DEV, V23, P1650, DOI 10.1101/gad.526109; Paterou A, 2006, J BIOL CHEM, V281, P39002, DOI 10.1074/jbc.M604280200; Ploubidou A, 1999, J CELL SCI, V112, P4641; Portal D, 2003, MOL BIOCHEM PARASIT, V127, P37, DOI 10.1016/S0166-6851(02)00301-8; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Siegel TN, 2008, MOL BIOCHEM PARASIT, V160, P171, DOI 10.1016/j.molbiopara.2008.04.004; Siegel TN, 2011, TRENDS PARASITOL, V27, P434, DOI 10.1016/j.pt.2011.05.006; Smirlis D, 2011, VIRULENCE, V2, P253, DOI 10.4161/viru.2.3.16278; Smirlis D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-107; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Timms MW, 2002, MOL BIOL CELL, V13, P3747, DOI 10.1091/mbc.E02-05-0266; Tu XM, 2005, MOL BIOL CELL, V16, P97, DOI 10.1091/mbc.E04-05-0368; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136070	10.1371/journal.pone.0136070	http://dx.doi.org/10.1371/journal.pone.0136070			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284933	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100100
J	Li, W; Cheng, JM; Yu, KL; Epstein, HE; Du, GZ				Li, Wei; Cheng, Ji-Min; Yu, Kai-Liang; Epstein, Howard E.; Du, Guo-Zhen			Niche and Neutral Processes Together Determine Diversity Loss in Response to Fertilization in an Alpine Meadow Community	PLOS ONE			English	Article							PLANT TRAITS; FUNCTIONAL TRAITS; NITROGEN DEPOSITION; RELATIVE ABUNDANCE; SPECIES ABUNDANCE; FIELD EXPERIMENT; COMPETITION; COEXISTENCE; ECOLOGY; NUTRIENT	Fertilization via nutrient deposition and agricultural inputs is one of the most important factors driving decreases in plant diversity. However, we still do not fully understand which processes (niche process or neutral process) are more important in leading to decreases in plant diversity caused by fertilization. A hypothesis-based approach was used to test the relative importance of niche versus neutral processes along a fertilization gradient in an alpine meadow community on the eastern Tibetan plateau, China. Niche overlap values were calculated for species biomass, and the null model was used to generate the values of niche overlap expected at random. A linear regression modeling was used to evaluate the relationship between functional traits (specific leaf area, leaf dry matter content, and leaf total nitrogen concentration) and species relative abundance. Our results demonstrated that observed niche overlap for species biomass was significantly higher than expected at lower fertilization gradients. Moreover, we also found a significantly negative correlation between species relative abundance and specific leaf area and leaf dry matter content, but a significantly positive correlation between relative abundance and leaf nitrogen concentration at lower fertilization gradients. However, these relationships were not significant at higher fertilization gradients. We concluded that community assembly is dynamic progression along the environmental gradients, and niche and neutral processes may together determine species diversity loss in response to fertilization.	[Li, Wei; Cheng, Ji-Min] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Li, Wei; Cheng, Ji-Min] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Li, Wei; Cheng, Ji-Min] Minist Water Resource, Yangling 712100, Shaanxi, Peoples R China; [Yu, Kai-Liang; Epstein, Howard E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Du, Guo-Zhen] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; University of Virginia; Lanzhou University	Li, W (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.	liwei20116@gmail.com			Key Program of National Natural Science Foundation of China [40930533]; Natural Science Foundation of China [41230852]; Key Program of Chinese Academy of Sciences [KJZD-EW-TZ-G10]; Northwest A F University [Z109021107, Z109021307, QN2013070]; West Light Foundation of Chinese Academy of Sciences [K318021305]; China Scholarship Council	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Northwest A F University; West Light Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); China Scholarship Council(China Scholarship Council)	This study was supported by Key Program of National Natural Science Foundation of China (40930533), Natural Science Foundation of China (41230852), Key Program of Chinese Academy of Sciences (KJZD-EW-TZ-G10), Northwest A & F University (Z109021107, Z109021307, QN2013070), West Light Foundation of Chinese Academy of Sciences (K318021305) and the China Scholarship Council.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cleland EE, 2010, ANN NY ACAD SCI, V1195, P46, DOI 10.1111/j.1749-6632.2010.05458.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dickson TL, 2014, ECOLOGY, V95, P2443, DOI 10.1890/13-1875.1; Diekmann M, 2002, J ECOL, V90, P108, DOI 10.1046/j.0022-0477.2001.00639.x; Ellwood MDF, 2009, ECOL LETT, V12, P277, DOI 10.1111/j.1461-0248.2009.01284.x; Gilbert B, 2009, AM NAT, V174, P850, DOI 10.1086/647903; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grime P., 2001, PLANT STRATEGIES VEG; Gross N, 2007, J ECOL, V95, P1296, DOI 10.1111/j.1365-2745.2007.01303.x; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hou, 1982, VEGETATION MAP PEOPL; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; Lamb EG, 2009, J ECOL, V97, P155, DOI 10.1111/j.1365-2745.2008.01454.x; Li W, 2013, NORD J BOT, V31, P247, DOI 10.1111/j.1756-1051.2012.01511.x; Li W, 2011, J PLANT ECOL, V4, P138, DOI 10.1093/jpe/rtq031; Lloret F, 2004, GLOBAL ECOL BIOGEOGR, V13, P37, DOI 10.1111/j.1466-882X.2004.00064.x; Luo YJ, 2006, J VEG SCI, V17, P417, DOI 10.1658/1100-9233(2006)17[417:IOATAF]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mouillot D, 2007, OECOLOGIA, V152, P729, DOI 10.1007/s00442-007-0688-0; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; PIELOU E C, 1969, P286; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Poorter H, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P81; Reader RJ, 1998, PLANT ECOL, V134, P43, DOI 10.1023/A:1009700100343; Reich PB, 2008, ECOL LETT, V11, P793, DOI 10.1111/j.1461-0248.2008.01185.x; Shipley B, 2000, ECOSCIENCE, V7, P183, DOI 10.1080/11956860.2000.11682587; Shipley B, 2010, PLANT TRAITS VEGETAT; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Soudzilovskaia NA, 2005, J VEG SCI, V16, P399, DOI 10.1111/j.1654-1103.2005.tb02379.x; Stevens MHH, 1999, J ECOL, V87, P490, DOI 10.1046/j.1365-2745.1999.00374.x; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Sun XM, 2016, J PLANT ECOL, V9, P201, DOI 10.1093/jpe/rtv037; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Uriarte M, 2003, P NATL ACAD SCI USA, V100, P1787, DOI 10.1073/pnas.0337167100; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Yang ZL, 2015, OECOLOGIA, V179, P261, DOI 10.1007/s00442-015-3313-7; Yang ZL, 2013, OECOLOGIA, V171, P495, DOI 10.1007/s00442-012-2433-6; Zhou SR, 2006, FUNCT ECOL, V20, P509, DOI 10.1111/j.1365-2435.2006.01132.x; Zhou Shu-Rong, 2006, Zhiwu Shengtai Xuebao, V30, P868; Zhou XL, 2016, J PLANT ECOL, V9, P144, DOI 10.1093/jpe/rtv043	61	4	5	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134560	10.1371/journal.pone.0134560	http://dx.doi.org/10.1371/journal.pone.0134560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280919	Green Published, Green Submitted, gold			2022-12-27	WOS:000359664300008
J	You, Y; Zheng, QD; Dong, YY; Wang, YH; Zhang, L; Xue, TC; Xie, XY; Hu, C; Wang, ZM; Chen, RX; Wang, YH; Cui, JF; Ren, ZG				You, Yang; Zheng, Qiongdan; Dong, Yinying; Wang, Yaohui; Zhang, Lan; Xue, Tongchun; Xie, Xiaoying; Hu, Chao; Wang, Zhiming; Chen, Rongxin; Wang, Yanhong; Cui, Jiefeng; Ren, Zhenggang			Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin beta 1/GSK3 beta/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							HEPATITIS-B; CANCER; GROWTH; METASTASIS; MICROENVIRONMENT; OVEREXPRESSION; PROGNOSIS; RECEPTOR; COLLAGEN; ENHANCER	Increased stromal stiffness is associated with hepatocellular carcinoma (HCC) development and progression. However, the molecular mechanism by which matrix stiffness stimuli modulate HCC progress is largely unknown. In this study, we explored whether matrix stiffness-mediated effects on osteopontin (OPN) expression occur in HCC cells. We used a previously reported in vitro culture system with tunable matrix stiffness and found that OPN expression was remarkably upregulated in HCC cells with increasing matrix stiffness. Furthermore, the phosphorylation level of GSK3 beta and the expression of nuclear beta-catenin were also elevated, indicating that GSK3 beta/beta-catenin pathway might be involved in OPN regulation. Knock-down analysis of integrin beta 1 showed that OPN expression and p-GSK3 beta level were downregulated in HCC cells grown on high stiffness substrate compared with controls. Simultaneously, inhibition of GSK-3 beta led to accumulation of beta-catenin in the cytoplasm and its enhanced nuclear translocation, further triggered the rescue of OPN expression, suggesting that the integrin beta 1/GSK-3 beta/beta-catenin pathway is specifically activated for matrix stiffness-mediated OPN upregulation in HCC cells. Tissue microarray analysis confirmed that OPN expression was positively correlated with the expression of LOX and COL1. Taken together, high matrix stiffness upregulated OPN expression in HCC cells via the integrin beta 1/GSK-3 beta/beta-catenin signaling pathway. It highlights a new insight into a pathway involving physical mechanical signal and biochemical signal molecules which contributes to OPN expression in HCC cells.	[You, Yang; Zheng, Qiongdan; Dong, Yinying; Zhang, Lan; Xue, Tongchun; Xie, Xiaoying; Chen, Rongxin; Wang, Yanhong; Cui, Jiefeng; Ren, Zhenggang] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, 136 Xue Yuan Rd, Shanghai 200032, Peoples R China; [You, Yang; Zheng, Qiongdan; Dong, Yinying; Zhang, Lan; Xue, Tongchun; Xie, Xiaoying; Chen, Rongxin; Wang, Yanhong; Cui, Jiefeng; Ren, Zhenggang] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200032, Peoples R China; [Wang, Yaohui] Fudan Univ, Shanghai Canc Ctr, Dept Intervent Radiol, Shanghai 200032, Peoples R China; [Hu, Chao] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China; [Wang, Zhiming] Fudan Univ, Zhongshan Hosp Subdiv, Dept Oncol, Shanghai 200052, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Cui, JF (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, 136 Xue Yuan Rd, Shanghai 200032, Peoples R China.	cui.jiefeng@zs-hospital.sh.cn; ren.zhenggang@zs-hospital.sh.cn	Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; Dong, Yinying/HHC-3041-2022; wang, yan/GSE-6489-2022	Hu, Chao/0000-0001-5895-6038	National Natural Science Foundation of China [81071902, 81272583]; Shanghai Science and Technology Programme [11JC1402100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Programme	This study was sponsored by grants from the National Natural Science Foundation of China (Nos. 81071902, 81272583) and the Shanghai Science and Technology Programme (11JC1402100).	Basson MD, 2008, CANCER RES, V68, P2, DOI 10.1158/0008-5472.CAN-07-2992; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bergamini C, 2007, HEPATOLOGY, V46, P1801, DOI 10.1002/hep.21936; Brabek J, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-22; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Cadigan K.M., 2012, COLD SPRING HARB PER, V4; Chen HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038378; Chen RX, 2010, J GASTROEN HEPATOL, V25, P1435, DOI 10.1111/j.1440-1746.2010.06277.x; Cho H, 2008, J CANCER RES CLIN, V134, P909, DOI 10.1007/s00432-007-0351-5; Chuang CY, 2012, GENE, V492, P262, DOI 10.1016/j.gene.2011.10.019; Denhardt DT, 2003, CLIN EXP METASTAS, V20, P77, DOI 10.1023/A:1022550721404; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dong YY, 2014, BIOCHEM BIOPH RES CO, V444, P427, DOI 10.1016/j.bbrc.2014.01.079; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Faouzi S, 1999, J HEPATOL, V30, P275, DOI 10.1016/S0168-8278(99)80074-9; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fiorino S, 2014, J PANCREAS, V15, P151, DOI 10.6092/1590-8577/2099; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Guirouilh J, 2000, INT J ONCOL, V17, P777; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Huang XB, 2013, ARTIF ORGANS, V37, P166, DOI 10.1111/j.1525-1594.2012.01546.x; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim Sung Hoon, 2009, Korean J Hepatol, V15, P320, DOI 10.3350/kjhep.2009.15.3.320; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Leal-Egana A, 2012, J MECH BEHAV BIOMED, V9, P113, DOI 10.1016/j.jmbbm.2012.01.013; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Liang Y, 2011, BIOMATERIALS, V32, P9308, DOI 10.1016/j.biomaterials.2011.08.045; Lin F, 2011, MOL BIOL REP, V38, P5205, DOI 10.1007/s11033-010-0671-4; Liu C, 2015, BIOTECHNOL APPL BIOC, V62, P556, DOI 10.1002/bab.1302; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Masuzaki R, 2008, J CLIN GASTROENTEROL, V42, P839, DOI 10.1097/MCG.0b013e318050074f; Mitra A, 2012, ONCOGENE, V31, P4472, DOI 10.1038/onc.2011.623; Ooi LPJ, 1997, J HEPATOL, V26, P798, DOI 10.1016/S0168-8278(97)80245-0; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Ramachandran S, 2013, MOL BIOL REP, V40, P3623, DOI 10.1007/s11033-012-2436-8; Ravindranath A, 2011, BRIT J CANCER, V105, P542, DOI 10.1038/bjc.2011.269; Ribeiro SA, 2008, INT J BIOL MARKER, V23, P154; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Sun J, 2010, J CANCER RES CLIN, V136, P1, DOI 10.1007/s00432-009-0629-x; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wang HB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113880, 10.1371/journal.pone.0089155, 10.1371/journal.pone.0091730]; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; Wong CCL, 2014, HEPATOLOGY, V60, P1645, DOI 10.1002/hep.27320; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Yoshioka K, 2014, HEPATOL RES; Zhang H, 2006, J CANCER RES CLIN, V132, P709, DOI 10.1007/s00432-006-0119-3; Zhao G, 2010, J SURG ONCOL, V102, P482, DOI 10.1002/jso.21613; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025	58	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134243	10.1371/journal.pone.0134243	http://dx.doi.org/10.1371/journal.pone.0134243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280346	Green Published, gold, Green Submitted			2022-12-27	WOS:000359664300003
J	Liu, PG; Wang, YQ; Du, X; Yao, LS; Li, FB; Meng, ZQ				Liu, Peigang; Wang, Yongqiang; Du, Xin; Yao, Lusong; Li, Fengbo; Meng, Zhiqi			Transcriptome Analysis of Thermal Parthenogenesis of the Domesticated Silkworm	PLOS ONE			English	Article							BOMBYX-MORI; DROSOPHILA ENCODES; ESCHERICHIA-COLI; ZINC-FINGER; DNA-DAMAGE; GENE; DIFFERENTIATION; TRANSPORTERS; RESISTANCE; TELOMERES	Thermal induction of parthenogenesis (also known as thermal parthenogenesis) in silkworms is an important technique that has been used in artificial insemination, expansion of hybridization, transgenesis and sericultural production; however, the exact mechanisms of this induction remain unclear. This study aimed to investigate the gene expression profile in silkworms undergoing thermal parthenogenesis using RNA-seq analysis. The transcriptome profiles indicated that in non-induced and induced eggs, the numbers of differentially expressed genes (DEGs) for the parthenogenetic line (PL) and amphigenetic line (AL) were 538 and 545, respectively, as determined by fold-change >= 2. Gene ontology (GO) analysis showed that DEGs between two lines were mainly involved in reproduction, formation of chorion, female gamete generation and cell development pathways. Upregulation of many chorion genes in AL suggests that the maturation rate of AL eggs was slower than PL eggs. Some DEGs related to reactive oxygen species removal, DNA repair and heat shock response were differentially expressed between the two lines, such as MPV-17, REV1 and HSP68. These results supported the view that a large fraction of genes are differentially expressed between PL and AL, which offers a new approach to identifying the molecular mechanism of silkworm thermal parthenogenesis.	[Liu, Peigang; Wang, Yongqiang; Du, Xin; Yao, Lusong; Li, Fengbo; Meng, Zhiqi] Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China; [Li, Fengbo; Meng, Zhiqi] Zhejiang Acad Agr Sci, Sericultural Res Inst, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences	Meng, ZQ (corresponding author), Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China.	zqmeng2011@sina.com		/0000-0001-8227-7537	National Natural Science Foundation of China [31172271, 31072084]; China Agriculture Research System [CARS-22-ZJ0108]; Zhejiang Province [2012C12910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Zhejiang Province	This work was supported by the National Natural Science Foundation of China (31172271, 31072084), China Agriculture Research System (CARS-22-ZJ0108), Major Project of Zhejiang Province (2012C12910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON A, 1969, BIOCHIM BIOPHYS ACTA, V177, P163, DOI 10.1016/0304-4165(69)90081-6; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Astaurov BL, 1940, ARTIFICIAL SILKWORM, P238; AUJAME L, 1988, MOL CELL BIOL, V8, P5486, DOI 10.1128/MCB.8.12.5486; BELL G, 1982, EVOLUTION GENETICS S; BOCK SC, 1986, DEV BIOL, V117, P215, DOI 10.1016/0012-1606(86)90364-7; BULLINI L, 1994, TRENDS ECOL EVOL, V9, P422, DOI 10.1016/0169-5347(94)90124-4; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Chen JE, 2012, BIOTECHNOL BIOPROC E, V17, P298, DOI 10.1007/s12257-012-0006-5; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Daschner K, 2001, PLANT PHYSIOL, V126, P601, DOI 10.1104/pp.126.2.601; Davis GK, 2012, J EXP ZOOL PART B, V318B, P448, DOI 10.1002/jez.b.22441; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Debnirmalya Gangopadhyay, 2005, International Journal of Industrial Entomology, V10, P1; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003; Ferreira JA, 2006, ANN STAT, V34, P1827, DOI 10.1214/009053606000000425; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Fujita Y, 2004, BIOSCI BIOTECH BIOCH, V68, P306, DOI 10.1271/bbb.68.306; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Giri J, 2011, NEW PHYTOL, V191, P721, DOI 10.1111/j.1469-8137.2011.03740.x; GOLDSMITH MR, 1980, GENETICS, V96, P201; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hanson SJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-412; He Pin-An, 2008, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V24, P719; Hock T, 2000, P NATL ACAD SCI USA, V97, P9519, DOI 10.1073/pnas.160271797; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KAGEYAMA T, 1990, EUR J BIOCHEM, V193, P203, DOI 10.1111/j.1432-1033.1990.tb19324.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kellner K, 2013, J EVOLUTION BIOL, V26, P108, DOI 10.1111/jeb.12025; Kirkendall LR, 2003, PARTHENOGENESIS ENCY, P851; Klymenko Vyacheslav V., 2001, Journal of Insect Biotechnology and Sericology, V70, P155; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Liu PG, 2014, BIOTECHNOL BIOPROC E, V19, P641, DOI 10.1007/s12257-014-0099-0; Liu Y, 2008, J INSECT SCI, V40, P235; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPILATO JE, 1984, J BACTERIOL, V158, P665, DOI 10.1128/JB.158.2.665-673.1984; Miri K, 2013, DEVELOPMENT, V140, P4480, DOI 10.1242/dev.096511; NADEL MR, 1980, DEV BIOL, V75, P26, DOI 10.1016/0012-1606(80)90141-4; Naturil-Alfonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051271; Normark B. B., 2009, ENCY INSECTS, P688; Park IK, 1996, INT J BIOCHEM CELL B, V28, P1169, DOI 10.1016/1357-2725(96)00047-7; Portoso Manuela, 2008, P29; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; Sato H, 1925, J SCI AGR SOC JAPAN, V274, P232; Stankunas K, 1998, DEVELOPMENT, V125, P4055; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Tichomirov AA, 1902, ZOLL ANZA, V25, P386; Tichomirov AA, 1903, IZV KOM SHELK MOSK O, V1, P3; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Umlauf D, 2013, J CELL SCI, V126, P2656, DOI 10.1242/jcs.118000; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vrijenhoek R. C., 1999, ENCY REPROD, V3, P695; Wang Y.Q., 2010, SCI SERI, V36, P268; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yin Y, 2014, PROTEIN CELL, V5, P8, DOI 10.1007/s13238-013-0006-z; Zhao YP, 2012, J INSECT PHYSIOL, V58, P1397, DOI 10.1016/j.jinsphys.2012.08.002	65	7	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135215	10.1371/journal.pone.0135215	http://dx.doi.org/10.1371/journal.pone.0135215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274803	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600056
J	Meindl, C; Stranzinger, S; Dzidic, N; Salar-Behzadi, S; Mohr, S; Zimmer, A; Frohlich, E				Meindl, Claudia; Stranzinger, Sandra; Dzidic, Neira; Salar-Behzadi, Sharareh; Mohr, Stefan; Zimmer, Andreas; Froehlich, Eleonore			Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; CELL-CULTURE MODELS; RESPIRATORY-TRACT; CALU-3 CELLS; LUNG; EXPOSURE; DELIVERY; NANOPARTICLES; ABSORPTION; MONOLAYERS	Background Pulmonary drug delivery is characterized by short onset times of the effects and an increased therapeutic ratio compared to oral drug delivery. This delivery route can be used for local as well as for systemic absorption applying drugs as single substance or as a fixed dose combination. Drugs can be delivered as nebulized aerosols or as dry powders. A screening system able to mimic delivery by the different devices might help to assess the drug effect in the different formulations and to identify potential interference between drugs in fixed dose combinations. The present study evaluates manual devices used in animal studies for their suitability for cellular studies. Methods Calu-3 cells were cultured submersed and in air-liquid interface culture and characterized regarding mucus production and transepithelial electrical resistance. The influence of pore size and material of the transwell membranes and of the duration of air-liquid interface culture was assessed. Compounds were applied in solution and as aerosols generated by MicroSprayer IA-1C Aerosolizer or by DP-4 Dry Powder Insufflator using fluorescein and rhodamine 123 as model compounds. Budesonide and formoterol, singly and in combination, served as examples for drugs relevant in pulmonary delivery. Results and Conclusions Membrane material and duration of air-liquid interface culture had no marked effect on mucus production and tightness of the cell monolayer. Co-application of budesonide and formoterol, applied in solution or as aerosol, increased permeation of formoterol across cells in air-liquid interface culture. Problems with the DP-4 Dry Powder Insufflator included compound-specific delivery rates and influence on the tightness of the cell monolayer. These problems were not encountered with the MicroSprayer IA-1C Aerosolizer. The combination of Calu-3 cells and manual aerosol generation devices appears suitable to identify interactions of drugs in fixed drug combination products on permeation.	[Meindl, Claudia; Froehlich, Eleonore] Med Univ Graz, Med Res Ctr, Graz, Austria; [Stranzinger, Sandra; Dzidic, Neira; Salar-Behzadi, Sharareh; Mohr, Stefan] Res Ctr Pharmaceut Engn GmbH, Graz, Austria; [Zimmer, Andreas] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Technol, Graz, Austria	Medical University of Graz; Research Center for Pharmaceutical Engineering (RCPE); University of Graz	Frohlich, E (corresponding author), Med Univ Graz, Med Res Ctr, Graz, Austria.	eleonore.froehlich@medunigraz.at	Fröhlich, Eleonore/M-8943-2014; Zimmer, Andreas/C-7290-2012	Fröhlich, Eleonore/0000-0002-6056-6829; Zimmer, Andreas/0000-0003-3127-287X	Research Center Pharmaceutical Engineering GmbH; Austrian Science Fund (FWF) [P 22576] Funding Source: researchfish	Research Center Pharmaceutical Engineering GmbH; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors received no specific funding for this work. Research Center Pharmaceutical Engineering GmbH provided support in the form of salaries for authors SS, ND, SSB and SM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arora Lakhani D, 2012, RESP DRUG DELIVERY, V1, P185; Artursson P, 1991, PHARM APPL CELL TISS, P93; Aufderheide M, 2000, EXP TOXICOL PATHOL, V52, P265, DOI 10.1016/S0940-2993(00)80044-5; Bakand S, 2010, J PHARMACOL TOX MET, V61, P76, DOI 10.1016/j.vascn.2010.01.010; Banga A, 2012, CELL PHYSIOL BIOCHEM, V29, P197, DOI 10.1159/000337601; Barnes PJ, 2012, ALLERGY ASTHMA PROC, V33, P140, DOI 10.2500/aap.2012.33.3512; Bates E, 2007, J CYST FIBROS, V6, P351, DOI 10.1016/j.jcf.2007.01.001; Blank F, 2006, J AEROSOL MED, V19, P392, DOI 10.1089/jam.2006.19.392; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Borchard G, 2002, J PHARM SCI-US, V91, P1561, DOI 10.1002/jps.10151; Bosquillon C, 2010, J PHARM SCI-US, V99, P2240, DOI 10.1002/jps.21995; Brillault J, 2010, ANTIMICROB AGENTS CH, V54, P543, DOI 10.1128/AAC.00733-09; Bur M, 2010, J AEROSOL MED PULM D, V23, P119, DOI 10.1089/jamp.2009.0757; Dekali S, 2014, TOXICOL REP, V1, P157, DOI 10.1016/j.toxrep.2014.03.003; Duret C, 2012, EUR J PHARM BIOPHARM, V81, P627, DOI 10.1016/j.ejpb.2012.04.004; Ehrhardt C, 2002, J AEROSOL MED, V15, P131, DOI 10.1089/089426802320282257; Ehrhardt C, 2008, DRUG ABSORPTION STUD; Eixarch H., 2010, J EPITHEL BIOL PHARM, V3, P1, DOI DOI 10.2174/1875044301003010001; Fernandes CA, 2009, EXPERT OPIN DRUG DEL, V6, P1231, DOI 10.1517/17425240903241788; Fiegel J, 2003, PHARM RES-DORDR, V20, P788, DOI 10.1023/A:1023441804464; Florea BI, 2001, BRIT J PHARMACOL, V134, P1555, DOI 10.1038/sj.bjp.0704390; Forbes B, 2003, INT J PHARM, V257, P161, DOI 10.1016/S0378-5173(03)00129-7; Foster KA, 2000, INT J PHARMACEUT, V208, P1, DOI 10.1016/S0378-5173(00)00452-X; Frohlich E, 2013, TOXICOL IN VITRO, V27, P409, DOI 10.1016/j.tiv.2012.08.008; Garcia-Canton C, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-41; Garnett JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076283; Gervelas C, 2007, J CONTROL RELEASE, V118, P78, DOI 10.1016/j.jconrel.2006.11.027; Geys J, 2006, TOXICOL LETT, V160, P218, DOI 10.1016/j.toxlet.2005.07.005; Ghio AJ, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-25; Grainger CI, 2009, EUR J PHARM BIOPHARM, V71, P318, DOI 10.1016/j.ejpb.2008.09.006; Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0; Gustafsson A, 2011, J IMMUNOTOXICOL, V8, P111, DOI 10.3109/1547691X.2010.546382; Haghi M, 2014, PHARM THER; Haghi M, 2013, RESPIROLOGY, V18, P1197, DOI 10.1111/resp.12146; Haghi M, 2012, AAPS J, V14, P79, DOI 10.1208/s12248-011-9317-2; Haghi M, 2010, DRUG DEV IND PHARM, V36, P1207, DOI 10.3109/03639041003695113; Harcourt JL, 2013, JOVE-J VIS EXP, DOI 10.3791/50157; Heuking S, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-29; Hoppentocht M, 2014, EUR J PHARM BIOPHARM, V88, P153, DOI 10.1016/j.ejpb.2014.06.014; Imanishi M, 2009, J OCCUP HEALTH, V51, P287, DOI 10.1539/joh.M8016; Kardia E, 2014, J AEROSOL MED PULM D, V27, P30, DOI 10.1089/jamp.2012.1020; Kim DS, 2004, NEOPLASIA, V6, P168, DOI 10.1593/neo.03310; Kim JS, 2014, TOXICOLOGY, V317, P31, DOI 10.1016/j.tox.2014.01.005; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; LEE JS, 1994, MOL PHARMACOL, V46, P627; Lenz AG, 2014, AM J RESP CELL MOL, V51, P526, DOI 10.1165/rcmb.2013-0479OC; Li Y, 2006, AM J RESP CELL MOL, V34, P600, DOI 10.1165/rcmb.2005-0421OC; Madlova M, 2009, J PHARM PHARMACOL, V61, P293, DOI 10.1211/jpp/61.03.0003; Mamlouk M, 2013, J ASTHMA, V50, P334, DOI 10.3109/02770903.2013.773518; Mansour H.M., 2015, DRUG DELIV, V1st, P71; Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023; Marusic M, 2014, ACTA CHIM SLOV, V61, P100; Mathias NR, 2002, J DRUG TARGET, V10, P31, DOI 10.1080/10611860290007504; Mukherjee M, 2012, INT J PHARMACEUT, V426, P7, DOI 10.1016/j.ijpharm.2011.12.036; Niwa Y, 2007, CIRC J, V71, P1157, DOI 10.1253/circj.71.1157; Olsson B, 2011, ADV DEL SCI TECHNOL, P21, DOI 10.1007/978-1-4419-9745-6_2; Patel J, 2002, PHARMACEUT RES, V19, P1696, DOI 10.1023/A:1020761514471; Pezron I, 2002, J PHARM SCI-US, V91, P1135, DOI 10.1002/jps.10114; PRITCHARD JN, 1985, ENVIRON RES, V36, P268, DOI 10.1016/0013-9351(85)90025-8; Ritter D, 2003, INHAL TOXICOL, V15, P67, DOI 10.1080/08958370304449; Ruge CA, 2013, LANCET RESP MED, V1, P402, DOI 10.1016/S2213-2600(13)70072-9; Sakamoto A, 2013, J PHARM SCI-US, V102, P3395, DOI 10.1002/jps.23606; Salomon JJ, 2012, EUR J PHARM BIOPHARM, V81, P351, DOI 10.1016/j.ejpb.2012.03.001; Schulze C, 2011, EURO NANOTOX LETT, V1, P0001; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Sondergaard HB, 2008, PFLUG ARCH EUR J PHY, V456, P611, DOI 10.1007/s00424-007-0421-1; Steimer A, 2005, J AEROSOL MED, V18, P137, DOI 10.1089/jam.2005.18.137; Steiner S, 2012, TOXICOL LETT, V214, P218, DOI 10.1016/j.toxlet.2012.08.026; Stentebjerg-Andersen A, 2011, EUR J PHARM BIOPHARM, V78, P19, DOI 10.1016/j.ejpb.2010.12.030; Suresh V, 2014, PEERJ PREPRINTS, V2; Teijeiro Osorio D, 2007, DESARROLLO MICRO NAN; Tewes F, 2013, EUR J PHARM BIOPHARM, V85, P604, DOI 10.1016/j.ejpb.2013.03.020; Witzenrath M, 2009, CRIT CARE MED, V37, P584, DOI 10.1097/CCM.0b013e3181959814; Zeng X.M., 2001, PARTICULATE INTERACT, P1; Zhang XY, 2010, MOL PHARMACEUT, V7, P456, DOI 10.1021/mp9001969	75	26	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135690	10.1371/journal.pone.0135690	http://dx.doi.org/10.1371/journal.pone.0135690			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274590	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600095
J	Niu, LL; Li, SM; Liang, HM; Li, H				Niu, Leilei; Li, Shumin; Liang, Huamao; Li, Hua			The hMLH1-93G > A Polymorphism and Risk of Ovarian Cancer in the Chinese Population	PLOS ONE			English	Article							DNA MISMATCH REPAIR; SINGLE-NUCLEOTIDE POLYMORPHISM; PROMOTER POLYMORPHISM; LUNG-CANCER; HMLH1 GENE; MLH1; IDENTIFICATION; MECHANISMS; CARCINOMA; PATHWAYS	Background As a mismatch repair (MMR) gene, hMLH1 plays an important role in the maintenance of chromosomal integrity. Several studies have investigated the associations of hMLH1 -93G>A (rs1800734) and Ile219Val (rs1799977) in diverse tumor types with discordant results, but their roles in ovarian cancer in the Chinese population remains to be elucidated. Methods In a case-control analysis, we assessed the association between these two polymorphisms and ovarian cancer risk in 421 ovarian cancer patients and 689 control subjects in the Chinese population using logistic regression. Results We found that the variant hMLH1 genotypes (-93AA and AG) are associated with risk of ovarian cancer (adjusted odds ratio [OR] = 2.02, 95% confidence interval [CI] = 1.42-2.89) compared with the -93GG genotype. The A allele increases the risk of ovarian cancer in a dose-dependent manner (P<10(-4)). Functional test showed that -93A allele increased hMLH1 promoter transcriptional activity and the luciferase activity. However, no significant difference was found in the genotype frequencies at the Ile219Val site between the cases and controls. Conclusions These findings indicate that the -93G>A polymorphism in hMLH1 may affect ovarian cancer susceptibility in the Chinese population.	[Niu, Leilei; Liang, Huamao; Li, Hua] Peking Univ, Dept Obstet & Gynecol, Hosp 3, Beijing 100871, Peoples R China; [Li, Shumin; Li, Hua] Chinese Acad Med Sci, Dept Gynecol Oncol, Canc Hosp, Beijing 100730, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Li, H (corresponding author), Peking Univ, Dept Obstet & Gynecol, Hosp 3, Beijing 100871, Peoples R China.	hua.li88@sina.com			National Natural Scientific Foundation of China [81202040]; Beijing Municipal Natural Science Foundation [7142167]; Beijing Nova Program [2009B03]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This study was supported by the National Natural Scientific Foundation of China grants (No. 81202040 to HL), Beijing Municipal Natural Science Foundation (No. 7142167 to HL) and Beijing Nova Program (No. 2009B03 to HL).	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Bandera CA, 2005, J REPROD MED, V50, P399; Banescu C, 2013, GENE, V526, P478, DOI 10.1016/j.gene.2013.05.054; Beiner ME, 2006, CANCER EPIDEM BIOMAR, V15, P1636, DOI 10.1158/1055-9965.EPI-06-0257; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Fredriksson H, 2006, EUR J CANCER, V42, P2802, DOI 10.1016/j.ejca.2006.04.024; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Green H, 2006, CLIN CANCER RES, V12, P854, DOI 10.1158/1078-0432.CCR-05-0950; Guo SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056213; HIBI K, 1992, ONCOGENE, V7, P445; Hsieh P, 2001, MUTAT RES-DNA REPAIR, V486, P71, DOI 10.1016/S0921-8777(01)00088-X; Hubner RA, 2007, J NATL CANCER I, V99, P1490, DOI 10.1093/jnci/djm137; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Ito E, 1999, BIOCHEM BIOPH RES CO, V256, P488, DOI 10.1006/bbrc.1999.0368; Jha R, 2013, GENE, V526, P223, DOI 10.1016/j.gene.2013.05.014; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Jiang L, 2011, BREAST CANCER RES TR, V126, P487, DOI 10.1007/s10549-010-1094-6; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kang S, 2006, EXP MOL MED, V38, P320, DOI 10.1038/emm.2006.38; Kim Jin C, 2004, Fam Cancer, V3, P129; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Li JH, 2005, WORLD J GASTROENTERO, V11, P3144, DOI 10.3748/wjg.v11.i20.3144; Li N, 2013, MOL BIOL REP, V40, P3749, DOI 10.1007/s11033-012-2451-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McDaid JR, 2009, BRIT J CANCER, V101, P441, DOI 10.1038/sj.bjc.6605186; Odicino F, 2008, INT J GYNECOL OBSTET, V101, P205, DOI 10.1016/j.ijgo.2007.11.004; Okada T, 2005, INT J CANCER, V116, P925, DOI 10.1002/ijc.21118; Park SH, 2004, INT J CANCER, V112, P678, DOI 10.1002/ijc.20359; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Ries LAG, 2003, ONCOLOGIST, V8, P541; Shi Wen-ping, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P235; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Shin KH, 2002, CANCER RES, V62, P38; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Tanaka Y, 2009, BIOCHEM BIOPH RES CO, V383, P440, DOI 10.1016/j.bbrc.2009.04.025; Vo C, 2007, OBSTET GYN CLIN N AM, V34, P687, DOI 10.1016/j.ogc.2007.09.008; Yan L, 2009, DIS ESOPHAGUS, V22, P396, DOI 10.1111/j.1442-2050.2008.00912.x; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307; Zheng J, 2012, INT J CANCER, V130, P1981, DOI 10.1002/ijc.26253; Zheng J, 2011, MOL CARCINOGEN, V50, P689, DOI 10.1002/mc.20803	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135822	10.1371/journal.pone.0135822	http://dx.doi.org/10.1371/journal.pone.0135822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275295	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600121
J	Miyai, M; Eikawa, S; Hosoi, A; Iino, T; Matsushita, H; Isobe, M; Uenaka, A; Udono, H; Nakajima, J; Nakayama, E; Kakimi, K				Miyai, Manami; Eikawa, Shingo; Hosoi, Akihiro; Iino, Tamaki; Matsushita, Hirokazu; Isobe, Midori; Uenaka, Akiko; Udono, Heiichiro; Nakajima, Jun; Nakayama, Eiichi; Kakimi, Kazuhiro			Detection and Tracking of NY-ESO-1-Specific CD8(+) T Cells by High-Throughput T Cell Receptor beta (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient	PLOS ONE			English	Article							INTERFERON-GAMMA; IDENTIFICATION; SECRETION; ANTITUMOR; RESPONSES	Comprehensive immunological evaluation is crucial for monitoring patients undergoing antigen-specific cancer immunotherapy. The identification and quantification of T cell responses is most important for the further development of such therapies. Using well-characterized clinical samples from a high responder patient (TK-f01) in an NY-ESO-1f peptide vaccine study, we performed high-throughput T cell receptor beta-chain (TCRB) gene next generation sequencing (NGS) to monitor the frequency of NY-ESO-1-specific CD8(+) T cells. We compared these results with those of conventional immunological assays, such as IFN-gamma capture, tetramer binding and limiting dilution clonality assays. We sequenced human TCRB complementarity-determining region 3 (CDR3) rearrangements of two NY-ESO-1f specific CD8(+) T cell clones, 6-8L and 2F6, as well as PBMCs over the course of peptide vaccination. Clone 6-8L possessed the TCRB CDR3 gene TCRBV11-03*01 and BJ02-01*01 with amino acid sequence CASSLRGNEQFF, whereas 2F6 possessed TCRBV05-08*01 and BJ02-04*01 (CASSLVGTNIQYF). Using these two sequences as models, we evaluated the frequency of NY-ESO-1-specific CD8(+) T cells in PBMCs ex vivo. The 6-8L CDR3 sequence was the second most frequent in PBMC and was present at high frequency (0.7133%) even prior to vaccination, and sustained over the course of vaccination. Despite a marked expansion of NY-ESO-1-specific CD8(+) T cells detected from the first through 6th vaccination by tetramer staining and IFN-gamma capture assays, as evaluated by CDR3 sequencing the frequency did not increase with increasing rounds of peptide vaccination. By clonal analysis using 12 day in vitro stimulation, the frequency of B*52:01-restricted NY-ESO-1f peptide-specific CD8(+) T cells in PBMCs was estimated as only 0.0023%, far below the 0.7133% by NGS sequencing. Thus, assays requiring in vitro stimulation might be underestimating the frequency of clones with lower proliferation potential. High-throughput TCRB sequencing using NGS can potentially better estimate the actual frequency of antigen-specific T cells and thus provide more accurate patient monitoring.	[Miyai, Manami; Hosoi, Akihiro; Iino, Tamaki; Matsushita, Hirokazu; Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Bunkyo Ku, Tokyo 113, Japan; [Eikawa, Shingo; Udono, Heiichiro] Okayama Univ, Dept Immunol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Okayama 7008530, Japan; [Isobe, Midori; Uenaka, Akiko; Nakayama, Eiichi] Kawasaki Univ Med Welf, Fac Hlth & Welf, Kurashiki, Okayama, Japan; [Nakajima, Jun] Tokyo Univ Hosp, Dept Thorac Surg, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; Okayama University; University of Tokyo	Kakimi, K (corresponding author), Tokyo Univ Hosp, Dept Immunotherapeut, Bunkyo Ku, Tokyo 113, Japan.	kakimi@m.u-tokyo.ac.jp		Nakajima, Jun/0000-0003-1174-0816	Project for Development of Innovative research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology [24501329]	Project for Development of Innovative research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology	This study was supported in part by a Grant-in-Aid for Scientific Research (24501329 KK) and a research program of the Project for Development of Innovative research on Cancer Therapeutics (P-Direct, EN and KK) of the Ministry of Education, Culture, Sports, Science and Technology (24501329 KK) [http://www.mext.go.jp/english/]. The study sponsors had no involvement in study design, collection, analysis, and interpretation of data, writing the report, or the decision to submit the report for publication.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Desombere I, 2004, J IMMUNOL METHODS, V286, P167, DOI 10.1016/j.jim.2004.01.001; Eikawa S, 2013, INT J CANCER, V132, P345, DOI 10.1002/ijc.27682; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Kakimi K, 2011, INT J CANCER, V129, P2836, DOI 10.1002/ijc.25955; Keilholz U, 2002, J IMMUNOTHER, V25, P97, DOI 10.1097/00002371-200203000-00001; Keilhoz U, 2006, CLIN CANCER RES, V12, p2346S, DOI 10.1158/1078-0432.CCR-05-2540; Lossius A, 2014, EUR J IMMUNOL, V44, P3439, DOI 10.1002/eji.201444662; Lurquin C, 2005, J EXP MED, V201, P249, DOI 10.1084/jem.20041378; Maino VC, 1998, CYTOMETRY, V34, P207, DOI 10.1002/(SICI)1097-0320(19981015)34:5<207::AID-CYTO1>3.0.CO;2-J; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; Morishima S, 2007, INT J CANCER, V120, P594, DOI 10.1002/ijc.22312; Nakasone H, 2014, BONE MARROW TRANSPL, V49, P87, DOI 10.1038/bmt.2013.122; Pittet MJ, 2001, J IMMUNOL, V166, P7634, DOI 10.4049/jimmunol.166.12.7634; Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Six A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00413; Valmori D, 2002, J IMMUNOL, V168, P4231, DOI 10.4049/jimmunol.168.8.4231; Wu D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003656	26	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136086	10.1371/journal.pone.0136086	http://dx.doi.org/10.1371/journal.pone.0136086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291626	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900051
J	Pelini, SL; Maran, AM; Chen, AR; Kaseman, J; Crowther, TW				Pelini, Shannon L.; Maran, Audrey M.; Chen, Angus R.; Kaseman, Justine; Crowther, Thomas W.			Higher Trophic Levels Overwhelm Climate Change Impacts on Terrestrial Ecosystem Functioning	PLOS ONE			English	Article							TOP-DOWN; COMMUNITY COMPOSITION; SOIL BIODIVERSITY; CARBON-CYCLE; BOTTOM-UP; FOOD-WEB; INVERTEBRATES; RESPIRATION; RESPONSES; DYNAMICS	Forest floor food webs play pivotal roles in carbon cycling, but they are rarely considered in models of carbon fluxes, including soil carbon dioxide emissions (respiration), under climatic warming. The indirect effects of invertebrates on heterotrophic (microbial and invertebrate) respiration through interactions with microbial communities are significant and will be altered by warming. However, the interactive effects of invertebrates and warming on heterotrophic respiration in the field are poorly understood. In this study we combined field and common garden laboratory approaches to examine relationships between warming, forest floor food web structure, and heterotrophic respiration. We found that soil animals can overwhelm the effects of warming (to 5 degrees Celsius above ambient) on heterotrophic respiration. In particular, the presence of higher trophic levels and burrowing detritivores strongly determined heterotrophic respiration rates in temperate forest soils. These effects were, however, context-dependent, with greater effects in a lower-latitude site. Without isolating and including the significant impact of invertebrates, climate models will be incomplete, hindering well-informed policy decisions.	[Pelini, Shannon L.; Maran, Audrey M.; Kaseman, Justine] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Chen, Angus R.; Kaseman, Justine] Harvard Univ, Harvard Forest, Petersham, MA 01366 USA; [Crowther, Thomas W.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	University System of Ohio; Bowling Green State University; Harvard University; Yale University	Crowther, TW (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	thomas.crowther11@gmail.com		Crowther, Thomas/0000-0001-5674-8913	United States National Science Foundation [DBI 10-03938, DBI 1459519]; Building Strength Program at Bowling Green State University; Yale University's Climate and Energy Institute; British Ecological Society; United States Department of Energy Program for Ecosystem Research [DE-FG02-08ER64510]	United States National Science Foundation(National Science Foundation (NSF)); Building Strength Program at Bowling Green State University; Yale University's Climate and Energy Institute; British Ecological Society; United States Department of Energy Program for Ecosystem Research	Funding was provided by United States National Science Foundation Long Term Ecological Research (DBI 10-03938) and Research Experiences for Undergraduates (DBI 1459519) awards to Harvard Forest. SLP received funds from the Building Strength Program at Bowling Green State University. TWC received funds from Yale University's Climate and Energy Institute and the British Ecological Society. The authors thank Rob Dunn, Aaron Ellison, Nick Gotelli, and Nate Sanders for allowing use of the warming chambers, funded by United States Department of Energy Program for Ecosystem Research (DE-FG02-08ER64510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Barrett JE, 2008, GLOBAL CHANGE BIOL, V14, P1734, DOI 10.1111/j.1365-2486.2008.01611.x; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; Baveye P, 2009, UNCERTAINTIES ENV MO; Best ML, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00302.1; Bradford MA, 2002, SCIENCE, V298, P615, DOI 10.1126/science.1075805; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Crowther T, 2015, PNAS IN PRESS; Crowther TW, 2013, ECOLOGY, V94, P2518, DOI 10.1890/13-0197.1; Crowther TW, 2011, ECOL LETT, V14, P1134, DOI 10.1111/j.1461-0248.2011.01682.x; Crowther TW, 2011, SOIL BIOL BIOCHEM, V43, P2060, DOI 10.1016/j.soilbio.2011.06.003; Crowther TW, 2011, FUNGAL ECOL, V4, P333, DOI 10.1016/j.funeco.2011.05.001; Crumsey JM, 2013, ECOLOGY, V94, P2827, DOI 10.1890/12-1555.1; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Ellison AM, 2009, ANTS CLIMATE CHANGE; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Jochum M, 2012, PHILOS T R SOC B, V367, P2962, DOI 10.1098/rstb.2012.0237; Kuiper I, 2013, GLOBAL CHANGE BIOL, V19, P2814, DOI 10.1111/gcb.12232; Laakso J, 1999, OECOLOGIA, V120, P279, DOI 10.1007/s004420050859; Lang B, 2012, J ANIM ECOL, V81, P516, DOI 10.1111/j.1365-2656.2011.01931.x; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lubbers IM, 2013, NAT CLIM CHANGE, V3, P187, DOI [10.1038/NCLIMATE1692, 10.1038/nclimate1692]; Makoto K, 2014, SOIL BIOL BIOCHEM, V72, P19, DOI 10.1016/j.soilbio.2014.01.016; Manning P, 2006, ECOL LETT, V9, P1015, DOI 10.1111/j.1461-0248.2006.00959.x; Mikola J, 1998, ECOLOGY, V79, P153, DOI 10.1890/0012-9658(1998)079[0153:NEOTCI]2.0.CO;2; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Pelini SL, 2011, METHODS ECOL EVOL, V2, P534, DOI 10.1111/j.2041-210X.2011.00100.x; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; POUGH FH, 1987, FOREST ECOL MANAG, V20, P1, DOI 10.1016/0378-1127(87)90146-0; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; Rouifed S, 2010, OECOLOGIA, V163, P247, DOI 10.1007/s00442-009-1528-1; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Schmitz OJ, 2014, ECOSYSTEMS, V17, P344, DOI 10.1007/s10021-013-9715-7; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Setala Heikki, 2005, P308; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Wall DH, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P1; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Zhao C, 2013, J ANIM ECOL, V82, P749, DOI 10.1111/1365-2656.12058	43	6	6	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136344	10.1371/journal.pone.0136344	http://dx.doi.org/10.1371/journal.pone.0136344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292214	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900078
J	Raats, JW; van Eijsden, WA; Crolla, RMPH; Steyerberg, EW; van der Laan, L				Raats, Jelle W.; van Eijsden, Wilbert A.; Crolla, Rogier M. P. H.; Steyerberg, Ewout W.; van der Laan, Lijckle			Risk Factors and Outcomes for Postoperative Delirium after Major Surgery in Elderly Patients	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; COLORECTAL SURGERY; COGNITIVE DYSFUNCTION; GERIATRIC POPULATION; VASCULAR-SURGERY; ADVERSE OUTCOMES; HIP FRACTURE; OPEN REPAIR; IMPLEMENTATION; VALIDATION	Background Early identification of patients at risk for delirium is important, since adequate well timed interventions could prevent occurrence of delirium and related detrimental outcomes. The aim of this study is to evaluate prognostic factors for delirium, including factors describing frailty, in elderly patients undergoing major surgery. Methods We included patients of 65 years and older, who underwent elective surgery from March 2013 to November 2014. Patients had surgery for Abdominal Aortic Aneurysm (AAA) or colorectal cancer. Delirium was scored prospectively using the Delirium Observation Screening Scale. Pre- and peri-operative predictors of delirium were analyzed using regression analysis. Outcomes after delirium included adverse events, length of hospital stay, discharge destination and mortality. Results We included 232 patients. 51 (22%) underwent surgery for AAA and 181 (78%) for colorectal cancer. Postoperative delirium occurred in 35 patients (15%). Predictors of postoperative delirium included: delirium in medical history (Odds Ratio 12 [95% Confidence Interval 2.7-50]), advancing age (Odds Ratio 2.0 [95% Confidence Interval 1.1-3.8]) per 10 years, and ASA-score >= 3 (Odds Ratio 2.6 [95% Confidence Interval 1.1-5.9]). Occurrence of delirium was related to an increase in adverse events, length of hospital stay and mortality. Conclusion Postoperative delirium is a frequent complication after major surgery in elderly patients and is related to an increase in adverse events, length of hospital stay, and mortality. A delirium in the medical history, advanced age, and ASA-score may assist in defining patients at increased risk for delirium. Further attention to prevention of delirium is essential in elderly patients undergoing major surgery.	[Raats, Jelle W.; van Eijsden, Wilbert A.; Crolla, Rogier M. P. H.; van der Laan, Lijckle] Amphia Hosp, Dept Surg, Breda, Netherlands; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Amphia Hospital; Erasmus University Rotterdam; Erasmus MC	Raats, JW (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	JRaats@amphia.nl	Crolla, Rogier/L-9847-2019	Crolla, Rogier/0000-0003-2617-1791; van der laan, lijckle/0000-0001-5631-594X				[Anonymous], 2012, EPIC HYPERSPACE; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Bekker Alex Y, 2003, Best Pract Res Clin Anaesthesiol, V17, P259, DOI 10.1016/S1521-6896(03)00005-3; Bilotta F, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-170; Bohner H, 2003, ANN SURG, V238, P149, DOI 10.1097/00000658-200307000-00019; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; de Mheen PJMV, 2007, QUAL SAF HEALTH CARE, V16, P428, DOI 10.1136/qshc.2006.021071; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Desormais I, 2014, EUR J VASC ENDOVASC, V48, P202, DOI 10.1016/j.ejvs.2014.04.005; Engelberger S, 2012, INT SURG, V97, P129, DOI 10.9738/CC125.1; Epstein D, 2014, BRIT J SURG, V101, P623, DOI 10.1002/bjs.9464; Freter SH, 2005, AGE AGEING, V34, P169, DOI 10.1093/ageing/afh245; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Joosten E, 2006, GERONTOLOGY, V52, P382, DOI 10.1159/000095126; Kalisvaart KJ, 2006, J AM GERIATR SOC, V54, P817, DOI 10.1111/j.1532-5415.2006.00704.x; Kehlet H, 2005, BRIT J SURG, V92, P3, DOI 10.1002/bjs.4841; Kiran RP, 2013, ANN SURG, V257, P905, DOI 10.1097/SLA.0b013e318269d337; Koebrugge B, 2010, VASCULAR, V18, P279, DOI 10.2310/6670.2010.00052; Korc-Grodzicki B, 2014, ANN SURG; Kruizenga HM, 2005, CLIN NUTR, V24, P75, DOI 10.1016/j.clnu.2004.07.015; Laurila JV, 2008, J PSYCHOSOM RES, V65, P249, DOI 10.1016/j.jpsychores.2008.05.026; Litaker D, 2001, GEN HOSP PSYCHIAT, V23, P84, DOI 10.1016/S0163-8343(01)00117-7; Marang-van de Mheen PJ, 2006, QUAL SAF HEALTH CARE, V15, P320, DOI 10.1136/qshc.2005.016220; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Noimark D, 2009, AGE AGEING, V38, P368, DOI 10.1093/ageing/afp024; Olin K, 2005, BRIT J SURG, V92, P1559, DOI 10.1002/bjs.5053; Patti R, 2011, EUR J ONCOL NURS, V15, P519, DOI 10.1016/j.ejon.2011.01.004; Raats JW, 2015, INT J SURG, V18, P216, DOI 10.1016/j.ijsu.2015.04.080; Raats JW SS, 2015, J GASTROINTESTINAL S; Rudolph JL, 2008, ANAESTHESIA, V63, P941, DOI 10.1111/j.1365-2044.2008.05523.x; Scheffer AC, 2011, INT J GERIATR PSYCH, V26, P284, DOI 10.1002/gps.2526; Schneider F, 2002, GEN HOSP PSYCHIAT, V24, P28, DOI 10.1016/S0163-8343(01)00168-2; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Siddiqi N, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub2; Steinmetz J, 2010, MINERVA ANESTESIOL, V76, P745; Steyerberg E., 2009, CLIN PREDICTION MODE; Tei M, 2010, SURG ENDOSC, V24, P2135, DOI 10.1007/s00464-010-0911-7; Wallace Meredith, 2007, Urol Nurs, V27, P93; WEED HG, 1995, LARYNGOSCOPE, V105, P1066, DOI 10.1288/00005537-199510000-00011; Zakriya KJ, 2002, ANESTH ANALG, V94, P1628, DOI 10.1097/00000539-200206000-00050	43	138	140	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136071	10.1371/journal.pone.0136071	http://dx.doi.org/10.1371/journal.pone.0136071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291459	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900049
J	Schlinkert, H; Westphal, C; Clough, Y; Laszlo, Z; Ludwig, M; Tscharntke, T				Schlinkert, Hella; Westphal, Catrin; Clough, Yann; Laszlo, Zoltan; Ludwig, Martin; Tscharntke, Teja			Plant Size as Determinant of Species Richness of Herbivores, Natural Enemies and Pollinators across 21 Brassicaceae Species	PLOS ONE			English	Article							BODY-SIZE; ARCHITECTURE; PARASITOIDS; DIVERSITY; SPECIFICITY; VISITATION; EVOLUTION; ABUNDANCE; DYNAMICS; INSECTS	Large plants are often more conspicuous and more attractive for associated animals than small plants, e.g. due to their wider range of resources. Therefore, plant size can positively affect species richness of associated animals, as shown for single groups of herbivores, but studies usually consider intraspecific size differences of plants in unstandardised environments. As comprehensive tests of interspecific plant size differences under standardised conditions are missing so far, we investigated effects of plant size on species richness of all associated arthropods using a common garden experiment with 21 Brassicaceae species covering a broad interspecific plant size gradient from 10 to 130 cm height. We recorded plant associated ecto-and endophagous herbivores, their natural enemies and pollinators on and in each aboveground plant organ, i.e. flowers, fruits, leaves and stems. Plant size (measured as height from the ground), the number of different plant organ entities and their biomass were assessed. Increasing plant size led to increased species richness of associated herbivores, natural enemies and pollinating insects. This pattern was found for ectophagous and endophagous herbivores, their natural enemies, as well as for herbivores associated with leaves and fruits and their natural enemies, independently of the additional positive effects of resource availability (i.e. organ biomass or number of entities and, regarding natural enemies, herbivore species richness). We found a lower R-2 for pollinators compared to herbivores and natural enemies, probably caused by the high importance of flower characteristics for pollinator species richness besides plant size. Overall, the increase in plant height from 10 to 130 cm led to a 2.7-fold increase in predicted total arthropod species richness. In conclusion, plant size is a comprehensive driver of species richness of the plant associated arthropods, including pollinators, herbivores and their natural enemies, whether they are endophagous or ectophagous or associated with leaves or fruits.	[Schlinkert, Hella; Westphal, Catrin; Clough, Yann; Ludwig, Martin; Tscharntke, Teja] Univ Gottingen, Agroecol, D-37073 Gottingen, Germany; [Clough, Yann] Ctr Environm & Climate Res, Lund, Sweden; [Laszlo, Zoltan] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, R-3400 Cluj Napoca, Romania; [Ludwig, Martin] Leibniz Univ Hannover, Inst Hort Prod Syst, Dept Phytomed, D-30167 Hannover, Germany	University of Gottingen; Babes Bolyai University from Cluj; Leibniz University Hannover	Schlinkert, H (corresponding author), Univ Gottingen, Agroecol, D-37073 Gottingen, Germany.	hella.schlinkert@agr.uni-goettingen.de	Laszlo, Zoltan/F-8651-2011; Westphal, Catrin/F-9560-2015; Tscharntke, Teja/N-5123-2014; Clough, Yann/B-9739-2014	Laszlo, Zoltan/0000-0001-5064-4785; Westphal, Catrin/0000-0002-2615-1339; Clough, Yann/0000-0002-2901-7602; Ludwig, Hella/0000-0001-7645-9529	State of Lower Saxony; University of Gottingen	State of Lower Saxony(European Commission); University of Gottingen	H.S. was supported by the State of Lower Saxony (Ministry of Science and Culture) in the frame of the Cluster of Excellence "Functional Biodiversity Research". The publication was funded by the University of Gottingen in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, BIODIVERSITYR PACKAG; Araujo APA, 2006, AUSTRAL ECOL, V31, P343, DOI 10.1111/j.1442-9993.2006.01563.x; BACH CE, 1981, OECOLOGIA, V50, P370, DOI 10.1007/BF00344978; Barton K., MUMIN MULTIMODEL INF; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Buchanan AL, 2013, OECOLOGIA, V173, P473, DOI 10.1007/s00442-013-2629-4; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; COHEN D, 1993, EVOL BIOL, V27, P197; Donnelly SE, 1998, AM J BOT, V85, P1618, DOI 10.2307/2446490; Espirito-Santo MM, 2007, OECOLOGIA, V153, P353, DOI 10.1007/s00442-007-0737-8; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; GEBER MA, 1985, ECOLOGY, V66, P762; Gomez JM, 2003, AM NAT, V162, P242, DOI 10.1086/376574; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; HAWKINS BA, 1990, ECOL ENTOMOL, V15, P275, DOI 10.1111/j.1365-2311.1990.tb00809.x; HAWKINS BA, 1987, NATURE, V326, P788, DOI 10.1038/326788a0; Haysom KA, 1998, ECOL ENTOMOL, V23, P377, DOI 10.1046/j.1365-2311.1998.00152.x; Hegland SJ, 2005, OECOLOGIA, V145, P586, DOI 10.1007/s00442-005-0165-6; Heiberger RM, HH STAT ANAL DATA DI; Hemptinne JL, 2012, BIOL INVASIONS, V14, P595, DOI 10.1007/s10530-011-0101-0; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HODEK I, 1993, BIOCONTROL SCI TECHN, V3, P91, DOI 10.1080/09583159309355264; HUNTER MD, 1992, ECOLOGY, V73, P724; KAY QON, 1976, NATURE, V261, P230, DOI 10.1038/261230a0; KLINKHAMER PGL, 1989, OIKOS, V54, P201, DOI 10.2307/3565267; Klotz S, 2002, BIOLFLOR DATENBANK B; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; LAWTON JH, 1979, J ANIM ECOL, V48, P619, DOI 10.2307/4183; LAWTON JH, 1983, ANNU REV ENTOMOL, V28, P23, DOI 10.1146/annurev.en.28.010183.000323; Leong JM, 1999, ECOL ENTOMOL, V24, P329, DOI 10.1046/j.1365-2311.1999.00196.x; Maj A, 2011, IMMFIT GOODNESS OF F; McCormick AC, 2012, TRENDS PLANT SCI, V17, P303, DOI 10.1016/j.tplants.2012.03.012; Murchie AK, 1997, J CHEM ECOL, V23, P917, DOI 10.1023/B:JOEC.0000006380.59526.bd; NEUVONEN S, 1981, OECOLOGIA, V51, P364, DOI 10.1007/BF00540907; Ohashi K, 2002, FUNCT ECOL, V16, P492, DOI 10.1046/j.1365-2435.2002.00644.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pinheiro J., NLME LINEAR NONLINEA; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; R Development Core Team, R LANG ENV STAT COMP; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Remmel T, 2009, J ANIM ECOL, V78, P973, DOI 10.1111/j.1365-2656.2009.01566.x; Reudler Talsma JH, 2008, J CHEM ECOL, V34, P1202, DOI 10.1007/s10886-008-9519-y; Riihimaki J, 2006, ECOL ENTOMOL, V31, P227, DOI 10.1111/j.1365-2311.2006.00784.x; Rutledge CE, 1996, CHEMOECOLOGY, V7, P121, DOI 10.1007/BF01245964; Sabbahi R, 2005, J ECON ENTOMOL, V98, P367, DOI 10.1603/0022-0493-98.2.367; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schlinkert H, 2014, PLANT SIZE GRADIENT, DOI [10.6084/m9.figshare.1246843, DOI 10.6084/M9.FIGSHARE.1246843]; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Strong D., 1984, INSECTS PLANTS COMMU; TSCHARNTKE T, 1995, ANNU REV ENTOMOL, V40, P535, DOI 10.1146/annurev.en.40.010195.002535; Ulber B, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P45, DOI 10.1007/978-90-481-3983-5_2; WESTOBY M, 1984, ADV ECOL RES, V14, P167, DOI 10.1016/S0065-2504(08)60171-3; Williams IH, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P1, DOI 10.1007/978-90-481-3983-5_1; Williams IH, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P215, DOI 10.1007/978-90-481-3983-5_7; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	60	34	34	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135928	10.1371/journal.pone.0135928	http://dx.doi.org/10.1371/journal.pone.0135928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291614	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900040
J	Silvestri, A; Palumbo, F; Rasi, I; Posca, D; Pavlidou, T; Paoluzi, S; Castagnoli, L; Cesareni, G				Silvestri, Alessandra; Palumbo, Francesco; Rasi, Ignazio; Posca, Daniela; Pavlidou, Theodora; Paoluzi, Serena; Castagnoli, Luisa; Cesareni, Giovanni			Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions	PLOS ONE			English	Article							PROTEIN-KINASE; DIABETIC-PATIENTS; TUMOR-CELLS; COMPLEX I; INHIBITION; METAANALYSIS; METABOLISM; INITIATION; EXPRESSION; THERAPY	Introduction Metformin is proposed as adjuvant therapy in cancer treatment because of its ability to limit cancer incidence by negatively modulating the PI3K/AKT/mTOR pathway. In vitro, in addition to inhibiting cancer cell proliferation, metformin can also induce apoptosis. The molecular mechanism underlying this second effect is still poorly characterized and published data are often contrasting. We investigated how nutrient availability can modulate metformin-induced apoptosis in three breast cancer cell lines. Material and Methods MCF7, SKBR3 and MDA-MB-231 cells were plated in MEM medium supplemented with increasing glucose concentrations or in DMEM medium and treated with 10 mM metformin. Cell viability was monitored by Trypan Blue assay and treatment effects on Akt/mTOR pathway and on apoptosis were analysed by Western Blot. Moreover, we determined the level of expression of pyruvate kinase M2 (PKM2), a well-known glycolytic enzyme expressed in cancer cells. Results Our results showed that metformin can induce apoptosis in breast cancer cells when cultured at physiological glucose concentrations and that the pro-apoptotic effect was completely abolished when cells were grown in high glucose/high amino acid medium. Induction of apoptosis was found to be dependent on AMPK activation but, at least partially, independent of TORC1 inactivation. Finally, we showed that, in nutrient-poor conditions, metformin was able to modulate the intracellular glycolytic equilibrium by downregulating PKM2 expression and that this mechanism was mediated by AMPK activation. Conclusion We demonstrated that metformin induces breast cancer cell apoptosis and PKM2 downregulation only in nutrient-poor conditions. Not only glucose levels but also amino acid concentration can influence the observed metformin inhibitory effect on the mTOR pathway as well as its pro-apoptotic effect. These data demonstrate that the reduction of nutrient supply in tumors can increase metformin efficacy and that modulation of PKM2 expression/activity could be a promising strategy to boost metformin anti-cancer effect.	[Silvestri, Alessandra; Palumbo, Francesco; Rasi, Ignazio; Posca, Daniela; Pavlidou, Theodora; Paoluzi, Serena; Castagnoli, Luisa; Cesareni, Giovanni] Univ Roma Tor Vergata, Dept Biol, Mol Genet Lab, I-00173 Rome, Italy; [Cesareni, Giovanni] Fdn Santa Lucia, IRCCS, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Rome Tor Vergata; IRCCS Santa Lucia	Silvestri, A (corresponding author), Cpo Cellular Phen & Oncol GmbH, Berlin, Germany.	silvestri.alessandra@gmail.com	Palumbo, Francesco/ABH-9395-2020; Cesareni, Gianni/AAW-1382-2020	Castagnoli, Luisa/0000-0001-5283-8671; Silvestri, Alessandra/0000-0003-4891-1826; Palumbo, Francesco/0000-0002-5352-6773	Ministry of Education, Italy [RBAP11LP2W]	Ministry of Education, Italy(Ministry of Education, Universities and Research (MIUR))	Funding provided by Ministry of Education, Italy; Grant Number: RBAP11LP2W; Grant Recipient: GC.	Adler AI, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1668; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Bailey CJ, 2008, CARDIOVASC DRUG THER, V22, P215, DOI 10.1007/s10557-008-6092-0; Berstein LM, 2011, MED ONCOL, V28, P1260, DOI 10.1007/s12032-010-9572-6; Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859; BRINCK U, 1994, VIRCHOWS ARCH, V424, P177; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Chen GX, 2015, AM J CANCER RES, V5, P1423; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Cossor FI, 2013, CANCER EPIDEMIOL, V37, P742, DOI 10.1016/j.canep.2013.04.015; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalinsky K, 2014, CANCER INVEST, V32, P150, DOI 10.3109/07357907.2014.889706; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Malki A, 2011, ONCOL RES, V19, P275, DOI 10.3727/096504011X13021877989838; Marini C, 2013, CELL CYCLE, V12, P3490, DOI 10.4161/cc.26461; Meiers P, 2010, SAN ANTONIO BREAST S, V70; Menendez JA, 2012, CELL CYCLE, V11, P2782, DOI 10.4161/cc.20948; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; REINACHER M, 1981, VIRCHOWS ARCH B, V37, P79, DOI 10.1007/BF02892557; Steinberg P, 1999, VIRCHOWS ARCH, V434, P213, DOI 10.1007/s004280050330; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wahdan-Alaswad R, 2013, CELL CYCLE, V12, P3759, DOI 10.4161/cc.26641; Zakikhani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049513; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhuang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108444; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	42	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136250	10.1371/journal.pone.0136250	http://dx.doi.org/10.1371/journal.pone.0136250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291325	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900070
J	Zhang, KC; Cui, JX; Xi, HQ; Bian, SB; Ma, LG; Shen, WS; Li, JY; Wang, N; Wei, B; Chen, L				Zhang, Kecheng; Cui, Jianxin; Xi, Hongqing; Bian, Shibo; Ma, Liangang; Shen, Weisong; Li, Jiyang; Wang, Ning; Wei, Bo; Chen, Lin			Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DIAGNOSTIC-TEST; CLINICAL-SIGNIFICANCE; EXTRACELLULAR DOMAIN; IMMUNOHISTOCHEMISTRY; CARCINOMA; C-ERBB-2; EXPRESSION; BIOMARKERS; PROGNOSIS	Determining the expression level of human epidermal growth factor receptor 2 (HER2) in tumor tissue is of great importance for personalized therapy in gastric cancer. Although several studies have investigated whether serum HER2 can serve as a surrogate for tissue HER2 status, results have been inconsistent. We therefore performed a meta-analysis of published clinical studies in an attempt to address this problem. PubMed, Embase, Web of Science, the Cochrane Library and Science Direct were queried for eligible studies that could provide sufficient data to construct 2 x 2 contingency tables. The quality of the studies included in the meta-analysis was assessed in accordance with the revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) criteria. The pooled sensitivity, specificity and diagnostic odds ratio (DOR) were calculated for the eligible studies. The summary receiver operating characteristic (SROC) curve was constructed and the area under the SROC (AUSROC) was used to evaluate overall diagnostic performance. Eight studies comprising a total of 1170 participants were included in our meta-analysis. The pooled sensitivity, specificity and DOR were 0.39 (95% CI: 0.21-0.61), 0.98 (95% CI: 0.87-1.00), and 27 (95% CI: 9-81), respectively. The AUSROC was 0.77 (95% CI: 0.73-0.80) and Deeks funnel plot suggested the absence of publication bias (p = 0.91). Meta-regression analysis indicated that threshold effect was the main source of heterogeneity. Assays for evaluating serum HER2 levels are highly specific and demonstrate moderate diagnostic performance for HER2 tissue status in gastric cancer.	[Zhang, Kecheng; Cui, Jianxin; Xi, Hongqing; Bian, Shibo; Ma, Liangang; Shen, Weisong; Li, Jiyang; Wang, Ning; Wei, Bo; Chen, Lin] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chen, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China.	chenlinbj301@163.com			National Nature Science Foundation of China [81272698, 81101883, 81172368]; People's Liberation Army Medical Technology Project for Fostering Youth [13QNP185]; Special Scientific Research Foundation of Health Sector from the National Health and Family Planning Commission of China [201302016]; capital health research and development of special [2011-5001-01]; PLA medical and health research fund project [11BJZ17]; PLA Medical Technology key project of scientific research in the 12th research projects in 12th Five-Year-Plan [BWS12J049]; National High Technology Research and Development Program of China [2012AA02A504]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); People's Liberation Army Medical Technology Project for Fostering Youth; Special Scientific Research Foundation of Health Sector from the National Health and Family Planning Commission of China; capital health research and development of special; PLA medical and health research fund project; PLA Medical Technology key project of scientific research in the 12th research projects in 12th Five-Year-Plan; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Nature Science Foundation of China (Nos. 81272698, 81101883, 81172368), a grant from People's Liberation Army Medical Technology Project for Fostering Youth (13QNP185), a grant from the Special Scientific Research Foundation of Health Sector from the National Health and Family Planning Commission of China (No. 201302016), a grant from the capital health research and development of special (No. 2011-5001-01), a grant from the PLA medical and health research fund project (No. 11BJZ17), a grant from the PLA Medical Technology key project of scientific research in the 12th research projects in 12th Five-Year-Plan (No. BWS12J049), and a grant from the Project supported by the National High Technology Research and Development Program of China (No. 2012AA02A504).	Albarello L, 2011, ADV ANAT PATHOL, V18, P53, DOI 10.1097/PAP.0b013e3182026d72; Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; An X, 2013, J CLIN ONCOLOGY, V31; Bang YJ, 2010, LANCET, V376, P1302; Cen DZ, 2014, J CANCER RES CLIN, V140, P993, DOI 10.1007/s00432-014-1605-7; Dai SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063458; Dang HZ, 2012, WORLD J GASTROENTERO, V18, P2402, DOI 10.3748/wjg.v18.i19.2402; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Farzadnia M, 2010, BREAST, V19, P489, DOI 10.1016/j.breast.2010.05.012; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Fornaro L, 2011, NAT REV GASTRO HEPAT, V8, P369, DOI 10.1038/nrgastro.2011.81; Gan YL, 2014, TUMOR BIOL, V35, P3953, DOI 10.1007/s13277-013-1563-8; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gomez-Martin C, 2012, J CLIN PATHOL, V65, P751, DOI 10.1136/jclinpath-2012-200774; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Janjigian YY, 2012, ANN ONCOL, V23, P2656, DOI 10.1093/annonc/mds104; Kong SY, 2006, J CLIN PATHOL, V59, P373, DOI 10.1136/jcp.2005.029603; Kono K, 2000, TUMOR BIOL, V21, P139, DOI 10.1159/000030120; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Li XG, 2013, HEPATO-GASTROENTEROL, V60, P1519, DOI 10.5754/hge13242; Ludovini V, 2008, ANN ONCOL, V19, P883, DOI 10.1093/annonc/mdm585; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Narita T, 2013, HEPATO-GASTROENTEROL, V60, P1083, DOI 10.5754/hge121022; Overman MJ, 2013, J CLIN ONCOL, V31, P17, DOI 10.1200/JCO.2012.43.1718; Oyama K, 2015, J GASTROENTEROL, V50, P41, DOI 10.1007/s00535-014-0941-3; Park KU, 2014, CLIN CHEM LAB MED, V52, P1033, DOI 10.1515/cclm-2013-0988; Peng Z, 2014, BIOMARK MED, V8, P663, DOI [10.2217/BMM.14.10, 10.2217/bmm.14.10]; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Saito M, 2013, ANN ONCOL, V24, P33; Sasaki T, 2012, J CLIN ONCOLOGY, V30; Sasaki T, 2015, JPN J CLIN ONCOL, V45, P43, DOI 10.1093/jjco/hyu174; Sheffield BS, 2014, ARCH PATHOL LAB MED, V138, P1495, DOI 10.5858/arpa.2013-0604-OA; Sugano K, 2000, INT J CANCER, V89, P329, DOI 10.1002/1097-0215(20000720)89:4<329::AID-IJC3>3.0.CO;2-P; Sui WG, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-83; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Takahashi M, 2013, ANN ONCOL, V24, pix92; Takahashi Y, 2013, ANN ONCOL, V24, P32, DOI 10.1093/annonc/mdt459.2; Takehana T, 2002, INT J CANCER, V98, P833, DOI 10.1002/ijc.10257; Tsigris C, 2002, ANTICANCER RES, V22, P3061; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Witzel I, 2010, BREAST CANCER RES TR, V123, P437, DOI 10.1007/s10549-010-1030-9; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Zhu XY, 2014, DIGEST DIS SCI, V59, P911, DOI 10.1007/s10620-013-2970-9	46	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136322	10.1371/journal.pone.0136322	http://dx.doi.org/10.1371/journal.pone.0136322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292093	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900077
J	Zhu, DS; Fu, J; Zhang, Y; Xie, C; Wang, XQ; Zhang, Y; Yang, J; Li, SX; Liu, XB; Wan, ZW; Dong, Q; Guan, YT				Zhu, De-Sheng; Fu, Jue; Zhang, Yi; Xie, Chong; Wang, Xiao-Qing; Zhang, Yue; Yang, Jie; Li, Shi-Xu; Liu, Xiao-Bei; Wan, Zhi-Wen; Dong, Qiang; Guan, Yang-Tai			Sensitivity and Specificity of Double-Track Sign in the Detection of Transverse Sinus Stenosis: A Multicenter Retrospective Study	PLOS ONE			English	Article							CEREBRAL VENOUS THROMBOSIS; EMPTY DELTA SIGN; DIAGNOSTIC PITFALLS; VEIN; CT; HYPERTENSION; MANAGEMENT; PROGNOSIS; STROKE	Background Transverse sinus stenosis (TSS) is common among patients with cerebral venous sinus thrombosis. No previous studies have reported on double-track sign detected on axial Gd-enhanced T1WI in TSS. This study aimed to determine the sensitivity and specificity of the double-track sign in the detection of TSS. Methods We retrospectively reviewed medical records of 383 patients with transverse sinus thrombosis (TST) and 30 patients with normal transverse sinus from 5 participating hospitals in china from January 2008 to June 2014. 167 feasible transverse sinuses included in this study were categorized into TSS (n = 76), transverse sinus occlusion (TSO) (n = 52) and transverse sinus normal (TSN) groups (n = 39) according to imaging diagnosis on digital subtraction angiography (DSA) or magnetic resonance venography (MRV). Double-track sign on axial Gd-enhanced T1WI was compared among the three groups. Sensitivity and specificity of double-track sign in detection of TSS were calculated, with final imaging diagnosis of TSS on DSA or MRV as the reference standard. Results Of 383 patients with TST recruited over a 6.5-year period, 128 patients were enrolled in the study, 255 patients were excluded because of insufficient clinical data, imaging finding and delay time, and 30 matched patients with normal transverse sinus were enrolled in the control group. Therefore, double-track sign assessment was conducted in 167 available transverse sinuses of 158 patients. Of the 76 sinuses in TSS group, 51 had double-track sign. Of the other 91 sinuses in TSO and TSN groups, 3 had a false-positive double-track sign. Thus, double-track sign on axial Gd-enhanced T1WI was 67.1% (95% CI 55.3-77.2) sensitive and 96.7%(95% CI 89.9-99.1) specific for detection of TSS. Conclusions The double-track sign on axial Gd-enhanced T1WI is highly specific and moderate sensitive for detection of TSS. Nevertheless, it could be a direct sign and might provide an early clue for TSS.	[Zhu, De-Sheng; Zhang, Yi; Guan, Yang-Tai] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Zhu, De-Sheng; Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Fu, Jue] Nanchang Univ, Fuzhou Med Coll, Dept Pathol, Fuzhou, Peoples R China; [Xie, Chong; Wang, Xiao-Qing; Li, Shi-Xu; Liu, Xiao-Bei; Wan, Zhi-Wen] Second Mil Med Univ, Dept Neurol, Changhai Hosp, Shanghai, Peoples R China; [Zhang, Yue] Nanyuan Hosp, Dept Neurol, Beijing, Peoples R China; [Yang, Jie] Tongji Univ, Sch Med, Dong Fang Hosp, Dept Neurol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University; Nanchang University; Naval Medical University; Tongji University	Dong, Q (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	qiangdong-fudan@hotmail.com; yangtaiguan@sina.com	zhu, desheng/AGY-8548-2022	zhu, desheng/0000-0003-2454-2173	Natural Science Foundation of China [81230027]; Postdoctoral Science Foundation of China [2014M560297]; Science and Technology Foundation of Shanghai [14140903300]; Science and Technology Foundation of Jiangxi [20112015]; Municipal Commission of Health and Family Planning Foundation of Shanghai [201440347, 20144Y0225]; Natural Science Foundation of Shanghai [14ZR1436700]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Science and Technology Foundation of Shanghai; Science and Technology Foundation of Jiangxi; Municipal Commission of Health and Family Planning Foundation of Shanghai; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was supported by the Natural Science Foundation of China (No. 81230027), the Postdoctoral Science Foundation of China (No. 2014M560297), the Science and Technology Foundation of Shanghai (No. 14140903300), the Science and Technology Foundation of Jiangxi (No. 20112015), the Municipal Commission of Health and Family Planning Foundation of Shanghai (No. 201440347, 20144Y0225), and the Natural Science Foundation of Shanghai (No. 14ZR1436700).	Anile C, 2011, NEUROL RES, V33, P1072, DOI 10.1179/1743132811Y.0000000056; Ayanzen RH, 2000, AM J NEURORADIOL, V21, P74; Bono Francesco, 2013, Neurology, V81, P695, DOI 10.1212/01.wnl.0000433838.88247.f3; Bugnicourt JM, 2007, J NEUROL NEUROSUR PS, V78, P699, DOI 10.1136/jnnp.2006.103465; Cohen HL, 2004, J ULTRAS MED, V23, P641, DOI 10.7863/jum.2004.23.5.641; Cumurciuc R, 2005, J NEUROL NEUROSUR PS, V76, P1084, DOI 10.1136/jnnp.2004.056275; CZERVIONKE LF, 1988, AM J NEURORADIOL, V9, P1149; Eddleman Christopher S, 2007, Neurosurg Focus, V23, pE4, DOI 10.3171/foc.2007.23.5.5; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Ferro JM, 2009, STROKE, V40, P3133, DOI 10.1161/STROKEAHA.109.553891; Gulati D, 2014, STROKE, V45, pE16, DOI 10.1161/STROKEAHA.113.003964; Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092990; Klijn CJM, 2010, LANCET NEUROL, V9, P1008, DOI 10.1016/S1474-4422(10)70185-X; Kojima T, 2007, SURG NEUROL, V68, P277, DOI 10.1016/j.surneu.2006.10.075; Kumral E, 2012, EUR J NEUROL, V19, P537, DOI 10.1111/j.1468-1331.2011.03562.x; Lee EJY, 2002, RADIOLOGY, V224, P788, DOI 10.1148/radiol.2243990978; Linn J, 2009, AM J NEURORADIOL, V30, P728, DOI 10.3174/ajnr.A1451; Martinelli I, 2012, INTERN EMERG MED, V7, pS221, DOI 10.1007/s11739-012-0806-9; Nagai M, 2010, NEUROSURGERY, V66, P560, DOI 10.1227/01.NEU.0000365745.49583.FD; OLoughlin VD, 1996, AM J PHYS ANTHROPOL, V101, P369; Piazza G, 2012, CIRCULATION, V125, P1704, DOI 10.1161/CIRCULATIONAHA.111.067835; Provenzale JM, 1998, AM J ROENTGENOL, V170, P777, DOI 10.2214/ajr.170.3.9490973; Randolph J. J., 2005, P JOENS LEARN INSTR; Rodallec MH, 2006, RADIOGRAPHICS, V26, pS5, DOI 10.1148/rg.26si065505; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Separham A, 2013, AM J MED SCI, V346, P503, DOI 10.1097/MAJ.0b013e31826af3b4; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; SZE G, 1988, AM J NEURORADIOL, V9, P679; Tanislav C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-69; Varma DR, 2008, NEUROLOGY, V70, P79, DOI 10.1212/01.wnl.0000277449.59456.cf; Viegas LD, 2014, CEREBROVASC DIS, V37, P43, DOI 10.1159/000356840; Vijay RKP, 2006, RADIOLOGY, V240, P299, DOI 10.1148/radiol.2401031739; Yoshida S, 2003, NEUROLOGY, V60, P146, DOI 10.1212/WNL.60.1.146	33	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135897	10.1371/journal.pone.0135897	http://dx.doi.org/10.1371/journal.pone.0135897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291452	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900038
J	Lam, F; Lin, YC; Tsai, HC; Chen, TL; Tam, KW; Chen, CY				Lam, Fai; Lin, Yu-Cih; Tsai, Hsiao-Chien; Chen, Ta-Liang; Tam, Ka-Wai; Chen, Chien-Yu			Effect of Intracuff Lidocaine on Postoperative Sore Throat and the Emergence Phenomenon: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							ENDOTRACHEAL-TUBE CUFF; TRACHEAL TUBE; ALKALINIZED LIDOCAINE; INTUBATION; PRESSURE; COUGH; AIR; EXTUBATION; SALINE; HOARSENESS	Background Postoperative sore throat and other airway morbidities are common and troublesome after endotracheal tube intubation general anesthesia (ETGA). We propose lidocaine as endotracheal tube (ETT) cuff inflation media to reduce the postintubation-related emergence phenomenon. Methods We searched PubMed, EMBASE, and Cochrane databases systematically for randomized controlled trials (RCTs) that have investigated the outcome of intracuff lidocaine versus air or saline in patients receiving ETGA. Using a random-effects model, we conducted a meta-analysis to assess the relative risks (RRs) and mean difference (MD) of the incidence and intensity of relevant adverse outcomes. Results We reviewed nineteen trials, which comprised 1566 patients. The incidence of early-and late-phase postoperative sore throat (POST), coughing, agitation, hoarseness, and dysphonia decreased significantly in lidocaine groups, with RRs of 0.46 (95% confidence interval [CI]: 0.31 to 0.68), 0.41 (95% CI: 0.25 to 0.66), 0.43 (95% CI: 0.31 to 0.62), 0.37 (95% CI: 0.25 to 0.55), 0.43 (95% CI: 0.29 to 0.63), and 0.19 (95% CI: 0.08 to 0.5), respectively, when compared with the control groups. The severity of POST also reduced significantly (mean difference [MD] - 16.43 mm, 95% CI: -21.48 to -11.38) at 1 h and (MD -10.22 mm, 95% CI: -13.5 to -6.94) at 24 h. Both alkalinized and non-alkalinized lidocaine in the subgroup analyses showed significant benefits in emergence phenomena prevention compared with the control. Conclusion Our results indicate that both alkalinized and non-alkalinized intracuff lidocaine may prevent and alleviate POST and postintubation-related emergence phenomena.	[Lam, Fai; Lin, Yu-Cih; Tsai, Hsiao-Chien; Chen, Ta-Liang; Chen, Chien-Yu] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lam, Fai] Taipei Med Univ, Coll Med, Inst Publ Hlth, Taipei, Taiwan; [Lin, Yu-Cih] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan; [Chen, Ta-Liang; Chen, Chien-Yu] Taipei Med Univ, Coll Med, Dept Anesthesiol, Sch Med, Taipei, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, New Taipei City, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Tam, Ka-Wai] Taipei Med Univ, Shuang Ho Hosp, Ctr Evidence Based Hlth Care, New Taipei City, Taiwan; [Tam, Ka-Wai] Taipei Med Univ Hosp, Evidence Based Med Ctr, Taipei, Taiwan; [Chen, Chien-Yu] Taipei Med Univ, Grad Inst Humanities Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Tam, KW (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, New Taipei City, Taiwan.	kelvintam@h.tmu.edu.tw; jc2jc@tmu.edu.tw	Chen, Chien-Yu/AAR-8724-2021	Chen, Chien-Yu/0000-0001-5895-9941				Ahmad NL, 2001, ANAESTH INTENS CARE, V29, P510, DOI 10.1177/0310057X0102900511; Ahmady MS, 2013, ANAESTH PAIN INTENSI, V17, P18; ALCOCK R, 1993, BRIT J ANAESTH, V70, P34, DOI 10.1093/bja/70.1.34; Altintas F, 2000, EUR J ANAESTH, V17, P436, DOI 10.1046/j.1365-2346.2000.00696.x; Bajaj Pramila, 2004, Middle East Journal of Anesthesiology, V17, P1055; BALDOCK GA, 1991, BIOPHARM DRUG DISPOS, V12, P481, DOI 10.1002/bdd.2510120702; Bennett MH, 2000, ANAESTH INTENS CARE, V28, P408, DOI 10.1177/0310057X0002800409; BIDWAI AV, 1979, ANESTHESIOLOGY, V51, P171, DOI 10.1097/00000542-197908000-00020; Biro P, 2005, EUR J ANAESTH, V22, P307, DOI 10.1017/S0265021505000529; Bousselmi Radhouane, 2014, Tunis Med, V92, P29; Navarro LH, 2007, SAO PAULO MED J, V125, P322, DOI 10.1590/S1516-31802007000600004; Navarro LHC, 2012, REV ASSOC MED BRAS, V58, P248; CHRISTENSEN AM, 1994, BRIT J ANAESTH, V73, P786, DOI 10.1093/bja/73.6.786; Combes X, 2001, ANESTHESIOLOGY, V95, P1120, DOI 10.1097/00000542-200111000-00015; D'Aragon F, 2013, CAN J ANESTH, V60, P370, DOI 10.1007/s12630-013-9896-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diachun CAB, 2001, J CLIN ANESTH, V13, P447, DOI 10.1016/S0952-8180(01)00299-9; Dollo G, 2001, EUR J PHARM SCI, V13, P319, DOI 10.1016/S0928-0987(01)00119-1; Dullenkopf A, 2004, ACTA ANAESTH SCAND, V48, P1180, DOI 10.1111/j.1399-6576.2004.00483.x; Estebe JP, 2005, ANESTH ANALG, V101, P1536, DOI 10.1213/01.ANE.0000180995.24211.89; Estebe JP, 2004, BRIT J ANAESTH, V92, P361, DOI 10.1093/bja/aeh078; Estebe JP, 2002, ANESTH ANALG, V94, P227, DOI 10.1097/00000539-200201000-00044; Fagan C, 2000, ANESTH ANALG, V91, P201; GEFKE K, 1983, ACTA ANAESTH SCAND, V27, P111, DOI 10.1111/j.1399-6576.1983.tb01917.x; GONZALEZ RM, 1994, ANESTH ANALG, V79, P792; Hirota W, 2000, CAN J ANAESTH, V47, P412, DOI 10.1007/BF03018969; Huang C J, 1998, Acta Anaesthesiol Sin, V36, P81; Hung NK, 2010, ANESTH ANALG, V111, P882, DOI 10.1213/ANE.0b013e3181d4854e; Jaichandran VV, 2009, SOUTH AFR J ANAESTH, V15, P11, DOI 10.1080/22201173.2009.10872600; LEECH P, 1974, BRIT J ANAESTH, V46, P315, DOI 10.1093/bja/46.4.315-a; Lev Roneet, 1994, Journal of Emergency Medicine, V12, P499, DOI 10.1016/0736-4679(94)90347-6; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MANDOE H, 1992, ANESTH ANALG, V74, P897; McHardy FE, 1999, ANAESTHESIA, V54, P444, DOI 10.1046/j.1365-2044.1999.00780.x; Minogue SC, 2004, ANESTH ANALG, V99, P1253, DOI 10.1213/01.ANE.0000132779.27085.52; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Navarro RM, 1997, J CLIN ANESTH, V9, P394, DOI 10.1016/S0952-8180(97)00068-8; NISHINO T, 1990, BRIT J ANAESTH, V64, P682, DOI 10.1093/bja/64.6.682; Porter N E, 1999, AANA J, V67, P49; SCONZO JM, 1990, REGION ANESTH, V15, P37; Scuderi PE, 2010, ANESTH ANALG, V111, P831, DOI 10.1213/ANE.0b013e3181ee85c7; Shroff PP, 2009, EUR J ANAESTH, V26, P458, DOI 10.1097/EJA.0b013e32832403fa; Soltani HA, 2002, J CLIN ANESTH, V14, P15, DOI 10.1016/S0952-8180(01)00344-0; STOELTING RK, 1977, ANESTHESIOLOGY, V47, P381, DOI 10.1097/00000542-197710000-00012; Sumathi PA, 2008, BRIT J ANAESTH, V100, P215, DOI 10.1093/bja/aem341; Tanaka Y, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004081.pub2; Tu HN, 1999, ANESTH ANALG, V89, P187, DOI 10.1097/00000539-199907000-00033; WALMSLEY AJ, 1988, ANAESTHESIA, V43, P399, DOI 10.1111/j.1365-2044.1988.tb09024.x; Wetzel Laura E, 2008, AANA J, V76, P105; YUKIOKA H, 1985, ANESTH ANALG, V64, P1189; Zamora Lozano J, 2007, Rev Esp Anestesiol Reanim, V54, P596	51	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136184	10.1371/journal.pone.0136184	http://dx.doi.org/10.1371/journal.pone.0136184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288276	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600118
J	Lehtinen, S; Lees, J; Bahler, J; Shawe-Taylor, J; Orengo, C				Lehtinen, Sonja; Lees, Jon; Baehler, Juerg; Shawe-Taylor, John; Orengo, Christine			Gene Function Prediction from Functional Association Networks Using Kernel Partial Least Squares Regression	PLOS ONE			English	Article							PROTEIN FUNCTION; SPARSE PLS; ONTOLOGY; INTEGRATION; GENEMANIA	With the growing availability of large-scale biological datasets, automated methods of extracting functionally meaningful information from this data are becoming increasingly important. Data relating to functional association between genes or proteins, such as co-expression or functional association, is often represented in terms of gene or protein networks. Several methods of predicting gene function from these networks have been proposed. However, evaluating the relative performance of these algorithms may not be trivial: concerns have been raised over biases in different benchmarking methods and datasets, particularly relating to non-independence of functional association data and test data. In this paper we propose a new network-based gene function prediction algorithm using a commute-time kernel and partial least squares regression (Compass). We compare Compass to GeneMANIA, a leading network-based prediction algorithm, using a number of different benchmarks, and find that Compass outperforms GeneMANIA on these benchmarks. We also explicitly explore problems associated with the non-independence of functional association data and test data. We find that a benchmark based on the Gene Ontology database, which, directly or indirectly, incorporates information from other databases, may considerably overestimate the performance of algorithms exploiting functional association data for prediction.	[Lehtinen, Sonja] UCL, CoMPLEX, London, England; [Lehtinen, Sonja; Lees, Jon; Orengo, Christine] UCL, Inst Struct & Mol Biol, London, England; [Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London, England; [Shawe-Taylor, John] UCL, Dept Comp Sci, London, England	University of London; University College London; University of London; Birkbeck University London; University College London; University of London; University College London; University of London; University College London	Orengo, C (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	c.orengo@ucl.ac.uk	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532; Shawe-Taylor, John/0000-0002-2030-0073	Biotechnology and Biological Sciences Research Council [974619, BB/M020088/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/L002817/1] Funding Source: Medline; Medical Research Council [MR/K006584/1] Funding Source: Medline; Wellcome Trust [095598] Funding Source: Medline; BBSRC [BB/L002817/1, BB/M020088/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bastien P, 2015, BIOINFORMATICS, V31, P397, DOI 10.1093/bioinformatics/btu660; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; CASTILLO LP, 2008, GENOME BIOL S1, V9, pS2, DOI DOI 10.1186/GB-2008-9-S1-S2; Chen BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069084; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Dessimoz C, 2013, TRENDS GENET, V29, P609, DOI 10.1016/j.tig.2013.09.005; Gillis Jesse, 2013, BMC Bioinformatics, V14 Suppl 3, pS15; Gillis J, 2013, BIOINFORMATICS, V29, P476, DOI 10.1093/bioinformatics/bts727; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Heriche JK, 2014, MOL BIOL CELL, V25, P2522, DOI 10.1091/mbc.E13-04-0221; Ito H, 2010, J BIOL CHEM, V285, P34616, DOI 10.1074/jbc.M110.175562; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lee H, 2006, OMICS, V10, P40, DOI 10.1089/omi.2006.10.40; Lees JG, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035008; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; Rogers MF, 2009, BIOINFORMATICS, V25, P1173, DOI 10.1093/bioinformatics/btp122; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170; Shawe-Taylor J, 2004, KERNEL METHODS FOR P; Sideri T, 2014, PARALLEL PROFILING O, VG3; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tsuda K, 2005, BIOINFORMATICS, V21, P59, DOI 10.1093/bioinformatics/bti1110; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yen L, 2007, LECT NOTES COMPUT SC, V4426, P1037	35	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134668	10.1371/journal.pone.0134668	http://dx.doi.org/10.1371/journal.pone.0134668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288239	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600027
J	Li, JW; Kendall, G				Li, Jiawei; Kendall, Graham			On Nash Equilibrium and Evolutionarily Stable States That Are Not Characterised by the Folk Theorem	PLOS ONE			English	Article							ITERATED PRISONERS-DILEMMA; REPEATED GAMES; COOPERATION; EMERGENCE; EXTORTION; STABILITY	In evolutionary game theory, evolutionarily stable states are characterised by the folk theorem because exact solutions to the replicator equation are difficult to obtain. It is generally assumed that the folk theorem, which is the fundamental theory for non-cooperative games, defines all Nash equilibria in infinitely repeated games. Here, we prove that Nash equilibria that are not characterised by the folk theorem do exist. By adopting specific reactive strategies, a group of players can be better off by coordinating their actions in repeated games. We call it a type-k equilibrium when a group of k players coordinate their actions and they have no incentive to deviate from their strategies simultaneously. The existence and stability of the type-k equilibrium in general games is discussed. This study shows that the sets of Nash equilibria and evolutionarily stable states have greater cardinality than classic game theory has predicted in many repeated games.	[Li, Jiawei; Kendall, Graham] Univ Nottingham, ASAP Res Grp, Sch Comp Sci, Nottingham NG8 1BB, England; [Kendall, Graham] Univ Nottingham, Sch Comp Sci, Semenyih 43500, Selangor Darul, Malaysia	University of Nottingham; University of Nottingham Malaysia	Li, JW (corresponding author), Univ Nottingham, ASAP Res Grp, Sch Comp Sci, Jubilee Campus,Wollaton Rd, Nottingham NG8 1BB, England.	jiawei.li@nottingham.ac.uk		Li, Jiawei/0000-0003-4685-2615	Engineering and Physical Sciences Research Council UK [EP/H000968/1]	Engineering and Physical Sciences Research Council UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by Engineering and Physical Sciences Research Council UK EP/H000968/1 (http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/H000968/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU D, 1994, ECONOMETRICA, V62, P939, DOI 10.2307/2951739; Aumann R., 1970, VALUES NONATOMIC GAM; Aumann RJ, 1959, CONTRIBUTIONS THEORY, VIV; Baye MR, 1999, ECON LETT, V65, P59, DOI 10.1016/S0165-1765(99)00118-4; Braun DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000468; Cressman R, 2003, ECON LEARN SOC EVOL, P1; Cressman R, 2014, P NATL ACAD SCI USA, V111, P10810, DOI 10.1073/pnas.1400823111; DUTTA PK, 1995, J ECON THEORY, V66, P1, DOI 10.1006/jeth.1995.1030; Ely JC, 2002, J ECON THEORY, V102, P84, DOI 10.1006/jeth.2000.2774; FERRIERE R, 1995, P ROY SOC B-BIOL SCI, V259, P77, DOI 10.1098/rspb.1995.0012; FRIEDMAN JW, 1971, REV ECON STUD, V38, P1, DOI 10.2307/2296617; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; FUDENBERG D, 1991, J ECON THEORY, V54, P26, DOI 10.1016/0022-0531(91)90103-B; Hauert C, 1997, P ROY SOC B-BIOL SCI, V264, P513, DOI 10.1098/rspb.1997.0073; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Horner J, 2006, ECONOMETRICA, V74, P1499, DOI 10.1111/j.1468-0262.2006.00717.x; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; Krams I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1475; Li JW, 2013, IEEE T CYBERNETICS, V43, P2044, DOI 10.1109/TCYB.2013.2239986; Li JW, 2013, IEEE T COMP INTEL AI, V5, P242, DOI 10.1109/TCIAIG.2013.2261894; Li JW, 2011, IEEE T COMP INTEL AI, V3, P348, DOI 10.1109/TCIAIG.2011.2166268; MATSUSHIMA H, 1991, ECON LETT, V35, P253, DOI 10.1016/0165-1765(91)90139-C; Maynard Smith J., 1982, pi; McCabe KA, 2000, P NATL ACAD SCI USA, V97, P3777, DOI 10.1073/pnas.040577397; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Mertens JF, 2004, INT J GAME THEORY, V32, P387, DOI 10.1007/s001820400166; Moreno D, 1996, GAME ECON BEHAV, V17, P80, DOI 10.1006/game.1996.0095; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Obara I, 2009, J ECON THEORY, V144, P120, DOI 10.1016/j.jet.2007.08.005; Olson M., 2009, LOGIC COLLECTIVE ACT, V124; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; RUBINSTEIN A, 1979, J ECON THEORY, V21, P1, DOI 10.1016/0022-0531(79)90002-4; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Shenoy P. P., 1979, International Journal of Game Theory, V8, P133, DOI 10.1007/BF01770064; Stewart AJ, 2012, P NATL ACAD SCI USA, V109, P10134, DOI 10.1073/pnas.1208087109; Wen Q, 2002, REV ECON STUD, V69, P493, DOI 10.1111/1467-937X.00214	38	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136032	10.1371/journal.pone.0136032	http://dx.doi.org/10.1371/journal.pone.0136032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288088	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600099
J	Liang, H; Fu, KW				Liang, Hai; Fu, King-wa			Testing Propositions Derived from Twitter Studies: Generalization and Replication in Computational Social Science	PLOS ONE			English	Article							NETWORKS	Replication is an essential requirement for scientific discovery. The current study aims to generalize and replicate 10 propositions made in previous Twitter studies using a representative dataset. Our findings suggest 6 out of 10 propositions could not be replicated due to the variations of data collection, analytic strategies employed, and inconsistent measurements. The study's contributions are twofold: First, it systematically summarized and assessed some important claims in the field, which can inform future studies. Second, it proposed a feasible approach to generating a random sample of Twitter users and its associated ego networks, which might serve as a solution for answering social-scientific questions at the individual level without accessing the complete data archive.	[Liang, Hai; Fu, King-wa] Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Fu, KW (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China.	kwfu@hku.hk	Liang, Hai/AAB-2150-2020; Fu, King-wa/A-2385-2010; Liang, Hai/F-3797-2015	Liang, Hai/0000-0003-1779-9552; Fu, King-wa/0000-0001-8157-5276; Liang, Hai/0000-0003-1779-9552	Small Project Funding from The University of Hong Kong [201409176011]; Public Policy Research Fund, Hong Kong Government [2013.A8.009.14A]	Small Project Funding from The University of Hong Kong(University of Hong Kong); Public Policy Research Fund, Hong Kong Government	This research was supported by the Small Project Funding from The University of Hong Kong (Project Code: 201409176011) and the Public Policy Research Fund, Hong Kong Government (2013.A8.009.14A).	Arnaboldi V., 2013, P 1 ACM C ONL SOC NE, P15, DOI DOI 10.1145/2512938.2512949; Arnaboldi V, 2013, INFOCOM 2013 P IEEE; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; Boyd D., 2010, 43 HAW INT C SYST SC; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Chalmers D, 2011, PRIV SEC RISK TRUST; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Conover M. D., 2011, 5 INT AAAI C WEBLOGS; De Choudhury M., 2010, P INT AAAI C WEB SOC, V4; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Fu KW, 2013, CYBERPSYCH BEH SOC N, V16, P702, DOI 10.1089/cyber.2012.0375; Fu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058356; Gayo-Avello D, 2013, SOC SCI COMPUT REV, V31, P649, DOI 10.1177/0894439313493979; Golder SA, 2010, SOC COMP SOCIALCOM 2; Golder SA, 2007, Communities and Technologies 2007, P41, DOI 10.1007/978-1-84628-905-7_3; Golder SA, 2014, ANNU REV SOCIOL, V40, P129, DOI 10.1146/annurev-soc-071913-043145; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Gonzalez-Bailon S, 2014, SOC NETWORKS, V38, P16, DOI 10.1016/j.socnet.2014.01.004; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Hale SA, 2014, P 32 ANN ACM C HUM F; Hodas NO, 2014, SCI REP-UK, V4, DOI 10.1038/srep04343; Huberman BA, 2008, 1 MONDAY, V14, P1, DOI [DOI 10.5210/FM.V14I1.2317, 10.2139/ssrn.1313405]; Huberman BA, 2009, J INF SCI, V35, P758, DOI 10.1177/0165551509346786; Java A., 2007, P 9 WEBKDD 1 SNA KDD; Kwak H., 2010, P 19 INT C WORLD WID; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Li Pei, 2014, ScientificWorldJournal, V2014, P914907, DOI 10.1155/2014/914907; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Morstatter F., 2013, P INT AAAI C WEB SOC; Myers SA, 2014, P COMP 23 INT C WORL; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Pareto V., 1906, MANUAL POLITICAL EC; Qi Gao, 2012, User Modeling, Adaptation, and Personalization. Proceedings 20th International Conference, UMAP 2012, P88, DOI 10.1007/978-3-642-31454-4_8; Romero D.M., 2011, WWW, P695; Ruths D, 2014, SCIENCE, V346, P1063, DOI 10.1126/science.346.6213.1063; Strohmaier M, 2014, IEEE INTELL SYST, V29, P84, DOI 10.1109/MIS.2014.80; Suh B., 2010, SOC COMP SOC 2010 IE; Watts D., 2013, BRIDGE FRONTIERS ENG, V2013, P5; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WENG J., 2010, P 3 ACM INT C WEB SE; Weng LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02522; Wilkinson DM, 2008, P 9 ACM C EL COMM; Yu L, 2011, PREPRINT; Zhou Z, 2010, P 1 WORKSH SOC MED A; Zhu JJH, 2011, SOC SCI COMPUT REV, V29, P327, DOI 10.1177/0894439310382512	49	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134270	10.1371/journal.pone.0134270	http://dx.doi.org/10.1371/journal.pone.0134270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287530	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600017
J	Singh, V; Pandita, SK; Tewari, R; van Hengstum, PJ; Pillai, SSK; Agnihotri, D; Kumar, K; Bhat, GD				Singh, Vartika; Pandita, Sundeep K.; Tewari, Rajni; van Hengstum, Peter J.; Pillai, Suresh S. K.; Agnihotri, Deepa; Kumar, Kamlesh; Bhat, G. D.			Thecamoebians (Testate Amoebae) Straddling the Permian-Triassic Boundary in the Guryul Ravine Section, India: Evolutionary and Palaeoecological Implications	PLOS ONE			English	Article							VASE-SHAPED MICROFOSSILS; MASS-EXTINCTION; ARCELLACEANS THECAMOEBIANS; MOLECULAR PHYLOGENY; BRITISH-COLUMBIA; CARBON-ISOTOPE; CHUAR GROUP; MARINE; BASIN; CLASSIFICATION	Exceptionally well-preserved organic remains of thecamoebians (testate amoebae) were preserved in marine sediments that straddle the greatest extinction event in the Phanerozoic: the Permian-Triassic Boundary. Outcrops from the Late Permian Zewan Formation and the Early Triassic Khunamuh Formation are represented by a complete sedimentary sequence at the Guryul Ravine Section in Kashmir, India, which is an archetypal Permian-Triassic boundary sequence [1]. Previous biostratigraphic analysis provides chronological control for the section, and a perspective of faunal turnover in the brachiopods, ammonoids, bivalves, conodonts, gastropods and foraminifera. Thecamoebians were concentrated from bulk sediments using palynological procedures, which isolated the organic constituents of preserved thecamoebian tests. The recovered individuals demonstrate exceptional similarity to the modern thecamoebian families Centropyxidae, Arcellidae, Hyalospheniidae and Trigonopyxidae, however, the vast majority belong to the Centropyxidae. This study further confirms the morphologic stability of the thecamoebian lineages through the Phanerozoic, and most importantly, their apparent little response to an infamous biological crisis in Earth's history.	[Singh, Vartika; Tewari, Rajni; Pillai, Suresh S. K.; Agnihotri, Deepa; Kumar, Kamlesh] Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India; [Pandita, Sundeep K.] Univ Jammu, Dept Geol, Jammu 180006, India; [van Hengstum, Peter J.] Texas A&M Univ, Dept Marine Sci, Galveston, TX 77553 USA; [Bhat, G. D.] Jammu & Kashmir Govt, Directorate Geol & Min, Srinagar 190002, Jammu & Kashmir, India	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); University of Jammu; Texas A&M University System	Tewari, R (corresponding author), Birbal Sahni Inst Paleobot, 53 Univ Rd, Lucknow 226007, Uttar Pradesh, India.	rajni_tewari@bsip.res.in	van Hengstum, Pete/AHC-5291-2022	van Hengstum, Pete/0000-0002-1125-2858	Birbal Sahni Institute of Palaeobotany, India	Birbal Sahni Institute of Palaeobotany, India(Department of Science & Technology (India))	Funding: This work was supported by the Birbal Sahni Institute of Palaeobotany, India.	Algeo T, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001823; Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V252, P328, DOI 10.1016/j.palaeo.2006.11.050; Algeo TJ, 2013, GLOBAL PLANET CHANGE, V105, P52, DOI 10.1016/j.gloplacha.2012.02.008; B RADLEY, 1931, US GEOLOGICAL SURVEY, P58; Bassi D, 2008, PALAEONTOLOGY, V51, P1335, DOI 10.1111/j.1475-4983.2008.00817.x; Bhat GM., 1997, GEOLOGY S ASIA 2 GEO, V7, P205; Boeuf O, 1997, CR ACAD SCI II A, V325, P623, DOI 10.1016/S1251-8050(97)89464-5; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brookfield ME, 2003, PALAEOGEOGR PALAEOCL, V198, P353, DOI 10.1016/S0031-0182(03)00476-0; Burgess SD, 2014, P NATL ACAD SCI USA, V111, P1; Carpenter W B, 1861, NATURAL HIST REV, V1, P456; Carter HJ., 1856, ANN MAG NAT HIST, V18, P221, DOI DOI 10.1080/00222935608697625; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P21, DOI 10.1016/j.ejop.2003.10.001; Cavalier-Smith T, 2009, J EUKARYOT MICROBIOL, V56, P26, DOI 10.1111/j.1550-7408.2008.00373.x; Charman DJ, 1998, HOLOCENE, V8, P209, DOI 10.1191/095968398676389446; Charman DJ, 2000, QUATERNARY RES ASS T, V9, P147, DOI DOI 10.1016/J.QUASCIREV.2004.03.008; DEFLANDRE GEORGES, 1929, ARCH PROTISTENK, V67, P322; Ehrenberg C. G., 1838, BLICK TIEFERE ORGANI; Ehrenberg C. G., 1841, KONIGLICHE AKADEMIE, P81; Ehrenberg C. G., 1832, PHYS ABHANDLUNGEN, P1; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Farooqui A, 2014, EUR J PROTISTOL, V50, P89, DOI 10.1016/j.ejop.2013.05.003; Foissner W, 2001, EUR J PROTISTOL, V37, P167, DOI 10.1078/0932-4739-00012; Foissner W, 2000, ACTA PROTOZOOL, V39, P257; Frenguelli G., 1933, BULLETTINO UNIONE MA, V52, P33; FURNISH WM, 1973, SCIENCE, V180, P188, DOI 10.1126/science.180.4082.188; Gehrels WR, 2001, J QUATERNARY SCI, V16, P201, DOI 10.1002/jqs.588; Henderson C.M., 1997, P 30 INT GEOL C, V11, P143; Henderson CM, 1997, B CAN PETROL GEOL, V45, P693; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Jennings HS, 1916, GENETICS, V1, P407; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Jung W., 1942, ARCH PRO TISTENK, V95, P253; Kaiho K, 2001, GEOLOGY, V29, P815, DOI 10.1130/0091-7613(2001)029<0815:EPCBAB>2.0.CO;2; Kapoor HM, 1996, PALEOZOIC MESOZOIC B; Kent WS, 1880, MANUAL INFUSORIA INC, P472; Korte C, 2010, J ASIAN EARTH SCI, V37, P293, DOI 10.1016/j.jseaes.2009.08.012; Kovary J., 1956, Foldtani Kozlony, V86, P266; Krull ES, 2004, PALAEOGEOGR PALAEOCL, V204, P297, DOI 10.1016/S0031-0182(03)00732-6; Krystyn L, 2003, PALAEOGEOGR PALAEOCL, V191, P329, DOI 10.1016/S0031-0182(02)00670-3; Kumar A, 2011, J MICROPALAEONTOL, V30, P75, DOI 10.1144/0262-821X10-021; Kumar Arun, 1998, Palaeontologia Electronica, V1, pUnpaginated; LOIEBLICH JR. A. R., 1964, TREATISE INVERTEBRAT; Martin-Gonzalez A, 2009, NATURWISSENSCHAFTEN, V96, P551, DOI 10.1007/s00114-009-0508-y; MATSUDA T, 1984, Journal of Geosciences Osaka City University, V27, P119; MATSUDA T, 1983, Journal of Geosciences Osaka City University, V26, P87; MATSUDA T, 1982, Journal of Geosciences Osaka City University, V25, P87; Matsuda T., 1981, Journal of Geosciences Osaka City University, V24, P75; Medioli F.S., 1999, Palaeontologia Electronica, V2, P1; MEDIOLI FS, 1990, NATO ADV SCI I C-MAT, V327, P813; MEDIOLI FS, 1987, J FORAMIN RES, V17, P28, DOI 10.2113/gsjfr.17.1.28; MEDIOLI FS, 1990, NATO ADV SCI I C-MAT, V327, P793; Medioli FS, 1983, SPECIAL PUBLICATION, V21, P63; Medioli FS, 2003, PALAEONTOL ELECTRON, V6, P1; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; Mundil R, 2004, SCIENCE, V305, P1760, DOI 10.1126/science.1101012; Nakazawa K, 1981, PALAEONTOLOGIA INDIC, V46, P1; Nakazawa K, 1975, SERIES GEOLOGY MINER, V41, P1; Ogden C.G., 1980, ATLAS FRESHWATER TES; Patterson RT, 2002, J PALEOLIMNOL, V28, P297, DOI 10.1023/A:1021621622090; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Penard E., 1902; POINAR GO, 1993, SCIENCE, V259, P222, DOI 10.1126/science.259.5092.222; Porter SM, 2000, PALEOBIOLOGY, V26, P360, DOI 10.1666/0094-8373(2000)026<0360:TAITNE>2.0.CO;2; Porter SM, 2003, J PALEONTOL, V77, P409, DOI 10.1666/0022-3360(2003)077<0409:VMFTNC>2.0.CO;2; Proemse BC, 2013, GEOLOGY, V41, P967, DOI 10.1130/G34466.1; Reinhardt EG, 2006, GEOLOGY, V34, P1061, DOI 10.1130/G22780A.1; Retallack GJ, 2003, GEOL SOC AM BULL, V115, P1133, DOI 10.1130/B25215.1; Sarkar A, 2003, PALAEOGEOGR PALAEOCL, V191, P1, DOI 10.1016/S0031-0182(02)00636-3; Schiller W., 1999, MAINZER NATURWISS AR, V37, P55; Schiller Wolfgang, 1997, Courier Forschungsinstitut Senckenberg, V201, P385; Schiller Wolfgang, 1998, Geologische Abhandlungen Hessen, V104, P173; Schmidt AR, 2004, PALAEONTOLOGY, V47, P185, DOI 10.1111/j.0031-0239.2004.00368.x; Schmidt AR, 2001, CRETACEOUS RES, V22, P423, DOI 10.1006/cres.2001.0267; Schonborn W, 1999, J EUKARYOT MICROBIOL, V46, P571, DOI 10.1111/j.1550-7408.1999.tb05133.x; Schultze F. E, 1877, ARCH MIKROSKOPISCHE, V13, P9; SCOTT D. B., 2001, MONITORING COASTAL E; Shen Shu Zhong, 2006, Palaeoworld, V15, P3, DOI 10.1016/j.palwor.2006.03.005; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Shen SZ, 2002, PALEOBIOLOGY, V28, P449, DOI 10.1666/0094-8373(2002)028<0449:PEPOPB>2.0.CO;2; Smirnov A, 2005, PROTIST, V156, P129, DOI 10.1016/j.protis.2005.06.002; Smirnov AV, 2011, PROTIST, V162, P545, DOI 10.1016/j.protis.2011.04.004; Smith RMH, 2001, GEOLOGY, V29, P1147, DOI 10.1130/0091-7613(2001)029<1147:POVEAA>2.0.CO;2; Song HJ, 2013, NAT GEOSCI, V6, P52, DOI [10.1038/NGEO1649, 10.1038/ngeo1649]; Tewari R, 2014, EARTH SCI IN PRESS; Twitchett RJ, 2004, GEOLOGY, V32, P805, DOI 10.1130/G20585.1; Twitchett RJ, 2001, GEOLOGY, V29, P351, DOI 10.1130/0091-7613(2001)029<0351:RASCOM>2.0.CO;2; van Hengstum PJ, 2008, J FORAMIN RES, V38, P305, DOI 10.2113/gsjfr.38.4.305; van Hengstum PJ, 2007, J FORAMIN RES, V37, P300, DOI 10.2113/gsjfr.37.4.300; van Hengstum PJ, 2010, QUATERNARY SCI REV, V29, P2788, DOI 10.1016/j.quascirev.2010.06.034; Vasicek M., 1957, Acta Musei Nationalis Pragae, V13B, P333; VONSTEIN SFN, 1859, KONIGLICHE BOHMISHCE, V10, P41; Waggoner Benjamin M., 1996, Paleobios, V17, P20; Waggoner Benjamin M., 1996, Paleobios, V17, P17; WANG K, 1994, GEOLOGY, V22, P580, DOI 10.1130/0091-7613(1994)022<0580:PTEOCE>2.3.CO;2; WIGHTMAN WG, 1994, PALAEOGEOGR PALAEOCL, V106, P187, DOI 10.1016/0031-0182(94)90010-8; WIGNALL PB, 1992, PALAEOGEOGR PALAEOCL, V93, P21, DOI 10.1016/0031-0182(92)90182-5; Wignall PB, 2003, PALAIOS, V18, P153, DOI 10.1669/0883-1351(2003)18<153:CDRFTU>2.0.CO;2; Wignall PB, 1998, GEOL MAG, V135, P47, DOI 10.1017/S0016756897008121; Wolf Monika, 1995, Palaeontologische Zeitschrift, V69, P1; Woodland WA, 1998, HOLOCENE, V8, P261, DOI 10.1191/095968398667004497	103	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135593	10.1371/journal.pone.0135593	http://dx.doi.org/10.1371/journal.pone.0135593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288245	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600057
J	Schiavano, GF; De Santi, M; Brandi, G; Fanelli, M; Bucchini, A; Giamperi, L; Giomaro, G				Schiavano, Giuditta Fiorella; De Santi, Mauro; Brandi, Giorgio; Fanelli, Mirco; Bucchini, Anahi; Giamperi, Laura; Giomaro, Giovanna			Inhibition of Breast Cancer Cell Proliferation and In Vitro Tumorigenesis by a New Red Apple Cultivar	PLOS ONE			English	Article							ANTIPROLIFERATIVE ACTIVITY; ANTIOXIDANT ACTIVITY; MAMMARY-TUMORS; FLAVONOIDS; COLON; VEGETABLES; APOPTOSIS; FRUIT; JUICE; CHEMOPREVENTION	Purpose The aim of this study was to evaluate the antiproliferative activity in breast cancer cells and the inhibition of tumorigenesis in pre-neoplastic cells of a new apple cultivar with reddish pulp, called the Pelingo apple. Methods The antiproliferative activity was evaluated in MCF-7 and MDA-MB-231 human breast cancer cells. The inhibition of tumorigenesis was performed in JB6 promotion-sensitive (P+) cells. Results Results showed that Pelingo apple juice is characterized by a very high polyphenol content and strongly inhibited breast cancer cell proliferation. Its antiproliferative activity was found to be higher than the other five apple juices tested. Pelingo juice induced cell accumulation in the G2/M phase of the cell cycle and autophagy through overexpression of p21, inhibition of extracellular signal-regulated kinases 1/2 (ERK1/2) activity and an increase in lipidated microtubule-associated protein-1 light chain-3 beta (LC3B). Remarkably, Pelingo juice inhibited the 12-o-tetra-decanoyl-phorbol-13-acetate (TPA)-induced tumorigenesis of JB6 P+ cells, suppressing colony formation in semi-solid medium and TPA-induced ERK1/2 phosphorylation. Conclusions Our data indicate that the Pelingo apple is rich in food components that can markedly inhibit in vitro tumorigenesis and growth of human breast cancer cells and could provide natural bioactive non-nutrient compounds, with potential chemopreventive activity.	[Schiavano, Giuditta Fiorella; De Santi, Mauro; Brandi, Giorgio; Fanelli, Mirco] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [Bucchini, Anahi; Giamperi, Laura; Giomaro, Giovanna] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, PU, Italy	University of Urbino; University of Urbino	Schiavano, GF (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy.	giuditta.schiavano@uniurb.it	De Santi, Mauro/F-5401-2013; Fanelli, Mirco/F-2665-2011	De Santi, Mauro/0000-0003-2983-8344; Fanelli, Mirco/0000-0002-9649-8661; Schiavano, Giuditta Fiorella/0000-0002-1427-3486; Bucchini, Anahi Elena Ada/0000-0003-3100-9262; Brandi, Giorgio/0000-0003-1380-6137				Amatori S, 2010, BRIT J CANCER, V103, P239, DOI 10.1038/sj.bjc.6605745; Barth SW, 2005, CARCINOGENESIS, V26, P1414, DOI 10.1093/carcin/bgi082; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; Brandi G, 2005, J NUTR, V135, P1503, DOI 10.1093/jn/135.6.1503; Brandi G, 2003, CANCER RES, V63, P4028; Chen MS, 2004, IN VIVO, V18, P73; Dalla Ragione L., 2006, ARCHEOLOGIA ARBOREA, P102; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; de Pascual-Teresa Sonia, 2008, Phytochemistry Reviews, V7, P281, DOI 10.1007/s11101-007-9074-0; De Santi M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2855; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Elisia I, 2007, FOOD CHEM, V101, P1052, DOI 10.1016/j.foodchem.2006.02.060; Fraternale D, 2011, REC NAT PROD, V5, P202; Gallus S, 2005, ANN ONCOL, V16, P1841, DOI 10.1093/annonc/mdi361; Galluzzi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043249; Gescher AJ, 2008, PLANTA MED, V74, P1523, DOI 10.1055/s-0028-1088300; Giomaro G, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-45; HAGERMAN AE, 1994, METHOD ENZYMOL, V234, P429; He X, 2008, J AGR FOOD CHEM, V56, P9905, DOI 10.1021/jf8015255; He XJ, 2007, J AGR FOOD CHEM, V55, P4366, DOI 10.1021/jf063563o; Hyson DA, 2011, ADV NUTR, V2, P408, DOI 10.3945/an.111.000513; Kang NJ, 2011, PHARMACOL THERAPEUT, V130, P310, DOI 10.1016/j.pharmthera.2011.02.004; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; Knekt P, 1997, AM J EPIDEMIOL, V146, P223, DOI 10.1093/oxfordjournals.aje.a009257; Vieira FGK, 2009, ARCH LATINOAM NUTR, V59, P101; Kuntz S, 1999, EUR J NUTR, V38, P133, DOI 10.1007/s003940050054; Lagiou P, 2004, CANCER CAUSE CONTROL, V15, P67, DOI 10.1023/B:CACO.0000016619.18041.b0; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Li JX, 2012, CARCINOGENESIS, V33, P459, DOI 10.1093/carcin/bgr281; Liu JR, 2009, J AGR FOOD CHEM, V57, P297, DOI 10.1021/jf801826w; Liu R. H., 2001, NY FRUIT Q, V9, P15; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Liu RH, 2005, J AGR FOOD CHEM, V53, P2341, DOI 10.1021/jf058010c; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mari A, 2010, FOOD CHEM, V123, P157, DOI 10.1016/j.foodchem.2010.04.023; McCann MJ, 2007, FOOD CHEM TOXICOL, V45, P1224, DOI 10.1016/j.fct.2007.01.003; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pedro M, 2006, TOXICOL LETT, V164, P24, DOI 10.1016/j.toxlet.2005.11.007; Peterson J, 2003, BRIT J CANCER, V89, P1255, DOI 10.1038/sj.bjc.6601271; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sporn MB, 2002, NAT REV CANCER, V2, P537, DOI 10.1038/nrc844; Steeves MA, 2010, CURR OPIN CELL BIOL, V22, P218, DOI 10.1016/j.ceb.2009.12.013; Steward WP, 2013, BRIT J CANCER, V109, P1, DOI 10.1038/bjc.2013.280; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Sun J, 2008, J AGR FOOD CHEM, V56, P11661, DOI 10.1021/jf8021223; Tow WW, 2011, J FOOD SCI, V76, pT163, DOI 10.1111/j.1750-3841.2011.02314.x; Tzulker R, 2007, J AGR FOOD CHEM, V55, P9559, DOI 10.1021/jf071413n; Veeriah S, 2006, MOL CARCINOGEN, V45, P164, DOI 10.1002/mc.20158; Wendt J, 2006, ONCOGENE, V25, P972, DOI 10.1038/sj.onc.1209031; Willett WC, 1995, ENVIRON HEALTH PERSP, V103, P165, DOI 10.2307/3432305; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Zessner H, 2008, MOL NUTR FOOD RES, V52, pS28, DOI 10.1002/mnfr.200700317	56	22	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135840	10.1371/journal.pone.0135840	http://dx.doi.org/10.1371/journal.pone.0135840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284516	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100073
J	Winklewski, PJ; Tkachenko, Y; Mazur, K; Kot, J; Gruszecki, M; Guminski, W; Czuszynski, K; Wtorek, J; Frydrychowski, AF				Winklewski, Pawel J.; Tkachenko, Yurii; Mazur, Kamila; Kot, Jacek; Gruszecki, Marcin; Guminski, Wojciech; Czuszynski, Krzysztof; Wtorek, Jerzy; Frydrychowski, Andrzej F.			Sympathetic Activation Does Not Affect the Cardiac and Respiratory Contribution to the Relationship between Blood Pressure and Pial Artery Pulsation Oscillations in Healthy Subjects	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; SUBARACHNOID SPACE; FUNDAMENTAL RELATIONSHIPS; CEREBRAL AUTOREGULATION; NONINVASIVE METHOD; WAVELET TRANSFORM; ACUTE HYPOTENSION; CROSS-TALK; FLOW; WIDTH	Introduction Using a novel method called near-infrared transillumination backscattering sounding (NIR-T/BSS) that allows for the non-invasive measurement of pial artery pulsation (cc-TQ) and subarachnoid width (sas-TQ) in humans, we assessed the influence of sympathetic activation on the cardiac and respiratory contribution to blood pressure (BP) cc-TQ oscillations in healthy subjects. Methods The pial artery and subarachnoid width response to handgrip (HGT) and cold test (CT) were studied in 20 healthy subjects. The cc-TQ and sas-TQ were measured using NIR-T/BSS; cerebral blood flow velocity (CBFV) was measured using Doppler ultrasound of the left internal carotid artery; heart rate (HR) and beat-to-beat mean BP were recorded using a continuous finger-pulse photoplethysmography; respiratory rate (RR), minute ventilation (MV), end-tidal CO2 (EtCO2) and end-tidal O-2 (EtO2) were measured using a metabolic and spirometry module of the medical monitoring system. Wavelet transform analysis was used to assess the relationship between BP and cc-TQ oscillations. Results HGT evoked an increase in BP (+15.9%; P<0.001), HR (14.7; P<0.001), SaO(2) (+0.5; P<0.001) EtO2 (+2.1; P<0.05) RR (+9.2%; P = 0.05) and MV (+15.5%; P<0.001), while sasTQ was diminished (-8.12%; P<0.001), and a clear trend toward cc-TQ decline was observed (-11.0%; NS). CBFV (+2.9%; NS) and EtCO2 (-0.7; NS) did not change during HGT. CT evoked an increase in BP (+7.4%; P<0.001), sas-TQ (+3.5%; P<0.05) and SaO(2)(+0.3%; P<0.05). HR (+2.3%; NS), CBFV (+2.0%; NS), EtO2 (-0.7%; NS) and EtCO2 (+0.9%; NS) remained unchanged. A trend toward decreased cc-TQ was observed (-5.1%; NS). The sas-TQ response was biphasic with elevation during the first 40 seconds (+8.8% vs. baseline; P<0.001) and subsequent decline (+4.1% vs. baseline; P<0.05). No change with respect to wavelet coherence and wavelet phase coherence was found between the BP and cc-TQ oscillations. Conclusions Short sympathetic activation does not affect the cardiac and respiratory contribution to the relationship between BP-cc-TQ oscillations. HGT and CT display divergent effects on the width of the subarachnoid space, an indirect marker of changes in intracranial pressure.	[Winklewski, Pawel J.; Frydrychowski, Andrzej F.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Tkachenko, Yurii; Kot, Jacek] Med Univ Gdansk, Inst Maritime & Trop Med, Natl Ctr Hyperbar Med, Gdynia, Poland; [Mazur, Kamila; Czuszynski, Krzysztof; Wtorek, Jerzy] Gdansk Univ Technol, Dept Biomed Engn, Fac Elect Telecommun & Informat, Gdansk, Poland; [Gruszecki, Marcin] Med Univ Gdansk, Dept Radiol Informat & Stat, Gdansk, Poland; [Guminski, Wojciech] Gdansk Univ Technol, Dept Comp Commun, Fac Elect Telecommun & Informat, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology	Winklewski, PJ (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	pawelwinklewski@wp.pl	Gumiński, Wojciech/B-5004-2013; Kot, Jacek/I-5284-2012; Wtorek, Jerzy/AAD-3731-2019	Gumiński, Wojciech/0000-0002-3113-3450; Kot, Jacek/0000-0001-5604-8407; 	European Union [264816]; Medical University of Gdansk; NIRT sp. z o. o., Wierzbice, Poland	European Union(European Commission); Medical University of Gdansk(Medical University Gdansk); NIRT sp. z o. o., Wierzbice, Poland	The study was conducted as a part of the PHYPODE Marie Curie Initial Training Networks (FP7-PEOPLE-2010-ITN) and received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FRP/2007-2013/under the Research Executive Agency grant agreement [grant number 264816]. Funding came also from the Medical University of Gdansk and NIRT sp. z o. o., Wierzbice, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumbach GL, 1996, HYPERTENSION, V27, P159, DOI 10.1161/01.HYP.27.2.159; Bernjak A, 2012, J PHYSIOL-LONDON, V590, P363, DOI 10.1113/jphysiol.2011.214528; Bhambhani Y, 2006, J REHABIL RES DEV, V43, P845, DOI 10.1682/JRRD.2005.09.0151; Cassaglia PA, 2008, AM J PHYSIOL-REG I, V294, pR1255, DOI 10.1152/ajpregu.00332.2007; Cassaglia PA, 2009, J APPL PHYSIOL, V106, P1050, DOI 10.1152/japplphysiol.91349.2008; Cassaglia PA, 2008, SLEEP, V31, P1729, DOI 10.1093/sleep/31.12.1729; Cui RF, 2014, MICROVASC RES, V93, P14, DOI 10.1016/j.mvr.2014.02.008; Frydrychowski AE, 2002, IEEE T BIO-MED ENG, V49, P887, DOI 10.1109/TBME.2002.800786; Frydrychowski AF, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753756; Frydrychowski AF, 2011, ACTA NEUROBIOL EXP, V71, P313; Frydrychowski AF, 2011, MICROVASC RES, V82, P156, DOI 10.1016/j.mvr.2011.05.005; Georgiadis D, 2000, EUR HEART J, V21, P407, DOI 10.1053/euhj.1999.1742; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Henskens LHG, 2008, HYPERTENSION, V52, P1120, DOI 10.1161/HYPERTENSIONAHA.108.119024; Heusser K, 2009, HYPERTENSION, V53, P719, DOI 10.1161/HYPERTENSIONAHA.108.127530; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Li ZY, 2013, J CEREBR BLOOD F MET, V33, P692, DOI 10.1038/jcbfm.2013.4; Li ZY, 2011, MICROVASC RES, V82, P304, DOI 10.1016/j.mvr.2011.08.004; Lucas SJE, 2013, J APPL PHYSIOL, V115, P202, DOI 10.1152/japplphysiol.00128.2013; Macey PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105261; Macey PM, 2012, AUTON NEUROSCI-BASIC, V168, P72, DOI 10.1016/j.autneu.2012.01.009; Ogoh S, 2008, J APPL PHYSIOL, V105, P1370, DOI 10.1152/japplphysiol.zdg-8199.pcpcomm.2008; Ogoh S, 2010, J PHYSIOL-LONDON, V588, P365, DOI 10.1113/jphysiol.2009.180844; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Panerai RB, 2014, MED ENG PHYS, V36, P576, DOI 10.1016/j.medengphy.2013.09.004; Safar ME, 2010, ACTA PHYSIOL, V198, P417, DOI 10.1111/j.1748-1716.2009.02073.x; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Stankovski T, 2013, J APPL PHYSIOL, V115, P1806, DOI 10.1152/japplphysiol.00802.2013; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Stefanovska A, 2007, IEEE ENG MED BIOL, V26, P25, DOI [10.1109/EMB.2007.907088, 10.1109/MEMB.2007.907088]; Tzeng YC, 2014, J APPL PHYSIOL, V117, P1037, DOI 10.1152/japplphysiol.00366.2014; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; Tzeng YC, 2010, J APPL PHYSIOL, V108, P1162, DOI 10.1152/japplphysiol.01390.2009; van Lieshout JJ, 2008, J APPL PHYSIOL, V105, P1364, DOI 10.1152/japplphysiol.90597.2008; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wilson TD, 2005, J CEREBR BLOOD F MET, V25, P136, DOI 10.1038/sj.jcbfm.9600015; Winklewski PJ, 2015, MICROVASC RES, V99, P86, DOI 10.1016/j.mvr.2015.03.003; Winklewski PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0213-4; Winklewski PJ, 2013, DIVING HYPERB MED, V43, P148; Winklewski PJ, 2013, BLOOD PRESSURE, V22, P27, DOI 10.3109/08037051.2012.701407; Winklewski PJ, 2015, PLOS ONE; Wszedybyl-Winklewska M, 2015, J HYPERTENS, V33, P1811, DOI 10.1097/HJH.0000000000000613; Wszedybyl-Winklewska M, 2012, ACTA NEUROBIOL EXP, V72, P80; Wszedybyl-Winklewska M, 2011, MICROVASC RES, V82, P369, DOI 10.1016/j.mvr.2011.08.003	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135751	10.1371/journal.pone.0135751	http://dx.doi.org/10.1371/journal.pone.0135751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284650	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100066
J	Yan, H; Li, HH; Li, Q; Zhao, PF; Wang, W; Cao, BW				Yan, Han; Li, Huihui; Li, Qin; Zhao, Pengfei; Wang, Wei; Cao, Bangwei			The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-III TRIAL; GEFITINIB; ERLOTINIB; GROWTH; GEMCITABINE; HEAD; NECK; CARBOPLATIN; PACLITAXEL	Background The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) currently has become the hotspot issue in the treatment of non-small lung cancer (NSCLC). This systematic review was conducted to compare the efficacy and safety of the synchronous combination of these two treatments with EGFR TKIs or chemotherapy alone in advanced NSCLC. Methods EMBASE, PubMed, the Central Registry of Controlled Trials in the Cochrane Library (CENTRAL), Chinese biomedical literature database (CNKI) and meeting summaries were searched. The Phase II/III randomized controlled trials were selected by which patients with advanced NSCLC were randomized to receive a combination of EGFR TKIs and chemotherapy by synchronous mode vs. EGFR TKIs or chemotherapy alone. Results A total of six randomized controlled trials (RCTs) including 4675 patients were enrolled in the systematic review. The meta-analysis demonstrated that the synchronous combination group of chemotherapy and EGFR TKIs did not reach satisfactory results; there was no significant difference in overall survival (OS), time to progression (TTP) and objective response rate (ORR), compared with monotherapy (OS: HR = 1.05, 95% CI = 0.98-1.12; TTP: HR = 0.94, 95% CI = 0.89-1.00; ORR: RR = 1.07, 95% CI = 0.98-1.17), and no significant difference in OS and progression-free survival (PFS), compared with EGFR TKIs alone (OS: HR = 1.10, 95% CI = 0.83-1.46; PFS: HR = 0.86, 95% CI = 0.67-1.10). The patients who received synchronous combined therapy presented with increased incidences of grade 3/4 anemia (RR = 1.40, 95% CI = 1.10-1.79) and rash (RR = 7.43, 95% CI = 4.56-12.09), compared with chemotherapy, grade 3/4 anemia (RR = 6.71, 95% CI = 1.25-35.93) and fatigue (RR = 9.60, 95% CI = 2.28-40.86) compared with EGFR TKI monotherapy. Conclusions The synchronous combination of chemotherapy and TKIs is not superior to chemotherapy or EGFR TKIs alone for the first-line treatment of NSCLC.	[Yan, Han; Li, Huihui; Li, Qin; Zhao, Pengfei; Cao, Bangwei] Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China; [Wang, Wei] Capital Med Univ, Beijing Friendship Hosp, Med Healthcare Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Cao, BW (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China.	oncology@ccmu.edu.cn			Natural Science Foundation of China [81272615]; Beijing Municipal Health System High-level Health Person Foundation Project [2011-3-007]; Beijing Municipal "Ten, Hundred, thousand" Person Foundation Project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Health System High-level Health Person Foundation Project; Beijing Municipal "Ten, Hundred, thousand" Person Foundation Project	This work was supported by Grants No. 81272615 from the Natural Science Foundation of China (to Bangwei Cao), by Grants from Beijing Municipal Health System High-level Health Person Foundation Project, No. 2011-3-007 (to Bangwei Cao), and by Grants from Beijing Municipal "Ten, Hundred, thousand" Person Foundation Project (2011-2013 to Bangwei Cao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2013, J CLIN ONCOL, V31, P1405, DOI 10.1200/JCO.2012.45.4272; Argiris A, 2011, CLIN CANCER RES, V17, P5755, DOI 10.1158/1078-0432.CCR-11-0861; Chen P, 2011, EUR J CLIN PHARMACOL, V67, P235, DOI 10.1007/s00228-010-0965-4; Chen YM, 2011, J THORAC ONCOL, V6, P1110, DOI 10.1097/JTO.0b013e3182121c09; Chun PY, 2006, CANCER RES, V66, P981, DOI 10.1158/0008-5472.CAN-05-2665; Ciardiello F, 2000, CLIN CANCER RES, V6, P2053; Curtis VF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054916; Davies AM, 2006, CLIN LUNG CANCER, V7, P385, DOI 10.3816/CLC.2006.n.021; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Janne PA, 2012, J CLIN ONCOL, V30, P2063, DOI 10.1200/JCO.2011.40.1315; Kataki A, 2002, J LAB CLIN MED, V140, P320, DOI 10.1067/mlc.2002.128317; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Martins RG, 2013, J CLIN ONCOL, V31, P1415, DOI 10.1200/JCO.2012.46.3299; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; MORIKAWA K, 1988, CANCER RES, V48, P6863; Moyer JD, 1997, CANCER RES, V57, P4838; Nyati MK, 2006, NAT REV CANCER, V6, P876, DOI 10.1038/nrc1953; Santoro A, 2008, ANN ONCOL, V19, P1888, DOI 10.1093/annonc/mdn401; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Solit DB, 2005, CLIN CANCER RES, V11, P1983, DOI 10.1158/1078-0432.CCR-04-1347; Stinchcombe TE, 2011, J THORAC ONCOL, V6, P1569, DOI 10.1097/JTO.0b013e3182210430; Xiao YY, 2013, EUR J CLIN PHARMACOL, V69, P151, DOI 10.1007/s00228-012-1333-3; Yang ZY, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009948.pub2; Zhang YL, 2013, ONCOTARGETS THER, V6, P1771, DOI 10.2147/OTT.S54502	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135829	10.1371/journal.pone.0135829	http://dx.doi.org/10.1371/journal.pone.0135829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285137	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100070
J	Brown, DK; Penkler, DL; Musyoka, TM; Bishop, OT				Brown, David K.; Penkler, David L.; Musyoka, Thommas M.; Bishop, Ozlem Tastan			JMS: An Open Source Workflow Management System and Web-Based Cluster Front-End for High Performance Computing	PLOS ONE			English	Article							SERVICES; DATABASE	Complex computational pipelines are becoming a staple of modern scientific research. Often these pipelines are resource intensive and require days of computing time. In such cases, it makes sense to run them over high performance computing (HPC) clusters where they can take advantage of the aggregated resources of many powerful computers. In addition to this, researchers often want to integrate their workflows into their own web servers. In these cases, software is needed to manage the submission of jobs from the web interface to the cluster and then return the results once the job has finished executing. We have developed the Job Management System (JMS), a workflow management system and web interface for high performance computing (HPC). JMS provides users with a user-friendly web interface for creating complex workflows with multiple stages. It integrates this workflow functionality with the resource manager, a tool that is used to control and manage batch jobs on HPC clusters. As such, JMS combines workflow management functionality with cluster administration functionality. In addition, JMS provides developer tools including a code editor and the ability to version tools and scripts. JMS can be used by researchers from any field to build and run complex computational pipelines and provides functionality to include these pipelines in external interfaces. JMS is currently being used to house a number of bioinformatics pipelines at the Research Unit in Bioinformatics (RUBi) at Rhodes University. JMS is an open-source project and is freely available at https://github.com/RUBi-ZA/JMS.	[Brown, David K.; Penkler, David L.; Musyoka, Thommas M.; Bishop, Ozlem Tastan] Rhodes Univ, Dept Biochem & Microbiol, Res Unit Bioinformat RUBi, ZA-6140 Grahamstown, South Africa	Rhodes University	Bishop, OT (corresponding author), Rhodes Univ, Dept Biochem & Microbiol, Res Unit Bioinformat RUBi, ZA-6140 Grahamstown, South Africa.	o.tastanbishop@ru.ac.za	Musyoka, Thommas/F-3357-2015; Bishop, Ozlem Tastan/J-3084-2016	Musyoka, Thommas/0000-0001-8906-9482; Bishop, Ozlem Tastan/0000-0001-6861-7849	National Institutes of Health [U41HG006941]; National Research Foundation (NRF), South Africa [93690]; Rhodes University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); Rhodes University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is partially supported by the National Institutes of Health Common Fund under grant number U41HG006941 to H3ABioNet. National Research Foundation (NRF), South Africa, (grant number 93690) and Rhodes University provided student fellowship financial support. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaptive Computing Enterprises Inc, 2015, AD COMP PROD; Adaptive Computing Enterprises Inc, 2015, TORQ; Ansible, 2015, ANS IS SIMPL IT AUT; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bhagat J, 2010, NUCLEIC ACIDS RES, V38, pW689, DOI 10.1093/nar/gkq394; Foundation DS, 2015, DJANG; Gentzsch W, 2001, FIRST IEEE/ACM INTERNATIONAL SYMPOSIUM ON CLUSTER COMPUTING AND THE GRID, PROCEEDINGS, P35, DOI 10.1109/CCGRID.2001.923173; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hatherley R, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0080-8; Hunter AA, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-1; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jackson D, 2001, LNCS, P87, DOI DOI 10.1007/3-540-45540-X; Kinder K., 2005, LINUX J, V2005, P6; Misra, 2011, INT C HIGH PERF COMP, P12; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Orvis J, 2010, BIOINFORMATICS, V26, P1488, DOI 10.1093/bioinformatics/btq167; Preston-Werner T., SEMANTIC VERSIONING; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sharma P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101144; Tilkov S, 2010, INFOQ EXPLORES, P127; Univa Corporation, 2015, UN GRID ENG; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wolstencroft K, 2013, NUCLEIC ACIDS RES, V41, pW557, DOI 10.1093/nar/gkt328; Yoo AB, 2003, LECT NOTES COMPUT SC, V2862, P44	30	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134273	10.1371/journal.pone.0134273	http://dx.doi.org/10.1371/journal.pone.0134273			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280450	Green Submitted, gold, Green Published			2022-12-27	WOS:000359664300004
J	Kilfoil, KM; Mayne, E; Scott, L; Stevens, W				Kilfoil, Kim Michelle; Mayne, Elizabeth; Scott, Lesley; Stevens, Wendy			A High Burden Human Immunodeficiency Virus and Tuberculosis Resource Limited Setting, Gains from Including Xpert MTB/RIF in the Diagnostic Algorithm of Fluid Specimens Submitted for Exclusion of Lymphoma by Immunophenotypic Analysis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; NONRESPIRATORY SPECIMENS; RAPID DIAGNOSIS; ASSAY; METAANALYSIS; SAMPLES	This study investigated the benefit of incorporating Xpert MTB/RIF into the diagnostic algorithm of fluid specimens received for immunophenotypic analysis to exclude lymphoma. It was found that in a high burden HIV/TB setting, like South Africa, 130/229 (57%) of fluid specimens referred for immunophenotypic analysis to exclude lymphoma are not referred for concurrent MTBC liquid culture testing by the treating clinician. Of 99/229 (43%) specimens with corresponding culture results, Xpert sensitivity and specificity were 50% (CI: 26-75%) and 99% (CI: 91-100%) respectively. This demonstrates that incorporation of Xpert into the laboratory diagnostic algorithm in the immunophenotypic laboratory would improve patient work-up and care.	[Kilfoil, Kim Michelle; Mayne, Elizabeth; Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa; [Scott, Lesley; Stevens, Wendy] Natl Hlth Lab Serv, Natl Prior Program, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service	Kilfoil, KM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa.	kim.kilfoil@nhls.ac.za		Mayne, Elizabeth/0000-0002-6360-3488; Scott, Lesley/0000-0001-6573-9525	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [3U2GPS0001328-04]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of 3U2GPS0001328-04 (to LS and WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Boehme CC, 2011, LANCET, V6736, P1; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Causse M, 2011, J CLIN MICROBIOL, V49, P3065, DOI 10.1128/JCM.00491-11; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Das DK, 2006, DIAGN CYTOPATHOL, V34, P335, DOI 10.1002/dc.20432; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P4341, DOI 10.1128/JCM.05454-11; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Ioannidis P, 2011, J CLIN MICROBIOL, V49, P3068, DOI 10.1128/JCM.00718-11; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Malbruny B, 2011, INT J TUBERC LUNG D, V15, P553, DOI 10.5588/ijtld.10.0497; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Moure R, 2012, J CLIN MICROBIOL, V50, P513, DOI 10.1128/JCM.06467-11; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Swerdlow SH CE, 2008, WHO CLASSIFICATION T; Teo J, 2011, J CLIN MICROBIOL, V49, P3659, DOI 10.1128/JCM.00211-11; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; World Health Organization, WHO REP GLOB TUB CON; World Health Organization, WHO GLOB TUB REP 201; World Health Organization, WHO TUB COUNTR PROF; World Health Organization, AUT REAL TIM NUCL AC	28	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134404	10.1371/journal.pone.0134404	http://dx.doi.org/10.1371/journal.pone.0134404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280548	Green Submitted, Green Published, gold			2022-12-27	WOS:000359664300005
J	Oliver, CJ; Softley, S; Williamson, SM; Stevenson, PC; Wright, GA				Oliver, Caitlin J.; Softley, Samantha; Williamson, Sally M.; Stevenson, Philip C.; Wright, Geraldine A.			Pyrethroids and Nectar Toxins Have Subtle Effects on the Motor Function, Grooming and Wing Fanning Behaviour of Honeybees (Apis mellifera)	PLOS ONE			English	Article							LEARNING PERFORMANCES; SODIUM-CHANNEL; APHID HONEYDEW; PESTICIDE; EXPOSURE; INSECTICIDES; BUMBLEBEES; RESIDUES; MEMORY; SITES	Sodium channels, found ubiquitously in animal muscle cells and neurons, are one of the main target sites of many naturally-occurring, insecticidal plant compounds and agricultural pesticides. Pyrethroids, derived from compounds found only in the Asteraceae, are particularly toxic to insects and have been successfully used as pesticides including on flowering crops that are visited by pollinators. Pyrethrins, from which they were derived, occur naturally in the nectar of some flowering plant species. We know relatively little about how such compounds-i.e., compounds that target sodium channels-influence pollinators at low or sub-lethal doses. Here, we exposed individual adult forager honeybees to several compounds that bind to sodium channels to identify whether these compounds affect motor function. Using an assay previously developed to identify the effect of drugs and toxins on individual bees, we investigated how acute exposure to 10 ng doses (1 ppm) of the pyrethroid insecticides (cyfluthrin, tau-fluvalinate, allethrin and permethrin) and the nectar toxins (aconitine and grayanotoxin I) affected honeybee locomotion, grooming and wing fanning behaviour. Bees exposed to these compounds spent more time upside down and fanning their wings. They also had longer bouts of standing still. Bees exposed to the nectar toxin, aconitine, and the pyrethroid, allethrin, also spent less time grooming their antennae. We also found that the concentration of the nectar toxin, grayanotoxin I (GTX), fed to bees affected the time spent upside down (i.e., failure to perform the righting reflex). Our data show that low doses of pyrethroids and other nectar toxins that target sodium channels mainly influence motor function through their effect on the righting reflex of adult worker honeybees.	[Oliver, Caitlin J.; Softley, Samantha; Williamson, Sally M.; Wright, Geraldine A.] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Oliver, Caitlin J.; Softley, Samantha; Williamson, Sally M.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Stevenson, Philip C.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Stevenson, Philip C.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	Newcastle University - UK; Newcastle University - UK; Royal Botanic Gardens, Kew; University of Greenwich	Wright, GA (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jeri.wright@ncl.ac.uk	Stevenson, Philip C/E-8822-2013; stevenson, philip c/E-8741-2013	Stevenson, Philip C/0000-0002-0736-3619; stevenson, philip c/0000-0002-0736-3619	Biotechnology and Biological Sciences Research Council [BB/I000143/1, BB/I000968/1]; Natural Environment Research Council [BB/I000143/1, BB/I000968/1]; Wellcome Trust [BB/I000143/1, BB/I000968/1]; Defra [BB/I000143/1, BB/I000968/1]; Scottish Government under the Insect Pollinators Initiative [BB/I000143/1, BB/I000968/1]; BBSRC [BB/I000143/1, BB/I000968/1, BB/I000445/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000445/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government under the Insect Pollinators Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded jointly by two grants from the Biotechnology and Biological Sciences Research Council, Natural Environment Research Council, the Wellcome Trust, Defra, and the Scottish Government under the Insect Pollinators Initiative: grant BB/I000143/1 to GAW and grant BB/I000968/1 to GAW and PCS.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Ahmad M, 2003, J ECON ENTOMOL, V96, P875, DOI 10.1603/0022-0493-96.3.875; Baron GL, 2014, J APPL ECOL, V51, P460, DOI 10.1111/1365-2664.12205; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; BISHOP JA, 1994, J KANSAS ENTOMOL SOC, V67, P220; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; ChemSpider, 2015, GRAYAN; ChemSpider, 2015, 3 ALL 2 METH 4 OX 2; ChemSpider, 2015, CHRYS AC EST ALL; ChemSpider, 2015, CIS CYFL; Choudhary A, 2008, ENVIRON MONIT ASSESS, V144, P143, DOI 10.1007/s10661-007-9952-3; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Department for Environment Food & Rural Affairs (DEFRA), 2013, NEON; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Front Matter, 2007, STAT POLL N AM; Frost EH, 2013, J EXP BIOL, V216, P2931, DOI 10.1242/jeb.086538; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Gosselin M, 2013, ECOL ENTOMOL, V38, P400, DOI 10.1111/een.12032; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Grdisa M, 2013, CHEM BIODIVERS, V10, P460, DOI 10.1002/cbdv.201200015; Gunasekara AS, 2004, ENV FATE PYRETHRINS; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Hurst V, 2014, J COMP PHYSIOL A, V200, P881, DOI 10.1007/s00359-014-0932-0; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Kadala A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112194; Katsuda Y, 2012, TOP CURR CHEM, V314, P1, DOI 10.1007/128_2011_252; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; LOMBET A, 1988, BRAIN RES, V459, P44, DOI 10.1016/0006-8993(88)90284-3; Maze IS, 2006, J INSECT PHYSIOL, V52, P1243, DOI 10.1016/j.jinsphys.2006.09.006; Medrzycki Piotr, 2003, Bulletin of Insectology, V56, P59; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; O'Reilly AO, 2014, PEST MANAG SCI, V70, P369, DOI 10.1002/ps.3561; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Retschnig G, 2014, J INVERTEBR PATHOL, V118, P18, DOI 10.1016/j.jip.2014.02.008; SHIRES SW, 1984, PESTIC SCI, V15, P543, DOI 10.1002/ps.2780150603; Su SK, 2007, J INSECT PHYSIOL, V53, P411, DOI 10.1016/j.jinsphys.2007.01.002; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Williamson SM, 2014, ECOTOXICOLOGY, V23, P1409, DOI 10.1007/s10646-014-1283-x; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Winston, 1987, BIOL HONEYBEE; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Zhou T, 2011, PESTIC BIOCHEM PHYS, V100, P35, DOI 10.1016/j.pestbp.2011.02.001	48	21	23	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0133733	10.1371/journal.pone.0133733	http://dx.doi.org/10.1371/journal.pone.0133733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280999	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000359664300001
J	Dansereau, E; Gakidou, E; Ng, M; Achan, J; Burstein, R; DeCenso, B; Gasasira, A; Ikilezi, G; Kisia, C; Masters, SH; Njuguna, P; Odeny, TA; Okiro, EA; Roberts, DA; Duber, HC				Dansereau, Emily; Gakidou, Emmanuela; Ng, Marie; Achan, Jane; Burstein, Roy; DeCenso, Brendan; Gasasira, Anne; Ikilezi, Gloria; Kisia, Caroline; Masters, Samuel H.; Njuguna, Pamela; Odeny, Thomas A.; Okiro, Emelda A.; Roberts, D. Allen; Duber, Herbert C.			Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda	PLOS ONE			English	Article							RESOURCE-CONSTRAINED SETTINGS; HIV-1 DRUG-RESISTANCE; AFRICA; MORTALITY; FAILURE; CHALLENGES; COUNTRIES	Introduction Patients receiving antiretroviral therapy (ART) require routine monitoring to track response to treatment and assess for treatment failure. This study aims to identify gaps in monitoring practices in Kenya and Uganda. Methods We conducted a systematic retrospective chart review of adults who initiated ART between 2007 and 2012. We assessed the availability of baseline measurements (CD4 count, weight, and WHO stage) and ongoing CD4 and weight monitoring according to national guidelines in place at the time. Mixed-effects logistic regression models were used to analyze facility and patient factors associated with meeting monitoring guidelines. Results From 2007 to 2012, at least 88% of patients per year in Uganda had a recorded weight at initiation, while in Kenya there was a notable increase from 69% to 90%. Patients with a documented baseline CD4 count increased from 69% to about 80% in both countries. In 2012, 83% and 86% of established patients received the recommended quarterly weight monitoring in Kenya and Uganda, respectively, while semiannual CD4 monitoring was less common (49% in Kenya and 38% in Uganda). Initiating at a more advanced WHO stage was associated with a lower odds of baseline CD4 testing. On-site CD4 analysis capacity was associated with increased odds of CD4 testing at baseline and in the future. Discussion Substantial gaps were noted in ongoing CD4 monitoring of patients on ART. Although guidelines have since changed, limited laboratory capacity is likely to remain a significant issue in monitoring patients on ART, with important implications for ensuring quality care.	[Dansereau, Emily; Gakidou, Emmanuela; Ng, Marie; Burstein, Roy; Ikilezi, Gloria; Roberts, D. Allen; Duber, Herbert C.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Achan, Jane] Makerere Univ, Dept Pediat & Child Hlth, Kampala, Uganda; [DeCenso, Brendan] RTI Int, Res Triangle Pk, NC USA; [Gasasira, Anne] African Leaders Malaria Alliance, Kampala, Uganda; [Kisia, Caroline] Action Africa Hlth Int, Nairobi, Kenya; [Masters, Samuel H.] Univ N Carolina, Chapel Hill, NC USA; [Njuguna, Pamela] IFC World Bank Grp, Nairobi, Kenya; [Odeny, Thomas A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Okiro, Emelda A.] Bill & Melinda Gates Fdn, Seattle, WA USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Makerere University; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; The World Bank; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation	Duber, HC (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	hduber@uw.edu		Roberts, Allen/0000-0003-3660-6330; Masters, Samuel/0000-0001-7581-8219; Duber, Herbert/0000-0002-5077-3170; Okiro, Emelda/0000-0001-9543-8360	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this work was provided by the Bill & Melinda Gates Foundation. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors is currently employed as a consultant by a commercial entity (PN), but was employed by Action Africa Help International-Kenya at the time of the study. No commercial entities had any role in any component of this study or its funding.	Belec L, 2011, FUTURE MICROBIOL, V6, P1251, DOI [10.2217/fmb.11.121, 10.2217/FMB.11.121]; Buscher A, 2013, AIDS PATIENT CARE ST, V27, P459, DOI 10.1089/apc.2013.0105; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; [Government of Kenya Ministry of Health], 2011, GUIDELINES FOR ANTIR; [Government of Kenya Ministry of Health], 2005, GUIDELINES FOR ANTIR; Hamers RL, 2013, CURR OPIN HIV AIDS, V8, P19, DOI 10.1097/COH.0b013e32835b7f94; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Institute for Health Metrics and Evaluation (IHME), 2014, EALTH SERVICE PROVIS; Institute for Health Metrics and Evaluation (IHME), 2015, ACCESS BOTTLENECKS C; Institute for Health Metrics and Evaluation (IHME), 2014, HEALTH SERVICE PROVI; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Lynen L, 2010, CURR OPIN HIV AIDS, V5, P1, DOI 10.1097/COH.0b013e3283333762; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Ministry of health, 2008, NATIONAL ANTIRETROVI; Mugyenyi P, 2009, IMPACT OF ROUTINE LA; [National AIDS and STI Control Program (NASCOP) Kenya Ministry of Health (MOH)], 2014, GUIDELINES ON USE OF; National AIDS Control Council, 2014, KENYA AIDS RESPONSE; Olmsted SS, 2010, AM J CLIN PATHOL, V134, P374, DOI 10.1309/AJCPDQOSB7QR5GLR; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Riolexus AA, 2014, VIRAL LOAD MONITORIN; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shafiee H, 2015, ANNU REV MED, V66, P387, DOI 10.1146/annurev-med-092112-143017; Siapka M, 2014, B WORLD HEALTH ORGAN, V92, P499, DOI 10.2471/BLT.13.127639; Siedner MJ, 2013, AIDS, V27, P1503, DOI 10.1097/QAD.0b013e32835fd873; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Uganda AIDS Commission, 2014, HIV AND AIDS UGANDA; Uganda Ministry of Health (MOH), 2013, ADDENDUM TO THE NATI; UNAIDS, ACCESS TO ANTIRETROV; UNAIDS and MSF, 2012, STRAT TOOLS POL GET, P1; WHO, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2013, GLOBAL UPDATE ON HIV; World Health Organization, ANTIRETROVIRAL THERA; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Yiannoutsos CT, 2012, SEX TRANSM INFECT, V88, pI33, DOI 10.1136/sextrans-2012-050658	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135653	10.1371/journal.pone.0135653	http://dx.doi.org/10.1371/journal.pone.0135653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275151	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600089
J	Petkari, E; Pietschnig, J				Petkari, Eleni; Pietschnig, Jakob			Associations of Quality of Life with Service Satisfaction in Psychotic Patients: A Meta-Analysis	PLOS ONE			English	Article							MENTAL-HEALTH-CARE; MEASURING EXPECTATIONS; 1ST-EPISODE PSYCHOSIS; PSYCHIATRIC-SERVICES; PATIENTS VIEWS; SCHIZOPHRENIA; DETERMINANTS; OUTPATIENTS; INSIGHT; ILLNESS	Background Quality of life (QoL) has gained increasing attention as a desired outcome of psychosocial treatments targeting psychotic patients. Yet, the relationship between the patients' satisfaction with services and QoL has not been clearly established, perhaps due to the multidimensionality of the QoL concept and the variability in its assessment. Aim This is the first systematic meta-analysis of all available evidence assessing the relationship between QoL and service satisfaction. Methods: In all, 19 studies reporting data of 21 independent samples (N = 5,337) were included in the present meta-analysis. In moderator analyses, effects of age, sex, diagnoses (schizophrenia vs. other psychoses), treatment context (inpatients vs. outpatients), study design (cross-sectional vs. longitudinal), and QoL domain (subjective vs. health-related) were examined. Results Analyses revealed a highly significant medium-sized effect (r = .30, p < .001) for the associations of QoL and service satisfaction. Effect sizes were significantly stronger for subjective than health-related quality of life (r = .35 vs. r = .14, respectively). Moreover, associations with subjective QoL remained largely robust when accounting for moderating variables, although there was a trend of stronger associations for outpatients compared to inpatients. In contrast, effect sizes for health-related QoL were small and only observable for samples with longitudinal designs. Conclusion Associations between QoL and service satisfaction appear to be robust but are differentiated in regard to QoL domain. Our findings suggest that agents responsible for service design and implementation need to take the patients' perception of the service adequacy for achieving QoL enhancement into account.	[Petkari, Eleni; Pietschnig, Jakob] Middlesex Univ Dubai, Dept Psychol, Dubai, U Arab Emirates; [Pietschnig, Jakob] Univ Vienna, Fac Psychol, Dept Appl Psychol Hlth Dev Enhancement & Interven, Vienna, Austria	Middlesex University; University of Vienna	Pietschnig, J (corresponding author), Middlesex Univ Dubai, Dept Psychol, Dubai, U Arab Emirates.	jakob.pietschnig@univie.ac.at	Pietschnig, Jakob/AAE-8913-2020; Petkari, Eleni/X-5885-2018; Petkari, Eleni/ACB-5242-2022	Pietschnig, Jakob/0000-0003-0222-9557; Petkari, Eleni/0000-0002-9261-6253; Petkari, Eleni/0000-0002-9261-6253	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna.	Adelufosi AO, 2013, PSYCHIAT RES, V209, P320, DOI 10.1016/j.psychres.2012.12.027; Anderson RL, 2000, J CLIN PSYCHOL, V56, P575, DOI 10.1002/(SICI)1097-4679(200004)56:4<575::AID-JCLP11>3.0.CO;2-S; Atkinson MJ, 1997, J AFFECT DISORDERS, V44, P169, DOI 10.1016/S0165-0327(97)00041-4; Baker F, 1982, Eval Program Plann, V5, P69, DOI 10.1016/0149-7189(82)90059-3; Barker DA, 1996, BRIT J PSYCHIAT, V168, P641, DOI 10.1192/bjp.168.5.641; Becker BJ, 2007, STAT SCI, V22, P414, DOI 10.1214/07-STS243; Berghofer G, 2001, PSYCHIATR SERV, V52, P104, DOI 10.1176/appi.ps.52.1.104; Berghofer G, 2011, COMMUNITY MENT HLT J, V47, P399, DOI 10.1007/s10597-010-9331-3; Blenkiron P, 2003, POSTGRAD MED J, V79, P337, DOI 10.1136/pmj.79.932.337; Boydell J, 2012, INT J SOC PSYCHIATR, V58, P98, DOI 10.1177/0020764010382691; Boyer L, 2012, PROG NEURO-PSYCHOPH, V36, P271, DOI 10.1016/j.pnpbp.2011.10.008; Boyer L, 2013, BRIT J PSYCHIAT, V202, P447, DOI 10.1192/bjp.bp.112.123463; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Haan L, 2002, SCHIZOPHRENIA BULL, V28, P431, DOI 10.1093/oxfordjournals.schbul.a006951; Drake RE, 2012, J DISABIL POLICY STU, V23, P110, DOI 10.1177/1044207311427403; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Eack SM, 2007, SCHIZOPHRENIA BULL, V33, P1225, DOI 10.1093/schbul/sbl071; Eklund M, 2005, QUAL LIFE RES, V14, P1157, DOI 10.1007/s11136-004-2960-7; Eklund M, 2001, NORD J PSYCHIAT, V55, P413, DOI 10.1080/08039480152693318; Evans Sherrill, 2007, P333, DOI 10.1007/978-1-4020-5779-3_18; Farriols N, 2006, Clínica y Salud, V17, P171; Gillispie R, 2005, AM J ORTHOPSYCHIAT, V75, P254, DOI 10.1037/0002-9432.75.2.254; Greenley JR, 1997, SOC WORK, V42, P244, DOI 10.1093/sw/42.3.244; Haas BK, 1999, WESTERN J NURS RES, V21, P728, DOI 10.1177/01939459922044153; Hansson L, 2007, ACTA PSYCHIAT SCAND, V116, P113, DOI 10.1111/j.1600-0447.2007.01005.x; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Holloway F, 2002, INT REV PSYCHIATR, V14, P175, DOI 10.1080/09540260220145000; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Karow A, 2008, EUR ARCH PSY CLIN N, V258, P152, DOI 10.1007/s00406-007-0768-5; Katschnig H, 2006, WORLD PSYCHIATRY, V5, P139; Lanfredi M, 2014, PSYCHIAT RES, V216, P185, DOI 10.1016/j.psychres.2014.01.045; Lehman AF, 1996, SOC PSYCH PSYCH EPID, V31, P78, DOI 10.1007/BF00801903; LEHMAN AF, 1993, QUAL LIFE RES, V2, P327, DOI 10.1007/BF00449427; Malla A, 2005, SCHIZOPHRENIA BULL, V31, P650, DOI 10.1093/schbul/sbi031; Malla AK, 2004, ACTA PSYCHIAT SCAND, V109, P46, DOI 10.1046/j.0001-690X.2003.00221.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nasrallah HA, 2005, PSYCHIAT SERV, V56, P273, DOI 10.1176/appi.ps.56.3.273; National Maritime Research Institute (NMRI), 2015, TOKYO 2015 WORKSHOP; Offer A, 1996, PURSUIT QUALITY LIFE, P256; Oliver JPJ, 1997, SOC PSYCH PSYCH EPID, V32, P76, DOI 10.1007/BF00788924; Patrick DL, 2000, MED CARE, V38, P14; Petkari E, 2010, THESIS U GRANADA SPA; Pigott TD, 2009, THE HANDBOOK OF RESE, P300; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; PRIEBE S, 1995, SCHIZOPHRENIA BULL, V21, P87, DOI 10.1093/schbul/21.1.87; Priebe S, 1998, J NERV MENT DIS, V186, P385, DOI 10.1097/00005053-199807000-00001; PRIEBE S, 1995, PSYCHIAT PRAX, V22, P140; Priebe S, 2002, SOC PSYCH PSYCH EPID, V37, P387, DOI 10.1007/s00127-002-0568-1; Priebe S, 2007, BRIT J PSYCHIAT, V191, P420, DOI 10.1192/bjp.bp.107.036939; Priebe S, 2011, EUR ARCH PSY CLIN N, V261, P377, DOI 10.1007/s00406-010-0179-x; Prigent A, 2014, PSYCHIAT RES, V215, P1, DOI 10.1016/j.psychres.2013.10.023; Prot K, 2011, PSYCHIATR POL, V45, P799; R Development Core Team, 2014, R LANG ENV STAT COMP; Reininghaus U, 2011, PSYCHOL MED, V41, P277, DOI 10.1017/S0033291710000784; Ritsner M, 2003, J CLIN PSYCHIAT, V64, P308, DOI 10.4088/JCP.v64n0313; Ritsner M, 2006, QUAL LIFE RES, V15, P515, DOI 10.1007/s11136-005-2808-9; Ritsner M, 2003, J NERV MENT DIS, V191, P287, DOI 10.1097/00005053-200305000-00003; Rohland BM, 2000, PSYCHIAT SERV, V51, P248, DOI 10.1176/appi.ps.51.2.248; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Ruggeri M, 1998, PSYCHOL MED, V28, P1421, DOI 10.1017/S0033291798007466; RUGGERI M, 1993, PSYCHOL MED, V23, P511, DOI 10.1017/S0033291700028609; Ruggeri M, 2005, BRIT J PSYCHIAT, V187, P121, DOI 10.1192/bjp.187.2.121; Ruggeri M, 2004, SOC PSYCH PSYCH EPID, V39, P60, DOI 10.1007/s00127-004-0705-0; Ruggeri M, 2003, SCHIZOPHRENIA BULL, V29, P229, DOI 10.1093/oxfordjournals.schbul.a007000; RUGGERI M, 1994, SOC PSYCH PSYCH EPID, V29, P265, DOI 10.1007/BF00802049; Ruggeri M, 2002, CURR OPIN PSYCHIATR, V15, P193, DOI 10.1097/00001504-200203000-00012; Ruggeri M, 2002, ACTA PSYCHIAT SCAND, V105, P131, DOI 10.1034/j.1600-0447.2002.01293.x; SARTORIUS N, 1993, QUALITY OF LIFE ASSESSMENT : KEY ISSUES IN THE 1990S, P201; Schmid R, 2006, PSYCHIAT PRAX, V33, P337, DOI 10.1055/s-2006-940120; Schmidt K, 2004, INT J SOC PSYCHIATR, V50, P262, DOI 10.1177/0020764004043140; Slade M, 2005, BRIT J PSYCHIAT, V187, P256, DOI 10.1192/bjp.187.3.256; Smith D, 2014, J MENT HEALTH, V23, P38, DOI 10.3109/09638237.2013.841864; Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P99; Tansella M, 2003, COPENHAGEN; Thornicroft G, 2004, SCHIZOPHR RES, V69, P125, DOI 10.1016/S0920-9964(03)00191-9; Tierney KR, 2011, ARCH PSYCHIAT NURS, V25, P77, DOI 10.1016/j.apnu.2010.07.006; van Baars AWB, 2013, COMPR PSYCHIAT, V54, P873, DOI 10.1016/j.comppsych.2013.03.016; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wiersma D, 2001, EUR ARCH PSY CLIN N, V251, P239, DOI 10.1007/s004060170033; Yen CF, 2008, BIPOLAR DISORD, V10, P617, DOI 10.1111/j.1399-5618.2007.00577.x; Zahid MA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-294; Zendjidjian XY, 2014, PATIENT PREFER ADHER, V8, P575, DOI 10.2147/PPA.S62278	83	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135267	10.1371/journal.pone.0135267	http://dx.doi.org/10.1371/journal.pone.0135267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275139	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600059
J	Rasubala, L; Pernapati, L; Velasquez, X; Burk, J; Ren, YF				Rasubala, Linda; Pernapati, Lavanya; Velasquez, Ximena; Burk, James; Ren, Yan-Fang			Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists	PLOS ONE			English	Article							DENTAL PAIN; ACETAMINOPHEN; ABUSE	Prescription Drug Monitoring Programs (PDMP) are statewide databases that collect data on prescription of controlled substances. New York State mandates prescribers to consult the PDMP registry before prescribing a controlled substance such as opioid analgesics. The effect of mandatory PDMP on opioid drug prescriptions by dentists is not known. This study investigates the impact of mandatory PDMP on frequency and quantity of opioid prescriptions by dentists in a dental urgent care center. Based on the sample size estimate, we collected patient records of a 3-month period before and two consecutive 3-month periods after the mandatory PDMP implementation and analyzed the data on number of visits, treatment types and drug prescriptions using Chi-square tests. For patients who were prescribed pain medications, 452 (30.6%), 190 (14.1%), and 140 (9.6%) received opioid analgesics in the three study periods respectively, signifying a statistically significant reduction in the number of opioid prescriptions after implementation of the mandatory PDMP (p<0.05). Total numbers of prescribed opioid pills in a 3-month period decreased from 5096 to 1120, signifying a 78% reduction in absolute quantity. Prescriptions for non-opioid analgesics acetaminophen increased during the same periods (p<0.05). We conclude that the mandatory PDMP significantly affected the prescription pattern for pain medications by dentists. Such change in prescription pattern represents a shift towards the evidence-based prescription practices for acute postoperative pain.	[Rasubala, Linda; Pernapati, Lavanya; Velasquez, Ximena; Burk, James; Ren, Yan-Fang] Univ Rochester, Eastman Inst Oral Hlth, Dept Gen Dent, Rochester, NY 14620 USA	University of Rochester	Ren, YF (corresponding author), Univ Rochester, Eastman Inst Oral Hlth, Dept Gen Dent, 625 Elmwood Ave, Rochester, NY 14620 USA.	yanfang_ren@urmc.rochester.edu	Ren, Yan-Fang/N-9369-2019	Ren, Yan-Fang/0000-0001-6428-2252				Becker Daniel E, 2010, Anesth Prog, V57, P67, DOI 10.2344/0003-3006-57.2.67; Brushwood DB, 2003, J LAW MED ETHICS, V31, P41, DOI 10.1111/j.1748-720X.2003.tb00058.x; Denisco RC, 2011, J AM DENT ASSOC, V142, P800, DOI 10.14219/jada.archive.2011.0268; Derry C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001548.pub2; Derry CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010210.pub2; Fox TR, 2013, ANN EMERG MED, V62, P237, DOI 10.1016/j.annemergmed.2012.11.020; FRICKE J, 1993, CLIN THER, V15, P500; Gaskell H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002763.pub2; Goodin A, 2012, PAIN PHYSICIAN, V15, pES169; Haffajee RL, 2015, JAMA-J AM MED ASSOC, V313, P891, DOI 10.1001/jama.2014.18514; Hersh Elliot V, 2011, Compend Contin Educ Dent, V32, P24; Hersh EV, 2011, COMPENDIUM CONTINUIN, V32, P1; Hersh EV, 2011, COMPENDIUM CONTINUIN, V32, P4; Hildebran C, 2014, PAIN MED, V15, P1179, DOI 10.1111/pme.12469; Irvine JM, 2014, J PAIN, V15, P747, DOI 10.1016/j.jpain.2014.04.003; Jeske Arthur H, 2005, Tex Dent J, V122, P622; Johnson D, 2008, EUR J PROSTHODONT RE, V16, P181; Litkowski LJ, 2005, CLIN THER, V27, P418, DOI 10.1016/j.clinthera.2005.04.010; Ma M, 2004, ANN EMERG MED, V44, P323, DOI 10.1016/j.annemergmed.2004.04.016; McCabe SE, 2013, PAIN, V154, P708, DOI 10.1016/j.pain.2013.01.011; Moore Paul A, 2006, Gen Dent, V54, P201; Moore PA, 2013, J AM DENT ASSOC, V144, P898, DOI 10.14219/jada.archive.2013.0207; Mutlu I, 2013, J ORAL MAXIL SURG, V71, P1500, DOI 10.1016/j.joms.2013.04.031; National Institute on Drug Abuse, 2011, TOP BRIEF PRESCR DRU; New York State Department of Health, 2015, I STOP PMP INT SYST; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Prescription Drug Monitoring Program Center of Excellence at Brandeis, 2014, MAND PDMP PART MED P; Reece AS, 2007, AUST DENT J, V52, P144, DOI 10.1111/j.1834-7819.2007.tb00480.x; Reifler LM, 2012, PAIN MED, V13, P434, DOI 10.1111/j.1526-4637.2012.01327.x; Richards D, 2004, EVID BASED DENT, V5, P22, DOI DOI 10.1038/SJ.EBD.6400237; Toms L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004602.pub2; Toms L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001547.pub2; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369; Weiner SG, 2013, ANN EMERG MED, V62, P281, DOI 10.1016/j.annemergmed.2013.05.025	34	76	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135957	10.1371/journal.pone.0135957	http://dx.doi.org/10.1371/journal.pone.0135957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274819	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600136
J	Zeynalov, E; Jones, SM; Seo, JW; Snell, LD; Elliott, JP				Zeynalov, Emil; Jones, Susan M.; Seo, Jeong-Woo; Snell, Lawrence D.; Elliott, J. Paul			Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice	PLOS ONE			English	Article							V-1 RECEPTOR; ANTIDIURETIC-HORMONE; INAPPROPRIATE SECRETION; AQP4 EXPRESSION; ANTAGONIST; HYPONATREMIA; SR49059; OSMOTHERAPY; DAMAGE	Background Stroke is a major cause of morbidity and mortality. Stroke is complicated by brain edema and blood-brain barrier (BBB) disruption, and is often accompanied by increased release of arginine-vasopressin (AVP). AVP acts through V1a and V2 receptors to trigger hyponatremia, vasospasm, and platelet aggregation which can exacerbate brain edema. The AVP receptor blockers conivaptan (V1a and V2) and tolvaptan (V2) are used to correct hyponatremia, but their effect on post-ischemic brain edema and BBB disruption remains to be elucidated. Therefore, we conducted this study to investigate if these drugs can prevent brain edema and BBB disruption in mice after stroke. Methods Experimental mice underwent the filament model of middle cerebral artery occlusion (MCAO) with reperfusion. Mice were treated with conivaptan, tolvaptan, or vehicle. Treatments were initiated immediately at reperfusion and administered IV (conivaptan) or orally (tolvaptan) for 48 hours. Physiological variables, neurological deficit scores (NDS), plasma and urine sodium and osmolality were recorded. Brain water content (BWC) and Evans Blue (EB) extravasation index were evaluated at the end point. Results Both conivaptan and tolvaptan produced aquaresis as indicated by changes in plasma and urine sodium levels. However plasma and urine osmolality was changed only by conivaptan. Unlike tolvaptan, conivaptan improved NDS and reduced BWC in the ipsilateral hemisphere: from 81.66 +/- 0.43% (vehicle) to 78.28 +/- 0.48% (conivaptan, 0.2 mg, p < 0.05 vs vehicle). Conivaptan also attenuated the EB extravasation from 1.22 +/- 0.08 (vehicle) to 1.01 +/- 0.02 (conivaptan, 0.2 mg, p < 0.05). Conclusion Continuous IV infusion with conivaptan for 48 hours after experimental stroke reduces brain edema, and BBB disruption. Conivaptan but not tolvaptan may potentially be used in patients to prevent brain edema after stroke.	[Zeynalov, Emil; Jones, Susan M.; Seo, Jeong-Woo] Swedish Med Ctr, Neurotrauma Res, Englewood, CO 80110 USA; [Snell, Lawrence D.] Colorado Neurol Inst, Englewood, CO USA; [Elliott, J. Paul] Colorado Brain & Spine Inst, Englewood, CO USA		Zeynalov, E (corresponding author), Swedish Med Ctr, Neurotrauma Res, Englewood, CO 80110 USA.	emil.zeynalov@healthonecares.com		Jones, Susan/0000-0002-9801-1239	Swedish Medical Center Research Grant	Swedish Medical Center Research Grant	This work was supported by the Swedish Medical Center Research Grant, awarded to Dr. J. Paul Elliott to lead a stroke research program. The Swedish Medical Center provided facilities and budget management of the relevant research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Drugs R D, V5, P94; [Anonymous], 2006, MED LETT DRUGS THER, V48, P51; Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Baylis PH, 2003, INT J BIOCHEM CELL B, V35, P1495, DOI 10.1016/S1357-2725(03)00139-0; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Bhardwaj A, 2006, ANN NEUROL, V59, P229, DOI 10.1002/ana.20788; Chen CH, 2007, NEUROCRIT CARE, V7, P92, DOI 10.1007/s12028-007-0033-9; Coussement J, 2012, AM J NEPHROL, V35, P265, DOI 10.1159/000336716; D'Auria D, 2012, TRANSL MED UNISA, V3, P1; Dhar R, 2011, NEUROCRIT CARE, V14, P97, DOI 10.1007/s12028-010-9366-x; Galton C, 2011, NEUROCRIT CARE, V14, P354, DOI 10.1007/s12028-011-9525-8; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Ghali JK, 2008, CARDIOLOGY, V111, P147, DOI 10.1159/000121596; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldsmith SR, 2008, J CARD FAIL, V14, P641, DOI 10.1016/j.cardfail.2008.06.003; Hedna VS, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0213-0; Hockel K, 2012, STROKE, V43, P227, DOI 10.1161/STROKEAHA.111.626168; Hoggatt AF, 2010, J AM ASSOC LAB ANIM, V49, P329; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Laczi Ferenc, 2008, Orvosi Hetilap, V149, P1347, DOI 10.1556/OH.2008.28409; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P191, DOI 10.1007/978-3-7091-0693-8_32; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Nase G, 2008, GLIA, V56, P895, DOI 10.1002/glia.20664; O'Donnell ME, 2005, AM J PHYSIOL-CELL PH, V289, pC283, DOI 10.1152/ajpcell.00001.2005; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Thibonnier M, 2001, ANNU REV PHARMACOL, V41, P175, DOI 10.1146/annurev.pharmtox.41.1.175; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Vantyghem MC, 2011, ANN ENDOCRINOL-PARIS, V72, P500, DOI 10.1016/j.ando.2011.10.001; Velez JCQ, 2010, NEPHROL DIAL TRANSPL, V25, P1524, DOI 10.1093/ndt/gfp731; Villabona Carles, 2010, Endocrinol Nutr, V57 Suppl 2, P41, DOI 10.1016/S1575-0922(10)70021-8; Weber R, 1997, HYPERTENSION, V30, P1121, DOI 10.1161/01.HYP.30.5.1121; Westermaier Thomas, 2012, Exp Transl Stroke Med, V4, P8, DOI 10.1186/2040-7378-4-8; Wun T, 1996, BRIT J HAEMATOL, V92, P968, DOI 10.1046/j.1365-2141.1996.436975.x; Xing Chi Hong, 2005, Hiroshima Journal of Medical Sciences, V54, P93; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853; Zeynalov E, 2014, CRIT CARE MED, V42	40	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0136121	10.1371/journal.pone.0136121	http://dx.doi.org/10.1371/journal.pone.0136121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275173	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600149
J	Beck, B; Cardini, F; Ladavas, E; Bertini, C				Beck, Brianna; Cardini, Flavia; Ladavas, Elisabetta; Bertini, Caterina			The Enfacement Illusion Is Not Affected by Negative Facial Expressions	PLOS ONE			English	Article							SELF-FACE RECOGNITION; NEURAL REPRESENTATIONS; TACTILE PERCEPTION; EMOTIONAL EMPATHY; OWN FACE; IDENTITY; ADAPTATION; IDENTIFICATION; PROSOPAGNOSIA; CORTICES	Enfacement is an illusion wherein synchronous visual and tactile inputs update the mental representation of one's own face to assimilate another person's face. Emotional facial expressions, serving as communicative signals, may influence enfacement by increasing the observer's motivation to understand the mental state of the expresser. Fearful expressions, in particular, might increase enfacement because they are valuable for adaptive behavior and more strongly represented in somatosensory cortex than other emotions. In the present study, a face was seen being touched at the same time as the participant's own face. This face was either neutral, fearful, or angry. Anger was chosen as an emotional control condition for fear because it is similarly negative but induces less somatosensory resonance, and requires additional knowledge (i.e., contextual information and social contingencies) to effectively guide behavior. We hypothesized that seeing a fearful face (but not an angry one) would increase enfacement because of greater somatosensory resonance. Surprisingly, neither fearful nor angry expressions modulated the degree of enfacement relative to neutral expressions. Synchronous interpersonal visuo-tactile stimulation led to assimilation of the other's face, but this assimilation was not modulated by facial expression processing. This finding suggests that dynamic, multisensory processes of self-face identification operate independently of facial expression processing.	[Beck, Brianna; Cardini, Flavia; Ladavas, Elisabetta; Bertini, Caterina] Univ Bologna, Ctr Studi & Ric Neurosci Cognit CNC, Cesena, Italy; [Beck, Brianna; Cardini, Flavia; Ladavas, Elisabetta; Bertini, Caterina] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna; University of Bologna	Beck, B (corresponding author), UCL, Inst Cognit Neurosci, London, England.	brianna.beck@ucl.ac.uk		Beck, Brianna/0000-0002-6784-6583; Cardini, Flavia/0000-0003-4301-611X	Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN)	Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was supported by grants from the Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN) to EL (http://prin.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1996, J NEUROSCI, V16, P7678; Apps MAJ, 2014, NEUROSCI BIOBEHAV R, V41, P85, DOI 10.1016/j.neubiorev.2013.01.029; Baudouin JY, 2000, MEMORY, V8, P285, DOI 10.1080/09658210050117717; Bobes MA, 2000, COGNITIVE BRAIN RES, V9, P249, DOI 10.1016/S0926-6410(00)00003-3; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bufalari I, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00102; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Cardini F, 2012, EMOTION, V12, P980, DOI 10.1037/a0027351; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; DAVIS MH, 1987, J PERS SOC PSYCHOL, V52, P126, DOI 10.1037/0022-3514.52.1.126; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Ellamil M, 2008, COGN AFFECT BEHAV NE, V8, P273, DOI 10.3758/CABN.8.3.273; Endo N., 1992, TOHOKU PSYCHOL FOLIA, V51, P37; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; Fini C, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00165; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Fox CJ, 2008, J VISION, V8, DOI 10.1167/8.3.11; Gallegos DR, 2005, BRAIN LANG, V93, P338, DOI 10.1016/j.bandl.2004.11.001; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Humphreys K, 2007, EXP BRAIN RES, V176, P356, DOI 10.1007/s00221-006-0621-5; Keenan J. P., 2003, FACE MIRROR SEARCH O; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Kottoor TM., 1989, PSYCHOL STUD, V34, P102; Maister L, 2013, EMOTION, V13, P7, DOI 10.1037/a0030884; Maselli A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00083; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Pichon S, 2009, NEUROIMAGE, V47, P1873, DOI 10.1016/j.neuroimage.2009.03.084; Pourtois G, 2004, EUR J NEUROSCI, V20, P3507, DOI 10.1111/j.1460-9568.2004.03794.x; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; SANSONE S, 1994, PSYCHOL FR, V39, P327; Schubert TW, 2002, SELF IDENTITY, V1, P353, DOI 10.1080/152988602760328012; Schweinberger SR, 1998, J EXP PSYCHOL HUMAN, V24, P1748, DOI 10.1037/0096-1523.24.6.1748; SERGENT J, 1989, BRAIN, V112, P975, DOI 10.1093/brain/112.4.975; Sergent J., 1994, VIS COGN, V1, P349, DOI [10.1080/13506289408402305, DOI 10.1080/13506289408402305]; Serino A, 2008, PSYCHOL SCI, V19, P434, DOI 10.1111/j.1467-9280.2008.02105.x; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Spangler SM, 2010, J EXP CHILD PSYCHOL, V105, P1, DOI 10.1016/j.jecp.2009.09.003; Sui J, 2007, PSYCHOL SCI, V18, P861, DOI 10.1111/j.1467-9280.2007.01992.x; Tajadura-Jimenez A, 2012, CONSCIOUS COGN, V21, P1725, DOI 10.1016/j.concog.2012.10.004; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Verosky SC, 2010, NEUROIMAGE, V49, P1690, DOI 10.1016/j.neuroimage.2009.10.017; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	51	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136273	10.1371/journal.pone.0136273	http://dx.doi.org/10.1371/journal.pone.0136273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291532	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900072
J	Chakraborty, D; Wang, TL; Andre, K; Konnert, M; Lexer, MJ; Matulla, C; Schueler, S				Chakraborty, Debojyoti; Wang, Tongli; Andre, Konrad; Konnert, Monika; Lexer, Manfred J.; Matulla, Christoph; Schueler, Silvio			Selecting Populations for Non-Analogous Climate Conditions Using Universal Response Functions: The Case of Douglas-Fir in Central Europe	PLOS ONE			English	Article							FOREST TREES; INTRASPECIFIC VARIATION; ASSISTED MIGRATION; GROWTH-RESPONSE; SEED ZONES; ADAPTATION; DROUGHT; SPRUCE; PINE; DISTRIBUTIONS	Identifying populations within tree species potentially adapted to future climatic conditions is an important requirement for reforestation and assisted migration programmes. Such populations can be identified either by empirical response functions based on correlations of quantitative traits with climate variables or by climate envelope models that compare the climate of seed sources and potential growing areas. In the present study, we analyzed the intraspecific variation in climate growth response of Douglas-fir planted within the non-analogous climate conditions of Central and continental Europe. With data from 50 common garden trials, we developed Universal Response Functions ( URF) for tree height and mean basal area and compared the growth performance of the selected best performing populations with that of populations identified through a climate envelope approach. Climate variables of the trial location were found to be stronger predictors of growth performance than climate variables of the population origin. Although the precipitation regime of the population sources varied strongly none of the precipitation related climate variables of population origin was found to be significant within the models. Overall, the URFs explained more than 88% of variation in growth performance. Populations identified by the URF models originate from western Cascades and coastal areas of Washington and Oregon and show significantly higher growth performance than populations identified by the climate envelope approach under both current and climate change scenarios. The URFs predict decreasing growth performance at low and middle elevations of the case study area, but increasing growth performance on high elevation sites. Our analysis suggests that population recommendations based on empirical approaches should be preferred and population selections by climate envelope models without considering climatic constrains of growth performance should be carefully appraised before transferring populations to planting locations with novel or dissimilar climate.	[Chakraborty, Debojyoti; Lexer, Manfred J.] Univ Nat Resources & Life Sci, Inst Silviculture, Dept Forest & Soil Sci, Vienna, Austria; [Wang, Tongli] Univ British Columbia, Dept Forest & Conservat Sci, Ctr Forest Conservat Genet, Vancouver, BC V5Z 1M9, Canada; [Andre, Konrad; Matulla, Christoph] Cent Inst Meteorol & Geodynam, Vienna, Austria; [Konnert, Monika] Bavarian Off Forest Seeding & Planting, Teisendorf, Germany; [Schueler, Silvio] Fed Res & Training Ctr Forest Nat Hazards & Lands, Dept Forest Genet, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of British Columbia	Schueler, S (corresponding author), Fed Res & Training Ctr Forest Nat Hazards & Lands, Dept Forest Genet, Vienna, Austria.	silvio.schueler@bfw.gv.at	Schueler, Silvio/V-2612-2019; Chakraborty, Debojyoti/GRI-9445-2022; Wang, Tongli/AAC-8644-2020; Wang, Tongli/AAW-4427-2020	Schueler, Silvio/0000-0003-0155-5692; Wang, Tongli/0000-0002-9967-6769; Chakraborty, Debojyoti/0000-0002-7128-2688	Austrian climate research programme ACRP [B175092]	Austrian climate research programme ACRP	Austrian climate research programme ACRP, 4th Call for Proposals, Project no. B175092 https://www.klimafonds.gv.at/foerderungen/aktuelle-foerderungen/2011/austrian-climate-research-program/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2011, TREE PHYSIOL, V31, P258, DOI 10.1093/treephys/tpr010; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Akaike H., 1974, IEEE T AUTOMATIC CON, P19; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andalo C, 2005, FOREST ECOL MANAG, V205, P169, DOI 10.1016/j.foreco.2004.10.045; Bansal S, 2015, GLOBAL CHANGE BIOL, V21, P947, DOI 10.1111/gcb.12719; Block K, 2013, J ADV MODEL EARTH SY, V5, P676, DOI 10.1002/jame.20041; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Buntgen U, 2010, CLIM DYNAM, V35, P315, DOI 10.1007/s00382-009-0563-2; Burnham KP, 2002, MODEL SELECTION MULT, P149, DOI [10.1007/978-0-387-22456-5_4, DOI 10.1007/978-0-387-22456-5_4]; Carter KK, 1996, CAN J FOREST RES, V26, P1089, DOI 10.1139/x26-120; Darychuk N, 2012, CAN J FOREST RES, V42, P1530, DOI [10.1139/X2012-092, 10.1139/x2012-092]; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eilmann B, 2013, FOREST ECOL MANAG, V302, P133, DOI 10.1016/j.foreco.2013.03.031; Hamann A, 2011, TREE GENET GENOMES, V7, P399, DOI 10.1007/s11295-010-0341-7; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Haslinger K, 2013, CLIM DYNAM, V40, P511, DOI 10.1007/s00382-012-1452-7; Hermann RK, 1999, NEW FOREST, V17, P53, DOI 10.1023/A:1006581028080; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Isaac-Renton MG, 2014, GLOBAL CHANGE BIOL, V20, P2607, DOI 10.1111/gcb.12604; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Kapeller S, 2012, FOREST ECOL MANAG, V271, P46, DOI 10.1016/j.foreco.2012.01.039; Kavanagh KL, 1999, TREE PHYSIOL, V19, P31; Konig A.O., 2005, CONSERVATION MANAGEM, P275; Kopp M, 2014, EVOL APPL, V7, P169, DOI 10.1111/eva.12127; Krakowski J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009069; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Leites LP, 2012, ECOL APPL, V22, P154, DOI 10.1890/11-0150.1; Lesser MR, 2006, CAN J FOREST RES, V36, P1572, DOI 10.1139/X06-047; Lindner M, 2014, J ENVIRON MANAGE, V146, P69, DOI 10.1016/j.jenvman.2014.07.030; Lumley T., 2009, LEAPS REGRESSION SUB; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Marris E., 2008, NATURE REPORTS, V2, P112, DOI DOI 10.1038/CLIMATE2008.86; Matyas C, 1996, EUPHYTICA, V92, P45, DOI 10.1007/BF00022827; MATYAS C, 1994, TREE PHYSIOL, V14, P797, DOI 10.1093/treephys/14.7-8-9.797; McKenney D, 2009, FOREST CHRON, V85, P258, DOI 10.5558/tfc85258-2; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; McLane SC, 2011, ECOL APPL, V21, P776, DOI 10.1890/10-0131.1; Midgley GF, 2001, PLANT PHYSL RESPONSE; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; O'Neill GA, 2008, J APPL ECOL, V45, P1040, DOI 10.1111/j.1365-2664.2008.01472.x; Ohlemuller R, 2006, GLOBAL ECOL BIOGEOGR, V15, P395, DOI 10.1111/j.1466-822X.2006.00245.x; Oney B, 2013, ECOL EVOL, V3, P437, DOI 10.1002/ece3.426; Petit RJ, 2008, SCIENCE, V320, P1450, DOI 10.1126/science.1155457; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P147, DOI 10.1016/j.foreco.2014.02.040; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P126, DOI 10.1016/j.foreco.2014.02.035; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Roberts DR, 2012, GLOBAL ECOL BIOGEOGR, V21, P121, DOI 10.1111/j.1466-8238.2011.00657.x; Sergent AS, 2014, ANN FOREST SCI, V71, P697, DOI 10.1007/s13595-012-0220-5; Sykes MT, 1996, J BIOGEOGR, V23, P203; Team RC, 2013, R LANGUAGE ENV STAT; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Wang T, 2006, GLOBAL CHANGE BIOL, V12, P2404, DOI 10.1111/j.1365-2486.2006.01271.x; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Yang J, 2015, FOREST ECOL MANAG, V339, P34, DOI 10.1016/j.foreco.2014.12.001; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	61	38	39	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136357	10.1371/journal.pone.0136357	http://dx.doi.org/10.1371/journal.pone.0136357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288363	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600134
J	Freire-Maia, FB; Auad, SM; de Abreu, MHNG; Sardenberg, F; Martins, MT; Paiva, SM; Pordeus, IA; Vale, MP				Freire-Maia, Fernanda Bartolomeo; Auad, Sheyla Marcia; Nogueira Guimaraes de Abreu, Mauro Henrique; Sardenberg, Fernanda; Martins, Milene Torres; Paiva, Saul Martins; Pordeus, Isabela Almeida; Vale, Miriam Pimenta			Oral Health-Related Quality of Life and Traumatic Dental Injuries in Young Permanent Incisors in Brazilian Schoolchildren: A Multilevel Approach	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; DENTOALVEOLAR TRAUMA; SCHOOL-CHILDREN; SEX-DIFFERENCES; IMPACT; ADOLESCENTS; POPULATION; QUESTIONNAIRE; PERCEPTIONS; FAMILIES	Background Traumatic dental injury (TDI) during childhood may negatively impact the quality of life of children. Objective To describe the association of oral health-related quality of life (OHRQoL) and domains (oral symptons, functional limitation, emotional-and social-well-being) of children with individual and contextual variables. Methods A cross-sectional study was performed using a representative sample of 1,201 schoolchildren, 8-10 years-old, from public and private schools of Belo Horizonte, Brazil. The CPQ8-10 was used to assess OHRQoL, dichotomized in low and high impact. Sociodemographic information was collected through questionnaires to parents. Children were examined at schools, using the Andreasen criteria. Individual variables were gender, age, number of residents in home, parents/caregivers' level of education, family income, and TDI (dichotomized into without trauma/mild trauma and severe trauma). Dental caries and malocclusion were considered co-variables. Contextual variables were the Social Vulnerability Index and type of school. Ethical approval and consent forms were obtained. Data were analyzed using SPSS for Windows 19.0 and HLM 6.06, including frequency distribution, chi-squared test and multilevel approach (p < 0.05). Results The prevalence of a negative impact on OHRQoL in children with severe trauma was 55.9%. The TDI negatively impacted emotional and social domains of OHRQoL. A multilevel analysis revealed a significant difference in OHRQoL according to the type of school and showed that 16% of the total variance was due to contextual characteristics (p < 0.001; ICC = 0.16). The negative impact on OHRQoL was higher in girls (p = 0.009), younger children (p = 0.023), with severe TDI (p = 0.014), those from public schools (p = 0.017) and whose parents had a lower education level (p = 0.001). Conclusion Severe trauma impacts OHRQoL on emotional and social domains. Contextual dimensions add information to individual variability to explain higher impact, emphasizing socioeconomic inequalities.	[Freire-Maia, Fernanda Bartolomeo; Auad, Sheyla Marcia; Sardenberg, Fernanda; Martins, Milene Torres; Paiva, Saul Martins; Pordeus, Isabela Almeida; Vale, Miriam Pimenta] Univ Fed Minas Gerais, Dept Paediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [Nogueira Guimaraes de Abreu, Mauro Henrique] Univ Fed Minas Gerais, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Freire-Maia, FB (corresponding author), Univ Fed Minas Gerais, Dept Paediat Dent & Orthodont, Belo Horizonte, MG, Brazil.	fernandabartolomeo@gmail.com	PORDEUS, ISABELA A/B-1570-2013; Auad, Sheyla/T-7290-2019; Abreu, Mauro Henrique/G-6502-2012; Paiva, Saul Martins/H-5757-2012	PORDEUS, ISABELA A/0000-0002-5902-7481; Abreu, Mauro Henrique/0000-0001-8794-5725; Paiva, Saul Martins/0000-0002-3968-1638; Auad, Sheyla/0000-0002-4572-6425	National Council for Scientific and Technological Development (CNPq); Ministry of Science and Technology; State of Minas Gerais Research Foundation (FAPEMIG), Brazilian Coordination of Higher Education (CAPES), Brazil	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); State of Minas Gerais Research Foundation (FAPEMIG), Brazilian Coordination of Higher Education (CAPES), Brazil	This study was supported by the National Council for Scientific and Technological Development (CNPq), the Ministry of Science and Technology and the State of Minas Gerais Research Foundation (FAPEMIG), Brazilian Coordination of Higher Education (CAPES), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanto J, 2014, INT J PEDIA IN PRESS; Abanto J, 2014, COMMUNITY DENT ORAL, V42, P385, DOI 10.1111/cdoe.12099; Aldrigui JM, 2014, COMMUNITY DENT ORAL, V42, P30, DOI 10.1111/cdoe.12053; Antunes LAA, 2013, PEDIATR DENT, V35, P37; Antunes LAA, 2012, DENT TRAUMATOL, V28, P256, DOI 10.1111/j.1600-9657.2011.01094.x; Andreasen JO, 2007, TXB COLOR ATLAS TRAU, V4th; Bendo CB, 2014, INT J PAEDIATR DENT, V24, P387, DOI 10.1111/ipd.12083; Bendo CB, 2014, COMMUNITY DENT ORAL, V42, P216, DOI 10.1111/cdoe.12078; Bendo CB, 2012, INT J ENV RES PUB HE, V9, P4278, DOI 10.3390/ijerph9124278; Bendo CB, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-114; Berger TD, 2009, DENT TRAUMATOL, V25, P462, DOI 10.1111/j.1600-9657.2009.00809.x; Castro RDL, 2011, COMMUNITY DENT ORAL, V39, P336, DOI 10.1111/j.1600-0528.2010.00601.x; Cortes MID, 2002, COMMUNITY DENT ORAL, V30, P193; Dame-Teixeira N, 2013, INT J PAEDIATR DENT, V23, P266, DOI 10.1111/ipd.12002; de Paula JS, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-10; Fakhruddin KS, 2008, DENT TRAUMATOL, V24, P309, DOI 10.1111/j.1600-9657.2007.00547.x; Gose M, 2013, INT J ENV RES PUB HE, V10, P5083, DOI 10.3390/ijerph10105083; Guedes RS, 2014, QUAL LIFE RES, V23, P2521, DOI 10.1007/s11136-014-0690-z; Jokovic A, 2004, PEDIATR DENT, V26, P512; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kumar S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-41; Lisboa CM, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-56; Locker D, 2007, COMMUNITY DENT ORAL, V35, P348, DOI 10.1111/j.1600-0528.2006.00323.x; Malikaew Peerasak, 2003, Oral Health Prev Dent, V1, P255; Mansour ME, 2003, PEDIATRICS, V111, P1372, DOI 10.1542/peds.111.6.1372; Martins MT, 2009, EUR J PAEDIATR DENT, V10, P135; Martins MT, 2014, COMMUNITY DENT ORAL, V42, P289, DOI 10.1111/cdoe.12087; McGrath C, 2004, COMMUNITY DENT ORAL, V32, P81, DOI 10.1111/j.1600-0528.2004.00149.x; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Moyses ST, 2003, HEALTH PROMOT INT, V18, P209, DOI 10.1093/heapro/dag016; Nahas MI, 2000, CAD CIENC SOC, V7, P75; Page LAF, 2013, INT J PAEDIATR DENT, V23, P415, DOI 10.1111/ipd.12011; Pappa E, 2009, INT J PUBLIC HEALTH, V54, P241, DOI 10.1007/s00038-009-8057-x; Patel M C, 2012, J Indian Soc Pedod Prev Dent, V30, P151, DOI 10.4103/0970-4388.99992; Pattussi MP, 2006, AM J PUBLIC HEALTH, V96, P1462, DOI 10.2105/AJPH.2005.066159; Paula JS, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-6; Peres MA, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-20; Piovesan C, 2012, J PUBLIC HEALTH DENT, V72, P156, DOI 10.1111/j.1752-7325.2011.00301.x; Piovesan C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-37; Piovesan C, 2010, QUAL LIFE RES, V19, P1359, DOI 10.1007/s11136-010-9692-7; Porritt JM, 2011, DENT TRAUMATOL, V27, P2, DOI 10.1111/j.1600-9657.2010.00943.x; Ramos-Jorge J, 2014, DENT TRAUMATOL, V30, P27, DOI 10.1111/edt.12048; Ramos-Jorge ML, 2007, DENT TRAUMATOL, V23, P114, DOI 10.1111/j.1600-9657.2005.00409.x; Sardenberg F, 2013, ANGLE ORTHOD, V83, P83, DOI 10.2319/010912-20.1; Scarpelli AC, 2013, COMMUNITY DENT ORAL, V41, P336, DOI 10.1111/cdoe.12022; Schuch HS, 2014, INT J PEDIA IN PRESS; Sellstrom E, 2006, J EPIDEMIOL COMMUN H, V60, P149, DOI 10.1136/jech.2005.036707; Siqueira MB, 2013, INT J ENV RES PUB HE, V10, P6422, DOI 10.3390/ijerph10126422; Snidjers TAB, 2012, MULTILEVEL ANAL INTR; Toprak ME, 2014, DENT TRAUMATOL, V30, P280, DOI 10.1111/edt.12092; Traebert J, 2012, DENT TRAUMATOL, V28, P423, DOI 10.1111/j.1600-9657.2012.01114.x; Viegas CM, 2014, DENT TRAUMATOL, V30, P338, DOI 10.1111/edt.12091; Viegas CM, 2012, PEDIATR DENT, V34, P300; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003	54	41	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135369	10.1371/journal.pone.0135369	http://dx.doi.org/10.1371/journal.pone.0135369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287386	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600045
J	Horigue, V; Pressey, RL; Mills, M; Brotankova, J; Cabral, R; Andrefouet, S				Horigue, Vera; Pressey, Robert L.; Mills, Morena; Brotankova, Jana; Cabral, Reniel; Andrefouet, Serge			Benefits and Challenges of Scaling Up Expansion of Marine Protected Area Networks in the Verde Island Passage, Central Philippines	PLOS ONE			English	Article							CUSTOMARY SEA TENURE; BIODIVERSITY CONSERVATION; CORAL-REEFS; AD HOC; MANAGEMENT; RESERVES; DESIGN; FISH; IMPLEMENTATION; CONNECTIVITY	Locally-established marine protected areas (MPAs) have been proven to achieve local-scale fisheries and conservation objectives. However, since many of these MPAs were not designed to form ecologically-connected networks, their contributions to broader-scale goals such as complementarity and connectivity can be limited. In contrast, integrated networks of MPAs designed with systematic conservation planning are assumed to be more effective-ecologically, socially, and economically-than collections of locally-established MPAs. There is, however, little empirical evidence that clearly demonstrates the supposed advantages of systematic MPA networks. A key reason is the poor record of implementation of systematic plans attributable to lack of local buy-in. An intermediate scenario for the expansion of MPAs is scaling up of local decisions, whereby locally-driven MPA initiatives are coordinated through collaborative partnerships among local governments and their communities. Coordination has the potential to extend the benefits of individual MPAs and perhaps to approach the potential benefits offered by systematic MPA networks. We evaluated the benefits of scaling up local MPAs to form networks by simulating seven expansion scenarios for MPAs in the Verde Island Passage, central Philippines. The scenarios were: uncoordinated community-based establishment of MPAs; two scenarios reflecting different levels of coordinated MPA expansion through collaborative partnerships; and four scenarios guided by systematic conservation planning with different contexts for governance. For each scenario, we measured benefits through time in terms of achievement of objectives for representation of marine habitats. We found that: in any governance context, systematic networks were more efficient than non-systematic ones; systematic networks were more efficient in broader governance contexts; and, contrary to expectations but with caveats, the uncoordinated scenario was slightly more efficient than the coordinated scenarios. Overall, however, coordinated MPA networks have the potential to be more efficient than the uncoordinated ones, especially when coordinated planning uses systematic methods.	[Horigue, Vera; Pressey, Robert L.; Brotankova, Jana] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Horigue, Vera] Univ Philippines, Inst Marine Sci, Quezon City 1110, Philippines; [Mills, Morena] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Cabral, Reniel] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Sustainable Fisheries Grp, Santa Barbara, CA 93106 USA; [Cabral, Reniel] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Cabral, Reniel] Univ Philippines, Natl Inst Phys, Quezon City 1110, Philippines; [Andrefouet, Serge] Inst Rech Dev, ENTROPIE UMR9220, Noumea, New Caledonia	James Cook University; University of the Philippines System; University of the Philippines Diliman; University of Queensland; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of the Philippines System; University of the Philippines Diliman; Institut de Recherche pour le Developpement (IRD)	Horigue, V (corresponding author), Univ Philippines, Inst Marine Sci, Marine Environm & Resources Fdn, Quezon City 1110, Philippines.	vera.horigue@my.jcu.edu.au	Mills, Morena/AAD-8916-2019; Mills, Morena/C-6546-2013	Mills, Morena/0000-0001-9865-0770; Horigue, Vera/0000-0003-1364-9952; Cabral, Reniel/0000-0002-1137-381X	Australian Research Council; James Cook University	Australian Research Council(Australian Research Council); James Cook University	Funding: This study was funded by the Australian Research Council, and James Cook University-Graduate Research Scheme. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2006, FISH B-NOAA, V104, P360; Alcala AC, 2005, CAN J FISH AQUAT SCI, V62, P98, DOI 10.1139/F04-176; Alcala AC, 1998, OCEAN COAST MANAGE, V38, P179, DOI 10.1016/S0964-5691(97)00072-0; Alino PM, 2006, 10TH INTERNATIONAL C; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Andrefouet S, 2006, 10TH INTERNATIONAL C; Aswani S, 2007, CORAL REEFS, V26, P1009, DOI 10.1007/s00338-007-0277-z; Aswani S, 2005, REV FISH BIOL FISHER, V15, P285, DOI 10.1007/s11160-005-4868-x; Aswani S, 2004, ENVIRON CONSERV, V31, P69, DOI 10.1017/S037689290400116X; Bach SS, 1998, MAR ECOL PROG SER, V174, P247, DOI 10.3354/meps174247; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Campos WL, 2008, KURISHIO SCIENCE, V2, P6; Campos WL, 2003, ASSESSMENT MANAGEMEN; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Christie P, 2005, OCEAN COAST MANAGE, V48, P252, DOI 10.1016/j.ocecoaman.2005.04.012; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Christie P, 2002, J ENVIRON MANAGE, V66, P441, DOI 10.1006/jema.2002.0595; Chua T, 2006, THE DYNAMICS OF INTE; Cowling RM, 2004, CONSERV BIOL, V18, P1674, DOI 10.1111/j.1523-1739.2004.00296.x; CTI, 2009, NATIONAL PLAN OF ACT; Dolorosa RG, 2005, SCI DILIMAN, V17, P1; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fidelman P, 2012, MAR POLICY, V36, P42, DOI 10.1016/j.marpol.2011.03.007; Govan H., 2009, SPC TRAD MAR RESOUR, V25, P16; Hamel MA, 2013, CONSERV LETT, V6, P46, DOI 10.1111/j.1755-263X.2012.00285.x; Hansen GJA, 2011, BIOL CONSERV, V144, P1866, DOI 10.1016/j.biocon.2011.04.002; Horigue V, 2014, OCEAN COAST MANAGE, V95, P11, DOI 10.1016/j.ocecoaman.2014.03.023; Horigue V, 2012, OCEAN COAST MANAGE, V64, P15, DOI 10.1016/j.ocecoaman.2012.04.012; IUCN-WCPA, 2008, ESTABLISHING MARINE; JOHANNES RE, 1982, AMBIO, V11, P258; Junio-Menez MA, 2008, AFTER THE ROMANCE CO, P133; Junio-Menez MA, 2007, IMPROVING THE GOVERN; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; McDonald RI, 2009, P NATL ACAD SCI USA, V106, P15101, DOI 10.1073/pnas.0908125106; Mills M, 2012, CONSERV LETT, V5, P387, DOI 10.1111/j.1755-263X.2012.00258.x; Mills M, 2010, CONSERV LETT, V3, P291, DOI 10.1111/j.1755-263X.2010.00134.x; Mumby PJ, 2006, BIOL CONSERV, V128, P215, DOI 10.1016/j.biocon.2005.09.042; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pollnac RB, 2005, OCEAN COAST MANAGE, V48, P233, DOI 10.1016/j.ocecoaman.2005.04.003; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Pressey RL, 1998, BIOL CONSERV, V85, P305, DOI 10.1016/S0006-3207(97)00146-8; PRESSEY RL, 1994, AUST J ECOL, V19, P375, DOI 10.1111/j.1442-9993.1994.tb00503.x; Pressey RL, 1989, BIOL CONSERV, V50, P16; Pressey RL, 2008, CONSERV BIOL, V22, P1340, DOI 10.1111/j.1523-1739.2008.01032.x; Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Quibilan M, 2008, TROPICAL COASTS, P8; REBELO AG, 1992, CONSERV BIOL, V6, P243, DOI 10.1046/j.1523-1739.1992.620243.x; Rodrigues ASL, 2002, CONSERV BIOL, V16, P674, DOI 10.1046/j.1523-1739.2002.00455.x; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Segi S, 2013, HUM ORGAN, V72, P336, DOI 10.17730/humo.72.4.b34794j6u00m0545; Strange N, 2006, BIOL CONSERV, V128, P455, DOI 10.1016/j.biocon.2005.10.009; Veron JEN, 2009, GALAXEA JOURNAL OF C, V11, P10; Weeks R, 2014, COAST MANAGE, V42, P183, DOI 10.1080/08920753.2014.877768; Weeks R, 2010, CONSERV LETT, V3, P445, DOI 10.1111/j.1755-263X.2010.00131.x; Weeks R, 2010, CONSERV BIOL, V24, P531, DOI 10.1111/j.1523-1739.2009.01340.x; White AT, 2014, COAST MANAGE, V42, P87, DOI 10.1080/08920753.2014.878177; White AT, 1982, 4TH INTERNATIONAL CO	67	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135789	10.1371/journal.pone.0135789	http://dx.doi.org/10.1371/journal.pone.0135789			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288089	Green Published, Green Accepted, gold			2022-12-27	WOS:000360018600069
J	Salkeld, DJ; Nieto, NC; Carbajales-Dale, P; Carbajales-Dale, M; Cinkovich, SS; Lambin, EF				Salkeld, Daniel J.; Nieto, Nathan C.; Carbajales-Dale, Patricia; Carbajales-Dale, Michael; Cinkovich, Stephanie S.; Lambin, Eric F.			Disease Risk & Landscape Attributes of Tick-Borne Borrelia Pathogens in the San Francisco Bay Area, California	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; LYME-DISEASE; NORTHWESTERN CALIFORNIA; GRANULOCYTIC ANAPLASMOSIS; MIYAMOTOI INFECTION; HABITAT TYPE; BURGDORFERI; SPIROCHETE; DIVERSITY; TRANSMISSION	Habitat heterogeneity influences pathogen ecology by affecting vector abundance and the reservoir host communities. We investigated spatial patterns of disease risk for two human pathogens in the Borrelia genus-B. burgdorferi and B. miyamotoi-that are transmitted by the western black-legged tick, Ixodes pacificus. We collected ticks (349 nymphs, 273 adults) at 20 sites in the San Francisco Bay Area, California, USA. Tick abundance, pathogen prevalence and density of infected nymphs varied widely across sites and habitat type, though nymphal western black-legged ticks were more frequently found, and were more abundant in coast live oak forest and desert/semi-desert scrub (dominated by California sagebrush) habitats. We observed Borrelia infections in ticks at all sites where we able to collect >10 ticks. The recently recognized human pathogen, B. miyamotoi, was observed at a higher prevalence (13/349 nymphs = 3.7%, 95% CI = 2.0-6.3; 5/273 adults = 1.8%, 95% CI = 0.6-4.2) than recent studies from nearby locations (Alameda County, east of the San Francisco Bay), demonstrating that tick-borne disease risk and ecology can vary substantially at small geographic scales, with consequences for public health and disease diagnosis.	[Salkeld, Daniel J.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Salkeld, Daniel J.; Cinkovich, Stephanie S.; Lambin, Eric F.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Nieto, Nathan C.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Carbajales-Dale, Patricia] Clemson Univ, Ctr Excellence Next Generat Comp, Clemson, SC USA; [Carbajales-Dale, Michael] Clemson Univ, Coll Engn & Sci, Clemson, SC USA; [Lambin, Eric F.] Stanford Univ, Sch Earth Energy & Environm, Stanford, CA 94305 USA	Colorado State University; Stanford University; Northern Arizona University; Clemson University; Clemson University; Stanford University	Salkeld, DJ (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	dan.salkeld@colostate.edu	Carbajales-Dale, Michael/I-7914-2015	Carbajales-Dale, Michael/0000-0002-1568-384X; Lambin, Eric/0000-0002-0673-5257	Bay Area Lyme Foundation	Bay Area Lyme Foundation	This study was supported by a grant from the Bay Area Lyme Foundation, http://www.bayarealyme.org/, to DJS, NCN and EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Bay Area Open Space Council, 2011, CONS LANDS NETW SAN; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Burnham K P, 2003, MODEL SELECT MULTIMO; Chowdri HR, 2013, ANN INTERN MED, V159, P21, DOI 10.7326/0003-4819-159-1-201307020-00005; Crawley MJ, 2005, STAT INTRO USING R; Crowder CD, 2014, EMERG INFECT DIS, V20, P1678, DOI 10.3201/eid2010.131583; Eisen L, 2009, J VECTOR ECOL, V34, P81, DOI [10.1111/j.1948-7134.2009.00010.x, 10.3376/038.034.0110]; Eisen RJ, 2006, AM J TROP MED HYG, V75, P669, DOI 10.4269/ajtmh.2006.75.669; Eisen RJ, 2010, TICKS TICK-BORNE DIS, V1, P35, DOI 10.1016/j.ttbdis.2009.12.002; Fedorova N, 2014, TICKS TICK-BORNE DIS, V5, P951, DOI 10.1016/j.ttbdis.2014.07.015; Finch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084758; Foley JE, 2009, AM J TROP MED HYG, V81, P1132, DOI 10.4269/ajtmh.2009.09-0372; Girard YA, 2009, APPL ENVIRON MICROB, V75, P7243, DOI 10.1128/AEM.01704-09; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Holden K, 2003, J MED ENTOMOL, V40, P534, DOI 10.1603/0022-2585-40.4.534; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Lane RS, 2010, TICKS TICK-BORNE DIS, V1, P159, DOI 10.1016/j.ttbdis.2010.09.004; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Newman EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118146; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Salkeld DJ, 2008, AM J TROP MED HYG, V79, P535, DOI 10.4269/ajtmh.2008.79.535; Salkeld DJ, 2014, TICKS TICK-BORNE DIS, V5, P790, DOI 10.1016/j.ttbdis.2014.05.002; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Salkeld DJ, 2013, ECOL LETT, V16, P679, DOI 10.1111/ele.12101; Salkeld DJ, 2010, ECOLOGY, V91, P293, DOI 10.1890/08-2106.1; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Shapiro MR, 2010, CLIN INFECT DIS, V50, P541, DOI 10.1086/649926; Taylor KR, 2013, VECTOR-BORNE ZOONOT, V13, P92, DOI 10.1089/vbz.2012.1027; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10	33	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134812	10.1371/journal.pone.0134812	http://dx.doi.org/10.1371/journal.pone.0134812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288371	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600029
J	Konstantyner, T; Sesso, R; de Camargo, MF; Feltran, LD; Koch-Nogueira, PC				Konstantyner, Tulio; Sesso, Ricardo; de Camargo, Maria Fernanda; Feltran, Luciana de Santis; Koch-Nogueira, Paulo Cesar			Pediatric Chronic Dialysis in Brazil: Epidemiology and Regional Inequalities	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL REPLACEMENT THERAPY; CHILDREN; PREVALENCE	Introduction There are few reports in the literature estimating the epidemiologic characteristics of pediatric chronic dialysis. These patients have impaired physical growth, high number of comorbidities and great need for continuous attention of specialized services with high demand for complex and costly procedures. Objective The aim of this study was to estimate the incidence and prevalence rates and describe the characteristics of children and adolescents undergoing chronic dialysis treatment in a Brazilian demographic health survey. Materials and Methods A cross-sectional study was performed in a representative sample of dialysis centers (n(c) = 239) that was established from the 2011 Brazilian Nephrology Society Census (N-c = 708). We collected data encompassing the five Brazilian macro-regions. We analyzed the data from all patients under 19 years of age. The sample population consisted of 643 children and adolescents who were on chronic dialysis program anytime in 2012. Data collection was carried out in the dialysis services by means of patients' records reviews and personal interviews with the centers' leaders. Results We estimated that there were a total of 1,283 pediatric patients on chronic dialysis treatment in Brazil, resulting in a prevalence of 20.0 cases per million age-related population (pmarp) (95% CI: 14.8-25.3) and an incidence of 6.6 cases pmarp in 2012 (95% CI: 4.8-8.4). The South region had the highest prevalence and incidence rates of patients under dialysis therapy, 27.7 (95% CI: 7.3-48.1) and 11.0 (95% CI: 2.8-19.3) cases pmarp, respectively; the lowest prevalence and incidence rates were found in the North-Midwest region, 13.8 (95% CI: 6.2-21.4), and in the Northeast region, 3.8 (95% CI: 1.4-6.3) cases pmarp, respectively.	[Konstantyner, Tulio; Sesso, Ricardo; de Camargo, Maria Fernanda; Feltran, Luciana de Santis; Koch-Nogueira, Paulo Cesar] Soc Hosp Samaritano, Sao Paulo, Brazil; [Konstantyner, Tulio; Koch-Nogueira, Paulo Cesar] Univ Fed Sao Paulo, Div Pediat, Sao Paulo, Brazil; [Sesso, Ricardo] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Konstantyner, T (corresponding author), Soc Hosp Samaritano, Sao Paulo, Brazil.	tkmed@uol.com.br	Nogueira, Paulo Cesar Koch/E-8376-2010; Feltran, Luciana S/F-2735-2013; Konstantyner, Tulio/N-1983-2013; Konstantyner, Tulio/H-3063-2019	Nogueira, Paulo Cesar Koch/0000-0002-9536-9665; Feltran, Luciana S/0000-0003-3339-0749; Konstantyner, Tulio/0000-0002-7931-9692; Konstantyner, Tulio/0000-0002-7931-9692; Sesso, Ricardo/0000-0002-1062-0073	Brazilian Ministry of Health by the 'Programa de Apoio ao Desenvolvimento Institucional do Sistema Unico de Saude - PROADI-SUS' [25000.180613/2011-11]	Brazilian Ministry of Health by the 'Programa de Apoio ao Desenvolvimento Institucional do Sistema Unico de Saude - PROADI-SUS'	'Sociedade Hospital Samaritano' received funding from the Brazilian Ministry of Health by the 'Programa de Apoio ao Desenvolvimento Institucional do Sistema Unico de Saude - PROADI-SUS', protocol number: 25000.180613/2011-11 (http://portalsaude.saude.gov.br/index.php?option=com_content&view=article&id=9538&Itemid=497). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Chadha V, 2005, ADV CHRONIC KIDNEY D, V12, P343, DOI 10.1053/j.ackd.2005.07.013; Chesnaye N, 2014, PEDIAT NEPHROL; de Araujo EM, 2009, INTERFACE-BOTUCATU, V13, P383, DOI 10.1590/S1414-32832009000400012; Garcia-Garcia G, 2015, PEDIATR NEPHROL, V30, P183, DOI 10.1007/s00467-014-2996-z; Gregg M, 2008, FIELD EPIDEMIOLOGY, V3rd; Harambat J, 2012, PEDIATR NEPHROL, V27, P363, DOI 10.1007/s00467-011-1939-1; [Interagency Network of Health Information of the Ministry of Health of Brazil (RIPSA) Brazil Ministry of Health], 2012, INT NETW HLTH INF MI; Jager KJ, 2007, KIDNEY INT, V72, P412, DOI 10.1038/sj.ki.5002341; Kirkwood B.R., 2003, ESSENTIAL MED STAT, P165; Nogueira PCK, 2011, REV ASSOC MED BRAS, V57, P443, DOI 10.1590/S0104-42302011000400020; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Lewis MA, 2010, NEPHRON CLIN PRACT, V115, pC279, DOI 10.1159/000301237; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Matas AJ, 2015, AM J TRANSPLANT, V15, DOI 10.1111/ajt.13195; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; McTaggart S, 2008, INCIDENCE PREVALENCE, P1; North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS), 2011, 2011 ANN DIAL REP; Paim J, 2011, LANCET; Prutsch U, 2014, HIST CIENC SAUDE-MAN, V21, P219, DOI 10.1590/S0104-59702014005000005; Registry ERA-EDTA, 2010, ERA EDTA REG ANN REP; Ribeiro Patricia Tavares, 2007, Cien Saude Colet, V12, P1525, DOI 10.1590/S1413-81232007000600014; Sesso Ricardo de Castro Cintra, 2012, J Bras Nefrol, V34, P272; StataCorp, 2013, STAT STAT SOFTW REL; Stengel B, 2006, J AM SOC NEPHROL, V17, P2094, DOI 10.1681/ASN.2006060636; The ESRD Incidence Study Group, 2006, NEPHROL DIAL TRANSPL; United Nations Development Programme, 2010, ATL HUM DEV BRAZ; United States Renal Data System, 2014, 2014 ANN DAT REP EP; van der Heijden BJ, 2004, PEDIATR NEPHROL, V19, P213, DOI 10.1007/s00467-003-1376-x; Warady BA, 2007, PEDIATR NEPHROL, V22, P1999, DOI 10.1007/s00467-006-0410-1	30	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135649	10.1371/journal.pone.0135649	http://dx.doi.org/10.1371/journal.pone.0135649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285019	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100053
J	Shannon, S; Vaca, C; Jia, DX; Entersz, I; Schaer, A; Carcione, J; Weaver, M; Avidar, Y; Pettit, R; Nair, M; Khan, A; Foty, RA				Shannon, Stephen; Vaca, Connan; Jia, Dongxuan; Entersz, Ildiko; Schaer, Andrew; Carcione, Jonathan; Weaver, Michael; Avidar, Yoav; Pettit, Ryan; Nair, Mohan; Khan, Atif; Foty, Ramsey A.			Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells	PLOS ONE			English	Article							CONTACT INHIBITION; STREPTOCOCCUS-PYOGENES; EMBRYONIC-TISSUES; GLIOMA-CELLS; INVASION; COHESION; GROWTH; MIGRATION; INTEGRIN; ADHESION	Despite resection and adjuvant therapy, the 5-year survival for patients with Glioblastoma multiforme (GBM) is less than 10%. This poor outcome is largely attributed to rapid tumor growth and early dispersal of cells, factors that contribute to a high recurrence rate and poor prognosis. An understanding of the cellular and molecular machinery that drive growth and dispersal is essential if we are to impact long-term survival. Our previous studies utilizing a series of immortalized GBM cell lines established a functional causation between activation of fibronectin matrix assembly (FNMA), increased tumor cohesion, and decreased dispersal. Activation of FNMA was accomplished by treatment with Dexamethasone (Dex), a drug routinely used to treat brain tumor related edema. Here, we utilize a broad range of qualitative and quantitative assays and the use of a human GBM tissue microarray and freshly-isolated primary human GBM cells grown both as conventional 2D cultures and as 3D spheroids to explore the role of Dex and FNMA in modulating various parameters that can significantly influence tumor cell dispersal. We show that the expression and processing of fibronectin in a human GBM tissue-microarray is variable, with 90% of tumors displaying some abnormality or lack in capacity to secrete fibronectin or assemble it into a matrix. We also show that low-passage primary GBM cells vary in their capacity for FNMA and that Dex treatment reactivates this process. Activation of FNMA effectively "glues" cells together and prevents cells from detaching from the primary mass. Dex treatment also significantly increases the strength of cell-ECM adhesion and decreases motility. The combination of increased cohesion and decreased motility discourages in vitro and ex vivo dispersal. By increasing cell-cell cohesion, Dex also decreases growth rate of 3D spheroids. These effects could all be reversed by an inhibitor of FNMA and by the glucocorticoid receptor antagonist, RU-486. Our results describe a new role for Dex as a suppressor of GBM dispersal and growth.	[Shannon, Stephen; Vaca, Connan; Jia, Dongxuan; Entersz, Ildiko; Schaer, Andrew; Carcione, Jonathan; Weaver, Michael; Avidar, Yoav; Pettit, Ryan; Nair, Mohan; Foty, Ramsey A.] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08901 USA; [Khan, Atif] Rutgers Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Foty, RA (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08901 USA.	fotyra@rwjms.rutgers.edu		Khan, Atif/0000-0001-8640-8530; Weaver, Michael/0000-0002-8761-3867	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aaberg-Jessen C, 2013, INT J CLIN EXP PATHO, V6, P546; ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Butler CM, 2011, JOVE-J VIS EXP, DOI 10.3791/2739; Caicedo-Carvajal CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011830; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; Donev K, 2010, NEUROPATH APPL NEURO, V36, P411, DOI 10.1111/j.1365-2990.2010.01078.x; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Foty RA, 1996, DEVELOPMENT, V122, P1611; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Galante LL, 2007, J CELL BIOL, V179, P999, DOI 10.1083/jcb.200707150; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; HATAM A, 1983, J COMPUT ASSIST TOMO, V7, P295, DOI 10.1097/00004728-198304000-00017; Haugland HK, 1997, ANTICANCER RES, V17, P1035; Hyder CL, 2014, J CELL SCI, V127, P2161, DOI 10.1242/jcs.125062; HYNES RO, 1986, SCI AM, V254, P42, DOI 10.1038/scientificamerican0686-42; Jia DX, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-94; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kim SN, 2014, DEVELOPMENT, V141, P3233, DOI 10.1242/dev.106039; LEIGUARDA R, 1985, EUR NEUROL, V24, P23, DOI 10.1159/000115757; MARTZ E, 1972, J CELL PHYSIOL, V79, P189, DOI 10.1002/jcp.1040790205; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mehta M, 2015, MOL CANCER THER, V14, P1171, DOI 10.1158/1535-7163.MCT-14-0708; Metcalfe P., 2011, PREDICTION PHARMACOK; Nackman GB, 1998, SURGERY, V124, P353, DOI 10.1016/S0039-6060(98)70141-2; Nelson PJ, 2002, KIDNEY INT S1, V61, P99, DOI DOI 10.1046/J.1523-1755.2002.0610S1099.X; PAULUS W, 1994, J NEUROSURG, V80, P515, DOI 10.3171/jns.1994.80.3.0515; Riemenschneider MJ, 2005, AM J PATHOL, V167, P1379, DOI 10.1016/S0002-9440(10)61225-4; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sabari J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024810; Sampetrean O, 2011, NEOPLASIA, V13, P784, DOI 10.1593/neo.11624; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Serres E, 2014, ONCOGENE, V33, P3451, DOI 10.1038/onc.2013.305; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Steinberg M, 2013, WIRES DEV BIOL; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Uhm J. H., 1999, FRONT BIOSCI, V4, P188; VECHT CJ, 1994, NEUROLOGY, V44, P675, DOI 10.1212/WNL.44.4.675; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vizirianakis IS, 2002, INT J ONCOL, V21, P135; Windler-Hart SL, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-14; Winters BS, 2005, INT J CANCER, V114, P371, DOI 10.1002/ijc.20722; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616	50	25	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135951	10.1371/journal.pone.0135951	http://dx.doi.org/10.1371/journal.pone.0135951			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284619	gold, Green Published, Green Submitted			2022-12-27	WOS:000359666100090
J	Watanabe, K; Ooishi, Y; Kashino, M				Watanabe, Ken; Ooishi, Yuuki; Kashino, Makio			Sympathetic Tone Induced by High Acoustic Tempo Requires Fast Respiration	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; CHEMOREFLEX RESPONSE; CATECHOLAMINE LEVELS; CENTRAL NUCLEUS; BLOOD-PRESSURE; MUSIC; NEURONS; PROJECTIONS; SYSTEM; RHYTHM	Many studies have revealed the influences of music, and particularly its tempo, on the autonomic nervous system (ANS) and respiration patterns. Since there is the interaction between the ANS and the respiratory system, namely sympatho-respiratory coupling, it is possible that the effect of musical tempo on the ANS is modulated by the respiratory system. Therefore, we investigated the effects of the relationship between musical tempo and respiratory rate on the ANS. Fifty-two healthy people aged 18-35 years participated in this study. Their respiratory rates were controlled by using a silent electronic metronome and they listened to simple drum sounds with a constant tempo. We varied the respiratory rate -acoustic tempo combination. The respiratory rate was controlled at 15 or 20 cycles per minute (CPM) and the acoustic tempo was 60 or 80 beats per minute (BPM) or the environment was silent. Electrocardiograms and an elastic chest band were used to measure the heart rate and respiratory rate, respectively. The mean heart rate and heart rate variability (HRV) were regarded as indices of ANS activity. We observed a significant increase in the mean heart rate and the low (0.04-0.15 Hz) to high (0.15-0.40 Hz) frequency ratio of HRV, only when the respiratory rate was controlled at 20 CPM and the acoustic tempo was 80 BPM. We suggest that the effect of acoustic tempo on the sympathetic tone is modulated by the respiratory system.	[Watanabe, Ken; Kashino, Makio] Tokyo Inst Technol, Dept Informat Proc, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Ooishi, Yuuki; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan; [Kashino, Makio] Japan Sci & Technol Agcy, CREST, Atsugi, Kanagawa, Japan	Tokyo Institute of Technology; Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	Watanabe, K (corresponding author), Tokyo Inst Technol, Dept Informat Proc, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan.	watanabe@u.ip.titech.ac.jp	nyakky, k/GXF-5548-2022	Watanabe, Ken/0000-0002-3035-1333	CREST, Japan Science and Technology Agency; NTT Corporation	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NTT Corporation	This work was supported by CREST, Japan Science and Technology Agency to Makio Kashino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NTT Corporation provided support in the form of salaries for authors Yuuki Ooishi and Makio Kashino, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baekey DM, 2010, RESP PHYSIOL NEUROBI, V174, P135, DOI 10.1016/j.resp.2010.09.006; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Bernardi L, 2009, CIRCULATION, V119, P3171, DOI 10.1161/CIRCULATIONAHA.108.806174; BORDI F, 1992, J NEUROSCI, V12, P2493; Brattico E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00308; Camm AJ, 1996, EUR HEART J, V17, P354; Dick TE, 2009, RESP PHYSIOL NEUROBI, V168, P76, DOI 10.1016/j.resp.2009.07.009; Ellis RJ, 2010, MUSIC PERCEPT, V27, P317, DOI 10.1525/MP.2010.27.4.317; HAAS F, 1986, J APPL PHYSIOL, V61, P1185, DOI 10.1152/jappl.1986.61.3.1185; Kondo K, 2002, DIABETIC MED, V19, P359, DOI 10.1046/j.1464-5491.2002.00720.x; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Larsen PD, 2010, RESP PHYSIOL NEUROBI, V174, P111, DOI 10.1016/j.resp.2010.04.021; McCrimmon DR, 2000, CLIN EXP PHARMACOL P, V27, P126, DOI 10.1046/j.1440-1681.2000.03193.x; Moraes DJA, 2012, J NEUROPHYSIOL, V108, P610, DOI 10.1152/jn.00057.2012; Nousiainen T, 2001, CLIN SCI, V101, P601, DOI 10.1042/CS20010102; Okada K, 2009, INT HEART J, V50, P95, DOI 10.1536/ihj.50.95; PILOWSKY P, 1992, CLIN EXP PHARMACOL P, V19, P335, DOI 10.1111/j.1440-1681.1992.tb00466.x; PILOWSKY P, 1994, BRAIN RES, V633, P63, DOI 10.1016/0006-8993(94)91522-9; PILOWSKY PM, 1990, J COMP NEUROL, V301, P604, DOI 10.1002/cne.903010409; Saha S, 2005, EUR J NEUROSCI, V21, P1921, DOI 10.1111/j.1460-9568.2005.04023.x; Saha S, 2005, CLIN EXP PHARMACOL P, V32, P450, DOI 10.1111/j.1440-1681.2005.04210.x; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Sato TG, 2012, NEUROSCI LETT, V521, P67, DOI 10.1016/j.neulet.2012.05.061; Spicuzza L, 2000, LANCET, V356, P1495, DOI 10.1016/S0140-6736(00)02881-6; Stark R, 2000, PSYCHOPHYSIOLOGY, V37, P302, DOI 10.1017/S0048577200980570; Szabo A, 1999, J SPORT MED PHYS FIT, V39, P220; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110; Zoccal DB, 2011, CURR HYPERTENS REP, V13, P229, DOI 10.1007/s11906-011-0198-7	30	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135589	10.1371/journal.pone.0135589	http://dx.doi.org/10.1371/journal.pone.0135589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284521	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100049
J	Wilson, ADM; Brownscombe, JW; Sullivan, B; Jain-Schlaepfer, S; Cooke, SJ				Wilson, Alexander D. M.; Brownscombe, Jacob W.; Sullivan, Brittany; Jain-Schlaepfer, Sofia; Cooke, Steven J.			Does Angling Technique Selectively Target Fishes Based on Their Behavioural Type?	PLOS ONE			English	Article							CATCH-AND-RELEASE; LARGEMOUTH BASS; LEPOMIS-MACROCHIRUS; INDUCED EVOLUTION; BLUEGILL SUNFISH; INDIVIDUAL-DIFFERENCES; PUMPKINSEED SUNFISH; ANIMAL TEMPERAMENT; HANDLING TIME; TELEOST FISH	Recently, there has been growing recognition that fish harvesting practices can have important impacts on the phenotypic distributions and diversity of natural populations through a phenomenon known as fisheries-induced evolution. Here we experimentally show that two common recreational angling techniques (active crank baits versus passive soft plastics) differentially target wild largemouth bass (Micropterus salmoides) and rock bass (Ambloplites rupestris) based on variation in their behavioural tendencies. Fish were first angled in the wild using both techniques and then brought back to the laboratory and tested for individual-level differences in common estimates of personality (refuge emergence, flight-initiation-distance, latency-to-recapture and with a net, and general activity) in an in-lake experimental arena. We found that different angling techniques appear to selectively target these species based on their boldness (as characterized by refuge emergence, a standard measure of boldness in fishes) but not other assays of personality. We also observed that body size was independently a significant predictor of personality in both species, though this varied between traits and species. Our results suggest a context-dependency for vulnerability to capture relative to behaviour in these fish species. Ascertaining the selective pressures angling practices exert on natural populations is an important area of fisheries research with significant implications for ecology, evolution, and resource management.	[Wilson, Alexander D. M.] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Waurn Ponds, Vic 3216, Australia; [Wilson, Alexander D. M.; Brownscombe, Jacob W.; Sullivan, Brittany; Jain-Schlaepfer, Sofia; Cooke, Steven J.] Carleton Univ, Fish Ecol & Conservat Physiol Lab, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Wilson, Alexander D. M.; Brownscombe, Jacob W.; Sullivan, Brittany; Jain-Schlaepfer, Sofia; Cooke, Steven J.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada	Deakin University; Carleton University; Carleton University	Wilson, ADM (corresponding author), Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, 75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia.	alexander.wilson@ymail.com	Cooke, Steven J/F-4193-2010; Wilson, Alexander/B-3329-2011	Cooke, Steven J/0000-0002-5407-0659; Wilson, Alexander/0000-0002-7696-1671	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	The research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) through discovery research grants to S.J.C. S.J.C. is also supported by the Canada Research Chairs program.	Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Alos J, 2014, MAR ECOL PROG SER, V503, P219, DOI 10.3354/meps10745; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Arlinghaus R, 2008, N AM J FISH MANAGE, V28, P123, DOI 10.1577/M06-263.1; Arlinghaus R, 2007, REV FISH SCI, V15, P75, DOI 10.1080/10641260601149432; Binder TR, 2012, T AM FISH SOC, V141, P1252, DOI 10.1080/00028487.2012.688919; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Brownscombe JW, 2014, FISHERIES, V39, P251, DOI 10.1080/03632415.2014.915811; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cooke SJ, 2001, N AM J FISH MANAGE, V21, P333, DOI 10.1577/1548-8675(2000)020&lt;1033:EORGOT&gt;2.0.CO;2; Cooke SJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P480, DOI 10.1086/520618; Farwell M, 2009, BEHAV ECOL, V20, P913, DOI 10.1093/beheco/arp059; Gaeta JW, 2013, N AM J FISH MANAGE, V33, P606, DOI 10.1080/02755947.2013.785997; Hanson KC, 2010, CAN J ZOOL, V88, P324, DOI 10.1139/Z10-006; Harkonen L, 2014, CAN J FISH AQUAT SCI, V71, P1900, DOI 10.1139/cjfas-2014-0221; Heino M, 2002, B MAR SCI, V70, P639; Isermann DA, 2013, N AM J FISH MANAGE, V33, P344, DOI 10.1080/02755947.2013.763877; Kekalainen J, 2014, J FISH BIOL, V85, P1603, DOI 10.1111/jfb.12516; Klefoth T, 2013, FISHERIES MANAG ECOL, V20, P174, DOI 10.1111/j.1365-2400.2012.00865.x; Kortet R, 2014, BEHAV ECOL SOCIOBIOL, V68, P927, DOI 10.1007/s00265-014-1705-z; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Kyle G., 2007, Human Dimensions of Wildlife, V12, P115, DOI 10.1080/10871200701196066; Mamuneas D, 2015, BEHAV ECOL, V26, P91, DOI 10.1093/beheco/aru160; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; Meyer KA, 2014, N AM J FISH MANAGE, V34, P1145, DOI 10.1080/02755947.2014.951803; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Muoneke Maurice I., 1994, Reviews in Fisheries Science, V2, P123; Myers R, 2008, N AM J FISH MANAGE, V28, P428, DOI 10.1577/M06-265.1; Nannini MA, 2011, J FISH BIOL, V79, P1017, DOI 10.1111/j.1095-8649.2011.03079.x; Niemela PT, 2013, BEHAV ECOL, V24, P935, DOI 10.1093/beheco/art014; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Quinn S, 2009, CENTRARCHID FISHES D; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Redpath TD, 2010, CAN J FISH AQUAT SCI, V67, P1983, DOI 10.1139/F10-120; Riesch R, 2009, BEHAV ECOL SOCIOBIOL, V63, P1515, DOI 10.1007/s00265-009-0780-z; Siepker MJ, 2007, FISHERIES MANAG ECOL, V14, P91, DOI 10.1111/j.1365-2400.2007.00529.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Thompson LA, 2008, N AM J FISH MANAGE, V28, P1059, DOI 10.1577/M07-079.1; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; van Wijk SJ, 2013, FRONT ECOL ENVIRON, V11, P181, DOI 10.1890/120229; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wilson ADM, 2011, CAN J FISH AQUAT SCI, V68, P749, DOI 10.1139/F2011-019; Wilson ADM, 2010, BEHAV ECOL, V21, P57, DOI 10.1093/beheco/arp157; Wilson ADM, 2010, ETHOLOGY, V116, P96, DOI 10.1111/j.1439-0310.2009.01719.x; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250	50	33	33	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135848	10.1371/journal.pone.0135848	http://dx.doi.org/10.1371/journal.pone.0135848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284779	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100075
J	Cui, B; Feng, L; Pan, ZZ; Yu, ML; Zeng, ZH; Sun, CJ; Zhao, X; Wang, Y; Cui, HX				Cui, Bo; Feng, Lei; Pan, Zhenzhong; Yu, Manli; Zeng, Zhanghua; Sun, Changjiao; Zhao, Xiang; Wang, Yan; Cui, Haixin			Evaluation of Stability and Biological Activity of Solid Nanodispersion of Lambda-Cyhalothrin	PLOS ONE			English	Article							DERMAL DELIVERY; SOLUBLE DRUGS; ORAL DELIVERY; DOSAGE FORMS; FORMULATION; NANOSUSPENSIONS; MICROEMULSION; NANOCRYSTALS; PESTICIDES; BIOAVAILABILITY	Pesticides are essential agrochemicals used to protect plants from diseases, pests and weeds. However, the formulation defects of conventional pesticides cause food toxicity and ecological environmental problems. In this study, a novel, efficient and environmentally friendly formulation of lambda-cyhalothrin, a solid nanodispersion, was successfully developed based on melt-emulsification and high-speed shearing methods. The solid nanodispersion presented excellent advantages over conventional pesticide formulations in such formulation functions as dispersibility, stability and bioavailability. The formulation is free of organic solvents, and the use of surfactant is reduced. Therefore, the application of the solid nanodispersion in crop production will improve efficacy and reduce the occurrence of both pesticide residues in food and environmental pollution from pesticides.	[Cui, Bo; Feng, Lei; Pan, Zhenzhong; Yu, Manli; Zeng, Zhanghua; Sun, Changjiao; Zhao, Xiang; Wang, Yan; Cui, Haixin] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Pan, Zhenzhong] Jilin Univ, Coll Plant Sci, Coll Nat Resources & Environm, Changchun 130023, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Jilin University	Cui, HX (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	cuihaixin@caas.cn			Major National Scientific Research Program of China [2014CB932200]; Basic Scientific Research Foundation of National non-Profit Scientific Institute of China [BSRF201406]; National 863 program of the People's Republic of China [2011AA10A201]	Major National Scientific Research Program of China; Basic Scientific Research Foundation of National non-Profit Scientific Institute of China; National 863 program of the People's Republic of China	This research was supported by Major National Scientific Research Program of China (No. 2014CB932200), Basic Scientific Research Foundation of National non-Profit Scientific Institute of China (No. BSRF201406) and National 863 program of the People's Republic of China (No. 2011AA10A201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amweg EL, 2005, ENVIRON TOXICOL CHEM, V24, P1300; Anjali CH, 2010, ECOTOX ENVIRON SAFE, V73, P1932, DOI 10.1016/j.ecoenv.2010.08.039; Bouwmeester H, 2009, REGUL TOXICOL PHARM, V53, P52, DOI 10.1016/j.yrtph.2008.10.008; Chin CP, 2012, IND ENG CHEM RES, V51, P4710, DOI 10.1021/ie201151p; Dong LF, 2013, MOD AGR, V12, P14; Dubey R, 2006, DRUG DELIV TECHNOL, V6, P65; Elek N, 2010, COLLOID SURFACE A, V372, P66, DOI 10.1016/j.colsurfa.2010.09.034; Fu Q, 2013, COLLOID SURFACE B, V109, P161, DOI 10.1016/j.colsurfb.2013.01.066; George M, 2013, EUR J PHARM SCI, V48, P142, DOI 10.1016/j.ejps.2012.10.004; Ghosh I, 2011, INT J PHARMACEUT, V409, P260, DOI 10.1016/j.ijpharm.2011.02.051; Guan HN, 2008, PESTIC BIOCHEM PHYS, V92, P83, DOI 10.1016/j.pestbp.2008.06.008; Iggland M, 2014, CHEM ENG SCI, V111, P106, DOI 10.1016/j.ces.2014.02.034; Jacobs C, 2002, PHARMACEUT RES, V19, P189, DOI 10.1023/A:1014276917363; KADOTA G, 1986, J PESTIC SCI, V11, P597; Kawakami K, 2012, ADV DRUG DELIVER REV, V64, P480, DOI 10.1016/j.addr.2011.10.009; Kesisoglou F, 2007, ADV DRUG DELIVER REV, V59, P631, DOI 10.1016/j.addr.2007.05.003; Khot LR, 2012, CROP PROT, V35, P64, DOI 10.1016/j.cropro.2012.01.007; Knoche M, 2000, PEST MANAG SCI, V56, P1005, DOI 10.1002/1526-4998(200012)56:12<1005::AID-PS188>3.0.CO;2-Y; Knowles Alan, 2008, Environmentalist, V28, P35, DOI 10.1007/s10669-007-9045-4; Kocbek P, 2006, INT J PHARMACEUT, V312, P179, DOI 10.1016/j.ijpharm.2006.01.008; Kumar RSS, 2013, ENVIRON SCI POLLUT R, V20, P2593, DOI 10.1007/s11356-012-1161-0; Le Roy Boehm A L, 2000, J Pharm Belg, V55, P40; Lee MK, 2010, INT J PHARMACEUT, V384, P173, DOI 10.1016/j.ijpharm.2009.09.041; Leuner C, 2000, EUR J PHARM BIOPHARM, V50, P47, DOI 10.1016/S0939-6411(00)00076-X; Li P, 2009, J PHARM SCI-US, V98, P1750, DOI 10.1002/jps.21547; Margni M, 2002, AGR ECOSYST ENVIRON, V93, P379, DOI 10.1016/S0167-8809(01)00336-X; Mishra PR, 2009, INT J PHARMACEUT, V371, P182, DOI 10.1016/j.ijpharm.2008.12.030; Mitri K, 2011, INT J PHARMACEUT, V420, P141, DOI 10.1016/j.ijpharm.2011.08.026; Mogul MG, 1996, RESOUR CONSERV RECY, V16, P289, DOI 10.1016/0921-3449(95)00063-1; Moore MT, 2001, AGR ECOSYST ENVIRON, V87, P309, DOI 10.1016/S0167-8809(01)00148-7; Mura P, 2002, J PHARMACEUT BIOMED, V30, P227, DOI 10.1016/S0731-7085(02)00252-2; Pan BL, 2009, VET PARASITOL, V164, P353, DOI 10.1016/j.vetpar.2009.05.030; Passerini N, 2002, EUR J PHARM SCI, V15, P71, DOI 10.1016/S0928-0987(01)00210-X; Patravale VB, 2004, J PHARM PHARMACOL, V56, P827, DOI 10.1211/0022357023691; Pereira JL, 2009, ECOTOXICOLOGY, V18, P455, DOI 10.1007/s10646-009-0300-y; Pignatello R, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070127; Pratap AP, 2008, J DISPER SCI TECHNOL, V29, P1325, DOI 10.1080/01932690701866815; Qian K, 2011, MICROCHIM ACTA, V173, P51, DOI 10.1007/s00604-010-0523-x; Qian L, 2005, ENV OCCUP MED, V22, P167; Serajuddin ATM, 1999, J PHARM SCI-US, V88, P1058, DOI 10.1021/js980403l; Sharma P, 2011, INT J PHARMACEUT, V408, P138, DOI 10.1016/j.ijpharm.2011.01.032; Talekar M, 2012, EUR J PHARM SCI, V47, P824, DOI 10.1016/j.ejps.2012.09.015; Teera-Arunsiri A, 2003, J ECON ENTOMOL, V96, P292, DOI 10.1603/0022-0493-96.2.292; Van Eerdenbrugh B, 2008, INT J PHARMACEUT, V364, P64, DOI 10.1016/j.ijpharm.2008.07.023; Vilhelmsen T, 2005, INT J PHARMACEUT, V303, P132, DOI 10.1016/j.ijpharm.2005.07.012; Wang, 2012, AGROCHEMICALS, V51, P351; Wang Zhen, 2012, Chinese Journal of Pesticide Science, V14, P551, DOI 10.3969/j.issn.1008-7303.2012.05.14; Weber J, 2010, SCI TOTAL ENVIRON, V408, P2966, DOI 10.1016/j.scitotenv.2009.10.077; Wiwattanapatapee R, 2009, J AGR FOOD CHEM, V57, P11234, DOI 10.1021/jf901862z; Xu LY, 2010, BIOSYST ENG, V106, P58, DOI 10.1016/j.biosystemseng.2010.02.004; Xu RF, 2008, MOD AGR, V7, P29; Yang L., 2009, WORLD PESTICIDES, V31, P5; Yue PF, 2013, INT J PHARMACEUT, V443, P279, DOI 10.1016/j.ijpharm.2012.12.036; Zeng H, 2008, J DISPER SCI TECHNOL, V29, P358, DOI 10.1080/01932690701716085; ZhangW Qu X, 2010, J ASTM INT, V7, P1; Zhao JK, 2011, APPL CLAY SCI, V51, P460, DOI 10.1016/j.clay.2011.01.009; Zhou F, 2013, PESTIC SCI ADM, V34, P59; Zou GS, 2002, JIANGXI CHEM IND, V4, P134	58	17	22	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135953	10.1371/journal.pone.0135953	http://dx.doi.org/10.1371/journal.pone.0135953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281043	gold, Green Published, Green Submitted			2022-12-27	WOS:000359664300028
J	Elyasi, M; Abreu, LG; Badri, P; Saltaji, H; Flores-Mir, C; Amin, M				Elyasi, Maryam; Abreu, Lucas Guimaraes; Badri, Parvaneh; Saltaji, Humam; Flores-Mir, Carlos; Amin, Maryam			Impact of Sense of Coherence on Oral Health Behaviors: A Systematic Review	PLOS ONE			English	Review							QUALITY-OF-LIFE; ANTONOVSKYS SENSE; SOCIOECONOMIC-STATUS; SOCIAL DETERMINANTS; ADOLESCENTS SENSE; CARIES EXPERIENCE; MOTHERS SENSE; SCALE; ASSOCIATION; STUDENTS	Objectives The aim of this review was to critically analyze the empirical evidence on the association between Sense of Coherence (SOC) and oral health behaviors through a systematic approach. Methods A systematic search up to April 2015 was carried out using the following electronic bibliographic databases: PubMed, Ovid MEDLINE; ISI Web of Science; and Ovid PsychInfo. Studies were included if they evaluated the relationship between SOC and oral health behaviors including tooth cleaning, fluoride usage, dietary habits, dental attendance, and smoking. We excluded studies that only assessed the relationship between oral health status and SOC without evaluating oral health behaviors. The New Castle Ottawa (NOS) quality assessment checklist was employed to evaluate the methodological quality of included studies. Results Thirty-nine potential papers met the preliminary selection criteria and following a full-text review, 9 papers were finally selected for this systematic review. Results provided by the included studies indicated different levels of association between SOC and oral health behaviors. The most frequent behaviors investigated were tooth brushing and dental attendance pattern. The impact of SOC on performing positive oral health behaviors, to some extent, was related to demographic and socio-economic factors. In addition, mothers' SOC influenced children's oral health practices. Conclusions A more favorable oral health behavior was observed among those with a stronger SOC suggesting that the SOC can be a determinant of oral health-related behaviors including tooth brushing frequency, daily smoking, and dental attendance.	[Elyasi, Maryam; Badri, Parvaneh; Amin, Maryam] Univ Alberta, Sch Dent, Div Pediat Dent, Edmonton, AB, Canada; [Abreu, Lucas Guimaraes] Univ Fed Minas Gerais, Sch Dent, Pediat Grad Program, Belo Horizonte, MG, Brazil; [Saltaji, Humam; Flores-Mir, Carlos] Univ Alberta, Sch Dent, Orthodont Grad Program, Edmonton, AB, Canada	University of Alberta; Universidade Federal de Minas Gerais; University of Alberta	Amin, M (corresponding author), Univ Alberta, Sch Dent, Div Pediat Dent, Edmonton, AB, Canada.	maryam.amin@ualberta.ca	Saltaji, Humam/N-6539-2014; Flores-Mir, Carlos/Q-5763-2016; Abreu, Lucas Guimarães/I-7369-2016	Saltaji, Humam/0000-0002-8978-458X; Flores-Mir, Carlos/0000-0002-0887-9385; Abreu, Lucas Guimarães/0000-0003-2258-8071	Alberta Innovates [201300026] Funding Source: researchfish	Alberta Innovates		ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A., 1984, BEHAV HLTH HDB HLTH; Antonovsky A, 1987, UNRAVELING MYSTERY H; Ayo-Yusuf OA, 2009, COMMUNITY DENT ORAL, V37, P68, DOI 10.1111/j.1600-0528.2008.00444.x; Bernabe E, 2012, CARIES RES, V46, P523, DOI 10.1159/000341219; Bernabe E, 2009, QUAL LIFE RES, V18, P629, DOI 10.1007/s11136-009-9469-z; Bernabe E, 2009, EUR J ORAL SCI, V117, P413, DOI 10.1111/j.1600-0722.2009.00655.x; Boman UW, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-14; Bonanato K, 2009, CARIES RES, V43, P103, DOI 10.1159/000209342; da Silva AN, 2011, COMMUNITY DENT ORAL, V39, P115, DOI 10.1111/j.1600-0528.2010.00576.x; Deinzer R, 2005, BRIT J HEALTH PSYCH, V10, P269, DOI 10.1348/135910705X26858; Dorri M, 2010, INT J PAEDIATR DENT, V20, P261, DOI 10.1111/j.1365-263X.2010.01048.x; Emami E, 2009, THESIS PROQUEST INFO; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/jech.2005.041616; Eriksson M, 2007, J EPIDEMIOL COMMUN H, V61, P938, DOI 10.1136/jech.2006.056028; Freire MariadoCarmoMatias, 2002, Community Dent Health, V19, P24; Freire MDM, 2001, COMMUNITY DENT ORAL, V29, P204; Garcia-Moya I, 2012, SCAND J PUBLIC HEALT, V40, P333, DOI 10.1177/1403494812449924; Groholt EK, 2003, EUR J PUBLIC HEALTH, V13, P195, DOI 10.1093/eurpub/13.3.195; Hallberg U, 2008, INT J PAEDIATR DENT, V18, P27, DOI 10.1111/j.1365-263X.2007.00867.x; Hermont AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111123; Igna CV, 2008, J HEALTH PSYCHOL, V13, P996, DOI 10.1177/1359105308097962; Kuuppelomaki M, 2003, INT J NURS STUD, V40, P383, DOI 10.1016/S0020-7489(02)00103-7; Liberati A., 2009, J CLIN EPIDEMIOL, V62, pE1, DOI [DOI 10.1016/J.JCLINEPI.2009.06.006, 10.1016/j.jclinepi.2009.06.006]; Lindmark U, 2011, COMMUNITY DENT ORAL, V39, P542, DOI 10.1111/j.1600-0528.2011.00627.x; Lindmark U, 2015, INT J DENT HYG, V13, P56, DOI 10.1111/idh.12099; Lindmark U, 2011, ACTA ODONTOL SCAND, V69, P12, DOI 10.3109/00016357.2010.517553; Moons Philip, 2006, Eur J Cardiovasc Nurs, V5, P16, DOI 10.1016/j.ejcnurse.2005.10.009; Motzer SU, 1996, RES NURS HEALTH, V19, P287, DOI 10.1002/(SICI)1098-240X(199608)19:4<287::AID-NUR3>3.3.CO;2-W; Mouradian WE, 2007, J DENT EDUC, V71, P619; Nammontri O, 2013, J DENT RES, V92, P26, DOI 10.1177/0022034512459757; Newton JT, 2005, COMMUNITY DENT ORAL, V33, P25, DOI 10.1111/j.1600-0528.2004.00190.x; Peker K, 2012, J DENT EDUC, V76, P774; Qiu RM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-239; Rivera F, 2013, J HEALTH PSYCHOL, V18, P800, DOI 10.1177/1359105312455077; Suglia SF, 2010, J EPIDEMIOL COMMUN H, V64, P636, DOI 10.1136/jech.2008.082842; Surtees P, 2003, AM J EPIDEMIOL, V158, P1202, DOI 10.1093/aje/kwg272; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Veenstra M, 2005, QUAL LIFE RES, V14, P1455, DOI 10.1007/s11136-004-0015-8; Watt RG, 2002, COMMUNITY DENT ORAL, V30, P241, DOI 10.1034/j.1600-0528.2002.300401.x; Wells BS GA, 2013, NEWCASTLE OTTAWA SCO; Wigen TI, 2015, ACTA ODONTOL SCAND, V73, P182, DOI 10.3109/00016357.2014.976264; Zaborskis A, 2010, COMMUNITY DENT HLTH, V27, P102, DOI 10.1922/CDH_2383Narbutaite07	44	54	55	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133918	10.1371/journal.pone.0133918	http://dx.doi.org/10.1371/journal.pone.0133918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275064	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600018
J	Meagher, RK; Daros, RR; Costa, JHC; von Keyserlingk, MAG; Hotzel, MJ; Weary, DM				Meagher, Rebecca K.; Daros, Rolnei R.; Costa, Joao H. C.; von Keyserlingk, Marina A. G.; Hoetzel, Maria J.; Weary, Daniel M.			Effects of Degree and Timing of Social Housing on Reversal Learning and Response to Novel Objects in Dairy Calves	PLOS ONE			English	Article							HUMAN-ANIMAL RELATIONSHIP; GENE-EXPRESSION; BEHAVIORAL FLEXIBILITY; STRESS REACTIVITY; FRONTAL-CORTEX; SUCKLER CALVES; MATERNAL-CARE; OPEN-FIELD; DEPRIVATION; DEFICITS	Rodents and primates deprived of early social contact exhibit deficits in learning and behavioural flexibility. They often also exhibit apparent signs of elevated anxiety, although the relationship between these effects has not been studied. To investigate whether dairy calves are similarly affected, we first compared calves housed in standard individual pens (n = 7) to those housed in a dynamic group with access to their mothers (n = 8). All calves learned to approach the correct stimulus in a visual discrimination task. Only one individually housed calf was able to re-learn the task when the stimuli were reversed, compared to all but one calf from the group. A second experiment investigated whether this effect might be explained by anxiety in individually housed animals interfering with their learning, and tested varying degrees of social contact in addition to the complex group: pair housing beginning early (approximately 6 days old) and late (6 weeks old). Again, fewer individually reared calves learned the reversal task (2 of 10 or 20%) compared to early paired and grouped calves (16 of 21 or 76% of calves). Late paired calves had intermediate success. Individually housed calves were slower to touch novel objects, but the magnitude of the fear response did not correlate with reversal performance. We conclude that individually housed calves have learning deficits, but these deficits were not likely associated with increased anxiety.	[Meagher, Rebecca K.; Daros, Rolnei R.; Costa, Joao H. C.; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada; [Hoetzel, Maria J.] Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Florianopolis, SC, Brazil	University of British Columbia; Universidade Federal de Santa Catarina (UFSC)	Meagher, RK (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	rkmeagher@gmail.com	Costa, Joao H. C./ABD-4749-2021; von Keyserlingk, Marina/AAB-6353-2019; Hötzel, Maria José/H-6975-2014; Daros, Ruan R./L-6395-2019; Costa, Joao H. C./M-6660-2014; Weary, Daniel M/A-8868-2010; Meagher, Rebecca/G-6530-2013	Costa, Joao H. C./0000-0001-9311-4741; von Keyserlingk, Marina/0000-0002-1427-3152; Hötzel, Maria José/0000-0003-1034-3202; Daros, Ruan R./0000-0003-2331-1648; Costa, Joao H. C./0000-0001-9311-4741; Weary, Daniel M/0000-0002-0917-3982; Meagher, Rebecca/0000-0002-6576-8155	Natural Sciences and Engineering Research Council of Canada Discovery Grant [F10-05562]; Emerging Leaders in the Americas Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Emerging Leaders in the Americas Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant F10-05562, http://www.nserc-crsng.gc.ca/index_eng.asp (DMW); Emerging Leaders in the Americas Program, www.scholarships-bourses.gc.ca (RRD); and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://www.cnpq.br/ (JHCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Boe KE, 2003, APPL ANIM BEHAV SCI, V80, P175, DOI 10.1016/S0168-1591(02)00217-4; BOISSY A, 1990, APPL ANIM BEHAV SCI, V25, P149, DOI 10.1016/0168-1591(90)90077-Q; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Bredy TW, 2003, NEUROSCIENCE, V118, P571, DOI 10.1016/S0306-4522(02)00918-1; Chudasama Y, 2012, J NEUROSCI, V32, P10915, DOI 10.1523/JNEUROSCI.1463-12.2012; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Costa JHC, 2015, J DAIRY SCI, V98, P6381, DOI 10.3168/jds.2015-9395; Costa JHC, 2014, J DAIRY SCI, V97, P7804, DOI 10.3168/jds.2014-8392; Croney CC, 2007, APPL ANIM BEHAV SCI, V103, P215, DOI 10.1016/j.applanim.2006.05.023; Daros RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098429; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; Duve LR, 2012, J DAIRY SCI, P95; EINON DF, 1978, DEV PSYCHOBIOL, V11, P213, DOI 10.1002/dev.420110305; Ennaceur A, 2014, PHYSIOL BEHAV, V135, P55, DOI 10.1016/j.physbeh.2014.05.032; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Faerevik G, 2006, APPL ANIM BEHAV SCI, V99, P205, DOI 10.1016/j.applanim.2005.10.012; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Franks B, 2012, J COMP PSYCHOL, V126, P347, DOI 10.1037/a0027244; Gaillard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090205; Gee DG, 2013, P NATL ACAD SCI USA, V110, P15638, DOI 10.1073/pnas.1307893110; Gluck J, 1971, COGNITIVE PROCESS, P105; GLUCK JP, 1976, DEV PSYCHOL, V12, P173, DOI 10.1037/0012-1649.12.2.173; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hebb D. O., 1949, ORGANIZATION OF BEHA; Hegelund L, 2007, ANIM WELFARE, V16, P169; Hemsworth PH, 2000, J ANIM SCI, V78, P2821; Himmler BT, 2013, NEUROSCI LETT, V556, P42, DOI 10.1016/j.neulet.2013.09.061; HOLSON R, 1984, PSYCHOL LEARN MOTIV, V18, P199, DOI 10.1016/S0079-7421(08)60363-1; Jensen MB, 2014, J DAIRY SCI, V97, P5035, DOI 10.3168/jds.2013-7311; Jensen MB, 1997, APPL ANIM BEHAV SCI, V54, P109, DOI 10.1016/S0168-1591(96)01183-5; Jensen MB, 1999, ACTA AGR SCAND A-AN, V49, P113, DOI 10.1080/090647099424178; JONES GH, 1991, BEHAV BRAIN RES, V43, P35, DOI 10.1016/S0166-4328(05)80050-6; Jones MR, 1970, MIAMI SYMPOSIUM ON T; KALER SR, 1994, J CHILD PSYCHOL PSYC, V35, P769, DOI 10.1111/j.1469-7610.1994.tb01220.x; Lensink J, 2006, APPL ANIM BEHAV SCI, V100, P171, DOI 10.1016/j.applanim.2005.11.021; Loman MM, 2010, NEUROSCI BIOBEHAV R, V34, P867, DOI 10.1016/j.neubiorev.2009.05.007; Lukkes JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.018.2009; MARTIN LJ, 1991, J NEUROSCI, V11, P3344; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MELZACK R, 1965, EXP NEUROL, V13, P163, DOI 10.1016/0014-4886(65)90106-8; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Mogensen L, 1999, ACTA AGR SCAND A-AN, V49, P163, DOI 10.1080/090647099424079; Poletto R, 2006, BRAIN RES, V1067, P36, DOI 10.1016/j.brainres.2005.10.001; Poletto R, 2006, BRAIN RES, V1068, P7, DOI 10.1016/j.brainres.2005.11.012; PURCELL D, 1991, APPL ANIM BEHAV SCI, V31, P147, DOI 10.1016/0168-1591(91)90001-E; Raussi S, 2003, ANIM WELFARE, V12, P191; Rushen J, 1999, J DAIRY SCI, V82, P720, DOI 10.3168/jds.S0022-0302(99)75289-6; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sabatini MJ, 2007, J NEUROSCI, V27, P3295, DOI 10.1523/JNEUROSCI.4765-06.2007; Souza AS, 2008, APPL ANIM BEHAV SCI, V110, P182, DOI 10.1016/j.applanim.2007.03.023; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Swaisgood RR, 2003, ZOO BIOL, V22, P347, DOI 10.1002/zoo.10111; Van Reenen CG, 2009, PHYSIOL BEHAV, V96, P307, DOI 10.1016/j.physbeh.2008.10.016; Ventura BA, 2013, J DAIRY SCI, V96, P6105, DOI 10.3168/jds.2012-6040; Vieira AD, 2012, J DAIRY SCI, V95, P5149, DOI 10.3168/jds.2011-5073; Vieira AD, 2010, J DAIRY SCI, V93, P3079, DOI 10.3168/jds.2009-2516; von Keyserlingk MAG, 2009, J DAIRY SCI, V92, P4101, DOI 10.3168/jds.2009-2326; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Wingfield JC, 2013, ANIM BEHAV, V85, P1127, DOI 10.1016/j.anbehav.2013.02.018; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; WOODGUSH DGM, 1984, BIOL BEHAV, V9, P295	65	43	43	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0132828	10.1371/journal.pone.0132828	http://dx.doi.org/10.1371/journal.pone.0132828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274583	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000359493600005
J	Neuhaus, W; Schlundt, M; Fehrholz, M; Ehrke, A; Kunzmann, S; Liebner, S; Speer, CP; Forster, CY				Neuhaus, Winfried; Schlundt, Marian; Fehrholz, Markus; Ehrke, Alexander; Kunzmann, Steffen; Liebner, Stefan; Speer, Christian P.; Foerster, Carola Y.			Multiple Antenatal Dexamethasone Treatment Alters Brain Vessel Differentiation in Newborn Mouse Pups	PLOS ONE			English	Article							PRETERM BIRTH; ENDOTHELIAL-CELLS; FETAL LUNG; IN-VITRO; BARRIER; CORTICOSTEROIDS; GLUCOCORTICOIDS; EXPRESSION; RAT; EXPOSURE	Antenatal steroid treatment decreases morbidity and mortality in premature infants through the maturation of lung tissue, which enables sufficient breathing performance. However, clinical and animal studies have shown that repeated doses of glucocorticoids such as dexamethasone and betamethasone lead to long-term adverse effects on brain development. Therefore, we established a mouse model for antenatal dexamethasone treatment to investigate the effects of dexamethasone on brain vessel differentiation towards the blood-brain barrier (BBB) phenotype, focusing on molecular marker analysis. The major findings were that in total brains on postnatal day (PN) 4 triple antenatal dexamethasone treatment significantly downregulated the tight junction protein claudin-5, the endothelial marker Pecam-1/CD31, the glucocorticoid receptor, the NR1 subunit of the N-methyl-D-aspartate receptor, and Abc transporters (Abcb1a, Abcg2 Abcc4). Less pronounced effects were found after single antenatal dexamethasone treatment and in PN10 samples. Comparisons of total brain samples with isolated brain endothelial cells together with the stainings for Pecam-1/CD31 and claudin-5 led to the assumption that the morphology of brain vessels is affected by antenatal dexamethasone treatment at PN4. On the mRNA level markers for angiogenesis, the sonic hedgehog and the Wnt pathway were downregulated in PN4 samples, suggesting fundamental changes in brain vascularization and/or differentiation. In conclusion, we provided a first comprehensive molecular basis for the adverse effects of multiple antenatal dexamethasone treatment on brain vessel differentiation.	[Neuhaus, Winfried; Schlundt, Marian; Foerster, Carola Y.] Univ Wurzburg, Dept Anaesthesia & Crit Care, D-97070 Wurzburg, Germany; [Neuhaus, Winfried] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Neuhaus, Winfried] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Fehrholz, Markus; Kunzmann, Steffen; Speer, Christian P.] Univ Childrens Hosp Wuerzburg, Wurzburg, Germany; [Ehrke, Alexander; Liebner, Stefan] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany	University of Wurzburg; University of Vienna; Medical University of Vienna; University of Wurzburg; Goethe University Frankfurt	Neuhaus, W (corresponding author), Univ Wurzburg, Dept Anaesthesia & Crit Care, D-97070 Wurzburg, Germany.	winfried.neuhaus@univie.ac.at; foerster_C@ukw.de		Neuhaus, Winfried/0000-0002-6552-7183	European Union [HEALTH-F2-2009-241778]	European Union(European Commission)	The research leading to these results was funded by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement No. HEALTH-F2-2009-241778 to CF and CPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aghajafari F, 2002, AM J OBSTET GYNECOL, V186, P843, DOI 10.1067/mob.2002.121624; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Anstrom JA, 2002, J NEUROPATH EXP NEUR, V61, P76, DOI 10.1093/jnen/61.1.76; Bauer H, 1999, EXP CELL RES, V250, P434, DOI 10.1006/excr.1999.4558; Choi Ehn-Kyoung, 2011, Lab Anim Res, V27, P77, DOI 10.5625/lar.2011.27.2.77; Chun CZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014732; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; Cuffe JSM, 2011, PLACENTA, V32, P981, DOI 10.1016/j.placenta.2011.09.009; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Frahm KA, 2015, BRAIN STRUCT FUNCT, V220, P2225, DOI 10.1007/s00429-014-0787-8; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; Hensleigh E, 2013, NEUROSCI LETT, V556, P191, DOI 10.1016/j.neulet.2013.09.067; Hewitt DP, 2006, ENDOCRINOLOGY, V147, P5568, DOI 10.1210/en.2006-0825; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Huang WL, 2001, INT J DEV NEUROSCI, V19, P415, DOI 10.1016/S0736-5748(01)00026-0; Jantzie LL, 2015, CEREB CORTEX, V25, P482, DOI 10.1093/cercor/bht246; Kim JW, 2013, COMPARATIVE MED, V63, P48; Kleinschnitz C, 2011, STROKE, V42, P1081, DOI 10.1161/STROKEAHA.110.592238; Kroll S, 2009, ANN NY ACAD SCI, V1165, P228, DOI 10.1111/j.1749-6632.2009.04040.x; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; McKinlay CJD, 2012, AM J OBSTET GYNECOL, V206, P187, DOI 10.1016/j.ajog.2011.07.042; Miyamoto N, 2014, CELL MOL LIFE SCI, V71, P1055, DOI 10.1007/s00018-013-1488-9; Moors M, 2012, TOXICOL SCI, V125, P488, DOI 10.1093/toxsci/kfr304; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; Neuhaus W, 2012, BLOOD BRAIN BARRIER, P145; Neuhaus W, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00352; Owen D, 2004, BIOL REPROD, V71, P676, DOI 10.1095/biolreprod.104.027946; Reynolds RM, 2013, CLIN ENDOCRINOL, V78, P665, DOI 10.1111/cen.12073; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Sadowska GB, 2006, J SOC GYNECOL INVEST, V13, P248, DOI 10.1016/j.jsgi.2006.02.012; Sadowska GB, 2010, AM J PHYSIOL-HEART C, V298, pH179, DOI 10.1152/ajpheart.00828.2009; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Shimizu F, 2008, J CELL PHYSIOL, V217, P388, DOI 10.1002/jcp.21508; Shin JA, 2015, BRAIN STRUCT FUNCT, V220, P13, DOI 10.1007/s00429-013-0632-5; Singh RR, 2012, CLIN EXP PHARMACOL P, V39, P979, DOI 10.1111/1440-1681.12009; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; Vorbrodt AW, 2001, J NEUROCYTOL, V30, P705, DOI 10.1023/A:1016581801188; Wang Q, 2014, BRAIN STRUCT FUNCT, V219, P1615, DOI 10.1007/s00429-013-0589-4; Whitelaw A, 2000, ARCH DIS CHILD-FETAL, V83, pF154, DOI 10.1136/fn.83.2.F154; Willis CL, 2004, GLIA, V48, P1, DOI 10.1002/glia.20049	46	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0136221	10.1371/journal.pone.0136221	http://dx.doi.org/10.1371/journal.pone.0136221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274818	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600156
J	Wondimu, A; Molla, F; Demeke, B; Eticha, T; Assen, A; Abrha, S; Melkam, W				Wondimu, Abrham; Molla, Fantahun; Demeke, Birhanu; Eticha, Tadele; Assen, Admassu; Abrha, Solomon; Melkam, Wondim			Household Storage of Medicines and Associated Factors in Tigray Region, Northern Ethiopia	PLOS ONE			English	Article							ADDIS-ABABA; HOME; COST	Introduction The presence of medicines in households is a risk factor for irrational drug use. This study aimed at investigating the prevalence and factors associated with home storage of medicines in Tigray Region, Ethiopia. Method A community based cross-sectional study was conducted in April 2013 in Tigray Region, Ethiopia. A total of 1034 participants were enrolled in the study. A multi-stage sampling method was employed to select households. Data were collected with the help of a pretested structured questionnaire and analyzed using descriptive statistics and bivariate and multivariate logistic regression. Result Of the total households visited, 293(29%) stored drugs. The mean number of drugs per household was 1.73. The most common classes of drugs found in households were analgesics 149(29%) and antibiotics 128(25%). Most of the medicines kept in households were used for ongoing treatments 316(62%) and available in tablet dosage form (70%). More than half of the medications kept at homes were not adequately labeled while drawer 180(36%) were reported as the main place of drug storage. The proportion of home storage of medicines in rural area (AOR = 0.56, 95% CI: 0.39-0.81) was lower than that of urban area. However, households having family member(s) working in health facilities (AOR = 2.03, 95% CI: 1.09-3.77) were associated with an increased home storage of medicines. Conclusion Most drugs kept at home were not appropriately labeled and stored in a safe place. Residence area (rural versus urban) and the presence of health professional(s) in the households affects household drug storage. Hence, public education campaign should be considered as an intervention to improve the storage condition of medicines in the households.	[Wondimu, Abrham; Molla, Fantahun; Demeke, Birhanu; Eticha, Tadele; Assen, Admassu; Abrha, Solomon; Melkam, Wondim] Mekelle Univ, Dept Pharm, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Eticha, T (corresponding author), Mekelle Univ, Dept Pharm, Coll Hlth Sci, Mekelle, Ethiopia.	td.eticha@gmail.com		Kassa, Fantahun Molla/0000-0002-4556-1245; Dagne, Abrham Wondimu/0000-0002-3922-287X; Abrha, Solomon/0000-0002-8192-6985	College of Health Sciences, Mekelle University	College of Health Sciences, Mekelle University	This study was supported by College of Health Sciences, Mekelle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALUBO S.O, 1987, 3 WORLD SOC, P89; Amare G, 1997, E AFR MED J, V74, P362; [Anonymous], HOUS SURV MED US OM; [Anonymous], 2004, WORLD MED SIT; Atinafu T, 2014, INT J PHARMA SCI RES, V5, P999; CSA, 2008, SUMM STAT REP 2007 P; Federal Ministry of Health Nigeria, 2010, ACC RAT US MED HOUS; Gedif T, 2002, PHARMACOEPIDEM DR S, V11, P587, DOI 10.1002/pds.729; Hu J, 2014, INT J INFECT DIS, V26, P103, DOI 10.1016/j.ijid.2014.04.017; Jassim Abdul-Mohsin, 2010, Oman Med J, V25, P79, DOI 10.5001/omj.2010.25; Kheir N, 2011, DRUG HEALTHC PATIENT, V3, P99, DOI 10.2147/DHPS.S25372; Kiyingi K S, 1993, World Health Forum, V14, P381; Lee See G, 2014, IJPTP, V5, P916; Ministry of Health, 2008, ACC US MED HOUS UG; Ministry of Medical Service Ministry of Public Health & Sanitation, 2009, ACC ESS MED KEN HOUS; Ocan M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-650; Shankar P. R., 2003, SMJ Singapore Medical Journal, V44, P352; Stratchounski LS, 2003, CLIN INFECT DIS, V37, P498, DOI 10.1086/376905; Sweileh WM, 2010, INT J CLIN PHARM TH, V48, P59; Tourinho FSV, 2008, J PEDIAT-BRAZIL, V84, P416, DOI [10.2223/JPED.1831, 10.1590/S0021-75572008000600007]; Tsegaye G., 1998, ETHIOP J HLTH SCI, V8, P89; Wasserfallen JB, 2003, ANN PHARMACOTHER, V37, P731, DOI 10.1345/aph.1C310; WHO. World Health Organization, 1993, INVESTIGATE DRUG USE; Wolde B., 2002, ETHIOP PHARM J, V20, P59; Yousif M A, 2002, East Mediterr Health J, V8, P422	25	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135650	10.1371/journal.pone.0135650	http://dx.doi.org/10.1371/journal.pone.0135650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275057	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600088
J	Bao, L; Li, T; Diao, N; Shen, YJ; Shao, LY; Zhang, Y; Lu, SH; Zhang, WH				Bao, Lei; Li, Tao; Diao, Ni; Shen, Yaojie; Shao, Lingyun; Zhang, Ying; Lu, Shuihua; Zhang, Wenhong			Fluctuating Behavior and Influential Factors in the Performance of the QuantiFERON-TB Gold In-Tube Assay in the Diagnosis of Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; CHILDREN; MTB/RIF; SPOT.TB; DISEASE; LATENT	Background The QuantiFERON-TB Gold In-Tube (QFT-GIT) is a newly developed but widely used interferon-. release assay for diagnosing tuberculosis (TB). However, research has not determined whether age or the use of an immune suppressive or anti-TB treatment influences this assay's ability to detect TB. We assessed the QFT-GIT diagnostic performance for active tuberculosis (ATB) in children and adults in an endemic country and explored the effects of glucocorticoids and anti-TB therapy on the diagnostic value of the QFT-GIT. Methods A total of 60 children and 212 adults with suspected ATB were evaluated with the QFT-GIT. The association between the QFT-GIT diagnostic value and pretreatment factors was qualitatively and quantitatively assessed. Results The sensitivity of the QFT-GIT was 83.9%(95% CI 66.3%-94.6%) in children, and 73.7% (95% CI 57.8%-85.2%) in adults. Glucocorticoids affected the mitogen-stimulated response in both children and adults. In subjects undergoing glucocorticoid pretreatment, 25.0% of the children presented with false-negative QFT-GIT results, 28.6% of adults presented with indeterminate results. For subjects pre-treated with anti-TB drugs, 44.4% presented with false-negative QFT-GIT results. Conclusions The QFT-GIT has higher sensitivity and specificity in children than adults. Glucocorticoid treatment negatively impacts the diagnostic value of the QFT-GIT in all age groups. Anti-TB treatment decreases the sensitivity of the QFT-GIT. Therefore, we recommend that the QFT-GIT assay be performed before TB-specific treatment is initiated and the test should not be used on people undergoing immunosuppression treatment, regardless of their age. A quantitative analysis of the QFT-GIT could be useful for assessing and monitoring TB-specific and non-specific immunity during conversion of the disease.	[Bao, Lei; Li, Tao; Diao, Ni; Shen, Yaojie; Shao, Lingyun; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Li, Tao; Lu, Shuihua] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept TB Dis, Shanghai 200433, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Zhang, Wenhong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fudan University	Lu, SH (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept TB Dis, Shanghai 200433, Peoples R China.	tubercle@shaphc.org; zhangwenhong@fudan.edu.cn			National Natural Science Foundation [30901277]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by a research grant from The National Natural Science Foundation (30901277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashenafi S, 2013, THORAX, V68, P269, DOI 10.1136/thoraxjnl-2012-201817; Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556; Belard E, 2011, INFLAMM BOWEL DIS, V17, P2340, DOI 10.1002/ibd.21605; Bunsow E, 2014, J INFECTION, V68, P338, DOI 10.1016/j.jinf.2013.11.012; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Critselis E, 2012, J PEDIATR-US, V161, P632, DOI 10.1016/j.jpeds.2012.04.007; Cruz AT, 2011, PEDIATRICS, V127, pE31, DOI 10.1542/peds.2010-1725; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Helwig U, 2012, J CROHNS COLITIS, V6, P419, DOI 10.1016/j.crohns.2011.09.011; Kobashi Y, 2008, CHEST, V133, P1196, DOI 10.1378/chest.07-1995; Ling DI, 2013, THORAX, V68, P860, DOI 10.1136/thoraxjnl-2012-203086; Organization WH, 2012, GLOB TUB CONTR WHO R; Organization WH, 2013, GLOB TUB CONTR WHO R; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Ramos JM, 2013, CLIN EXP MED, V13, P177, DOI 10.1007/s10238-012-0192-7; Rose MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037851; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sohn H, 2014, CLIN INFECT DIS, V58, P970, DOI 10.1093/cid/ciu022; Wang XS, 2012, J IMMUNOL, V189, P3092, DOI 10.4049/jimmunol.1200573; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044944; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	22	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0103763	10.1371/journal.pone.0103763	http://dx.doi.org/10.1371/journal.pone.0103763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287382	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600001
J	Cao, HX; Dong, W; Shen, HC; Xu, J; Zhu, LH; Liu, Q; Du, JJ				Cao, Hongxin; Dong, Wei; Shen, Hongchang; Xu, Jun; Zhu, Linhai; Liu, Qi; Du, Jiajun			Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer	PLOS ONE			English	Article							RECEPTOR MONOCLONAL-ANTIBODY; IGF-I; INHIBITION; GROWTH; METFORMIN; INSULIN; RESISTANCE; EFFICACY; MEK	Background Small cell lung cancer (SCLC) is a recalcitrant malignancy with distinct biologic properties. Antibody targeting therapy has been actively investigated as a new drug modality. Methods We tested the expression of IGF-1R and calculated the survival in 61 SCLC patients. We also evaluated the anti-tumor effects of anti-IGF-1R monoclonal antibody Figitumumab (CP) on SCLC, and tried two drug combinations to improve CP therapy. Results Our clinical data suggested that high IGF-1R expression was correlated with low SCLC patient survival. We then demonstrated the effect of CP was likely through IGF-1R blockage and down-regulation without IGF-1R auto-phosphorylation and PI3K/AKT activation. However, we observed elevated MEK/ERK activation upon CP treatment in SCLC cells, and this MEK/ERK activation was enhanced by beta-arrestin1 knockdown while attenuated by beta-arrestin2 knockdown. We found both MEK/ERK inhibitor and metformin could enhance CP treatment in SCLC cells. We further illustrated the additive effect of metformin was likely through promoting further IGF-1R down-regulation. Conclusion Our results highlighted the potential of anti-IGF-1R therapy and the adjuvant therapy strategy with either MEK/ERK inhibitor or metformin to target SCLC, warranting further studies.	[Cao, Hongxin; Dong, Wei; Shen, Hongchang; Xu, Jun; Zhu, Linhai; Liu, Qi; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China; [Dong, Wei; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Du, JJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China.	jiajundusdu@gmail.com			Provincial Science and Technology Development Planning of Shandong [2012GG0021836, 2014WS0342]; National Natural Science Foundation of China [81301728]; Natural Science Foundation of Shandong Province [ZR2013HZ001]; Shandong Provincial Natural Science Fund [ZR2014HQ073]	Provincial Science and Technology Development Planning of Shandong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Provincial Natural Science Fund(Natural Science Foundation of Shandong Province)	Funding: The work was supported by Provincial Science and Technology Development Planning of Shandong (2012GG0021836 and 2014WS0342), National Natural Science Foundation of China (81301728), Key Project of Natural Science Foundation of Shandong Province (ZR2013HZ001), and Shandong Provincial Natural Science Fund (ZR2014HQ073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; D'Angelo SP, 2010, CANCER BIOL THER, V10, P1, DOI 10.4161/cbt.10.1.12045; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Flanigan SA, 2013, CLIN CANCER RES, V19, P6219, DOI 10.1158/1078-0432.CCR-13-0145; Gately K, 2011, CLIN LUNG CANCER, V12, P38, DOI 10.3816/CLC.2011.n.005; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Holt SV, 2012, BRIT J CANCER, V106, P858, DOI 10.1038/bjc.2012.8; Hu CT, 2013, CELL SIGNAL, V25, P1539, DOI 10.1016/j.cellsig.2013.03.022; Hu P, 2013, BRIT J CANCER, V109, P1609, DOI 10.1038/bjc.2013.485; Ii M, 2011, CLIN CANCER RES, V17, P5048, DOI 10.1158/1078-0432.CCR-10-3131; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Kurmasheva RT, 2009, CANCER RES, V69, P7662, DOI 10.1158/0008-5472.CAN-09-1693; Lund SS, 2013, DIABETOLOGIA, V56, P937, DOI 10.1007/s00125-013-2843-y; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma H, 2014, SCI WORLD J, DOI 10.1155/2014/230835; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Quinn BJ, 2013, CANCER PREV RES, V6, P801, DOI 10.1158/1940-6207.CAPR-13-0058-T; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Rossi A, 2008, CLIN LUNG CANCER, V9, P271, DOI 10.3816/CLC.2008.n.042; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Sattler M, 2003, SEMIN ONCOL, V30, P57, DOI 10.1053/sonc.2003.50019; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Sikka A, 2012, CELL CYCLE, V11, P1374, DOI 10.4161/cc.19798; Takahashi O, 2012, CLIN CANCER RES, V18, P1641, DOI 10.1158/1078-0432.CCR-11-2324; Teicher BA, 2014, BIOCHEM PHARMACOL, V87, P211, DOI 10.1016/j.bcp.2013.09.014; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang SY, 2013, DIABETES CARE, V36, pE155, DOI 10.2337/dc13-0708; Zhan JB, 2013, EXPERT OPIN INV DRUG, V22, P235, DOI 10.1517/13543784.2013.750293; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081264; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P20620, DOI 10.1073/pnas.1216348110; Zhu P, 2013, CANC PREV RES PHILA; Zinn RL, 2013, MOL CANCER THER, V12, P1131, DOI 10.1158/1535-7163.MCT-12-0618	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135844	10.1371/journal.pone.0135844	http://dx.doi.org/10.1371/journal.pone.0135844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287334	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600075
J	Liu, XJ; Jiang, BH; Wang, AD; Di, JB; Wang, ZZ; Chen, L; Su, XQ				Liu, Xijuan; Jiang, Beihai; Wang, Aidong; Di, Jiabo; Wang, Zaozao; Chen, Lei; Su, Xiangqian			GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; COLON-CANCER; STAGE-II; GENE; EXPRESSION; TRANSCRIPTION; CHEMOTHERAPY; MUTATIONS; NPAS2	Background GATA binding protein 2 (GATA2) is a transcription factor that has essential roles in hematologic malignancies and progression of various solid tumors. Our previous studies suggested that high GATA2 expression is associated with recurrence of colorectal cancer (CRC). However, the influence of GATA2 single nucleotide polymorphisms (SNPs) on the survival of CRC remains unknown. Methods We genotyped GATA2 SNP rs2335052 using Sanger sequencing after PCR amplification, and determined GATA2 expression by immunohistochemistry in a cohort of 180 CRC patients. Kaplan-Meier survival analysis and Cox proportional hazard regression were used to analyze the association between the GATA2 rs2335052 genotypes and the clinical outcome of CRC. Results We found that there was no significant correlation between the rs2335052 genotypes and the expression of GATA2. However, the Kaplan-Meier survival analysis suggested that the carriers of the A-allele of SNP rs2335052 were significantly associated with increased risk of recurrence and reduced disease-free survival (DFS), compared with those carrying the variant genotype of GG in rs2335052 (P = 0.021). Moreover, univariate and multivariate Cox regression analyses revealed that GATA2 SNP rs2335052 was an independent risk factor for the DFS of CRC patients. Conclusion Our results demonstrated that GATA2 SNP rs2335052 is an independent predictor for prognosis of CRC patients. This raised the possibility that SNP rs2335052 may serve as a potential indicator for predicting recurrence of CRC after curative colectomy.	[Liu, Xijuan] Peking Univ, Canc Hosp & Inst, Cent Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Jiang, Beihai; Wang, Aidong; Di, Jiabo; Wang, Zaozao; Chen, Lei; Su, Xiangqian] Peking Univ, Canc Hosp & Inst, Dept Minimally Invas Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Su, XQ (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Minimally Invas Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	suxiangqian@bjmu.edu.cn		Jiang, Beihai/0000-0002-3665-9291	National Natural Science Foundation of China [81272766, 81450028, 81470129, 81402346]; National High Technology Research and Development Program of China (863 Program) [2014AA020603]; Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission) [Z121107001012130]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [XM201309]; Peking University (PKU); Peking University [2014-MB-04]; Beijing Natural Science Foundation [7132054]; Beijing Nova Program (Beijing Municipal Science & Technology Commission) [Z111102054511075, 2011060]; Program for Excellent Talents in Beijing [2013D003034000009]; Excellent Overseas-Returnee Scholar Program (Ministry of Human Resources and Social Security); Science Foundation of Peking University Cancer Hospital Institute [2014-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Peking University (PKU); Peking University(Peking University); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program (Beijing Municipal Science & Technology Commission); Program for Excellent Talents in Beijing; Excellent Overseas-Returnee Scholar Program (Ministry of Human Resources and Social Security); Science Foundation of Peking University Cancer Hospital Institute	This study was supported by the grants from the National Natural Science Foundation of China (No. 81272766, No. 81450028, No. 81470129, and No. 81402346), the National High Technology Research and Development Program of China (863 Program, No. 2014AA020603), Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission No. Z121107001012130), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (No. XM201309), Peking University (PKU) 985 Special Funding for Collaborative Research with PKU Hospitals (To Xiangqian Su and Fan Bai), Seeding Grant for Medicine and Life Sciences of Peking University (2014-MB-04), Beijing Natural Science Foundation (No. 7132054), the Beijing Nova Program (Beijing Municipal Science & Technology Commission No. Z111102054511075, 2011060), Program for Excellent Talents in Beijing (No. 2013D003034000009), the Excellent Overseas-Returnee Scholar Program (Ministry of Human Resources and Social Security, to Jiabo Di), and Science Foundation of Peking University Cancer Hospital & Institute (No. 2014-14).	Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bohm M, 2009, ONCOGENE, V28, P3847, DOI 10.1038/onc.2009.243; Chen L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0498-7; Chiang YT, 2014, ONCOTARGET, V5, P451, DOI 10.18632/oncotarget.1296; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dickinson RE, 2014, BLOOD, V123, P863, DOI 10.1182/blood-2013-07-517151; Edgen S, 2010, AJCC CANC STAGING MA; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Gilliland DG, 2001, CURR OPIN HEMATOL, V8, P189, DOI 10.1097/00062752-200107000-00001; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Horne BD, 2009, ANN HUM GENET, V73, P551, DOI 10.1111/j.1469-1809.2009.00540.x; Jonker DJ, 2011, CLIN ONCOL-UK, V23, P314, DOI 10.1016/j.clon.2011.02.010; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Kunicka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101740; Kurzawski M, 2010, PARKINSONISM RELAT D, V16, P284, DOI 10.1016/j.parkreldis.2009.10.006; Li YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087505; Liu YH, 2014, GENET MOL RES, V13, P2619, DOI 10.4238/2014.April.8.4; Luesink M, 2012, BLOOD, V120, P2064, DOI 10.1182/blood-2011-12-397083; Morris M, 2007, INT J COLORECTAL DIS, V22, P887, DOI 10.1007/s00384-006-0262-y; Muiya NP, 2014, GENE, V544, P152, DOI 10.1016/j.gene.2014.04.064; Ng SC, 2013, BRIT MED BULL, V105, P29, DOI 10.1093/bmb/lds040; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Wang Y, 2012, HUM MOL GENET, V21, P569, DOI 10.1093/hmg/ddr491; Weiser MR, 2008, J CLIN ONCOL, V26, P380, DOI 10.1200/JCO.2007.14.1291; Weiser MR, 2011, J CLIN ONCOL, V29, P4796, DOI 10.1200/JCO.2011.36.5080; Wu DY, 2014, NUCLEIC ACIDS RES, V42, P3607, DOI 10.1093/nar/gkt1382; Xing XF, 2009, HISTOPATHOLOGY, V54, P309, DOI 10.1111/j.1365-2559.2009.03226.x; Yamada A, 2013, BREAST CANCER RES TR, V137, P773, DOI 10.1007/s10549-012-2398-5; Yi CH, 2010, BREAST CANCER RES TR, V120, P663, DOI 10.1007/s10549-009-0484-0; Yu XH, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-98; Yuan P, 2014, CANCER SCI, V105, P825, DOI 10.1111/cas.12428; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136020	10.1371/journal.pone.0136020	http://dx.doi.org/10.1371/journal.pone.0136020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287967	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600097
J	Mehrabian, M; Brethour, D; Wang, HS; Xi, ZR; Rogaeva, E; Schmitt-Ulms, G				Mehrabian, Mohadeseh; Brethour, Dylan; Wang, Hansen; Xi, Zhengrui; Rogaeva, Ekaterina; Schmitt-Ulms, Gerold			The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; POLYSIALIC ACID SYNTHASE; OF-INTIMACY ENCODES; SYNAPTIC PLASTICITY; PSA-NCAM; SUPRACHIASMATIC NUCLEUS; NEURITE OUTGROWTH; CIRCADIAN CLOCK; ZIP FAMILY; E-CADHERIN	Despite its multi-faceted role in neurodegenerative diseases, the physiological function of the prion protein (PrP) has remained elusive. On the basis of its evolutionary relationship to ZIP metal ion transporters, we considered that PrP may contribute to the morphogenetic reprogramming of cells underlying epithelial-to-mesenchymal transitions (EMT). Consistent with this hypothesis, PrP transcription increased more than tenfold during EMT, and stable PrP-deficient cells failed to complete EMT in a mammalian cell model. A global comparative proteomics analysis identified the neural cell adhesion molecule 1 (NCAM1) as a candidate mediator of this impairment, which led to the observation that PrP-deficient cells fail to undergo NCAM1 polysialylation during EMT. Surprisingly, this defect was caused by a perturbed transcription of the polysialyltransferase ST8SIA2 gene. Proteomics data pointed toward beta-catenin as a transcriptional regulator affected in PrP-deficient cells. Indeed, pharmacological blockade or siRNA-based knockdown of beta-catenin mimicked PrP-deficiency in regards to NCAM1 polysialylation. Our data established the existence of a PrP-ST8SIA2-NCAM signaling loop, merged two mature fields of investigation and offer a simple model for explaining phenotypes linked to PrP.	[Mehrabian, Mohadeseh; Brethour, Dylan; Wang, Hansen; Xi, Zhengrui; Rogaeva, Ekaterina; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Mehrabian, Mohadeseh; Brethour, Dylan; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Rogaeva, Ekaterina] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	wang, hansen/I-2510-2019	wang, hansen/0000-0003-4414-3372	Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation (CFI); Ontario Trillium Scholarship (OTS); W. Garfield Weston Foundation	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Trillium Scholarship (OTS); W. Garfield Weston Foundation	The project received support from the Canadian Institute for Health Research (CIHR) and the Canadian Foundation for Innovation (CFI). MM gratefully acknowledges support from an Ontario Trillium Scholarship (OTS). GS received generous support from the W. Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Carratu MR, 1996, MICROSC RES TECHNIQ, V34, P489, DOI 10.1002/(SICI)1097-0029(19960815)34:6<489::AID-JEMT1>3.0.CO;2-F; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; DAVID G, 1981, J NATL CANCER I, V67, P719; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Ehsani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026800; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8; Glass JD, 2003, NEUROSCIENCE, V117, P203, DOI 10.1016/S0306-4522(02)00817-5; GLASS JD, 1994, NEUROENDOCRINOLOGY, V60, P87; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Herbst A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003755; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; Hu W, 2008, J NEUROL SCI, V264, P1, DOI 10.1016/j.jns.2007.06.019; Jungnickel J, 2012, GLYCOBIOLOGY, V22, P107, DOI 10.1093/glycob/cwr113; Karapetyan YE, 2013, P NATL ACAD SCI US; Kiss JZ, 2001, REV NEUROSCIENCE, V12, P297; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Livstone MS, 2011, CURR PROTOC BIOINFOR; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Massaro AR, 2002, NEUROL SCI, V22, P429, DOI 10.1007/s100720200001; Mathews WR, 2005, J BIOL CHEM, V280, P787, DOI 10.1074/jbc.M411308200; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Mehrabian M, 2014, FRONT CELL DEV BIOL, P2; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Mendelsohn AR, 1999, SCIENCE, V284, P1948, DOI 10.1126/science.284.5422.1948; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Misiewicz M, 2013, J BIOL CHEM; Nicolas O, 2009, BRAIN RES REV, V61, P170, DOI 10.1016/j.brainresrev.2009.06.002; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Premzl M, 2003, GENE, V314, P89, DOI 10.1016/S0378-1119(03)00707-8; Prosser RA, 2003, J NEUROSCI, V23, P652, DOI 10.1523/JNEUROSCI.23-02-00652.2003; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PUCKETT C, 1991, AM J HUM GENET, V49, P320; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Saeki K, 1996, VIRUS GENES, V12, P15, DOI 10.1007/BF00369996; Sakudo A, 2009, CURR MED CHEM, V16, P380, DOI 10.2174/092986709787002673; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008; Shen HM, 1997, J NEUROSCI, V17, P5221; Shen HM, 2001, PHYSIOL BEHAV, V73, P185, DOI 10.1016/S0031-9384(01)00468-1; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Suzuki M, 2003, J BIOL CHEM, V278, P49459, DOI 10.1074/jbc.M308316200; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; Van Doren M, 2003, DEVELOPMENT, V130, P2355, DOI 10.1242/dev.00454; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	71	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133741	10.1371/journal.pone.0133741	http://dx.doi.org/10.1371/journal.pone.0133741			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288071	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600009
J	Sanchez, ZM; Ribeiro, KJ; Wagner, GA				Sanchez, Zila M.; Ribeiro, Karen J.; Wagner, Gabriela A.			Binge Drinking Associations with Patrons' Risk Behaviors and Alcohol Effects after Leaving a Nightclub: Sex Differences in the "Balada com Ciencia" Portal Survey Study in Brazil	PLOS ONE			English	Article							UNITED-STATES; COLLEGE-STUDENTS; EUROPEAN CITIES; CONSUMPTION; GENDER; BARS; INTOXICATION; AGGRESSION; DEPENDENCE; NIGHTLIFE	The purpose of the present study was to investigate the potential associations of binge drinking detected at the exit of nightclubs and risk behaviors and alcohol effects just after leaving the venue in a representative sample of Brazilian nightclub patrons according to sex. For this purpose, a portal survey study called Balada com Ciencia was conducted in 2013 in the megacity of Sao Paulo, Brazil, using a two-stage cluster sampling survey design. Individual-level data were collected in 2422 subjects at the entrance and 1822 subjects at the exit of 31 nightclubs, and breath alcohol concentration (BrAC) was measured using a breathalyzer. The following day, 1222 patrons answered an online follow-up survey that included questions about risk behaviors and alcohol effects practiced just after leaving the nightclub. Weighted logistic regressions were used to analyze binge drinking associated with risk behaviors by sex. For both sexes, the most prevalent risk behaviors practiced after leaving a nightclub were drinking and driving (men=27.9%; women=20.4%), the use of illicit drugs (men=15.8%; women=9.4%) and risky sexual behavior (men=11.4%; women=6.8%). The practice of binge drinking increased the behavior of illicit drug use after leaving the nightclub by 2.54 times [95% CI: 1.26-5.09] among men who drank and increased the risk of an episode of new alcohol use by 5.80 times [95% CI: 1.50-22.44] among women who drank. Alcoholic blackouts were more prevalent among men [OR=8.92; 95% CI: 3.83-20.80] and women [OR=5.31; 95% CI: 1.68-16.84] whose BrAC was equivalent to binge drinking compared with patrons with a lower BrAC. Public policies aiming to reduce patrons' BrAC at the exit of nightclubs, such as staff training in responsible beverage service and legislation to prevent alcohol sales to drunk individuals, would be useful to protect patrons from the risk behaviors associated with binge drinking in nightclubs.	[Sanchez, Zila M.; Ribeiro, Karen J.; Wagner, Gabriela A.] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Sanchez, ZM (corresponding author), Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil.	zila.sanchez@unifesp.br	Sanchez, Zila M/F-7994-2010; Sanchez, Zila M/AAA-2369-2019	Sanchez, Zila M/0000-0002-7427-7956; Sanchez, Zila M/0000-0002-7427-7956	FAPESP (Sao Paulo State Research Foundation) [2011/51658-0]	FAPESP (Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Sao Paulo State Research Foundation) - research grant to Dr. Sanchez (grant number 2011/51658-0) (http://www.bv.fapesp.br/pt/pesquisa/?sort=-data_inicio&q2=%28id_pesquisador_exact%3A106030%29+AND+%28%28situacao_exact%3A%22Em+andamento%22+AND+auxilio%3A%2A%29%29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey A, 2004, AGGRESS VIOLENT BEH, V9, P271, DOI 10.1016/S1359-1789(03)00011-9; ABEP (Associacao Brasileira de Empresas de Pesquisa), 2012, CRIT CLASS EC BRAS; Ammendola A, 2000, ALCOHOL ALCOHOLISM, V35, P368, DOI 10.1093/alcalc/35.4.368; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Bellis MA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-155; Blay N, 2010, PSICOTHEMA, V22, P396; Brewer RD, 2005, JAMA-J AM MED ASSOC, V294, P616, DOI 10.1001/jama.294.5.616; Calafat A, 2011, EUR J PUBLIC HEALTH, V21, P311, DOI 10.1093/eurpub/ckq141; Calafat A, 2009, ADICCIONES, V21, P387, DOI 10.20882/adicciones.226; Carlini C, 2014, DRUG ALCOHOL REV, V33, P358, DOI 10.1111/dar.12155; Castro DS, 2012, DRUG ALCOHOL DEPEN, V126, P272, DOI 10.1016/j.drugalcdep.2012.05.017; Clapp JD, 2007, EVALUATION REV, V31, P469, DOI 10.1177/0193841X07303582; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; Day AM, 2014, ADDICT BEHAV, V39, P354, DOI 10.1016/j.addbeh.2013.10.014; Duarte P, 2010, RELATORIO BRASILEIRO; Duff C, 2008, INT J DRUG POLICY, V19, P384, DOI 10.1016/j.drugpo.2007.07.003; Fernandez-Sola J, 1997, AM J CARDIOL, V80, P481; Graham K, 2004, DRUG ALCOHOL REV, V23, P31, DOI 10.1080/09595230410001645538; Graham K, 2006, ADDICTION, V101, P1569, DOI 10.1111/j.1360-0443.2006.01608.x; Graham K, 2014, DRUG ALCOHOL REV, V33, P393, DOI 10.1111/dar.12153; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P1493, DOI 10.1111/j.1530-0277.2008.00719.x; Grucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P763, DOI 10.1111/j.1530-0277.2008.00635.x; Haffner HT, 2003, INT J LEGAL MED, V117, P276, DOI 10.1007/s00414-003-0384-5; Hughes K, 2014, J EPIDEMIOL COMMUN H, V68, P453, DOI 10.1136/jech-2013-203287; Hughes K, 2011, ADDICTION, V106, P37, DOI 10.1111/j.1360-0443.2010.03316.x; Kelley-Baker Tara, 2008, J Alcohol Drug Educ, V52, P46; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; Kuntsche E, 2004, SOC SCI MED, V59, P113, DOI 10.1016/j.socscimed.2003.10.009; Lange JE, 2000, ADDICTION, V95, P521, DOI 10.1046/j.1360-0443.2000.9545214.x; Lange JE, 2001, PSYCHOL ADDICT BEHAV, V15, P310, DOI 10.1037/0893-164X.15.4.310; Laranjeira R, 2007, 1 BRAZILIAN HOUSEHOL; Laranjeira RR, 2007, BRIT MED J, V335, P735, DOI 10.1136/bmj.39360.432940.BE; Livingston M, 2007, DRUG ALCOHOL REV, V26, P557, DOI 10.1080/09595230701499191; LOFT S, 1987, SCAND J GASTROENTERO, V22, P1251, DOI 10.3109/00365528708996472; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; McClatchley K, 2014, DRUG ALCOHOL REV, V33, P367, DOI 10.1111/dar.12150; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; NIAAA, 2004, NIAAA NEWSLETTER, V3; Norstrom T, 2005, DRUG ALCOHOL REV, V24, P537, DOI 10.1080/09595230500293845; Pechansky F, 2012, REV BRAS PSIQUIATR, V34, P277, DOI 10.1016/j.rbp.2012.06.002; Perham N, 2007, ADDICTION, V102, P377, DOI 10.1111/j.1360-0443.2006.01699.x; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; Rehm J, 2001, EUR ADDICT RES, V7, P138, DOI 10.1159/000050731; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rose ME, 2010, J ADDICT MED, V4, P61, DOI 10.1097/ADM.0b013e3181e1299d; Sanchez ZM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-201; Smith GW, 2011, DRUG ALCOHOL DEPEN, V113, P222, DOI 10.1016/j.drugalcdep.2010.08.010; Testa M, 2004, J STUD ALCOHOL, V65, P320, DOI 10.15288/jsa.2004.65.320; Voas RB, 2006, EVALUATION REV, V30, P44, DOI 10.1177/0193841X05277285; Voas RB, 2013, DRUG ALCOHOL DEPEN, V132, P69, DOI 10.1016/j.drugalcdep.2013.01.014; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; WECHSLER H, 1995, AM J PUBLIC HEALTH, V85, P982, DOI 10.2105/AJPH.85.7.982; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack R. W., 2005, Alcohol, gender and drinking problems: perspectives from low and middle income countries, P1; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zhao GZ, 2010, TRAFFIC INJ PREV, V11, P342, DOI 10.1080/15389581003789573	57	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133646	10.1371/journal.pone.0133646	http://dx.doi.org/10.1371/journal.pone.0133646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287954	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600007
J	Sinclair, EH; Walker, WA; Thomason, JR				Sinclair, Elizabeth H.; Walker, William A.; Thomason, James R.			Body Size Regression Formulae, Proximate Composition and Energy Density of Eastern Bering Sea Mesopelagic Fish and Squid	PLOS ONE			English	Article							NORTHERN FUR SEALS; CALLORHINUS-URSINUS; OTOLITH SIZE; SOUTHERN-CALIFORNIA; MIDWATER FISHES; FORAGE FISHES; FOOD-WEB; PACIFIC; ECOLOGY; WESTERN	The ecological significance of fish and squid of the mesopelagic zone (200 m-1000 m) is evident by their pervasiveness in the diets of a broad spectrum of upper pelagic predators including other fishes and squids, seabirds and marine mammals. As diel vertical migrators, mesopelagic micronekton are recognized as an important trophic link between the deep scattering layer and upper surface waters, yet fundamental aspects of the life history and energetic contribution to the food web for most are undescribed. Here, we present newly derived regression equations for 32 species of mesopelagic fish and squid based on the relationship between body size and the size of hard parts typically used to identify prey species in predator diet studies. We describe the proximate composition and energy density of 31 species collected in the eastern Bering Sea during May 1999 and 2000. Energy values are categorized by body size as a proxy for relative age and can be cross-referenced with the derived regression equations. Data are tabularized to facilitate direct application to predator diet studies and food web models.	[Sinclair, Elizabeth H.; Walker, William A.; Thomason, James R.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Sinclair, EH (corresponding author), NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Seattle, WA 98115 USA.	beth.sinclair@noaa.gov						Anderson Richard O., 1996, P447; Anderson TR, 2010, J MARINE SYST, V81, P4, DOI 10.1016/j.jmarsys.2009.12.015; Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; AOAC, 2002, OFFICIAL METHODS ANA, Vfifteenth; ATKINSON D B, 1991, Journal of Northwest Atlantic Fishery Science, V11, P7; Aydin K, 2007, DEEP-SEA RES PT II, V54, P2501, DOI 10.1016/j.dsr2.2007.08.022; Battaglia P, 2010, SCI MAR, V74, P605, DOI 10.3989/scimar.2010.74n3605; Beamish RJ, 1999, PROG OCEANOGR, V43, P399, DOI 10.1016/S0079-6611(99)00017-8; Bilge G, 2013, ACTA ICHTHYOL PISCAT, V43, P293, DOI 10.3750/AIP2013.43.4.05; CHILDRESS JJ, 1980, MAR BIOL, V61, P27, DOI 10.1007/BF00410339; CHILDRESS JJ, 1973, DEEP-SEA RES, V20, P1093, DOI 10.1016/0011-7471(73)90023-5; Clarke M. R., 1962, Bulletin of the British Museum (Natural History) Zoology, V8, P419; Clarke M.R, 1986, HDB IDENTIFICATION C; Col LA, 2010, SC64EM2 INT WHAL COM; CROXALL JP, 1982, BRIT ANTARCTIC SURV, V55, P27; DONNELLY J, 1990, MAR BIOL, V106, P13, DOI 10.1007/BF02114670; Eder EB, 2005, MAR ECOL PROG SER, V291, P43, DOI 10.3354/meps291043; FITCH JE, 1968, J FISH RES BOARD CAN, V25, P2561, DOI 10.1139/f68-227; Fritz LW, 2005, MAR MAMMAL SCI, V21, P476, DOI 10.1111/j.1748-7692.2005.tb01245.x; Gudmundson CJ, 2006, FISH B-NOAA, V104, P445; Harvey JT, 2000, NOAA TECH REP NMFS, V150; Hidaka K, 2001, DEEP-SEA RES PT I, V48, P1923, DOI 10.1016/S0967-0637(01)00003-6; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Kaartvedt S, 2012, MAR ECOL PROG SER, V456, P1, DOI 10.3354/meps09785; Kubodera T., 1986, B INT N PACIF FISH C, V47, P215; Logerwell Elizabeth A., 2005, Aquatic Mammals, V31, P62, DOI 10.1578/AM.31.1.2005.62; Longenecker K, 2008, PAC SCI, V62, P533, DOI 10.2984/1534-6188(2008)62[533:RBOSAB]2.0.CO;2; LONGHURST AR, 1988, DEEP-SEA RES, V35, P881, DOI 10.1016/0198-0149(88)90065-9; Mori J, 2001, FISH RES, V52, P91, DOI 10.1016/S0165-7836(01)00233-8; Murray J, 38 FAO SIFAR, P200; O'Hea B, 2013, ACTA ICHTHYOL PISCAT, V43, P285, DOI 10.3750/AIP2013.43.4.04; OHIZUMI H, 2001, AQUABIOLOGY, V137, P626; Olsson CO, 1997, IBIS, V139, P504; Payne SA, 1999, FISH OCEANOGR, V8, P159, DOI 10.1046/j.1365-2419.1999.00097.x; Radchenko VI, 2007, RAFFLES B ZOOL, P265; Robinson C, 2010, DEEP-SEA RES PT II, V57, P1504, DOI 10.1016/j.dsr2.2010.02.018; Saila S., 1988, BASIC FISHERY SCI PR; Sinclair EH, 2008, DEEP-SEA RES PT II, V55, P1897, DOI 10.1016/j.dsr2.2008.04.031; Sinclair EH, 1999, UASGCP REP, V99, P485; Sinclair EH, 2002, DEEP-SEA RES PT II, V49, P6127, DOI 10.1016/S0967-0645(02)00337-5; Smale M.J., 1995, ICHTHYOLOGICAL MONOG; Spear LB., 2007, STUD AVIAN BIOL, V35, P1; STICKNEY DG, 1989, MAR BIOL, V103, P13, DOI 10.1007/BF00391060; Tierney M, 2002, ANTARCT SCI, V14, P225, DOI 10.1017/S0954102002000020; Van de Putte A, 2006, POLAR BIOL, V29, P1045, DOI 10.1007/s00300-006-0148-z; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; Waessle JA, 2003, SCI MAR, V67, P233, DOI 10.3989/scimar.2003.67n2233; Walker WA, 2002, MAR MAMMAL SCI, V18, P902, DOI 10.1111/j.1748-7692.2002.tb01081.x; Wolff GA, 1984, NOAA TECH REP NMFS, V17, P50; Yonezaki S, 2011, MAMM STUDY, V36, P159; YOUNG RE, 1978, FISH B-NOAA, V76, P583	51	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0132289	10.1371/journal.pone.0132289	http://dx.doi.org/10.1371/journal.pone.0132289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287534	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600003
J	Desrousseaux, C; Cueff, R; Aumeran, C; Garrait, G; Mailhot-Jensen, B; Traore, O; Sautou, V				Desrousseaux, Camille; Cueff, Regis; Aumeran, Claire; Garrait, Ghislain; Mailhot-Jensen, Benedicte; Traore, Ousmane; Sautou, Valerie			Fabrication of Acrylonitrile-Butadiene-Styrene Nanostructures with Anodic Alumina Oxide Templates, Characterization and Biofilm Development Test for Staphylococcus epidermidis	PLOS ONE			English	Article							BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA; NEEDLELESS CONNECTORS; ESCHERICHIA-COLI; PORE ARRAYS; IN-VITRO; SURFACES; CELL; REPLICATION; TOPOGRAPHY	Medical devices can be contaminated by microbial biofilm which causes nosocomial infections. One of the strategies for the prevention of such microbial adhesion is to modify the biomaterials by creating micro or nanofeatures on their surface. This study aimed (1) to nanostructure acrylonitrile-butadiene-styrene (ABS), a polymer composing connectors in perfusion devices, using Anodic Alumina Oxide templates, and to control the reproducibility of this process; (2) to characterize the physico-chemical properties of the nanostructured surfaces such as wettability using captive-bubble contact angle measurement technique; (3) to test the impact of nanostructures on Staphylococcus epidermidis biofilm development. Fabrication of Anodic Alumina Oxide molds was realized by double anodization in oxalic acid. This process was reproducible. The obtained molds present hexagonally arranged 50 nm diameter pores, with a 100 nm interpore distance and a length of 100 nm. Acrylonitrile-butadiene-styrene nanostructures were successfully prepared using a polymer solution and two melt wetting methods. For all methods, the nanopicots were obtained but inside each sample their length was different. One method was selected essentially for industrial purposes and for better reproducibility results. The flat ABS surface presents a slightly hydrophilic character, which remains roughly unchanged after nanostructuration, the increasing apparent wettability observed in that case being explained by roughness effects. Also, the nanostructuration of the polymer surface does not induce any significant effect on Staphylococcus epidermidis adhesion.	[Desrousseaux, Camille; Cueff, Regis; Mailhot-Jensen, Benedicte; Sautou, Valerie] Univ Auvergne, Clermont Univ, C BIOSENSS, EA 4676, F-63000 Clermont Ferrand, France; [Desrousseaux, Camille; Aumeran, Claire; Traore, Ousmane] Univ Blaise Pascal, Clermont Univ, F-63000 Clermont Ferrand, France; [Desrousseaux, Camille; Aumeran, Claire; Traore, Ousmane] Univ Auvergne, CNRS, UMR 6023, LMGE, F-63000 Clermont Ferrand, France; [Aumeran, Claire; Traore, Ousmane] CHU Clermont Ferrand, Serv Hyg Hosp, F-63003 Clermont Ferrand, France; [Garrait, Ghislain] Univ Auvergne, Clermont Univ, CIDAM, EA 4678, F-63000 Clermont Ferrand, France; [Sautou, Valerie] CHU Clermont Ferrand, Serv Pharm, F-63003 Clermont Ferrand, France	Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Sautou, V (corresponding author), Univ Auvergne, Clermont Univ, C BIOSENSS, EA 4676, BP 10448, F-63000 Clermont Ferrand, France.	vsautou@chu-clermontferrand.fr		MAILHOT-JENSEN, Benedicte/0000-0002-7573-9702; Ghislain, GARRAIT/0000-0001-6939-9142; SAUTOU, Valerie/0000-0002-3944-3752				Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; Affrossman S, 1996, MACROMOLECULES, V29, P5010, DOI 10.1021/ma9516910; An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001; Bico J, 2001, EUROPHYS LETT, V55, P214, DOI 10.1209/epl/i2001-00402-x; Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4; Bokria JG, 2002, POLYMER, V43, P3239, DOI 10.1016/S0032-3861(02)00152-0; Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854; Cheng YT, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895487; Chernecky CC, 2013, AM J INFECT CONTROL, V41, P278, DOI 10.1016/j.ajic.2012.03.020; Choi MK, 2011, LANGMUIR, V27, P2132, DOI 10.1021/la104839a; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015; Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498; Darmanin T, 2014, PROG POLYM SCI, V39, P656, DOI 10.1016/j.progpolymsci.2013.10.003; Desrousseaux C, 2013, J HOSP INFECT, V85, P87, DOI 10.1016/j.jhin.2013.06.015; Donlan RM, 2001, J CLIN MICROBIOL, V39, P750, DOI 10.1128/JCM.39.2.750-753.2001; Efte-khari A, NANOSTRUCTURED MAT E, P59; Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102; Ercan B, 2011, ACTA BIOMATER, V7, P3003, DOI 10.1016/j.actbio.2011.04.002; Fu Q, 2004, J AM CHEM SOC, V126, P8904, DOI 10.1021/ja047895q; Geoghegan M, 2008, FARADAY DISCUSS, V139, P85, DOI 10.1039/b717046g; Goh C, 2005, NANO LETT, V5, P1545, DOI 10.1021/nl050704c; Grimm S, 2008, NANO LETT, V8, P1954, DOI 10.1021/nl080842c; HEITZ J, 1994, APPL PHYS A-MATER, V59, P289, DOI 10.1007/BF00348232; Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k; Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316; Hui CY, 2002, LANGMUIR, V18, P1394, DOI 10.1021/la0113567; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; Jin L, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/5/055702; Kobayashi H, 2009, CLIN ORTHOP RELAT R, V467, P1360, DOI 10.1007/s11999-008-0609-5; Lee W, 2004, LANGMUIR, V20, P7665, DOI 10.1021/la049411+; Lee W, 2002, ADV MATER, V14, P1187, DOI 10.1002/1521-4095(20020903)14:17<1187::AID-ADMA1187>3.0.CO;2-X; Lee Y, 2008, THIN SOLID FILMS, V516, P3431, DOI 10.1016/j.tsf.2007.12.131; Li AP, 1998, J APPL PHYS, V84, P6023, DOI 10.1063/1.368911; Li JY, 2012, SURF COAT TECH, V206, P2161, DOI 10.1016/j.surfcoat.2011.09.052; Martin J, 2009, LANGMUIR, V25, P1181, DOI 10.1021/la803127w; Miikkulainen V, 2008, LANGMUIR, V24, P4473, DOI 10.1021/la800285s; Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8; Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o; Pasquali M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/37/375605; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pokroy B, 2009, ADV MATER, V21, P463, DOI 10.1002/adma.200801432; Puukilainen E, 2007, LANGMUIR, V23, P7263, DOI 10.1021/la063588h; Puukilainen E, 2006, COLLOID SURFACE A, V287, P175, DOI 10.1016/j.colsurfa.2006.03.056; Quere D, 2002, PHYSICA A, V313, P32, DOI 10.1016/S0378-4371(02)01033-6; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039; Roca-Cusachs P, 2005, LANGMUIR, V21, P5542, DOI 10.1021/la046931w; Santos RM, 2010, J APPL POLYM SCI, V116, P2005, DOI 10.1002/app.31663; Saviello D, 2014, ANAL CHIM ACTA, V843, P59, DOI 10.1016/j.aca.2014.07.021; Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728; Smart T, 2008, NANO TODAY, V3, P38, DOI 10.1016/S1748-0132(08)70043-4; Stormonth-Darling JM, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/7/075019; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Tan JS, 2008, J POROUS MAT, V15, P619, DOI 10.1007/s10934-007-9141-3; Tarrade J, 2014, APPL SURF SCI, V292, P782, DOI 10.1016/j.apsusc.2013.12.051; VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893, DOI 10.1128/AEM.53.8.1893-1897.1987; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995; Wypych G., 2012, HDB POLYM, P3; Xu LC, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035003; Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009; Yao C, 2014, J BIOMED MATER RES A, V102, P1823, DOI 10.1002/jbm.a.34856; Yoon SH, 2014, J FOOD ENG, V131, P135, DOI 10.1016/j.jfoodeng.2014.01.031; Yu WQ, 2011, J BIOMED MATER RES B, V99B, P207, DOI 10.1002/jbm.b.31888; Zhang FX, 2010, J COLLOID INTERF SCI, V343, P109, DOI 10.1016/j.jcis.2009.11.038; Zhang Y, 2006, LANGMUIR, V22, P8595, DOI 10.1021/la061372+; Zhong P, 2010, NANO-MICRO LETT, V2, P1, DOI 10.5101/nml.v2i1.p1-5; Zhou WM, 2009, APPL SURF SCI, V255, P8019, DOI 10.1016/j.apsusc.2009.05.006	71	20	22	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135632	10.1371/journal.pone.0135632	http://dx.doi.org/10.1371/journal.pone.0135632			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284922	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100052
J	Jia, YM; Xie, YT; Wang, YJ; Han, JY; Tian, XX; Fang, WG				Jia, Yu-Mian; Xie, Yun-Tao; Wang, Ya-Jun; Han, Ji-Yuan; Tian, Xin-Xia; Fang, Wei-Gang			Association of Genetic Polymorphisms in CDH1 and CTNNB1 with Breast Cancer Susceptibility and Patients' Prognosis among Chinese Han Women	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SINGLE-NUCLEOTIDE POLYMORPHISMS; WNT SIGNALING PATHWAY; BETA-CATENIN; E-CADHERIN; GASTRIC-CANCER; OVARIAN CARCINOMAS; MUTATIONS; RISK; POPULATION	This study aims to investigate whether the germline variants in CDH1 and CTNNB1 would affect breast cancer susceptibility and patients' prognosis among Chinese Han women using a haplotype-based association analysis. We genotyped 12 haplotype-tagging single nucleotide polymorphisms (htSNPs) in CDH1 and CTNNB1 among 1,160 BC cases and 1,336 age-matched cancer-free controls using the TaqMan (R) Genotyping Assay. For association analyses of germline variants with breast cancer susceptibility, the results showed that rs7200690, rs7198799, rs17715799, rs13689 and diplotype CGC/TGC (rs7200690 + rs12185157 + rs7198799) in CDH1 as well as rs2293303 in CTNNB1 were associated with increased breast cancer risk. In addition, the Generalized Multifactor Dimensionality Reduction (GMDR) and logistic regression analysis predicted an interaction on breast cancer risk between rs17715799 and rs13689 as well as rs13689 and menarche-FFTP (First Full-Term Pregnancy) interval. For survival analyses, the results demonstrated that the minor allele homozygotes of rs13689 and haplotype TGC in CDH1 were linked with unfavorable event-free survival of breast cancer, whereas, rs4783689 of CDH1 showed the opposite effect under dominant model. Notably, the stratified analysis revealed that rs7186053 was associated with favorable event-free survival among patients with estrogen receptor (ER)-positive, progesterone receptor (PR)-positive or lymph node metastasis negative patients. Moreover, rs7200690 and rs7198799 in CDH1 as well as rs4533622 in CTNNB1 were associated with worse event-free survival among patients with clinical stage 0-I tumors. This study indicated that the genetic polymorphisms of CDH1 and CTNNB1 were associated with breast cancer susceptibility and patients' prognosis.	[Jia, Yu-Mian; Wang, Ya-Jun; Han, Ji-Yuan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ,Sch Basic Med Sci, Beijing 100871, Peoples R China; [Jia, Yu-Mian; Wang, Ya-Jun; Han, Ji-Yuan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Dept Pathol, Hosp 3, Beijing 100871, Peoples R China; [Xie, Yun-Tao] Peking Univ, Sch Oncol, Breast Ctr, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Tian, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ,Sch Basic Med Sci, Beijing 100871, Peoples R China.	tianxinxia@163.com; wgfang@bjmu.edu.cn			National Natural Science Foundation of China [81171961, 81321003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants to XXT and WGF from the National Natural Science Foundation of China (no 81171961 and No 81321003) [http://www.nsfc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim Dalia, 2009, J Egypt Natl Canc Inst, V21, P185; Alanazi MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059555; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beeghly-Fadiel A, 2010, BREAST CANCER RES TR, V121, P445, DOI 10.1007/s10549-009-0579-7; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Black Michael D, 2014, Hawaii J Med Public Health, V73, P204; Chen QH, 2013, WORLD J GASTROENTERO, V19, P909, DOI 10.3748/wjg.v19.i6.909; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Cui Y, 2011, DNA CELL BIOL, V30, P937, DOI 10.1089/dna.2011.1257; Dapic Vesna, 2005, Cancer Control, V12, P127; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Fanelli MA, 2008, CELL STRESS CHAPERON, V13, P207, DOI 10.1007/s12192-007-0007-z; Ferlay J, 2014, INT J CANC J INT CAN; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goode EL, 2002, CANCER RES, V62, P3052; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Han JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049296; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Karabacak T, 2011, TURK J PATHOL, V27, P185, DOI 10.5146/tjpath.2011.01073; Kizildag S, 2008, J BUON, V13, P533; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Lei HX, 2002, INT J CANCER, V98, P199, DOI 10.1002/ijc.10176; Li LC, 2000, CANCER RES, V60, P873; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084489; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Masciari S, 2007, J MED GENET, V44, P726, DOI 10.1136/jmg.2007.051268; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924; Mostowska A, 2014, MOL DIAGN THER, V18, P85, DOI 10.1007/s40291-013-0059-y; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Ruan Y, 2011, J PATHOL, V225, P535, DOI 10.1002/path.2902; Saegusa M, 2001, J PATHOL, V194, P59, DOI 10.1002/path.856; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Ting WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056196; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wang H, 2012, BREAST CANCER RES TR, V136, P241, DOI 10.1007/s10549-012-2244-9; Wang SZ, 2012, MUTAGENESIS, V27, P623, DOI 10.1093/mutage/ges027; Xie ZM, 2011, CANCER-AM CANCER SOC, V117, P3112, DOI 10.1002/cncr.25876; Yu JC, 2006, J BIOMED SCI, V13, P419, DOI 10.1007/s11373-006-9069-7; Zhan Z, 2012, MOL BIOL REP, V39, P8107, DOI 10.1007/s11033-012-1658-0; Zhang XF, 2008, DIS ESOPHAGUS, V21, P21, DOI 10.1111/j.1442-2050.2007.00724.x	45	14	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135865	10.1371/journal.pone.0135865	http://dx.doi.org/10.1371/journal.pone.0135865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285011	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100077
J	Rouse, EJ; Villagaray-Carski, NC; Emerson, RW; Herr, HM				Rouse, Elliott J.; Villagaray-Carski, Nathan C.; Emerson, Robert W.; Herr, Hugh M.			Design and Testing of a Bionic Dancing Prosthesis	PLOS ONE			English	Article							ANKLE-FOOT PROSTHESIS; WALKING	Traditionally, prosthetic leg research has focused on improving mobility for activities of daily living. Artistic expression such as dance, however, is not a common research topic and consequently prosthetic technology for dance has been severely limited for the disabled. This work focuses on investigating the ankle joint kinetics and kinematics during a Latin-American dance to provide unique motor options for disabled individuals beyond those of daily living. The objective of this study was to develop a control system for a bionic ankle prosthesis that outperforms conventional prostheses when dancing the rumba. The biomechanics of the ankle joint of a non-amputee, professional dancer were acquired for the development of the bionic control system. Subsequently, a professional dancer who received a traumatic transtibial amputation in April 2013 tested the bionic dance prosthesis and a conventional, passive prosthesis for comparison. The ability to provide similar torque-angle behavior of the biological ankle was assessed to quantify the biological realism of the prostheses. The bionic dancing prosthesis overlapped with 37 +/- 6% of the non-amputee ankle torque and ankle angle data, compared to 26 +/- 2% for the conventional, passive prosthesis, a statistically greater overlap (p = 0.01). This study lays the foundation for quantifying unique, expressive activity modes currently unavailable to individuals with disabilities. Future work will focus on an expansion of the methods and types of dance investigated in this work.	[Rouse, Elliott J.; Villagaray-Carski, Nathan C.; Herr, Hugh M.] MIT, Biomechatron Grp, Media Lab, Cambridge, MA 02139 USA; [Villagaray-Carski, Nathan C.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Emerson, Robert W.] Step Ahead Prosthet, Burlington, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Herr, HM (corresponding author), MIT, Biomechatron Grp, Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hherr@media.mit.edu	Rouse, Elliott/AAP-1756-2021	Rouse, Elliott/0000-0003-3880-1527	MIT Media Lab	MIT Media Lab	The authors used consortia funding from the MIT Media Lab to fund this work.	Au SK, 2008, IEEE ROBOT AUTOM MAG, V15, P52, DOI 10.1109/MRA.2008.927697; Hargrove LJ, 2013, NEW ENGL J MED, V369, P1237, DOI 10.1056/NEJMoa1300126; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; KEARNEY RE, 1990, CRIT REV BIOMED ENG, V18, P55; Rouse EJ, 2014, IEEE T NEUR SYS REH, V22, P870, DOI 10.1109/TNSRE.2014.2307256; Sup F, 2009, IEEE-ASME T MECH, V14, P667, DOI 10.1109/TMECH.2009.2032688	6	12	12	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135148	10.1371/journal.pone.0135148	http://dx.doi.org/10.1371/journal.pone.0135148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285201	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100023
J	Sugimori, M; Hayakawa, Y; Boman, BM; Fields, JZ; Awaji, M; Kozano, H; Tamura, R; Yamamoto, S; Ogata, T; Yamada, M; Endo, S; Kurimoto, M; Kuroda, S				Sugimori, Michiya; Hayakawa, Yumiko; Boman, Bruce M.; Fields, Jeremy Z.; Awaji, Miharu; Kozano, Hiroko; Tamura, Ryoi; Yamamoto, Seiji; Ogata, Toru; Yamada, Mitsuhiko; Endo, Shunro; Kurimoto, Masanori; Kuroda, Satoshi			Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations	PLOS ONE			English	Article							TUMOR-GROWTH; CANCER; TEMOZOLOMIDE; EVOLUTION	Background Accumulating evidence indicates that cancer stem cells (CSCs) drive tumorigenesis. This suggests that CSCs should make ideal therapeutic targets. However, because CSC populations in tumors appear heterogeneous, it remains unclear how CSCs might be effectively targeted. To investigate the mechanisms by which CSC populations maintain heterogeneity during self-renewal, we established a glioma sphere (GS) forming model, to generate a population in which glioma stem cells (GSCs) become enriched. We hypothesized, based on the clonal evolution concept, that with each passage in culture, heterogeneous clonal sub-lines of GSs are generated that progressively show increased proliferative ability. Methodology/Principal Findings To test this hypothesis, we determined whether, with each passage, glioma neurosphere culture generated from four different glioma cell lines become progressively proliferative (i.e., enriched in large spheres). Rather than monitoring self-renewal, we measured heterogeneity based on neurosphere clone sizes (#cells/clone). Log-log plots of distributions of clone sizes yielded a good fit (r>0.90) to a straight line (log(% total clones) = k* log(#cells/clone)) indicating that the system follows a power-law (y = x(k)) with a specific degree exponent (k = -1.42). Repeated passaging of the total GS population showed that the same power-law was maintained over six passages (CV = -1.01 to -1.17). Surprisingly, passage of either isolated small or large subclones generated fully heterogeneous populations that retained the original power-law-dependent heterogeneity. The anti-GSC agent Temozolomide, which is well known as a standard therapy for glioblastoma multiforme (GBM), suppressed the self-renewal of clones, but it never disrupted the power-law behavior of a GS population. Conclusions/Significance Although the data above did not support the stated hypothesis, they did strongly suggest a novel mechanism that underlies CSC heterogeneity. They indicate that power-law growth governs the self-renewal of heterogeneous glioma stem cell populations. That the data always fit a power-law suggests that: (i) clone sizes follow continuous, non-random, and scale-free hierarchy; (ii) precise biologic rules that reflect self-organizing emergent behaviors govern the generation of neurospheres. That the power-law behavior and the original GS heterogeneity are maintained over multiple passages indicates that these rules are invariant. These self-organizing mechanisms very likely underlie tumor heterogeneity during tumor growth. Discovery of this power-law behavior provides a mechanism that could be targeted in the development of new, more effective, anti-cancer agents.	[Sugimori, Michiya; Awaji, Miharu; Kozano, Hiroko; Tamura, Ryoi] Toyama Univ, Dept Integrat Neurosci, Toyama, Toyama 9300194, Japan; [Hayakawa, Yumiko; Endo, Shunro; Kurimoto, Masanori; Kuroda, Satoshi] Toyama Univ, Dept Neurosurg, Toyama, Toyama 9300194, Japan; [Boman, Bruce M.] Univ Delaware, Dept Biol, Ctr Translat Canc Res, Helen F Graham Canc Ctr, Newark, DE 19711 USA; [Boman, Bruce M.] Univ Delaware, Dept Math, Ctr Translat Canc Res, Helen F Graham Canc Ctr, Newark, DE 19711 USA; [Boman, Bruce M.] Res Inst, Newark, DE 19711 USA; [Fields, Jeremy Z.] CATX Inc, Biotech Res, Gladwyne, PA 19035 USA; [Yamamoto, Seiji] Toyama Univ, Dept Pathol, Toyama, Toyama 9300194, Japan; [Ogata, Toru] NRCD Hosp, Natl Rehabil Ctr Persons Disabil, Ctr Sports Sci & Hlth Promot, Tokorozawa, Saitama 3598555, Japan; [Yamada, Mitsuhiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsycopharmacol, Kodaira, Tokyo 1878553, Japan	University of Toyama; University of Toyama; Helen F. Graham Cancer Center & Research Institute; University of Delaware; Helen F. Graham Cancer Center & Research Institute; University of Delaware; University of Toyama; National Center for Neurology & Psychiatry - Japan	Sugimori, M (corresponding author), Toyama Univ, Dept Integrat Neurosci, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	sugimmic@med.u-toyama.ac.jp	Yamamoto, Seiji/U-8660-2018; Ogata, Toru/ADC-3560-2022; Yamada, Mitsuhiko/AAO-1107-2020	Yamamoto, Seiji/0000-0003-1007-6271; Ogata, Toru/0000-0001-9011-8640; Yamada, Mitsuhiko/0000-0002-5649-2310	Ministry of Education, Culture, Sports, Science and Technology, Japan [21591866]; Takeda Science Foundation; Uehara Memorial Foundation [201010211]; Intramural Research Grant for Neurological and Psychiatric Disorders in NCNP [24-2];  [21700379];  [23300204]; Grants-in-Aid for Scientific Research [26350992, 25293093, 25293305] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Intramural Research Grant for Neurological and Psychiatric Disorders in NCNP; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from The Ministry of Education, Culture, Sports, Science and Technology, Japan (21591866 to M.K.); in part supported by a grant-in-aid for young scientists (B) (21700379 to M.S.); grant-in-aid (23300204 to T.O.); Takeda Science Foundation (to M.S.); the Uehara Memorial Foundation (201010211 to M.S.); Intramural Research Grant 24-2 (to M.Y.) for Neurological and Psychiatric Disorders in NCNP. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author J.Z.F. is an emeritus scientist of CATX, Inc. and did not receive a salary from CATX, Inc. CATX, Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. NO FUNDING WAS PROVIDED BY CATX, INC., NOT EVEN AUTHORS' SALARIES. No monetary support was provided by CATX for the study or for J.Z.F.'s salary.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; BUICK RN, 1984, CANCER RES, V44, P4909; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Denysenko T, 2010, CELL BIOCHEM FUNCT, V28, P343, DOI 10.1002/cbf.1666; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jordan CT, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000914; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Loeffler M, 2002, CELLS TISSUES ORGANS, V171, P8, DOI 10.1159/000057688; Mandelbrot BB, 1998, SCIENCE, V279, P783; Mertins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057099; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Opdenaker LM, 2009, STEM CELLS CANC PARA, P90; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Prestegarden L, 2010, CANCER RES, V70, P4274, DOI 10.1158/0008-5472.CAN-09-3904; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rutka JT, 2009, J NEURO-ONCOL, V92, P261, DOI 10.1007/s11060-009-9829-0; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Setoguchi T, 2004, CELL CYCLE, V3, P414; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Tsuboi Y, 2009, J NEUROSURG, V110, P594, DOI 10.3171/2008.8.JNS17648; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010	45	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135760	10.1371/journal.pone.0135760	http://dx.doi.org/10.1371/journal.pone.0135760			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284929	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100068
J	Wang, BB; Gao, L; Zhang, QF; Li, AM; Deng, Y; Guo, XL				Wang, Bingbo; Gao, Lin; Zhang, Qingfang; Li, Aimin; Deng, Yue; Guo, Xingli			Diversified Control Paths: A Significant Way Disease Genes Perturb the Human Regulatory Network	PLOS ONE			English	Article							PROTEOME-SCALE MAP; AMYLOID-BETA; CONTROLLABILITY; EXPRESSION; CELL	Background The complexity of biological systems motivates us to use the underlying networks to provide deep understanding of disease etiology and the human diseases are viewed as perturbations of dynamic properties of networks. Control theory that deals with dynamic systems has been successfully used to capture systems-level knowledge in large amount of quantitative biological interactions. But from the perspective of system control, the ways by which multiple genetic factors jointly perturb a disease phenotype still remain. Results In this work, we combine tools from control theory and network science to address the diversified control paths in complex networks. Then the ways by which the disease genes perturb biological systems are identified and quantified by the control paths in a human regulatory network. Furthermore, as an application, prioritization of candidate genes is presented by use of control path analysis and gene ontology annotation for definition of similarities. We use leave-one-out cross-validation to evaluate the ability of finding the gene-disease relationship. Results have shown compatible performance with previous sophisticated works, especially in directed systems. Conclusions Our results inspire a deeper understanding of molecular mechanisms that drive pathological processes. Diversified control paths offer a basis for integrated intervention techniques which will ultimately lead to the development of novel therapeutic strategies.	[Wang, Bingbo; Gao, Lin; Zhang, Qingfang; Deng, Yue; Guo, Xingli] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Deng, Yue] Xidian Univ, Inst Software Engn, Xian, Peoples R China; [Li, Aimin] Xian Univ Technol, Sch Comp Sci & Technol, Xian, Peoples R China	Xidian University; Xidian University; Xi'an University of Technology	Wang, BB (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	w_bingbo@163.com; lgao@mail.xidian.edu.cn		Li, Aimin/0000-0002-6983-2310				Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Asgari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079397; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backes C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1227; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheng XR, 2013, J ALZHEIMERS DIS, V37, P823, DOI 10.3233/JAD-130836; Cho M, 2013, J CANCER, V4, P671, DOI 10.7150/jca.7118; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gao JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6415; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jia T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02354; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Kapelko-Slowik K, 2013, POSTEP HIG MED DOSW, V67, P553, DOI 10.5604/17322693.1052449; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kuntzer J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-367; Kuhn HW, 2005, NAV RES LOG, V52, P7, DOI 10.1002/nav.20053; Lebeck J, 2012, ACTA DIABETOL, V49, pS215, DOI 10.1007/s00592-012-0430-1; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; POLJAK S, 1990, IEEE T AUTOMAT CONTR, V35, P367, DOI 10.1109/9.50361; Rajapakse I, 2011, P NATL ACAD SCI USA, V108, P17257, DOI 10.1073/pnas.1113249108; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; Sun J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208701; Tran K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087973, DOI 10.1371/J0URNAL.P0NE.0087973]; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang BB, 2014, SCI REP-UK, V4, DOI 10.1038/srep05399; Wang BB, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/58003; Wang BB, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/04/P04011; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wuchty S, 2014, P NATL ACAD SCI USA, V111, P7156, DOI 10.1073/pnas.1311231111; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; Zhao LJ, 2012, ASIAN PAC J CANCER P, V13, P3631, DOI 10.7314/APJCP.2012.13.8.3631; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	48	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135491	10.1371/journal.pone.0135491	http://dx.doi.org/10.1371/journal.pone.0135491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284649	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100042
J	Yang, EJ; Ahn, S; Ryu, J; Choi, MS; Choi, S; Chong, YH; Hyun, JW; Chang, MJ; Kim, HS				Yang, Eun-Jeong; Ahn, Sangzin; Ryu, Junghwa; Choi, Moon-Seok; Choi, Shinkyu; Chong, Young Hae; Hyun, Jin-Won; Chang, Moon-Jeong; Kim, Hye-Sun			Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							INDUCED CELL-DAMAGE; PAIRED HELICAL FILAMENTS; AMYLOID PLAQUE-FORMATION; PROTEIN-TAU TAU; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; HYDROGEN-PEROXIDE; TRANSGENIC MICE; IN-VITRO; ANTIOXIDANT PROPERTIES	Alzheimer's disease (AD) is the most common form of dementia among the elderly. Neuritic plaques whose primary component is amyloid beta peptide (A beta) and neurofibrillary tangles which are composed of hyperphosphorylated tau, are known to be the neuropathological hallmarks of AD. In addition, impaired synaptic plasticity in neuronal networks is thought to be important mechanism underlying for the cognitive deficits observed in AD. Although various causative factors, including excitotoxicity, mitochondrial dysregulation and oxidative damage caused by A beta, are involved in early onset of AD, fundamental therapeutics that can modify the progression of this disease are not currently available. In the present study, we investigated whether phloroglucinol (1, 3, 5-trihydroxybenzene), a component of phlorotannins, which are plentiful in Ecklonia cava, a marine brown alga species, displays therapeutic activities in AD. We found that phloroglucinol attenuates the increase in reactive oxygen species (ROS) accumulation induced by oligomeric A beta(1-42) (A beta(1-42)) treatment in HT-22, hippocampal cell line. In addition, phloroglucinol was shown to ameliorate the reduction in dendritic spine density induced by A beta(1-42) treatment in rat primary hippocampal neuron cultures. We also found that the administration of phloroglucinol to the hippocampal region attenuated the impairments in cognitive dysfunction observed in 22-week-old 5XFAD (Tg6799) mice, which are used as an AD animal model. These results indicate that phloroglucinol displays therapeutic potential for AD by reducing the cellular ROS levels.	[Yang, Eun-Jeong; Ahn, Sangzin; Ryu, Junghwa; Choi, Moon-Seok; Choi, Shinkyu] Seoul Natl Univ, Coll Med, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Chong, Young Hae] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Hyun, Jin-Won] Jeju Natl Univ, Sch Med, Dept Biochem, Jeju, South Korea; [Chang, Moon-Jeong] Kookmin Univ, Dept Foods & Nutr, Coll Nat Sci, Seoul, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Songnam, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea	Seoul National University (SNU); Ewha Womans University; Jeju National University; Kookmin University; Seoul National University (SNU); Seoul National University (SNU)	Chang, MJ (corresponding author), Kookmin Univ, Dept Foods & Nutr, Coll Nat Sci, Seoul, South Korea.	cmoon@kookmin.ac.kr; hyisun@snu.ac.kr	Ryu, Junghwa/K-4034-2015; Ahn, Sangzin/E-8807-2016	Ahn, Sangzin/0000-0003-2749-0014; Choi, Moonseok/0000-0002-2816-239X	Korea Healthcare Technology R&D Project by the Ministry for Health, Welfare and Family Affairs of the Republic of Korea [HI12C0983]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0021866]	Korea Healthcare Technology R&D Project by the Ministry for Health, Welfare and Family Affairs of the Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was financially supported by grants from the Korea Healthcare Technology R&D Project (HI12C0983) by the Ministry for Health, Welfare and Family Affairs of the Republic of Korea and the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (grant number 2011-0021866).	Abdul HM, 2006, J NEUROCHEM, V96, P1322, DOI 10.1111/j.1471-4159.2005.03647.x; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Balboa EM, 2013, FOOD CHEM, V138, P1764, DOI 10.1016/j.foodchem.2012.11.026; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Devi L, 2014, NEUROBIOL AGING, V35, P2272, DOI 10.1016/j.neurobiolaging.2014.04.031; Dinamarca MC, 2006, MOL PSYCHIATR, V11, P1032, DOI 10.1038/sj.mp.4001866; Du H, 2014, BBA-MOL BASIS DIS, V1842, P2517, DOI 10.1016/j.bbadis.2013.03.004; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V425, P534, DOI DOI 10.1016/J.BBRC.2012.08.020; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Kamsler A, 2003, J NEUROSCI, V23, P269; Kang KA, 2006, J CELL BIOCHEM, V97, P609, DOI 10.1002/jcb.20668; Kang KA, 2010, CHEM-BIOL INTERACT, V185, P215, DOI 10.1016/j.cbi.2010.02.031; Katsuki H, 1997, EUR J PHARMACOL, V337, P213, DOI 10.1016/S0014-2999(97)01323-X; Kim HS, 2012, J PHARMACOL SCI, V119, P186, DOI 10.1254/jphs.12056FP; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsuoka Y, 2001, NEUROSCIENCE, V104, P609, DOI 10.1016/S0306-4522(01)00115-4; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Moon C, 2008, PHYTOTHER RES, V22, P238, DOI 10.1002/ptr.2298; Morris JK, 2014, BBA-MOL BASIS DIS, V1842, P1340, DOI 10.1016/j.bbadis.2014.04.012; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Parajuli B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.503; Piao MJ, 2014, INT J RADIAT BIOL, V90, P928, DOI 10.3109/09553002.2014.911990; Queguineur B, 2012, FOOD CHEM TOXICOL, V50, P2886, DOI 10.1016/j.fct.2012.05.026; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Ripoli C, 2013, NEUROBIOL AGING, V34, P1032, DOI 10.1016/j.neurobiolaging.2012.06.027; Ruszkiewicz J., 2015, NEUROCHEMISTRY INT; Ryu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071178; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; So Mi Jung, 2014, Prev Nutr Food Sci, V19, P129, DOI 10.3746/pnf.2014.19.3.129; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zeng YQ, 2015, J NEUROCHEM, V133, P38, DOI 10.1111/jnc.13056	52	43	45	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135686	10.1371/journal.pone.0135686	http://dx.doi.org/10.1371/journal.pone.0135686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284625	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100058
J	Pruller, S; Rensch, U; Meemken, D; Kaspar, H; Kopp, PA; Klein, G; Kehrenberg, C				Prueller, Sandra; Rensch, Ulrike; Meemken, Diana; Kaspar, Heike; Kopp, Peter A.; Klein, Guenter; Kehrenberg, Corinna			Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; PASTEURELLA-MULTOCIDA; ESCHERICHIA-COLI; ANTIBIOTIC SUSCEPTIBILITY; RESPIRATORY-INFECTIONS; PATHOGENIC BACTERIA; ATROPHIC RHINITIS; BETA-LACTAMASE; PIGS; CHLORAMPHENICOL	Bordetella bronchiseptica causes infections of the respiratory tract in swine and other mammals and is a precursor for secondary infections with Pasteurella multocida. Treatment of B. bronchiseptica infections is conducted primarily with antimicrobial agents. Therefore it is essential to get an overview of the susceptibility status of these bacteria. The aim of this study was to comparatively analyse broth microdilution susceptibility testing according to CLSI recommendations with an incubation time of 16 to 20 hours and a longer incubation time of 24 hours, as recently proposed to obtain more homogenous MICs. Susceptibility testing against a panel of 22 antimicrobial agents and two fixed combinations was performed with 107 porcine isolates from different farms and regions in Germany and 43 isolates obtained from companion animals in Germany and other European countries. Isolates with increased MICs were investigated by PCR assays for the presence of resistance genes. For ampicillin, all 107 porcine isolates were classified as resistant, whereas only a single isolate was resistant to florfenicol. All isolates obtained from companion animals showed elevated MICs for beta-lactam antibiotics and demonstrated an overall low susceptibility to cephalosporines. Extension of the incubation time resulted in 1-2 dilution steps higher MIC50 values of porcine isolates for seven antimicrobial agents tested, while isolates from companion animals exhibited twofold higher MIC50/90 values only for tetracycline and cefotaxime. For three antimicrobial agents, lower MIC50 and MIC90 values were detected for both, porcine and companion animal isolates. Among the 150 isolates tested, the resistance genes bla(BOR-1) (n = 147), bla(OXA-2), (n = 4), strA and strB (n = 17), sul1 (n = 10), sul2 (n = 73), dfrA7 (n = 3) and tet(A) (n = 8) were detected and a plasmid localisation was identified for several of the resistance genes.	[Prueller, Sandra; Rensch, Ulrike; Meemken, Diana; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, D-30173 Hannover, Germany; [Kaspar, Heike] Fed Off Consumer Protect & Food Safety BVL, Berlin, Germany; [Kopp, Peter A.] Vet Med Lab GmbH, Div IDEXX Labs, Ludwigsburg, Germany	University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Bischofsholer Damm 15, D-30173 Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Klein, Günter/G-5321-2013; Kehrenberg, Corinna/GSI-9835-2022	Klein, Günter/0000-0003-1931-2701; 	Federal Ministry of Food and Agriculture (BMEL) through the German Antibiotics Resistance Strategy (DART) project [FKZ 2811HS010]; Vet Med Labor GmbH	Federal Ministry of Food and Agriculture (BMEL) through the German Antibiotics Resistance Strategy (DART) project; Vet Med Labor GmbH	This study was financially supported by the Federal Ministry of Food and Agriculture (BMEL) through the German Antibiotics Resistance Strategy (DART) project (grant number FKZ 2811HS010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vet Med Labor GmbH provided support in the form of a salary for author PAK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Bert F, 2002, J ANTIMICROB CHEMOTH, V50, P11, DOI 10.1093/jac/dkf069; Bose A, 2008, CLIN MICROBIOL NEWSL, V30, P117; Brockmeier SL, 2007, VET MICROBIOL, V125, P284, DOI 10.1016/j.vetmic.2007.05.022; Brockmeier S.L., 2012, DIS SWINE, P670; Burton PJ, 1996, J VET DIAGN INVEST, V8, P464, DOI 10.1177/104063879600800411; Chalker VJ, 2003, CLIN DIAGN LAB IMMUN, V10, P352, DOI 10.1128/CDLI.10.3.352-356.2003; Chander Y, 2011, VET J, V187, P139, DOI 10.1016/j.tvjl.2009.10.013; CHIOU CS, 1995, GENE, V152, P47, DOI 10.1016/0378-1119(94)00721-4; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Clinical and Laboratory Standards Institute, 2013, VET01A4 CLSI; Dayao DAE, 2014, VET MICROBIOL, V171, P232, DOI 10.1016/j.vetmic.2014.03.014; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; DEEB BJ, 1990, J CLIN MICROBIOL, V28, P70, DOI 10.1128/JCM.28.1.70-75.1990; DeRosa DC, 2000, J VET DIAGN INVEST, V12, P541, DOI 10.1177/104063870001200608; Dunkel B, 2015, J VET EMERG CRIT CAR, V25, P89, DOI 10.1111/vec.12275; Fonseca EL, 2006, J CLIN MICROBIOL, V44, P2767, DOI 10.1128/JCM.01916-05; Frech G, 2000, J APPL MICROBIOL, V89, P633, DOI 10.1046/j.1365-2672.2000.01160.x; Frech G, 2003, J ANTIMICROB CHEMOTH, V51, P180, DOI 10.1093/jac/dkg058; Garcia-Cantu MC, 2000, EQUINE VET EDUC, V12, P45, DOI 10.1111/j.2042-3292.2000.tb01763.x; Garcia-de-la-Fuente C, 2015, DIAGN MICROBIOL INFE; GILES CJ, 1980, VET REC, V106, P25, DOI 10.1136/vr.106.2.25; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Hansen LM, 1996, ANTIMICROB AGENTS CH, V40, P1558, DOI 10.1128/AAC.40.6.1558; Horiguchi Y, 2012, CURR TOP MICROBIOL, V361, P113, DOI 10.1007/82_2012_206; Hozbor D, 1999, RES MICROBIOL, V150, P333, DOI 10.1016/S0923-2508(99)80059-X; Kadlec K, 2005, J ANTIMICROB CHEMOTH, V56, P485, DOI 10.1093/jac/dki262; Kadlec K, 2004, ANTIMICROB AGENTS CH, V48, P4903, DOI 10.1128/AAC.48.12.4903-4906.2004; Kadlec K, 2007, J ANTIMICROB CHEMOTH, V59, P396, DOI 10.1093/jac/dkl515; Kadlec K, 2006, J ANTIMICROB CHEMOTH, V58, P225, DOI 10.1093/jac/dkl149; Karriker L. A., 2012, DIS SWINE, P106; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Kehrenberg C, 2001, FEMS MICROBIOL LETT, V205, P283, DOI 10.1111/j.1574-6968.2001.tb10962.x; Keyes K, 2000, ANTIMICROB AGENTS CH, V44, P421, DOI 10.1128/AAC.44.2.421-424.2000; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; Lartigue MF, 2005, ANTIMICROB AGENTS CH, V49, P2565, DOI 10.1128/AAC.49.6.2565-2567.2005; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MCCANDLISH IAP, 1978, VET REC, V102, P298, DOI 10.1136/vr.102.14.293; Morrissey I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086669; MORTENSEN JE, 1989, ANTIMICROB AGENTS CH, V33, P771, DOI 10.1128/AAC.33.5.771; Perreten V, 2003, ANTIMICROB AGENTS CH, V47, P1169, DOI 10.1128/AAC.47.3.1169-1172.2003; PIJPERS A, 1989, J VET PHARMACOL THER, V12, P267, DOI 10.1111/j.1365-2885.1989.tb00670.x; Priebe S, 2003, ANTIMICROB AGENTS CH, V47, P2703, DOI 10.1128/AAC.47.8.2703-2705.2003; Pruller S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123883; Rheinwald M, 2015, VET REC, V176, P357, DOI 10.1136/vr.102694; Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000; ROBERTS MC, 1993, MOL CELL PROBE, V7, P387, DOI 10.1006/mcpr.1993.1057; Rose S, 2012, ANTIMICROB AGENTS CH, V56, P3664, DOI 10.1128/AAC.00266-12; Rougier S, 2006, VET MICROBIOL, V115, P192, DOI 10.1016/j.vetmic.2006.02.003; SCHOLZ P, 1989, GENE, V75, P271, DOI 10.1016/0378-1119(89)90273-4; Schwarz S, 2007, BERL MUNCH TIERARZTL, V120, P423, DOI 10.2376/0005-9366-120-423; Seydel JK, 1973, J INFECT DIS, V128, P470; Speakman AJ, 1997, VET MICROBIOL, V54, P63, DOI 10.1016/S0378-1135(96)01256-4; Speakman AJ, 2000, VET MICROBIOL, V71, P193, DOI 10.1016/S0378-1135(99)00171-6; Steinfeld A, 2012, TIERAERZTL PRAX K H, V40, P309; Stepniewska K, 2014, POL J VET SCI, V17, P71, DOI 10.2478/pjvs-2014-0009; Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x; Terry NS, 1911, J INFECT DIS, V8, P399; Viejo G, 2002, SCAND J INFECT DIS, V34, P628, DOI 10.1080/00365540210147697; WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243, DOI 10.1128/CMR.4.3.243-255.1991; Zhao ZQ, 2011, J VET MED SCI, V73, P103, DOI 10.1292/jvms.10-0184	62	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135703	10.1371/journal.pone.0135703	http://dx.doi.org/10.1371/journal.pone.0135703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275219	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600100
J	Shi, FM; Xiao, Y; Xiong, W; Zhou, Q; Yang, P; Huang, XQ				Shi, Fenmei; Xiao, Ying; Xiong, Wei; Zhou, Qin; Yang, Peng; Huang, Xiongqing			Effects of Fentanyl on Emergence Agitation in Children under Sevoflurane Anesthesia: Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							INTRANASAL FENTANYL; PEDIATRIC-PATIENTS; DOSE FENTANYL; BILATERAL MYRINGOTOMY; DELIRIUM; DESFLURANE; PREVENTION; HALOTHANE; PROPOFOL; SURGERY	Background and Objectives The goal of this meta-analysis study was to assess the effects of fentanyl on emergence agitation (EA) under sevoflurane anesthesia in children. Subjects and Methods We searched electronic databases (PubMed, Embase, Web of Science and the Cochrane Central Register of Controlled Trials) for articles published until December 2014. Randomized controlled trials (RCTs) that assessed the effects of fentanyl and placebo on EA under sevoflurane anesthesia in children that the outcome were the incidence of EA, postoperative pain, emergence time or adverse effects were included in this meta-analysis. Results A total of 16 studies, including 1362 patients (737 patients for the fentanyl group and 625 for the placebo group), were evaluated in final analysis. We found that administration of fentanyl decreased the incidences of EA (RR = 0.37, 95% CI 0.27 similar to 0.49, P<0.00001) and postoperative pain (RR = 0.59, 95% CI 0.41 similar to 0.85, P = 0.004) but increased the incidence of postoperative nausea and vomiting (PONV) (RR = 2.23, 95% CI 1.33 similar to 3.77, P = 0.003). The extubation time (WMD = 0.71 min, 95% CI 0.12 similar to 1.3, P = 0.02), emergence time (WMD = 4.90 min, 95% CI 2.49 similar to 7.30, P<0.0001), and time in the postanesthesia care unit (PACU) (WMD = 2.65 min, 95% CI 0.76 similar to 4.53, P = 0.006) were slightly increased. There were no significant differences in the time to discharge of day patients (WMD = 3.72 min, 95% CI -2.80 similar to 10.24, P = 0.26). Conclusion Our meta-analysis suggests that fentanyl decreases the incidence of EA under sevoflurane anesthesia in children and postoperative pain, but has a higher incidence of PONV. Considering the inherent limitations of the included studies, more RCTs with extensive follow-up should be performed to validate our findings in the future.	[Shi, Fenmei] Sun Yat Sen Univ, Dept Anaesthesiol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, Ying; Xiong, Wei; Zhou, Qin; Yang, Peng; Huang, Xiongqing] Sun Yat Sen Univ, Dept Anaesthesiol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Huang, XQ (corresponding author), Sun Yat Sen Univ, Dept Anaesthesiol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	hxiongqing@163.com						Abdelhalim Ashraf Arafat, 2013, Saudi J Anaesth, V7, P392, DOI 10.4103/1658-354X.121047; Aouad MT, 2007, ANESTHESIOLOGY, V107, P733, DOI 10.1097/01.anes.0000287009.46896.a7; Aouad MT, 2005, ACTA ANAESTH SCAND, V49, P300, DOI 10.1111/j.1399-6576.2005.00642.x; Bajwa SA, 2010, PEDIATR ANESTH, V20, P704, DOI 10.1111/j.1460-9592.2010.03328.x; Bakhamees HS, 2009, SAUDI MED J, V30, P500; Binstock W, 2004, PEDIATR ANESTH, V14, P759, DOI 10.1111/j.1460-9592.2004.01296.x; Bortone L, 2014, PEDIATR ANESTH, V24, P614, DOI 10.1111/pan.12388; Cohen IT, 2002, ANESTH ANALG, V94, P1178, DOI 10.1097/00000539-200205000-00023; Costi D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007084.pub2; Cravero J, 2000, PAEDIATR ANAESTH, V10, P419, DOI 10.1046/j.1460-9592.2000.00560.x; Cravero JP, 2003, ANESTH ANALG, V97, P364, DOI 10.1213/01.ANE.0000070227.78670.43; Cravero JP, 2001, AN ABSTR SCI PAP ANN, P1222; Dahmani S, 2010, BRIT J ANAESTH, V104, P216, DOI 10.1093/bja/aep376; [DEM S MM R], 2014, EGYPTIAN J ANAESTHES, P2; Demirbilek S, 2004, EUR J ANAESTH, V21, P538, DOI 10.1017/S0265021504007069; [DY K CH K YJ K MJ I], 2004, KOREAN J ANESTHESIOL, P1; ECKENHOFF J, 1961, ANESTHESIOLOGY, V22, P667, DOI 10.1097/00000542-196109000-00002; Erdil F, 2009, ANAESTH INTENS CARE, V37, P571, DOI 10.1177/0310057X0903700405; Finkel J, 2000, AN ABSTR SCI PAP ANN, P1252; Finkel JC, 2001, ANESTH ANALG, V92, P1164; Galinkin JL, 2000, ANESTHESIOLOGY, V93, P1378, DOI 10.1097/00000542-200012000-00006; Galinkin JL, 2000, AN ABSTR SCI PAP ANN, P1253; [关雷 GUAN Lei], 2011, [临床麻醉学杂志, The Journal of Clinical Anesthestology], V27, P644; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hippard HK, 2012, ANESTH ANALG, V115, P356, DOI 10.1213/ANE.0b013e31825afef3; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hung WT, 2005, J CLIN ANESTH, V17, P494, DOI 10.1016/j.jclinane.2004.09.014; Inomata S, 2010, BRIT J ANAESTH, V105, P361, DOI 10.1093/bja/aeq168; Ioannidis JP, 2009, PLOS MED, V6, pE; JIN HEE CHEOL, 2004, Korean Journal of Anesthesiology, V46, P524; Jung HJ, 2010, KOREAN J ANESTHESIOL, V58, P148, DOI 10.4097/kjae.2010.58.2.148; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kain ZN, 2004, ANESTH ANALG, V99, P1648, DOI 10.1213/01.ANE.0000136471.36680.97; 박성용, 2005, Korean Journal of Anesthesiology, V49, P502; Kim MS, 2013, BRIT J ANAESTH, V110, P274, DOI 10.1093/bja/aes382; Kuratani N, 2008, ANESTHESIOLOGY, V109, P225, DOI 10.1097/ALN.0b013e31817f5c18; Li J, 2011, CHINESE MED J-PEKING, V124, P3682, DOI 10.3760/cma.j.issn.0366-6999.2011.22.015; Li XZ, 2013, SAUDI MED J, V34, P40; Locatelli BG, 2013, PEDIATR ANESTH, V23, P301, DOI 10.1111/pan.12038; Lynch EP, 1998, ANESTH ANALG, V86, P781; [M A G E H E AA R BS E MY M], 2009, EGYPTIAN J ANAESTHES, P4; [M A AT D O K B I], 2005, TURK ANESTEZIYOLOJI, P5; [M H MY M SS E OM A], 2011, EGYPTIAN J ANAESTHES, P1; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Oh AY, 2005, ACTA ANAESTH SCAND, V49, P297, DOI 10.1111/j.1399-6576.2005.00687.x; Patel A, 2010, ANESTH ANALG, V111, P1004, DOI 10.1213/ANE.0b013e3181ee82fa; [裴春明 Pei Chunming], 2012, [临床麻醉学杂志, The Journal of Clinical Anesthestology], V28, P17; Pestieau SR, 2011, PEDIATR ANESTH, V21, P1128, DOI 10.1111/j.1460-9592.2011.03615.x; Rampersad S, 2010, PEDIATR ANESTH, V20, P1028, DOI 10.1111/j.1460-9592.2010.03427.x; [沈霞 Shen Xia], 2010, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V30, P303; Sikich N, 2004, ANESTHESIOLOGY, V100, P1138, DOI 10.1097/00000542-200405000-00015; SM A, 2008, EGYPTIAN J ANAESTHES, P1; Somaini M, 2015, PEDIATR ANESTH, V25, P524, DOI 10.1111/pan.12580; Veyckemans F, 2001, Curr Opin Anaesthesiol, V14, P339, DOI 10.1097/00001503-200106000-00010; Vlajkovic GP, 2007, ANESTH ANALG, V104, P84, DOI 10.1213/01.ane.0000250914.91881.a8; Welborn LG, 1996, ANESTH ANALG, V83, P917, DOI 10.1097/00000539-199611000-00005; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099718; Zhang CM, 2013, CLIN THER, V35, P1622, DOI 10.1016/j.clinthera.2013.08.016; ZHANG YY, 2012, SHIP ELECT ENG, V32, P12; 김치효, 2007, Korean Journal of Anesthesiology, V53, P609; 김혜경, 2005, Korean Journal of Anesthesiology, V49, P370	63	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135244	10.1371/journal.pone.0135244	http://dx.doi.org/10.1371/journal.pone.0135244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275039	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600058
J	Li, WY; Jiang, YF; Wang, XM; Jin, JL; Qi, Y; Chi, XM; Zhang, H; Feng, XW; Niu, JQ				Li, Wanyu; Jiang, Yanfang; Wang, Xiaomei; Jin, Jinglan; Qi, Yue; Chi, Xiumei; Zhang, Hong; Feng, Xiangwei; Niu, Junqi			Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation	PLOS ONE			English	Article							CELLS; INFECTION; RESPONSES; HBV; NK; EXPRESSION; INJURY; INNATE; GENES	Natural killer (NK) cells play an important role in hepatitis B virus (HBV) infection control, and are regulated by a complex network of activating and inhibitory receptors. However, NK cell activity in HBV patients remains poorly understood. The objective of this study was to investigate the phenotypic and functional characteristics of circulating NK cells in patients during different chronic hepatitis B (CHB) infection stages. We investigated NK cell phenotypes, receptor expression and function in 86 CHB patients and 20 healthy controls. NK cells were purified and NK cell subsets were characterized by flow cytometry. Cytotoxic activity (CD107a) and interferon-gamma (IFN-gamma) secretion were examined, and Natural Killer p46 (NKP46) blockade and spontaneous NK cell cytolytic activity against K562, HepG2 and HepG2.215 cell lines was studied. Activating NKp46 receptor expression was higher in inactive HBsAg carriers when compared with other groups (p = 0.008). NKp46 expression negatively correlated with HBV DNA (R = -0.253, p = 0.049) and ALT (R = -0.256, p = 0.045) levels. CD107a was higher in immune-activated groups when compared with immune-tolerant groups (p = 0.039). CD107a expression was related to viral load (p = 0.02) and HBeAg status (p = 0.024). In vitro NKp46 blockade reduced NK cell cytolytic activity against HepG2 and HepG2.215 cell lines (p = 0.02; p = 0.039). Furthermore, NK cells from high viral load CHB patients displayed significantly lower specific cytolytic activity against anti-NKp46-loaded K562 targets (p = 0.0321). No significant differences were observed in IFN-gamma secretion (p > 0.05). In conclusion, NKp46 expression regulates NK cell cytolytic function. NKp46 may moderate NK cell activity during HBV replication suppression and HBV-associated liver damage and may be critical for NK cell activity during CHB infection.	[Li, Wanyu; Jiang, Yanfang; Wang, Xiaomei; Jin, Jinglan; Qi, Yue; Chi, Xiumei; Zhang, Hong; Feng, Xiangwei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130021, Peoples R China	Jilin University	Niu, JQ (corresponding author), Jilin Univ, Hosp 1, Dept Hepatol, 71 Xinmin St, Changchun 130021, Peoples R China.	82232559@qq.com			National Natural Science Foundation of China [81301413]; Youth Science Foundation of the First Hospital of Jilin University [JDYY42013010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of the First Hospital of Jilin University	This study was supported by grants from National Natural Science Foundation of China (No. 81301413), and the Youth Science Foundation of the First Hospital of Jilin University (No. JDYY42013010).	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Cho H, 2013, J MICROBIOL, V51, P247, DOI 10.1007/s12275-013-2522-1; Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Francesca B, 2013, IMMUNOLOGY LETT; Guy CS, 2008, J VIROL, V82, P8579, DOI 10.1128/JVI.01022-08; Heeg M, 2012, HEPATOLOGY, V56, P1197, DOI 10.1002/hep.25858; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P1, DOI 10.1189/jlb.0907650; Kapoor R, 2014, FUTURE VIROL, V9, P565, DOI 10.2217/FVL.14.36; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Li FL, 2013, GASTROENTEROLOGY, V144, P392, DOI 10.1053/j.gastro.2012.10.039; Li WY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/138237; Li WY, 2011, LIVER INT, V31, P1118, DOI 10.1111/j.1478-3231.2011.02507.x; Lucy GM, 2012, HEPATOLOGY, V56, P1214, DOI [10.1002/hep.25771, DOI 10.1002/HEP.25771]; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Mondelli MU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00351; Mondelli MU, 2010, EUR J CLIN INVEST, V40, P851, DOI 10.1111/j.1365-2362.2010.02332.x; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sprengers D, 2006, J MED VIROL, V78, P561, DOI 10.1002/jmv.20576; Sun C, 2015, CELL MOL IMMUNOL, V12, P292, DOI 10.1038/cmi.2014.91; Tjwa ETTL, 2011, J HEPATOL, V54, P209, DOI 10.1016/j.jhep.2010.07.009; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Werner JM, 2013, HEPATOLOGY, V58, P1621, DOI 10.1002/hep.26353; Wolterbeek HT, 2005, ASSAY DRUG DEV TECHN, V3, P675, DOI 10.1089/adt.2005.3.675; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; Zhao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049542; Zou Y, 2010, J IMMUNOL, V184, P466, DOI 10.4049/jimmunol.0900687	29	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135874	10.1371/journal.pone.0135874	http://dx.doi.org/10.1371/journal.pone.0135874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291078	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900036
J	Vanderwerf, SM; Buck, DC; Wilmarth, PA; Sears, LM; David, LL; Morton, DB; Neve, KA				Vanderwerf, Scott M.; Buck, David C.; Wilmarth, Phillip A.; Sears, Leila M.; David, Larry L.; Morton, David B.; Neve, Kim A.			Role for Rab10 in Methamphetamine-Induced Behavior	PLOS ONE			English	Article							STIMULATED GLUT4 TRANSLOCATION; CANINE KIDNEY-CELLS; DROSOPHILA-MELANOGASTER; DOPAMINE-RECEPTOR; FUNCTIONAL-CHARACTERIZATION; PLASMA-MEMBRANE; NEURONS; AMPHETAMINE; TRANSPORTER; IDENTIFICATION	Lipid rafts are specialized, cholesterol-rich membrane compartments that help to organize transmembrane signaling by restricting or promoting interactions with subsets of the cellular proteome. The hypothesis driving this study was that identifying proteins whose relative abundance in rafts is altered by the abused psychostimulant methamphetamine would contribute to fully describing the pathways involved in acute and chronic effects of the drug. Using a detergent-free method for preparing rafts from rat brain striatal membranes, we identified density gradient fractions enriched in the raft protein flotillin but deficient in calnexin and the transferrin receptor, markers of non-raft membranes. Dopamine D1- and D2-like receptor binding activity was highly enriched in the raft fractions, but pretreating rats with methamphetamine ( 2 mg/kg) once or repeatedly for 11 days did not alter the distribution of the receptors. LC-MS analysis of the protein composition of raft fractions from rats treated once with methamphetamine or saline identified methamphetamine-induced changes in the relative abundance of 23 raft proteins, including the monomeric GTP-binding protein Rab10, whose abundance in rafts was decreased 2.1-fold by acute methamphetamine treatment. Decreased raft localization was associated with a selective decrease in the abundance of Rab10 in a membrane fraction that includes synaptic vesicles and endosomes. Inhibiting Rab10 activity by panneuronal expression of a dominant-negative Rab10 mutant in Drosophila melanogaster decreased methamphetamine-induced activity and mortality and decreased caffeine-stimulated activity but not mortality, whereas inhibiting Rab10 activity selectively in cholinergic neurons had no effect. These results suggest that activation and redistribution of Rab10 is critical for some of the behavioral effects of psychostimulants.	[Vanderwerf, Scott M.; Buck, David C.; Neve, Kim A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Vanderwerf, Scott M.; Sears, Leila M.; Morton, David B.] Oregon Hlth & Sci Univ, Dept Integrat Biosci, Portland, OR 97201 USA; [Wilmarth, Phillip A.; David, Larry L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Neve, Kim A.] VA Portland Hlth Care Syst, Res Serv, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Neve, KA (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	nevek@ohsu.edu		Neve, Kim/0000-0003-0109-7345	Department of Veterans Affairs [BX000810]; National Institutes of Health [R01GM105396, P30EY010572, P30CA069533]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105396] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by Department of Veterans Affairs (http://www.research.va.gov/) BX000810 (KAN), National Institutes of Health (https://grants.nih.gov/grants/oer.htm) R01GM105396 (DBM), P30EY010572 (LLD), and P30CA069533 (LLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat-Mendes C, 2012, PHARMACOL BIOCHEM BE, V101, P201, DOI 10.1016/j.pbb.2011.10.025; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Celver J, 2012, J NEUROCHEM, V120, P56, DOI 10.1111/j.1471-4159.2011.07559.x; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chen Y, 2009, BIOCHEM J, V422, P229, DOI 10.1042/BJ20090624; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Feng GP, 1996, J NEUROSCI, V16, P3925; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Greenspan RJ, 2004, FLY PUSHING; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kaun KR, 2012, HUM GENET, V131, P959, DOI 10.1007/s00439-012-1146-6; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kovtun O, 2015, ACS CHEM NEUROSCI, V6, P526, DOI 10.1021/cn500202c; Lan HX, 2006, MOL PHARMACOL, V69, P185, DOI 10.1124/mol.105.017244; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Leaf DS, 1998, EXP CELL RES, V243, P39, DOI 10.1006/excr.1997.3917; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Pizzo AB, 2013, MOL PSYCHIATR, V18, P824, DOI 10.1038/mp.2012.82; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Schuck S, 2007, TRAFFIC, V8, P47, DOI 10.1111/j.1600-0854.2006.00506.x; Sharma M, 2013, J BIOL CHEM, V288, P12554, DOI 10.1074/jbc.M112.443945; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; UNODC, 2011, AMPH ECST ATS GLOB A; Voulalas PJ, 2011, MOL CELL NEUROSCI, V46, P645, DOI 10.1016/j.mcn.2011.01.004; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Wiemerslage L, 2013, J NEUROCHEM, V126, P529, DOI 10.1111/jnc.12228; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223; YOKEL RA, 1975, SCIENCE, V187, P547, DOI 10.1126/science.1114313; Yu PY, 2004, KIDNEY INT, V66, P2167, DOI 10.1111/j.1523-1755.2004.66007.x; Zhang JS, 2007, NAT NEUROSCI, V10, P77, DOI 10.1038/nn1816; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	49	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136167	10.1371/journal.pone.0136167	http://dx.doi.org/10.1371/journal.pone.0136167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291453	Green Submitted, gold, Green Published			2022-12-27	WOS:000359919900060
J	Ellis, DA; Wiseman, R; Jenkins, R				Ellis, David A.; Wiseman, Richard; Jenkins, Rob			Mental Representations of Weekdays	PLOS ONE			English	Article							DECISION-MAKING; UNITED-STATES; MEMORY; MONDAY; TIME; MOOD; SIMILARITY; SLEEP; MODEL; CYCLE	Keeping social appointments involves keeping track of what day it is. In practice, mismatches between apparent day and actual day are common. For example, a person might think the current day is Wednesday when in fact it is Thursday. Here we show that such mismatches are highly systematic, and can be traced to specific properties of their mental representations. In Study 1, mismatches between apparent day and actual day occurred more frequently on midweek days (Tuesday, Wednesday, and Thursday) than on other days, and were mainly due to intrusions from immediately neighboring days. In Study 2, reaction times to report the current day were fastest on Monday and Friday, and slowest midweek. In Study 3, participants generated fewer semantic associations for "Tuesday", "Wednesday" and "Thursday" than for other weekday names. Similarly, Google searches found fewer occurrences of midweek days in webpages and books. Analysis of affective norms revealed that participants' associations were strongly negative for Monday, strongly positive for Friday, and graded over the intervening days. Midweek days are confusable because their mental representations are sparse and similar. Mondays and Fridays are less confusable because their mental representations are rich and distinctive, forming two extremes along a continuum of change.	[Ellis, David A.] Lincoln Univ, Sch Psychol, Lincoln, England; [Wiseman, Richard] Univ Hertfordshire, Sch Psychol, Hatfield AL10 9AB, Herts, England; [Jenkins, Rob] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of Lincoln; University of Hertfordshire; University of York - UK	Ellis, DA (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	dellis@lincoln.ac.uk	Jenkins, Rob/C-5289-2008; Ellis, David/A-8322-2011	Ellis, David/0000-0001-6172-3323	ESRC studentship [ES/G017271/1]; ESRC research grant [RES-060-25-0010]	ESRC studentship(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC research grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an ESRC studentship to DAE (ES/G017271/1), and an ESRC research grant to RJ (RES-060-25-0010), http://www.esrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1983, J VERB LEARN VERB BE, V22, P261, DOI 10.1016/S0022-5371(83)90201-3; Angie AD, 2011, COGNITION EMOTION, V25, P1393, DOI 10.1080/02699931.2010.550751; Areni CS, 2008, J APPL SOC PSYCHOL, V38, P1395, DOI 10.1111/j.1559-1816.2008.00353.x; Areni CS, 2011, PSYCHOL REP, V109, P723, DOI 10.2466/13.20.PR0.109.6.723-733; BADDELEY AD, 1968, Q J EXP PSYCHOL, V20, P249, DOI 10.1080/14640746808400159; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Brown GDA, 2007, PSYCHOL REV, V114, P539, DOI 10.1037/0033-295X.114.3.539; Cajochen C, 2013, CURR BIOL, V23, P1485, DOI 10.1016/j.cub.2013.06.029; Chakraborty U, 2013, BIOL RHYTHM RES, P1; Colson FH., 1926, WEEK ESSAY ORIGIN DE; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Cross F., 1973, FINANCIAL ANALYSTS J, V29, P67, DOI 10.2469/faj.v29.n6.67; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; EICH E, 1995, PSYCHOL SCI, V6, P67, DOI 10.1111/j.1467-9280.1995.tb00309.x; Ellis DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051365; Estes WK, 1997, PSYCHOL REV, V104, P148, DOI 10.1037/0033-295X.104.1.148; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; GETTY DJ, 1979, PERCEPT PSYCHOPHYS, V26, P1, DOI 10.3758/BF03199856; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gregory RichardL., 2009, SEEING ILLUSIONS; Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221; HUTTENLOCHER J, 1992, J EXP PSYCHOL GEN, V121, P313, DOI 10.1037/0096-3445.121.3.313; Huttenlocher J, 2007, J EXP PSYCHOL GEN, V136, P502, DOI 10.1037/0096-3445.136.3.502; JAFFE JF, 1989, J BANK FINANC, V13, P641, DOI 10.1016/0378-4266(89)90035-6; Johnson Helen, 2005, Health Stat Q, P13; Kamara A, 1997, J BUS, V70, P63, DOI 10.1086/209708; Kanai R, 2006, PERCEPT PSYCHOPHYS, V68, P1113, DOI 10.3758/BF03193714; Leech G, 2001, WORD FREQUENCIES WRI; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; MAIRE M, 2013, J COGN BEHAV PSYCHOT, V13, P133; MALDONADO G, 1991, SUICIDE LIFE-THREAT, V21, P174; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Neath I, 2006, PSYCHOL LEARN MOTIV, V46, P201, DOI 10.1016/S0079-7421(06)46006-0; Pettengill G.N., 2003, Q J BUSINESS EC, V42, P3; Redelmeier DA, 1996, PAIN, V66, P3, DOI 10.1016/0304-3959(96)02994-6; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; Rohan KJ, 2009, CURR PSYCHIATRY REV, V5, P37, DOI 10.2174/157340009787315299; Schwarz N, 2000, COGNITION EMOTION, V14, P433, DOI 10.1080/026999300402745; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; TULVING E, 1970, ANNU REV PSYCHOL, V21, P437, DOI 10.1146/annurev.ps.21.020170.002253; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Vigliocco G, 2002, COGNITION, V85, pB61, DOI 10.1016/S0010-0277(02)00107-5; WILLICH SN, 1994, CIRCULATION, V90, P87, DOI 10.1161/01.CIR.90.1.87; Zerubavel E, 1985, 7 DAY CIRCLE HIST ME	49	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134555	10.1371/journal.pone.0134555	http://dx.doi.org/10.1371/journal.pone.0134555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26288194	Green Published, Green Accepted, gold			2022-12-27	WOS:000360018600026
J	Kawaguchi, T; Tsukiyama, T; Kimura, K; Matsuyama, S; Minami, N; Yamada, M; Imai, H				Kawaguchi, Takamasa; Tsukiyama, Tomoyuki; Kimura, Koji; Matsuyama, Shuichi; Minami, Naojiro; Yamada, Masayasu; Imai, Hiroshi			Generation of Naive Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors	PLOS ONE			English	Article							DEFINED FACTORS; ES CELLS; FIBROBLASTS; INDUCTION; EFFICIENT; STATE; LINES; MASS; PIG; ESTABLISHMENT	Generation of pluripotent stem cells (PSCs) in large domestic animals has achieved only limited success; most of the PSCs obtained to date have been classified as primed PSCs, which possess very little capacity to produce chimeric offspring. By contrast, mouse PSCs have been classified as naive PSCs that can contribute to most of the tissues of chimeras, including germ cells. Here, we describe the generation of two different types of bovine induced pluripotent stem cells (biPSCs) from amnion cells, achieved through introduction of piggyBac vectors containing doxycycline-inducible transcription factors (Oct3/4, Sox2, Klf4, and c-Myc). One type of biPSCs, cultured in medium supplemented with knockout serum replacement (KSR), FGF2, and bovine leukemia inhibitory factor (bLIF), had a flattened morphology like human PSCs; these were classified as primed-type. The other type biPSCs, cultured in KSR, bLIF, Mek/Erk inhibitor, GSK3 inhibitor and forskolin, had a compact morphology like mouse PSCs; these were classified as naive-type. Cells could easily be switched between these two types of biPSCs by changing the culture conditions. Both types of biPSCs had strong alkaline phosphatase activity, expressed pluripotent markers (OCT3/4, NANOG, REX1, ESRR beta, STELLA, and SOCS3), and formed embryoid bodies that gave rise to differentiated cells from all three embryonic germ layers. However, only naive-type biPSCs showed the hallmarks of naive mouse PSCs, such as LIF-dependent proliferation, lack of FGF5 expression, and active XIST expression with two active X chromosomes. Furthermore, naive-type biPSCs could contribute to the inner cell mass (ICM) of host blastocysts and most tissues within chimeric embryos. This is the first report of generation of biPSCs with several characteristics similar to those of naive mouse PSCs and a demonstrated potential to contribute to chimeras.	[Kawaguchi, Takamasa; Minami, Naojiro; Yamada, Masayasu; Imai, Hiroshi] Kyoto Univ, Grad Sch Agricuture, Reprod Biol Lab, Kyoto, Japan; [Tsukiyama, Tomoyuki] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Shiga, Japan	Kyoto University; Shiga University of Medical Science	Imai, H (corresponding author), Kyoto Univ, Grad Sch Agricuture, Reprod Biol Lab, Kyoto, Japan.	imai@kais.kyoto-u.ac.jp	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719	Ministry of Education, Science and Culture [24380172, 26292168]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: This work was supported in part by a grant from the Ministry of Education, Science and Culture to K.K. and H.I. (grant 24380172 and 26292168). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Booth P J, 2001, Cloning Stem Cells, V3, P139, DOI 10.1089/153623001753205098; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Cao SB, 2009, J EXP ZOOL PART A, V311A, P368, DOI 10.1002/jez.535; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Furusawa T, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106641; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hirano K, 2012, STEM CELLS DEV, V21, P1287, DOI 10.1089/scd.2011.0283; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kinoshita M, 2014, MED BIOL, P1, DOI [10.1007/s12522-014-0199-8, DOI 10.1007/S12522-014-0199-8]; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishishita N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038389; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ozawa M, 2012, THERIOGENOLOGY, V78, P1243, DOI 10.1016/j.theriogenology.2012.05.020; Ozawa M, 2014, STEM CELL RES, V13, P75, DOI 10.1016/j.scr.2014.04.012; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Suemori Hirofumi, 2006, V329, P81; Sumer H, 2011, J ANIM SCI, V89, P2708, DOI 10.2527/jas.2010-3666; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Tsukiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095329; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhao HX, 2010, DIFFERENTIATION, V80, P123, DOI 10.1016/j.diff.2010.03.002	49	38	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135403	10.1371/journal.pone.0135403	http://dx.doi.org/10.1371/journal.pone.0135403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287611	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600048
J	Klein, C; Terrao, M; Gil, DI; Clayton, C				Klein, Cornelia; Terrao, Monica; Gil, Diana Inchaustegui; Clayton, Christine			Polysomes of Trypanosoma brucei: Association with Initiation Factors and RNA-Binding Proteins	PLOS ONE			English	Article							TRANSLATION INITIATION; MESSENGER-RNAS; LIFE-CYCLE; GENE-EXPRESSION; POTENTIAL ROLES; COMPLEX; LEISHMANIA; HOMOLOG; STABILITY; DEPLETION	We report here the results of experiments designed to identify RNA-binding proteins that might be associated with Trypanosoma brucei polysomes. After some preliminary mass spectrometry of polysomal fractions, we investigated the distributions of selected tagged proteins using sucrose gradients and immunofluorescence. As expected, the polysomal fractions contained nearly all annotated ribosomal proteins, the translation-associated protein folding complex, and many translation factors, but also many other abundant proteins. Results suggested that cap-binding proteins EIF4E3 and EIF4E4 were associated with both free and membrane-bound polysomes. The EIF4E binding partners EIF4G4 and EIF4G3 were present but the other EIF4E and EIF4G paralogues were not detected. The dominant EIF4E in the polysomal fraction is EIF4E4 and very few polysomal mRNAs are associated with EIF4G. Thirteen potential mRNA-binding proteins were detected in the polysomes, including the known polysome-associated protein RBP42. The locations of two of the other proteins were tested after epitope tagging: RBP29 was in the nucleus and ZC3H29 was in the cytoplasm. Quantitative analyses showed that specific association of an RNA-binding protein with the polysome fraction in sucrose gradients will not be detected if the protein is in more than 25-fold molar excess over its target binding sites.	[Klein, Cornelia; Terrao, Monica; Gil, Diana Inchaustegui; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, C (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Clayton, Christine/K-7700-2019		Deutsche Forschungsgemeinschaft [Cl112/16-1]; HBIGS (The Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology) graduate school - DFG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HBIGS (The Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology) graduate school - DFG	This study was supported by Cl112/16-1Deutsche Forschungsgemeinschaft http://www.dfg.de; Stipend from HBIGS (The Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology) graduate school (ultimately DFG-funded) http://www.hbigs.uni-heidelberg.de.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Archer SK, 2015, RNA BIOL, V12, P248, DOI 10.1080/15476286.2015.1017242; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bonderoff JM, 2010, NUCLEIC ACIDS RES, V38, P7054, DOI 10.1093/nar/gkq566; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; CLAYTON CE, 1987, J CELL BIOL, V105, P2649, DOI 10.1083/jcb.105.6.2649; Clayton C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003680; Das A, 2012, RNA, V18, P1968, DOI 10.1261/rna.033829.112; Delhi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025112; Dhalia R, 2005, MOL BIOCHEM PARASIT, V140, P23, DOI 10.1016/j.molbiopara.2004.12.001; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Fernandez-Moya SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048870; Freire ER, 2014, RNA, V20, P1272, DOI 10.1261/rna.045534.114; Freire ER, 2014, EUKARYOT CELL, V13, P896, DOI 10.1128/EC.00071-14; Freire ER, 2011, MOL BIOCHEM PARASIT, V176, P25, DOI 10.1016/j.molbiopara.2010.11.011; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gupta SK, 2014, RNA BIOL, V11, P715, DOI 10.4161/rna.29143; Gupta SK, 2013, NUCLEIC ACIDS RES, V41, P6577, DOI 10.1093/nar/gkt369; Gupta SK, 2013, J BIOL CHEM, V288, P4991, DOI 10.1074/jbc.M112.416578; Haanstra JR, 2008, J BIOL CHEM, V283, P2495, DOI 10.1074/jbc.M705782200; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Jha BA, 2014, EUKARYOT CELL, V13, P664, DOI 10.1128/EC.00018-14; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Luu VD, 2006, MOL BIOCHEM PARASIT, V150, P340, DOI 10.1016/j.molbiopara.2006.09.007; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Moura DMN, 2015, RNA BIOL, V12, P305, DOI 10.1080/15476286.2015.1017233; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Rezende AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1175; Schumann Burkard G, 2013, MOL MICROBIOL; Singh A, 2014, NUCLEIC ACIDS RES, V42, P4652, DOI 10.1093/nar/gkt1416; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06; Yoffe Y, 2009, NUCLEIC ACIDS RES, V37, P3243, DOI 10.1093/nar/gkp190; Zinoviev A, 2012, MOL BIOCHEM PARASIT, V185, P127, DOI 10.1016/j.molbiopara.2012.08.001; Zinoviev A, 2011, NUCLEIC ACIDS RES, V39, P8404, DOI 10.1093/nar/gkr555	45	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135973	10.1371/journal.pone.0135973	http://dx.doi.org/10.1371/journal.pone.0135973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287607	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600093
J	Knight, BA; Shields, BM; Brook, A; Hill, A; Bhat, DS; Hattersley, AT; Yajnik, CS				Knight, Bridget Ann; Shields, Beverley M.; Brook, Adam; Hill, Anita; Bhat, Dattatray S.; Hattersley, Andrew T.; Yajnik, Chittaranjan S.			Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population	PLOS ONE			English	Article							MATERNAL NUTRITION; VITAMIN-B-12	Objective Vitamin B12 and folate are critical micronutrients needed to support the increased metabolic demands of pregnancy. Recent studies from India have suggested that low vitamin B12 and folate concentrations in pregnancy are associated with increased obesity; however differences in diet, antenatal vitamin supplementation, and socioeconomic status may limit the generalisability of these findings. We aimed to explore the cross-sectional relationship of circulating serum vitamin B12 and folate at 28 weeks' gestation with maternal adiposity and related biochemical markers in a white non diabetic UK obstetric cohort. Methods Anthropometry and biochemistry data was available on 995 women recruited at 28 weeks gestation to the Exeter Family Study of Childhood Health. Associations between B12 and folate with maternal BMI and other obesity-related biochemical factors (HOMA-R, fasting glucose, triglycerides, HDL and AST) were explored using regression analysis, adjusting for potential confounders (socioeconomic status, vegetarian diet, vitamin supplementation, parity, haemodilution (haematocrit)). Results Higher 28 week BMI was associated with lower circulating vitamin B12 (r = -0.25; P<0.001) and folate (r = -0.15; P<0.001). In multiple regression analysis higher 28 week BMI remained an independent predictor of lower circulating B12 (beta (95% CI) = -0.59 (-0.74, -0.44) i.e. for every 1% increase in BMI there was a 0.6% decrease in circulating B12). Other markers of adiposity/body fat metabolism (HOMA-R, triglycerides and AST) were also independently associated with circulating B12. In a similar multiple regression AST was the only independent obesity-related marker associated with serum folate (beta (95% CI) = 0.16 (0.21, 0.51)) Conclusion In conclusion, our study has replicated the previous Indian findings of associations between lower serum B12 and higher obesity and insulin resistance during pregnancy in a non-diabetic White British population. These findings may have important implications for fetal and maternal health in obese pregnancies.	[Knight, Bridget Ann; Shields, Beverley M.; Brook, Adam; Hattersley, Andrew T.] Univ Exeter, Sch Med, Exeter NIHR Clin Res Facil, Exeter, Devon, England; [Knight, Bridget Ann; Hill, Anita] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Bhat, Dattatray S.; Yajnik, Chittaranjan S.] KEM Hosp & Res Ctr, Diabet Unit, Pune, Maharashtra, India	University of Exeter; University of Exeter	Knight, BA (corresponding author), Univ Exeter, Sch Med, Exeter NIHR Clin Res Facil, Exeter, Devon, England.	B.A.Knight@ex.ac.uk		Hattersley, Andrew/0000-0001-5620-473X; Bhat, Dattatray/0000-0001-9512-2366	South West National Health Service Research and Development; Exeter national Health Service Research and Development; Darlington Trust; National Institute for Health Research; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish	South West National Health Service Research and Development; Exeter national Health Service Research and Development; Darlington Trust; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Exeter Family Study Of Childhood Health was funded by the South West National Health Service Research and Development, Exeter national Health Service Research and Development, and the Darlington Trust. Andrew Hattersley is an National Institute for Health Research Senior investigator and a Wellcome Trust Senior investigator. Bridget Knight held an National Health Service Research and Development Studentship. Current project was funded through the National Institute for Health Research. BS, ATH, BK are core members of the National Institute for Health Research Exeter Clinical Research Facility.	Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Kimmons Joel E, 2006, MedGenMed, V8, P59; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Krishnaveni GV, 2009, DIABETOLOGIA, V52, P2350, DOI 10.1007/s00125-009-1499-0; Stewart CP, 2011, J NUTR, V141, P1912, DOI 10.3945/jn.111.144717; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Thurnham DI, 2001, HUMAN NUTR DIETETICS, P249; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Xanthakos SA, 2009, PEDIATR CLIN N AM, V56, P1105, DOI 10.1016/j.pcl.2009.07.002; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yajnik CS, 2012, REV ENDOCR METAB DIS, V13, P121, DOI 10.1007/s11154-012-9214-8	12	66	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135268	10.1371/journal.pone.0135268	http://dx.doi.org/10.1371/journal.pone.0135268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288227	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600042
J	Maganga, E; Smart, LR; Kalluvya, S; Kataraihya, JB; Saleh, AM; Obeid, L; Downs, JA; Fitzgerald, DW; Peck, RN				Maganga, Emmanuel; Smart, Luke R.; Kalluvya, Samuel; Kataraihya, Johannes B.; Saleh, Ahmed M.; Obeid, Lama; Downs, Jennifer A.; Fitzgerald, Daniel W.; Peck, Robert N.			Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; DIABETES-MELLITUS; INSULIN SENSITIVITY; PRIMARY-CARE; LIPODYSTROPHY; PREVALENCE; AIDS; INITIATION; MARKERS	Introduction Millions of HIV-infected Africans are living longer due to long-term antiretroviral therapy (ART), yet little is known about glucose metabolism disorders in this group. We aimed to compare the prevalence of glucose metabolism disorders among HIV-infected adults on long-term ART to ART-naive adults and HIV-negative controls, hypothesizing that the odds of glucose metabolism disorders would be 2-fold greater even after adjusting for possible confounders. Methods In this cross-sectional study conducted between October 2012 and April 2013, consecutive adults (> 18 years) attending an HIV clinic in Tanzania were enrolled in 3 groups: 153 HIV-negative controls, 151 HIV-infected, ART-naive, and 150 HIV-infected on ART for >= 2 years. The primary outcome was the prevalence of glucose metabolism disorders as determined by oral glucose tolerance testing. We compared glucose metabolism disorder prevalence between each HIV group vs. the control group by Fisher's exact test and used multivariable logistic regression to determine factors associated with glucose metabolism disorders. Results HIV-infected adults on ART had a higher prevalence of glucose metabolism disorders (49/150 (32.7%) vs. 11/153 (7.2%), p<0.001) and frank diabetes mellitus (27/150 (18.0%) vs. 8/153 (5.2%), p = 0.001) than HIV-negative adults, which remained highly significant even after adjusting for age, gender, adiposity and socioeconomic status (OR = 5.72 (2.78-11.77), p<0.001). Glucose metabolism disorders were significantly associated with higher CD4+ T-cell counts. Awareness of diabetes mellitus was <25%. Conclusions HIV-infected adults on long-term ART had 5-fold greater odds of glucose metabolism disorders than HIV-negative controls but were rarely aware of their diagnosis. Intensive glucose metabolism disorder screening and education are needed in HIV clinics in sub-Saharan Africa. Further research should determine how glucose metabolism disorders might be related to immune reconstitution.	[Maganga, Emmanuel; Smart, Luke R.; Kalluvya, Samuel; Kataraihya, Johannes B.; Downs, Jennifer A.; Peck, Robert N.] Catholic Univ Hlth & Allied Sci, Dept Internal Med, Mwanza, Tanzania; [Smart, Luke R.; Kalluvya, Samuel; Kataraihya, Johannes B.; Downs, Jennifer A.; Peck, Robert N.] Bugando Med Ctr, Dept Internal Med, Mwanza, Tanzania; [Smart, Luke R.; Downs, Jennifer A.; Fitzgerald, Daniel W.; Peck, Robert N.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA; [Saleh, Ahmed M.; Obeid, Lama] Weill Cornell Med Coll Qatar, Doha, Qatar	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Peck, RN (corresponding author), Catholic Univ Hlth & Allied Sci, Dept Internal Med, Mwanza, Tanzania.	rnp2002@gmail.com	Smart, Luke R./AAI-1561-2020	Smart, Luke R./0000-0003-4083-0060; Downs, Jennifer/0000-0001-9537-204X; Peck, Robert/0000-0002-4526-2480	National Institutes of Health Fogarty Foundation [TW000018]; National Institute of Allergy and Infectious Diseases [K24 AI098627]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI098627] Funding Source: NIH RePORTER	National Institutes of Health Fogarty Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health Fogarty Foundation (TW000018) and the National Institute of Allergy and Infectious Diseases (K24 AI098627). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MK, 2014, JAIDS-J ACQ IMM DEF, V67, pS27, DOI 10.1097/QAI.0000000000000256; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Awotedu K, 2010, DIABETES METAB SYND, V4, P210, DOI 10.1016/j.dsx.2010.09.002; Berhane T, 2012, PAN AFR MED J, V13; Bonfanti P, 2007, JAIDS-J ACQ IMM DEF, V45, P426, DOI 10.1097/QAI.0b013e318074ef83; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Brown TT, 2005, AIDS, V19, P1375, DOI 10.1097/01.aids.0000181011.62385.91; Calza L, 2011, INT J STD AIDS, V22, P43, DOI 10.1258/ijsa.2010.010256; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Dave JA, 2011, JAIDS-J ACQ IMM DEF, V57, P284, DOI 10.1097/QAI.0b013e318221863f; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Erlandson KM, 2014, AIDS, V28, P1451, DOI 10.1097/QAD.0000000000000266; Goff LM, 2003, BRIT J NUTR, V89, P365, DOI 10.1079/BJN2002789; Hattingh Z, 2009, S AFR J CLIN NUTR, V22, P22; Home P, 2006, DIABETIC MED, V23, P579; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Manuthu E M, 2008, East Afr Med J, V85, P10; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Mercier S, 2009, JAIDS-J ACQ IMM DEF, V51, P224, DOI 10.1097/QAI.0b013e31819c16f4; Msyamboza KP, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-41; Narayan KMV, 2014, JAIDS-J ACQ IMM DEF, V67, pS2, DOI 10.1097/QAI.0000000000000267; National Guidelines For the Management of HIV and AIDS, 2009, NATIONAL GUIDELINES; Ngatchou W, 2013, VASC HEALTH RISK MAN, V9, P509, DOI 10.2147/VHRM.S42350; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Petersen M, 2014, JAIDS-J ACQ IMM DEF, V67, pS8, DOI 10.1097/QAI.0000000000000253; Priya M, 2011, DIABETES TECHNOL THE, V13, P586, DOI 10.1089/dia.2010.0218; Tanzania Commission for AIDS, 2013, TANZANIA HIV AIDS AN; Thompson V, 2011, AIDS RES HUM RETROV, V27, P785, DOI [10.1089/aid.2010.0272, 10.1089/AID.2010.0272]; UNAIDS, 2020, UNAIDS 2020 GLOB REP; World Health Organization, 2013, GLOBAL UPDATE ON HIV; World Health Organization, 2011, WHO STEPS INSTRUMENT; Zannou DM, 2009, ANTIVIR THER, V14, P371	35	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134410	10.1371/journal.pone.0134410	http://dx.doi.org/10.1371/journal.pone.0134410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287742	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600020
J	Meid, AD; Quinzler, R; Freigofas, J; Saum, KU; Schottker, B; Holleczek, B; Heider, D; Konig, HH; Brenner, H; Haefeli, WE				Meid, Andreas D.; Quinzler, Renate; Freigofas, Julia; Saum, Kai-Uwe; Schoettker, Ben; Holleczek, Bernd; Heider, Dirk; Koenig, Hans-Helmut; Brenner, Hermann; Haefeli, Walter E.			Medication Underuse in Aging Outpatients with Cardiovascular Disease: Prevalence, Determinants, and Outcomes in a Prospective Cohort Study	PLOS ONE			English	Article							OLDER-PEOPLE; ELDERLY-PATIENTS; SCREENING TOOL; ALERT DOCTORS; ALL-CAUSE; CRITERIA; POPULATION; POLYPHARMACY; PREVENTION; MORTALITY	Background Cardiovascular disease is a leading cause of death in older people, and the impact of being exposed or not exposed to preventive cardiovascular medicines is accordingly high. Underutilization of beneficial drugs is common, but prevalence estimates differ across settings, knowledge on predictors is limited, and clinical consequences are rarely investigated. Methods Using data from a prospective population-based cohort study, we assessed the prevalence, determinants, and outcomes of medication underuse based on cardiovascular criteria from Screening Tool To Alert to Right Treatment (START). Results Medication underuse was present in 69.1% of 1454 included participants (mean age 71.1 +/- 6.1 years) and was significantly associated with frailty (odds ratio: 2.11 [95% confidence interval: 1.24-3.63]), body mass index (1.03 [1.01-1.07] per kg/m(2)), and inversely with the number of prescribed drugs (0.84 [0.79-0.88] per drug). Using this information for adjustment in a follow-up evaluation (mean follow-up time 2.24 years) on cardiovascular and competing outcomes, we found no association of medication underuse with cardiovascular events (fatal and non-fatal) (hazard ratio: 1.00 [0.65-1.56]), but observed a significant association of medication underuse with competing deaths from non-cardiovascular causes (2.52 [1.01-6.30]). Conclusion Medication underuse was associated with frailty and adverse non-cardiovascular clinical outcomes. This may suggest that cardiovascular drugs were withheld because of serious co-morbidity or that concurrent illness can preclude benefit from cardiovascular prevention. In the latter case, adapted prescribing criteria should be developed and evaluated in those patients.	[Meid, Andreas D.; Quinzler, Renate; Freigofas, Julia; Haefeli, Walter E.] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany; [Saum, Kai-Uwe; Schoettker, Ben; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Heider, Dirk; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf	Haefeli, WE (corresponding author), Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Neuenheimer Feld 410, Heidelberg, Germany.	walter.emil.haefeli@med.uni-heidelberg.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017; Schöttker, Ben/F-8183-2014; König, Hans-Helmut/P-1211-2018; Haefeli, Walter Emil/AAJ-3024-2020	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Schöttker, Ben/0000-0002-1217-4521; König, Hans-Helmut/0000-0001-5711-6862; Haefeli, Walter Emil/0000-0003-0672-6876	German Federal Ministry of Education and Research (BMBF, Berlin, Germany) [01ET0717, 01ET1004B, 01GY1320B]	German Federal Ministry of Education and Research (BMBF, Berlin, Germany)(Federal Ministry of Education & Research (BMBF))	This work was supported in part by institutional funding and ADM, RQ, and JF received funding from the German Federal Ministry of Education and Research (BMBF, Berlin, Germany) under Grant Numbers 01ET0717, 01ET1004B, and 01GY1320B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; Beer C, 2011, BRIT J CLIN PHARMACO, V71, P592, DOI 10.1111/j.1365-2125.2010.03875.x; Bohm M, 2013, AM HEART J, V166, P306, DOI 10.1016/j.ahj.2013.04.016; Byatt K, 2014, EVID BASED MED; Cherubini A, 2012, DRUG AGING, V29, P463, DOI 10.2165/11631750-000000000-00000; Cooper JA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0484-6; Dalleur O, 2012, DRUG AGING, V29, P829, DOI 10.1007/s40266-012-0016-1; De Wilde S, 2003, LANCET, V362, P746, DOI 10.1016/S0140-6736(03)14216-X; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2007, J CLIN PHARM THER, V32, P113, DOI 10.1111/j.1365-2710.2007.00793.x; Gallagher PF, 2011, CLIN PHARMACOL THER, V89, P845, DOI 10.1038/clpt.2011.44; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Galvin R, 2014, EUR J CLIN PHARM; Gaw A, 2004, INT J CLIN PRACT, V58, P777, DOI 10.1111/j.1368-5031.2004.00300.x; Glynn RJ, 2006, J CLIN EPIDEMIOL, V59, P819, DOI 10.1016/j.jclinepi.2005.12.012; Hanlon JT, 2011, J AM GERIATR SOC, V59, P1412, DOI 10.1111/j.1532-5415.2011.03522.x; Hughes CM, 2004, DRUG AGING, V21, P793, DOI 10.2165/00002512-200421120-00004; Kuijpers MAJ, 2008, BRIT J CLIN PHARMACO, V65, P130, DOI 10.1111/j.1365-2125.2007.02961.x; Liu CL, 2012, ARCH GERONTOL GERIAT, V55, P148, DOI 10.1016/j.archger.2011.07.001; Neutel CI, 2007, CAN J PUBLIC HEALTH, V98, P412, DOI 10.1007/BF03405430; Ryan C, 2009, BRIT J CLIN PHARMACO, V68, P936, DOI 10.1111/j.1365-2125.2009.03531.x; Saum KU, 2012, J AM GERIATR SOC, V60, P2110, DOI 10.1111/j.1532-5415.2012.04192.x; Schottker B, 2013, AM J CLIN NUTR, V97, P782, DOI 10.3945/ajcn.112.047712; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Szadkowska I, 2010, ARCH GERONTOL GERIAT, V50, P114, DOI 10.1016/j.archger.2008.12.012; Ubeda Amalia, 2012, Pharmacy Pract (Granada), V10, P83, DOI 10.4321/s1886-36552012000200004; Weiss NS, 2014, EUR J EPIDEMIOL, V29, P147, DOI 10.1007/s10654-014-9899-y; Witticke D, 2013, DRUG SAFETY, V36, P31, DOI 10.1007/s40264-012-0007-5; Zint K, 2010, PHARMACOEPIDEM DR S, V19, P1248, DOI 10.1002/pds.2031	30	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136339	10.1371/journal.pone.0136339	http://dx.doi.org/10.1371/journal.pone.0136339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26288222	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600132
J	Prevato, M; Ferlenghi, I; Bonci, A; Uematsu, Y; Anselmi, G; Giusti, F; Bertholet, S; Legay, F; Telford, JL; Settembre, EC; Maione, D; Cozzi, R				Prevato, Marua; Ferlenghi, Ilaria; Bonci, Alessandra; Uematsu, Yasushi; Anselmi, Giulia; Giusti, Fabiola; Bertholet, Sylvie; Legay, Francois; Telford, John Laird; Settembre, Ethan C.; Maione, Domenico; Cozzi, Roberta			Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay	PLOS ONE			English	Article							VIRUS NEURAMINIDASE; VIRAL NEURAMINIDASE; MAMMALIAN-CELLS; VACCINE ANTIGEN; HEMAGGLUTININ; PROTECTION; ANTIBODY; IMMUNIZATION; INFECTION; SYSTEM	Developing a universal influenza vaccine that induces broad spectrum and longer-term immunity has become an important potentially achievable target in influenza vaccine research and development. Hemagglutinin (HA) and neuraminidase (NA) are the two major influenza virus antigens. Although antibody responses against influenza virus are mainly directed toward HA, NA is reported to be more genetically stable; hence NA-based vaccines have the potential to be effective for longer time periods. NA-specific immunity has been shown to limit the spread of influenza virus, thus reducing disease symptoms and providing cross-protection against heterosubtypic viruses in mouse challenge experiments. The production of large quantities of highly pure and stable NA could be beneficial for the development of new antivirals, subunit-based vaccines, and novel diagnostic tools. In this study, recombinant NA (rNA) was produced in mammalian cells at high levels from both swine A/California/07/2009 (H1N1) and avian A/turkey/Turkey/01/2005 (H5N1) influenza viruses. Biochemical, structural, and immunological characterizations revealed that the soluble rNAs produced are tetrameric, enzymatically active and immunogenic, and finally they represent good alternatives to conventionally used sources of NA in the Enzyme-Linked Lectin Assay (ELLA).	[Prevato, Marua; Ferlenghi, Ilaria; Bonci, Alessandra; Uematsu, Yasushi; Anselmi, Giulia; Bertholet, Sylvie; Telford, John Laird; Maione, Domenico; Cozzi, Roberta] Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy; [Giusti, Fabiola] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Legay, Francois] Novartis Vaccines & Diagnost, Vaccine Res, Basel, Switzerland; [Settembre, Ethan C.] Novartis Vaccines & Diagnost Inc, Vaccine Res, Cambridge, MA USA	Novartis; University of Siena; Novartis; Novartis	Maione, D (corresponding author), Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020		Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was supported by internal funding from Novartis Vaccines and Diagnostics. The funder provided support in the form of salaries for authors IF AB YU SB FL JLT ECS DM RC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Air GM, 2012, INFLUENZA OTHER RESP, V6, P245, DOI 10.1111/j.1750-2659.2011.00304.x; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Brett IC, 2005, VIROLOGY, V339, P273, DOI 10.1016/j.virol.2005.06.006; BURMEISTER WP, 1994, J GEN VIROL, V75, P381, DOI 10.1099/0022-1317-75-2-381; Cate TR, 2010, VACCINE, V28, P2076, DOI 10.1016/j.vaccine.2009.12.041; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; Dalakouras T, 2006, J CHROMATOGR A, V1136, P48, DOI 10.1016/j.chroma.2006.09.067; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; KILBOURNE ED, 1987, INFLUENZA; LAMBRE CR, 1990, J IMMUNOL METHODS, V135, P49, DOI 10.1016/0022-1759(90)90255-T; Lawrenz M, 2010, PROTEINS, V78, P2523, DOI 10.1002/prot.22761; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Marcelin G, 2012, REV MED VIROL, V22, P267, DOI 10.1002/rmv.1713; Martinet W, 1997, EUR J BIOCHEM, V247, P332, DOI 10.1111/j.1432-1033.1997.00332.x; MATHER KA, 1992, VIRUS RES, V26, P127, DOI 10.1016/0168-1702(92)90152-Y; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Nivitchanyong T, 2011, J VIROL METHODS, V178, P44, DOI 10.1016/j.jviromet.2011.08.010; Organization TWH, 2014, INFL SEAS; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; Schmidt PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016284; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; Sylte MJ, 2009, CURR TOP MICROBIOL, V333, P227, DOI 10.1007/978-3-540-92165-3_12; VANHEEL M, 1988, SCANNING MICROSCOPY, P295; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WEBSTER RG, 1967, J IMMUNOL, V99, P49; WEBSTER RG, 1984, VIROLOGY, V135, P30, DOI 10.1016/0042-6822(84)90114-4; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Yongkiettrakul S, 2009, J VIROL METHODS, V156, P44, DOI 10.1016/j.jviromet.2008.10.025	39	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135474	10.1371/journal.pone.0135474	http://dx.doi.org/10.1371/journal.pone.0135474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280677	Green Submitted, Green Published, gold			2022-12-27	WOS:000359664300015
J	Bahnan, W; Boettner, DR; Westermark, L; Fallman, M; Schesser, K				Bahnan, Wael; Boettner, Douglas R.; Westermark, Linda; Faellman, Maria; Schesser, Kurt			Pathogenic Yersinia Promotes Its Survival by Creating an Acidic Fluid-Accessible Compartment on the Macrophage Surface	PLOS ONE			English	Article							PLASMA-MEMBRANE; PSEUDOTUBERCULOSIS; PROTEIN; TRANSLOCATION; PESTIS; CELLS; ENTEROCOLITICA; TRAFFICKING; YOPE; AUTOPHAGOSOMES	Microbial pathogens and host immune cells each initiate events following their interaction in an attempt to drive the outcome to their respective advantage. Here we show that the bacterial pathogen Yersinia pseudotuberculosis sustains itself on the surface of a macrophage by forming acidic fluid-accessible compartments that are partially bounded by the host cell plasma membrane. These Yersinia-containing acidic compartments (YACs) are bereft of the early endosomal marker EEA1 and the lysosomal antigen LAMP1 and readily form on primary macrophages as well as macrophage-like cell lines. YAC formation requires the presence of the Yersinia virulence plasmid which encodes a type III secretion system. Unexpectedly, we found that the initial formation of YACs did not require translocation of the type III effectors into the host cell cytosol; however, the duration of YACs was markedly greater in infections using translocation-competent Y. pseudotuberculosis strains as well as strains expressing the effector YopJ. Furthermore, it was in this translocation- and YopJ-dependent phase of infection that the acidic environment was critical for Y. pseudotuberculosis survival during its interaction with macrophages. Our findings indicate that during its extracellular phase of infection Y. pseudotuberculosis initiates and then, by a separate mechanism, stabilizes the formation of a highly intricate structure on the surface of the macrophage that is disengaged from the endocytic pathway.	[Bahnan, Wael; Schesser, Kurt] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Boettner, Douglas R.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Westermark, Linda; Faellman, Maria] Umea Univ, Dept Mol Biol, Umea, Sweden	University of Miami; University of Miami; Umea University	Schesser, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	kschesser@med.miami.edu		Abu Kwaik, Yousef/0000-0002-2119-2078; Boettner, Douglas/0000-0002-0591-443X	National Institute of Health [RO1-AI53459, RO1-GM055796]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055796] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received support from National Institute of Health RO1-AI53459 (KS); National Institute of Health RO1-GM055796 (DRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Bartra S, 2001, BMC Microbiol, V1, P22, DOI 10.1186/1471-2180-1-22; BOLIN I, 1982, INFECT IMMUN, V37, P506; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Edgren T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002669; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; Fahlgren A, 2009, CELL MICROBIOL, V11, P1750, DOI 10.1111/j.1462-5822.2009.01365.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Leka O, 2014, FEBS J, V281, P2115, DOI 10.1111/febs.12783; Mesaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019764; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Moreau K, 2010, CELL MICROBIOL, V12, P1108, DOI 10.1111/j.1462-5822.2010.01456.x; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Ray A, 2010, J VIS EXP; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; Sarantis H, 2012, CELL HOST MICROBE, V11, P117, DOI 10.1016/j.chom.2012.01.010; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Siefker DT, 2014, INFECT IMMUN, V82, P762, DOI 10.1128/IAI.01489-13; Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Trulzsch K, 2005, J IMMUNOL, V174, P4244, DOI 10.4049/jimmunol.174.7.4244; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133298	10.1371/journal.pone.0133298	http://dx.doi.org/10.1371/journal.pone.0133298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275291	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600011
J	Bourdet, I; Lampin-Saint-Amaux, A; Preat, T; Goguel, V				Bourdet, Isabelle; Lampin-Saint-Amaux, Aurelie; Preat, Thomas; Goguel, Valerie			Amyloid-beta Peptide Exacerbates the Memory Deficit Caused by Amyloid Precursor Protein Loss-of-Function in Drosophila	PLOS ONE			English	Article							SECRETASE CLEAVAGE; OLFACTORY MEMORY; MUSHROOM BODIES; APP-FAMILY; A-BETA; EXPRESSION; BACE1; MODEL; NEURODEGENERATION; IDENTIFICATION	The amyloid precursor protein (APP) plays a central role in Alzheimer's disease (AD). APP can undergo two exclusive proteolytic pathways: cleavage by the a-secretase initiates the non-amyloidogenic pathway while cleavage by the beta-secretase initiates the amyloidogenic pathway that leads, after a second cleavage by the gamma-secretase, to amyloid-beta (A beta) peptides that can form toxic extracellular deposits, a hallmark of AD. The initial events leading to AD are still unknown. Importantly, aside from A beta toxicity whose molecular mechanisms remain elusive, several studies have shown that APP plays a positive role in memory, raising the possibility that APP loss-of-function may participate to AD. We previously showed that APPL, the Drosophila APP ortholog, is required for associative memory in young flies. In the present report, we provide the first analysis of the amyloidogenic pathway's influence on memory in the adult. We show that transient overexpression of the beta-secretase in the mushroom bodies, the center for olfactory memory, did not alter memory. In sharp contrast, beta-secretase overexpression affected memory when associated with APPL partial loss-offunction. Interestingly, similar results were observed with Drosophila A beta peptide. Because A beta overexpression impaired memory only when combined to APPL partial loss-of-function, the data suggest that A beta affects memory through the APPL pathway. Thus, memory is altered by two connected mechanisms-APPL loss-of-function and amyloid peptide toxicity -revealing in Drosophila a functional interaction between APPL and amyloid peptide.	[Bourdet, Isabelle; Lampin-Saint-Amaux, Aurelie; Preat, Thomas; Goguel, Valerie] PSL Res Univ, ESPCI ParisTech, CNRS, Genes & Dynam Memory Syst,Brain Plast Unit, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Preat, T (corresponding author), PSL Res Univ, ESPCI ParisTech, CNRS, Genes & Dynam Memory Syst,Brain Plast Unit, 10 Rue Vauquelin, F-75005 Paris, France.	thomas.preat@espci.fr; valerie.goguel@espci.fr			Region Ile-de-France (DIM NERF); Agence Nationale de la Recherche [11BSV40071]; Fondation pour la Recherche Medicale [DEQ20140329540]	Region Ile-de-France (DIM NERF)(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by: Region Ile-de-France (DIM NERF 2011) to IB; Agence Nationale de la Recherche (11BSV40071) to TP; Fondation pour la Recherche Medicale (DEQ20140329540) to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bignante EA, 2013, NEUROBIOL AGING, V34, P2525, DOI 10.1016/j.neurobiolaging.2013.04.021; Bolkan BJ, 2012, J NEUROSCI, V32, P16181, DOI 10.1523/JNEUROSCI.0228-12.2012; Bour A, 2004, NEUROBIOL LEARN MEM, V81, P27, DOI 10.1016/S1074-7427(03)00071-6; Bourdet I, 2015, J NEUROSCI, V35, P1043, DOI 10.1523/JNEUROSCI.2093-14.2015; Bouzaiane E, 2015, CELL REP, V11, P1280, DOI 10.1016/j.celrep.2015.04.044; Carmine-Simmen K, 2009, NEUROBIOL DIS, V33, P274, DOI 10.1016/j.nbd.2008.10.014; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chen YM, 2012, J NEUROSCI, V32, P11390, DOI 10.1523/JNEUROSCI.0757-12.2012; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Ghosh AK, 2012, J NEUROCHEM, V120, P71, DOI 10.1111/j.1471-4159.2011.07476.x; Goguel V, 2011, J NEUROSCI, V31, P1032, DOI 10.1523/JNEUROSCI.2896-10.2011; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Heber S, 2000, J NEUROSCI, V20, P7951; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Kedikian G, 2010, J NEUROSCI RES, V88, P1795, DOI 10.1002/jnr.22347; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lefort R, 2012, J NEUROSCI, V32, P10674, DOI 10.1523/JNEUROSCI.6473-11.2012; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; Ma HF, 2007, P NATL ACAD SCI USA, V104, P8167, DOI 10.1073/pnas.0609521104; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Plucinska K, 2014, J NEUROSCI, V34, P10710, DOI 10.1523/JNEUROSCI.0433-14.2014; Poeck B, 2012, EXP BRAIN RES, V217, P413, DOI 10.1007/s00221-011-2860-3; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Shimada T, 2005, PHYSICA A, V350, P144, DOI 10.1016/j.physa.2004.11.033; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sofola O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001087; Vigo FS, 2009, NEUROBIOL AGING, V30, P1379, DOI 10.1016/j.neurobiolaging.2007.11.017; Soldano A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001562; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Torroja L, 1996, J NEUROSCI, V16, P4638; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Van Nostrand WE, 2002, J BIOL CHEM, V277, P36392, DOI 10.1074/jbc.M204676200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; YANG MY, 1995, NEURON, V15, P45; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010	69	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135741	10.1371/journal.pone.0135741	http://dx.doi.org/10.1371/journal.pone.0135741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274614	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600105
J	Strassl, R; Rutter, K; Stattermayer, AF; Beinhardt, S; Kammer, M; Hofer, H; Ferenci, P; Popow-Kraupp, T				Strassl, Robert; Rutter, Karoline; Staettermayer, Albert Friedrich; Beinhardt, Sandra; Kammer, Michael; Hofer, Harald; Ferenci, Peter; Popow-Kraupp, Theresia			Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENOTYPE 1 INFECTION; COBAS AMPLIPREP/COBAS TAQMAN; ABBOTT REALTIME; QUANTITATIVE DETECTION; TELAPREVIR; PERFORMANCE; BOCEPREVIR; EPIDEMIOLOGY; MANAGEMENT	Background and Aims Monitoring of chronic Hepatitis C (CHC) treatment relies on HCV RNA quantification by means of real-time PCR methods. Assay specific analytical sensitivities may impact therapy management. Methods Comparative analysis between three commercial assays (Roche COBAS AmpliPrep/COBAS TaqMan Version 1 (CAP/CTM Ver. 1), Version 2 (CAP/CTM Ver. 2) and the Abbott RealTime HCV (ART) assay) was performed on 247 available samples taken at key decision time points during antiviral therapy of 105 genotype 1 patients (triple therapy: n = 70; dual therapy: n = 35). Results Overall concordance of HCV RNA measurements was high between the two Roche systems (89%; n = 220/247) but lower between the Roche assays and the ART (CAP/CTM Ver. 1 vs ART:77.3%; n = 191/247 and CAP/CTM v.2 vs ART:80.1%; n = 198/247). Most discrepancies were noted in week 4/8 samples with residual viremia (<LLOQ) detected by ART (<LLOQ: n = 45, 44.1%) but undetectable HCV RNA by CAP/CTM Ver. 1 (<LLOQ: n = 18, 17.6%) or CAP/CTM Ver. 2 (<LLOQ: n = 26, 25.5%). Based on results by CAP/CTM Ver. 1, 13 eligible patients underwent an abbreviated course of therapy (24 weeks). Only 1 patient experienced virologic breakthrough. If tested by ART, only 6/13 patients (46.2%) would have been eligible for shortened treatment. Consequently, RGT guidelines were adapted and shortening of therapy was allowed if residual viremia was detected by ART at week 4/8. Conclusion An abbreviated course of treatment can safely be applied in patients with residual viremia (<LLOQ) detected by ART in samples collected at week 4/8 of treatment.	[Strassl, Robert; Popow-Kraupp, Theresia] Med Univ Vienna, Div Clin Virol, Dept Lab Med, Vienna, Austria; [Rutter, Karoline; Staettermayer, Albert Friedrich; Beinhardt, Sandra; Hofer, Harald; Ferenci, Peter] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Kammer, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst CeMSII, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Popow-Kraupp, T (corresponding author), Med Univ Vienna, Div Clin Virol, Dept Lab Med, Vienna, Austria.	theresia.popow-kraupp@meduniwien.ac.at		Kammer, Michael/0000-0003-4821-9928; Stattermayer, Albert/0000-0003-0737-4091				Al Olaby RR, 2011, EXPERT REV MOL DIAGN, V11, P53, DOI 10.1586/ERM.10.101; [Anonymous], 2015, JOURNAL OF HEPATOLOG; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Chevaliez S, 2009, J CLIN MICROBIOL, V47, P1726, DOI 10.1128/JCM.01300-08; Cobb B, 2013, AM J GASTROENTEROL, V108, P471, DOI 10.1038/ajg.2012.248; Ferenci P, 2008, GASTROENTEROLOGY, V135, P451, DOI 10.1053/j.gastro.2008.04.015; Fevery B, 2014, ANTIVIR THER, V19, P559, DOI 10.3851/IMP2760; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Harrington PR, 2012, HEPATOLOGY, V55, P1048, DOI 10.1002/hep.24791; Hezode C, 2015, EASL; Jacobson IM, 2012, J VIRAL HEPATITIS, V19, P1, DOI 10.1111/j.1365-2893.2012.01590.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; LaRue H, 2012, J CLIN MICROBIOL, V50, P1769, DOI 10.1128/JCM.06723-11; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Maasoumy B, 2014, ALIMENT PHARM THER, V39, P85, DOI 10.1111/apt.12544; Maasoumy B, 2015, EASL; Maasoumy B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110857; Martinot-Peignoux M, 2009, J CLIN VIROL, V46, P216, DOI 10.1016/j.jcv.2009.08.011; Michelin BDA, 2007, J CLIN VIROL, V38, P96, DOI 10.1016/j.jcv.2006.11.007; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Pyne MT, 2009, J CLIN MICROBIOL, V47, P2872, DOI 10.1128/JCM.02329-08; Sarrazin C, 2015, J CLIN MICROBIOL, V53, P1264, DOI 10.1128/JCM.03030-14; Schutten M, 2007, J CLIN VIROL, V40, P99, DOI 10.1016/j.jcv.2007.07.013; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sidharthan S, 2015, CROI; Tuaillon E, 2007, J CLIN MICROBIOL, V45, P3077, DOI 10.1128/JCM.00111-07; Vermehren J, 2008, J CLIN MICROBIOL, V46, P3880, DOI 10.1128/JCM.00755-08; Vermehren J, 2014, J HEPATOL, V60, P913, DOI 10.1016/j.jhep.2014.01.002; Wiesmann F, 2014, MED MICROBIOLOGY; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	34	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135963	10.1371/journal.pone.0135963	http://dx.doi.org/10.1371/journal.pone.0135963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274922	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600137
J	Huszthy, PC; Sakariassen, PO; Espedal, H; Brokstad, KA; Bjerkvig, R; Miletic, H				Huszthy, Peter C.; Sakariassen, Per O.; Espedal, Heidi; Brokstad, Karl A.; Bjerkvig, Rolf; Miletic, Hrvoje			Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-FACTOR; EXPRESSION; MODEL; IL-6; INFILTRATION; RECRUITMENT; ACTIVATION; INHIBITOR	Transplantation of glioblastoma patient biopsy spheroids to the brain of T cell-compromised Rowett (nude) rats has been established as a representative animal model for human GBMs, with a tumor take rate close to 100%. In immunocompetent littermates however, primary human GBM tissue is invariably rejected. Here we show that after repeated passaging cycles in nude rats, human GBM spheroids are enabled to grow in the brain of immunocompetent rats. In case of engraftment, xenografts in immunocompetent rats grow progressively and host leukocytes fail to enter the tumor bed, similar to what is seen in nude animals. In contrast, rejection is associated with massive infiltration of the tumor bed by leukocytes, predominantly ED1+ microglia/macrophages, CD4+ T helper cells and CD8+ effector cells, and correlates with elevated serum levels of pro-inflammatory cytokines IL-1 beta, IL-18 and TNF-alpha. We observed that in nude rat brains, an adaptation to the host occurs after several in vivo passaging cycles, characterized by striking attenuation of microglial infiltration. Furthermore, tumor-derived chemokines that promote leukocyte migration and their entry into the CNS such as CXCL-10 and CXCL-12 are down-regulated, and the levels of TGF-beta 2 increase. We propose that through serial in vivo passaging in nude rats, human GBM cells learn to avoid and or/suppress host immunity. Such adapted GBM cells are in turn able to engraft in immunocompetent rats without signs of an inflammatory response.	[Huszthy, Peter C.; Sakariassen, Per O.; Espedal, Heidi; Bjerkvig, Rolf; Miletic, Hrvoje] Univ Bergen, Dept Biomed, KG Jebsen Brain Tumour Res Ctr, Bergen, Norway; [Huszthy, Peter C.] Univ Oslo, Natl Hosp, Dept Immunol, Ctr Immune Regulat, Oslo, Norway; [Brokstad, Karl A.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Bjerkvig, Rolf] CRP Sante, NorLux Neurooncol Lab, Luxembourg, Luxembourg; [Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Oslo; National Hospital Norway; University of Bergen; Luxembourg Institute of Health; University of Bergen; Haukeland University Hospital	Huszthy, PC (corresponding author), Univ Bergen, Dept Biomed, KG Jebsen Brain Tumour Res Ctr, Bergen, Norway.	p.c.huszthy@medisin.uio.no; hrvoje.miletic@biomed.uib.no	Brokstad, Karl Albert/AAU-9639-2020; Huszthy, Peter Csaba/H-1414-2016; Brokstad, Karl Albert/N-8096-2015; Espedal, Heidi/ABE-1829-2020	Brokstad, Karl Albert/0000-0003-0593-2731; Huszthy, Peter Csaba/0000-0003-0184-8989; Brokstad, Karl Albert/0000-0003-0593-2731; Espedal, Heidi/0000-0002-0190-8999	Research Council of Norway; Norwegian Cancer Society, Helse Vest, Haukeland University Hospital; K.G. Jebsen Research Foundation; Bergen Medical Research Foundation	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society, Helse Vest, Haukeland University Hospital; K.G. Jebsen Research Foundation; Bergen Medical Research Foundation	Funding was provided by the Research Council of Norway, The Norwegian Cancer Society, Helse Vest, Haukeland University Hospital, the K.G. Jebsen Research Foundation and the Bergen Medical Research Foundation.	Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631; Bedke J, 2010, MOL IMMUNOL, V47, P1047, DOI 10.1016/j.molimm.2009.11.012; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Cascalho M, 2001, IMMUNITY, V14, P437, DOI 10.1016/S1074-7613(01)00124-8; Chang CY, 2005, J CLIN NEUROSCI, V12, P930, DOI 10.1016/j.jocn.2004.11.017; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Fack F, 2015, ACTA NEUROPATHOL, V129, P115, DOI 10.1007/s00401-014-1352-5; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; GIMBRONE MA, 1989, SCIENCE, V246, P1601, DOI 10.1126/science.2688092; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; GREENE HSN, 1953, CANCER RES, V13, P422; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Huszthy PC, 2005, HUM GENE THER, V16, P381, DOI 10.1089/hum.2005.16.381; Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135; Huszthy PC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006314; KIRSCHKE H, 1989, BIOCHEM J, V264, P467, DOI 10.1042/bj2640467; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; KREMENTZ ET, 1953, CANCER, V6, P100, DOI 10.1002/1097-0142(195301)6:1<100::AID-CNCR2820060110>3.0.CO;2-H; Leveque X, 2011, CURR OPIN ORGAN TRAN, V16, P190, DOI 10.1097/MOT.0b013e32834494b5; Marshall SE, 1996, TRANSPLANTATION, V62, P1614, DOI 10.1097/00007890-199612150-00015; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Melchior B, 2002, J NEUROSCI RES, V68, P284, DOI 10.1002/jnr.10216; Merrill JE, 1997, BRAIN BEHAV IMMUN, V11, P245, DOI 10.1006/brbi.1997.0496; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Revoltella RP, 2012, CYTOKINE, V57, P347, DOI 10.1016/j.cyto.2011.11.016; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Rolstad B, 2001, IMMUNOL REV, V184, P136, DOI 10.1034/j.1600-065x.2001.1840113.x; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Souza DG, 2004, BRIT J PHARMACOL, V143, P132, DOI 10.1038/sj.bjp.0705862; STROMBLAD LG, 1982, ACTA NEUROCHIR, V65, P217, DOI 10.1007/BF01405848; Talasila KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081183; Talasila KM, 2013, ACTA NEUROPATHOL, V125, P683, DOI 10.1007/s00401-013-1101-1; Tiemessen MM, 2003, INT IMMUNOL, V15, P1495, DOI 10.1093/intimm/dxg147; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Weissenberger J, 2004, ONCOGENE, V23, P3308, DOI 10.1038/sj.onc.1207455; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yeung YT, 2013, BRIT J PHARMACOL, V168, P591, DOI 10.1111/bph.12008; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917	42	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136089	10.1371/journal.pone.0136089	http://dx.doi.org/10.1371/journal.pone.0136089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291724	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900052
J	Lizarraga, F; Ceballos-Cancino, G; Espinosa, M; Vazquez-Santillan, K; Maldonado, V; Melendez-Zajgla, J				Lizarraga, Floria; Ceballos-Cancino, Gisela; Espinosa, Magali; Vazquez-Santillan, Karla; Maldonado, Vilma; Melendez-Zajgla, Jorge			Tissue Inhibitor of Metalloproteinase-4 Triggers Apoptosis in Cervical Cancer Cells	PLOS ONE			English	Article							EXPRESSION; DEATH; SMAC/DIABLO; ACTIVATION; PRO-MMP-2; RELEASE; TIMP-4; ROLES	Tissue inhibitor of metalloproteinase-4 (TIMP-4) is a member of extracellular matrix (ECM) metalloproteinases inhibitors that has pleiotropic functions. However, TIMP-4 roles in carcinogenesis are not well understood. Cell viability and flow cytometer assays were employed to evaluate cell death differences between H-Vector and H-TIMP-4 cell lines. Immunobloting and semi-quantitative RT-PCR were used to evaluate the expression of apoptosis regulators. We showed that TIMP-4 has apoptosis-sensitizing effects towards several death stimuli. Consistent with these findings, regulators of apoptosis from Inhibitors of Apoptosis Proteins (IAP), FLICE-like inhibitor proteins (FLIP) and Bcl-2 family members were modulated by TIMP-4. In addition, TIMP-4 knockdown resulted in cell survival increase after serum deprivation, as assessed by clonogenic cell analyses. This report shows that TIMP-4 regulates carcinogenesis through apoptosis activation in cervical cancer cells. Understanding TIMP-4 effects in tumorigenesis may provide clues for future therapies.	[Lizarraga, Floria; Ceballos-Cancino, Gisela; Espinosa, Magali; Vazquez-Santillan, Karla; Maldonado, Vilma; Melendez-Zajgla, Jorge] Natl Inst Genom Med, Funct Genom Lab, Basic Res Subdiv, Del Tlalpan Mexico 14610, DF, Mexico	Instituto Nacional de Medicina Genomica	Melendez-Zajgla, J (corresponding author), Natl Inst Genom Med, Funct Genom Lab, Basic Res Subdiv, Periferico Sur 4809, Del Tlalpan Mexico 14610, DF, Mexico.	jmelendez@inmegen.gob.mx	Ceballos, Gisela/AAR-2437-2021; Vazquez, Karla/ABG-7256-2020; Melendez-Zajgla, Jorge/A-5708-2008	Vazquez, Karla/0000-0003-1380-2494; 	Consejo Nacional de Ciencia y Tecnologia, conacyt.mx [1616519, 87855]	Consejo Nacional de Ciencia y Tecnologia, conacyt.mx	Consejo Nacional de Ciencia y Tecnologia, Grants 1616519, 87855, conacyt.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Bai LC, 2014, ANNU REV MED, V65, P139, DOI 10.1146/annurev-med-010713-141310; Ceballos-Cancino G, 2007, ONCOGENE, V26, P7569, DOI 10.1038/sj.onc.1210560; Celiker MY, 2001, ONCOGENE, V20, P4337, DOI 10.1038/sj.onc.1204508; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Espinosa M, 2012, CANCER LETT, V318, P61, DOI 10.1016/j.canlet.2011.12.002; Fulda S, 2015, SEMIN CANCER BIOL, V31, P84, DOI 10.1016/j.semcancer.2014.05.002; Groft LL, 2001, BRIT J CANCER, V85, P55, DOI 10.1054/bjoc.2001.1854; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Guo YH, 2004, LIFE SCI, V75, P2483, DOI 10.1016/j.lfs.2004.07.007; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez-Barrantes S, 2001, BIOCHEM BIOPH RES CO, V281, P126, DOI 10.1006/bbrc.2001.4323; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Jiang YF, 2001, CANCER RES, V61, P2365; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Koyama S, 2004, DIGEST DIS SCI, V49, P1621, DOI 10.1023/B:DDAS.0000043375.35611.dd; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Li XJ, 2012, CELL PHYSIOL BIOCHEM, V30, P889, DOI 10.1159/000341466; Lizarraga F, 2005, ANTICANCER RES, V25, P623; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Tong WN, 2013, AM J PHYSIOL-REG I, V304, pR613, DOI 10.1152/ajpregu.00515.2012; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tummalapalli CM, 2001, J CELL BIOCHEM, V80, P512, DOI 10.1002/1097-4644(20010315)80:4<512::AID-JCB1005>3.0.CO;2-N; Tunuguntla R, 2003, GYNECOL ONCOL, V89, P453, DOI 10.1016/S0090-8258(03)00077-5	27	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135929	10.1371/journal.pone.0135929	http://dx.doi.org/10.1371/journal.pone.0135929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291714	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900041
J	Vaha-Ypya, H; Vasankari, T; Husu, P; Manttarl, A; Vuorimaa, T; Suni, J; Sievanen, H				Vaha-Ypya, Henri; Vasankari, Tommi; Husu, Pauliina; Manttarl, Ari; Vuorimaa, Timo; Suni, Jaana; Sievanen, Harri			Validation of Cut-Points for Evaluating the Intensity of Physical Activity with Accelerometry-Based Mean Amplitude Deviation (MAD)	PLOS ONE			English	Article							ENERGY-EXPENDITURE; WALKING; SPEED; ACCELERATION; CALIBRATION; DURATION; MODEL; WORK	Purpose Our recent study of three accelerometer brands in various ambulatory activities showed that the mean amplitude deviation (MAD) of the resultant acceleration signal performed best in separating different intensity levels and provided excellent agreement between the three devices. The objective of this study was to derive a regression model that estimates oxygen consumption (VO2) from MAD values and validate the MAD-based cut-points for light, moderate and vigorous locomotion against VO2 within a wide range of speeds. Methods 29 participants performed a pace-conducted non-stop test on a 200 m long indoor track. The initial speed was 0.6 m/s and it was increased by 0.4 m/s every 2.5 minutes until volitional exhaustion. The participants could freely decide whether they preferred to walk or run. During the test they carried a hip-mounted tri-axial accelerometer and mobile metabolic analyzer. The MAD was calculated from the raw acceleration data and compared to directly measured incident VO2. Cut-point between light and moderate activity was set to 3.0 metabolic equivalent (MET, 1 MET = 3.5 ml.kg(-1).min(-1)) and between moderate and vigorous activity to 6.0 MET as per standard use. Results The MAD and VO2 showed a very strong association. Within individuals, the range of r values was from 0.927 to 0.991 providing the mean r = 0.969. The optimal MAD cut-point for 3.0 MET was 91 mg (milligravity) and 414 mg for 6.0 MET. Conclusion The present study showed that the MAD is a valid method in terms of the VO2 within a wide range of ambulatory activities from slow walking to fast running. Being a device-independent trait, the MAD facilitates directly comparable, accurate results on the intensity of physical activity with all accelerometers providing tri-axial raw data.	[Vaha-Ypya, Henri; Vasankari, Tommi; Husu, Pauliina; Manttarl, Ari; Suni, Jaana; Sievanen, Harri] UKK Inst Hlth Promot Res, Tampere, Finland; [Vuorimaa, Timo] Haaga Helia Univ Appl Sci, Vierumaki, Finland	UKK Institute; Haaga-Helia University of Applied Sciences	Vaha-Ypya, H (corresponding author), UKK Inst Hlth Promot Res, Tampere, Finland.	henri.vaha-ypya@uta.fi	Vähä-Ypyä, Henri/AAN-1632-2021; Vähä-Ypyä, Henri/GSO-2044-2022	Husu, Pauliina/0000-0003-1502-7428	Tekes Grant [40247/12]	Tekes Grant(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by a Tekes Grant 40247/12 (http://www.tekes.fi/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittasalo M, MEAN AMPLITUDE DEVIA; Bonomi AG, 2009, MED SCI SPORT EXER, V41, P1770, DOI 10.1249/MSS.0b013e3181a24536; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; Cavagna GA, 2006, J EXP BIOL, V209, P4051, DOI 10.1242/jeb.02344; Crouter SE, 2008, BRIT J SPORT MED, V42, P217, DOI 10.1136/bjsm.2006.033399; CUNNINGHAM DA, 1982, J GERONTOL, V37, P560, DOI 10.1093/geronj/37.5.560; Esliger D.W., 2007, CANADIAN J PUBLIC S2, V98, P195; Fan Jerome, 2006, CJEM, V8, P19; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fudge BW, 2007, MED SCI SPORT EXER, V39, P192, DOI 10.1249/01.mss.0000235884.71487.21; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; HRELJAC A, 1993, MED SCI SPORT EXER, V25, P1158; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; John D, 2010, MED SCI SPORT EXER, V42, P368, DOI 10.1249/MSS.0b013e3181b3af49; Marschollek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063522; MARTIN PE, 1992, J APPL PHYSIOL, V73, P200; McGregor SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007355; Orme M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-34; Pasqui G, 2013, OBES REV, V14, P451, DOI [10.1111/obr.12021, DOI 10.1111/OBR.12021]; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Rowlands AV, 2007, MED SCI SPORT EXER, V39, P716, DOI 10.1249/mss.0b013e318031126c; Sentija D, 2009, INT J SPORTS MED, V30, P795, DOI 10.1055/s-0029-1237711; SHVARTZ E, 1990, AVIAT SPACE ENVIR MD, V61, P3; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; US Department of Health and Human Services, 2008, PHYS ACT GUID AM BE; Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; Vanhelst J, 2009, J SPORT SCI, V27, P669, DOI 10.1080/02640410802680580; Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f; WILLEMS PA, 1995, J EXP BIOL, V198, P379; Yngve A, 2003, MED SCI SPORT EXER, V35, P320, DOI 10.1249/01.MSS.0000048829.75758.A0	33	124	125	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134813	10.1371/journal.pone.0134813	http://dx.doi.org/10.1371/journal.pone.0134813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292225	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900012
J	den Hoedt, CH; Grooteman, MPC; Bots, ML; Blankestijn, PJ; van der Tweel, I; van der Weerd, NC; Penne, EL; Mazairac, AHA; Levesque, R; ter Wee, PM; Nube, MJ; van den Dorpel, MA				den Hoedt, Claire H.; Grooteman, Muriel P. C.; Bots, Michiel L.; Blankestijn, Peter J.; van der Tweel, Ingeborg; van der Weerd, Neelke C.; Penne, E. Lars; Mazairac, Albert H. A.; Levesque, Renee; ter Wee, Piet M.; Nube, Menso J.; van den Dorpel, Marinus A.		CONTRAST Investigators	The Effect of Online Hemodiafiltration on Infections: Results from the CONvective TRAnsport STudy	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEMODIALYSIS-PATIENTS; RISK-FACTORS; HOSPITALIZATION; MORBIDITY	Background Hemodialysis (HD) patients have a high risk of infections. The uremic milieu has a negative impact on several immune responses. Online hemodiafiltration (HDF) may reduce the risk of infections by ameliorating the uremic milieu through enhanced clearance of middle molecules. Since there are few data on infectious outcomes in HDF, we compared the effects of HDF with low-flux HD on the incidence and type of infections. Patients and Methods We used data of the 714 HD patients (age 64 +/- 14, 62% men, 25% Diabetes Mellitus, 7% catheters) participating in the CONvective TRAnsport STudy (CONTRAST), a randomized controlled trial evaluating the effect of HDF as compared to low-flux HD. The events were adjudicated by an independent event committee. The risk of infectious events was compared with Cox regression for repeated events and Cox proportional hazard models. The distributions of types of infection were compared between the groups. Results Thirty one percent of the patients suffered from one or more infections leading to hospitalization during the study (median follow-up 1.96 years). The risk for infections during the entire follow-up did not differ significantly between treatment arms (HDF 198 and HD 169 infections in 800 and 798 person-years respectively, hazard ratio HDF vs. HD 1.09 (0.88-1.34), P = 0.42. No difference was found in the occurrence of the first infectious event (either fatal, non-fatal or type specific). Of all infections, respiratory infections (25% in HDF, 28% in HD) were most common, followed by skin/musculoskeletal infections (21% in HDF, 13% in HD). Conclusions HDF as compared to HD did not result in a reduced risk of infections, larger studies are needed to confirm our findings.	[den Hoedt, Claire H.; van den Dorpel, Marinus A.] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands; [den Hoedt, Claire H.; Blankestijn, Peter J.; Mazairac, Albert H. A.] Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands; [Grooteman, Muriel P. C.; ter Wee, Piet M.; Nube, Menso J.] Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [Grooteman, Muriel P. C.; ter Wee, Piet M.; Nube, Menso J.] Vrije Univ Amsterdam Med Ctr, VU Med Ctr ICaR VU, Inst Cardiovasc Res, Amsterdam, Netherlands; [Bots, Michiel L.; van der Tweel, Ingeborg] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Weerd, Neelke C.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Penne, E. Lars] Med Ctr Alkmaar, Alkmaar, Netherlands; [Levesque, Renee] St Luc Hosp, Ctr Hosp Univ Montreal, Montreal, PQ, Canada	Maasstad Hospital; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Medical Center Of Alkmaar; Universite de Montreal	van den Dorpel, MA (corresponding author), Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands.	dorpelm@maasstadziekenhuis.nl	Grooteman, Muriel/AAA-2602-2019; van Hamersvelt, H.W./L-4348-2015	Grooteman, Muriel/0000-0001-5447-2546; boer, walther/0000-0001-5048-2755; van Buren, Marjolijn/0000-0002-1822-6863; Penne, Erik/0000-0002-6018-4679	Dutch Kidney Foundation (Nierstichting Nederland) [C02.2019]; Fresenius Medical Care (The Netherlands); Gambro Lundia AB (Sweden); Dr. E.E. Twiss Fund, Roche Netherlands; International Society of Nephrology/Baxter Extramural Grant Program; Dutch Organization for Health Research and Development (ZonMW) [17088.2802]	Dutch Kidney Foundation (Nierstichting Nederland); Fresenius Medical Care (The Netherlands)(Netherlands Government); Gambro Lundia AB (Sweden); Dr. E.E. Twiss Fund, Roche Netherlands; International Society of Nephrology/Baxter Extramural Grant Program; Dutch Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	Funding: CONTRAST is financially supported by a grant from the Dutch Kidney Foundation (Nierstichting Nederland, grant C02.2019) and unrestricted grants from Fresenius Medical Care (The Netherlands) and Gambro Lundia AB (Sweden). Additional support was received from the Dr. E.E. Twiss Fund, Roche Netherlands; the International Society of Nephrology/Baxter Extramural Grant Program; the Dutch Organization for Health Research and Development (ZonMW, grant 17088.2802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon M, 2005, NEPHROL DIAL TRANSPL, V20, P1180, DOI 10.1093/ndt/gfh729; Allon M, 2003, J AM SOC NEPHROL, V14, P1863, DOI 10.1097/01.ASN.0000074237.78764.D1; [Anonymous], 2015, NEPHROL DIAL TRAN S3, V30; [Anonymous], 2009, FILTR NEUR STAG KID; Foley RN, 2004, J AM SOC NEPHROL, V15, P1038, DOI 10.1097/01.ASN.0000119144.95922.C4; Foley RN, 2008, PERITON DIALYSIS INT, V28, pS167; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; KAPLOWITZ LG, 1988, INFECT CONT HOSP EP, V9, P534; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; Penne EL, 2009, KIDNEY INT, V76, P665, DOI 10.1038/ki.2009.245; Penne EL, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-8; Rayner HC, 2004, NEPHROL DIAL TRANSPL, V19, P108, DOI 10.1093/ndt/gfg483; Schild AF, 2008, J VASC ACCESS, V9, P231, DOI 10.1177/112972980800900402; Slinin Y, 2006, KIDNEY INT, V70, P1135, DOI 10.1038/sj.ki.5001714; Therneau T.M., 2000, MODELING SURVIVAL DA; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P1541; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020	20	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135908	10.1371/journal.pone.0135908	http://dx.doi.org/10.1371/journal.pone.0135908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288091	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600084
J	Ahlers, AA; Cotner, LA; Wolff, PJ; Mitchell, MA; Heske, EJ; Schooley, RL				Ahlers, Adam A.; Cotner, Lisa A.; Wolff, Patrick J.; Mitchell, Mark A.; Heske, Edward J.; Schooley, Robert L.			Summer Precipitation Predicts Spatial Distributions of Semiaquatic Mammals	PLOS ONE			English	Article							MINK MUSTELA-VISON; MUSKRATS ONDATRA-ZIBETHICUS; AMERICAN MINK; CLIMATE-CHANGE; HABITAT PREFERENCES; HOME RANGES; SPACE USE; OCCUPANCY; SELECTION; SURVIVAL	Climate change is predicted to increase the frequency of droughts and intensity of seasonal precipitation in many regions. Semiaquatic mammals should be vulnerable to this increased variability in precipitation, especially in human-modified landscapes where dispersal to suitable habitat or temporary refugia may be limited. Using six years of presence-absence data (2007-2012) spanning years of record-breaking drought and flood conditions, we evaluated regional occupancy dynamics of American mink (Neovison vison) and muskrats (Ondatra zibethicus) in a highly altered agroecosystem in Illinois, USA. We used noninvasive sign surveys and a multiseason occupancy modeling approach to estimate annual occupancy rates for both species and related these rates to summer precipitation. We also tracked radiomarked individuals to assess mortality risk for both species when moving in terrestrial areas. Annual model-averaged estimates of occupancy for mink and muskrat were correlated positively to summer precipitation. Mink and muskrats were widespread during a year (2008) with above-average precipitation. However, estimates of site occupancy declined substantially for mink (0.56) and especially muskrats (0.09) during the severe drought of 2012. Mink are generalist predators that probably use terrestrial habitat during droughts. However, mink had substantially greater risk of mortality away from streams. In comparison, muskrats are more restricted to aquatic habitats and likely suffered high mortality during the drought. Our patterns are striking, but a more mechanistic understanding is needed of how semiaquatic species in human-modified ecosystems will respond ecologically in situ to extreme weather events predicted by climate-change models.	[Ahlers, Adam A.; Cotner, Lisa A.; Wolff, Patrick J.; Schooley, Robert L.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Ahlers, Adam A.; Heske, Edward J.] Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Mitchell, Mark A.] Univ Illinois, Coll Vet Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Ahlers, AA (corresponding author), Kansas State Univ, Dept Hort Forestry & Recreat Resources, Manhattan, KS 66506 USA.	aahlers2@ksu.edu.edu		Ahlers, Adam/0000-0002-5699-0897	Federal Aid and Wildlife Restoration Fund [W-149-R-2]; Illinois Department of Natural Resources Furbearer Fund; Illinois Trappers Association	Federal Aid and Wildlife Restoration Fund; Illinois Department of Natural Resources Furbearer Fund; Illinois Trappers Association	Funding was provided by grants from Federal Aid and Wildlife Restoration Fund(W-149-R-2), Illinois Department of Natural Resources Furbearer Fund, and the Illinois Trappers Association.	Ahlers AA, 2010, CAN J ZOOL, V88, P1011, DOI 10.1139/Z10-069; Ahlers AA, 2011, J WILDLIFE DIS, V47, P685, DOI 10.7589/0090-3558-47.3.685; Ahlers AA, 2010, WILDLIFE BIOL, V16, P400, DOI 10.2981/10-044; Andersen DC, 2000, J MAMMAL, V81, P1087, DOI 10.1644/1545-1542(2000)081<1087:MPORSM>2.0.CO;2; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baker DB, 2004, J AM WATER RESOUR AS, V40, P503, DOI 10.1111/j.1752-1688.2004.tb01046.x; Bellrose Frank C., 1943, JOUR MAMMAL, V24, P173, DOI 10.2307/1374798; Black A, 2009, 2008 RECORD WET STOR; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cosentino BJ, 2011, LANDSCAPE ECOL, V26, P371, DOI 10.1007/s10980-010-9563-1; Cotner LA, 2011, J WILDLIFE MANAGE, V75, P1637, DOI 10.1002/jwmg.197; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Erb J, 2001, OIKOS, V93, P365, DOI 10.1034/j.1600-0706.2001.930302.x; Errington P. L., 1943, Res Bull Agric exp Stat Iowa State Coll, V320, P798; Errington PL, 1939, ECOLOGY, V20, P168, DOI 10.2307/1930738; Estay SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027766; GERELL R, 1970, OIKOS, V21, P160, DOI 10.2307/3543672; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; Hof C, 2012, BIOL LETTERS, V8, P639, DOI 10.1098/rsbl.2012.0023; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holmengen N, 2009, OIKOS, V118, P440, DOI 10.1111/j.1600-0706.2008.16613.x; Illinois State Water Survey, 2012, DROUGHT UPD; KINLER QJ, 1990, ESTUARIES, V13, P337, DOI 10.2307/1351925; Klamt M, 2011, GLOBAL CHANGE BIOL, V17, P3011, DOI 10.1111/j.1365-2486.2011.02472.x; Kupferberg SJ, 2012, CONSERV BIOL, V26, P513, DOI 10.1111/j.1523-1739.2012.01837.x; Lariviere Serge, 1999, Mammalian Species, V608, P1, DOI 10.2307/3504420; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; McCauley LA, 2005, ECOL APPL, V15, P1199, DOI 10.1890/04-0647; Melero Y, 2008, EUR J WILDLIFE RES, V54, P609, DOI 10.1007/s10344-008-0186-7; MESSIER F, 1990, OECOLOGIA, V84, P380, DOI 10.1007/BF00329763; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piha H, 2007, GLOBAL CHANGE BIOL, V13, P300, DOI 10.1111/j.1365-2486.2006.01276.x; Reynolds JC, 2004, BIOL CONSERV, V120, P533, DOI 10.1016/j.biocon.2004.03.026; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; SAS Institute Inc, 2009, SAS 9 23 SAS; Schooley RL, 2012, J WILDLIFE MANAGE, V76, P824, DOI 10.1002/jwmg.294; Schooley RL, 2009, ECOL APPL, V19, P1708, DOI 10.1890/08-2169.1; Shier CJ, 2009, J MAMMAL, V90, P897, DOI 10.1644/07-MAMM-A-410.1; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Suloway L, 1994, WETLAND RESOURCES IL; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Viljugrein H, 2001, J ANIM ECOL, V70, P671, DOI 10.1046/j.1365-2656.2001.00526.x; Virgl JA, 1997, J ZOOL, V243, P237, DOI 10.1111/j.1469-7998.1997.tb02779.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wolff PJ, 2015, WILDLIFE BIOL, V21, P9, DOI 10.2981/wlb.00031; Wuebbles D. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P335, DOI 10.1023/B:MITI.0000038843.73424.de; Yamaguchi N, 2003, J MAMMAL, V84, P1356, DOI 10.1644/1545-1542(2003)084<1356:HPOFAM>2.0.CO;2	56	14	14	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135036	10.1371/journal.pone.0135036	http://dx.doi.org/10.1371/journal.pone.0135036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284916	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100020
J	Kunoh, T; Wang, WX; Kobayashi, H; Matsuzaki, D; Togo, Y; Tokuyama, M; Hosoi, M; Koseki, K; Wada, S; Nagai, N; Nakamura, T; Nomura, S; Hasegawa, M; Sasaki, R; Mizukami, T				Kunoh, Tatsuki; Wang, Weixiang; Kobayashi, Hiroaki; Matsuzaki, Daisuke; Togo, Yuki; Tokuyama, Masahiro; Hosoi, Miho; Koseki, Koichi; Wada, Shu-ichi; Nagai, Nobuo; Nakamura, Toshinobu; Nomura, Shintaro; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio			Human Dynactin-Associated Protein Transforms NIH3T3 Cells to Generate Highly Vascularized Tumors with Weak Cell-Cell Interaction	PLOS ONE			English	Article							AKT PHOSPHORYLATION; COMPLEX 2; MTOR; RICTOR; GROWTH; ACTIVATION; AKT/PKB; KINASE; RAPTOR; MICE	Human dynactin-associated protein (dynAP) is a transmembrane protein that promotes AktSer473 phosphorylation. Here, we report the oncogenic properties of dynAP. In contrast to control NIH3T3 cells expressing LacZ (NIH3T3LacZ), NIH3T3dynAP cells vigorously formed foci in two-dimensional culture, colonies on soft agar, and spheroids in anchorage-deficient three-dimensional culture. NIH3T3dynAP cells injected into nude mice produced tumors with abundant blood vessels and weak cell-cell contacts. Expression of dynAP elevated the level of rictor (an essential subunit of mTORC2) and promoted phosphorylation of FOXO3aSer253. FOXO3a is a transcriptional factor that stimulates expression of pro-apoptotic genes and phosphorylation of FOXO3a abrogates its function, resulting in promoted cell survival. Knockdown of rictor in NIH3T3dynAP cells reduced AktSer473 phosphorylation and formation of foci, colony in soft agar and spheroid, indicating that dynAP-induced activation of the mTORC2/AktSer473 pathway for cell survival contributes to cell transformation. E-cadherin and its mRNA were markedly reduced upon expression of dynAP, giving rise to cells with higher motility, which may be responsible for the weak cell-cell adhesion in tumors. Thus, dynAP could be a new oncoprotein and a target for cancer therapy.	[Kunoh, Tatsuki; Wang, Weixiang; Kobayashi, Hiroaki; Matsuzaki, Daisuke; Togo, Yuki; Tokuyama, Masahiro; Hosoi, Miho; Koseki, Koichi; Wada, Shu-ichi; Nagai, Nobuo; Nakamura, Toshinobu; Nomura, Shintaro; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio] Nagahama Inst Biosci & Technol, Grad Sch Biosci, Nagahama, Shiga, Japan; [Sasaki, Ryuzo; Mizukami, Tamio] Frontier Pharma, Nagahama, Shiga, Japan		Mizukami, T (corresponding author), Nagahama Inst Biosci & Technol, Grad Sch Biosci, Nagahama, Shiga, Japan.	mizukami@nagahama-i-bio.ac.jp	Kunoh, Tatsuki/AAQ-7881-2021; Nakamura, Toshinobu/ABD-5906-2020; Kunoh, Tatsuki/K-7824-2019	Kunoh, Tatsuki/0000-0002-8423-2903; Nakamura, Toshinobu/0000-0003-3881-3368	JSPS KAKENHI [24300343]; Daiichi Sankyo, Inc.; Grants-in-Aid for Scientific Research [25112006, 26640063] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Daiichi Sankyo, Inc.(Daiichi Sankyo Company Limited); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (Grant Number 24300343 to TM). This work was also supported by Daiichi Sankyo, Inc. (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; GREIG RG, 1985, P NATL ACAD SCI USA, V82, P3698, DOI 10.1073/pnas.82.11.3698; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081081; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kunoh T, 2010, MOL CANCER THER, V9, P2934, DOI 10.1158/1535-7163.MCT-10-0730; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Liao Y, 2010, AM J TRANSL RES, V2, P19; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Oneyama C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080300; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sekigawa M, 2010, J BIOMOL SCREEN, V15, P368, DOI 10.1177/1087057110363822; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135836	10.1371/journal.pone.0135836	http://dx.doi.org/10.1371/journal.pone.0135836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284361	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100072
J	Miura, H; Inoko, H; Tanaka, M; Nakaoka, H; Kimura, M; Gurumurthy, CB; Sato, M; Ohtsuka, M				Miura, Hiromi; Inoko, Hidetoshi; Tanaka, Masafumi; Nakaoka, Hirofumi; Kimura, Minoru; Gurumurthy, Channabasavaiah B.; Sato, Masahiro; Ohtsuka, Masato			Assessment of Artificial MiRNA Architectures for Higher Knockdown Efficiencies without the Undesired Effects in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SHORT HAIRPIN RNAS; TARGETED TRANSGENESIS; PRONUCLEAR INJECTION; GENE-EXPRESSION; INTERFERENCE; PIGGYBAC; VECTORS; OVEREXPRESSION; GENERATION	RNAi-based strategies have been used for hypomorphic analyses. However, there are technical challenges to achieve robust, reproducible knockdown effect. Here we examined the artificial microRNA (amiRNA) architectures that could provide higher knockdown efficiencies. Using transient and stable transfection assays in cells, we found that simple amiRNA-expression cassettes, that did not contain a marker gene (-MG), displayed higher amiRNA expression and more efficient knockdown than those that contained a marker gene (+MG). Further, we tested this phenomenon in vivo, by analyzing amiRNA-expressing mice that were produced by the pronuclear injection-based targeted transgenesis (PITT) method. While we observed significant silencing of the target gene (eGFP) in + MG hemizygous mice, obtaining -MG amiRNA expression mice, even hemizygotes, was difficult and the animals died perinatally. We obtained only mosaic mice having both "-MG amiRNA" cells and "amiRNA low-expression" cells but they exhibited growth retardation and cataracts, and they could not transmit the -MG amiRNA allele to the next generation. Furthermore, +MG amiRNA homozygotes could not be obtained. These results suggested that excessive amiRNAs transcribed by -MG expression cassettes cause deleterious effects in mice, and the amiRNA expression level in hemizygous +MG amiRNA mice is near the upper limit, where mice can develop normally. In conclusion, the PITT-(+MG amiRNA) system demonstrated here can generate knockdown mouse models that reliably express highest and tolerable levels of amiRNAs.	[Miura, Hiromi; Inoko, Hidetoshi; Tanaka, Masafumi; Kimura, Minoru; Ohtsuka, Masato] Tokai Univ, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Sch Med, Isehara, Kanagawa 2591193, Japan; [Nakaoka, Hirofumi] Natl Inst Genet, Dept Integrated Genet, Div Human Genet, Mishima, Shizuoka 4118540, Japan; [Gurumurthy, Channabasavaiah B.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Mouse Genome Engn Core Facil, Omaha, NE 68198 USA; [Sato, Masahiro] Kagoshima Univ, Frontier Sci Res Ctr, Sect Gene Express Regulat, Kagoshima, Kagoshima 8900065, Japan; [Ohtsuka, Masato] Tokai Univ, Inst Med Sci, Isehara, Kanagawa 2591193, Japan	Tokai University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Nebraska System; University of Nebraska Medical Center; Kagoshima University; Tokai University	Ohtsuka, M (corresponding author), Tokai Univ, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	masato@is.icc.u-tokai.ac.jp	Gurumurthy, Channabasavaiah B/H-8268-2016; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; Sato, Masahiro/0000-0003-1334-2950; Nakaoka, Hirofumi/0000-0002-8454-1159; Ohtsuka, Masato/0000-0002-6952-4238	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23700514, 25290035]; Tokai University School of Medicine; MEXT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110768] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokai University School of Medicine; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant-in-Aid for Young Scientists (B) (23700514) and Grant-in-Aid for Scientific Research (25290035) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and by 2011-2012 Tokai University School of Medicine, Project Research to M.O., and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Borner K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt836; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Ely A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp446; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Gao X, 2007, PHYSIOLOGY, V22, P161, DOI 10.1152/physiol.00002.2007; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimm Dirk, 2011, Silence, V2, P8, DOI 10.1186/1758-907X-2-8; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hu T, 2010, MOL BIOTECHNOL, V46, P34, DOI 10.1007/s12033-010-9264-7; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Klein D, 2000, GENE THER, V7, P458, DOI 10.1038/sj.gt.3301112; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Miura H, 2013, ANAL BIOCHEM, V437, P29, DOI 10.1016/j.ab.2013.02.003; Nakagata N, 2011, METHODS MOL BIOL, V693, P57, DOI 10.1007/978-1-60761-974-1_4; Ohtsuka M, 2006, GENES GENET SYST, V81, P143, DOI 10.1266/ggs.81.143; Ohtsuka M, 2012, EXP ANIM TOKYO, V61, P489, DOI 10.1538/expanim.61.489; Ohtsuka M, 2012, TRANSGENIC RES, V21, P225, DOI 10.1007/s11248-011-9505-y; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Podolska K, 2011, BRIEF FUNCT GENOMICS, V10, P238, DOI 10.1093/bfgp/elr013; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Qiu LH, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-77; Sato M, 2004, MOL REPROD DEV, V69, P268, DOI 10.1002/mrd.20124; Shan ZX, 2009, MOL CELL BIOCHEM, V323, P81, DOI 10.1007/s11010-008-9966-3; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wong MD, 2014, DEVELOPMENT, V141, P2533, DOI 10.1242/dev.107722; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135919	10.1371/journal.pone.0135919	http://dx.doi.org/10.1371/journal.pone.0135919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285215	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100087
J	Zeng, CX; Wu, JS; Zhang, XZ				Zeng, Chaoxu; Wu, Jianshuang; Zhang, Xianzhou			Effects of Grazing on Above- vs. Below-Ground Biomass Allocation of Alpine Grasslands on the Northern Tibetan Plateau	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; PRECIPITATION GRADIENT; ENVIRONMENTAL-FACTORS; ABOVEGROUND BIOMASS; USE EFFICIENCY; CLIMATE-CHANGE; DIVERSITY; EXCLUSION; ROOT; SCALE	Biomass allocation is an essential concept for understanding above-vs. below-ground functions and for predicting the dynamics of community structure and ecosystem service under ongoing climate change. There is rare available knowledge of grazing effects on biomass allocation in multiple zonal alpine grassland types along climatic gradients across the Northern Tibetan Plateau. We collected the peak above-and below-ground biomass (AGB and BGB) values at 106 pairs of well-matched grazed vs. fenced sites during summers of 2010-2013, of which 33 pairs were subject to meadow, 52 to steppe and 21 to desert-steppe. The aboveground net primary productivity (ANPP) was represented by the peak AGB while the belowground net primary productivity (BNPP) was estimated from ANPP, the ratio of living vs. dead BGB, and the root turnover rate. Two-ways analyses of variance (ANOVA) and paired samples comparisons with t-test were applied to examine the effects of pasture managements (PMS, i.e., grazed vs. fenced) and zonal grassland types on both ANPP and BNPP. Allometric and isometric allocation hypotheses were also tested between logarithmically transformed ANPP and BNPP using standardized major axis (SMA) analyses across grazed, fenced and overall sites. In our study, a high community-dependency was observed to support the allometric biomass allocation hypothesis, in association with decreased ANPP and a decreasing-to-increasing BNPP proportions with increasing aridity across the Northern Tibetan Plateau. Grazing vs. fencing seemed to have a trivial effect on ANPP compared to the overwhelming influence of different zonal grassland types. Vegetation links above-and below-ground ecological functions through integrated meta-population adaptive strategies to the increasing severity of habitat conditions. Therefore, more detailed studies on functional diversity are essentially to achieve conservation and sustainability goals under ongoing climatic warming and intensifying human influences.	[Zeng, Chaoxu; Wu, Jianshuang; Zhang, Xianzhou] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Lhasa Plateau Ecosyst Res Stn, Beijing, Peoples R China; [Zeng, Chaoxu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wu, Jianshuang] Free Univ Berlin, Dahlem Ctr Plant Sci, Funct Biodivers, Berlin, Germany	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Free University of Berlin	Wu, JS (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Lhasa Plateau Ecosyst Res Stn, Beijing, Peoples R China.	wujs.07s@igsnrr.ac.cn	zhang, xian/GYA-0290-2022; WU, Jianshuang/N-4694-2015	WU, Jianshuang/0000-0002-6768-8255	Strategic Priority Research Program from the Chinese Academy of Sciences (CAS) [XDB03030401]; CAS Action-Plan for West Development [KZCXZ-XB3-08]; National Natural Sciences Foundation of China [41171044, 41401070]; China Scholarship Council [201400260118]; Office of China Postdoctoral Council [20140041]	Strategic Priority Research Program from the Chinese Academy of Sciences (CAS); CAS Action-Plan for West Development; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Office of China Postdoctoral Council	Xianzhou Zhang received the Strategic Priority Research Program from the Chinese Academy of Sciences (CAS, No. XDB03030401), the CAS Action-Plan for West Development (No. KZCXZ-XB3-08), and National Natural Sciences Foundation of China (No. 41171044). Jianshuang Wu received a scholarship from the China Scholarship Council (No. 201400260118), an international postdoctoral exchange fellowship program from the Office of China Postdoctoral Council (No. 20140041), and a research grant from the National Natural Sciences Foundation of China (No. 41401070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, WHOLE PLANT PERSPECT; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; Bessler H, 2009, ECOLOGY, V90, P1520, DOI 10.1890/08-0867.1; Chen BX, 2014, AGR FOREST METEOROL, V189, P11, DOI 10.1016/j.agrformet.2014.01.002; Chen ZQ, 2012, SCI CHINA EARTH SCI, V55, P1306, DOI 10.1007/s11430-012-4389-0; Craine JM, 2001, OIKOS, V93, P274, DOI 10.1034/j.1600-0706.2001.930210.x; Evans TL, 2013, ECOHYDROLOGY, V6, P713, DOI 10.1002/eco.1292; Falster DS, 2006, MATR STANDARDIZED MA; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Fan JW, 2010, ENVIRON MONIT ASSESS, V170, P571, DOI 10.1007/s10661-009-1258-1; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gill RA, 2002, PLANT ECOL, V159, P241, DOI 10.1023/A:1015529507670; Gill RA, 2002, GLOBAL ECOL BIOGEOGR, V11, P79, DOI 10.1046/j.1466-822X.2001.00267.x; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Hu ZM, 2010, GLOBAL ECOL BIOGEOGR, V19, P842, DOI 10.1111/j.1466-8238.2010.00564.x; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Kang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069561; KORNER C, 1987, OECOLOGIA, V74, P411, DOI 10.1007/BF00378938; Leifeld J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119184; Li XL, 2013, LAND DEGRAD DEV, V24, P72, DOI 10.1002/ldr.1108; Li XJ, 2011, ENVIRON EARTH SCI, V64, P1911, DOI 10.1007/s12665-011-1004-1; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071749; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; McNaughton SJ, 1998, ECOLOGY, V79, P587, DOI 10.1890/0012-9658(1998)079[0587:RBAPIA]2.0.CO;2; Medina-Roldan E, 2012, OECOLOGIA, V170, P159, DOI 10.1007/s00442-012-2287-y; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Niklas KJ, 2002, AM NAT, V159, P482, DOI 10.1086/339459; PANDEY CB, 1992, ECOLOGY, V73, P2007, DOI 10.2307/1941451; Patty L, 2010, FLORA, V205, P695, DOI 10.1016/j.flora.2009.12.039; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Pucheta E, 2004, AUSTRAL ECOL, V29, P201, DOI 10.1111/j.1442-9993.2004.01337.x; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; R Core Team, 2014, R A LANGUAGE AND ENV; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Semmartin M, 2008, PLANT SOIL, V303, P177, DOI 10.1007/s11104-007-9497-9; Shi Y, 2014, BIOGEOSCIENCES, V11, P2003, DOI 10.5194/bg-11-2003-2014; Sun H. L., 2012, ACTA GEOGRAPHICA SIN, V67, P4; Sun J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108821; SUNDRIYAL R C, 1990, Tropical Ecology, V31, P84; VANDERMAAREL E, 1989, OIKOS, V56, P364, DOI 10.2307/3565622; Veen GF, 2014, OIKOS, V123, P800, DOI 10.1111/j.1600-0706.2013.01077.x; Veen GF, 2012, OECOLOGIA, V168, P511, DOI 10.1007/s00442-011-2093-y; Wang LA, 2010, SCI CHINA LIFE SCI, V53, P851, DOI 10.1007/s11427-010-4027-z; Wang LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093566; Wang Z, 2013, J VEG SCI, V24, P189, DOI 10.1111/j.1654-1103.2012.01442.x; Wu JS, 2013, J MT SCI-ENGL, V10, P1097, DOI 10.1007/s11629-013-2435-9; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Wu JS, 2014, CHINESE SCI BULL, V59, P4332, DOI 10.1007/s11434-014-0362-y; Wu JS, 2014, ARCT ANTARCT ALP RES, V46, P419, DOI 10.1657/1938-4246-46.2.419; Wu JS, 2014, ALPINE BOT, V124, P13, DOI 10.1007/s00035-014-0125-z; Wu JS, 2013, RANGELAND ECOL MANAG, V66, P454, DOI 10.2111/REM-D-12-00051.1; Wu JianShuang, 2012, Journal of Resources and Ecology, V3, P236; Wu YB, 2011, PLANT SOIL, V338, P497, DOI 10.1007/s11104-010-0562-4; Yang YH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043920; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yao TD, 2012, ENVIRON DEV, V3, P52, DOI 10.1016/j.envdev.2012.04.002; Yu CQ, 2012, ENVIRON SCI TECHNOL, V46, P1979, DOI 10.1021/es2047188; [钟祥浩 Zhong Xianghao], 2010, [山地学报, Journal of Mountain Science], V28, P1; [钟祥浩 Zhong Xianhao], 2006, [山地学报, Journal of Mountain Science], V24, P129; Zhou X. M, 2001, CHINESE KOBRESIA MEA	65	59	64	17	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135173	10.1371/journal.pone.0135173	http://dx.doi.org/10.1371/journal.pone.0135173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284515	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100025
J	Bian, C; Xu, SM; Wang, H; Li, NN; Wu, JY; Zhao, YW; Li, P; Lu, H				Bian, Cheng; Xu, Shuman; Wang, Heng; Li, Niannian; Wu, Jingya; Zhao, Yunwu; Li, Peng; Lu, Hua			A Study on the Application of the Information-Motivation-Behavioral Skills (IMB) Model on Rational Drug Use Behavior among Second-Level Hospital Outpatients in Anhui, China	PLOS ONE			English	Article							RISK REDUCTION INTERVENTION; CONDOM USE	Background The high prevalence of risky irrational drug use behaviors mean that outpatients face high risks of drug resistance and even death. This study represents the first application of the Information-Motivation-Behavioral Skills (IMB) model on rational drug use behavior among second-level hospital outpatients from three prefecture-level cities in Anhui, China. Using the IMB model, our study examined predictors of rational drug use behavior and determined the associations between the model constructs. Methods This study was conducted with a sample of 1,214 outpatients aged 18 years and older in Anhui second-level hospitals and applied the structural equation model (SEM) to test predictive relations among the IMB model variables related to rational drug use behavior. Results Age, information and motivation had significant direct effects on rational drug use behavior. Behavioral skills as an intermediate variable also significantly predicted more rational drug use behavior. Female gender, higher educational level, more information and more motivation predicted more behavioral skills. In addition, there were significant indirect impacts on rational drug use behavior mediated through behavioral skills. Conclusions The IMB-based model explained the relationships between the constructs and rational drug use behavior of outpatients in detail, and it suggests that future interventions among second-level hospital outpatients should consider demographic characteristics and should focus on improving motivation and behavioral skills in addition to the publicity of knowledge.	[Bian, Cheng; Wang, Heng; Li, Niannian; Zhao, Yunwu; Li, Peng] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Xu, Shuman] Guangdong Prov Maternal & Child Hlth Hosp, Guangzhou, Guangdong, Peoples R China; [Wu, Jingya] Anhui Med Univ, Affiliated Hosp 4, Hefei, Anhui, Peoples R China; [Lu, Hua] Anhui Prov Hosp, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Wang, H (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China.	wangheng1969@163.com			national natural science foundation [71473003]; natural science foundation of Anhui province [1408085MG143]; provincial natural science research key project of colleges and universities of Anhui province [KJ2013A162]	national natural science foundation(National Natural Science Foundation of China (NSFC)); natural science foundation of Anhui province(Natural Science Foundation of Anhui Province); provincial natural science research key project of colleges and universities of Anhui province	This study was supported by grants from national natural science foundation (71473003) (https://isis.nsfc.gov.cn/), natural science foundation of Anhui province (1408085MG143) (http://www.ahkjt.gov.cn/) and provincial natural science research key project of colleges and universities of Anhui province (KJ2013A162) (http://ky.ahedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2006, ANN BEHAV MED, V31, P70, DOI 10.1207/s15324796abm3101_11; [Anonymous], 2000, AIDS PREVENT MENT H; Bazargan M, 2010, J SCHOOL HEALTH, V80, P287, DOI 10.1111/j.1746-1561.2010.00503.x; Carrus G, 2008, J ENVIRON PSYCHOL, V28, P51, DOI 10.1016/j.jenvp.2007.09.003; Copenhaver MM, 2006, J URBAN HEALTH, V83, P1132, DOI 10.1007/s11524-006-9090-1; Cornman DH, 2007, SOC SCI MED, V64, P1572, DOI 10.1016/j.socscimed.2006.11.011; [丁洁卫 Ding Jiewei], 2010, [中国药房, China Pharmacy], V21, P1913; Ding YF, 2012, CHINESE J PHARMACOEP, V21, P272; Fisher JD, 1996, HEALTH PSYCHOL, V15, P114, DOI 10.1037/0278-6133.15.2.114; Fisher JD, 2002, HEALTH PSYCHOL, V21, P177, DOI 10.1037//0278-6133.21.2.177; FISHER JD, 1994, HEALTH PSYCHOL, V13, P238, DOI 10.1037/0278-6133.13.3.238; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Fisher Jeffrey D, 2008, Curr HIV/AIDS Rep, V5, P193, DOI 10.1007/s11904-008-0028-y; Fisher WA, 2003, BLACKW SER HLTH PSYC, P82, DOI 10.1002/9780470753552.ch4; Fisher WA., 1999, AIDS BEHAV, V3, P13, DOI [10.1023/A:1025411317851, DOI 10.1023/A:1025411317851]; Garson GD., 2015, STRUCTURAL EQUATION; Goodell LS, 2012, J NUTR EDUC BEHAV, V44, P240, DOI 10.1016/j.jneb.2010.07.012; HOPPER JR, 1991, ENVIRON BEHAV, V23, P195, DOI 10.1177/0013916591232004; Hu X, 2009, CHINA LICENSED PHARM, V6, P20; Jackson DL, 2003, STRUCT EQU MODELING, V10, P128, DOI 10.1207/S15328007SEM1001_6; Kiene SM, 2006, J ADOLESCENT HEALTH, V39, P404, DOI 10.1016/j.jadohealth.2005.12.029; Kline RB, 2005, PRINCIPLES PRACTICE; Meng Y, 2013, CHINESE J HLTH ED, V29, P782; Osborn CY, 2010, PATIENT EDUC COUNS, V79, P49, DOI 10.1016/j.pec.2009.07.016; Robertson AA, 2006, J ADOLESCENT HEALTH, V38, P18, DOI 10.1016/j.jadohealth.2004.08.013; Seacat JD, 2010, J ENVIRON PSYCHOL, V30, P393, DOI 10.1016/j.jenvp.2010.02.002; [唐万琴 Tang Wanqin], 2012, [中国卫生统计, Chinese Journal of Health Statistics], V29, P535; The Core Information Interpretation of Health Education in Rational Drug Use, 2013, COD INF INT HLTH ED; [王凤潇 WANG Feng-xiao], 2010, [中国药房, China Pharmacy], V21, P1541; World Health Organization, 1985, C EXP; Zhang XP, 2010, MED SOC, V23, P23; 胡浩, 2010, [中国公共卫生, China Public Health], V26, P915	32	14	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135782	10.1371/journal.pone.0135782	http://dx.doi.org/10.1371/journal.pone.0135782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275301	Green Published, gold			2022-12-27	WOS:000359493600111
J	Maghami, M; Hizam, H; Gomes, C; Hajighorbani, S; Rezaei, N				Maghami, Mohammadreza; Hizam, Hashim; Gomes, Chandima; Hajighorbani, Shahrooz; Rezaei, Nima			Evaluation of the 2013 Southeast Asian Haze on Solar Generation Performance	PLOS ONE			English	Article							AIR-POLLUTION; PHOTOVOLTAIC SYSTEMS; DUST DEPOSITION; IMPACTS; FIELD	Pollution in Southeast Asia is a major public energy problem and the cause of energy losses. A significant problem with respect to this type of pollution is that it decreases energy yield. In this study, two types of photovoltaic (PV) solar arrays were used to evaluate the effect of air pollution. The performance of two types of solar arrays were analysed in this research, namely, two units of a 1 kWp tracking flat photovoltaic (TFP) and two units of a 1 kWp fixed flat photovoltaic arrays (FFP). Data analysis was conducted on 2,190 samples at 30 min intervals from 01st June 2013, when both arrays were washed, until 30th June 2013. The performance was evaluated by using environmental data (irradiation, temperature, dust thickness, and air pollution index), power output, and energy yield. Multiple regression models were predicted in view of the environmental data and PV array output. Results showed that the fixed flat system was more affected by air pollution than the tracking flat plate. The contribution of this work is that it considers two types of photovoltaic arrays under the Southeast Asian pollution 2013.	[Maghami, Mohammadreza; Hizam, Hashim; Gomes, Chandima; Hajighorbani, Shahrooz; Rezaei, Nima] Univ Putra Malaysia, Dept Elect & Elect Engn, Serdang 43400, Selangor, Malaysia; [Maghami, Mohammadreza; Hizam, Hashim; Hajighorbani, Shahrooz; Rezaei, Nima] Univ Putra Malaysia, Ctr Adv Power & Energy Res CAPER, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Maghami, M (corresponding author), Univ Putra Malaysia, Dept Elect & Elect Engn, Serdang 43400, Selangor, Malaysia.	mr.maghami@gmail.com	Gomes, Chandima/S-1662-2019; Rezaei, Nima/B-4245-2008; hizam, hashim/AAF-5759-2020; Gomes, Chandima/G-4899-2010; MAGHAMI, MOHAMMADREZA/I-1304-2013	Gomes, Chandima/0000-0001-5018-8054; Rezaei, Nima/0000-0002-3836-1827; Gomes, Chandima/0000-0001-5018-8054; MAGHAMI, MOHAMMADREZA/0000-0003-1840-4823	Universiti Putra Malaysia	Universiti Putra Malaysia	This study was funded by Universiti Putra Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz R, 2003, ENVIRON RES, V92, P71, DOI 10.1016/S0013-9351(02)00059-2; Ahmad A., 2000, MALAYSIAN J REMOTE S, V1, P77; Asl-Soleimani E, 2001, RENEW ENERG, V24, P459, DOI 10.1016/S0960-1481(01)00029-5; Chung CE, 2003, J CLIMATE, V16, P1791, DOI 10.1175/1520-0442(2003)016<1791:SAHFRI>2.0.CO;2; El-Nashar AM, 2009, DESALINATION, V239, P66, DOI 10.1016/j.desal.2008.03.007; GOOSSENS D, 1993, SOL ENERGY, V50, P75, DOI 10.1016/0038-092X(93)90009-D; Hajiah A, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/178175; Hajighorbani S, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/719126; Hinds W.C., AEROSOL TECHNOLOGY P, Vsecond; Hottel H. C., 1942, T ASME, P64, DOI [10.1109/JPHOTOV.2015.2495208, DOI 10.1109/JPHOTOV.2015.2495208]; Kymakis E, 2009, ENERG CONVERS MANAGE, V50, P433, DOI 10.1016/j.enconman.2008.12.009; Maghami M, 2014, POW EN PECON 2014 IE; Maghami M, LIFE SCI J, V11; Mani M, 2010, RENEW SUST ENERG REV, V14, P3124, DOI 10.1016/j.rser.2010.07.065; Meral ME, 2011, RENEW SUST ENERG REV, V15, P2176, DOI 10.1016/j.rser.2011.01.010; Murdiyarso D., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P3, DOI 10.1007/s11027-006-9055-4; Ngan M.S., 2011, APPL POW EL C IAPEC; Nie N. H., 1975, SPSS STAT PACKAGE SO, V227; PETERSON JT, 1977, SOL ENERGY, V19, P23, DOI 10.1016/0038-092X(77)90085-8; Pollutant N, 1998, CLEAN AIR, V32, P11; Razykov T, SOLAR ENERGY, V85, P1580; SHAW GE, 1993, METEOROL ATMOS PHYS, V51, P227, DOI 10.1007/BF01030496; Sheraz M, 2012, IEEE INT C POW EN; Tsoutsos T, 2005, ENERG POLICY, V33, P289, DOI 10.1016/S0301-4215(03)00241-6; Ya'acob ME, 2014, ENERG CONVERS MANAGE, V78, P8, DOI 10.1016/j.enconman.2013.10.064; You RY, 2012, AEROSOL SCI TECH, V46, P1090, DOI 10.1080/02786826.2012.695096; Youngsin C, 2004, METEOROL ATMOS PHYS, V87, P143, DOI 10.1007/s00703-003-0067-2; Zhao B, AEROSOL SCI TECHNOLO, V47, P1363	28	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135118	10.1371/journal.pone.0135118	http://dx.doi.org/10.1371/journal.pone.0135118			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275303	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600051
J	Thorrington, D; Eames, K				Thorrington, Dominic; Eames, Ken			Measuring Health Utilities in Children and Adolescents: A Systematic Review of the Literature	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER; LEUKOTRIENE RECEPTOR ANTAGONISTS; COST-EFFECTIVENESS; STANDARD GAMBLE; CYSTIC-FIBROSIS; INHALED CORTICOSTEROIDS; CLINICAL EFFECTIVENESS; ECONOMIC-EVALUATION; STATE UTILITIES	Background The objective of this review was to evaluate the use of all direct and indirect methods used to estimate health utilities in both children and adolescents. Utilities measured pre- and post-intervention are combined with the time over which health states are experienced to calculate quality-adjusted life years (QALYs). Cost-utility analyses (CUAs) estimate the cost-effectiveness of health technologies based on their costs and benefits using QALYs as a measure of benefit. The accurate measurement of QALYs is dependent on using appropriate methods to elicit health utilities. Objective We sought studies that measured health utilities directly from patients or their proxies. We did not exclude those studies that also included adults in the analysis, but excluded those studies focused only on adults. Methods and Findings We evaluated 90 studies from a total of 1,780 selected from the databases. 47 (52%) studies were CUAs incorporated into randomised clinical trials; 23 (26%) were health-state utility assessments; 8 (9%) validated methods and 12 (13%) compared existing or new methods. 22 unique direct or indirect calculation methods were used a total of 137 times. Direct calculation through standard gamble, time trade-off and visual analogue scale was used 32 times. The EuroQol EQ-5D was the most frequently-used single method, selected for 41 studies. 15 of the methods used were generic methods and the remaining 7 were disease-specific. 48 of the 90 studies (53%) used some form of proxy, with 26 (29%) using proxies exclusively to estimate health utilities. Conclusions Several child- and adolescent-specific methods are still being developed and validated, leaving many studies using methods that have not been designed or validated for use in children or adolescents. Several studies failed to justify using proxy respondents rather than administering the methods directly to the patients. Only two studies examined missing responses to the methods administered with respect to the patients' ages.	[Thorrington, Dominic; Eames, Ken] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Thorrington, D (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England.	dominic.thorrington@lshtm.ac.uk			Career Development Fellowship - National Institute for Health Research [NIHR-CDF-2011-04-019]	Career Development Fellowship - National Institute for Health Research	This work was funded by a Career Development Fellowship supported by the National Institute for Health Research (grant number NIHR-CDF-2011-04-019). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Adams R, 2010, PHARMACOECONOMICS, V28, P477, DOI 10.2165/11533010-000000000-00000; Adlard N, 2014, VALUE HEALTH; Adobor RD, 2010, SPINE, V35, P206, DOI 10.1097/BRS.0b013e3181b43bdf; [Anonymous], 2010, THE CHILD HEALTH UTI; Australian Government Department of Health, 2008, SECTION D ECONOMIC E; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Bichey BG, 2002, OTOL NEUROTOL, V23, P323, DOI 10.1097/00129492-200205000-00016; Bodden Denise H M, 2008, Clin Child Psychol Psychiatry, V13, P543, DOI 10.1177/1359104508090602; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Burstrom K, 2011, EUR J PUBLIC HEALTH, V21, P178, DOI 10.1093/eurpub/ckq042; Canaway AG, 2013, QUAL LIFE RES, V22, P173, DOI 10.1007/s11136-012-0119-5; CasasFernandez C, 1997, REV NEUROLOGIA, V25, P415; Centre for Health Economics The University of York, 1994, TIME TRADE OFF USER; Chadha NK, 2010, OTOLARYNG HEAD NECK, V143, P685, DOI 10.1016/j.otohns.2010.08.005; Cheng AK, 2000, JAMA-J AM MED ASSOC, V284, P850, DOI 10.1001/jama.284.7.850; Chiou CF, 2005, INT J QUAL HEALTH C, V17, P23, DOI 10.1093/intqhc/mzh086; Cooke MW, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13130; Dahlquist L M, 1994, Child Health Care, V23, P149, DOI 10.1207/s15326888chc2303_1; DeWitt EM, 2012, VALUE HEALTH, V15, P277, DOI 10.1016/j.jval.2011.11.027; Drummond M. F., 2005, METHODS EC EVALUATIO, P379; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Eidt-Koch D, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-55; Eiser C, 2001, Health Technol Assess, V5, P1; EISER C, 1995, PSYCHO-ONCOL, V4, P121, DOI 10.1002/pon.2960040206; Ekert H, 2001, HAEMOPHILIA, V7, P279, DOI 10.1046/j.1365-2516.2001.00502.x; Epps H, 2005, HEALTH TECHNOL ASSES, V9, pIII; Erickson P, 1998, QUAL LIFE RES, V7, P101, DOI 10.1023/A:1008897107977; EuroQol, 2013, EQ 5D Y EQ 5D PRODUC; EuroQol, 2004, MEASURING SELF REPOR; FEENY D, 1992, J CLIN ONCOL, V10, P923, DOI 10.1200/JCO.1992.10.6.923; Ferreira LN, 2010, VALUE HEALTH, V13, P624, DOI 10.1111/j.1524-4733.2010.00701.x; Friedman Joelle Y, 2004, BMC Pediatr, V4, P21, DOI 10.1186/1471-2431-4-21; GAFNI A, 1994, HEALTH SERV RES, V29, P207; Gensichen J, 2013, BRIT J PSYCHIAT, V202, P441, DOI 10.1192/bjp.bp.112.118257; Gerald JK, 2012, J ASTHMA, V49, P260, DOI 10.3109/02770903.2012.656863; Gilbert FJ, 2004, RADIOLOGY, V231, P343, DOI 10.1148/radiol.2312030886; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; GOLDSTEIN MK, 1994, MED DECIS MAKING, V14, P336, DOI 10.1177/0272989X9401400404; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; Guyatt GH, 1997, PEDIATRICS, V99, P165, DOI 10.1542/peds.99.2.165; Hakkaart-van Roijen L, 2011, DYSLEXIA, V17, P256, DOI 10.1002/dys.436; Health Services Research Center University of California, 2008, QUALITY OF WELL BEIN; Hollmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060477; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Jelsma J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-72; Jelsma J, 2010, INT J REHABIL RES, V33, P172, DOI 10.1097/MRR.0b013e32832bb0f7; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Keating CL, 2011, VALUE HEALTH, V14, P752, DOI 10.1016/j.jval.2011.02.1181; Keren R, 2004, PHARMACOECONOMICS, V22, P71, DOI 10.2165/00019053-200422020-00001; Kromm SK, 2012, QUAL LIFE RES, V21, P1315, DOI 10.1007/s11136-011-0049-7; La Greca AM, 1990, THOUGH THE EYES OF T; Ladapo JA, 2007, PHARMACOECONOMICS, V25, P817, DOI 10.2165/00019053-200725100-00002; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Levi R, 1998, MEASURING HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS, P3; Lin MR, 2012, ARCH PHYS MED REHAB, V93, P245, DOI 10.1016/j.apmr.2011.08.039; Lloyd A, 2010, VALUE HEALTH, V13, P636, DOI 10.1111/j.1524-4733.2010.00705.x; Lock C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14130; Malmivaara K, 2011, EUR J NEUROL, V18, P402, DOI 10.1111/j.1468-1331.2010.03162.x; Matza LS, 2005, QUAL LIFE RES, V14, P735; McGrath P, 1996, PAIN, V64, P435, DOI 10.1016/0304-3959(95)00171-9; Miller T, 2013, PREV SCI, V14, P503, DOI 10.1007/s11121-012-0315-0; Moodie M, 2010, VALUE HEALTH, V13, P1014, DOI 10.1111/j.1524-4733.2010.00780.x; National Institute for Health and Care Excellence (NICE), 2013, GUIDE TO THE METHODS; Neumann PJ, 2005, MED DECIS MAKING, V25, P429, DOI 10.1177/0272989X05276853; Norum J, 1996, EUR J CANCER, V32A, P1510, DOI 10.1016/0959-8049(96)00142-6; Office of Health Economics the International Federation of Pharmaceutical Manufactuers' Associations, 2004, TRENDS IN ECONOMIC E; Oluboyede Y, 2011, EUR J HEALTH ECON, V14, P1; Oostenbrink R, 2002, J CLIN EPIDEMIOL, V55, P791, DOI 10.1016/S0895-4356(02)00448-1; Patrick D. L., 1993, HLTH STATUS HLTH POL; Petrou S, 2003, HEALTH ECON, V12, P697, DOI 10.1002/hec.775; Petrou S, 2010, VALUE HEALTH, V13, P543, DOI 10.1111/j.1524-4733.2010.00711.x; Petrou S, 2009, MED DECIS MAKING, V29, P291, DOI 10.1177/0272989X08327398; Phanthunane P, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-24; PHARMAC, 2012, PRESCRIPTION FOR PHA; Philipsson Anna, 2013, Cost Eff Resour Alloc, V11, P4, DOI 10.1186/1478-7547-11-4; Poley MJ, 2001, J PEDIATR SURG, V36, P1471, DOI 10.1053/jpsu.2001.27025; Pollock-BarZiv SM, 2003, TRANSPL P, V35, P2468, DOI 10.1016/j.transproceed.2003.08.028; Polsky D, 2010, ADDICTION, V105, P1616, DOI 10.1111/j.1360-0443.2010.03001.x; Powell CVE, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17450; Prosser LA, 2007, PHARMACOECONOMICS, V25, P713, DOI 10.2165/00019053-200725090-00001; Prosser LA, 2009, J PEDIATR-US, V155, P7, DOI 10.1016/j.jpeds.2009.03.007; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Ratcliffe J, 2012, PHARMACOECONOMICS, V30, P713, DOI 10.2165/11597900-000000000-00000; Ratcliffe J, 2011, APPL HEALTH ECON HEA, V9, P15, DOI 10.2165/11536960-000000000-00000; Ravens-Sieberer U, 2006, PHARMACOECONOMICS, V24, P1199, DOI 10.2165/00019053-200624120-00005; Redekop W, 2004, DIABETES METAB, V30, P549, DOI 10.1016/S1262-3636(07)70154-4; Richardson JRJ, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-38; Riley AW, 2004, AMBUL PEDIATR, V4, P371, DOI 10.1367/A03-178R.1; Rosenbaum P, 1990, PEDIAT ASSESSING QUA, P205; Rosenbaum P, 1990, PEDIATRICS ASSESSING; ROSS DM, 1984, PAIN, V20, P179, DOI 10.1016/0304-3959(84)90099-X; Campos MR, 2009, NEUROLOGIA, V24, P30; Saigal S, 1999, JAMA-J AM MED ASSOC, V281, P1991, DOI 10.1001/jama.281.21.1991; Secnik K, 2005, MED DECIS MAKING, V25, P56, DOI 10.1177/0272989X04273140; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Stallard P, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17470; Statens Beredning For Medicinsk Utvardering, 2013, UTVARDERING AV METOD; Tan SS, 2010, SCAND J MED SCI SPOR, V20, P568, DOI 10.1111/j.1600-0838.2009.00980.x; Tarride JE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-12; The Canadian agency for drugs and technologies in health, 2012, GUID EC EV HLTH TECH; Thomas KS, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15080; THOMPSON RJ, 1992, J PEDIATR PSYCHOL, V17, P741, DOI 10.1093/jpepsy/17.6.741; Thorrington D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105153; Tilford JM, 2012, PHARMACOECONOMICS, V30, P661, DOI 10.2165/11597200-000000000-00000; Tilford JM, 2005, QUAL LIFE RES, V14, P1087, DOI 10.1007/s11136-004-3305-2; Turk DC, 2001, SELF REPORT SCALES A; Ungar WJ, 2004, ARCH DIS CHILD, V89, P26; Ungar WJ, 2003, VALUE HEALTH, V6, P584, DOI 10.1046/j.1524-4733.2003.65253.x; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; van Litsenburg RRL, 2013, QUAL LIFE RES, V22, P677, DOI 10.1007/s11136-012-0183-x; Versteegh MM, 2012, VALUE HEALTH, V15, P504, DOI 10.1016/j.jval.2011.12.003; Wasserman J, 2005, HAEMOPHILIA, V11, P49, DOI 10.1111/j.1365-2516.2005.01054.x; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams NH, 2004, FAM PRACT, V21, P643, DOI 10.1093/fampra/cmh612; Williams NH, 2003, FAM PRACT, V20, P662, DOI 10.1093/fampra/cmg607; Williamson I, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13370; Wilson ECF, 2010, PHARMACOECONOMICS, V28, P597, DOI 10.2165/11537550-000000000-00000; Wilson ECF, 2010, PHARMACOECONOMICS, V28, P585, DOI 10.2165/11537560-000000000-00000; Wu XY, 2010, QUAL LIFE RES, V19, P969, DOI 10.1007/s11136-010-9663-z; Wyatt K, 2012, Health Technol Assess, V16, P1, DOI 10.3310/hta16390	122	63	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135672	10.1371/journal.pone.0135672	http://dx.doi.org/10.1371/journal.pone.0135672			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275302	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600091
J	Wang, M; Wang, HL; Zhang, RB; Ma, MP; Mei, K; Fang, F; Wang, XD				Wang, Mei; Wang, Huili; Zhang, Rongbo; Ma, Meiping; Mei, Kun; Fang, Fang; Wang, Xuedong			Photolysis of Low-Brominated Diphenyl Ethers and Their Reactive Oxygen Species-Related Reaction Mechanisms in an Aqueous System	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; DECA-BROMODIPHENYL ETHER; SINGLET OXYGEN; DECABROMODIPHENYL ETHER; HUMIC SUBSTANCES; RATE CONSTANTS; PHOTOSENSITIZED DEGRADATION; FLAME RETARDANTS; FURFURYL ALCOHOL; WATER	To date, no report was concerned with participation of reactive oxygen species in waters during photolysis of low-brominated diphenyl ethers (LBDEs). Herein, we found that electron spin resonance (ESR) signals rapidly increased with increasing irradiation time in the solution of LBDEs and 4-oxo-TMP solutions. But this phenomenon did not occur in the presence of NaN3 (O-1(2) quencher) demonstrating generation of O-1(2) in process of LBDEs photolysis. The indirect photolytic contribution rate for BDE-47 and BDE-28 was 18.8% and 17.3% via O-1(2), and 4.9% and 6.6% via center dot OH, respectively. Both D2O and NaN3 experiments proved that the indirect photolysis of LBDEs was primarily attributable to O-1(2). The bimolecular reaction rate constants of O-1(2) with BDE-47 and BDE-28 were 3.12 and 3.64 x 10(6) M-1 s(-1), respectively. The rate constants for BDE-47 and BDE-28 (9.01 and 17.52 x 10(-3) min(-1)), added to isopropyl alcohol, were very close to those (9.65 and 18.42 x 10(-3) min(-1)) in water, proving the less indirect photolytic contribution of center dot OH in water. This is the first comprehensive investigation examining the indirect photolysis of LBDEs in aqueous solution.	[Wang, Mei; Zhang, Rongbo; Ma, Meiping; Mei, Kun; Fang, Fang; Wang, Xuedong] Wenzhou Med Univ, Key Lab Watershed Sci & Hlth Zhejiang Prov, Wenzhou 325035, Peoples R China; [Wang, Huili] Wenzhou Med Univ, Coll Life Sci, Wenzhou 325035, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Ma, MP (corresponding author), Wenzhou Med Univ, Key Lab Watershed Sci & Hlth Zhejiang Prov, Wenzhou 325035, Peoples R China.	mmp@wzmc.edu.cn; zjuwxd@163.com	Wang, Xuedong/B-3279-2018; wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022		National Natural Science Foundation of China [21377100]; Natural Science Foundation of Zhejiang Province [LY13D010006, LY15B070009]; Analyzing and Testing Project of Zhejiang Province [2015C37006, 2015C37033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Analyzing and Testing Project of Zhejiang Province	This work was jointly supported by the National Natural Science Foundation of China (21377100), the Natural Science Foundation of Zhejiang Province (LY13D010006 and LY15B070009), and the Analyzing and Testing Project of Zhejiang Province (2015C37006 and 2015C37033).	Bektasoglu B, 2006, BIOCHEM BIOPH RES CO, V345, P1194, DOI 10.1016/j.bbrc.2006.05.038; Bendig P, 2010, ENVIRON SCI TECHNOL, V44, P1650, DOI 10.1021/es903023m; Bezares-Cruz J, 2004, ENVIRON SCI TECHNOL, V38, P4149, DOI 10.1021/es049608o; Boreen AL, 2008, ENVIRON SCI TECHNOL, V42, P5492, DOI 10.1021/es800185d; Brezova V, 2004, DYES PIGMENTS, V61, P177, DOI 10.1016/j.dyepig.2003.10.012; Choi J, 2004, ENVIRON SCI TECHNOL, V38, P2082, DOI 10.1021/es034916s; de Wit CA, 2010, SCI TOTAL ENVIRON, V408, P2885, DOI 10.1016/j.scitotenv.2009.08.037; DULIN D, 1982, ENVIRON SCI TECHNOL, V16, P815, DOI 10.1021/es00105a017; Eriksson J, 2004, ENVIRON SCI TECHNOL, V38, P3119, DOI 10.1021/es049830t; Fang L, 2008, CHEMOSPHERE, V71, P258, DOI 10.1016/j.chemosphere.2007.09.041; Fang L, 2009, ECOTOX ENVIRON SAFE, V72, P1587, DOI 10.1016/j.ecoenv.2008.09.013; Freccero M, 2003, J AM CHEM SOC, V125, P13182, DOI 10.1021/ja036000r; Ge L, 2009, ENVIRON SCI TECHNOL, V43, P3101, DOI 10.1021/es8031727; Gerecke AC, 2005, ENVIRON SCI TECHNOL, V39, P1078, DOI 10.1021/es048634j; HAAG WR, 1984, CHEMOSPHERE, V13, P631, DOI 10.1016/0045-6535(84)90199-1; Hale RC, 2001, ENVIRON SCI TECHNOL, V35, P4585, DOI 10.1021/es010845q; Halladja S, 2007, ENVIRON SCI TECHNOL, V41, P6066, DOI 10.1021/es070656t; He JZ, 2006, ENVIRON SCI TECHNOL, V40, P4429, DOI 10.1021/es052508d; He P, 2011, TOXICOL IND HEALTH, V27, P279, DOI 10.1177/0748233710387002; Huang AZ, 2013, ENVIRON SCI TECHNOL, V47, P518, DOI 10.1021/es302935e; Kajiwara N, 2013, ENVIRON SCI-PROC IMP, V15, P1957, DOI 10.1039/c3em00359k; Kuivikko M, 2007, ENVIRON SCI TECHNOL, V41, P7016, DOI 10.1021/es070422+; Latch DE, 2003, ENVIRON SCI TECHNOL, V37, P3342, DOI 10.1021/es0340782; Leal JF, 2013, ENVIRON SCI TECHNOL, V47, P14010, DOI 10.1021/es4035254; LEIFER A, 1988, KINETICS ENV AQUATIC, P304; Li LX, 2004, ANAL CHIM ACTA, V512, P121, DOI 10.1016/j.aca.2004.02.020; Li Y, 2009, TALANTA, V78, P1429, DOI 10.1016/j.talanta.2009.02.046; Lin XX, 2012, J SEP SCI, V35, P2553, DOI 10.1002/jssc.201200211; LION Y, 1976, NATURE, V263, P442, DOI 10.1038/263442a0; Liu XJ, 2009, J CHROMATOGR A, V1216, P2220, DOI 10.1016/j.chroma.2008.12.092; Luo XZ, 2012, WATER RES, V46, P1327, DOI 10.1016/j.watres.2011.12.052; Luo Y.R., 2003, HDB BOND DISSOCIATIO, P380; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; MATHESON IBC, 1978, CHEM PHYS LETT, V55, P49, DOI 10.1016/0009-2614(78)85129-X; MERKEL PB, 1972, J AM CHEM SOC, V94, P7244, DOI 10.1021/ja00776a003; Qiu XH, 2007, ENVIRON HEALTH PERSP, V115, P1052, DOI 10.1289/ehp.10011; Sanchez-Prado L, 2006, J CHROMATOGR A, V1124, P157, DOI 10.1016/j.chroma.2006.06.037; Schroter-Kermani C, 2000, ORGANOHALOGEN COMPD, P47; SCULLY FE, 1987, CHEMOSPHERE, V16, P681, DOI 10.1016/0045-6535(87)90004-X; Shih YH, 2009, J HAZARD MATER, V165, P34, DOI 10.1016/j.jhazmat.2008.09.103; Siddiqi Muhammad Akmal, 2003, Clin Med Res, V1, P281; Suh YW, 2009, ENVIRON SCI TECHNOL, V43, P2581, DOI 10.1021/es8022978; TRATNYEK PG, 1991, ENVIRON SCI TECHNOL, V25, P1596, DOI 10.1021/es00021a011; Vione D, 2009, WATER RES, V43, P1959, DOI 10.1016/j.watres.2009.01.027; Wei H, 2013, ENVIRON POLLUT, V174, P194, DOI 10.1016/j.envpol.2012.11.035; Xie Q, 2009, CHEMOSPHERE, V76, P1486, DOI 10.1016/j.chemosphere.2009.06.054; Xu HM, 2011, WATER RES, V45, P632, DOI 10.1016/j.watres.2010.08.024; Yao YY, 2014, J HAZARD MATER, V264, P323, DOI 10.1016/j.jhazmat.2013.10.063; Zang LY, 1995, BIOCHEM MOL BIOL INT, V37, P1187; Zhan MJ, 2006, CHEMOSPHERE, V63, P378, DOI 10.1016/j.chemosphere.2005.08.046; Zhang HM, 2013, BRAIN RES, V1517, P44, DOI 10.1016/j.brainres.2013.04.014; Zhao Yunfeng, 2010, Wei Sheng Yan Jiu, V39, P326; Zhu XD, 2014, CHEMOSPHERE, V107, P274, DOI 10.1016/j.chemosphere.2013.12.060	53	7	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135400	10.1371/journal.pone.0135400	http://dx.doi.org/10.1371/journal.pone.0135400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274605	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600065
J	Htun, P; Nee, J; Ploeckinger, U; Eder, K; Geisler, T; Gawaz, M; Bocksch, W; Fateh-Moghadam, S				Htun, Patrik; Nee, Jens; Ploeckinger, Ursula; Eder, Klaus; Geisler, Tobias; Gawaz, Meinrad; Bocksch, Wolfgang; Fateh-Moghadam, Suzanne			Fish-Free Diet in Patients with Phenylketonuria Is Not Associated with Early Atherosclerotic Changes and Enhanced Platelet Activation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; CARDIOVASCULAR RISK-FACTORS; MYOCARDIAL-INFARCTION; CONSUMPTION; MORTALITY; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; PROGRESSION; OIL	Background and Purpose Since patients with phenylketonuria (PKU) have to follow a lifelong restriction of natural protein to lower phenylalanine-intake, they never eat fish. This diet may lead to a chronic deficit of omega-3 and omega-6 fatty acids with the risk of early atherosclerotic changes. The aim of the study was to analyse the fatty acid profile of PKU patients and to correlate the results with surrogate markers of early atherosclerotic changes [enhanced carotid intima media thickness (CIMT) and beta-stiffness index] and platelet activation. Methods In 43 PKU patients and in 58 healthy controls we prospectively examined the fatty acid profile, CIMT, beta-stiffness index and platelet activation (flow cytometric determination of markers of platelet activation). CIMT was measured bilaterally by ultrasound. CIMTmean was defined as the mean value of the sum of CIMTleft and CIMTright. Results Despite of lower HDL-cholesterol and higher triglyceride concentrations in the PKU group, there was no significant difference in the omega-6 or omega-3 fatty acid profile, CIMT, beta-stiffness index between both groups. Platelet activation was not enhanced in the PKU group. Conclusions Fish-free diet does not induce early atherosclerotic changes or enhanced platelet activation in PKU patients.	[Htun, Patrik] Zent Klinikum, Zent Notaufnahme & Med Klin 4, Augsburg, Germany; [Nee, Jens] Humboldt Univ, Charite Univ Med Campus Virchow Klinikum, Med Klin Schwerpunkt Nephrol & Intens Med, Tubingen, Germany; [Ploeckinger, Ursula] Humboldt Univ, Charite Univ Med Campus Virchow Klinikum, Interdisziplinaeres Stoffwechsel Ctr, Augsburg, Germany; [Eder, Klaus] Univ Giessen, Inst Tierernahrung & Ernahrungsphysiol, Giessen, Germany; [Geisler, Tobias; Gawaz, Meinrad; Bocksch, Wolfgang; Fateh-Moghadam, Suzanne] Univ Tubingen, Abt Kardiol & Kreislauferkrankungen, Med Klin 3, Tubingen, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Justus Liebig University Giessen; Eberhard Karls University of Tubingen	Fateh-Moghadam, S (corresponding author), Univ Tubingen, Abt Kardiol & Kreislauferkrankungen, Med Klin 3, Tubingen, Germany.	suzanne.fateh-moghadam@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020		Charite Research Fund (Anschubfinanzierung); DFG - Klinische Forschergruppe Platelet-Basic Mechanisms and Translational Medicine [KFO274]; Deutsche Interessengemeinschaft Phenylketonurie und verwandte Stoffwechselstorungen e.V. (DIG-PKU)	Charite Research Fund (Anschubfinanzierung); DFG - Klinische Forschergruppe Platelet-Basic Mechanisms and Translational Medicine(German Research Foundation (DFG)); Deutsche Interessengemeinschaft Phenylketonurie und verwandte Stoffwechselstorungen e.V. (DIG-PKU)	This study was supported in part by grants from the Charite Research Fund (Anschubfinanzierung), by the DFG - Klinische Forschergruppe (KFO274) Platelet-Basic Mechanisms and Translational Medicine and "Deutsche Interessengemeinschaft Phenylketonurie und verwandte Stoffwechselstorungen e.V. (DIG-PKU)".	Angerer P, 2002, CARDIOVASC RES, V54, P183, DOI 10.1016/S0008-6363(02)00229-8; [Anonymous], 1985, N ENGL J MED, V313, P820; [Anonymous], 2001, METABOLIC MOL BASES, DOI DOI 10.1036/OMMBID.97; BANG HO, 1976, ACTA MED SCAND, V200, P69; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Bowersox J, 2001, PEDIATRICS, V108, P972; BRADEN GA, 1990, CIRCULATION, V82, P178, DOI 10.1161/01.CIR.82.1.178; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; BURR ML, 1989, LANCET, V2, P757; CHETTY N, 1983, THROMB RES, V30, P619, DOI 10.1016/0049-3848(83)90270-0; Conquer JA, 1999, THROMB RES, V96, P239, DOI 10.1016/S0049-3848(99)00106-1; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; EDER K, 1993, CLIN CHIM ACTA, V219, P93, DOI 10.1016/0009-8981(93)90200-N; Emoto M, 1998, DIABETES CARE, V21, P1178, DOI 10.2337/diacare.21.7.1178; Fateh-Moghadam S, 2005, ARTERIOSCL THROM VAS, V25, P1299, DOI 10.1161/01.ATV.0000165699.41301.c5; Fateh-Moghadam S, 2000, CIRCULATION, V102, P890; Fateh-Moghadam S, 2007, THROMB HAEMOSTASIS, V97, P974, DOI 10.1160/TH06-12-0725; Gawaz M, 1999, CIRCULATION, V99, P2; Hanley WB, 2004, AM J MED, V117, P590, DOI 10.1016/j.amjmed.2004.03.042; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78; Hooper L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003177.PUB2; Iannuzzi A, 2006, AM J CARDIOL, V97, P528, DOI 10.1016/j.amjcard.2005.08.072; KROMHOUT D, 1995, INT J EPIDEMIOL, V24, P340, DOI 10.1093/ije/24.2.340; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; LEAF A, 1994, CIRCULATION, V90, P2248, DOI 10.1161/01.CIR.90.5.2248; Li D, 1999, EUR J CLIN NUTR, V53, P612, DOI 10.1038/sj.ejcn.1600817; McCarty MF, 2004, MED HYPOTHESES, V63, P426, DOI 10.1016/j.mehy.2002.11.007; Mezzano D, 1999, THROMB HAEMOSTASIS, V81, P913; Mori TA, 1997, ARTERIOSCL THROM VAS, V17, P279, DOI 10.1161/01.ATV.17.2.279; MORRISON WR, 1964, J LIPID RES, V5, P600; Moseley K, 2002, J INHERIT METAB DIS, V25, P56, DOI 10.1023/A:1015142001578; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Myrup B, 2001, SCAND J CLIN LAB INV, V61, P349, DOI 10.1080/003655101316911387; Nelson GJ, 1997, LIPIDS, V32, P1129, DOI 10.1007/s11745-997-0145-6; Oomen CM, 2000, AM J EPIDEMIOL, V151, P999, DOI 10.1093/oxfordjournals.aje.a010144; PRISCO D, 1995, METABOLISM, V44, P562, DOI 10.1016/0026-0495(95)90111-6; Rodriguez BL, 1996, CIRCULATION, V94, P952, DOI 10.1161/01.CIR.94.5.952; Ruf A, 1997, BRIT J HAEMATOL, V98, P51, DOI 10.1046/j.1365-2141.1997.1502965.x; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; Schoene NW, 2001, NUTRITION, V17, P793, DOI 10.1016/S0899-9007(01)00644-X; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Yuan JM, 2001, AM J EPIDEMIOL, V154, P809, DOI 10.1093/aje/154.9.809	43	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135930	10.1371/journal.pone.0135930	http://dx.doi.org/10.1371/journal.pone.0135930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291823	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900042
J	Kaltofen, T; Haase, M; Thome, UH; Laube, M				Kaltofen, Till; Haase, Melanie; Thome, Ulrich H.; Laube, Mandy			Male Sex is Associated with a Reduced Alveolar Epithelial Sodium Transport	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ESTROGEN-RECEPTOR-BETA; LUNG LIQUID CLEARANCE; FLUID CLEARANCE; BIOPHYSICAL PROPERTIES; SURFACTANT PRODUCTION; ANDROGEN RECEPTOR; GENE-EXPRESSION; FETAL LAMB; ADULT RATS	Respiratory distress syndrome (RDS) is the most frequent pulmonary complication in preterm infants. RDS incidence differs between genders, which has been called the male disadvantage. Besides maturation of the surfactant system, Na+ transport driven alveolar fluid clearance is crucial for the prevention of RDS. Na+ transport is mediated by the epithelial Na+ channel (ENaC) and the Na,K-ATPase, therefore potential differences in their expression or activity possibly contribute to the gender imbalance observed in RDS. Fetal distal lung epithelial (FDLE) cells of rat fetuses were separated by sex and analyzed regarding expression and activity of the Na+ transporters. Ussing chamber experiments showed a higher baseline short-circuit current (I-SC) and amiloride-sensitive Delta I-SC in FDLE cells of female origin. In addition, maximal amiloride-sensitive.ISC and maximal ouabain-sensitive Delta I-SC of female cells were higher when measured in the presence of a permeabilized basolateral or apical membrane, respectively. The number of FDLE cells per fetus recoverable during cell isolation was also significantly higher in females. In addition, lung wet-to-dry weight ratio was lower in fetal and newborn female pups. Female derived FDLE cells had higher mRNA levels of the ENaC- and Na,K-ATPase subunits. Furthermore, estrogen (ER) and progesterone receptor (PR) mRNA levels were higher in female cells, which might render female cells more responsive, while concentrations of placenta-derived sex steroids do not differ between both genders during fetal life. Inhibition of ER-beta abolished the sex differences in Na+ transport and female cells were more responsive to estradiol stimulation. In conclusion, a higher alveolar Na+ transport, possibly attributable to a higher expression of hormone receptors in female FDLE cells, provides an explanation for the well known sex-related difference in RDS occurrence and outcome.	[Kaltofen, Till; Haase, Melanie; Thome, Ulrich H.; Laube, Mandy] Univ Leipzig, Ctr Pediat Res Leipzig, Div Neonatol, Hosp Children & Adolescents, D-04109 Leipzig, Germany	Leipzig University	Laube, M (corresponding author), Univ Leipzig, Ctr Pediat Res Leipzig, Div Neonatol, Hosp Children & Adolescents, D-04109 Leipzig, Germany.	mandy.laube@medizin.uni-leipzig.de		Laube, Mandy/0000-0002-7180-2858	German Research Foundation (DFG); Leipzig University	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.	Althaus M, 2011, PULM MED, V2011, DOI 10.1155/2011/830320; Altman M, 2013, PAEDIATR PERINAT EP, V27, P172, DOI 10.1111/ppe.12035; Anadkat JS, 2012, J PERINATOL, V32, P780, DOI 10.1038/jp.2011.191; Barker PM, 1997, J PEDIATR-US, V130, P373, DOI 10.1016/S0022-3476(97)70198-7; BARKER PM, 1993, AM J PHYSIOL, V265, pL512, DOI 10.1152/ajplung.1993.265.5.L512; Bastarache JA, 2011, J CRIT CARE, V26, P249, DOI 10.1016/j.jcrc.2010.06.005; Berger PJ, 1998, AM J OBSTET GYNECOL, V178, P223, DOI 10.1016/S0002-9378(98)80004-5; BLAND RD, 1982, J APPL PHYSIOL, V53, P992, DOI 10.1152/jappl.1982.53.4.992; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Bresson E, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-2; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Dammann CEL, 2000, ENDOCRINOLOGY, V141, P2923, DOI 10.1210/en.141.8.2923; Dobrian A, 1999, AM J PHYSIOL-HEART C, V276, pH2159, DOI 10.1152/ajpheart.1999.276.6.H2159; Factor P, 1998, J CLIN INVEST, V102, P1421, DOI 10.1172/JCI3214; FARRELL PM, 1975, AM REV RESPIR DIS, V111, P657; FLEISHER B, 1985, OBSTET GYNECOL, V66, P327; GANDELMAN R, 1977, NATURE, V266, P722, DOI 10.1038/266722a0; Gonzalez-Arenas A, 2004, STEROIDS, V69, P351, DOI 10.1016/j.steroids.2004.03.004; Gortner L, 2013, KLIN PADIATR, V225, P64, DOI 10.1055/s-0033-1333758; Greenlee MM, 2013, AM J PHYSIOL-LUNG C, V305, pL878, DOI 10.1152/ajplung.00008.2013; Grenache DG, 2006, CLIN BIOCHEM, V39, P1, DOI 10.1016/j.clinbiochem.2005.10.008; Guo Y, 1998, AM J PHYSIOL-LUNG C, V274, pL369, DOI 10.1152/ajplung.1998.274.3.L369; HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2; Helve O, 2009, NEONATOLOGY, V95, P347, DOI 10.1159/000209300; Hsu I, 2014, CARCINOGENESIS, V35, P651, DOI 10.1093/carcin/bgt348; Hume R, 2001, BIOL NEONATE, V80, P18, DOI 10.1159/000047172; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Icard P, 1999, AM J PHYSIOL-LUNG C, V277, pL1232, DOI 10.1152/ajplung.1999.277.6.L1232; JASSAL D, 1991, IN VITRO CELL DEV B, V27, P625; Kelly Michelle M, 2006, J Pediatr Health Care, V20, P238, DOI 10.1016/j.pedhc.2006.01.001; KERO PO, 1979, EUR J PEDIATR, V132, P7, DOI 10.1007/BF00443198; Kienitz T, 2009, HORM METAB RES, V41, P356, DOI 10.1055/s-0029-1192033; KIRK KL, 1980, NATURE, V287, P237, DOI 10.1038/287237a0; Kooijman EE, 2011, AM J PHYSIOL-LUNG C, V301, pL804, DOI 10.1152/ajplung.00445.2010; Laube M, 2011, PEDIATR RES, V69, P200, DOI 10.1203/PDR.0b013e3182070ec8; Lazrak A, 2000, AM J PHYSIOL-CELL PH, V279, pC762, DOI 10.1152/ajpcell.2000.279.3.C762; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Manno FAM, 2008, PHYSIOL BEHAV, V93, P364, DOI 10.1016/j.physbeh.2007.09.011; Massaro D, 2006, AM J PHYSIOL-LUNG C, V290, pL866, DOI 10.1152/ajplung.00396.2005; Massaro D, 2004, AM J PHYSIOL-LUNG C, V287, pL1154, DOI 10.1152/ajplung.00228.2004; Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL110, DOI 10.1152/ajplung.1996.270.1.L110; MASSARO GD, 1995, P NATL ACAD SCI USA, V92, P1105, DOI 10.1073/pnas.92.4.1105; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; NIELSEN HC, 1982, J CLIN INVEST, V69, P611, DOI 10.1172/JCI110488; O'Brodovich H M, 1995, New Horiz, V3, P240; OBRODOVICH H, 1993, AM J PHYSIOL, V264, pC1137, DOI 10.1152/ajpcell.1993.264.5.C1137; OBrodovich HM, 1996, P ASSOC AM PHYSICIAN, V108, P345; OLVER RE, 1986, J PHYSIOL-LONDON, V376, P321, DOI 10.1113/jphysiol.1986.sp016156; PARKER CR, 1987, PEDIATR RES, V21, P386, DOI 10.1203/00006450-198704000-00013; Patrone C, 2003, MOL CELL BIOL, V23, P8542, DOI 10.1128/MCB.23.23.8542-8552.2003; PERKS AM, 1990, CAN J PHYSIOL PHARM, V68, P505, DOI 10.1139/y90-072; Pfister RE, 2001, J PHYSIOL-LONDON, V535, P889, DOI 10.1111/j.1469-7793.2001.00889.x; Quinkler M, 2005, HYPERTENSION, V46, P787, DOI 10.1161/01.HYP.0000184362.61744.c1; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Ridge KM, 1997, AM J PHYSIOL-LUNG C, V273, pL246, DOI 10.1152/ajplung.1997.273.1.L246; Roberge S, 2011, J OBSTET GYNAECOL CA, V33, P216, DOI 10.1016/S1701-2163(16)34822-8; Schmidt C, 2014, LUNG, V192, P935, DOI 10.1007/s00408-014-9640-3; Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001; SHANKLIN DR, 1970, J REPROD MED, V5, P53; Shao RJ, 2006, J ENDOCRINOL, V190, P857, DOI 10.1677/joe.1.06896; Simard M, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-25; Sweezey N, 1998, AM J PHYSIOL-CELL PH, V274, pC379, DOI 10.1152/ajpcell.1998.274.2.C379; Thame U, 2001, AM J RESP CELL MOL, V24, P245, DOI 10.1165/ajrcmb.24.3.3994; Thome UH, 2003, AM J PHYSIOL-LUNG C, V284, pL376, DOI 10.1152/ajplung.00218.2002; TORDAY JS, 1990, ENDOCRINOLOGY, V126, P3240, DOI 10.1210/endo-126-6-3240; TORDAY JS, 1987, EXP LUNG RES, V12, P1, DOI 10.3109/01902148709068811; Trotter A, 2006, PEDIATR RES, V60, P60, DOI 10.1203/01.pdr.0000220360.77567.d8; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Yin J, 2014, CELL PHYSIOL BIOCHEM, V33, P1681, DOI 10.1159/000362951; Yusef YR, 2014, PHYSL REP, V2, P5	74	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136178	10.1371/journal.pone.0136178	http://dx.doi.org/10.1371/journal.pone.0136178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291531	Green Submitted, gold, Green Published			2022-12-27	WOS:000359919900061
J	Mascherbauer, J; Kammerlander, AA; Marzluf, BA; Graf, A; Kocher, A; Bonderman, D				Mascherbauer, Julia; Kammerlander, Andreas A.; Marzluf, Beatrice A.; Graf, Alexandra; Kocher, Alfred; Bonderman, Diana			Prognostic Impact of Tricuspid Regurgitation in Patients Undergoing Aortic Valve Surgery for Aortic Stenosis	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; EUROPEAN ASSOCIATION; ECHOCARDIOGRAPHY; HEART; REPLACEMENT; GUIDELINES; SURVIVAL; RECOMMENDATIONS; DYSFUNCTION; SECONDARY	Background The prognostic significance of tricuspid regurgitation (TR) and right ventricular (RV) function in patients undergoing aortic valve replacement (AVR) for severe aortic stenosis (AS) is unknown. The aim of the present study was to evaluate the impact of TR and RV systolic dysfunction on early and late mortality in this setting. Methods This was a prospective single-center observational study. 465 consecutive patients who were referred to AVR for severe AS were investigated. Significant TR was defined as TR >= moderate by transthoracic echocardiography. Results At baseline, significant TR was present in 26 (5.6%) patients. Patients with TR presented with a higher EuroSCORE I (p = 0.001), a higher incidence of previous cardiac surgery (p<0.001), pulmonary hypertension (p = 0.003), more dilated RVs (p = 0.001), and more frequent RV dysfunction (p = 0.001). Patients were followed for an average of 5.2 (+/- 2.8 SD) years. By multivariable Cox regression analysis TR (p = 0.014), RV dysfunction (p = 0.046), age (p = 0.001) and concomitant coronary artery bypass graft surgery (CABG, p = 0.003) were independently associated with overall mortality. By Kaplan-Meier analysis, survival rates were significantly worse in patients with significant than with non-significant TR (log rank p = 0.001). Conclusions TR, RV dysfunction, age, and concomitant CABG are associated with outcome in patients undergoing AVR for severe AS. This finding underlines the importance of a thorough echocardiographic evaluation with particular consideration of the right heart in these patients.	[Mascherbauer, Julia; Kammerlander, Andreas A.; Bonderman, Diana] Med Univ Vienna, Dept Cardiol, Vienna, Austria; [Marzluf, Beatrice A.] Otto Wagner Hosp, Dept Thorac Surg, Vienna, Austria; [Graf, Alexandra] Med Univ Vienna, Dept Med Stat, Vienna, Austria; [Kocher, Alfred] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Mascherbauer, J (corresponding author), Med Univ Vienna, Dept Cardiol, Vienna, Austria.	julia.mascherbauer@meduniwien.ac.at	Kammerlander, Andreas/F-7391-2018	Kammerlander, Andreas/0000-0002-7632-9879; Graf, Alexandra/0000-0003-0035-2658; Mascherbauer, Julia/0000-0001-7478-1450	Austrian Society of Cardiology; Osterreichischer Herzfonds; Austrian fellowship grant [KLI 245]; Austrian Science Fund (FWF) [KLI 245] Funding Source: researchfish	Austrian Society of Cardiology; Osterreichischer Herzfonds; Austrian fellowship grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study received support from the Austrian Society of Cardiology (to JM) the Osterreichischer Herzfonds (to JM) and the Austrian fellowship grant KLI 245 (to JM). There are no relationships with industry.	Adda J, 2012, CIRC-CARDIOVASC IMAG, V5, P27, DOI 10.1161/CIRCIMAGING.111.967554; Ben-Dor I, 2011, AM J CARDIOL, V107, P1046, DOI 10.1016/j.amjcard.2010.11.031; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Cam A, 2011, J THORAC CARDIOV SUR, V142, P800, DOI 10.1016/j.jtcvs.2010.12.024; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; GROVES PH, 1991, BRIT HEART J, V66, P295; Hung J, 1998, AM J CARDIOL, V82, P1301, DOI 10.1016/S0002-9149(98)00624-9; JOHNSON LW, 1988, J THORAC CARDIOV SUR, V95, P603; Kammerlander AA, 2014, J AM COLL CARDIOL; Koelling TM, 2002, AM HEART J, V144, P524, DOI 10.1067/mhj.2002.123575; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Malouf JF, 2002, J AM COLL CARDIOL, V40, P789, DOI 10.1016/S0735-1097(02)02002-8; Mascherbauer J, 2013, INT J CARDIOL, V165, P87, DOI 10.1016/j.ijcard.2011.07.088; Mascherbauer J, 2010, EUR HEART J, V31, P2841, DOI 10.1093/eurheartj/ehq303; Melby SJ, 2011, J THORAC CARDIOV SUR, V141, P1424, DOI 10.1016/j.jtcvs.2011.02.028; Messika-Zeitoun D, 2004, J THORAC CARDIOV SUR, V128, P296, DOI 10.1016/j.jtcvs.2004.01.035; Mutlak D, 2012, AM J MED SCI, V343, P397, DOI 10.1097/MAJ.0b013e3182309431; Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036; Neuhold S, 2013, EUR HEART J, V34, P844, DOI 10.1093/eurheartj/ehs465; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Pai RG, 2007, ANN THORAC SURG, V84, P80, DOI 10.1016/j.athoracsur.2007.02.094; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; SAGIE A, 1994, J AM COLL CARDIOL, V24, P696, DOI 10.1016/0735-1097(94)90017-5; Simek C L, 1995, J Am Soc Echocardiogr, V8, P37, DOI 10.1016/S0894-7317(05)80356-6; Taramasso M, 2012, J AM COLL CARDIOL, V59, P703, DOI 10.1016/j.jacc.2011.09.069; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Zuern CS, 2012, CLIN RES CARDIOL, V101, P81, DOI 10.1007/s00392-011-0367-3	31	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136024	10.1371/journal.pone.0136024	http://dx.doi.org/10.1371/journal.pone.0136024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291082	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900047
J	Pelosi, B; Pratelli, M; Migliarini, S; Pacini, G; Pasqualetti, M				Pelosi, Barbara; Pratelli, Marta; Migliarini, Sara; Pacini, Giulia; Pasqualetti, Massimo			Generation of a Tph2 Conditional Knockout Mouse Line for Time- and Tissue-Specific Depletion of Brain Serotonin	PLOS ONE			English	Article							HUMAN TRYPTOPHAN-HYDROXYLASE; AGGRESSIVE-BEHAVIOR; RECEPTOR; CRE; TRANSPORTER; EXPRESSION; NOREPINEPHRINE; DELETION; ANXIETY; EMBRYOGENESIS	Serotonin has been gaining increasing attention during the last two decades due to the dual function of this monoamine as key regulator during critical developmental events and as neurotransmitter. Importantly, unbalanced serotonergic levels during critical temporal phases might contribute to the onset of neuropsychiatric disorders, such as schizophrenia and autism. Despite increasing evidences from both animal models and human genetic studies have underpinned the importance of serotonin homeostasis maintenance during central nervous system development and adulthood, the precise role of this molecule in time-specific activities is only beginning to be elucidated. Serotonin synthesis is a 2-step process, the first step of which is mediated by the rate-limiting activity of Tph enzymes, belonging to the family of aromatic amino acid hydroxylases and existing in two isoforms, Tph1 and Tph2, responsible for the production of peripheral and brain serotonin, respectively. In the present study, we generated and validated a conditional knockout mouse line, Tph2(flox/flox), in which brain serotonin can be effectively ablated with time specificity. We demonstrated that the Cre-mediated excision of the third exon of Tph2 gene results in the production of a Tph2(null) allele in which we observed the near-complete loss of brain serotonin, as well as the growth defects and perinatal lethality observed in serotonin conventional knockouts. We also revealed that in mice harbouring the Tph2null allele, but not in wild-types, two distinct Tph2 mRNA isoforms are present, namely Tph2 Delta 3 and Tph2 Delta 3 Delta 4, with the latter showing an in-frame deletion of amino acids 84-178 and coding a protein that could potentially retain non-negligible enzymatic activity. As we could not detect Tph1 expression in the raphe, we made the hypothesis that the Tph2 Delta 3 Delta 4 isoform can be at the origin of the residual, sub-threshold amount of serotonin detected in the brain of Tph2(null/null) mice. Finally, we set up a tamoxifen administration protocol that allows an efficient, time-specific inactivation of brain serotonin synthesis. On the whole, we generated a suitable genetic tool to investigate how serotonin depletion impacts on time-specific events during central nervous system development and adulthood life.	[Pelosi, Barbara; Pratelli, Marta; Migliarini, Sara; Pacini, Giulia; Pasqualetti, Massimo] Univ Pisa, Unit Cell & Dev Biol, Dept Biol, I-56127 Pisa, Italy; [Pasqualetti, Massimo] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, I-38068 Rovereto, TN, Italy	University of Pisa; Istituto Italiano di Tecnologia - IIT	Pasqualetti, M (corresponding author), Univ Pisa, Unit Cell & Dev Biol, Dept Biol, SS 12 Abetone & Brennero 4, I-56127 Pisa, Italy.	massimo.pasqualetti@unipi.it	Pratelli, Marta/GWQ-6324-2022	Pelosi, Barbara/0000-0002-2829-2979; Pasqualetti, Massimo/0000-0002-0844-8139; Migliarini, Sara/0000-0003-2741-269X	Italian Ministry of Education, University and Research (MIUR) [200894SYW2]; Toscana Life Sciences Foundation [0108]; Norvegian Research Council; University of Pisa; Regional Program; European Social Fund	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Toscana Life Sciences Foundation; Norvegian Research Council; University of Pisa; Regional Program; European Social Fund(European Social Fund (ESF))	This work was supported by Italian Ministry of Education, University and Research (MIUR) (Prin 2008, 200894SYW2), Toscana Life Sciences Foundation (Orphan 0108 program) and Norvegian Research Council to M. Pasqualetti. BP, M. Pratelli and GP were supported by PhD program from University of Pisa. SM was supported by Regional Program and European Social Fund.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Bengel D, 1999, MOL PSYCHIATR, V4, P463, DOI 10.1038/sj.mp.4000550; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Brust P, 2000, J NEUROCHEM, V74, P1241; Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408; Carkaci-Salli N, 2006, J BIOL CHEM, V281, P28105, DOI 10.1074/jbc.M602817200; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; Compan V, 2004, J NEUROSCI, V24, P412, DOI 10.1523/JNEUROSCI.2806-03.2004; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kim JY, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-48; Knobelman DA, 2001, J PHARMACOL EXP THER, V298, P1092; Kriegebaum C, 2010, NEUROCHEM INT, V57, P512, DOI 10.1016/j.neuint.2010.06.015; Lane HY, 2008, J PSYCHIATR NEUROSCI, V33, P47; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; Lesch KP, 2012, NEURON, V76, P175, DOI 10.1016/j.neuron.2012.09.013; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; MANN JJ, 1990, ANN NY ACAD SCI, V600, P476, DOI 10.1111/j.1749-6632.1990.tb16903.x; Martinez A, 2001, CURR MED CHEM, V8, P1077, DOI 10.2174/0929867013372616; McKinney JA, 2009, HUM MUTAT, V30, P787, DOI 10.1002/humu.20956; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Mijimolle N, 2005, CANCER CELL, V7, P313, DOI 10.1016/j.ccr.2005.03.004; Mockus SM, 1997, BBA-PROTEIN STRUCT M, V1342, P132, DOI 10.1016/S0167-4838(97)00069-1; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Mosienko V, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0003-6; Mosienko V, 2015, BEHAV BRAIN RES, V277, P78, DOI 10.1016/j.bbr.2014.06.005; Murthy S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6524; Nakamura K, 2006, J NEUROSCI, V26, P530, DOI 10.1523/JNEUROSCI.1835-05.2006; Neal KB, 2009, J PHYSIOL-LONDON, V587, P567, DOI 10.1113/jphysiol.2008.160416; Pasqualetti M, 2002, GENESIS, V32, P109, DOI 10.1002/gene.10053; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Pelosi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104318; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Ramoz N, 2007, EXPERT OPIN PHARMACO, V8, P2029, DOI 10.1517/14656566.8.13.2029; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; Ren SY, 2002, GENESIS, V32, P105, DOI 10.1002/gene.10052; Riccio O, 2012, CEREB CORTEX, V22, P86, DOI 10.1093/cercor/bhr086; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Skjaerven L, 2001, STRUCTURE FUNCTION R; Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tenner K, 2007, J NEUROCHEM, V102, P1887, DOI 10.1111/j.1471-4159.2007.04664.x; Wakayama K, 2002, NEUROSCI RES, V44, P173, DOI 10.1016/S0168-0102(02)00120-7; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Whitaker-Azmitia PM, 2001, BRAIN RES BULL, V56, P479, DOI 10.1016/S0361-9230(01)00615-3; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yang SH, 2009, TRANSGENIC RES, V18, P483, DOI 10.1007/s11248-008-9237-9; YANG XJ, 1994, P NATL ACAD SCI USA, V91, P6659, DOI 10.1073/pnas.91.14.6659; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	75	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136422	10.1371/journal.pone.0136422	http://dx.doi.org/10.1371/journal.pone.0136422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291320	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900081
J	Wang, Y; Wu, KC; Yang, ZP; Zhao, QC; Fan, DM; Xu, P; Nie, YZ; Fan, DM				Wang, Ying; Wu, Kaichun; Yang, Zhiping; Zhao, Qingchuan; Fan, Dongmei; Xu, Po; Nie, Yongzhan; Fan, Daiming			Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer	PLOS ONE			English	Article							CIRCADIAN CLOCK GENES; DRUG RESPONSE ASSAY; BREAST-CANCER; MESSENGER-RNA; CELLS; POLYMORPHISMS; NOD2/CARD15; OVEREXPRESSION; IDENTIFICATION; METASTASIS	The effect of chemotherapy of gastric cancer (GC) remains very poor because of multidrug resistance (MDR). However, the mechanisms underlying MDR of GC remains far from fully understood. The aim of this study is to illustrate the potential mechanisms of the MDR of GC at mainly the long non-coding RNA (lncRNA) level. In this study, GC cell line, SGC7901, and two MDR sublines, SGC7901/VCR and SGC7901/ADR were subjected to an lncRNA microarray analysis. Bioinformatics and verification experiments were performed to investigate the potential lncRNAs involved in the development of MDR. Pathway analysis indicated that 15 pathways corresponded to down-regulated transcripts and that 20 pathways corresponded to up-regulated transcripts (p-value cut-off is 0.05). GO analysis showed that the highest enriched GOs targeted by up-regulated transcripts were "system development" and the highest esenriched GOs targeted by the down-regulated transcripts were "sterol biosynthetic process". Our study is the first to interrogate differentially expressed lncRNAs in human GC cell line and MDR sublines and indicates that lncRNAs are worthwhile for further study to be the novel candidate biomarkers for the clinical diagnosis of MDR and potential targets for further therapy.	[Wang, Ying; Wu, Kaichun; Yang, Zhiping; Zhao, Qingchuan; Nie, Yongzhan; Fan, Daiming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Wang, Ying; Wu, Kaichun; Yang, Zhiping; Zhao, Qingchuan; Nie, Yongzhan; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Wang, Ying] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Oncol, Luoyang, Henan, Peoples R China; [Fan, Dongmei] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Obstet & Gynaecol, Luoyang, Henan, Peoples R China; [Xu, Po] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Urol, Luoyang, Henan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Henan University of Science & Technology; Henan University of Science & Technology; Henan University of Science & Technology	Fan, DM (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, 15 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China.	fandaim@fmmu.edu.cn			National Program on Key Basic Research Project ("973" Program) [2010CB529302, 2010CB529305, 2010CB529306]; National Natural Science Foundation of China [81301763]; Henan provincial key scientific and technological projects [142102310473]; Key Program, National Natural Science Foundation of China [81030044]	National Program on Key Basic Research Project ("973" Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan provincial key scientific and technological projects; Key Program, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Program on Key Basic Research Project ("973" Program, No. 2010CB529302, No. 2010CB529305, No. 2010CB529306); National Natural Science Foundation of China (No. 81301763); Henan provincial key scientific and technological projects (No. 142102310473); Key Program, National Natural Science Foundation of China (No. 81030044).	Arase M, 2014, CANC SCI; Behjati S, 2014, NAT GENET, V46, P376, DOI 10.1038/ng.2921; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Gallion HH, 2003, J CLIN ONCOL, V21, P3808, DOI 10.1200/JCO.2003.10.083; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grange JM, 2008, VACCINE, V26, P4984, DOI 10.1016/j.vaccine.2008.06.092; Gu CH, 2013, LEUKEMIA RES, V37, P1750, DOI 10.1016/j.leukres.2013.10.010; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gwak HS, 2011, J KOREAN NEUROSURG S, V50, P426, DOI 10.3340/jkns.2011.50.5.426; Hassen W, 2015, ONCOTARGET, V6, P6431, DOI 10.18632/oncotarget.3237; Hong L, 2013, EXPERT OPIN THER TAR, V17, P1073, DOI 10.1517/14728222.2013.819853; Hsu CM, 2012, TUMOR BIOL, V33, P149, DOI 10.1007/s13277-011-0258-2; Hu ML, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-67; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Krawczyk M, 2014, ELIFE, V3, DOI 10.7554/eLife.01776; Lee SW, 2012, ACTA MED OKAYAMA, V66, P271; Lener MR, 2006, BREAST CANCER RES TR, V95, P141, DOI 10.1007/s10549-005-9057-z; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Li TT, 2013, J BIOL CHEM, V288, P4135, DOI 10.1074/jbc.M112.345942; Li WY, 2014, CANCER CELL, V25, P557, DOI 10.1016/j.ccr.2014.04.014; Lin YM, 2008, MOL CARCINOGEN, V47, P925, DOI 10.1002/mc.20446; Liu JH, 2014, ASIAN PAC J CANCER P, V15, P2971, DOI 10.7314/APJCP.2014.15.7.2971; Liu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089340; Liu LL, 2010, INT J CANCER, V127, P820, DOI 10.1002/ijc.25098; Malik R, 2014, MOLECULAR CANCER RES; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mayor NP, 2007, J CLIN ONCOL, V25, P4262, DOI 10.1200/JCO.2007.12.1897; Ozen SC, 2006, J GASTROENTEROL, V41, P304, DOI 10.1007/s00535-005-1780-z; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2014, ONCOTARGET, V5, P1434, DOI 10.18632/oncotarget.1846; Ren F, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-73; Rosenstiel P, 2006, CELL MICROBIOL, V8, P1188, DOI 10.1111/j.1462-5822.2006.00701.x; Shieh J-M, 2014, AN INCREASE IN REACT; Slotwinski R, 2013, THE JOURNAL OF IMMUN, V190; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; Stevens RG, 2005, EPIDEMIOLOGY, V16, P254, DOI 10.1097/01.ede.0000152525.21924.54; Sun  B., 2015, P 16 INT C THERM MEC, P1; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Szafranski P, 2014, AMERICAN JOURNAL OF; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Ture-Ozdemir F, 2008, ANTICANCER RES, V28, P3697; Walters TD, 2006, JOURNAL OF PEDIATRIC, V43, pE71; Wang L, 2010, TUMOR BIOL, V31, P225, DOI 10.1007/s13277-010-0036-6; Wang Y, 2014, MOL CELL BIOL, V34, P3182, DOI 10.1128/MCB.01580-13; Wang Y, 2014, MOL GENET GENOMICS, V289, P291, DOI 10.1007/s00438-013-0810-4; Wang Y, 2014, CELL PHYSIOL BIOCHEM, V33, P1225, DOI 10.1159/000358692; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu H, 2003, CANCER RES, V63, P1515; Wu Z-H, ONCOLOGY REPORTS; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xue ZF, 2012, J CELL BIOCHEM, V113, P302, DOI 10.1002/jcb.23356; Yang MY, 2006, CANCER SCI, V97, P1298, DOI 10.1111/j.1349-7006.2006.00331.x; Zhang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094793; Zhao YQ, 2002, CANCER LETT, V185, P211, DOI 10.1016/S0304-3835(02)00264-1	56	26	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135461	10.1371/journal.pone.0135461	http://dx.doi.org/10.1371/journal.pone.0135461			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291830	Green Published, gold			2022-12-27	WOS:000359919900020
J	Yang, PL; Huang, GS; Tsai, CS; Lou, MF				Yang, Pei-Lin; Huang, Guey-Shiun; Tsai, Chien-Sung; Lou, Meei-Fang			Sleep Quality and Emotional Correlates in Taiwanese Coronary Artery Bypass Graft Patients 1 Week and 1 Month after Hospital Discharge: A Repeated Descriptive Correlational Study	PLOS ONE			English	Article							CARDIAC-SURGERY; CANCER-PATIENTS; BREAST-CANCER; DEPRESSION; ANXIETY; PATTERNS; INSOMNIA; THERAPY; ASSOCIATIONS; PREDICTORS	Background Poor sleep quality is a common health problem for coronary artery bypass graft patients, however few studies have evaluated sleep quality during the period immediately following hospital discharge. Purpose The aim of this study was to investigate changes in sleep quality and emotional correlates in coronary artery bypass graft patients in Taiwan at 1 week and 1 month after hospital discharge. Methods We used a descriptive correlational design for this study. One week after discharge, 87 patients who had undergone coronary artery bypass surgery completed two structured questionnaires: the Pittsburgh Sleep Quality Index and the Hospital Anxiety and Depression Scale. Three weeks later (1 month after discharge) the patients completed the surveys again. Pearson correlations, t-tests, ANOVA and linear multiple regression analysis were used to analyze the data. Results A majority of the participants had poor sleep quality at 1 week (82.8%) and 1 month (66.7%) post-hospitalization, based on the global score of the Pittsburgh Sleep Quality Index. Despite poor sleep quality at both time-points the sleep quality at 1 month was significantly better than at 1-week post hospitalization. Poorer sleep quality correlated with older age, poorer heart function, anxiety and depression. The majority of participants had normal levels of anxiety at 1 week (69.0%) and 1 month (88.5%) as measured by the Hospital Anxiety and Depression Scale. However, some level of depression was seen at 1 week (78.1%) and 1 month (59.7%). Depression was a significant predictor of sleep quality at 1 week; at 1 month after hospital discharge both anxiety and depression were significant predictors of sleep quality. Conclusion Sleep quality, anxiety and depression all significantly improved 1 month after hospital discharge. However, more than half of the participants continued to have poor sleep quality and some level of depression. Health care personnel should be encouraged to assess sleep and emotional status in patients after coronary artery bypass surgery and offer them appropriate management strategies to improve sleep and reduce anxiety and depression.	[Yang, Pei-Lin] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Huang, Guey-Shiun; Lou, Meei-Fang] Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei 10764, Taiwan; [Tsai, Chien-Sung] Tri Serv Gen Hosp, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Chien-Sung] Natl Def Med Ctr, Sch Med, Taipei, Taiwan	National Defense Medical Center; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Lou, MF (corresponding author), Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei 10764, Taiwan.	mfalou@ntu.edu.tw	Yang, Pei-Lin/GPP-2641-2022	HUANG, GUEY-SHIUN/0000-0003-2170-0084; LOU, MEEI-FANG/0000-0001-6574-8050	Tri-Service-Hospital, Taipei, Taiwan [TSGH-C100-164]	Tri-Service-Hospital, Taipei, Taiwan	This study was supported by the support grant from Tri-Service-Hospital, Taipei, Taiwan (TSGH-C100-164), which made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EA, 1987, J CONSULT CLIN PSYCH, V55, P513, DOI 10.1037/0022-006X.55.4.513; Andrew MJ, 2000, J PSYCHOSOM RES, V48, P537, DOI 10.1016/S0022-3999(00)00089-1; [Anonymous], AUST CRIT CARE; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Brummett BH, 2006, HEALTH PSYCHOL, V25, P220, DOI 10.1037/0278-6133.25.2.220; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen P.Y., 1999, FORMOSAN J MED, V3, P373; Chocron S, 2013, ANN THORAC SURG, V95, P1609, DOI 10.1016/j.athoracsur.2013.02.035; Edell-Gustaffson UM, 2002, J ADV NURS, V37, P414, DOI 10.1046/j.1365-2648.2002.02106.x; Edell-Gustafsson UM, 1999, J ADV NURS, V29, P1213, DOI 10.1046/j.1365-2648.1999.01006.x; Edell-Gustafsson UM, 1999, SCAND J CARING SCI, V13, P137, DOI 10.1080/02839319950162697; Fang CS, 2007, J EVIDENCE BASED NUR, V3, P54; Fleming L, 2014, PSYCHO-ONCOLOGY, V23, P679, DOI 10.1002/pon.3468; Fortier-Brochu E, 2014, SLEEP, V37, P1789, DOI 10.5665/sleep.4172; Foulk MA, 2014, J GERONTOL SOC WORK, V57, P498, DOI 10.1080/01634372.2013.869787; Gregory AM, 2005, J ABNORM CHILD PSYCH, V33, P157, DOI 10.1007/s10802-005-1824-0; Haimov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061390; Hedges C, 2008, AM J CRIT CARE, V17, P133; Johansson I, 2010, EUR J CARDIOVASC NUR, V9, P175, DOI 10.1016/j.ejcnurse.2009.12.003; Kim KH, 2009, JOGNN-J OBST GYN NEO, V38, P344, DOI 10.1111/j.1552-6909.2009.01029.x; KNAPPSPOONER C, 1992, HEART LUNG, V21, P342; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lemma Seblewengel, 2012, Sleep Disord, V2012, P583510, DOI 10.1155/2012/583510; Liang SY., 1998, THESIS NATL YANG MIN; Liao WC, 2011, J NURS RES, V19, P275, DOI 10.1097/JNR.0b013e318236cf68; Liou HL, 2004, TZU CHI N J, V3, P61; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; McNeely ML, 2006, CAN MED ASSOC J, V175, P34, DOI 10.1503/cmaj.051073; Ministry of Health and Welfare, 2014, 2013 STAT CAUS DEATH; MOORE SM, 1994, APPL NURS RES, V7, P170, DOI 10.1016/0897-1897(94)90023-X; Nieveen JL, 2008, HEART LUNG, V37, P17, DOI 10.1016/j.hrtlng.2006.12.002; Peric V, 2008, J CARDIAC SURG, V23, P648, DOI 10.1111/j.1540-8191.2008.00667.x; Proyer RT, 2014, AGING MENT HEALTH, V18, P997, DOI 10.1080/13607863.2014.899978; Redeker N S, 1993, Clin Nurs Res, V2, P148, DOI 10.1177/105477389300200205; Redeker N.S., 2008, SLEEP QUAL LIFE CLIN, P367; Redeker Nancy S, 2002, J Cardiovasc Nurs, V17, P56; Redeker NS, 2004, RES NURS HEALTH, V27, P217, DOI 10.1002/nur.20023; Redeker NS, 2004, NURS RES, V53, P154, DOI 10.1097/00006199-200405000-00002; Redeker NS, 1996, APPL NURS RES, V9, P115, DOI 10.1016/S0897-1897(96)80206-0; Rymaszewska J, 2003, EUR PSYCHIAT, V18, P155, DOI 10.1016/S0924-9338(03)00052-X; Sampson B K, 1998, Dimens Crit Care Nurs, V17, P158, DOI 10.1097/00003465-199805000-00009; Savard J, 2005, J CLIN ONCOL, V23, P6083, DOI 10.1200/JCO.2005.09.548; Schaefer K M, 1996, Prog Cardiovasc Nurs, V11, P5; Schulz PS, 2011, APPL NURS RES, V24, P65, DOI 10.1016/j.apnr.2009.03.001; Shiao HC., 2008, THESIS NATL TAIWAN U; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tully PJ, 2012, J GERIATR CARDIOL, V9, P197, DOI 10.3724/SP.J.1263.2011.12221; Tzeng YJ, 2007, THESIS CHUNG SHAN ME; Utriyaprasit Ketsarin, 2005, J Transcult Nurs, V16, P97, DOI 10.1177/1043659604273548; WATSON D, 1995, J ABNORM PSYCHOL, V104, P3, DOI 10.1037/0021-843X.104.1.3; Wells RD, 2004, PSYCHOSOM MED, V66, P692, DOI 10.1097/01.psy.0000140002.84288.e1; Wu Y, 2002, FORMOSAN J MED, V6, P288; Yilmaz H, 2007, CIRC J, V71, P1506, DOI 10.1253/circj.71.1506; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136431	10.1371/journal.pone.0136431	http://dx.doi.org/10.1371/journal.pone.0136431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291524	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900083
J	Goddard, NS; Statham, MJ; Sacks, BN				Goddard, Natalie S.; Statham, Mark J.; Sacks, Benjamin N.			Mitochondrial Analysis of the Most Basal Canid Reveals Deep Divergence between Eastern and Western North American Gray Foxes (Urocyon spp.) and Ancient Roots in Pleistocene California	PLOS ONE			English	Article							NEVADA RED FOX; POPULATION-STRUCTURE; MTDNA VARIATION; EVOLUTION; ORIGIN; DIVERSIFICATION; DIFFERENTIATION; PHYLOGEOGRAPHY; COALESCENT; EXPANSION	Pleistocene aridification in central North America caused many temperate forest-associated vertebrates to split into eastern and western lineages. Such divisions can be cryptic when Holocene expansions have closed the gaps between once-disjunct ranges or when local morphological variation obscures deeper regional divergences. We investigated such cryptic divergence in the gray fox (Urocyon cinereoargenteus), the most basal extant canid in the world. We also investigated the phylogeography of this species and its diminutive relative, the island fox (U. littoralis), in California. The California Floristic Province was a significant source of Pleistocene diversification for a wide range of taxa and, we hypothesized, for the gray fox as well. Alternatively, gray foxes in California potentially reflected a recent Holocene expansion from further south. We sequenced mitochondrial DNA from 169 gray foxes from the southeastern and southwestern United States and 11 island foxes from three of the Channel Islands. We estimated a 1.3% sequence divergence in the cytochrome b gene between eastern and western foxes and used coalescent simulations to date the divergence to approximately 500,000 years before present (YBP), which is comparable to that between recognized sister species within the Canidae. Gray fox samples collected from throughout California exhibited high haplotype diversity, phylogeographic structure, and genetic signatures of a late-Holocene population decline. Bayesian skyline analysis also indicated an earlier population increase dating to the early Wisconsin glaciation (similar to 70,000 YBP) and a root height extending back to the previous interglacial (similar to 100,000 YBP). Together these findings support California's role as a long-term Pleistocene refugium for western Urocyon. Lastly, based both on our results and re-interpretation of those of another study, we conclude that island foxes of the Channel Islands trace their origins to at least 3 distinct female founders from the mainland rather than to a single matriline, as previously suggested.	[Goddard, Natalie S.; Statham, Mark J.; Sacks, Benjamin N.] Univ Calif Davis, Sch Vet Med, Vet Genet Lab, Mammalian Ecol & Conservat Unit, Davis, CA 95616 USA; [Sacks, Benjamin N.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Sacks, BN (corresponding author), Univ Calif Davis, Sch Vet Med, Vet Genet Lab, Mammalian Ecol & Conservat Unit, Davis, CA 95616 USA.	bnsacks@ucdavis.edu		Statham, Mark/0000-0002-5416-8699				Aubry KB, 2009, MOL ECOL, V18, P2668, DOI 10.1111/j.1365-294X.2009.04222.x; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bozarth CA, 2011, J MAMMAL, V92, P283, DOI 10.1644/10-MAMM-A-141.1; Calsbeek R, 2003, MOL ECOL, V12, P1021, DOI 10.1046/j.1365-294X.2003.01794.x; Dawson NG, 2012, BIOL CONSERVATION MA, P23, DOI DOI 10.7591/9780801466076; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 1996, AM J HUM GENET, V59, P935; FRITZELL E K, 1982, Mammalian Species, P1, DOI 10.2307/3503957; Fu YX, 1997, GENETICS, V147, P915; Graham R.W., 2010, FAUNMAP 2 NEW DATA N; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hofman CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118240; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Krebs CJ., 1999, ECOLOGICAL METHODOLO; Kurten B., 1980, PLEISTOCENE MAMMALS; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MERCURE A, 1993, EVOLUTION, V47, P1313, DOI 10.1111/j.1558-5646.1993.tb02157.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Perini FA, 2010, J EVOLUTION BIOL, V23, P311, DOI 10.1111/j.1420-9101.2009.01901.x; Perrine JD, 2007, CONSERV GENET, V8, P1083, DOI 10.1007/s10592-006-9265-z; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reding DM, 2012, MOL ECOL, V21, P3078, DOI 10.1111/j.1365-294X.2012.05595.x; Rick TC, 2009, QUATERNARY RES, V71, P93, DOI 10.1016/j.yqres.2008.12.003; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Sacks BN, 2013, MOL BIOL EVOL, V30, P1103, DOI 10.1093/molbev/mst027; Sacks BN, 2011, MOL ECOL, V20, P326, DOI 10.1111/j.1365-294X.2010.04943.x; Sacks BN, 2010, CONSERV GENET, V11, P1523, DOI 10.1007/s10592-010-0053-4; Sacks BN, 2005, J MAMMAL, V86, P1036, DOI 10.1644/1545-1542(2005)86[1036:RABCOC]2.0.CO;2; Sacks BN, 2004, MOL ECOL, V13, P1265, DOI 10.1111/j.1365-294X.2004.02110.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Schneider S., 2000, SOFTWARE POPULATION; Statham MJ, 2012, NORTHWEST SCI, V86, P122, DOI 10.3955/046.086.0204; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tedford Richard H., 2009, Bulletin of the American Museum of Natural History, V325, P1, DOI 10.1206/574.1; TEMPLETON AR, 1995, GENETICS, V140, P767; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Wood J. E., 1958, Journal of Mammalogy, V39, P74, DOI 10.2307/1376612	51	8	8	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136329	10.1371/journal.pone.0136329	http://dx.doi.org/10.1371/journal.pone.0136329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288066	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600129
J	Paez, UAH; Romero, IAG; Restrepo, SR; Gutierrez, FAA; Castano, DM				Hurtado Paez, Uriel Alonso; Garcia Romero, Ibonne Aydee; Restrepo, Silvia Restrepo; Aristizabal Gutierrez, Fabio Ancizar; Montoya Castano, Dolly			Assembly and Analysis of Differential Transcriptome Responses of Hevea brasiliensis on Interaction with Microcyclus ulei	PLOS ONE			English	Article							RNA-SEQ DATA; DISEASE RESISTANCE; MOLECULAR MARKERS; REFERENCE GENOME; GENE-EXPRESSION; GENERATION; QUANTIFICATION; ANNOTATION; PATHWAYS; SEQUENCE	Natural rubber (Hevea brasiliensis) is a tropical tree used commercially for the production of latex, from which 40,000 products are generated. The fungus Microcyclus ulei infects this tree, causing South American leaf blight (SALB) disease. This disease causes developmental delays and significant crop losses, thereby decreasing the production of latex. Currently several groups are working on obtaining clones of rubber tree with durable resistance to SALB through the use of extensive molecular biology techniques. In this study, we used a secondary clone that was resistant to M. ulei isolate GCL012. This clone, FX 3864 was obtained by crossing between clones PB 86 and B 38 (H. brasiliensis x H. brasiliensis). RNA-Seq high-throughput sequencing technology was used to analyze the differential expression of the FX 3864 clone transcriptome at 0 and 48 h post infection (hpi) with the M. ulei isolate GCL012. A total of 158,134,220 reads were assembled using the de novo assembly strategy to generate 90,775 contigs with an N50 of 1672. Using a reference-based assembly, 76,278 contigs were generated with an N50 of 1324. We identified 86 differentially expressed genes associated with the defense response of FX 3864 to GCL012. Seven putative genes members of the AP2/ERF ethylene (ET)-dependent superfamily were found to be down-regulated. An increase in salicylic acid (SA) was associated with the up-regulation of three genes involved in cell wall synthesis and remodeling, as well as in the down-regulation of the putative gene CPR5. The defense response of FX 3864 against the GCL012 isolate was associated with the antagonistic SA, ET and jasmonic acid (JA) pathways. These responses are characteristic of plant resistance to biotrophic pathogens.	[Hurtado Paez, Uriel Alonso; Garcia Romero, Ibonne Aydee; Aristizabal Gutierrez, Fabio Ancizar] Univ Nacl Colombia, Inst Biotecnol, Lab Caracterizac Mol, Bogota, Colombia; [Restrepo, Silvia Restrepo] Univ Los Andes, Lab Micol & Fitopatol, Bogota, Colombia; [Hurtado Paez, Uriel Alonso; Garcia Romero, Ibonne Aydee; Aristizabal Gutierrez, Fabio Ancizar; Montoya Castano, Dolly] Univ Nacl Colombia, Inst Biotecnol, Grp Bioproc & Bioprospecc, Bogota, Colombia	Universidad Nacional de Colombia; Universidad de los Andes (Colombia); Universidad Nacional de Colombia	Paez, UAH (corresponding author), Univ Nacl Colombia, Inst Biotecnol, Lab Caracterizac Mol, Bogota, Colombia.	uahurtadop@unal.edu.co	Aristizabal, Fabio A./AAG-8356-2020; Montoya, Dolly/N-4986-2016	Montoya, Dolly/0000-0001-7891-5452; Restrepo, Silvia/0000-0001-9016-1040; Aristizabal, Fabio/0000-0002-6405-7079; Garcia-Romero, Ibonne Aydee/0000-0002-8834-0899	Administratice Department of Science, Technology and Innovation-Colciencias [110152128525]	Administratice Department of Science, Technology and Innovation-Colciencias	Funding provided by Administratice Department of Science, Technology and Innovation-Colciencias, www.colciencias.gov.co, grant number: 110152128525, DMC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2012, FASTQC QUALITY CONTR; Avrova AO, 2003, FUNGAL GENET BIOL, V40, P4, DOI 10.1016/S1087-1845(03)00063-X; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Castellanos OF, 2009, AGENA PROSPECTIVA IN; Cazypedia, 2015, CARB ACT ENZ GLYC HY; CCC. Confederacion Colombiana de Caucho, 2013, CENS NAC CAUCH 2011; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flors V, 2007, PLANT J, V52, P1027, DOI 10.1111/j.1365-313X.2007.03299.x; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Garcia D, 2011, PHYSIOL MOL PLANT P, V76, P126, DOI 10.1016/j.pmpp.2011.07.006; Garcia IA, 2012, ESTUDIO INTERACCION; García Ibonne A., 2011, Rev. colomb. biotecnol, V13, P144; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gordon A, 2012, FASTX TOOLKIT SHORT; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; IRSG. International Rubber Statistical Group, 2014, INT RUBB STAT GROUP, P68; Junqueira NTV, 1989, FITOPATOL BRAS, V14, P147; Junqueira NTV., 1984, REV CERES, V31, P322; Kingston RE, 2010, PREPARATION ANAL RNA, DOI [10.1002/0471142727.mb0400s89, DOI 10.1002/0471142727.MB0400S89]; Langford MH, 1945, TECH B USDA, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; LIEBEREI R, 1983, J RUBBER RES I MALAY, V31, P227; Lieberei R, 2007, ANN BOT-LONDON, V100, P1125, DOI 10.1093/aob/mcm133; Lodha TD, 2012, MOL BIOTECHNOL, V50, P87, DOI 10.1007/s12033-011-9418-2; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mattos C. R. R., 2003, Fitopatologia Brasileira, V28, P502, DOI 10.1590/S0100-41582003000500006; Nongpiur R, 2012, PLANT SIGNAL BEHAV, V7, P1230, DOI 10.4161/psb.21516; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Perazza D, 2011, PLANT PHYSIOL, V157, P1232, DOI 10.1104/pp.111.179804; Rahman A.Y.A., 2013, BMC GENOMICS, V2013, P14; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salgado LR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-236; Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; Varghese YA, 1997, PLANT BREEDING, V116, P47, DOI 10.1111/j.1439-0523.1997.tb00973.x; Venu RC, 2007, MOL GENET GENOMICS, V278, P421, DOI 10.1007/s00438-007-0260-y; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Xu L, 2011, J PHYTOPATHOL, V159, P606, DOI 10.1111/j.1439-0434.2011.01813.x	59	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134837	10.1371/journal.pone.0134837	http://dx.doi.org/10.1371/journal.pone.0134837			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287380	Green Published, gold			2022-12-27	WOS:000360018600030
J	Zhang, SS; Sun, XX; Chang, WJ; Dai, YY; Ma, XL				Zhang, Shanshan; Sun, Xiaoxi; Chang, Wenjiao; Dai, Yuanyuan; Ma, Xiaoling			Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates	PLOS ONE			English	Review							BLOOD-STREAM INFECTIONS; REDUCED GLYCOPEPTIDE SUSCEPTIBILITY; METHICILLIN-RESISTANT; CLINICAL-FEATURES; MOLECULAR EPIDEMIOLOGY; STRAINS; PREVALENCE; BACTEREMIA; HOSPITALS; MRSA	Background Vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA) are associated with vancomycin treatment failure, and are becoming an increasing public health problem. Therefore, we undertook this study of 91 published studies and made subgroup comparisons of hVISA/VISA incidence in different study years, locations, and types of clinical samples. We also analyzed the genetic backgrounds of these strains. Methods A systematic literature review of relevant articles published in PubMed and EMBASE from January 1997 to August 2014 was conducted. We selected and assessed journal articles reporting the prevalence rates of hVISA/VISA. Results The pooled prevalence of hVISA was 6.05% in 99,042 methicillin-resistant S. aureus (MRSA) strains and that of VISA was 3.01% in 68,792 MRSA strains. The prevalence of hVISA was 4.68% before 2006, 5.38% in 2006-2009, and 7.01% in 2010-2014. VISA prevalence was 2.05%, 2.63%, and 7.93%, respectively. In a subgroup analysis of different isolation locations, the prevalence of hVISA strains was 6.81% in Asia and 5.60% in Europe/America, and that of VISA was 3.42% and 2.75%, respectively. The frequencies of hVISA isolated from blood culture samples and from all clinical samples were 9.81% and 4.68%, respectively, and those of VISA were 2.00% and 3.07%, respectively. The most prevalent genotype was staphylococcal cassette chromosome mec (SCCmec) II, which accounted for 48.16% and 37.74% of hVISA and VISA, respectively. Sequence Type (ST) 239 was most prevalent. Conclusion The prevalence of hVISA/VISA has been increasing in recent years, but has been grossly underestimated. Its incidence is higher in Asia than in Europe/America. hVISA is isolated from blood culture samples more often than from other samples. These strains are highly prevalent in epidemic MRSA strains. This study clarifies the epidemiology of hVISA/VISA and indicates that the detection of these strains and the control of nosocomial infections must be strengthened.	[Zhang, Shanshan] Shandong Univ, Sch Med, Jinan 250061, Peoples R China; [Sun, Xiaoxi; Chang, Wenjiao; Dai, Yuanyuan; Ma, Xiaoling] Anhui Med Univ, Dept Clin Lab, Affiliated Prov Hosp, Hefei 230001, Peoples R China	Shandong University; Anhui Medical University	Ma, XL (corresponding author), Anhui Med Univ, Dept Clin Lab, Affiliated Prov Hosp, Hefei 230001, Peoples R China.	xiaolingma@126.com	MA, XIAO/HHN-5611-2022	Ma, Xiaoling/0000-0002-2732-8669				Adam HJ, 2010, ANTIMICROB AGENTS CH, V54, P945, DOI 10.1128/AAC.01316-09; [Anonymous], 2006, CLIN INFECT DIS, V42; [Anonymous], 2013, BMC INFECT DIS, V13, P46; [Anonymous], 2012, MED J MALAYSIA; [Anonymous], 2003, CLIN INFECT DIS OFFI, V36, P429; Ariza J, 1999, LANCET, V353, P1587, DOI 10.1016/S0140-6736(99)01017-X; Aucken HM, 2000, J ANTIMICROB CHEMOTH, V46, P639, DOI 10.1093/jac/46.4.639-a; Bataineh H. A., 2006, Pakistan Journal of Medical Sciences, V22, P144; Bert F, 2003, J CLIN MICROBIOL, V41, P5147, DOI 10.1128/JCM.41.11.5147-5152.2003; Bierbaum G, 1999, EUR J CLIN MICROBIOL, V18, P691, DOI 10.1007/s100960050380; Campanile F, 2010, INT J ANTIMICROB AG, V36, P415, DOI 10.1016/j.ijantimicag.2010.06.044; Canton R, 1999, Rev Esp Quimioter, V12, P48; Cartolano GL, 2004, CLIN MICROBIOL INFEC, V10, P448, DOI 10.1111/j.1469-0691.2004.00830.x; Casapao AM, 2014, ANTIMICROB AGENTS CH, V58, P4636, DOI 10.1128/AAC.02820-13; Chang W, 2015, INDIAN J MED MICROBI, V33, P262, DOI 10.4103/0255-0857.148837; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Chaudhari C N, 2015, Med J Armed Forces India, V71, P15, DOI 10.1016/j.mjafi.2014.03.008; Chaudhary M, 2013, AM J INFECT DIS, V9, P63, DOI 10.3844/ajidsp.2013.63.70; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen HB, 2011, DIAGN MICR INFEC DIS, V71, P301, DOI 10.1016/j.diagmicrobio.2011.06.010; Chung G, 2010, J MICROBIOL BIOTECHN, V20, P637, DOI 10.4014/jmb.0906.06018; de Lassence A, 2006, CLIN INFECT DIS, V42, P170, DOI 10.1086/498898; Silveira ACDO, 2014, DIAGN MICR INFEC DIS, V79, P401, DOI 10.1016/j.diagmicrobio.2014.04.008; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; Debasmita Dubey, 2013, Asian Pacific Journal of Tropical Disease, V3, P133, DOI 10.1016/S2222-1808(13)60057-2; Delgado A, 2007, J CLIN MICROBIOL, V45, P1325, DOI 10.1128/JCM.02437-06; Denis O, 2002, J ANTIMICROB CHEMOTH, V50, P383, DOI 10.1093/jac/dkf142; El Ayoubi MD, 2014, MED MALADIES INFECT, V44, P223, DOI 10.1016/j.medmal.2014.03.004; Equia JM, 2005, CLIN INFECT DIS, V40, P1617, DOI 10.1086/429906; Eriksson J, 2013, VET MICROBIOL, V163, P110, DOI 10.1016/j.vetmic.2012.12.006; Fink SL, 2012, ANTIMICROB AGENTS CH, V56, P582, DOI 10.1128/AAC.05024-11; Fitzgibbon MM, 2007, J CLIN MICROBIOL, V45, P3263, DOI 10.1128/JCM.00836-07; Fong RKC, 2009, EUR J CLIN MICROBIOL, V28, P983, DOI 10.1007/s10096-009-0741-5; Franchi D, 1999, CLIN INFECT DIS, V29, P1566, DOI 10.1086/313530; FREEMAN MF, 1950, BIOMETRICS, V6, P180; Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542; Garnier F, 2006, J ANTIMICROB CHEMOTH, V57, P146, DOI 10.1093/jac/dki413; Geisel R, 1999, J ANTIMICROB CHEMOTH, V43, P846, DOI 10.1093/jac/43.6.846; Gemmell Curtis G., 2004, Journal of Infection and Chemotherapy, V10, P69, DOI 10.1007/s10156-004-0307-5; Gowrishankar S, 2013, INFECT GENET EVOL, V14, P383, DOI 10.1016/j.meegid.2013.01.002; [郭宇 Guo Yu], 2013, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V33, P401; Hafer C, 2012, ANTIMICROB AGENTS CH, V56, P5845, DOI 10.1128/AAC.01139-12; Hanaki Hideaki, 2007, Journal of Infection and Chemotherapy, V13, P118, DOI 10.1007/s10156-006-0498-z; Hanaki H, 2014, J INFECT CHEMOTHER, V20, P527, DOI 10.1016/j.jiac.2014.06.012; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu Keiichi, 1998, American Journal of Medicine, V104, p7S, DOI 10.1016/S0002-9343(98)00149-1; Ho CM, 2010, EUR J CLIN MICROBIOL, V29, P383, DOI 10.1007/s10096-009-0868-4; Ho PL, 2010, J INFECTION, V60, P140, DOI 10.1016/j.jinf.2009.11.011; Horne KC, 2009, ANTIMICROB AGENTS CH, V53, P3447, DOI 10.1128/AAC.01365-08; Hsueh PR, 2010, INT J ANTIMICROB AG, V36, P307, DOI 10.1016/j.ijantimicag.2010.06.035; Hubert SK, 1999, J CLIN MICROBIOL, V37, P3590, DOI 10.1128/JCM.37.11.3590-3593.1999; Ike Y, 2001, J CLIN MICROBIOL, V39, P4445, DOI 10.1128/JCM.39.12.4445-4451.2001; Kaleem F, 2012, INT J INFECT DIS, V16, pE420, DOI 10.1016/j.ijid.2012.05.582; Kantzanou M, 1999, J ANTIMICROB CHEMOTH, V43, P729, DOI 10.1093/jac/43.5.729; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kaye KS, 2004, EMERG INFECT DIS, V10, P1125, DOI 10.3201/eid1006.020665; Khanal B, 2010, INT J INFECT DIS, V14, pE342, DOI 10.1016/j.ijid.2010.02.381; Khatib R, 2011, J ANTIMICROB CHEMOTH, V66, P1594, DOI 10.1093/jac/dkr169; Khosrovaneh A, 2004, CLIN INFECT DIS, V38, P1328, DOI 10.1086/383036; Kim HB, 2003, J CLIN MICROBIOL, V41, P2279, DOI [10.1128/JCM.41.6.2279-2281.2003, 10.1128/JCM.41.6.2779-2281.2003]; Kim MN, 2000, J CLIN MICROBIOL, V38, P3879, DOI 10.1128/JCM.38.10.3879-3881.2000; Kim MN, 2002, J CLIN MICROBIOL, V40, P1376, DOI 10.1128/JCM.40.4.1376-1380.2002; Kirby A, 2010, J ANTIMICROB CHEMOTH, V65, P721, DOI 10.1093/jac/dkq009; Kleinschmidt SL, 2006, INT J ANTIMICROB AG, V27, P168, DOI 10.1016/j.ijantimicag.2005.10.009; Kosowska-Shick K, 2008, ANTIMICROB AGENTS CH, V52, P4510, DOI 10.1128/AAC.01073-08; Laird N, 1986, CONTROLLED CLIN TRIA; Lewis T, 2009, CLIN MICROBIOL INFEC, V15, pS544; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Lin SY, 2012, J MICROBIOL IMMUNOL, V45, P435, DOI 10.1016/j.jmii.2012.05.004; Liu C, 2003, ANTIMICROB AGENTS CH, V47, P3040, DOI 10.1128/AAC.47.10.3040-3045.2003; Liu C, 2014, J MICROBIOLOGY IMMUN; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lulitanond A, 2009, J CLIN MICROBIOL, V47, P2311, DOI 10.1128/JCM.01749-08; MANTEL N, 1959, BIOMETRICS, V15, P639; Maor Y, 2007, J CLIN MICROBIOL, V45, P1511, DOI 10.1128/JCM.01262-06; Maor Y, 2009, J INFECT DIS, V199, P619, DOI 10.1086/596629; Marchese A, 2000, J CLIN MICROBIOL, V38, P866, DOI 10.1128/JCM.38.2.866-869.2000; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Mlynarczyk Andrzej, 2003, Medycyna Doswiadczalna i Mikrobiologia, V55, P209; Moore CL, 2012, CLIN INFECT DIS, V54, P51, DOI 10.1093/cid/cir764; Musta AC, 2009, J CLIN MICROBIOL, V47, P1640, DOI 10.1128/JCM.02135-08; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nakipoglu Y, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-31; Neoh H-m, ANN CLIN MICROBIOLOG, V6, P13; Nonhoff C, 2005, CLIN MICROBIOL INFEC, V11, P214, DOI 10.1111/j.1469-0691.2004.01060.x; Panomket Pawana, 2014, Journal of the Medical Association of Thailand, V97, pS7; Parer S, 2012, INFECT CONT HOSP EP, V33, P167, DOI 10.1086/663703; Park KH, 2012, J ANTIMICROB CHEMOTH, V67, P1843, DOI 10.1093/jac/dks131; Pastagia M, 2009, CLIN MICROBIOL INFEC, V15, pS20; Pastagia M, 2012, EMERG INFECT DIS, V18, P1072, DOI 10.3201/eid1807.101371; Pierard D, 2004, PATHOL BIOL, V52, P486, DOI 10.1016/j.patbio.2004.07.016; Pitz AM, 2011, J CLIN MICROBIOL, V49, P269, DOI 10.1128/JCM.00914-10; Ramli Siti Roszilawati, 2012, Infect Dis Rep, V4, pe20, DOI 10.4081/idr.2012.e20; Reverdy ME, 2001, CLIN MICROBIOL INFEC, V7, P267, DOI 10.1046/j.1198-743x.2001.00256.x; Richter SS, 2011, J CLIN MICROBIOL, V49, P4203, DOI 10.1128/JCM.01152-11; Robert J, 2006, J ANTIMICROB CHEMOTH, V57, P506, DOI 10.1093/jac/dki486; Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08; Rybak MJ, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161010-00001; Sader HS, 2009, J ANTIMICROB CHEMOTH, V64, P1024, DOI 10.1093/jac/dkp319; Saito M, 2014, ANTIMICROB AGENTS CH, V58, P5024, DOI 10.1128/AAC.02470-13; Sancak B, 2005, J ANTIMICROB CHEMOTH, V56, P519, DOI 10.1093/jac/dki272; Schmitz FJ, 1999, EUR J CLIN MICROBIOL, V18, P528, DOI 10.1007/s100960050340; Sng LH, 2005, INT J ANTIMICROB AG, V25, P177, DOI 10.1016/j.ijantimicag.2004.11.001; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P4926, DOI 10.1128/AAC.48.12.4926-4928.2004; Sun WJ, 2009, ANTIMICROB AGENTS CH, V53, P3642, DOI 10.1128/AAC.00206-09; Takata T, 2009, AM J INFECT CONTROL, V37, pE15; Takesue Y, 2011, J INFECT CHEMOTHER, V17, P52, DOI 10.1007/s10156-010-0086-0; Tallent SM, 2002, J CLIN MICROBIOL, V40, P2249, DOI 10.1128/JCM.40.6.2249-2250.2002; Tenover FC, 2001, EMERG INFECT DIS, V7, P327, DOI 10.3201/eid0702.010237; Trakulsomboon S, 2001, J CLIN MICROBIOL, V39, P591, DOI 10.1128/JCM.39.2.591-595.2001; Uckay I, 2012, ANTIMICROB AGENTS CH, V56, P1258, DOI 10.1128/AAC.05808-11; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; Van Hal SJ, 2011, CLIN MICROBIOL INFEC, V17, pS58; Vaudaux P, 2012, EUR J CLIN MICROBIOL, V31, P3367, DOI 10.1007/s10096-012-1705-8; Wang JL, 2013, INT J ANTIMICROB AG, V42, P390, DOI 10.1016/j.ijantimicag.2013.07.010; Wang WY, 2009, J CLIN MICROBIOL, V47, P3617, DOI 10.1128/JCM.00539-09; Wang Y, 2013, CHINESE MED J-PEKING, V126, P505, DOI 10.3760/cma.j.issn.0366-6999.20120812; Wong SSY, 1999, CLIN INFECT DIS, V29, P760, DOI 10.1086/520429; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399	122	47	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136082	10.1371/journal.pone.0136082	http://dx.doi.org/10.1371/journal.pone.0136082			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287490	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600106
J	Abdallah, HM; Reuland, EA; Wintermans, BB; al Naiemi, N; Koek, A; Abdelwahab, AM; Ammar, AM; Mohamed, AA; Vandenbroucke-Grauls, CMJE				Abdallah, H. M.; Reuland, E. A.; Wintermans, B. B.; al Naiemi, N.; Koek, A.; Abdelwahab, A. M.; Ammar, A. M.; Mohamed, A. A.; Vandenbroucke-Grauls, C. M. J. E.			Extended-Spectrum beta-Lactamases and/or Carbapenemases-Producing Enterobacteriaceae Isolated from Retail Chicken Meat in Zagazig, Egypt	PLOS ONE			English	Article							REAL-TIME PCR; ESCHERICHIA-COLI; CTX-M; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE; RESISTANCE GENES; HIGH PREVALENCE; EMERGENCE; POULTRY; ANTIBIOTICS	Objectives The aim of the present study was to determine the prevalence and to characterize extended-spectrum beta-lactamases-and/or carbapenemases-producing Enterobacteriaceae among Enterobacteriaceae isolated from retail chicken meat in Zagazig, Egypt. Methods One hundred and six Enterobacteriaceae isolates were collected from retail chicken meat samples purchased in Zagazig, Egypt in 2013. Species identification was done by MALDI-TOF MS. Screening for ESBL-E was performed by inoculation of isolates recovered from meat samples onto the EbSA (Cepheid Benelux, Apeldoorn, the Netherlands) selective screening agar. ESBL production was confirmed by combination disc diffusion test with clavulanic acid (Rosco, Taastrup, Denmark). Carbapenemases production was confirmed with double disk synergy tests. Resistance genes were characterized by PCR with specific primers for TEM, SHV, and CTX-M and carbapenemases (KPC, NDM, OXA-48, IMP and VIM). PCR products of CTX-M genes were purified and sequenced. Phylogenetic grouping of E. coli was performed by a PCR-based method. Results Of these 106 isolates 69 (65.09%) were ESBL producers. Twelve (11.32%) of these isolates were also phenotypically class B carbapenemases producer. TEM genes were detected in 61 (57.55%) isolates. 49 (46.23%) isolates harbored CTX-M genes, and 25 (23.58%) carried genes of the SHV family. All CPE belonged to the NDM group. The predominant CTX-M sequence type was CTX-M-15 (89.80%). The majority (80%) of the ESBL-EC belonged to low virulence phylogroups A and B1. Conclusions This is the first study from Egypt reporting high rates of ESBLs and carbapenemases (65.09% and 11.32%, respectively) in Enterobacteriaceae isolated from retail chicken meat. These results raise serious concerns about public health and food safety as retail meat could serve as a reservoir for these resistant bacteria which could be transferred to humans through the food chain.	[Abdallah, H. M.; Reuland, E. A.; Wintermans, B. B.; al Naiemi, N.; Koek, A.; Vandenbroucke-Grauls, C. M. J. E.] Vrije Univ Amsterdam Med Ctr, Med Microbiol & Infect Control, Amsterdam, Netherlands; [al Naiemi, N.] Lab Med Microbiol & Publ Hlth, Hengelo, Netherlands; [al Naiemi, N.] Ziekenhuisgroep Twente, Microbiol & Infect Control, Amsterdam, Netherlands; [Abdelwahab, A. M.; Ammar, A. M.; Mohamed, A. A.] Zagazig Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Zagazig, Egypt	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Egyptian Knowledge Bank (EKB); Zagazig University	Abdallah, HM (corresponding author), Vrije Univ Amsterdam Med Ctr, Med Microbiol & Infect Control, Amsterdam, Netherlands.	bactine_ho@yahoo.com	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; abdallah, Hossam/0000-0003-0384-7322	Egyptian high education ministry; VU medical center, the Netherlands	Egyptian high education ministry(Ministry of Higher Education & Scientific Research (MHESR)); VU medical center, the Netherlands	The research is funded by the joint supervision mission between Egyptian high education ministry and VU medical center, the Netherlands.	Abdelaziz MO, 2013, J GLOB ANTIMICROB RE, V1, P213, DOI 10.1016/j.jgar.2013.06.003; Al Naiemi N, 2009, EUR J CLIN MICROBIOL, V28, P989, DOI 10.1007/s10096-009-0714-8; Al Naiemi N, NVMM GUIDELINE LAB D; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Blaak H, 2014, APPL ENVIRON MICROB, V80, P239, DOI 10.1128/AEM.02616-13; Borjesson S, 2013, APPL ENVIRON MICROB, V79, P2463, DOI 10.1128/AEM.03893-12; Bouchillon SK, 2004, INT J ANTIMICROB AG, V24, P119, DOI 10.1016/j.ijantimicag.2004.01.010; Campos CB, 2014, INT J MED MICROBIOL, V304, P678, DOI 10.1016/j.ijmm.2014.04.012; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; CLSI, 2014, PERF STAND ANT; Coleman K, 2011, CURR OPIN MICROBIOL, V14, P550, DOI 10.1016/j.mib.2011.07.026; Cox NA, 2010, J FOOD PROTECT, V73, P976, DOI 10.4315/0362-028X-73.5.976; De Medici D, 2003, APPL ENVIRON MICROB, V69, P3456, DOI 10.1128/AEM.69.6.3456-3461.2003; Doi Y, 2010, CLIN MICROBIOL INFEC, V16, P33, DOI 10.1111/j.1469-0691.2009.03001.x; Essack SY, 2001, PHARM RES-DORDR, V18, P1391, DOI 10.1023/A:1012272403776; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P478, DOI 10.1093/jac/dks393; Guerra B, 2014, VET MICROBIOL, V171, P290, DOI 10.1016/j.vetmic.2014.02.001; Hughes LA, 2013, EQUINE VET J, V45, P141, DOI 10.1111/j.2042-3306.2012.00602.x; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kola A, 2012, J ANTIMICROB CHEMOTH, V67, P2631, DOI 10.1093/jac/dks295; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Livermore DM, 2005, J ANTIMICROB CHEMOTH, V56, P451, DOI 10.1093/jac/dki239; Mulvey MR, 2003, J CLIN MICROBIOL, V41, P460, DOI 10.1128/JCM.41.1.460-462.2003; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pasteran F, 2009, J CLIN MICROBIOL, V47, P1631, DOI 10.1128/JCM.00130-09; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P2781, DOI 10.1093/jac/dkr384; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Randall LP, 2011, J ANTIMICROB CHEMOTH, V66, P86, DOI 10.1093/jac/dkq396; Rawat D, 2010, J GLOB INFECT DIS, V2, P263, DOI 10.4103/0974-777X.68531; Schaumburg F, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0286-3; Seiffert SN, 2013, ANTIMICROB AGENTS CH, V57, P6406, DOI 10.1128/AAC.01773-13; Shahcheraghi F, 2013, MICROB DRUG RESIST, V19, P30, DOI 10.1089/mdr.2012.0078; Sonnevend A, 2013, J MED MICROBIOL, V62, P1044, DOI 10.1099/jmm.0.059014-0; Tsakris A, 2009, J CLIN MICROBIOL, V47, P362, DOI 10.1128/JCM.01922-08; Wang LJ, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-9; Weill FX, 2004, J CLIN MICROBIOL, V42, P2432, DOI 10.1128/JCM.42.6.2432-2437.2004	40	48	51	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136052	10.1371/journal.pone.0136052	http://dx.doi.org/10.1371/journal.pone.0136052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284654	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100098
J	Motbainor, A; Worku, A; Kumie, A				Motbainor, Achenef; Worku, Alemayehu; Kumie, Abera			Stunting Is Associated with Food Diversity while Wasting with Food Insecurity among Underfive Children in East and West Gojjam Zones of Amhara Region, Ethiopia	PLOS ONE			English	Article								Background Food insecurity has detrimental effects in protecting child undernutrition. This study sought to determine the level of child undernutrition and its association with food insecurity. Methods A community based comparative cross-sectional study design involving multistage sampling technique was implemented from 24th of May to 20th of July 2013. Using two population proportion formula, a total of 4110 randomly selected households were included in the study. Availability of the productive safety net programme was used for grouping the study areas. A multiple linear regression model was used to assess the association between food insecurity and child malnutrition. Clustering effects of localities were controlled during analysis. Results Stunting (37.5%), underweight (22.0%) and wasting (17.1%) were observed in East Gojjam zone, while 38.3% stunting, 22.5% underweight, and 18.6% wasting for the West Gojjam zone. Food insecurity was significantly associated with wasting (beta = -0.108, P < 0.05). Food diversity and number of meals the child ate per day significantly associated with stunting (beta = 0.039, P < 0.01) and underweight (beta = 0.035, P < 0.05) respectively. Residential area was the significant predictor of all indices. Conclusion The magnitude of child undernutrition was found to be very high in the study areas. Food insecurity was the significant determinant of wasting. Food diversity and number of meals the child ate per day were the significant determinants of stunting and underweight respectively. Child nutrition intervention strategies should take into account food security, dietary diversity, and carefully specified with regard to residential locations. Addressing food insecurity is of paramount importance.	[Motbainor, Achenef; Worku, Alemayehu; Kumie, Abera] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Motbainor, A (corresponding author), Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia.	motbainor2@gmail.com	Kumie, Abera/AAC-8537-2022	Motbainor, Achenef/0000-0001-7620-5780	Addis Ababa University	Addis Ababa University	This study was funded by Addis Ababa University, School of Public Health who provide money for data collection. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali D, 2013, J NUTR, V143, P2015, DOI 10.3945/jn.113.175182; [Anonymous], 2013, STATE FOOD INSECURIT; [Anonymous], 2005, MAN MEAS INT MALN MO; Belachew T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-604; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Derseh B., 2014, OALIB, V01, P1; Development ABoFaE, 2014, POP SIZ SEX AG GROUP; Endale Worku, 2014, BMC Res Notes, V7, P130, DOI 10.1186/1756-0500-7-130; Ethiopia FDRo, 2008, NAT NUTR STRAT ADD A; Furness BW, 2004, PUBLIC HEALTH NUTR, V7, P791, DOI 10.1079/PHN2004608; Gebre GG, 2012, INTERDISCIP DESCR CO, V10, P159; Ghattas H., 2014, FOOD SECURITY NUTR C; Gilberto K, 2012, PLOS ONE, V7, P1, DOI [10.1371/journal.pone.0045747, DOI 10.1371/J0URNAL.P0NE.0045747]; Gudina E, 2014, BMC PEDIAT, V14; Hasan M.M., 2013, J FOOD SECURITY, V1, P52; International CSAEaI, 2012, ETH DEM HLTH SURV 20; Isanaka S, 2007, J NUTR, V137, P2747, DOI 10.1093/jn/137.12.2747; Jesmin A, 2011, J HEALTH POPUL NUTR, V29, P494; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Keino S, 2014, AGR FOOD SECUR, V3, P2, DOI [10.1186/2048-7010-3-2, DOI 10.1186/2048-7010-3-2]; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Masresha T, 2013, PAN AFRICAN MED J, V14, DOI 10.11604/pamj.2013.14.75.1630; Mercedes d.O., 1997, WHO GLOBAL DATABASE; Nguyen Ngoc Hien, 2009, Pakistan Journal of Nutrition, V8, P958; Noreen W, 2011, STAT CANADA HLTH REP, V22; Oluwole SI., 2012, J MED MED SCI, V3, P005; Osei A, 2010, FOOD NUTR BULL, V31, P483, DOI 10.1177/156482651003100402; Paudel R, 2012, Kathmandu Univ Med J (KUMJ), V10, P18; Rachel S, 2006, ETHIOPIA PRODUCTIVE; Saha KK, 2009, PUBLIC HEALTH NUTR, V12, P1556, DOI 10.1017/S1368980009004765; Santos Leonardo Pozza dos, 2013, Rev. bras. epidemiol., V16, P984, DOI 10.1590/S1415-790X2013000400018; Sarah C-B, 2013, TARGETING FOOD SECUR; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Shaibu MO, 2013, J POPULATION RES, V12; Solomon Amsalu, 2008, Ethiopian Journal of Health Development, V22, P21; State AR, 2002, STRAT PLAN SUST DEV; Stephanie P, 2012, POPULATION HLTH METR, V10; Teshome B, 2009, ETHIOP J HEALTH DEV, V23, P98; Willows ND, 2009, PUBLIC HEALTH NUTR, V12, P1150, DOI 10.1017/S1368980008004345; Wondimagegn ZT, 2014, CURR RES NUTR FOOD S, V2, P88, DOI 10.12944/CRNFSJ.2.2.05; Zipporah NB, 2014, J NUTR METABOLISM, V2014	42	61	62	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0133542	10.1371/journal.pone.0133542	http://dx.doi.org/10.1371/journal.pone.0133542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285047	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100005
J	Oshoma, CE; Greetham, D; Louis, EJ; Smart, KA; Phister, TG; Powell, C; Du, CY				Oshoma, Cyprian E.; Greetham, Darren; Louis, Edward J.; Smart, Katherine A.; Phister, Trevor G.; Powell, Chris; Du, Chenyu			Screening of Non- Saccharomyces cerevisiae Strains for Tolerance to Formic Acid in Bioethanol Fermentation	PLOS ONE			English	Article							ACETIC-ACID; PHENOTYPIC CHARACTERIZATION; ETHANOL PRODUCTIVITY; YEAST; INHIBITORS; GROWTH; GLYCOGEN; TREHALOSE; IDENTIFICATION; ADAPTATION	Formic acid is one of the major inhibitory compounds present in hydrolysates derived from lignocellulosic materials, the presence of which can significantly hamper the efficiency of converting available sugars into bioethanol. This study investigated the potential for screening formic acid tolerance in non-Saccharomyces cerevisiae yeast strains, which could be used for the development of advanced generation bioethanol processes. Spot plate and phenotypic microarray methods were used to screen the formic acid tolerance of 7 non-Saccharomyces cerevisiae yeasts. S. kudriavzeii IFO1802 and S. arboricolus 2.3319 displayed a higher formic acid tolerance when compared to other strains in the study. Strain S. arboricolus 2.3319 was selected for further investigation due to its genetic variability among the Saccharomyces species as related to Saccharomyces cerevisiae and availability of two sibling strains: S. arboricolus 2.3317 and 2.3318 in the lab. The tolerance of S. arboricolus strains (2.3317, 2.3318 and 2.3319) to formic acid was further investigated by lab-scale fermentation analysis, and compared with S. cerevisiae NCYC2592. S. arboricolus 2.3319 demonstrated improved formic acid tolerance and a similar bioethanol synthesis capacity to S. cerevisiae NCYC2592, while S. arboricolus 2.3317 and 2.3318 exhibited an overall inferior performance. Metabolite analysis indicated that S. arboricolus strain 2.3319 accumulated comparatively high concentrations of glycerol and glycogen, which may have contributed to its ability to tolerate high levels of formic acid.	[Oshoma, Cyprian E.; Greetham, Darren; Powell, Chris; Du, Chenyu] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Louis, Edward J.] Univ Leicester, Ctr Genet Architecture Complex Traits, Leicester, Leics, England; [Smart, Katherine A.] SAB Miller PLC, Surrey, England; [Phister, Trevor G.] PepsiCo Int Beaumont Pk, Leicester, Leics, England; [Du, Chenyu] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England	University of Nottingham; University of Leicester; Anheuser-Busch InBev; SABMiller; PepsiCo; University of Huddersfield	Du, CY (corresponding author), Univ Nottingham, Sch Biosci, Bioenergy & Brewing Sci Bldg, Loughborough, Leics, England.	C.du@hud.ac.uk	Powell, Chris/Y-2298-2019; Louis, Edward/B-7920-2008	Powell, Chris/0000-0001-9524-8137; Louis, Edward/0000-0003-1157-3608; Oshoma, Cyprian/0000-0002-1063-6286; Du, Chenyu/0000-0002-8216-0504	Biotechnology and Biological Sciences Research Council (BBSRC), under the programme of Lignocellulosic Conversion to Ethanol (LACE) [BB/G01616X/1]; Educational Trust Fund from the University of Benin, Benin City, Nigeria for Cyprian Oshoma's PhD scholarship; SAB Miller PLC; PepsiCo Int.; Biotechnology and Biological Sciences Research Council [BB/G01616X/1, BB/L022508/1] Funding Source: researchfish; BBSRC [BB/L022508/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC), under the programme of Lignocellulosic Conversion to Ethanol (LACE)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Educational Trust Fund from the University of Benin, Benin City, Nigeria for Cyprian Oshoma's PhD scholarship; SAB Miller PLC; PepsiCo Int.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council (BBSRC), under the programme of Lignocellulosic Conversion to Ethanol (LACE) (BB/G01616X/1, www.bbsrc.ac.uk). The authors also thank the financial support provided by Educational Trust Fund from the University of Benin, Benin City, Nigeria for Cyprian Oshoma's PhD scholarship. SAB Miller PLC and PepsiCo Int. provided support in the form of salaries for authors KAS and TGP, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KAS and TGP moved to SABMiller and PepsiCo, during this project, after which they were not involved in any further research. The specific roles of these authors are articulated in the 'author contributions' section.	Almeida JRM, 2009, BIORESOURCE TECHNOL, V100, P3674, DOI 10.1016/j.biortech.2009.02.057; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Barber AR, 2000, J IND MICROBIOL BIOT, V25, P104, DOI 10.1038/sj.jim.7000031; Bauer BE, 2003, EUR J BIOCHEM, V270, P3189, DOI 10.1046/j.1432-1033.2003.03701.x; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Casey E, 2010, FEMS YEAST RES, V10, P385, DOI 10.1111/j.1567-1364.2010.00623.x; Chandel A. K., 2007, Biotechnology and Molecular Biology Reviews, V2, P014; Deshpande PS, 2011, J I BREWING, V117, P113, DOI 10.1002/j.2050-0416.2011.tb00451.x; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Fujita Y, 2002, APPL ENVIRON MICROB, V68, P5136, DOI 10.1128/AEM.68.10.5136-5141.2002; Greetham D, 2014, J IND MICROBIOL BIOT; Hasunuma T, 2012, BIOTECHNOL ADV, V30, P1207, DOI 10.1016/j.biotechadv.2011.10.011; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Hasunuma T, 2011, APPL MICROBIOL BIOT, V90, P997, DOI 10.1007/s00253-011-3085-x; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; Huang HZ, 2011, BIORESOURCE TECHNOL, V102, P7486, DOI 10.1016/j.biortech.2011.05.008; Ivanova V., 2011, INT REV CHEM ENG, V3, P289, DOI [10.48550/arXiv.1105.0619, DOI 10.48550/ARXIV.1105.0619]; Keating JD, 2006, BIOTECHNOL BIOENG, V93, P1196, DOI 10.1002/bit.20838; Larsson S, 1999, ENZYME MICROB TECH, V24, P151, DOI 10.1016/S0141-0229(98)00101-X; Liti G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-69; Martin C, 2002, WORLD J MICROB BIOT, V18, P857, DOI 10.1023/A:1021258708507; Naumov GI, 2010, ANTON LEEUW INT J G, V98, P1, DOI 10.1007/s10482-010-9441-5; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 1999, BIOTECHNOL BIOENG, V63, P46, DOI 10.1002/(SICI)1097-0290(19990405)63:1<46::AID-BIT5>3.0.CO;2-J; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pampulha ME, 2000, FEMS MICROBIOL LETT, V184, P69, DOI 10.1016/S0378-1097(00)00022-7; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; SAMI M, 1994, J FERMENT BIOENG, V78, P212, DOI 10.1016/0922-338X(94)90292-5; Samokhvalov VA, 2004, MICROBIOLOGY+, V73, P378, DOI 10.1023/B:MICI.0000036979.96786.78; Somani A, 2012, J AM SOC BREW CHEM, V70, P123, DOI 10.1094/ASBCJ-2012-0427-01; Sun WL, 2010, AFR J MICROBIOL RES, V4, P1105; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Taherzadeh MJ, 1999, J BIOSCI BIOENG, V87, P169, DOI 10.1016/S1389-1723(99)89007-0; Taherzadeh MJ, 1997, CHEM ENG SCI, V52, P2653, DOI 10.1016/S0009-2509(97)00080-8; Taherzadeh MJ, 2000, APPL MICROBIOL BIOT, V53, P701, DOI 10.1007/s002530000328; Taherzadeh MJ, 2000, BIOTECHNOL BIOENG, V69, P330, DOI [10.1002/1097-0290(20000805)69:3<330::AID-BIT11>3.0.CO;2-Q, 10.1002/1097-0290(20000805)69:3&lt;330::AID-BIT11&gt;3.0.CO;2-Q]; Tomas-Pejo E, 2010, J IND MICROBIOL BIOT, V37, P1211, DOI 10.1007/s10295-010-0768-8; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; van Wyk JPH, 2001, TRENDS BIOTECHNOL, V19, P172, DOI 10.1016/S0167-7799(01)01601-8; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Walker G.M., 1998, YEAST PHYSL BIOTECHN; Wang SA, 2008, INT J SYST EVOL MICR, V58, P510, DOI 10.1099/ijs.0.65331-0; Wikandari R., 2010, AGR J, V5, P105, DOI DOI 10.3923/aj.2010.105.109; Wimalasena TT, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-47; Zheng DQ, 2011, BIORESOURCE TECHNOL, V102, P3020, DOI 10.1016/j.biortech.2010.09.122	45	10	11	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135626	10.1371/journal.pone.0135626	http://dx.doi.org/10.1371/journal.pone.0135626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284784	Green Published, Green Accepted, gold			2022-12-27	WOS:000359666100051
J	Zhao, JN; Zhang, XX; He, XC; Yang, GR; Zhang, XQ; Xin, WG; Li, HC				Zhao, Jiang-nan; Zhang, Xian-xin; He, Xiao-chun; Yang, Guo-ru; Zhang, Xiao-qi; Xin, Wen-gen; Li, Huai-chen			Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China	PLOS ONE			English	Article							RISK-FACTORS; DRUG-RESISTANCE; PREVALENCE	Background Relatively little is known about the specific relationship and impact from chronic obstructive pulmonary disease (COPD) on multidrug-resistant tuberculsosis (MDR-TB). Methods We conducted a retrospective study included patients aged >= 40 years with a confirmed pulmonary TB at three tertiary hospitals (Shandong, China) between January 2011 and October 2014. Univariable and multivariable analyses were performed to identify the relationship of MDR-TB and COPD. Results A total of 2164 patients aged >= 40 years with available results of drug susceptibility test (DST) and medical records were screened for this study: 268 patients with discharge diagnosis of COPD and 1896 patients without COPD. Overall, 14.2% of patients with COPD and 8.5% patients without COPD were MDR-TB. The rate of MDR-TB were significantly higher in patients with COPD (P<0.05). Migrant (odds ratios (OR) 1.32, 95% confidence interval (CI) 1.02-1.72), previous anti-TB treatment (OR 4.58, 95% CI 1.69-12.42), cavity (OR 2.33, 95% CI 1.14-4.75), and GOLD stage (OR 1.86, 95% CI 1.01-2.93) were the independent predictors for MDR-TB among patients with COPD. Conclusions MDR-TB occurs more frequently in patients with underlying COPD, especially those with being migrant, previous anti-TB therapy, cavity and severe airway obstruction.	[Zhao, Jiang-nan; He, Xiao-chun; Li, Huai-chen] Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250100, Peoples R China; [Zhang, Xian-xin] Shandong Prov Chest Hosp, Dept Resp Med, Jinan, Peoples R China; [Yang, Guo-ru] Chest Specially Hosp Weifang, Dept Resp Med, Weifang, Peoples R China; [Zhang, Xiao-qi; Xin, Wen-gen] Chest Specially Hosp Weifang, Dept TB Med, Weifang, Peoples R China	Shandong University; Shandong University	Li, HC (corresponding author), Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250100, Peoples R China.	zjn911016@126.com			Science and Technology Development plan of Shandong Province [2009GG10002054]	Science and Technology Development plan of Shandong Province	This work was supported by a Science and Technology Development plan of Shandong Province (Grant Number: 2009GG10002054). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID SURV DRUG RES T; Arevalo M, 1996, EUR RESPIR J, V9, P274, DOI 10.1183/09031936.96.09020274; Bastos ML, 2014, CLIN INFECT DIS, V59, P1364, DOI 10.1093/cid/ciu619; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Chakrabarti Biswajit, 2007, Int J Chron Obstruct Pulmon Dis, V2, P263; Daley CL, 2014, CLIN INFECT DIS, V59, P1064, DOI 10.1093/cid/ciu578; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gunther G, 2015, EMERG INFECT DIS; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Kim JH, 2013, CHEST, V143, P1018, DOI 10.1378/chest.12-1225; Kiran B, 2010, ARCH MED SCI, V6, P77, DOI 10.5114/aoms.2010.13511; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Liu CH, 2011, RESPIROLOGY, V16, P918, DOI 10.1111/j.1440-1843.2011.01990.x; Long R, 2009, CLIN INFECT DIS, V48, P1354, DOI 10.1086/598196; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Sharma SK, 2003, INFECT GENET EVOL, V3, P183, DOI 10.1016/S1567-1348(03)00086-8; Shen X, 2009, INT J TUBERC LUNG D, V13, P253; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2014, GLOB TUB REP; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC	30	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135205	10.1371/journal.pone.0135205	http://dx.doi.org/10.1371/journal.pone.0135205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284920	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100028
J	Liu, ZY; Li, XL; Wang, ZL; Sun, QZ				Liu, Zhiying; Li, Xiliang; Wang, Zongli; Sun, Qizhong			Contrasting Strategies of Alfalfa Stem Elongation in Response to Fall Dormancy in Early Growth Stage: The Tradeoff between Internode Length and Internode Number	PLOS ONE			English	Article							WINTER HARDINESS; CYTOCHROME-P450 MONOOXYGENASE; STELLARIA-LONGIPES; ROOT PHYSIOLOGY; NUTRITIVE-VALUE; LIGHT QUALITY; LEAF; GIBBERELLINS; TISSUES; TRAITS	Fall dormancy (FD) in alfalfa (Medicago sativa L.) can be described using 11 FD ratings, is widely used as an important indicator of stress resistance, productive performance and spring growth. However, the contrasting growth strategies in internode length and internode number in alfalfa cultivars with different FD rating are poorly understood. Here, a growth chamber study was conducted to investigate the effect of FD on plant height, aboveground biomass, internode length, and internode number in alfalfa individuals in the early growth stages. In order to simulate the alfalfa growth environment in the early stage, 11 alfalfa cultivars with FD ratings from one to 11 were chosen and seeded at the greenhouse, and then were transplanted into an artificial growth chamber. The experimental design was a randomized complete block in a split-plot arrangement with three replicates. Plant height, above-ground biomass, internode length, and internode number were measured in early growth stage in all individuals. Our findings showed that plant height and the aboveground biomass of alfalfa did not significantly differ among 11 different FD rated cultivars. Also, internode length and internode number positively affected plant height and the aboveground biomass of alfalfa individuals and the average internode length significantly increased with increasing FD rating. However, internode number tended to sharply decline when the FD rating increased. Moreover, there were no correlations, slightly negative correlations, and strongly negative correlations between internode length and internode number in alfalfa individuals among the three scales, including within-FD ratings, within-FD categories and inter-FD ratings, respectively. Therefore, our results highlighted that contrasting growth strategies in stem elongation were adopted by alfalfa with different FD ratings in the early growth stage. Alfalfa cultivars with a high FD rating have longer internodes, whereas more dormant alfalfa cultivars have a larger number of internodes. There were tradeoffs between internode length and internode number in response to FD in alfalfa, which reflected certain scale-dependence.	[Liu, Zhiying; Li, Xiliang; Wang, Zongli; Sun, Qizhong] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China; [Liu, Zhiying; Li, Xiliang] Chinese Acad Agr Sci, Grad Sch, Beijing, Peoples R China; [Wang, Zongli] Minist Agr, Dept Anim Husb, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Ministry of Agriculture & Rural Affairs	Sun, QZ (corresponding author), Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China.	sunqz@126.com			China Agriculture Research System [CARS-35]; Agricultural Science and Technology Innovation Program of CAAS [CAAS-ASTIP-IGR 2015-02]	China Agriculture Research System; Agricultural Science and Technology Innovation Program of CAAS	This research was supported by the China Agriculture Research System (CARS-35) and the Agricultural Science and Technology Innovation Program of CAAS (CAAS-ASTIP-IGR 2015-02).	Anderson Edgar, 1944, ANN MISSOURI BOT GARD, V31, P241, DOI 10.2307/2394288; Barillot R, 2014, ANN BOT-LONDON, V114, P725, DOI 10.1093/aob/mcu099; Brock MT, 2010, MOL ECOL, V19, P1187, DOI 10.1111/j.1365-294X.2010.04538.x; BROWN LG, 1990, AGRON J, V82, P267, DOI 10.2134/agronj1990.00021962008200020018x; Brummer EC, 2000, CROP SCI, V40, P971, DOI 10.2135/cropsci2000.404971x; Brummer EC, 2002, AGRON J, V94, P782; Buck-Sorlin GH, 2005, NEW PHYTOL, V166, P859, DOI 10.1111/j.1469-8137.2005.01324.x; Cici SZH, 2008, ANN BOT-LONDON, V101, P1311, DOI 10.1093/aob/mcn040; Cunningham SM, 2003, CROP SCI, V43, P562, DOI 10.2135/cropsci2003.0562; Cunningham SM, 2001, CROP SCI, V41, P1091, DOI 10.2135/cropsci2001.4141091x; de Saint Germain A, 2013, PLANT PHYSIOL, V163, P1012, DOI 10.1104/pp.113.220541; Dong C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023942; Engels FM, 2005, ANIM FEED SCI TECH, V120, P309, DOI 10.1016/j.anifeedsci.2005.03.003; Engels FM, 1998, ANN BOT-LONDON, V82, P561, DOI 10.1006/anbo.1998.0705; Haagenson DM, 2003, CROP SCI, V43, P1441, DOI 10.2135/cropsci2003.1441; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; HEICHEL GH, 1990, CROP SCI, V30, P1123, DOI 10.2135/cropsci1990.0011183X003000050033x; INGRAM TJ, 1987, PLANT PHYSIOL, V83, P1048, DOI 10.1104/pp.83.4.1048; JONES FR, 1950, AGRON J, V42, P432, DOI 10.2134/agronj1950.00021962004200090003x; Jung HG, 2006, CROP SCI, V46, P2054, DOI 10.2135/cropsci2005.12.0470; Jung HG, 2002, CROP SCI, V42, P524, DOI 10.2135/cropsci2002.0524; Kallenbach RL, 2002, AGRON J, V94, P1094, DOI 10.2134/agronj2002.1094; KAUFMAN PB, 1976, PLANT PHYSIOL, V58, P131, DOI 10.1104/pp.58.2.131; Kurepin LV, 2007, J EXP BOT, V58, P2145, DOI 10.1093/jxb/erm068; Kurepin LV, 2006, PLANT CELL ENVIRON, V29, P1319, DOI 10.1111/j.1365-3040.2006.01512.x; Kurepin LV, 2006, PLANT CELL ENVIRON, V29, P647, DOI 10.1111/j.1365-3040.2005.01443.x; Lauriault L.M., 2009, FORAGE GRAZINGLANDS, V7, P1, DOI [10.1094/fg-2009-0508-01-rs, DOI 10.1094/FG-2009-0508-01-RS]; Lemerle D, 2001, AUST J AGR RES, V52, P527, DOI 10.1071/AR00056; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Malinowski DP, 2007, AGRON J, V99, P621, DOI 10.2134/agronj2006.0056; Marquez-Ortiz J. J., 1999, Crop Science, V39, P38; PERRY LJ, 1974, CROP SCI, V14, P693, DOI 10.2135/cropsci1974.0011183X001400050025x; Retta A, 2000, AGRON J, V92, P225, DOI 10.1007/s100870050026; Rimi F, 2014, AGRON J, V106, P1258, DOI 10.2134/agronj13.0495; Rimi F, 2012, AGRON J, V104, P415, DOI 10.2134/agronj2011.0222; Rimi F, 2010, AGRON J, V102, P1578, DOI 10.2134/agronj2010.0193; Sheaffer CC, 2000, AGRON J, V92, P733, DOI 10.2134/agronj2000.924733x; SHERIDAN KP, 1968, CROP SCI, V8, P289, DOI 10.2135/cropsci1968.0011183X00080003008x; SPRAGUE M. A., 1941, JOUR AMER SOC AGRON, V33, P437; SPRAY C, 1984, PLANTA, V160, P464, DOI 10.1007/BF00429764; Teuber L.R., 1998, STANDARD TESTS CHARA, pA; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; Ventroni LM, 2010, FIELD CROP RES, V119, P252, DOI 10.1016/j.fcr.2010.07.015; VOLENEC JJ, 1985, CROP SCI, V25, P822, DOI 10.2135/cropsci1985.0011183X002500050023x; Wang CZ, 2009, AGRON J, V101, P1146, DOI 10.2134/agronj2009.0026; Wang ChengZhang, 2006, Acta Prataculturae Sinica, V15, P30; Weishaar MA, 2005, CROP SCI, V45, P60, DOI 10.2135/cropsci2005.0060; Williams R. W., 1996, Proceedings of the 8th Australian Agronomy Conference, Toowoomba, Queensland, Australia, 30 January-2 February, 1996., P586; Woodman HE, 1935, J AGR SCI, V25, P578, DOI 10.1017/S0021859600019675; Yoshida S, 1981, FUNDAMENTALS RICE CR; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	51	7	9	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135934	10.1371/journal.pone.0135934	http://dx.doi.org/10.1371/journal.pone.0135934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281014	gold, Green Published, Green Submitted			2022-12-27	WOS:000359664300027
J	Akasheva, DU; Plokhova, EV; Tkacheva, ON; Strazhesko, ID; Dudinskaya, EN; Kruglikova, AS; Pykhtina, VS; Brailova, NV; Pokshubina, IA; Sharashkina, NV; Agaltsov, MV; Skvortsov, D; Boytsov, SA				Akasheva, Dariga U.; Plokhova, Ekaterina V.; Tkacheva, Olga N.; Strazhesko, Irina D.; Dudinskaya, Ekaterina N.; Kruglikova, Anna S.; Pykhtina, Valentina S.; Brailova, Natalia V.; Pokshubina, Inna A.; Sharashkina, Natalia V.; Agaltsov, Mikhail V.; Skvortsov, Dmitry; Boytsov, Sergey A.			Age-Related Left Ventricular Changes and Their Association with Leukocyte Telomere Length in Healthy People	PLOS ONE			English	Article							DIASTOLIC FUNCTION; HEART-FAILURE; CARDIOVASCULAR-DISEASE; SYSTOLIC FUNCTION; ATHEROSCLEROSIS; CARDIOMYOCYTE; PARAMETERS; ATTRITION; HUMANS; TISSUE	Introduction With advancing age the left ventricle (LV) undergoes structural and functional changes, thereby creating the substrate for the development of diseases. One possible mechanism of the ageing heart is a cellular senescence. Leukocyte telomere length (LTL) is a marker of replicative ageing. The purpose of this study was to evaluate the structure and function of the LV in people of different ages free of cardiovascular diseases (CVD) and regular drug medication and to assess their relationship with LTL. We hypothesized that age-related changes in LV myocardium are associated with telomere length. Methods The study population consisted of 150 healthy, non-obese volunteers aged 28 to 78 years without history of CVD, significant deviations by 12-lead electrocardiogram and negative exercise test (treadmill stress test). All the participants underwent standardized transthoracic echocardiography using an available system (iE33; Philips). The LTL was measured by real-time quantitative polymerase chain reaction. We determined the relative ratio of telomere repeat copy number (T) to single-copy gene copy number (S). Results In the older people there was a higher wall thickness than in the younger (1.03 +/- 0.09 vs. 0.88 +/- 0.10, p<0.01), whereas LV mass index was comparable between them (85.8 +/- 15. 40 vs. 83.1 +/- 11.8, p = 0.20). There was a decrease in LV dimensions with advancing age (p<0.001). Older subjects had impairment in LV relaxation. LTL was associated with decreased E/A, Em/Am ratio (beta = -0.323, p = 0.0001) after adjusting for age, sex and risk factors. There is no relation between the LTL and the structure of LV. Conclusions Our data suggest that the ageing process leads to changes in LV structure and diastolic function and is linked with a phenotype of concentric LV remodeling. Telomere attrition is associated with age-related LV diastolic dysfunction. Telomere length appears to be a biomarker of myocardial ageing.	[Akasheva, Dariga U.; Plokhova, Ekaterina V.; Tkacheva, Olga N.; Strazhesko, Irina D.; Dudinskaya, Ekaterina N.; Kruglikova, Anna S.; Pykhtina, Valentina S.; Brailova, Natalia V.; Pokshubina, Inna A.; Sharashkina, Natalia V.; Agaltsov, Mikhail V.; Boytsov, Sergey A.] Natl Res Ctr Prevent Med, Dept Study Ageing & Prevent Age Associated Dis, Moscow, Russia; [Skvortsov, Dmitry] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia	National Medical Research Center for Therapy & Preventive Medicine; Lomonosov Moscow State University	Plokhova, EV (corresponding author), Natl Res Ctr Prevent Med, Dept Study Ageing & Prevent Age Associated Dis, Moscow, Russia.	ekaterina.naydenko@gmail.com	Tkacheva, Olga/M-4510-2014; Dudinskaya, Ekaterina/H-3281-2013; Boytsov, Sergey A/M-4486-2014; Drapkina, Oksana/AAE-5376-2021; Boytsov, Sergey/AAK-5354-2021; Strazhesko, Irina/AAD-9390-2019; Skvortsov, Dmitry A/D-3738-2015; Akasheva, Dariga U/K-2764-2017	Tkacheva, Olga/0000-0002-4193-688X; Dudinskaya, Ekaterina/0000-0001-7891-6850; Boytsov, Sergey A/0000-0001-6998-8406; Drapkina, Oksana/0000-0002-4453-8430; Boytsov, Sergey/0000-0001-6998-8406; Akasheva, Dariga U/0000-0003-0694-7062; Skvortsov, Dmitry/0000-0001-8336-8596; Plokhova, Ekaterina/0000-0001-9869-2153				Bekaert S, 2005, ANTICANCER RES, V25, P3011; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chahal NS, 2010, EUR J ECHOCARDIOGR, V11, P51, DOI 10.1093/ejechocard/jep164; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Denil SLIJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115071; Ganau A, 1995, J HYPERTENS, V13, P1818; Gates PE, 2003, EUR HEART J, V24, P2213, DOI 10.1016/j.ehj.2003.09.026; Hastings R, 2004, EXP GERONTOL, V39, P855, DOI 10.1016/j.exger.2004.02.003; Kawel N, 2012, CIRC-CARDIOVASC IMAG, V5, P500, DOI 10.1161/CIRCIMAGING.112.973560; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nilsson PM, 2013, TRANSL RES, V162, P371, DOI 10.1016/j.trsl.2013.05.004; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Ruan QY, 2005, EXP PHYSIOL, V90, P527, DOI 10.1113/expphysiol.2005.030007; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; Solomon Scott D., 2006, CIRCULATION, V113, pe396; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Takubo K, 2010, GERIATR GERONTOL INT, V10, pS197, DOI 10.1111/j.1447-0594.2010.00605.x; Terai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02401; Vasan RS, 2009, CIRCULATION, V120, P1195, DOI 10.1161/CIRCULATIONAHA.109.853895	26	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135883	10.1371/journal.pone.0135883	http://dx.doi.org/10.1371/journal.pone.0135883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275065	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600128
J	Gao, F; Xiong, XY; Pan, WT; Yang, XY; Zhou, CC; Yuan, QP; Zhou, LQ; Yang, M				Gao, Feng; Xiong, Xiangyu; Pan, Wenting; Yang, Xinyu; Zhou, Changchun; Yuan, Qipeng; Zhou, Liqing; Yang, Ming			A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK; LOCI; SMOKING; IDENTIFICATION; PROTEIN; ALLELE; SITE	A functional rs4245739 A>C single nucleotide polymorphism (SNP) locating in the MDM43'-untranslated (3'-UTR) region creates a miR-191-5p or miR-887-3p targeting sites. This change results in decreased expression of oncogene MDM4. Therefore, we examined the association between this SNP and small cell lung cancer (SCLC) risk as well as its regulatory function in SCLC cells. Genotypes were determined in two independent case-control sets consisted of 520SCLC cases and 1040 controls from two regions of China. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by logistic regression. The impact of the rs4245739 SNP on miR-191-5p/miR-887-3p mediated MDM4 expression regulation was investigated using luciferase reporter gene assays. We found that the MDM4 rs4245739AC and CC genotypes were significantly associated with decreased SCLC susceptibility compared with the AA genotype in both case-control sets (Shandong set: OR = 0.53, 95% CI = 0.32-0.89, P = 0.014; Jiangsu set: OR = 0.47, 95% CI = 0.26-0.879, P = 0.017). Stratified analyses indicated that there was a significantly multiplicative interaction between rs4245739 and smoking (P-interactioin = 0.048). After co-tranfection of miRNAs and different allelic-MDM4 reporter constructs into SCLC cells, we found that the both miR-191-5p and miR-887-3p can lead to significantly decreased MDM4 expression activities in the construct with C-allelic 3'-UTR but not A-allelic 3'-UTR, suggesting a consistent genotype-phenotype correlation. Our data illuminate that the MDM4rs4245739SNP contributes to SCLC risk and support the notion that gene 3'-UTR genetic variants, impacting miRNA-binding, might modify SCLC susceptibility.	[Gao, Feng; Yuan, Qipeng] Chinese PLA, Gen Staff Dept, Hlth Div, Guard Bur, Beijing, Peoples R China; [Xiong, Xiangyu; Pan, Wenting; Yang, Xinyu; Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Zhou, Changchun] Shandong Canc Hosp, Shandong Acad Med Sci, Clin Lab, Jinan, Shandong, Peoples R China; [Zhou, Liqing] Huaian 2 Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China	Beijing University of Chemical Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhou, LQ (corresponding author), Huaian 2 Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China.	zlq-hill@163.com; yangm@mail.buct.edu.cn	, CC. Zhou/AGI-1229-2022; yang, xinyu/AAE-9355-2022; yang, xinyu/AFD-8194-2022; Yang, Ming/G-4705-2012	Yang, Ming/0000-0002-7722-7487	National Natural Science Foundation of China [31271382, 81201586]; National High-Tech Research and Development Program of China [2015AA020950]; Fundamental Research Funds for the Central Universities [YS1407]; Beijing Higher Education Young Elite Teacher Project [YETP0521]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Higher Education Young Elite Teacher Project; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The study was supported by grants from National Natural Science Foundation of China (grant numbers: 31271382 & 81201586; URL: http://www.nsfc.gov.cn/); the National High-Tech Research and Development Program of China (grant numbers: 2015AA020950; URL: http://www.most.gov.cn/); the Fundamental Research Funds for the Central Universities (grant numbers: YS1407; URL: http://www.moe.edu.cn/); Beijing Higher Education Young Elite Teacher Project (grant numbers: YETP0521; URL: http://www.bjedu.gov.cn/); and Program for Changjiang Scholars and Innovative Research Team in University (grant numbers: IRT13045; URL: http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Dally H, 2003, PHARMACOGENETICS, V13, P607, DOI 10.1097/00008571-200310000-00004; Dally H, 2002, INT J CANCER, V102, P530, DOI 10.1002/ijc.10756; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Fan CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107047; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Kadakia M, 2002, ONCOGENE, V21, P8776, DOI 10.1038/sj.onc.1205993; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Liu JB, 2013, BREAST CANCER RES TR, V140, P151, DOI 10.1007/s10549-013-2615-x; McEvoy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042739; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miller KR, 2010, CELL CYCLE, V9, P3376, DOI 10.4161/cc.9.16.12779; Shi J, 2013, INT J CANCER, V132, P2799, DOI 10.1002/ijc.27959; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Simon GR, 2003, CHEST, V123, p259S, DOI 10.1378/chest.123.1_suppl.259S; Stegeman S, 2015, ENDOCR-RELAT CANCER, V22, P265, DOI 10.1530/ERC-15-0013; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang XY, 2015, J BIOL CHEM, V290, P3925, DOI 10.1074/jbc.M114.596866; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Xiong SB, 2010, CANCER RES, V70, P7148, DOI 10.1158/0008-5472.CAN-10-1457; Yang M, 2012, CANCER-AM CANCER SOC, V118, P4681, DOI 10.1002/cncr.27455; Zhang XJ, 2014, CARCINOGENESIS, V35, P2062, DOI 10.1093/carcin/bgu103; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331	35	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135647	10.1371/journal.pone.0135647	http://dx.doi.org/10.1371/journal.pone.0135647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274820	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600086
J	Hedil, M; Sterken, MG; de Ronde, D; Lohuis, D; Kormelink, R				Hedil, Marcio; Sterken, Mark G.; de Ronde, Dryas; Lohuis, Dick; Kormelink, Richard			Analysis of Tospovirus NSs Proteins in Suppression of Systemic Silencing	PLOS ONE			English	Article							SPOTTED WILT-VIRUS; STRANDED-RNA-BINDING; NONSTRUCTURAL PROTEIN; VIRAL SUPPRESSORS; GENE; IDENTIFICATION; RESISTANCE; STRATEGY	RNA silencing is a sequence-specific gene regulation mechanism that in plants also acts antiviral. In order to counteract antiviral RNA silencing, viruses have evolved RNA silencing suppressors (RSS). In the case of tospoviruses, the non-structural NSs protein has been identified as the RSS. Although the tomato spotted wilt virus (TSWV) tospovirus NSs protein has been shown to exhibit affinity to long and small dsRNA molecules, its ability to suppress the non-cell autonomous part of RNA silencing has only been studied to a limited extent. Here, the NSs proteins of TSWV, groundnut ringspot virus (GRSV) and tomato yellow ring virus (TYRV), representatives for three distinct tospovirus species, have been studied on their ability and strength to suppress local and systemic silencing. A system has been developed to quantify suppression of GFP silencing in Nicotiana benthamiana 16C lines, to allow a comparison of relative RNA silencing suppressor strength. It is shown that NSs of all three tospoviruses are suppressors of local and systemic silencing. Unexpectedly, suppression of systemic RNA silencing by NSs(TYRV) was just as strong as those by NSs(TSWV) and NSs(GRSV), even though NSs(TYRV) was expressed in lower amounts. Using the system established, a set of selected NSs(TSWV) gene constructs mutated in predicted RNA binding domains, as well as NSs from TSWV isolates 160 and 171 (resistance breakers of the T-SW resistance gene), were analyzed for their ability to suppress systemic GFP silencing. The results indicate another mode of RNA silencing suppression by NSs that acts further downstream the biogenesis of siRNAs and their sequestration. The findings are discussed in light of the affinity of NSs for small and long dsRNA, and recent mutant screen of NSs(TSWV) to map domains required for RSS activity and triggering of T-SW-governed resistance.	[Hedil, Marcio; Sterken, Mark G.; de Ronde, Dryas; Lohuis, Dick; Kormelink, Richard] Wageningen Univ, Dept Plant Sci, Virol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Kormelink, R (corresponding author), Wageningen Univ, Dept Plant Sci, Virol Lab, NL-6700 AP Wageningen, Netherlands.	Richard.kormelink@wur.nl	; Kormelink, Richard/F-7437-2010	Sterken, Mark/0000-0001-7119-6213; Hedil, Marcio/0000-0001-8018-6850; Kormelink, Richard/0000-0001-7360-1884	Brazilian National Council for Scientific and Technological Development (CNPq); Dutch Technology Foundation STW	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Dutch Technology Foundation STW(Technologiestichting STW)	The present research was financially supported by the Brazilian National Council for Scientific and Technological Development (CNPq; MH) and the Dutch Technology Foundation STW (DdR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.stw.nl, www.cnpq.br.	Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Baulcombe D, 2002, TRENDS MICROBIOL, V10, P306, DOI 10.1016/S0966-842X(02)02387-9; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bhushan L, 2015, ARCH VIROL, V160, P959, DOI 10.1007/s00705-014-2331-9; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Carbonell A, 2008, VIROLOGY, V371, P44, DOI 10.1016/j.virol.2007.09.031; Chen TC, 2006, PHYTOPATHOLOGY, V96, P1296, DOI 10.1094/PHYTO-96-1296; de Ronde D, 2014, MOL PLANT PATHOL, V15, P185, DOI 10.1111/mpp.12082; De Ronde D, 2013, MOL PLANT PATHOL, V14, P405, DOI 10.1111/mpp.12016; DEAVILA AC, 1993, ARCH VIROL, V128, P211, DOI 10.1007/BF01309435; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Giner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000996; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hassani-Mehraban A, 2005, PHYTOPATHOLOGY, V95, P852, DOI 10.1094/PHYTO-95-0852; Hassani-Mehraban A, 2009, MOL PLANT MICROBE IN, V22, P1250, DOI 10.1094/MPMI-22-10-1250; Hedil M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106027; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; King AM, 2012, 9 REPORT INT COMMITT, P770; KORMELINK R, 1991, VIROLOGY, V181, P459, DOI 10.1016/0042-6822(91)90878-F; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lichner Z, 2003, J GEN VIROL, V84, P975, DOI 10.1099/vir.0.18987-0; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; Luna AP, 2012, MOL PLANT MICROBE IN, V25, P1294, DOI 10.1094/MPMI-04-12-0094-R; Margaria P, 2015, VIRUS RES, V208, P30, DOI 10.1016/j.virusres.2015.05.021; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Molnar A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2010-11-12-219; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Roth BM, 2004, VIRUS RES, V102, P97, DOI 10.1016/j.virusres.2004.01.020; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Silhavy D, 2004, TRENDS PLANT SCI, V9, P76, DOI 10.1016/j.tplants.2003.12.010; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	41	26	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134517	10.1371/journal.pone.0134517	http://dx.doi.org/10.1371/journal.pone.0134517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275304	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600031
J	Kovacs, L; Kezer, FL; Tozser, J; Szenci, O; Poti, P; Pajor, F				Kovacs, Levente; Kezer, Fruzsina Luca; Tozser, Janos; Szenci, Otto; Poti, Peter; Pajor, Ferenc			Heart Rate and Heart Rate Variability in Dairy Cows with Different Temperament and Behavioural Reactivity to Humans	PLOS ONE			English	Article							COPING STYLES; MILK-YIELD; ANIMALS; AVOIDANCE; WELFARE; STRESS; CATTLE; PIGS; FEAR; RESPONSES	From the 1990s, extensive research was started on the physiological aspects of individual traits in animals. Previous research has established two extreme (proactive and reactive) coping styles in several animal species, but the means of reactivity with the autonomic nervous system (ANS) activity has not yet been investigated in cattle. The aim of this study was the characterization of cardiac autonomic activity under different conditions in cows with different individual characteristics. For this purpose, we investigated heart rate and ANS-related heart rate variability (HRV) parameters of dairy cows (N = 282) on smaller-and larger-scale farms grouped by (1) temperament and (2) behavioural reactivity to humans (BRH). Animals with high BRH scores were defined as impulsive, while animals with low BRH scores were defined as reserved. Cardiac parameters were calculated for undisturbed lying (baseline) and for milking bouts, the latter with the presence of an unfamiliar person (stressful situation). Sympathetic tone was higher, while vagal activity was lower in temperamental cows than in calm animals during rest both on smaller-and larger-scale farms. During milking, HRV parameters were indicative of a higher sympathetic and a lower vagal activity of temperamental cows as compared to calm ones in farms of both sizes. Basal heart rate did not differ between BRH groups either on smaller-or larger-scale farms. Differences between basal ANS activity of impulsive and reserved cows reflected a higher resting vagal and lower sympathetic activity of reserved animals compared to impulsive ones both on smaller-and larger-scale farms. There was no difference either in heart rate or in HRV parameters between groups during milking neither in smaller-nor in larger-scale farms. These two groupings allowed to draw possible parallels between personality and cardiac autonomic activity during both rest and milking in dairy cows. Heart rate and HRV seem to be useful for characterisation of physiological differences related to temperament and BRH.	[Kovacs, Levente; Kezer, Fruzsina Luca; Tozser, Janos; Szenci, Otto] MTA SZIE Large Anim Clin Res Grp, Ullo Dora Major, Hungary; [Kovacs, Levente; Kezer, Fruzsina Luca; Poti, Peter; Pajor, Ferenc] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Anim Husb, Godollo, Hungary; [Szenci, Otto] Szent Istvan Univ, Fac Vet Sci, Dept & Clin Reprod, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Kovacs, L (corresponding author), MTA SZIE Large Anim Clin Res Grp, Ullo Dora Major, Hungary.	Kovacs.Levente@mkk.szie.hu	Ferenc, Pajor/AAK-1498-2020	Ferenc, Pajor/0000-0003-1501-0968	Research Centre of Excellence [9878/2015/FEKUT]	Research Centre of Excellence	Funding was provided by Research Centre of Excellence - 9878/2015/FEKUT project, http://kih.gov.hu/nemzeti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Burrow H. M., 1997, Animal Breeding Abstracts, V65, P477; Camm AJ, 1996, CIRCULATION, V93, P1043; Cannon WB., BODILY CHANGES PAIN, DOI [10.1037/10013-000, DOI 10.1037/10013-000]; Carere C, 2013, INT COMP BIOL, V53, P873; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Curley KO, 2008, HORM BEHAV, V53, P20, DOI 10.1016/j.yhbeh.2007.08.005; Dodzi MS, 2011, APPL ANIM BEHAV SCI, V133, P11, DOI 10.1016/j.applanim.2011.04.014; Engel B. T., 1972, S PHYS EM PSYCH ILLN, P57; FOKKEMA DS, 1995, PHYSIOL BEHAV, V57, P857, DOI 10.1016/0031-9384(94)00333-Z; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Frondelius L, 2005, PHYSIOL BEHAV, V139, P437; Gygax L, 2008, APPL ANIM BEHAV SCI, V109, P167, DOI 10.1016/j.applanim.2007.03.010; Hagen K, 2005, PHYSIOL BEHAV, V85, P195, DOI 10.1016/j.physbeh.2005.03.019; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 1999, PHYSIOL BEHAV, V65, P649; Kovacs L, 2014, J DAIRY SCI, V97, P6955, DOI 10.3168/jds.2014-8327; Kovacs L, 2014, ANIMAL, V8, P316, DOI 10.1017/S1751731113002140; Kovacs L, 2013, J DAIRY SCI, V96, P7743, DOI 10.3168/jds.2013-7030; Lazarus RS, 1966, PSYCHOSOCIAL STRESS; MANTECA X, 1993, ANIM WELFARE, V2, P247; Marchant-Forde RM, 2004, PHYSIOL BEHAV, V80, P449, DOI 10.1016/j.physbeh.2003.09.007; Mohr E, 2002, PHYSIOL BEHAV, V75, P251, DOI 10.1016/S0031-9384(01)00651-5; Munksgaard L, 1997, J DAIRY SCI, V80, P1106, DOI 10.3168/jds.S0022-0302(97)76036-3; Munksgaard L, 2001, APPL ANIM BEHAV SCI, V73, P15, DOI 10.1016/S0168-1591(01)00119-8; Ndou SP, 2011, AFR J BIOTECHNOL, V10, P1049; Phillips C, 2002, CATTLE BEHAV WELFARE; Piccione G, 2005, RES VET SCI, V79, P155, DOI 10.1016/j.rvsc.2004.11.010; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Reimert I, 2014, PHYSIOL BEHAV, V129, P221, DOI 10.1016/j.physbeh.2014.02.059; Rousing T, 2006, LIVEST SCI, V101, P219, DOI 10.1016/j.livprodsci.2005.11.013; Ruis MAW, 2001, APPL ANIM BEHAV SCI, V70, P201, DOI 10.1016/S0168-1591(00)00150-7; Sgoifo A, 1997, AM J PHYSIOL-HEART C, V273, pH1754, DOI 10.1152/ajpheart.1997.273.4.H1754; Steimer T, 2005, NEUROSCI BIOBEHAV R, V29, P99, DOI 10.1016/j.neubiorev.2004.07.002; Strelau J, 1987, EUR J PERSONALITY, V1, P107, DOI DOI 10.1002/PER.2410010205; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Valance D, 2007, GENES BRAIN BEHAV, V6, P339, DOI 10.1111/j.1601-183X.2006.00262.x; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Waiblinger S, 2004, APPL ANIM BEHAV SCI, V85, P31, DOI 10.1016/j.applanim.2003.07.002; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; WECHSLER B, 1995, APPL ANIM BEHAV SCI, V43, P123, DOI 10.1016/0168-1591(95)00557-9; Welfare Quality<(R)>, 2009, ASS PROT CATTL; Zuckerman M., 2005, PSYCHOBIOLOGY PERSON	49	16	17	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136294	10.1371/journal.pone.0136294	http://dx.doi.org/10.1371/journal.pone.0136294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291979	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900076
J	Askevold, ET; Gullestad, L; Nymo, S; Kjekshus, J; Yndestad, A; Latini, R; Cleland, JGF; McMurray, JJV; Aukrust, P; Ueland, T				Askevold, Erik Tandberg; Gullestad, Lars; Nymo, Stale; Kjekshus, John; Yndestad, Arne; Latini, Roberto; Cleland, John G. F.; McMurray, John J. V.; Aukrust, Pal; Ueland, Thor			Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; WNT; ATHEROSCLEROSIS; INHIBITION; OUTCOMES; PATHWAY; DISEASE; EVENTS; SFRP2; DKK-1	Background We have previously demonstrated an association between increased sFRP3 expression and adverse outcome in a population of HF irrespective of cause and left ventricular ejection fraction. In this study we evaluated the prognostic value of sFRP3 in older patients with chronic systolic HF of ischemic origin. Methods We evaluated sFRP3, by tertiles, as a risk factor for the primary endpoint (cardiovascular [ CV] mortality, nonfatal myocardial infarction, nonfatal stroke), all-cause mortality, CV mortality, death from worsening HF (WHF), any coronary event, including sudden death, as well as hospitalizations for CV causes and WHF in 1444 patients from the CORONA population, randomly assigned to 10 mg rosuvastatin or placebo. Results Kaplan-Meier curves for the primary endpoint, as well as all-cause-and CV mortality revealed a markedly better survival for patients with sFRP3 levels in the middle tertile of compared to the 1st and 3rd tertile. In multivariable Cox-regression, after full adjustment including high-sensitive CRP and NT-proBNP, a lower event rate for the primary end point, all cause and CV mortality was observed for patients with tertile 2 sFRP3 levels (HR 0.57 [0.44-0.74], 0.55 [0.44-0.74] and 0.52 [0.39-0.69]; p<0.001), as well as for the number of coronary events (HR 0.62 [0.47-0.82], p = 0.001) and sudden death (HR 0.55 [0.37-0.82], p = 0.002). Applying sFRP3 values to the fully adjusted regression model resulted in highly significant continuous net reclassification improvements for the primary endpoint, all cause and CV mortality, coronary events and sudden death (range 0.24-0.31; p <= 0.002 for all). Conclusions Intermediate serum sFRP3 levels are associated with better survival and fewer CV events than low or high sFRP3 levels, independently of conventional risk factors, in older patients with chronic systolic HF of ischemic origin. Our study suggests that balanced Wnt activity might confer protective effects in a clinical HF setting.	[Askevold, Erik Tandberg; Gullestad, Lars; Kjekshus, John] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Askevold, Erik Tandberg; Nymo, Stale; Yndestad, Arne; Aukrust, Pal; Ueland, Thor] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Gullestad, Lars; Kjekshus, John; Aukrust, Pal; Ueland, Thor] Univ Oslo, Fac Med, Oslo, Norway; [Askevold, Erik Tandberg; Gullestad, Lars; Kjekshus, John; Yndestad, Arne] KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Askevold, Erik Tandberg; Gullestad, Lars; Kjekshus, John; Yndestad, Arne] Ctr Heart Failure Res, Oslo, Norway; [Yndestad, Arne; Aukrust, Pal; Ueland, Thor] KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Aukrust, Pal; Ueland, Thor] Univ Tromso, KG Jebsen Thrombosis Res & Expertise Ctr, Tromso, Norway; [Latini, Roberto] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy; [Cleland, John G. F.] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Dept Cardiol, Kingston Upon Hull, Yorks, England; [McMurray, John J. V.] Univ Glasgow, Glasgow Cardiovasc Res Ctr, British Heart Fdn, Glasgow, Lanark, Scotland	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; UiT The Arctic University of Tromso; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Hull; University of York - UK; University of Glasgow	Ueland, T (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway.	thor.ueland@medisin.uio.no	Cleland, John G./AAZ-4185-2020; Latini, Roberto/AAB-1410-2020; mcmurray, John/B-2467-2013	Cleland, John G./0000-0002-1471-7016; Latini, Roberto/0000-0002-3729-4650; mcmurray, John/0000-0002-6317-3975	AstraZeneca; National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish	AstraZeneca(AstraZeneca); National Institute for Health Research(National Institute for Health Research (NIHR))	The CORONA study was supported by AstraZeneca and the current study was supported by a donation from the Blix Family Foundation. The funder provided support in the form of salaries for authors JK, LG, JGFC, JJVM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Askevold ET, 2014, J INTERN MED, V275, P621, DOI 10.1111/joim.12175; Askevold ET, 2013, CIRC-HEART FAIL, V6, P91, DOI 10.1161/CIRCHEARTFAILURE.112.972653; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Barandon L, 2011, ARTERIOSCL THROM VAS, V31, pE80, DOI 10.1161/ATVBAHA.111.232280; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cleland JGF, 2009, J AM COLL CARDIOL, V54, P1850, DOI 10.1016/j.jacc.2009.06.041; Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Heider U, 2009, EUR J HAEMATOL, V82, P31, DOI 10.1111/j.1600-0609.2008.01164.x; Jiang T, 2009, INT J GYNECOL CANCER, V19, P1177, DOI 10.1111/IGC.0b013e31819d8b2d; Johnson ML, 2006, REV ENDOCR METAB DIS, V7, P41, DOI 10.1007/s1154-006-9003-3; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim KI, 2011, J KOREAN MED SCI, V26, P1178, DOI 10.3346/jkms.2011.26.9.1178; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; McMurray JJV, 2009, CIRCULATION, V120, P2188, DOI 10.1161/CIRCULATIONAHA.109.849117; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Motiwala SR, 2014, J CARDIOVASC TRANSL, V7, P250, DOI 10.1007/s12265-013-9522-8; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van de Schans VAM, 2008, EUR J PHARMACOL, V585, P338, DOI 10.1016/j.ejphar.2008.02.093; Wedel H, 2009, EUR J HEART FAIL, V11, P281, DOI 10.1093/eurjhf/hfn046; Xavier CP, 2014, CELL SIGNAL, V26, P94, DOI 10.1016/j.cellsig.2013.09.016	28	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133970	10.1371/journal.pone.0133970	http://dx.doi.org/10.1371/journal.pone.0133970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288364	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000360018600014
J	Sanchez-Alavez, M; Nguyen, W; Mori, S; Moroncini, G; Viader, A; Nomura, DK; Cravatt, BF; Conti, B				Sanchez-Alavez, Manuel; Nguyen, William; Mori, Simone; Moroncini, Gianluca; Viader, Andreu; Nomura, Daniel K.; Cravatt, Benjamin F.; Conti, Bruno			Monoacylglycerol Lipase Regulates Fever Response	PLOS ONE			English	Article							PROSTAGLANDIN EP3 RECEPTOR; LIPOPOLYSACCHARIDE-INDUCED FEVER; BRAIN ENDOTHELIAL-CELLS; ACID AMIDE HYDROLASE; FEBRILE RESPONSE; ALZHEIMERS-DISEASE; RAT HYPOTHALAMUS; MICE; CYCLOOXYGENASE-2; NEURONS	Cyclooxygenase inhibitors such as ibuprofen have been used for decades to control fever through reducing the levels of the pyrogenic lipid transmitter prostaglandin E2 (PGE2). Historically, phospholipases have been considered to be the primary generator of the arachidonic acid (AA) precursor pool for generating PGE2 and other eicosanoids. However, recent studies have demonstrated that monoacyglycerol lipase (MAGL), through hydrolysis of the endocannabinoid 2-arachidonoylglycerol, provides a major source of AA for PGE2 synthesis in the mammalian brain under basal and neuroinflammatory states. We show here that either genetic or pharmacological ablation of MAGL leads to significantly reduced fever responses in both centrally or peripherally-administered lipopolysaccharide or interleukin-1 beta-induced fever models in mice. We also show that a cannabinoid CB1 receptor antagonist does not attenuate these anti-pyrogenic effects of MAGL inhibitors. Thus, much like traditional nonsteroidal anti-inflammatory drugs, MAGL inhibitors can control fever, but appear to do so through restricted control over prostaglandin production in the nervous system.	[Sanchez-Alavez, Manuel; Nguyen, William; Mori, Simone; Viader, Andreu; Cravatt, Benjamin F.; Conti, Bruno] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Moroncini, Gianluca] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Ancona, Italy; [Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Scripps Research Institute; Marche Polytechnic University; University of California System; University of California Berkeley	Conti, B (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bconti@scripps.edu	; MORONCINI, Gianluca/K-6021-2016	Mori, Simone/0000-0002-0793-7045; Conti, Bruno/0000-0002-9185-5201; MORONCINI, Gianluca/0000-0002-0380-0105; Sanchez-Alavez, Manuel/0000-0002-8164-8452	NIH [DA032933, CA172667, GM109315, NS085155]; NATIONAL CANCER INSTITUTE [R01CA172667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113894, K01GM109315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH grants DA032933 (B.F.C.), CA172667 (D.K.N.), GM109315 (A.V.), and NS085155 (B.C.).	BELL RL, 1979, P NATL ACAD SCI USA, V76, P3238, DOI 10.1073/pnas.76.7.3238; BROEKMAN MJ, 1986, J LIPID RES, V27, P884; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; DINARELLO CA, 1974, J EXP MED, V139, P1369, DOI 10.1084/jem.139.6.1369; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Hruba L, 2015, J PHARMACOL EXP THER, V353, P261, DOI 10.1124/jpet.115.222836; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Kohnz RA, 2014, CHEM SOC REV, V43, P6859, DOI 10.1039/c4cs00047a; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Li S, 2001, BRAIN RES, V910, P163, DOI 10.1016/S0006-8993(01)02707-X; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Matsumura K, 1998, J NEUROSCI, V18, P6279; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Mulvihill MM, 2013, LIFE SCI, V92, P492, DOI 10.1016/j.lfs.2012.10.025; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 1999, NEUROSCI LETT, V260, P117, DOI 10.1016/S0304-3940(98)00962-8; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Ranels HJ, 2003, BRAIN RES, V964, P42, DOI 10.1016/S0006-8993(02)04063-5; Rosenberger TA, 2003, J LIPID RES, V44, P109, DOI 10.1194/jlr.M200298-JLR200; Sanchez-Alavez M, 2006, P NATL ACAD SCI USA, V103, P2904, DOI 10.1073/pnas.0510960103; Sanchez-Alavez M, 2007, BRAIN RES, V1158, P71, DOI 10.1016/j.brainres.2007.05.010; Sanchez-Alavez M, 2010, DIABETES, V59, P43, DOI 10.2337/db09-1128; Scammell TE, 1996, J NEUROSCI, V16, P6246; SCHOENER EP, 1976, BRAIN RES, V117, P157, DOI 10.1016/0006-8993(76)90567-9; Steiner AA, 2011, J PHYSIOL-LONDON, V589, P2415, DOI 10.1113/jphysiol.2010.202465; STITT JT, 1973, J PHYSIOL-LONDON, V232, P163, DOI 10.1113/jphysiol.1973.sp010262; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; WILLIAMS JW, 1977, BRAIN RES, V120, P251, DOI 10.1016/0006-8993(77)90904-0; Wise LE, 2012, ACS CHEM NEUROSCI, V3, P369, DOI 10.1021/cn200130s; Yamagata K, 2001, J NEUROSCI, V21, P2669, DOI 10.1523/JNEUROSCI.21-08-02669.2001; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134437	10.1371/journal.pone.0134437	http://dx.doi.org/10.1371/journal.pone.0134437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287872	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600021
J	Tranchida, F; Shintu, L; Rakotoniaina, Z; Tchiakpe, L; Deyris, V; Hiol, A; Caldarelli, S				Tranchida, Fabrice; Shintu, Laetitia; Rakotoniaina, Zo; Tchiakpe, Leopold; Deyris, Valerie; Hiol, Abel; Caldarelli, Stefano			Metabolomic and Lipidomic Analysis of Serum Samples following Curcuma longa Extract Supplementation in High-Fructose and Saturated Fat Fed Rats	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE; ACID-CONCENTRATIONS; ETHANOL-METABOLISM; DIABETES-MELLITUS; MEMBRANE-FLUIDITY; PROTEIN-SYNTHESIS; LIVER; OBESE; GLUCOSE	We explored, using nuclear magnetic resonance (NMR) metabolomics and fatty acids profiling, the effects of a common nutritional complement, Curcuma longa, at a nutritionally relevant dose with human use, administered in conjunction with an unbalanced diet. Indeed, traditional food supplements have been long used to counter metabolic impairments induced by unbalanced diets. Here, rats were fed either a standard diet, a high level of fructose and saturated fatty acid (HFS) diet, a diet common to western countries and that certainly contributes to the epidemic of insulin resistance (IR) syndrome, or a HFS diet with a Curcuma longa extract (1% of curcuminoids in the extract) for ten weeks. Orthogonal projections to latent structures discriminant analysis (OPLS-DA) on the serum NMR profiles and fatty acid composition (determined by GC/MS) showed a clear discrimination between HFS groups and controls. This discrimination involved metabolites such as glucose, amino acids, pyruvate, creatine, phosphocholine/glycerophosphocholine, ketone bodies and glycoproteins as well as an increase of monounsaturated fatty acids (MUFAs) and a decrease of n-6 and n-3 polyunsaturated fatty acids (PUFAs). Although the administration of Curcuma longa did not prevent the observed increase of glucose, triglycerides, cholesterol and insulin levels, discriminating metabolites were observed between groups fed HFS alone or with addition of a Curcuma longa extract, namely some MUFA and n-3 PUFA, glycoproteins, glutamine, and methanol, suggesting that curcuminoids may act respectively on the fatty acid metabolism, the hexosamine biosynthesis pathway and alcohol oxidation. Curcuma longa extract supplementation appears to be beneficial in these metabolic pathways in rats. This metabolomic approach highlights important serum metabolites that could help in understanding further the metabolic mechanisms leading to IR.	[Tranchida, Fabrice; Shintu, Laetitia; Rakotoniaina, Zo; Deyris, Valerie; Caldarelli, Stefano] Aix Marseille Univ, CNRS, ISm2, Cent Marseille,UMR 7313, Marseille, France; [Tchiakpe, Leopold] Aix Marseille Univ, Lab Nutr Dietet, Fac Pharm, Marseille, France; [Hiol, Abel] Univ La Reunion, CIRAD, ESIROI, UMR QualiSud, St Denis, France; [Caldarelli, Stefano] CNRS, Inst Chim Subst Nat, UPR 2301, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; University of La Reunion; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Tranchida, F (corresponding author), Aix Marseille Univ, CNRS, ISm2, Cent Marseille,UMR 7313, Marseille, France.	fabrice.tranchida@univ-amu.fr; laetitia.shintu@univ-amu.fr	Stefano, Caldaralli/B-2750-2017; shintu, laetitia/B-6293-2009	Stefano, Caldaralli/0000-0001-9008-9392; shintu, laetitia/0000-0003-2730-121X				Araujo CAC, 2001, MEM I OSWALDO CRUZ, V96, P723, DOI 10.1590/S0074-02762001000500026; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; Balkau B, 2002, DIABETES METAB, V28, P364; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRENNER RR, 1966, J BIOL CHEM, V241, P5213; Candiloros H, 1996, J CLIN ENDOCR METAB, V81, P2912, DOI 10.1210/jc.81.8.2912; CASTELLINO P, 1987, J CLIN INVEST, V80, P1784, DOI 10.1172/JCI113272; Cazzola R, 2004, J LIPID RES, V45, P1846, DOI 10.1194/jlr.M300509-JLR200; Clore JN, 2000, METABOLISM, V49, P232, DOI 10.1016/S0026-0495(00)91455-0; D'Angelo G, 2005, HYPERTENSION, V46, P806, DOI 10.1161/01.HYP.0000182697.39687.34; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Faure P, 1997, J NUTR, V127, P103, DOI 10.1093/jn/127.1.103; FUKUDA N, 1982, J BIOL CHEM, V257, P4066; Ghafoorunissa, 2005, J NUTR, V135, P2634, DOI 10.1093/jn/135.11.2634; Girard A, 2005, NUTRITION, V21, P240, DOI 10.1016/j.nut.2004.04.022; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Haffner HT, 1998, INT J LEGAL MED, V111, P27; HANDLER JA, 1988, FEBS LETT, V238, P139, DOI 10.1016/0014-5793(88)80243-6; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; HIRANO T, 1989, AM J PHYSIOL, V256, pE559, DOI 10.1152/ajpendo.1989.256.4.E559; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Joint Expert Committee on Food Additives, 2004, WHO TECHN REP SER, V922; JULIA P, 1987, EUR J BIOCHEM, V162, P179, DOI 10.1111/j.1432-1033.1987.tb10559.x; Katsanos CS, 2009, J CLIN ENDOCR METAB, V94, P2984, DOI 10.1210/jc.2008-2686; Kawashima H, 1996, BIOSCI BIOTECH BIOCH, V60, P108, DOI 10.1271/bbb.60.108; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Lin SH, 2011, MOL BIOSYST, V7, P1537, DOI 10.1039/c0mb00246a; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Mahendran Y, 2013, DIABETES, V62, P3618, DOI 10.2337/db12-1363; Malik VS, 2006, AM J CLIN NUTR, V84, P274; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Na LX, 2011, NUTR METAB CARDIOVAS, V21, P526, DOI 10.1016/j.numecd.2009.11.009; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Neyrinck AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081252; Pari L, 2007, PLANT FOOD HUM NUTR, V62, P25, DOI 10.1007/s11130-006-0037-1; PATIL TN, 1971, INDIAN J EXP BIOL, V9, P167; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Pongchaidecha A, 2009, NUTRITION, V25, P870, DOI 10.1016/j.nut.2009.02.001; Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520; Rippe JM, 2013, ADV NUTR, V4, P236, DOI 10.3945/an.112.002824; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; SCHNEIDER WJ, 1978, EUR J BIOCHEM, V85, P181, DOI 10.1111/j.1432-1033.1978.tb12226.x; SCHOLZ R, 1976, EUR J BIOCHEM, V63, P449, DOI 10.1111/j.1432-1033.1976.tb10247.x; SENSI M, 1993, DIABETOLOGIA, V36, P797, DOI 10.1007/BF00400352; Seo KI, 2008, MOL NUTR FOOD RES, V52, P995, DOI 10.1002/mnfr.200700184; Sestili P, 2011, AMINO ACIDS, V40, P1385, DOI 10.1007/s00726-011-0875-5; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Sreejayan N, 1997, INT J PHARM, V151, P127, DOI 10.1016/S0378-5173(97)04900-4; Stumvoll M, 1996, DIABETES, V45, P863, DOI 10.2337/diabetes.45.7.863; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; TEPHLY TR, 1991, LIFE SCI, V48, P1031, DOI 10.1016/0024-3205(91)90504-5; Thresher JS, 2000, AM J PHYSIOL-REG I, V279, pR1334, DOI 10.1152/ajpregu.2000.279.4.R1334; TONG P, 1995, LANCET, V345, P357, DOI 10.1016/S0140-6736(95)90343-7; Tranchida F, 2012, J ZHEJIANG UNIV-SC B, V13, P307, DOI 10.1631/jzus.B1100090; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tsai J, 2009, AM J PHYSIOL-GASTR L, V296, pG1287, DOI 10.1152/ajpgi.90540.2008; TYGSTRUP N, 1965, J CLIN INVEST, V44, P817, DOI 10.1172/JCI105194; WOODS HG, 1970, BIOCHEM J, V119, P501, DOI 10.1042/bj1190501; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	72	17	18	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135948	10.1371/journal.pone.0135948	http://dx.doi.org/10.1371/journal.pone.0135948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288372	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600089
J	Jung, HM; Lee, JS; Lairson, DR; Kim, Y				Jung, Hye-Min; Lee, Jin-Seok; Lairson, David R.; Kim, Yoon			The Effect of National Cancer Screening on Disparity Reduction in Cancer Stage at Diagnosis by Income Level	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH; KOREA; PREVALENCE; MORTALITY	Background Early detection of cancer is an effective and efficient cancer management strategy. In South Korea, the National Health Insurance administers the National Cancer Screening Program to its beneficiaries. We examined the impact of the National Cancer Screening Program on socioeconomic disparities in cancer stage at diagnosis. Methods Cancer patients registered in the Korean Central Cancer Registry from January 1, 2010 to December 31, 2010 with a diagnosis of gastric cancer (n = 22,470), colon cancer (n = 16,323), breast cancer (n = 10,076), or uterine cervical cancer (n = 2,447) were included. Income level was divided into three groups according to their monthly contribution of National Health Insurance. We employed absolute (age-standardized prevalence rate, slope index of inequality) and relative (relative index of inequality) measures to separately examine social disparities among participants and non-participants of the National Cancer Screening Program in terms of the early-stage rate. Results Age-standardized prevalence rates of early-stage by income group were always higher in participants than in non-participants. Furthermore, the age-standardized prevalence rate of early-stage in the low income group of the participants was also higher than that of the high income group of the non-participants. The sizes of disparities (both slope index of inequality and relative index of inequality) are smaller in participants compared to non-participants. Conclusion National Cancer Screening Program participation reduced income disparity in cancer stage at diagnosis. Population-based cancer screening programs can be used as an effective measure to reduce income disparity in cancer care.	[Jung, Hye-Min; Lee, Jin-Seok; Kim, Yoon] Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea; [Lee, Jin-Seok; Kim, Yoon] Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea; [Lairson, David R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University (SNU); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Lee, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea.	phealth@snu.ac.kr		Jung, Hyemin/0000-0001-7339-7983	Ministry of Health and Welfare, Republic of Korea	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Funding for this work was provided by the Ministry of Health and Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2001, CHALLENGING INEQUITI, P49; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bretthauer M, 2013, BRIT J SURG, V100, P55, DOI 10.1002/bjs.8995; Cho HJ, 2013, J KOREAN MED ASSOC, V56, P184, DOI 10.5124/jkma.2013.56.3.184; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Halpern MT, 2008, LANCET ONCOL, V9, P222, DOI 10.1016/S1470-2045(08)70032-9; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Lee HY, 2010, CANCER EPIDEM BIOMAR, V19, P1919, DOI 10.1158/1055-9965.EPI-09-1308; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Sassi F, 2006, AM J PUBLIC HEALTH, V96, P2165, DOI 10.2105/AJPH.2005.071761; Schwartz KL, 2003, CANCER CAUSE CONTROL, V14, P761, DOI 10.1023/A:1026321923883; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; von Karsa L., 2008, CANC SCREENING EUROP; World Health Organization, 2007, CANC CONTR KNOWL ACT	16	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136036	10.1371/journal.pone.0136036	http://dx.doi.org/10.1371/journal.pone.0136036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26284526	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100097
J	Ding, D; Wang, M; Su, DF; Hong, CJ; Li, XR; Yang, YO; Zhang, Y; Hu, G; Ling, WH				Ding, Ding; Wang, Min; Su, Dongfang; Hong, Changjiang; Li, Xinrui; Yang, Yunou; Zhang, Yuan; Hu, Gang; Ling, Wenhua			Body Mass Index, High-Sensitivity C-Reactive Protein and Mortality in Chinese with Coronary Artery Disease	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; PRACTICE GUIDELINES COMMITTEE; AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR-DISEASE; DIALYSIS PATIENTS; OBESITY PARADOX; RISK-FACTOR; TASK-FORCE; INFLAMMATION; OUTCOMES	Background To investigate single and joint associations of body mass index (BMI) and serum high-sensitivity C-reactive protein (hsCRP) with death. Methods The study included 1871 coronary artery disease (CAD) patients aged 40-85 year-old recruited from 2008 to 2011. Cox regression models were used to estimate the association of BMI and hsCRP with mortality. The data was analyzed in 2014. Results During 3.1 years follow-up, 141 deaths were recorded, 110 died of cardiovascular disease (CVD). After adjustment of major CVD risk factors, there was a J-shaped association between BMI and all-cause and CVD mortality, and a positive association between hsCRP and mortality. The J-shaped association of BMI with mortality was present among patients who never smoked or with elevated hsCRP (>= 3.0 mg/L). Compared with overweight (BMI 24-27.9 kg/m(2)) patients with normal hsCRP (<3.0 mg/L), obese patients (BMI >= 28 kg/m(2)) with elevated hsCRP had a 3.41-fold risk of all-cause mortality (95% CI 1.49-7.80) and a 3.50-fold risk of CVD mortality (1.40-8.75), lean patients (BMI<24 kg/m(2)) with elevated hsCRP concentration had a 2.54-fold risk of all-cause mortality (1.36-4.74) and a 2.36-fold risk of CVD mortality (1.19-4.70). Conclusions The association pattern between baseline BMI and mortality changed among different baseline hsCRP concentrations, indicating that low-grade inflammation may be related to BMI and secondary prognosis of CAD.	[Ding, Ding; Wang, Min; Su, Dongfang; Li, Xinrui; Yang, Yunou; Ling, Wenhua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Hong, Changjiang; Zhang, Yuan; Hu, Gang] Guangzhou Mil Command Peoples Liberat Army, Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Hu, G (corresponding author), Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gang.hu@pbrc.edu; lingwh@mail.sysu.edu.cn	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Key Project of National Natural Science Fund, China [81130052]; China Scholarship Council	Key Project of National Natural Science Fund, China; China Scholarship Council(China Scholarship Council)	This work was supported by the Key Project of National Natural Science Fund [grant number 81130052], China (http://www.nsfc.gov.cn/) to WL. DD is supported by a Scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeras O, 2013, EUR HEART J, V34, P345, DOI 10.1093/eurheartj/ehs217; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bergstrom J, 1998, AM J KIDNEY DIS, V32, P834, DOI 10.1016/S0272-6386(98)70148-9; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Das SR, 2011, J AM COLL CARDIOL, V58, P2642, DOI 10.1016/j.jacc.2011.09.030; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Ding D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120633; Ding D, 2014, DIABETES CARE, V37, P546, DOI 10.2337/dc13-1387; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; FLORES EA, 1989, J CLIN INVEST, V83, P1614, DOI 10.1172/JCI114059; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Gurm HS, 2002, J AM COLL CARDIOL, V39, P834, DOI 10.1016/S0735-1097(02)01687-X; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1343, DOI 10.1053/ajkd.2001.29250; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Kaysen GA, 2000, NEPHROL DIAL TRANSPL, V15, P1521, DOI 10.1093/ndt/15.10.1521; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kennedy LMA, 2005, J AM COLL CARDIOL, V45, P156, DOI 10.1016/j.jacc.2004.10.001; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; McCarthy DO, 2000, RES NURS HEALTH, V23, P222, DOI 10.1002/1098-240X(200006)23:3<222::AID-NUR6>3.0.CO;2-3; McEwen LN, 2012, DIABETES CARE, V35, P1301, DOI 10.2337/dc11-2281; Motie M, 2014, EXP THER MED, V8, P181, DOI 10.3892/etm.2014.1673; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Organization WH, 2009, GLOB HLTH RISKS MORT; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Poston WSC, 2004, INT J OBESITY, V28, P1011, DOI 10.1038/sj.ijo.0802703; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Voeikov VL, 2006, J ALTERN COMPLEM MED, V12, P111, DOI 10.1089/acm.2006.12.111; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x	34	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135713	10.1371/journal.pone.0135713	http://dx.doi.org/10.1371/journal.pone.0135713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280165	Green Submitted, gold, Green Published			2022-12-27	WOS:000359664300020
J	Meng, FY; Wu, H				Meng, Fanyong; Wu, Hao			Indoor Air Pollution by Methylsiloxane in Household and Automobile Settings	PLOS ONE			English	Article							LINEAR SILOXANES; CYCLIC SILOXANES; PERSONAL-CARE; WATER; SOIL; D5	This study examines characteristics of atmospheric methylsiloxane pollution in indoor settings where interior renovation/redecoration is being undertaken, in addition to ordinary family homes and inside family cars. Concentrations of atmospheric methylsiloxane in these locations were approximately one order of magnitude higher than that in outdoor areas. The average indoor concentration of methylsiloxane where renovation was being undertaken was 9.4 mu g/m(3), which is slightly higher than that in an ordinary family home (7.88 mu g/m(3)), while samples from family cars showed lower concentration (3.10 mu g/m(3)). The indoor atmospheric concentration during renovation/redecoration work was significantly positively correlated with the duration of the work. The structure of atmospheric methylsiloxane pollution is basically the same in these three venues. The concentration of annulus siloxane was much higher than that of linear compounds (85% of the total methylsiloxane concentrations). Household dust in average family homes showed total methylsiloxane concentration of 9.5 mu g/m(3) (average); the structure mainly consisted of linear siloxane (approximately 98% of total concentration), thereby differing from that of atmospheric methylsiloxane pollution. The comparatively high concentration of methylsiloxane in these three venues indicates that interior renovation and decoration work, and even travelling in cars, can involve exposure to more serious siloxane contamination during everyday activities.	[Meng, Fanyong; Wu, Hao] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China	Beihang University	Meng, FY (corresponding author), Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.	meng_fy@sohu.com; by0081wuhao@hotmail.com			China Recycle Economy Research Center, Beihang University	China Recycle Economy Research Center, Beihang University	This study was supported by the China Recycle Economy Research Center, Beihang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borga K, 2012, ENVIRON SCI TECHNOL, V46, P6347, DOI 10.1021/es300875d; He B, 2003, TOXICOL APPL PHARM, V192, P254, DOI 10.1016/S0041-008X(03)00282-5; Horii Y, 2008, ARCH ENVIRON CON TOX, V55, P701, DOI 10.1007/s00244-008-9172-z; Kaj L., 2005, SILOXANES NORDIC ENV; Kierkegaard A, 2011, ENVIRON SCI TECHNOL, V45, P5936, DOI 10.1021/es200707r; Lu Y, 2011, ENVIRON POLLUT, V159, P3522, DOI 10.1016/j.envpol.2011.08.015; Lu Y, 2010, ENVIRON SCI TECHNOL, V44, P6081, DOI 10.1021/es101368n; McGoldrick DJ, 2014, ENVIRON POLLUT, V186, P141, DOI 10.1016/j.envpol.2013.12.003; Shields HC, 1996, INDOOR AIR, V6, P2, DOI 10.1111/j.1600-0668.1996.t01-3-00002.x; Surita SC, 2014, SCI TOTAL ENVIRON, V468, P46, DOI 10.1016/j.scitotenv.2013.08.006; Velicogna J, 2012, CHEMOSPHERE, V87, P77, DOI 10.1016/j.chemosphere.2011.11.064; Wang DG, 2013, CHEMOSPHERE, V93, P766, DOI 10.1016/j.chemosphere.2012.10.047; Xu L, 2013, WATER RES, V47, P715, DOI 10.1016/j.watres.2012.10.046; Xu L, 2012, ENVIRON SCI TECHNOL, V46, P11718, DOI 10.1021/es3023368	14	3	5	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135509	10.1371/journal.pone.0135509	http://dx.doi.org/10.1371/journal.pone.0135509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280831	Green Published, gold, Green Submitted			2022-12-27	WOS:000359664300016
J	Aadland, E; Ylvisaker, E				Aadland, Eivind; Ylvisaker, Einar			Reliability of the Actigraph GT3X+Accelerometer in Adults under Free-Living Conditions	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INTERINSTRUMENT RELIABILITY; TECHNICAL RELIABILITY; STATISTICAL-METHODS; GT3X ACCELEROMETER; ACTIVITY MONITORS; MEASUREMENT ERROR; SPORTS-MEDICINE; UNITED-STATES; VARIABILITY	Background Reliability of the Actigraph GT3X+ accelerometer has not been determined under normal wear time criteria in a large sample of subjects and accelerometer units. The aim of this study was to assess contralateral hip difference and inter-instrument reliability of the Actigraph GT3X+ monitor in adults under long-term free-living conditions. Methods Eighty-seven adult subjects (28 men; mean (standard deviation) age 31.3 (12.2) years; body mass index 23.7 (3.1) kg/m(2)) concurrently wore two GT3X+ accelerometers (174 units in total) attached to contralateral hips for 21 days. Reliability was assessed using Bland-Altman plots, mixed model regression analyses and absolute measures of agreement for different lengths of data accumulation (single-day-, 7-day- and 21-day periods). Results There were no significant differences between contralateral hips (effect size <= 0.042; p >= .213). Inter-instrument reliability increased with increased length of data-accumulation. For a 7-day measurement period (n = 232 weeks), limits of agreement were +/- 68 cpm (vertical axis) and +/- 81.3 cpm (vector magnitude) for overall physical activity (PA) level, +/- 51 min for sedentary time, +/- 18.2 min for light PA, +/- 6.3 min for moderate PA, +/- 3.5 min for vigorous PA, and +/- 6.7 min for moderate-to-vigorous PA. Conclusions The Actigraph GT3X+ accelerometer is a reliable tool for measuring PA in adults under free-living conditions using normal data-reduction criteria. Contralateral hip differences are very small. We suggest accelerometers be attached to the right hip and data to be accumulated over several days of measurement.	[Aadland, Eivind; Ylvisaker, Einar] Sogn & Fjordane Univ Coll, Fac Teacher Educ & Sport, Sogndal, Norway	Western Norway University of Applied Sciences	Aadland, E (corresponding author), Sogn & Fjordane Univ Coll, Fac Teacher Educ & Sport, Sogndal, Norway.	eivind.aadland@hisf.no						Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Barnett A, 2006, MED SCI SPORT EXER, V38, P761, DOI 10.1249/01.mss.0000210206.55941.b2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brage S, 2003, MEAS PHYS ED EXERC S, V7, P101, DOI DOI 10.1207/S15327841MPEE0702_; Esliger DW, 2006, MED SCI SPORT EXER, V38, P2173, DOI 10.1249/01.mss.0000239394.55461.08; Greenfield MLVH, 1998, AM J SPORT MED, V26, P483, DOI 10.1177/03635465980260032401; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Jarrett H, 2015, J PHYS ACT HEALTH, V12, P382, DOI 10.1123/jpah.2013-0070; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Mcclain JJ, 2007, MED SCI SPORT EXER, V39, P1509, DOI 10.1249/mss.0b013e3180dc9954; Metcalf BS, 2002, MED SCI SPORT EXER, V34, P1533, DOI 10.1097/00005768-200209000-00022; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Moeller NC, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-19; Ozemek C, 2014, PHYSIOL MEAS, V35, P129, DOI 10.1088/0967-3334/35/2/129; Santos-Lozano A, 2012, INT J SPORTS MED, V33, P994, DOI 10.1055/s-0032-1312580; Santos-Lozano A, 2012, MED ENG PHYS, V34, P787, DOI 10.1016/j.medengphy.2012.02.005; Sirard JR, 2011, J PHYS ACT HEALTH, V8, P668, DOI 10.1123/jpah.8.5.668; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Vanhelst J, 2012, PERCEPT MOTOR SKILL, V114, P584, DOI 10.2466/03.26.PMS.114.2.584-594; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98	25	147	148	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134606	10.1371/journal.pone.0134606	http://dx.doi.org/10.1371/journal.pone.0134606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274586	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600035
J	Janczura, M; Bochenek, G; Nowobilski, R; Dropinski, J; Kotula-Horowitz, K; Laskowicz, B; Stanisz, A; Lelakowski, J; Domagala, T				Janczura, Miroslaw; Bochenek, Grazyna; Nowobilski, Roman; Dropinski, Jerzy; Kotula-Horowitz, Katarzyna; Laskowicz, Bartosz; Stanisz, Andrzej; Lelakowski, Jacek; Domagala, Teresa			The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function - An Occupational Cohort-Based Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; INCIDENT CARDIOVASCULAR EVENTS; REDUCED LUNG-FUNCTION; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; ARTERY-DISEASE; JOB STRAIN; PSYCHOSOCIAL STRESS; BLOOD-PRESSURE; YOUNG-ADULTS	Background and Aims Higher levels of stress impact the prevalence of metabolic syndrome (MetS) and coronary heart disease. The association between MetS, impaired pulmonary function and low level of physical activity is still pending assessment in the subjects exposed to stress. The study aimed to examine whether higher levels of stress might be related to MetS and the plaque presence, as well as whether MetS might affect pulmonary function. Design and Methods The study embraced 235 police officers (mean age 40.97 years) from the south of Poland. The anthropometrics and biochemical variables were measured; MetS was diagnosed using the International Diabetes Federation criteria. Computed tomography coronary angiography of coronary arteries, exercise ECG, measurements of brachial flow-mediated dilation, and carotid artery intima-media thickness were completed. In order to measure the self-perception of stress, 10-item Perceived Stress Scale (PSS-10) was applied. Pulmonary function and physical activity levels were also addressed. Multivariate logistic regression analyses were applied to determine the relationships between: 1/incidence of coronary plaque and MetS per se, MetS components and the number of classical cardiovascular risk factors, 2/perceived stress and MetS, 3/MetS and pulmonary function parameters. Results Coronary artery atherosclerosis was less associated with MetS (OR = 2.62, 95% CI 1.24-5.52; p = 0.011) than with a co-existence of classical cardiovascular risk factors (OR = 5.67, 95% CI 1.07-29.85, p = 0.03; for 3 risk factors and OR = 9.05; 95% CI 1.24-66.23, p = 0.02; for 6 risk factors, respectively). Perceived stress increased MetS prevalence (OR = 1.07, 95% CI 1.03-1.13; p = 0.03), and impacted coronary plaque prevalence (OR = 1.05, 95% CI 1.001-1.10; p = 0.04). Leisure-time physical activity reduced the chances of developing MetS (OR = 0.98 95% CI 0.96-0.99; p = 0.02). MetS subjects had significantly lower values of certain pulmonary function parameters. Conclusions Exposure to job-specific stress among police officers increased the prevalence of MetS and impacted coronary plaque presence. MetS subjects had worse pulmonary function parameters. Early-stage, comprehensive therapeutic intervention may reduce overall risk of cardiovascular events and prevent pulmonary function impairment in this specific occupational population.	[Janczura, Miroslaw] John Paul 2 Hosp, Dept Anesthesiol & Intens Pulm Care, Krakow, Poland; [Bochenek, Grazyna; Nowobilski, Roman; Dropinski, Jerzy; Kotula-Horowitz, Katarzyna; Domagala, Teresa] Jagiellonian Univ, Sch Med, Dept Internal Med, Krakow, Poland; [Nowobilski, Roman] Jagiellonian Univ, Sch Med, Fac Publ Hlth, Unit Rehabil Internal Dis, Krakow, Poland; [Laskowicz, Bartosz] John Paul 2 Hosp, Dept Radiol & Diagnost Imaging, Krakow, Poland; [Stanisz, Andrzej] Jagiellonian Univ, Sch Med, Dept Bioinformat & Telemed, Krakow, Poland; [Lelakowski, Jacek] John Paul 2 Hosp, Inst Cardiol, Dept Electrocardiol, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Domagala, T (corresponding author), Jagiellonian Univ, Sch Med, Dept Med Biochem, Krakow, Poland.	domagala32@yahoo.com		Janczura, Miroslaw/0000-0001-8485-0683; Domagala, Teresa/0000-0003-0747-5757	Leading National Research Centre	Leading National Research Centre	Project co-financed by the Leading National Research Centre 2012-2017.	Achenbach S, 2008, EUR RADIOL, V18, P1188, DOI 10.1007/s00330-008-0883-3; Ahluwalia N, 2006, ATHEROSCLEROSIS, V186, P345, DOI 10.1016/j.atherosclerosis.2005.07.021; Ahmadi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118998; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arcari A, 2013, EUR J PREV CARDIOL, V20, P862, DOI 10.1177/2047487312447904; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; BRUCE RA, 1971, ANN CLIN RES, V3, P323; Brunner EJ, 2007, AM J EPIDEMIOL, V165, P828, DOI 10.1093/aje/kwk058; Butler J, 2008, AM J CARDIOL, V101, P1127, DOI 10.1016/j.amjcard.2007.12.012; Cameron A, 2010, MATURITAS, V65, P117, DOI 10.1016/j.maturitas.2009.11.026; Can SH, 2014, IND HEALTH, V52, P240, DOI 10.2486/indhealth.2013-0237; Carson T. L., 2015, Journal of Obesity, V2015, P203164; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Franke WD, 1998, J OCCUP ENVIRON MED, V40, P441, DOI 10.1097/00043764-199805000-00006; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Guimont C, 2006, AM J PUBLIC HEALTH, V96, P1436, DOI 10.2105/AJPH.2004.057679; Guo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120632; Hamburg NM, 2008, AM J CARDIOL, V101, P82, DOI 10.1016/j.amjcard.2007.07.053; Hamer M, 2012, PSYCHOSOM MED, V74, P896, DOI 10.1097/PSY.0b013e31827457f4; Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P243; Hartley TA, 2011, J OCCUP ENVIRON MED, V53, P553, DOI 10.1097/JOM.0b013e3182171995; Hsiao FC, 2010, METABOLISM, V59, P848, DOI 10.1016/j.metabol.2009.10.001; Juonala M, 2004, CIRCULATION, V110, P2918, DOI 10.1161/01.CIR.0000147540.88559.00; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kibler JL, 2014, WORLD J CARDIOL, V6, P455, DOI 10.4330/wjc.v6.i6.455; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Konstantinou DM, 2010, METAB SYNDR RELAT D, V8, P201, DOI 10.1089/met.2009.0059; Koskinen J, 2010, CIRCULATION, V121, P392, DOI 10.1161/CIRCULATIONAHA.109.894584; Kozey S, 2010, J PHYS ACT HEALTH, V7, P508, DOI 10.1123/jpah.7.4.508; Kukkonen-Harjula K, 2007, SCAND J WORK ENV HEA, V33, P401, DOI 10.5271/sjweh.1161; Lee CMY, 2008, DIABETES RES CLIN PR, V81, P377, DOI 10.1016/j.diabres.2008.05.011; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Lim SY, 2010, J KOREAN MED SCI, V25, P1480, DOI 10.3346/jkms.2010.25.10.1480; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Lind L, 2008, ATHEROSCLEROSIS, V196, P795, DOI 10.1016/j.atherosclerosis.2007.01.014; Mattsson N, 2008, EUR HEART J, V29, P784, DOI 10.1093/eurheartj/ehm576; McClean KM, 2008, THORAX, V63, P649, DOI 10.1136/thx.2007.086801; Mellen PB, 2006, ARTERIOSCL THROM VAS, V26, P189, DOI 10.1161/01.ATV.0000191656.71812.7c; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mons U, 2014, HEART, V100, P1043, DOI 10.1136/heartjnl-2013-305242; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nakajima K, 2008, CHEST, V134, P712, DOI 10.1378/chest.07-3003; Niu L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067809, DOI 10.1371/ANNOTATION/8941AEE3-4BB8-42A0-B09A-E7C416BEEEF7]; Oginska-Bulik N, 2009, NARZEDZIA POMIARU ST; Ohlin B, 2004, EUR HEART J, V25, P867, DOI 10.1016/j.ehj.2004.03.003; Paek YJ, 2010, METABOLISM, V59, P1300, DOI 10.1016/j.metabol.2009.12.005; Park HY, 2010, RESP MED, V104, P1326, DOI 10.1016/j.rmed.2010.02.024; Petersen CB, 2014, PREV MED, V69, P5, DOI 10.1016/j.ypmed.2014.08.022; Pigna G, 2011, ATHEROSCLEROSIS, V215, P417, DOI 10.1016/j.atherosclerosis.2010.12.038; Prasad A, 2000, J AM COLL CARDIOL, V36, P1467, DOI 10.1016/S0735-1097(00)00892-5; Ramey SL, 2011, AAOHN J, V59, P221, DOI 10.3928/08910162-20110418-02; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; Rogliani P, 2010, RESP MED, V104, P47, DOI 10.1016/j.rmed.2009.08.009; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sattar N, 2008, INT J OBESITY, V32, pS30, DOI 10.1038/ijo.2008.33; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Sygnowska E, 2012, KARDIOL POL, V70, P718; Tharkar Shabana, 2008, J Assoc Physicians India, V56, P845; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Title LM, 2008, VASC MED, V13, P263, DOI 10.1177/1358863X08095154; U. S. Department of Health and Human Services, 2008, PHYS ACT GUID AM; Violanti John M, 2006, Int J Emerg Ment Health, V8, P227; Wanahita N, 2010, J OCCUP ENVIRON MED, V52, P661, DOI 10.1097/JOM.0b013e3181e36457; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028610; Wiernik E, 2013, HYPERTENSION, V61, P571, DOI 10.1161/HYPERTENSIONAHA.111.00302; Wongpakaran N, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-6; Yarnell J, 2008, EUR HEART J, V29, P579, DOI 10.1093/eurheartj/ehm641; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Zdrojewski T, 2013, KARDIOL POL, V71, P381, DOI 10.5603/KP.2013.0066	89	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133750	10.1371/journal.pone.0133750	http://dx.doi.org/10.1371/journal.pone.0133750			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26274823	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600016
J	Vargas-Santos, AB; Castelar-Pinheiro, GD; Coutinho, ESF; Schumacher, HR; Singh, JA; Schlesinger, N				Vargas-Santos, Ana Beatriz; Castelar-Pinheiro, Geraldo da Rocha; Freire Coutinho, Evandro Silva; Schumacher, H. Ralph, Jr.; Singh, Jasvinder A.; Schlesinger, Naomi			Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists	PLOS ONE			English	Article							CURRENT PRESCRIBING PRACTICES; EVIDENCE-BASED RECOMMENDATIONS; URATE-LOWERING DRUGS; PHYSICIAN QUESTIONNAIRE; TASK-FORCE; ARTHRITIS; DIAGNOSIS; CARE; HYPERURICEMIA; COLCHICINE	Objective To describe the current pharmacological approach to gout treatment reported by rheumatologists in Brazil. Methods We performed a cross-sectional survey study using an online questionnaire e-mailed to 395 rheumatologists, randomly selected, from among the members of the Brazilian Society of Rheumatology. Results Three hundred and nine rheumatologists (78.2%) responded to the survey. For acute gout attacks, combination therapy (NSAIDs or steroid + colchicine) was often used, even in monoarticular involvement, and colchicine was commonly started as monotherapy after 36 hours or more from onset of attack. During an acute attack, urate-lowering therapy (ULT) was withdrawn by approximately a third of rheumatologists. Anti-inflammatory prophylaxis (98% colchicine) was initiated when ULT was started in most cases (92.4%), but its duration was varied. Most (70%) respondents considered the target serum uric acid level to be less than 6 mg/dl. Approximately 50% of rheumatologists reported starting allopurinol at doses of 100 mg daily or less and 42% reported the initial dose to be 300 mg daily in patients with normal renal function. ULT was maintained indefinitely in 76% of gout patients with tophi whereas in gout patients without tophi its use was kept indefinitely in 39.6%. Conclusion This is the first study evaluating gout treatment in a representative, random sample of Brazilian rheumatologists describing common treatment practices among these specialists. We identified several gaps in reported gout management, mainly concerning the use of colchicine and ULT and the duration of anti-inflammatory prophylaxis and ULT. Since rheumatologists are considered as opinion leaders in this disease, a program for improving quality of care for gout patients should focus on increasing their knowledge in this common disease.	[Vargas-Santos, Ana Beatriz; Castelar-Pinheiro, Geraldo da Rocha] Univ Estado Rio de Janeiro, Dept Internal Med, Div Rheumatol, BR-20550011 Rio De Janeiro, RJ, Brazil; [Freire Coutinho, Evandro Silva] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Schumacher, H. Ralph, Jr.] Univ Penn, Sch Med, Div Rheumatol, Philadelphia, PA 19104 USA; [Schumacher, H. Ralph, Jr.] Vet Affairs Med Ctr, Philadelphia, PA USA; [Singh, Jasvinder A.] Birmingham Vet Affairs Med Ctr, Med Serv, Birmingham, AL USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Sch Publ Hlth, Div Epidemiol, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA; [Schlesinger, Naomi] Rutgers State Univ, Robert Wood Johnson Med Sch, Div Rheumatol, Dept Med, New Brunswick, NJ 08903 USA	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Mayo Clinic; Rutgers State University New Brunswick; Rutgers State University Medical Center	Vargas-Santos, AB (corresponding author), Univ Estado Rio de Janeiro, Dept Internal Med, Div Rheumatol, BR-20550011 Rio De Janeiro, RJ, Brazil.	anabvargas@gmail.com	Singh, Jasvinder/R-6172-2019; dos Santos, Ana Beatriz Vargas/S-4908-2019	Singh, Jasvinder/0000-0003-3485-0006; dos Santos, Ana Beatriz Vargas/0000-0001-5307-0254; schlesinger, naomi/0000-0002-1558-1202; Coutinho, Evandro/0000-0002-4649-7353; Pinheiro, Geraldo/0000-0002-7778-569X	Astrazeneca; Abbvie; Takeda; Ardea; Merck; Metabolex; Novartis Pharmaceutical Corporation; Regeneron; Savient; Allergan; Sobi; BMS; Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS); National Institute of Aging (NIA); National Cancer Institute (NCI)	Astrazeneca(AstraZeneca); Abbvie(AbbVie); Takeda(Takeda Pharmaceutical Company Ltd); Ardea; Merck(Merck & Company); Metabolex; Novartis Pharmaceutical Corporation; Regeneron(Regeneron); Savient; Allergan(AbbVieAllergan); Sobi; BMS(Bristol-Myers Squibb); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ana Beatriz Vargas-Santos has received consultant fee from Astrazeneca; H. Ralph Schumacher Jr. has received research grants from Abbvie and Takeda, and consultant fees from Abbvie, Ardea, AstraZeneca, Merck, Metabolex, Novartis Pharmaceutical Corporation, Regeneron and Takeda; Jasvinder A. Singh has received research and travel grants from Takeda and Savient, and consultant fees from Savient, Takeda, Allergan and Regeneron; Naomi Schlesinger has received grants from Novartis Pharmaceutical Corporation, consultant fees from Novartis Pharmaceutical Corporation, Sobi, BMS, is on the Speakers' Bureau of Novartis Pharmaceutical Corporation and Takeda, and serves on the advisory boards of Novartis Pharmaceutical Corporation, Takeda and Sobi. Jasvinder A. Singh is also supported by grants from the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs), National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institute of Aging (NIA) and National Cancer Institute (NCI). Geraldo da Rocha Castelar-Pinheiro and Evandro Silva Freire Coutinho have declared that no competing interests exist. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Araujo F, 2014, ACTA REUMATOL PORT, V39, P158; BELLAMY N, 1988, J RHEUMATOL, V15, P1841; BELLAMY N, 1989, MED J AUSTRALIA, V151, P531, DOI 10.5694/j.1326-5377.1989.tb128510.x; Burns CM, 2011, LANCET, V377, P165, DOI 10.1016/S0140-6736(10)60665-4; Crofford LJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4174; De Vera MA, 2014, ARTHRIT CARE RES, V66, P1551, DOI 10.1002/acr.22336; Diaz-Torne C, 2015, CURR OPIN RHEUMATOL, V27, P164, DOI 10.1097/BOR.0000000000000146; Doherty M, 2007, ANN RHEUM DIS, V66, P1685, DOI 10.1136/ard.2007.071530; Edwards NL, 2011, CURR RHEUMATOL REP, V13, P154, DOI 10.1007/s11926-010-0154-6; Fang Wei-gang, 2006, Zhonghua Yi Xue Za Zhi, V86, P1901; Fang WG, 2006, J RHEUMATOL, V33, P2041; Fara N, 2012, ARGENT REUMATOL CLIN, V8, P306, DOI DOI 10.1016/J.REUMA.2012.05.008; FERRAZ MB, 1994, J RHEUMATOL, V21, P374; Harrold LR, 2013, RHEUMATOLOGY, V52, P1623, DOI 10.1093/rheumatology/ket158; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Juraschek SP, 2015, ARTHRIT CARE RES, V67, P588, DOI 10.1002/acr.22469; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Kuo CF, 2015, ANN RHEUM DIS, V74, P661, DOI 10.1136/annrheumdis-2013-204463; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mikuls TR, 2006, J RHEUMATOL, V33, P562; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Neogi T, 2006, J RHEUMATOL, V33, P104; Oderda GM, 2014, POSTGRAD MED, V126, P257, DOI 10.3810/pgm.2014.05.2774; Owens D, 2008, Ir Med J, V101, P147; Pascart T, 2013, CLIN RHEUMATOL, V32, P1693, DOI 10.1007/s10067-013-2402-4; Pascual E, 2007, ANN RHEUM DIS, V66, P1269, DOI 10.1136/ard.2007.078469; Rees F, 2013, ANN RHEUM DIS, V72, P826, DOI 10.1136/annrheumdis-2012-201676; Reinders MK, 2008, ANN RHEUM DIS, V67, P1049, DOI 10.1136/ard.2007.085902; Riedel AA, 2004, J RHEUMATOL, V31, P1575; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Rozenberg S, 1996, REV RHUM, V63, P255; Sarawate CA, 2006, MAYO CLIN PROC, V81, P925, DOI 10.4065/81.7.925; Sautner J, 2014, Z RHEUMATOL, V73, P836, DOI 10.1007/s00393-014-1371-6; Schlesinger N, 2006, J RHEUMATOL, V33, P2050; Schlesinger N, 2012, SEMIN ARTHRITIS RHEU, V42, P155, DOI 10.1016/j.semarthrit.2012.03.010; Sibaud V, 2014, JOINT BONE SPINE, V81, P374, DOI 10.1016/j.jbspin.2013.12.007; Singh JA, 2007, ARTHRIT RHEUM-ARTHR, V57, P822, DOI 10.1002/art.22767; Singh Jasvinder A, 2009, Curr Rheumatol Rep, V11, P154; Sivera F, 2014, ANN RHEUM DIS, V73, P328, DOI 10.1136/annrheumdis-2013-203325; Stamp LK, 2011, ARTHRITIS RHEUM-US, V63, P412, DOI 10.1002/art.30119; STUART RA, 1991, NEW ZEAL MED J, V104, P115; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; Vazquez-Mellado J, 2003, REV INVEST CLIN, V55, P621; WALLACE SL, 1991, J RHEUMATOL, V18, P264; Weaver AL, 2008, JCR-J CLIN RHEUMATOL, V14, pS42, DOI 10.1097/RHU.0b013e3181896b1e; Yamanaka H, 2011, NUCLEOS NUCLEOT NUCL, V30, P1018, DOI 10.1080/15257770.2011.596496; Yeap SS, 2009, INT J RHEUM DIS, V12, P329, DOI 10.1111/j.1756-185X.2009.01431.x; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251	51	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135805	10.1371/journal.pone.0135805	http://dx.doi.org/10.1371/journal.pone.0135805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274585	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600115
J	Zhai, H; Lu, SX; Wu, HY; Zhang, YP; Zhang, XZ; Yang, JY; Wang, YY; Yang, G; Qiu, HM; Cui, TT; Xia, ZJ				Zhai, Hong; Lu, Shixiang; Wu, Hongyan; Zhang, Yupeng; Zhang, Xingzheng; Yang, Jiayin; Wang, Yaying; Yang, Guang; Qiu, Hongmei; Cui, Tingting; Xia, Zhengjun			Diurnal Expression Pattern, Allelic Variation, and Association Analysis Reveal Functional Features of the E1 Gene in Control of Photoperiodic Flowering in Soybean	PLOS ONE			English	Article							MAP-BASED CLONING; MATURITY LOCI; L MERRILL; TIME; INSENSITIVITY; INHERITANCE; RESPONSES; GIGANTEA; PLANT; E3	Although four maturity genes, E1 to E4, in soybean have been successfully cloned, their functional mechanisms and the regulatory network of photoperiodic flowering remain to be elucidated. In this study, we investigated how the diurnal expression pattern of the E1 gene is related to photoperiodic length; and to what extent allelic variation in the B3-like domain of the E1 gene is associated with flowering time phenotype. The bimodal expression of the E1 gene peaked first at around 2 hours after dawn in long-day condition. The basal expression level of E1 was enhanced by the long light phase, and decreased by duration of dark. We identified a 5bp (3 SNP and 2-bp deletion) mutation, referred to an e1-b3a, which occurs in the middle of B3 domain of the E1 gene in the early flowering cultivar Yanhuang 3. Subcellular localization analysis showed that the putative truncated e1-b3a protein was predominately distributed in nuclei, indicating the distribution pattern of e1-b3a was similar to that of E1, but not to that of e1-as. Furthermore, genetic analysis demonstrated allelic variations at the E1 locus significantly underlay flowering time in three F-2 populations. Taken together, we can conclude the legume specific E1 gene confers some special features in photoperiodic control of flowering in soybean. Further characterization of the E1 gene will extend our understanding of the soybean flowering pathway in soybean.	[Zhai, Hong; Lu, Shixiang; Wu, Hongyan; Zhang, Yupeng; Zhang, Xingzheng; Wang, Yaying; Yang, Guang; Cui, Tingting; Xia, Zhengjun] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China; [Lu, Shixiang; Zhang, Yupeng; Zhang, Xingzheng; Wang, Yaying] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yang, Jiayin] Huaiyin Inst Agr Sci Xuhuai Reg Jiangsu, Huaian, Peoples R China; [Qiu, Hongmei] Jilin Acad Agr Sci, Soybean Res Inst, Changchun, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jiangsu Academy of Agricultural Sciences; Jilin Academy of Agricultural Sciences	Xia, ZJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China.	xiazhj@iga.ac.cn			National Natural Science of China [31430065, 31471518, 31271742, 31301338]; Chinese Academy of Sciences [XDA08010105, KZCX 2-EW-303]; National Science and Technology Ministry of China [2011BAD35B06-2]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Ministry of China	This work was supported by the State Key Program (31430065) and Programs (31471518, 31271742, and 31301338) from National Natural Science of China; by Programs (XDA08010105, Hundred Talents Program, and KZCX 2-EW-303) from Chinese Academy of Sciences; by Program (2011BAD35B06-2) from National Science and Technology Ministry of China.	Abe J, 2003, CROP SCI, V43, P1300, DOI 10.2135/cropsci2003.1300; Bendix C, 2015, MOL PLANT, V8, P1135, DOI 10.1016/j.molp.2015.03.003; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cober ER, 1996, CROP SCI, V36, P606, DOI 10.2135/cropsci1996.0011183X003600030014x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Garner WW, 1923, J AGRIC RES, V23, P0871; Garner WW., 1920, J AGR RES, VXVII, P553; Kawasaki S, 2000, J PLANT RES, V113, P497, DOI 10.1007/PL00013960; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCBLAIN BA, 1987, CROP SCI, V27, P1127, DOI 10.2135/cropsci1987.0011183X002700060008x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Owen FV, 1927, GENETICS, V12, P519; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; UPADHYAY AP, 1994, ANN BOT-LONDON, V74, P87, DOI [10.1006/anbo.1994.1097, 10.1093/aob/74.1.87]; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Xia Z, 2007, DNA RES, V14, P257, DOI 10.1093/dnares/dsm027; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xie QG, 2015, P NATL ACAD SCI USA, V112, P3829, DOI 10.1073/pnas.1421803112; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Zhai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097636; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	35	19	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135909	10.1371/journal.pone.0135909	http://dx.doi.org/10.1371/journal.pone.0135909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275311	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600131
J	Dohn, LH; Pappot, H; Iversen, BR; Illemann, M; Hoyer-Hansen, G; Christensen, IJ; Thind, P; Salling, L; von der Maase, H; Laerum, OD				Dohn, Line Hammer; Pappot, Helle; Iversen, Benedikte Richter; Illemann, Martin; Hoyer-Hansen, Gunilla; Christensen, Ib Jarle; Thind, Peter; Salling, Lisbeth; von der Maase, Hans; Laerum, Ole Didrik			uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder - Possible Clinical Implications	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; TUMOR-ASSOCIATED MACROPHAGES; LIBERATED DOMAIN I; UROKINASE RECEPTOR; CLEAVED FORMS; COLON-CANCER; CELLS; PLASMA; INHIBITOR; SURVIVAL	The objective of the present study was to confirm the expression and localisation pattern of the urokinase-type plasminogen activator receptor (uPAR) focusing on its possible clinical relevance in patients with urothelial neoplasia of the bladder. uPAR is a central molecule in tissue remodelling during cancer invasion and metastasis and is an established prognostic marker in various cancer diseases other than bladder cancer. Formalin-fixed and paraffin-embedded tumour-tissue blocks from 186 patients treated with radical cystectomy were analysed. uPAR expression was scored as either negative or positive as well as by the actual score. Separate scores were obtained for cancer cells, macrophages and myofibroblasts at the invasive front and in tumour core. We were able to confirm, in an independent patient cohort, the tissue expression and localisation pattern of uPAR as investigated by Immunohistochemistry as well as a significant association between uPAR positivity and increasing tumour stage and tumour grade. This demonstrates the robustness of our previous and current findings. In addition the association between uPAR positive myofibroblasts and poor survival was reproduced. The highest hazard ratios for survival were seen for uPAR positive myofibroblasts both at the invasive front and in tumour core. Evaluating uPAR expression by the actual score showed a significant association between uPAR positive myofibroblasts in tumour core and an increased risk of cancer specific mortality. Our investigations have generated new and valuable biological information about the cell types being involved in tumour invasion and progression through the plasminogen activation system.	[Dohn, Line Hammer; Pappot, Helle; von der Maase, Hans] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Dohn, Line Hammer; Illemann, Martin; Hoyer-Hansen, Gunilla; Christensen, Ib Jarle; Laerum, Ole Didrik] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Iversen, Benedikte Richter] Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Illemann, Martin; Hoyer-Hansen, Gunilla; Christensen, Ib Jarle; Laerum, Ole Didrik] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Thind, Peter; Salling, Lisbeth] Rigshosp, Dept Urol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Dohn, LH (corresponding author), Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark.	line.hammer.dohn@regionh.dk	Illemann, Martin/M-7361-2015; Pappot, Helle/ADY-3530-2022		Oncological Research Foundation at Department of Oncology at Rigshospitalet; Dansk Kraeftforsknings Fond; Merchant Georg Bjorkner and wife Ellen Bjorkner Foundation; Harboe Foundation	Oncological Research Foundation at Department of Oncology at Rigshospitalet; Dansk Kraeftforsknings Fond; Merchant Georg Bjorkner and wife Ellen Bjorkner Foundation; Harboe Foundation	This study was funded by the Oncological Research Foundation at Department of Oncology at Rigshospitalet, Dansk Kraeftforsknings Fond, Merchant Georg Bjorkner and wife Ellen Bjorkner Foundation, and The Harboe Foundation. Grant numbers and URLs are not available for any of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasi CE, 2013, APMIS, V121, P189, DOI 10.1111/j.1600-0463.2012.02955.x; Almasi CE, 2011, PROSTATE, V71, P899, DOI 10.1002/pros.21306; Almasi CE, 2011, LUNG CANCER, V74, P510, DOI 10.1016/j.lungcan.2011.05.008; Alpizar-Alpizar W, 2012, INT J CANCER, V131, pE329, DOI 10.1002/ijc.26417; Alpizar-Alpizar W, 2010, INT J CANCER, V126, P405, DOI 10.1002/ijc.24755; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Bhuvarahamurthy V, 2004, ONCOL REP, V12, P909; Casella R, 2002, CANCER, V95, P2494, DOI 10.1002/cncr.10989; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Dohn LH, 2015, UROL ONCOL; EBLE JN, 2004, TUMOURS URINARY SYST, P90; Ecke TH, 2005, ANTICANCER RES, V25, P635; Gakis G, 2012, BJU INT, V110, P233, DOI 10.1111/j.1464-410X.2011.10839.x; Grunnet M, 2014, CLIN BIOCHEM, V47, P599, DOI 10.1016/j.clinbiochem.2014.01.030; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Henic E, 2008, CLIN CANCER RES, V14, P5785, DOI 10.1158/1078-0432.CCR-08-0096; Illemann M, 2014, CANCER MED-US, V3, P855, DOI 10.1002/cam4.242; Illemann M, 2009, INT J CANCER, V124, P1860, DOI 10.1002/ijc.24166; Janicke F, 2001, J NATL CANCER I, V93, P913, DOI 10.1093/jnci/93.12.913; Kamat AM, 2013, EUR UROL, V63, P4, DOI 10.1016/j.eururo.2012.09.057; Kotzsch M, 2010, HISTOPATHOLOGY, V57, P461, DOI 10.1111/j.1365-2559.2010.03644.x; Laerum OD, 2012, INT J CANCER, V131, P558, DOI 10.1002/ijc.26382; Mantovani A, 2013, ARTERIOSCL THROM VAS, V33, P1478, DOI 10.1161/ATVBAHA.113.300168; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; PLESNER T, 1994, BLOOD, V83, P808; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; RONNE E, 1995, BREAST CANCER RES TR, V33, P199, DOI 10.1007/BF00665944; Shariat SF, 2003, J UROLOGY, V170, P2244, DOI 10.1097/01.ju.0000090965.71697.37; Shariat SF, 2010, UROL ONCOL-SEMIN ORI, V28, P389, DOI 10.1016/j.urolonc.2010.02.011; Sidaway P, 2015, NAT REV UROL, V12; Sobin LH, 2009, TNM CLASSIFICATION M, P262; STERNBERG C, 2014, LANCET ONCOL; Thurison T, 2010, CLIN CHEM, V56, P1636, DOI 10.1373/clinchem.2010.144410; Usher PA, 2005, INT J CANCER, V113, P870, DOI 10.1002/ijc.20665; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046	37	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135824	10.1371/journal.pone.0135824	http://dx.doi.org/10.1371/journal.pone.0135824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292086	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900033
J	Dorazio, RM; Connor, EF; Askins, RA				Dorazio, Robert M.; Connor, Edward F.; Askins, Robert A.			Estimating the Effects of Habitat and Biological Interactions in an Avian Community	PLOS ONE			English	Article							HETEROSPECIFIC ATTRACTION; CENSUS-DATA; COMPETITION; ABUNDANCE; MODELS; FOREST; DIVERSITY; COOCCURRENCE; COEFFICIENTS; SCALE	We used repeated sightings of individual birds encountered in community-level surveys to investigate the relative roles of habitat and biological interactions in determining the distribution and abundance of each species. To analyze these data, we developed a multispecies N-mixture model that allowed estimation of both positive and negative correlations between abundances of different species while also estimating the effects of habitat and the effects of errors in detection of each species. Using a combination of single-and multispecies N-mixture modeling, we examined for each species whether our measures of habitat were sufficient to account for the variation in encounter histories of individual birds or whether other habitat variables or interactions with other species needed to be considered. In the community that we studied, habitat appeared to be more influential than biological interactions in determining the distribution and abundance of most avian species. Our results lend support to the hypothesis that abundances of forest specialists are negatively affected by forest fragmentation. Our results also suggest that many species were associated with particular types of vegetation as measured by structural attributes of the forests. The abundances of 6 of the 73 species observed in our study were strongly correlated. These species included large birds (American Crow (Corvus brachyrhynchos) and Red-winged Blackbird (Agelaius phoeniceus)) that forage on the ground in open habitats and small birds (Red-eyed Vireo (Vireo olivaceus), House Wren (Troglodytes aedon), Hooded Warbler (Setophaga citrina), and Prairie Warbler (Setophaga discolor)) that are associated with dense shrub cover. Species abundances were positively correlated within each size group and negatively correlated between groups. Except for the American Crow, which preys on eggs and nestlings of small song birds, none of the other 5 species is known to display direct interactions, so we suspect that the correlations may have been associated with species-specific responses to habitat components not adequately measured by our covariates.	[Dorazio, Robert M.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA; [Connor, Edward F.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Askins, Robert A.] Connecticut Coll, Dept Biol, New London, CT 06320 USA	United States Department of the Interior; United States Geological Survey; California State University System; San Francisco State University; Connecticut College	Dorazio, RM (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA.	bdorazio@usgs.gov			National Institute for Mathematical and Biological Synthesis (NIMBIOS); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; Nature Conservancy; Connecticut College Arboretum; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Institute for Mathematical and Biological Synthesis (NIMBIOS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); Nature Conservancy; Connecticut College Arboretum; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute for Mathematical and Biological Synthesis (NIMBIOS), which was sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award \#EF-0832858. The field research was funded by the Nature Conservancy and the Connecticut College Arboretum.	AITCHISON J, 1989, BIOMETRIKA, V76, P643; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; ASKINS RA, 1987, BIOL CONSERV, V39, P129, DOI 10.1016/0006-3207(87)90030-9; Barnagaud JY, 2014, ECOLOGY, V95, P78, DOI 10.1890/13-0791.1; Chandler RB, 2013, CONSERV BIOL, V27, P785, DOI 10.1111/cobi.12046; Chen GK, 2013, J ECOL, V101, P183, DOI 10.1111/1365-2745.12021; Cimprich DA, 2000, BIRDS N AM ONLINE; Clark JS, 2014, ECOL APPL, V24, P990, DOI 10.1890/13-1015.1; CLAYTON DG, 1993, INT J EPIDEMIOL, V22, P1193, DOI 10.1093/ije/22.6.1193; Clements FE, 1905, RES METHODS ECOLOGY; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; DeGraaf R.M., 2001, UPNE; DEGRAAF RM, 1985, ENVIRON MANAGE, V9, P493, DOI 10.1007/BF01867324; Dellinger R., 2012, BIRDS N AM ONLINE, DOI [10.2173/bna.261, DOI 10.2173/BNA.261]; Diamond J.M., 1975, P342; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094323; Dorazio RM, 2011, BIODIVERSITY LOSS IN A CHANGING PLANET, P277; Fox BJ, 1996, OIKOS, V77, P291, DOI 10.2307/3546068; Freemark Kathryn E., 1995, P381; Geyer CJ, 2011, CH CRC HANDB MOD STA, P3; Gleason H. A, 1917, B TORREY BOTANICAL C, V44, P463, DOI DOI 10.2307/2479596; HOLT RD, 1987, OIKOS, V48, P110, DOI 10.2307/3565696; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Lack D., 1954, P343; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MONKKONEN M, 1990, OECOLOGIA, V85, P218, DOI 10.1007/BF00319404; Ovaskainen O, 2011, ECOLOGY, V92, P289, DOI 10.1890/10-1251.1; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Paciorek CJ, 2010, STAT SCI, V25, P107, DOI 10.1214/10-STS326; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; R Core Team, 2013, R LANG ENV STAT COMP; Ritchie EG, 2009, J ANIM ECOL, V78, P724, DOI 10.1111/j.1365-2656.2008.01520.x; Royle JA, 2006, J AGR BIOL ENVIR ST, V11, P249, DOI 10.1198/108571106X129153; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Sebastian-Gonzalez E, 2010, P ROY SOC B-BIOL SCI, V277, P2983, DOI 10.1098/rspb.2010.0244; Shenbrot G, 2002, OIKOS, V99, P47, DOI 10.1034/j.1600-0706.2002.990105.x; Smith HS, 1935, J ECON ENTOMOL, V28, P873, DOI 10.1093/jee/28.6.873; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Thompson FR, 2002, STUD AVIAN BIOL-SER, P8; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; WIENS JA, 1977, AM SCI, V65, P590; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	47	18	18	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135987	10.1371/journal.pone.0135987	http://dx.doi.org/10.1371/journal.pone.0135987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287671	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600094
J	McGregor, H; Legge, S; Jones, ME; Johnson, CN				McGregor, Hugh; Legge, Sarah; Jones, Menna E.; Johnson, Christopher N.			Feral Cats Are Better Killers in Open Habitats, Revealed by Animal-Borne Video	PLOS ONE			English	Article							SMALL MAMMALS; PREDATION RISK; FELIS-CATUS; HOUSE CATS; AUSTRALIA; DECLINE; EXTINCTION; FIRE; WILDLIFE; SAVANNA	One of the key gaps in understanding the impacts of predation by small mammalian predators on prey is how habitat structure affects the hunting success of small predators, such as feral cats. These effects are poorly understood due to the difficulty of observing actual hunting behaviours. We attached collar-mounted video cameras to feral cats living in a tropical savanna environment in northern Australia, and measured variation in hunting success among different microhabitats (open areas, dense grass and complex rocks). From 89 hours of footage, we recorded 101 hunting events, of which 32 were successful. Of these kills, 28% were not eaten. Hunting success was highly dependent on microhabitat structure surrounding prey, increasing from 17% in habitats with dense grass or complex rocks to 70% in open areas. This research shows that habitat structure has a profound influence on the impacts of small predators on their prey. This has broad implications for management of vegetation and disturbance processes (like fire and grazing) in areas where feral cats threaten native fauna. Maintaining complex vegetation cover can reduce predation rates of small prey species from feral cat predation.	[McGregor, Hugh; Legge, Sarah] Mornington Wildlife Sanctuary, Australian Wildlife Conservancy, Derby, WA 6728, Australia; [McGregor, Hugh; Jones, Menna E.; Johnson, Christopher N.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia	University of Tasmania	McGregor, H (corresponding author), Mornington Wildlife Sanctuary, Australian Wildlife Conservancy, PMB 925, Derby, WA 6728, Australia.	hugh.mcgregor@australianwildlife.org	Johnson, Christopher/J-7894-2014; Legge, Sarah/GYE-1554-2022; McGregor, Hugh W/T-2283-2017; Legge, Sarah/AAB-7229-2019	Johnson, Christopher/0000-0002-9719-3771; McGregor, Hugh W/0000-0003-3255-9282; Legge, Sarah/0000-0001-6968-2781; Jones, Menna/0000-0001-7558-9022	Australian Wildlife Conservancy; Australian Research Council; Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy)	Australian Wildlife Conservancy; Australian Research Council(Australian Research Council); Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy)	This research was funded by supporters of the Australian Wildlife Conservancy, the Australian Research Council, and the Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt DG, 1998, WILDLIFE RES, V25, P475, DOI 10.1071/WR97026; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burbidge AA, 2002, J BIOGEOGR, V29, P465, DOI 10.1046/j.1365-2699.2002.00699.x; Conner LM, 2011, J WILDLIFE MANAGE, V75, P938, DOI 10.1002/jwmg.110; Coughlin CE, 2014, WILDLIFE RES, V41, P606, DOI 10.1071/WR14160; Denny E., 2010, REV CAT ECOLOGY MANA; Doherty TS, 2015, J BIOGEOGR, V42, P964, DOI 10.1111/jbi.12469; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Fisher DO, 2014, GLOBAL ECOL BIOGEOGR, V23, P181, DOI 10.1111/geb.12088; Fitzgerald B. Mike, 2000, P151; Frank ASK, 2014, J APPL ECOL, V51, P1486, DOI 10.1111/1365-2664.12323; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Griffiths AD, 2015, BIOL CONSERV, V186, P337, DOI 10.1016/j.biocon.2015.03.021; Griffiths AD, 2014, INT J WILDLAND FIRE, V23, P1034, DOI 10.1071/WF14026; Hebblewhite M, 2005, OIKOS, V111, P101, DOI 10.1111/j.0030-1299.2005.13858.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Johnson C, 2006, AUSTR MAMMAL EXTINCT; KONECNY MJ, 1987, OIKOS, V50, P24, DOI 10.2307/3565398; Leahy L, 2015, AMPLIFIED P IN PRESS; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2013, BIOL CONSERV, V160, P183, DOI 10.1016/j.biocon.2013.01.008; Martin GR, 1996, WILDLIFE RES, V23, P475, DOI 10.1071/WR9960475; Mattisson J, 2011, BIOL CONSERV, V144, P3009, DOI 10.1016/j.biocon.2011.09.004; McGregor HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109097; McGregor HW, 2015, WILDLIFE RE IN PRESS; Medina FM, 2011, GLOBAL CHANGE BIOL, V17, P3503, DOI 10.1111/j.1365-2486.2011.02464.x; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Oakwood M, 2000, AUST J ZOOL, V48, P519, DOI 10.1071/ZO00028; Orsdol KG, 1984, AFR J ECOL, V22, P79; PANAMAN R, 1981, Z TIERPSYCHOL, V56, P59; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; Peck DR, 2008, ANIM CONSERV, V11, P65, DOI 10.1111/j.1469-1795.2007.00153.x; R Core Team, 2018, R LANG ENV STAT COMP; Schooley RL, 1996, CAN J ZOOL, V74, P157, DOI 10.1139/z96-020; Sinclair E. A., 1996, Australian Mammalogy, V19, P69; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; TOLAND B R, 1987, Journal of Raptor Research, V21, P14; Williams CR, 2000, J HERPETOL, V34, P431, DOI 10.2307/1565367; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x	47	130	135	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133915	10.1371/journal.pone.0133915	http://dx.doi.org/10.1371/journal.pone.0133915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288224	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600012
J	Michel, ES; Demarais, S; Strickland, BK; Belant, JL				Michel, Eric S.; Demarais, Stephen; Strickland, Bronson K.; Belant, Jerrold L.			Contrasting the Effects of Maternal and Behavioral Characteristics on Fawn Birth Mass in White-Tailed Deer	PLOS ONE			English	Article							FEMALE MOUNTAIN GOATS; DOMINANCE HIERARCHIES; REPRODUCTIVE SUCCESS; TERRITORY SIZE; PATH MODELS; SOCIAL RANK; BODY-SIZE; AGE; SELECTION; GROWTH	Maternal care influences offspring quality and can improve a mother's inclusive fitness. However, improved fitness may only occur when offspring quality (i.e., offspring birth mass) persists throughout life and enhances survival and/or reproductive success. Although maternal body mass, age, and social rank have been shown to influence offspring birth mass, the inter-dependence among these variables makes identifying causation problematic. We established that fawn birth mass was related to adult body mass for captive male and female white-tailed deer (Odocoileus virginianus), thus maternal care should improve offspring fitness. We then used path analysis to identify which maternal characteristic(s) most influenced fawn birth mass of captive female white-tailed deer. Maternal age, body mass and social rank had varying effects on fawn birth mass. Maternal body mass displayed the strongest direct effect on fawn birth mass, followed by maternal age and social rank. Maternal body mass had a greater effect on social rank than age. The direct path between social rank and fawn birth mass may indicate dominance as an underlying mechanism. Our results suggest that heavier mothers could use dominance to improve access to resources, resulting in increased fitness through production of heavier offspring.	[Michel, Eric S.; Demarais, Stephen; Strickland, Bronson K.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Forest & Wildlife Res Ctr, Deer Ecol & Management Lab, Mississippi State, MS 39762 USA; [Belant, Jerrold L.] Mississippi State Univ, Carnivore Ecol Lab, Forest & Wildlife Res Ctr, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Michel, ES (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Forest & Wildlife Res Ctr, Deer Ecol & Management Lab, Mississippi State, MS 39762 USA.	esm120@msstate.edu	Belant, Jerrold/HDM-7749-2022		Federal Aid in Wildlife Restoration Fund [W-48-61]	Federal Aid in Wildlife Restoration Fund	Our project was supported by the Federal Aid in Wildlife Restoration Fund under project number W-48-61. State wildlife agency employees helped with data collection.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; APPLEBY MC, 1980, BEHAVIOUR, V74, P294, DOI 10.1163/156853980X00519; ARMSTRONG RA, 1950, AM MIDL NAT, V43, P650, DOI 10.2307/2421857; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Biro PA, 2014, J ANIM ECOL, V83, P1186, DOI 10.1111/1365-2656.12210; Burnham K. P., 1998, MODEL SELECTION INFE; Ceacero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032780; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1976, Z TIERPSYCHOL, V41, P202; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Coltman DW, 2002, P ROY SOC B-BIOL SCI, V269, P165, DOI 10.1098/rspb.2001.1851; Cote SD, 2001, ANIM BEHAV, V62, P173, DOI 10.1006/anbe.2001.1719; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; Dahle B, 2006, J ZOOL, V269, P273, DOI 10.1111/j.1469-7998.2006.00127.x; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; Demarais S., 2000, ECOLOGY MANAGEMENT L, P601; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Ditchkoff SS, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P43; Donohue RN, 2013, J WILDLIFE MANAGE, V77, P1401, DOI 10.1002/jwmg.606; Feder C, 2008, OECOLOGIA, V156, P773, DOI 10.1007/s00442-008-1035-9; Festa-Bianchet M, 2000, BEHAV ECOL, V11, P633, DOI 10.1093/beheco/11.6.633; French AR, 2005, BIOTROPICA, V37, P96, DOI 10.1111/j.1744-7429.2005.04051.x; Gaillard JM, 2000, P ROY SOC B-BIOL SCI, V267, P471, DOI 10.1098/rspb.2000.1024; GREEN WCH, 1991, OECOLOGIA, V86, P521, DOI 10.1007/BF00318318; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; Isaac JL, 2005, BIOL LETTERS, V1, P271, DOI 10.1098/rsbl.2005.0326; Killen SS, 2011, J ANIM ECOL, V80, P1024, DOI 10.1111/j.1365-2656.2011.01844.x; Kreeger T.J., 1996, HDB WILDLIFE CHEM IM; MATTINGLY DK, 1982, ECOLOGY, V63, P183, DOI 10.2307/1937043; MAUTZ W W, 1978, Wildlife Society Bulletin, V6, P88; Miller BF, 2004, J WILDLIFE DIS, V40, P533, DOI 10.7589/0090-3558-40.3.533; Mitchell R.J., 2001, DESIGN ANAL ECOLOGIC, P217; Monteith KL, 2009, J MAMMAL, V90, P651, DOI 10.1644/08-MAMM-A-191R1.1; OZOGA JJ, 1986, J WILDLIFE MANAGE, V50, P480, DOI 10.2307/3801110; OZOGA JJ, 1972, J WILDLIFE MANAGE, V36, P861, DOI 10.2307/3799441; Palomares F, 1998, J ANIM ECOL, V67, P967, DOI 10.1046/j.1365-2656.1998.6760967.x; Pekins PJ, 1998, CAN J ZOOL, V76, P1091, DOI 10.1139/cjz-76-6-1091; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; Schumacker R. E, 2004, BEGINNERS GUIDE STRU, V2nd, DOI DOI 10.4135/9781412973380.N17; Sempere AJ, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P161; Shipley B, 2003, STRUCT EQU MODELING, V10, P214, DOI 10.1207/S15328007SEM1002_3; Shipley B., 2000, CAUSE AND CORRELATIO; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Shipley B, 2013, ECOLOGY, V94, P560, DOI 10.1890/12-0976.1; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Solberg EJ, 2008, OECOLOGIA; Stearns S., 1992, EVOLUTION LIFE HIST; Steiger S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1225; Strickland BK, 2000, J WILDLIFE MANAGE, V64, P903, DOI 10.2307/3803198; Taillon J, 2007, ANIM BEHAV, V74, P265, DOI 10.1016/j.anbehav.2006.11.018; Thomas DW, 2007, FUNCT ECOL, V21, P947, DOI 10.1111/j.1365-2435.2007.01301.x; VERME LJ, 1989, J MAMMAL, V70, P438, DOI 10.2307/1381538; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4	61	10	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136034	10.1371/journal.pone.0136034	http://dx.doi.org/10.1371/journal.pone.0136034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288141	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600100
J	Sanchez-Veliz, R; Carmona, MJ; Otsuki, DA; Freitas, C; Benicio, A; Negri, EM; Malbouisson, LM				Sanchez-Veliz, Rodrigo; Carmona, Maria Jose; Otsuki, Denise Aya; Freitas, Claudia; Benicio, Anderson; Negri, Elnara Marcia; Malbouisson, Luiz Marcelo			Impact of Cardiopulmonary Bypass on Respiratory Mucociliary Function in an Experimental Porcine Model	PLOS ONE			English	Article							TRACHEAL MUCOUS VELOCITY; BRONCHIAL TRANSECTION; MUCUS CLEARANCE; LUNG INJURY; TRANSPORT; ATELECTASIS; ANESTHESIA; RESPONSES; MANNITOL	Background The impact of cardiac surgery using cardiopulmonary bypass (CPB) on the respiratory mucociliary function is unknown. This study evaluated the effects of CPB and interruption of mechanical ventilation on the respiratory mucociliary system. Methods Twenty-two pigs were randomly assigned to the control (n = 10) or CPB group (n = 12). After the induction of anesthesia, a tracheostomy was performed, and tracheal tissue samples were excised (T0) from both groups. All animals underwent thoracotomy. In the CPB group, an aorto-bicaval CPB was installed and maintained for 90 minutes. During the CPB, mechanical ventilation was interrupted, and the tracheal tube was disconnected. A second tracheal tissue sample was obtained 180 minutes after the tracheostomy (T180). Mucus samples were collected from the trachea using a bronchoscope at T0, T90 and T180. Ciliary beat frequency (CBF) and in situ mucociliary transport (MCT) were studied in ex vivo tracheal epithelium. Mucus viscosity (MV) was assessed using a cone-plate viscometer. Qualitative tracheal histological analysis was performed at T180 tissue samples. Results CBF decreased in the CPB group (13.1 +/- 1.9 Hz vs. 11.1 +/- 2.1 Hz, p < 0.05) but not in the control group (13.1 +/- 1 Hz vs. 13 +/- 2.9 Hz). At T90, viscosity was increased in the CPB group compared to the control (p < 0.05). No significant differences were observed in in situ MCT. Tracheal histology in the CPB group showed areas of ciliated epithelium loss, submucosal edema and infiltration of inflammatory cells. Conclusion CPB acutely contributed to alterations in tracheal mucocilliary function.	[Sanchez-Veliz, Rodrigo; Carmona, Maria Jose; Otsuki, Denise Aya; Freitas, Claudia; Malbouisson, Luiz Marcelo] Univ Sao Paulo, Sch Med, Lab Anesthesiol LIM08, Sao Paulo, Brazil; [Benicio, Anderson] Univ Sao Paulo, Sch Med, Cardiac Surg Div, Heart Inst InCor, Sao Paulo, Brazil; [Negri, Elnara Marcia] Univ Sao Paulo, Sch Med, Expt Air Pollut Lab, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Malbouisson, LM (corresponding author), Univ Sao Paulo, Sch Med, Lab Anesthesiol LIM08, Sao Paulo, Brazil.	luiz.malbouisson@hc.fm.usp.br	Benício, Anderson/O-6002-2015; Negri, Elnara M/F-3643-2019; CARMONA, MARIA JOSÉ CARVALHO/G-3653-2014; Sa Malbouisson, Luiz Marcelo/F-4819-2012	Benício, Anderson/0000-0002-6273-3416; Negri, Elnara M/0000-0002-6428-6066; CARMONA, MARIA JOSÉ CARVALHO/0000-0002-3031-2924; Sa Malbouisson, Luiz Marcelo/0000-0002-3261-5603	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazil [478485/2004-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Sao Paulo, Brazil [07/52127-3]	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding: This study was supported by a grant from Conselho Nacional de Pesquisa e Desenvolvimento (CNPq - Grant 478485/2004-2), Brazil. Rodrigo Sanchez-Veliz received a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP (Process 07/52127-3), Sao Paulo, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini-Yagi CS, 2005, RESP PHYSIOL NEUROBI, V145, P101, DOI 10.1016/j.resp.2004.08.010; Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; BUTLER J, 1993, J THORAC CARDIOV SUR, V105, P25, DOI 10.1016/S0022-5223(19)33843-7; Carney DE, 1999, CIRCULATION, V100, P400, DOI 10.1161/01.CIR.100.4.400; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; HIRSCH JA, 1975, J APPL PHYSIOL, V39, P242; HOLT JP, 1968, AM J PHYSIOL, V215, P704, DOI 10.1152/ajplegacy.1968.215.3.704; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; HUBER AR, 1989, J CLIN INVEST, V83, P1122, DOI 10.1172/JCI113992; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Keller C, 1998, ANESTH ANALG, V86, P1280, DOI 10.1097/00000539-199806000-00028; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KOLFF W J, 1958, Cleve Clin Q, V25, P65; KONRAD F, 1992, CHEST, V102, P1377, DOI 10.1378/chest.102.5.1377; LANDA JF, 1975, J APPL PHYSIOL, V38, P946, DOI 10.1152/jappl.1975.38.5.946; LAURENZI GA, 1968, NEW ENGL J MED, V279, P333, DOI 10.1056/NEJM196808152790701; Magnusson L, 1997, ANESTHESIOLOGY, V87, P1153, DOI 10.1097/00000542-199711000-00020; Massoudy P, 1999, Eur J Med Res, V4, P178; Massoudy P, 2001, CHEST, V119, P31, DOI 10.1378/chest.119.1.31; Ng CSH, 2002, CHEST, V121, P1269, DOI 10.1378/chest.121.4.1269; Pazetti R, 2008, ANN THORAC SURG, V85, P1925, DOI 10.1016/j.athoracsur.2008.02.084; Piccin VS, 2011, INTENS CARE MED, V37, P132, DOI 10.1007/s00134-010-2056-5; Rivero DHRF, 2001, CHEST, V119, P1510, DOI 10.1378/chest.119.5.1510; Robinson M, 1999, EUR RESPIR J, V14, P678, DOI 10.1034/j.1399-3003.1999.14c30.x; Rothen HU, 1999, BRIT J ANAESTH, V82, P551, DOI 10.1093/bja/82.4.551; SACKNER MA, 1975, CHEST, V68, P774, DOI 10.1378/chest.68.6.774; Schlensak C, 2001, EUR J CARDIO-THORAC, V19, P326, DOI 10.1016/S1010-7940(01)00581-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Wan S, 1996, J THORAC CARDIOV SUR, V111, P469, DOI 10.1016/S0022-5223(96)70458-0; Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676; YENMEZ K, 1988, TURKISH J PEDIATR, V30, P123	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135564	10.1371/journal.pone.0135564	http://dx.doi.org/10.1371/journal.pone.0135564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288020	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600053
J	Rego, FDMGR; Caldas, RAA; Kurachi, C; Bagnato, VS; de Araujo, MT				Martins Gomes Rego Filho, Francisco de Assis; Alencar Caldas, Romualdo Arthur; Kurachi, Cristina; Bagnato, Vanderlei Salvador; de Araujo, Maria Tereza			Possibility for the Conjugated Use of Photodynamic Therapy and Electrosurgical Devices	PLOS ONE			English	Article							YAG LASER; SKIN; ACID; MICRODERMABRASION; ENHANCEMENT; DELIVERY	Because tissue optics limits the treated volume during anti-tumor Photodynamic Therapy (PDT), its conjugation with prior tissue debulking has been suggested clinically. In this context, the conjugation of radiofrequency ablation and PDT has already been demonstrated. However, the basic principles that enable the success of these protocols have not been discussed. This proof-of-principle study analyzes the possibility of conjugating electrosurgery (ES) and PDT, analyzing different sequences of photosensitizer (PS) administration in an animal model. The animals were distributed over five groups: ES, PS+Light, PS+ES, ES +PS+Light and PS+ES+Light. The PS Photogem was administered systemically. An electrosurgical unit (480 kHz) was used to remove a portion of the liver, leaving a plane surface for PDT illumination (630 nm, 150 J/cm(2)). Fluorescence was collected during the stages of the experiment to monitor the PS accumulation. After 30 hours, histological processing was performed. The fluorescence spectra revealed strong Photogem emission in both administration sequences (ES+PS; PS+ES), and little PS bleach after ES was observed. The maximum necrosis depth was observed for the PS+ES+Light group-(716 +/- 75) mu m-higher than its respective control group (160 +/- 28) mu m, proving successful conjugation. Histological features from ES and PDT on both conjugation sequences were observed. Pre-photosensitized tissue presented decreased ES-related thermal damage. A simple physical hypothesis, based on the Joule effect and the tissue electrical conductivity, was proposed to support these findings. In conclusion, the results successfully demonstrated the possibility of conjugating ES and PDT in a single protocol.	[Martins Gomes Rego Filho, Francisco de Assis; de Araujo, Maria Tereza] Univ Fed Alagoas, Inst Fis, Maceio, Alagoas, Brazil; [Alencar Caldas, Romualdo Arthur] Univ Fed Alagoas, Hosp Univ HUPAA, Maceio, Alagoas, Brazil; [Kurachi, Cristina; Bagnato, Vanderlei Salvador] Univ Sao Paulo, Inst Fis Sao Carlos, BR-01498 Sao Carlos, SP, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade de Sao Paulo	Rego, FDMGR (corresponding author), Univ Fed Alagoas, Inst Fis, Maceio, Alagoas, Brazil.	francisco.rego@fis.ufal.br	Kurachi, Cristina/G-3731-2012; Bagnato, Vanderlei S/C-3133-2012; de Assis Martins Gomes Rego Filho, Francisco/P-7703-2014	de Assis Martins Gomes Rego Filho, Francisco/0000-0002-4968-9916; INCT de Optica Basica e Aplicada as Ciencias da Vida (CNPq), CePOF (FAPESP)/0000-0002-6403-4037; Bagnato, Vanderlei Salvador/0000-0003-4833-239X	CAPES; CNPq; FAPESP; FINEP	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP(Financiadora de Inovacao e Pesquisa (Finep))	Financial support and scholarships provided by CAPES, CNPq, FAPESP and FINEP. The funders did not participate on the experimental design, data collection and analysis, manuscript preparation or any decision related to the publication process.	Brown DB, 2005, J VASC INTERV RADIOL, V16, P597, DOI 10.1097/01.RVI.0000156097.63027.7B; Buttemere CR, 2004, J BIOMED OPT, V9, P1018, DOI 10.1117/1.1779627; Carruth JAS, 1986, MED LASERS SCI CLIN, P51; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Ceilley RI, 2006, INT J DERMATOL, V45, P489, DOI 10.1111/j.1365-4632.2006.02673.x; Cushing H., 1928, SURG GYNECOL OBSTET, V47, P751; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Fang JY, 2004, BRIT J DERMATOL, V151, P132, DOI 10.1111/j.1365-2133.2004.06051.x; Ferraz RCMC, 2009, PHOTOMED LASER SURG, V27, P93, DOI 10.1089/pho.2007.2207; Ferreira J, 2004, LASER PHYS, V14, P209; Gao S, 2003, CHIN OPT LETT, V2, P160; Karakullukcu B, 2011, PHOTODIAGN PHOTODYN, V8, P264, DOI 10.1016/j.pdpdt.2011.03.340; Korbelik M, 2006, LASER SURG MED, V38, P500, DOI 10.1002/lsm.20337; KROSL G, 1995, BRIT J CANCER, V71, P549, DOI 10.1038/bjc.1995.108; Lee WR, 2006, DERMATOL SURG, V32, P1013, DOI 10.1111/j.1524-4725.2006.32224.x; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Lins E. C., 2009, World Congress on Medical Physics and Biomedical Engineering. World Congress 2009. Diagnostic and Therapeutic Instrumentation, Clinical Engineering, P714, DOI 10.1007/978-3-642-03885-3_198; Livraghi T, 1999, RADIOLOGY, V210, P655, DOI 10.1148/radiology.210.3.r99fe40655; MacCormack Mollie A, 2006, Adv Dermatol, V22, P219, DOI 10.1016/j.yadr.2006.09.008; Masilamani V, 2004, J LUMIN, V109, P143, DOI 10.1016/j.jlumin.2004.02.001; Mcintyre WJ, 2007, AM FAM PHYSICIAN, V76, P667; Medtech Insight, 2007, A606 MEDT INS LLC DI, P1; Melo CAS, 2004, J PHOTOCH PHOTOBIO B, V73, P183, DOI 10.1016/j.jphotobiol.2003.11.005; Melo CAS, 2001, J CLIN LASER MED SUR, V19, P175, DOI 10.1089/104454701316918925; Nicolodelli G, 2014, J BIOPHOTONICS, V7, P631, DOI 10.1002/jbio.201300024; Olson JM, 2012, DERMATOL CLIN, V30, P153, DOI 10.1016/j.det.2011.08.011; Palanker D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/123022; Pearce JA, 1986, ELECTROSURGERY; POPE AJ, 1991, BRIT J UROL, V68, P1, DOI 10.1111/j.1464-410X.1991.tb15246.x; Rego RF, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/7/075603; Rego FG, 2011, PROC SPIE, V8092, DOI 10.1117/12.889688; Shen SC, 2006, J PHARM SCI-US, V95, P929, DOI 10.1002/jps.20577; Shokrollahi K, 2013, ANN PLAS SURG, V70, P1, DOI 10.1097/SAP.0b013e31827ed58e; Shokrollahi Kayvan, 2009, Cases J, V2, P7920, DOI 10.4076/1757-1626-2-7920; Sietses C, 2001, SURG ENDOSC-ULTRAS, V15, P69, DOI 10.1007/s004640010061; Smucler R, 2008, LASER SURG MED, V40, P153, DOI 10.1002/lsm.20606; Sokolov VV, 1994, P SOC PHOTO-OPT INS, V2325, P367; Souza CS, 2007, DERMATOL SURG, V33, P194, DOI 10.1111/j.1524-4725.2006.33038.x; Sun JH, 2002, PHOTOCH PHOTOBIO SCI, V1, P690, DOI 10.1039/b204254a; Thissen MRTM, 2000, BRIT J DERMATOL, V142, P338, DOI 10.1046/j.1365-2133.2000.03404.x; Whitaker IS, 2007, ANN PLAS SURG, V59, P484, DOI 10.1097/SAP.0b013e3180338536	41	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136194	10.1371/journal.pone.0136194	http://dx.doi.org/10.1371/journal.pone.0136194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284935	gold, Green Published, Green Submitted			2022-12-27	WOS:000359666100108
J	Mittag, F; Romer, M; Zell, A				Mittag, Florian; Roemer, Michael; Zell, Andreas			Influence of Feature Encoding and Choice of Classifier on Disease Risk Prediction in Genome-Wide Association Studies	PLOS ONE			English	Article							GENETIC RISK; GWAS; VARIANTS; CANCER; TESTS; SCORE	Various attempts have been made to predict the individual disease risk based on genotype data from genome-wide association studies (GWAS). However, most studies only investigated one or two classification algorithms and feature encoding schemes. In this study, we applied seven different classification algorithms on GWAS case-control data sets for seven different diseases to create models for disease risk prediction. Further, we used three different encoding schemes for the genotypes of single nucleotide polymorphisms (SNPs) and investigated their influence on the predictive performance of these models. Our study suggests that an additive encoding of the SNP data should be the preferred encoding scheme, as it proved to yield the best predictive performances for all algorithms and data sets. Furthermore, our results showed that the differences between most state-of-the-art classification algorithms are not statistically significant. Consequently, we recommend to prefer algorithms with simple models like the linear support vector machine (SVM) as they allow for better subsequent interpretation without significant loss of accuracy.	[Mittag, Florian; Roemer, Michael; Zell, Andreas] Univ Tubingen, Cognit Syst Grp, Tubingen, Germany	Eberhard Karls University of Tubingen	Mittag, F (corresponding author), Univ Tubingen, Cognit Syst Grp, Tubingen, Germany.	florian.mittag@uni-tuebingen.de		Mittag, Florian/0000-0002-6472-0221	program for medical genome research; Federal Ministry of Education and Research (BMBF) [01GS08134]; Deutsche Forschungsgemeinschaft; University of Tubingen	program for medical genome research; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This study was funded by the program for medical genome research with financial support from the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) under the support code 01GS08134 (recipient AZ). The authors also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.	Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Botta V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093379; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen S, 2010, MOL CELL, V37, P451, DOI 10.1016/j.molcel.2010.02.006; Conde L, 2013, AM J HUM GENET, V92, P126, DOI 10.1016/j.ajhg.2012.11.009; Conover WJ, 1999, PRACTICAL NONPARAMET, V22; Cosgun E, 2011, BIOINFORMATICS, V27, P1384, DOI 10.1093/bioinformatics/btr159; Costafreda SG, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-18; Demsar J, 2006, J MACH LEARN RES, V7, P1; Depeursinge A, 2010, J DIGIT IMAGING, V23, P18, DOI 10.1007/s10278-008-9158-4; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Franken H, 2011, LECT N BIOINFORMAT, V7036, P121, DOI 10.1007/978-3-642-24855-9_11; Frayling TM, 2014, DIABETES, V63, P1836, DOI 10.2337/db14-0130; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Henckaerts L, 2009, CLIN GASTROENTEROL H, V7, P972, DOI 10.1016/j.cgh.2009.05.001; Hertz DL, 2012, BREAST CANCER RES TR, V134, P401, DOI 10.1007/s10549-012-2054-0; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P571, DOI 10.1080/03610928008827904; James M, 1986, CLASSIFICATION ALGOR, V6; Loley C, 2011, HUM HERED, V71, P23, DOI 10.1159/000323768; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Miller DJ, 2009, BIOINFORMATICS, V25, P2478, DOI 10.1093/bioinformatics/btp435; Mittag F, 2012, HUM MUTAT, V33, P1708, DOI 10.1002/humu.22161; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Mosley JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081503; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nemenyi P., 1963, DISTRIBUTION FREE MU; Pirooznia M, 2012, PSYCHIAT GENET, V22, P55, DOI 10.1097/YPG.0b013e32834dc40d; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi QB, 2012, DIABETES, V61, P745, DOI 10.2337/db11-1254; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smola AJ, 1998, NEURAL NETWORKS, V11, P637, DOI 10.1016/S0893-6080(98)00032-X; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wolpert DH, 1996, NEURAL COMPUT, V8, P1391, DOI 10.1162/neco.1996.8.7.1391; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407	50	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135832	10.1371/journal.pone.0135832	http://dx.doi.org/10.1371/journal.pone.0135832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285210	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100071
J	Achtman, M; Zhou, ZM; Didelot, X				Achtman, Mark; Zhou, Zhemin; Didelot, Xavier			Formal Comment to Pettengill: The Time to Most Recent Common Ancestor Does Not (Usually) Approximate the Date of Divergence	PLOS ONE			English	Editorial Material							MOLECULAR CLOCKS; HOST ADAPTATION; SALMONELLA; PARATYPHI; SELECTION; PATHOGEN; PATTERNS	In 2013 Zhou et al. concluded that Salmonella enterica serovar Agona represents a genetically monomorphic lineage of recent ancestry, whose most recent common ancestor existed in 1932, or earlier. The Abstract stated 'Agona consists of three lineages with minimal mutational diversity: only 846 single nucleotide polymorphisms (SNPs) have accumulated in the non-repetitive, core genome since Agona evolved in 1932 and subsequently underwent a major population expansion in the 1960s.' These conclusions have now been criticized by Pettengill, who claims that the evolutionary models used to date Agona may not have been appropriate, the dating estimates were inaccurate, and the age of emergence of Agona should have been qualified by an upper limit reflecting the date of its divergence from an outgroup, serovar Soerenga. We dispute these claims. Firstly, Pettengill's analysis of Agona is not justifiable on technical grounds. Secondly, an upper limit for divergence from an outgroup would only be meaningful if the outgroup were closely related to Agona, but close relatives of Agona are yet to be identified. Thirdly, it is not possible to reliably date the time of divergence between Agona and Soerenga. We conclude that Pettengill's criticism is comparable to a tempest in a teapot.	[Achtman, Mark; Zhou, Zhemin] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Didelot, Xavier] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England	University of Warwick; Imperial College London	Achtman, M (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	m.achtman@warwick.ac.uk	Didelot, Xavier/P-4282-2019; Zhou, Zhemin/AAX-5539-2020	Didelot, Xavier/0000-0003-1885-500X; Zhou, Zhemin/0000-0001-9783-0366	Biotechnology and Biological Sciences Research Council [BB/L020319/1] Funding Source: Medline; Medical Research Council [MR/K010174/1] Funding Source: Medline; BBSRC [BB/L020319/1, BB/L023458/1] Funding Source: UKRI; MRC [MR/K010174/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L023458/1] Funding Source: researchfish; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Balloux F, 2012, EVOLUTION, V66, P605, DOI 10.1111/j.1558-5646.2011.01458.x; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Desai PT, 2013, MBIO, V4; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Didelot X, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005072; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Hall BG, 2016, CLADISTICS, V32, P90, DOI 10.1111/cla.12113; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Langridge GC, 2015, P NATL ACAD SCI USA, V112, P863, DOI 10.1073/pnas.1416707112; Laubach T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-110; Levantesi C, 2012, FOOD RES INT, V45, P587, DOI 10.1016/j.foodres.2011.06.037; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Pettengill JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128407; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281; Younus M, 2010, ZOONOSES PUBLIC HLTH, V57, pE170, DOI 10.1111/j.1863-2378.2010.01324.x; Zhou ZM, 2014, P NATL ACAD SCI USA, V111, P12199, DOI 10.1073/pnas.1411012111; Zhou ZM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003471	26	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134435	10.1371/journal.pone.0134435	http://dx.doi.org/10.1371/journal.pone.0134435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274924	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600027
J	Chaplin, AV; Efimov, BA; Smeianov, VV; Kafarskaia, LI; Pikina, AP; Shkoporov, AN				Chaplin, Andrei V.; Efimov, Boris A.; Smeianov, Vladimir V.; Kafarskaia, Lyudmila I.; Pikina, Alla P.; Shkoporov, Andrei N.			Intraspecies Genomic Diversity and Long-Term Persistence of Bifidobacterium longum	PLOS ONE			English	Article							SUBSP INFANTIS; PAN-GENOME; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; MILK UTILIZATION; STRAINS; PLASMIDS; REVEALS; IDENTIFICATION; CONSTRUCTION	Members of genus Bifidobacterium are Gram-positive bacteria, representing a large part of the human infant microbiota and moderately common in adults. However, our knowledge about their diversity, intraspecific phylogeny and long-term persistence in humans is still limited. Bifidobacterium longum is generally considered to be the most common and prevalent species in the intestinal microbiota. In this work we studied whole genome sequences of 28 strains of B. longum, including 8 sequences described in this paper. Part of these strains were isolated from healthy children during a long observation period (up to 10 years between isolation from the same patient). The three known subspecies (longum, infantis and suis) could be clearly divided using sequence-based phylogenetic methods, gene content and the average nucleotide identity. The profiles of glycoside hydrolase genes reflected the different ecological specializations of these three subspecies. The high impact of horizontal gene transfer on genomic diversity was observed, which is possibly due to a large number of prophages and rapidly spreading plasmids. The pan-genome characteristics of the subspecies longum corresponded to the open pan-genome model. While the major part of the strain-specific genetic loci represented transposons and phage-derived regions, a large number of cell envelope synthesis genes were also observed within this category, representing high variability of cell surface molecules. We observed the cases of isolation of high genetically similar strains of B. longum from the same patients after long periods of time, however, we didn't succeed in the isolation of genetically identical bacteria: a fact, reflecting the high plasticity of microbiota in children.	[Chaplin, Andrei V.; Efimov, Boris A.; Kafarskaia, Lyudmila I.; Pikina, Alla P.; Shkoporov, Andrei N.] Pirogov Russian Natl Res Med Univ, Microbiol & Virol Dept, Moscow, Russia; [Smeianov, Vladimir V.] North Caucasus State Acad Humanities & Technol, Inst Med, Dept Nat Sci, Cherkessk, Russia	Pirogov Russian National Research Medical University	Chaplin, AV (corresponding author), Pirogov Russian Natl Res Med Univ, Microbiol & Virol Dept, Moscow, Russia.	chaplin.andr@gmail.com	Smeianov, Vladimir/U-9585-2019; Shkoporov, Andrey/AAA-3043-2020; Chaplin, Andrei/AAL-7487-2020; Efimov, Boris/B-8114-2019	Chaplin, Andrei/0000-0003-1377-7153; Smeianov, Vladimir/0000-0002-8950-9684; Shkoporov, Andrey/0000-0002-5547-8672				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biavati B, 2000, ANN MICROBIOL, V50, P117; Bottacini F, 2014, APPL ENV MICROBIOL; Bottacini F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-170; Briner AE, 2014, APPL ENVIRON MICROB, V80, P994, DOI 10.1128/AEM.03015-13; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Martinez FAC, 2013, BIOTECHNOL ADV, V31, P482, DOI 10.1016/j.biotechadv.2013.01.010; Corneau N, 2004, PLASMID, V51, P87, DOI 10.1016/j.plasmid.2003.12.003; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Maayer P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-404; Deletoile A, 2010, RES MICROBIOL, V161, P82, DOI 10.1016/j.resmic.2009.12.006; Delgado S, 2008, J APPL MICROBIOL, V104, P1119, DOI 10.1111/j.1365-2672.2007.03642.x; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foroni E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S16; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Fujita K, 2014, APPL ENVIRON MICROB, V80, P4577, DOI 10.1128/AEM.00802-14; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Garrido D, 2012, ADV NUTR, V3, p415S, DOI 10.3945/an.111.001586; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guglielmetti S, 2007, APPL MICROBIOL BIOT, V74, P1053, DOI 10.1007/s00253-006-0755-1; Ham JS, 2011, J BACTERIOL, V193, P5044, DOI 10.1128/JB.05620-11; Hao YL, 2011, J BACTERIOL, V193, P787, DOI 10.1128/JB.01213-10; Ishikawa E, 2013, J BIOSCI BIOENG, V116, P265, DOI 10.1016/j.jbiosc.2013.02.010; Ito T, 2014, BIOCHEM BIOPH RES CO, V447, P32, DOI 10.1016/j.bbrc.2014.03.096; Ivanov D, 2006, J BIOL CHEM, V281, P17246, DOI 10.1074/jbc.M601678200; Khokhlova EV, 2012, MICROBIOL IMMUNOL, V56, P27, DOI 10.1111/j.1348-0421.2011.00398.x; Kim GB, 2005, BIOTECHNOL LETT, V27, P817, DOI 10.1007/s10529-005-6717-3; Klijn A, 2005, FEMS MICROBIOL REV, V29, P491, DOI 10.1016/j.femsre.2005.04.010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2006, APPL ENVIRON MICROB, V72, P527, DOI 10.1128/AEM.72.1.527-535.2006; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Lee JH, 2011, APPL ENVIRON MICROB, V77, P5879, DOI 10.1128/AEM.00571-11; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu GJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-775; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Matamoros S, 2011, J MICROBIOL METH, V87, P378, DOI 10.1016/j.mimet.2011.10.005; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Mattarelli P, 2008, INT J SYST EVOL MICR, V58, P767, DOI 10.1099/ijs.0.65319-0; Maughan Heather, 2009, PLoS One, V4, pe5854, DOI 10.1371/journal.pone.0005854; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Menard O, 2010, APPL ENVIRON MICROB, V76, P2846, DOI 10.1128/AEM.01714-09; Milani C, 2014, APPL ENVIRON MICROB, V80, P6290, DOI 10.1128/AEM.02308-14; Miyauchi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079735; Monzingo AF, 2007, J MOL BIOL, V366, P165, DOI 10.1016/j.jmb.2006.11.031; Moon GS, 2009, J MICROBIOL BIOTECHN, V19, P403, DOI 10.4014/jmb.0806.378; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Ringel-Kulka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064315; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Said HM, 2013, AM J PHYSIOL-GASTR L, V305, pG601, DOI 10.1152/ajpgi.00231.2013; Sakata S, 2002, INT J SYST EVOL MICR, V52, P1945, DOI [10.1099/ijs.0.02221-0, 10.1099/00207713-52-6-1945]; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; SGORBATI B, 1982, J GEN MICROBIOL, V128, P2121; Shkoporov AN, 2008, B EXP BIOL MED+, V146, P782, DOI 10.1007/s10517-009-0423-4; Shkoporov A. N., 2006, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P45; Shkoporov AN, 2013, GENOME ANNOUNC, V1; Shkoporov AN, 2008, PLASMID, V60, P136, DOI 10.1016/j.plasmid.2008.06.005; Shkoporov AN, 2008, BIOSCI BIOTECH BIOCH, V72, P742, DOI 10.1271/bbb.70628; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; STAHL M, 1990, INT J SYST BACTERIOL, V40, P189, DOI 10.1099/00207713-40-2-189; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Turroni F, 2014, APPL ENVIRON MICROB, V80, P730, DOI 10.1128/AEM.03313-13; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Turroni F, 2010, APPL ENVIRON MICROB, V76, P3206, DOI 10.1128/AEM.02938-09; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Varani AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r30; Ventura M, 2009, APPL ENVIRON MICROB, V75, P6929, DOI 10.1128/AEM.01112-09; Viborg AH, 2014, GLYCOBIOLOGY, V24, P208, DOI 10.1093/glycob/cwt104; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wei YX, 2010, J BACTERIOL, V192, P4076, DOI 10.1128/JB.00538-10; Yang Y-S, 1998, [No title captured], Patent No. 5711977; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zhurina D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01084-13	87	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135658	10.1371/journal.pone.0135658	http://dx.doi.org/10.1371/journal.pone.0135658			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275230	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600090
J	Cokic, VP; Mossuz, P; Han, J; Socoro, N; Beleslin-Cokic, BB; Mitrovic, O; Suboticki, T; Diklic, M; Lekovic, D; Gotic, M; Puri, RK; Noguchi, CT; Schechter, AN				Cokic, Vladan P.; Mossuz, Pascal; Han, Jing; Socoro, Nuria; Beleslin-Cokic, Bojana B.; Mitrovic, Olivera; Suboticki, Tijana; Diklic, Milos; Lekovic, Danijela; Gotic, Mirjana; Puri, Raj K.; Noguchi, Constance Tom; Schechter, Alan N.			Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway	PLOS ONE			English	Article							GENE-EXPRESSION; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; MAMMALIAN TARGET; BREAST-CANCER; MEGAKARYOCYTE PROGENITORS; HEMATOPOIETIC STEM; RHEB GTPASE; CELLS; PROLIFERATION	The gene and protein expression profiles in myeloproliferative neoplasms (MPNs) may reveal gene and protein markers of a potential clinical relevance in diagnosis, treatment and prediction of response to therapy. Using cDNA microarray analysis of 25,100 unique genes, we studied the gene expression profile of CD34(+) cells and granulocytes obtained from peripheral blood of subjects with essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF). The microarray analyses of the CD34(+) cells and granulocytes were performed from 20 de novo MPN subjects: JAK2 positive ET, PV, PMF subjects, and JAK2 negative ET/PMF subjects. The granulocytes for proteomic studies were pooled in 4 groups: PV with JAK2 mutant allele burden above 80%, ET with JAK2 mutation, PMF with JAK2 mutation and ET/PMF with no JAK2 mutation. The number of differentially regulated genes was about two fold larger in CD34(+) cells compared to granulocytes. Thirty-six genes (including RUNX1, TNFRSF19) were persistently highly expressed, while 42 genes (including FOXD4, PDE4A) were underexpressed both in CD34(+) cells and granulocytes. Using proteomic studies, significant up-regulation was observed for MAPK and PI3K/AKT signaling regulators that control myeloid cell apoptosis and proliferation: RAC2, MNDA, S100A8/9, CORO1A, and GNAI2. When the status of the mTOR signaling pathway related genes was analyzed, PI3K/AKT regulators were preferentially up-regulated in CD34(+) cells of MPNs, with down-regulated major components of the protein complex EIF4F. Molecular profiling of CD34(+) cells and granulocytes of MPN determined gene expression patterns beyond their recognized function in disease pathogenesis that included dominant up-regulation of PI3K/AKT signaling.	[Cokic, Vladan P.; Mitrovic, Olivera; Suboticki, Tijana; Diklic, Milos] Univ Belgrade, Inst Med Res, Belgrade, Serbia; [Mossuz, Pascal] CHU Grenoble, Inst Biol & Pathol, Dept Hematol, F-38043 Grenoble, France; [Han, Jing; Puri, Raj K.] US FDA, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Socoro, Nuria] Fac Med Grenoble, Lab TIMC IMAG, Grenoble, France; [Beleslin-Cokic, Bojana B.] Clin Ctr Serbia, Clin Endocrinol Diabet & Dis Metab, Belgrade, Serbia; [Lekovic, Danijela; Gotic, Mirjana] Clin Ctr Serbia, Clin Hematol, Belgrade, Serbia; [Gotic, Mirjana] Univ Belgrade, Fac Med, Belgrade, Serbia; [Noguchi, Constance Tom; Schechter, Alan N.] Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bethesda, MD USA	University of Belgrade; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); US Food & Drug Administration (FDA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Clinical Centre of Serbia; Clinical Centre of Serbia; University of Belgrade; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cokic, VP (corresponding author), Univ Belgrade, Inst Med Res, Belgrade, Serbia.	vl@imi.bg.ac.rs	Subotički, Tijana/ABE-3583-2021; Ajtić, Olivera Mitrović/AAS-4741-2021	Lekovic, Danijela/0000-0002-6194-8298; Diklic, Milos/0000-0003-1171-5186; Cokic, Vladan/0000-0002-0362-1449; Suboticki, Tijana/0000-0002-5132-8319	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Serbian Ministry of Education, Science and Technological Development [175053]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025016, ZIADK025021] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Serbian Ministry of Education, Science and Technological Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health and by a grant from the Serbian Ministry of Education, Science and Technological Development [175053].	Bartalucci N, 2013, J CELL MOL MED, V17, P1385, DOI 10.1111/jcmm.12162; Bogani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054826; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Cazzola M, 2014, BLOOD, V123, P3714, DOI 10.1182/blood-2014-03-530865; Chow S, 2006, EXP HEMATOL, V34, P1183, DOI 10.1016/j.exphem.2006.05.002; Cokic VP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-116; Dai CH, 2005, EXP HEMATOL, V33, P152, DOI 10.1016/j.exphem.2004.10.017; Dong ZW, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-17; Drayer AL, 2006, STEM CELLS, V24, P105, DOI 10.1634/stemcells.2005-0062; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fiskus W, 2013, MOL CANCER THER, V12, P577, DOI 10.1158/1535-7163.MCT-12-0862; Gallardo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-142; Geest CR, 2009, HAEMATOL-HEMATOL J, V94, P901, DOI 10.3324/haematol.13766; Goerttler PS, 2005, BRIT J HAEMATOL, V129, P138, DOI 10.1111/j.1365-2141.2005.05416.x; Grimwade LF, 2009, BRIT J HAEMATOL, V147, P495, DOI 10.1111/j.1365-2141.2009.07870.x; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Guglielmelli P, 2011, BLOOD, V118, P2069, DOI 10.1182/blood-2011-01-330563; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085567; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jones LC, 2005, STEM CELLS, V23, P631, DOI 10.1634/stemcells.2004-0131; Kralovics R, 2005, BLOOD, V106, P3374, DOI 10.1182/blood-2005-05-1889; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Mossuz P, 2008, EXP HEMATOL, V36, P1642, DOI 10.1016/j.exphem.2008.07.013; Nagao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084746; Pellagatti A, 2003, CANCER RES, V63, P3940; Puigdecanet E, 2008, LEUKEMIA, V22, P1368, DOI 10.1038/leu.2008.112; Raslova H, 2006, BLOOD, V107, P2303, DOI 10.1182/blood-2005-07-3005; Rojo F, 2014, CANCER EPIDEM BIOMAR, V23, P288, DOI 10.1158/1055-9965.EPI-13-0761; Schwernmers S, 2007, EXP HEMATOL, V35, P1695, DOI 10.1016/j.exphem.2007.07.004; Skov V, 2012, EXP HEMATOL, V40, P771, DOI 10.1016/j.exphem.2012.05.011; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Steidl U, 2005, ANN NY ACAD SCI, V1044, P94, DOI 10.1196/annals.1349.013; Tasian SK, 2012, BLOOD, V120, P833, DOI 10.1182/blood-2011-12-389932; Tenedini E, 2004, BLOOD, V104, P3126, DOI 10.1182/blood-2003-07-2597; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Uniacke J, 2014, CANCER RES, V74, P1379, DOI 10.1158/0008-5472.CAN-13-2278; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Vicari L, 2012, BRIT J HAEMATOL, V159, P237, DOI 10.1111/j.1365-2141.2012.09246.x; Yang XL, 2014, ONCOTARGETS THER, V7, P1033, DOI 10.2147/OTT.S63145; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	41	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135463	10.1371/journal.pone.0135463	http://dx.doi.org/10.1371/journal.pone.0135463			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275051	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600068
J	Marques, ARA; Aten, J; Ottenhoff, R; van Roomen, CPAA; Moro, DH; Claessen, N; Veloz, MFV; Zhou, KK; Lin, ZM; Mirzaian, M; Boot, RG; De Zeeuw, CI; Overkleeft, HS; Yildiz, Y; Aerts, JMFG				Marques, Andre R. A.; Aten, Jan; Ottenhoff, Roelof; van Roomen, Cindy P. A. A.; Moro, Daniela Herrera; Claessen, Nike; Veloz, Maria Fernanda Vinueza; Zhou, Kuikui; Lin, Zhanmin; Mirzaian, Mina; Boot, Rolf G.; De Zeeuw, Chris I.; Overkleeft, Herman S.; Yildiz, Yildiz; Aerts, Johannes M. F. G.			Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice	PLOS ONE			English	Article							NONLYSOSOMAL GLUCOSYLCERAMIDASE; N-BUTYLDEOXYNOJIRIMYCIN; STORAGE DISORDER; IN-SITU; DISEASE; GLUCOCEREBROSIDASE; DEFICIENCY; INHIBITORS; CHOLESTEROL; METABOLISM	The enzyme glucocerebrosidase (GBA) hydrolyses glucosylceramide (GlcCer) in lysosomes. Markedly reduced GBA activity is associated with severe manifestations of Gaucher disease including neurological involvement. Mutations in the GBA gene have recently also been identified as major genetic risk factor for Parkinsonism. Disturbed metabolism of GlcCer may therefore play a role in neuropathology. Besides lysosomal GBA, cells also contain a non-lysosomal glucosylceramidase (GBA2). Given that the two beta-glucosidases share substrates, we speculated that over-activity of GBA2 during severe GBA impairment might influence neuropathology. This hypothesis was studied in Niemann-Pick type C (Npc1(-/-)) mice showing secondary deficiency in GBA in various tissues. Here we report that GBA2 activity is indeed increased in the brain of Npc1(-/-) mice. We found that GBA2 is particularly abundant in Purkinje cells (PCs), one of the most affected neuronal populations in NPC disease. Inhibiting GBA2 in Npc1(-/-) mice with a brain-permeable low nanomolar inhibitor significantly improved motor coordination and extended lifespan in the absence of correction in cholesterol and ganglioside abnormalities. This trend was recapitulated, although not to full extent, by introducing a genetic loss of GBA2 in Npc1(-/-) mice. Our findings point to GBA2 activity as therapeutic target in NPC.	[Marques, Andre R. A.; Ottenhoff, Roelof; van Roomen, Cindy P. A. A.; Moro, Daniela Herrera; Mirzaian, Mina; Boot, Rolf G.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Aten, Jan; Claessen, Nike] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Veloz, Maria Fernanda Vinueza; Zhou, Kuikui; Lin, Zhanmin; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [De Zeeuw, Chris I.] Royal Dutch Acad Arts & Sci, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Overkleeft, Herman S.; Aerts, Johannes M. F. G.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Yildiz, Yildiz] Hosp Bregenz, Dept Internal Med, A-6900 Bregenz, Austria	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University - Excl LUMC	Aerts, JMFG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.f.g.aerts@lic.leidenuniv.nl	Marques, André R. A./Q-3892-2018; Aerts, Johannes/A-1028-2009	Marques, André R. A./0000-0001-9674-3017; Aerts, Johannes/0000-0001-8168-2565; Mirzaian, Mina/0000-0001-9404-2903; Aten, Jan/0000-0002-0997-6777; Herrera Moro Chao, Daniela/0000-0001-8406-1377; Overkleeft, Herman/0000-0001-6976-7005; Boot, Rolf/0000-0002-7031-3390	ERC-EU [294775, 290836]	ERC-EU	Chris I. De Zeeuw was supported by the ERC-advanced (294775) programs of the EU. Johannes Aerts and Herman Overkleeft were supported by the ERC-advanced (290836) program of the EU.	Aerts JM, 2003, PHILOS T R SOC B, V358, P905, DOI 10.1098/rstb.2003.1273; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Ashe KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021758; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Burke DG, 2013, J INHERIT METAB DIS, V36, P869, DOI 10.1007/s10545-012-9561-3; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Dekker N, 2011, BLOOD, V118, pE118, DOI 10.1182/blood-2011-05-352971; Elleder M, 2006, J INHERIT METAB DIS, V29, P707, DOI 10.1007/s10545-006-0411-z; FOLCH J, 1957, J BIOL CHEM, V226, P497; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hopfner F, 2013, MOVEMENT DISORD, V28, P538, DOI 10.1002/mds.25349; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Mistry PK, 2014, P NATL ACAD SCI USA, V111, P4934, DOI 10.1073/pnas.1400768111; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; Nietupski JB, 2012, MOL GENET METAB, V105, P621, DOI 10.1016/j.ymgme.2012.01.020; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Parra J, 2011, BIOCHEM BIOPH RES CO, V413, P400, DOI 10.1016/j.bbrc.2011.08.096; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; PENTCHEV PG, 1980, BIOCHIM BIOPHYS ACTA, V619, P669, DOI 10.1016/0005-2760(80)90116-2; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Salvioli R, 2004, J BIOL CHEM, V279, P17674, DOI 10.1074/jbc.M313517200; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Sorli SC, 2013, FASEB J, V27, P489, DOI 10.1096/fj.12-215152; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; van der Loos CM, 2010, J HISTOTECHNOL, V33, P31, DOI 10.1179/his.2010.33.1.31; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Veloz MFV, 2012, GENES BRAIN BEHAV, V11, P325, DOI 10.1111/j.1601-183X.2011.00763.x; Veloz MFV, 2015, BRAIN STRUCT FUNCT, V220, P3513, DOI 10.1007/s00429-014-0870-1; Vlugt KGVD, 2008, CLIN CHIM ACTA, V389, P109, DOI 10.1016/j.cca.2007.12.001; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Yildiz Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-151; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7	43	39	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135889	10.1371/journal.pone.0135889	http://dx.doi.org/10.1371/journal.pone.0135889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275242	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600130
J	Bonaccorsi-Riani, E; Danger, R; Lozano, JJ; Martinez-Picola, M; Kodela, E; Mas-Malavila, R; Bruguera, M; Collins, HL; Hider, RC; Martinez-Llordella, M; Sanchez-Fueyo, A				Bonaccorsi-Riani, Eliano; Danger, Richard; Lozano, Juan Jose; Martinez-Picola, Marta; Kodela, Elisavet; Mas-Malavila, Roser; Bruguera, Miquel; Collins, Helen L.; Hider, Robert C.; Martinez-Llordella, Marc; Sanchez-Fueyo, Alberto			Iron Deficiency Impairs Intra-Hepatic Lymphocyte Mediated Immune Response	PLOS ONE			English	Article							KILLER T-CELLS; LIVER-INJURY; CONCANAVALIN-A; MICE; EXPRESSION; TOLERANCE; TRANSPLANTATION; ACTIVATION; MECHANISMS; HEPATITIS	Hepatic expression of iron homeostasis genes and serum iron parameters predict the success of immunosuppression withdrawal following clinical liver transplantation, a phenomenon known as spontaneous operational tolerance. In experimental animal models, spontaneous liver allograft tolerance is established through a process that requires intrahepatic lymphocyte activation and deletion. Our aim was to determine if changes in systemic iron status regulate intra-hepatic lymphocyte responses. We used a murine model of lymphocyte-mediated acute liver inflammation induced by Concanavalin A (ConA) injection employing mice fed with an iron-deficient (IrDef) or an iron-balanced diet (IrRepl). While the mild iron deficiency induced by the IrDef diet did not significantly modify the steady state immune cell repertoire and systemic cytokine levels, it significantly dampened inflammatory liver damage after ConA challenge. These findings were associated with a marked decrease in T cell and NKT cell activation following ConA injection in IrDef mice. The decreased liver injury observed in IrDef mice was independent from changes in the gut microflora, and was replicated employing an iron specific chelator that did not modify intrahepatic hepcidin secretion. Furthermore, low-dose iron chelation markedly impaired the activation of isolated T cells in vitro. All together, these results suggest that small changes in iron homeostasis can have a major effect in the regulation of intra-hepatic lymphocyte mediated responses.	[Bonaccorsi-Riani, Eliano; Danger, Richard; Kodela, Elisavet; Mas-Malavila, Roser; Martinez-Llordella, Marc; Sanchez-Fueyo, Alberto] Kings Coll London Univ, Kings Coll Hosp, Div Transplantat Immunol & Mucosal Biol,Dept Live, Med Res Council MRC,Ctr Transplantat,Fac Life Sci, London, England; [Lozano, Juan Jose; Martinez-Picola, Marta; Bruguera, Miquel] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain; [Lozano, Juan Jose; Martinez-Picola, Marta; Bruguera, Miquel] Hosp Clin Barcelona, CIBEREHD, Bioinformat Platform, Barcelona, Spain; [Collins, Helen L.] Kings Coll London, Dept Immunobiol, Div Immunol Infect & Inflammatory Dis, Fac Life Sci & Med, London WC2R 2LS, England; [Hider, Robert C.] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London WC2R 2LS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; University of London; King's College London; University of London; King's College London	Sanchez-Fueyo, A (corresponding author), Kings Coll London Univ, Kings Coll Hosp, Div Transplantat Immunol & Mucosal Biol,Dept Live, Med Res Council MRC,Ctr Transplantat,Fac Life Sci, Denmark Hill, London, England.	sanchez_fueyo@kcl.ac.uk	RIANI, ELIANO BONACCORSI/J-4542-2019	Hider, Robert/0000-0003-1330-5797; Sanchez-Fueyo, Alberto/0000-0002-8316-3504; Lozano, Juan Jose/0000-0001-7613-3908; Danger, Richard/0000-0002-5058-795X	Medical Research Council (MRC) Centre for Transplantation, King's College London, UK - MRC [MR/J006742/1]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; MRC [MR/L008890/1] Funding Source: UKRI; Medical Research Council [MR/L008890/1, MR/J006742/1] Funding Source: researchfish	Medical Research Council (MRC) Centre for Transplantation, King's College London, UK - MRC; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Institute of Liver Studies (KCL) is supported by the Medical Research Council (MRC) Centre for Transplantation, King's College London, UK (transplantation.kcl.ac.uk) - MRC grant no. MR/J006742/1 and by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2011, BBA-GENE REGUL MECH, V1809, P262, DOI 10.1016/j.bbagrm.2011.04.010; Benitez C, 2013, HEPATOLOGY, V58, P1824, DOI 10.1002/hep.26426; Benseler V, 2007, SEMIN LIVER DIS, V27, P194, DOI 10.1055/s-2007-979471; Bjorkholm B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006958; Bohne F, 2012, J CLIN INVEST, V122, P368, DOI 10.1172/JCI59411; Chen JN, 2014, SCI REP-UK, V4, DOI 10.1038/srep07259; Corbitt N, 2013, AM J PATHOL, V182, P180, DOI 10.1016/j.ajpath.2012.09.010; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; Evstatiev R, 2014, AM J HEMATOL, V89, P524, DOI 10.1002/ajh.23682; Fakih S, 2009, J PHARM SCI-US, V98, P2212, DOI 10.1002/jps.21583; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Grant SM, 2003, J NUTR, V133, P2635, DOI 10.1093/jn/133.8.2635; HOFFBRAND AV, 1976, BRIT J HAEMATOL, V33, P517, DOI 10.1111/j.1365-2141.1976.tb03570.x; Ikeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089355; Imaizumi T, 2015, NEUROSCI RES, V94, P10, DOI 10.1016/j.neures.2015.01.001; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; KUVIBIDILA S, 1991, AM J CLIN NUTR, V54, P944, DOI 10.1093/ajcn/54.5.944; Kuvibidila SR, 1998, J NUTR, V128, P1077, DOI 10.1093/jn/128.7.1077; Li W, 2008, AM J TRANSPLANT, V8, P1639, DOI 10.1111/j.1600-6143.2008.02300.x; LUCAS JJ, 1995, BLOOD, V86, P2268, DOI 10.1182/blood.V86.6.2268.bloodjournal8662268; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Oexle H, 2003, J LEUKOCYTE BIOL, V74, P287, DOI 10.1189/jlb.0802420; Otogawa K, 2008, AM J PHYSIOL-REG I, V294, pR311, DOI 10.1152/ajpregu.00735.2007; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Sato T, 2011, HEPATOL RES, V41, P660, DOI 10.1111/j.1872-034X.2011.00821.x; Tiegs G., 1992, CLIN INVESTIGATOR, V90, P196, DOI DOI 10.1172/JCI115836; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100	37	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136106	10.1371/journal.pone.0136106	http://dx.doi.org/10.1371/journal.pone.0136106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287688	gold, Green Published			2022-12-27	WOS:000360018600109
J	Gilbert, CC; Steininger, CM; Kibii, JM; Berger, LR				Gilbert, Christopher C.; Steininger, Christine M.; Kibii, Job M.; Berger, Lee R.			Papio Cranium from the Hominin-Bearing Site of Malapa: Implications for the Evolution of Modern Baboon Cranial Morphology and South African Plio-Pleistocene Biochronology	PLOS ONE			English	Article							AUSTRALOPITHECUS-SEDIBA; FOSSIL CERCOPITHECIDAE; AFAR REGION; PHYLOGEOGRAPHY; STERKFONTEIN; SYSTEMATICS; ASSEMBLAGE; PHYLOGENY; AGE	A new partial cranium (UW 88-886) of the Plio-Pleistocene baboon Papio angusticeps from Malapa is identified, described and discussed. UW 88-886 represents the only non-hominin primate yet recovered from Malapa and is important both in the context of baboon evolution as well as South African hominin site biochronology. The new specimen may represent the first appearance of modern baboon anatomy and coincides almost perfectly with molecular divergence date estimates for the origin of the modern P. hamadryas radiation. The fact that the Malapa specimen is dated between similar to 2.026-2.36 million years ago (Ma) also has implications for the biochronology of other South African Plio-Pleistocene sites where P. angusticeps is found.	[Gilbert, Christopher C.] CUNY Hunter Coll, Dept Anthropol, New York, NY 10065 USA; [Gilbert, Christopher C.] CUNY, Grad Ctr, PhD Programs Anthropol & Biol, New York, NY 10016 USA; [Gilbert, Christopher C.] New York Consortium Evolutionary Primatol, New York, NY USA; [Steininger, Christine M.; Kibii, Job M.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, Johannesburg, South Africa	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; University of Witwatersrand	Gilbert, CC (corresponding author), CUNY Hunter Coll, Dept Anthropol, 695 Pk Ave, New York, NY 10065 USA.	cgilbert@hunter.cuny.edu	Berger, Lee Rogers/AAC-3484-2020; Steininger, Christoph/U-8815-2019	Berger, Lee Rogers/0000-0002-0367-7629; Steininger, Christoph/0000-0003-3500-7205; Gilbert, Christopher/0000-0001-8768-3171; Steininger, Christine/0000-0002-9082-0672	National Geographic Society; National Research Foundation of South Africa; Lyda Hill Foundation; DST-NRF Centre of Excellence in Palaeosciences; Gauteng Provincial Government; Department of Arts and Culture of South Africa; Hunter College; Wenner-Gren Foundation	National Geographic Society(National Geographic Society); National Research Foundation of South Africa(National Research Foundation - South Africa); Lyda Hill Foundation; DST-NRF Centre of Excellence in Palaeosciences; Gauteng Provincial Government; Department of Arts and Culture of South Africa; Hunter College; Wenner-Gren Foundation	Funding for the Malapa project was generously provided by the National Geographic Society, the National Research Foundation of South Africa, the Lyda Hill Foundation, the DST-NRF Centre of Excellence in Palaeosciences, the Gauteng Provincial Government and the Department of Arts and Culture of South Africa. Funding for CCG was generously provided by Hunter College and the Wenner-Gren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2013, J HUM EVOL, V64, P693, DOI 10.1016/j.jhevol.2013.02.009; Alemseged Z, 2000, CR ACAD SCI II A, V331, P549, DOI 10.1016/S1251-8050(00)01450-6; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; BERGER LR, 1993, AM J PHYS ANTHROPOL, V92, P107, DOI 10.1002/ajpa.1330920109; Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; BROWN FH, 1985, ANCESTORS HARD EVIDE, P82; Brugal JP, 2003, CR PALEVOL, V2, P675, DOI 10.1016/j.crpv.2003.09.028; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Delson E., 1988, P317; Delson E., 1984, Courier Forschungsinstitut Senckenberg, V69, P199; Delson Eric, 2000, Anthropological Papers of the American Museum of Natural History, V83, P1; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; EISENHART WL, 1974, THESIS HARVARD COLL; Freedman L., 1957, Annals of the Transvaal Museum, V23, P121; Frost SR, 2003, ANAT REC PART A, V275A, P1048, DOI 10.1002/ar.a.10112; Frost SR, 2007, J HUM EVOL, V53, P227, DOI 10.1016/j.jhevol.2007.02.003; Frost SR, 2007, AM J PHYS ANTHROPOL, V134, P460, DOI 10.1002/ajpa.20688; Gilbert CC, 2013, AM J PHYS ANTHROPOL, V150, P129; Gilbert CC, 2013, J HUM EVOL, V64, P399, DOI 10.1016/j.jhevol.2013.01.013; Granger DE, 2015, NATURE, V522, P85, DOI 10.1038/nature14268; Harrison T, 2011, VERTEBR PALEOBIOL PA, P83, DOI 10.1007/978-90-481-9962-4_6; Hartstone-Rose Adam, 2013, Transactions of the Royal Society of South Africa, V68, P1, DOI 10.1080/0035919X.2012.748698; Heaton JL., 2006, THESIS INDIANA U BLO; Herries AIR, 2014, S AFR J SCI, V110, P40, DOI 10.1590/sajs.2014/20130102; Herries Andy I.R., 2013, P21; Herries AIR, 2009, QUATERN INT, V202, P14, DOI 10.1016/j.quaint.2008.05.017; Irish JD, 2013, SCIENCE, V340, DOI 10.1126/science.1233062; JABLONSKI N. G., 2008, KOOBI FORA RES PROJE, V6, P397; Jablonski NG, 2002, CAM S BIO EVOL ANTHR, V33, P255; Keyser AW, 2000, S AFR J SCI, V96, P193; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Kuhn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026940; Leakey M.G., 1976, Fossil Vertebr Afr, V4, P121; Leakey M.G., 1987, P91; McKee Jeffrey K., 1993, Palaeontologia Africana, V30, P43; MCKEE JK, 1994, INT J PRIMATOL, V15, P823, DOI 10.1007/BF02736070; MCKEE JK, 1995, AM J PHYS ANTHROPOL, V96, P235, DOI 10.1002/ajpa.1330960303; Newman TK, 2004, AM J PHYS ANTHROPOL, V124, P17, DOI 10.1002/ajpa.10340; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Remane A, 1925, WISSENSCHAFTLICHE ER, V2, P83; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; SZALAY F. S., 1979, EVOLUTIONARY HIST PR; Wildman DE, 2004, MOL PHYLOGENET EVOL, V32, P287, DOI 10.1016/j.ympev.2003.12.014; Williams BA, 2012, AM J PHYS ANTHROPOL, V149, P1, DOI 10.1002/ajpa.22093; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Zinner D, 2013, AM J PHYS ANTHROPOL, V150, P133, DOI 10.1002/ajpa.22185; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	53	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133361	10.1371/journal.pone.0133361	http://dx.doi.org/10.1371/journal.pone.0133361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287673	Green Published, gold			2022-12-27	WOS:000360018600005
J	Gomez-Grau, M; Garrido, E; Cozar, M; Rodriguez-Sureda, V; Dominguez, C; Arenas, C; Gatti, RA; Cormand, B; Grinberg, D; Vilageliu, L				Gomez-Grau, Marta; Garrido, Elena; Cozar, Monica; Rodriguez-Sureda, Victor; Dominguez, Carmen; Arenas, Concepcion; Gatti, Richard A.; Cormand, Bru; Grinberg, Daniel; Vilageliu, Lluisa			Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases	PLOS ONE			English	Article							MAROTEAUX-LAMY-SYNDROME; MPS I-H; READ-THROUGH; NONSENSE MUTATIONS; SUPPRESSION; IDENTIFICATION; GENE; GENTAMICIN; SPANISH; STRATEGIES	Nonsense mutations are quite prevalent in inherited diseases. Readthrough drugs could provide a therapeutic option for any disease caused by this type of mutation. Geneticin (G418) and gentamicin were among the first to be described. Novel compounds have been generated, but only a few have shown improved results. PTC124 is the only compound to have reached clinical trials. Here we first investigated the readthrough effects of gentamicin on fibroblasts from one patient with Sanfilippo B, one with Sanfilippo C, and one with Maroteaux-Lamy. We found that ARSB activity (Maroteaux-Lamy case) resulted in an increase of 2-3 folds and that the amount of this enzyme within the lysosomes was also increased, after treatment. Since the other two cases (Sanfilippo B and Sanfilippo C) did not respond to gentamicin, the treatments were extended with the use of geneticin and five non-aminoglycoside (PTC124, RTC13, RTC14, BZ6 and BZ16) readthrough compounds (RTCs). No recovery was observed at the enzyme activity level. However, mRNA recovery was observed in both cases, nearly a two-fold increase for Sanfilippo B fibroblasts with G418 and around 1.5 fold increase for Sanfilippo C cells with RTC14 and PTC124. Afterwards, some of the products were assessed through in vitro analyses for seven mutations in genes responsible for those diseases and, also, for Niemann-Pick A/B. Using the coupled transcription/translation system (TNT), the best results were obtained for SMPD1 mutations with G418, reaching a 35% recovery at 0.25 mu g/ml, for the p.W168X mutation. The use of COS cells transfected with mutant cDNAs gave positive results for most of the mutations with some of the drugs, although to a different extent. The higher enzyme activity recovery, of around two-fold increase, was found for gentamicin on the ARSB p.W146X mutation. Our results are promising and consistent with those of other groups. Further studies of novel compounds are necessary to find those with more consistent efficacy and fewer toxic effects.	[Gomez-Grau, Marta; Garrido, Elena; Cozar, Monica; Cormand, Bru; Grinberg, Daniel; Vilageliu, Lluisa] Univ Barcelona, Fac Biol, Dept Genet, IBUB,CIBERER, Barcelona, Spain; [Rodriguez-Sureda, Victor; Dominguez, Carmen] Hosp Univ Vall dHebron, CIBERER, CIBBIM Nanomed, VHIR, Barcelona, Spain; [Arenas, Concepcion] Univ Barcelona, Fac Biol, Dept Estadist, Barcelona, Spain; [Gatti, Richard A.] David Geffen UCLA Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA; [Gatti, Richard A.] David Geffen UCLA Sch Med, Dept Human Genet, Los Angeles, CA USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Grinberg, D (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, IBUB,CIBERER, Barcelona, Spain.	dgrinberg@ub.edu	Grinberg, Daniel/F-3641-2010; Arenas, Concepcion/H-5579-2015; Cormand, Bru/H-5338-2015	Grinberg, Daniel/0000-0001-9859-2590; Arenas, Concepcion/0000-0002-6489-4934; Cormand, Bru/0000-0001-5318-4382	Spanish Ministry of Science and Innovation [SAF2010-17589, SAF2011-25431]; Catalan Government [2009SGR971]; Jonah's Just Begun-Foundation; Jonah's Just Begun-Foundation to Cure Sanfilippo Inc. (USA); Association Sanfilippo Sud (France); Fundacion Stop Sanfilippo (Spain); Asociacion MPS Espana (Spain); APRAT (A-T, France); A-T Ease (A-T, New York, USA); BioMarin; University of Barcelona (APIF)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government; Jonah's Just Begun-Foundation; Jonah's Just Begun-Foundation to Cure Sanfilippo Inc. (USA); Association Sanfilippo Sud (France); Fundacion Stop Sanfilippo (Spain); Asociacion MPS Espana (Spain); APRAT (A-T, France); A-T Ease (A-T, New York, USA); BioMarin; University of Barcelona (APIF)	Funding: This study was partially funded by grants from the Spanish Ministry of Science and Innovation (SAF2010-17589, SAF2011-25431) and from the Catalan Government (2009SGR971), and by financial support from 'patient-support' associations, such as Jonah's Just Begun-Foundation to Cure Sanfilippo Inc. (USA), Association Sanfilippo Sud (France), Fundacion Stop Sanfilippo (Spain), Asociacion MPS Espana (Spain), APRAT (A-T, France), and A-T Ease (A-T, New York, USA). RAG was partially supported by a Sponsored Research Grant for readthrough drug development from BioMarin. MGG was supported by a grant from the University of Barcelona (APIF).	Allamand V, 2008, J GENE MED, V10, P217, DOI 10.1002/jgm.1140; Bartolomeo R, 2013, J INHERIT METAB DIS, V36, P363, DOI 10.1007/s10545-012-9521-y; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Bellais S, 2010, EUR J HUM GENET, V18, P130, DOI 10.1038/ejhg.2009.122; Bidou L, 2004, GENE THER, V11, P619, DOI 10.1038/sj.gt.3302211; Bidou L, 2012, TRENDS MOL MED, V18, P679, DOI 10.1016/j.molmed.2012.09.008; Bordeira-Carrico R, 2012, TRENDS MOL MED, V18, P667, DOI 10.1016/j.molmed.2012.09.004; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; Brooks DA, 2006, TRENDS MOL MED, V12, P367, DOI 10.1016/j.molmed.2006.06.001; Buck NE, 2009, MOL GENET METAB, V97, P244, DOI 10.1016/j.ymgme.2009.04.004; Coll MJ, 2001, J INHERIT METAB DIS, V24, P83, DOI 10.1023/A:1005627311402; de Winter JCF, 2013, PRACTICAL ASSESSMENT, V18, P1; Dranchak PK, 2011, J CELL BIOCHEM, V112, P1250, DOI 10.1002/jcb.22979; Du LT, 2013, MOL THER, V21, P1653, DOI 10.1038/mt.2013.150; Du LT, 2009, J EXP MED, V206, P2285, DOI 10.1084/jem.20081940; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Du M, 2006, J MOL MED, V84, P573, DOI 10.1007/s00109-006-0045-5; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Finkel RS, 2010, J CHILD NEUROL, V25, P1158, DOI 10.1177/0883073810371129; Floquet C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002608; Floquet C, 2011, NUCLEIC ACIDS RES, V39, P3350, DOI 10.1093/nar/gkq1277; Garrido E, 2008, MOL GENET METAB, V94, P305, DOI 10.1016/j.ymgme.2008.02.012; Garrido E, 2007, MOL GENET METAB, V92, P122, DOI 10.1016/j.ymgme.2007.06.002; Gatti RA, 2012, ANN NY ACAD SCI, V1250, P33, DOI 10.1111/j.1749-6632.2012.06467.x; Goldmann T, 2011, HUM GENE THER, V22, P537, DOI 10.1089/hum.2010.067; Gregory-Evans CY, 2014, J CLIN INVEST, V124, P111, DOI 10.1172/JCI70462; Gunn G, 2014, MOL GENET METAB, V111, P374, DOI 10.1016/j.ymgme.2013.12.007; Hein LK, 2004, J MOL BIOL, V338, P453, DOI 10.1016/j.jmb.2004.03.012; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Hrebicek M, 2006, AM J HUM GENET, V79, P807, DOI 10.1086/508294; Jung ME, 2011, BIOORG MED CHEM LETT, V21, P5842, DOI 10.1016/j.bmcl.2011.07.107; Kayali R, 2012, HUM MOL GENET, V21, P4007, DOI 10.1093/hmg/dds223; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; KLEIN U, 1978, P NATL ACAD SCI USA, V75, P5185, DOI 10.1073/pnas.75.10.5185; Kuschal C, 2013, P NATL ACAD SCI USA, V110, P19483, DOI 10.1073/pnas.1312088110; Lai CH, 2004, P NATL ACAD SCI USA, V101, P15676, DOI 10.1073/pnas.0405155101; Lee HLR, 2012, PHARMACOL THERAPEUT, V136, P227, DOI 10.1016/j.pharmthera.2012.07.007; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; Matalonga L, 2014, J INHERIT METAB DIS, V37, P439, DOI 10.1007/s10545-013-9668-1; Matos L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0180-y; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Ouesleti S, 2011, CLIN CHIM ACTA, V412, P2326, DOI 10.1016/j.cca.2011.08.032; Peltz SW, 2013, ANNU REV MED, V64, P407, DOI 10.1146/annurev-med-120611-144851; Rodriguez-Pascau L, 2009, HUM MUTAT, V30, P1117, DOI 10.1002/humu.21018; Ruijter GJG, 2008, MOL GENET METAB, V93, P104, DOI 10.1016/j.ymgme.2007.09.011; Sanchez-Alcudia R, 2012, HUM MUTAT, V33, P973, DOI 10.1002/humu.22047; SCHUCHMAN EH, 1995, HUM MUTAT, V6, P352, DOI 10.1002/humu.1380060412; Schuchman EH, 2001, METABOLIC MOL BASES, V3, P3589; Tan L, 2011, J INHERIT METAB DIS, V34, P443, DOI 10.1007/s10545-010-9265-5; Villani GRD, 1999, BBA-MOL BASIS DIS, V1453, P185, DOI 10.1016/S0925-4439(98)00099-4; Voskoboeva E. Yu., 2000, Genetika, V36, P837; Wang D, 2012, MOL GENET METAB, V105, P116, DOI 10.1016/j.ymgme.2011.10.005; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756	59	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135873	10.1371/journal.pone.0135873	http://dx.doi.org/10.1371/journal.pone.0135873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287674	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600079
J	Kim, JY; Balamurugan, A; Azari, K; Hofmann, C; Ng, HL; Reed, EF; McDiarmid, S; Yang, OO				Kim, Joseph Y.; Balamurugan, Arumugam; Azari, Kodi; Hofmann, Christian; Ng, Hwee L.; Reed, Elaine F.; McDiarmid, Suzanne; Yang, Otto O.			Clonal CD8(+) T Cell Persistence and Variable Gene Usage Bias in a Human Transplanted Hand	PLOS ONE			English	Article							RENAL-ALLOGRAFT REJECTION; V-BETA-REPERTOIRE; CARDIAC ALLOGRAFTS; IN-VITRO; KIDNEY ALLOGRAFT; LYMPHOCYTES; ALLORECOGNITION; RECOGNITION; RESPONSES; SELECTION	Immune prophylaxis and treatment of transplanted tissue rejection act indiscriminately, risking serious infections and malignancies. Although animal data suggest that cellular immune responses causing rejection may be rather narrow and predictable based on genetic background, there are only limited data regarding the clonal breadth of anti-donor responses in humans after allogeneic organ transplantation. We evaluated the graft-infiltrating CD8(+) T lymphocytes in skin punch biopsies of a transplanted hand over 178 days. Profiling of T cell receptor (TCR) variable gene usage and size distribution of the infiltrating cells revealed marked skewing of the TCR repertoire indicating oligoclonality, but relatively normal distributions in the blood. Although sampling limitation prevented complete assessment of the TCR repertoire, sequencing further identified 11 TCR clonal expansions that persisted through varying degrees of clinical rejection and immunosuppressive therapy. These 11 clones were limited to three TCR beta chain variable (BV) gene families. Overall, these data indicate significant oligoclonality and likely restricted BV gene usage of alloreactive CD8(+) T lymphocytes, and suggest that changes in rejection status are more due to varying regulation of their activity or number rather than shifts in the clonal populations in the transplanted organ. Given that controlled animal models produce predictable BV usage in T lymphocytes mediating rejection, understanding the determinants of TCR gene usage associated with rejection in humans may have application in specifically targeted immunotherapy.	[Kim, Joseph Y.; Balamurugan, Arumugam; Hofmann, Christian; Ng, Hwee L.; Yang, Otto O.] Univ Calif Los Angeles, Dept Med, Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90024 USA; [Kim, Joseph Y.; Yang, Otto O.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Geffen Sch Med, Los Angeles, CA USA; [Azari, Kodi] Univ Calif Los Angeles, Dept Orthopaed Surg, Geffen Sch Med, Los Angeles, CA USA; [Reed, Elaine F.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Geffen Sch Med, Los Angeles, CA USA; [Reed, Elaine F.] Univ Calif Los Angeles, UCLA Immunogenet Ctr, Geffen Sch Med, Los Angeles, CA USA; [McDiarmid, Suzanne] Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol, Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yang, OO (corresponding author), Univ Calif Los Angeles, Dept Med, Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90024 USA.	OYang@mednet.ucla.edu			NIH [T32 AI089398, UL1TR000124]; Department of Medicine at the Geffen School of Medicine at UCLA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine at the Geffen School of Medicine at UCLA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants T32 AI089398 and UL1TR000124, and the Department of Medicine at the Geffen School of Medicine at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CM, 2005, AM J TRANSPLANT, V5, P746, DOI 10.1111/j.1600-6143.2005.00756.x; AUCHINCLOSS H, 1993, P NATL ACAD SCI USA, V90, P3373, DOI 10.1073/pnas.90.8.3373; Balamurugan A, 2010, J IMMUNOL, V185, P5935, DOI 10.4049/jimmunol.1002236; Baron C, 2001, J IMMUNOL, V167, P4154, DOI 10.4049/jimmunol.167.8.4154; Barth C, 1996, KIDNEY INT, V50, P2020, DOI 10.1038/ki.1996.524; BONNEVILLE M, 1988, J IMMUNOL, V141, P4187; Budino BS, 2004, TRANSPL P, V36, P787, DOI 10.1016/j.transproceed.2004.03.044; CARLQUIST JF, 1994, CIRCULATION, V90, P686, DOI 10.1161/01.CIR.90.2.686; Corer PA, 1937, J PATHOL BACTERIOL, V44, P691; DATEMA G, 1994, TRANSPLANTATION, V57, P1119, DOI 10.1097/00007890-199404150-00023; DATEMA G, 1993, TRANSPLANT P, V25, P77; DeBruyne LA, 1996, J IMMUNOL, V156, P3493; Douillard P, 1998, INT IMMUNOL, V10, P71, DOI 10.1093/intimm/10.1.71; FINN OJ, 1989, TRANSPLANT P, V21, P346; FINN OJ, 1988, TRANSPLANT P, V20, P155; Game DS, 2002, TRANSPL IMMUNOL, V10, P101, DOI 10.1016/S0966-3274(02)00055-2; GOSS JA, 1993, J EXP MED, V177, P35, DOI 10.1084/jem.177.1.35; HALL BL, 1992, TRANSPLANTATION, V53, P1088, DOI 10.1097/00007890-199205000-00022; Ibarrondo FJ, 2005, J VIROL, V79, P4289, DOI 10.1128/JVI.79.7.4289-4297.2005; Jones N, 2003, J IMMUNOL METHODS, V274, P139, DOI 10.1016/S0022-1759(02)00510-0; Li HJ, 2012, CELL RES, V22, P33, DOI 10.1038/cr.2012.1; MALISSEN M, 1988, CELL, V55, P49, DOI 10.1016/0092-8674(88)90008-6; Mannon RB, 1996, TRANSPLANTATION, V62, P96, DOI 10.1097/00007890-199607150-00019; MCWHINNIE DL, 1986, TRANSPLANTATION, V42, P352, DOI 10.1097/00007890-198610000-00004; Obata F, 1998, TRANSPLANTATION, V66, P1389, DOI 10.1097/00007890-199811270-00022; Obata F, 2004, TRANSPL IMMUNOL, V13, P233, DOI 10.1016/j.trim.2004.04.002; Paraoan MT, 2005, TRANSPLANTATION, V80, P1805, DOI 10.1097/01.tp.0000181194.42642.97; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; Shirwan H, 1997, IMMUNOLOGY, V90, P572, DOI 10.1046/j.1365-2567.1997.00187.x; SHIRWAN H, 1993, J IMMUNOL, V151, P5228; SHIRWAN H, 1993, TRANSPLANT P, V25, P2780; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Wolfram D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099926; WONG JT, 1987, J IMMUNOL, V139, P1369; Zhai Y, 2001, TRANSPLANTATION, V71, P1701, DOI 10.1097/00007890-200106270-00001	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136235	10.1371/journal.pone.0136235	http://dx.doi.org/10.1371/journal.pone.0136235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287728	Green Published, gold			2022-12-27	WOS:000360018600125
J	Mai, M; Wang, K; Huber, G; Kirby, M; Shattuck, MD; O'Hern, CS				Mai, Manuel; Wang, Kun; Huber, Greg; Kirby, Michael; Shattuck, Mark D.; O'Hern, Corey S.			Outcome Prediction in Mathematical Models of Immune Response to Infection	PLOS ONE			English	Article							ACUTE INFLAMMATORY RESPONSE; A VIRUS-INFECTION; DYNAMICS IN-VIVO; HIV-1 INFECTION; TUBERCULOSIS; INNATE; MEMORY	Clinicians need to predict patient outcomes with high accuracy as early as possible after disease inception. In this manuscript, we show that patient-to-patient variability sets a fundamental limit on outcome prediction accuracy for a general class of mathematical models for the immune response to infection. However, accuracy can be increased at the expense of delayed prognosis. We investigate several systems of ordinary differential equations (ODEs) that model the host immune response to a pathogen load. Advantages of systems of ODEs for investigating the immune response to infection include the ability to collect data on large numbers of 'virtual patients', each with a given set of model parameters, and obtain many time points during the course of the infection. We implement patient-to-patient variability v in the ODE models by randomly selecting the model parameters from distributions with coefficients of variation v that are centered on physiological values. We use logistic regression with one-versus-all classification to predict the discrete steady-state outcomes of the system. We find that the prediction algorithm achieves near 100% accuracy for v = 0, and the accuracy decreases with increasing v for all ODE models studied. The fact that multiple steady-state outcomes can be obtained for a given initial condition, i.e. the basins of attraction overlap in the space of initial conditions, limits the prediction accuracy for v > 0. Increasing the elapsed time of the variables used to train and test the classifier, increases the prediction accuracy, while adding explicit external noise to the ODE models decreases the prediction accuracy. Our results quantify the competition between early prognosis and high prediction accuracy that is frequently encountered by clinicians.	[Mai, Manuel; O'Hern, Corey S.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Wang, Kun; Kirby, Michael] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Wang, Kun; Shattuck, Mark D.; O'Hern, Corey S.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT USA; [Huber, Greg] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Kirby, Michael] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA; [Shattuck, Mark D.] CUNY, Benjamin Levich Inst, New York, NY 10021 USA; [Shattuck, Mark D.] CUNY, Dept Phys, New York, NY 10021 USA; [O'Hern, Corey S.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [O'Hern, Corey S.] Yale Univ, Grad Program Computat Biol & Bioinformat, New Haven, CT USA	Yale University; Colorado State University; Yale University; University of California System; University of California Santa Barbara; Colorado State University; City University of New York (CUNY) System; City University of New York (CUNY) System; Yale University; Yale University	Mai, M (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.	manuel.mai@yale.edu	Shattuck, Mark D/F-5680-2015; O'Hern, Corey/I-3459-2014	Shattuck, Mark D/0000-0001-8473-2505; O'Hern, Corey/0000-0002-8272-5640	DARPA (Space and Naval Warfare System Center Pacific) [N66001-11-1-4184]; National Science Foundation [NSF PHY11-25915]; Yale University; Infectious Disease Supercluster, Colorado State University; NSF [CNS-0821132]	DARPA (Space and Naval Warfare System Center Pacific); National Science Foundation(National Science Foundation (NSF)); Yale University; Infectious Disease Supercluster, Colorado State University; NSF(National Science Foundation (NSF))	Funding: This work was partially supported by DARPA (Space and Naval Warfare System Center Pacific, http://www.darpa.mil) under award number N66001-11-1-4184 (M.S., M.K., G.H., and C.O.) and partially supported by the National Science Foundation Grant (www.nsf.gov) No. NSF PHY11-25915 (M.S., C.O., and G.H.). Additional support for this work was provided by Yale University (www.yale.edu) (M.M.) and the Infectious Disease Supercluster, Colorado State University, 2012 seed grant (http://infectiousdisease.colostate.edu/pages/clusters.aspx) (K.W. and M.K.). This work also benefited from the facilities and staff of the Yale University Faculty of Arts and Sciences High Performance Computing Center and NSF Grant No. CNS-0821132 that partially funded acquisition of the computational facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266; CastilloChavez C, 1997, J MATH BIOL, V35, P629, DOI 10.1007/s002850050069; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; Hastie T., 2009, UNSUPERVISED LEARNIN; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Klipp E, 2005, SYSTEMS BIOLOGY IN PRACTICE: CONCEPTS, IMPLEMENTATION AND APPLICATION, P1, DOI 10.1002/3527603603; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Nelson PW, 2002, MATH BIOSCI, V179, P73, DOI 10.1016/S0025-5564(02)00099-8; O'Hara S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-832; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Serdobova I, 2006, AM J PUBLIC HEALTH, V96, P1554, DOI 10.2105/AJPH.2005.074583; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082700; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102; Wetterstrand K.A., DNA SEQUENCING COSTS; Wodarz D, 2002, BIOESSAYS, V24, P1178, DOI 10.1002/bies.10196; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919	28	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135861	10.1371/journal.pone.0135861	http://dx.doi.org/10.1371/journal.pone.0135861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287609	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600078
J	Schnitzler, F; Friedrich, M; Stallhofer, J; Schonermarck, U; Fischereder, M; Habicht, A; Karbalai, N; Wolf, C; Angelberger, M; Olszak, T; Beigel, F; Tillack, C; Goke, B; Zachoval, R; Denk, G; Guba, M; Rust, C; Gruner, N; Brand, S				Schnitzler, Fabian; Friedrich, Matthias; Stallhofer, Johannes; Schoenermarck, Ulf; Fischereder, Michael; Habicht, Antje; Karbalai, Nazanin; Wolf, Christiane; Angelberger, Marianne; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Goeke, Burkhard; Zachoval, Reinhart; Denk, Gerald; Guba, Markus; Rust, Christian; Gruener, Norbert; Brand, Stephan			Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; ORTHOTOPIC LIVER-TRANSPLANTATION; HEMOLYTIC-UREMIC SYNDROME; ULCERATIVE-COLITIS; CLINICAL-COURSE; KIDNEY-TRANSPLANTATION; CROHNS-DISEASE; RISK-FACTORS; CASE SERIES; IMMUNOSUPPRESSION	Background Currently, limited data of the outcome of inflammatory bowel disease (IBD) in patients after solid organ transplantation (SOT) are available. We aimed to analyze effects of SOT on the IBD course in a large IBD patient cohort. Methods Clinical data from 1537 IBD patients were analyzed for patients who underwent SOT (n = 31) between July 2002 and May 2014. Sub-analyses included SOT outcome parameters, IBD activity before and after SOT, and efficacy of IBD treatment. Results 4.74% of patients with ulcerative colitis (UC) and 0.84% of patients with Crohn's disease (CD) underwent SOT (p = 2.69 x 10(-6), UC vs. CD). 77.4% of patients with SOT underwent liver transplantation (LTx) with tacrolimus-based immunosuppressive therapy after SOT. All LTx were due to primary sclerosing cholangitis (PSC) or PSC overlap syndromes. Six patients (19.4%) required renal transplantation and one patient (3.2%) heart transplantation. A survival rate of 83.9% after a median follow-up period of 103 months was observed. Before SOT, 65.0% of patients were in clinical remission and 5 patients received immunosuppressive therapy (16.1%). After SOT, 61.0% of patients were in remission (p = 1.00 vs. before SOT) and 29.0% required IBD-specific immunosuppressive or anti-TNF therapy (p = 0.54 vs. before SOT). 42.9% of patients with worsening of IBD after SOT were at higher risk of needing steroid therapy for increased IBD activity (p = 0.03; relative risk (RR): 10.29; 95% CI 1.26-84.06). Four patients (13.0%) needed anti-TNF therapy after SOT (response rate 75%). Conclusions SOT was more common in UC patients due to the higher prevalence of PSC-related liver cirrhosis in UC. Despite mainly tacrolimus-based immunosuppressive regimens, outcome of SOT and IBD was excellent in this cohort. In this SOT cohort, concomitant immunosuppressive therapy due to IBD was well tolerated.	[Schnitzler, Fabian; Friedrich, Matthias; Stallhofer, Johannes; Angelberger, Marianne; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Goeke, Burkhard; Denk, Gerald; Gruener, Norbert; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Friedrich, Matthias] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Schoenermarck, Ulf; Fischereder, Michael] Univ Munich, Dept Med Nephrol Grosshadern 4, Munich, Germany; [Fischereder, Michael; Habicht, Antje; Zachoval, Reinhart; Denk, Gerald; Guba, Markus; Gruener, Norbert] Univ Munich, Transplantat Ctr Grosshadern, Munich, Germany; [Karbalai, Nazanin; Wolf, Christiane] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Guba, Markus] Univ Munich, Dept Surg Grosshadern, Munich, Germany; [Rust, Christian] Hosp Barmherzige Bruder, Dept Gastroenterol, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; Max Planck Society; University of Munich	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Mirza-Schreiber, Nazanin/AAD-1563-2022; Schönermarck, Ulf/AAE-6590-2020; Mirza-Schreiber, Nazanin/AAD-1558-2022; Zachoval, Roman/Q-6488-2016; Guba, Markus/M-4309-2019	Mirza-Schreiber, Nazanin/0000-0003-0836-8267; Zachoval, Roman/0000-0003-0906-269X; Schonermarck, Ulf/0000-0002-3266-9791; Stallhofer, Johannes/0000-0001-8698-6103	Deutsche Forschungsgemeinschaft (DFG) [BR1912/6-1, OL/324-1]; Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium) [2010_EKES.32]; DFG [BE 4490/2-1]; Ludwig-Maximilians-University Munich	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium); DFG(German Research Foundation (DFG)); Ludwig-Maximilians-University Munich	Funding: S. Brand was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BR1912/6-1) and the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32). F. Beigel was supported by DFG (BE 4490/2-1). C. Tillack was supported by a grant of Ludwig-Maximilians-University Munich (FoFoLe program). T. Olszak was supported by a grant from Deutsche Forschungsgemeinschaft (DFG, OL/324-1) and by a grant from the Ludwig-Maximilians-University Munich (FoFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambruzs JM, 2014, CLIN J AM SOC NEPHRO, V9, P265, DOI 10.2215/CJN.04660513; Azevedo P, 2013, TRANSPL P, V45, P1084, DOI 10.1016/j.transproceed.2013.03.008; Befeler AS, 1998, TRANSPLANTATION, V65, P393, DOI 10.1097/00007890-199802150-00017; Bergquist A, 2002, J HEPATOL, V36, P321, DOI 10.1016/S0168-8278(01)00288-4; Boonstra K, 2012, INFLAMM BOWEL DIS, V18, P2270, DOI 10.1002/ibd.22938; BROOME U, 1995, HEPATOLOGY, V22, P1404, DOI 10.1016/0270-9139(95)90144-2; Broome U, 2006, SEMIN LIVER DIS, V26, P31, DOI 10.1055/s-2006-933561; Cholongitas E, 2007, LIVER TRANSPLANT, V13, P552, DOI 10.1002/lt.21077; Dvorchik I, 2002, HEPATOLOGY, V35, P380, DOI 10.1053/jhep.2002.30695; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; El-Nachef N, 2010, AM J GASTROENTEROL, V105, P1210, DOI 10.1038/ajg.2010.33; GAVALER JS, 1991, DIGEST DIS SCI, V36, P321, DOI 10.1007/BF01318204; Gheith O, 2010, TRANSPL INFECT DIS, V12, P164, DOI 10.1111/j.1399-3062.2009.00474.x; Gizard E, 2014, ALIMENT PHARM THER, V40, P3, DOI 10.1111/apt.12794; Ha C, 2009, AM J GASTROENTEROL, V104, P1445, DOI 10.1038/ajg.2009.81; Haagsma EB, 2003, ALIMENT PHARM THER, V18, P33, DOI 10.1046/j.1365-2036.2003.01613.x; Ho GT, 2005, EUR J GASTROEN HEPAT, V17, P1379, DOI 10.1097/00042737-200512000-00018; Hueppelshaeuser R, 2012, PEDIATR NEPHROL, V27, P1103, DOI 10.1007/s00467-012-2126-8; Indriolo A, 2013, ALIMENT PHARM THER, V37, P840, DOI 10.1111/apt.12256; Indriolo A, 2014, WORLD J GASTROENTERO, V20, P3525, DOI 10.3748/wjg.v20.i13.3525; Joo M, 2009, AM J SURG PATHOL, V33, P854, DOI 10.1097/PAS.0b013e318196d018; Jorgensen KK, 2013, CLIN GASTROENTEROL H, V11, P517, DOI 10.1016/j.cgh.2012.12.027; Jorgensen KK, 2012, INFLAMM BOWEL DIS, V18, P536, DOI 10.1002/ibd.21699; Joshi D, 2013, LIVER INT, V33, P53, DOI 10.1111/j.1478-3231.2011.02677.x; Kaplan BS, 1998, J AM SOC NEPHROL, V9, P1126; Lal S, 2007, EUR J GASTROEN HEPAT, V19, P277, DOI 10.1097/MEG.0b013e3280116ccc; Lewis B, 2013, INFLAMM BOWEL DIS, V19, P1846, DOI 10.1097/MIB.0b013e31828a661e; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; Lundqvist K, 1997, DIS COLON RECTUM, V40, P451, DOI 10.1007/BF02258391; MacLean AR, 2003, DIS COLON RECTUM, V46, P1124, DOI 10.1007/s10350-004-7291-9; McAlister VC, 2006, AM J TRANSPLANT, V6, P1578, DOI 10.1111/j.1600-6143.2006.01360.x; Mohabbat AB, 2012, ALIMENT PHARM THER, V36, P569, DOI 10.1111/j.1365-2036.2012.05217.x; Moncrief KJ, 2010, CAN J GASTROENTEROL, V24, P40, DOI 10.1155/2010/830291; Navaneethan U, 2012, ALIMENT PHARM THER, V35, P1054, DOI 10.1111/j.1365-2036.2012.05067.x; O'Toole A, 2012, CLIN GASTROENTEROL H, V10, P439, DOI 10.1016/j.cgh.2011.11.010; Oikonomou K, 2011, INFLAMM BOWEL DIS, V17, P1034, DOI 10.1002/ibd.21468; OLSSON R, 1991, GASTROENTEROLOGY, V100, P1319; Papatheodoridis GV, 1998, GUT, V43, P639, DOI 10.1136/gut.43.5.639; Parameswaran S, 2011, Indian J Nephrol, V21, P120, DOI 10.4103/0971-4065.78063; Peraldi MN, 1997, NEPHROL DIAL TRANSPL, V12, P2744, DOI 10.1093/ndt/12.12.2744; Primas C, 2013, J CROHNS COLITIS, V7, P630, DOI DOI 10.1016/J.CR0HNS.2013.05.001; Reinisch W, 2008, AM J GASTROENTEROL, V103, P2284, DOI 10.1111/j.1572-0241.2008.02024.x; Rust C, 2011, GUT, V60, P1165, DOI 10.1136/gut.2011.240309; Saldeen K, 1999, SCAND J GASTROENTERO, V34, P535, DOI 10.1080/003655299750026308; Sandhu A, 2012, ALIMENT PHARM THER, V36, P159, DOI 10.1111/j.1365-2036.2012.05141.x; Sano H, 2011, J HEPATO-BIL-PAN SCI, V18, P154, DOI 10.1007/s00534-010-0319-8; Sattianayagam PT, 2013, DIGEST DIS SCI, V58, P1689, DOI 10.1007/s10620-012-2549-x; Shaked A, 1992, ANN SURG, V215, P4; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Singh S, 2013, AM J GASTROENTEROL, V108, P1417, DOI 10.1038/ajg.2013.163; Soetikno RM, 2002, GASTROINTEST ENDOSC, V56, P48, DOI 10.1067/mge.2002.125367; Sokol H, 2008, WORLD J GASTROENTERO, V14, P3497, DOI 10.3748/wjg.14.3497; STEPHENS J, 1993, TRANSPLANT P, V25, P1122; Temme J, 2010, TRANSPL P, V42, P3880, DOI 10.1016/j.transproceed.2010.08.044; Van de Vrie W, 2003, EUR J GASTROEN HEPAT, V15, P657, DOI 10.1097/00042737-200306000-00013; Verdonka RC, 2006, AM J TRANSPLANT, V6, P1422, DOI 10.1111/j.1600-6143.2006.01333.x; Yanai H, 2015, J CROHNS COLITIS, V9, P177, DOI 10.1093/ecco-jcc/jju013	57	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135807	10.1371/journal.pone.0135807	http://dx.doi.org/10.1371/journal.pone.0135807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288187	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600071
J	Ban, SS; Pressey, RL; Graham, NAJ				Ban, Stephen S.; Pressey, Robert L.; Graham, Nicholas A. J.			Assessing the Effectiveness of Local Management of Coral Reefs Using Expert Opinion and Spatial Bayesian Modeling	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE PROTECTED AREAS; CLIMATE-CHANGE; MULTIPLE STRESSORS; BELIEF NETWORK; WATER-QUALITY; PHASE-SHIFTS; CONSERVATION; RESILIENCE; NUTRIENT	Multiple stressors are an increasing concern in the management and conservation of ecosystems, and have been identified as a key gap in research. Coral reefs are one example of an ecosystem where management of local stressors may be a way of mitigating or delaying the effects of climate change. Predicting how multiple stressors interact, particularly in a spatially explicit fashion, is a difficult challenge. Here we use a combination of an expert-elicited Bayesian network (BN) and spatial environmental data to examine how hypothetical scenarios of climate change and local management would result in different outcomes for coral reefs on the Great Barrier Reef (GBR), Australia. Parameterizing our BN using the mean responses from our experts resulted in predictions of limited efficacy of local management in combating the effects of climate change. However, there was considerable variability in expert responses and uncertainty was high. Many reefs within the central GBR appear to be at risk of further decline based on the pessimistic opinions of our expert pool. Further parameterization of the model as more data and knowledge become available could improve predictive power. Our approach serves as a starting point for subsequent work that can fine-tune parameters and explore uncertainties in predictions of responses to management.	[Ban, Stephen S.; Pressey, Robert L.; Graham, Nicholas A. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University	Ban, SS (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	Stephen.ban@gmail.com	Graham, Nicholas AJ/C-8360-2014	Graham, Nicholas AJ/0000-0002-0304-7467	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	This study was supported by Australian Postgraduate Award.	Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Alvarez-Romero JG, 2013, J ENVIRON MANAGE, V119, P194, DOI 10.1016/j.jenvman.2013.01.036; Ban NC, 2012, CONSERV BIOL, V26, P799, DOI 10.1111/j.1523-1739.2012.01894.x; Ban SS, 2014, GLOBAL ENVIRON CHANG, V27, P64, DOI 10.1016/j.gloenvcha.2014.04.018; Bansal S, 2013, TREE PHYSIOL, V33, P451, DOI 10.1093/treephys/tpt019; BARRETT GW, 1976, BIOSCIENCE, V26, P192, DOI 10.2307/1297248; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bos AR, 2013, OCEAN COAST MANAGE, V71, P116, DOI 10.1016/j.ocecoaman.2012.09.011; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Burgman MA, 2013, DIVERS DISTRIB, V19, P485, DOI 10.1111/ddi.12060; Cain J., 2001, PLANNING IMPROVEMENT; Camerer CF, 1997, RES JUDGMENT DECISIO; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Chin A, 2012, MAR ECOL PROG SER, V460, P115, DOI 10.3354/meps09722; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Day J, 2000, P 9 INT COR REEF S B; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DPI F, 2012, ANN STAT REP 2011 CO; Drescher M, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00415.1; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; GOEDEN GB, 1982, BIOL CONSERV, V22, P273, DOI 10.1016/0006-3207(82)90022-2; GOREAU TJ, 1994, AMBIO, V23, P176; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Great Barrier Reef Marine Park Authority, 2013, ZON PERM PLANS 2013; Grech A, 2010, AQUAT CONSERV, V20, P437, DOI 10.1002/aqc.1107; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Haynes D, 2007, ENVIRON MANAGE, V40, P993, DOI 10.1007/s00267-007-9009-y; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; Holmes G, 2010, ECOL MODEL, V221, P1173, DOI 10.1016/j.ecolmodel.2010.01.010; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUSS WR, 1988, INT J FORECASTING, V4, P377, DOI 10.1016/0169-2070(88)90105-7; Kininmonth S, 2010, ECOL MODEL, V221, P2870, DOI 10.1016/j.ecolmodel.2010.08.042; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Kujala H, 2013, CONSERV LETT, V6, P73, DOI 10.1111/j.1755-263X.2012.00299.x; Landis WG, 2013, ENVIRON TOXICOL CHEM, V32, P79, DOI 10.1002/etc.2047; Leigh GM, 2014, QUEENSLAND DEPARTMEN; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Lindenmayer DB, 2010, P NATL ACAD SCI USA, V107, P21957, DOI 10.1073/pnas.1015696107; MacNeil MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P412, DOI 10.1111/j.1466-8238.2009.00515.x; Mantyka-Pringle CS, 2014, J APPL ECOL, V51, P572, DOI 10.1111/1365-2664.12236; Marcot BG, 2006, ECOLOGY SOC, V11; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Meesters EH, 1998, CONSERV BIOL, V12, P957, DOI 10.1046/j.1523-1739.1998.96421.x; Melbourne-Thomas J, 2011, ENVIRON MODELL SOFTW, V26, P66, DOI 10.1016/j.envsoft.2010.03.033; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; NOAA (National Oceanic and Atmospheric Administration), 2012, NOAAS INT ASS PROGR; Norsys Software Corporation, 1992, NET; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Page CA, 2009, DIS AQUAT ORGAN, V87, P135, DOI 10.3354/dao02112; Palmer M, 2011, MAR ECOL PROG SER, V430, P87, DOI 10.3354/meps09109; Payo DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2660; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Possingham HP, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P389, DOI 10.1007/0-387-24091-8_19; Pressey R, 2007, TRENDS ECOL EVOL; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; ROBERTS CM, 1995, CONSERV BIOL, V9, P988, DOI 10.1046/j.1523-1739.1995.9051332.x-i1; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Salbu B, 2005, J ENVIRON MONITOR, V7, P539, DOI 10.1039/b506220a; Schroeder T, 2012, MAR POLLUT BULL, V65, P210, DOI 10.1016/j.marpolbul.2012.02.022; Smith CS, 2007, BIOL CONSERV, V139, P333, DOI 10.1016/j.biocon.2007.06.025; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; Stelzenmuller V, 2011, MAR ECOL PROG SER, V441, P197, DOI 10.3354/meps09354; Stelzenmuller V, 2010, MAR POLLUT BULL, V60, P1743, DOI 10.1016/j.marpolbul.2010.06.024; Swart RJ, 2004, GLOBAL ENVIRON CHANG, V14, P137, DOI 10.1016/j.gloenvcha.2003.10.002; Thomas CR, 2008, BAYESIAN BELIEF NETW; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Wooldridge S, 2007, MARINE TROPICAL SCI, P21; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535	86	22	23	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135465	10.1371/journal.pone.0135465	http://dx.doi.org/10.1371/journal.pone.0135465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284372	Green Published, gold, Green Accepted			2022-12-27	WOS:000359666100040
J	Hsieh, CH; Chung, RH; Lee, WJ; Lin, MW; Chuang, LM; Quertermous, T; Assimes, T; Hung, YJ; Yu, YW				Hsieh, Chang-Hsun; Chung, Ren-Hua; Lee, Wen-Jane; Lin, Ming-Wei; Chuang, Lee-Ming; Quertermous, Thomas; Assimes, Themistocles; Hung, Yi-Jen; Yu, Ya-Wen			Effect of Common Genetic Variants of Growth Arrest-Specific 6 Gene on Insulin Resistance, Obesity and Type 2 Diabetes in an Asian Population	PLOS ONE			English	Article							TYROSINE KINASE RECEPTOR; ADIPOSE-TISSUE DEVELOPMENT; GAS6 GENE; PROTEIN-S; ASSOCIATION; INFLAMMATION; AXL; GLUCOSE; MICE; ADIPOGENESIS	Objectives Growth arrest-specific 6 (Gas6), a vitamin K-dependent protein, has been implicated in systemic inflammation, obesity, and insulin resistance (IR). Data from recent studies suggest that polymorphisms in the Gas6 gene are associated with cardiovascular disorders and type 2 diabetes (T2D). However, the association of Gas6 gene variants with obesity, IR, and T2D development has not been explored. Materials and Methods Four common single nucleotide polymorphisms (SNPs) in the Gas6 gene were genotyped in 984 participants from the Stanford Asia-Pacific Program for Hypertension and Insulin Resistance (SAPPHIRe) family cohort. An insulin suppression test was performed to determine IR based on steady-state plasma glucose (SSPG). Associations between IR indices and obesity, and SNP genotypes, based on previously-reported data for this cohort (Phase I), were analyzed. In the present follow-up study (Phase II), the effects of gene variants of Gas6 on the progression to T2D were explored in individuals who were free of T2D in Phase I. The mean follow-up period for Phase II was 5.7 years. Results The mean age of the study population in Phase I was 49.5 years and 16.7% of individuals developed T2D during follow-up. After adjusting for covariates, three SNPs (rs8191973, rs8197974, and rs7323932) were found to be associated with SSPG levels (p = 0.007, p = 0.03, and p = 0.011, respectively). This association remained significant after multiple testing and showed a significant interaction with physical activity for SNP rs8191973. However, no other significant correlations were observed between Gas6 polymorphisms and other indices of IR or obesity. A specific haplotype, AACG (from rs8191974, rs7323932, rs7331124, and rs8191973), was positively associated with SSPG levels (p = 0.0098). None of the polymorphisms were associated with an increased risk of T2D development. Conclusions Our results suggest that Gas6 gene variants are associated with IR, although their effects on subsequent progression to T2D were minimal in this prospective Asian cohort.	[Hsieh, Chang-Hsun; Hung, Yi-Jen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Chung, Ren-Hua; Yu, Ya-Wen] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Miaoli Country, Taiwan; [Lee, Wen-Jane; Lin, Ming-Wei] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Grad Inst Prevent Med, Sch Publ Hlth, Taipei 10764, Taiwan; [Quertermous, Thomas; Assimes, Themistocles] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Quertermous, Thomas; Assimes, Themistocles] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA	National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Stanford University; Stanford University	Hsieh, CH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan.	10324peter@gmail.com	Chung, Ren-Hua/AAB-8364-2019; Chuang, Lee-Ming/AAF-3324-2019; Assimes, Themistocles Leonard/D-9696-2015	Assimes, Themistocles Leonard/0000-0003-2349-0009; CHUANG, LEE-MING/0000-0003-0978-2662; Quertermous, Thomas/0000-0002-7645-9067	Tri-Service General Hospital [TSGH-C101-119, TSGH-C102-117]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107437] Funding Source: NIH RePORTER	Tri-Service General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present study was supported by grants from the Tri-Service General Hospital (TSGH-C101-119 and TSGH-C102-117).	Ader H., 2008, ADVISING RES METHODS, P271; Alciato F, 2010, J LEUKOCYTE BIOL, V87, P869, DOI 10.1189/jlb.0909610; Augustine KA, 1999, J CELL PHYSIOL, V181, P433, DOI 10.1002/(SICI)1097-4652(199912)181:3<433::AID-JCP7>3.0.CO;2-Y; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bellosta P, 1997, ONCOGENE, V15, P2387, DOI 10.1038/sj.onc.1201419; Blostein MD, 2011, J THROMB THROMBOLYS, V32, P272, DOI 10.1007/s11239-011-0597-2; Chang YC, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-58; Chung RH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-199; Ekman C, 2010, CLIN BIOCHEM, V43, P110, DOI 10.1016/j.clinbiochem.2009.07.025; Fourcot A, 2011, AM J PHYSIOL-GASTR L, V300, pG1043, DOI 10.1152/ajpgi.00311.2010; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; Hsiao FC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674069; Hsiao FC, 2013, J CLIN ENDOCR METAB, V98, pE267, DOI 10.1210/jc.2012-3179; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Hwu CM, 2004, BLOOD PRESSURE, V13, P355, DOI 10.1080/08037050410004828; Jiang L, 2009, AM J CLIN PATHOL, V131, P738, DOI 10.1309/AJCP3CX3AUVRBHCF; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Laurance S, 2012, ADV NUTR, V3, P196, DOI 10.3945/an.111.001826; Lee CH, 2012, DIABETES RES CLIN PR, V95, P201, DOI 10.1016/j.diabres.2011.09.013; Lijnen HR, 2011, J PHARMACOL EXP THER, V337, P457, DOI 10.1124/jpet.110.178046; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Maquoi E, 2005, ARTERIOSCL THROM VAS, V25, P1002, DOI 10.1161/01.ATV.0000160611.68791.c6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Munoz X, 2004, HUM MUTAT, V23, P506, DOI 10.1002/humu.20025; Munoz X, 2007, THROMB HAEMOSTASIS, V98, P406, DOI 10.1160/TH06-12-0681; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scroyen I, 2012, OBESITY, V20, P1168, DOI 10.1038/oby.2011.399; SHEN SW, 1970, J CLIN INVEST, V49, P2151, DOI 10.1172/JCI106433; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu KD, 2002, HYPERTENS RES, V25, P529	34	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135681	10.1371/journal.pone.0135681	http://dx.doi.org/10.1371/journal.pone.0135681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284522	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100057
J	Liu, JH; Zhang, XQ; Zhang, W; Gu, GJ; Wang, PJ				Liu, Jianhui; Zhang, Xiaoqing; Zhang, Wei; Gu, Guojun; Wang, Peijun			Effects of Sevoflurane on Young Male Adult C57BL/6 Mice Spatial Cognition	PLOS ONE			English	Article							EXTRASYNAPTIC NMDA RECEPTORS; NITROUS OXIDE ANESTHESIA; IN-VIVO; SYNAPTIC PLASTICITY; RAT BRAIN; AGED RATS; MEMORY; ISOFLURANE; EXPOSURE; ENHANCEMENT	Inhalation anesthetics are reported to affect cognition in both animals and humans. The influence of inhalation anesthetics in learning and memory are contradictory. We therefore investigated the effects of sevoflurane anesthesia with different durations on cognitive performance and the levels of NMDA receptor subunit NR2B, phosphorylated ERK1/2 (p-ERK1/2) and activated caspase3 in mouse hippocampus. We anaesthetized eight-week old male C57BL/6 mice with 2.5% sevoflurane for durations ranging from one to four hours. Non-anaesthetized mice served as controls. Mice exposed to sevoflurane for one to three hours showed improved performance, whereas mice with exposure up to four hours displayed similar behavioral performance as control group. NR2B was increased both at 24h and at two weeks post sevoflurane exposure in all groups. The p-ERK1/2: total ERK1/2 ratio increased at 24h in all anesthesia groups. The ratio remained elevated at two weeks in groups with two- to four-hour exposure. Activated caspase3 was detected elevated at 24h in groups with two- to four-hour exposure. The elevated trend of activated caspase3 was still detectable at two weeks in groups with three- to four-hour exposure. At two weeks post anesthesia, the typical morphology associated with apoptotic cells was observed in the hippocampus of mice exposed to four hours of sevoflurane. Our results indicate that 2.5% sevoflurane exposure for one to three hours improved spatial cognitive performance in young adult mice. The cognitive improvement might be related to the increase of NR2B, the p-ERK1/2: total ERK1/2 ratio in hippocampus. However, exposure to sevoflurane for four hours caused neurotoxicity due to caspase3 activation and apoptosis.	[Liu, Jianhui; Zhang, Xiaoqing] Tongji Univ, Tongji Hosp, Dept Anesthesiol, Shanghai 200092, Peoples R China; [Zhang, Wei; Gu, Guojun; Wang, Peijun] Tongji Univ, Tongji Hosp, Dept Med Image, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wang, PJ (corresponding author), Tongji Univ, Tongji Hosp, Dept Med Image, Shanghai 200092, Peoples R China.	peijunwang1246@163.com			National Nature Science Foundation of China [81200934]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China awarded to PJ Wang (81200934). The funder had roles in data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2008, P NATL ACAD SCI USA, V105, P1722, DOI 10.1073/pnas.0711651105; Bibb JA, 2010, J NEUROSCI, V30, P14987, DOI 10.1523/JNEUROSCI.4419-10.2010; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Edwards DA, 2010, ANESTHESIOLOGY, V112, P567, DOI 10.1097/ALN.0b013e3181cf9138; Fang F, 2012, NEUROSCI BULL, V28, P499, DOI 10.1007/s12264-012-1260-4; Feng X, 2012, BRIT J ANAESTH, V109, P225, DOI 10.1093/bja/aes121; Gibert S, 2012, ANESTHESIOLOGY, V117, P1253, DOI 10.1097/ALN.0b013e318273e272; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Haseneder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064732; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; KOMATSU H, 1993, ANESTH ANALG, V76, P609; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Rammes G, 2009, NEUROPHARMACOLOGY, V56, P626, DOI 10.1016/j.neuropharm.2008.11.002; Sakai EM, 2005, PHARMACOTHERAPY, V25, P1773, DOI 10.1592/phco.2005.25.12.1773; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Sava A, 2012, NEUROPHARMACOLOGY, V62, P925, DOI 10.1016/j.neuropharm.2011.09.025; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Sgambato V, 1998, J NEUROSCI, V18, P214; Solt K, 2007, CURR OPIN ANESTHESIO, V20, P300, DOI 10.1097/ACO.0b013e32816678a5; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Wang WY, 2016, MOL NEUROBIOL, V53, P216, DOI 10.1007/s12035-014-9005-1; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Zhang XG, 2008, NEUROSCI LETT, V447, P109, DOI 10.1016/j.neulet.2008.09.083; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006	37	18	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134217	10.1371/journal.pone.0134217	http://dx.doi.org/10.1371/journal.pone.0134217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285216	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100007
J	Tardivo, JP; Baptista, MS; Correa, JA; Adami, F; Pinhal, MAS				Tardivo, Joao Paulo; Baptista, Mauricio S.; Correa, Joao Antonio; Adami, Fernando; Silva Pinhal, Maria Aparecida			Development of the Tardivo Algorithm to Predict Amputation Risk of Diabetic Foot	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; OSTEOMYELITIS; MANAGEMENT; SEVERITY; SURGERY; ULCERS; FOCUS; SCORE; CARE	Diabetes is a chronic disease that affects almost 19% of the elderly population in Brazil and similar percentages around the world. Amputation of lower limbs in diabetic patients who present foot complications is a common occurrence with a significant reduction of life quality, and heavy costs on the health system. Unfortunately, there is no easy protocol to define the conditions that should be considered to proceed to amputation. The main objective of the present study is to create a simple prognostic score to evaluate the diabetic foot, which is called Tardivo Algorithm. Calculation of the score is based on three main factors: Wagner classification, signs of peripheral arterial disease (PAD), which is evaluated by using Peripheral Arterial Disease Classification, and the location of ulcers. The final score is obtained by multiplying the value of the individual factors. Patients with good peripheral vascularization received a value of 1, while clinical signs of ischemia received a value of 2 (PAD 2). Ulcer location was defined as forefoot, midfoot and hind foot. The conservative treatment used in patients with scores below 12 was based on a recently developed Photodynamic Therapy (PDT) protocol. 85.5% of these patients presented a good outcome and avoided amputation. The results showed that scores 12 or higher represented a significantly higher probability of amputation (Odds ratio and logistic regression-IC 95%, 12.2-1886.5). The Tardivo algorithm is a simple prognostic score for the diabetic foot, easily accessible by physicians. It helps to determine the amputation risk and the best treatment, whether it is conservative or surgical management.	[Tardivo, Joao Paulo; Correa, Joao Antonio; Adami, Fernando; Silva Pinhal, Maria Aparecida] Fac Med ABC, Santo Andre, SP, Brazil; [Tardivo, Joao Paulo] Fac Med ABC, Ctr Treatment Diabet Feet, Santo Andre, SP, Brazil; [Baptista, Mauricio S.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, SP, Brazil	Faculdade de Medicina do ABC; Faculdade de Medicina do ABC; Universidade de Sao Paulo	Baptista, MS (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, SP, Brazil.	baptista@iq.usp.br	Adami, Fernando/D-3855-2012; Baptista, Mauricio S/AAO-5749-2021; Baptista, Mauricio S/A-5140-2008; Pinhal, Maria Aparecida Silva/J-1797-2012	Adami, Fernando/0000-0003-1918-3364; Baptista, Mauricio S/0000-0001-7079-7666; Baptista, Mauricio S/0000-0001-7079-7666; Pinhal, Maria Aparecida Silva/0000-0003-4001-1663	FAPESP [12/50680-5, 13/07937-8]; CNPq [303016/2007-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (grants 12/50680-5 and 13/07937-8) who provided funds to buy equipments and reagents and CNPq (grant 303016/2007-8) provides funds for the activity of MASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayati MA, 2013, MED CLIN N AM, V97, P821, DOI 10.1016/j.mcna.2013.03.009; [Anonymous], NATIONAL DIABETES ST; Apelqvist J, 2011, J VASC SURG, V53, P1582, DOI 10.1016/j.jvs.2011.02.006; Barberan J, 2010, ENFERM INFEC MICR CL, V28, P680, DOI 10.1016/j.eimc.2009.12.017; Beckert S, 2006, DIABETES CARE, V29, P988, DOI 10.2337/dc05-2431; Bisland SK, 2006, PHOTOCH PHOTOBIO SCI, V5, P31, DOI 10.1039/b507082a; Brechow A, 2013, THER ADV ENDOCRINOL, V4, P83, DOI 10.1177/2042018813489719; Chung J, 2015, J VASC SURG, V61, P162, DOI 10.1016/j.jvs.2014.05.101; Elgzyri T, 2014, EUR J VASC ENDOVASC, V48, P440, DOI 10.1016/j.ejvs.2014.06.041; Goodney PP, 2014, JAMA SURG, V149, P34, DOI 10.1001/jamasurg.2013.4277; Henke PK, 2005, ANN SURG, V241, P885, DOI 10.1097/01.sla.0000164172.28918.3f; Jeffcoate WJ, 2011, DIABETOLOGIA, V54, P991, DOI 10.1007/s00125-011-2075-y; Lipsky BA, 2011, DIABETES CARE, V34, P1695, DOI 10.2337/dc11-0331; Lowe J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001814; Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Tardivo JP, 2009, PHOTOMED LASER SURG, V27, P145, DOI 10.1089/pho.2008.2252; Tardivo JP, 2014, PHOTODIAGN PHOTODYN, V11, P342, DOI 10.1016/j.pdpdt.2014.04.007; Tardivo JP, 2012, PHOTODYNAMIC THERAPY, P121; Trignano E, 2016, MICROSURG, V36, P37, DOI 10.1002/micr.22378; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Wukich DK, 2013, DIABETES CARE, V36, P2862, DOI 10.2337/dc12-2712	23	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135707	10.1371/journal.pone.0135707	http://dx.doi.org/10.1371/journal.pone.0135707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281044	Green Published, Green Submitted, gold			2022-12-27	WOS:000359664300019
J	Andrey, DO; Jousselin, A; Villanueva, M; Renzoni, A; Monod, A; Barras, C; Rodriguez, N; Kelley, WL				Andrey, Diego O.; Jousselin, Ambre; Villanueva, Maite; Renzoni, Adriana; Monod, Antoinette; Barras, Christine; Rodriguez, Natalia; Kelley, William L.			Impact of the Regulators SigB, Rot, SarA and sarS on the Toxic Shock Tst Promoter and TSST-1 Expression in Staphylococcus aureus	PLOS ONE			English	Article							VIRULENCE-DETERMINANT EXPRESSION; FIBRONECTIN-BINDING PROTEINS; GLOBAL REGULATION; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ALPHA-HEMOLYSIN; PATHOGENICITY ISLANDS; ENVIRONMENTAL-FACTORS; NASAL COLONIZATION; 2-COMPONENT SYSTEM	Staphylococcus aureus is an important pathogen manifesting virulence through diverse disease forms, ranging from acute skin infections to life-threatening bacteremia or systemic toxic shock syndromes. In the latter case, the prototypical superantigen is TSST-1 (Toxic Shock Syndrome Toxin 1), encoded by tst(H), and carried on a mobile genetic element that is not present in all S. aureus strains. Transcriptional regulation of tst is only partially understood. In this study, we dissected the role of sarA, sarS (sarH1), RNAIII, rot, and the alternative stress sigma factor sigB (sigma(B)). By examining tst promoter regulation predominantly in the context of its native sequence within the SaPI1 pathogenicity island of strain RN4282, we discovered that sB emerged as a particularly important tst regulator. We did not detect a consensus sigma(B) site within the tst promoter, and thus the effect of sigma(B) is likely indirect. We found that sigma(B) strongly repressed the expression of the toxin via at least two distinct regulatory pathways dependent upon sarA and agr. Furthermore rot, a member of SarA family, was shown to repress tst expression when overexpressed, although its deletion had no consistent measurable effect. We could not find any detectable effect of sarS, either by deletion or overexpression, suggesting that this regulator plays a minimal role in TSST-1 expression except when combined with disruption of sarA. Collectively, our results extend our understanding of complex multifactorial regulation of tst, revealing several layers of negative regulation. In addition to environmental stimuli thought to impact TSST-1 production, these findings support a model whereby sporadic mutation in a few key negative regulators can profoundly affect and enhance TSST-1 expression.	[Andrey, Diego O.; Renzoni, Adriana; Monod, Antoinette; Barras, Christine] Univ Hosp Geneva, Infect Dis Serv, CH-1211 Geneva 14, Switzerland; [Andrey, Diego O.; Jousselin, Ambre; Villanueva, Maite; Renzoni, Adriana; Monod, Antoinette; Barras, Christine; Rodriguez, Natalia; Kelley, William L.] Med Sch Geneva, CH-1211 Geneva 14, Switzerland; [Jousselin, Ambre; Villanueva, Maite; Rodriguez, Natalia; Kelley, William L.] Univ Hosp Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva; University of Geneva	Kelley, WL (corresponding author), Univ Hosp Geneva, Infect Dis Serv, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	william.kelley@unige.ch	Villanueva, Maite/AAA-9550-2020	Villanueva, Maite/0000-0002-3894-0060; jousselin, ambre/0000-0001-7003-5426; Renzoni, Adriana/0000-0002-4897-5208; ANDREY, Diego/0000-0003-3247-9274	Swiss National Science Foundation [3100A0-120428, 310030-146540]; Swiss Academy of Medical Sciences via the F. Hoffmann-La Roche Research Foundation; Swiss Society of Infections Diseases; University Hospital and Medical School of Geneva; Canton of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Academy of Medical Sciences via the F. Hoffmann-La Roche Research Foundation; Swiss Society of Infections Diseases; University Hospital and Medical School of Geneva; Canton of Geneva	This work was supported by grants from the Swiss National Science Foundation 3100A0-120428 and 310030-146540 (to WLK), an MD-PhD thesis doctoral training grant from the Swiss Academy of Medical Sciences via the F. Hoffmann-La Roche Research Foundation (to DOA), a fellowship grant from the Swiss Society of Infections Diseases (to NR), the University Hospital and Medical School of Geneva, and the Canton of Geneva.	Andrey DO, 2010, J BACTERIOL, V192, P6077, DOI 10.1128/JB.00146-10; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Baek KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077122; Ballal A, 2009, MICROBIOL-SGM, V155, P2342, DOI 10.1099/mic.0.027417-0; Benson MA, 2012, J BACTERIOL, V194, P4355, DOI 10.1128/JB.00706-12; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Bisognano C, 2004, J BIOL CHEM, V279, P9064, DOI 10.1074/jbc.M309836200; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Chan PF, 1998, J BACTERIOL, V180, P6232; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Cheung AL, 2001, INFECT IMMUN, V69, P2448, DOI 10.1128/IAI.69.4.2448-2455.2001; CHEUNG AL, 1994, J BACTERIOL, V176, P580, DOI 10.1128/jb.176.3.580-585.1994; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung AL, 1999, INFECT IMMUN, V67, P1331, DOI 10.1128/IAI.67.3.1331-1337.1999; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; GAVENTA S, 1989, REV INFECT DIS, V11, pS28; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Gertz S, 2000, J BACTERIOL, V182, P6983, DOI 10.1128/JB.182.24.6983-6991.2000; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Heinrichs JH, 1996, J BACTERIOL, V178, P418, DOI 10.1128/jb.178.2.418-423.1996; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jelsbak L, 2010, INT J MED MICROBIOL, V300, P229, DOI 10.1016/j.ijmm.2009.07.003; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Karlsson-Kanth A, 2006, INT J MED MICROBIOL, V296, P229, DOI 10.1016/j.ijmm.2006.01.067; KASS EH, 1989, REV INFECT DIS, V11, pS167; Kass EH, 1989, REV INFECT DIS SUPPL, V11, pS73; Kimber I, 2013, TOXICOL SCI, V134, P49, DOI 10.1093/toxsci/kft099; KIYOTA H, 1989, J INFECT DIS, V160, P1061, DOI 10.1093/infdis/160.6.1061; Koch G, 2014, CELL, V158, P1060, DOI 10.1016/j.cell.2014.06.046; KREISWIRTH BN, 1984, SURV SYN PATHOL RES, V3, P73; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; KREISWIRTH BN, 1989, REV INFECT DIS, V11, pS83; Kullik I, 1997, ARCH MICROBIOL, V167, P151, DOI 10.1007/s002030050428; Lamy B, 2012, EUR J CLIN MICROBIOL, V31, P1279, DOI 10.1007/s10096-011-1441-5; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Li JR, 2011, P NATL ACAD SCI USA, V108, P3360, DOI 10.1073/pnas.1017431108; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; Manna AC, 1998, J BACTERIOL, V180, P3828, DOI 10.1128/JB.180.15.3828-3836.1998; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McNamara PJ, 2009, ANTIMICROB AGENTS CH, V53, P1898, DOI 10.1128/AAC.01293-08; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Megevand C, 2010, CLIN MICROBIOL INFEC, V16, P1414, DOI 10.1111/j.1469-0691.2009.03090.x; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; MILLS JT, 1986, INFECT IMMUN, V53, P663, DOI 10.1128/IAI.53.3.663-670.1986; Mir-Sanchis I, 2012, MOL MICROBIOL, V85, P833, DOI 10.1111/j.1365-2958.2012.08145.x; Nagao M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-52; Nielsen JS, 2011, ARCH MICROBIOL, V193, P23, DOI 10.1007/s00203-010-0641-1; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Oscarsson J, 2005, INT J MED MICROBIOL, V295, P253, DOI 10.1016/j.ijmm.2005.05.003; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Parsonnet J, 2005, J CLIN MICROBIOL, V43, P4628, DOI 10.1128/JCM.43.9.4628-4634.2005; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Pragman AA, 2007, BIOCHEMISTRY-US, V46, P314, DOI 10.1021/bi0603266; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Ram G, 2012, P NATL ACAD SCI USA, V109, P16300, DOI 10.1073/pnas.1204615109; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Renzoni A, 2004, ANTIMICROB AGENTS CH, V48, P2958, DOI 10.1128/AAC.48.8.2958-2965.2004; Renzoni A, 2009, ANTIMICROB AGENTS CH, V53, P903, DOI 10.1128/AAC.01287-08; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; SARAFIAN SK, 1987, J MED MICROBIOL, V24, P75, DOI 10.1099/00222615-24-1-75; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Schlievert PM, 2013, ANTIMICROB AGENTS CH, V57, P5432, DOI 10.1128/AAC.01279-13; SCHLIEVERT PM, 1984, J INFECT DIS, V149, P471, DOI 10.1093/infdis/149.3.471; Schmidt KA, 2003, INFECT IMMUN, V71, P5139, DOI 10.1128/IAI.71.9.5139-5148.2003; Schulthess B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-17; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Seidl K, 2008, INFECT IMMUN, V76, P5093, DOI 10.1128/IAI.00724-08; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Subedi A, 2007, MICROBIOL-SGM, V153, P3235, DOI 10.1099/mic.0.2007/006932-0; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; TAYLOR D, 1989, REV INFECT DIS, V11, pS151; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; Ubeda C, 2005, MOL MICROBIOL, V56, P836, DOI 10.1111/j.1365-2958.2005.04584.x; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Yarwood JM, 2000, J CLIN MICROBIOL, V38, P1797, DOI 10.1128/JCM.38.5.1797-1803.2000; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	108	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135579	10.1371/journal.pone.0135579	http://dx.doi.org/10.1371/journal.pone.0135579			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275216	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600080
J	Chan, DL; Pavlakis, N; Shapiro, J; Price, TJ; Karapetis, CS; Tebbutt, NC; Segelov, E				Chan, David L.; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J.; Karapetis, Christos S.; Tebbutt, Niall C.; Segelov, Eva			Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature	PLOS ONE			English	Article							PHASE-III TRIAL; RANDOMIZED CONTROLLED-TRIAL; PLUS CETUXIMAB TREATMENT; KRAS WILD-TYPE; 1ST-LINE TREATMENT; RAS MUTATIONS; OPEN-LABEL; FLUOROURACIL; BEVACIZUMAB; LEUCOVORIN	Importance The EGFR inhibitors (EGFR-I) cetuximab and panitumumab and the angiogenesis inhibitors (AIs) bevacizumab and aflibercept have demonstrated varying efficacy in mCRC. Objective To document the overall impact of specific chemotherapy regimens on the efficacy of targeted agents in treating patients with mCRC. Data sources: MEDLINE, EMBASE and Cochrane databases were searched to 2014, supplemented by hand-searching ASCO/ESMO conference abstracts. Study Selection Published RCTs of patients with histologically confirmed mCRC were included if they investigated either 1) chemotherapy with or without a biological agent or 2) different chemotherapy regimens with the same biological agent. EGFR-I trials were restricted to KRAS exon 2 wild-type (WT) populations. Data Extraction and Synthesis Data were independently abstracted by two authors and trial quality assessed according to Cochrane criteria. The primary outcome was overall survival with secondary endpoints progression free survival (PFS), overall response rate (ORR) and toxicity. Results EGFR-I added to irinotecan-based chemotherapy modestly improved OS with HR 0.90 (95% CI 0.81-1.00, p = 0.04), but more so PFS with HR 0.77 (95% CI 0.69-0.86, p< 0.00001). No benefit was evident for EGFR-I added to oxaliplatin-based chemotherapy (OS HR 0.97 (95% CI 0.87-1.09) and PFS HR 0.92 (95% CI 0.83-1.02)). Significant oxaliplatin-irinotecan subgroup interactions were present for PFS with I-2 = 82%, p = 0.02. Further analyses of oxaliplatin+EGFR-I trials showed greater efficacy with infusional 5FU regimens (PFS HR 0.82, 95% CI 0.72-0.94) compared to capecitabine (HR 1.09; 95% CI 0.91-1.30) and bolus 5FU (HR 1.07; 95% CI 0.79-1.45); subgroup interaction was present with I-2 = 72%, p = 0.03. The oxaliplatin-irinotecan interaction was not evident for infusional 5FU regimens. For AIs, OS benefit was observed with both oxaliplatin-based (HR 0.83) and irinotecan- based (HR 0.77) regimens without significant subgroup interactions. Oxaliplatin+AI trials showed no subgroup interactions by type of FP, whilst an interaction was present for irinotecan+AI trials although aflibercept was only used with infusional FP (I-2 = 89.7%, p = 0.002). Conclusion and Relevance The addition of EGFR-I to irinotecan-based chemotherapy has consistent efficacy, regardless of FP regimen, whereas EGFR-I and oxaliplatin-based regimens were most active with infusional 5FU. No such differential activity was observed with the varying chemotherapy schedules when combined with AIs.	[Chan, David L.; Pavlakis, Nick] Univ Sydney, Royal N Shore Hosp, Northern Clin Sch, St Leonards, NSW 2065, Australia; [Shapiro, Jeremy] Monash Univ, Dept Med Oncol, Clayton, Vic 3800, Australia; [Price, Timothy J.] Queen Elizabeth Hosp, Woodville South, SA, Australia; [Price, Timothy J.] Univ Adelaide, Adelaide, SA 5005, Australia; [Karapetis, Christos S.] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Karapetis, Christos S.] Flinders Ctr Innovat Canc, Flinders Med Ctr, Bedford Pk, SA, Australia; [Tebbutt, Niall C.] Austin Hlth, Heidelberg, Vic, Australia; [Segelov, Eva] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia	Royal North Shore Hospital; University of Sydney; Monash University; University of Adelaide; Flinders University South Australia; Flinders Medical Centre; Flinders University South Australia; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of New South Wales Sydney	Chan, DL (corresponding author), Univ Sydney, Royal N Shore Hosp, Northern Clin Sch, St Leonards, NSW 2065, Australia.	dlhchan1@gmail.com	Segelov, Eva/Q-7611-2019; Chan, David L/E-7149-2017	Segelov, Eva/0000-0002-4410-6144; Karapetis, Christos/0000-0003-1741-996X	Sanofi; Roche	Sanofi(Sanofi-Aventis); Roche(Roche Holding)	DC has received honoraria from Roche and a travel grant from Sanofi. NP has received honoraria from Bayer, Roche and Sanofi, provided advice to Roche, Merck, Bayer, Sanofi and Amgen, and received a travel grant from Roche. JS has provided advice to Merck, Sanofi and Roche. TP has provided advice to Merck, Amgen, Sanofi and Roche. CK has provided advice to Merck, Amgen and Roche. ES has provided advice to Merck, Amgen, Sanofi and Roche. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bokemeyer C, 2015, EUR J CANCER, V51, P1243, DOI 10.1016/j.ejca.2015.04.007; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Borner M, 2008, ANN ONCOL, V19, P1288, DOI 10.1093/annonc/mdn058; Cassidy J, 2011, BRIT J CANCER, V105, P58, DOI 10.1038/bjc.2011.201; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Guan Zhong-Zhen, 2011, Chin J Cancer, V30, P682, DOI 10.5732/cjc.011.10188; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2013, ONCOLOGIST, V18, P1004, DOI 10.1634/theoncologist.2013-0107; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kabbinavar FF, 2008, ONCOLOGIST, V13, P1021, DOI 10.1634/theoncologist.2008-0003; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khattak MA, 2015, CLIN COLORECTAL CANC, V14, P81, DOI 10.1016/j.clcc.2014.12.011; Loupakis F, 2012, CANCER-AM CANCER SOC, V118, P1523, DOI 10.1002/cncr.26460; Masi G, 2013, ASCO M, V31, P3615; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Moosmann N, 2011, J CLIN ONCOL, V29, P1050, DOI 10.1200/JCO.2010.31.1936; Ocvirk J, 2010, WORLD J GASTROENTERO, V16, P3133, DOI 10.3748/wjg.v16.i25.3133; Passardi A, 2015, ANNALS OF ONCOLOGY O; Pericay C, 2012, ANN ONCOL, V23, P16, DOI 10.1016/S0923-7534(19)66488-4; Primrose J, 2014, LANCET ONCOL, V15, P601, DOI 10.1016/S1470-2045(14)70105-6; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Seymour MT, 2013, LANCET ONCOL, V14, P749, DOI 10.1016/S1470-2045(13)70163-3; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Vale CL, 2012, CANCER TREAT REV, V38, P618, DOI 10.1016/j.ctrv.2011.11.002; Van Cutsem E, 2015, J CLIN ONCOL, V33, P692, DOI 10.1200/JCO.2014.59.4812; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Venook AP, 2014, J CLIN ONCOLOGY OFFI, V32; Ye LC, 2013, J CLIN ONCOL, V31, P1931, DOI 10.1200/JCO.2012.44.8308; Zhou SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050925	40	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135599	10.1371/journal.pone.0135599	http://dx.doi.org/10.1371/journal.pone.0135599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275292	Green Published, gold			2022-12-27	WOS:000359493600081
J	Mahdavi, S; Kuyucak, S				Mahdavi, Somayeh; Kuyucak, Serdar			Mechanism of Ion Permeation in Mammalian Voltage-Gated Sodium Channels	PLOS ONE			English	Article							FREE-ENERGY SIMULATIONS; MOLECULAR-DYNAMICS; SELECTIVITY FILTER; CRYSTAL-STRUCTURE; CYSTEINE MUTAGENESIS; POTASSIUM CHANNELS; STRUCTURAL BASIS; MU-CONOTOXINS; BINDING-SITE; K+ CHANNEL	Recent determination of the crystal structures of bacterial voltage-gated sodium (Na-V) channels have raised hopes that modeling of the mammalian counterparts could soon be achieved. However, there are substantial differences between the pore domains of the bacterial and mammalian Na-V channels, which necessitates careful validation of mammalian homology models constructed from the bacterial Na-V structures. Such a validated homology model for the Na(V)1.4 channel was constructed recently using the extensive mutagenesis data available for binding of mu-conotoxins. Here we use this Na(V)1.4 model to study the ion permeation mechanism in mammalian Na-V channels. Linking of the DEKA residues in the selectivity filter with residues in the neighboring domains is found to be important for keeping the permeation pathway open. Molecular dynamics simulations and potential of mean force calculations reveal that there is a binding site for a Na+ ion just inside the DEKA locus, and 1-2 Na+ ions can occupy the vestibule near the EEDD ring. These sites are separated by a low free energy barrier, suggesting that inward conduction occurs when a Na+ ion in the vestibule goes over the free energy barrier and pushes the Na+ ion in the filter to the intracellular cavity, consistent with the classical knock-on mechanism. The Na(V)1.4 model also provides a good description of the observed Na+/K+ selectivity.	[Mahdavi, Somayeh; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney	Kuyucak, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	serdar@physics.usyd.edu.au	Kuyucak, Serdar/AAH-8417-2021	Kuyucak, Serdar/0000-0003-4315-9532				Ashcroft FM, 2001, ION CHANNELS DIS CHA; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Bastug T, 2006, BIOPHYS J, V90, P3941, DOI 10.1529/biophysj.105.074633; Bastug T, 2011, BIOPHYS J, V100, P629, DOI 10.1016/j.bpj.2010.12.3718; Bastug T, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2904461; Bastug T, 2009, BIOPHYS J, V96, P4006, DOI 10.1016/j.bpj.2009.02.041; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; Boiteux C, 2014, P NATL ACAD SCI USA, V111, P3454, DOI 10.1073/pnas.1320907111; Carnevale V, 2011, J PHYS CHEM LETT, V2, P2504, DOI 10.1021/jz2011379; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093267; Chiamvimonvat N, 1996, J PHYSIOL-LONDON, V491, P51, DOI 10.1113/jphysiol.1996.sp021195; Corry B, 2012, J AM CHEM SOC, V134, P1840, DOI 10.1021/ja210020h; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; Furini S, 2014, BIOPHYS J, V106, P2175, DOI 10.1016/j.bpj.2014.04.005; Furini S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002476; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Korkosh VS, 2014, J GEN PHYSIOL, V144, P231, DOI 10.1085/jgp.201411226; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li RA, 2004, TOXICON, V44, P117, DOI 10.1016/j.toxicon.2004.03.028; Mahdavi S, 2014, TOXINS, V6, P3454, DOI 10.3390/toxins6123454; Mahdavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105300; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Stock L, 2013, J PHYS CHEM B, V117, P3782, DOI 10.1021/jp401403b; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Xia MD, 2013, BIOPHYS J, V104, P2401, DOI 10.1016/j.bpj.2013.04.035; Yamagishi T, 1997, BIOPHYS J, V73, P195, DOI 10.1016/S0006-3495(97)78060-3; Zhang X, 2013, CELL RES, V23, P409, DOI 10.1038/cr.2012.173; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	48	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133000	10.1371/journal.pone.0133000	http://dx.doi.org/10.1371/journal.pone.0133000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274802	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600006
J	Onofriescu, M; Siriopol, D; Voroneanu, L; Hogas, S; Nistor, I; Apetrii, M; Florea, L; Veisa, G; Mititiuc, I; Kanbay, M; Sascau, R; Covic, A				Onofriescu, Mihai; Siriopol, Dimitrie; Voroneanu, Luminita; Hogas, Simona; Nistor, Ionut; Apetrii, Mugurel; Florea, Laura; Veisa, Gabriel; Mititiuc, Irina; Kanbay, Mehmet; Sascau, Radu; Covic, Adrian			Overhydration, Cardiac Function and Survival in Hemodialysis Patients	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; RANDOMIZED CONTROLLED-TRIAL; GUIDED FLUID MANAGEMENT; CHRONIC KIDNEY-DISEASE; MAINTENANCE HEMODIALYSIS; DIALYSIS PATIENTS; MORTALITY RISK; DRY-WEIGHT; BIOIMPEDANCE; ASSOCIATION	Background and objectives Chronic subclinical volume overload occurs very frequently and may be ubiquitous in hemodialysis (HD) patients receiving the standard thrice-weekly treatment. It is directly associated with hypertension, increased arterial stiffness, left ventricular hipertrophy, heart failure, and eventually, higher mortality and morbidity. We aimed to assess for the first time if the relationship between bioimpedance assessed overhydration and survival is maintained when adjustments for echocardiographic parameters are considered. Design, setting, participants and measurements A prospective cohort trial was conducted to investigate the impact of overhydration on all cause mortality and cardiovascular events (CVE), by using a previously reported cut-off value for overhydration and also investigating a new cut-off value derived from our analysis of this specific cohort. The body composition of 221 HD patients from a single center was assessed at baseline using bioimpedance. In 157 patients supplemental echocardiography was performed (echocardiography subgroup). Comparative survival analysis was performed using two cut-off points for relative fluid overload (RFO): 15% and 17.4%(a value determined by statistical analysis to have the best predictive value for mortality in our cohort). Results In the entire study population, patients considered overhydrated (using both cut-offs) had a significant increased risk for all-cause mortality in both univariate (HR = 2.12, 95% CI = 1.30-3.47 for RFO> 15% and HR = 2.86, 95% CI = 1.72-4.78 for RFO> 17.4%, respectively) and multivariate (HR = 1.87, 95% CI = 1.12-3.13 for RFO> 15% and HR = 2.72, 95% CI = 1.60-4.63 for RFO> 17.4%, respectively) Cox survival analysis. In the echocardiography subgroup, only the 17.4% cut-off remained associated with the outcome after adjustment for different echocardiographic parameters in the multivariate survival analysis. The number of CVE was significantly higher in overhydrated patients in both univariate (HR = 2.46, 95% CI = 1.56-3.87 for RFO > 15% and HR = 3.67, 95% CI = 2.29-5.89 for RFO > 17.4%) and multivariate (HR = 2.31, 95% CI = 1.42-3.77 for RFO > 15% and HR = 4.17, 95% CI = 2.48-7.02 for RFO > 17.4%) Cox regression analysis. Conclusions The study shows that the hydration status is associated with the mortality risk in a HD population, independently of cardiac morphology and function. We also describe and propose a new cut-off for RFO, in order to better define the relationship between overhydration and mortality risk. Further studies are needed to properly validate this new cut-off in other HD populations.	[Onofriescu, Mihai; Siriopol, Dimitrie; Voroneanu, Luminita; Hogas, Simona; Nistor, Ionut; Apetrii, Mugurel; Florea, Laura; Veisa, Gabriel; Mititiuc, Irina; Covic, Adrian] Univ Med & Pharm Gr T Popa, Dept Nephrol, Iasi, Romania; [Sascau, Radu] Univ Med & Pharm Gr T Popa, Dept Cardiol, Iasi, Romania; [Kanbay, Mehmet] Koc Univ, Sch Med, Div Nephrol, Dept Med, Istanbul, Turkey	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Koc University	Covic, A (corresponding author), Univ Med & Pharm Gr T Popa, Dept Nephrol, Iasi, Romania.	accovic@gmail.com	Siriopol, Dimitrie/AAA-4704-2020; Onofriescu, Mihai/HGE-3410-2022; Onofriescu, Mihai/GWQ-4875-2022; Covic, Adrian/G-5017-2016; Apetrii, Mugurel/AAQ-6163-2020; 1, 1/L-6277-2019	Siriopol, Dimitrie/0000-0003-1297-0648; Covic, Adrian/0000-0002-9985-2486; 	University of Medicine and Pharmacy [1643/01.02.2013]; UEFISCDI IDEI PCE [PN-II-ID-PCE-2011-3-0637]	University of Medicine and Pharmacy; UEFISCDI IDEI PCE(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This research was partially funded by University of Medicine and Pharmacy "Gr. T. Popa" Iasi, Grant no. 1643/01.02.2013 and UEFISCDI IDEI PCE, Grant nr. PN-II-ID-PCE-2011-3-0637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charra B, 1996, NEPHROL DIAL TRANSPL, V11, P16; CHARRA B, 1992, KIDNEY INT, V41, P1286, DOI 10.1038/ki.1992.191; Chazot C, 1999, NEPHROL DIAL TRANSPL, V14, P121, DOI 10.1093/ndt/14.1.121; Chazot C, 2012, NEPHROL DIAL TRANSPL, V27, P2404, DOI 10.1093/ndt/gfr678; Covic AC, 2013, ANN NONINVAS ELECTRO, V18, P188, DOI 10.1111/anec.12007; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; Ferrario M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-26; FOLEY RN, 1995, J AM SOC NEPHROL, V5, P2024; Grambsch PM, 1995, BIOMETRICS, V51, P1469, DOI 10.2307/2533277; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Innes A, 1999, NEPHROL DIAL TRANSPL, V14, P919, DOI 10.1093/ndt/14.4.919; Kramer A, 2012, CLIN J AM SOC NEPHRO, V7, P1655, DOI 10.2215/CJN.10461011; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu S, 2012, HEMODIAL INT, V16, P504, DOI 10.1111/j.1542-4758.2012.00700.x; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; Machek P, 2010, NEPHROL DIAL TRANSPL, V25, P538, DOI 10.1093/ndt/gfp487; Moissl U, 2013, CLIN J AM SOC NEPHRO, V8, P1575, DOI 10.2215/CJN.12411212; Onofriescu M, 2014, AM J KIDNEY DIS, V64, P111, DOI 10.1053/j.ajkd.2014.01.420; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Wabel P, 2008, NEPHROL DIAL TRANSPL, V23, P2965, DOI 10.1093/ndt/gfn228; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Yu WC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-115; Zoccali C, 2001, J AM SOC NEPHROL, V12, P2768, DOI 10.1681/ASN.V12122768	24	64	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135691	10.1371/journal.pone.0135691	http://dx.doi.org/10.1371/journal.pone.0135691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274811	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600096
J	Shershakova, N; Bashkatova, E; Babakhin, A; Andreev, S; Nikonova, A; Shilovsky, I; Kamyshnikov, O; Buzuk, A; Elisyutina, O; Fedenko, E; Khaitov, M				Shershakova, Nadezda; Bashkatova, Elena; Babakhin, Alexander; Andreev, Sergey; Nikonova, Alexandra; Shilovsky, Igor; Kamyshnikov, Oleg; Buzuk, Andrey; Elisyutina, Olga; Fedenko, Elena; Khaitov, Musa			Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; EPICUTANEOUS SENSITIZATION; LYSINE SUCCINYLATION; AIRWAY INFLAMMATION; PROTEINS; IL-17; SKIN; MECHANISMS; EXPOSURE; EFFICACY	Atopic dermatitis (AD) is a widespread and difficult to treat allergic skin disease and is a tough challenge for healthcare. In this study, we investigated whether allergen-specific immunotherapy (ASIT) with a monomeric allergoid obtained by succinylation of ovalbumin (sOVA) is effective in a mouse model of atopic dermatitis. An experimental model of AD was reproduced by epicutaneous sensitization with ovalbumin (OVA). ASIT was performed with subcutaneous (SC) administration of increasing doses of OVA or sOVA. The levels of anti-OVA antibodies, as well as cytokines, were detected by ELISA. Skin samples from patch areas were taken for histologic examination. ASIT with either OVA or sOVA resulted in a reduction of both the anti-OVA IgE level and the IgG1/IgG2a ratio. Moreover, ASIT with sOVA increased the IFN-gamma level in supernatants after splenocyte stimulation with OVA. Histologic analysis of skin samples from the sites of allergen application showed that ASIT improved the histologic picture by decreasing allergic inflammation in comparison with untreated mice. These data suggest that ASIT with a succinylated allergen represents promising approach for the treatment of AD.	[Shershakova, Nadezda; Bashkatova, Elena; Babakhin, Alexander; Andreev, Sergey; Nikonova, Alexandra; Shilovsky, Igor; Kamyshnikov, Oleg; Khaitov, Musa] Fed Med Biol Agcy Russia, Natl Res Ctr, Dept Nanobiomed Technol, Inst Immunol, Moscow, Russia; [Elisyutina, Olga; Fedenko, Elena] Fed Med Biol Agcy Russia, Natl Res Ctr, Dept Skin Allergol & Immunopathol, Inst Immunol, Moscow, Russia; [Buzuk, Andrey] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, London, England	NRC Institute of Immunology FMBA of Russia; NRC Institute of Immunology FMBA of Russia; Imperial College London	Shershakova, N (corresponding author), Fed Med Biol Agcy Russia, Natl Res Ctr, Dept Nanobiomed Technol, Inst Immunol, Moscow, Russia.	nn.shershakova@nrcii.ru; sm.andreev@nrcii.ru; mr.khaitov@nrcii.ru	Khaitov, Musa R/L-3369-2017; Elisyutina, Olga/S-2549-2016; Shershakova, Nadezda/AAW-8734-2020; Fedenko, Elena S./P-6912-2015; Baraboshkina, Elena/G-6848-2017; Khaitov, Musa/AAC-1516-2021; Fedenko, Elena/AAH-9814-2020; Nikonova, Alexandra/A-4206-2014	Khaitov, Musa R/0000-0003-4961-9640; Elisyutina, Olga/0000-0002-4609-2591; Shershakova, Nadezda/0000-0001-6444-6499; Fedenko, Elena S./0000-0003-3358-5087; Khaitov, Musa/0000-0003-4961-9640; Fedenko, Elena/0000-0003-3358-5087; Nikonova, Alexandra/0000-0001-9610-0935	Ministry of Science and Education of the Russian Federation, Federal target program "Research and development on priority directions of scientific-technological complex of Russia" [14.604.21.0059, RFMEFI60414X0059]	Ministry of Science and Education of the Russian Federation, Federal target program "Research and development on priority directions of scientific-technological complex of Russia"	This work was supported by the Ministry of Science and Education of the Russian Federation, the Federal target program "Research and development on priority directions of scientific-technological complex of Russia in 2014 - 2020" (agreement 14.604.21.0059, the unique identifier RFMEFI60414X0059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2011, ALLERGY, V66, P1261, DOI 10.1111/j.1398-9995.2011.02656.x; Akdis CA, 2000, INT ARCH ALLERGY IMM, V121, P261, DOI 10.1159/000024352; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; ANDREEV SM, 1986, BIOORG KHIM+, V12, P725; ANDREEV SM, 1987, BIOORG KHIM+, V13, P696; Arkwright PD, 2013, J ALLER CL IMM-PRACT, V1, P142, DOI 10.1016/j.jaip.2012.09.002; Babakhin A.A., 2011, IMMUNOPHARMACOGENOMI, V7, P17; Babakhin A.A., 2011, IMMUNOFARMAKOGENOMIK, V11, P3; BABAKHIN AA, 1995, ALLERGY PROC, V16, P261, DOI 10.2500/108854195778702620; Bae JM, 2013, J ALLERGY CLIN IMMUN, V132, P110, DOI 10.1016/j.jaci.2013.02.044; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Bieber T, 2009, CURR ALLERGY ASTHM R, V9, P291, DOI 10.1007/s11882-009-0041-2; Bonness S, 2007, CURR OPIN ALLERGY CL, V7, P382, DOI 10.1097/ACI.0b013e3282a643c3; Bussmann C, 2007, CLIN EXP ALLERGY, V37, P1277, DOI 10.1111/j.1365-2222.2007.02783.x; Calderon M.A., 2012, CLIN TRANSL ALLERGY, V2, P1, DOI DOI 10.1186/2045-7022-2-20; CHANG TS, 1978, INT J PEPT PROT RES, V11, P65; Compalati E, 2012, CURR OPIN ALLERGY CL, V12, P427, DOI 10.1097/ACI.0b013e328354e540; Darsow U, 2011, CURR ALLERGY ASTHM R, V11, P277, DOI 10.1007/s11882-011-0194-7; Dioszeghy V, 2011, J IMMUNOL, V186, P5629, DOI 10.4049/jimmunol.1003134; Gushchin I. S., 1997, Russ J Immunol, V2, P111; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; He R, 2009, J ALLERGY CLIN IMMUN, V124, P761, DOI 10.1016/j.jaci.2009.07.040; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Kezic S, 2014, FRONT BIOSCI-LANDMRK, V19, P541, DOI 10.2741/4225; Khaitov M.R., 2004, ROSSIYSKIY ALLERGOLO, V1, P73; Kushak RI, 1987, IZVESTIA ACAD NAUK L, V7, P74; Liu ZX, 2014, NUCLEIC ACIDS RES, V42, pD531, DOI 10.1093/nar/gkt1093; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; MISTRELLO G, 1994, IMMUNOL LETT, V40, P31, DOI 10.1016/0165-2478(94)90202-X; Mosges R, 2010, ACTA DERMATOVEN ALP, V19, P3; Mondoulet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031967; Nakatsukasa H, 2009, J HEALTH SCI, V55, P516, DOI 10.1248/jhs.55.516; Noon L, 1911, LANCET, V1, P1572; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Passalacqua G, 1998, LANCET, V351, P629, DOI 10.1016/S0140-6736(97)07055-4; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Shershakova N.N., 2011, PHYSL PATHOLOGIYA IM, V18, P3; Silva CJSM, 2004, FOOD TECHNOL BIOTECH, V42, P51; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; TAYYAB S, 1986, J BIOCHEM, V100, P1125, DOI 10.1093/oxfordjournals.jbchem.a121816; Toda M, 2003, J ALLERGY CLIN IMMUN, V111, P875, DOI 10.1067/mai.2003.1414; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Wollenberg A, 2012, ANN DERMATOL, V24, P253, DOI 10.5021/ad.2012.24.3.253; Yu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039032; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	47	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135070	10.1371/journal.pone.0135070	http://dx.doi.org/10.1371/journal.pone.0135070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275152	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600049
J	Ding, D; Do, A; Schmidt, HM; Bauman, AE				Ding, Ding; Do, Anna; Schmidt, Heather-Marie; Bauman, Adrian E.			A Widening Gap? Changes in Multiple Lifestyle Risk Behaviours by Socioeconomic Status in New South Wales, Australia, 2002-2012	PLOS ONE			English	Article							HEALTH BEHAVIORS; US ADULTS; ALL-CAUSE; MORTALITY; INEQUALITIES; POPULATION; SAMPLE; CARE	Background Socioeconomic inequalities in health outcomes have increased over the past few decades in some countries. However, the trends in inequalities related to multiple health risk behaviours have been infrequently reported. In this study, we examined the trends in individual health risk behaviours and a summary lifestyle risk index in New South Wales, Australia, and whether the absolute and relative inequalities in risk behaviours by socioeconomic positions have changed over time. Methods Using data from the annual New South Wales Adult Population Health Survey during the period of 2002-2012, we examined four individual risk behaviours (smoking, higher than recommended alcohol consumption, insufficient fruit and vegetable intake, and insufficient physical activity) and a combined lifestyle risk indicator. Socioeconomic inequalities were assessed based on educational attainment and postal area-level index of relative socioeconomic disadvantage (IRSD), and were presented as prevalence difference for absolute inequalities and prevalence ratio for relative inequalities. Trend tests and survey logistic regression models examined whether the degree of absolute and relative inequalities between the most and least disadvantaged subgroups have changed over time. Results The prevalence of all individual risk behaviours and the summary lifestyle risk indicator declined from 2002 to 2012. Particularly, the prevalence of physical inactivity and smoking decreased from 52.6% and 22% in 2002 to 43.8% and 17.1% in 2012 (p for trend<0.001). However, a significant trend was observed for increasing absolute and relative inequalities in smoking, insufficient fruit and vegetable consumption, and the summary lifestyle risk indicator. Conclusions The overall improvement in health behaviours in New South Wales, Australia, co-occurred with a widening socioeconomic gap.	[Ding, Ding; Bauman, Adrian E.] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Camperdown, NSW, Australia; [Do, Anna] New South Wales Minist Hlth, Ctr Epidemiol & Evidence, Sydney, NSW, Australia; [Schmidt, Heather-Marie] New South Wales Minist Hlth, Ctr Populat Hlth, Sydney, NSW, Australia	University of Sydney	Ding, D (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Camperdown, NSW, Australia.	melody.ding@sydney.edu.au	Ding, Ding/AAF-9985-2021	Ding, Ding/0000-0001-9850-9224; Schmidt, Heather-Marie/0000-0002-2629-6407	Early Career Fellowship from National Health and Medical Research Council	Early Career Fellowship from National Health and Medical Research Council	This study is funded by an Early Career Fellowship from the National Health and Medical Research Council (Ding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NSW POPULATION HEALT; Australian Bureau of Statistics, 2011, PHYSICAL ACTIVITY IN; Australian Bureau of Statistics, 2013, SMOKING KEY SERIES; Australian Government Department of Health and Ageing, 2013, EAT FOR HEALTH AUSTR; Australian Government National Health and Medical Research Council, 2009, AUSTRALIAN GUIDELINE; Australian Institute of Health and Welfare, 2012, CAT NO PHE 157; Australian Institute of Health and Welfare (AIHW), 2003, THE ACTIVE AUSTRALIA; Barr M, 2008, POPULATION HEALTH SU; Barr M., 2013, CALL OUTCOME INFORMA; Barr ML, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-177; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P535, DOI 10.1111/j.1753-6405.2008.00305.x; Buck D, 2012, CLUSTERING OF UNHEAL; Cancer Institute NSW, 2009, NSW GO FOR 2 5 2008; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Centre for Epidemiology and Research, 2008, 2008 REPORT ON ADULT; Centre for Population Health, 2012, SMOKE FREE LEGISLATI; Chipperfield JO, 2013, 59TH ISI WORLD STATI; Crombie IK, 2005, CLOSING THE HEALTH I; Ding D, 2014, PREV MED, V60, P102, DOI 10.1016/j.ypmed.2013.12.021; Drieskens S, 2010, EUR J PUBLIC HEALTH, V20, P634, DOI 10.1093/eurpub/ckp185; Foundation for Alcohol Research and Education, 2013, 10 YEARS ON AN ANALY; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; King EL, 2017, HLTH ED RES, V28, P1029; Korda RJ, 2007, INT J EPIDEMIOL, V36, P157, DOI [10.1093/ijc/dyl282, 10.1093/ije/dyl282]; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Miller Yvette, 2005, N S W Public Health Bull, V16, P141; Najman JM, 2006, B WORLD HEALTH ORGAN, V84, P976, DOI 10.2471/BLT.05.028928; O'Hara B, 2013, BMC PUBLIC HEALTH, V13, P1; Pink B., 2013, SOCIO ECONOMIC INDEX; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Rogers Everett M, 2003, DIFFUSION INNOVATION, V5th ed., DOI DOI 10.1016/J.JMIG.2007.07.001; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; Woolcott Research, 2007, RESEARCH REPORT EVAL; World Health Organization, 2014, WORLD HEALTH STATIST; World Health Organization, 2009, GLOBAL HEALTH RISKS; World Health Organization (WHO), 1999, EUROPEAN HEALTH FOR	44	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135338	10.1371/journal.pone.0135338	http://dx.doi.org/10.1371/journal.pone.0135338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291457	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900016
J	Zhu, WJ; Xu, BH				Zhu, Wenjie; Xu, Binghe			Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study	PLOS ONE			English	Article							HEMOGLOBIN LEVELS; TREATMENT RESISTANCE; RADIATION-THERAPY; PROGNOSTIC-FACTOR; TUMOR HYPOXIA; CELLS; IMPACT; ERYTHROPOIETIN; CARCINOMA; OUTCOMES	Background Anemia related to adjuvant chemotherapy might predict compromised survival in patients with breast cancer. The present population-based study was to investigate the correlation of pretreatment anemia with pathological response and long-term prognosis of breast cancer patients receiving neoadjuvant chemotherapy (NCT). Methods From 1999 to 2011, a total of 655 patients with operable or locally advanced breast cancer who underwent NCT before definitive surgery were reviewed. The patients were subdivided into anemic (baseline hemoglobin (Hb)<12.0g/dL) and non-anemic (Hb >= 12.0g/dL) groups. Comparison was made between anemic and non-anemic groups concerning the rate of pathological complete response (pCR), relapse-free survival (RFS), overall survival (OS) and cancer-specific survival (CSS). Logistic and Cox regression models were utilized to determine the predictive value of pretreatment anemia in outcomes of patients undergoing NCT. Results 166 women (25.3%) were anemic before treatment. Patients in the anemic group were less likely to achieve pCR in NCT than their non-anemic counterparts (odds ratio (OR) 0.428, 95% confidence interval (CI) 0.198-0.927, p = 0.031). Patients with baseline anemia displayed inferior 10-year RFS (59.1% vs 66.0%, p = 0.022 by log-rank), OS (75.3% vs 90.9%, p <0.001) and CSS (82.4% vs 94.4%, p<0.001) compared with those without. After adjustment for confounders, pretreatment anemia was demonstrated to correlate with elevated risk of relapse (hazard ratio (HR) 1.453, 95% CI 1.077-1.962, p = 0.015), cancer-specific mortality (HR 2.961, 95% CI 1.679-5.222, p<0.001) and all-cause mortality (HR 2.873, 95% CI 1.757-4.699, p<0.001). Conclusions Pretreatment anemia was associated with worse pathological response to NCT as well as survival status in breast cancer. Further studies are warranted to identify optimal interventions and improve the prognosis of this subgroup.	[Xu, Binghe] Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, BH (corresponding author), Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing 100730, Peoples R China.	bhxu@hotmail.com						Aapro M, 2015, ANN ONCOL, V26, P688, DOI 10.1093/annonc/mdu579; Beresford MJ, 2006, CLIN ONCOL-UK, V18, P453, DOI 10.1016/j.clon.2006.04.006; Boehm DU, 2007, ANTICANCER RES, V27, P1223; Bottini A, 2003, BRIT J CANCER, V89, P977, DOI 10.1038/sj.bjc.6601216; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Dubsky P, 2008, CLIN CANCER RES, V14, P2082, DOI 10.1158/1078-0432.CCR-07-2068; DUNPHY EP, 1989, INT J RADIAT ONCOL, V16, P1173, DOI 10.1016/0360-3016(89)90277-0; Feldmann HJ, 2001, LUNG CANCER S1, V33, P77; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Flamant L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-191; Gilreath JA, 2014, AM J HEMATOL, V89, P203, DOI 10.1002/ajh.23628; Green SL, 1998, CANCER J SCI AM, V4, P218; Grogan M, 1999, CANCER, V86, P1528, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E; Harrison LB, 2002, ONCOLOGIST, V7, P492, DOI 10.1634/theoncologist.7-6-492; Hedley BD, 2011, CLIN CANCER RES, V17, P6151, DOI 10.1158/1078-0432.CCR-10-3298; Henke M, 2004, STRAHLENTHER ONKOL, V180, P45, DOI 10.1007/s00066-004-1123-7; Hu Kenneth, 2005, Curr Treat Options Oncol, V6, P31, DOI 10.1007/s11864-005-0011-4; Kamby C, 1999, CLIN ONCOL-UK, V11, P156, DOI 10.1053/clon.1999.9033; Khorana AA, 2008, ARCH INTERN MED, V168, P2377, DOI 10.1001/archinte.168.21.2377; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Matthews NE, 2001, J NATL CANCER I, V93, P1879, DOI 10.1093/jnci/93.24.1879; PAN SS, 1981, MOL PHARMACOL, V19, P184; Rodgers GM, 2012, J NATL COMPR CANC NE, V10, P628, DOI 10.6004/jnccn.2012.0064; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Thompson CA, 2006, BRIT J HAEMATOL, V135, P405, DOI 10.1111/j.1365-2141.2006.06295.x; Todaro M, 2013, CANCER RES, V73, P6393, DOI 10.1158/0008-5472.CAN-13-0248; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2005, TRANSFUS CLIN BIOL, V12, P5, DOI 10.1016/j.tracli.2004.11.005; Wilson J, 2007, HEALTH TECHNOL ASSES, V11, P1; Zhang YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-844	30	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136268	10.1371/journal.pone.0136268	http://dx.doi.org/10.1371/journal.pone.0136268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291454	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900071
J	Davis, AJ; Phillips, ML; Doherty, PF				Davis, Amy J.; Phillips, Michael L.; Doherty, Paul F., Jr.			Nest Success of Gunnison Sage-Grouse in Colorado, USA	PLOS ONE			English	Article							CENTROCERCUS-UROPHASIANUS; HABITAT SELECTION; SITE SELECTION; MONO COUNTY; PREDATION; SURVIVAL	Gunnison Sage-Grouse (Centrocercus minimus) is a species of concern for which little demographic information exists. To help fill this information gap, we investigated factors affecting nest success in two populations of Gunnison Sage-Grouse. We assessed the relative effects of (1) vegetation characteristics (e.g., shrub height, shrub cover, grass cover, and grass height), (2) temporal factors (e.g., year, timing of incubation initiation, and nest age), (3) precipitation, and (4) age of the nesting female (yearling or adult) on nest success rates. We found 177 nests in the Gunnison Basin population (that contains 85-90% of the species) from 2005-2010 and 20 nests in the San Miguel population (that contains < 10% of the species) from 2007-2010. Temporal factors had the greatest impact on nest success compared to vegetation characteristics, precipitation, and female age. Nest success varied considerably among years ranging from 4.0%-60.2% in Gunnison Basin and from 12.9%51.9% in San Miguel. Nests that were initiated earlier in the breeding season had higher nest success (at least one egg hatches). Daily nest survival rates decreased during the course of incubation. None of the vegetation characteristics we examined were strongly related to nest success.	[Davis, Amy J.; Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Phillips, Michael L.] Colorado Pk & Wildlife, Ft Collins, CO USA	Colorado State University	Davis, AJ (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Ft Collins, CO 80521 USA.	Amy.J.Davis@aphis.usda.gov			Colorado State University	Colorado State University	Colorado Parks and Wildlife funded the research with support from Colorado State University.	Aldridge CL, 2012, J WILDLIFE MANAGE, V76, P391, DOI 10.1002/jwmg.268; Aldridge CL, 2002, J WILDLIFE MANAGE, V66, P433, DOI 10.2307/3803176; Apa A.D., 2004, HABITAT USE MO UNPUB; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Beck T. D. I., 1975, SEX AGE DETERMINATIO; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; Coates PS, 2008, CONDOR, V110, P627, DOI 10.1525/cond.2008.8579; CONNELLY JW, 1993, CONDOR, V95, P1041, DOI 10.2307/1369443; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Connelly JW, 2011, STUDIES AVIAN BIOL, V38; Conover MR, 2010, CONDOR, V112, P331, DOI 10.1525/cond.2010.090172; Crete M, 2003, CAN J ZOOL, V81, P1808, DOI 10.1139/Z03-182; Dalke P. D., 1963, Journal of Wildlife Management, V27, P811; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Davis, 2012, THESIS COLORADO STAT; Dinkins JB, 2012, AUK, V129, P600, DOI 10.1525/auk.2012.12009; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Doherty KE, 2014, WILDLIFE BIOL, V20, P320, DOI 10.2981/wlb.00004; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; GREGG MA, 1994, J WILDLIFE MANAGE, V58, P162, DOI 10.2307/3809563; Gunnison Sage-Grouse Rangewide Steering Committee, 2005, GUNN SAG GROUS RENG; Hagen CA, 2007, WILDLIFE BIOL, V13, P42, DOI 10.2981/0909-6396(2007)13[42:AMOGSC]2.0.CO;2; Herman-Brunson KM, 2009, WILDLIFE BIOL, V15, P395, DOI 10.2981/09-005; HINES JE, 1983, J WILDLIFE MANAGE, V47, P1063, DOI 10.2307/3808165; Holloran MJ, 2005, J WILDLIFE MANAGE, V69, P638, DOI 10.2193/0022-541X(2005)069[0638:GSNHSA]2.0.CO;2; HUPP JW, 1989, J WILDLIFE MANAGE, V53, P823, DOI 10.2307/3809220; Johnson HE, 2010, ECOL APPL, V20, P1753, DOI 10.1890/09-1107.1; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1341, DOI 10.2193/2008-339; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1333, DOI 10.2193/2008-338; Mabille G, 2010, POPUL ECOL, V52, P537, DOI 10.1007/s10144-010-0198-5; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Miller R, 2011, ECOLOGY CONSERVATION; Moynahan BJ, 2007, J WILDLIFE MANAGE, V71, P1773, DOI 10.2193/2005-386; Nams VO, 1990, LOCATE; National Oceanic and Atmospheric Administration, 2012, CLIM DAT ANN SUMM CO, P110; Patterson BR, 1998, CAN J ZOOL, V76, P1885, DOI 10.1139/cjz-76-10-1885; Popham GP, 2003, WILDLIFE BIOL, V9, P327, DOI 10.2981/wlb.2003.021; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Randa LA, 2009, J MAMMAL, V90, P594, DOI 10.1644/08-MAMM-A-092R1.1; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Stiver JA, 2007, POLYGYNY EFFECTIVE P; Stiver JR, 2008, BIOL CONSERV, V141, P472, DOI 10.1016/j.biocon.2007.10.018; Sveum CM, 1998, J RANGE MANAGE, V51, P265, DOI 10.2307/4003409; U.S. Fish and Wildlife Service, 2014, THREAT STAT GUNN SAG; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; WALLESTAD R, 1974, J WILDLIFE MANAGE, V38, P630, DOI 10.2307/3800029; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winter M, 2005, J WILDLIFE MANAGE, V69, P185, DOI 10.2193/0022-541X(2005)069&lt;0185:VIVEOD&gt;2.0.CO;2; Wisdom MJ, 1997, J WILDLIFE MANAGE, V61, P302, DOI 10.2307/3802585; Young JR, 1994, THESIS PURDUE U W LA	53	6	6	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136310	10.1371/journal.pone.0136310	http://dx.doi.org/10.1371/journal.pone.0136310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287996	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600128
J	Fast, SM; Gonzalez, MC; Markuzon, N				Fast, Shannon M.; Gonzalez, Marta C.; Markuzon, Natasha			Cost-Effective Control of Infectious Disease Outbreaks Accounting for Societal Reaction	PLOS ONE			English	Article							IMPACT	Background Studies of cost-effective disease prevention have typically focused on the tradeoff between the cost of disease transmission and the cost of applying control measures. We present a novel approach that also accounts for the cost of social disruptions resulting from the spread of disease. These disruptions, which we call social response, can include heightened anxiety, strain on healthcare infrastructure, economic losses, or violence. Methodology The spread of disease and social response are simulated under several different intervention strategies. The modeled social response depends upon the perceived risk of the disease, the extent of disease spread, and the media involvement. Using Monte Carlo simulation, we estimate the total number of infections and total social response for each strategy. We then identify the strategy that minimizes the expected total cost of the disease, which includes the cost of the disease itself, the cost of control measures, and the cost of social response. Conclusions The model-based simulations suggest that the least-cost disease control strategy depends upon the perceived risk of the disease, as well as media intervention. The most cost-effective solution for diseases with low perceived risk was to implement moderate control measures. For diseases with higher perceived severity, such as SARS or Ebola, the most cost-effective strategy shifted toward intervening earlier in the outbreak, with greater resources. When intervention elicited increased media involvement, it remained important to control high severity diseases quickly. For moderate severity diseases, however, it became most cost-effective to implement no intervention and allow the disease to run its course. Our simulation results imply that, when diseases are perceived as severe, the costs of social response have a significant influence on selecting the most cost-effective strategy.	[Fast, Shannon M.; Markuzon, Natasha] Charles Stark Draper Lab, Informat & Decis Syst Div, Cambridge, MA USA; [Gonzalez, Marta C.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	The Charles Stark Draper Laboratory, Inc.; Massachusetts Institute of Technology (MIT)	Markuzon, N (corresponding author), Charles Stark Draper Lab, Informat & Decis Syst Div, Cambridge, MA USA.	nmarkuzon@draper.com	Gonzalez, Marta C./E-9456-2011	Gonzalez, Marta C./0000-0002-8482-0318	US Defense Threat Reduction Agency [HDTRA1-12-C-0061]	US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This research was funded by the US Defense Threat Reduction Agency (www.dtra.mil) contract HDTRA1-12-C-0061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, EC IMP 2014 EB EP SH, DOI 10.1596/978-1-4648-0438-0; Araz OM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-449; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Barabasi A-L, 2008, SCALE FREE NETWORKS; Bonneux L, 2006, BMJ-BRIT MED J, V332, P786, DOI 10.1136/bmj.332.7544.786; CDC, 2014, HOW FLU SPREADS; Cheng Cecilia, 2004, Asian Perspective, V28, P67; Fast S, 2014, THESIS MIT; Fast SM, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1105; Gilman SL, 2010, LANCET, V375, P1866, DOI 10.1016/S0140-6736(10)60862-8; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Kelso JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-211; Kinsman J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-15; Lofquist D., 2012, 2010 CENSUS BRIEFS; Maharaj S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-679; MCGRATH JW, 1991, AM J PHYS ANTHROPOL, V84, P407, DOI 10.1002/ajpa.1330840405; McKenna M., 2009, CTR INFECT DIS RES P; McKibben WJ, 2003, LOWY I WORKING PAPER, V5; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMra1108296, 10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862; STRONG P, 1990, SOCIOL HEALTH ILL, V12, P249, DOI 10.1111/1467-9566.ep11347150; WHO, 2004, SUMM PROB SARS CAS O; Zaracostas J, 2010, BMJ-BRIT MED J, V341, P7259	24	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136059	10.1371/journal.pone.0136059	http://dx.doi.org/10.1371/journal.pone.0136059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26288274	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600103
J	Fatfouta, R; Schulreich, S; Meshi, D; Heekeren, H				Fatfouta, Ramzi; Schulreich, Stefan; Meshi, Dar; Heekeren, Hauke			So Close to a Deal: Spatial-Distance Cues Influence Economic Decision-Making in a Social Context	PLOS ONE			English	Article							PSYCHOLOGICAL DISTANCE; AUTOMATICITY; BEHAVIOR; SELF	Social distance (i.e., the degree of closeness to another person) affects the way humans perceive and respond to fairness during financial negotiations. Feeling close to someone enhances the acceptance of monetary offers. Here, we explored whether this effect also extends to the spatial domain. Specifically, using an iterated version of the Ultimatum Game in a within-subject design, we investigated whether different visual spatial distance-cues result in different rates of acceptance of otherwise identical monetary offers. Study 1 found that participants accepted significantly more offers when they were cued with spatial closeness than when they were cued with spatial distance. Study 2 replicated this effect using identical procedures but different spatial-distance cues in an independent sample. Importantly, our results could not be explained by feelings of social closeness. Our results demonstrate that mere perceptions of spatial closeness produce analogous-but independent-effects to those of social closeness.	[Fatfouta, Ramzi; Schulreich, Stefan; Meshi, Dar; Heekeren, Hauke] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Fatfouta, Ramzi] Free Univ Berlin, Cluster Languages Emot, Berlin, Germany; [Fatfouta, Ramzi] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin	Fatfouta, R (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.	ramzi.fatfouta@hu-berlin.de	Schulreich, Stefan/H-6013-2019	Schulreich, Stefan/0000-0001-9708-1545; Meshi, Dar/0000-0003-0772-037X; Heekeren, Hauke/0000-0001-7912-6826				Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Bar-Anan Y, 2007, J EXP PSYCHOL GEN, V136, P610, DOI 10.1037/0096-3445.136.4.610; Bargh JA, 2012, TRENDS COGN SCI, V16, P593, DOI 10.1016/j.tics.2012.10.002; Bargh JA, 2010, BEHAV BRAIN SCI, V33, P267, DOI 10.1017/S0140525X10000993; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bowlby J., 1969, ATTACHMENT AND LOSS; Burnette JL, 2012, PERS SOC PSYCHOL B, V38, P345, DOI 10.1177/0146167211424582; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Campanha C, 2011, J NEUROSCI, V31, P15569, DOI 10.1523/JNEUROSCI.1253-11.2011; Charness G, 2012, J ECON BEHAV ORGAN, V81, P1, DOI 10.1016/j.jebo.2011.08.009; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Dijksterhuis A., 2007, SOCIAL PSYCHOL UNCON, P51; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fraley RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109019; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Henderson MD, 2010, CURR DIR PSYCHOL SCI, V19, P390, DOI 10.1177/0963721410390802; IJzerman H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00464; Ijzerman H, 2010, J EXP SOC PSYCHOL, V46, P867, DOI 10.1016/j.jesp.2010.07.015; IJzerman H, 2009, PSYCHOL SCI, V20, P1214, DOI 10.1111/j.1467-9280.2009.02434.x; Karremans JC, 2007, J EXP SOC PSYCHOL, V43, P902, DOI 10.1016/j.jesp.2006.10.012; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George., 1999, PHILOS FLESH EMBODIE; Lakoff George, 1987, WOMEN FIRE, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Leiner DJ., 2019, SOSCI SURVEY VERSION; Linke LH, 2012, CURR PSYCHOL, V31, P291, DOI 10.1007/s12144-012-9146-1; Loersch C, 2011, PERSPECT PSYCHOL SCI, V6, P234, DOI 10.1177/1745691611406921; Maalej ZA, 2012, DISCOURSE SOC, V23, P679, DOI 10.1177/0957926512452973; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; McCullough ME, 2013, BEHAV BRAIN SCI, V36, P1, DOI 10.1017/S0140525X11002160; Mussel P, 2013, JUDGM DECIS MAK, V8, P381; Parkinson C, 2014, J NEUROSCI, V34, P1979, DOI 10.1523/JNEUROSCI.2159-13.2014; Pashler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042510; Pohlmann C, 2006, EUR J PERSONALITY, V20, P525, DOI 10.1002/per.599; PRENTICE DA, 1992, PSYCHOL BULL, V112, P160, DOI 10.1037/0033-2909.112.1.160; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Williams LE, 2008, PSYCHOL SCI, V19, P302, DOI 10.1111/j.1467-9280.2008.02084.x; Williams LE, 2009, EUR J SOC PSYCHOL, V39, P1257, DOI 10.1002/ejsp.665	40	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135968	10.1371/journal.pone.0135968	http://dx.doi.org/10.1371/journal.pone.0135968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287528	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600092
J	Forster, M; Gerger, G; Leder, H				Forster, Michael; Gerger, Gernot; Leder, Helmut			Everything's Relative? Relative Differences in Processing Fluency and the Effects on Liking	PLOS ONE			English	Article							DISCREPANCY-ATTRIBUTION HYPOTHESIS; PERCEPTUAL FLUENCY; FEELINGS; UNCERTAINTY; LEVEL	Explanations of aesthetic pleasure based on processing fluency have shown that ease-of-processing fosters liking. What is less clear, however, is how processing fluency arises. Does it arise from a relative comparison among the stimuli presented in the experiment? Or does it arise from a comparison to an internal reference or standard? To address these questions, we conducted two experiments in which two ease-of-processing manipulations were applied: either (1) within-participants, where relative comparisons among stimuli varying in processing ease were possible, or (2) between-participants, where no relative comparisons were possible. In total, 97 participants viewed simple line drawings with high or low visual clarity, presented at four different presentation durations, and rated for felt fluency, liking, and certainty. Our results show that the manipulation of visual clarity led to differences in felt fluency and certainty regardless of being manipulated within-or between-participants. However, liking ratings were only affected when ease-of-processing was manipulated within-participants. Thus, feelings of fluency do not depend on the nature of the reference. On the other hand, participants liked fluent stimuli more only when there were other stimuli varying in ease-of-processing. Thus, relative differences in fluency seem to be crucial for liking judgments.	[Forster, Michael; Gerger, Gernot; Leder, Helmut] Univ Vienna, Fac Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria	University of Vienna	Forster, M (corresponding author), Univ Vienna, Fac Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria.	michael.forster@univie.ac.at	Gerger, Gernot/W-3534-2018; Forster, Michael/G-1420-2012	Gerger, Gernot/0000-0001-5189-3441; Forster, Michael/0000-0003-4634-4434	Vienna Science and Technology Fund (WWTF) [CS11-023]; Austrian Science Fund (FWF) [P23538]; University of Vienna	Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Vienna	This research was supported by grants from the Vienna Science and Technology Fund (WWTF, CS11-023, www.wwtf.at) and Austrian Science Fund (FWF, P23538, https://www.fwf.ac.at/) to Helmut Leder and by the Open Access Publishing Fund of the University of Vienna to Michael Forster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter AL, 2007, J EXP PSYCHOL GEN, V136, P569, DOI 10.1037/0096-3445.136.4.569; Alter AL, 2009, PERS SOC PSYCHOL REV, V13, P219, DOI 10.1177/1088868309341564; BORNSTEIN RF, 1994, SOC COGNITION, V12, P103, DOI 10.1521/soco.1994.12.2.103; Dechene A, 2009, J EXP SOC PSYCHOL, V45, P1117, DOI 10.1016/j.jesp.2009.06.019; Forster M, 2013, EMOTION, V13, P280, DOI 10.1037/a0030115; Gartus A, 2013, I-PERCEPTION, V4, P361, DOI 10.1068/i0588sas; Gerger G, 2011, SWISS J PSYCHOL, V70, P75, DOI 10.1024/1421-0185/a000041; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Hansen J, 2008, J EXP SOC PSYCHOL, V44, P687, DOI 10.1016/j.jesp.2007.04.005; HELSON H, 1948, PSYCHOL REV, V55, P297, DOI 10.1037/h0056721; Jacoby L. L., 1989, VARIETIES MEMORY CON, P391, DOI DOI 10.1002/ACP.2350050509; Jakesch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074084; Lanska M, 2014, J EXP PSYCHOL LEARN, V40, P1, DOI 10.1037/a0034309; Leder H, 2011, PERCEPTION, V40, P649, DOI 10.1068/p6845; Leder Helmut, 2003, EMPIR STUD ARTS, V21, P165, DOI [DOI 10.2190/G6MK-6KL7-KETB-ELND, 10.2190/G6MK-6KL7-KETB-ELND]; Lee AY, 2001, PERS SOC PSYCHOL B, V27, P1255, DOI 10.1177/01461672012710002; Oppenheimer DM, 2008, TRENDS COGN SCI, V12, P237, DOI 10.1016/j.tics.2008.02.014; Parducci A., 1995, HAPPINESS PLEASURE J; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Reber R, 2004, CONSCIOUS COGN, V13, P47, DOI 10.1016/S1053-8100(03)00049-7; Regenberg NFE, 2012, EXP PSYCHOL, V59, P30, DOI 10.1027/1618-3169/a000122; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Schneider W., 2002, E PRIME USERS GUIDE; Schwarz N., 2011, HDB THEORIES SOCIAL, VOne, P289; Simmons JP, 2006, J EXP PSYCHOL GEN, V135, P409, DOI 10.1037/0096-3445.135.3.409; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Tinio PPL, 2011, PSYCHOL AESTHET CREA, V5, P165, DOI 10.1037/a0019542; Whittlesea BWA, 2001, J EXP PSYCHOL LEARN, V27, P14, DOI 10.1037/0278-7393.27.1.14; Whittlesea BWA, 2001, J EXP PSYCHOL LEARN, V27, P3, DOI 10.1037/0278-7393.27.1.3; Whittlesea BWA, 2000, J EXP PSYCHOL LEARN, V26, P547, DOI 10.1037/0278-7393.26.3.547; Winkielman P, 2003, PSYCHOLOGY OF EVALUATION, P189; Winkielman P, 2002, PSYCHE, V8, P175	33	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135944	10.1371/journal.pone.0135944	http://dx.doi.org/10.1371/journal.pone.0135944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26288314	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600088
J	Raghu, A; Praveen, D; Peiris, D; Tarassenko, L; Clifford, G				Raghu, Arvind; Praveen, Devarsetty; Peiris, David; Tarassenko, Lionel; Clifford, Gari			Implications of Cardiovascular Disease Risk Assessment Using the WHO/ISH Risk Prediction Charts in Rural India	PLOS ONE			English	Article							SELECTION	Cardiovascular disease (CVD) risk in India is currently assessed using the World Health Organization/International Society for Hypertension (WHO/ISH) risk prediction charts since no population-specific models exist. The WHO/ISH risk prediction charts have two versions -one with total cholesterol as a predictor (the high information (HI) model) and the other without (the low information (LI) model). However, information on the WHO/ISH risk prediction charts including guidance on which version to use and when, as well as relative performance of the LI and HI models, is limited. This article aims to, firstly, quantify the relative performance of the LI and HI WHO/ISH risk prediction (for WHO-South East Asian Region D) using data from rural India. Secondly, we propose a pre-screening (simplified) point-of-care (POC) test to identify patients who are likely to benefit from a total cholesterol (TC) test, and subsequently when the LI model is preferential to HI model. Analysis was performed using cross-sectional data from rural Andhra Pradesh collected in 2005 with recorded blood cholesterol measurements (N = 1066). CVD risk was computed using both LI and HI models, and high risk individuals who needed treatment(T-HR) were subsequently identified based on clinical guidelines. Model development for the POC assessment of a TC test was performed through three machine learning techniques: Support Vector Machine (SVM), Regularised Logistic Regression (RLR), and Random Forests (RF) along with a feature selection process. Disagreement in CVD risk predicted by LI and HI WHO/ISH models was 14.5% (n = 155; p<0.01) overall and comprised 36 clinically relevant T-HR patients (31% of patients identified as T-HR by using either model). Using two patient-specific parameters (age, systolic blood pressure), our POC assessment can pre-determine the benefit of TC testing and choose the appropriate risk model (out-of-sample AUCs: RF-0.85, SVM-0.84, RLR: 0.82 and maximum sensitivity-98%). The identification of patients benefitting from a TC test for CVD risk stratification can aid planning for resource-allocation and save costs for large-scale screening programmes.	[Raghu, Arvind; Tarassenko, Lionel] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Oxford OX1 3PJ, England; [Praveen, Devarsetty] George Inst Global Hlth, Hyderabad, Andhra Pradesh, India; [Praveen, Devarsetty] Univ Sydney, Sydney, NSW 2006, Australia; [Peiris, David] George Inst Global Hlth, Sydney, NSW, Australia; [Clifford, Gari] Emory Univ, Atlanta, GA 30322 USA; [Clifford, Gari] Georgia Inst Technol, Atlanta, GA 30332 USA	University of Oxford; University of Sydney; George Institute for Global Health; University of Sydney; Emory University; University System of Georgia; Georgia Institute of Technology	Raghu, A (corresponding author), Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Parks Rd, Oxford OX1 3PJ, England.	arvind.raghu@eng.ox.ac.uk	Clifford, Gari/GRJ-0376-2022; Praveen, Devarsetty/K-8729-2014	Clifford, Gari/0000-0002-5709-201X; Peiris, David/0000-0002-6898-3870; Praveen, Devarsetty/0000-0002-0973-943X	Wellcome Trust/EPSRC Oxford Centre for Excellence in Medical Engineering [WT 088877/Z/09/Z]; University of Oxford; Centre for Affordable Healthcare Technology; Australian Agency for International Development (AusAID); NHMRC post-doctoral fellowship [1054754]	Wellcome Trust/EPSRC Oxford Centre for Excellence in Medical Engineering(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Oxford; Centre for Affordable Healthcare Technology; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); NHMRC post-doctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Arvind Raghu is funded by the Wellcome Trust/EPSRC Oxford Centre for Excellence in Medical Engineering (grant number WT 088877/Z/09/Z), University of Oxford and the Centre for Affordable Healthcare Technology through a donation from ARM. Devarsetty Praveen is supported by the Australian Agency for International Development (AusAID). David Peiris is supported by a NHMRC post-doctoral fellowship (ID 1054754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1996, OUT OF BAG ESTIMATIO; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chauhan S, 2013, INT J SCI RES PUBLIC, V3, P212; Chow C, 2007, INT J CARDIOL, V116, P180, DOI 10.1016/j.ijcard.2006.03.043; Chow CK, 2008, ATHEROSCLEROSIS, V196, P943, DOI 10.1016/j.atherosclerosis.2007.02.027; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Director General of Health Services Ministry of Health and Family Welfare Government of India, 2009, MIN HLTH FAM WELF GO; Goyal A, 2006, INDIAN J MED RES, V124, P235; Gupta R, 2012, J HUM HYPERTENS, V26, P585, DOI 10.1038/jhh.2011.79; Hussain SM, 2013, ASSESSMENT CARDIOVAS, V2013; International Institute for Population Sciences, 2007, NAT FAM HLTH SURV 3; Ministry of Health and Family Welfare Government of India, 2009, NAT PROGR PREV CONTR; National Institute of Health Fogarty International Centre, 2011, NEWS ART RED GUESSW; Pednekar MS, 2009, AM J HYPERTENS, V22, P1076, DOI 10.1038/ajh.2009.131; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Praveen D, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3568; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; WHO, HLTH FIN; World Bank, 2013, WORLD BANK GROUP IMPACT EVALUATIONS: RELEVANCE AND EFFECTIVENESS, P1, DOI 10.1596/978-0-8213-9717-6; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization/International Society for Hypertension, 2011, POCK GUID ASS MAN CA; Xing JC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r113	26	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133618	10.1371/journal.pone.0133618	http://dx.doi.org/10.1371/journal.pone.0133618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287807	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600006
J	Rashtak, S; Khaleghi, S; Marietta, EV; Pittelkow, MR; Larson, JJ; Lahr, BD; Murray, JA				Rashtak, Shadi; Khaleghi, Shahryar; Marietta, Eric V.; Pittelkow, Mark R.; Larson, Joseph J.; Lahr, Brian D.; Murray, Joseph A.			Isotretinoin Exposure and Risk of Celiac Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELLS; IMMUNE-RESPONSES; POPULATION; PREVALENCE	Background Isotretinoin (13-cis retinoic acid) is a metabolite of vitamin A and has anti-inflammatory and immunoregulatory effects; however, a recent publication by DePaolo et al. demonstrated that in the presence of IL-15, retinoic acid can act as an adjuvant and promote inflammation against dietary proteins. Objective To evaluate the risk of overt and latent celiac disease (CD) among users of isotretinoin. Material and Methods Medical records of patients from 1995 to 2011 who had a mention of isotretinoin in their records (N = 8393) were searched for CD diagnosis using ICD-09CM codes. Isotretinoin exposure was compared across overt CD patients and their age-and gender-matched controls from the same pool. To evaluate the risk of latent CD with isotretinoin exposure, patients were overlapped with a community-based list of patients with waste serum samples that were tested for CD serology, excluding those with overt CD (2006-2011). Isotretinoin exposure was defined as the use of isotretinoin prior to CD diagnosis or serology. Results Of 8393 patients, 25 had a confirmed CD diagnosis. Compared to matched controls (N = 75), isotretinoin exposure was not significantly different between overt CD patients versus controls (36% versus 39%, respectively; P = 0.712). Likewise, latent CD defined as positive serology was not statistically different between isotretinoin exposed (N = 506) versus non-exposed (N = 571) groups (1.8% versus 1.4%, respectively; P = 0.474). Conclusions There was no association between isotretinoin use and risk of either overt or latent CD.	[Rashtak, Shadi; Marietta, Eric V.; Pittelkow, Mark R.] Mayo Clin, Dept Dermatol, Rochester, MN USA; [Khaleghi, Shahryar; Marietta, Eric V.; Murray, Joseph A.] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Marietta, Eric V.; Murray, Joseph A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Larson, Joseph J.; Lahr, Brian D.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Murray, JA (corresponding author), Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA.	murray.joseph@mayo.edu			National Institutes of Health [DK057982]; Mayo Clinic	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic	Funding: This study was funded by the National Institutes of Health, grant number DK057982 (Dr. Murray) and the Mayo Clinic.	Alhusayen RO, 2013, J INVEST DERMATOL, V133, P907, DOI 10.1038/jid.2012.387; Bernstein CN, 2009, AM J GASTROENTEROL, V104, P2774, DOI 10.1038/ajg.2009.417; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crockett SD, 2010, AM J GASTROENTEROL, V105, P1986, DOI 10.1038/ajg.2010.124; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Palma G, 2010, J LEUKOCYTE BIOL, V87, P765, DOI 10.1189/jlb.0709471; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Etminan M, 2013, JAMA DERMATOL, V149, P216, DOI 10.1001/jamadermatol.2013.1344; Godfrey JD, 2010, GASTROENTEROLOGY, V139, P763, DOI 10.1053/j.gastro.2010.05.041; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Holtmann MH, 2004, GUT, V53, P1065, DOI 10.1136/gut.2003.038232; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kratzer W, 2013, WORLD J GASTROENTERO, V19, P2612, DOI 10.3748/wjg.v19.i17.2612; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Marild K, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-109; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Rashtak S, 2014, JAMA DERMATOL, V150, P1322, DOI 10.1001/jamadermatol.2014.1540; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Sanz Y, 2011, INT REV IMMUNOL, V30, P207, DOI 10.3109/08830185.2011.599084; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Zhu YF, 2013, BIOMED ENVIRON SCI, V26, P774, DOI 10.3967/0895-3988.2013.09.010	24	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135881	10.1371/journal.pone.0135881	http://dx.doi.org/10.1371/journal.pone.0135881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287738	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600080
J	Sun, JH; Nie, CH; Zhang, YL; Zhou, GH; Ai, J; Zhou, TY; Zhu, TY; Zhang, AB; Wang, WL; Zheng, SS				Sun, Jun-Hui; Nie, Chun-Hui; Zhang, Yue-Lin; Zhou, Guan-Hui; Ai, Jing; Zhou, Tan-Yang; Zhu, Tong-Yin; Zhang, Ai-Bin; Wang, Wei-Lin; Zheng, Shu-Sen			Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma	PLOS ONE			English	Article							CAVERNOUS HEMANGIOMA; LIVER HEMANGIOMAS; HEPATOCELLULAR-CARCINOMA; CT FINDINGS; RESECTION; PINGYANGMYCIN; TUMORS; CHEMOEMBOLIZATION; ASSOCIATION; ULTRASOUND	Giant hepatic hemangioma is a benign liver condition that may be treated using surgery. We studied the digital subtraction angiographic (DSA) characteristics of giant hepatic hemangioma, and the effectiveness of transcatheter arterial embolization (TAE) alone for its treatment. This was a retrospective study of 27 patients diagnosed with giant hepatic hemangioma and treated with TAE alone (using lipiodol mixed with pingyangmycin) at the Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University, between January 2010 and March 2013. The feeding arteries were identified using DSA. All patients were followed up for between three weeks and 12 months. Changes in tumor diameter and symptoms were observed. The 27 patients included had giant hepatic hemangiomas ranging from 5.3 to 24.5 cm (mean, 11.24 +/- 5.08 cm) in the right (n = 13), left (n = 1) or both (n = 13) lobes. Preoperative hepatic angiography showed multiple abnormal vascular lakes in the early phase, known as the " early leaving but late returning, hanging nut on a twig" sign. On the day after TAE, hepatic transaminase levels were increased (ALT: 22.69 +/- 17.95 to 94.88 +/- 210.32 U/L; ALT: 24.00 +/- 12.37 to 99.70 +/- 211.54 U/L; both P<0.05), but not total bilirubin. Six patients complained of abdominal pain, and 12 experienced transient fever. In the months after TAE, tumor size decreased (baseline: 11.24 +/- 5.08; 3 months: 8.95 +/- 4.33; 6 months: 7.60 +/- 3.90 cm; P<0.05), and the patients' condition improved. These results indicated that TAE was effective and safe for treating giant hepatic hemangioma. TAE may be a useful alternative to surgery for the treatment of hepatic hemangioma.	[Sun, Jun-Hui; Nie, Chun-Hui; Zhang, Yue-Lin; Zhou, Guan-Hui; Zhou, Tan-Yang; Zhu, Tong-Yin; Zhang, Ai-Bin; Wang, Wei-Lin; Zheng, Shu-Sen] Zhejiang Univ, Sch Med, Hepatobiliary & Pancreat Intervent Treatment Ctr, Div Hepatobiliary & Pancreat Surg,Affiliated Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Ai, Jing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Ophthalmol,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Hepatobiliary & Pancreat Intervent Treatment Ctr, Div Hepatobiliary & Pancreat Surg,Affiliated Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	medscisjh@126.com			National Clinical Key Subject Construction Project; National Natural Science Foundation of China [81371658]; Zhejiang Provincial Natural Science Foundation of China [LQ14H120001, Y2110183]; Medical Health Fund of Zhejiang Province [2013KYB097]	National Clinical Key Subject Construction Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Medical Health Fund of Zhejiang Province	This study was supported by the National Clinical Key Subject Construction Project (General Surgery), the National Natural Science Foundation of China (No. 81371658), Zhejiang Provincial Natural Science Foundation of China (No. LQ14H120001 and NO.Y2110183), and Medical Health Fund of Zhejiang Province (No. 2013KYB097).	Akamatsu Nobuhisa, 2010, J Med Case Rep, V4, P283, DOI 10.1186/1752-1947-4-283; Anderson SW, 2009, RADIOGRAPHICS, V29, P211, DOI 10.1148/rg.291085099; BELLI L, 1992, SURG GYNECOL OBSTET, V174, P474; Duxbury MS, 2010, DIGEST SURG, V27, P7, DOI 10.1159/000268108; FARGES O, 1995, WORLD J SURG, V19, P19, DOI 10.1007/BF00316974; GANDOLFI L, 1991, GUT, V32, P677, DOI 10.1136/gut.32.6.677; Gedaly R, 1999, ARCH SURG-CHICAGO, V134, P407, DOI 10.1001/archsurg.134.4.407; GRAHAM E, 1993, OBSTET GYNECOL, V81, P813; Ho Hui-Yu, 2012, Chang Gung Med J, V35, P70; Hochwald S N, 2000, HPB Surg, V11, P413, DOI 10.1155/2000/25954; Hoekstra LT, 2013, EXPERT REV GASTROENT, V7, P263, DOI [10.1586/egh.13.10, 10.1586/EGH.13.10]; Hou J, 2011, INT J ORAL MAX SURG, V40, P1246, DOI 10.1016/j.ijom.2011.07.906; Huang YD, 2014, EXP THER MED, V7, P473, DOI 10.3892/etm.2013.1428; Jain Vaibhav, 2010, Saudi J Gastroenterol, V16, P116, DOI 10.4103/1319-3767.61240; Jang HJ, 2003, AM J ROENTGENOL, V180, P135, DOI 10.2214/ajr.180.1.1800135; Jangjoo Ali, 2010, Acta Med Iran, V48, P419; JOHN TG, 1994, ANN SURG, V220, P711, DOI 10.1097/00000658-199412000-00002; Kaido T, 2003, NEW ENGL J MED, V349, pE19, DOI 10.1056/ENEJMicm010097; Kim GE, 2006, LIVER INT, V26, P334, DOI 10.1111/j.1478-3231.2005.01226.x; Kim JT, 2009, J NEUROIMAGING, V19, P394, DOI 10.1111/j.1552-6569.2009.00380.x; KRISTIDIS P, 1991, J PAEDIATR CHILD H, V27, P57, DOI 10.1111/j.1440-1754.1991.tb00348.x; Lee MG, 1996, J COMPUT ASSIST TOMO, V20, P905, DOI 10.1097/00004728-199611000-00007; Lehmann FS, 1999, J HEPATOL, V30, P951, DOI 10.1016/S0168-8278(99)80152-4; Lerner SM, 2004, ARCH SURG-CHICAGO, V139, P818, DOI 10.1001/archsurg.139.8.818; Lupinacci RM, 2011, G CHIR, V32, P469; Mahajan D, 2008, J HEPATOL, V49, P867, DOI 10.1016/j.jhep.2008.06.028; MCFARLAND EG, 1994, RADIOLOGY, V193, P43, DOI 10.1148/radiology.193.1.8090920; Ozden I, 2000, ARCH SURG-CHICAGO, V135, P978, DOI 10.1001/archsurg.135.8.978; Perkins AB, 2000, J CLIN ULTRASOUND, V28, P159, DOI 10.1002/(SICI)1097-0096(200005)28:4<159::AID-JCU1>3.0.CO;2-B; SAEGUSA T, 1995, INTERNAL MED, V34, P207, DOI 10.2169/internalmedicine.34.207; Seo HI, 2009, WORLD J GASTROENTERO, V15, P3437, DOI 10.3748/wjg.15.3437; TRASTEK VF, 1983, AM J SURG, V145, P49, DOI 10.1016/0002-9610(83)90165-4; Unal E, 2011, EXP CLIN TRANSPLANT, V9, P344; Wang ZJ, 2012, J CLIN PATHOL, V65, P146, DOI 10.1136/jclinpath-2011-200365; Yamashita Y, 1997, RADIOLOGY, V203, P121, DOI 10.1148/radiology.203.1.9122378; Yu JS, 2001, RADIOLOGY, V221, P429, DOI 10.1148/radiol.2212010339; Yue H, 2013, BRIT J OPHTHALMOL, V97, P739, DOI 10.1136/bjophthalmol-2012-302900; Zeng QG, 2004, CARDIOVASC INTER RAD, V27, P481; Zhou JX, 2013, WORLD J GASTROENTERO, V19, P2974, DOI 10.3748/wjg.v19.i19.2974	39	30	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135158	10.1371/journal.pone.0135158	http://dx.doi.org/10.1371/journal.pone.0135158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287964	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600037
J	Fusco, F; D'Anzeo, G; Henneges, C; Rossi, A; Buttner, H; Nickel, JC				Fusco, Ferdinando; D'Anzeo, Gianluca; Henneges, Carsten; Rossi, Andrea; Buettner, Hartwig; Nickel, J. Curtis			Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; HEALTH-STATUS; IMPACT INDEX; POOLED DATA; QUESTIONNAIRES; MANAGEMENT	Background A significant percentage of patients with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) achieve clinically meaningful improvement when receiving placebo or tadalafil 5mg once daily. However, individual patient characteristics associated with treatment response are unknown. Methods This integrated clinical data mining analysis was designed to identify factors associated with a clinically meaningful response to placebo or tadalafil 5mg once daily in an individual patient with LUTS-BPH. Analyses were performed on pooled data from four randomized, placebo-controlled, double-blind, clinical studies, including about 1,500 patients, from which 107 baseline characteristics were selected and 8 response criteria. The split set evaluation method (1,000 repeats) was used to estimate prediction accuracy, with the database randomly split into training and test subsets. Logistic Regression (LR), Decision Tree (DT), Support Vector Machine (SVM) and Random Forest (RF) models were then generated on the training subset and used to predict response in the test subset. Prediction models were generated for placebo and tadalafil 5mg once daily Receiver Operating Curve (ROC) analysis was used to select optimal prediction models lying on the ROC surface. Findings International Prostate Symptom Score (IPSS) baseline group (mild/moderate vs. severe) for active treatment and placebo achieved the highest combined sensitivity and specificity of 70% and similar to 50% for all analyses, respectively. This was below the sensitivity and specificity threshold of 80% that would enable reliable allocation of an individual patient to either the responder or non-responder group Conclusions This extensive clinical data mining study in LUTS-BPH did not identify baseline clinical or demographic characteristics that were sufficiently predictive of an individual patient response to placebo or once daily tadalafil 5mg. However, the study reaffirms the efficacy of tadalalfil 5mg once daily in the treatment of LUTS-BPH in the majority of patients and the importance of evaluating individual patient need in selecting the most appropriate treatment.	[Fusco, Ferdinando] Univ Naples Federico II, Urol Clin, Naples, Italy; [D'Anzeo, Gianluca; Rossi, Andrea] Eli Lilly Italy SpA, Sesto Fiorentino, FI, Italy; [Henneges, Carsten; Buettner, Hartwig] Lilly Deutschland GmbH, Bad Homburg, Germany; [Nickel, J. Curtis] Queens Univ, Dept Urol, Kingston, ON, Canada	University of Naples Federico II; Eli Lilly; Eli Lilly; Lilly Deutschland GmbH; Queens University - Canada	Henneges, C (corresponding author), Lilly Deutschland GmbH, Bad Homburg, Germany.	henneges_carsten@lilly.com	Rossi, Andrea/AAT-1759-2021	Rossi, Andrea/0000-0003-4019-4412; Fusco, Ferdinando/0000-0002-5158-5526	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This work was funded by Eli Lilly and Company. The funders were involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	AUA Practice Guidelines Committee, 2010, AUA GUID MAN BEN PRO; Barry MJ, 2013, J UROLOGY, V189, P987, DOI 10.1016/j.juro.2012.08.257; BARRY MJ, 1995, MED CARE, V33, pAS145; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Bechara A, 2014, J SEX MED, V11, P498, DOI 10.1111/jsm.12386; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1993, CLASSIFICATION REGRE; Brock G, 2013, BJU INT, V112, P990, DOI 10.1111/bju.12251; Brock GB, 2014, J UROLOGY, V191, P405, DOI 10.1016/j.juro.2013.09.057; Chapple CR, 2015, EUR UROL, V67, P114, DOI 10.1016/j.eururo.2014.08.072; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Egerdie RB, 2012, J SEX MED, V9, P271, DOI 10.1111/j.1743-6109.2011.02504.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Godman B, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-179; Govorov A, 2014, CENT EUR J UROL, V67, P167, DOI 10.5173/ceju.2014.02.art10; Gravas S, 2014, GUIDELINES MANAGEMEN; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Homma Y, 1996, Int J Urol, V3, P267, DOI 10.1111/j.1442-2042.1996.tb00532.x; Iavindrasana J, 2009, Yearb Med Inform, P121; Kaplan Steven A, 2005, Rev Urol, V7 Suppl 7, pS34; Lepor Herbert, 2004, Rev Urol, V6 Suppl 1, pS8; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Meyer D, PACKAGE E1071 MISC F; Nickel JC, 2015, BJU INT, V115, P815, DOI 10.1111/bju.12926; Oelke M, 2014, J UROLOGY, DOI [10.1016/j.juro.2014.11.094, DOI 10.1016/J.JUR0.2014.11.094]; Oelke M, 2012, EUR UROL, V61, P917, DOI 10.1016/j.eururo.2012.01.013; Park NC, 2014, SIGNIFICANCE TESTOST; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Porst H, 2013, UROLOGY, V82, P667, DOI 10.1016/j.urology.2013.05.005; Porst H, 2013, J SEX MED, V10, P2044, DOI 10.1111/jsm.12212; Porst H, 2011, EUR UROL, V60, P1105, DOI 10.1016/j.eururo.2011.08.005; Roehrborn CG, 2008, J UROLOGY, V180, P1228, DOI 10.1016/j.juro.2008.06.079; Roehrborn CG, 2014, J UROLOGY, V191, P1045, DOI 10.1016/j.juro.2013.10.074; Roehrborn Claus G, 2008, Rev Urol, V10, P14; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Therneau T. M., 2012, RPART RECURSIVE PART; Um YH, 2014, NEUROENDOCRINOL LETT, V35, P116; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Viktrup L, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-30; Yang YJ, 2014, J KOREAN MED SCI, V29, P1145, DOI 10.3346/jkms.2014.29.8.1145	44	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135484	10.1371/journal.pone.0135484	http://dx.doi.org/10.1371/journal.pone.0135484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284523	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100041
J	Nkomazana, O; Mash, R; Shaibu, S; Phaladze, N				Nkomazana, Oathokwa; Mash, Robert; Shaibu, Sheila; Phaladze, Nthabiseng			Stakeholders' Perceptions on Shortage of Healthcare Workers in Primary Healthcare in Botswana: Focus Group Discussions	PLOS ONE			English	Article							QUALITATIVE RESEARCH; SYSTEMS; AFRICA; LAW	Background An adequate health workforce force is central to universal health coverage and positive public health outcomes. However many African countries have critical shortages of healthcare workers, which are worse in primary healthcare. The aim of this study was to explore the perceptions of healthcare workers, policy makers and the community on the shortage of healthcare workers in Botswana. Method Fifteen focus group discussions were conducted with three groups of policy makers, six groups of healthcare workers and six groups of community members in rural, urban and remote rural health districts of Botswana. All the participants were 18 years and older. Recruitment was purposive and the framework method was used to inductively analyse the data. Results There was a perceived shortage of healthcare workers in primary healthcare, which was believed to result from an increased need for health services, inequitable distribution of healthcare workers, migration and too few such workers being trained. Migration was mainly the result of unfavourable personal and family factors, weak and ineffective healthcare and human resources management, low salaries and inadequate incentives for rural and remote area service. Conclusions Botswana has a perceived shortage of healthcare workers, which is worse in primary healthcare and rural areas, as a result of multiple complex factors. To address the scarcity the country should train adequate numbers of healthcare workers and distribute them equitably to sufficiently resourced healthcare facilities. They should be competently managed and adequately remunerated and the living conditions and rural infrastructure should also be improved.	[Nkomazana, Oathokwa] Univ Botswana, Fac Med, Gaborone, Botswana; [Mash, Robert] Univ Stellenbosch, Div Family Med & Primary Care, Cape Town, South Africa; [Shaibu, Sheila; Phaladze, Nthabiseng] Univ Botswana, Sch Nursing, Gaborone, Botswana	University of Botswana; Stellenbosch University; University of Botswana	Nkomazana, O (corresponding author), Univ Botswana, Fac Med, Gaborone, Botswana.	nkomazanao@mopipi.ub.bw	Nkomazana, Oathokwa/AAP-7953-2020	Mash, Robert/0000-0001-7373-0774; Nkomazana, Oathokwa/0000-0002-2040-4059	European Union [265727]; Medical Education Partnership Initiative from Presidents Emergency Plan for AIDS Relieve; United State Health Resources and Services Administration;  [T84HA21125]	European Union(European Commission); Medical Education Partnership Initiative from Presidents Emergency Plan for AIDS Relieve; United State Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); 	The research is part of the Human Resources for African Primary Care (HURAPRIM) and is supported through the European Union's FP7 programme; grant agreement no: 265727: http://www.huraprim-project.eu to ON. ON was supported by the Medical Education Partnership Initiative, from Presidents Emergency Plan for AIDS Relieve and the United State Health Resources and Services Administration, to attend a manuscript writing workshop when developing the manuscript. Grant Number: T84HA21125. http://www.pepfar.gov/partnerships/initiatives/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antwi J, 2013, J DEV ECON, V102, P101, DOI 10.1016/j.jdeveco.2012.10.004; Appiagyei AA, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-47; Blacklock C, 2014, SOC SCI MED, V100, P99, DOI 10.1016/j.socscimed.2013.10.032; Bonenberger M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-43; Bryman A., 2002, ANAL QUALITATIVE DAT; Chen C, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-4; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Gow J, 2013, AFR HEALTH SCI, V13, P800, DOI 10.4314/ahs.v13i3.40; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Lehmann U, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-19; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Mokone GG, 2014, ACAD MED, V89, pS83, DOI 10.1097/ACM.0000000000000329; Moosa S, 2014, BRIT J GEN PRACT, V64, pE321, DOI 10.3399/bjgp14X680089; Moosa S, 2013, LANCET GLOB HEALTH, V1, pE332, DOI 10.1016/S2214-109X(13)70119-0; Nkomazana O, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.716; Oberoi Sumit S, 2006, Aust Health Rev, V30, P25; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; Silverstein L. B., 2003, QUALITATIVE STUDIES; Speziale H.S., 2007, QUALITATIVE RES NURS, V4th ed.; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Taylor AL, 2011, NEW ENGL J MED, P2349; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; WHO, 2007, EV BUS STRENGTH HLTH; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization, 2008, PRIM CAR MOR EV 2008; World Health Organization, 2012, WORLD HLTH STAT; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	29	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135846	10.1371/journal.pone.0135846	http://dx.doi.org/10.1371/journal.pone.0135846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26284617	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100074
J	Nomoto, H; Miyoshi, H; Furumoto, T; Oba, K; Tsutsui, H; Miyoshi, A; Kondo, T; Tsuchida, K; Atsumi, T; Manda, N; Kurihara, Y; Aoki, S				Nomoto, Hiroshi; Miyoshi, Hideaki; Furumoto, Tomoo; Oba, Koji; Tsutsui, Hiroyuki; Miyoshi, Arina; Kondo, Takuma; Tsuchida, Kenichi; Atsumi, Tatsuya; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin		SAIS Study Grp	A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2)	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FLOW-MEDIATED DILATION; IMPAIRED GLUCOSE-TOLERANCE; OXIDATIVE STRESS; BRACHIAL-ARTERY; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; VASCULAR-DISEASE; NITRIC-OXIDE; MOUSE MODEL	Objectives GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on atherosclerosis. However, it has not been fully elucidated whether GLP-1 is able to improve endothelial function in patients with type 2 diabetes. Therefore, we investigated the efficacy of the GLP-1 analogue, liraglutide on endothelial function and glycemic metabolism compared with insulin glargine therapy. Materials and Methods In this multicenter, prospective randomized parallel-group comparison study, 31 diabetic outpatients (aged 60.3 +/- 10.3 years with HbA1c levels of 8.6 +/- 0.8%) with current metformin and/or sulfonylurea treatment were enrolled and randomly assigned to receive liraglutide or glargine therapy once daily for 14 weeks. Flow mediated dilation (FMD), a comprehensive panel of hemodynamic parameters (Task Force Monitor), and serum metabolic markers were assessed before and after the treatment period. Results A greater reduction (worsening) in % FMD was observed in the glargine group, although this change was not statistically different from the liraglutide group (liraglutide; 5.7 to 5.4%, glargine 6.7 to 5.7%). The augmentation index, C-peptide index, derivatives of reactive oxygen metabolites and BMI were significantly improved in the liraglutide group. Central systolic blood pressure and NT-proBNP also tended to be improved in the liraglutide-treated group, while improvements in HbA1c levels were similar between groups. Cardiac index, blood pressure and most other metabolic parameters were not different. Conclusions Regardless of glycemic improvement, early liraglutide therapy did not affect endothelial function but may provide favorable effects on beta-cell function and cardioprotection in type 2 diabetics without advanced atherosclerosis.	[Nomoto, Hiroshi; Miyoshi, Hideaki; Miyoshi, Arina; Kondo, Takuma; Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan; [Furumoto, Tomoo] NTT East Japan Sapporo Hosp, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Furumoto, Tomoo; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Oba, Koji] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Biostat, Tokyo, Japan; [Oba, Koji] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan; [Tsuchida, Kenichi; Manda, Naoki] Manda Mem Hosp, Sapporo, Hokkaido, Japan; [Kurihara, Yoshio] Kurihara Clin, Sapporo, Hokkaido, Japan; [Aoki, Shin] Aoki Clin, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; University of Tokyo; University of Tokyo	Miyoshi, H (corresponding author), Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan.	hmiyoshi@med.hokudai.ac.jp	Nomoto, Hiroshi/AGJ-2652-2022; OBA, Koji/I-3980-2019	Nomoto, Hiroshi/0000-0003-0713-221X; OBA, Koji/0000-0001-5468-8988	Hokkaido Diabetes Clinical Research Organization; Aoki Clinic; Kurihara Clinic; Manda Memorial Hospital; Hokkaido University Hospital; NTT East Japan Sapporo Hospital; Yuri Ono Clinic; Clark Hospital	Hokkaido Diabetes Clinical Research Organization; Aoki Clinic; Kurihara Clinic; Manda Memorial Hospital; Hokkaido University Hospital; NTT East Japan Sapporo Hospital; Yuri Ono Clinic; Clark Hospital	This work was financially supported by grants from the Hokkaido Diabetes Clinical Research Organization including Aoki Clinic, Kurihara Clinic, Manda Memorial Hospital, Hokkaido University Hospital, NTT East Japan Sapporo Hospital, Yuri Ono Clinic, and Clark Hospital.	Amir O, 2004, AM J CARDIOL, V93, P947, DOI 10.1016/j.amjcard.2003.12.032; Basu A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1289, DOI 10.1152/ajpendo.00373.2007; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Brooks BA, 2001, DIABETIC MED, V18, P374, DOI 10.1046/j.1464-5491.2001.00479.x; Calles-Escandon J, 2001, ENDOCR REV, V22, P36, DOI 10.1210/er.22.1.36; Cesarone MR, 1999, INT ANGIOL, V18, P127; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Furumoto T, 2004, AM J CARDIOL, V93, P997, DOI 10.1016/j.amjcard.2003.12.053; Gaspari T, 2011, DIABETES VASC DIS RE, V8, P117, DOI 10.1177/1479164111404257; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Han LN, 2012, DIABETES RES CLIN PR, V97, P453, DOI 10.1016/j.diabres.2012.04.001; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Hollenberg SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7706; Hopkins ND, 2013, DIABETES OBES METAB, V15, P770, DOI 10.1111/dom.12089; Iketani T, 2000, HYPERTENS RES, V23, P451, DOI 10.1291/hypres.23.451; Irace C, 2013, DIABETES VASC DIS RE, V10, P72, DOI 10.1177/1479164112449562; Iwata M, 2012, AM J CARDIOVASC DIS, V2, P111; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Kelly AS, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-64; Kimura K, 2005, CEREBROVASC DIS, V19, P171, DOI 10.1159/000083252; Koska J, 2010, DIABETES CARE, V33, P1028, DOI 10.2337/dc09-1961; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090217; Luo X, 2013, J DIABETES, V5, P421, DOI 10.1111/1753-0407.12061; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P29, DOI 10.1161/01.ATV.0000150649.39934.13; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Merani S, 2008, ENDOCRINOLOGY, V149, P4322, DOI 10.1210/en.2008-0501; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Okamoto T, 2013, CLIN PHYSIOL FUNCT I, V33, P455, DOI 10.1111/cpf.12052; Okuno Y, 2013, METABOLISM, V62, P1470, DOI 10.1016/j.metabol.2013.05.022; Papathanassiou K, 2009, ATHEROSCLEROSIS, V205, P221, DOI 10.1016/j.atherosclerosis.2008.11.027; Pyke C, 2013, ENDOCRINOLOGY, V154, P4, DOI 10.1210/en.2012-2124; Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Song XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10202; Spieker LE, 2002, CIRCULATION, V105, P2817, DOI 10.1161/01.CIR.0000021598.15895.34; Takagi H, 2012, INT J CARDIOL, V158, P285, DOI 10.1016/j.ijcard.2012.04.054; Tomiyama H, 2012, INT HEART J, V53, P170, DOI 10.1536/ihj.53.170; Wascher TC, 2005, EUR J CLIN INVEST, V35, P551, DOI 10.1111/j.1365-2362.2005.01550.x	44	31	32	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135854	10.1371/journal.pone.0135854	http://dx.doi.org/10.1371/journal.pone.0135854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284918	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100076
J	Soonthornchai, W; Chaiyapechara, S; Jarayabhand, P; Soderhall, K; Jiravanichpaisal, P				Soonthornchai, Wipasiri; Chaiyapechara, Sage; Jarayabhand, Padermsak; Soderhall, Kenneth; Jiravanichpaisal, Pikul			Interaction of Vibrio spp. with the Inner Surface of the Digestive Tract of Penaeus monodon	PLOS ONE			English	Article							HOST-MICROBIAL INTERACTIONS; SHRIMP SICYONIA-INGENTIS; CHITIN-BINDING PROTEINS; PACIFIC WHITE SHRIMP; REAL-TIME PCR; LITOPENAEUS-VANNAMEI; INTESTINAL MICROFLORA; PERITROPHIC MEMBRANE; RELATIVE ABUNDANCE; MARINE-BACTERIA	Several species of Vibrio are the causative agent of gastroenteritis in humans. In aquaculture, Vibrio harveyi (Vh) and V. parahaemolyticus (Vp) have long been considered as shrimp pathogens in freshwater, brackish and marine environments. Here we show by using scanning electron microscopy (SEM) that Penaeus monodon orally inoculated with each of these two pathogens via an Artemia diet had numerous bacteria attached randomly across the stomach surface, in single and in large biofilm-like clusters 6 h post-infection. A subsequent marked proliferation in the number of V. harveyi within the biofilm-like formations resulted in the development of infections in the stomach, the upper and middle midgut, but neither in the posterior midgut nor the hindgut. SEM also revealed the induced production of peritrichous pili-like structures by the Vp attaching to the stomach lining, whilst only a single polar fibre was seen forming an apparent physical bridge between Vh and the host's epithelium. In contrast to these observations, no such adherences or linkages were seen when trials were conducted with non-pathogenic Vibrio spp. or with Micrococcus luteus, with no obvious resultant changes to the host's gut surface. In naive shrimp, the hindgut was found to be a favorable site for bacteria notably curved, short-rod shaped bacteria which probably belong to Vibrio spp. Data from the current study suggests that pathogens of P. monodon must be able to colonize the digestive tract, particularly the stomach, where chitin is present, and then they use an array of virulent factors and enzymes to infect their host resulting in disease. Oral infection is a better way of mimicking natural routes of infection; investigating the host-bacteria interactions occurring in the digestive tract may lead to new strategies for the prevention or control of bacterial infections in penaeids.	[Soonthornchai, Wipasiri] Chulalongkorn Univ, Program Biotechnol, Fac Sci, Bangkok 10330, Thailand; [Chaiyapechara, Sage; Jiravanichpaisal, Pikul] NSTDA, Aquat Mol Genet & Biotechnol Lab, Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang 12120, Pathumthani, Thailand; [Jarayabhand, Padermsak] Chulalongkorn Univ, Grad Sch, Interdisciplinary Grad Program Maritime Adm, Bangkok 10330, Thailand; [Soderhall, Kenneth; Jiravanichpaisal, Pikul] Uppsala Univ, Dept Comparat Physiol, SE-75236 Uppsala, Sweden; [Jiravanichpaisal, Pikul] Fish Vet Grp Asia Ltd, Bangkok 10210, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Uppsala University	Chaiyapechara, S (corresponding author), NSTDA, Aquat Mol Genet & Biotechnol Lab, Natl Ctr Genet Engn & Biotechnol BIOTEC, 113 Paholyothin Rd,Klong 1, Klongluang 12120, Pathumthani, Thailand.	sage.cha@biotec.or.th		Chaiyapechara, Sage/0000-0002-6836-2759	Institute for the Promotion of the Teaching Science and Technology of Thailand (IPST) in the Development and Promotion of Science and Technology Talents Project (DPST); National Center for Genetic Engineering and Biotechnology (BIOTEC) [P-14-50570]	Institute for the Promotion of the Teaching Science and Technology of Thailand (IPST) in the Development and Promotion of Science and Technology Talents Project (DPST); National Center for Genetic Engineering and Biotechnology (BIOTEC)	The project received funding support from (1) the Institute for the Promotion of the Teaching Science and Technology of Thailand (IPST) in the Development and Promotion of Science and Technology Talents Project (DPST) for Ms. Wipasiri Soonthornchai's tuition, research, and stipends, and (2) National Center for Genetic Engineering and Biotechnology (BIOTEC) (Project# P-14-50570) for the detection of pathogenic Vibrio using specific PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 2006, THESCIENTIFICWORLDJO, V6, P931, DOI 10.1100/tsw.2006.181; AVTSYN A P, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V102, P342; BASSLER BL, 1991, J BIOL CHEM, V266, P24268; Bignell D.E., 1989, INVERTEBRATE MICROBI, P205; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Ceccaldi Hubert J., 1998, Reviews in Fisheries Science, V6, P13, DOI 10.1080/10641269891314177; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Corbari L, 2012, CR BIOL, V335, P142, DOI 10.1016/j.crvi.2011.12.005; CRAWFORD CS, 1983, INT J INSECT MORPHOL, V12, P301, DOI 10.1016/0020-7322(83)90025-9; Defoirdt T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003603; Dempsey AC, 1989, CRUSTACEANA, V56, P266; Drobne Damjana, 1995, Acta Microbiologica et Immunologica Hungarica, V42, P45; Epis S, 2013, TICKS TICK-BORNE DIS, V4, P39, DOI 10.1016/j.ttbdis.2012.06.005; Farzanfar A, 2006, FEMS IMMUNOL MED MIC, V48, P149, DOI 10.1111/j.1574-695X.2006.00116.x; Fegatella F, 1998, APPL ENVIRON MICROB, V64, P4433; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; GILDEMEISTER OS, 1994, GLYCOCONJUGATE J, V11, P518, DOI 10.1007/BF00731302; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HUQ A, 1986, APPL ENVIRON MICROB, V52, P586, DOI 10.1128/AEM.52.3.586-588.1986; HUSEBYE E, 1994, DIGEST DIS SCI, V39, P946, DOI 10.1007/BF02087542; ISHIMARU K, 1995, INT J SYST BACTERIOL, V45, P134, DOI 10.1099/00207713-45-1-134; Jiravanichpaisal P., 1994, Journal of Aquatic Animal Health, V6, P27, DOI 10.1577/1548-8667(1994)006&lt;0027:HBAPOV&gt;2.3.CO;2; Johnson CN, 2008, J WORLD AQUACULT SOC, V39, P251, DOI 10.1111/j.1749-7345.2008.00155.x; Jonson Ann-Beth, 2005, V12, P67, DOI 10.1159/000081690; Joshi J, 2014, AQUACULTURE, V428, P297, DOI 10.1016/j.aquaculture.2014.03.030; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; KRAXBERGERBEATTY T, 1990, J FISH DIS, V13, P557, DOI 10.1111/j.1365-2761.1990.tb00819.x; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lau WWY, 2002, MICROBIAL ECOL, V43, P455, DOI 10.1007/s00248-001-1043-3; LAVILLAPITOGO CR, 1990, AQUACULTURE, V91, P1, DOI 10.1016/0044-8486(90)90173-K; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Li P, 2007, J NUTR, V137, P2763, DOI 10.1093/jn/137.12.2763; Lightner D.V., 1983, CRC HDB MARICULTURE, P289; Lightner DV, 1990, DISEASES OF CRUSTACE; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin GG, 2006, BIOL BULL-US, V211, P275, DOI 10.2307/4134549; Martin GG, 2004, DIS AQUAT ORGAN, V60, P21, DOI 10.3354/dao060021; McCarter Linda, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P51; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mohan CV, 2012, FHS AFS, V10, P1; MONTGOMERY MT, 1994, APPL ENVIRON MICROB, V60, P4284, DOI 10.1128/AEM.60.12.4284-4288.1994; MONTGOMERY MT, 1993, APPL ENVIRON MICROB, V59, P373, DOI 10.1128/AEM.59.2.373-379.1993; Moss SM, 2000, J WORLD AQUACULT SOC, V31, P255, DOI 10.1111/j.1749-7345.2000.tb00361.x; NAGASAWA S, 1987, P JPN ACAD B-PHYS, V63, P33, DOI 10.2183/pjab.63.33; Nayduch D, 2005, INVERTEBR BIOL, V124, P74, DOI 10.1111/j.1744-7410.2005.1241-09.x; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; Ofek I, 2003, BACTERIAL ADHESION T; Oxley APA, 2002, J APPL MICROBIOL, V93, P214, DOI 10.1046/j.1365-2672.2002.01673.x; Peters W, 1992, PERITROPHIC MEMBRANE; Pinn EH, 1999, MAR BIOL, V133, P103, DOI 10.1007/s002270050448; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Rengpipat S, 2003, DIS AQUAT ORGAN, V55, P169, DOI 10.3354/dao055169; Ringo E, 1999, AQUAC RES, V30, P73, DOI 10.1046/j.1365-2109.1999.00302.x; Rungrassamee W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091853; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Shakibazadeh S, 2009, ANN MICROBIOL, V59, P425, DOI 10.1007/BF03175126; Soonthornchai W, 2010, DEV COMP IMMUNOL, V34, P19, DOI 10.1016/j.dci.2009.07.007; Sousa L, 2006, BIOCELL, V30, P287; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Sung HH, 1999, J EXP MAR BIOL ECOL, V236, P261, DOI 10.1016/S0022-0981(98)00206-8; Thaithongnum S, 2006, AQUACULTURE, V261, P1, DOI 10.1016/j.aquaculture.2006.07.001; Theethakaew C, 2013, APPL ENVIRON MICROB, V79, P2358, DOI 10.1128/AEM.03067-12; Uribe A, 1997, SCAND J GASTROENTERO, V32, P691, DOI 10.3109/00365529708996520; Vaseeharan B, 2003, MICROBIOL RES, V158, P299, DOI 10.1078/0944-5013-00208; Venkateswaran K, 1998, APPL ENVIRON MICROB, V64, P681; Wang P, 1998, J INVERTEBR PATHOL, V72, P57, DOI 10.1006/jipa.1998.4759; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0	78	50	50	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135783	10.1371/journal.pone.0135783	http://dx.doi.org/10.1371/journal.pone.0135783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285030	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100069
J	Umemura, S; Imai, S; Mimura, A; Fujiwara, M; Ebihara, S				Umemura, Shoya; Imai, Saki; Mimura, Ayumi; Fujiwara, Mari; Ebihara, Shizufumi			Impaired Maternal Behavior in Usp46 Mutant Mice: A Model for Trans-Generational Transmission of Maternal Care	PLOS ONE			English	Article							RECEPTOR SUBUNIT EXPRESSION; PARENTAL BEHAVIOR; LATER ADOPTIONS; SEXUAL-ABUSE; CHILD-ABUSE; INBRED MICE; STRESS; MALTREATMENT; RAT; MECHANISMS	Usp46 mutant mice (congenic strain on a B6 genetic background; MT mice) have a low weaning rate and display poor maternal behavior compared to C57BL/6J mice (B6 mice). Based on these observations, we examined how maternal behavior is shaped by cross-fostering and in-fostering MT and B6 mice. The experiments consisted of six groups: B6 mice fostered by their biological mother (B6-CO); MT mice fostered by their biological mother (MT-CO); B6 mice fostered by a different B6 mother (B6-IF); MT mice fostered by a different MT mother (MT-IF); B6 mice fostered by an MT mother (B6-CF); and MT mice fostered by a B6 mother (MT-CF). Maternal behavior was assessed using the pup-retrieval test in adult female offspring, and four parameters, time nursing pups in the nest, time sniffing or licking pups, rearing behavior, and latency to retrieve pups, were measured. Cross-fostering significantly reduced time spent nursing and sniffing/licking pup, and increased the number of instances of rearing in the B6-CF group, and improved three parameters of maternal behaviors (nursing, rearing and latency) in the MT-CF group. These results indicate that the level of maternal care is transmitted to their pups and proper maternal behaviors can be shaped if adequate postpartum maternal care is given, even in genetically vulnerable mice. However, the offspring's genotype may also influence the development of maternal behaviors in adulthood. Thus, MT mice may prove useful as a model for trans-generational transmission of maternal care, and these findings may provide insight into the mechanisms of maltreating behaviors in human child abuse.	[Umemura, Shoya; Imai, Saki; Mimura, Ayumi; Fujiwara, Mari; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan	Nagoya University	Ebihara, S (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	ebihara@kwansei.ac.jp			JSPS KAKENHI [22658093, 25292186]; Life Science Foundation of Japan; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This research was supported by JSPS KAKENHI (Grant Number 22658093, 25292186), Life Science Foundation of Japan and Takeda Science Foundation to S.E.	Barbazanges A, 1996, J NEUROSCI, V16, P7783; BARTH RP, 1983, SOC SERV REV, V57, P477, DOI 10.1086/644120; Bebbington PE, 2004, BRIT J PSYCHIAT, V185, P220, DOI 10.1192/bjp.185.3.220; Berlin LJ, 2011, CHILD DEV, V82, P162, DOI 10.1111/j.1467-8624.2010.01547.x; Caldji C, 2004, NEUROPSYCHOPHARMACOL, V29, P1344, DOI 10.1038/sj.npp.1300436; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Cicchetti D, 2006, DEV PSYCHOPATHOL, V18, P623, DOI 10.1017/S0954579406060329; Curley JP, 2010, BEHAV GENET, V40, P220, DOI 10.1007/s10519-010-9334-4; Darnaudery M, 2004, BEHAV NEUROSCI, V118, P590, DOI 10.1037/0735-7044.118.3.590; EGELAND B, 1988, CHILD DEV, V59, P1080, DOI 10.1111/j.1467-8624.1988.tb03260.x; Fluke JD, 1999, CHILD ABUSE NEGLECT, V23, P633, DOI 10.1016/S0145-2134(99)00039-3; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Freyd JJ, 2005, SCIENCE, V308, P501, DOI 10.1126/science.1108066; Imai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058566; Imai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039084; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Kuroda KO, 2007, MOL CELL NEUROSCI, V36, P121, DOI 10.1016/j.mcn.2007.05.010; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Lu LL, 2009, BEHAV BRAIN RES, V198, P172, DOI 10.1016/j.bbr.2008.10.031; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Mullen PE, 1996, CHILD ABUSE NEGLECT, V20, P7, DOI 10.1016/0145-2134(95)00112-3; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Pears KC, 2001, CHILD ABUSE NEGLECT, V25, P1439, DOI 10.1016/S0145-2134(01)00286-1; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Schury K, 2012, ANN NY ACAD SCI, V1262, P93, DOI 10.1111/j.1749-6632.2012.06617.x; Shoji H, 2009, DEV PSYCHOBIOL, V51, P345, DOI 10.1002/dev.20375; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; TRIVERS RL, 1974, AM ZOOL, V14, P249; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010	34	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136016	10.1371/journal.pone.0136016	http://dx.doi.org/10.1371/journal.pone.0136016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284364	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100096
J	Wang, M; Yang, JX; Wang, ZW; Lu, SF				Wang, Min; Yang, Jinxiu; Wang, Zhiwei; Lu, Shuangfang			Nanometer-Scale Pore Characteristics of Lacustrine Shale, Songliao Basin, NE China	PLOS ONE			English	Article							TIGHT GAS-RESERVOIR; SOIL ORGANIC-MATTER; BARNETT SHALE; ELECTRON-MICROSCOPY; MERCURY INTRUSION; THERMAL MATURITY; NORTHEAST CHINA; SURFACE-AREA; ALBANY SHALE; BLACK SHALES	In shale, liquid hydrocarbons are accumulated mainly in nanometer-scale pores or fractures, so the pore types and PSDs (pore size distributions) play a major role in the shale oil occurrence (free or absorbed state), amount of oil, and flow features. The pore types and PSDs of marine shale have been well studied; however, research on lacustrine shale is rare, especially for shale in the oil generation window, although lacustrine shale is deposited widely around the world. To investigate the relationship between nanometer-scale pores and oil occurrence in the lacustrine shale, 10 lacustrine shale core samples from Songliao Basin, NE China were analyzed. Analyses of these samples included geochemical measurements, SEM (scanning electron microscope) observations, low pressure CO2 and N-2 adsorption, and high-pressure mercury injection experiments. Analysis results indicate that: (1) Pore types in the lacustrine shale include inter-matrix pores, intergranular pores, organic matter pores, and dissolution pores, and these pores are dominated by mesopores and micropores; (2) There is no apparent correlation between pore volumes and clay content, however, a weak negative correlation is present between total pore volume and carbonate content; (3) Pores in lacustrine shale are well developed when the organic matter maturity (Ro) is >1.0% and the pore volume is positively correlated with the TOC (total organic carbon) content. The statistical results suggest that oil in lacustrine shale mainly occurs in pores with diameters larger than 40 nm. However, more research is needed to determine whether this minimum pore diameter for oil occurrence in lacustrine shale is widely applicable.	[Wang, Min; Yang, Jinxiu; Wang, Zhiwei; Lu, Shuangfang] China Univ Petr East China, RIUP & RE, Qingdao 266580, Shandong, Peoples R China; [Wang, Min] CSIRO Energy Flagship, N Ryde, NSW 2113, Australia	China University of Petroleum; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lu, SF (corresponding author), China Univ Petr East China, RIUP & RE, Qingdao 266580, Shandong, Peoples R China.	lushuangfang@upc.edu.cn		LU, Shuangfang/0000-0002-0758-4075; WANG, MIN/0000-0003-4611-2684	"the Fundamental Research Funds for the Central Universities" [14CX05017A, 13CX05013A]; Natural Science Foundation of China [41402110, 41330313, 41172134, U1262106]; China National Petroleum Corporation Innovation Foundation [2011D-5006-0101]	"the Fundamental Research Funds for the Central Universities"(Fundamental Research Funds for the Central Universities); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Petroleum Corporation Innovation Foundation	This study was supported by grants from "the Fundamental Research Funds for the Central Universities" (14CX05017A, 13CX05013A), the Natural Science Foundation of China (41402110, 41330313, 41172134, U1262106) and the China National Petroleum Corporation Innovation Foundation (2011D-5006-0101).	Ambrose RJ, 2012, 131772 SPE; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BRALOWER TJ, 1994, PALAIOS, V9, P335, DOI 10.2307/3515055; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Bustin RM, 2008, SPE SHAL GAS PROD C, DOI [10.2118/119892-MS, DOI 10.2118/119892-MS]; Cai YD, 2013, FUEL, V103, P258, DOI 10.1016/j.fuel.2012.06.055; Chalmers GR, 2012, AAPG BULL, V96, P1099, DOI 10.1306/10171111052; Chalmers GRL, 2007, INT J COAL GEOL, V70, P223, DOI 10.1016/j.coal.2006.05.001; Chalmers GRL, 2012, MAR PETROL GEOL, V38, P53, DOI 10.1016/j.marpetgeo.2012.08.004; Clarkson CR, 2013, FUEL, V103, P606, DOI 10.1016/j.fuel.2012.06.119; Clarkson CR, 2012, FUEL, V95, P371, DOI 10.1016/j.fuel.2011.12.010; Curtis ME, 2012, INT J COAL GEOL, V103, P26, DOI 10.1016/j.coal.2012.08.004; deJonge H, 1996, ENVIRON SCI TECHNOL, V30, P408, DOI 10.1021/es950043t; DUBININ MM, 1980, J COLLOID INTERF SCI, V75, P34, DOI 10.1016/0021-9797(80)90346-X; Fathi E, 2012, 146821 SPE; Feng ZQ, 2010, BASIN RES, V22, P79, DOI 10.1111/j.1365-2117.2009.00445.x; Fishman NS, 2012, INT J COAL GEOL, V103, P32, DOI 10.1016/j.coal.2012.07.012; Gao R.Q., 1997, FORMATION CONDITIONS, P104; Gong YY, 2014, MAR POLLUT BULL, V79, P16, DOI 10.1016/j.marpolbul.2013.12.024; Gregg S.J., 1982, ADSORPTION SURFACE A, V2nd, P303, DOI [10.1002/bbpc.19820861019, DOI 10.1002/BBPC.19820861019]; Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1; Heath JE, 2011, GEOSPHERE, V7, P429, DOI 10.1130/GES00619.1; Javadpour F, 2009, J CAN PETROL TECHNOL, V48, P16, DOI 10.2118/09-08-16-DA; JENKYNS HC, 1980, J GEOL SOC LONDON, V137, P171, DOI 10.1144/gsjgs.137.2.0171; Kuila U., 2011, 146869 SPE; Loucks RG, 2012, AAPG BULL, V96, P1071, DOI 10.1306/08171111061; Loucks RG, 2009, J SEDIMENT RES, V79, P848, DOI 10.2110/jsr.2009.092; Mastalerz M, 2013, AAPG BULL, V97, P1621, DOI 10.1306/04011312194; Mastalerz M, 2012, ENERG FUEL, V26, P5109, DOI 10.1021/ef300735t; Melnichenko YB, 2012, FUEL, V91, P200, DOI 10.1016/j.fuel.2011.06.026; Milliken KL, 2013, AAPG BULL, V97, P177, DOI 10.1306/07231212048; Nelson PH, 2009, AAPG BULL, V93, P329, DOI 10.1306/10240808059; Pignatello JJ, 2006, ENVIRON SCI TECHNOL, V40, P7757, DOI 10.1021/es061307m; Ran Y, 2013, J ENVIRON QUAL, V42, P806, DOI 10.2134/jeq2012.0286; Reed RM, 2014, INT J COAL GEOL, V127, P111, DOI 10.1016/j.coal.2013.11.012; Rippen D, 2013, ORG GEOCHEM, V63, P18, DOI 10.1016/j.orggeochem.2013.07.013; Romero-Sarmiento MF, 2014, ORG GEOCHEM, V71, P7, DOI 10.1016/j.orggeochem.2014.03.008; Schmitt M, 2013, MAR PETROL GEOL, V39, P138, DOI 10.1016/j.marpetgeo.2012.09.001; Sing K., 1985, PURE APPL CHEM, V5714, P603, DOI DOI 10.1351/PAC198557040603; Strapoc D, 2010, AAPG BULL, V94, P1713, DOI 10.1306/06301009197; Tian H, 2013, MAR PETROL GEOL, V48, P8, DOI 10.1016/j.marpetgeo.2013.07.008; Wang M, 2011, MAR PETROL GEOL, V28, P1714, DOI 10.1016/j.marpetgeo.2011.07.004; Wang Y, 2014, ENERG FUEL, V28, P945, DOI 10.1021/ef402159e; Xing BS, 1997, ENVIRON SCI TECHNOL, V31, P792, DOI 10.1021/es960481f; [姚军 Yao Jun], 2013, [中国科学. 物理学, 力学, 天文学, Scientia Sinica Physica, Mechanica & Astronomica], V43, P1527; Zeng L, 2010, OIL GAS IND STANDARD; Zhang TW, 2012, ORG GEOCHEM, V47, P120, DOI 10.1016/j.orggeochem.2012.03.012; [朱如凯 Zhu Rukai], 2013, [古地理学报, Journal of Palaeogeography], V15, P615; Zou CN, 2011, ACTA PETROL SIN, V27, P1857	49	24	23	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135252	10.1371/journal.pone.0135252	http://dx.doi.org/10.1371/journal.pone.0135252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285123	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100030
J	Yoshioka, K; Oda, A; Notsu, C; Ohtsuka, T; Kawai, Y; Suzuki, S; Nakamura, T; Mabuchi, Y; Matsuzaki, Y; Goitsuka, R				Yoshioka, Kentaro; Oda, Akihisa; Notsu, Chihiro; Ohtsuka, Takafumi; Kawai, Yasuhiro; Suzuki, Sadafumi; Nakamura, Takuro; Mabuchi, Yo; Matsuzaki, Yumi; Goitsuka, Ryo			Loss of the Homeodomain Transcription Factor Prep1 Perturbs Adult Hematopoiesis in the Bone Marrow	PLOS ONE			English	Article							STEM-CELLS; MEIS1; PKNOX1; PBX; HOX; PROTEIN; MICE; GENE; DNA; RECEPTOR	Prep1, a TALE-family homeodomain transcription factor, has been demonstrated to play a critical role in embryonic hematopoiesis, as its insufficiency caused late embryonic lethality associated with defective hematopoiesis and angiogenesis. In the present study, we generated hematopoietic- and endothelial cell-specific Prep1-deficient mice and demonstrated that expression of Prep1 in the hematopoietic cell compartment is not essential for either embryonic or adult hematopoiesis, although its absence causes significant hematopoietic abnormalities in the adult bone marrow. Loss of Prep1 promotes cell cycling of hematopoietic stem/progenitor cells (HSPC), leading to the expansion of the HSPC pool. Prep1 deficiency also results in the accumulation of lineage-committed progenitors, increased monocyte/macrophage differentiation and arrested erythroid maturation. Maturation of T cells and B cells is also perturbed in Prep-deficient mice. These findings provide novel insight into the pleiotropic roles of Prep1 in adult hematopoiesis that were unrecognized in previous studies using germline Prep1 hypomorphic mice.	[Yoshioka, Kentaro; Oda, Akihisa; Notsu, Chihiro; Ohtsuka, Takafumi; Kawai, Yasuhiro; Goitsuka, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Noda, Chiba 278, Japan; [Suzuki, Sadafumi] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Nakamura, Takuro] Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Koto Ku, Tokyo 170, Japan; [Mabuchi, Yo] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo, Japan; [Matsuzaki, Yumi] Shimane Univ, Fac Med, Dept Canc Biol, Izumo, Shimane, Japan	Tokyo University of Science; Keio University; Japanese Foundation for Cancer Research; Tokyo Medical & Dental University (TMDU); Shimane University	Goitsuka, R (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Noda, Chiba 278, Japan.	ryogoi@rs.noda.tus.ac.jp	Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966; Matsuzaki, Yumi/0000-0002-3729-2997	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25111513, 25292194, 15H01163]; Grants-in-Aid for Scientific Research [26660259] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by Grant-in-Aid for Scientific Research (25111513, 25292194 and 15H01163 to R. G.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Arata Y, 2006, DEV CELL, V11, P105, DOI 10.1016/j.devcel.2006.04.020; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Berthelsen J, 1998, GENOMICS, V47, P323, DOI 10.1006/geno.1997.5086; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Broudy VC, 1996, BLOOD, V88, P75; Carbe C, 2012, DEV BIOL, V363, P320, DOI 10.1016/j.ydbio.2011.12.038; Chen HM, 1997, GENOMICS, V41, P193, DOI 10.1006/geno.1997.4632; Crist RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023665; Dardaei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096711; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferretti E, 1999, MECH DEVELOP, V83, P53, DOI 10.1016/S0925-4773(99)00031-3; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Ficara F, 2013, J CELL SCI, V126, P3181, DOI 10.1242/jcs.125435; Fognani C, 2002, NUCLEIC ACIDS RES, V30, P2043, DOI 10.1093/nar/30.9.2043; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; Iotti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048353; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kanzleiter T, 2014, MOL CELL BIOL, V34, P290, DOI 10.1128/MCB.01232-13; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Micali N, 2009, MOL CELL BIOL, V29, P1143, DOI 10.1128/MCB.01273-08; Modica L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107916; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Okada Y, 2003, BLOOD, V101, P4748, DOI 10.1182/blood-2002-02-0380; Okada Y, 2003, BIOCHEM BIOPH RES CO, V305, P155, DOI 10.1016/S0006-291X(03)00718-6; Oriente F, 2013, DIABETOLOGIA, V56, P2713, DOI 10.1007/s00125-013-3053-3; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199; Zeddies S, 2014, HAEMATOLOGICA, V99, P1555, DOI 10.3324/haematol.2014.106567	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136107	10.1371/journal.pone.0136107	http://dx.doi.org/10.1371/journal.pone.0136107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285139	gold, Green Published, Green Submitted			2022-12-27	WOS:000359666100102
J	Chalermwatanachai, T; Zhang, N; Holtappels, G; Bachert, C				Chalermwatanachai, Thanit; Zhang, Nan; Holtappels, Gabriele; Bachert, Claus			Association of Mucosal Organisms with Patterns of Inflammation in Chronic Rhinosinusitis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; NASAL POLYPS; HOST-DEFENSE; CELLS; PNEUMONIA; IMMUNITY; PROTEIN; EUROPE; ASTHMA	Background Chronic rhinosinusitis is a multifactorial process disease in which bacterial infection or colonization may play an important role in the initiation or persistence of inflammatory response. The association between mucosal bacteria presence and inflammatory patterns has only been partially explored. Objective To demonstrate specific mucosal microorganisms possible association with inflammatory patterns. Methods We collected nasal polyps or sinus tissues from a clinical selection of six patient groups with defined sinus disease using tissue biomarkers. In the tissues, we detected bacteria using peptide nucleic acid fluorescence in situ hybridization (PNA-FISH). Results After reviewing a total of 115 samples (15-20 samples per group), the mucosal presence of Staphylococcus aureus was correlated with IL-5 and SE-IgE positive chronic rhinosinusitis with nasal polyps and nasal polyps from cystic fibrosis patients. Chronic rhinosinusitis without nasal polyps with TNF alpha >20 pg/ml was associated with the mucosal presence of Pseudomonas aeruginosa. Conclusion This study identifies the relationship between intramucosal microbes and inflammatory patterns, suggesting that bacteria may affect the type of inflammation in chronic rhinosinusitis. Additional investigation is needed to further identify the nature of the relationship.	[Chalermwatanachai, Thanit; Zhang, Nan; Holtappels, Gabriele; Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium; [Chalermwatanachai, Thanit] Phramongkutklao Hosp, Dept Otolaryngol, Bangkok, Thailand; [Chalermwatanachai, Thanit] Coll Med, Bangkok, Thailand; [Bachert, Claus] Karolinska Inst, Div ENT Dis, Clintec, Stockholm, Sweden	Ghent University; Ghent University Hospital; Phramongkutklao Hospital; Karolinska Institutet	Bachert, C (corresponding author), Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium.	Claus.Bachert@UGent.be	Zhang, Nan/AAQ-3944-2020; Bachert, Claus/J-8825-2012		European Commission [260895]; Flemish Scientific Research Board, FWO [A12/5-HB-KH3, G.0436.04, 3G.0489, G.0642.10N]; Global Allergy and Asthma European Network (GA2LEN); Interuniversity Attraction Poles Program-Belgian State Belgian Science Policy [IAP P7/30]; Royal Thai Government	European Commission(European CommissionEuropean Commission Joint Research Centre); Flemish Scientific Research Board, FWO(FWO); Global Allergy and Asthma European Network (GA2LEN); Interuniversity Attraction Poles Program-Belgian State Belgian Science Policy(Belgian Federal Science Policy Office); Royal Thai Government	Supported by grants to C. Bachert from the European Commission's Seventh Framework programme under grant agreement no. 260895 (PREDICTA); from the Flemish Scientific Research Board, FWO, No. A12/5-HB-KH3, project G.0436.04, 3G.0489, G.0642.10N; by the Global Allergy and Asthma European Network (GA2LEN); and by the Interuniversity Attraction Poles Program-Belgian State Belgian Science Policy, No. IAP P7/30. It was also supported by scholarship to C. Thanit by the Royal Thai Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Arkin Abdureyim, 2011, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V25, P482; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Braun H, 2003, LARYNGOSCOPE, V113, P264, DOI 10.1097/00005537-200302000-00013; Chalermwatanachai T, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-014-0048-6; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Corriveau MN, 2009, AM J RHINOL ALLERGY, V23, P461, DOI 10.2500/ajra.2009.23.3367; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Eyigor H, 2008, EUR ARCH OTO-RHINO-L, V265, P651, DOI 10.1007/s00405-007-0529-0; FOKKENS WJ, 2012, RHINOLOGY, V50, P1, DOI DOI 10.4193/RHINO12.000; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Hajjar AM, 2005, AM J RESP CELL MOL, V33, P470, DOI 10.1165/rcmb.2005-0199OC; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Lau A, 2009, FUTURE MICROBIOL, V4, P1185, DOI [10.2217/fmb.09.70, 10.2217/FMB.09.70]; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mear JB, 2014, INFECT IMMUN, V82, P306, DOI 10.1128/IAI.01085-13; Ou J, 2014, EUR ARCH OTO-RHINO-L, V271, P2729, DOI 10.1007/s00405-014-2955-0; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Pernet E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6105; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Tsui CKM, 2011, IMA FUNGUS, V2, P177, DOI 10.5598/imafungus.2011.02.02.09; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Van Zele T, 2014, AM J RHINOL ALLERGY, V28, P192, DOI 10.2500/ajra.2014.28.4033; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zhang YY, 2014, INDIAN J MICROBIOL, V54, P163, DOI 10.1007/s12088-013-0436-6; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	28	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0136068	10.1371/journal.pone.0136068	http://dx.doi.org/10.1371/journal.pone.0136068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275068	Green Published, gold			2022-12-27	WOS:000359493600148
J	Huang, CD; Liu, QQ; Heerink, N; Stomph, T; Li, BS; Liu, RL; Zhang, HY; Wang, C; Li, XL; Zhang, CC; van der Werf, W; Zhang, FS				Huang, Chengdong; Liu, Quanqing; Heerink, Nico; Stomph, TjeerdJan; Li, Baoshen; Liu, Ruili; Zhang, Hongyan; Wang, Chong; Li, Xiaolin; Zhang, Chaochun; van der Werf, Wopke; Zhang, Fusuo			Economic Performance and Sustainability of a Novel Intercropping System on the North China Plain	PLOS ONE			English	Article							REDUCING ENVIRONMENTAL RISK; NUTRIENT-USE EFFICIENCY; FOOD SECURITY; CROP PRODUCTIVITY; N MANAGEMENT; RESOURCE USE; AGRICULTURE; COMPETITION; FERTILIZER; DIVERSITY	Double cropping of wheat and maize is common on the North China Plain, but it provides limited income to rural households due to the small farm sizes in the region. Local farmers in Quzhou County have therefore innovated their production system by integration of watermelon as a companion cash crop into the system. We examine the economic performance and sustainability of this novel intercropping system using crop yield data from 2010 to 2012 and farm household survey data collected in 2012. Our results show that the gross margin of the intercropping system exceeded that of the double cropping system by more than 50% in 2012. Labor use in the intercropping system was more than three times that in double cropping. The lower returns per labor hour in intercropping, however, exceeded the average off-farm wage in the region by a significant margin. Nutrient surpluses and irrigation water use are significant larger under the intercropping system. We conclude that the novel wheat-maize/watermelon intercropping system contributes to rural poverty alleviation and household-level food security, by raising farm incomes and generating more employment, but needs further improvement to enhance its sustainability.	[Huang, Chengdong; Li, Baoshen; Liu, Ruili; Zhang, Hongyan; Wang, Chong; Li, Xiaolin; Zhang, Chaochun; Zhang, Fusuo] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China; [Liu, Quanqing] Hebei Acad Agr & Forestry Sci, Inst Agr Resources Environm, Shijiazhuang, Peoples R China; [Heerink, Nico] Wageningen Univ, Dev Econ Grp, NL-6700 AP Wageningen, Netherlands; [Stomph, TjeerdJan; van der Werf, Wopke] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands	China Agricultural University; Hebei Academy of Agricultural & Forestry Sciences; Wageningen University & Research; Wageningen University & Research	Zhang, CC (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	zhangcc@cau.edu.cn	Heerink, Nico/AAA-2045-2020; Huang, Chengdong/T-6146-2017; Zhang, Fusuo/AAV-4517-2021; Stomph, Tjeerd-Jan/AAU-2582-2021; van der Werf, Wopke/A-2557-2009	Heerink, Nico/0000-0002-9911-3501; Huang, Chengdong/0000-0003-4992-4485; van der Werf, Wopke/0000-0002-5506-4699; Stomph, Tjeerd Jan/0000-0001-5984-1523	National Natural Science Foundation of China [31210103906]; Innovative Group Grant of the National Science Foundation of China [31421092]; Chinese National Basic Research Program [2015CB150400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Group Grant of the National Science Foundation of China; Chinese National Basic Research Program(National Basic Research Program of China)	This work received financial supports from the National Natural Science Foundation of China (NO. 31210103906) and the Innovative Group Grant of the National Science Foundation of China (31421092) and the Chinese National Basic Research Program (2015CB150400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Q, 2004, NUTR CYCL AGROECOSYS, V69, P51, DOI 10.1023/B:FRES.0000025293.99199.ff; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Cui ZL, 2008, FIELD CROP RES, V105, P48, DOI 10.1016/j.fcr.2007.07.008; Cui ZL, 2013, ENVIRON SCI TECHNOL, V47, P6015, DOI 10.1021/es4003026; Dawe D, 2012, GLOB FOOD SECUR-AGR, V1, P127, DOI 10.1016/j.gfs.2012.09.001; Fan MS, 2012, J EXP BOT, V63, P13, DOI 10.1093/jxb/err248; Fan SG, 2005, AGR ECON-BLACKWELL, V32, P135, DOI 10.1111/j.0169-5150.2004.00019.x; Feike T, 2010, RENEW AGR FOOD SYST, V25, P272, DOI 10.1017/S1742170510000293; Gale HF, 2013, USDA ERS ECONOMIC RE; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; IMAM SA, 1990, FIELD CROP RES, V25, P111, DOI 10.1016/0378-4290(90)90076-N; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Khan S, 2009, AGR WATER MANAGE, V96, P349, DOI 10.1016/j.agwat.2008.09.022; Knorzer H, 2009, CLIMATE CHANGE, INTERCROPPING, PEST CONTROL AND BENEFICIAL MICROORGANISMS, P13, DOI 10.1007/978-90-481-2716-0_3; Koninklijke Nederlandse Akademie van Wetenschappen (KNAW), 2003, GEDR GEBR SOONSG WET; Lester GE, 2005, J AM SOC HORTIC SCI, V130, P649, DOI 10.21273/JASHS.130.4.649; Li CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008049; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Lithourgidis AS, 2011, EUR J AGRON, V34, P287, DOI 10.1016/j.eja.2011.02.007; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; National Bureau of Statistics of China, 2013, CHIN CIT STAT YB 201; NJOROGE JM, 1993, EXP AGR, V29, P373, DOI 10.1017/S0014479700020937; Nosengo N, 2003, NATURE, V425, P894, DOI 10.1038/425894a; Piesse J, 2009, FOOD POLICY, V34, P119, DOI 10.1016/j.foodpol.2009.01.001; Qu FT, 2011, CHINA ECON REV, V22, P444, DOI 10.1016/j.chieco.2010.08.005; Shen JB, 2013, GLOB FOOD SECUR-AGR, V2, P1, DOI 10.1016/j.gfs.2012.12.004; Shi XP, 2011, CHINA ECON REV, V22, P524, DOI 10.1016/j.chieco.2010.08.003; Statistical Bureau of Quzhou County, 2010, QUZH STAT YB; Statistical Bureau of Quzhou County, 2012, QUZH STAT YB; Sun QP, 2011, AGR WATER MANAGE, V98, P808, DOI 10.1016/j.agwat.2010.12.007; Tsimba R, 2013, FIELD CROP RES, V150, P145, DOI 10.1016/j.fcr.2013.05.021; Tsubo M, 2005, FIELD CROP RES, V93, P10, DOI 10.1016/j.fcr.2004.09.002; van Asten PJA, 2011, AGR SYST, V104, P326, DOI 10.1016/j.agsy.2010.12.004; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Vereniging van Samenwerkende Nederlandse Universiteiten (VSNU), 2014, NED GEDR WET PRINC G; Wang SQ, 2009, J GEOGR SCI, V19, P175, DOI 10.1007/s11442-009-0175-0; WILLEY RW, 1990, AGR WATER MANAGE, V17, P215, DOI 10.1016/0378-3774(90)90069-B; WILLEY RW, 1980, EXP AGR, V16, P117, DOI 10.1017/S0014479700010802; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhang FS, 2013, NATURE, V497, P33, DOI 10.1038/497033a; Zhang FS, 2011, J ENVIRON QUAL, V40, P1051, DOI 10.2134/jeq2010.0292; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhao JM, 2014, CAN J AGR ECON, V62, P307, DOI 10.1111/cjag.12033	46	27	29	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135518	10.1371/journal.pone.0135518	http://dx.doi.org/10.1371/journal.pone.0135518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275297	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600071
J	Wright, LS; Pinilla, I; Saha, J; Clermont, JM; Lien, JS; Borys, KD; Capowski, EE; Phillips, MJ; Gamm, DM				Wright, Lynda S.; Pinilla, Isabel; Saha, Jishnu; Clermont, Joshua M.; Lien, Jessica S.; Borys, Katarzyna D.; Capowski, Elizabeth E.; Phillips, M. Joseph; Gamm, David M.			VSX2 and ASCL1 Are Indicators of Neurogenic Competence in Human Retinal Progenitor Cultures	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NON-SYNDROMIC MICROPHTHALMIA/ANOPHTHALMIA; VESICLE-LIKE STRUCTURES; HOMEOBOX GENE CHX10; IN-VITRO EXPANSION; TRANSCRIPTION FACTORS; NEURAL RETINA; PHOTORECEPTOR DIFFERENTIATION; FATE DETERMINATION; MAMMALIAN RETINA	Three dimensional (3D) culture techniques are frequently used for CNS tissue modeling and organoid production, including generation of retina-like tissues. A proposed advantage of these 3D systems is their potential to more closely approximate in vivo cellular microenvironments, which could translate into improved manufacture and/or maintenance of neuronal populations. Visual System Homeobox 2 (VSX2) labels all multipotent retinal progenitor cells (RPCs) and is known to play important roles in retinal development. In contrast, the proneural transcription factor Acheate scute-like 1 (ASCL1) is expressed transiently in a subset of RPCs, but is required for the production of most retinal neurons. Therefore, we asked whether the presence of VSX2 and ASCL1 could gauge neurogenic potential in 3D retinal cultures derived from human prenatal tissue or ES cells (hESCs). Short term prenatal 3D retinal cultures displayed multiple characteristics of human RPCs (hRPCs) found in situ, including robust expression of VSX2. Upon initiation of hRPC differentiation, there was a small increase in co-labeling of VSX2+cells with ASCL1, along with a modest increase in the number of PKC alpha+neurons. However, 3D prenatal retinal cultures lost expression of VSX2 and ASCL1 over time while concurrently becoming refractory to neuronal differentiation. Conversely, 3D optic vesicles derived from hESCs (hESC-OVs) maintained a robust VSX2+ hRPC population that could spontaneously co-express ASCL1 and generate photoreceptors and other retinal neurons for an extended period of time. These results show that VSX2 and ASCL1 can serve as markers for neurogenic potential in cultured hRPCs. Furthermore, unlike hESC-OVs, maintenance of 3D structure does not independently convey an advantage in the culture of prenatal hRPCs, further illustrating differences in the survival and differentiation requirements of hRPCs extracted from native tissue vs. those generated entirely in vitro.	[Wright, Lynda S.; Saha, Jishnu; Clermont, Joshua M.; Lien, Jessica S.; Borys, Katarzyna D.; Capowski, Elizabeth E.; Phillips, M. Joseph; Gamm, David M.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Wright, Lynda S.; Phillips, M. Joseph; Gamm, David M.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA; [Pinilla, Isabel] Lozano Blesa Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Pinilla, Isabel] Aragones Hlth Sci Inst, Zaragoza, Spain; [Clermont, Joshua M.] New England Coll Optometry, Boston, MA USA; [Gamm, David M.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Lozano Blesa University Clinical Hospital; University of Wisconsin System; University of Wisconsin Madison	Gamm, DM (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	dgamm@wisc.edu		Pinilla, Isabel/0000-0003-0349-9997	National Institutes of Health [R01EY21218, P30HD03352]; Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program [TA-RM-1013-0610-UWI-WG]; Retina Research Foundation-Kathryn and Latimer Murfee Chair; Retina Research Foundation-Emmet A. Humble Distinguished Directorship; McPherson Eye Research Institute-Sandra Lemke Trout Chair in Eye Research; David and Nancy Walsh Family Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program; Retina Research Foundation-Kathryn and Latimer Murfee Chair; Retina Research Foundation-Emmet A. Humble Distinguished Directorship; McPherson Eye Research Institute-Sandra Lemke Trout Chair in Eye Research; David and Nancy Walsh Family Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health grant numbers R01EY21218 (DG) and P30HD03352; the Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program grant TA-RM-1013-0610-UWI-WG (www.blindness.org) (DG); the Retina Research Foundation-Kathryn and Latimer Murfee Chair (retinaresearchfnd.org) (DG); the Retina Research Foundation-Emmet A. Humble Distinguished Directorship (DG); the McPherson Eye Research Institute-Sandra Lemke Trout Chair in Eye Research https://vision.wisc.edu) (DG); and the David and Nancy Walsh Family Fund (DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab U, 2009, EXP EYE RES, V89, P301, DOI 10.1016/j.exer.2009.03.025; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Bae SK, 2000, DEVELOPMENT, V127, P2933; Bar-Yosef U, 2004, HUM GENET, V115, P302, DOI 10.1007/s00439-004-1154-2; Baranov PY, 2014, TISSUE ENG PT A, V20, P1465, DOI [10.1089/ten.tea.2013.0361, 10.1089/ten.TEA.2013.0361]; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Boije H, 2014, CURR OPIN NEUROBIOL, V27, P68, DOI 10.1016/j.conb.2014.02.014; Boucherie C, 2013, STEM CELLS, V31, P408, DOI 10.1002/stem.1268; Bozanic D, 2004, ANAT EMBRYOL, V208, P381, DOI 10.1007/s00429-004-0410-5; Brzezinski JA, 2011, DEVELOPMENT, V138, P3519, DOI 10.1242/dev.064006; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Czekaj M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041798; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Faiyaz-Ul-Haque M, 2007, CLIN GENET, V72, P164, DOI 10.1111/j.1399-0004.2007.00846.x; Gamm DM, 2008, INVEST OPHTH VIS SCI, V49, P788, DOI 10.1167/iovs.07-0777; Gamm DM, 2008, STEM CELLS, V26, P3182, DOI 10.1634/stemcells.2008-0300; Gamm DM, 2005, ANN NY ACAD SCI, V1049, P107, DOI 10.1196/annals.1334.011; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Haverkamp S, 2003, VISUAL NEUROSCI, V20, P589, DOI 10.1017/S0952523803206015; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Jasoni CL, 1996, J COMP NEUROL, V369, P319; KELLEY MW, 1995, INVEST OPHTH VIS SCI, V36, P1280; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Klassen H, 2004, J NEUROSCI RES, V77, P334, DOI 10.1002/jnr.20183; KOLB H, 1993, VISUAL NEUROSCI, V10, P341, DOI 10.1017/S0952523800003734; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1; Liang L, 2008, EXP EYE RES, V86, P541, DOI 10.1016/j.exer.2007.03.004; LINBERG KA, 1990, VISUAL NEUROSCI, V5, P43, DOI 10.1017/S0952523800000067; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Livne-Bar I, 2006, P NATL ACAD SCI USA, V103, P4988, DOI 10.1073/pnas.0600083103; Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]; Ma WX, 2006, MOL CELL NEUROSCI, V31, P463, DOI 10.1016/j.mcn.2005.10.018; Mansergh FC, 2010, EXP EYE RES, V91, P500, DOI 10.1016/j.exer.2010.07.003; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nelson BR, 2008, DEV DYNAM, V237, P1565, DOI 10.1002/dvdy.21550; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Nistor G, 2005, J NEUROSCI METH, V190, P63; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; ORAHILLY R, 1975, EXP EYE RES, V21, P93, DOI 10.1016/0014-4835(75)90075-5; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Phillips MJ, 2014, STEM CELLS, V32, P1480, DOI 10.1002/stem.1667; Phillips MJ, 2012, INVEST OPHTH VIS SCI, V53, P2007, DOI 10.1167/iovs.11-9313; Pinilla I, 2007, EXP EYE RES, V85, P381, DOI 10.1016/j.exer.2007.06.002; Pollak J, 2013, DEVELOPMENT, V140, P2619, DOI 10.1242/dev.091355; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Raposo AASF, 2015, CELL REP, V10, P1544, DOI 10.1016/j.celrep.2015.02.025; RHODES RH, 1979, AM J ANAT, V154, P195, DOI 10.1002/aja.1001540206; Ringuette R, 2014, INVEST OPHTH VIS SCI, V55, P43, DOI 10.1167/iovs.13-12592; Rowan S, 2004, DEVELOPMENT, V131, P5139, DOI 10.1242/dev.01300; Sasai Y, 2012, DEVELOPMENT, V139, P4111, DOI 10.1242/dev.079590; Sharma RK, 2007, BRAIN RES, V1176, P11, DOI 10.1016/j.brainres.2007.07.090; Smirnov E B, 2004, Neurosci Behav Physiol, V34, P643, DOI 10.1023/B:NEAB.0000028299.76009.1c; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Vasconcelos FF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00412; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; West EL, 2012, STEM CELLS, V30, P1424, DOI 10.1002/stem.1123; Wong LL, 2009, DEVELOPMENT, V136, P1707, DOI 10.1242/dev.027607; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Yang P, 2002, EXP NEUROL, V177, P326, DOI 10.1006/exnr.2002.7955; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054552	82	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135830	10.1371/journal.pone.0135830	http://dx.doi.org/10.1371/journal.pone.0135830			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292211	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900034
J	Alonso, C; Raynor, PC; Davies, PR; Torremorell, M				Alonso, Carmen; Raynor, Peter C.; Davies, Peter R.; Torremorell, Montserrat			Concentration, Size Distribution, and Infectivity of Airborne Particles Carrying Swine Viruses	PLOS ONE			English	Article							PORCINE-EPIDEMIC-DIARRHEA; RESPIRATORY SYNDROME VIRUS; INFLUENZA-A-VIRUS; MOUTH-DISEASE; TRANSMISSION; QUANTIFICATION; TRANSPORT; AEROSOLS; PRRSV; PIGS	When pathogens become airborne, they travel associated with particles of different size and composition. Particle size determines the distance across which pathogens can be transported, as well as the site of deposition and the survivability of the pathogen. Despite the importance of this information, the size distribution of particles bearing viruses emitted by infectious animals remains unknown. In this study we characterized the concentration and size distribution of inhalable particles that transport influenza A virus (IAV), porcine reproductive and respiratory syndrome virus (PRRSV), and porcine epidemic diarrhea virus (PEDV) generated by acutely infected pigs and assessed virus viability for each particle size range. Aerosols from experimentally infected pigs were sampled for 24 days using an Andersen cascade impactor able to separate particles by size (ranging from 0.4 to 10 micrometer (mu m) in diameter). Air samples collected for the first 9, 20 and the last 3 days of the study were analyzed for IAV, PRRSV and PEDV, respectively, using quantitative reverse transcription polymerase chain reaction (RT-PCR) and quantified as geometric mean copies/m(3) within each size range. IAV was detected in all particle size ranges in quantities ranging from 5.5x10(2) (in particles ranging from 1.1 to 2.1 mu m) to 4.3x105 RNA copies/m(3) in the largest particles (9.0-10.0 mu m). PRRSV was detected in all size ranges except particles between 0.7 and 2.1 mu m in quantities ranging from 6x10(2) (0.4-0.7 mu m) to 5.1x10(4) RNA copies/m(3) (9.0-10.0 mu m). PEDV, an enteric virus, was detected in all particle sizes and in higher quantities than IAV and PRRSV (p < 0.0001) ranging from 1.3x106 (0.4-0.7 mu m) to 3.5x10(8) RNA copies/m(3) (9.0-10.0 mu m). Infectious status was demonstrated for the 3 viruses, and in the case of IAV and PRRSV, viruses were isolated from particles larger than 2.1 mu m. In summary, our results indicated that airborne PEDV, IAV and PRRSV can be found in a wide range of particle sizes. However, virus viability is particle size dependent.	[Alonso, Carmen; Davies, Peter R.; Torremorell, Montserrat] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Populat Med, St Paul, MN USA; [Raynor, Peter C.] Univ Minnesota Twin Cities, Sch Publ Hlth, Div Environm Hlth Sci, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Populat Med, St Paul, MN USA.	torr0033@umn.edu			Agricultural Experimental Extension Project [MIN-62-106 MT]	Agricultural Experimental Extension Project	Funding: Funding for this study was provided by Agricultural Experimental Extension Project, project number MIN-62-106 MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0073-z; Alonso C, 2013, PREV VET MED, V112, P109, DOI 10.1016/j.prevetmed.2013.06.001; Appert J, 2012, AEROSOL SCI TECH, V46, P249, DOI 10.1080/02786826.2011.619224; AUSTIN E, 1979, AM IND HYG ASSOC J, V40, P1055, DOI 10.1080/15298667991430703; Bahnson P, 1994, ENZOOTIC PNEUMONIA S; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Bonifait L, 2015, CLIN INFECT DIS, V61, P299, DOI 10.1093/cid/civ321; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Cho JG, 2006, AM J VET RES, V67, P489, DOI 10.2460/ajvr.67.3.489; Corzo CA, 2014, TRANSBOUND EMERG DIS, V61, P28, DOI 10.1111/j.1865-1682.2012.01367.x; Dee S, 2010, VIRUS RES, V154, P177, DOI 10.1016/j.virusres.2010.07.022; Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; DONALDSON AI, 1983, VET REC, V113, P490, DOI 10.1136/vr.113.21.490; DONALDSON AI, 1987, RES VET SCI, V43, P339, DOI 10.1016/S0034-5288(18)30804-X; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Gloster J, 2007, VET J, V174, P42, DOI 10.1016/j.tvjl.2006.05.020; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; HYSLOP NSG, 1971, J AM VET MED ASSOC, V159, P1500; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lindsley W, 2010, CLIN INFECT DIS, V50; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mengeling WL, 1996, VET MICROBIOL, V49, P105, DOI 10.1016/0378-1135(95)00173-5; MILLER WS, 1967, P SOC EXP BIOL MED, V125, P222, DOI 10.3181/00379727-125-32054; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Park JE, 2014, VIRUS RES, V191, P143, DOI 10.1016/j.virusres.2014.07.038; Romagosa A, 2012, INFLUENZA OTHER RESP, V6, P110, DOI 10.1111/j.1750-2659.2011.00276.x; ROSSOW KD, 1994, J VET DIAGN INVEST, V6, P3, DOI 10.1177/104063879400600102; Sattler T, 2014, VET RES, V10; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Stilianakis NI, 2010, J R SOC INTERFACE, V7, P1355, DOI 10.1098/rsif.2010.0026; Tseng CC, 2010, J ENVIRON HEALTH, V73, P22; Vincent AL, 2010, INFLUENZA OTHER RESP, V4, P53, DOI 10.1111/j.1750-2659.2009.00121.x; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zuo ZL, 2013, AEROSOL SCI TECH, V47, P373, DOI 10.1080/02786826.2012.754841	39	70	72	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135675	10.1371/journal.pone.0135675	http://dx.doi.org/10.1371/journal.pone.0135675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287616	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600063
J	Ludovico, O; Carella, M; Bisceglia, L; Basile, G; Mastroianno, S; Palena, A; De Cosmo, S; Copetti, M; Prudente, S; Trischitta, V				Ludovico, Ornella; Carella, Massimo; Bisceglia, Luigi; Basile, Giorgio; Mastroianno, Sandra; Palena, Antonio; De Cosmo, Salvatore; Copetti, Massimiliano; Prudente, Sabrina; Trischitta, Vincenzo			Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus	PLOS ONE			English	Article							MUTATIONS; YOUNG	Background Some patients diagnosed as having type 2 diabetes mellitus (T2DM) are, instead, affected by multigenerational diabetes whose clinical characteristics are mostly undefined. Objective 1. To identify among patients who had been previously defined as affected by T2DM those, in fact, affected by multigenerational diabetes; 2. After excluding patients carrying the most common MODY genes and mitochondrial mutations, we compared clinical features of remaining patients with those of patients with T2DM. Methods Among 2,583 consecutive adult patients who had been defined as affected by T2DM, we looked for those with diabetes in >= 3 consecutive generations. All probands were screened for mutations in six MODY genes (HNF4A, GCK, HNF1A, PDX1, HNF1B and NeuroD1) and for the A3243G mitochondrial mutation. After excluding patients with mutations in one of such genes, we compared clinical features of the remaining 67 patients (2.6% of the whole initial sample) affected by multigenerational "familial diabetes of the adulthood" (FDA) and of their diabetic relatives (n = 63) to those with T2DM (n = 1,028) by generalized hierarchical linear models followed by pairwise comparisons. Results Age, age at diagnosis, proportion of hypertension (all p<0.001), and waist circumference (p<0.05) were lower in FDA than T2DM. Nonetheless, the two groups had similar age-adjusted incidence rate of all-cause mortality. Conclusions Beside younger age at diagnosis, FDA patients show lower waist circumference and reduced proportion of hypertension as compared to those with T2DM; despite such reduced potential cardiovascular risk factors, FDA patients did not show a reduced mortality risk than patients with T2DM.	[Ludovico, Ornella; Palena, Antonio] IRCCS Casa Sollievo Sofferenza, Endocrine Clin Unit, San Giovanni Rotondo, Italy; [Carella, Massimo; Bisceglia, Luigi] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Basile, Giorgio; Prudente, Sabrina; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Mendel Lab, San Giovanni Rotondo, Italy; [Basile, Giorgio; Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Mastroianno, Sandra] IRCCS Casa Sollievo Sofferenza, Unit Cardiol, San Giovanni Rotondo, Italy; [De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Med Unit, San Giovanni Rotondo, Italy; [Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Prudente, S (corresponding author), IRCCS Casa Sollievo Sofferenza, Mendel Lab, San Giovanni Rotondo, Italy.	s.prudente@css-mendel.it; vincenzo.trischitta@uniroma1.it	Copetti, Massimiliano/K-3186-2016; Basile, Giorgio/AAD-2202-2022; Bisceglia, Luigi/B-8720-2017; Trischitta, Vincenzo/K-1487-2016; COPETTI, MASSIMILIANO/AAG-1473-2021; Prudente, Sabrina/H-2886-2016; De Cosmo, Salvatore/J-7420-2016; Carella, Massimo/A-2804-2014	Copetti, Massimiliano/0000-0002-7960-5947; Basile, Giorgio/0000-0001-9900-4922; Bisceglia, Luigi/0000-0001-5367-8518; Trischitta, Vincenzo/0000-0003-1174-127X; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Prudente, Sabrina/0000-0001-9220-8981; De Cosmo, Salvatore/0000-0001-8787-8286; Carella, Massimo/0000-0002-6830-6829; Mastroianno, Sandra/0000-0001-6898-4657	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Funding: This work was supported by the Italian Ministry of Health (Ricerca Corrente 2013 and 2014 to SP and VT).	Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011; De Cosmo S, 2013, DIABETES CARE, V36, P2830, DOI 10.2337/dc12-1906; Doria A, 1999, DIABETES CARE, V22, P253, DOI 10.2337/diacare.22.2.253; Ellard S, 2013, DIABETOLOGIA, V56, P1958, DOI 10.1007/s00125-013-2962-5; Fajans SS, 2011, DIABETES CARE, V34, P1878, DOI 10.2337/dc11-0035; Prudente S, 2015, AM J HUM GENET, V97, P177, DOI 10.1016/j.ajhg.2015.05.011; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Weng J, 2001, DIABETOLOGIA, V44, P249, DOI 10.1007/s001250051608	10	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135855	10.1371/journal.pone.0135855	http://dx.doi.org/10.1371/journal.pone.0135855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287533	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600077
J	Sinclair, LI; Button, KS; Munafo, MR; Day, INM; Lewis, G				Sinclair, Lindsey I.; Button, Katherine S.; Munafo, Marcus R.; Day, Ian N. M.; Lewis, Glyn			Possible Association of APOE Genotype with Working Memory in Young Adults	PLOS ONE			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; HEAD-INJURY; EPSILON-4; HEALTHY; ALLELE; ATTENTION; PROTEIN; BENEFIT; TASKS	Background Possession of the epsilon 4 allele of the Apolipoprotein E (APOE) gene is associated with an increased risk of Alzheimer's disease. Early adult life effects of epsilon 4 are less well understood. Working memory has been relatively little studied (compared to episodic memory) in relation to APOE genotype despite its importance in cognitive functioning. Our hypothesis was that epsilon 4 would lead to an impairment in working memory in young adults. Methods We studied working memory using a computerised n-back task in the Avon Longitudinal Study of Parents and Children (ALSPAC) at age 18. Data was available for 1049-1927 participants and for the 2- and 3-back versions of the task. Using multiple and multi-level regression controlling for important confounders we examined the association between APOE genotype on accuracy and reaction times. Results There was no evidence of a genotype effect on accuracy when the two difficulty levels were examined separately. There was some evidence to support a deleterious effect of the epsilon 4 allele on n-back accuracy in the multi-level regression. There was weak evidence that the epsilon 22 group were less accurate but the numbers were very low in this group. The epsilon 34 group had faster reaction times than the reference epsilon 33 group in all adjusted analyses but the epsilon 44 group were only faster in the 3-back condition in multi-level analyses. Conclusions There was no evidence of benefit in epsilon 4 carriers, but there was some evidence of a detrimental effect on working memory in this large study.	[Sinclair, Lindsey I.; Button, Katherine S.; Day, Ian N. M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Munafo, Marcus R.] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England; [Lewis, Glyn] UCL, Div Psychiat, London, England; [Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, UK Ctr Tobacco & Alcohol Studies, Bristol, Avon, England	University of Bristol; University of Bristol; University of London; University College London; University of Bristol	Sinclair, LI (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	lindsey.sinclair@bristol.ac.uk	Lewis, Glyn/E-9944-2012; Munafo, Marcus/AAE-2306-2020	Lewis, Glyn/0000-0001-5205-8245; Munafo, Marcus/0000-0002-4049-993X; Button, Katherine/0000-0003-4332-8789	Wellcome Trust [084268/Z/07/Z, 096114/Z/11/Z]; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; UK Clinical Research Collaboration; National Institute for Health Research School for Primary Care Research (NIHR SPCR); MRC [MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6, MC_PC_15018] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); UK Clinical Research Collaboration; National Institute for Health Research School for Primary Care Research (NIHR SPCR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This publication was supported by the Wellcome Trust (084268/Z/07/Z). LS is supported by a research training fellowship from the Wellcome Trust (096114/Z/11/Z). MRM is a member of the UK Centre for Tobacco Control Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. KSB is funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR). The NIHR SPCR is a partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham, Oxford, Southampton and University College London. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi MR, 2006, CLIN CHEM, V52, P1420, DOI 10.1373/clinchem.2006.067082; Alexander DM, 2007, BIOL PSYCHOL, V75, P229, DOI 10.1016/j.biopsycho.2007.03.001; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Belleville S, 2007, NEUROPSYCHOLOGY, V21, P458, DOI 10.1037/0894-4105.21.4.458; Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bunce D, 2011, NEUROPSYCHOLOGIA, V49, P1693, DOI 10.1016/j.neuropsychologia.2011.02.042; Caselli RJ, 2010, NEUROSCI LETT, V473, P168, DOI 10.1016/j.neulet.2010.02.016; Chen CJ, 2013, AM J NEURORADIOL, V34, P1197, DOI 10.3174/ajnr.A3369; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deary IJ, 2004, PSYCHOL AGING, V19, P367, DOI 10.1037/0882-7974.19.2.367; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Deeny SP, 2008, BIOL PSYCHOL, V78, P179, DOI 10.1016/j.biopsycho.2008.02.007; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Ennis S, 2006, ANN HUM GENET, V70, P170, DOI 10.1111/j.1529-8817.2005.00220.x; Ensembl, 2012, ENSEMBL GENOME BROWS; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Greenwood PM, 2005, NEUROPSYCHOLOGY, V19, P199, DOI 10.1037/0894-4105.19.2.199; Hubacek JA, 2001, NEUROPSYCHOBIOLOGY, V43, P200, DOI 10.1159/000054890; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Mumford SE, 1999, ARCH DIS CHILD-FETAL, V81, pF146, DOI 10.1136/fn.81.2.F146; O'Hara R, 2008, J PSYCHIATR RES, V42, P199, DOI 10.1016/j.jpsychires.2006.12.001; Ohm TG, 1999, ACTA NEUROPATHOL, V98, P273, DOI 10.1007/s004010051080; Reinvang I, 2010, NEUROPSYCHOLOGIA, V48, P566, DOI 10.1016/j.neuropsychologia.2009.10.018; Rusted JM, 2013, NEUROIMAGE, V65, P364, DOI 10.1016/j.neuroimage.2012.10.010; Scarmeas N, 2005, J NEUROL NEUROSUR PS, V76, P1440, DOI 10.1136/jnnp.2004.053645; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; TALBOT C, 1994, LANCET, V343, P1432, DOI 10.1016/S0140-6736(94)92557-7; Taylor AE, 2011, BIOL PSYCHIAT, V70, P152, DOI 10.1016/j.biopsych.2010.10.033; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Trachtenberg AJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.011; Turic D, 2001, NEUROSCI LETT, V299, P97, DOI 10.1016/S0304-3940(00)01789-4; Wardle MC, 2013, NEUROPSYCHOPHARMACOL, V38, P1253, DOI 10.1038/npp.2013.24; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhong N, 2009, CURR ALZHEIMER RES, V6, P415, DOI 10.2174/156720509789207921	48	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135894	10.1371/journal.pone.0135894	http://dx.doi.org/10.1371/journal.pone.0135894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287823	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600081
J	Wang, R; Guo, SL; Li, NN; Li, RJ; Zhang, YJ; Jiang, JS; Wang, ZQ; Liu, QF; Wu, DF; Sun, QQ; Du, LL; Zhao, M				Wang, Rui; Guo, Shengli; Li, Nana; Li, Rujian; Zhang, Yanjun; Jiang, Jishao; Wang, Zhiqi; Liu, Qingfang; Wu, Defeng; Sun, Qiqi; Du, Lanlan; Zhao, Man			Phosphorus Accumulation and Sorption in Calcareous Soil under Long-Term Fertilization	PLOS ONE			English	Article							MITIGATION OPTIONS; MANURE; SATURATION; CHINA; AGRICULTURE; ADSORPTION; AVAILABILITY; MANAGEMENT; INDEXES; RISK	Application of phosphorus (P) fertilizers to P-deficient soils can also result in P accumulation. In this study, soil P status and P uptake by apple trees were investigated in 5-, 10-, and 15-year-old orchards in the semi-arid Loess Plateau, China, and subset soils with different soil P statuses (14-90 Olsen-P mg kg(-1)) were selected to evaluate the characteristic P adsorption. Due to the low P-use efficiency (4-6%), total soil P increased from 540 mg kg(-1) to 904 mg kg(-1), Olsen-P ranged from 3.4 mg kg(-1) to 30.7 mg kg(-1), and CaCl2-P increased from less than 0.1 mg kg(-1) to 0.66 mg kg(-1) under continuous P fertilization. The P sorption isotherms for each apple orchard were found to fit the Langmuir isotherm model (R-2 = 0.91-0.98). K (binding energy) and Q(m) (P sorption maximum) decreased, whereas DPS (degree of phosphorus sorption) increased with increasing P concentration. CaCl2-P increased significantly with the increase of Olsen-P, especially above the change point of 46.1 mg kg(-1). Application of surplus P could result in P enrichment in P-deficient soil which has high P fixation capacity, thus posing a significant environmental risk.	[Wang, Rui; Guo, Shengli; Liu, Qingfang; Wu, Defeng; Zhao, Man] Northwest A&F Univ, Coll Resources & Environm, Yangling 712100, Shaanxi, Peoples R China; [Guo, Shengli; Li, Nana; Li, Rujian; Zhang, Yanjun; Wang, Zhiqi; Du, Lanlan] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Jishao; Sun, Qiqi] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Jishao; Sun, Qiqi] Minist Water Resource, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Guo, SL (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling 712100, Shaanxi, Peoples R China.	slguo@ms.iswc.ac.cn			Chinese Academy of Sciences [XDA05050504]; Non-profit Research Foundation for Agriculture [201203039]	Chinese Academy of Sciences(Chinese Academy of Sciences); Non-profit Research Foundation for Agriculture	This work is supported by the "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (Grant No. XDA05050504), and the Non-profit Research Foundation for Agriculture (No. 201203039).	Allen BL, 2006, SOIL SCI SOC AM J, V70, P454, DOI 10.2136/sssaj2005.0031; Bai ZH, 2013, PLANT SOIL, V372, P27, DOI 10.1007/s11104-013-1696-y; Beauchemin S, 1999, CAN J SOIL SCI, V79, P615, DOI 10.4141/S98-087; Bolland MDA, 2003, AUST J SOIL RES, V41, P1369, DOI 10.1071/SR02098; Casson JP, 2006, J ENVIRON QUAL, V35, P2212, DOI 10.2134/jeq2006.0085; Djodjic F, 2005, SOIL USE MANAGE, V21, P94, DOI [10.1079/SUM2005305, 10.1111/j.1475-2743.2005.tb00413.x]; Eghball B, 1996, J ENVIRON QUAL, V25, P1339, DOI 10.2134/jeq1996.00472425002500060024x; Fan HZ, 2006, GROWTH NUTR UPTAKE U; Guo SL, 2008, PEDOSPHERE, V18, P248, DOI 10.1016/S1002-0160(08)60014-4; Guo ShengLi, 2005, Plant Nutrition and Fertilizer Science, V11, P33; HECKRATH G, 1995, J ENVIRON QUAL, V24, P904, DOI 10.2134/jeq1995.00472425002400050018x; Hooda PS, 2001, ADV ENVIRON RES, V5, P13, DOI 10.1016/S1093-0191(00)00037-X; Jordan C, 2000, SOIL USE MANAGE, V16, P27, DOI 10.1111/j.1475-2743.2000.tb00168.x; Kronvang B, 2009, J ENVIRON QUAL, V38, P1924, DOI 10.2134/jeq2009.0051; Kyllingsbaek A, 2007, NUTR CYCL AGROECOSYS, V79, P267, DOI 10.1007/s10705-007-9114-6; [来璐 Lai Lu], 2003, [水土保持研究, Research of Soil and Water Conservation], V10, P68; [李亚星 Li Yaxing], 2013, [水土保持学报, Journal of Soil and Water Conservation], V27, P98; Lu R. K., 1996, CHINESE J SOIL SCI, V27, P193; Lu SC, 2012, J PLANT NUTR, V35, P1509, DOI 10.1080/01904167.2012.689911; Maguire RO, 2009, J ENVIRON QUAL, V38, P1989, DOI 10.2134/jeq2007.0659; Mejias JH, 2013, GEODERMA, V207, P49, DOI 10.1016/j.geoderma.2013.04.030; MOZAFFARI M, 1994, SOIL SCI, V157, P97, DOI 10.1097/00010694-199402000-00005; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI [DOI 10.1016/S0003-2670(00)88444-5, 10.1016/S0003-2670(00)88444-5]; NAIR PS, 1984, J ENVIRON QUAL, V13, P591, DOI 10.2134/jeq1984.00472425001300040016x; OLSEN STERLING R., 1957, SOIL SCI SOC AMER PROC, V21, P144; Pautler MC, 2000, SOIL SCI SOC AM J, V64, P765, DOI 10.2136/sssaj2000.642765x; Peng L, 1998, ACTA AGRIC BOREALI O, V7, P104; Pothig R, 2010, ENVIRON SCI POLLUT R, V17, P497, DOI 10.1007/s11356-009-0230-5; Rubaek GH, 2013, GEODERMA, V209, P241, DOI 10.1016/j.geoderma.2013.06.022; Sattari SZ, 2012, P NATL ACAD SCI USA, V109, P6348, DOI 10.1073/pnas.1113675109; Sharpley AN, 1996, SOIL SCI SOC AM J, V60, P1459, DOI 10.2136/sssaj1996.03615995006000050025x; Skopp J, 2009, J CHEM EDUC, V86, P1341, DOI 10.1021/ed086p1341; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; WERNER W, 1995, WATER SCI TECHNOL, V31, P87, DOI 10.1016/0273-1223(95)00360-Y; Whalen JK, 2002, COMMUN SOIL SCI PLAN, V33, P1011, DOI 10.1081/CSS-120003870; Whalen JK, 2001, J ENVIRON QUAL, V30, P229, DOI 10.2134/jeq2001.301229x; Withers PJA, 2001, SOIL USE MANAGE, V17, P139, DOI 10.1079/SUM200181; Wu FQ, 2008, NUTR CYCL AGROECOSYS, V81, P95, DOI 10.1007/s10705-007-9155-x; Xin LJ, 2012, J GEOGR SCI, V22, P643, DOI 10.1007/s11442-012-0953-y; ZHU XA, 1983, GEODERMA, V29, P237, DOI 10.1016/0016-7061(83)90090-3; ZHU XM, 1989, SOILS AGR LOESS PLAT, P286	41	23	26	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135160	10.1371/journal.pone.0135160	http://dx.doi.org/10.1371/journal.pone.0135160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288011	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600038
J	Miller, MA; O'Leary, CJ; Allen, PD; Crane, BT				Miller, Mark A.; O'Leary, Catherine J.; Allen, Paul D.; Crane, Benjamin T.			Human Vection Perception Using Inertial Nulling and Certainty Estimation: The Effect of Migraine History	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; VISUAL-VESTIBULAR INTERACTIONS; ROOM TILT ILLUSION; OPTIC-FLOW; OPTOKINETIC NYSTAGMUS; VELOCITY STORAGE; SICKNESS; TRANSLATION; MODULATION; VISION	Vection is an illusory perception of self-motion that can occur when visual motion fills the majority of the visual field. This study examines the effect of the duration of visual field movement (VFM) on the perceived strength of self-motion using an inertial nulling (IN) and a magnitude estimation technique based on the certainty that motion occurred (certainty estimation, CE). These techniques were then used to investigate the association between migraine diagnosis and the strength of perceived vection. Visual star-field stimuli consistent with either looming or receding motion were presented for 1, 4, 8 or 16s. Subjects reported the perceived direction of self-motion during the final 1s of the stimulus. For the IN method, an inertial nulling motion was delivered during this final 1s of the visual stimulus, and subjects reported the direction of perceived self-motion during this final second. The magnitude of inertial motion was varied adaptively to determine the point of subjective equality (PSE) at which forward or backward responses were equally likely. For the CE trials the same range of VFM was used but without inertial motion and subjects rated their certainty of motion on a scale of 0-100. PSE determined with the IN technique depended on direction and duration of visual motion and the CE technique showed greater certainty of perceived vection with longer VFM duration. A strong correlation between CE and IN techniques was present for the 8s stimulus. There was appreciable between-subject variation in both CE and IN techniques and migraine was associated with significantly increased perception of self-motion by CE and IN at 8 and 16s. Together, these results suggest that vection may be measured by both CE and IN techniques with good correlation. The results also suggest that susceptibility to vection may be higher in subjects with a history of migraine.	[Miller, Mark A.; O'Leary, Catherine J.] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA; [Allen, Paul D.; Crane, Benjamin T.] Univ Rochester, Dept Otolaryngol, Rochester, NY 14642 USA; [Crane, Benjamin T.] Univ Rochester, Dept Bioengn, Rochester, NY 14642 USA; [Allen, Paul D.; Crane, Benjamin T.] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, 601 Elmwood Ave,Box 629, Rochester, NY 14642 USA.	Benjamin_Crane@urmc.rochester.edu			United States National Institute of Health, National Institute of Deafness and Communicative Disorders (NIDCD) [K23 DC011298, P30 DC005409, T32 DC009974]; Triological Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011298, P30DC005409, R01DC013580] Funding Source: NIH RePORTER	United States National Institute of Health, National Institute of Deafness and Communicative Disorders (NIDCD); Triological Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by a grant from the United States National Institute of Health, National Institute of Deafness and Communicative Disorders (NIDCD K23 DC011298, P30 DC005409, and T32 DC009974). Support was also provided by a Triological Society Career Scientist Award (to BTC). All funders had a roll in study design, data collection, analysis, and preparation of the manuscript.	ANDERSEN GJ, 1985, J EXP PSYCHOL HUMAN, V11, P122, DOI 10.1037/0096-1523.11.2.122; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; [Anonymous], 2004, CEPHALALGIA S1, V24, P9; Arjona A, 2002, NEUROLOGIA, V17, P338; AU YN, 2007, J NEUROPHYSIOL, V97, P1100; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bubka A, 2008, PERCEPTION, V37, P704, DOI 10.1068/p5781; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; CARPENTERSMITH TR, 1995, PERCEPT PSYCHOPHYS, V57, P35, DOI 10.3758/BF03211848; CARPENTERSMITH TR, 1992, ANN NY ACAD SCI, V656, P817, DOI 10.1111/j.1749-6632.1992.tb25262.x; COHEN B, 1981, ANN NY ACAD SCI, V374, P421, DOI 10.1111/j.1749-6632.1981.tb30888.x; Crane BT, 2013, EXP BRAIN RES, V224, P165, DOI 10.1007/s00221-012-3299-x; Crane BT, 2012, EXP BRAIN RES, V219, P477, DOI 10.1007/s00221-012-3105-9; Cuturi LF, 2014, CURR BIOL, V24, P2817, DOI 10.1016/j.cub.2014.10.015; DeAngelis G.C., 2012, NEURAL BASES MULTISE, P1; Dominguez JML, 2007, NEUROLOGIA, V22, P58; Drummond PD, 2005, HEADACHE, V45, P653, DOI 10.1111/j.1526-4610.2005.05132.x; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Flanagan MB, 2002, AVIAT SPACE ENVIR MD, V73, P1067; Furman Joseph M, 2012, Continuum (Minneap Minn), V18, P1102, DOI 10.1212/01.CON.0000421621.18407.96; GESCHEIDER GA, 1988, ANNU REV PSYCHOL, V39, P169, DOI 10.1146/annurev.psych.39.1.169; Grunfeld E, 1998, BRAIN RES BULL, V47, P433, DOI 10.1016/S0361-9230(98)00099-9; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Hu SQ, 1997, AVIAT SPACE ENVIR MD, V68, P306; HUANG JK, 1987, AVIAT SPACE ENVIR MD, V58, P1197; Jeong SH, 2010, J NEUROL, V257, P905, DOI 10.1007/s00415-009-5435-5; Ji JTT, 2009, HUM FACTORS, V51, P739, DOI 10.1177/0018720809349708; KAYAN A, 1984, BRAIN, V107, P1123, DOI 10.1093/brain/107.4.1123; Keshavarz B, 2014, EXP BRAIN RES, V232, P827, DOI 10.1007/s00221-013-3793-9; Kitazaki M, 2003, PERCEPTION, V32, P475, DOI 10.1068/p5037; KURITZKY A, 1981, HEADACHE, V21, P227, DOI 10.1111/j.1526-4610.1981.hed2105227.x; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Nakamura S, 2013, PERCEPTION, V42, P153, DOI 10.1068/p7321; Nakamura S, 2010, PERCEPTION, V39, P320, DOI 10.1068/p6534; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; OHMI M, 1988, PERCEPTION, V17, P5, DOI 10.1068/p170005; Palmisano S, 2002, PERCEPTION, V31, P463, DOI 10.1068/p3321; Roditi RE, 2012, EXP BRAIN RES, V219, P369, DOI 10.1007/s00221-012-3099-3; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Seno T, 2012, PERCEPTION, V41, P577, DOI 10.1068/p7184; Seno T, 2011, VISION RES, V51, P2499, DOI 10.1016/j.visres.2011.10.007; Seno T, 2010, SEEING PERCEIVING, V23, P273, DOI 10.1163/187847510X532667; Sharon JD, 2014, LARYNGOSCOPE, V124, P969, DOI 10.1002/lary.24285; STERN RM, 1990, AVIAT SPACE ENVIR MD, V61, P712; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; TEGHTSOONIAN R, 1981, ACTA PSYCHOL, V49, P83, DOI 10.1016/0001-6918(81)90034-2; Webb NA, 2002, AVIAT SPACE ENVIR MD, V73, P351; ZACHARIAS GL, 1981, EXP BRAIN RES, V41, P159	51	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135335	10.1371/journal.pone.0135335	http://dx.doi.org/10.1371/journal.pone.0135335			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280172	Green Published, gold, Green Submitted			2022-12-27	WOS:000359664300011
J	Siddiqui, MF; Reza, AW; Kanesan, J				Siddiqui, Muhammad Faisal; Reza, Ahmed Wasif; Kanesan, Jeevan			An Automated and Intelligent Medical Decision Support System for Brain MRI Scans Classification	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; VECTOR MACHINE; IMAGE CLASSIFICATION; SELECTION	A wide interest has been observed in the medical health care applications that interpret neuroimaging scans by machine learning systems. This research proposes an intelligent, automatic, accurate, and robust classification technique to classify the human brain magnetic resonance image (MRI) as normal or abnormal, to cater down the human error during identifying the diseases in brain MRIs. In this study, fast discrete wavelet transform (DWT), principal component analysis (PCA), and least squares support vector machine (LS-SVM) are used as basic components. Firstly, fast DWT is employed to extract the salient features of brain MRI, followed by PCA, which reduces the dimensions of the features. These reduced feature vectors also shrink the memory storage consumption by 99.5%. At last, an advanced classification technique based on LS-SVM is applied to brain MR image classification using reduced features. For improving the efficiency, LS-SVM is used with non-linear radial basis function (RBF) kernel. The proposed algorithm intelligently determines the optimized values of the hyper-parameters of the RBF kernel and also applied k-fold stratified cross validation to enhance the generalization of the system. The method was tested by 340 patients' benchmark datasets of T1-weighted and T2-weighted scans. From the analysis of experimental results and performance comparisons, it is observed that the proposed medical decision support system outperformed all other modern classifiers and achieves 100% accuracy rate (specificity/sensitivity 100%/100%). Furthermore, in terms of computation time, the proposed technique is significantly faster than the recent well-known methods, and it improves the efficiency by 71%, 3%, and 4% on feature extraction stage, feature reduction stage, and classification stage, respectively. These results indicate that the proposed well-trained machine learning system has the potential to make accurate predictions about brain abnormalities from the individual subjects, therefore, it can be used as a significant tool in clinical practice.	[Siddiqui, Muhammad Faisal; Reza, Ahmed Wasif; Kanesan, Jeevan] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Reza, AW (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.	wasif@um.edu.my	KANESAN, JEEVAN/B-8707-2010; Reza, Ahmed Wasif/ABE-5779-2020	KANESAN, JEEVAN/0000-0001-9949-3105; 	University of Malaya [RG286-14AFR]	University of Malaya(Universiti Malaya)	This research work is supported by the University of Malaya Research Grant (UMRG) scheme (RG286-14AFR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cawley GC, 2004, NEURAL NETWORKS, V17, P1467, DOI 10.1016/j.neunet.2004.07.002; Chaplot S, 2006, BIOMED SIGNAL PROCES, V1, P86, DOI 10.1016/j.bspc.2006.05.002; Chen GC, 2013, IEEE COMPUT INTELL M, V8, P33, DOI 10.1109/MCI.2012.2228592; Chu W, 2005, IEEE T NEURAL NETWOR, V16, P498, DOI 10.1109/TNN.2004.841785; Das S, 2013, PROG ELECTROMAGN RES, V137, P1, DOI 10.2528/PIER13010105; Duan K, 2003, NEUROCOMPUTING, V51, P41, DOI 10.1016/S0925-2312(02)00601-X; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; El-Dahshan ESA, 2010, DIGIT SIGNAL PROCESS, V20, P433, DOI 10.1016/j.dsp.2009.07.002; Faisal A, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9938-3; Guo XC, 2006, LECT NOTES COMPUT SC, V4233, P1138; Kloppel S, 2008, BRAIN, V131, P2969, DOI 10.1093/brain/awn239; Kumar P., 2012, INT J COMPUTER APPL, V53, P25; Lendasse A, 2005, LECT NOTES COMPUT SC, V3697, P625; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Magalhaes F, 2013, LECT NOTES COMPUT SC, V7950, P758, DOI 10.1007/978-3-642-39094-4_87; Maitra M, 2006, BIOMED SIGNAL PROCES, V1, P299, DOI 10.1016/j.bspc.2006.12.001; Maji P, 2007, ICCTA 2007: INTERNATIONAL CONFERENCE ON COMPUTING: THEORY AND APPLICATIONS, PROCEEDINGS, P372; Matoug S, 2012, J PHYS C SERIES; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McRobbie D. W., 2006, MRI PICTURE PROTON; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Patil NS, 2005, CHEM ENG RES DES, V83, P1030, DOI 10.1205/cherd.03144; Prasad PV., 2006, MAGNETIC RESONANCE I; Scapaticci R., 2012, Progress In Electromagnetics Research B, V40, P305; Sengur A, 2008, COMPUT BIOL MED, V38, P329, DOI 10.1016/j.compbiomed.2007.11.004; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; van Gestel T, 2004, MACH LEARN, V54, P5, DOI 10.1023/B:MACH.0000008082.80494.e0; Vapnik V.N., 1995, NATURE STAT LEARNING; Wang FF, 2011, PROG ELECTROM RES LE, V23, P119, DOI 10.2528/PIERL11031106; Westbrook C, 2013, HDB MRI TECHNIQUE; Zhang W, 2009, 5 INT C NAT COMP 200; Zhang Y, 2012, PROG ELECTROMAGN RES, V130, P369, DOI 10.2528/PIER12061410; Zhang Y, 2011, PROG ELECTROMAGN RES, V116, P65, DOI 10.2528/PIER11031709; Zhang Y, 2010, PROG ELECTROMAGN RES, V109, P325, DOI 10.2528/PIER10090105; Zhang YD, 2011, SENSORS-BASEL, V11, P4721, DOI 10.3390/s110504721; Zhang YD, 2011, EXPERT SYST APPL, V38, P10049, DOI 10.1016/j.eswa.2011.02.012	36	38	38	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135875	10.1371/journal.pone.0135875	http://dx.doi.org/10.1371/journal.pone.0135875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280918	Green Published, Green Submitted, gold			2022-12-27	WOS:000359664300026
J	Hoseini, N; Sexton, BM; Kurtz, K; Liu, Y; Block, HJ				Hoseini, Najmeh; Sexton, Brandon M.; Kurtz, Karl; Liu, Yang; Block, Hannah J.			Adaptive Staircase Measurement of Hand Proprioception	PLOS ONE			English	Article							POSITION SENSE; MOVEMENT; DEFICITS; BALANCE; INDIVIDUALS; PLASTICITY; PEOPLE; STROKE	Clinicians and researchers often need to measure proprioception (position sense), for example to monitor the progress of disease, to identify the cause of movement or balance problems, or to ascertain the effects of an intervention. While researchers can use sophisticated equipment to estimate proprioceptive acuity with good precision, clinicians lack this option and must rely on the subjective and imprecise methods currently available in the clinic. Here we describe a novel technique that applies psychometric adaptive staircase procedures to hand proprioception with a simple tablet-style apparatus that could easily be adapted for the clinic. We report test-retest reliability, inter-rater reliability, and construct validity of the adaptive staircase method vs. two other methods that are commonly used in clinical settings: passive motion direction discrimination (PMDD) and matching. As a first step, we focus on healthy adults. Subjects ages 18-82 had their proprioception measured with each of the three techniques, at the metacarpophalangeal joint in the second finger of the right hand. A subset completed a second session in which the measures were repeated, to assess test-retest reliability. Another subset had the measurements done by two different testers to assess inter-rater reliability. Construct validity was assessed using stepwise regression on age and activity level, and correlations calculated across the three methods. Results suggest that of the three methods, the adaptive staircase method yields the best test-retest reliability, inter-rater reliability, and construct validity. The adaptive staircase method may prove to be a valuable clinical tool where more accurate assessment of proprioception is needed.	[Hoseini, Najmeh] Midwestern Univ, Phys Therapy Program, Glendale, AZ USA; [Sexton, Brandon M.; Liu, Yang; Block, Hannah J.] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Kurtz, Karl] Florida Int Univ, Dept Occupat Therapy, Miami, FL 33199 USA; [Liu, Yang; Block, Hannah J.] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA	Midwestern University; Indiana University System; Indiana University Bloomington; State University System of Florida; Florida International University; Indiana University System; Indiana University Bloomington	Block, HJ (corresponding author), Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA.	hjblock@indiana.edu		Block, Hannah/0000-0002-1561-2718	Indiana University, School of Public Health, Faculty Research Grant Program	Indiana University, School of Public Health, Faculty Research Grant Program	This study was supported by Indiana University, School of Public Health, Faculty Research Grant Program (HJB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Bosco G, 1997, J NEUROPHYSIOL, V78, P1421, DOI 10.1152/jn.1997.78.3.1421; Brindle TJ, 2010, SCAND J MED SCI SPOR, V20, P262, DOI 10.1111/j.1600-0838.2009.00887.x; Bullock-Saxton JE, 2001, EXP BRAIN RES, V136, P400, DOI 10.1007/s002210000595; Campfens SF, 2015, EXP BRAIN RES, V233, P1339, DOI 10.1007/s00221-015-4206-z; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Epstein O, 2008, CLINICAL EXAMINATION; Friden T, 2001, J ORTHOP SPORT PHYS, V31, P567, DOI 10.2519/jospt.2001.31.10.567; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Gill KP, 1998, SPINE, V23, P371, DOI 10.1097/00007632-199802010-00017; Gilman S, 2002, J NEUROL NEUROSUR PS, V73, P473, DOI 10.1136/jnnp.73.5.473; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; Gokeler A, 2012, BRIT J SPORT MED, V46, P180, DOI 10.1136/bjsm.2010.082578; Grob KR, 2002, J BONE JOINT SURG BR, V84B, P614, DOI 10.1302/0301-620X.84B4.11241; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Hillier S, 2015, NEUROREHAB NEURAL RE, V29, P933, DOI 10.1177/1545968315573055; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Leibowitz N, 2008, DISABIL REHABIL, V30, P1829, DOI 10.1080/09638280701640145; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Li KY, 2014, CLIN INTERV AGING, V9, P1123, DOI 10.2147/CIA.S62037; Lincoln N., 1991, CLIN REHABIL, V5, P273, DOI [DOI 10.1177/026921559100500403, 10.1177/026921559100500403]; Mundy P, 2010, AUTISM, V14, P408, DOI 10.1177/1362361310366315; Nilsagard Y, 2009, CLIN REHABIL, V23, P259, DOI 10.1177/0269215508095087; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Schmitt Katrin, 2008, Ther Umsch, V65, P421, DOI 10.1024/0040-5930.65.8.421; SMITH DL, 1983, AGE AGEING, V12, P63, DOI 10.1093/ageing/12.1.63; Smitt MS, 2013, CLIN RHEUMATOL, V32, P469, DOI 10.1007/s10067-013-2193-7; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; TWITCHELL TE, 1951, BRAIN, V74, P443, DOI 10.1093/brain/74.4.443; Tyson SF, 2008, NEUROREHAB NEURAL RE, V22, P166, DOI 10.1177/1545968307305523; Vahdat S, 2014, J NEUROSCI, V34, P2451, DOI 10.1523/JNEUROSCI.4291-13.2014; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Vidoni ED, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-36; Weimer AK, 2001, J DEV BEHAV PEDIATR, V22, P92, DOI 10.1097/00004703-200104000-00002; Wycherley AS, 2005, RHEUMATOLOGY, V44, P638, DOI 10.1093/rheumatology/keh568	42	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135757	10.1371/journal.pone.0135757	http://dx.doi.org/10.1371/journal.pone.0135757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274824	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600106
J	Kempuraj, D; Thangavel, R; Yang, E; Pattani, S; Zaheer, S; Santillan, DA; Santillan, MK; Zaheer, A				Kempuraj, Duraisamy; Thangavel, Ramasamy; Yang, Evert; Pattani, Sagar; Zaheer, Smita; Santillan, Donna A.; Santillan, Mark K.; Zaheer, Asgar			Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins alpha-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; VASOACTIVE-INTESTINAL-PEPTIDE; PARKINSONS-DISEASE; FACTOR-BETA; FACTOR OVEREXPRESSION; ASTROCYTES; EXPRESSION; MICROGLIA; NEUROINFLAMMATION; MODEL	Parkinson's disease (PD) is characterized by the presence of Lewy bodies and degeneration of dopaminergic neurons. 1-methyl-4-phenylpyridinium (MPP+), a metabolite of neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Lewy body component alpha-synuclein activates glia in PD pathogenesis. Mast cells and glia maturation factor (GMF) are implicated in neuroinflammatory conditions including Multiple Sclerosis. However, the role of mast cells in PD is not yet known. We have analyzed the effect of recombinant GMF, MPP+, alpha-synuclein and interleukin-33 (IL-33) on mouse bone marrow-derived cultured mast cells (BMMCs), human umbilical cord blood-derived cultured mast cells (hCBMCs) and mouse brain-derived cultured astrocytes by quantifying cytokines/chemokines released using ELISA or by detecting the expression of co-stimulatory molecules CD40 and CD40L by flow cytometry. GMF significantly released chemokine (C-C motif) ligand 2 (CCL2) from BMMCs but its release was reduced in BMMCs from GMF knockout mice. GMF, alpha-synuclein and MPP+ released IL-1 beta, beta-hexosaminidase from BMMCs, and IL-8 from hCBMCs. GMF released CCL5, and IL-33- induced the expression of GMF from hCBMCs. Novel GMF expression was detected in hCBMCs and BMMCs by immunocytochemistry. GMF released tumor necrosis factor-alpha (TNF-alpha) from mouse astrocytes, and this release was greater in BMMC-astrocyte coculture than in individual cultures. Flow cytometry results showed increased IL-33 expression by GMF and MPP+, and GMF-induced CD40 expression in astrocytes. Proinflammatory mediator release by GMF, MPP+ and alpha-synuclein, as well as GMF expression by mast cells indicate a potential therapeutic target for neurodegenerative diseases including PD.	[Kempuraj, Duraisamy; Thangavel, Ramasamy; Zaheer, Asgar] Vet Affairs Hlth Care Syst, Iowa City, IA USA; [Kempuraj, Duraisamy; Thangavel, Ramasamy; Yang, Evert; Pattani, Sagar; Zaheer, Smita; Zaheer, Asgar] Univ Iowa Hosp & Clin, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Santillan, Donna A.; Santillan, Mark K.] Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Carver Coll Med, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa; University of Iowa	Zaheer, A (corresponding author), Vet Affairs Hlth Care Syst, Iowa City, IA USA.	asgar-zaheer@uiowa.edu	duraisamy, kempuraj/R-3043-2019; Duraisamy, Kempuraj/AAC-5638-2022	Santillan, Donna/0000-0002-6180-9714; Santillan, Mark/0000-0002-3991-8017	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [BX002477-01]; National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [NS073670]; Reproductive Scientist Development Program [HD000849, RR024980]; CSTA [U54TR001013]; University of Iowa Carver College of Medicine; Department of Obstetrics Gynecology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001013] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073670] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002477] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Reproductive Scientist Development Program; CSTA; University of Iowa Carver College of Medicine; Department of Obstetrics Gynecology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This material is based upon work supported, in part, by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (BX002477-01, AZ), and by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant NS073670 (AZ), and the Reproductive Scientist Development Program HD000849, RR024980 (MS) and CSTA U54TR001013. The Maternal Fetal Tissue Bank at the University of Iowa is supported by the University of Iowa Carver College of Medicine and Department of Obstetrics & Gynecology.	Alexandrakis M, 2003, EUR J HAEMATOL, V71, P448, DOI 10.1046/j.0902-4441.2003.00167.x; Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Beraud D, 2013, J NEUROIMMUNE PHARM, V8, P94, DOI 10.1007/s11481-012-9401-0; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Chikahisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078434; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Freeman JG, 2001, J NEUROIMMUNOL, V119, P231, DOI 10.1016/S0165-5728(01)00384-8; Fukuishi N, 2014, J IMMUNOL, V193, P1886, DOI 10.4049/jimmunol.1302520; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; HOSLI L, 1984, NEUROSCI LETT, V48, P287, DOI 10.1016/0304-3940(84)90052-1; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; KAPLAN R, 1991, J NEUROCHEM, V57, P483, DOI 10.1111/j.1471-4159.1991.tb03777.x; Karagkouni A, 2013, AUTOIMMUN REV, V12, P947, DOI 10.1016/j.autrev.2013.02.006; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; Kempuraj D, 2013, J NEUROIMMUNE PHARM, V8, P643, DOI 10.1007/s11481-013-9439-7; Kempuraj D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-20; Khan MM, 2014, J MOL NEUROSCI, V53, P590, DOI 10.1007/s12031-013-0225-z; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Kim DY, 2010, J IMMUNOL, V185, P273, DOI 10.4049/jimmunol.1000991; Korkmaz OT, 2010, J MOL NEUROSCI, V41, P278, DOI 10.1007/s12031-009-9307-3; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee HJ, 2010, OXID MED CELL LONGEV, V3, P283, DOI 10.4161/oxim.3.4.12809; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; Lim R, 2004, BRAIN RES, V1024, P225, DOI 10.1016/j.brainres.2004.08.003; LIM R, 1991, ADV EXP MED BIOL, V296, P161; LIM RM, 1990, FASEB J, V4, P3360, DOI 10.1096/fasebj.4.15.2253851; Marx CE, 2001, BIOL PSYCHIAT, V50, P743, DOI 10.1016/S0006-3223(01)01209-4; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Nelissen S, 2013, ACTA NEUROPATHOL, V125, P637, DOI 10.1007/s00401-013-1092-y; Radinger Madeleine, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0737s90; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Ryan BJ, 2014, FREE RADICAL BIO MED, V67, P58, DOI 10.1016/j.freeradbiomed.2013.10.008; Saito T, 2005, NEUROMOL MED, V7, P79, DOI 10.1385/NMM:7:1-2:079; Santillan MK, 2014, EUR J OBSTET GYN R B, V179, P94, DOI 10.1016/j.ejogrb.2014.05.023; Sayed BA, 2011, J IMMUNOL, V186, P3294, DOI 10.4049/jimmunol.1003574; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SEELDRAYERS PA, 1992, J NEUROIMMUNOL, V36, P239, DOI 10.1016/0165-5728(92)90056-Q; Silver R, 2013, TRENDS NEUROSCI, V36, P513, DOI 10.1016/j.tins.2013.06.001; Silverman AJ, 2000, J NEUROSCI, V20, P401, DOI 10.1523/JNEUROSCI.20-01-00401.2000; Sismanopoulos N, 2012, CURR PHARM DESIGN, V18, P2261, DOI 10.2174/138161212800165997; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; Skaper SD, 2013, MOL NEUROBIOL, V48, P340, DOI 10.1007/s12035-013-8487-6; Skaper SD, 2012, PHILOS T R SOC B, V367, P3312, DOI 10.1098/rstb.2011.0391; Skaper SD, 2012, FASEB J, V26, P3103, DOI 10.1096/fj.11-197194; Tagen M, 2009, J IMMUNOL, V183, P6313, DOI 10.4049/jimmunol.0803422; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Tore F, 2009, CURR PHARM DESIGN, V15, P3433, DOI 10.2174/138161209789105036; Trudler D, 2015, J NEURAL TRANSM; Tuncel N, 2005, PEPTIDES, V26, P827, DOI 10.1016/j.peptides.2004.12.019; Tung HY, 2014, J INTERF CYTOK RES, V34, P141, DOI 10.1089/jir.2012.0066; Walker ME, 2012, BBA-MOL BASIS DIS, V1822, P57, DOI 10.1016/j.bbadis.2011.02.009; WANG BR, 1992, BRAIN RES, V591, P1, DOI 10.1016/0006-8993(92)90971-B; Xiong Z, 2014, J ALZHEIMERS DIS, V40, P297, DOI 10.3233/JAD-132081; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; ZAHEER A, 1993, J NEUROCHEM, V60, P914, DOI 10.1111/j.1471-4159.1993.tb03237.x; Zaheer A, 2001, NEUROCHEM RES, V26, P1293, DOI 10.1023/A:1014241300179; Zaheer A, 2002, BIOCHEM BIOPH RES CO, V294, P238, DOI 10.1016/S0006-291X(02)00467-9; Zaheer A, 2008, BRAIN RES, V1208, P192, DOI 10.1016/j.brainres.2008.02.093; Zaheer A, 2008, BRAIN RES, V1190, P206, DOI 10.1016/j.brainres.2007.11.011; Zaheer A, 2007, J NEUROCHEM, V101, P364, DOI 10.1111/j.1471-4159.2006.04385.x; Zaheer S, 2011, NEUROSCIENCE, V194, P227, DOI 10.1016/j.neuroscience.2011.07.069; Zaltieri M., 2015, PARKINSONS DIS-US, V2015, DOI [DOI 10.1155/2015/108029, 10.1155/2015/108029]; Zhang S, 2012, CELL PHYSIOL BIOCHEM, V29, P931, DOI 10.1159/000171029	74	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135776	10.1371/journal.pone.0135776	http://dx.doi.org/10.1371/journal.pone.0135776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275153	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600109
J	Orozco-Davila, D; Adriano-Anaya, MD; Quintero-Fong, L; Salvador-Figueroa, M				Orozco-Davila, Dina; de Lourdes Adriano-Anaya, Maria; Quintero-Fong, Luis; Salvador-Figueroa, Miguel			Sterility and Sexual Competitiveness of Tapachula-7 Anastrepha ludens Males Irradiated at Different Doses	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLIES; MATING PERFORMANCE; GAMMA-RADIATION; DIPTERA; TEPHRITIDAE; FLY; COMPATIBILITY; ERADICATION; RELEASE	A genetic sexing strain of Anastrepha ludens (Loew), Tapachula-7, was developed by the Mexican Program Against Fruit Flies to produce and release only males in programs where the sterile insect technique (SIT) is applied. Currently, breeding are found at a massive scale, and it is necessary to determine the optimum irradiation dose that releases sterile males with minimum damage to their sexual competitiveness. Under laboratory and field conditions, we evaluated the effects of gamma irradiation at doses of 0, 20, 40, 60 and 80 Gy on the sexual competitiveness of males, the induction of sterility in wild females and offspring survivorship. The results of the study indicate that irradiation doses have a significant effect on the sexual behavior of males. A reduction of mating capacity was inversely proportional to the irradiation dose of males. It is estimated that a dose of 60 Gy can induce more than 99% sterility in wild females. In all treatments, the degree of offspring fertility was correlated with the irradiation dose of the parents. In conclusion, the results of the study indicate that a dose of 60 Gy can be applied in sterile insect technique release programs. The application of this dose in the new genetic sexing strain of A. ludens is discussed.	[Orozco-Davila, Dina; Quintero-Fong, Luis] Programa Moscafrut, Metapa De Dominguez, Chiapas, Mexico; [de Lourdes Adriano-Anaya, Maria; Salvador-Figueroa, Miguel] Univ Autonoma Chiapas, Ctr Biociencias, Tapachula, Chiapas, Mexico	Universidad Autonoma de Chiapas	Quintero-Fong, L (corresponding author), Programa Moscafrut, Metapa De Dominguez, Chiapas, Mexico.	jose.quintero@iica-moscafrut.org.mx	Orozco-Davila, Dina/AAJ-2862-2021; Orozco-Davila, Dina/B-4050-2016; Orozco-Davila, Dina/B-3236-2016; Quintero, Jose Luis/B-6213-2013; Orozco-Davila, Dina/T-5369-2019	Orozco-Davila, Dina/0000-0002-6806-0945; Orozco-Davila, Dina/0000-0002-6806-0945; Quintero, Jose Luis/0000-0002-2066-9524; Adriano-Anaya, Lourdes/0000-0002-4356-5429	Programa Nacional Moscas de la fruta SAGARPA-IICA	Programa Nacional Moscas de la fruta SAGARPA-IICA	This research was funded and supported by the Programa Nacional Moscas de la fruta SAGARPA-IICA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinghi A, 2007, FLA ENTOMOL, V90, P96, DOI 10.1653/0015-4040(2007)90[96:IOSIAF]2.0.CO;2; Aluja M, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P375; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Barry JD, 2003, J ECON ENTOMOL, V96, P615, DOI 10.1603/0022-0493-96.3.615; Calkins C.O., 1985, Folia Entomologica Mexicana, P205; CALKINS CO, 1994, FRUIT FLIES AND THE STERILE INSECT TECHNIQUE, P85; CALKINS CO, 1989, J APPL ENTOMOL, V108, P401, DOI 10.1111/j.1439-0418.1989.tb00474.x; CALKINS CO, 1983, FLA ENTOMOL, V66, P512, DOI 10.2307/3494025; Calkins CO, 1988, S MOD INS CONTR NUCL, P299; Cunningham R. T., 1980, Citrograph, V65, P63; Dominiak BC, 2003, AUST J EXP AGR, V43, P519, DOI 10.1071/EA01146; Enkerlin D, 1982, STERILE INSECT TECHN, P323; FAO/IAEA/USDA, 2019, PROD QUAL CONTR STER; Favret E., 1995, Mendeliana, V11, P69; Gutiurrez JM., 2010, MOSCAS FRUTA FUNDAME, P3; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; HOOPER G H S, 1975, Journal of the Australian Entomological Society, V14, P81; Hooper GHS., 1989, WORLD CROP PESTS A, P153; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kuba H, 1996, FRUIT FLY PESTS, P543; Lux SA, 2002, FLA ENTOMOL, V85, P102, DOI 10.1653/0015-4040(2002)085[0102:EOIOTC]2.0.CO;2; Meza JS, 2005, J ECON ENTOMOL, V98, P1930, DOI 10.1603/0022-0493-98.6.1930; Meza-Hernandez JS, 2006, J ECON ENTOMOL, V99, P1979, DOI 10.1603/0022-0493-99.6.1979; Orozco D, 2012, 8 M WORK GROUP FRUIT; Orozco D, 2013, J ECON ENTOMOL, V106, P735, DOI 10.1603/EC12441; Ramirez E, 2012, 8 M WORK GROUP FRUIT; RHODE RH, 1961, J ECON ENTOMOL, V54, P202, DOI 10.1093/jee/54.1.202; Robinson AS, 2002, MUTAT RES-REV MUTAT, V511, P113, DOI 10.1016/S1383-5742(02)00006-6; Rull J, 2007, J ECON ENTOMOL, V100, P1153, DOI 10.1603/0022-0493(2007)100[1153:IOALDT]2.0.CO;2; Rull J, 2014, INT J TROP INSECT SC, V34, pS28, DOI 10.1017/S174275841400006X; SEO ST, 1990, J ECON ENTOMOL, V83, P1948, DOI 10.1093/jee/83.5.1949; Zepeda-Cisneros CS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S1; TOLEDO J, 1993, FRUIT FLIES, P301; Toledo J, 2004, J ECON ENTOMOL, V97, P383, DOI 10.1603/0022-0493-97.2.383; WALDER JM, 1992, FLA ENTOMOL, V75, P267, DOI 10.2307/3495629; Walder JMM, 1993, SCI AGR, V50, P157, DOI DOI 10.1590/S0103-90161993000200001; Zar J.H., 2010, BIOSTAT ANAL	38	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135759	10.1371/journal.pone.0135759	http://dx.doi.org/10.1371/journal.pone.0135759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274926	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600107
J	Taborda, NA; Gonzalez, SM; Alvarez, CM; Correa, LA; Montoya, CJ; Rugeles, MT				Andrea Taborda, Natalia; Milena Gonzalez, Sandra; Mauricio Alvarez, Cristiam; Alfonso Correa, Luis; Julio Montoya, Carlos; Teresa Rugeles, Maria			Higher Frequency of NK and CD4(+) T-Cells in Mucosa and Potent Cytotoxic Response in HIV Controllers	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ELITE CONTROLLERS; IMMUNE ACTIVATION; GRANZYME-B; CENTRAL MEMORY; INFECTION; DISEASE; EXPRESSION; DEPLETION; PROGRESSION	HIV infection induces immune alterations, mainly in gut mucosa, where the main target cells reside. However, the evolution of the infection is variable among infected individuals, as evidenced by HIV controllers who exhibit low or undetectable viral load in the absence of treatment. The aim of this study was to evaluate the frequency, phenotype and activity of T and NK cells in peripheral blood and gut mucosa in a cohort of Colombian HIV controllers. Blood and gut biopsies were included. The frequency and the activation status of T and NK cells were performed by flow cytometry. In addition, Gag-stimulated CD8(+) T-cells and cytokine-stimulated NK cells were tested for cytotoxic activity. Finally, microbial translocation was measured by plasma lipopolysaccharide quantification. Compared with HIV-progressors, HIV controllers exhibited higher frequency of CD4(+) T and NK cells, and lower expression of activation molecules in blood and mucosal immune cells, as well as lower microbial translocation. An increased production of molecules associated with cytotoxic activity of CD8(+) T-cells in blood and mucosa and a higher percentage of polyfunctional CD8(+) T cells in blood were also observed in HIV controllers. In addition, an increased activity of NK cells was observed in blood. These findings suggest that HIV controllers have a potent immune response, mainly mediated by cytotoxic cells that control HIV replication, which contribute to reducing alterations at the gut mucosa.	[Andrea Taborda, Natalia; Milena Gonzalez, Sandra; Julio Montoya, Carlos; Teresa Rugeles, Maria] Univ Antioquia, UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Mauricio Alvarez, Cristiam] Univ Antioquia, UdeA, Fac Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia; [Alfonso Correa, Luis] Univ Antioquia, UdeA, Fac Med, Secc Dermatol,Dept Med Interna, Medellin, Colombia; [Alfonso Correa, Luis] Obra Congregac Mariana, Lab Clin VID, Lab Patol, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia	Rugeles, MT (corresponding author), Univ Antioquia, UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia.	maria.rugeles@udea.edu.co		Taborda, Natalia/0000-0002-6169-0119; Rugeles, Maria T./0000-0001-7855-1409; Taborda Vanegas, Natalia Andrea/0000-0001-6085-855X	CODI-Universidad de Antioquia convocatoria mediana cuantia; Estrategia para Sostenibilidad de Grupos Universidad de Antioquia; CIHR IID&GH Program of the University of Manitoba, Canada; Colciencias "Convocatoria Nacional 511 para el estudio de Doctorado en Colombia ano"	CODI-Universidad de Antioquia convocatoria mediana cuantia; Estrategia para Sostenibilidad de Grupos Universidad de Antioquia; CIHR IID&GH Program of the University of Manitoba, Canada; Colciencias "Convocatoria Nacional 511 para el estudio de Doctorado en Colombia ano"	This investigation was financially supported by CODI-Universidad de Antioquia convocatoria mediana cuantia 2011; Estrategia para Sostenibilidad de Grupos 2014-2015 Universidad de Antioquia; CIHR IID&GH Program of the University of Manitoba, Canada; Natalia Taborda received a scholarship from Colciencias "Convocatoria Nacional 511 para el estudio de Doctorado en Colombia ano 2010".	Alter G, 2007, J IMMUNOL, V178, P7658, DOI 10.4049/jimmunol.178.12.7658; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Belyakov IM, 2012, CURR TOP MICROBIOL, V354, P157, DOI 10.1007/82_2010_119; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brunetta E, 2010, J LEUKOCYTE BIOL, V88, P1119, DOI 10.1189/jlb.0410225; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hendel H, 1996, BIOMED PHARMACOTHER, V50, P480, DOI 10.1016/S0753-3322(97)89278-5; Hong HS, 2010, J VIROL, V84, P1183, DOI 10.1128/JVI.01675-09; Jaspan HB, 2003, EXP MOL PATHOL, V74, P13, DOI 10.1016/S0014-4800(03)80003-5; Jost S, 2012, MICROBES INFECT, V14, P904, DOI 10.1016/j.micinf.2012.05.001; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Kuri-Cervantes L, 2014, J LEUKOCYTE BIOL, V96, P7, DOI 10.1189/jlb.0913514; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Rueda CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030307; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mela CM, 2007, AIDS, V21, P2177, DOI 10.1097/QAD.0b013e3282f08b72; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Naranbhai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053251; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Ranasinghe C, 2007, J IMMUNOL, V178, P2370, DOI 10.4049/jimmunol.178.4.2370; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Reitano KN, 2009, AIDS RES HUM RETROV, V25, P1029, DOI 10.1089/aid.2008.0311; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Sips M, 2012, MUCOSAL IMMUNOL, V5, P30, DOI 10.1038/mi.2011.40; Taborda NA, 2015, J ACQUIR IMMUNE DEFI; Taborda NA, 2012, JAIDS-J ACQ IMM DEF, V60, P12, DOI 10.1097/QAI.0b013e31824876ca; Turk G, 2013, J VIROL, V87, P7445, DOI 10.1128/JVI.00865-13; Wong AHW, 2010, AIDS RES HUM RETROV, V26, P459, DOI 10.1089/aid.2009.0176; Yan JY, 2013, J VIROL, V87, P5170, DOI 10.1128/JVI.02379-12; Yang OO, 2005, VIROLOGY, V332, P16, DOI 10.1016/j.virol.2004.11.028	44	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136292	10.1371/journal.pone.0136292	http://dx.doi.org/10.1371/journal.pone.0136292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291824	gold, Green Submitted, Green Published			2022-12-27	WOS:000359919900075
J	Krediet, CJ; DeNofrio, JC; Caruso, C; Burriesci, MS; Cella, K; Pringle, JR				Krediet, Cory J.; DeNofrio, Jan C.; Caruso, Carlo; Burriesci, Matthew S.; Cella, Kristen; Pringle, John R.			Rapid, Precise, and Accurate Counts of Symbiodinium Cells Using the Guava Flow Cytometer, and a Comparison to Other Methods	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; MARINE-INVERTEBRATES; QUANTITATIVE PCR; BLEACHING EVENT; MODEL SYSTEM; REEF CORALS; SEA; ZOOXANTHELLAE; NUMBERS; LARVAE	In studies of both the establishment and breakdown of cnidarian-dinoflagellate symbiosis, it is often necessary to determine the number of Symbiodinium cells relative to the quantity of host tissue. Ideally, the methods used should be rapid, precise, and accurate. In this study, we systematically evaluated methods for sample preparation and storage and the counting of algal cells using the hemocytometer, a custom image-analysis program for automated counting of the fluorescent algal cells, the Coulter Counter, or the Millipore Guava flowcytometer. We found that although other methods may have value in particular applications, for most purposes, the Guava flow cytometer provided by far the best combination of precision, accuracy, and efficient use of investigator time (due to the instrument's automated sample handling), while also allowing counts of algal numbers over a wide range and in small volumes of tissue homogenate. We also found that either of two assays of total homogenate protein provided a precise and seemingly accurate basis for normalization of algal counts to the total amount of holobiont tissue.	[Krediet, Cory J.; DeNofrio, Jan C.; Caruso, Carlo; Burriesci, Matthew S.; Cella, Kristen; Pringle, John R.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Pringle, JR (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	jpringle@stanford.edu		DeNofrio, Jan/0000-0002-4690-2507	Gordon and Betty Moore Foundation [2629]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by the Gordon and Betty Moore Foundation, Grant 2629 to JRP (www.moore.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2009, MAR ECOL PROG SER, V377, P149, DOI 10.3354/meps07834; ATILOLA MAO, 1986, CAN J VET RES, V50, P282; Berkson J, 1940, AM J PHYSIOL, V128, P0309; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Cavender-Bares KK, 1998, LIMNOL OCEANOGR, V43, P1383, DOI 10.4319/lo.1998.43.6.1383; Cordoba-Matson MV, 2010, J APPL PHYCOL, V22, P427, DOI 10.1007/s10811-009-9475-0; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; Dani V, 2014, MOL ECOL, V23, P4527, DOI 10.1111/mec.12876; Edmunds PJ, 2003, CORAL REEFS, V22, P54, DOI 10.1007/s00338-003-0278-5; EVANS J H, 1970, Hydrobiologia, V35, P401, DOI 10.1007/BF00184567; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; Graham MD, 2003, JALA J ASS LAB AUTOM, V8, P72, DOI [DOI 10.1016/S1535-5535(03)00023-6, 10.1016/s1535-5535-03-00023-6, DOI 10.1016/S1535-5535-03-00023-6]; Guillard RRL, 2005, ALGAL CULTURING TECH, P239, DOI DOI 10.1016/B978-012088426-1/50017-2; Hambleton EA, 2014, J EXP BIOL, V217, P1613, DOI 10.1242/jeb.095679; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hospodsky D, 2010, APPL ENVIRON MICROB, V76, P7004, DOI 10.1128/AEM.01240-10; Johnson CE, 2007, J EXP MAR BIOL ECOL, V353, P287, DOI 10.1016/j.jembe.2007.10.003; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Jones RJ, 1997, MAR ECOL PROG SER, V158, P51, DOI 10.3354/meps158051; KUBITSCHEK HE, 1958, NATURE, V182, P234, DOI 10.1038/182234a0; Lange H., 1993, Biotechnology Techniques, V7, P223, DOI 10.1007/BF02566152; Lee CS, 2012, CYTOM PART A, V81A, P888, DOI 10.1002/cyto.a.22111; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Logan DDK, 2010, J PHYCOL, V46, P525, DOI 10.1111/j.1529-8817.2010.00819.x; Loram JE, 2007, BIOL BULL-US, V212, P259, DOI 10.2307/25066608; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; Lurling M, 2003, HYDROBIOLOGIA, V491, P145, DOI 10.1023/A:1024436508387; Maguire Jr B, 2000, PROC 9TH INT CORAL R, V2, P1129; MALONEY TE, 1962, PHYCOLOGIA, V2, P1, DOI DOI 10.2216/I0031-8884-2-1-1.1; Marie D., 2005, ALGAL CULTURING TECH, P253, DOI DOI 10.1016/B978-012088426-1/50018-4; MENKVELD R, 1984, ANDROLOGIA, V16, P554; Meron D, 2012, ISME J, V6, P1775, DOI 10.1038/ismej.2012.19; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; MOORE SJ, 1989, J MAR BIOL ASSOC UK, V69, P803, DOI 10.1017/S0025315400032173; Nir O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084968; Oakley CA, 2014, CORAL REEFS, V33, P501, DOI 10.1007/s00338-014-1130-9; Piniak GA, 2009, BIOL BULL-US, V216, P55, DOI 10.1086/BBLv216n1p55; Prathalingam NS, 2006, J ANDROL, V27, P257, DOI 10.2164/jandrol.05112; Pringle J R, 1975, Methods Cell Biol, V11, P131, DOI 10.1016/S0091-679X(08)60320-9; Rodrigues LJ, 2008, J EXP BIOL, V211, P2502, DOI 10.1242/jeb.012369; Rodriguez-Lanetty M, 2006, MAR BIOL, V149, P713, DOI 10.1007/s00227-006-0272-x; Saragosti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012508; Sawyer SJ, 2001, J EXP BIOL, V204, P3443; Schnitzler CE, 2012, MAR BIOL, V159, P633, DOI 10.1007/s00227-011-1842-0; SHELDON RW, 1967, J FISH RES BOARD CAN, V24, P909, DOI 10.1139/f67-081; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; SMITHER R, 1975, J APPL BACTERIOL, V39, P157, DOI 10.1111/j.1365-2672.1975.tb00557.x; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; SWANTON ELLEN M., 1962, APPL MICROBIOL, V10, P480; Tolleter D, 2013, CURR BIOL, V23, P1782, DOI 10.1016/j.cub.2013.07.041; TRENCH RK, 1981, BER DEUT BOT GES, V94, P529; TRENCH RK, 1987, J PHYCOL, V23, P469, DOI 10.1111/j.1529-8817.1987.tb02534.x; Venn AA, 2006, PLANT CELL ENVIRON, V29, P2133, DOI 10.1111/j.1365-3040.2006.001587.x; Wood WM., 1966, J SOC COSMET CHEM, V17, P197; Xiang TT, 2013, J PHYCOL, V49, P447, DOI 10.1111/jpy.12055	59	27	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135725	10.1371/journal.pone.0135725	http://dx.doi.org/10.1371/journal.pone.0135725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291447	gold, Green Submitted, Green Published			2022-12-27	WOS:000359919900027
J	Aleng, NA; Sung, YY; MacRae, TH; Abd Wahid, ME				Aleng, Nor Afiqah; Sung, Yeong Yik; MacRae, Thomas H.; Abd Wahid, Mohd Effendy			Non-Lethal Heat Shock of the Asian Green Mussel, Perna viridis, Promotes Hsp70 Synthesis, Induces Thermotolerance and Protects Against Vibrio Infection	PLOS ONE			English	Article							PACIFIC OYSTER; CRASSOSTREA-VIRGINICA; ARGOPECTEN-IRRADIANS; ARTEMIA-FRANCISCANA; MOLECULAR-CLONING; GENE-EXPRESSION; CDNA CLONING; PROTEINS; RESISTANCE; CHALLENGE	Mild heat stress promotes thermotolerance and protection against several different stresses in aquatic animals, consequences correlated with the accumulation of heat shock protein 70 (Hsp70). The purpose of this study was to determine if non-lethal heat shock (NLHS) of the Asian green mussel, Perna viridis, an aquatic species of commercial value, promoted the production of Hsp70 and enhanced its resistance to stresses. Initially, the LT50 and LHT for P. viridis were determined to be 42 degrees C and 44 degrees C, respectively, with no heat shock induced death of mussels at 40 degrees C or less. Immunoprobing of western blots revealed augmentation of constitutive (PvHsp70-1) and inducible (PvHsp70-2) Hsp70 in tissue from adductor muscle, foot, gill and mantel of P. viridis exposed to 38 degrees C for 30 min followed by 6 h recovery, NLHS conditions for this organism. Characterization by liquid chromatography-tandem mass spectrometry (LC-MS/MS) revealed that PvHsp70-1 and PvHsp70-2 respectively corresponded most closely to Hsp70 from P. viridis and Mytilus galloprovincialis. Priming of adult mussels with NLHS promoted thermotolerance and increased resistance to V. alginolyticus. The induction of Hsp70 in parallel with enhanced thermotolerance and improved protection against V. alginolyticus, suggests Hsp70 functions in P. viridis as a molecular chaperone and as a stimulator of the immune system.	[Aleng, Nor Afiqah; Sung, Yeong Yik; Abd Wahid, Mohd Effendy] Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu 21030, Malaysia; [Sung, Yeong Yik; Abd Wahid, Mohd Effendy] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu 21030, Malaysia; [MacRae, Thomas H.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada	Universiti Malaysia Terengganu; Universiti Malaysia Terengganu; Dalhousie University	Sung, YY (corresponding author), Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu 21030, Malaysia.	yeong@umt.edu.my; effendy@umt.edu.my	Afiqah-Aleng, Nor/AAK-6912-2020; Wahid, Mohd Effendy Abd/M-9901-2018; Sung, Yeong Yik/AAA-2654-2020	Afiqah-Aleng, Nor/0000-0003-0919-5126; Wahid, Mohd Effendy Abd/0000-0002-4685-7048; Sung, Yeong Yik/0000-0001-5897-9037	E-Science Fund from Ministry of Science, Technology and Innovation (MOSTI), Malaysia [04-01-12-SS0109]; ERGS from Ministry of Education, Malaysia [55090]; Natural Sciences and Engineering Research Council	E-Science Fund from Ministry of Science, Technology and Innovation (MOSTI), Malaysia; ERGS from Ministry of Education, Malaysia; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: Funded by E-Science Fund No: 04-01-12-SS0109 from the Ministry of Science, Technology and Innovation (MOSTI), Malaysia to MEAW (www.mosti.gov.my), ERGS No. 55090 from the Ministry of Education, Malaysia(www.moe.gov.my) to YYS, and Natural Sciences and Engineering Research Council Discovery Grant to THM.	Arkush KD, 2008, ACTA ZOOL-STOCKHOLM, V89, P331, DOI 10.1111/j.1463-6395.2008.00321.x; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bahrndorff S, 2009, FUNCT ECOL, V23, P233, DOI 10.1111/j.1365-2435.2009.01541.x; Balakrishnan K, 2006, CELL STRESS CHAPERON, V11, P44, DOI 10.1379/CSC-136R1.1; Biusing R., 2001, ASSESSMENT COASTAL F; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Brown HM, 2004, J SHELLFISH RES, V23, P135; Brun NT, 2009, J EXP MAR BIOL ECOL, V371, P77, DOI 10.1016/j.jembe.2009.01.006; Campisi J, 2003, J APPL PHYSIOL, V94, P43, DOI 10.1152/japplphysiol.00681.2002; CHATTERJI A, 1984, AQUACULTURE, V40, P47, DOI 10.1016/0044-8486(84)90215-1; Chen HS, 2006, J ENDOCRINOL, V190, P433, DOI 10.1677/joe.1.06692; Clegg JS, 1998, MOL MAR BIOL BIOTECH, V7, P21; Clegg JS, 2000, J EXP MAR BIOL ECOL, V252, P85, DOI 10.1016/S0022-0981(00)00239-2; de la Vega E, 2006, AQUACULTURE, V253, P82, DOI 10.1016/j.aquaculture.2005.07.041; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Ellis RP, 2015, J EXP MAR BIOL ECOL, V462, P83, DOI 10.1016/j.jembe.2014.10.015; Encomio VG, 2007, DIS AQUAT ORGAN, V76, P251, DOI 10.3354/dao076251; Fabbri E., 2008, ISJ, V5, P135; FAO, FIGIS TIM SER QUER A; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hooper C, 2007, FISH SHELLFISH IMMUN, V22, P363, DOI 10.1016/j.fsi.2006.06.009; HUPPERT HW, 1980, MAR ECOL PROG SER, V3, P113, DOI 10.3354/meps003113; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Nair M, 2003, AQUAC RES, V34, P1037; Loc NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073199; Park K, 2015, FISH SHELLFISH IMMUN, V42, P233, DOI 10.1016/j.fsi.2014.10.036; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Perrigault M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-377; Piano A, 2002, CELL STRESS CHAPERON, V7, P250, DOI 10.1379/1466-1268(2002)007<0250:HEITSO>2.0.CO;2; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Qiu LM, 2007, FISH SHELLFISH IMMUN, V22, P451, DOI 10.1016/j.fsi.2006.05.003; Richards GP, 2015, APPL ENVIRON MICROB, V81, P292, DOI 10.1128/AEM.02930-14; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Sallih K. B., 2005, MUSSEL FARMING STATE; Sayuthi S, 1993, P AQ WORKSH SEAFDEC, P57; Scott MA, 2003, J EXP BIOL, V206, P303, DOI 10.1242/jeb.00107; Shamseldin AA, 1997, J SHELLFISH RES, V16, P487; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Song LS, 2006, FISH SHELLFISH IMMUN, V21, P335, DOI 10.1016/j.fsi.2005.12.011; Song LS, 2010, ADV EXP MED BIOL, V708, P44; Sung YY, 2007, FISH SHELLFISH IMMUN, V22, P318, DOI 10.1016/j.fsi.2006.05.008; Sung YY, 2011, REV AQUACULT, V3, P120, DOI 10.1111/j.1753-5131.2011.01049.x; Sung YT, 2014, ADV MECH ENG, DOI 10.1155/2014/349078; Sung YY, 2014, MAR SCI RES DEV, V4, pe126; Sung YY., 2011, J AQUACUL RES DEV, V2, P006, DOI [10.4172/2155-9546, DOI 10.4172/2155-9546.S2-006, DOI 10.4172/2155-9546]; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Toyohara H, 2005, FISHERIES SCI, V71, P327, DOI 10.1111/j.1444-2906.2005.00968.x; Trivedi V, 2010, INT J PHARM SCI REV, V2, P57; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wang YJ, 2011, MAR POLLUT BULL, V63, P201, DOI 10.1016/j.marpolbul.2011.05.035; Wu XW, 2014, GENE, V543, P275, DOI 10.1016/j.gene.2013.11.103; Yue X, 2011, FISH SHELLFISH IMMUN, V30, P791, DOI 10.1016/j.fsi.2010.12.027	55	20	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135603	10.1371/journal.pone.0135603	http://dx.doi.org/10.1371/journal.pone.0135603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288319	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600058
J	Bae, JH; Shin, DS; Lee, SC; Hwang, IC				Bae, Jeong Hun; Shin, Doo Sup; Lee, Sung Chul; Hwang, In Cheol			Sodium Intake and Socioeconomic Status as Risk Factors for Development of Age-Related Cataracts: The Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							LONG-TERM INCIDENCE; LENS OPACITIES; BLOOD-PRESSURE; SMOKING; PREVALENCE; HYPERTENSION; ASSOCIATION; PROGRESSION; EXCRETION; DISEASE	Purpose Cataract is a very prevalent ocular disorder, and environmental risk factors for age-related cataracts have been widely investigated. We aimed to evaluate an association of dietary sodium intake and socioeconomic factors with the development of age-related cataracts. Methods A cross-sectional case-control study based on the 2008-2011 Korea National Health and Nutrition Examination Survey. Dietary sodium intake was estimated using urinary sodium to creatinine ratio (U[Na+]/Cr). Results Among a total 12,693 participants, 2,687 (21.1%) had cataracts and 10,006 patients without cataracts served as controls. The prevalence of cataracts increased with age and quartiles of U[Na+]/Cr (p for trend < 0.001). Multivariate logistic regression analyses revealed that factors related to the development of cataracts were age >= 50 years (adjusted odds ratio [aOR] 15.34, 95% confidence interval [CI] 13.31-17.69), low income (aOR 1.85, 95% CI 1.64-2.09), low educational attainment (aOR 1.76, 95% CI 1.57-1.96), and high sodium intake (U[Na+]/Cr > 16.4 mmol/mmol; aOR 1.29, 95% CI 1.16-1.44). In a subgroup analysis, a robust effect on cataracts across U[Na+]/Cr quartiles was observed in patients >= 50 years of age (aOR 1.11, 95% CI 1.04-1.18), though not in younger patients (aOR 1.06, 95% CI 0.96-1.17). Conclusions Our results suggest that high sodium intake and low socioeconomic status may affect the development of cataracts, and that a low-salt diet could be helpful for the prevention of cataracts in an older population. Furthermore, efforts to close gaps in health services due to socioeconomic factors may contribute to a reduction in the prevalence of cataracts.	[Bae, Jeong Hun] Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Kangbuk Samsung Hosp, Seoul, South Korea; [Shin, Doo Sup] Seoul Natl Univ Hosp, Dept Educ & Res, Seoul 110744, South Korea; [Bae, Jeong Hun; Lee, Sung Chul] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Hwang, In Cheol] Gachon Univ, Gil Med Ctr, Dept Family Med, Inchon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Gachon University	Hwang, IC (corresponding author), Gachon Univ, Gil Med Ctr, Dept Family Med, Inchon, South Korea.	spfe0211@gmail.com		Shin, Doosup/0000-0003-4960-5732	Senior-Friendly Product R&D program - Ministry of Health & Welfare thorough the Korea Health Industry Development Institute [HI14C1435]	Senior-Friendly Product R&D program - Ministry of Health & Welfare thorough the Korea Health Industry Development Institute	This study was supported by the Senior-Friendly Product R&D program funded by the Ministry of Health & Welfare thorough the Korea Health Industry Development Institute (HI14C1435, http://www.khidi.or.kr/eps). ICH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiov PA, 2008, BRIT J OPHTHALMOL, V92, P1169, DOI 10.1136/bjo.2008.139725; Bentley B, 2006, J CARDIOVASC NURS, V21, P63, DOI 10.1097/00005082-200601000-00012; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Christopher-Stine L, 2004, J RHEUMATOL, V31, P1557; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cumming RG, 2000, OPHTHALMOLOGY, V107, P450, DOI 10.1016/S0161-6420(99)00024-X; Cumming RG, 2000, AM J EPIDEMIOL, V151, P624, DOI 10.1093/oxfordjournals.aje.a010251; Dandona R, 2001, BRIT J OPHTHALMOL, V85, P1484, DOI 10.1136/bjo.85.12.1484; Deaton A, 2003, SOC SCI MED, V56, P1139, DOI 10.1016/S0277-9536(02)00115-6; EDERER F, 1981, AM J OPHTHALMOL, V91, P381, DOI 10.1016/0002-9394(81)90293-2; GLYNN RJ, 1995, ARCH OPHTHALMOL-CHIC, V113, P1131, DOI 10.1001/archopht.1995.01100090057023; Hiller R, 2003, OPHTHALMOLOGY, V110, P578, DOI 10.1016/S0161-6420(02)01762-1; JAHN CE, 1986, OPHTHALMIC RES, V18, P112, DOI 10.1159/000265424; Kanthan GL, 2011, ACTA OPHTHALMOL, V89, pE434, DOI 10.1111/j.1755-3768.2011.02149.x; Kim TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094189; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; KLEIN R, 1994, OPHTHALMOLOGY, V101, P1969; Krishnaiah S, 2005, INVEST OPHTH VIS SCI, V46, P58, DOI 10.1167/iovs.04-0089; Lee SG, 2013, CLIN CHIM ACTA, V424, P168, DOI 10.1016/j.cca.2013.05.027; LESKE MC, 1983, AM J EPIDEMIOL, V118, P152, DOI 10.1093/oxfordjournals.aje.a113625; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Miglior S, 1989, Dev Ophthalmol, V17, P158; Mirsamadi Mansour, 2004, Int J Med Sci, V1, P165; Miyaki K, 2013, INT J ENV RES PUB HE, V10, P980, DOI 10.3390/ijerph10030980; Rhee MY, 2014, NUTRIENTS, V6, P2360, DOI 10.3390/nu6062360; RODRIGUEZSARGENT C, 1989, INVEST OPHTH VIS SCI, V30, P2356; RODRIGUEZSARGENT C, 1987, HYPERTENSION, V9, P304, DOI 10.1161/01.HYP.9.3.304; Seah SKL, 2002, OPHTHALMOLOGY, V109, P2058, DOI 10.1016/S0161-6420(02)01221-6; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P155, DOI 10.1080/09286580701840362; Tavani A, 1996, ANN EPIDEMIOL, V6, P41, DOI 10.1016/1047-2797(95)00099-2; WEST S, 1989, ARCH OPHTHALMOL-CHIC, V107, P1166, DOI 10.1001/archopht.1989.01070020232031; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	37	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136218	10.1371/journal.pone.0136218	http://dx.doi.org/10.1371/journal.pone.0136218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287670	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600124
J	Orand, A; Gupta, A; Shih, W; Presson, AP; Hammer, C; Niesler, B; Heendeniya, N; Mayer, EA; Chang, L				Orand, Alexa; Gupta, Arpana; Shih, Wendy; Presson, Angela P.; Hammer, Christian; Niesler, Beate; Heendeniya, Nuwanthi; Mayer, Emeran A.; Chang, Lin			Catecholaminergic Gene Polymorphisms Are Associated with GI Symptoms and Morphological Brain Changes in Irritable Bowel Syndrome	PLOS ONE			English	Article							ADVERSE LIFE EVENTS; GRAY-MATTER VOLUME; CHRONIC PAIN; SOMATOSENSORY CORTEX; STRESS; ABUSE; INVENTORY; THICKNESS; PREVALENCE; PERCEPTION	Background Genetic and environmental factors contribute to the pathophysiology of irritable bowel syndrome (IBS). In particular, early adverse life events (EALs) and the catecholaminergic system have been implicated. Aims To investigate whether catecholaminergic SNPs with or without interacting with EALs are associated with: 1) a diagnosis of IBS, 2) IBS symptoms and 3) morphological alterations in brain regions associated with somatosensory, viscerosensory, and interoceptive processes. Methods In 277 IBS and 382 healthy control subjects (HCs), 11 SNPs in genes of the catecholaminergic signaling pathway were genotyped. A subset (121 IBS, 209 HCs) underwent structural brain imaging (magnetic resonance imaging [MRI]). Logistic and linear regressions evaluated each SNP separately and their interactions with EALs in predicting IBS and GI symptom severity, respectively. General linear models determined grey matter (GM) alterations from the SNPs and EALs that were predictive of IBS. Results 1) Diagnosis: There were no statistically significant associations between the SNPs and IBS status with or without the interaction with EAL after adjusting for multiple comparisons. 2) Symptoms: GI symptom severity was associated with ADRA1D rs1556832 (P = 0.010). 3) Brain morphometry: In IBS, the homozygous genotype of the major ADRA1D allele was associated with GM increases in somatosensory regions (FDR q = 0.022), left precentral gyrus (q = 0.045), and right hippocampus (q = 0.009). In individuals with increasing sexual abuse scores, the ADRA beta 2 SNP was associated with GM changes in the left posterior insula (q = 0.004) and left putamen volume (q = 0.029). Conclusion In IBS, catecholaminergic SNPs are associated with symptom severity and morphological changes in brain regions concerned with sensory processing and modulation and affect regulation. Thus, certain adrenergic receptor genes may facilitate or worsen IBS symptoms.	[Orand, Alexa; Gupta, Arpana; Heendeniya, Nuwanthi; Mayer, Emeran A.; Chang, Lin] Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Ctr Neurobiol Stress, Los Angeles, CA 90095 USA; [Shih, Wendy; Presson, Angela P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Presson, Angela P.] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA; [Hammer, Christian; Niesler, Beate] Heidelberg Univ, Dept Human Mol Genet, Inst Human Genet, Heidelberg, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; Ruprecht Karls University Heidelberg	Chang, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Ctr Neurobiol Stress, Los Angeles, CA 90095 USA.	linchang@mednet.ucla.edu	Chang, Lin/AAI-4333-2021; Hammer, Christian/C-5827-2014	Chang, Lin/0000-0001-6800-2967; Hammer, Christian/0000-0003-4548-7548	Medical Faculty University of Heidelberg [P50 DK064539, RO1 DK048351, P30 DK041301]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064539, P30DK041301, R01DK048351] Funding Source: NIH RePORTER	Medical Faculty University of Heidelberg; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: The work was supported by P50 DK064539 (EAM), RO1 DK048351 (EAM), P30 DK041301, Medical Faculty University of Heidelberg (BN).	[Anonymous], 1997, FED REG; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arborelius L, 2007, NEUROSCIENCE, V145, P738, DOI 10.1016/j.neuroscience.2006.12.007; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berman S, 2012, NEUROIMAGE, V63, P1854, DOI 10.1016/j.neuroimage.2012.08.028; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Camilleri M, 2013, NEUROGASTROENT MOTIL, V25, P458, DOI 10.1111/nmo.12132; Camilleri M, 2013, AM J PHYSIOL-GASTR L, V304, pG553, DOI 10.1152/ajpgi.00376.2012; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; Cheng P, 2013, NEUROGASTROENT MOTIL, V25, pE650, DOI 10.1111/nmo.12177; Chung MK, 2005, LECT NOTES COMPUT SC, V3565, P627; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Diatchenko L, 2006, PAIN, V123, P226, DOI 10.1016/j.pain.2006.04.015; Diatchenko L, 2006, AM J MED GENET B, V141B, P449, DOI 10.1002/ajmg.b.30324; Dickhaus B, 2003, AM J GASTROENTEROL, V98, P135; Dina OA, 2001, EUR J NEUROSCI, V13, P2227, DOI 10.1046/j.0953-816x.2001.01614.x; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Elsenbruch S, 2014, PAIN, V155, P244, DOI 10.1016/j.pain.2013.09.027; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gupta A, 2014, PSYCHOSOM MED, V76, P404, DOI 10.1097/PSY.0000000000000089; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Heitkemper M, 2001, DIGEST DIS SCI, V46, P1276, DOI 10.1023/A:1010671514618; Ibeakanma C, 2011, GASTROENTEROLOGY, V141, P2098, DOI 10.1053/j.gastro.2011.08.006; Ishizuka O, 2013, INT J UROL, V20, P73, DOI 10.1111/j.1442-2042.2012.03223.x; Iwata N, 1998, PSYCHOL REP, V82, P651, DOI 10.2466/PR0.82.2.651-656; Jiang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073932; Khasar SG, 1999, J NEUROPHYSIOL, V81, P1104, DOI 10.1152/jn.1999.81.3.1104; Kilpatrick LA, 2011, GASTROENTEROLOGY, V140, P1943, DOI 10.1053/j.gastro.2011.03.011; Kitayama N, 2006, J AFFECT DISORDERS, V90, P171, DOI 10.1016/j.jad.2005.11.006; Korner A, 2008, PSYCHOTHER PSYCH MED, V58, P238, DOI 10.1055/s-2007-986199; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Labus JS, 2014, PAIN, V155, P137, DOI 10.1016/j.pain.2013.09.020; Labus JS, 2004, ALIMENT PHARM THER, V20, P89, DOI 10.1111/j.1365-2036.2004.02007.x; Leung K, 2010, THESIS U CALIFORNIA; Leung KT, 2008, LECT NOTES COMPUT SC, V5069, P612; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; LONGSTRETH GF, 1993, DIGEST DIS SCI, V38, P1581, DOI 10.1007/BF01303163; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; McCrory E, 2012, J ROY SOC MED, V105, P151, DOI 10.1258/jrsm.2011.110222; McCrory E, 2010, J CHILD PSYCHOL PSYC, V51, P1079, DOI 10.1111/j.1469-7610.2010.02271.x; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Schmulson M, 1999, AM J GASTROENTEROL, V94, P2929, DOI 10.1111/j.1572-0241.1999.01440.x; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shi YG, 2011, LECT NOTES COMPUT SC, V6892, P327, DOI 10.1007/978-3-642-23629-7_40; Su AM, 2014, NEUROGASTROENT MOTIL, V26, P36, DOI 10.1111/nmo.12220; Sugaya K, 2002, NEUROSCI LETT, V328, P74, DOI 10.1016/S0304-3940(02)00459-7; Sugaya K, 2002, J UROLOGY, V168, P2668, DOI 10.1016/S0022-5347(05)64241-3; Tillisch K, 2005, GUT, V54, P1396, DOI 10.1136/gut.2004.058685; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; Ung H, 2012, MULTIVARIATE CLASSIF; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weniger G, 2008, ACTA PSYCHIAT SCAND, V118, P281, DOI 10.1111/j.1600-0447.2008.01246.x; Wilson S, 2004, BRIT J GEN PRACT, V54, P495; Wouters MM, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01919.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	69	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135910	10.1371/journal.pone.0135910	http://dx.doi.org/10.1371/journal.pone.0135910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288143	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600085
J	Shoeb, M; Singh, BR; Mobin, M; Afreen, G; Khan, W; Naqvi, AH				Shoeb, Mohd; Singh, Braj Raj; Mobin, Mohammad; Afreen, Gul; Khan, Wasi; Naqvi, Alim H.			Kinetic Study on Mutagenic Chemical Degradation through Three Pot Synthesiszed Graphene@ZnO Nanocomposite	PLOS ONE			English	Article							PHOTOCATALYTIC DEGRADATION; OXIDE NANOCOMPOSITE; CDS NANOPARTICLES; FACILE SYNTHESIS; METHYLENE-BLUE; REDUCTION; COMPOSITES; FABRICATION; CELLS; PARTICLES	The study was taken up with the objective to synthesize graphene-zinc oxide nano particles (NPs) nanocomposite (Gr@ZnO-Nc) via In-situ synthesis method. The structural, optical, thermal, electrical and photocatalytic properties of the synthesized Gr@ZnO-Nc were studied. The characterization data confirmed that the ZnO NPs were successfully incorporated into the graphene sheets. Further, TGA/DTA results exhibited an enhanced thermal stability of the Gr@ZnO-Nc compared with the graphene. The Gr@ZnO-Nc, graphene sheets were uniformly wrapped by ZnO NPs, which can protect graphene and delay their oxidation in air. The synthesized Gr@ZnO-Nc was used for the efficient photodegradation of a carcinogenic methyl orange (MO) dye. The results exhibited promising photodegradation of the MO dye under UV light irradiation through the production of reactive oxygen species (ROS). The promising effect of Gr@ZnO-Nc on the photodegradation properties was conferred by the large surface area which increased adsorption capacity, and the strong electron transfer ability. Thus, it is encouraging to conclude that the synthesized Gr@ZnO-Nc has environmental significance with its utility in remediation in the hazardous MO dye.	[Shoeb, Mohd; Singh, Braj Raj; Khan, Wasi; Naqvi, Alim H.] Aligarh Muslim Univ, Ctr Excellence Mat Sci Nanomat, Dept Appl Phys, ZH Coll Engn & Tech, Aligarh, Uttar Pradesh, India; [Shoeb, Mohd; Mobin, Mohammad] Aligarh Muslim Univ, Dept Appl Chem, ZH Coll Engn & Tech, Aligarh, Uttar Pradesh, India; [Afreen, Gul] Indian Inst Technol Delhi, Dept Chem Engn, Delhi, India	Aligarh Muslim University; Zakir Husain College Of Engineering & Technology; Aligarh Muslim University; Zakir Husain College Of Engineering & Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Singh, BR (corresponding author), Aligarh Muslim Univ, Ctr Excellence Mat Sci Nanomat, Dept Appl Phys, ZH Coll Engn & Tech, Aligarh, Uttar Pradesh, India.	brajviro@gmail.com	Mobin, Mohammad/AAX-6438-2021; Shoeb, Mohd/B-4206-2014; , Mobin/D-1273-2014	Mobin, Mohammad/0000-0003-4829-7491; Shoeb, Mohd/0000-0003-0582-7034; , Mobin/0000-0003-1940-3822				Akhavan O, 2011, CARBON, V49, P11, DOI 10.1016/j.carbon.2010.08.030; An XQ, 2011, RSC ADV, V1, P1426, DOI 10.1039/c1ra00382h; Ansari SA, 2012, MATER SCI ENG B-ADV, V177, P428, DOI 10.1016/j.mseb.2012.01.022; Azarang M, 2014, J APPL PHYS, V116, DOI 10.1063/1.4894141; Chen D, 2013, ENERG ENVIRON SCI, V6, P1362, DOI 10.1039/c3ee23586f; Chen Z, 2013, CRYSTENGCOMM, V15, P3022, DOI 10.1039/c3ce27021a; Chu DW, 2010, LANGMUIR, V26, P2811, DOI 10.1021/la902866a; Chua CK, 2014, CHEM SOC REV, V43, P291, DOI 10.1039/c3cs60303b; CHUNG KT, 1981, APPL ENVIRON MICROB, V42, P641, DOI 10.1128/AEM.42.4.641-648.1981; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Dutta S, 2005, PHYS STATUS SOLIDI A, V202, P1172, DOI 10.1002/pssa.200406932; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Fan HG, 2012, CATAL COMMUN, V29, P29, DOI 10.1016/j.catcom.2012.09.013; Fan XB, 2008, ADV MATER, V20, P4490, DOI 10.1002/adma.200801306; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Hilder M, 2012, PHYS CHEM CHEM PHYS, V14, P14034, DOI 10.1039/c2cp42385e; Hong Y, 2013, J MATER CHEM A, V1, P5700, DOI 10.1039/c3ta10218a; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Ji QM, 2010, ANGEW CHEM INT EDIT, V49, P9737, DOI 10.1002/anie.201004929; Ji YZ, 2013, MAT SCI ENG C-MATER, V33, P3811, DOI 10.1016/j.msec.2013.05.016; Jin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106991; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Kavitha MK, 2013, J MATER CHEM C, V1, P3669, DOI 10.1039/c3tc30323c; Khan JA, 2014, CR CHIM, V17, P91, DOI 10.1016/j.crci.2013.08.006; Khan JA, 2013, SPECTROCHIM ACTA A, V109, P313, DOI 10.1016/j.saa.2013.03.011; Khenfouch M, 2012, OPT MATER, V34, P1320, DOI 10.1016/j.optmat.2012.02.005; Kim YK, 2012, ACS APPL MATER INTER, V4, P6545, DOI 10.1021/am301658p; Lai Q, 2012, AIP ADV, V2, DOI 10.1063/1.4747817; Leng WH, 2005, J PHYS CHEM B, V109, P15008, DOI 10.1021/jp051821z; Li BJ, 2011, J MATER CHEM, V21, P3346, DOI 10.1039/c0jm03253k; Li BX, 2012, J COLLOID INTERF SCI, V377, P114, DOI 10.1016/j.jcis.2012.03.060; Liu Q, 2009, ADV FUNCT MATER, V19, P894, DOI 10.1002/adfm.200800954; Liu XJ, 2012, CHEM ENG J, V183, P238, DOI 10.1016/j.cej.2011.12.068; Loh KP, 2010, J MATER CHEM, V20, P2277, DOI 10.1039/b920539j; Lu K, 2012, CHINESE SCI BULL, V57, P1223, DOI 10.1007/s11434-012-4986-5; Luo QP, 2012, J PHYS CHEM C, V116, P8111, DOI 10.1021/jp2113329; Lv T, 2012, CATAL SCI TECHNOL, V2, P2297, DOI 10.1039/c2cy20023f; Lv X, 2009, SMALL, V5, P1682, DOI 10.1002/smll.200900044; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2014, KONA POWDER PART J, P92; Nethravathi C, 2008, CARBON, V46, P1994, DOI 10.1016/j.carbon.2008.08.013; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Pawar RC, 2014, APPL CATAL B-ENVIRON, V144, P57, DOI 10.1016/j.apcatb.2013.06.022; Pawar RC, 2013, MATER CHEM PHYS, V141, P686, DOI 10.1016/j.matchemphys.2013.05.062; Pawar RC, 2013, CURR APPL PHYS, V13, pS50, DOI 10.1016/j.cap.2012.12.031; Peng WC, 2013, NANO RES, V6, P286, DOI 10.1007/s12274-013-0306-x; Rao RAK, 2014, J ENVIRON CHEM ENG, V2, P199, DOI 10.1016/j.jece.2013.12.011; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Roy P, 2013, ENVIRON SCI TECHNOL, V47, P6688, DOI 10.1021/es400422k; Saravanakumar B, 2013, MATER RES BULL, V48, P878, DOI 10.1016/j.materresbull.2012.11.048; Shoeb M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035015; Siddique YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080944; Singh BR, 2012, BIOMATERIALS, V33, P5753, DOI 10.1016/j.biomaterials.2012.04.045; Singh S, 2014, J MOL STRUCT, V1056, P194, DOI 10.1016/j.molstruc.2013.10.020; Song M, 2012, J NANOMATER, V2012, DOI 10.1155/2012/135138; Upadhyay RK, 2014, RSC ADV, V4, P3823, DOI 10.1039/c3ra45013a; Wahab R, 2013, COLLOID SURFACE B, V111, P211, DOI 10.1016/j.colsurfb.2013.06.003; Wahab R, 2012, J BIOMED NANOTECHNOL, V8, P424, DOI 10.1166/jbn.2012.1448; Wahab R, 2011, CHEM ENG J, V175, P450, DOI 10.1016/j.cej.2011.09.055; Wang LX, 2013, DALTON T, V42, P8070, DOI 10.1039/c3dt50333j; Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r; Wu JL, 2010, APPL SURF SCI, V256, P2826, DOI 10.1016/j.apsusc.2009.11.034; Xiong P, 2012, J MATER CHEM, V22, P17485, DOI 10.1039/c2jm31522j; Xu TG, 2011, APPL CATAL B-ENVIRON, V101, P382, DOI 10.1016/j.apcatb.2010.10.007; Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y; Yan DH, 2009, J PHYS CHEM B, V113, P6047, DOI 10.1021/jp808805w; Yang HF, 2009, J MATER CHEM, V19, P4632, DOI 10.1039/b901421g; Yang L, 2013, J APPL PHYS, V113; Yang Y, 2011, APPL SURF SCI, V257, P8950, DOI 10.1016/j.apsusc.2011.05.070; Yavari F, 2010, SMALL, V6, P2535, DOI 10.1002/smll.201001384; Zhang H, 2010, ACS NANO, V4, P380, DOI 10.1021/nn901221k; Zhang L, 2013, PHYSICA E, V47, P279, DOI 10.1016/j.physe.2012.10.008; Zhang Q, 2012, J MATER CHEM, V22, P11778, DOI 10.1039/c2jm31401k; Zhang W, 2009, APPL CATAL A-GEN, V371, P1, DOI 10.1016/j.apcata.2009.09.038; Zhang YP, 2011, PROG NAT SCI-MATER, V21, P467, DOI 10.1016/S1002-0071(12)60084-7; Zhang YJ, 2012, CHINESE SCI BULL, V57, P3086, DOI 10.1007/s11434-012-5333-6; Zhang ZY, 2013, ACS APPL MATER INTER, V5, P2227, DOI 10.1021/am303299r; Zheng Q, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/45/455103	81	31	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135055	10.1371/journal.pone.0135055	http://dx.doi.org/10.1371/journal.pone.0135055			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287672	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600034
J	Sola-Villa, D; Dilme, JF; Rodriguez, C; Soto, B; Vila, L; Escudero, JR; Martinez-Gonzalez, J; Camacho, M				Sola-Villa, David; Dilme, Jaime-Felix; Rodriguez, Cristina; Soto, Begona; Vila, Luis; Escudero, Jose-Roman; Martinez-Gonzalez, Jose; Camacho, Mercedes			Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHESIS; SMOOTH-MUSCLE-CELLS; I-SYNTHASE ACTIVITY; ENDOTHELIAL-CELLS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE-2 EXPRESSION; THROMBOXANE A(2); SUPPRESSOR; DEPENDS; PGE(2)	PGE(2) has been implicated in abdominal aortic aneurysm (AAA) associated hypervascularization. PGE(2)-metabolism involves 15-hydroxyprostaglandin-dehydrogenase (15-PGDH) the expression of which in AAA is unknown. The aim of this study was to examine the expression and cell distribution of 15-PGDH in AAA. Here, we show that 15-PGDH mRNA levels were significantly higher in aorta samples from patients undergoing AAA repair than in those from healthy multiorgan donors. Consequently, the ratio of metabolized PGE(2) secreted by aortic samples was significantly higher in AAA. AAA production of total PGE(2) and PGE(2) metabolites correlated positively with PGI(2) production, while the percentage of metabolized PGE(2) correlated negatively with the total amount of PGE(2) and with PGI(2). Transcript levels of 15-PGDH were statistically associated with leukocyte markers but did not correlate with microvascular endothelial cell markers. Immunohistochemistry revealed 15-PGDH in the areas of leukocyte infiltration in AAA samples, mainly associated with CD45-positive cells, but not in normal aorta samples. We provide new data concerning 15-PGDH expression in human AAA, showing that 15-PGDH is upregulated in AAA and mainly expressed in infiltrating leukocytes. Our data suggest that microvasculature was not involved in PGE(2) catabolism, reinforcing the potential role of microvasculature derived PGE(2) in AAA-associated hypervascularization.	[Sola-Villa, David] Autonomous Univ Barcelona, Inst Biomed Res II B St Pau, Barcelona, Spain; [Dilme, Jaime-Felix; Soto, Begona; Vila, Luis; Escudero, Jose-Roman; Camacho, Mercedes] Inst Biomed Res II B St Pau, Angiol Vasc Biol & Inflammat Lab, Barcelona, Spain; [Dilme, Jaime-Felix; Soto, Begona; Escudero, Jose-Roman] Inst Biomed Res II B St Pau, Dept Vasc Surg, Barcelona, Spain; [Rodriguez, Cristina; Martinez-Gonzalez, Jose] Inst Biomed Res II B St Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Camacho, M (corresponding author), Inst Biomed Res II B St Pau, Angiol Vasc Biol & Inflammat Lab, Barcelona, Spain.	mcamacho@santpau.cat	Rodriguez, Cristina/D-3099-2011; Dilme, Jaime/AAB-6994-2019	Rodriguez, Cristina/0000-0002-6472-5647; Martinez-Gonzalez, Jose/0000-0002-3894-7166; Camacho, Mercedes/0000-0001-5970-3294	Spanish Ministry of Economy and Competiveness [SAF2010-21392, SAF2013-46707-R, SAF2012-40127]; Instituto de Salud Carlos III [PI12/01952, RD12/0042/0051, RD12/0042/0053]; Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe	Spanish Ministry of Economy and Competiveness(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe	This work was supported by grants SAF2010-21392 (LV), SAF2013-46707-R (LV, MC), SAF2012-40127 (JM-G) from the Spanish Ministry of Economy and Competiveness, PI12/01952 (CR) and Red de Investigacion Cardiovascular RD12/0042/0051 (LV) and RD12/0042/0053 (JM-G) from the Instituto de Salud Carlos III. The study was cofunded by Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGGARD E, 1971, ACTA PHYSIOL SCAND, V81, P396, DOI 10.1111/j.1748-1716.1971.tb04914.x; Bishop-Bailey D, 2006, ARTERIOSCL THROM VAS, V26, P956, DOI 10.1161/01.ATV.0000219672.68024.bc; Bru A, 2009, TUMOUR CELL LINES HT; Camacho M, 1998, CIRC RES, V83, P353, DOI 10.1161/01.RES.83.4.353; Camacho M, 2007, J THROMB HAEMOST, V5, P1411, DOI 10.1111/j.1538-7836.2007.02555.x; Camacho M, 2000, THROMB RES, V99, P155, DOI 10.1016/S0049-3848(00)00241-3; Camacho M, 2015, J PATHOL, V235, P125, DOI 10.1002/path.4453; Camacho M, 2013, J LIPID RES, V54, P3506, DOI 10.1194/jlr.M042481; Casos K, 2011, MICROVASC RES, V81, P261, DOI 10.1016/j.mvr.2011.01.006; Chapple KS, 2007, ANN VASC SURG, V21, P61, DOI 10.1016/j.avsg.2006.10.008; Cheuk BLY, 2007, INT J MOL MED, V20, P391; Choke E, 2006, ARTERIOSCL THROM VAS, V26, P2077, DOI 10.1161/01.ATV.0000234944.22509.f9; Salvado MD, 2009, ARTERIOSCL THROM VAS, V29, P1131, DOI 10.1161/ATVBAHA.109.188540; Gitlin JM, 2007, CARDIOVASC RES, V73, P227, DOI 10.1016/j.cardiores.2006.10.015; HERRON GS, 1991, ARTERIOSCLER THROMB, V11, P1667, DOI 10.1161/01.ATV.11.6.1667; Holmes DR, 1997, J VASC SURG, V25, P810, DOI 10.1016/S0741-5214(97)70210-6; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Paik DC, 2004, EXP MOL MED, V36, P524, DOI 10.1038/emm.2004.67; Sola-Villa D, 2006, KIDNEY INT, V70, P1935, DOI 10.1038/sj.ki.5001948; Soler M, 2000, CIRC RES, V87, P504; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Vila L, 2004, MED RES REV, V24, P399, DOI 10.1002/med.10065; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wang M, 2008, CIRCULATION, V117, P1302, DOI 10.1161/CIRCULATIONAHA.107.731398; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136201	10.1371/journal.pone.0136201	http://dx.doi.org/10.1371/journal.pone.0136201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287481	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600121
J	Bill, J; Buesing, L; Habenschuss, S; Nessler, B; Maass, W; Legenstein, R				Bill, Johannes; Buesing, Lars; Habenschuss, Stefan; Nessler, Bernhard; Maass, Wolfgang; Legenstein, Robert			Distributed Bayesian Computation and Self-Organized Learning in Sheets of Spiking Neurons with Local Lateral Inhibition	PLOS ONE			English	Article							EXCITATORY NEURONS; VISUAL-CORTEX; CONNECTIONS; MODEL; ORIENTATION; SPECIFICITY; INTEGRATION; PLASTICITY; NETWORKS; DYNAMICS	During the last decade, Bayesian probability theory has emerged as a framework in cognitive science and neuroscience for describing perception, reasoning and learning of mammals. However, our understanding of how probabilistic computations could be organized in the brain, and how the observed connectivity structure of cortical microcircuits supports these calculations, is rudimentary at best. In this study, we investigate statistical inference and self-organized learning in a spatially extended spiking network model, that accommodates both local competitive and large-scale associative aspects of neural information processing, under a unified Bayesian account. Specifically, we show how the spiking dynamics of a recurrent network with lateral excitation and local inhibition in response to distributed spiking input, can be understood as sampling from a variational posterior distribution of a well-defined implicit probabilistic model. This interpretation further permits a rigorous analytical treatment of experience-dependent plasticity on the network level. Using machine learning theory, we derive update rules for neuron and synapse parameters which equate with Hebbian synaptic and homeostatic intrinsic plasticity rules in a neural implementation. In computer simulations, we demonstrate that the interplay of these plasticity rules leads to the emergence of probabilistic local experts that form distributed assemblies of similarly tuned cells communicating through lateral excitatory connections. The resulting sparse distributed spike code of a well-adapted network carries compressed information on salient input features combined with prior experience on correlations among them. Our theory predicts that the emergence of such efficient representations benefits from network architectures in which the range of local inhibition matches the spatial extent of pyramidal cells that share common afferent input.	[Bill, Johannes; Habenschuss, Stefan; Maass, Wolfgang; Legenstein, Robert] Graz Univ Technol, Inst Theoret Comp Sci, Graz, Austria; [Buesing, Lars] Columbia Univ, Dept Stat, New York, NY USA; [Nessler, Bernhard] Frankfurt Inst Adv Studies, Frankfurt, Germany	Graz University of Technology; Columbia University	Bill, J (corresponding author), Graz Univ Technol, Inst Theoret Comp Sci, Graz, Austria.	bill.scientific@gmail.com		Legenstein, Robert/0000-0002-8724-5507	CHIST-ERAERA-Net (Project FWF) [I753-N23]; European Union project [FP7-269921, FP7-237955]; Austrian Science Fund (FWF) [I 753] Funding Source: researchfish	CHIST-ERAERA-Net (Project FWF)(Austrian Science Fund (FWF)); European Union project(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was written under partial support of CHIST-ERAERA-Net (Project FWF # I753-N23, PNEUMA) and the European Union projects # FP7-269921 (BrainScaleS) and # FP7-237955 (FACETSITN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; [Anonymous], ARXIV13113211; [Anonymous], 1989, ANALOG VLSI IMPLEMEN; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bill J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00412; Bishop C. M, 2006, PATTERN RECOGNITION; Bosking WH, 1997, J NEUROSCI, V17, P2112; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Carreira-Perpinan M.A., 2005, P ARTIFICIAL INTELLI, VR5:, P33; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Deneve S., 2005, ADV NEURAL INFORM PR, V17, P353; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Ganchev J., 2008, P C NEUR INF PROC SY, P569; Gentet LJ, 2010, NEURON; Goodman ND, 2008, COGNITIVE SCI, V32, P108, DOI 10.1080/03640210701802071; Habenschuss S, 2013, PLOS COMPUTATIONAL B, V9, DOI [10.1371/journal.pcbi.1003311, DOI 10.1371/J0URNAL.PCBI.1003311]; Habenschuss S, 2012, ADV NEURAL INFORM PR, V25, P782; Habenschuss S, 2013, NEURAL COMPUT, V25, P1371, DOI 10.1162/NECO_a_00446; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hinton G. E., 1986, PARALLEL DISTRIBUTED, V1, DOI DOI 10.1234/12345678; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hyvarinen A, 2002, NIPS; Hyvarinen A, 2006, NEURAL COMPUT, V18, P2283, DOI 10.1162/neco.2006.18.10.2283; Indiveri G, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/38/384010; Johansson C, 2006, LECT NOTES COMPUT SC, V3853, P265; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Kappel D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003511; Kerlin AM, 2010, NEURON; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lansner A., 1989, International Journal of Neural Systems, V1, P77, DOI 10.1142/S0129065789000499; Lansner A, 2003, THEOR BIOSCI, V122, P19, DOI 10.1078/1431-7613-00072; Lansner A, 2009, TRENDS NEUROSCIENCES; Lansner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073776; Legenstein R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003859; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Lochmann T, 2011, CURR OPIN NEUROBIOL, V21, P774, DOI 10.1016/j.conb.2011.05.018; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Mayr C., 2012, ADV NEURAL INF PROCE, V25, P1700; Moreno-Bote R, 2014, PLOS COMPUT BIOL, V10, DOI [10.1371/journal.pcbi.1003522, DOI 10.1371/J0URNAL.PCBI.1003522]; Moreno-Bote R, 2011, P NATL ACAD SCI USA, V108, P12491, DOI 10.1073/pnas.1101430108; Neal RM, 1998, NATO ADV SCI I D-BEH, V89, P355; Nessler B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003037; Orban G, 2008, P NATL ACAD SCI USA, V105, P2745, DOI 10.1073/pnas.0708424105; Pecevski D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002294; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pouget A, 2013, NAT NEUROSCI, V16, P1170, DOI 10.1038/nn.3495; Poulet JF, 2012, TRENDS NEUROSCIENCES; Querlioz D, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1775, DOI 10.1109/IJCNN.2011.6033439; Rao R. P. N., 2004, P ADV NEUR INF PROC, P1113; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; RAO RPN, 2007, BAYESIAN BRAIN PROBA, P239; Runyan CA, 2010, NEURON; Salakhutdinov R., 2009, ARTIF INTELL, P1; Sato M.-A., 1999, FAST LEARNING ON LIN; Savin C, 2014, ADV NEURAL INF PROCE, P2024; Schemmel J, 2006, IEEE IJCNN, P1; Schemmel J, 2008, IEEE IJCNN, P431, DOI 10.1109/IJCNN.2008.4633828; Serrano-Gotarredona T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00002; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Snider GS, 2008, 2008 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURES, P85, DOI 10.1109/NANOARCH.2008.4585796; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Steimer A, 2009, NEURAL COMPUT, V21, P2502, DOI 10.1162/neco.2009.08-08-837; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Sundareswara R, 2008, J VISION, V8, DOI 10.1167/8.5.12; Suri M, 2013, IEEE T ELECTRON DEV, V60, P2402, DOI 10.1109/TED.2013.2263000; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Tully Philip J, 2014, Front Synaptic Neurosci, V6, P8, DOI 10.3389/fnsyn.2014.00008; van Rossum G., 1995, CENTRUM WISKUNDE INF; Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zariwala HA, 2011, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00162; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	86	5	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134356	10.1371/journal.pone.0134356	http://dx.doi.org/10.1371/journal.pone.0134356			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284370	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100008
J	Dueregger, A; Schopf, B; Eder, T; Hofer, J; Gnaiger, E; Aufinger, A; Kenner, L; Perktold, B; Ramoner, R; Klocker, H; Eder, IE				Dueregger, Andrea; Schoepf, Bernd; Eder, Theresa; Hoefer, Julia; Gnaiger, Erich; Aufinger, Astrid; Kenner, Lukas; Perktold, Bernhard; Ramoner, Reinhold; Klocker, Helmut; Eder, Iris E.			Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate	PLOS ONE			English	Article							CANCER-CELLS; KETOGENIC DIET; LOW-CARBOHYDRATE; SMALL BIOPSIES; METABOLISM; PROGRESSION; GLUCOSE; GROWTH; ZINC; DEHYDROGENASE	Tumor cells adapt via metabolic reprogramming to meet elevated energy demands due to continuous proliferation, for example by switching to alternative energy sources. Nutrients such as glucose, fatty acids, ketone bodies and amino acids may be utilized as preferred substrates to fulfill increased energy requirements. In this study we investigated the metabolic characteristics of benign and cancer cells of the prostate with respect to their utilization of medium chain (MCTs) and long chain triglycerides (LCTs) under standard and glucose-starved culture conditions by assessing cell viability, glycolytic activity, mitochondrial respiration, the expression of genes encoding key metabolic enzymes as well as mitochondrial mass and mtDNA content. We report that BE prostate cells (RWPE-1) have a higher competence to utilize fatty acids as energy source than PCa cells (LNCaP, ABL, PC3) as shown not only by increased cell viability upon fatty acid supplementation but also by an increased beta-oxidation of fatty acids, although the base-line respiration was 2-fold higher in prostate cancer cells. Moreover, BE RWPE-1 cells were found to compensate for glucose starvation in the presence of fatty acids. Of notice, these findings were confirmed in vivo by showing that PCa tissue has a lower capacity in oxidizing fatty acids than benign prostate. Collectively, these metabolic differences between benign and prostate cancer cells and especially their differential utilization of fatty acids could be exploited to establish novel diagnostic and therapeutic strategies.	[Dueregger, Andrea; Eder, Theresa; Hoefer, Julia; Klocker, Helmut; Eder, Iris E.] Med Univ Innsbruck, Dept Urol, Div Expt Urol, A-6020 Innsbruck, Austria; [Dueregger, Andrea; Schoepf, Bernd; Klocker, Helmut] Oncotyrol GmbH, Ctr Personalized Med, Innsbruck, Austria; [Schoepf, Bernd] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Schoepf, Bernd; Gnaiger, Erich] Oroboros Instruments, High Resolut Respirometry, Innsbruck, Austria; [Aufinger, Astrid; Kenner, Lukas] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Perktold, Bernhard; Ramoner, Reinhold] FHG Zentrum Gesundheitsberufe Tirol GmbH, Diatol, Innsbruck, Austria; [Gnaiger, Erich] Med Univ Innsbruck, D Swarovski Res Lab, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Vienna; Medical University of Innsbruck	Eder, IE (corresponding author), Med Univ Innsbruck, Dept Urol, Div Expt Urol, A-6020 Innsbruck, Austria.	iris.eder@i-med.ac.at	Klocker, Helmut/AAI-7130-2020	Kenner, Lukas/0000-0003-2184-1338; Hoefer, Julia/0000-0003-1138-3134; Gnaiger, Erich/0000-0003-3647-5895; Eder, Iris/0000-0003-3716-0027	Competence Center Oncotyrol within the scope of the Austrian Competence Centers for Excellent Technologies program [2.3.3, 2.1.5]; Austrian Cancer Aid Tyrol; autonomous province Bozen [37/40.3]; Oroboros Instruments and Oncotyrol GmbH	Competence Center Oncotyrol within the scope of the Austrian Competence Centers for Excellent Technologies program; Austrian Cancer Aid Tyrol; autonomous province Bozen; Oroboros Instruments and Oncotyrol GmbH	This work was supported by the Competence Center Oncotyrol (grant numbers: 2.3.3 and 2.1.5) within the scope of the Austrian Competence Centers for Excellent Technologies program conducted by the Austrian Research Promotion Agency (FFG). In addition, the study was partly funded by a category B research funding from the Austrian Cancer Aid Tyrol and the autonomous province Bozen (grant number: 37/40.3). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Oroboros Instruments and Oncotyrol GmbH provided support in the form of salaries for authors [AD, BS, EG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012; BABSON AL, 1973, CLIN CHEM, V19, P766; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Barfeld SJ, 2014, ENDOCR-RELAT CANCER, V21, pT57, DOI 10.1530/ERC-13-0515; Barrientos A., 2009, CURR PROTOC HUM GENE, V19, P13, DOI DOI 10.1002/0471142905.HG1903S63; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Bracarda S, 2011, BJU INT, V107, P13, DOI 10.1111/j.1464-410X.2010.10036.x; Bu H, 2013, FEBS J, V280, P1249, DOI 10.1111/febs.12118; CARROLL JJ, 1970, BIOCHEM MED METAB B, V4, P171, DOI 10.1016/0006-2944(70)90093-1; Champ CE, 2014, J NEURO-ONCOL, V117, P125, DOI 10.1007/s11060-014-1362-0; Christensen CE, 2014, J BIOL CHEM, V289, P2344, DOI 10.1074/jbc.M113.498626; Chua ME, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/826254; Cohen MB, 2009, J CELL BIOCHEM, V106, P363, DOI 10.1002/jcb.22022; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Costello LC, 2005, MITOCHONDRION, V5, P143, DOI 10.1016/j.mito.2005.02.001; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Dasgupta S, 2015, J CLIN INVEST, V125, P1174, DOI 10.1172/JCI76029; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dueregger A, 2013, PHYTOMEDICINE, V20, P1306, DOI 10.1016/j.phymed.2013.07.009; Eser PO, 2013, MOL CLIN ONCOL, V1, P444, DOI 10.3892/mco.2013.76; FRIEDMAN MI, 1990, AM J PHYSIOL, V258, pR216, DOI 10.1152/ajpregu.1990.258.1.R216; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh SK, 2010, CANCER RES, V70, P6119, DOI 10.1158/0008-5472.CAN-10-1008; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Grupp K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-145; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Higgins LH, 2009, BBA-BIOENERGETICS, V1787, P1433, DOI 10.1016/j.bbabio.2009.06.003; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Ho VW, 2011, CANCER RES, V71, P4484, DOI 10.1158/0008-5472.CAN-10-3973; Huebner SM, 2014, J NUTR, V144, P177, DOI 10.3945/jn.113.182550; JOHNSON RC, 1990, AM J CLIN NUTR, V52, P502, DOI 10.1093/ajcn/52.3.502; Kim JL, 2014, ASIAN PAC J CANCER P, V15, P433, DOI 10.7314/APJCP.2014.15.1.433; Klement RJ, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-75; Kolonel LN, 1999, JNCI-J NATL CANCER I, V91, P414, DOI 10.1093/jnci/91.5.414; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Liu YY, 2010, ANTICANCER RES, V30, P369; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPASCHUK GD, 1994, J BIOL CHEM, V269, P25871; MILLER WR, 1990, J STEROID BIOCHEM, V37, P317, DOI 10.1016/0960-0760(90)90480-9; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Pelser C, 2013, CANCER EPIDEM BIOMAR, V22, P697, DOI 10.1158/1055-9965.EPI-12-1196-T; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pinthus JH, 2007, PROSTATE, V67, P1330, DOI 10.1002/pros.20609; Sakharkar MK, 2013, PPAR RES, V2013, DOI 10.1155/2013/109285; Sampson N, 2013, IN VITRO MODEL SYSTE; Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340; Schmidt M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-54; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Upadhyay M, 2013, PHARMACOL THERAPEUT, V137, P318, DOI 10.1016/j.pharmthera.2012.11.003; WARBURG O, 1956, SCIENCE, V124, P269; Zadra G, 2013, BBA-MOL CELL BIOL L, V1831, P1518, DOI 10.1016/j.bbalip.2013.03.010; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958; Zhang YF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-204; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	65	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135704	10.1371/journal.pone.0135704	http://dx.doi.org/10.1371/journal.pone.0135704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285134	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100062
J	Lorkova, L; Scigelova, M; Arrey, TN; Vit, O; Pospisilova, J; Doktorova, E; Klanova, M; Alam, M; Vockova, P; Maswabi, B; Klener, P; Petrak, J				Lorkova, Lucie; Scigelova, Michaela; Arrey, Tabiwang Ndipanquang; Vit, Ondrej; Pospisilova, Jana; Doktorova, Eliska; Klanova, Magdalena; Alam, Mahmudul; Vockova, Petra; Maswabi, Bokang; Klener, Pavel, Jr.; Petrak, Jiri			Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MOLECULAR PATHOGENESIS; REPLICATION STRESS; TYROSINE KINASE; IN-VIVO; B-CELLS; CHEMORESISTANCE; MECHANISMS; CLADRIBINE; EXPRESSION	Mantle cell lymphoma (MCL) is a chronically relapsing aggressive type of B-cell non-Hodgkin lymphoma considered incurable by currently used treatment approaches. Fludarabine is a purine analog clinically still widely used in the therapy of relapsed MCL. Molecular mechanisms of fludarabine resistance have not, however, been studied in the setting of MCL so far. We therefore derived fludarabine-resistant MCL cells (Mino/FR) and performed their detailed functional and proteomic characterization compared to the original fludarabine sensitive cells (Mino). We demonstrated that Mino/FR were highly cross-resistant to other antinucleosides (cytarabine, cladribine, gemcitabine) and to an inhibitor of Bruton tyrosine kinase (BTK) ibrutinib. Sensitivity to other types of anti-lymphoma agents was altered only mildly (methotrexate, doxorubicin, bortezomib) or remained unaffacted (cisplatin, bendamustine). The detailed proteomic analysis of Mino/FR compared to Mino cells unveiled over 300 differentially expressed proteins. Mino/FR were characterized by the marked downregulation of deoxycytidine kinase (dCK) and BTK (thus explaining the observed crossresistance to antinucleosides and ibrutinib), but also by the upregulation of several enzymes of de novo nucleotide synthesis, as well as the up-regulation of the numerous proteins of DNA repair and replication. The significant upregulation of the key antiapoptotic protein Bcl-2 in Mino/FR cells was associated with the markedly increased sensitivity of the fludarabine-resistant MCL cells to Bcl-2-specific inhibitor ABT199 compared to fludarabine-sensitive cells. Our data thus demonstrate that a detailed molecular analysis of drug-resistant tumor cells can indeed open a way to personalized therapy of resistant malignancies.	[Lorkova, Lucie; Vit, Ondrej; Pospisilova, Jana; Doktorova, Eliska; Klanova, Magdalena; Alam, Mahmudul; Vockova, Petra; Maswabi, Bokang; Klener, Pavel, Jr.; Petrak, Jiri] Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague, Czech Republic; [Scigelova, Michaela; Arrey, Tabiwang Ndipanquang] Thermo Fisher Sci, Bremen, Germany; [Klanova, Magdalena; Vockova, Petra; Klener, Pavel, Jr.] Gen Univ Hosp, Dept Med 1, Dept Hematol, Prague, Czech Republic; [Klanova, Magdalena; Vockova, Petra; Klener, Pavel, Jr.] Charles Univ Prague, Prague, Czech Republic; [Petrak, Jiri] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic	Charles University Prague; Thermo Fisher Scientific; General University Hospital Prague; Charles University Prague; Institute of Hematology Prague	Petrak, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague, Czech Republic.	jpetr@lf1.cuni.cz	Klener, Pavel/AAA-2789-2021; Klener, Pavel/F-7185-2017; Doktorová, Eliska/I-9719-2017; Petrak, Jiri/I-8950-2017; Vočková, Petra/H-3557-2017; Klanova, Magdalena/AAG-9785-2021; Alam, Mahmudul/AAX-4097-2020; Vit, Ondrej/I-8905-2017	Klener, Pavel/0000-0001-7786-9378; Doktorová, Eliska/0000-0001-9230-0972; Petrak, Jiri/0000-0002-8695-4803; Vočková, Petra/0000-0001-9968-6054; Klanova, Magdalena/0000-0003-3526-8114; Alam, Mahmudul/0000-0002-3464-4125; Vit, Ondrej/0000-0002-7941-0699; Maswabi, Bokang/0000-0003-4699-5392; Pospisilova, Jana/0000-0001-6020-1048	ministry of health of CR [IGA-MZ NT13201-4, NT12248-5, 15-32961A, 15-27757A]; Minsitry of Education, Youth and Sports of the Czech Republic [PRVOUK P24/LF1/3, PRVOUK P27/LF1/1, UNCE 204021, SVV-2013-260033]; Charles University [GAUK 700712 253284, 595912]; Czech Science Foundation [15-02986S, 14-19590S, 15-14200S]; BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University in Vestec from the ERDF [CZ.1.05/1.1.00/02.0109]	ministry of health of CR; Minsitry of Education, Youth and Sports of the Czech Republic; Charles University; Czech Science Foundation(Grant Agency of the Czech Republic); BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University in Vestec from the ERDF	The work was supported by The ministry of health of CR (www.mzcr.cz) via grants: IGA-MZ NT13201-4 (PK), NT12248-5 (JP), 15-32961A (JP) and 15-27757A (PK). The work was also supported by the Minsitry of Education, Youth and Sports of the Czech Republic (www.msmt.cz) via institutional grants PRVOUK P24/LF1/3 (JP) and PRVOUK P27/LF1/1(PK), UNCE 204021 (PK) and SVV-2013-260033 (JP) and grants from Charles University (www.cuni.cz) GAUK 700712 253284 (OV) and 595912 (BM) and from the Czech Science Foundation (www.gacr.cz) grants 15-02986S (PK), 14-19590S (PK) and 15-14200S (JP). The project was also supported by BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec (CZ.1.05/1.1.00/02.0109), from the ERDF (www.biocev.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Austen B, 2007, J CLIN ONCOL, V25, P5448, DOI 10.1200/JCO.2007.11.2649; Austin WR, 2012, J EXP MED, V209, P2215, DOI 10.1084/jem.20121061; Bai L, 1998, J CANCER RES CLIN, V124, P367, DOI 10.1007/s004320050185; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Cinar M, 2013, LEUKEMIA RES, V37, P1271, DOI 10.1016/j.leukres.2013.07.028; Constantinou A, 2012, CHROMOSOMA, V121, P21, DOI 10.1007/s00412-011-0349-2; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; de Campos-Nebel M, 2008, MUTAT RES-FUND MOL M, V646, P8, DOI 10.1016/j.mrfmmm.2008.08.013; de la Fuente MT, 2003, BIOCHEM BIOPH RES CO, V311, P708, DOI 10.1016/j.bbrc.2003.10.054; Dreyling M, 2013, LEUKEMIA LYMPHOMA, V54, P699, DOI 10.3109/10428194.2012.733882; Florczyk U, 2011, CANCER LETT, V300, P40, DOI 10.1016/j.canlet.2010.09.003; Forstpointner R, 2004, BLOOD, V104, P3064, DOI 10.1182/blood-2004-04-1323; Gandhi V, 2002, CLIN PHARMACOKINET, V41, P93, DOI 10.2165/00003088-200241020-00002; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Jares P, 2012, J CLIN INVEST, V122, P3416, DOI 10.1172/JCI61272; Kim SS, 2013, BIOCHEM BIOPH RES CO, V440, P658, DOI 10.1016/j.bbrc.2013.09.120; Klanova M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-159; Kluin-Nelemans HC, 2012, NEW ENGL J MED, V367, P520, DOI 10.1056/NEJMoa1200920; Lai R, 2002, LEUKEMIA RES, V26, P849, DOI 10.1016/S0145-2126(02)00013-9; Li P, 2014, MOL BIOL CELL, V25, P2934, DOI 10.1091/mbc.E14-05-0957; Lin TS, 2010, J CLIN ONCOL, V28, P418, DOI 10.1200/JCO.2009.24.1570; Lotfi K, 1999, CLIN CANCER RES, V5, P2438; Mackey JR, 2005, BLOOD, V105, P767, DOI 10.1182/blood-2004-03-1046; Mansson E, 2003, BIOCHEM PHARMACOL, V65, P237, DOI 10.1016/S0006-2952(02)01484-3; Mansson E, 1999, CANCER RES, V59, P5956; Messina M, 2014, BLOOD, V123, P2378, DOI 10.1182/blood-2013-10-534271; Moussay E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-115; Mraz M, 2015, EUR J HAEMATOL; NATSUMEDA Y, 1984, CANCER RES, V44, P2475; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Qin TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023372; Reed JC, 1997, SEMIN HEMATOL, V34, P9; Reed JC, 1996, J CLIN INVEST, V97, P2403, DOI 10.1172/JCI118684; Reiman T, 2002, LEUKEMIA, V16, P1886, DOI 10.1038/sj.leu.2402579; Rossi D, 2012, BLOOD, V119, P2854, DOI 10.1182/blood-2011-12-395673; Saba N, 2014, CURR OPIN HEMATOL, V21, P350, DOI 10.1097/MOH.0000000000000057; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Sharma A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.155; Sharma A, 2014, MOL CANCER RES, V12, P1205, DOI 10.1158/1541-7786.MCR-14-0124; Smith SC, 2014, NUCLEIC ACIDS RES, V42, P11517, DOI 10.1093/nar/gku840; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; TEW KD, 1994, CANCER RES, V54, P4313; Vie N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-14; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zenz T, 2009, BLOOD, V114, P2589, DOI 10.1182/blood-2009-05-224071	50	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135314	10.1371/journal.pone.0135314	http://dx.doi.org/10.1371/journal.pone.0135314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285204	gold, Green Published			2022-12-27	WOS:000359666100031
J	Zhang, XL; Zhu, QQ; Zhu, L; Jiang, H; Xie, J; Huang, W; Xu, B				Zhang, Xinlin; Zhu, Qingqing; Zhu, Li; Jiang, He; Xie, Jun; Huang, Wei; Xu, Biao			Spatial/Frontal QRS-T Angle Predicts All-Cause Mortality and Cardiac Mortality: A Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK STRATIFICATION; ELECTROCARDIOGRAPHIC ABNORMALITIES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; POSTMENOPAUSAL WOMEN; PROGNOSTIC VALUE; SUDDEN-DEATH; HEALTH; YOUNG	Background A number of studies have assessed the predictive effect of QRS-T angles in various populations since the last decade. The objective of this meta-analysis was to evaluate the prognostic value of spatial/frontal QRS-T angle on all-cause death and cardiac death. Methods PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials were searched from their inception until June 5, 2014. Studies reporting the predictive effect of spatial/frontal QRS-T angle on all-cause/cardiac death in all populations were included. Relative risk (RR) was used as a measure of effect. Results Twenty-two studies enrolling 164,171 individuals were included. In the combined analysis in all populations, a wide spatial QRS-T angle was associated with an increase in all-cause death (maximum-adjusted RR: 1.40; 95% confidence interval [CI]: 1.32 to 1.48) and cardiac death (maximum-adjusted RR: 1.71; 95% CI: 1.54 to 1.90), a wide frontal QRS-T angle also predicted a higher rate of all-cause death (maximum-adjusted RR: 1.71; 95% CI: 1.54 to 1.90). Largely similar results were found using different methods of categorizing for QRS-T angles, and similar in subgroup populations such as general population, populations with suspected coronary heart disease or heart failure. Other stratified analyses and meta-analyses using unadjusted data also generated consistent findings. Conclusions Spatial QRS-T angle held promising prognostic value on all-cause death and cardiac death. Frontal QRS-T angle was also a promising predictor of all-cause death. Given the good predictive value of QRS-T angle, a combined stratification strategy in which QRS-T angle is of vital importance might be expected.	[Zhang, Xinlin; Jiang, He; Xie, Jun; Huang, Wei; Xu, Biao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Qingqing] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Li] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Radiol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Huang, W (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China.	huangweisd@126.com; xubiao@medmail.com.cn	祝, 清清/AHD-0460-2022; xie, jun/C-2193-2017	xie, jun/0000-0002-9385-3242	National Natural Science Foundation of China [81070195, 81270281, 81200148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NO. 81070195, 81270281, and 81200148). The funder had no role in the study design, data collection and analysis, writing of the report, and decision to submit the article for publication.	Aro AL, 2012, EUROPACE, V14, P872, DOI 10.1093/europace/eur393; Bailey JJ, 2001, J AM COLL CARDIOL, V38, P1902, DOI 10.1016/S0735-1097(01)01667-9; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borleffs CJW, 2009, CIRC-ARRHYTHMIA ELEC, V2, P548, DOI 10.1161/CIRCEP.109.859108; Brosnan M, 2015, HEART RHYTHM, V12, P130, DOI 10.1016/j.hrthm.2014.09.060; Church TR, 2002, J ELECTROCARDIOL, V35, P117, DOI 10.1054/jelc.2002.37168; de Bie MK, 2013, EUROPACE, V15, P290, DOI 10.1093/europace/eus306; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; de Torbal A, 2004, CARDIOLOGY, V101, P199, DOI 10.1159/000076697; DERN PL, 1967, CIRCULATION, V36, P823, DOI 10.1161/01.CIR.36.6.823; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Goldberger JJ, 2014, J AM COLL CARDIOL, V63, P1879, DOI 10.1016/j.jacc.2013.12.021; Goldberger JJ, 2011, CIRCULATION, V123, P2423, DOI 10.1161/CIRCULATIONAHA.110.959734; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Gotsman I, 2013, AM J CARDIOL, V111, P1452, DOI 10.1016/j.amjcard.2013.01.294; Halkin A, 2012, J AM COLL CARDIOL, V60, P2271, DOI 10.1016/j.jacc.2012.09.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; KANNEL WB, 1987, AM HEART J, V113, P370, DOI 10.1016/0002-8703(87)90280-8; Kardys I, 2003, EUR HEART J, V24, P1357, DOI 10.1016/S0195-668X(03)00203-3; Kentta T, 2011, EUROPACE, V13, P701, DOI 10.1093/europace/euq461; Laukkanen JA, 2014, AM J CARDIOL, V113, P1178, DOI 10.1016/j.amjcard.2013.12.026; Leslie LK, 2012, CIRCULATION, V125, P2621, DOI 10.1161/CIRCULATIONAHA.111.087940; Lipton JA, 2010, CORONARY ARTERY DIS, V21, P26, DOI 10.1097/MCA.0b013e328332ee32; Lown MT, 2012, AM J CARDIOL, V109, P307, DOI 10.1016/j.amjcard.2011.09.014; Macfarlane PW, 2012, EUROPACE, V14, P773, DOI 10.1093/europace/eus057; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maron BJ, 2014, J AM COLL CARDIOL, V64, P1479, DOI 10.1016/j.jacc.2014.05.006; Maron BJ, 1998, CIRCULATION, V97, P2294, DOI 10.1161/01.CIR.97.22.2294; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Pavri BB, 2008, CIRCULATION, V117, P3181, DOI 10.1161/CIRCULATIONAHA.107.733451; Raposeiras-Roubin S, 2014, AM J CARDIOL, V113, P1312, DOI 10.1016/j.amjcard.2014.01.406; Rautaharju PM, 2006, AM J CARDIOL, V97, P309, DOI 10.1016/j.amjcard.2005.08.046; Rautaharju PM, 2006, CIRCULATION, V113, P481, DOI 10.1161/CIRCULATIONAHA.105.537415; Rautaharju PM, 2006, CIRCULATION, V113, P473, DOI 10.1161/CIRCULATIONAHA.104.496091; Rubulis A, 2010, J ELECTROCARDIOL, V43, P310, DOI 10.1016/j.jelectrocard.2010.05.004; Selvaraj S, 2014, J AM SOC ECHOCARDIOG, V27, P74, DOI 10.1016/j.echo.2013.08.023; Strauss DG, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1156, DOI 10.1161/CIRCEP.113.000411; Vend N, 2013, HEART RHYTHM, V10, pS110; Wells G.A., NEWCASTLE OTTAWA SCA; Whang W, 2012, AM J CARDIOL, V109, P981, DOI 10.1016/j.amjcard.2011.11.027; Yamazaki T, 2005, HEART RHYTHM, V2, P73, DOI 10.1016/j.hrthm.2004.10.040; Zhang ZM, 2007, AM J CARDIOL, V100, P844, DOI 10.1016/j.amjcard.2007.03.104	43	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136174	10.1371/journal.pone.0136174	http://dx.doi.org/10.1371/journal.pone.0136174			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284799	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100107
J	Costantini, D; Goutte, A; Barbraud, C; Faivre, B; Sorci, G; Weimerskirch, H; Delord, K; Chastel, O				Costantini, David; Goutte, Aurelie; Barbraud, Christophe; Faivre, Bruno; Sorci, Gabriele; Weimerskirch, Henri; Delord, Karine; Chastel, Olivier			Demographic Responses to Oxidative Stress and Inflammation in the Wandering Albatross (Diomedea exulans)	PLOS ONE			English	Article							RECAPTURE MODELS; REPRODUCTION; SURVIVAL; MULTIEVENT; UNCERTAIN; COSTS; CARE	One of the major challenges in ecological research is the elucidation of physiological mechanisms that underlie the demographic traits of wild animals. We have assessed whether a marker of plasma oxidative stress (TBARS) and plasma haptoglobin (protein of the acute inflammatory phase response) measured at time t predict five demographic parameters (survival rate, return rate to the breeding colony, breeding probability, hatching and fledging success) in sexually mature wandering albatrosses over the next four years (Diomedea exulans) using a five-year individual-based dataset. Non-breeder males, but not females, having higher TBARS at time t had reduced future breeding probabilities; haptoglobin was not related to breeding probability. Neither TBARS nor haptoglobin predicted future hatching or fledging success. Haptoglobin had a marginally positive effect on female survival rate, while TBARS had a marginally negative effect on return rate. Our findings do not support the role for oxidative stress as a constraint of future reproductive success in the albatross. However, our data point to a potential mechanism underlying some aspects of reproductive senescence and survival. Our results also highlight that the study of the consequences of oxidative stress should consider the life-cycle stage of an individual and its reproductive history.	[Costantini, David] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Costantini, David] Univ Glasgow, IBAHCM, Glasgow, Lanark, Scotland; [Goutte, Aurelie; Barbraud, Christophe; Weimerskirch, Henri; Delord, Karine; Chastel, Olivier] Univ La Rochelle, CEBC, CNRS, UMR7372, F-79360 La Rochelle, France; [Goutte, Aurelie] Univ Paris 06, EPHE, CNRS, UMR 7619, F-75005 Paris, France; [Faivre, Bruno; Sorci, Gabriele] Univ Bourgogne, UMR CNRS Biogeosci 6282, F-21000 Dijon, France	University of Antwerp; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Universite de Bourgogne	Costantini, D (corresponding author), Univ Antwerp, Dept Biol, Univ Pl 1, B-2610 Antwerp, Belgium.	david.costantini@uantwerpen.be	Weimerskirch, Henri/F-5562-2013; Goutte, Aurelie/F-7572-2017; Barbraud, Christophe/A-5870-2012; Weimerskirch, Henri/K-7306-2019	Barbraud, Christophe/0000-0003-0146-212X; Weimerskirch, Henri/0000-0002-0457-586X; Goutte, Aurelie/0000-0001-8322-5843; Sorci, Gabriele/0000-0002-0799-3995; Costantini, David/0000-0002-8140-8790	French Polar Institute (IPEV), Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE) [109]; Agence Nationale de la Recherche (ANR STRESS OX AGE)	French Polar Institute (IPEV), Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE); Agence Nationale de la Recherche (ANR STRESS OX AGE)(French National Research Agency (ANR))	This project was supported by the French Polar Institute (IPEV, program 109, H.W.), Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE). B.F. and G.S. received financial support from the Agence Nationale de la Recherche (ANR STRESS OX & AGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, ESTIMATION ANIMAL AB; Barbraud C, 2012, J ORNITHOL, V152, pS605, DOI 10.1007/s10336-011-0686-1; Beaulieu M, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot004; Beaulieu M, 2011, FUNCT ECOL, V25, P577, DOI 10.1111/j.1365-2435.2010.01825.x; Bergeron P, 2011, FUNCT ECOL, V25, P1063, DOI 10.1111/j.1365-2435.2011.01868.x; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cam E, 1998, ECOLOGY, V79, P2917, DOI 10.1890/0012-9658(1998)079[2917:AANPPT]2.0.CO;2; Noguera JC, 2012, BIOL LETTERS, V8, P61, DOI 10.1098/rsbl.2011.0756; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Costantini D., 2014, OXIDATIVE STRESS HOR; Costantini D, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov024; Costantini D, 2014, OECOLOGIA, V175, P1107, DOI 10.1007/s00442-014-2975-x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Goutte A, 2011, BIOL LETTERS, V7, P790, DOI 10.1098/rsbl.2011.0196; Hunter CM, 2009, MODELING DEMOGRAPHIC, P324; Jelena A, 2013, J PHYSIOL BIOCHEM, V69, P45, DOI 10.1007/s13105-012-0186-7; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Losdat S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0888; Newton I, 2010, POPULATION ECOLOGY R; Pardo D, 2013, OECOLOGIA, V173, P1283, DOI 10.1007/s00442-013-2704-x; Pardo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060389; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Santos ESA, 2012, J EVOLUTION BIOL, V25, P1911, DOI 10.1111/j.1420-9101.2012.02569.x; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Wegmann M, 2015, PHYSIOL BEHAV, V141, P127, DOI 10.1016/j.physbeh.2015.01.017; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Weimerskirch H, 1999, P 22 INT ORN C DURB, P1178	33	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133967	10.1371/journal.pone.0133967	http://dx.doi.org/10.1371/journal.pone.0133967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275171	Green Published, gold			2022-12-27	WOS:000359493600019
J	Shin, DH; Kim, EJ; Kim, SJ; Park, JY; Oh, J				Shin, Dong Ho; Kim, Eun Jung; Kim, Soo Jin; Park, Ji-Young; Oh, Jieun			Delta Neutrophil Index as a Marker for Differential Diagnosis between Acute Graft Pyelonephritis and Acute Graft Rejection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; MYCOPHENOLATE-MOFETIL; RENAL-TRANSPLANTATION; INFECTION; KIDNEY; SEPSIS; PROCALCITONIN; BACTERIURIA	Introduction The delta neutrophil index (DNI) is the fraction of circulating immature granulocytes, which reflect infectious and/or septic condition. Acute graft pyelonephritis (AGPN) versus acute graft rejection is a frequently encountered diagnostic and therapeutic dilemma in kidney transplant recipients, but little is known about the clinical usefulness of DNI value in the differentiation of the two conditions. Material & Methods A total of 90 episodes of AGPN or acute graft rejection were evaluated at the Kangdong Sacred Heart Hospital between 2008 and 2014. We performed retrospective analysis of demographic, clinical, and laboratory parameters data. Receiver operating curves (ROC) and multivariate logistic regression were conducted to ascertain the utility of DNI in discriminating between AGPN and acute graft rejection. Results AGPN group had significantly higher DNI values than acute graft rejection group (2.9% vs. 1.9%, P < 0.001). The area under the ROC curve for DNI value to discriminate between AGPN and acute graft rejection was 0.85 (95% confidence interval [CI]; 0.76-0.92, P < 0.001). A DNI value of 2.7% was selected as the cut-off value for AGPN, and kidney transplant recipients with a DNI value >= 2.7% were found to be at a higher risk of infection than those with a DNI < 2.7% (odd ratio [OR] 40.50; 95% CI 8.68-189.08; P < 0.001). In a multivariate logistic regression analysis, DNI was a significant independent factor for predicting AGPN after adjusting age, sex, log WBC count, log neutorphil count, log lymphocyte count, CRP concentration, and procalcitonin concentration (OR 4.32; 95% CI 1.81-10.34, P < 0.001). Conclusions This study showed that DNI was an effective marker to differentiate between AGPN and acute graft rejection. Thus, these finding suggest that DNI may be a useful marker in the management of these patients.	[Shin, Dong Ho; Kim, Eun Jung; Kim, Soo Jin; Oh, Jieun] Hallym Univ, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Park, Ji-Young] Hallym Univ, Kangdong Sacred Heart Hosp, Dept Lab Med, Seoul, South Korea; [Oh, Jieun] Hallym Univ, Hallym Kidney Res Inst, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea	Hallym University; Hallym University; Hallym University	Oh, J (corresponding author), Hallym Univ, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea.	jieunmd@gmail.com	Oh, Jieun/ABA-4669-2020	Oh, Jieun/0000-0001-9429-9602				Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; Arnon S, 2008, CURR OPIN INFECT DIS, V21, P223, DOI 10.1097/QCO.0b013e3282fa15dd; Berthoux F, 2000, NEPHROL DIAL TRANSPL, V15, P2, DOI 10.1093/ndt/15.suppl_7.2; Chuang P, 2005, CLIN TRANSPLANT, V19, P230, DOI 10.1111/j.1399-0012.2005.00327.x; Cornbleet PJ, 2002, CLIN LAB MED, V22, P101, DOI 10.1016/S0272-2712(03)00069-6; DUTCHER TF, 1984, CLIN LAB MED, V4, P71; Fortun J, 2010, TRANSPL INFECT DIS, V12, P397, DOI 10.1111/j.1399-3062.2010.00526.x; Giral M, 2002, KIDNEY INT, V61, P1880, DOI 10.1046/j.1523-1755.2002.00323.x; Hammer S, 2000, INTENS CARE MED, V26, pS182, DOI 10.1007/BF02900735; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Hooton TM, 2013, NEW ENGL J MED, V369, P1883, DOI 10.1056/NEJMoa1302186; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; KASS EH, 1962, ANN INTERN MED, V56, P46, DOI 10.7326/0003-4819-56-1-46; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Maes BD, 2004, KIDNEY INT, V65, P1842, DOI 10.1111/j.1523-1755.2004.00588.x; Ng PC, 1997, ARCH DIS CHILD-FETAL, V77, pF221, DOI 10.1136/fn.77.3.F221; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; NORDEN CW, 1968, ANNU REV MED, V19, P431, DOI 10.1146/annurev.me.19.020168.002243; Oghumu S, 2014, TRANSPLANTATION, V97, P559, DOI 10.1097/01.TP.0000441322.95539.b3; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; Pethig K, 2004, J HEART LUNG TRANSPL, V23, P61, DOI 10.1016/S1053-2498(03)00097-4; Pyo JY, 2013, LUPUS, V22, P1102, DOI 10.1177/0961203313499957; Rubin RH, 1981, CLIN APPROACH INFECT, P629; Seebach JD, 1997, AM J CLIN PATHOL, V107, P582; Senthilnayagam B, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/483670, DOI 10.1155/2012/483670]; SHOENFELD Y, 1981, AM J MED, V71, P773, DOI 10.1016/0002-9343(81)90363-6; Their M, 2002, PEDIATR TRANSPLANT, V6, P153, DOI 10.1034/j.1399-3046.2002.01071.x; Wong BM, 2007, TRANSPLANTATION, V83, P48, DOI 10.1097/01.tp.0000248864.21574.92	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135819	10.1371/journal.pone.0135819	http://dx.doi.org/10.1371/journal.pone.0135819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275220	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600120
J	Wienand, K; Lechner, M; Becker, F; Jung, H; Frey, E				Wienand, Karl; Lechner, Matthias; Becker, Felix; Jung, Heinrich; Frey, Erwin			Non-Selective Evolution of Growing Populations	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; GENETIC DRIFT; URN MODELS; COMMUNITIES; COOPERATION; SIZE; SELECTION; BIOFILMS	Non-selective effects, like genetic drift, are an important factor in modern conceptions of evolution, and have been extensively studied for constant population sizes (Kimura, 1955; Otto and Whitlock, 1997). Here, we consider non-selective evolution in the case of growing populations that are of small size and have varying trait compositions (e.g. after a population bottleneck). We find that, in these conditions, populations never fixate to a trait, but tend to a random limit composition, and that the distribution of compositions "freezes" to a steady state. This final state is crucially influenced by the initial conditions. We obtain these findings from a combined theoretical and experimental approach, using multiple mixed subpopulations of two Pseudomonas putida strains in non-selective growth conditions (Matthijs et al, 2009) as model system. The experimental results for the population dynamics match the theoretical predictions based on the Polya urn model (Eggenberger and Polya, 1923) for all analyzed parameter regimes. In summary, we show that exponential growth stops genetic drift. This result contrasts with previous theoretical analyses of non-selective evolution (e.g. genetic drift), which investigated how traits spread and eventually take over populations (fixate) (Kimura, 1955; Otto and Whitlock, 1997). Moreover, our work highlights how deeply growth influences non-selective evolution, and how it plays a key role in maintaining genetic variability. Consequently, it is of particular importance in life-cycles models (Melbinger et al, 2010; Cremer et al, 2011; Cremer et al, 2012) of periodically shrinking and expanding populations.	[Wienand, Karl; Lechner, Matthias; Frey, Erwin] Univ Munich, Dept Phys, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany; [Wienand, Karl; Lechner, Matthias; Frey, Erwin] Univ Munich, Dept Phys, Ctr NanoSci, Munich, Germany; [Becker, Felix; Jung, Heinrich] Univ Munich, Dept Biol 1, Microbiol, Martinsried, Germany	University of Munich; University of Munich; University of Munich	Frey, E (corresponding author), Univ Munich, Dept Phys, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany.	frey@lmu.de	Frey, Erwin/M-2613-2017; Jung, Heinrich/K-3790-2014	Frey, Erwin/0000-0001-8792-3358; Jung, Heinrich/0000-0002-5450-3063	Deutsche Forschungsgemeinschaft [1617, FR 850/11-1, JU 333/5-1]; German Excellence Initiative via the programme "Nanosystems Initiative Munich" (NIM); Elitenetzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative via the programme "Nanosystems Initiative Munich" (NIM); Elitenetzwerk Bayern	EF was funded by the Deutsche Forschungsgemeinschaft, Priority Programme 1617 "Phenotypic heterogeneity and sociobiology of bacterial populations", grant FR 850/11-1 and the German Excellence Initiative via the programme "Nanosystems Initiative Munich" (NIM). HJ was funded by the Deutsche Forschungsgemeinschaft, Priority Programme 1617 "Phenotypic heterogeneity and sociobiology of bacterial populations", grant JU 333/5-1 (http://www.spp1617.org/). KW was supported by the Elitenetzwerk Bayern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L.J.S., 2010, INTRO STOCHASTIC PRO; ARTHUR WB, 1987, EUR J OPER RES, V30, P294, DOI 10.1016/0377-2217(87)90074-9; ATHREYA KB, 1968, ANN MATH STAT, V39, P1801, DOI 10.1214/aoms/1177698013; BIRD DF, 1984, CAN J FISH AQUAT SCI, V41, P1015, DOI 10.1139/f84-118; Blythe RA, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07018; BROWN VI, 1965, J CLIN PATHOL, V18, P752, DOI 10.1136/jcp.18.6.752; Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; BURI P, 1956, EVOLUTION, V10, P367, DOI 10.1111/j.1558-5646.1956.tb02864.x; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; COHEN JE, 1976, BIOSCIENCE, V26, P391, DOI 10.2307/1297412; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Cremer J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00281; Cremer J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051921; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Eggenberger F, 1923, Z ANGEW MATH MECH, V3, P279, DOI 10.1002/zamm.19230030407; Frey E, 2005, ANN PHYS-BERLIN, V14, P20, DOI 10.1002/andp.200410132; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie JH, 2001, EVOLUTION, V55, P2161; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Hahn MW, 2008, EVOLUTION, V62, P255, DOI 10.1111/j.1558-5646.2007.00308.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Hammerschmidt K, 2014, NATURE, V515, P75, DOI 10.1038/nature13884; Hartl D., 1989, PRINCIPLES POPULATIO; Hurst LD, 2009, NAT REV GENET, V10, P83, DOI 10.1038/nrg2506; Kimura M, 1955, PNAS; KING EO, 1954, J LAB CLIN MED, V44, P301; Kotz S, 2000, STAT PROBABIL LETT, V49, P163, DOI 10.1016/S0167-7152(00)00045-6; Kurjak A, 2006, TXB PERINATAL MED; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; Matthijs S, 2009, BIOMETALS, V22, P951, DOI 10.1007/s10534-009-9247-y; Melbinger A, EMERGENCE COOPERATIO; Melbinger A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.178101; Oliveira NM, 2014, P NATL ACAD SCI USA, V111, P17941, DOI 10.1073/pnas.1412673111; Otto SP, 1997, GENETICS, V146, P723; Parsons TL, 2010, GENETICS, V185, P1345, DOI 10.1534/genetics.110.115030; Pemantle R, 2007, PROBAB SURV, V4, P1, DOI 10.1214/07-PS094; Sanchez A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001547; Schreiber SJ, 2001, SIAM J APPL MATH, V61, P2148, DOI 10.1137/S0036139999352857; Sornette D, 2009, WHY STOCK MARKETS CR; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49, DOI 10.1177/002215549704500107; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	45	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134300	10.1371/journal.pone.0134300	http://dx.doi.org/10.1371/journal.pone.0134300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274606	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600025
J	Fujisawa, TX; Jung, M; Kojima, M; Saito, DN; Kosaka, H; Tomoda, A				Fujisawa, Takashi X.; Jung, Minyoung; Kojima, Masahiko; Saito, Daisuke N.; Kosaka, Hirotaka; Tomoda, Akemi			Neural Basis of Psychological Growth following Adverse Experiences: A Resting-State Functional MRI Study	PLOS ONE			English	Article							DEFAULT MODE NETWORK; POSTTRAUMATIC-STRESS-DISORDER; ROSTRAL PREFRONTAL CORTEX; PARIETAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; CONNECTIVITY; BRAIN; INFORMATION; DEPRESSION	Over the past decade, research on the aftereffects of stressful or traumatic events has emphasized the negative outcomes from these experiences. However, the positive outcomes deriving from adversity are increasingly being examined, and such positive changes are described as posttraumatic growth (PTG). To investigate the relationship between basal whole-brain functional connectivity and PTG, we employed resting-state functional magnetic resonance imaging and analyzed the neural networks using independent component analysis in a sample of 33 healthy controls. Correlations were calculated between the network connectivity strength and the Posttraumatic Growth Inventory (PTGI) score. There were positive associations between the PTGI scores and brain activation in the rostral prefrontal cortex and superior parietal lobule (SPL) within the left central executive network (CEN) (respectively, r = 0.41, p < 0.001; r = 0.49, p < 0.001). Individuals with higher psychological growth following adverse experiences had stronger activation in prospective or working memory areas within the executive function network than did individuals with lower psychological growth (r = 0.40, p < 0.001). Moreover, we found that individuals with higher PTG demonstrated stronger connectivity between the SPL and supramarginal gyrus (SMG). The SMG is one of the brain regions associated with the ability to reason about the mental states of others, otherwise known as mentalizing. These findings suggest that individuals with higher psychological growth may have stronger functional connectivity between memory functions within the CEN and social functioning in the SMG, and that their better sociality may result from using more memory for mentalizing during their daily social interactions.	[Fujisawa, Takashi X.; Jung, Minyoung; Saito, Daisuke N.; Kosaka, Hirotaka; Tomoda, Akemi] Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan; [Fujisawa, Takashi X.; Jung, Minyoung; Kojima, Masahiko; Saito, Daisuke N.; Kosaka, Hirotaka; Tomoda, Akemi] Univ Fukui, United Grad Sch Child Dev, Div Dev Higher Brain Funct, Fukui 910, Japan; [Saito, Daisuke N.] Univ Fukui, Biomed Imaging Res Ctr, Fukui 910, Japan; [Kosaka, Hirotaka] Univ Fukui, Fac Med Sci, Dept Neuropsychiat, Fukui 910, Japan	University of Fukui; University of Fukui; University of Fukui; University of Fukui	Tomoda, A (corresponding author), Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan.	atomoda@u-fukui.ac.jp	Kosaka, Hirotaka/AFG-5500-2022; Fujisawa, Takashi/Z-4461-2019	Kosaka, Hirotaka/0000-0003-2210-5025; Jung, Minyoung/0000-0001-9188-0549	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI) [24300149, 25560386]; Center of Developmental Education and Research (CORDER) [2509]; Grants-in-Aid for Scientific Research [25560386] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Center of Developmental Education and Research (CORDER); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B) and Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI, https://www.jsps.go.jp/english/index.html, grant numbers 24300149 and 25560386 to Akemi Tomoda) and by a grant from Center of Developmental Education and Research (CORDER, http://www.coder.or.jp/index.html) in Japan (grant number 2509 to Takashi X. Fujisawa). There are no conflicts of interest, including any financial, personal, or other relationships with persons or organizations, for any author related to the work described in this article.	Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Allen JG, 2006, COPING TRAUMA HOPE U; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bryant RA, 2000, J ABNORM PSYCHOL, V109, P341, DOI 10.1037/0021-843X.109.2.341; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Dekel S, 2012, PSYCHOL TRAUMA-US, V4, P94, DOI 10.1037/a0021865; Dickstein DP, 2010, BIOL PSYCHIAT, V68, P839, DOI 10.1016/j.biopsych.2010.06.029; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Eren-Kocak E, 2014, J NERV MENT DIS, V202, P859, DOI 10.1097/NMD.0000000000000211; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Jung M, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-35; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Lewis GJ, 2014, SOC COGN AFFECT NEUR, V9, P615, DOI 10.1093/scan/nst032; Liao HY, 2012, BRAIN IMAGING BEHAV, V6, P397, DOI 10.1007/s11682-012-9154-7; McDaniel MA., 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; Morris BA, 2012, SUPPORT CARE CANCER, V20, P749, DOI 10.1007/s00520-011-1143-7; O'Donnell ML, 2007, BEHAV RES THER, V45, P601, DOI 10.1016/j.brat.2006.03.015; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Rabe S, 2006, J CONSULT CLIN PSYCH, V74, P880, DOI 10.1037/0022-006X.74.5.880; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shakespeare-Finch J, 2014, J ANXIETY DISORD, V28, P223, DOI 10.1016/j.janxdis.2013.10.005; Shakespeare-Finch J, 2010, J LOSS TRAUMA, V15, P69, DOI 10.1080/15325020903373151; Taku K, 2007, ANXIETY STRESS COPIN, V20, P353, DOI 10.1080/10615800701295007; Taku K, 2009, ANXIETY STRESS COPIN, V22, P129, DOI 10.1080/10615800802317841; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, V1st; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Uddin LQ, 2013, JAMA PSYCHIAT, V70, P869, DOI 10.1001/jamapsychiatry.2013.104; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Urry HL, 2004, PSYCHOL SCI, V15, P367, DOI 10.1111/j.0956-7976.2004.00686.x; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vranceanu AM, 2007, CHILD ABUSE NEGLECT, V31, P71, DOI 10.1016/j.chiabu.2006.04.010; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Weber DL, 2005, PSYCHIAT RES-NEUROIM, V140, P27, DOI 10.1016/j.pscychresns.2005.07.003; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yonemoto T, 2009, ANTICANCER RES, V29, P4287	62	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136427	10.1371/journal.pone.0136427	http://dx.doi.org/10.1371/journal.pone.0136427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291449	gold, Green Submitted, Green Published			2022-12-27	WOS:000359919900082
J	Wang, H; Gao, JE; Li, XH; Zhang, SL; Wang, HJ				Wang, Hong; Gao, Jian-en; Li, Xing-hua; Zhang, Shao-long; Wang, Hong-jie			Nitrate Accumulation and Leaching in Surface and Ground Water Based on Simulated Rainfall Experiments	PLOS ONE			English	Article							KINETIC-ENERGY RELATIONSHIPS; FLOW SYSTEM; AGRICULTURE; POLLUTION; NITROGEN; RECHARGE; MANAGEMENT; INTENSITY; CHINA; PRECIPITATION	To evaluate the process of nitrate accumulation and leaching in surface and ground water, we conducted simulated rainfall experiments. The experiments were performed in areas of 5.3 m(2) with bare slopes of 3 degrees that were treated with two nitrogen fertilizer inputs, high (22.5 g/m(2) NH4NO3) and control (no fertilizer), and subjected to 2 hours of rainfall, with. From the 1st to the 7th experiments, the same content of fertilizer mixed with soil was uniformly applied to the soil surface at 10 minutes before rainfall, and no fertilizer was applied for the 8th through 12th experiments. Initially, the time-series nitrate concentration in the surface flow quickly increased, and then it rapidly decreased and gradually stabilized at a low level during the fertilizer experiments. The nitrogen loss in the surface flow primarily occurred during the first 18.6 minutes of rainfall. For the continuous fertilizer experiments, the mean nitrate concentrations in the groundwater flow remained at less than 10 mg/L before the 5th experiment, and after the 7th experiment, these nitrate concentrations were greater than 10 mg/L throughout the process. The time-series process of the changing concentration in the groundwater flow exhibited the same parabolic trend for each fertilizer experiment. However, the time at which the nitrate concentration began to change lagged behind the start time of groundwater flow by approximately 0.94 hours on average. The experiments were also performed with no fertilizer. In these experiments, the mean nitrate concentration of groundwater initially increased continuously, and then, the process exhibited the same parabolic trend as the results of the fertilization experiments. The nitrate concentration decreased in the subsequent experiments. Eight days after the 12 rainfall experiments, 50.53% of the total nitrate applied remained in the experimental soil. Nitrate residues mainly existed at the surface and in the bottom soil layers, which represents a potentially more dangerous pollution scenario for surface and ground water. The surface and subsurface flow would enter into and contaminate water bodies, thus threatening the water environment.	[Wang, Hong; Gao, Jian-en] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Hong; Gao, Jian-en] Minist Water Resources, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Jian-en] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Hong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Jian-en; Li, Xing-hua; Zhang, Shao-long; Wang, Hong-jie] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi Provinc, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China	Gao, JE (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China.	gaojianen@126.com			Natural Science Foundation of China [41371276, 51309194]; National Technology Support Project [2011BAD31B05]; Science and Technology Project of Shaanxi Province [2013KTDZ03-03-01]; Subject of National Science and Technology Major Project [2009ZX07212-002-003-02]; Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS MWR [A315021304]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technology Support Project; Science and Technology Project of Shaanxi Province; Subject of National Science and Technology Major Project; Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS MWR	This paper was supported by Natural Science Foundation of China (41371276, 51309194), by National Technology Support Project (2011BAD31B05), by Science and Technology Project of Shaanxi Province (2013KTDZ03-03-01), by the Subject of National Science and Technology Major Project (2009ZX07212-002-003-02) and by Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS & MWR (A315021304).	Addiscott T.M., 1991, FARMING FERTILIZERS; Almasri MN, 2004, J HYDROL, V295, P225, DOI 10.1016/j.jhydrol.2004.03.013; Archna, 2012, E-J CHEM, V9, P1667, DOI 10.1155/2012/154616; Ator S.W., 1997, NITRATE SELECTED PES; Bakhsh A, 2000, T ASAE, V43, P69, DOI 10.13031/2013.2689; Bengtson RL, 1984, T AM SOC AGR ENG, V27; Boers PCM, 1996, WATER SCI TECHNOL, V33, P183, DOI 10.1016/0273-1223(96)00229-6; Cerda A, 1997, SOIL TECHNOL, V11, P163, DOI 10.1016/S0933-3630(96)00135-3; Chen J, 2005, HYDROGEOL J, V13, P481, DOI 10.1007/s10040-004-0321-9; Chen XiaoMin, 2001, China Environmental Science, V21, P481; CORTAS NK, 1990, CLIN CHEM, V36, P1440; Dourson M, 1991, NATO ASI SER G, V30, P477; Dragon K, 2013, ENVIRON EARTH SCI, V68, P2099, DOI 10.1007/s12665-012-1895-5; Eigel J.D., 1983, EFFECT RAINFALL ENER; EIGEL JD, 1983, T ASAE, V26, P1079; Elrashidi MA, 2015, COMMUN SOIL SCI PLAN, V46, P16, DOI 10.1080/00103624.2014.956883; EPAU, 1996, DRINK WAT REG HLTH A; Fan J, 2010, CAN J SOIL SCI, V90, P429, DOI 10.4141/CJSS09105; [冯绍元 Feng Shaoyuan], 2010, [灌溉排水学报, Journal of Irrigation and Drainage], V29, P11; Fennessy MS, 1997, CRIT REV ENV SCI TEC, V27, P285, DOI 10.1080/10643389709388502; Groves SJ, 2004, SOIL USE MANAGE, V20, P96, DOI 10.1079/SUM2003229; Hall MD, 2001, J AM WATER RESOUR AS, V37, P139, DOI 10.1111/j.1752-1688.2001.tb05481.x; HALLBERG GR, 1987, RURAL GROUNDWATER CO; Hanson C., 2002, NITRATE CONCENTRATIO; Heathwaite AL, 1996, HYDROL PROCESS, V10, P263, DOI 10.1002/(SICI)1099-1085(199602)10:2&lt;263::AID-HYP441&gt;3.0.CO;2-K; Hu CX, 1993, CHINESE J SOIL SCI, V24, P118; Huang M. X., 2001, SOIL ENV SCI, V10, P6; Hudak PF, 2000, J HYDROL, V228, P37, DOI 10.1016/S0022-1694(99)00206-1; Hunag RH, 2004, STUDY SIMULATING EXP; Kaufmann V, 2014, J CONTAM HYDROL, V160, P53, DOI 10.1016/j.jconhyd.2014.02.005; KINNELL PIA, 1981, SOIL SCI SOC AM J, V45, P153, DOI 10.2136/sssaj1981.03615995004500010033x; Kronvang B, 1996, WATER SCI TECHNOL, V33, P81, DOI 10.1016/0273-1223(96)00217-X; LEE YW, 1992, J WATER RES PL-ASCE, V118, P151, DOI 10.1061/(ASCE)0733-9496(1992)118:2(151); Liang XQ, 2011, PHYS CHEM EARTH, V36, P395, DOI 10.1016/j.pce.2010.03.017; Line DE, 1998, WATER ENVIRON RES, V70, P895, DOI 10.2175/106143098X134514; Liu BZ, 1997, THE SOIL EROSION; Meisinger JJ, 2002, J SOIL WATER CONSERV, V57, P485; Misiti TM, 2011, WATER RES, V45, P5587, DOI 10.1016/j.watres.2011.08.019; Narula KK, 2013, SCI TOTAL ENVIRON, V468, pS102, DOI 10.1016/j.scitotenv.2013.01.022; Neal C, 2000, SCI TOTAL ENVIRON, V251, P5, DOI 10.1016/S0048-9697(00)00410-1; Neal C, 2000, SCI TOTAL ENVIRON, V251, P441, DOI 10.1016/S0048-9697(00)00398-3; Nolan BT, 2002, ENVIRON SCI TECHNOL, V36, P2138, DOI 10.1021/es0113854; Randall GW, 1997, J ENVIRON QUAL, V26, P1240, DOI 10.2134/jeq1997.00472425002600050007x; RANDALL GW, 1995, J ENVIRON QUAL, V24, P360, DOI 10.2134/jeq1995.00472425002400020020x; Rodvang SJ, 2001, HYDROGEOL J, V9, P44; SAFFIGNA PG, 1977, GROUND WATER, V15, P170, DOI 10.1111/j.1745-6584.1977.tb03162.x; Sanford W, 2002, HYDROGEOL J, V10, P110, DOI 10.1007/s10040-001-0173-5; SCHEPERS JS, 1991, MANAGING NITROGEN FOR GROUNDWATER QUALITY AND FARM PROFITABILITY, P125; Sha RD, 1997, CORPUS SHAYUQING; Sha YQ, 1956, SEDIMENT RES, V1, P1; Shu R.J., 2006, SCI SOIL WATER CONSE, V4, P65; SPALDING RF, 1993, J ENVIRON QUAL, V22, P392, DOI 10.2134/jeq1993.00472425002200030002x; van Dijk AIJM, 2002, J HYDROL, V261, P1, DOI 10.1016/S0022-1694(02)00020-3; Wang H, 2015, CATENA, V127, P80, DOI 10.1016/j.catena.2014.12.014; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079103; Wang HY, 2010, AGR WATER MANAGE, V97, P1646, DOI 10.1016/j.agwat.2010.05.022; Wang SL, 2008, MODELING NITROGEN TR; Wang WK., 2006, GROUNDWATER ENV EVOL; Wang Z, 2014, AGR WATER MANAGE, V142, P19, DOI 10.1016/j.agwat.2014.04.013; WISCHMEIER WALTER H., 1958, TRANS AMER GEOPHYS UNION, V39, P285; Wolfe AH, 2002, AMBIO, V31, P120, DOI 10.1639/0044-7447(2002)031[0120:RNAHHA]2.0.CO;2; Wriedt G, 2007, J HYDROL, V343, P154, DOI 10.1016/j.jhydrol.2007.06.010; WYLIE BK, 1995, WATER RESOUR BULL, V31, P399; [谢红梅 Xie Hongmei], 2003, [生态环境, Ecology and Environment], V12, P349; Yakovlev V, 2015, APPL GEOCHEM, V53, P71, DOI 10.1016/j.apgeochem.2014.12.009; Yi X., 1993, AGROENVIRONMENTAL PR, V12, P250; Zhang Qingzhong, 2002, Yingyong Shengtai Xuebao, V13, P233; Zhang W. L., 1995, PLANT NUTR FERTILIZE, V1, P80; Zhang WL, 1996, AGR ECOSYST ENVIRON, V59, P223, DOI 10.1016/0167-8809(96)01052-3; Zhang X., 2000, ACTA GEOGRAPHICAL SI, V55, P617	70	29	30	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136274	10.1371/journal.pone.0136274	http://dx.doi.org/10.1371/journal.pone.0136274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291616	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900073
J	Liu, ZY; Liu, J; Li, L; Nie, D; Tao, QL; Wu, J; Fan, JJ; Lin, C; Zhao, SW; Ju, DW				Liu, Zhongyu; Liu, Jun; Li, Li; Nie, Dan; Tao, Qilei; Wu, Jian; Fan, Jiajun; Lin, Chen; Zhao, Shuwei; Ju, Dianwen			Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; PLATINUM COMPLEXES; INDUCED APOPTOSIS; ROS GENERATION; STEM-CELLS; THERAPY; CHEMORADIOTHERAPY; CHEMOTHERAPY; RADIOTHERAPY; ACTIVATION	Nedaplatin, a cisplatin analog, was developed to reduce the toxicity of cisplatin, whereas it can be cross-resistant with cisplatin in some circumstances. This study aimed to investigate the role of autophagy in nedaplatin induced cell death in cisplatin-resistant nasopharyngeal carcinoma cells. Here, we showed that HNE1/DDP and CNE2/DDP cells were resistant to nedaplatin-induced cell death with reduced apoptotic activity. Nedaplatin treatment resulted in autophagosome accumulation and increased expression of LC3-II, indicating the induction of autophagy by nedaplatin in HNE1/DDP and CNE2/DDP cells. Inhibition of autophagy by Bafilomycin A1 (Baf A1) and 3-Methyladenine (3-MA) remarkably enhanced the antitumor efficacy of nedaplatin in HNE1/DDP and CNE2/DDP cells, suggesting that the resistance to nedaplatin-induced cell death was caused by enhanced autophagy in nedaplatin-resistant NPC cells. Additionally, Baf A1 enhanced reactive oxygen species (ROS) generation and apoptosis induced by nedaplatin in HNE1/DDP cells. Mechanistically, nedaplatin treatment caused activation of ERK1/2 and suppression of Akt/mTOR signaling pathways. While inhibition of ERK1/2 by MEK1/2 inhibitor, U0126, could reduce the expression of LC3-II in nedaplatin-resistant NPC cells. Furthermore, suppression of ROS could inhibit nedaplatin-induced ERK activation in HNE1/DDP cells, indicating that ROS and ERK were involved in nedaplatin-induced autophagy. Together, these findings suggested that autophagy played a cytoprotective role in nedaplatin-induced cytotoxicity of HNE1/DDP and CNE2/DDP cells. Furthermore, our results highlighted a potential approach to restore the sensitivity of cisplatin-resistant nasopharyngeal cancer cells to nedaplatin in combination with autophagy inhibitors.	[Liu, Zhongyu; Li, Li; Tao, Qilei; Wu, Jian; Lin, Chen; Zhao, Shuwei] Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Liu, Jun] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Nie, Dan] Tradit Chinese Med Hosp Guangdong Prov, Dept Otolaryngol, Guangzhou, Guangdong, Peoples R China; [Fan, Jiajun; Ju, Dianwen] Fudan Univ, Sch Pharm, Dept Biosynth, Shanghai 200433, Peoples R China	Naval Medical University; West Virginia University; Guangzhou University of Chinese Medicine; Fudan University	Zhao, SW (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.	zhaoshw@live.cn; dianwenju@fudan.edu.cn			National Key Basic Research Program of China [2015CB931800]; Shanghai Science and Technology Commission [13431900303]; Shanghai Health and Family Planning Commission [2013012]	National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)Shanghai Science & Technology Committee); Shanghai Health and Family Planning Commission	This study was supported by funds from National Key Basic Research Program of China (2015CB931800), Shanghai Science and Technology Commission (13431900303); and Shanghai Health and Family Planning Commission (2013012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Alberto ME, 2009, J PHYS CHEM B, V113, P14473, DOI 10.1021/jp9056835; ALSARRAF M, 1990, J CLIN ONCOL, V8, P1342, DOI 10.1200/JCO.1990.8.8.1342; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bhogal RH, 2012, AUTOPHAGY, V8, P545, DOI 10.4161/auto.19012; Bhutia SK, 2013, ADV CANCER RES, V118, P61, DOI 10.1016/B978-0-12-407173-5.00003-0; Botta G, 2012, HUM GENE THER, V23, P623, DOI 10.1089/hum.2011.120; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Friesen C, 1999, LEUKEMIA, V13, P1854, DOI 10.1038/sj.leu.2401333; Friesen C, 1997, LEUKEMIA, V11, P1833, DOI 10.1038/sj.leu.2400827; FUKUDA M, 1995, ANTICANCER RES, V15, P393; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hou J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.338; Jia WH, 2012, SEMIN CANCER BIOL, V22, P117, DOI 10.1016/j.semcancer.2012.01.009; Kano G, 2013, J ALLERGY CLIN IMMUN, V132, P437, DOI 10.1016/j.jaci.2013.03.024; Kawai Y, 2005, BIOL PHARM BULL, V28, P1385, DOI 10.1248/bpb.28.1385; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kong DJ, 2012, BIOMED PHARMACOTHER, V66, P271, DOI 10.1016/j.biopha.2011.12.002; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Peng PJ, 2013, CANCER CHEMOTH PHARM, V72, P323, DOI 10.1007/s00280-013-2203-0; Rosenfeldt MT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001306; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; SASAKI Y, 1989, CANCER CHEMOTH PHARM, V23, P243, DOI 10.1007/BF00451649; Sciarretta S, 2014, AUTOPHAGY, V10, P699, DOI 10.4161/auto.27955; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Sirichanchuen B, 2012, MOL CELL BIOCHEM, V364, P11, DOI 10.1007/s11010-011-1199-1; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Tonino SH, 2011, ONCOGENE, V30, P701, DOI 10.1038/onc.2010.441; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; Wangpaichitr Medhi, 2009, Cancers (Basel), V1, P23; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Xu JH, 2014, HEAD NECK-J SCI SPEC, V36, P1474, DOI 10.1002/hed.23487; Yu H, 2011, EUR J CANCER, V47, P1585, DOI 10.1016/j.ejca.2011.01.019; Zheng JJ, 2010, JPN J CLIN ONCOL, V40, P425, DOI 10.1093/jjco/hyp183	46	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135236	10.1371/journal.pone.0135236	http://dx.doi.org/10.1371/journal.pone.0135236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288183	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600041
J	Ramanoel, S; Kauffmann, L; Cousin, E; Dojat, M; Peyrin, C				Ramanoel, Stephen; Kauffmann, Louise; Cousin, Emilie; Dojat, Michel; Peyrin, Carole			Age-Related Differences in Spatial Frequency Processing during Scene Categorization	PLOS ONE			English	Article							CONTRAST SENSITIVITY DECLINE; TO-FINE CATEGORIZATION; MACULAR DEGENERATION; GLOBAL PRECEDENCE; VISUAL SCENES; RECOGNITION; CORTEX; PREVALENCE; STATISTICS; ATTENTION	Visual analysis of real-life scenes starts with the parallel extraction of different visual elementary features at different spatial frequencies. The global shape of the scene is mainly contained in low spatial frequencies (LSF), and the edges and borders of objects are mainly contained in high spatial frequencies (HSF). The present fMRI study investigates the effect of age on the spatial frequency processing in scenes. Young and elderly participants performed a categorization task (indoor vs. outdoor) on LSF and HSF scenes. Behavioral results revealed performance degradation for elderly participants only when categorizing HSF scenes. At the cortical level, young participants exhibited retinotopic organization of spatial frequency processing, characterized by medial activation in the anterior part of the occipital lobe for LSF scenes (compared to HSF), and the lateral activation in the posterior part of the occipital lobe for HSF scenes (compared to LSF). Elderly participants showed activation only in the anterior part of the occipital lobe for LSF scenes (compared to HSF), but not significant activation for HSF (compared to LSF). Furthermore, a ROI analysis revealed that the parahippocampal place area, a scene-selective region, was less activated for HSF than LSF for elderly participants only. Comparison between groups revealed greater activation of the right inferior occipital gyrus in young participants than in elderly participants for HSF. Activation of temporo-parietal regions was greater in elderly participants irrespective of spatial frequencies. The present findings indicate a specific low-contrasted HSF deficit for normal elderly people, in association with an occipito-temporal cortex dysfunction, and a functional reorganization of the categorization of filtered scenes.	[Ramanoel, Stephen; Kauffmann, Louise; Cousin, Emilie; Peyrin, Carole] Univ Grenoble Alpes, LPNC, F-38000 Grenoble, France; [Ramanoel, Stephen; Kauffmann, Louise; Cousin, Emilie; Peyrin, Carole] CNRS, LPNC, F-38000 Grenoble, France; [Ramanoel, Stephen; Dojat, Michel] Univ Grenoble Alpes, GIN, F-38000 Grenoble, France; [Cousin, Emilie] UMS IRMaGe, F-38000 Grenoble, France; [Dojat, Michel] INSERM U836, GIN, F-38000 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Peyrin, C (corresponding author), Univ Grenoble Alpes, LPNC, F-38000 Grenoble, France.	carole.peyrin@upmf-grenoble.fr	Dojat, Michel/G-7758-2011; Ramanoel, Stephen/AAB-5080-2022	Dojat, Michel/0000-0003-2747-6845; Ramanoel, Stephen/0000-0003-4735-1097; Peyrin, Carole/0000-0001-7792-092X	Agence Nationale pour la Recherche [ANR-12-JHS2-0002-01 RECOR]; French program "Investissement d'Avenir" [ANR-11-INBS-0006]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); French program "Investissement d'Avenir"(French National Research Agency (ANR))	This work was supported by Agence Nationale pour la Recherche grant ANR-12-JHS2-0002-01 RECOR. Grenoble MRI facility IRMaGE was partly funded by the French program "Investissement d'Avenir" run by the "Agence Nationale pour la Recherche": Grant "Infrastructure d'Avenir en Biologie Sante" (ANR-11-INBS-0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BADCOCK JC, 1990, PERCEPTION, V19, P617, DOI 10.1068/p190617; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; BREITMEYER B, 1975, VISION RES, V15, P411, DOI 10.1016/0042-6989(75)90090-5; Brewer Alyssa A, 2012, Health (Irvine Calif), V4, P695; Brewer AA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00074; BROWN B, 1993, OPTOMETRY VISION SCI, V70, P45, DOI 10.1097/00006324-199301000-00009; Bruyer R, 2000, EXP AGING RES, V26, P285, DOI 10.1080/036107300750015705; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Cabeza R, 2002, CURRENT OPINION NEUR, V13, P415; Crossland MD, 2008, INVEST OPHTH VIS SCI, V49, P3734, DOI 10.1167/iovs.07-1621; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; de Fockert JW, 2009, BRAIN RES, V1282, P67, DOI 10.1016/j.brainres.2009.05.060; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; ELLIOTT D, 1990, VISION RES, V30, P541, DOI 10.1016/0042-6989(90)90066-T; ELLIOTT DB, 1987, OPHTHAL PHYSL OPT, V7, P415, DOI 10.1111/j.1475-1313.1987.tb00771.x; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Elliott SL, 2010, J VISION, V10, DOI 10.1167/10.4.4; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2005, VIS COGN, V12, P954, DOI 10.1080/13506280444000607; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; Epstein RA, 2010, CEREB CORTEX, V20, P294, DOI 10.1093/cercor/bhp099; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Friedman L, 1998, BRAIN LANG, V64, P231, DOI 10.1006/brln.1998.1953; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Geerligs L, 2014, NEUROIMAGE, V91, P52, DOI 10.1016/j.neuroimage.2014.01.029; Gerlach C, 2000, NEUROPSYCHOLOGIA, V38, P1693, DOI 10.1016/S0028-3932(00)00082-8; GINSBURG AP, 1986, HDB PERCEPTION HUMAN, V2, P1; GITTINGS NS, 1986, EXP GERONTOL, V21, P423, DOI 10.1016/0531-5565(86)90047-1; Glascher J, 2008, CONTRAST WEIGH UNPUB; Guyader N, 2004, CR BIOL, V327, P313, DOI 10.1016/j.crvi.2004.02.006; Hardy JL, 2005, J OPT SOC AM A, V22, P49, DOI 10.1364/JOSAA.22.000049; Haring AE, 2013, BRAIN RES, V1499, P69, DOI 10.1016/j.brainres.2013.01.003; Henriksson L, 2008, J VISION, V8, DOI 10.1167/8.10.5; HIGGINS KE, 1988, J OPT SOC AM A, V5, P2173, DOI 10.1364/JOSAA.5.002173; Hughes HC, 1996, J COGNITIVE NEUROSCI, V8, P197, DOI 10.1162/jocn.1996.8.3.197; Kauffmann L, 2015, NEUROIMAGE, V112, P86, DOI 10.1016/j.neuroimage.2015.02.058; Kauffmann L, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00037; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; LAMB MR, 1993, PERCEPT PSYCHOPHYS, V54, P773, DOI 10.3758/BF03211802; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lux S, 2008, CORTEX, V44, P21, DOI 10.1016/j.cortex.2005.08.001; Marchand WR, 2011, NEUROIMAGE, V55, P194, DOI 10.1016/j.neuroimage.2010.12.030; Mummery CJ, 1998, J COGNITIVE NEUROSCI, V10, P766, DOI 10.1162/089892998563059; Musel B, 2014, J COGNITIVE NEUROSCI, V26, P2287, DOI 10.1162/jocn_a_00643; Musel B, 2013, J COGNITIVE NEUROSCI, V25, P1315, DOI 10.1162/jocn_a_00397; Musel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038493; Musel B, 2011, VISUAL NEUROSCI, V28, P529, DOI 10.1017/S0952523811000435; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Oken BS, 1999, J GERIATR PSYCH NEUR, V12, P76, DOI 10.1177/089198879901200207; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Palmer S, 1993, UNDERSTANDING VISION, P39; Park D. C., 1999, COGNITIVE AGING PRIM; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Parker DM, 1996, J EXP PSYCHOL HUMAN, V22, P1448, DOI 10.1037/0096-1523.22.6.1448; Peyrin C, 2004, NEUROIMAGE, V23, P698, DOI 10.1016/j.neuroimage.2004.06.020; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; Pokorny J, 1997, J OPT SOC AM A, V14, P2477, DOI 10.1364/JOSAA.14.002477; Rajimehr R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000608; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Roux F, 2001, BRAIN COGNITION, V46, P383, DOI 10.1006/brcg.2001.1296; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; SEKULER R, 1980, SCIENCE, V209, P1255, DOI 10.1126/science.7403884; SHULMAN GL, 1986, PERCEPTION, V15, P259, DOI 10.1068/p150259; Staudinger MR, 2011, CORTEX, V47, P854, DOI 10.1016/j.cortex.2010.08.001; Szlyk JP, 2009, INVEST OPHTH VIS SCI, V50, P4487, DOI 10.1167/iovs.08-2258; Talairach J., 1988, COPLANAR STEREOTAXIC; Thioux M, 2005, COGNITIVE BRAIN RES, V24, P284, DOI 10.1016/j.cogbrainres.2005.02.009; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Van Essen David C., 1995, P383; Viggiano MP, 2006, ARCH GERONTOL GERIAT, V42, P329, DOI 10.1016/j.archger.2005.08.003; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Willenbockel V, 2010, J EXP PSYCHOL HUMAN, V36, P122, DOI 10.1037/a0016465	85	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134554	10.1371/journal.pone.0134554	http://dx.doi.org/10.1371/journal.pone.0134554			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288146	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600025
J	Wang, ZW; Katsaros, D; Shen, Y; Fu, YY; Canuto, EM; Benedetto, C; Lu, LG; Chu, WM; Risch, HA; Yu, H				Wang, Zhanwei; Katsaros, Dionyssios; Shen, Yi; Fu, Yuanyuan; Canuto, Emilie Marion; Benedetto, Chiara; Lu, Lingeng; Chu, Wen-Ming; Risch, Harvey A.; Yu, Herbert			Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis	PLOS ONE			English	Article							MITOTIC CHECKPOINT GENES; CHROMOSOMAL INSTABILITY; CELL-PROLIFERATION; BIOINFORMATICS; ANEUPLOIDY; OVEREXPRESSION; INACTIVATION; METASTASIS; RECURRENCE; POPULATION	To investigate the biologic relevance and clinical implication of genes involved in multiple gene expression signatures for breast cancer prognosis, we identified 16 published gene expression signatures, and selected two genes, MAD2L1 and BUB1. These genes appeared in 5 signatures and were involved in cell-cycle regulation. We analyzed the expression of these genes in relation to tumor features and disease outcomes. In vitro experiments were also performed in two breast cancer cell lines, MDA-MB-231 and MDA-MB-468, to assess cell proliferation, migration and invasion after knocking down the expression of these genes. High expression of these genes was found to be associated with aggressive tumors and poor disease-free survival of 203 breast cancer patients in our study, and the association with survival was confirmed in an online database consisting of 914 patients. In vitro experiments demonstrated that lowering the expression of these genes by siRNAs reduced tumor cell growth and inhibited cell migration and invasion. Our investigation suggests that MAD2L1 and BUB1 may play important roles in breast cancer progression, and measuring the expression of these genes may assist the prediction of breast cancer prognosis.	[Wang, Zhanwei; Shen, Yi; Fu, Yuanyuan; Yu, Herbert] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Katsaros, Dionyssios; Canuto, Emilie Marion; Benedetto, Chiara] Azienda Osped Univ Citta Salute, Gynecol Oncol, Dept Surg Sci, Turin, Italy; [Lu, Lingeng; Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Chu, Wen-Ming] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of Hawaii System; A.O.U. Citta della Salute e della Scienza di Torino; Yale University; Cancer Research Center of Hawaii; University of Hawaii System	Yu, H (corresponding author), Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA.	hyu@cc.hawaii.edu	wang, zhanwei/AAR-4978-2020; wang, zhanwei/F-9958-2016		NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA071789] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bian Y, 2014, P NATL ACAD SCI USA, V111, P1628, DOI 10.1073/pnas.1315588111; Boidot R, 2008, GENE CHROMOSOME CANC, V47, P299, DOI 10.1002/gcc.20533; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hempen PM, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9120; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mannelqvist M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098787; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mu L, 2012, BREAST CANCER RES TR, V133, P321, DOI 10.1007/s10549-012-1952-5; Nyati S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005379; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Pulverer B, 2004, NAT CELL BIOL, V6, P806, DOI 10.1038/ncb0904-806; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shichiri M, 2002, CANCER RES, V62, P13; Shigeishi H, 2001, PATHOBIOLOGY, V69, P24, DOI 10.1159/000048754; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Thorner AR, 2009, ONCOGENE, V28, P742, DOI 10.1038/onc.2008.430; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yin ZQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-49; Yoon CH, 2012, J BIOL CHEM, V287, P19516, DOI 10.1074/jbc.M111.337428; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	53	34	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136246	10.1371/journal.pone.0136246	http://dx.doi.org/10.1371/journal.pone.0136246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287798	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600126
J	Wenz, H; Maros, ME; Meyer, M; Forster, A; Haubenreisser, H; Kurth, S; Schoenberg, SO; Flohr, T; Leidecker, C; Groden, C; Scharf, J; Henzler, T				Wenz, Holger; Maros, Mate E.; Meyer, Mathias; Foerster, Alex; Haubenreisser, Holger; Kurth, Stefan; Schoenberg, Stefan O.; Flohr, Thomas; Leidecker, Christianne; Groden, Christoph; Scharf, Johann; Henzler, Thomas			Image Quality of 3rd Generation Spiral Cranial Dual-Source CT in Combination with an Advanced Model Iterative Reconstruction Technique: A Prospective Intra-Individual Comparison Study to Standard Sequential Cranial CT Using Identical Radiation Dose	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; COMPUTED-TOMOGRAPHY; VOLUMETRIC CT; HELICAL CT; REDUCTION; BRAIN; FEASIBILITY	Objectives To prospectively intra-individually compare image quality of a 3rd generation Dual-Source-CT (DSCT) spiral cranial CT (cCT) to a sequential 4-slice Multi-Slice-CT (MSCT) while maintaining identical intra-individual radiation dose levels. Methods 35 patients, who had a non-contrast enhanced sequential cCT examination on a 4-slice MDCT within the past 12 months, underwent a spiral cCT scan on a 3rd generation DSCT. CTDIvol identical to initial 4-slice MDCT was applied. Data was reconstructed using filtered backward projection (FBP) and 3rd-generation iterative reconstruction (IR) algorithm at 5 different IR strength levels. Two neuroradiologists independently evaluated subjective image quality using a 4-point Likert-scale and objective image quality was assessed in white matter and nucleus caudatus with signal-to-noise ratios (SNR) being subsequently calculated. Results Subjective image quality of all spiral cCT datasets was rated significantly higher compared to the 4-slice MDCT sequential acquisitions (p<0.05). Mean SNR was significantly higher in all spiral compared to sequential cCT datasets with mean SNR improvement of 61.65% (p*(Bonferroni0.05)<0.0024). Subjective image quality improved with increasing IR levels. Conclusion Combination of 3rd-generation DSCT spiral cCT with an advanced model IR technique significantly improves subjective and objective image quality compared to a standard sequential cCT acquisition acquired at identical dose levels.	[Wenz, Holger; Maros, Mate E.; Foerster, Alex; Kurth, Stefan; Groden, Christoph; Scharf, Johann] Heidelberg Univ, Dept Neuroradiol, Univ Med Ctr Mannheim, Med Fac Mannheim, Mannheim, Germany; [Meyer, Mathias; Haubenreisser, Holger; Schoenberg, Stefan O.; Henzler, Thomas] Heidelberg Univ, Inst Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Mannheim, Germany; [Flohr, Thomas; Leidecker, Christianne] Div Computed Tomog, Siemens Healthcare Sect, Forchheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Siemens AG; Siemens Germany	Wenz, H (corresponding author), Heidelberg Univ, Dept Neuroradiol, Univ Med Ctr Mannheim, Med Fac Mannheim, Mannheim, Germany.	Holger-Wenz@gmx.de	Maros, Máté E./ABB-3203-2021	Maros, Máté E./0000-0002-1589-8699	German Federal Ministry of Education and Research (BMBF) [13GW00926]; Siemens Healthcare Sector	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Siemens Healthcare Sector	This research project is part of the Research Campus M<SUP>2</SUP>OLIE and funded by the German Federal Ministry of Education and Research (BMBF) within the Framework "Forschungscampus: public-private partnership for Innovations" under the funding code 13GW00926. Siemens Healthcare Sector provided support in the form of salaries for authors Thomas Flohr and Christianne Leidecker but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alberico RA, 2000, AM J ROENTGENOL, V175, P1361, DOI 10.2214/ajr.175.5.1751361; Bahner ML, 1998, EUR RADIOL, V8, P416, DOI 10.1007/s003300050403; Becker HC, 2012, INVEST RADIOL, V47, P202, DOI 10.1097/RLI.0b013e31823a86d5; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; Bodelle B, 2014, AM J NEURORADIOL, V35, P445, DOI 10.3174/ajnr.A3801; Buhk JH, 2013, ROFO-FORTSCHR RONTG, V185, P741, DOI 10.1055/s-0033-1335937; Dorenbeck U, 2000, ROFO-FORTSCHR RONTG, V172, P342, DOI 10.1055/s-2000-347; Ebersberger U, 2013, EUR RADIOL, V23, P125, DOI 10.1007/s00330-012-2580-5; Gordic S, 2014, INVEST RADIOL, V49, P465, DOI 10.1097/RLI.0000000000000037; Groenestege-Kreb DT, 2014, BRIT J ANAESTH, V113, P258, DOI 10.1093/bja/aeu236; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Haubenreisser H, 2014, EUR J RADIOL, V83, P964, DOI 10.1016/j.ejrad.2014.01.026; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; KALENDER WA, 1990, RADIOLOGY, V176, P181, DOI 10.1148/radiology.176.1.2353088; KALENDER WA, 1991, MED PHYS, V18, P910, DOI 10.1118/1.596607; Komlosi P, 2014, NEURORADIOLOGY, V56, P187, DOI 10.1007/s00234-013-1313-z; Kuntz R, 1998, EUR J RADIOL, V26, P235, DOI 10.1016/S0720-048X(97)01179-0; Lahiji K, 2014, AM J ROENTGENOL, V203, P763, DOI 10.2214/AJR.13.11838; Meyer M, 2014, EUR J RADIOL, V83, P315, DOI 10.1016/j.ejrad.2013.11.008; NEY DR, 1992, RADIOLOGY, V185, P865, DOI 10.1148/radiology.185.3.1438777; Ozdoba C, 2014, CLIN NEURORADIOL, V24, P23, DOI 10.1007/s00062-013-0263-5; Reichelt A, 2012, EUR J RADIOL, V81, P789, DOI 10.1016/j.ejrad.2011.01.090; RIGAUTS H, 1990, J COMPUT ASSIST TOMO, V14, P675, DOI 10.1097/00004728-199007000-00035; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Spears JR, 2014, ACAD RADIOL, V21, P318, DOI 10.1016/j.acra.2013.11.008; van Straten M, 2007, AM J NEURORADIOL, V28, P421; VOCK P, 1990, RADIOLOGY, V176, P864, DOI 10.1148/radiology.176.3.2389050; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136054	10.1371/journal.pone.0136054	http://dx.doi.org/10.1371/journal.pone.0136054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288186	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600101
J	Yi, SY; Tuot, S; Chhoun, P; Pal, K; Tith, K; Brody, C				Yi, Siyan; Tuot, Sovannary; Chhoun, Pheak; Pal, Khuondyla; Tith, Khimuy; Brody, Carinne			Factors Associated with Inconsistent Condom Use among Men Who Have Sex with Men in Cambodia	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; HIV-POSITIVE MEN; UNITED-STATES; HONG-KONG; RISK BEHAVIOR; CHINESE MEN; PREVENTION; PARTNERS; INFECTIONS; PREVALENCE	Background Compared to the general population, men who have sex with men (MSM) are at greater risk for HIV and less understood due to their more hidden and stigmatized nature. Moreover, the discrepancy in findings in the literature merits further investigations in MSM populations from different cultures and settings. We therefore conducted this study to explore factors associated with inconsistent condom use among high-risk MSM in Cambodia. Methods This cross-sectional study was conducted in 2014 among 367 MSM randomly selected from Battembang and Siem Reap using a two-stage cluster sampling method. A structured questionnaire was used for face-to-face interviews to collect information on characteristics of respondents, HIV testing history, self-perception of HIV risk, substance use, sexual behaviors, mental disorders, and HIV knowledge. Multivariable logistic regression analysis was performed to identify factors independently associated with inconsistent condom use. Results On average, 62.3% of respondents reported that they always used condoms over the past three months. The rates varied with types of sexual partners; the proportion of respondents who reported always using condoms was 55.1%, 64.2%, 75.9%, 73.0%, 78.1%, and 70.3%, for sexual partners who were girlfriends, boyfriends, female sex workers, male sex workers, female clients, or male clients, respectively. After adjustment, inconsistent condom use was significantly associated with age of >= 25 (AOR = 1.77, 95% CI = 1.09-2.86), self-rated quality of life as good or very good (AOR = 4.37, 95% CI = 1.79-5.67), self-perception of higher HIV risk compared to the general population (AOR = 2.37, 95% CI = 1.35-4.17), illicit drug use in the past three months (AOR = 5.76, 95% CI = 1.65-10.09), and reported consistent lubricant use when selling anal sex to men in the past three months (AOR = 2.85, 95% CI = 1.07-8.12). Conclusions We found risky sexual behaviors to be considerably high among MSM in this study, especially among those who used illicit drugs or were older than 25. HIV education and social marketing should be expanded and specifically designed for MSM to better educate on the increased risk of HIV with unprotected anal sex and illicit drug use as risk factors, and the importance of the use of both condoms and lubricant during anal intercourse.	[Yi, Siyan; Tuot, Sovannary; Chhoun, Pheak; Pal, Khuondyla; Tith, Khimuy] KHANA, Res Ctr, Phnom Penh, Cambodia; [Yi, Siyan; Brody, Carinne] Touro Univ Calif, Ctr Global Hlth Res, Publ Hlth Program, Vallejo, CA USA	Touro University California	Yi, SY (corresponding author), KHANA, Res Ctr, Phnom Penh, Cambodia.	siyan@doctor.com	Chhoun, Pheak/AAR-3361-2021	Chhoun, Pheak/0000-0001-6369-0190; Brody, Carinne/0000-0001-9376-5528	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Data used for this analysis were collected as part of an impact evaluation study of the Sustainable Action against HIV and AIDS in Communities (SAHACOM) which was funded by the United States Agency for International Development (USAID). However, the authors received no specific finding for this work.	Aho J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099591; Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; [Anonymous], 1994, PREVENTING AIDS THEO; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Balan IC, 2009, AIDS EDUC PREV, V21, P14, DOI 10.1521/aeap.2009.21.1.14; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baral SD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18768; Barron-Limon S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-433; Bell David C, 2003, Clin Lab Sci, V16, P20; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cai Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-205; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Centers for Disease Control and Prevention (CDC), 2013, COND STDS FACTSH PUB; Chen SY, 2003, AIDS, V17, P942, DOI 10.1097/00002030-200304110-00031; Clark Holie, 2012, Morbidity and Mortality Weekly Report, V61, P962; Deshpande S, 2015, GLOB PUBLIC HEALTH, V10, P103, DOI 10.1080/17441692.2014.972968; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Hirshfield S, 2004, AIDS CARE, V16, P1036, DOI 10.1080/09540120412331292525; Hubach RD, 2015, AIDS EDUC PREV, V27, P72, DOI 10.1521/aeap.2015.27.1.72; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Lau JTF, 2013, AIDS BEHAV, V17, P1395, DOI 10.1007/s10461-012-0244-8; Lau JTF, 2012, AIDS CARE, V24, P59, DOI 10.1080/09540121.2011.592813; Levy ME, 2014, AIDS BEHAV, V18, P972, DOI 10.1007/s10461-014-0719-x; Li DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119977; Liu KL, 2010, BROS KHMER BEHAV RIS; Mansergh G, 2006, AIDS BEHAV, V10, P743, DOI 10.1007/s10461-006-9108-4; Margolis AD, 2014, SEX TRANSM DIS, V41, P749, DOI 10.1097/OLQ.0000000000000206; Ministry of Education Youth and Sports (MEYS), 2012, EX LIF EXP HIV RISKS; National Center for HIV/ AIDS, 2013, BEH SENT SURV BSS 20; National Institute of Public Health National Institute of Statistics and ORC Macro, 2010, CAMB DEM HLTH SURV 2; Nelson LE, 2015, RES NURS HEALTH, V38, P194, DOI 10.1002/nur.21650; Nelson LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115504; Ramanathan S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-827; Rogers RW., 1997, HDB HLTH BEHAV RES P, P113; Semple S, 2009, AM J ADDICTION, V18, P65, DOI 10.1080/10550490802544466; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; Tuot S., 2013, MIDTERM REV SUSTAINA; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Vun MC, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18905; World Health Organization (WHO), 2010, COND HIV PREV; Xu JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0642-9; Yi S, 2015, INT J TROP DIS HLTH, V5, P37; Yi S, 2014, GLOB J MED PUBLIC HL, V3, P1; Yi SY, 2015, BMC INFECT DIS, V15, DOI [10.1186/s12879-015-0954-4, 10.1186/s12889-015-2096-4]; Yi SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121461; Yi SY, 2011, J SUBST USE, V16, P14, DOI 10.3109/14659890903531261; Yi SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-477; Yi SY, 2009, AIDS CARE, V21, P529, DOI 10.1080/09540120802270268; Zhang H, 2015, ARCH SEX BEHAV, V44, P375, DOI 10.1007/s10508-014-0396-x; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	56	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136114	10.1371/journal.pone.0136114	http://dx.doi.org/10.1371/journal.pone.0136114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287731	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600110
J	Almeida, D; Maldonado, E; Vasconcelos, V; Antunes, A				Almeida, Daniela; Maldonado, Emanuel; Vasconcelos, Vitor; Antunes, Agostinho			Adaptation of the Mitochondrial Genome in Cephalopods: Enhancing Proton Translocation Channels and the Subunit Interactions	PLOS ONE			English	Article							AMINO-ACID SITES; DETECTING POSITIVE SELECTION; CYTOCHROME-C-OXIDASE; HEREDITARY OPTIC NEUROPATHY; NADH-QUINONE OXIDOREDUCTASE; PHYLOGENETIC ANALYSIS; COMPLEX-I; ND6 GENE; STATISTICAL-METHODS; CODON-SUBSTITUTION	Mitochondrial protein-coding genes (mt genes) encode subunits forming complexes of crucial cellular pathways, including those involved in the vital process of oxidative phosphorylation (OXPHOS). Despite the vital role of the mitochondrial genome (mt genome) in the survival of organisms, little is known with respect to its adaptive implications within marine invertebrates. The molluscan Class Cephalopoda is represented by a marine group of species known to occupy contrasting environments ranging from the intertidal to the deep sea, having distinct metabolic requirements, varied body shapes and highly advanced visual and nervous systems that make them highly competitive and successful worldwide predators. Thus, cephalopods are valuable models for testing natural selection acting on their mitochondrial subunits (mt subunits). Here, we used concatenated mt genes from 17 fully sequenced mt genomes of diverse cephalopod species to generate a robust mitochondrial phylogeny for the Class Cephalopoda. We followed an integrative approach considering several branches of interest-covering cephalopods with distinct morphologies, metabolic rates and habitats-to identify sites under positive selection and localize them in the respective protein alignment and/or tridimensional structure of the mt subunits. Our results revealed significant adaptive variation in several mt subunits involved in the energy production pathway of cephalopods: ND5 and ND6 from Complex I, CYTB from Complex III, COX2 and COX3 from Complex IV, and in ATP8 from Complex V. Furthermore, we identified relevant sites involved in protein-interactions, lining proton translocation channels, as well as disease/deficiencies related sites in the aforementioned complexes. A particular case, revealed by this study, is the involvement of some positively selected sites, found in Octopoda lineage in lining proton translocation channels (site 74 from ND5) and in interactions between subunits (site 507 from ND5) of Complex I.	[Almeida, Daniela; Maldonado, Emanuel; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, P-4100 Oporto, Portugal; [Almeida, Daniela; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Almeida, Daniela/D-1956-2019; Maldonado, Emanuel/X-1620-2019; Vasconcelos, Vitor/A-8933-2008	Almeida, Daniela/0000-0002-9874-933X; Maldonado, Emanuel/0000-0002-0084-6116; Vasconcelos, Vitor/0000-0003-3585-2417; Antunes, Agostinho/0000-0002-1328-1732	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/79766/2011]; European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT [PEst-C/MAR/LA0015/2013, PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490)]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	DA was funded by a PhD grant (SFRH/BD/79766/2011) from Fundacao para a Ciencia e a Tecnologia (FCT). AA was partially supported by the European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme and national funds through FCT under the projects PEst-C/MAR/LA0015/2013 and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490).	Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; Albertin CB, 2012, STAND GENOMIC SCI, V7, P175, DOI 10.4056/sigs.3136559; Allcock AL, 2011, ZOOL J LINN SOC-LOND, V161, P573, DOI 10.1111/j.1096-3642.2010.00656.x; Alnajjar KS, 2014, BIOCHEMISTRY-US, V53, P496, DOI 10.1021/bi401535q; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; [Anonymous], TRACER V1 6; Arends A, 2001, COMP BIOCHEM PHYS A, V130, P105, DOI 10.1016/S1095-6433(01)00371-3; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Bonaccorso FJ, 2003, J COMP PHYSIOL B, V173, P43, DOI 10.1007/s00360-002-0308-6; BROWN MD, 1992, GENETICS, V130, P163; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DeVries DD, 1996, AM J HUM GENET, V58, P703; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; DOnorio de Meo P, 2011, MITOZOA DB CASPUR201, P10; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Drummond AJ., 2011, GENEIOUS PRO 5 4; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fontanillas P, 2005, MOL ECOL, V14, P661, DOI 10.1111/j.1365-294X.2004.02414.x; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Garvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024127; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Horvath R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Janssens TKS, 2009, INSECT SCI, V16, P3, DOI 10.1111/j.1744-7917.2009.00249.x; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D; Korsloot A., 2004, Environmental stress and cellular response in arthropods; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lindgren AR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-129; Lupi R, 2010, MITOCHONDRION, V10, P192, DOI 10.1016/j.mito.2010.01.004; Maldonado E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096243; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; MarineBio, 2012, VAMP SQUIDS VAMP INF; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mayorov V, 2005, ANN NEUROL, V58, P807, DOI 10.1002/ana.20669; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; McNab BK, 2000, NATURE, V407, P584, DOI 10.1038/35036695; Meikejohn KA, 2014, MOL PHYLOGENET EVOL, V78, P314, DOI 10.1016/j.ympev.2014.06.003; Melo-Ferreira J, 2014, GENOME BIOL EVOL, V6, P886, DOI 10.1093/gbe/evu059; Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Nateewathana A, 1998, P SEAFDEC SEM FISH R, P76; Nielsen R, 1998, GENETICS, V148, P929; Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schrodinger L., 2020, PYMOL; Scott GR, 2011, MOL BIOL EVOL, V28, P351, DOI 10.1093/molbev/msq205; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Strugnell J, 2005, MOL PHYLOGENET EVOL, V37, P426, DOI 10.1016/j.ympev.2005.03.020; Suzuki Y, 2002, MOL BIOL EVOL, V19, P1865, DOI 10.1093/oxfordjournals.molbev.a004010; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	88	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135405	10.1371/journal.pone.0135405	http://dx.doi.org/10.1371/journal.pone.0135405			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285039	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100037
J	Bertoli, D; Serana, F; Sottini, A; Cordioli, C; Maimone, D; Amato, MP; Centonze, D; Florio, C; Puma, E; Capra, R; Imberti, L				Bertoli, Diego; Serana, Federico; Sottini, Alessandra; Cordioli, Cinzia; Maimone, Davide; Amato, Maria Pia; Centonze, Diego; Florio, Ciro; Puma, Elisa; Capra, Ruggero; Imberti, Luisa			Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G > C Polymorphism at Position-174 of the IL-6 Promoter Gene	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; INTERLEUKIN-6 GENE; GUINEA-PIGS; TNF-ALPHA; SYMPTOMS; THERAPY; FEVER; LPS; MS	One of the most common adverse event of interferon beta (IFN beta) therapy for multiple sclerosis is flu-like syndrome (FLS), which has been reportedly related to increased levels of cytokines such as interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha). Average cytokine levels can be affected by single nucleotide polymorphism in the gene promoter regions. To investigate whether IL-6 -174 G>C and TNF-alpha -376 G>A polymorphisms could be correlated to the incidence of FLS, and whether an anti-inflammatory/antipyretic therapy may influence FLS development, a prospective observational study was performed in 190 treatment naive, multiple sclerosis patients who started IM IFN beta-1a 30mcg once weekly. The identification ofIL-6 -174 G>C and TNF-alpha -376 G>A polymorphisms was achieved by performing an amplification-refractory mutation system. Serum IL-6 levels were measured using enzyme-linked immunosorbent assay in blood samples taken before therapy and then after the first and last IFN beta-1a injection of the follow-up. FLS-related symptoms were recorded by patients once per week during the first 12 weeks of therapy into a self-reported diary. We found that patients carrying at least one copy of the C allele at position -174 in the promoter of IL-6 gene produced lower levels of IL-6 and were less prone to develop FLS, which was also less severe. On the contrary, the polymorphism of TNF-alpha had no effect on FLS. Patients taking the first dose of anti-inflammatory/antipyretic therapy in the peri-injection period (within 1 hour) experienced a reduced FLS severity. In conclusion, the study of IL-6 -174 G>C polymorphism would allow the identification of patients lacking the C nucleotide on both alleles who are at risk of a more severe FLS, and may be addressed to a timely and stronger anti-inflammatory/antipyretic therapy for a more effective FLS prevention.	[Bertoli, Diego; Serana, Federico; Sottini, Alessandra; Imberti, Luisa] Spedali Civil Brescia, Diagnost Dept, CREA, I-25125 Brescia, Italy; [Cordioli, Cinzia; Capra, Ruggero] Spedali Civil Brescia, Multiple Sclerosis Ctr, I-25125 Brescia, Italy; [Maimone, Davide] Garibaldi Hosp, Dept Neurol, Catania, Italy; [Amato, Maria Pia] Univ Florence, Careggi Hosp, Dept Neurol, Florence, Italy; [Centonze, Diego] Univ Roma Tor Vergata, Dept Neurosci, S Lucia Fdn IRCCS, Rome, Italy; [Florio, Ciro] Osped Caldarelli, Dept Neurol, Naples, Italy; [Puma, Elisa] Biogen Italy, Dept Med, Milan, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Santa Lucia; University of Rome Tor Vergata	Imberti, L (corresponding author), Spedali Civil Brescia, Diagnost Dept, CREA, I-25125 Brescia, Italy.	limberti@yahoo.it	Amato, Maria Pia/AAC-5940-2022; amato, Maria Pia/AAL-5998-2020; Centonze, Diego/J-7767-2016	amato, Maria Pia/0000-0003-3325-3760; Centonze, Diego/0000-0002-8390-8545; Serana, Federico/0000-0001-6740-4307; Imberti, Luisa/0000-0002-2075-8391	Biogen [BD0109]	Biogen(Biogen)	Biogen (http://www.biogen.com/) sponsored and funded this study (BD0109) to RC. The funders were not responsible for the study design, but monitored clinical data collection; they also reviewed and provided feedback on the manuscript to the authors, who had full editorial control of the manuscript and provided their final approval of all content.	Bennermo M, 2004, CLIN CHEM, V50, P2136, DOI 10.1373/clinchem.2004.037531; Brandes DW, 2007, CURR MED RES OPIN, V23, P1667, DOI 10.1185/030079907X210741; Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280; Cardellini M, 2005, DIABETES CARE, V28, P2007, DOI 10.2337/diacare.28.8.2007; Chakraborty B, 2014, ASIA-PAC J CLIN ONCO, DOI [10.1111/ajco.12290, DOI 10.1111/AJC0.12290]; Christophi GP, 2011, J NEUROL SCI, V307, P41, DOI 10.1016/j.jns.2011.05.024; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Fernandez-Arquero M, 1999, NEUROLOGY, V53, P1361, DOI 10.1212/WNL.53.6.1361; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Galetta SL, 2005, CNS DRUGS, V19, P239, DOI 10.2165/00023210-200519030-00005; Jones KG, 2001, CIRCULATION, V103, P2260; KLIR JJ, 1995, AM J PHYSIOL-REG I, V268, pR480, DOI 10.1152/ajpregu.1995.268.2.R480; Kox M, 2014, P NATL ACAD SCI USA, V111, P7379, DOI 10.1073/pnas.1322174111; Kumpfel T, 2007, MULT SCLER J, V13, P1138, DOI 10.1177/1352458507078685; Leon LR, 1997, AM J PHYSIOL-REG I, V272, pR563, DOI 10.1152/ajpregu.1997.272.2.R563; LONG NC, 1992, AM J PHYSIOL, V263, pR987, DOI 10.1152/ajpregu.1992.263.5.R987; LONG NC, 1990, AM J PHYSIOL, V259, pR724, DOI 10.1152/ajpregu.1990.259.4.R724; Mahdy AM, 2002, BRIT J ANAESTH, V88, P797, DOI 10.1093/bja/88.6.797; Martinez-Caceres EM, 1998, ANN NEUROL, V44, P682, DOI 10.1002/ana.410440415; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Montalban X, 2000, J NEUROL, V247, P259, DOI 10.1007/s004150050580; Moses H, 2008, CURR MED RES OPIN, V24, P2679, DOI [10.1185/03007990802329959, 10.1185/03007990802329959 ]; Nadjar Y, 2011, CLIN NEUROL NEUROSUR, V113, P316, DOI 10.1016/j.clineuro.2010.12.013; Nakatsuji Y, 2006, CYTOKINE, V36, P69, DOI 10.1016/j.cyto.2006.10.013; Neilley LK, 1996, NEUROLOGY, V46, P552, DOI 10.1212/WNL.46.2.552; Plosker GL, 2011, CNS DRUGS, V25, P67, DOI 10.2165/11206430-000000000-00000; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reess J, 2002, MULT SCLER, V8, P15; Rio J, 2004, NEUROLOGY, V63, P525, DOI 10.1212/01.WNL.0000133206.44931.25; Roth J, 1998, J PHYSIOL-LONDON, V509, P267, DOI 10.1111/j.1469-7793.1998.267bo.x; Roth J, 1997, AM J PHYSIOL-REG I, V273, pR1529, DOI 10.1152/ajpregu.1997.273.4.R1529; SELMAJ K, 1991, J IMMUNOL, V147, P1522; Serana F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094794; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Trejaut JA, 2004, TISSUE ANTIGENS, V64, P492, DOI 10.1111/j.1399-0039.2004.00287.x; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135441	10.1371/journal.pone.0135441	http://dx.doi.org/10.1371/journal.pone.0135441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285213	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100039
J	Bouklata, N; Supply, P; Jaouhari, S; Charof, R; Seghrouchni, F; Sadki, K; El Achhab, Y; Nejjari, C; Filali-Maltouf, A; Lahlou, O; El Aouad, R				Bouklata, Nada; Supply, Philip; Jaouhari, Sanae; Charof, Reda; Seghrouchni, Fouad; Sadki, Khalid; El Achhab, Youness; Nejjari, Chakib; Filali-Maltouf, Abdelkarim; Lahlou, Ouafae; El Aouad, Rajae			Molecular Typing of Mycobacterium Tuberculosis Complex by 24-Locus Based MIRU-VNTR Typing in Conjunction with Spoligotyping to Assess Genetic Diversity of Strains Circulating in Morocco	PLOS ONE			English	Article							POPULATION-STRUCTURE; CASABLANCA; DATABASE; EPIDEMIOLOGY; POLYMORPHISM; GENOTYPES; FAMILY; AREA	Background Standard 24-locus Mycobacterial Interspersed Repetitive Unit Variable Number Tandem Repeat (MIRU-VNTR) typing allows to get an improved resolution power for tracing TB transmission and predicting different strain (sub) lineages in a community. Methodology During 2010-2012, a total of 168 Mycobacterium tuberculosis Complex (MTBC) isolates were collected by cluster sampling from 10 different Moroccan cities, and centralized by the National Reference Laboratory of Tuberculosis over the study period. All isolates were genotyped using spoligotyping, and a subset of 75 was genotyped using 24-locus based MIRU-VNTR typing, followed by first line drug susceptibility testing. Corresponding strain lineages were predicted using MIRU-VNTRplus database. Principal Findings Spoligotyping resulted in 137 isolates in 18 clusters (2-50 isolates per cluster: clustering rate of 81.54%) corresponding to a SIT number in the SITVIT database, while 31(18.45%) patterns were unique of which 10 were labelled as "unknown" according to the same database. The most prevalent spoligotype family was LAM; (n = 81 or 48.24% of isolates, dominated by SIT42, n = 49), followed by Haarlem (23.80%), T superfamily (15.47%), > Beijing (2.97%), > U clade (2.38%) and S clade (1.19%). Subsequent 24-Locus MIRU-VNTR typing identified 64 unique types and 11 isolates in 5 clusters (2 to 3isolates per cluster), substantially reducing clusters defined by spoligotyping only. The single cluster of three isolates corresponded to two previously treated MDR-TB cases and one new MDR-TB case known to be contact a same index case and belonging to a same family, albeit residing in 3 different administrative regions. MIRU-VNTR loci 4052, 802, 2996, 2163b, 3690, 1955, 424, 2531, 2401 and 960 were highly discriminative in our setting (HGDI > 0.6). Conclusions 24-locus MIRU-VNTR typing can substantially improve the resolution of large clusters initially defined by spoligotyping alone and predominating in Morocco, and could therefore be used to better study tuberculosis transmission in a population-based, multi-year sample context.	[Bouklata, Nada; Jaouhari, Sanae; Charof, Reda; Lahlou, Ouafae] Natl Inst Hyg, Natl TB Reference Lab, Rabat, Morocco; [Supply, Philip] INSERM, U1018, F-59045 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Supply, Philip] Inst Pasteur, CIIL, Lille, France; [Supply, Philip] Univ Lille, Lille, France; [Bouklata, Nada; Sadki, Khalid; Filali-Maltouf, Abdelkarim] Univ Mohammed 5, Lab Microbiol & Mol Biol, Fac Sci, Rabat, Morocco; [El Achhab, Youness; Nejjari, Chakib] Sidi Mohamed Ben Abdillah Univ, Fac Med & Pharm Fes, Dept Epidemiol & Publ Hlth, Fes, Morocco; [El Aouad, Rajae] Univ Mohamed VI Sci & Hlth, Sch Publ Hlth & Management Syst Hlth, Casablanca, Morocco; [Supply, Philip] Genoscreen, Lille, France; [Seghrouchni, Fouad] Natl Inst Hyg, Dept Immunol, Lab Cell Immunol, Rabat, Morocco	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Mohammed V University in Rabat; Sidi Mohamed Ben Abdellah University of Fez; Mohammed VI University of Health Sciences (UM6SS)	Bouklata, N (corresponding author), Natl Inst Hyg, Natl TB Reference Lab, Rabat, Morocco.	bouklatanada@gmail.com	EL ACHHAB, Youness/V-5153-2019; Filali-Maltouf, Abdelkarim/AAD-3681-2022; Supply, Philip/A-9580-2019	EL ACHHAB, Youness/0000-0002-2527-2518; Filali-Maltouf, Abdelkarim/0000-0002-2727-3389; Supply, Philip/0000-0003-3690-3853; SADKI, khalid/0000-0002-9224-5050; EL AOUAD, Rajae/0000-0002-2686-6924	Academie Hassan II des Sciences [1169]; Euro Mediterranean Network against Tuberculosis, European Commission	Academie Hassan II des Sciences; Euro Mediterranean Network against Tuberculosis, European Commission	The work performed was funded by Academie Hassan II des Sciences (grant number 1169). The collaboration with Institut Pasteur de Lille France was financed through the Euro Mediterranean Network against Tuberculosis, European Commission, 7th Framework program (EUMEDNETvsTB; http://www.eumednet-tb.org/index. html). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Philip Supply is a Consultant for Genoscreen. Genoscreen provided support in the form of consultancy fee for author PS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol M, 2009, HIST MAROC, P756; Al Hajoj S, 2010, ANN THORAC MED, V5, P149, DOI 10.4103/1817-1737.65045; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; [Anonymous], GLOB TUB CONTR WHO R; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bidovec-Stojkovic U, 2011, RESP MED, V105, pS67, DOI 10.1016/S0954-6111(11)70014-2; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chaoui I, 2014, INFECT GENET EVOL, V21, P463, DOI 10.1016/j.meegid.2013.05.023; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; David H, 1987, METHODES LAB MYCOBAC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Diraa O, 2005, INT J TUBERC LUNG D, V9, P1294; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; ElBaghdadi J, 1997, B SOC PATHOL EXOT, V90, P156; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lahlou O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047113; Maes M, 2008, TUBERCULOSIS, V88, P490, DOI 10.1016/j.tube.2008.04.003; Martins MC, 2013, INFECT GENET EVOL, V14, P39, DOI 10.1016/j.meegid.2012.10.015; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Niemann S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021188; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Qiao L, 2011, BMC INFECT DIS; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Soini H, 2000, J CLIN MICROBIOL, V38, P669, DOI 10.1128/JCM.38.2.669-676.2000; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tazi L, 2004, J CLIN MICROBIOL, V42, P461, DOI 10.1128/JCM.42.1.461-466.2004; Tazi L, 2007, INFECT GENET EVOL, V7, P636, DOI 10.1016/j.meegid.2007.06.005; Valcheva V, 2008, J CLIN MICROBIOL, V46, P1014, DOI 10.1128/JCM.01841-07; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, J CLIN MICROBIOL, V42, P5774, DOI 10.1128/JCM.42.12.5774-5782.2004; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization Geneva, 2014, GLOB TUB CONTR WHO R	46	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135695	10.1371/journal.pone.0135695	http://dx.doi.org/10.1371/journal.pone.0135695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285026	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100061
J	Ptatscheck, C; Traunspurger, W				Ptatscheck, Christoph; Traunspurger, Walter			Meio- and Macrofaunal Communities in Artificial Water-Filled Tree Holes: Effects of Seasonality, Physical and Chemical Parameters, and Availability of Food Resources	PLOS ONE			English	Article							SECONDARY PRODUCTION; BOTTOM-UP; MEIOFAUNA; MOSQUITO; PRODUCTIVITY; POPULATIONS; DISPERSAL; DYNAMICS; LAKES; COLONIZATION	Objectives In this study we investigated the dynamics of meiofaunal and macrofaunal communities in artificial water-filled tree holes. The abundances and, for the first time, biomasses and secondary production rates of these communities were examined. The experimental set-up consisted of 300 brown plastic cups placed in temperate mixed forests and sampled five times over a period of 16 months to determine the impact of (i) seasonal events, (ii) physicochemical parameters, and (iii) food resources on the tree hole metazoans. Outcomes Metazoan organisms, especially the meiofauna (rotifers and nematodes) occupied nearly all of the cups (> 99%) throughout the year. Between 55% and 99% of themetazoan community was represented by rotifers (max. 557,000 individuals 100 cm(-2)) and nematodes (max. 58,000 individuals 100 cm(-2)). Diptera taxa, particularly Dasyhelea sp. (max. 256 individuals 100 cm(-2)) dominated the macrofaunal community. Macrofauna accounted for the majority of the metazoan biomass, with a mean dry weight of 5,800 mu g 100 cm(-2) and an annual production rate of 20,400 mu g C 100 cm(-2), whereas for meiofauna mean biomass and annual production were 100 mu g 100 cm(-2) and 5,300 mu g C 100 cm(-2), respectively. The macrofaunal taxa tended to show more fluctuating population dynamic while the meiofaunal dynamic was rather low with partly asynchronous development. Seasonality (average temperature and rain intervals) had a significant impact on both meiofauna and macrofauna. Furthermore, bottom-up control (chlorophyll-a and organic carbon), mainly attributable to algae, was a significant factor that shaped the metazoan communities. In contrast, physicochemical water parameters had no evident influence. 23.7% of organism density distribution was explained by redundancy analysis (RDA) indicating a high dynamic and asynchrony of the systems.	[Ptatscheck, Christoph; Traunspurger, Walter] Univ Bielefeld, Anim Ecol, D-33615 Bielefeld, Germany	University of Bielefeld	Ptatscheck, C (corresponding author), Univ Bielefeld, Anim Ecol, Konsequenz 45, D-33615 Bielefeld, Germany.	christoph.ptatscheck@uni-bielefeld.de		Ptatscheck, Christoph/0000-0002-2079-4130	German Federal Environmental Foundation (DBU)	German Federal Environmental Foundation (DBU)	The study was supported by the German Federal Environmental Foundation (DBU; https://www.dbu.de/). The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RS, 1980, HYDROBIOLOGIA, V70, P257, DOI 10.1007/BF00016768; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Bergtold M, 2005, J N AM BENTHOL SOC, V24, P321, DOI 10.1899/03-038.1; BRADSHAW WE, 1988, OECOLOGIA, V74, P507, DOI 10.1007/BF00380047; Brouard O, 2012, FRESHWATER BIOL, V57, P815, DOI 10.1111/j.1365-2427.2012.02749.x; Brouard O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020129; Butkas KJ, 2011, AQUAT SCI, V73, P153, DOI 10.1007/s00027-010-0168-1; Caceres CE, 2002, OECOLOGIA, V131, P402, DOI 10.1007/s00442-002-0897-5; CARPENTER SR, 1982, OECOLOGIA, V53, P1, DOI 10.1007/BF00377128; Devetter Miloslav, 2004, Acta Societatis Zoologicae Bohemicae, V68, P161; Dezerald O, 2014, HYDROBIOLOGIA, V723, P77, DOI 10.1007/s10750-013-1464-2; Dolbeth M, 2012, CAN J FISH AQUAT SCI, V69, P1230, DOI 10.1139/F2012-050; Feller R.J., 1988, P181; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foit K, 2012, AQUAT TOXICOL, V109, P243, DOI 10.1016/j.aquatox.2011.09.013; Fontaneto Diego, 2004, P121; Frankland PF, 1886, P R SOC LONDON, V40, P509; Frisch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040205; Herzig A., 1984, FUNDAMENTAL REQUIREM; JACKSON JM, 1991, HYDROBIOLOGIA, V209, P59, DOI 10.1007/BF00006718; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Jocque M, 2014, HYDROBIOLOGIA, V730, P153, DOI 10.1007/s10750-014-1831-7; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kitching RL, 2001, ANNU REV ENTOMOL, V46, P729, DOI 10.1146/annurev.ento.46.1.729; KITCHING RL, 1971, J ANIM ECOL, V40, P281, DOI 10.2307/3247; Kutikova LA, 2003, BIOL BULL+, V30, P271, DOI 10.1023/A:1023811929889; Macia A, 2000, OECOLOGIA, V125, P55, DOI 10.1007/PL00008891; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Marino NAC, 2011, HYDROBIOLOGIA, V678, P191, DOI 10.1007/s10750-011-0848-4; McSorley R, 2003, FLA ENTOMOL, V86, P138, DOI 10.1653/0015-4040(2003)086[0138:AONTEE]2.0.CO;2; Michiels IC, 2004, NEMATOLOGY, V6, P655, DOI 10.1163/1568541042843568; Muschiol D, 2009, AQUAT ECOL, V43, P235, DOI 10.1007/s10452-008-9202-y; NALEPA TF, 1983, J GREAT LAKES RES, V9, P530, DOI 10.1016/S0380-1330(83)71926-X; Paradise Christopher J., 2008, BMC Ecology, V8, P22, DOI 10.1186/1472-6785-8-22; PIMM SL, 1987, OIKOS, V50, P302, DOI 10.2307/3565490; PLANTE C, 1989, CAN J FISH AQUAT SCI, V46, P1489, DOI 10.1139/f89-191; Ptatscheck C, 2014, AQUAT ECOL, V48, P285, DOI 10.1007/s10452-014-9483-2; Ptatscheck C, 2015, HYDROBIOLOGIA, V757, P143, DOI 10.1007/s10750-015-2246-9; Ricci C, 2005, INTEGR COMP BIOL, V45, P759, DOI 10.1093/icb/45.5.759; Ristau K, 2012, FRESHWATER BIOL, V57, P824, DOI 10.1111/j.1365-2427.2012.02750.x; Schmid PE, 1997, FRESHWATER BIOL, V38, P67, DOI 10.1046/j.1365-2427.1997.00197.x; Schmid-Araya JM, 2000, FRESHWATER BIOL, V44, P149, DOI 10.1046/j.1365-2427.2000.00594.x; Schmidl J, 2008, HYDROBIOLOGIA, V598, P285, DOI 10.1007/s10750-007-9163-5; Schroeder F, 2012, FUND APPL LIMNOL, V181, P143, DOI 10.1127/1863-9135/2012/0332; SOTA T, 1994, RES POPUL ECOL, V36, P93, DOI 10.1007/BF02515090; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Stead TK, 2005, LIMNOL OCEANOGR, V50, P398, DOI 10.4319/lo.2005.50.1.0398; Stich HB, 2005, ARCH HYDROBIOL, V162, P111, DOI 10.1127/0003-9136/2005/0162-0111; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; Tod SP, 2009, LIMNOL OCEANOGR, V54, P450, DOI 10.4319/lo.2009.54.2.0450; Traunspurger W, 2000, FRESHWATER BIOL, V44, P29, DOI 10.1046/j.1365-2427.2000.00585.x; Traunspurger W, 2012, FUND APPL LIMNOL, V180, P233, DOI 10.1127/1863-9135/2012/0144; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; WHARTON DA, 1995, BIOL REV, V70, P161, DOI 10.1111/j.1469-185X.1995.tb01442.x; Yanoviak SP, 2005, METH ECOL, P168, DOI 10.1002/9780470750513.ch8; Yanoviak SP, 2001, FLA ENTOMOL, V84, P265, DOI 10.2307/3496178; Yee DA, 2007, OECOLOGIA, V153, P153, DOI 10.1007/s00442-007-0707-1	59	15	15	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0133447	10.1371/journal.pone.0133447	http://dx.doi.org/10.1371/journal.pone.0133447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284811	gold, Green Published, Green Submitted			2022-12-27	WOS:000359666100003
J	Roubalova, L; Vosahlikova, M; Brejchova, J; Sykora, J; Rudajev, V; Svoboda, P				Roubalova, Lenka; Vosahlikova, Miroslava; Brejchova, Jana; Sykora, Jan; Rudajev, Vladimir; Svoboda, Petr			High Efficacy but Low Potency of delta-Opioid Receptor-G Protein Coupling in Brij-58-Treated, Low-Density Plasma Membrane Fragments	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RESONANCE ENERGY-TRANSFER; BETA-ADRENERGIC-RECEPTOR; A2 ADENOSINE RECEPTORS; LIPID RAFTS; BIOLOGICAL-MEMBRANES; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; CAVEOLAE MICRODOMAINS; CARDIAC MYOCYTES	Principal Findings HEK293 cells stably expressing PTX-insensitive delta-opioid receptor-Gi1 alpha ((CI)-I-351) fusion protein were homogenized, treated with low concentrations of non-ionic detergent Brij-58 at 0 degrees C and fractionated by flotation in sucrose density gradient. In optimum range of detergent concentrations (0.025-0.05% w/v), Brij-58-treated, low-density membranes exhibited 2-3fold higher efficacy of DADLE-stimulated, high-affinity [P-32]GTPase and [S-35]GTP.S binding than membranes of the same density prepared in the absence of detergent. The potency of agonist DADLE response was significantly decreased. At high detergent concentrations (>0.1%), the functional coupling between delta-opioid receptors and G proteins was completely diminished. The same detergent effects were measured in plasma membranes isolated from PTX-treated cells. Therefore, the effect of Brij-58 on delta-opioid receptor-G protein coupling was not restricted to the covalently bound G(i)1 alpha within delta-opioid receptor-G(i)1 alpha fusion protein, but it was also valid for PTX-sensitive G proteins of G(i)/G(o) family endogenously expressed in HEK293 cells. Characterization of the direct effect of Brij-58 on the hydrophobic interior of isolated plasma membranes by steady-state anisotropy of diphenylhexatriene (DPH) fluorescence indicated a marked increase of membrane fluidity. The time-resolved analysis of decay of DPH fluorescence by the "wobble in cone" model of DPH motion in the membrane indicated that the exposure to the increasing concentrations of Brij-58 led to a decreased order and higher motional freedom of the dye. Summary Limited perturbation of plasma membrane integrity by low concentrations of non-ionic detergent Brij-58 results in alteration of delta-OR-G protein coupling. Maximum G protein-response to agonist stimulation (efficacy) is increased; affinity of response (potency) is decreased. The total degradation plasma membrane structure at high detergent concentrations results in diminution of functional coupling between delta-opioid receptors and G proteins.	[Roubalova, Lenka; Vosahlikova, Miroslava; Brejchova, Jana; Svoboda, Petr] Acad Sci Czech Republ, Inst Physiol, Dept Biomath, Prague, Czech Republic; [Sykora, Jan] Acad Sci Czech Republ, J Heyrovsky Inst Phys Chem, Dept Biophys Chem, Prague, Czech Republic; [Rudajev, Vladimir] Acad Sci Czech Republ, Inst Physiol, Dept Neurochem, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Svoboda, P (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Biomath, Prague, Czech Republic.	svobodap@biomed.cas.cz	Rudajev, Vladimir/T-3851-2019; Sykora, Jan/F-5179-2014; Rudajev, Vladimir/C-3356-2012; Svoboda, Petr/C-2619-2012; Roubalova, Lenka/C-2628-2012; Brejchova, Jana/L-9368-2015; Vosahlikova, Miroslava/G-3022-2014	Svoboda, Petr/0000-0002-3076-4672; Roubalova, Lenka/0000-0002-0603-7184; Brejchova, Jana/0000-0002-2126-6671; Vosahlikova, Miroslava/0000-0003-4832-7953	Grant Agency of the Czech Republic [P207/12/0919]; Institute of Physiology, Academy of Sciences of the Czech Republic [RVO:67985823]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Physiology, Academy of Sciences of the Czech Republic	This work was supported by the Grant Agency of the Czech Republic (P207/12/0919) and from institutional project of the Institute of Physiology, Academy of Sciences of the Czech Republic (RVO:67985823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Alves ID, 2005, BIOCHEMISTRY-US, V44, P9168, DOI 10.1021/bi050207a; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bourova L, 2003, J NEUROCHEM, V85, P34, DOI 10.1046/j.1471-4159.2003.01667.x; Brejchova J, 2011, BBA-BIOMEMBRANES, V1808, P2819, DOI 10.1016/j.bbamem.2011.08.010; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; De Luca A, 2000, J CELL BIOCHEM, V77, P529, DOI 10.1002/(SICI)1097-4644(20000615)77:4<529::AID-JCB2>3.0.CO;2-X; Dessy C, 2000, EMBO J, V19, P4272, DOI 10.1093/emboj/19.16.4272; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; GROSS W, 1991, MOL PHARMACOL, V39, P524; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; KAWATO S, 1977, BIOCHEMISTRY-US, V16, P2319, DOI 10.1021/bi00630a002; KINOSITA K, 1982, BIOPHYS J, V37, P461, DOI 10.1016/S0006-3495(82)84692-4; Lasley RD, 2000, J BIOL CHEM, V275, P4417, DOI 10.1074/jbc.275.6.4417; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; LOHSE MJ, 1991, MOL PHARMACOL, V39, P517; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Moon HE, 2001, NEUROPHARMACOLOGY, V41, P321, DOI 10.1016/S0028-3908(01)00076-4; Moravcova Z, 2004, BBA-MOL CELL RES, V1691, P51, DOI 10.1016/j.bbamcr.2003.12.004; Murthy KS, 2000, J BIOL CHEM, V275, P30211, DOI 10.1074/jbc.M002194200; Neubig RR, 1998, SEMIN NEUROSCI, V9, P189, DOI 10.1006/smns.1997.0117; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Remmers AE, 2000, EUR J PHARMACOL, V396, P67, DOI 10.1016/S0014-2999(00)00212-0; Rybin VO, 2003, MOL PHARMACOL, V63, P1338, DOI 10.1124/mol.63.6.1338; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; Salamon Z, 2000, BIOPHYS J, V79, P2463, DOI 10.1016/S0006-3495(00)76489-7; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Schwencke C, 1999, J CELL BIOCHEM, V75, P64, DOI 10.1002/(SICI)1097-4644(19991001)75:1<64::AID-JCB7>3.0.CO;2-L; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; STICKLE D, 1993, MOL PHARMACOL, V43, P397; Stickle D, 1996, BBA-MOL CELL RES, V1310, P242, DOI 10.1016/0167-4889(95)00147-6; Stohr J, 2004, DEV BRAIN RES, V151, P67, DOI 10.1016/j.devbrainres.2004.03.014; Sykora J, 2009, BBA-BIOMEMBRANES, V1788, P324, DOI 10.1016/j.bbamem.2008.11.008; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Ushio-Fukai M, 2001, J BIOL CHEM, V276, P48269, DOI 10.1074/jbc.M105901200; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6	77	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135664	10.1371/journal.pone.0135664	http://dx.doi.org/10.1371/journal.pone.0135664			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285205	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100055
J	Shimokawabe, A; Yamaura, Y; Akasaka, T; Sato, T; Shida, Y; Yamanaka, S; Nakamura, F				Shimokawabe, Ayuma; Yamaura, Yuichi; Akasaka, Takumi; Sato, Tomonori; Shida, Yuichiro; Yamanaka, Satoshi; Nakamura, Futoshi			The Distribution of Cool Spots as Microrefugia in a Mountainous Area	PLOS ONE			English	Article							CLIMATE-CHANGE; SCALE; PROJECTIONS; CAPACITY; IMPACTS; REFUGIA; FUTURE; MODELS; MAXENT	It has recently been proposed that microrefugia played an important role in species survival during past climate change events. However, the current distributions of microrefugia remain largely unknown. Wind-hole sites are areas affected by preferential flows of cool air generated in interstitial spaces created by rock fragments or colluvia. Alpine plant species occurring in lowland wind-hole sites isolated from alpine zones may be relicts of the last glacial period. Hokkaido, northern Japan, is known to contain many wind-hole sites in which alpine plant species can occur. Here we surveyed 55 wind-hole sites in the Kitami region, eastern Hokkaido, and observed two alpine plant species (lingonberry, Vaccinium vitis-idaea, and Labrador tea, Rhododendron groenlandicum ssp. diversipilosum var. diversipilosum) in 14 wind-hole sites. Statistical modeling showed that wind-hole sites are likely to occur in areas with high maximum slope angles and volcanic rock cover, and concave surfaces. Our predictions of wind-hole site distributions suggest that such topographic conditions are common in our study area, and that many undiscovered wind-hole sites exist. Ignoring microhabitats may greatly underestimate species distributions in topographically complex regions, and dispersed cool spots may also function as stepping stones and temporal habitats for cold-adapted species. Because these localized unique habitats usually occur in economically unproductive sites, identifying and protecting potential microrefugia (cool spots) would be a robust and cost-effective mitigation of climate change impacts.	[Shimokawabe, Ayuma; Yamaura, Yuichi; Akasaka, Takumi; Shida, Yuichiro; Yamanaka, Satoshi; Nakamura, Futoshi] Hokkaido Univ, Grad Sch Agr, Div Environm Resources, Sapporo, Hokkaido, Japan; [Sato, Tomonori] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Yamaura, Yuichi] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan; [Akasaka, Takumi] Obihiro Univ Agr & Vet Med, Lab Wildlife Ecol, Obihiro, Hokkaido 080, Japan	Hokkaido University; Hokkaido University; Forestry & Forest Products Research Institute - Japan; Obihiro University of Agriculture & Veterinary Medicine	Yamaura, Y (corresponding author), Hokkaido Univ, Grad Sch Agr, Div Environm Resources, Sapporo, Hokkaido, Japan.	yamaura@ffpri.affrc.go.jp	Sato, Tomonori/GOP-2277-2022; Sato, Tomonori/A-3415-2012; Yamaura, Yuichi/A-3638-2012; Nakamura, Futoshi/A-6696-2012	Sato, Tomonori/0000-0001-6541-742X; Sato, Tomonori/0000-0001-6541-742X; Yamaura, Yuichi/0000-0001-9355-4413; Nakamura, Futoshi/0000-0003-4351-2578	Japan Science Society [26-542]; JSPS KAKENHI [23248021, 23780153]	Japan Science Society; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AS was supported by A Sasakawa Scientific Research Grant from the Japan Science Society, no. 26-542. AS YY TA YS SY FN were supported by JSPS KAKENHI Grant no. 23248021, and YY was supported by JSPS KAKENHI Grant no. 23780153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Chandler R, 2013, MAXLIKE MODEL SPECIE; deMaynadier Phillip, 1997, P68; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Guillera-Arroita G, 2014, METHODS ECOL EVOL, V5, P1192, DOI 10.1111/2041-210X.12252; Hannah L, 2014, TRENDS ECOL EVOL, V29, P390, DOI 10.1016/j.tree.2014.04.006; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Higa M, 2015, DIVERS DISTRIB, V21, P46, DOI 10.1111/ddi.12255; Hjort J, 2015, CONSERV BIOL, V29, P630, DOI 10.1111/cobi.12510; Keppel G, 2015, FRONT ECOL ENVIRON, V13, P106, DOI 10.1890/140055; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lundquist JD, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009879; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; Merow C, 2014, METHODS ECOL EVOL, V5, P215, DOI 10.1111/2041-210X.12152; Mosblech NAS, 2011, J BIOGEOGR, V38, P419, DOI 10.1111/j.1365-2699.2010.02436.x; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; R Core Team, 2012, R LANG ENV STAT COMP; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Ruzicka Vlastimil, 1999, Decheniana Beihefte, V37, P141; Sasaki H., 1986, Ecological Review, V21, P21; Sato K., 1995, BULL HIGAS TAISET MU, V17, P107; Sato Ken, 1993, Japanese Journal of Ecology (Sendai), V43, P91; Sawada Y, 2003, GEOMORPHOLOGY, V52, P121, DOI 10.1016/S0169-555X(02)00252-0; Shiboi T, 1975, MEM KITAMI I TECHN, V7, P163; Shiboi T, 1974, MEM KITAMI I TECHN, V5, P213; Shiboi T, 1980, KITAMI DAIGAKU RONSH, V3, P141; Shimizu C, 2004, KOMAZAWA GEOGRAPHY, V40, P121; Storlie C, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0576; Tanaka HL, 2000, J METEOROL SOC JPN, V78, P611, DOI 10.2151/jmsj1965.78.5_611; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838	41	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135732	10.1371/journal.pone.0135732	http://dx.doi.org/10.1371/journal.pone.0135732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285206	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100063
J	Sun, JX; Hu, JR; Tu, CL; Zhong, AY; Xu, HY				Sun, Jinxian; Hu, Jianrong; Tu, Chunlin; Zhong, Anyuan; Xu, Huajun			Obstructive Sleep Apnea Susceptibility Genes in Chinese Population: A Field Synopsis and Meta-Analysis of Genetic Association Studies	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; HYPOPNEA SYNDROME; I/D POLYMORPHISM; TRANSPORTER GENE; RECEPTOR GENES; VARIANTS; RISK; PREVALENCE; DISEASE; GAMMA	Background Epidemiological studies to date have evaluated the association between genetic variants and the susceptibility to obstructive sleep apnea (OSA). However, the results of these studies have been inconclusive. In this current study we performed meta-analysis of genetic association studies (GAS) to pool OSA-susceptible genes in Chinese population, to perform a more precise evaluation of the association. Methods Various databases (i.e., PubMed, EMBASE, HuGE Navigator, Wanfang and CNKI) were searched to identify all eligible GAS-related variants associated with susceptibility to OSA. The generalized odds ratio metric (ORG) and the odds ratio (OR) of the allele contrast were used to quantify the impact of genetic variants on the risk of OSA. Cumulative and recursive cumulative meta-analyses (CMA) were also performed to investigate the trend and stability of effect sizes as evidence was accumulated. Results Thirty-two GAS evaluating 13 polymorphisms in 10 genes were included in our meta-analysis. Significant associations were derived for four polymorphisms either for the allele contrast or for the ORG. The variants TNF-alpha-308G/A, 5-HTTLPR, 5-HTTVNTR, and APOE showed marginal significance for ORG (95% confidence interval [CI]): 2.01(1.31-3.07); 1.31 (1.09-1.58); 1.85(1.16-2.95); 1.79(1.10-2.92); and 1.79(1.10-2.92) respectively. In addition, the TNF-alpha-308G/A, 5-HTTLPR, and 5-HTTVNTR variants showed significance for the allele contrast: 2.15(1.39-3.31); 2.26(1.58-3.24); 1.32(1.12-1.55); and 1.86(1.12-3.08) respectively. CMA showed a trend towards an association, and recursive CMA indicated that more evidence was needed to determine whether this was significant. Conclusions TNF alpha- 5-HTT, and APOE genes can all be proposed as OSA-susceptibility genes in Chinese population. Genome-wide association studies ( GWAS) are therefore urgently needed to confirm our findings within a larger sample of OSA patients in China.	[Sun, Jinxian; Hu, Jianrong; Tu, Chunlin] Jiading Cent Hosp, Dept Resp Med, Shanghai 201800, Peoples R China; [Zhong, Anyuan] Soochow Univ, Dept Resp Dis, Affiliated Hosp 2, Suzhou 215004, Peoples R China; [Xu, Huajun] Shanghai Jiao Tong Univ, Otolaryngol Inst, Affiliated Peoples Hosp 6, Dept Otolaryngol, Shanghai 200233, Peoples R China	Soochow University - China; Shanghai Jiao Tong University	Tu, CL (corresponding author), Jiading Cent Hosp, Dept Resp Med, 1 Chengbei Rd, Shanghai 201800, Peoples R China.	tuchunlin2015@163.com; 476617439@qq.com; sunnydayxu2010@163.com						Barcelo A, 2001, EUR RESPIR J, V17, P728, DOI 10.1183/09031936.01.17407280; Chang Z, 2007, CLIN FOCUS, V22, P1752; Chen HB, 2013, SLEEP BREATH, V17, P1241, DOI 10.1007/s11325-013-0829-0; Chung WK, 1996, GENOME RES, V6, P431, DOI 10.1101/gr.6.5.431; Du XZ, 2010, CHINESE GEN PRACTICE, V13, P3526; Feng Y, 2013, GENET MOL RES, V12, P74, DOI 10.4238/2013.January.22.6; Guan J, 2011, J LARYNGOL OTOL, V125, P1042, DOI 10.1017/S002221511100123X; [关建 Guan Jian], 2013, [中国耳鼻咽喉头颈外科, Chinese Archives of Otolaryngology-Head and Neck Surgery], V20, P8; Han L, 2012, THESIS HEBEI UNITED; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Huang Rong, 2003, Zhonghua Jiehe He Huxi Zazhi, V26, P517; Kitsios G, 2007, AM J EPIDEMIOL, V166, P619, DOI 10.1093/aje/kwm129; Kripke DF, 2015, SLEEP MED, V16, P217, DOI 10.1016/j.sleep.2014.11.003; Lee P, 2012, EUR RESPIR J, V40, P394, DOI 10.1183/09031936.00100211; Leong WB, 2014, J CLIN ENDOCR METAB, V99, pE1650, DOI 10.1210/jc.2014-1260; Leong WB, 2013, J CLIN SLEEP MED, V9, P853, DOI 10.5664/jcsm.2978; Li S, 2004, CHIN J RESP CRIT CAR, V3, P350; Li T, 2014, ACAD J CHIN PLA MED, V5, P276; Li TZ, 2013, ACAD J CHINESE PLA M, V12, P1265; Li WQ, 2006, CHIN J TRAD MED SCI, V13, P75; Li Yanzhong, 2004, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V18, P456; Lin H, 2014, SLEEP BREATH, V18, P509, DOI 10.1007/s11325-013-0912-6; Ling M, 2014, J CHIN PRACT DIAGN T, V28, P1172; Liu Hui-guo, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P596; Luo X, 2006, THESIS WENZHOU MED S; Luo Y, 2008, THESIS ZHONG SHAN U; Lv D, 2015, SLEEP BREATH; Mirrakhimov AE, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-10; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Pallayova M, 2014, DIABETES RES CLIN PR, V104, P197, DOI 10.1016/j.diabres.2014.01.007; Ping F, 2001, CHIN GEN PRACT, V4, P24; Qin BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095856; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Thakre TP, 2009, SLEEP, V32, P1507, DOI 10.1093/sleep/32.11.1507; Tian Y., 2006, J OTOLARYNGOL OPHTHA; [佟浩 Tong Hao], 2011, [中国组织化学与细胞化学杂志, Chinese Journal of Histochemistry and Cytochemistry], V20, P148; Varvarigou V, 2011, SLEEP, V34, P1461, DOI 10.5665/sleep.1376; Wang B, 2008, THESIS SHAN XI MED U; Woods A, 2000, EUR HEART J, V21, P1574, DOI 10.1053/euhj.1999.2207; Xiao Y, 1999, CHINESE MED J-PEKING, V112, P701; Xu HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086460; Yin GP, 2012, ACTA OTO-LARYNGOL, V132, P203, DOI 10.3109/00016489.2011.628951; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Yu Q, 2008, INT J RESP, V28, P659; Yue Wei-hua, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P533; Yue WH, 2008, SLEEP, V31, P1535, DOI 10.1093/sleep/31.11.1535; Zhang J, 2000, HYPERTENS RES, V23, P407, DOI 10.1291/hypres.23.407; Zhang Li-qiang, 2005, Zhonghua Nei Ke Za Zhi, V44, P333; Zhang Li-qiang, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P507; Zhang XQ, 2009, INT J MOL MED, V23, P485, DOI 10.3892/ijmm_00000155; Zhong AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106270; Zhu Jian-yong, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P912; Ziakas PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081047; Ziakas PD, 2013, BIOMARKERS, V18, P625, DOI 10.3109/1354750X.2013.840799; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011; Zintzaras E, 2008, J HUM GENET, V53, P1, DOI 10.1007/s10038-007-0223-5; Zintzaras E, 2013, COMPUT BIOL MED, V43, P1293, DOI 10.1016/j.compbiomed.2013.04.017; Zintzaras E, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1804; Zintzaras E, 2012, PSYCHIAT GENET, V22, P189, DOI 10.1097/YPG.0b013e328353ae53; Zintzaras E, 2012, CANCER EPIDEMIOL, V36, P169, DOI 10.1016/j.canep.2011.10.002; Zintzaras E, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-171; Zintzaras E, 2010, EUR J EPIDEMIOL, V25, P553, DOI 10.1007/s10654-010-9467-z; Zintzaras E, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1542; 李建瑞, 2014, [中国耳鼻咽喉头颈外科, Chinese Archives of Otolaryngology-Head and Neck Surgery], V21, P495	65	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135942	10.1371/journal.pone.0135942	http://dx.doi.org/10.1371/journal.pone.0135942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284518	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100089
J	Wabnegger, A; Ille, R; Schwingenschuh, P; Katschnig-Winter, P; Kogl-Wallner, M; Wenzel, K; Schienle, A				Wabnegger, Albert; Ille, Rottraut; Schwingenschuh, Petra; Katschnig-Winter, Petra; Koegl-Wallner, Mariella; Wenzel, Karoline; Schienle, Anne			Facial Emotion Recognition in Parkinson's Disease: An fMRI Investigation	PLOS ONE			English	Article							EXPRESSION RECOGNITION; DISGUST; METAANALYSIS	Background Findings of behavioral studies on facial emotion recognition in Parkinson's disease (PD) are very heterogeneous. Therefore, the present investigation additionally used functional magnetic resonance imaging (fMRI) in order to compare brain activation during emotion perception between PD patients and healthy controls. Methods and Findings We included 17 nonmedicated, nondemented PD patients suffering from mild to moderate symptoms and 22 healthy controls. The participants were shown pictures of facial expressions depicting disgust, fear, sadness, and anger and they answered scales for the assessment of affective traits. The patients did not report lowered intensities for the displayed target emotions, and showed a comparable rating accuracy as the control participants. The questionnaire scores did not differ between patients and controls. The fMRI data showed similar activation in both groups except for a generally stronger recruitment of somatosensory regions in the patients. Conclusions Since somatosensory cortices are involved in the simulation of an observed emotion, which constitutes an important mechanism for emotion recognition, future studies should focus on activation changes within this region during the course of disease.	[Wabnegger, Albert; Ille, Rottraut; Schienle, Anne] Graz Univ, Clin Psychol, BioTechMedGraz, Graz, Austria; [Schwingenschuh, Petra; Katschnig-Winter, Petra; Koegl-Wallner, Mariella; Wenzel, Karoline] Med Univ Graz, Dept Neurol, Graz, Austria	University of Graz; Medical University of Graz	Schienle, A (corresponding author), Graz Univ, Clin Psychol, BioTechMedGraz, Graz, Austria.	anne.schienle@uni-graz.at	wabnegger, albert/I-6257-2019	wabnegger, albert/0000-0003-1170-4639; Schienle, Anne/0000-0003-2173-6626	Austrian Science Fund [P 23258-B18]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (P 23258-B18).	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 1998, NEUROPSYCHOLOGY, V12, P253, DOI 10.1037/0894-4105.12.2.253; Anders S, 2012, BRAIN, V135, P1128, DOI 10.1093/brain/aws040; [Anonymous], 1992, STATE TRAIT ARGERAUS; Clark US, 2008, NEUROPSYCHOLOGIA, V46, P2300, DOI 10.1016/j.neuropsychologia.2008.03.014; Dujardin K, 2004, NEUROPSYCHOLOGIA, V42, P239, DOI 10.1016/S0028-3932(03)00154-4; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Hautzinger M., 1994, BECK DEPRESSIONSINVE, pHANS; Hennenlotter A, 2004, BRAIN, V127, P1446, DOI 10.1093/brain/awh165; Hipp G, 2014, J NEUROL SCI, V338, P178, DOI 10.1016/j.jns.2013.12.047; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Ihl R, 2000, FORTSCHR NEUROL PSYC, V68, P413, DOI 10.1055/s-2000-11799; Laux L., 1981, STATE TRAIT ANGSTINV; Lawrence AD, 2007, NEUROPSYCHOLOGIA, V45, P65, DOI 10.1016/j.neuropsychologia.2006.04.016; Lundqvist D., 1998, KAROLINSKA DIRECTED; Pell MD, 2005, COGNITIVE BRAIN RES, V23, P327, DOI 10.1016/j.cogbrainres.2004.11.004; Peron J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090092; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Schienle A, 2002, Z KL PSYCH PSYCHOTH, V31, P110, DOI 10.1026//1616-3443.31.2.110; Sprengelmeyer R, 2003, NEUROPSYCHOLOGIA, V41, P1047, DOI 10.1016/S0028-3932(02)00295-6; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Suzuki A, 2006, BRAIN, V129, P707, DOI 10.1093/brain/awl011; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002	28	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136110	10.1371/journal.pone.0136110	http://dx.doi.org/10.1371/journal.pone.0136110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285212	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100103
J	Xu, D; You, X; Wang, ZG; Zeng, QY; Xu, JH; Jiang, LD; Gong, L; Wu, FQ; Gu, JR; Tao, Y; Chen, JW; Zhao, JL; Li, MT; Zhao, Y; Zeng, XF				Xu, Dong; You, Xin; Wang, Zhengang; Zeng, Qingyu; Xu, Jianhua; Jiang, Lindi; Gong, Lu; Wu, Fengqi; Gu, Jieruo; Tao, Yi; Chen, Jinwei; Zhao, Jiuliang; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng		CSTAR	Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							PRIMARY RENAL-DISEASE; ALCOHOL-CONSUMPTION; CUTANEOUS LUPUS; AUTOANTIBODY PRODUCTION; RISK; ASSOCIATION; FAILURE; COHORT; POPULATION; NEPHRITIS	Objectives Our study aimed to investigate the effect of cigarette smoking on the clinical phenotype of patients registered in the Chinese Systemic Lupus Erythematosus (SLE) Treatment and Research (CSTAR) group registry database, the first online registry of Chinese patients with SLE. Methods A prospective cross-sectional study of Chinese SLE patients was conducted using the CSTAR. Our case-control analysis was performed on age-and gender-matched subjects to explore the potential effect of cigarette smoking on the clinical manifestation of SLE. Results Smokers comprised 8.9% (65/730) of patients, and the ratio of females/males was 19/46. Thirty-nine patients were current smokers, and 26 were ex-smokers. Data showed significant differences between smokers and nonsmokers in the following areas: nephropathy (58.5% vs. 39.2%; p = 0.003), microscopic hematuria (30.8% vs. 19.1%; p = 0.025), proteinuria (53.8% vs. 34.4%; p = 0.002), and SLE Disease Activity Index(DAI) scores (12.38 +/- 8.95 vs. 9.83 +/- 6.81; p = 0.028). After adjusting for age and gender, significant differences between smokers and nonsmokers were found with photosensitivity (35.9% vs. 18%; p = 0.006), nephropathy (59.4% vs. 39.8%; p = 0.011), and proteinuria (54.7% vs. 35.2%). Although smokers tended to have greater disease severity compared with nonsmokers (SLEDAI scores: 12.58 +/- 8.89 vs. 10.5 +/- 7.09), the difference was not significant (p = 0.081). Conclusions Cigarette smoking triggers the development and exacerbation of SLE, especially with respect to renal involvement. Chinese smokers with SLE should be advised to discontinue cigarette use.	[Xu, Dong; You, Xin; Zhao, Jiuliang; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, Beijing 100730, Peoples R China; [Xu, Dong; You, Xin; Zhao, Jiuliang; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Xu, Dong; You, Xin; Zhao, Jiuliang; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; [Wang, Zhengang] Capital Med Univ, Beijing Tongren Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Zeng, Qingyu] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Rheumatol, Shantou 515041, Peoples R China; [Xu, Jianhua] Anhui Med Univ, Affiliated Hosp 1, Dept Rheumatol, Hefei 230022, Peoples R China; [Jiang, Lindi] Fudan Univ, Zhongshan Hosp, Dept Rheumatol, Shanghai 200032, Peoples R China; [Gong, Lu] Tianjing Med Univ, Gen Hosp, Dept Rheumatol, Tianjin 300052, Peoples R China; [Wu, Fengqi] Capital Inst Pediat, Dept Rheumatol, Beijing 100020, Peoples R China; [Gu, Jieruo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou 510630, Guangdong, Peoples R China; [Tao, Yi] Guangzhou Med Univ, Affiliated Hosp 2, Dept Rheumatol, Guangzhou 510120, Guangdong, Peoples R China; [Chen, Jinwei] Cent S Univ, Xiangya Hosp 2, Dept Rheumatol, Changsha 410011, Hunan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Shantou University; Anhui Medical University; Fudan University; Tianjin Medical University; Capital Institute of Pediatrics (CIP); Sun Yat Sen University; Guangzhou Medical University; Central South University	Zeng, XF (corresponding author), Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, 1 Shuaifuyuan, Beijing 100730, Peoples R China.	xiaofeng.zeng@cstar.org.cn	Xu, Huji/AAB-2902-2021; meng, li/GVT-2063-2022; Jiuliang, Zhao/AAW-5669-2020	Xu, Huji/0000-0002-8588-118X; Jiuliang, Zhao/0000-0001-9308-2858; Zhang, Fengxiao/0000-0002-5109-4196	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China)	This work was funded by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02), and the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513), both received by XFZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya-Amaya J, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/794383; Bourre-Tessier J, 2013, ARTHRIT CARE RES, V65, P1275, DOI 10.1002/acr.21966; Costenbader KH, 2006, LUPUS, V15, P737, DOI 10.1177/0961203306069344; Costenbader KH, 2004, ARTHRITIS RHEUM-US, V50, P849, DOI 10.1002/art.20049; Ekblom-Kullberg S, 2013, CLIN RHEUMATOL, V32, P1219, DOI 10.1007/s10067-013-2224-4; Formica MK, 2003, J RHEUMATOL, V30, P1222; Freemer MM, 2006, ANN RHEUM DIS, V65, P581, DOI 10.1136/ard.2005.039438; Gallego H, 1999, CUTIS, V63, P231; Ghaussy NO, 2003, J RHEUMATOL, V30, P1215; Ghaussy NO, 2001, J RHEUMATOL, V28, P2449; Gustafsson JT, CIGARETTE SMOKING AN; Halimi JM, 2000, NEPHROL DIAL TRANSPL, V15, P938, DOI 10.1093/ndt/15.7.938; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; Hardy CJ, 1998, ANN RHEUM DIS, V57, P451, DOI 10.1136/ard.57.8.451; Harel-Meir M, 2007, NAT CLIN PRACT RHEUM, V3, P707, DOI 10.1038/ncprheum0655; Ho KT, 2005, RHEUMATOLOGY, V44, P1303, DOI 10.1093/rheumatology/kei014; Jewell ML, 2000, J AM ACAD DERMATOL, V42, P983, DOI 10.1016/S0190-9622(00)90290-1; June RR, 2013, JCR-J CLIN RHEUMATOL, V19, P367, DOI 10.1097/RHU.0000000000000017; Kiyohara C, 2012, J RHEUMATOL, V39, P1363, DOI 10.3899/jrheum.111609; Leroux G, 2007, ANN RHEUM DIS, V66, P1547, DOI 10.1136/ard.2007.072587; Li M, 2013, LUPUS, V22, P1192, DOI 10.1177/0961203313499086; MCALINDON T, 1993, ANN RHEUM DIS, V52, P720, DOI 10.1136/ard.52.10.720; Mont MA, 1997, J RHEUMATOL, V24, P654; Moraes-Fontes Maria Francisca, 2012, ISRN Rheumatol, V2012, P989218, DOI 10.5402/2012/989218; Orth SR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018401.82863.FD; Orth SR, 2001, TOHOKU J EXP MED, V194, P1, DOI 10.1620/tjem.194.1; Orth SR, 1998, KIDNEY INT, V54, P926, DOI 10.1046/j.1523-1755.1998.00067.x; Orth SR, 1997, KIDNEY INT, V51, P1669, DOI 10.1038/ki.1997.232; Piette EW, 2011, J INVEST DERMATOL, V131, pS86; Rahman P, J RHEUMATOL, V25, P1716; Rubin RL, 2005, TOXICOL SCI, V87, P86, DOI 10.1093/toxsci/kfi217; SanchezGuerrero J, 1996, ARTHRITIS RHEUM, V39, P657, DOI 10.1002/art.1780390418; Schiffl H, 2002, J NEPHROL, V15, P270; Simard JF, 2009, LUPUS, V18, P431, DOI 10.1177/0961203308098186; Stengel B, 2000, KIDNEY INT, V57, P2519, DOI 10.1016/S0085-2538(15)47011-5; Susanne Ekblom-Kullberg, 2014, RHEUMATOL INT, V34, P341, DOI [10.1007/s00296-013-2889-7, DOI 10.1007/S00296-013-2889-7]; Takvorian SU, 2014, LUPUS, V23, P537, DOI 10.1177/0961203313501400; Turchin I, 2009, J RHEUMATOL, V36, P2691, DOI 10.3899/jrheum.090403; WARD MM, 1992, ARCH INTERN MED, V152, P2082, DOI 10.1001/archinte.152.10.2082; Washio Masakazu, 2006, Mod Rheumatol, V16, P143; Young KA, 2014, LUPUS, V23, P360, DOI 10.1177/0961203314520838	41	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134451	10.1371/journal.pone.0134451	http://dx.doi.org/10.1371/journal.pone.0134451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280671	Green Published, gold, Green Submitted			2022-12-27	WOS:000359664300006
J	Yang, WL; Liu, Y; Slovik, KJ; Wu, JC; Duncan, SA; Rader, DJ; Morrisey, EE				Yang, Wenli; Liu, Ying; Slovik, Katherine J.; Wu, Joseph C.; Duncan, Stephen A.; Rader, Daniel J.; Morrisey, Edward E.			Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells	PLOS ONE			English	Article							INTRAPATIENT VARIATIONS; DIFFERENTIATION	Although significant advancement has been made in the induced pluripotent stem cell (iPSC) field, current methods for iPSC derivation are labor intensive and costly. These methods involve manual selection, expansion, and characterization of multiple clones for each reprogrammed cell sample and therefore significantly hampers the feasibility of studies where a large number of iPSCs need to be derived. To develop higher throughput iPSC reprogramming methods, we generated iPSCs as a pooled culture using rigorous cell surface pluripotent marker selection with TRA-1-60 or SSEA4 antibodies followed by Magnetic Activated Cell Sorting (MACS). We observed that pool-selected cells are similar or identical to clonally derived iPSC lines from the same donor by all criteria examined, including stable expression of endogenous pluripotency genes, normal karyotype, loss of exogenous reprogramming factors, and in vitro spontaneous and lineage directed differentiation potential. This strategy can be generalized for iPSC generation using both integrating and non-integrating reprogramming methods. Our studies provide an attractive alternative to clonal derivation of iPSCs using rigorously selected cell pools and is amenable to automation.	[Yang, Wenli; Liu, Ying; Slovik, Katherine J.; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Yang, Wenli; Liu, Ying; Slovik, Katherine J.; Rader, Daniel J.; Morrisey, Edward E.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rader, Daniel J.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Joseph C.] Stanford Univ, Dept Med, Sch Med, Div Cardiol, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Program Regenerat Med & Stem Cell Biol, Milwaukee, WI 53226 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University; Medical College of Wisconsin	Yang, WL (corresponding author), Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA.	wenliyan@mail.med.upenn.edu; emorrise@mail.med.upenn.edu	Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041; Duncan, Stephen/0000-0002-2507-7827	National Institutes of Health [U01-HG006398, U01-HL099776]; Health Research Formula Fund HRFF - Pennsylvania Department of Health [554248]; Institute for Regenerative Medicine of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Formula Fund HRFF - Pennsylvania Department of Health; Institute for Regenerative Medicine of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grants U01-HG006398 to EEM, DJR and SAD, and U01-HL099776 to JCW; by a Health Research Formula Fund HRFF 554248 sponsored by the Pennsylvania Department of Health; and by the Institute for Regenerative Medicine of the University of Pennsylvania. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Cayo MA, 2012, HEPATOLOGY, V56, P2163, DOI 10.1002/hep.25871; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chou BK, 2015, STEM CELL TRANSL MED, V4, P320, DOI 10.5966/sctm.2014-0214; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gu MX, 2015, EUR HEART J, V36, P806, DOI 10.1093/eurheartj/ehu411; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Kahler DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059867; Li Q, 2013, PREP BIOCHEM BIOTECH, V43, P197, DOI 10.1080/10826068.2012.719846; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Mallanna Sunil K, 2013, Curr Protoc Stem Cell Biol, V26, DOI 10.1002/9780470151808.sc01g04s26; Mills JA, 2013, BLOOD, V122, P2047, DOI 10.1182/blood-2013-02-484444; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nasu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053771; Noto Fallon K, 2014, BMC Res Notes, V7, P437, DOI 10.1186/1756-0500-7-437; Sgodda M, 2013, MOL THER, V21, P5, DOI 10.1038/mt.2012.273; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Singh VK, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00002; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer AG, 2012, JOVE-J VIS EXP, DOI 10.3791/4327; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thatava T, 2013, MOL THER, V21, P228, DOI 10.1038/mt.2012.245; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valamehr B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00213; Willmann CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065324; Yang W., 2012, IPSC REPROGRAMMING H; Zhou HY, 2015, STEM CELL REV REP, V11, P652, DOI 10.1007/s12015-015-9586-8	28	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134995	10.1371/journal.pone.0134995	http://dx.doi.org/10.1371/journal.pone.0134995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281015	Green Submitted, gold, Green Published			2022-12-27	WOS:000359664300009
J	Bottino-Rojas, V; Talyuli, OAC; Jupatanakul, N; Sim, S; Dimopoulos, G; Venancio, TM; Bahia, AC; Sorgine, MH; Oliveira, PL; Paiva-Silva, GO				Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Jupatanakul, Natapong; Sim, Shuzhen; Dimopoulos, George; Venancio, Thiago M.; Bahia, Ana C.; Sorgine, Marcos H.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.			Heme Signaling Impacts Global Gene Expression, Immunity and Dengue Virus Infectivity in Aedes aegypti	PLOS ONE			English	Article							GENOME-WIDE; BLOOD MEAL; VECTOR; MIDGUT; INSECT; CELLS; PROTEIN; DETOXIFICATION; MITOCHONDRIA; PROTECTION	Blood-feeding mosquitoes are exposed to high levels of heme, the product of hemoglobin degradation. Heme is a pro-oxidant that influences a variety of cellular processes. We performed a global analysis of heme-regulated Aedes aegypti (yellow fever mosquito) transcriptional changes to better understand influence on mosquito physiology at the molecular level. We observed an iron-and reactive oxygen species (ROS)-independent signaling induced by heme that comprised genes related to redox metabolism. By modulating the abundance of these transcripts, heme possibly acts as a danger signaling molecule. Furthermore, heme triggered critical changes in the expression of energy metabolism and immune response genes, altering the susceptibility towards bacteria and dengue virus. These findings seem to have implications on the adaptation of mosquitoes to hematophagy and consequently on their ability to transmit diseases. Altogether, these results may also contribute to the understanding of heme cell biology in eukaryotic cells.	[Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Bahia, Ana C.; Sorgine, Marcos H.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Bahia, Ana C.; Sorgine, Marcos H.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] INCT EM, Rio De Janeiro, Brazil; [Jupatanakul, Natapong; Sim, Shuzhen; Dimopoulos, George] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Sim, Shuzhen] Genome Inst Singapore, Singapore 138672, Singapore; [Venancio, Thiago M.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, BR-28013602 Campos Dos Goytacazes, Brazil	Universidade Federal do Rio de Janeiro; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Universidade Estadual do Norte Fluminense	Paiva-Silva, GO (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.	gosilva@bioqmed.ufrj.br	Jupatanakul, Natapong/GPF-9058-2022; Nascimento, Ana Cristina Bahia/G-2372-2015; Bottino-Rojas, Vanessa/AAX-2172-2020; Venancio, Thiago M/B-5003-2011; L. Oliveira, Pedro/A-9438-2010	Jupatanakul, Natapong/0000-0003-2326-4255; Nascimento, Ana Cristina Bahia/0000-0002-4584-1888; Bottino-Rojas, Vanessa/0000-0001-8019-9942; Venancio, Thiago M/0000-0002-2215-8082; Talyuli Cunha, Octavio Augusto/0000-0002-7026-463X; L. Oliveira, Pedro/0000-0003-0307-354X	FAPERJ; CNPq; National Institutes of Health/National Institute of Allergy and Infectious Disease [R21AI090188, R01AI101431, R01AI061576]; Agency for Science, Technology and Research (A*STAR), Singapore; Royal Thai Government fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090188, R01AI061576, R01AI101431] Funding Source: NIH RePORTER	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Royal Thai Government fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: FAPERJ, CNPq, National Institutes of Health/National Institute of Allergy and Infectious Disease grants R21AI090188, R01AI101431, R01AI061576, a fellowship from the Agency for Science, Technology and Research (A*STAR), Singapore to SS, a Royal Thai Government fellowship to NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoedo ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022264; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Cosgrove JB, 1996, MED VET ENTOMOL, V10, P260, DOI 10.1111/j.1365-2915.1996.tb00740.x; Cruz J, 2012, MOL CELL ENDOCRINOL, V349, P262, DOI 10.1016/j.mce.2011.11.006; DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893; Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991; Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6; Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148; Gao Y, 1999, INSECT MOL BIOL, V8, P311, DOI 10.1046/j.1365-2583.1999.83119.x; Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GRACE TDC, 1966, NATURE, V211, P366, DOI 10.1038/211366a0; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; HAMILTON SD, 1984, CLIN CHEM, V30, P226; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Larsen R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910; Oliveira PL, 2002, FEBS LETT, V525, P3, DOI 10.1016/S0014-5793(02)03026-0; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Pakpour N, 2013, MICROBES INFECT, V15, P243, DOI 10.1016/j.micinf.2013.01.003; Pereira LOR, 2007, BIOCHEMISTRY-US, V46, P6822, DOI 10.1021/bi700011d; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Wegiel B, 2014, ANTIOXID REDOX SIGN, V20, P1709, DOI 10.1089/ars.2013.5667; Wijayanti N, 2004, CURR MED CHEM, V11, P981, DOI 10.2174/0929867043455521; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	53	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135985	10.1371/journal.pone.0135985	http://dx.doi.org/10.1371/journal.pone.0135985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275150	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600139
J	Garland, HG; Kimbro, DL				Garland, Hanna G.; Kimbro, David L.			Drought Increases Consumer Pressure on Oyster Reefs in Florida, USA	PLOS ONE			English	Article							ECOSYSTEM; ESTUARIES; SALINITY; DYNAMICS; IMPACTS; ECOLOGY	Coastal economies and ecosystems have historically depended on oyster reefs, but this habitat has declined globally by 85% because of anthropogenic activities. In a Florida estuary, we investigated the cause of newly reported losses of oysters. We found that the oyster reefs have deteriorated from north to south and that this deterioration was positively correlated with the abundance of carnivorous conchs and water salinity. In experiments across these gradients, oysters survived regardless of salinity if conchs were excluded. After determining that conchs were the proximal cause of oyster loss, we tested whether elevated water salinity was linked to conch abundance either by increasing conch growth and survivorship or by decreasing the abundance of a predator of conchs. In field experiments across a salinity gradient, we failed to detect spatial variation in predation on conchs or in conch growth and survivorship. A laboratory experiment, however, demonstrated the role of salinity by showing that conch larvae failed to survive at low salinities. Because this estuary's salinity increased in 2006 in response to reduced inputs of freshwater, we concluded that the ultimate cause of oyster decline was an increase in salinity. According to records from 2002 to 2012, oyster harvests have remained steady in the northernmost estuaries of this ecoregion (characterized by high reef biomass, low salinity, and low conch abundance) but have declined in the southernmost estuaries (characterized by lower reef biomass, increases in salinity, and increases in conch abundance). Oyster conservation in this ecoregion, which is probably one of the few that still support viable oyster populations, may be undermined by drought-induced increases in salinity causing an increased abundance of carnivorous conchs.	[Garland, Hanna G.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Kimbro, David L.] Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01908 USA	State University System of Florida; Florida State University; Northeastern University	Kimbro, DL (corresponding author), Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01908 USA.	d.kimbro@neu.edu			National Science Foundation [1338372]; National Park Service [P11AT51041]; North Carolina and Florida SeaGrant [2011-R/MG-1107]	National Science Foundation(National Science Foundation (NSF)); National Park Service; North Carolina and Florida SeaGrant	Funding provided by National Science Foundation (award #1338372 to DLK), National Park Service (Task agreement # P11AT51041 to DLK) and North Carolina and Florida SeaGrant (award # 2011-R/MG-1107 to HGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Boettiger C, 2013, THEOR ECOL-NETH, V6, P255, DOI 10.1007/s12080-013-0192-6; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; BROWN KM, 1992, J EXP MAR BIOL ECOL, V160, P67, DOI 10.1016/0022-0981(92)90111-M; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burnham K. P., 2002, MODEL SELECTION AND; Byers JE, 2015, LIMNOL OCEANOGR, DOI [10.1002/lno.10073, DOI 10.1002/LN0.10073]; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Crain CM, 2004, ECOLOGY, V85, P2539, DOI 10.1890/03-0745; Dayton P.K., 1972, P C CONSERVATION PRO, P81; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; GARTON D, 1980, BIOL BULL, V158, P49, DOI 10.2307/1540757; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HATHAWAY RALPH R., 1961, BULL MARINE SCI GULF AND CARIBBEAN, V11, P45; Hayes KA, 2009, J BIOGEOGR, V36, P28, DOI 10.1111/j.1365-2699.2008.01966.x; HECK KL, 1995, J EXP MAR BIOL ECOL, V189, P205, DOI 10.1016/0022-0981(95)00012-G; Hoffman GE, 2001, BIOL BULL, V291, P374; HOFMANN EE, 1995, J SHELLFISH RES, V14, P121; Kimbro DL, 2014, ECOL LETT, V17, P845, DOI 10.1111/ele.12293; Kimbro DL, 2012, ECOLOGY, V93, P334, DOI 10.1890/11-0596.1; Kimbro DL, 2009, OECOLOGIA, V160, P563, DOI 10.1007/s00442-009-1322-0; Kirby MX, 2000, PALAIOS, V15, P132, DOI 10.2307/3515499; Largier JL, 1997, ESTUAR COAST SHELF S, V45, P789, DOI 10.1006/ecss.1997.0279; Livingston RJ, 2000, ESTUAR COAST SHELF S, V50, P655, DOI 10.1006/ecss.1999.0597; Loftin JL, 1987, THESIS, V101; Lord JP, 2012, MAR BIOL, V159, P1177, DOI 10.1007/s00227-012-1896-7; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; MEADE RH, 1969, J SEDIMENT PETROL, V39, P222; MENZEL R. WINSTON, 1958, BULL MARINE SCI GULF AND CARIBBEAN, V8, P125; PAINE RT, 1963, ECOLOGY, V44, P63, DOI 10.2307/1933181; Petes LE, 2012, ECOL EVOL, V2, P1712, DOI 10.1002/ece3.291; Pollack JB, 2011, ESTUAR COAST, V34, P187, DOI 10.1007/s12237-010-9338-6; Robinson EM, 2014, AQUAT BIOL, V20, P111, DOI 10.3354/ab00549; Sheng YP, 2008, J COASTAL RES, P9, DOI 10.2112/SI55-002.1; SIH A, 1987, THEOR POPUL BIOL, V31, P1, DOI 10.1016/0040-5809(87)90019-0; Silliman BR, 2013, ANNU REV ECOL EVOL S, V44, P503, DOI 10.1146/annurev-ecolsys-110512-135753; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Trenberth KE, 2007, J HYDROMETEOROL, V8, P758, DOI 10.1175/JHM600.1; USGCRP (U.S. Global Change Research Program), 2009, GLOBAL CLIMATE CHANG; Waldbusser GG, 2013, ECOLOGY, V94, P895, DOI 10.1890/12-1179.1; Walter C., 2013, APALACHICOLA BAY OYS; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; WILBER TP, 1982, J CRUSTACEAN BIOL, V2, P588, DOI 10.2307/1548099	51	19	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0125095	10.1371/journal.pone.0125095	http://dx.doi.org/10.1371/journal.pone.0125095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275296	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600001
J	Jiao, Y; Ma, S; Li, J; Shan, LQ; Wang, YJ; Tian, M; Yang, YW; Sun, JL; Ban, JH; Chen, JH				Jiao, Yang; Ma, Sai; Li, Jing; Shan, Lequn; Wang, Yingjie; Tian, Min; Yang, Yanwei; Sun, Jinlong; Ban, Jinghao; Chen, Jihua			N-Acetyl Cysteine (NAC)-Directed Detoxification of Methacryloxylethyl Cetyl Ammonium Chloride (DMAE-CB)	PLOS ONE			English	Article							CATIONIC ANTIBACTERIAL MONOMER; DENTAL RESIN MONOMERS; 2-HYDROXYETHYL METHACRYLATE; OXIDATIVE STRESS; ADDUCT FORMATION; IN-VITRO; GLUTATHIONE; CYTOTOXICITY; APOPTOSIS; TOXICITY	Methacryloxylethyl cetyl ammonium chloride (DMAE-CB) is a polymerizable antibacterial monomer and has been proved as an effective strategy to achieve bioactive bonding with reliable bacterial inhibitory effects. However, the toxicity of DMAE-CB may hamper its wide application in clinical situations. Thus, this study was designed to investigate the toxicity of DMAE-CB and explore the possible protective effects of N-acetyl cysteine (NAC). High performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) analysis showed that chemical binding of NAC and DMAE-CB occurred in a time dependent manner. Pre-incubation of fourty-eight hours is required for adequate reaction between DMAE-CB and NAC. DMAE-CB reduced human dental pulp cells (hDPCs) viability in a dose-dependent manner. The toxic effects of DMAE-CB were accompanied by increased reactive oxygen species (ROS) level and reduced glutathione (GSH) content. NAC alleviated DMAE-CB-induced oxidative stress. Annexin V/Propidium Iodide (PI) staining and Hoechst 33342 staining indicated that DMAE-CB induced apoptosis. Collapsed mitochondrial membrane potential (MMP) and activation of caspase-3 were also observed after DMAE-CB treatment. NAC rescued hDPCs from DMAE-CB-induced apoptosis, accompanied by lower level of MMP loss and caspase-3 activity. This study assists to elucidate the mechanism underlying the cytotoxic effects of DMAE-CB and provides theoretical supports for the searching of effective strategies to reduce toxicity of quaternary ammonium dental monomers.	[Jiao, Yang; Ma, Sai; Tian, Min; Yang, Yanwei; Sun, Jinlong; Ban, Jinghao; Chen, Jihua] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China; [Li, Jing] Fourth Mil Med Univ, Dept Orthopaed Oncol, Xijing Hosp, Xian 710032, Peoples R China; [Shan, Lequn] Fourth Mil Med Univ, Dept Orthopaed Surg, Tangdu Hosp, Xian 710032, Peoples R China; [Wang, Yingjie] Fourth Mil Med Univ, Sch Stomatol, Dept Gen & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Chen, JH (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China.	jhchen@fmmu.edu.cn	SUN, JIN/GPX-9641-2022	Chen, Ji-hua/0000-0002-1151-0693	National Nature Science Foundation of China [81130078, 81300927]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT13051]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was financially supported by grant 81130078 (principal investigator JC) and grant 81300927 (principal investigator SM) from the National Nature Science Foundation of China, and Program No. IRT13051 from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eckhardt A, 2010, DENT MATER, V26, P232, DOI 10.1016/j.dental.2009.10.005; GREIM H, 1995, CHEMOSPHERE, V31, P2637, DOI 10.1016/0045-6535(95)00136-V; IMAZATO S, 1994, J DENT RES, V73, P1437, DOI 10.1177/00220345940730080701; Inacio AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019850; Jiao Y, 2015, PEERJ, V3, DOI 10.7717/peerj.868; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kitagawa R, 2014, J DENT RES, V93, P1277, DOI 10.1177/0022034514549808; Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019; Krifka S, 2012, BIOMATERIALS, V33, P5177, DOI 10.1016/j.biomaterials.2012.04.013; Lefeuvre M, 2004, J DENT RES, V83, P914, DOI 10.1177/154405910408301205; Li F, 2009, J DENT RES, V88, P372, DOI 10.1177/0022034509334499; Li F, 2011, J AM DENT ASSOC, V142, P184, DOI 10.14219/jada.archive.2011.0062; Ma S, 2013, DENT MATER, V29, P1219, DOI 10.1016/j.dental.2013.09.008; Ma S, 2011, BRAZ J MED BIOL RES, V44, P1125, DOI [10.1590/S0100-879X2011007500130, 10.1590/S0100-879X2011001100008]; Marcotte L, 2005, J COLLOID INTERF SCI, V292, P219, DOI 10.1016/j.jcis.2005.05.060; Nocca G, 2007, J DENT, V35, P187, DOI 10.1016/j.jdent.2006.07.008; Nocca G, 2011, DENT MATER, V27, pE87, DOI 10.1016/j.dental.2011.01.002; Nocca G, 2010, BIOMATERIALS, V31, P2508, DOI 10.1016/j.biomaterials.2009.12.015; Ramp U, 2003, BRIT J CANCER, V88, P1800, DOI 10.1038/sj.bjc.6600984; Sai M., 2011, BRAZ J MED BIOL RES, V44, P1125; Samuelsen JT, 2011, J BIOMED MATER RES A, V96A, P395, DOI 10.1002/jbm.a.32993; Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001; Schweikl H, 2014, BIOMATERIALS, V35, P2890, DOI 10.1016/j.biomaterials.2013.12.044; Spagnuolo G, 2013, DENT MATER, V29, pE153, DOI 10.1016/j.dental.2013.04.023; Stanislawski L, 2003, J BIOMED MATER RES A, V66A, P476, DOI 10.1002/jbm.a.10600; Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12; Walther UI, 2004, ARCH ORAL BIOL, V49, P125, DOI 10.1016/j.archoralbio.2003.08.008; Xiao YH, 2009, J BIOMED MATER RES B, V90B, P813, DOI 10.1002/jbm.b.31350; Zhang K, 2013, J DENT, V41, P464, DOI 10.1016/j.jdent.2013.02.001	29	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135815	10.1371/journal.pone.0135815	http://dx.doi.org/10.1371/journal.pone.0135815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274909	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600117
J	Liu, SZ; Jiang, LG; Zhong, T; Kong, SH; Zheng, RB; Kong, FY; Zhang, C; Zhang, L; An, LG				Liu, Shuzhen; Jiang, Ligang; Zhong, Tao; Kong, Shuhui; Zheng, Rongbin; Kong, Fengyun; Zhang, Cong; Zhang, Lei; An, Liguo			Effect of Acrylamide on Oocyte Nuclear Maturation and Cumulus Cells Apoptosis in Mouse In Vitro	PLOS ONE			English	Article							DEVELOPMENTAL COMPETENCE; GRANULOSA-CELLS; CHROMOSOME CONGRESSION; MICROTUBULE DYNAMICS; ACTIVIN RECEPTOR; BOVINE OOCYTES; GERM-CELLS; EXPOSURE; COMPLEXES; MICE	Acrylamide (ACR) is a chemical compound with severe neurotoxicity, genotoxicity, carcinogenicity and reproductive toxicity. Recent studies showed that ACR impairs the function of reproductive organs, e.g., epididymis and testes. In vitro maturation of mouse oocyte is a sensitive assay to identify potential chemical hazard to female fertility. The aim of this study was to evaluate the adverse effects of ACR on the nuclear maturation and cumulus cells apoptosis of mouse oocytes in vitro. Cumulus-oocyte complexes were incubated in a maturation medium containing 0, 5, 10 and 20 mu M of ACR. Chromosome alignment and spindle morphology of oocytes was determined by immunofluorescence and confocal microscopy. Our results showed that oocytes exposed to different doses of ACR in vitro were associated with a significant decrease of oocyte maturation, significant increase of chromosome misalignment rate, occurrence of abnormal spindle configurations, and the inhibition of oocyte parthenogenetic activation. Furthermore, apoptosis of cumulus cells was determined by TUNEL and CASPASE-3 assay. Results showed that apoptosis in cumulus cells was enhanced and the expression of CASPASE-3 was increased after cumulus-oocyte complexes were exposed to ACR. Therefore, ACR may affect the nuclear maturation of oocytes via the apoptosis of cumulus cells in vitro.	[Liu, Shuzhen; Zhong, Tao; Kong, Shuhui; Zheng, Rongbin; Zhang, Cong; Zhang, Lei; An, Liguo] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Peoples R China; [Jiang, Ligang] Shandong Univ, Qilu Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; [Kong, Fengyun] Shandong Univ Tradit Chinese Med, Hosp Affiliated 2, Reprod Med Ctr, Jinan, Shandong, Peoples R China	Shandong Normal University; Shandong University; Shandong University of Traditional Chinese Medicine	Liu, SZ (corresponding author), Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Peoples R China.	shuzhen26@163.com; anlg@sdnu.edu.cn			National Nature Science Foundation of China [31101068]; National Undergraduate Training Programs for Innovation and Entrepreneurship [201310445095 12]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Undergraduate Training Programs for Innovation and Entrepreneurship	This study was supported by the National Nature Science Foundation of China (Grant number 31101068) and National Undergraduate Training Programs for Innovation and Entrepreneurship (number 201310445095 12).	Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Appeltant R, 2015, THERIOGENOLOGY, V83, P567, DOI 10.1016/j.theriogenology.2014.10.026; Avazeri N, 2006, BIOCHIMIE, V88, P1823, DOI 10.1016/j.biochi.2006.04.011; Brevini TAL, 2005, REPROD DOMEST ANIM, V40, P291, DOI 10.1111/j.1439-0531.2005.00592.x; Can A, 2000, MOL HUM REPROD, V6, P154, DOI 10.1093/molehr/6.2.154; Channing C P, 1980, Int Rev Physiol, V22, P117; Claus A, 2008, J CEREAL SCI, V47, P118, DOI 10.1016/j.jcs.2007.06.016; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; De la Fuente R, 2001, DEV BIOL, V229, P224, DOI 10.1006/dbio.2000.9947; DEARFIELD KL, 1995, MUTAT RES-FUND MOL M, V330, P71, DOI 10.1016/0027-5107(95)00037-J; DENG H, 1993, INT ARCH OCC ENV HEA, V65, P53, DOI 10.1007/BF00586059; Downs SM, 2015, REPROD FERT DEVELOP, V27, P572, DOI 10.1071/RD14343; Duan X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11562; Eichenlaub-Ritter U, 2007, BIOL REPROD, V76, P784, DOI 10.1095/biolreprod.106.055111; El-Sayyad HI, 2011, NUTRITION, V27, P343, DOI 10.1016/j.nut.2010.11.005; Exon J H, 2006, J Toxicol Environ Health B Crit Rev, V9, P397, DOI 10.1080/10937400600681430; Fabritius AS, 2011, CURR OPIN CELL BIOL, V23, P78, DOI 10.1016/j.ceb.2010.07.008; Favor J, 2005, MUTAT RES-GEN TOX EN, V580, P21, DOI 10.1016/j.mrgentox.2004.09.010; Fennell TR, 2006, TOXICOL SCI, V93, P256, DOI 10.1093/toxsci/kfl069; FRIEDMAN MA, 1995, FUND APPL TOXICOL, V27, P95, DOI 10.1006/faat.1995.1112; Gandolfi TALB, 2001, THERIOGENOLOGY, V55, P1255, DOI 10.1016/S0093-691X(01)00481-2; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; Grossman D, 2012, CELL BIOL TOXICOL, V28, P383, DOI 10.1007/s10565-012-9230-1; Guan HB, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0046-9; Ha AN, 2015, REPROD DOMEST ANIM, V50, P292, DOI 10.1111/rda.12487; Hall B. K., 2008, FINS LIMBS EVOLUTION; HE FS, 1989, SCAND J WORK ENV HEA, V15, P125, DOI 10.5271/sjweh.1878; Hogervorst JG, 2008, AM J CLIN NUTR, V87, P1428, DOI 10.1093/ajcn/87.5.1428; Holland N, 1999, REPROD TOXICOL, V13, P167, DOI 10.1016/S0890-6238(99)00011-8; Host E, 2002, FERTIL STERIL, V77, P511, DOI 10.1016/S0015-0282(01)03006-0; Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737; Izadyar F, 1998, MOL REPROD DEV, V49, P186, DOI 10.1002/(SICI)1098-2795(199802)49:2&lt;186::AID-MRD9&gt;3.0.CO;2-L; Ju JC, 2005, THERIOGENOLOGY, V64, P1677, DOI 10.1016/j.theriogenology.2005.03.025; Konings EJM, 2003, FOOD CHEM TOXICOL, V41, P1569, DOI 10.1016/S0278-6915(03)00187-X; Lee KS, 2001, J ASSIST REPROD GEN, V18, P490, DOI 10.1023/A:1016649026353; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Lenie S, 2008, MUTAT RES-GEN TOX EN, V651, P71, DOI 10.1016/j.mrgentox.2007.10.017; Li R, 2000, BIOL REPROD, V63, P839, DOI 10.1095/biolreprod63.3.839; Liu SZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102064; LOPACHIN RM, 1994, NEUROTOXICOLOGY, V15, P247; MARLOWE C, 1986, TOXICOL APPL PHARM, V86, P457, DOI 10.1016/0041-008X(86)90373-X; Mattioli Mauro, 1994, Zygote, V2, P347; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Mehri S, 2012, CELL MOL NEUROBIOL, V32, P227, DOI 10.1007/s10571-011-9752-8; Meo SC, 2005, THERIOGENOLOGY, V63, P2089, DOI 10.1016/j.theriogenology.2004.08.012; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; Pedreschi F, 2004, LEBENSM-WISS TECHNOL, V37, P679, DOI 10.1016/j.lwt.2004.03.001; Pocar P, 2005, REPRODUCTION, V130, P857, DOI 10.1530/rep.1.00761; Rossi G, 2006, REPROD TOXICOL, V22, P51, DOI 10.1016/j.reprotox.2005.11.005; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Sidis Y, 1998, BIOL REPROD, V59, P807, DOI 10.1095/biolreprod59.4.807; Sutton ML, 2003, HUM REPROD UPDATE, V9, P35, DOI 10.1093/humupd/dmg009; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805; TILSON HA, 1981, NEUROBEH TOXICOL TER, V3, P445; TSUDA H, 1993, MUTAGENESIS, V8, P23, DOI 10.1093/mutage/8.1.23; Tyl RW, 2000, REPROD TOXICOL, V14, P147, DOI 10.1016/S0890-6238(00)00066-6; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wang Wei-Hua, 2002, Cloning and Stem Cells, V4, P269, DOI 10.1089/15362300260339557; Wei QW, 2014, REPROD TOXICOL, V46, P121, DOI 10.1016/j.reprotox.2014.03.007; Yokoo M, 2004, INT REV CYTOL, V235, P251, DOI 10.1016/S0074-7696(04)35006-0; Yuan YQ, 2005, THERIOGENOLOGY, V63, P2147, DOI 10.1016/j.theriogenology.2004.09.054; Zenzes Maria Teresa, 2004, Tob Induc Dis, V2, P151, DOI 10.1186/1617-9625-2-3-151	65	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135818	10.1371/journal.pone.0135818	http://dx.doi.org/10.1371/journal.pone.0135818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275143	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600119
J	O'Connell, RP; Musa, H; Gomez, MS; Avula, UM; Herron, TJ; Kalifa, J; Anumonwo, JMB				O'Connell, Ryan P.; Musa, Hassan; Gomez, Mario San Martin; Avula, Uma Mahesh; Herron, Todd J.; Kalifa, Jerome; Anumonwo, Justus M. B.			Free Fatty Acid Effects on the Atrial Myocardium: Membrane Ionic Currents Are Remodeled by the Disruption of T-Tubular Architecture	PLOS ONE			English	Article							MOUSE VENTRICULAR MYOCYTES; CARDIOVASCULAR HEALTH; ADIPOSE-TISSUE; FIBRILLATION; HEART; CALCIUM; OBESITY; STRESS; PLASMA; GROWTH	Background Epicardial adiposity and plasma levels of free fatty acids (FFAs) are elevated in atrial fibrillation, heart failure and obesity, with potentially detrimental effects on myocardial function. As major components of epicardial fat, FFAs may be abnormally regulated, with a potential to detrimentally modulate electro-mechanical function. The cellular mechanisms underlying such effects of FFAs are unknown. Objective To determine the mechanisms underlying electrophysiological effects of palmitic (PA), stearic (SA) and oleic (OA) FFAs on sheep atrial myocytes. Methods We used electrophysiological techniques, numerical simulations, biochemistry and optical imaging to examine the effects of acutely (<= 15 min), short-term (4-6 hour) or 24-hour application of individual FFAs (10 mu M) on isolated ovine left atrial myocytes (LAMs). Results Acute and short-term incubation in FFAs resulted in no differences in passive or active properties of isolated left atrial myocytes (LAMs). 24-hour application had differential effects depending on the FFA. PA did not affect cellular passive properties but shortened (p<0.05) action potential duration at 30% repolarization (APD(30)). APD(50) and APD(80) were unchanged. SA had no effect on resting membrane potential but reduced membrane capacitance by 15% (p<0.05), and abbreviated APD at all values measured (p <= 0.001). OA did not significantly affect passive or active properties of LAMs. Measurement of the major voltage-gated ion channels in SA treated LAMs showed a similar to 60% reduction (p<0.01) of the L-type calcium current (ICa-L) and similar to 30% reduction (p<0.05) in the transient outward potassium current (I-TO). A human atrial cell model recapitulated SA effects on APD. Optical imaging showed that SA incubated for 24 hours altered t-tubular structure in isolated cells (p<0.0001). Conclusions SA disrupts t-tubular architecture and remodels properties of membrane ionic currents in sheep atrial myocytes, with potential implications in arrhythmogenesis.	[O'Connell, Ryan P.; Musa, Hassan; Gomez, Mario San Martin; Avula, Uma Mahesh; Herron, Todd J.; Kalifa, Jerome; Anumonwo, Justus M. B.] Univ Michigan, Sch Med, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [O'Connell, Ryan P.; Herron, Todd J.; Anumonwo, Justus M. B.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Anumonwo, JMB (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA.	anumonwo@med.umich.edu	Musa, Hassan/AAQ-1548-2021; Avula, Uma Mahesh/B-8047-2014	Avula, Uma Mahesh/0000-0002-4786-3722	American Heart Association [12PRE1205004312]; National Institutes of Health [1RO1-GM-076608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076608] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	American Heart Association awarded predoctoral fellowship 12PRE1205004312 (to ROC) and National Institutes of Health 1RO1-GM-076608 (to JMBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; ANUMONWO JMB, 1990, J PHYSIOL-LONDON, V425, P145, DOI 10.1113/jphysiol.1990.sp018097; Barber MC, 2000, J ANIM SCI, V78, P62; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cheng LF, 2011, AM J PHYSIOL-HEART C, V301, pH1984, DOI 10.1152/ajpheart.00304.2011; Dhamoon AS, 2004, CIRC RES, V94, P1332, DOI 10.1161/01.RES.0000128408.66946.67; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; Djousse L, 2013, CIRC-HEART FAIL, V6, P964, DOI 10.1161/CIRCHEARTFAILURE.113.000521; Doolan GK, 2002, FASEB J, V16, P1662, DOI 10.1096/fj.02-0084fje; Dublin S, 2006, ARCH INTERN MED, V166, P2322, DOI 10.1001/archinte.166.21.2322; EMKEN EA, 1994, AM J CLIN NUTR, V60, p1023S, DOI 10.1093/ajcn/60.6.1023S; Frisk M, 2014, AM J PHYSIOL-HEART C, V307, pH609, DOI 10.1152/ajpheart.00295.2014; Gong D., 2003, CURR OPIN ENDOCRINOL, V10, P115, DOI [10.1097/00060793-200304000-00004, DOI 10.1097/00060793-200304000-00004]; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Graner M, 2013, J CLIN ENDOCR METAB, V98, P1189, DOI 10.1210/jc.2012-3190; Haim TE, 2010, J MOL CELL CARDIOL, V48, P395, DOI 10.1016/j.yjmcc.2009.10.004; Hendrickson SC, 1997, MOL CELL BIOCHEM, V166, P85, DOI 10.1023/A:1006886601825; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; KANG JX, 1995, P NATL ACAD SCI USA, V92, P3997, DOI 10.1073/pnas.92.9.3997; Khawaja O, 2012, AM J CARDIOL, V110, P212, DOI 10.1016/j.amjcard.2012.03.010; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Leaf A, 2001, EUR HEART J SUPPL, V3, pD98, DOI 10.1016/S1520-765X(01)90127-0; Lemieux H, 2011, MITOCHONDRION, V11, P97, DOI 10.1016/j.mito.2010.07.014; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Lin YK, 2014, INT J CARDIOL, V176, P191, DOI 10.1016/j.ijcard.2014.07.004; Lin YK, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0293-1; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Louch WE, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/503906; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Maan A, 2013, J INNOVATIONS CARDIA, V4, P1077; Marshall C, 2007, BIOCHEM BIOPH RES CO, V356, P756, DOI 10.1016/j.bbrc.2007.03.047; Martins RP, 2014, CIRCULATION, V129, P1472, DOI 10.1161/CIRCULATIONAHA.113.004742; Moench I, 2013, EXP PHYSIOL, V98, P1164, DOI 10.1113/expphysiol.2013.072470; Musa H, 2013, HEART RHYTHM OFFICIA; Musa H, 2013, HEART RHYTHM, V10, P1044, DOI 10.1016/j.hrthm.2013.03.014; Pantanowitz L, 2001, HEART, V85, P253, DOI 10.1136/heart.85.3.253; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Rennison JH, 2009, CIRC-ARRHYTHMIA ELEC, V2, P460, DOI 10.1161/CIRCEP.109.880773; Ricci E, 2006, OBESITY, V14, P778, DOI 10.1038/oby.2006.90; RICHIERI GV, 1995, J LIPID RES, V36, P229; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; SUZUKI T, 1968, TOHOKU J EXP MED, V95, P271, DOI 10.1620/tjem.95.271; Vaidyanathan R, 2010, J BIOL CHEM; Vaidyanathan R, 2013, HEART RHYTHM, V10, P80, DOI 10.1016/j.hrthm.2012.10.002; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Veiga-Lopez A, 2013, ENDOCRINOLOGY, V154, P1731, DOI 10.1210/en.2012-2145; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661	52	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133052	10.1371/journal.pone.0133052	http://dx.doi.org/10.1371/journal.pone.0133052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274906	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600007
J	Zhao, H; Xu, LC; Dong, HH; Hu, JH; Gao, HN; Yang, MF; Zhang, X; Chen, XM; Fan, J; Ma, WH				Zhao, Hong; Xu, Lichen; Dong, Huihui; Hu, Jianhua; Gao, Hainv; Yang, Meifang; Zhang, Xuan; Chen, Xiaoming; Fan, Jun; Ma, Weihang			Correlations between Clinical Features and Mortality in Patients with Vibrio vulnificus Infection	PLOS ONE			English	Article								Vibrio vulnificus is a common gram-negative bacterium, which might cause morbidity and mortality in patients following consumption of seafood or exposure to seawater in Southeast China. We retrospectively analyzed clinical data of patients with laboratory confirmed V. vulnificus infection. Twenty one patients were divided into a survival group and a non-surviving (or death) group according to their clinical outcome. Clinical data and measurements were statistically analyzed. Four patients (19.05%) died and five patients gave positive cultures from bile fluid, and 16 other patients gave positive culture from blood or blisters. Ten patients (47.62%) had an underlying liver disease and marine-related events were found in sixteen patients (76.2%). Patients with heavy drinking habits might be at increased mortality (p = 0.028). Clinical manifestations of cellulitis (47.6%), septic shock (42.9%) and multiple organ failure (28.6%) were statistically significant when comparing survivors and non-survivors (p = 0.035, p = 0.021 and p = 0.003, respectively). The laboratory results, including hemoglobin < 9.0 g/L (p = 0.012), platelets < 2.0x10(9)/L, prothrombin time activity (PTA) < 20%, decreased serum creatinine and increased urea nitrogen were statistically significant (p = 0.012, p = 0.003, p = 0.028 and p = 0.028, respectively). Patients may be at a higher risk of mortality under situations where they have a history of habitual heavy alcoholic drink consumption (p = 0.028, OR = 22.5, 95% CI 1.5-335.3), accompanied with cellulitis, shock, multiple organ failure, and laboratory examinations that are complicated by decreased platelets, hemoglobin and significantly prolonged prothrombin time (PT).	[Zhao, Hong; Xu, Lichen; Dong, Huihui; Hu, Jianhua; Gao, Hainv; Yang, Meifang; Zhang, Xuan; Chen, Xiaoming; Fan, Jun; Ma, Weihang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Ma, WH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	1510005@zju.edu.cn	Xu, Lichen/B-2650-2015	Xu, Lichen/0000-0002-4271-5149; Zhou, Dongsheng/0000-0003-3827-5969				BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; Bross MH, 2007, AM FAM PHYSICIAN, V76, P539; Chao WN, 2013, AM J SURG, V206, P32, DOI 10.1016/j.amjsurg.2012.08.008; Chen SC, 2010, CRIT CARE MED, V38, P1984, DOI 10.1097/CCM.0b013e3181eeda2c; Chou TNK, 2010, WORLD J SURG, V34, P1669, DOI 10.1007/s00268-010-0455-y; CHUANG YC, 1992, CLIN INFECT DIS, V15, P271, DOI 10.1093/clinids/15.2.271; FARMER JJ, 1979, LANCET, V2, P903; HOLLIS DG, 1976, J CLIN MICROBIOL, V3, P425; Hong GL, 2014, CHINESE MED J-PEKING, V127, P1984, DOI 10.3760/cma.j.issn.0366-6999.20140145; Lee YC, 2014, EUR J CLIN MICROBIOL, V33, P1011, DOI 10.1007/s10096-013-2039-x; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Miyoshi S, 2012, WORLD J MICROB BIOT, V28, P1633, DOI 10.1007/s11274-011-0969-y; Newton A, 2012, CLIN INFECT DIS, V54, pS391, DOI 10.1093/cid/cis243; ROLAND FP, 1970, NEW ENGL J MED, V282, P1306, DOI 10.1056/NEJM197006042822306; Tsai J, 2010, ALCOHOL CLIN EXP RES, V34, P1465, DOI 10.1111/j.1530-0277.2010.01231.x; Tsai YH, 2010, CLIN ORTHOP RELAT R, V468, P2230, DOI 10.1007/s11999-010-1311-y	16	12	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0136019	10.1371/journal.pone.0136019	http://dx.doi.org/10.1371/journal.pone.0136019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274504	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600144
J	Pallesen, KJ; Bailey, CJ; Brattico, E; Gjedde, A; Palva, JM; Palva, S				Pallesen, Karen Johanne; Bailey, Christopher J.; Brattico, Elvira; Gjedde, Albert; Palva, J. Matias; Palva, Satu			Experience Drives Synchronization: The phase and Amplitude Dynamics of Neural Oscillations to Musical Chords Are Differentially Modulated by Musical Expertise	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; PRIMARY AUDITORY-CORTEX; SHORT-TERM-MEMORY; PITCH PERCEPTION; AWAKE MONKEY; NEURONAL OSCILLATIONS; MISMATCH NEGATIVITY; TEMPORAL DYNAMICS; EVOKED-POTENTIALS; CORTICAL ACTIVITY	Musical expertise is associated with structural and functional changes in the brain that underlie facilitated auditory perception. We investigated whether the phase locking (PL) and amplitude modulations (AM) of neuronal oscillations in response to musical chords are correlated with musical expertise and whether they reflect the prototypicality of chords in Western tonal music. To this aim, we recorded magnetoencephalography (MEG) while musicians and non-musicians were presented with common prototypical major and minor chords, and with uncommon, non-prototypical dissonant and mistuned chords, while watching a silenced movie. We then analyzed the PL and AM of ongoing oscillations in the theta (4-8 Hz) alpha (8-14 Hz), beta- (14-30 Hz) and gamma- (30-80 Hz) bands to these chords. We found that musical expertise was associated with strengthened PL of ongoing oscillations to chords over a wide frequency range during the first 300 ms from stimulus onset, as opposed to increased alpha-band AM to chords over temporal MEG channels. In musicians, the gamma- band PL was strongest to non-prototypical compared to other chords, while in non-musicians PL was strongest to minor chords. In both musicians and non-musicians the long-latency (> 200 ms) gamma-band PL was also sensitive to chord identity, and particularly to the amplitude modulations (beats) of the dissonant chord. These findings suggest that musical expertise modulates oscillation PL to musical chords and that the strength of these modulations is dependent on chord prototypicality.	[Pallesen, Karen Johanne; Gjedde, Albert] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Pallesen, Karen Johanne] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, DK-8000 Aarhus, Denmark; [Pallesen, Karen Johanne; Bailey, Christopher J.; Gjedde, Albert] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Brattico, Elvira] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland; [Brattico, Elvira] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Gjedde, Albert] Aarhus Univ Hosp, Pathophysiol & Expt Tomog Ctr, DK-8000 Aarhus, Denmark; [Palva, J. Matias; Palva, Satu] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Palva, Satu] Univ Helsinki, Cent Hosp, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland	University of Copenhagen; Aarhus University; Aarhus University; University of Helsinki; University of Helsinki; Aarhus University; University of Helsinki; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital	Pallesen, KJ (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	karepall@rm.dk	Palva, Matias/D-5837-2013; Palva, Satu/D-7400-2013; Brattico, Elvira/M-1455-2019; Palva, Satu/AAH-6938-2020; Gjedde, Albert/U-3751-2019; Gjedde, Albert/I-2452-2019	Palva, Satu/0000-0001-9496-7391; Gjedde, Albert/0000-0002-3756-7401; Brattico, Elvira/0000-0003-0676-6464; Palva, J. Matias/0000-0003-1885-2749; Bailey, Christopher/0000-0003-3318-3344	Academy of Finland [133673, 1126967, 266402, 253130, 256472]; Helsinki University Research Grants [490083, 788/51/2010]	Academy of Finland(Academy of Finland); Helsinki University Research Grants	This work was supported by the Academy of Finland, http://www.aka.fi/en-GB/A/ project numbers 133673, 1126967, 266402 (SP), and 253130, and 256472 ( MP); The Helsinki University Research Grants, http://www.helsinki.fi/tiedesaatio/english/index.htm, project numbers 490083 and 788/51/2010 (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken SJ, 2008, EAR HEARING, V29, P139, DOI 10.1097/AUD.0b013e31816453dc; Anaki D, 2007, NEUROIMAGE, V37, P1407, DOI 10.1016/j.neuroimage.2007.05.054; Anderson S, 2010, J NEUROSCI, V30, P4922, DOI 10.1523/JNEUROSCI.0107-10.2010; Bailey JA, 2010, EXP BRAIN RES, V204, P91, DOI 10.1007/s00221-010-2299-y; Becker R, 2008, NEUROIMAGE, V39, P707, DOI 10.1016/j.neuroimage.2007.09.016; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besle J, 2011, J NEUROSCI, V31, P3176, DOI 10.1523/JNEUROSCI.4518-10.2011; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Brattico E, 2003, NEUROREPORT, V14, P2489, DOI 10.1097/00001756-200312190-00039; Brattico E, 2013, PSYCHOPHYSIOLOGY, V50, P653, DOI 10.1111/psyp.12049; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Brugge JF, 2009, J NEUROPHYSIOL, V102, P2358, DOI 10.1152/jn.91346.2008; Cousineau M, 2012, P NATL ACAD SCI USA, V109, P19858, DOI 10.1073/pnas.1207989109; Dellacherie D, 2011, PSYCHOPHYSIOLOGY, V48, P337, DOI 10.1111/j.1469-8986.2010.01075.x; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Fellinger R, 2011, BRAIN RES BULL, V85, P417, DOI 10.1016/j.brainresbull.2011.03.025; Fiebach CJ, 2005, J NEUROSCI, V25, P3414, DOI 10.1523/JNEUROSCI.4107-04.2005; Fishman YI, 2000, J ACOUST SOC AM, V108, P247, DOI 10.1121/1.429461; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; Fishman YI, 2000, J ACOUST SOC AM, V108, P235, DOI 10.1121/1.429460; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gander RE, 2010, HEARING RES, V269, P81, DOI 10.1016/j.heares.2010.07.001; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Gill KZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008144; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Helmholtz HLF, 1954, SENSATIONS TONE; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Honkanen R, 2015, CEREB CORTEX, V25, P3788, DOI 10.1093/cercor/bhu263; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kaiser J, 2006, NEUROIMAGE, V30, P1376, DOI 10.1016/j.neuroimage.2005.10.042; Kaiser J, 2008, CEREB CORTEX, V18, P2286, DOI 10.1093/cercor/bhm251; Kaiser J, 2007, CEREB CORTEX, V17, P2258, DOI 10.1093/cercor/bhl134; Kaiser J, 2009, NEUROIMAGE, V44, P257, DOI 10.1016/j.neuroimage.2008.08.018; Keil A, 2010, BRAIN RES, V1313, P172, DOI 10.1016/j.brainres.2009.12.006; Koelsch S, 2001, NEUROREPORT, V12, P1385, DOI 10.1097/00001756-200105250-00019; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kuriki S, 2006, J NEUROSCI, V26, P4046, DOI 10.1523/JNEUROSCI.3907-05.2006; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2013, CURR BIOL, V23, P968, DOI 10.1016/j.cub.2013.04.031; Martinovic J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003781; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; NAATANEN R, 1995, EAR HEARING, V16, P6; Ott CGM, 2013, NEUROREPORT, V24, P445, DOI 10.1097/WNR.0b013e328360abdb; Pallesen KJ, 2005, ANN NY ACAD SCI, V1060, P450, DOI 10.1196/annals.1360.047; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Pallesen KJ, 2009, J COGNITIVE NEUROSCI, V21, P1065, DOI 10.1162/jocn.2009.21086; Palva S, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0003.2002; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Pantev C, 2011, NEUROSCI BIOBEHAV R, V35, P2140, DOI 10.1016/j.neubiorev.2011.06.010; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Patel AD, 2001, NAT NEUROSCI, V4, P839, DOI 10.1038/90557; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Plomin R, 2014, INTELLIGENCE, V45, P46, DOI 10.1016/j.intell.2013.06.008; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Ruiz MH, 2009, HUM BRAIN MAPP, V30, P1207, DOI 10.1002/hbm.20584; Schellenberg EG, 1996, PSYCHOL SCI, V7, P272, DOI 10.1111/j.1467-9280.1996.tb00373.x; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; SHACKLETON TM, 1994, J ACOUST SOC AM, V95, P3529, DOI 10.1121/1.409970; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Simonton DK, 2014, INTELLIGENCE, V45, P66, DOI 10.1016/j.intell.2013.04.007; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Singer W, 2009, COGN NEURODYNAMICS, V3, P189, DOI 10.1007/s11571-009-9087-z; SINKKONEN J, 1995, J NEUROSCI METH, V56, P99, DOI 10.1016/0165-0270(94)00111-S; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TERHARDT E, 1978, PERCEPT PSYCHOPHYS, V23, P483, DOI 10.3758/BF03199523; van Wassenhove V, 2007, J NEUROSCI, V27, P2663, DOI 10.1523/JNEUROSCI.4844-06.2007; Vidal JR, 2006, J COGNITIVE NEUROSCI, V18, P1850, DOI 10.1162/jocn.2006.18.11.1850; Widmann A, 2007, CEREB CORTEX, V17, P2696, DOI 10.1093/cercor/bhl178; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; Zatorre RJ, 2013, SCIENCE, V342, P585, DOI 10.1126/science.1238414; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0; Zion-Golumbic E, 2008, NEUROIMAGE, V39, P1980, DOI 10.1016/j.neuroimage.2007.10.025; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100	95	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134211	10.1371/journal.pone.0134211	http://dx.doi.org/10.1371/journal.pone.0134211			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291324	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000359919900004
J	Prior, JC; Naess, M; Langhammer, A; Forsmo, S				Prior, Jerilynn C.; Naess, Marit; Langhammer, Arnulf; Forsmo, Siri			Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles - A Population-Based Cohort from HUNT3, Norway	PLOS ONE			English	Article							COGNITIVE DIETARY RESTRAINT; PREMENOPAUSAL WOMEN; PROGESTERONE LEVELS; SERUM PROGESTERONE; EARLY-PREGNANCY; URINARY; DISTURBANCES; CORTISOL; RISK; CONFIRMATION	Background Ovulatory menstrual cycles are essential for women's fertility and needed to prevent bone loss. There is a medical/ cultural expectation that clinically normal menstrual cycles are inevitably ovulatory. Currently within the general population it is unknown the proportion of regular, normal-length menstrual cycles that are ovulatory. Thus, the objective of this study was to determine the population point prevalence of ovulation in premenopausal, normally menstruating women. The null hypothesis was that such cycles are ovulatory. Methods This is a single-cycle, cross-sectional, population-based study-a sub-study of the HUNT3 health study in the semi-rural county (Nord Trondelag) in mid-Norway. Participants included >3,700 spontaneously (no hormonal contraception) menstruating women, primarily Caucasian, ages 20-49.9 from that county. Participation rate was 51.9%. All reported the date previous flow started. A single, random serum progesterone level was considered ovulatory if >= 9.54 nmol/L on cycle days 14 to -3 days before usual cycle length (CL). Results Ovulation was assessed in 3,168 women mean age 41.7 (interquartile range, [IQR] 36.8 to 45.5), cycle length 28 days (d) (IQR 28 to 28) and body mass index (BMI) 26.3 kg/m2 (95% CI 26.1 to 26.4). Parity was 95.6%, 30% smoked, 61.3% exercised regularly and 18% were obese. 1,545 women with a serum progesterone level on cycle days 14 to -3 were presumed to be in the luteal phase. Of these, 63.3% of women had an ovulatory cycle (n = 978) and 37% (n = 567) were anovulatory. Women with/without ovulation did not differ in age, BMI, cycle day, menarche age, cigarette use, physical activity, % obesity or self-reported health. There were minimal differences in parity (96.7% vs. 94.5%, P = 0.04) and major differences in progesterone level (24.5 vs. 3.8 nmol/L, P = 0.001). Conclusion Anovulation in a random population occurs in over a third of clinically normal menstrual cycles.	[Prior, Jerilynn C.; Forsmo, Siri] Univ British Columbia, Ctr Menstrual Cycle & Ovulat Res, Vancouver, BC V5Z 1M9, Canada; [Prior, Jerilynn C.] Univ British Columbia, Dept Med, Div Endocrinol, Vancouver, BC, Canada; [Prior, Jerilynn C.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Prior, Jerilynn C.] Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Naess, Marit; Langhammer, Arnulf] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway; [Forsmo, Siri] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway	University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Prior, JC (corresponding author), Univ British Columbia, Ctr Menstrual Cycle & Ovulat Res, Vancouver, BC V5Z 1M9, Canada.	Jerilynn.prior@ubc.ca			Canadian Institutes for Health Research under the International Opportunities Programme [80033]	Canadian Institutes for Health Research under the International Opportunities Programme(Canadian Institutes of Health Research (CIHR))	The authors appreciate that The Nord-Trondelag Health Study (The HUNT Study) involves collaboration between the HUNT Research Centre (Faculty of Medicine, Norwegian University of Science and Technology, NTNU), the Nord-Trondelag County Council, the Central Norway Health Authority, and the Norwegian Institute of Public Health. This ovulation point prevalence study's hormonal analyses were funded (2005) by the Canadian Institutes for Health Research under the International Opportunities Programme (Grant # 80033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2008, REPROD BIOMED ONLINE, V17, P101, DOI 10.1016/S1472-6483(10)60300-8; Bedford JL, 2010, J CLIN ENDOCR METAB, V95, P3291, DOI 10.1210/jc.2009-2497; Bedford JL, 2009, EUR J OBSTET GYN R B, V146, P76, DOI 10.1016/j.ejogrb.2009.05.001; Brown JB, 2011, HUM REPROD UPDATE, V17, P141, DOI 10.1093/humupd/dmq040; De Souza MJ, 2010, HUM REPROD, V25, P491, DOI 10.1093/humrep/dep411; Gorgels WJMJ, 1997, J CLIN EPIDEMIOL, V50, P275, DOI 10.1016/S0895-4356(96)00367-8; GRATTAROLA R, 1964, CANCER, V17, P1119, DOI 10.1002/1097-0142(196409)17:9<1119::AID-CNCR2820170904>3.0.CO;2-1; Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1210/jc.2011-3362, 10.1097/gme.0b013e31824d8f40]; ISRAEL R, 1972, AM J OBSTET GYNECOL, V112, P1043, DOI 10.1016/0002-9378(72)90178-0; Kharazmi E, 2011, HEART, V97, P49, DOI 10.1136/hrt.2010.202226; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Li DN, 2014, EPIDEMIOL REV, V36, P137, DOI 10.1093/epirev/mxt012; MACDONALD PC, 1991, ENDOCR REV, V12, P372, DOI 10.1210/edrv-12-4-372; Malcolm CE, 2003, OBSTET GYNECOL, V102, P317, DOI 10.1016/S0029-7844(03)00527-1; McLean JA, 2001, AM J CLIN NUTR, V73, P7; Mumford SL, 2011, HUM REPROD, V26, P423, DOI 10.1093/humrep/deq322; Naess M, 2011, THESIS U TROMSO UIT; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; O'Connor KA, 2006, HUM REPROD, V21, P1442, DOI 10.1093/humrep/dei497; O'Connor KA, 2009, MENOPAUSE, V16, P1178, DOI 10.1097/gme.0b013e3181aa192d; Prior J. C., 2014, J RESTORATIVE MED, V3, P85; PRIOR JC, 1990, NEW ENGL J MED, V323, P1221, DOI 10.1056/NEJM199011013231801; PRIOR JC, 1990, CLIN INVEST MED, V13, P123; Santoro N, 2003, AM J PHYSIOL-ENDOC M, V284, pE521, DOI 10.1152/ajpendo.00381.2002; Seifert-Klauss V, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/845180; Selye H, 1939, ENDOCRINOLOGY, V25, P615, DOI 10.1210/endo-25-4-615; SHEPARD MK, 1977, FERTIL STERIL, V28, P541; Shepard R.J, 1978, PHUSICALACTIVITY AGI; Sowers M, 1998, J BONE MINER RES, V13, P1191, DOI 10.1359/jbmr.1998.13.7.1191; Vitzthum VJ, 2009, YEARB PHYS ANTHROPOL, V52, P95, DOI 10.1002/ajpa.21195; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P548, DOI 10.1002/ajhb.20936; Vitzthum VJ, 2004, P NATL ACAD SCI USA, V101, P1443, DOI 10.1073/pnas.0302640101; Vitzthum VJ, 2002, HUM REPROD, V17, P1906, DOI 10.1093/humrep/17.7.1906; Vollman RF, 1977, MAJOR PROBLEMS OBSTE, V7, P11; Waller K, 1996, J CLIN ENDOCR METAB, V81, P663, DOI 10.1210/jc.81.2.663; Weiss G, 2004, JAMA-J AM MED ASSOC, V292, P2991, DOI 10.1001/jama.292.24.2991; Williams NI, 2007, AM J PHYSIOL-ENDOC M, V293, pE270, DOI 10.1152/ajpendo.00108.2007; World Health Organization Task Force, 1985, INT J FERTIL, V30, P18; Xu WH, 2004, INT J CANCER, V108, P613, DOI 10.1002/ijc.11598	40	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134473	10.1371/journal.pone.0134473	http://dx.doi.org/10.1371/journal.pone.0134473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291617	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900007
J	Sinha, R; Samaddar, S; De, RK				Sinha, Rituparna; Samaddar, Sandip; De, Rajat K.			CNV-CH: A Convex Hull Based Segmentation Approach to Detect Copy Number Variations (CNV) Using Next-Generation Sequencing Data	PLOS ONE			English	Article								Copy number variation (CNV) is a form of structural alteration in the mammalian DNA sequence, which are associated with many complex neurological diseases as well as cancer. The development of next generation sequencing (NGS) technology provides us a new dimension towards detection of genomic locations with copy number variations. Here we develop an algorithm for detecting CNVs, which is based on depth of coverage data generated by NGS technology. In this work, we have used a novel way to represent the read count data as a two dimensional geometrical point. A key aspect of detecting the regions with CNVs, is to devise a proper segmentation algorithm that will distinguish the genomic locations having a significant difference in read count data. We have designed a new segmentation approach in this context, using convex hull algorithm on the geometrical representation of read count data. To our knowledge, most algorithms have used a single distribution model of read count data, but here in our approach, we have considered the read count data to follow two different distribution models independently, which adds to the robustness of detection of CNVs. In addition, our algorithm calls CNVs based on the multiple sample analysis approach resulting in a low false discovery rate with high precision.	[Sinha, Rituparna] Heritage Inst Technol, Dept Informat Technol, Kolkata, W Bengal, India; [Samaddar, Sandip] Heritage Inst Technol, Dept Comp Sci & Engn, Kolkata, W Bengal, India; [De, Rajat K.] Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India	Heritage Institute of Technology (HITK); Heritage Institute of Technology (HITK); Indian Statistical Institute; Indian Statistical Institute Kolkata	De, RK (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India.	rajat@isical.ac.in						Benjamini Y ST, 2012, NUCLEIC ACIDS RES, P41; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Buysse K, 2009, EUR J MED GENET, V52, P398, DOI 10.1016/j.ejmg.2009.09.002; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Goon AM, 1968, FUNDAMENTALS STAT; Ivakhno S, 2010, BIOINFORMATICS, V26, P3051, DOI 10.1093/bioinformatics/btq587; Junbo D, 2013, BMC BIOINFORMATICS, V14, P1471; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2012, BIOINFORMATICS, V28, P470, DOI 10.1093/bioinformatics/btr707; Magi A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr068; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Min Z, 2013, BMC BIOINFORMATICS, P14; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Szatkiewicz JP, 2013, NUCLEIC ACIDS RES, V41, P1519, DOI 10.1093/nar/gks1363; THOMAS H, 1990, INTRO ALGORITHMS; Wang ZY, 2013, J COMPUT BIOL, V20, P224, DOI 10.1089/cmb.2012.0258; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang QY, 2010, BIOINFORMATICS, V26, P464, DOI 10.1093/bioinformatics/btp708	24	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135895	10.1371/journal.pone.0135895	http://dx.doi.org/10.1371/journal.pone.0135895			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291322	Green Published, gold			2022-12-27	WOS:000359919900037
J	Derkow, K; Kruger, C; Dembny, P; Lehnardt, S				Derkow, Katja; Krueger, Christina; Dembny, Paul; Lehnardt, Seija			Microglia Induce Neurotoxic IL-17+gamma delta T Cells Dependent on TLR2, TLR4, and TLR9 Activation	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GAMMA-DELTA; IL-17 PRODUCTION; INNATE IMMUNITY; PIVOTAL ROLE; RECEPTOR; PROMOTE; PATHOGENESIS; EXPRESSION; RESPONSES	Background Interleukin-17 (IL-17) acts as a key regulator in central nervous system (CNS) inflammation. gamma delta T cells are an important innate source of IL-17. Both IL-17+gamma delta T cells and microglia, the major resident immune cells of the brain, are involved in various CNS disorders such as multiple sclerosis and stroke. Also, activation of Toll-like receptor (TLR) signaling pathways contributes to CNS damage. However, the mechanisms underlying the regulation and interaction of these cellular and molecular components remain unclear. Objective In this study, we investigated the crosstalk between gamma delta T cells and microglia activated by TLRs in the context of neuronal damage. To this end, co-cultures of IL-17+ gamma delta T cells, neurons, and microglia were analyzed by immunocytochemistry, flow cytometry, ELISA and multiplex immunoassays. Results We report here that IL-17+ gamma delta T cells but not naive gamma delta T cells induce a dose-and time-dependent decrease of neuronal viability in vitro. While direct stimulation of gamma delta T cells with various TLR ligands did not result in up-regulation of CD69, CD25, or in IL-17 secretion, supernatants of microglia stimulated by ligands specific for TLR2, TLR4, TLR7, or TLR9 induced activation of gamma delta T cells through IL-1 beta and IL-23, as indicated by up-regulation of CD69 and CD25 and by secretion of vast amounts of IL-17. This effect was dependent on the TLR adaptor myeloid differentiation primary response gene 88 (MyD88) expressed by both gamma delta T cells and microglia, but did not require the expression of TLRs by gamma delta T cells. Similarly to cytokine-primed IL-17+ gamma delta T cells, IL-17+ gamma delta T cells induced by supernatants derived from TLR-activated microglia also caused neurotoxicity in vitro. While these neurotoxic effects required stimulation of TLR2, TLR4, or TLR9 in microglia, neuronal injury mediated by bone marrow-derived macrophages did not require TLR signaling. Neurotoxicity mediated by IL-17+ gamma delta T cells required a direct cell-cell contact between T cells and neurons. Conclusion Taken together, these results point to a crucial role for microglia activated through TLRs in polarization of gamma delta T cells towards neurotoxic IL-17+ gamma delta T cells.	[Derkow, Katja; Krueger, Christina; Dembny, Paul; Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Inst Cell Biol & Neurobiol, Ctr Anat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Derkow, K (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	katja.derkow@charite.de	Lehnardt, Seija/AAA-4113-2022		Deutsche Forschungsgemeinschaft [SFB TRR-43, NeuroCure Exc 257]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This research was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) SFB TRR-43 and NeuroCure Exc 257 (to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chang J, 2013, P NATL ACAD SCI USA, V110, P2270, DOI 10.1073/pnas.1206048110; Chen ZH, 2016, J NEUROCHEM, V136, P10, DOI 10.1111/jnc.13062; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009; Esen N, 2006, J IMMUNOL, V176, P6802, DOI 10.4049/jimmunol.176.11.6802; Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Hanamsagar R, 2011, J NEUROCHEM, V119, P736, DOI 10.1111/j.1471-4159.2011.07481.x; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hu MH, 2014, CLIN EXP IMMUNOL, V175, P268, DOI 10.1111/cei.12219; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kaul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037767; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lehmann SM, 2012, J IMMUNOL, V189, P1448, DOI 10.4049/jimmunol.1201078; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liblau RS, 2013, TRENDS NEUROSCI, V36, P315, DOI 10.1016/j.tins.2013.01.008; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McCandless EE, 2009, J IMMUNOL, V183, P613, DOI 10.4049/jimmunol.0802258; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miller NM, 2013, ASN NEURO, V5, DOI 10.1042/AN20120087; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Odyniec A, 2004, J IMMUNOL, V173, P682, DOI 10.4049/jimmunol.173.1.682; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Schirmer L, 2013, JAMA NEUROL, V70, P345, DOI 10.1001/2013.jamaneurol.409; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Schwacha MG, 2014, INNATE IMMUN-LONDON, V20, P261, DOI 10.1177/1753425913488969; Schwacha MG, 2008, CYTOKINE, V44, P328, DOI 10.1016/j.cyto.2008.09.001; SELMAJ K, 1991, P NATL ACAD SCI USA, V88, P6452, DOI 10.1073/pnas.88.15.6452; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Sonobe Y, 2005, BRAIN RES, V1040, P202, DOI 10.1016/j.brainres.2005.01.100; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wang DD, 2009, J NEUROIMMUNOL, V212, P17, DOI 10.1016/j.jneuroim.2009.04.007; Wang WW, 2008, GLIA, V56, P241, DOI 10.1002/glia.20609; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Zhang JX, 2013, 2013 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), P1, DOI [10.1109/WCNCW.2013.6533305, 10.1109/PLASMA.2013.6633336]; Zimmermann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057307	57	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135898	10.1371/journal.pone.0135898	http://dx.doi.org/10.1371/journal.pone.0135898			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288016	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600083
J	Felt, W; Selinger, JC; Donelan, JM; Remy, CD				Felt, Wyatt; Selinger, Jessica C.; Donelan, J. Maxwell; Remy, C. David			"Body-In-The-Loop": Optimizing Device Parameters Using Measures of Instantaneous Energetic Cost	PLOS ONE			English	Article							HUMAN WALKING; ALIGNMENT; GAIT	This paper demonstrates methods for the online optimization of assistive robotic devices such as powered prostheses, orthoses and exoskeletons. Our algorithms estimate the value of a physiological objective in real-time (with a body "in-the-loop") and use this information to identify optimal device parameters. To handle sensor data that are noisy and dynamically delayed, we rely on a combination of dynamic estimation and response surface identification. We evaluated three algorithms (Steady-State Cost Mapping, Instantaneous Cost Mapping, and Instantaneous Cost Gradient Search) with eight healthy human subjects. Steady-State Cost Mapping is an established technique that fits a cubic polynomial to averages of steady-state measures at different parameter settings. The optimal parameter value is determined from the polynomial fit. Using a continuous sweep over a range of parameters and taking into account measurement dynamics, Instantaneous Cost Mapping identifies a cubic polynomial more quickly. Instantaneous Cost Gradient Search uses a similar technique to iteratively approach the optimal parameter value using estimates of the local gradient. To evaluate these methods in a simple and repeatable way, we prescribed step frequency via a metronome and optimized this frequency to minimize metabolic energetic cost. This use of step frequency allows a comparison of our results to established techniques and enables others to replicate our methods. Our results show that all three methods achieve similar accuracy in estimating optimal step frequency. For all methods, the average error between the predicted minima and the subjects' preferred step frequencies was less than 1% with a standard deviation between 4% and 5%. Using Instantaneous Cost Mapping, we were able to reduce subject walking-time from over an hour to less than 10 minutes. While, for a single parameter, the Instantaneous Cost Gradient Search is not much faster than Steady-State Cost Mapping, the Instantaneous Cost Gradient Search extends favorably to multi-dimensional parameter spaces.	[Felt, Wyatt; Remy, C. David] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Selinger, Jessica C.; Donelan, J. Maxwell] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	University of Michigan System; University of Michigan; Simon Fraser University	Remy, CD (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	cdremy@umich.edu.edu	Felt, Wyatt/AAC-4207-2019	Felt, Wyatt/0000-0003-3968-1889; Remy, C David/0000-0002-4072-8034	MCubed program at the University of Michigan; U.S. Army Research Office [W911NF-13-1-0268]; Natural Sciences and Engineering Research Council of Canada; Vanier Canadian Graduate Scholarship; National Science Foundation Graduate Research Fellowship [DGE 1256260]	MCubed program at the University of Michigan; U.S. Army Research Office; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Vanier Canadian Graduate Scholarship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	Funding for the work of the RAMlab came through the MCubed program at the University of Michigan (CDR) (http://mcubed.umich.edu/projects/reducing-effort-through-augmented-lower-limb-prostheses). Funding for the work done by the Locomotion Lab was supported by: U.S. Army Research Office Grant #W911NF-13-1-0268 (JMD) (www.aro.army.mil), Natural Sciences and Engineering Research Council of Canada, Discovery Grant (JMD), and Vanier Canadian Graduate Scholarship (JCS) (http://www.nserc-crsng.gc.ca/). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (WF) under Grant No. DGE 1256260. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram JEA, 2005, J EXP BIOL, V208, P979, DOI 10.1242/jeb.01498; Bhatnagar S, 2013, LECT NOTES CONTROL I, P434, DOI [10.1007/978-1-4471-4285-0_10, DOI 10.1007/978-1-4471-4285-0_10]; BiOM Personal Bionics, T2 PROD BROCH; Boone DA, 2012, J REHABIL RES DEV, V49, P843, DOI 10.1682/JRRD.2011.08.0143; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Felt W, INSTANTANEUOS COST M; Galle S, 2014, 2D PARAMETER SWEEP B; Isermann R, 2011, IDENTIFICATION OF DYNAMIC SYSTEMS: AN INTRODUCTION WITH APPLICATIONS, P1, DOI 10.1007/978-3-540-78879-9; Israel JF, 2006, PHYS THER, V86, P1466, DOI 10.2522/ptj.20050266; Kobayashi T, 2015, PROSTHET ORTHOT INT, V39, P512, DOI 10.1177/0309364614545421; LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003, DOI 10.1152/jappl.1987.62.5.2003; Lawrence G., 2002, P 19 C UNC ART INT, P354; Lawson BE, 2013, IEEE INT CONF ROBOT, P3888, DOI 10.1109/ICRA.2013.6631124; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; McLean J.A., 2007, ANIMAL HUMAN CALORIM; MYERS J, 1990, J APPL PHYSIOL, V68, P404, DOI 10.1152/jappl.1990.68.1.404; Myers R. H., 2009, RESPONSE SURFACE MET, V705; Olkin I, 1960, CONTRIBUTIONS PROBAB; RALSTON H J, 1958, Int Z Angew Physiol, V17, P277; Sawicki GS, 2009, J EXP BIOL, V212, P32, DOI 10.1242/jeb.017277; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Selinger JC, 2014, J APPL PHYSIOL, V117, P1406, DOI 10.1152/japplphysiol.00445.2014; Snaterse M, 2011, J APPL PHYSIOL, V110, P1682, DOI 10.1152/japplphysiol.00536.2010; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Umberger BR, 2007, J EXP BIOL, V210, P3255, DOI 10.1242/jeb.000950; Zahedi M S, 1986, J Rehabil Res Dev, V23, P2; Zelik KE, 2011, IEEE T NEUR SYS REH, V19, P411, DOI 10.1109/TNSRE.2011.2159018	29	67	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135342	10.1371/journal.pone.0135342	http://dx.doi.org/10.1371/journal.pone.0135342			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288361	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600044
J	Wu, CY; Lin, YW; Kuo, CH; Liu, WH; Tai, HF; Pan, CH; Chen, YT; Hsiao, PW; Chan, CH; Chang, CC; Liu, CC; Chow, YH; Chen, JR				Wu, Chia-Ying; Lin, Yi-Wen; Kuo, Chia-Ho; Liu, Wan-Hsin; Tai, Hsiu-Fen; Pan, Chien-Hung; Chen, Yung-Tsung; Hsiao, Pei-Wen; Chan, Chi-Hsien; Chang, Ching-Chuan; Liu, Chung-Cheng; Chow, Yen-Hung; Chen, Juine-Ruey			Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse	PLOS ONE			English	Article							COXSACKIEVIRUS A16; NEUTRALIZING ANTIBODIES; MOUTH-DISEASE; STRAIN; HAND; MICE; FOOT; IMMUNIZATION; INFECTIONS; SELECTION	Epidemics and outbreaks caused by infections of several subgenotypes of EV71 and other serotypes of coxsackie A viruses have raised serious public health concerns in the Asia-Pacific region. These concerns highlight the urgent need to develop a scalable manufacturing platform for producing an effective and sufficient quantity of vaccines against deadly enteroviruses. In this report, we present a platform for the large-scale production of a vaccine based on the inactivated EV71(E59-B4) virus. The viruses were produced in Vero cells in a 200 L bioreactor with serum-free medium, and the viral titer reached 10(7) TCID50/mL 10 days after infection when using an MOI of 10(-4). The EV71 virus particles were harvested and purified by sucrose density gradient centrifugation. Fractions containing viral particles were pooled based on ELISA and SDS-PAGE. TEM was used to characterize the morphologies of the viral particles. To evaluate the cross-protective efficacy of the EV71 vaccine, the pooled antigens were combined with squalene-based adjuvant (AddaVAX) or aluminum phosphate (AlPO4) and tested in human SCARB2 transgenic (Tg) mice. The Tg mice immunized with either the AddaVAX- or AlPO4-adjuvanted EV71 vaccine were fully protected from challenges by the subgenotype C2 and C4 viruses, and surviving animals did not show any degree of neurological paralysis symptoms or muscle damage. Vaccine treatments significantly reduced virus antigen presented in the central nervous system of Tg mice and alleviated the virus-associated inflammatory response. These results strongly suggest that this preparation results in an efficacious vaccine and that the microcarrier/bioreactor platform offers a superior alternative to the previously described roller-bottle system.	[Wu, Chia-Ying; Kuo, Chia-Ho; Liu, Wan-Hsin; Tai, Hsiu-Fen; Pan, Chien-Hung; Chen, Yung-Tsung; Chan, Chi-Hsien; Chang, Ching-Chuan; Liu, Chung-Cheng; Chen, Juine-Ruey] Adimmune Corp, Taichung, Taiwan; [Lin, Yi-Wen; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan; [Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Liu, Chung-Cheng] Enimmune Corp, Taichung, Taiwan; [Chow, Yen-Hung] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan	Chow, YH (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan.	choeyenh@nhri.org.tw; JR_Chen@adimmune.com.tw	Hsiao, Pei-Wen/V-5653-2018	Hsiao, Pei-Wen/0000-0002-3589-6754	Adimmune Corporation; Enimmune Corporation; Ministry of Economic Affairs, Taiwan [101-EC-17-A-20-I1-0054]	Adimmune Corporation; Enimmune Corporation; Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan)	This study was supported by funds from Adimmune Corporation, Enimmune Corporation and the Ministry of Economic Affairs, Taiwan (grant no. 101-EC-17-A-20-I1-0054). Enimmune is a subsidiary of Adimmune Corp. Coauthors CYW, CHK, WHL, HFT, CHP, YTC, CHC, CCC, CCL and JRC are all employees of Adimmune Corporation. CCL is also serving as acting general manager of Enimmune Corporation. The parties provided the financial support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Cai YC, 2014, VACCINE, V32, P2406, DOI 10.1016/j.vaccine.2014.03.012; Cai YC, 2013, VACCINE, V31, P2215, DOI 10.1016/j.vaccine.2013.03.007; Chang JY, 2012, VACCINE, V30, P703, DOI 10.1016/j.vaccine.2011.11.087; Chong P, 2014, CLIN INFECT DIS OFFI; Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739; Chong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049973; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chou AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034834; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Khong WX, 2012, J VIROL; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Li JX, 2014, EXPERT REV VACCINES, V13, P609, DOI 10.1586/14760584.2014.897617; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Liang ZL, 2013, HUM VACC IMMUNOTHER, V9, P1701, DOI 10.4161/hv.24949; Lin CW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/670506; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057591; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2014, VACCINE, V32, P6177, DOI 10.1016/j.vaccine.2014.08.064; Liu CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106756; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sabanathan S, 2014, J EPIDEMIOL COMMUN H, V68, P500, DOI 10.1136/jech-2014-203836; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	46	22	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136420	10.1371/journal.pone.0136420	http://dx.doi.org/10.1371/journal.pone.0136420			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287531	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600137
J	Zhou, XL; Zhang, CJ; Wang, M; Yu, LN; Yan, M				Zhou, Xuelong; Zhang, Chenjing; Wang, Min; Yu, LiNa; Yan, M.			Dezocine for Preventing Postoperative Pain: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							DOUBLE-BLIND; INTRAMUSCULAR DEZOCINE; PLACEBO; BUTORPHANOL; MORPHINE; RELIEF; ANALGESIA	Background Dezocine is considered to be an alternative medication for managing postoperative pain. The aim of this study was to assess the efficacy and safety of this drug in this regard. Methods Medline, EMBASE and the Cochrane Central Register of Control Trials (CENTRAL) were searched to identify all randomized controlled trials (RCTs) that compare dezocine with placebo or dezocine with morphine on postoperative pain. The data were extracted and pooled using Mantel-Haenszel random effects model. Heterogeneity was tested using the I-2 statistic with values >50% and Chi(2) test with P <= 0.05 indicating obvious heterogeneity between the studies. Results Seven trials evaluating 665 patients were included. The number of patients with at least 50% pain relief was increased (N = 234; RR 3.04, 95% CI 2.27 to 4.08) and physician (N = 465; RR 2.84, 95% CI 1.66 to 4.84) and patient satisfaction (N = 390; RR 2.81, 95% CI 1.85 to 4.26) were improved following the administration of dezocine compared with the placebo. The effects of dezocine were similar to those of morphine in terms of the number of patients reporting at least 50% pain relief within 2-6 h after surgery (N = 235; RR 1.29, 95% CI 1.15 to 1.46) and physician (N = 234; RR 1.18, 95% CI 0.93 to 1.49) and patient (N = 158; RR 1.33, 95% CI 0.93 to 1.92) satisfaction. While, the number of patients with at least 50% pain relief within 0-1 h after surgery increased following dezocine compared with morphine treatment (N = 79; RR 1.45, 95% CI 1.18 to 1.77). There was no difference in the incidence of postoperative nausea and vomiting (PONV) following dezocine treatment compared with the placebo (N = 391; RR 1.06, 95% CI 0.42 to 2.68) or morphine treatment (N = 235; RR 0.65, 95% CI 0.14 to 2.93). Conclusion Dezocine is a promising analgesic for preventing postoperative pain, but further studies are required to evaluate its safety.	[Zhou, Xuelong; Yu, LiNa; Yan, M.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Chenjing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, LiNa; Yan, M.] Xuzhou Med Coll, Jiangsu Key Lab Anesthesiol, Xuzhou, Peoples R China	Zhejiang University; Zhejiang University; Xuzhou Medical University	Yan, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China.	zryanmin@zju.edu.cn						Capdevila X, 1999, ANESTHESIOLOGY, V91, P8, DOI 10.1097/00000542-199907000-00006; COHEN RI, 1993, ANESTH ANALG, V77, P533; DOWNING JW, 1981, BRIT J ANAESTH, V53, P59, DOI 10.1093/bja/53.1.59; Edwards WT, 1986, CLIN J PAIN, V2, P183; FINUCANE BT, 1986, SOUTHERN MED J, V79, P548, DOI 10.1097/00007611-198605000-00008; FRAGEN RJ, 1978, ANESTH ANALG, V57, P563, DOI 10.1213/00000539-197857050-00010; GALLOWAY FM, 1986, ANESTH ANALG, V65, P283; Garimella V, 2013, CLIN COLON RECT SURG, V26, P191, DOI 10.1055/s-0033-1351138; GRAVENSTEIN JS, 1984, INT J CLIN PHARM TH, V22, P502; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kehlet H, 2001, BRIT J ANAESTH, V87, P62, DOI 10.1093/bja/87.1.62; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Liu RY, 2014, ANESTHESIOLOGY, V120, P714, DOI 10.1097/ALN.0000000000000076; OBRIEN JJ, 1989, DRUGS, V38, P226, DOI 10.2165/00003495-198938020-00005; PANDIT SK, 1985, CAN ANAESTH SOC J, V32, P583, DOI 10.1007/BF03011403; PANDIT UA, 1986, J CLIN PHARMACOL, V26, P275, DOI 10.1002/j.1552-4604.1986.tb03523.x; STAMBAUGH JE, 1987, CLIN PHARMACOL THER, V42, P210, DOI 10.1038/clpt.1987.134; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Vadivelu N, 2014, LOCAL REG ANESTH, V7, P17, DOI 10.2147/LRA.S62160; Wu Fei-Xiang, 2014, Transl Perioper Pain Med, V1, P5; Zhu YM, 2011, J BIOMED RES, V25, P356, DOI 10.1016/S1674-8301(11)60047-X	24	26	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136091	10.1371/journal.pone.0136091	http://dx.doi.org/10.1371/journal.pone.0136091			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287536	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600107
J	Barbone, D; Follo, C; Echeverry, N; Gerbaudo, VH; Klabatsa, A; Bueno, R; Felley-Bosco, E; Broaddus, VC				Barbone, Dario; Follo, Carlo; Echeverry, Nohemy; Gerbaudo, Victor H.; Klabatsa, Astero; Bueno, Raphael; Felley-Bosco, Emanuela; Broaddus, V. Courtney			Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models	PLOS ONE			English	Article							3-KINASE/MAMMALIAN TARGET; APOPTOTIC RESISTANCE; INHIBITOR GDC-0980; KINASE INHIBITOR; LUNG-CANCER; MTOR; PATHWAY; PROTEINS; SURVIVAL; BCL-2	Malignant pleural mesothelioma is a highly chemoresistant solid tumor. We have studied this apoptotic resistance using in vitro and ex vivo three-dimensional models, which acquire a high level of chemoresistance that can be reduced by PI3K/mTOR inhibitors. Here, we investigate the activity of GDC-0980, a novel dual PI3K/mTOR inhibitor, which has been proposed to be effective in mesothelioma. In this work, we aimed to identify mechanisms and markers of efficacy for GDC-0980 by utilizing 3D models of mesothelioma, both in vitro multicellular spheroids and ex vivo tumor fragment spheroids grown from patient tumor samples. We found that a subset of mesothelioma spheroids is sensitive to GDC-0980 alone and to its combination with chemotherapy. Unexpectedly, this sensitivity did not correlate with the activation of the Akt/mTOR pathway. Instead, sensitivity to GDC-0980 correlated with the presence of constitutive ATG13 puncta, a feature of autophagy, a cellular program that supports cells under stress. In tumor fragment spheroids grown from 21 tumors, we also found a subset (n = 11) that was sensitive to GDC-0980, a sensitivity that also correlated with the presence of ATG13 puncta. Interference with autophagy by siRNA of ATG7, an essential autophagic protein, increased the response to chemotherapy, but only in the sensitive multicellular spheroids. In the spheroids resistant to GDC-0980, autophagy appeared to play no role. In summary, we show that GDC-0980 is effective in mesothelioma 3D models that display ATG13 puncta, and that blockade of autophagy increases their response to chemotherapy. For the first time, we show a role for autophagy in the response to chemotherapy of 3D models of mesothelioma and propose ATG13 as a potential biomarker of the therapeutic responsiveness of mesothelioma.	[Barbone, Dario; Follo, Carlo; Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA; [Echeverry, Nohemy; Felley-Bosco, Emanuela] Univ Zurich Hosp, Clin Oncol, CH-8044 Zurich, Switzerland; [Gerbaudo, Victor H.] Brigham & Womens Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02115 USA; [Klabatsa, Astero] Kings Coll London, Dept Res Oncol, London, England; [Bueno, Raphael] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Zurich; University Zurich Hospital; Harvard University; Brigham & Women's Hospital; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barbone, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA.	dario.barbone@ucsf.edu	Felley-Bosco, Emanuela/E-7484-2017; Klampatsa, Astero/AAK-4419-2020	Felley-Bosco, Emanuela/0000-0002-3408-0294; Klampatsa, Astero/0000-0003-0572-502X; Follo, Carlo/0000-0001-9711-2655	Mesothelioma Applied Research Foundation Grant [255458]; Simmons Mesothelioma Foundation - Simmons Fellowship in Mesothelioma Research; Swiss National Science Foundation; Baugarten Foundation	Mesothelioma Applied Research Foundation Grant; Simmons Mesothelioma Foundation - Simmons Fellowship in Mesothelioma Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baugarten Foundation	This work was supported by Mesothelioma Applied Research Foundation Grant 255458 to DB (http://www.curemeso.org). Additional funding was provided by the Simmons Mesothelioma Foundation - Simmons Fellowship in Mesothelioma Research to CF (http://www.simmonsmesotheliomafoundation.org/). Further support was provided by the Swiss National Science Foundation and Baugarten Foundation grants to EFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Alers S, 2014, AUTOPHAGY, V10, P944, DOI 10.4161/auto.28987; Alers S, 2011, AUTOPHAGY, V7, P1424, DOI 10.4161/auto.7.12.18027; Alifrangis CC, 2014, MOL ONCOL, V8, P1112, DOI 10.1016/j.molonc.2014.05.014; Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Barbone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052753; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Battisti S, 2012, AM J RESP CELL MOL, V46, P498, DOI 10.1165/rcmb.2011-0195OC; Broaddus VC, 2005, J BIOL CHEM, V280, P12486, DOI 10.1074/jbc.M408190200; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; Cedres S, 2012, LUNG CANCER, V77, P192, DOI 10.1016/j.lungcan.2012.02.022; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Claerhout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039400; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fischer B, 2012, LUNG CANCER, V78, P23, DOI 10.1016/j.lungcan.2012.07.005; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Gump JM, 2014, NAT CELL BIOL, V16, P47, DOI 10.1038/ncb2886; Guo J, 2013, ONCOGENE, V32, P151, DOI 10.1038/onc.2012.39; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARASAWA R, 1993, RES MICROBIOL, V144, P489, DOI 10.1016/0923-2508(93)90057-9; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hoda MA, 2011, J THORAC ONCOL, V6, P852, DOI 10.1097/JTO.0b013e31820e1a25; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kanteti R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105919; Klabatsa A, 2014, EUR J NUCL MED MOL I, V41, P276, DOI 10.1007/s00259-013-2561-1; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li JR, 2013, TOXICOL LETT, V220, P267, DOI 10.1016/j.toxlet.2013.04.021; METCALF RA, 1992, CANCER RES, V52, P2610; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; POPESCU NC, 1988, CANCER RES, V48, P142; Ramos-Nino ME, 2008, AM J RESP CELL MOL, V38, P209, DOI 10.1165/rcmb.2007-0206OC; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Salphati L, 2012, DRUG METAB DISPOS, V40, P1785, DOI 10.1124/dmd.112.046052; Sartore-Bianchi A, 2007, CLIN CANCER RES, V13, P5942, DOI 10.1158/1078-0432.CCR-07-0536; Satoh M, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-19; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Sutherlin DP, 2011, J MED CHEM, V54, P7579, DOI 10.1021/jm2009327; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Suzuki Y, 2009, MOL MED REP, V2, P181, DOI 10.3892/mmr_00000081; Tang JY, 2014, BIOCHEM BIOPH RES CO, V453, P533, DOI 10.1016/j.bbrc.2014.09.115; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Wallin JJ, 2011, MOL CANCER THER, V10, P2426, DOI 10.1158/1535-7163.MCT-11-0446; Watson PM, 2008, AM J RESP CELL MOL, V38, P671, DOI 10.1165/rcmb.2007-0205OC; Watzka SB, 2011, EUR J CARDIO-THORAC, V39, P180, DOI 10.1016/j.ejcts.2010.05.007; Wilson SM, 2008, AM J RESP CELL MOL, V39, P576, DOI 10.1165/rcmb.2007-0460OC; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Zhou S, 2014, BRIT J CANCER, V110, P2479, DOI 10.1038/bjc.2014.220	55	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134825	10.1371/journal.pone.0134825	http://dx.doi.org/10.1371/journal.pone.0134825			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284517	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100017
J	Lebeau, J; Wesselingh, RA; Van Dyck, H				Lebeau, Julie; Wesselingh, Renate A.; Van Dyck, Hans			Butterfly Density and Behaviour in Uncut Hay Meadow Strips: Behavioural Ecological Consequences of an Agri-Environmental Scheme	PLOS ONE			English	Article							CENTAUREA-SCABIOSA L; NECTAR AMINO-ACIDS; MANIOLA-JURTINA; LIFE-HISTORY; NIGRA L; CONSERVATION; GRASSLANDS; DIVERSITY; BIODIVERSITY; POLLINATORS	Sparing zones from mowing has been proposed, and applied, to improve local conditions for survival and reproduction of insects in hay meadows. However, little is known about the efficiency of refuge zones and the consequences for local populations. We studied population densities of butterflies before and after mowing in the refuge zone of 15 meadows in 2009 and 2011. We also studied the behaviour of the meadow brown (Maniola jurtina) comparing nectar use, interactions and flights in the refuge zone before and after mowing. Densities of grassland butterflies in this zone doubled on average after mowing. The density of females of M. jurtina increased on average fourfold, while males showed a more modest increase. In line with the idea of increased scramble competition in the refuge zone after mowing, M. jurtina increased the time spent on nectar feeding, the preferred nectar source was visited more frequently, and females made more use of non-preferred nectar sources. Maniola jurtina did not interact more with conspecifics after mowing, but interactions lasted longer. Flight tracks did not change in linearity, but were faster and shorter after mowing. After mowing, only a part of the local grassland butterflies moved to the uncut refuge zone. The resulting concentration effect alters the time allocated to different activities, nectar use and movements. These aspects have been largely ignored for agri-environmental schemes and grassland management in nature reserves and raise questions about optimal quantities and quality of uncut refuge sites for efficient conservation of grassland arthropods in agricultural landscapes.	[Lebeau, Julie; Wesselingh, Renate A.; Van Dyck, Hans] UCL, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium	Universite Catholique Louvain	Van Dyck, H (corresponding author), UCL, Biodivers Res Ctr, Earth & Life Inst, Croix Sud 4-5,Box L7-07-04, B-1348 Louvain, Belgium.	hans.vandyck@uclouvain.be	Wesselingh, Renate A./F-4240-2011	Wesselingh, Renate A./0000-0003-0241-2255				Aviron S, 2007, AGR ECOSYST ENVIRON, V122, P295, DOI 10.1016/j.agee.2006.12.035; Aviron S, 2011, RESTOR ECOL, V19, P500, DOI 10.1111/j.1526-100X.2010.00649.x; Balmer O, 2000, CONSERV BIOL, V14, P746, DOI 10.1046/j.1523-1739.2000.98612.x; Berwaerts K, 2004, OECOLOGIA, V141, P536, DOI 10.1007/s00442-004-1661-9; Blake RJ, 2011, J INSECT CONSERV, V15, P221, DOI 10.1007/s10841-010-9339-6; BOGGS CL, 1993, ECOLOGY, V74, P433, DOI 10.2307/1939305; BRAKEFIELD PM, 1982, J ANIM ECOL, V51, P713, DOI 10.2307/4000; Braschler B, 2009, ECOL ENTOMOL, V34, P321, DOI 10.1111/j.1365-2311.2008.01080.x; Buri P, 2013, AGR ECOSYST ENVIRON, V181, P22, DOI 10.1016/j.agee.2013.09.003; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; Cowley MJR, 2001, J ANIM ECOL, V70, P410, DOI 10.1046/j.1365-2656.2001.00508.x; Croxton PJ, 2005, BIOL CONSERV, V121, P579, DOI 10.1016/j.biocon.2004.06.008; Dahlstrom A., 2008, Environment and History, V14, P385, DOI 10.3197/096734008X333572; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; Delattre T, 2013, AGR ECOSYST ENVIRON, V166, P102, DOI 10.1016/j.agee.2011.06.018; Delattre T, 2010, OIKOS, V119, P1900, DOI 10.1111/j.1600-0706.2010.18615.x; Dover JW, 2010, J INSECT CONSERV, V14, P413, DOI 10.1007/s10841-010-9267-5; Dover JW, 1997, AGR ECOSYST ENVIRON, V63, P31, DOI 10.1016/S0167-8809(96)01120-6; Dover JW, 1996, J APPL ECOL, V33, P723, DOI 10.2307/2404943; Erhardt A, 1998, OECOLOGIA, V117, P536, DOI 10.1007/s004420050690; Feber RE, 1996, J APPL ECOL, V33, P1191, DOI 10.2307/2404698; Field RG, 2006, BIODIVERS CONSERV, V16, P465; Hirsch M, 2003, AGR ECOSYST ENVIRON, V98, P331, DOI 10.1016/S0167-8809(03)00093-8; Hossain Z, 2002, J APPL ECOL, V39, P445, DOI 10.1046/j.1365-2664.2002.00729.x; Humbert JY, 2010, J APPL ENTOMOL, V134, P592, DOI 10.1111/j.1439-0418.2009.01503.x; Humbert JY, 2012, BIOL CONSERV, V152, P96, DOI 10.1016/j.biocon.2012.03.015; Humbert JY, 2009, AGR ECOSYST ENVIRON, V130, P1, DOI 10.1016/j.agee.2008.11.014; Jervis MA, 2005, TRENDS ECOL EVOL, V20, P585, DOI 10.1016/j.tree.2005.08.015; Johst K, 2006, J APPL ECOL, V43, P333, DOI 10.1111/j.1365-2664.2006.01125.x; Kohler F, 2008, J APPL ECOL, V45, P753, DOI 10.1111/j.1365-2664.2007.01394.x; Kulfan J, 2012, POL J ECOL, V60, P601; LACK AJ, 1982, NEW PHYTOL, V91, P309, DOI 10.1111/j.1469-8137.1982.tb03315.x; LACK AJ, 1982, NEW PHYTOL, V91, P321, DOI 10.1111/j.1469-8137.1982.tb03316.x; Littlewood NA, 2012, INSECT CONSERV DIVER, V5, P1, DOI 10.1111/j.1752-4598.2011.00174.x; Meek B, 2002, BIOL CONSERV, V106, P259, DOI 10.1016/S0006-3207(01)00252-X; Merckx T, 2002, J INSECT BEHAV, V15, P541, DOI 10.1023/A:1016385301634; Mevi-Schutz J, 2005, AM NAT, V165, P411, DOI 10.1086/429150; O'Brien DM, 2004, OIKOS, V105, P279, DOI 10.1111/j.0030-1299.2004.13012.x; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; ODENDAAL FJ, 1989, OECOLOGIA, V78, P283, DOI 10.1007/BF00377167; Ouin A, 2004, AGR ECOSYST ENVIRON, V103, P473, DOI 10.1016/j.agee.2003.11.003; POLLARD E, 1994, MONITORING BUTTERFLI; Pryke SR, 2001, BIOL CONSERV, V101, P85, DOI 10.1016/S0006-3207(01)00042-8; Pywell RF, 2004, BIOL CONSERV, V118, P313, DOI 10.1016/j.biocon.2003.09.011; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Sang A, 2011, INSECT CONSERV DIVER, V4, P257, DOI 10.1111/j.1752-4598.2011.00134.x; SAS, 2012, SAS STAT 12 1 US GUI; Schneider C, 2003, ECOL ENTOMOL, V28, P219, DOI 10.1046/j.1365-2311.2003.00494.x; Schultz CB, 1999, OECOLOGIA, V119, P231, DOI 10.1007/s004420050781; Tallowin JRB, 2005, GRASS FORAGE SCI, V60, P225, DOI 10.1111/j.1365-2494.2005.00470.x; Thorbek P, 2004, J APPL ECOL, V41, P526, DOI 10.1111/j.0021-8901.2004.00913.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Valtonen A., 2006, Animal Biodiversity and Conservation, V29, P133; Van Dyck H, 2010, ANIM BEHAV, V80, P621, DOI 10.1016/j.anbehav.2010.06.021; van Swaay C, 2006, J INSECT CONSERV, V10, P189, DOI 10.1007/s10841-006-6293-4; Van Swaay CAM, 2013, EUROPEAN GRASSLAND B, P1; Venables WN., 2002, MODERN APPL STAT S 4; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; WICKMAN PO, 1988, ZOOL J LINN SOC-LOND, V93, P357, DOI 10.1111/j.1096-3642.1988.tb01367.x; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	64	16	17	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134945	10.1371/journal.pone.0134945	http://dx.doi.org/10.1371/journal.pone.0134945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284618	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100018
J	Lee, S; Kim, JE; Hong, SH; Lee, AY; Park, EJ; Seo, HW; Chae, C; Doble, P; Bishop, D; Cho, MH				Lee, Somin; Kim, Ji-Eun; Hong, Seong-Ho; Lee, Ah-Young; Park, Eun-Jung; Seo, Hwi Won; Chae, Chanhee; Doble, Philip; Bishop, David; Cho, Myung-Haing			High Inorganic Phosphate Intake Promotes Tumorigenesis at Early Stages in a Mouse Model of Lung Cancer	PLOS ONE			English	Article							DIETARY PHOSPHORUS; TRANSLATION INITIATION; PROTEIN TRANSLATION; CELL-CYCLE; ANGIOGENESIS; METABOLISM; APOPTOSIS; AUTOPHAGY; GROWTH; MTOR	Inorganic phosphate (Pi) is required by all living organisms for the development of organs such as bone, muscle, brain, and lungs, regulating the expression of several critical genes as well as signal transduction. However, little is known about the effects of prolonged dietary Pi consumption on lung cancer progression. This study investigated the effects of a high-phosphate diet (HPD) in a mouse model of adenocarcinoma. K-ras(LA1) mice were fed a normal diet (0.3% Pi) or an HPD (1% Pi) for 1, 2, or 4 months. Mice were then sacrificed and subjected to inductively coupled plasma mass/optical emission spectrometry and laser ablation inductively coupled plasma mass-spectrometry analyses, western blot analysis, histopathological, immunohistochemical, and immunocytochemical analyses to evaluate tumor formation and progression (including cell proliferation, angiogenesis, and apoptosis), changes in ion levels and metabolism, autophagy, epithelial-to-mesenchymal transition, and protein translation in the lungs. An HPD accelerated tumorigenesis, as evidenced by increased adenoma and adenocarcinoma rates as well as tumor size. However, after 4 months of the HPD, cell proliferation was arrested, and marked increases in liver and lung ion levels and in energy production via the tricarboxylic acid cycle in the liver were observed, which were accompanied by increased autophagy and decreased angiogenesis and apoptosis. These results indicate that an HPD initially promotes but later inhibits lung cancer progression because of metabolic adaptation leading to tumor cell quiescence. Moreover, the results suggest that carefully regulated Pi consumption are effective in lung cancer prevention.	[Lee, Somin; Kim, Ji-Eun; Hong, Seong-Ho; Lee, Ah-Young; Cho, Myung-Haing] Seoul Natl Univ, Res Inst Vet Sci, PLUSProgram Creat Vet Sci Res BK21, Toxicol Lab, Seoul 151742, South Korea; [Lee, Somin; Kim, Ji-Eun; Hong, Seong-Ho; Lee, Ah-Young; Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Seoul 151742, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Suwon 443270, South Korea; [Park, Eun-Jung] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Seo, Hwi Won; Chae, Chanhee] Seoul Natl Univ, Coll Vet Med, Pathol Lab, Seoul 151742, South Korea; [Doble, Philip; Bishop, David] Univ Technol Sydney, Dept Chem & Forens Sci, Elemental Bioimaging Facil, Sydney, NSW 2007, Australia; [Lee, Somin; Cho, Myung-Haing] Seoul Natl Univ, Grad Grp Tumor Biol, Seoul 151742, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ajou University; Seoul National University (SNU); University of Technology Sydney; Seoul National University (SNU); Seoul National University (SNU)	Cho, MH (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, PLUSProgram Creat Vet Sci Res BK21, Toxicol Lab, Seoul 151742, South Korea.	mchotox@snu.ac.kr	Cho, Myung-Haing/B-7362-2014; Doble, Philip/A-8812-2012; Park, Eun-Jung/Y-4427-2019; Bishop, David P/F-2891-2019; Kim, Ji-Eun/AAL-8406-2021	Cho, Myung-Haing/0000-0002-3993-2011; Doble, Philip/0000-0002-8472-1301; Bishop, David P/0000-0002-6533-4410; Kim, Ji-Eun/0000-0002-3643-2177; Chae, Chanhee/0000-0002-0190-1957	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012M3A9C4048819]; Research Institute for Veterinary Science, Seoul National University; Kenelec Scientific as part of the Linkage Projects program [LP100200254]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Research Institute for Veterinary Science, Seoul National University; Kenelec Scientific as part of the Linkage Projects program	Part of this work is supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9C4048819). M.H. Cho was also partially supported by the Research Institute for Veterinary Science, Seoul National University. LA-IPC-MS experiments were performed with support from the Australian Research Council, Agilent Technologies, and Kenelec Scientific as part of the Linkage Projects program (LP100200254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; CALVO MS, 1993, J NUTR, V123, P1627, DOI 10.1093/jn/123.9.1627; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chang SH, 2013, J TOXICOL SCI, V38, P823; Ducker GS, 2014, ONCOGENE, V33, P1590, DOI 10.1038/onc.2013.92; Fujimura K, 2012, NUCLEIC ACIDS RES, V40, P8099, DOI 10.1093/nar/gks566; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hinnebusch AG, 2012, MOL CELL, V46, P717, DOI 10.1016/j.molcel.2012.06.001; Hong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077121; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; HUNTINGTON GB, 1990, REPROD NUTR DEV, V30, P35, DOI 10.1051/rnd:19900103; Israelsen WJ, 2010, CELL, V143, P669, DOI 10.1016/j.cell.2010.11.010; Jin H, 2006, TOXICOL SCI, V90, P221, DOI 10.1093/toxsci/kfj066; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Jin H, 2007, TOXICOL SCI, V100, P215, DOI 10.1093/toxsci/kfm202; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Krasko A, 2002, DNA CELL BIOL, V21, P67, DOI 10.1089/10445490252810320; Ku JH, 2012, UROL ONCOL-SEMIN ORI, V30, P562, DOI 10.1016/j.urolonc.2010.06.001; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lampila LE, 2013, ANN NY ACAD SCI, V1301, P37, DOI 10.1111/nyas.12230; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Lear J, 2012, ANAL CHEM, V84, P6707, DOI 10.1021/ac301156f; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; Sosa MS, 2013, ADV EXP MED BIOL, V734, P73, DOI 10.1007/978-1-4614-1445-2_5; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Takeda E, 2012, NUTR REV, V70, P311, DOI 10.1111/j.1753-4887.2012.00473.x; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Tuquet C, 2000, CELL BIOL TOXICOL, V16, P207, DOI 10.1023/A:1007695308257; Untergasser G, 2000, BIOCHEM BIOPH RES CO, V279, P607, DOI 10.1006/bbrc.2000.3975; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wulaningsih W, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-257; Xu CX, 2008, AM J PHYSIOL-GASTR L, V295, pG654, DOI 10.1152/ajpgi.90213.2008; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135582	10.1371/journal.pone.0135582	http://dx.doi.org/10.1371/journal.pone.0135582			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285136	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100046
J	Park, JI; Bae, E; Kim, YL; Kang, SW; Yang, CW; Kim, NH; Lee, JP; Kim, DK; Joo, KW; Kim, YS; Lee, H				Park, Ji In; Bae, Eunjin; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Lee, Jung Pyo; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Lee, Hajeong			Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea	PLOS ONE			English	Article							INTENSIVE GLUCOSE CONTROL; FOLLOW-UP; HEMODIALYSIS; SURVIVAL; HEMOGLOBIN; OUTCOMES; THERAPY; DEATH	Background Active glycemic control has been proven to delay the onset and slow the progression of diabetic retinopathy, nephropathy, and neuropathy in diabetic patients, but the optimal level is obscure in end-stage renal disease. In this study, we evaluated the effect of hemoglobin A1c (HbA1c) on mortality of diabetic patients on dialysis, focusing on age and dialysis type. Methods Of 3,302 patients enrolled in the prospective cohort for end-stage renal disease in Korea between August 2008 and October 2013, 1,239 diabetic patients who had been diagnosed with diabetes or having HbA1c >= 6.5% at the time of enrollment were analyzed. Age was categorized as <55, 55-64 and >= 65 years old. Age, sex, modified Charlson comorbidity index, hemoglobin, primary renal disease, body mass index, and dialysis duration were adjusted. Results A total of 873 patients received hemodialysis (HD) and 366 underwent peritoneal dialysis (PD). During the mean follow-up of 19.1 months, 141 patients died. Patients with poor glucose control (HbA1c >= 8%) showed worse survival than patients with HbA1c<8% (hazard ratio [HR], 2.2; 95% confidence interval [CI], 1.48-3.29; P<0.001). Subgroup analysis divided by age revealed that HbA1c >= 8% was a predictor of mortality in age <55 (HR, 4.3; 95% CI, 1.78-10.41; P = 0.001) and age 55-64 groups (HR, 3.3; 95% CI, 1.56-7.05; P = 0.002), but not in age >= 65 group. Combining dialysis type and age, poor glucose control negatively affected survival only in age < 55 group among HD patients, but it was significant in age < 55 and age 55-64 groups in PD patients. Deaths from infection were more prevalent in the PD group, and poor glucose control tended to correlate with more deaths from infection in PD patients (P = 0.050). Conclusions In this study, the effect of glycemic control differed according to age and dialysis type in diabetic patients. Thus, the target of glycemic control should be customized; further observational studies may strengthen the clinical relevance.	[Park, Ji In] Kangwon Natl Univ, Dept Internal Med, Coll Med, Chunchon, South Korea; [Park, Ji In; Bae, Eunjin; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Lee, Jung Pyo; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Lee, Hajeong] Clin Res Ctr End Stage Renal Dis Korea, Daegu, South Korea; [Bae, Eunjin; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Lee, Hajeong] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Dept Internal Med, Sch Med, Gwangju, South Korea; [Lee, Jung Pyo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea	Kangwon National University; Seoul National University (SNU); Kyungpook National University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Seoul National University (SNU); Seoul National University Hospital	Lee, H (corresponding author), Clin Res Ctr End Stage Renal Dis Korea, Daegu, South Korea.	mdhjlee@gmail.com	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852; Park, Ji In/0000-0003-4662-3759	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). Clinical research center for end-stage renal disease received the funding, and the leader of the center is YLK. The "Ministry of Health and Welfare" URL is: http://www.mw.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2014, DIABETES CARE, V37, P1304, DOI 10.2337/dc13-0553; American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS67, DOI 10.2337/dc15-S013; [Anonymous], 2015, DIABETES CARE, V38, pS33, DOI 10.2337/dc15-S009; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Duong U, 2011, CLIN J AM SOC NEPHRO, V6, P1041, DOI 10.2215/CJN.08921010; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Hill CJ, 2014, AM J KIDNEY DIS, V63, P84, DOI 10.1053/j.ajkd.2013.06.020; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2011, DIABETES CARE, V34, P1329, DOI 10.2337/dc10-2377; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kirkman MS, 2012, J AM GERIATR SOC, V60, P2342, DOI 10.1111/jgs.12035; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Marron B, 2008, KIDNEY INT, V73, pS42, DOI 10.1038/sj.ki.5002600; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Ramirez SPB, 2012, DIABETES CARE, V35, P2527, DOI 10.2337/dc12-0573; Ricks J, 2012, DIABETES, V61, P708, DOI 10.2337/db11-1015; Sekercioglu N, 2012, INT UROL NEPHROL, V44, P1861, DOI 10.1007/s11255-012-0180-6; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wu MS, 1999, PERITONEAL DIALYSIS; Yoo DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030072; Yu CC, 1997, PERITON DIALYSIS INT, V17, P262; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	30	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136085	10.1371/journal.pone.0136085	http://dx.doi.org/10.1371/journal.pone.0136085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285034	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100101
J	Pfleging, J; Stucheli, M; Iovita, R; Buchli, J				Pfleging, Johannes; Stuecheli, Marius; Iovita, Radu; Buchli, Jonas			Dynamic Monitoring Reveals Motor Task Characteristics in Prehistoric Technical Gestures	PLOS ONE			English	Article							STONE; MICROWEAR	Reconstructing ancient technical gestures associated with simple tool actions is crucial for understanding the co-evolution of the human forelimb and its associated control-related cognitive functions on the one hand, and of the human technological arsenal on the other hand. Although the topic of gesture is an old one in Paleolithic archaeology and in anthropology in general, very few studies have taken advantage of the new technologies from the science of kinematics in order to improve replicative experimental protocols. Recent work in paleoanthropology has shown the potential of monitored replicative experiments to reconstruct tool-use-related motions through the study of fossil bones, but so far comparatively little has been done to examine the dynamics of the tool itself. In this paper, we demonstrate that we can statistically differentiate gestures used in a simple scraping task through dynamic monitoring. Dynamics combines kinematics (position, orientation, and speed) with contact mechanical parameters (force and torque). Taken together, these parameters are important because they play a role in the formation of a visible archaeological signature, use-wear. We present our new affordable, yet precise methodology for measuring the dynamics of a simple hide-scraping task, carried out using a pull-to (PT) and a push-away (PA) gesture. A strain gage force sensor combined with a visual tag tracking system records force, torque, as well as position and orientation of hafted flint stone tools. The set-up allows switching between two tool configurations, one with distal and the other one with perpendicular hafting of the scrapers, to allow for ethnographically plausible reconstructions. The data show statistically significant differences between the two gestures: scraping away from the body (PA) generates higher shearing forces, but requires greater hand torque. Moreover, most benchmarks associated with the PA gesture are more highly variable than in the PT gesture. These results demonstrate that different gestures used in 'common' prehistoric tasks can be distinguished quantitatively based on their dynamic parameters. Future research needs to assess our ability to reconstruct these parameters from observed use-wear patterns.	[Pfleging, Johannes; Buchli, Jonas] ETH, Agile & Dexterous Robot Lab, Zurich, Switzerland; [Stuecheli, Marius] ETH, Prod Dev Grp Zurich, Zurich, Switzerland; [Iovita, Radu] RGZM, MONREPOS Archaeol Res Ctr & Museum, Neuwied, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leibniz-Forschungsinstitut fur Archaologie (RGZM)	Pfleging, J (corresponding author), ETH, Agile & Dexterous Robot Lab, Zurich, Switzerland.	pfleginj@ethz.ch; iovita@rgzm.de	Iovita, Radu/B-9580-2015	Iovita, Radu/0000-0001-9531-1159	Swiss National Science Foundation through a Professorship Award; NCCR robotics by Research Grant of ETH Zurich [ETH-36 14-1, ETH-22 13-2]; MONREPOS Archaeological Research Centre of the Romisch-Germanisches Zentralmuseum (RGZM)	Swiss National Science Foundation through a Professorship Award; NCCR robotics by Research Grant of ETH Zurich; MONREPOS Archaeological Research Centre of the Romisch-Germanisches Zentralmuseum (RGZM)	This research has been supported by the Swiss National Science Foundation through a Professorship Award to Jonas Buchli (www.snf.ch) and the NCCR robotics (www.nccrrobotics.ch, JP and JB), by Research Grants of ETH Zurich (www.ethz.ch), ETH-36 14-1 (JB/JP) and ETH-22 13-2 (MS). Radu Iovita thanks the MONREPOS Archaeological Research Centre of the Romisch-Germanisches Zentralmuseum (RGZM, www.rgzm.de) for supporting this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PC, 2006, J ARCHAEOL SCI, V33, P1559, DOI 10.1016/j.jas.2006.02.011; Barcelo Alvarez JA, 2008, PREHISTORIC TECHNOLO, P63; Beyries S., 2008, PREHISTORIC TECHNOLO, P21; CHRISTENSEN M, 1992, NUCL INSTRUM METH B, V64, P488, DOI 10.1016/0168-583X(92)95521-R; Cooper HM, 1954, MAT CULTURE AUSTR AB; Evans AA, 2005, J ARCHAEOL SCI, V32, P1733, DOI 10.1016/j.jas.2005.06.010; Gallagher J. P., 1977, J FIELD ARCHAEOL, V4, P407, DOI [DOI 10.2307/529396, 10.2307/529396]; Gendel P.A., 1982, STUDIA PRAEHISTORICA, V2, P251; Gonzalez-Urquijo J, 2015, MAN ARCHAEOL METH, P27, DOI 10.1007/978-3-319-08257-8_3; Hardy BL, 2008, J HUM EVOL, V54, P648, DOI 10.1016/j.jhevol.2007.10.003; Key AJM, 2013, LITHIC TECHNOL, V38, P32, DOI 10.1179/0197726113Z.0000000001; KNUTSSON K, 1984, ARCHAEOMETRY, V26, P49, DOI 10.1111/j.1475-4754.1984.tb00317.x; Lemonnier Pierre, 1992, ELEMENTS ANTHR TECHN, V88; Leroi-Gourhan A., 1964, GESTE PAROLE TECHNIQ; Mauss M., 1935, J PSYCHOL, V32, P271; Morrow JE., 1997, LITHIC TECHNOL, V22, P70, DOI [10.1080/01977261.1997.11754534, DOI 10.1080/01977261.1997.11754534]; Nissen K., 1974, TEBIWA, V17, P67; Odell G.H., 1980, J FIELD ARCHAEOL, V7, P87, DOI DOI 10.1179/009346980791505545; Odell G.H., 1981, J FIELD ARCHAEOL, V8, P197; ODELL GH, 1994, J ANTHROPOL ARCHAEOL, V13, P51, DOI 10.1006/jaar.1994.1004; Olson Edwin, 2011, 2011 IEEE International Conference on Robotics and Automation, P3400; Rots V, 2004, J ARCHAEOL SCI, V31, P1287, DOI 10.1016/j.jas.2004.02.009; Sahle Y, 2012, AFR ARCHAEOL REV, V29, P383, DOI 10.1007/s10437-012-9114-z; Schlanger N, 1996, CAMB ARCHAEOL J, V6, P231, DOI DOI 10.1017/S0959774300001724; Schmitt D, 2003, J ARCHAEOL SCI, V30, P103, DOI 10.1006/jasc.2001.0814; Seeman MF, 2013, AM ANTIQUITY, V78, P407, DOI 10.7183/0002-7316.78.3.407; Semenov S., 1964, PREHISTORIC TECHNOLO; Shaw CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040349; Shea J., 1992, EVOL ANTHROPOL, V1, P143, DOI DOI 10.1002/EVAN.1360010407; Shott MJ, 2007, J ARCHAEOL SCI, V34, P1016, DOI 10.1016/j.jas.2006.09.009; Sigaut F., 1991, COUTEAU NE SERT PAS, P21; Skinner MM, 2015, SCIENCE, V347, P395, DOI 10.1126/science.1261735; Smit Z, 1999, NUCL INSTRUM METH B, V150, P565, DOI 10.1016/S0168-583X(98)00941-0; Takase K., 2010, ASIAN PERSPECT, V49, P363, DOI [10.1353/asi.2010.0013, DOI 10.1353/ASI.2010.0013]; Tomenchuk J., 1985, THESIS U TORONTO; Tora Belkin KW, 2006, WOMAN TOOLMAKER HIDE; Unrath G, 1984, EARLY MAN NEWS, P117; Williams EM, 2012, J HUM EVOL, V62, P520, DOI 10.1016/j.jhevol.2012.02.005	38	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134570	10.1371/journal.pone.0134570	http://dx.doi.org/10.1371/journal.pone.0134570			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26284785	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100011
J	Sanderman, J; Reseigh, J; Wurst, M; Young, MA; Austin, J				Sanderman, Jonathan; Reseigh, Jodie; Wurst, Michael; Young, Mary-Anne; Austin, Jenet			Impacts of Rotational Grazing on Soil Carbon in Native Grass-Based Pastures in Southern Australia	PLOS ONE			English	Article							ORGANIC-CARBON; PATCH DYNAMICS; LAND-USE; MANAGEMENT; STOCKS; SEQUESTRATION; PARAMETERS; VEGETATION; FRACTIONS; CLIMATE	Rotational grazing management strategies have been promoted as a way to improve the sustainability of native grass-based pasture systems. From disturbance ecology theory, rotational grazing relative to continuous grazing can increase pasture productivity by allowing vegetation to recover after short intense grazing periods. This project sought to assess whether soil organic carbon (SOC) stocks would also increase with adoption of rotational grazing management. Twelve pairs of rotationally and continuously grazed paddocks were sampled across a rainfall gradient in South Australia. Pasture productivity approximated as the normalized difference vegetation index (NDVI) was on average no different between management categories, but when the data from all sites were aggregated as log response ratios (rotational/continuous) a significant positive trend of increasing NDVI under rotational grazing relative to continuous grazing was found (R-2 = 0.52). Mean SOC stocks (0-30 cm) were 48.3 Mg C ha(-1) with a range of 20-80 Mg C ha-1 across the study area with no differences between grazing management categories. SOC stocks were well correlated with rainfall and temperature (multiple linear regression R-2 = 0.61). After removing the influence of climate on SOC stocks, the management variables, rest periods, stocking rate and grazing days, were found to be significantly correlated with SOC, explaining 22% of the variance in SOC, but there were still no clear differences in SOC stocks at paired sites. We suggest three reasons for the lack of SOC response. First, changes in plant productivity and turnover in low-medium rainfall regions due to changes in grazing management are small and slow, so we would only expect at best small incremental changes in SOC stocks. This is compounded by the inherent variability within and between paddocks making detection of a small real change difficult on short timescales. Lastly, the management data suggests that there is a gradation in implementation of rotational grazing and the use of two fixed categories (i.e. rotational v. continuous) may not be the most appropriate method of comparing diverse management styles.	[Sanderman, Jonathan] CSIRO Sustainable Agr Flagship, Urrbrae, SA, Australia; [Reseigh, Jodie; Wurst, Michael; Young, Mary-Anne] Rural Solut SA, Primary Ind & Regions South Australia, Adelaide, SA, Australia; [Austin, Jenet] CSIRO Land & Water Flagship, Black Mountain, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sanderman, J (corresponding author), Woods Hole Res Ctr, Falmouth, MA 02540 USA.	jsanderman@whrc.org	Austin, Jenet/F-8476-2013	Austin, Jenet/0000-0002-9421-0388; Sanderman, Jonathan/0000-0002-3215-1706	Australian Department of Agriculture, CSIRO Sustainable Agriculture Flagship and Rural Solutions South Australia	Australian Department of Agriculture, CSIRO Sustainable Agriculture Flagship and Rural Solutions South Australia	This project was supported by funding from the Australian Department of Agriculture, CSIRO Sustainable Agriculture Flagship and Rural Solutions South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DE, 2013, SOIL RES, V51, P695, DOI 10.1071/SR13041; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2011, 1 2 SRTM DERIVED DIG; Badini O, 2007, AGR SYST, V94, P87, DOI 10.1016/j.agsy.2005.09.010; Bai G, 2013, MYCORRHIZA, V23, P289, DOI 10.1007/s00572-012-0468-5; Baldock JA, 2013, SOIL RES, V51, P577, DOI 10.1071/SR13077; Baldock JA, 2013, SOIL RES, V51, P561, DOI 10.1071/SR12374; Baldock JA, 2011, HDB SOIL SCI; Briske DD, 2008, RANGELAND ECOL MANAG, V61, P3, DOI 10.2111/06-159R.1; BROUGHAM R. W., 1959, NEW ZEALAND JOUR AGRIC RES, V2, P1232; Chan KY, 2010, AUST J SOIL RES, V48, P7, DOI 10.1071/SR09092; Chappell A, 2012, GLOBAL CHANGE BIOL, V18, P2081, DOI 10.1111/j.1365-2486.2012.02682.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conant RT, 2003, BIOL FERT SOILS, V38, P386, DOI 10.1007/s00374-003-0652-z; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Dorrough J, 2004, AUST J AGR RES, V55, P279, DOI 10.1071/AR03024; Earl J. M., 1996, Rangeland Journal, V18, P327, DOI 10.1071/RJ9960327; Fitzgerald D, 2000, PROGRAZIER AUTUMN, P14; Gifford RM, 2003, GLOBAL CHANGE BIOL, V9, P1507, DOI 10.1046/j.1365-2486.2003.00677.x; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Janik LJ, 2006, PREDICT VER 6 0 MIR; Kahn LP, 2010, RANGELAND J, V32, P379, DOI 10.1071/RJ10003; Kemp DR, 2000, AUST J EXP AGR, V40, P343, DOI 10.1071/EA99001; King EA, 2013, NORMALIZED DIFFERENC; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; LEIGH JH, 1978, AUST J EXP AGR, V18, P381, DOI 10.1071/EA9780381; Lodge G. M., 1985, AUST RANGELAND J, V7, P6; Lodge GM, 1997, NSW AGR TECHNICAL B; Loveland P, 2003, SOIL TILL RES, V70, P1, DOI 10.1016/S0167-1987(02)00139-3; Macdonald LM, 2013, SOIL RES, V51, P738, DOI 10.1071/SR13156; Mcsherry ME, 2013, GLOBAL CHANGE BIOL, V19, P1347, DOI 10.1111/gcb.12144; NASA Land Processes Distributed Active Archive Center LP DAAC, 2013, NASA LAND PROC DISTR; Paget M. J., 2008, 004 CSIRO; Queensland Government, 2014, SILO CLIM DAT STAT Q; Rayment G.E., 2011, SOIL CHEM METHODS AU; Reseigh J, 2004, THESIS U NEW ENGLAND; Sanderman J, 2013, 1 FIELD LAB METH CSI; Sanderman J, 2014, DATA COLLECTION, DOI [10.4225/08/53B0EC7D91D4B, DOI 10.4225/08/53B0EC7D91D4B]; Sanderman J, 2014, 53 FTRG AUSTR DEP AG; Sanford P, 2003, AUST J EXP AGR, V43, P945, DOI 10.1071/EA02209; Sanjari G, 2009, AUST J SOIL RES, V47, P796, DOI 10.1071/SR09032; Smith P, 2004, EUR J AGRON, V20, P229, DOI 10.1016/j.eja.2003.08.002; Soil Survey Staff, 2009, USDA HDB, P436; State Herbarium of South Australia, 2014, EL FLOR S AUSTR; Teague R, 2013, J ENVIRON MANAGE, V128, P699, DOI 10.1016/j.jenvman.2013.05.064; Teague WR, 2011, AGR ECOSYST ENVIRON, V141, P310, DOI 10.1016/j.agee.2011.03.009; Teague WR, 2010, AGR ECOSYST ENVIRON, V137, P113, DOI 10.1016/j.agee.2010.01.010; Teague WR, 2003, J ARID ENVIRON, V53, P211, DOI 10.1006/jare.2002.1036; Teague WR, 2004, J ARID ENVIRON, V58, P97, DOI 10.1016/S0140-1963(03)00122-8; Wilson BR, 2013, SOIL RES, V51, P668, DOI 10.1071/SR12376; Xu B, 2008, INT J REMOTE SENS, V29, P5313, DOI 10.1080/01431160802036276	58	33	35	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136157	10.1371/journal.pone.0136157	http://dx.doi.org/10.1371/journal.pone.0136157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284658	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100106
J	Scott, JC; Shah, N; Porco, T; Flood, J				Scott, James C.; Shah, Neha; Porco, Travis; Flood, Jennifer			Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; ADVERSE EVENTS; MDR-TB; SAFETY; REGIMENS; RIFAMPIN	Background From 2012 through 2014, the United States experienced acute shortages and price escalations of several first-line anti-tuberculosis (TB) medications. Because secondary TB drug regimens are longer and adverse events occur more frequently with them, we sought to conservatively estimate the cost, to patients and the health care system, of TB treatment and medication adverse events from alternative regimens during drug shortages. Methods We assessed the cost of treatment for TB disease in the absence of isoniazid (INH), rifampin (RIF), or pyrazinamide (PZA), or both INH and RIF. We simulated adverse events based on published probabilities using a monthly discrete-time stochastic model. For total costs, we summed costs of medications, routine testing, and treatment of adverse events using procedural terminology codes. We report average cost ratios of TB treatment during drug shortages to standard TB treatment. Results The cost ratio of TB treatment without INH, RIF, or PZA to standard treatment was 1.7 (Range: 1.2, 2.3), 4.9 (Range: 3.2, 7.3), and 1.1 (Range: 0.7, 1.7) times higher, respectively. Without both INH and RIF, the cost ratio was 18.6 (Range: 10.0, 39.0) times higher. When the prices for INH, RIF and PZA were increased, the cost for standard treatment increased by a factor of 2.7 (Range: 1.9, 3.0). The percentage of patients experiencing at least one adverse event while taking standard therapy was 3.9% (Range: 1.3%, 11.8%). This percentage increased to 51.5%(Range: 20.1%, 83.8%) when RIF was unavailable, and increased to 82.5% (Range: 41.2%, 98.5%) when both INH and RIF were unavailable. Conclusions Our conservative model illustrates that an interruption in first-line anti-TB medications leads to appreciable additional costs and adverse events for patients. The availability of these drugs in the United States should be ensured. Models that incorporate the effectiveness of alternative regimens, delays in treatment initiation, and TB transmission can provide broader perspectives on the impact of drug shortages.	[Scott, James C.] Colby Coll, Dept Math & Stat, Waterville, ME 04901 USA; [Scott, James C.; Porco, Travis] Francis I Proctor Fdn, San Francisco, CA USA; [Shah, Neha; Flood, Jennifer] Calif Dept Hlth TB Control Branch, Richmond, CA 94804 USA; [Shah, Neha] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Porco, Travis] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Colby College; California Department of Public Health; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Shah, N (corresponding author), Calif Dept Hlth TB Control Branch, Richmond, CA 94804 USA.	nshah6@cdc.gov			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087728] Funding Source: NIH RePORTER; NIGMS NIH HHS [U01-GM087728, U01 GM087728] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2013, REP TUB US; [Anonymous], 2012, CURR PROC TERM CPT 2; Ball P, 2004, CLIN THER, V26, P940, DOI 10.1016/S0149-2918(04)90170-1; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Centers for Disease Control and Prevention, 2003, MMWR, V52; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P1029; COX H, 2012, INT J TUBERC LUNG D, V16, P447, DOI DOI 10.5588/IJTLD.11.0451; Curry International Tuberculosis Center, 2012, TUB DRUG INF GUID; FOX W, 1999, INT J TUBERC LUNG S2, V3, pS231; Francis J., 2008, DRUG RESISTANT TUBER; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Hwang TJ, 2013, INT J TUBERC LUNG D, V17, P1257, DOI 10.5588/ijtld.12.0863; Kanouse J, 2014, NAT TUB CONTR ASS AN; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Law S, 2014, EUR RESPIR J, V43, P566, DOI 10.1183/09031936.00005613; Martinez E, 1999, MEDICINE, V78, P361, DOI 10.1097/00005792-199911000-00001; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Modongo C, 2012, INT J TUBERC LUNG D, V16, P1561, DOI 10.5588/ijtld.12.0403; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; National Tuberculosis Controllers Association, 2014, NAT TUB CONT ASS ANN; Peloquin C, 2004, CHEST, V126, P1722, DOI 10.1378/chest.126.6.1722; Peloquin CA, 2004, CLIN INFECT DIS, V38, P1538, DOI 10.1086/420742; Porco TC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-157; R Development Core Team, 2014, R LANG ENV STAT COMP; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Scott Bentley T., 2011, US ORGAN TISSUE TRAN; Seaworth BJ, 2013, MMWR-MORBID MORTAL W, V62, P23; Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912; STEELE MA, 1988, CHEST, V94, P845, DOI 10.1378/chest.94.4.845; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; SWAI OB, 1988, TUBERCLE, V69, P5, DOI 10.1016/0041-3879(88)90035-9; Warkentin J, 2013, MMWR-MORBID MORTAL W, V62, P398; World Health Organization, 2011, WHO PUBLIC ASSESSMEN	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134597	10.1371/journal.pone.0134597	http://dx.doi.org/10.1371/journal.pone.0134597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284924	Green Published, gold			2022-12-27	WOS:000359666100012
J	Taylor, DL; Kahawita, TM; Cairncross, S; Ensink, JHJ				Taylor, Dawn L.; Kahawita, Tanya M.; Cairncross, Sandy; Ensink, Jeroen H. J.			The Impact of Water, Sanitation and Hygiene Interventions to Control Cholera: A Systematic Review	PLOS ONE			English	Review							DRINKING-WATER; SOLAR DISINFECTION; RISK-FACTORS; TRANSMISSION; OUTBREAK; DIARRHEA; STORAGE; O1; CHLORINATION; CHILDREN	Background and Methods Cholera remains a significant threat to global public health with an estimated 100,000 deaths per year. Water, sanitation and hygiene (WASH) interventions are frequently employed to control outbreaks though evidence regarding their effectiveness is often missing. This paper presents a systematic literature review investigating the function, use and impact of WASH interventions implemented to control cholera. Results The review yielded eighteen studies and of the five studies reporting on health impact, four reported outcomes associated with water treatment at the point of use, and one with the provision of improved water and sanitation infrastructure. Furthermore, whilst the reporting of function and use of interventions has become more common in recent publications, the quality of studies remains low. The majority of papers (>60%) described water quality interventions, with those at the water source focussing on ineffective chlorination of wells, and the remaining being applied at the point of use. Interventions such as filtration, solar disinfection and distribution of chlorine products were implemented but their limitations regarding the need for adherence and correct use were not fully considered. Hand washing and hygiene interventions address several transmission routes but only 22% of the studies attempted to evaluate them and mainly focussed on improving knowledge and uptake of messages but not necessarily translating this into safer practices. The use and maintenance of safe water storage containers was only evaluated once, under-estimating the considerable potential for contamination between collection and use. This problem was confirmed in another study evaluating methods of container disinfection. One study investigated uptake of household disinfection kits which were accepted by the target population. A single study in an endemic setting compared a combination of interventions to improve water and sanitation infrastructure, and the resulting reductions in cholera incidence. Discussion and Recommendations This review highlights a focus on particular routes of transmission, and the limited number of interventions tested during outbreaks. There is a distinct gap in knowledge of which interventions are most appropriate for a given context and as such a clear need for more robust impact studies evaluating a wider array of WASH interventions, in order to ensure effective cholera control and the best use of limited resources.	[Taylor, Dawn L.; Kahawita, Tanya M.; Cairncross, Sandy; Ensink, Jeroen H. J.] Univ London London Sch Hyg & Trop Med, Environm Hlth Grp, London WC1E 7HT, England; [Taylor, Dawn L.] Med Sans Frontieres Artsen Zonder Grenzen, NL-1001 EA Amsterdam, Netherlands	University of London; London School of Hygiene & Tropical Medicine	Ensink, JHJ (corresponding author), Univ London London Sch Hyg & Trop Med, Environm Hlth Grp, Keppel St, London WC1E 7HT, England.	jeroen.ensink@lshtm.ac.uk			Department for International Development (DFID) as part of the SHARE Research Programme [P04990]	Department for International Development (DFID) as part of the SHARE Research Programme	The research was funded by UK aid from the Department for International Development (DFID) as part of the SHARE Research Programme (grant nr P04990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CJ, 2001, EMERG INFECT DIS, V7, P583; AZURIN JC, 1974, B WORLD HEALTH ORGAN, V51, P19; Blanchet K., 2013, EVIDENCE REV RES HLT; BLUM D, 1983, INT J EPIDEMIOL, V12, P357, DOI 10.1093/ije/12.3.357; Bompangue D, 2008, EMERG INFECT DIS, V14, P798, DOI 10.3201/eid1405.071260; Brown J., 2012, Waterlines, V31, P11, DOI 10.3362/1756-3488.2012.004; Cairncross S., 2004, Waterlines, V22, P4, DOI 10.3362/0262-8104.2004.003; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Cavallaro EC, 2011, J WATER HEALTH, V9, P394, DOI 10.2166/wh.2011.122; Clasen TF, 2004, TROP MED INT HEALTH, V9, P187, DOI 10.1046/j.1365-3156.2003.01191.x; Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE; Clasen T, 2009, ENVIRON SCI TECHNOL, V43, P5542, DOI 10.1021/es9008147; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Conroy RM, 1996, LANCET, V348, P1695, DOI 10.1016/S0140-6736(96)02309-4; Conroy RM, 2001, ARCH DIS CHILD, V85, P293, DOI 10.1136/adc.85.4.293; De Rochars VEMB, 2011, EMERG INFECT DIS, V17, P2158, DOI 10.3201/eid1711.110818; DEB BC, 1986, B WORLD HEALTH ORGAN, V64, P127; DEB BC, 1982, INDIAN J MED RES, V76, P814; Department for International Development (DfID), 2013, WAT SAN HYG; DuBois AE, 2006, EPIDEMIOL INFECT, V134, P1226, DOI 10.1017/S0950268806006273; Dunston C, 2001, AM J PUBLIC HEALTH, V91, P1574, DOI 10.2105/AJPH.91.10.1574; Einarsdottir J, 2001, Int J Infect Dis, V5, P133, DOI 10.1016/S1201-9712(01)90087-6; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Feachem R G, 1982, Trop Dis Bull, V79, P1; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Garandeau R., 2006, Waterlines, V24, P19, DOI 10.3362/0262-8104.2006.008; Gartley M, 2013, J WATER HEALTH, V11, P623, DOI 10.2166/wh.2013.050; Guevart E, 2008, Med Trop (Mars), V68, P507; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; HUQ A, 1984, APPL ENVIRON MICROB, V48, P420, DOI 10.1128/AEM.48.2.420-424.1984; Huq A, 2010, MBIO, V1, DOI 10.1128/mBio.00034-10; Hutin Yvan, 2003, Journal of Water and Health, V1, P45; Jensen PK, 2002, TROP MED INT HEALTH, V7, P604, DOI 10.1046/j.1365-3156.2002.00901.x; Kone-Coulibaly A, 2010, East Afr J Public Health, V7, P311; Lantagne DS, 2012, ENVIRON SCI TECHNOL, V46, P11352, DOI 10.1021/es301842u; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mahadik V J, 1983, Med J Zambia, V17, P32; Patrick M, 2013, AM J TROP MED HYG, V89, P647, DOI 10.4269/ajtmh.13-0308; [Private Partnership for Handwashing Initiative Global Public], 2008, HANDW HDB GUID DEV H; Quick RE, 1996, AM J TROP MED HYG, V54, P511, DOI 10.4269/ajtmh.1996.54.511; Quick RE, 1996, INT J EPIDEMIOLOGY, V25; Rowe Alexander K., 1998, International Journal of Environmental Health Research, V8, P339, DOI 10.1080/09603129873444; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Shapiro RL, 1999, AM J TROP MED HYG, V60, P271, DOI 10.4269/ajtmh.1999.60.271; Share Consortium, 2012, EV REV RES PRIOR WAT; Shultz A, 2009, AM J TROP MED HYG, V80, P640, DOI 10.4269/ajtmh.2009.80.640; Siddiqui FJ, 2006, T ROY SOC TROP MED H, V100, P476, DOI 10.1016/j.trstmh.2005.07.019; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n; Steele A, 2008, J WATER HEALTH, V6, P559, DOI 10.2166/wh.2008.072; UNICEF, 2013, CHOL TOOLK; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Waddington H., 2009, WATER SANITATION HYG; WHO, 2012, FACT SHEET NO 107; WHO, 1983, INT DRINK WAT SUPPL; WHO, 2014, 31 WHO	56	105	106	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135676	10.1371/journal.pone.0135676	http://dx.doi.org/10.1371/journal.pone.0135676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284367	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100056
J	Tripathy, D; Choudhary, A; Banerjee, UC; Singh, IP; Chatterjee, A				Tripathy, Debabrata; Choudhary, Alka; Banerjee, Uttam Chand; Singh, Inder Pal; Chatterjee, Anupam			Induction of Apoptosis and Reduction of Endogenous Glutathione Level by the Ethyl-Acetate Soluble Fraction of the Methanol Extract of the Roots of Potentilla fulgens in Cancer Cells	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; NATURAL-PRODUCTS; URSOLIC ACID; ANTIOXIDANT; MODULATION; PREVENTION; TUMORS; DRUGS; MICE	Potentilla fulgens root traditionally used as a folk remedy in Meghalaya, India. However, systematic evaluation of its anticancer efficacy was limited. We investigated the anticancer potentials of the various extracts prepared by partitioning of the methanol extract of the root with the aim to discover major contributing factors from the most effective fractions. Methanol extract of P. fulgens roots (PRE) was prepared by maceration which was subsequently fractionated into hexane, ethyl-acetate (EA) and n-butanol soluble fractions. Various assays (clonogenic assay, Flow cytometry analysis, western blot, semiquantitative RT-PCR and the level of endogenous glutathione) were used to evaluate different parameters, such as Cell survivability, PARP-1 proteolysis, expression pattern of anti-apoptotic and.-glutamylcysteine synthetase heavy subunit (GCSC) genes in both MCF-7 and U87 cancer cell lines. Since the EA-fraction showed most efficient growth inhibitory effect, it was further purified and a total of nine compounds and some monomeric and dimeric flavan-3-ols were identified and characterized. Three compounds viz., epicatechin (EC), gallic acid (GA) and ursolic acid (UA) were taken on the basis of their higher yield and 10 mu g/ml of each was mixed together. The concentration used in this study for PRE, EA-and Hex-fraction was 100 mu g/ml, which was higher than the IC50 value. Apoptotic cell death in the PRE, EA-fraction and EC+GA+UA treated cancer cell cultures was significantly greater than in normal cells due to suppression of anti-apoptotic protein Bcl2 following treatment. Depletion of glutathione by downregulating GCSC was also observed. Induction of apoptosis and lowering the level of glutathione are considered to be positive activity for an anticancer agent. Therefore, modulation of GSH concentration in tumor cells by PRE and its EA-fraction opened up the possibility of a new therapeutic approach because these plant products are not harmful to normal cells and may regulate the tumor cellular response to different anticancer treatments. Thus, it would be interesting to examine efficacy of these plant products or EA-fraction in human cancer treatment.	[Tripathy, Debabrata; Chatterjee, Anupam] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Mol Genet Lab, Shillong 793022, Meghalaya, India; [Choudhary, Alka; Banerjee, Uttam Chand] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut Technol Biotechnol, Sect 67, Sas Nagar 160062, Punjab, India; [Singh, Inder Pal] Natl Inst Pharmaceut Educ & Res, Dept Nat Prod, Sect 67, Sas Nagar 160062, Punjab, India	North Eastern Hill University; National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Chatterjee, A (corresponding author), North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Mol Genet Lab, Shillong 793022, Meghalaya, India.	chatterjeeanupam@hotmail.com		Tripathy, Debabrata/0000-0003-1081-2232; Banerjee, uttam Chand/0000-0002-7363-4042	DBT, Govt. of India [BT/59/NE/TBP/2010]; DBT fellowship; DST-Inspire fellowship [IF 120044]	DBT, Govt. of India(Department of Biotechnology (DBT) India); DBT fellowship; DST-Inspire fellowship	This work was supported by DBT, Govt. of India (BT/59/NE/TBP/2010) to AC, UCB, and IPS; DBT fellowship and DST-Inspire fellowship (IF 120044) to Alka Choudhary; DBT-fellowship to DT.	Akerboom T P, 1981, Methods Enzymol, V77, P373; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Chattopadhyay A, 1999, INT J RADIAT BIOL, V75, P1283, DOI 10.1080/095530099139449; Choudhary A, 2015, PHYTOCHEM ANALYSIS, V26, P161, DOI 10.1002/pca.2547; Choudhary A, 2013, FITOTERAPIA, V91, P290, DOI 10.1016/j.fitote.2013.09.008; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; Coseri S, 2009, MINI-REV MED CHEM, V9, P560, DOI 10.2174/138955709788167592; De Angel RE, 2010, NUTR CANCER, V62, P1074, DOI 10.1080/01635581.2010.492092; Elbaz HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088322; ESTRELA JM, 1995, NAT MED, V1, P84, DOI 10.1038/nm0195-84; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Fang Y, 2012, J BIOL CHEM, V287, P35234, DOI 10.1074/jbc.M112.389494; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Gamcsik MP, 2012, BIOMARKERS, V17, P671, DOI 10.3109/1354750X.2012.715672; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jenny Marcel, 2005, J Carcinog, V4, P15, DOI 10.1186/1477-3163-4-15; Jew S, 2009, J MED FOOD, V12, P925, DOI 10.1089/jmf.2008.0268; Lauterburg Bernhard H, 2002, Am J Ther, V9, P225, DOI 10.1097/00045391-200205000-00008; Lauthier F, 2000, ANTI-CANCER DRUG, V11, P737; Lu Y, 2010, EUR J PHARMACOL, V641, P102, DOI 10.1016/j.ejphar.2010.05.043; Myhrstad MCW, 2002, FREE RADICAL BIO MED, V32, P386, DOI 10.1016/S0891-5849(01)00812-7; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; POOT M, 1995, J CELL PHYSIOL, V163, P555, DOI 10.1002/jcp.1041630316; Prasad S, 2011, J BIOL CHEM, V286, P5546, DOI 10.1074/jbc.M110.183699; Radhika M, 2012, J COMPLEMENTARY INTE, V9, P1; Ramos AA, 2010, MUTAT RES-FUND MOL M, V692, P6, DOI 10.1016/j.mrfmmm.2010.07.004; Rosangkima G., 2004, Indian Journal of Experimental Biology, V42, P981; Safarzadeh E, 2014, ADV PHARM BULL, V4, P421, DOI 10.5681/apb.2014.062; Shushunov S, 2009, J MED FOOD, V12, P1173, DOI 10.1089/jmf.2008.0281; Siegelin MD, 2008, MOL CANCER THER, V7, P3566, DOI 10.1158/1535-7163.MCT-08-0236; Soldani C, 2001, EXP CELL RES, V269, P193, DOI 10.1006/excr.2001.5293; Syiem D, 2002, J ETHNOPHARMACOL, V83, P55, DOI 10.1016/S0378-8741(02)00190-3; Thayyullathil F, 2011, BIOCHEM BIOPH RES CO, V411, P1, DOI 10.1016/j.bbrc.2011.05.156; Tomczyk M, 2010, MOLECULES, V15, P4639, DOI 10.3390/molecules15074639; Tomczyk M, 2009, J ETHNOPHARMACOL, V122, P184, DOI 10.1016/j.jep.2008.12.022; Verma S, 2013, ENVIRON TOXICOL PHAR, V35, P473, DOI 10.1016/j.etap.2013.02.011; Wang SS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-321; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682; Zhao YL, 2008, PHYTOMEDICINE, V15, P253, DOI 10.1016/j.phymed.2008.01.005	45	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135890	10.1371/journal.pone.0135890	http://dx.doi.org/10.1371/journal.pone.0135890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284809	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100083
J	de Haan, GA; Melis-Dankers, BJM; Brouwer, WH; Tucha, O; Heutink, J				de Haan, Gera A.; Melis-Dankers, Bart J. M.; Brouwer, Wiebo H.; Tucha, Oliver; Heutink, Joost			The Effects of Compensatory Scanning Training on Mobility in Patients with Homonymous Visual Field Defects: A Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTGENICULATE DAMAGE; HEMIANOPIC PATIENTS; STROKE PATIENTS; VISION; REHABILITATION; EXPLORATION; SEARCH; EYE; RECOVERY	Introduction Homonymous visual field defects (HVFD) are a common consequence of postchiasmatic acquired brain injury and often lead to mobility-related difficulties. Different types of compensatory scanning training have been developed, aimed at decreasing consequences of the HVFD by changing visual scanning. Aim The aim of the present study is to examine the effects of a compensatory scanning training program using horizontal scanning on mobility-related activities and participation in daily life. Method The main interest of this study is to assess the effectiveness of training on mobility-related activities and participation in daily life. Visual scanning tests, such as dot counting and visual search, and control measures for visual functions and reading have been included as well. First, it is examined how performance on scanning and mobility-related measures is affected in patients with HVFD by comparing scores with scores of a healthy control group (n = 25). Second, the effect of training is assessed using an RCT design, in which performance of 26 patients before and after training is compared to performance of 23 patients in a waiting list control group. Results Self-reported improvements after training were found, accompanied by improvements in detecting peripheral stimuli and avoiding obstacles during walking, especially in dual task situations in which a second task limits the attentional capacity available for compensatory scanning. Training only improved mobility-related activities in which detection of peripheral stimuli is important, while no improvement was found on tests that require other visual skills, such as reading, visual counting and visual search. Conclusion This is the first RCT to evaluate the effects of a compensatory scanning training that is based on a systematic horizontal scanning rhythm. This training improved mobility-related activities. The results suggest that different types of compensatory scanning strategies are appropriate for different types of activities.	[de Haan, Gera A.; Brouwer, Wiebo H.; Tucha, Oliver; Heutink, Joost] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [de Haan, Gera A.; Melis-Dankers, Bart J. M.; Heutink, Joost] Royal Dutch Visio Ctr Expertise Blind & Partially, Haren, Netherlands; [Brouwer, Wiebo H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	de Haan, GA (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	G.A.de.Haan@rug.nl	Tucha, Oliver/AAD-1403-2019; Heutink, Joost/A-9694-2013	de Haan, Gera/0000-0002-3055-3920; Heutink, Joost/0000-0002-4811-968X	Royal Dutch Visio [OI0204]; University of Groningen; ZonMw-InZicht [94307005]	Royal Dutch Visio; University of Groningen; ZonMw-InZicht	The study was funded by Royal Dutch Visio (OI0204), The University of Groningen and ZonMw-InZicht (94307005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimola L, 2014, NEUROREHAB NEURAL RE, V28, P207, DOI 10.1177/1545968313503219; Ali M, 2013, NEUROREHAB NEURAL RE, V27, P133, DOI 10.1177/1545968312454683; American Medical Association, 2008, GUIDES EVALUATION PE, P281; Bahnemann M, 2015, J NEUROL, V262, P316, DOI 10.1007/s00415-014-7554-x; BLYTHE IM, 1987, BRAIN, V110, P887, DOI 10.1093/brain/110.4.887; Bolognini N, 2005, BRAIN, V128, P2830, DOI 10.1093/brain/awh656; Bouwmeester L, 2007, J NEUROL NEUROSUR PS, V78, P555, DOI 10.1136/jnnp.2006.103853; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Haan GA, 2015, J NEUROOPHT IN PRESS; de Haan GA, 2014, SURV OPHTHALMOL, V59, P77, DOI 10.1016/j.survophthal.2013.02.006; Duits A., 2006, NEUROPSYCHOLOGISCHE, P119; FEIGENSON JS, 1977, STROKE, V8, P8; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Gall C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-33; Gilhotra JS, 2002, STROKE, V33, P2417, DOI 10.1161/01.STR.0000037647.10414.d2; Hardiess G, 2010, VISION RES, V50, P1158, DOI 10.1016/j.visres.2010.04.004; Hayes A, 2012, NEUROREHABILITATION, V31, P19, DOI 10.3233/NRE-2012-0771; Iorizzo DB, 2011, VISION RES, V51, P1173, DOI 10.1016/j.visres.2011.03.006; Kasneci E, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.6.2; Keller I, 2010, NEUROREHAB NEURAL RE, V24, P666, DOI 10.1177/1545968310372774; KERKHOFF G, 1992, RESTOR NEUROL NEUROS, V4, P245, DOI 10.3233/RNN-1992-4402; KERKHOFF G, 1994, ARCH NEUROL-CHICAGO, V51, P474, DOI 10.1001/archneur.1994.00540170050016; KERKHOFF G, 1990, NERVENARZT, V61, P711; Kerkhoff G, 1999, RESTOR NEUROL NEUROS, V15, P255; KOOIJMAN AC, 1994, INVEST OPHTH VIS SCI, V35, P1371; Lane AR, 2010, BRAIN, V133, P1717, DOI 10.1093/brain/awq088; Langelaan M, 2005, OPHTHAL PHYSL OPT, V25, P136, DOI 10.1111/j.1475-1313.2004.00266.x; Maaijwee K J M, 2007, Ned Tijdschr Geneeskd, V151, P2494; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mannan SK, 2010, J NEUROL, V257, P1812, DOI 10.1007/s00415-010-5615-3; Matthews EE, 2010, RES NURS HEALTH, V33, P243, DOI 10.1002/nur.20375; Modden C, 2012, NEUROREHAB NEURAL RE, V26, P463, DOI 10.1177/1545968311425927; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Nelles G, 2001, NEUROSCI LETT, V306, P189, DOI 10.1016/S0304-3940(01)01907-3; Nelles G, 2010, J NEUROL, V257, P1832, DOI 10.1007/s00415-010-5617-1; Nelles G, 2009, J NEUROL, V256, P726, DOI 10.1007/s00415-009-5005-x; Pambakian ALM, 2004, J NEUROL NEUROSUR PS, V75, P1443, DOI 10.1136/jnnp.2003.025957; Pambakian ALM, 1997, BRIT J OPHTHALMOL, V81, P324, DOI 10.1136/bjo.81.4.324; Papageorgiou E, 2007, GRAEF ARCH CLIN EXP, V245, P1749, DOI 10.1007/s00417-007-0644-z; Passamonti C, 2009, NEUROPSYCHOLOGIA, V47, P546, DOI 10.1016/j.neuropsychologia.2008.10.008; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Pollock A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008388.pub2; Radner T, 1998, KLIN MONATSBL AUGENH, V213, P174, DOI 10.1055/s-2008-1034969; Roth T, 2009, NEUROLOGY, V72, P324, DOI 10.1212/01.wnl.0000341276.65721.f2; Schuett S, 2012, BRAIN, V135, P912, DOI 10.1093/brain/awr356; Tant MLM, 2002, VISUAL PERFORMANCE H; TROBE JD, 1973, ARCH OPHTHALMOL-CHIC, V89, P377, DOI 10.1001/archopht.1973.01000040379005; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P865; Van der Sterre GW, 2001, NATL EYE I VISUAL FU; Vlakveld W, 2011, HAZARD ANTICIPATION, P115; Wagenbreth C, 2010, KLIN MONATSBL AUGENH, V227, P138, DOI 10.1055/s-0028-1109655; Warren M, 2009, AM J OCCUP THER, V63, P626, DOI 10.5014/ajot.63.5.626; Zhang X, 2006, NEUROLOGY, V66, P906, DOI 10.1212/01.wnl.0000203913.12088.93; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22; ZIHL J, 1985, BRAIN, V108, P335, DOI 10.1093/brain/108.2.335; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A	57	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134459	10.1371/journal.pone.0134459	http://dx.doi.org/10.1371/journal.pone.0134459			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275160	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600029
J	Tabana, H; Nkonki, L; Hongoro, C; Doherty, T; Ekstrom, AM; Naik, R; Zembe-Mkabile, W; Jackson, D; Thorson, A				Tabana, Hanani; Nkonki, Lungiswa; Hongoro, Charles; Doherty, Tanya; Ekstrom, Anna Mia; Naik, Reshma; Zembe-Mkabile, Wanga; Jackson, Debra; Thorson, Anna			A Cost-Effectiveness Analysis of a Home-Based HIV Counselling and Testing Intervention versus the Standard (Facility Based) HIV Testing Strategy in Rural South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HEALTH; TRANSMISSION; ACCEPTABILITY; CARE	Introduction There is growing evidence concerning the acceptability and feasibility of home-based HIV testing. However, less is known about the cost-effectiveness of the approach yet it is a critical component to guide decisions about scaling up access to HIV testing. This study examined the cost-effectiveness of a home-based HIV testing intervention in rural South Africa. Methods Two alternatives: clinic and home-based HIV counselling and testing were compared. Costs were analysed from a provider's perspective for the period of January to December 2010. The outcome, HIV counselling and testing (HCT) uptake was obtained from the Good Start home-based HIV counselling and testing (HBHCT) cluster randomised control trial undertaken in KwaZulu-Natal province. Cost-effectiveness was estimated for a target population of 22,099 versus 23,864 people for intervention and control communities respectively. Average costs were calculated as the cost per client tested, while cost-effectiveness was calculated as the cost per additional client tested through HBHCT. Results Based on effectiveness of 37% in the intervention (HBHCT) arm compared to 16% in control arm, home based testing costs US$29 compared to US$38 per person for clinic HCT. The incremental cost effectiveness per client tested using HBHCT was $19. Conclusions HBHCT was less costly and more effective. Home- based HCT could present a cost- effective alternative for rural 'hard to reach' populations depending on affordability by the health system, and should be considered as part of community outreach programs.	[Tabana, Hanani; Doherty, Tanya; Naik, Reshma; Zembe-Mkabile, Wanga] Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Tabana, Hanani; Ekstrom, Anna Mia; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Tabana, Hanani; Doherty, Tanya; Jackson, Debra] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Ekstrom, Anna Mia; Thorson, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Nkonki, Lungiswa] Univ Stellenbosch, Div Community Hlth, Fac Hlth Sci, Cape Town, South Africa; [Naik, Reshma] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Naik, Reshma] Populat Reference Bur, Washington, DC USA; [Hongoro, Charles] Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Pretoria, South Africa	Karolinska Institutet; University of the Western Cape; Karolinska Institutet; Karolinska University Hospital; Stellenbosch University; Boston University; Human Sciences Research Council-South Africa	Tabana, H (corresponding author), Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa.	htabana@uwc.ac.za	Tabana, Hanani/AAJ-5361-2020; Nkonki, Lungiswa/AAA-8613-2021; Mo, Xiumei/C-9340-2013; Tabana, Hanani/AAP-8143-2020	Tabana, Hanani/0000-0003-1576-2238; Tabana, Hanani/0000-0003-1576-2238; Thorson, Anna/0000-0002-8703-6561; Zembe-Mkabile, Wanga/0000-0003-4106-4513; Nkonki, Lungiswa/0000-0003-2011-5844; Hongoro, Charles/0000-0002-9715-4940; Jackson, Debra/0000-0003-3307-632X	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was financed using funds from the South African Medical Research Council. The institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2007, COSTIT SOFTWARE 2007; [Anonymous], 2011, PROV GUID IMPL 3 STR; [Anonymous], 2007, METHODS EC EVALUATIO; Baron P, 2011, PHASA NEWSLETTE 1115; Bateganya MH, 2007, COCHRANE DATABASE SY, P4; Bateganya MH, 2007, COCHRANE DB SYST REV, P4; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Costing Guidelines for HIV Prevention Strategies, 2000, COST GUID HIV PREV S; De Cock KM, 2003, LANCET, V362, P1847, DOI 10.1016/S0140-6736(03)14906-9; Doherty T, 2013, BMJ-BRIT MED J, V346, P1; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Johns B, 2005, HEALTH POLICY PLANN, V20, P1, DOI 10.1093/heapol/czi001; Lugada E, 2010, JAIDS-J ACQ IMM DEF, V55, P245, DOI 10.1097/QAI.0b013e3181e9e069; Marseille E, 2002, COST EFFECTIVENESS H; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; McCord GC, 2013, B WORLD HEALTH ORGAN, V91, P244, DOI 10.2471/BLT.12.109660; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mulogo EM, 2013, AFR HEALTH SCI, V13, P423, DOI 10.4314/ahs.v13i2.32; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Shisana O, 2014, S AFRICAN NATL HIV P; Statistics South Africa, 2011, STAT S AFR; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Tabana H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066390; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Thielman NM, 2006, AM J PUBLIC HEALTH, V96, P114, DOI 10.2105/AJPH.2004.056796; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; UMzimkhulu Local Municipality, 2010, INT DEV PLAN 2009 20	34	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135048	10.1371/journal.pone.0135048	http://dx.doi.org/10.1371/journal.pone.0135048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275059	gold, Green Published			2022-12-27	WOS:000359493600048
J	Toyonaga, T; Nakase, H; Ueno, S; Matsuura, M; Yoshino, T; Honzawa, Y; Itou, A; Namba, K; Minami, N; Yamada, S; Koshikawa, Y; Uede, T; Chiba, T; Okazaki, K				Toyonaga, Takahiko; Nakase, Hiroshi; Ueno, Satoru; Matsuura, Minoru; Yoshino, Takuya; Honzawa, Yusuke; Itou, Ayako; Namba, Kazuyoshi; Minami, Naoki; Yamada, Satoshi; Koshikawa, Yorimitsu; Uede, Toshimitsu; Chiba, Tsutomu; Okazaki, Kazuichi			Osteopontin Deficiency Accelerates Spontaneous Colitis in Mice with Disrupted Gut Microbiota and Macrophage Phagocytic Activity	PLOS ONE			English	Article							MURINE EXPERIMENTAL COLITIS; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; EXPRESSION; ACTIVATION; CELLS; PROGRESSION; RECEPTORS	Background Osteopontin (OPN) is a multifunctional protein expressed in a variety of tissues and cells. Recent studies revealed increased OPN expression in the inflamed intestinal tissues of patients with inflammatory bowel disease (IBD). The role of OPN in the pathophysiology of IBD, however, remains unclear. Aims To investigate the role of OPN in the development of intestinal inflammation using a murine model of IBD, interleukin-10 knock out (IL-10 KO) mice. Methods We compared the development of colitis between IL-10 KO and OPN/IL-10 double KO (DKO) mice. OPN expression in the colonic tissues of IL-10 KO mice was examined by fluorescence in situ hybridization (FISH) analysis. Enteric microbiota were compared between IL-10 KO and OPN/IL-10 DKO mice by terminal restriction fragment length polymorphism analysis. The effect of OPN on macrophage phagocytic function was evaluated by phagocytosis assay. Results OPN/IL-10 DKO mice had an accelerated onset of colitis compared to IL-10 KO mice. FISH analysis revealed enhanced OPN synthesis in the colonic epithelial cells of IL-10 KO mice. OPN/IL-10 DKO mice had a distinctly different enteric bacterial profile with a significantly lower abundance of Clostridium subcluster XIVa and a greater abundance of Clostridium cluster XVIII compared to IL-10 KO mice. Intracellular OPN deletion in macrophages impaired phagocytosis of fluorescence particle-conjugated Escherichia coli in vitro. Exogenous OPN enhanced phagocytosis by OPN-deleted macrophages when administered at doses of 1 to 100 ng/ml, but not 1000 ng/ml. Conclusions OPN deficiency accelerated the spontaneous development of colitis in mice with disrupted gut microbiota and macrophage phagocytic activity.	[Toyonaga, Takahiko; Okazaki, Kazuichi] Kansai Med Univ, Dept Gastroenterol & Hepatol, Hirakata, Osaka, Japan; [Nakase, Hiroshi; Matsuura, Minoru; Yoshino, Takuya; Honzawa, Yusuke; Minami, Naoki; Yamada, Satoshi; Koshikawa, Yorimitsu; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto, Japan; [Ueno, Satoru] Takashima Municipal Hosp, Dept Internal Med, Takashima, Shiga, Japan; [Itou, Ayako; Namba, Kazuyoshi] Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Zama, Kanagawa, Japan; [Uede, Toshimitsu] Hokkaido Univ, Inst Med Genet, Dept Matrix Med, Sapporo, Hokkaido, Japan	Kansai Medical University; Kyoto University; Morinaga Milk Industry Company, Ltd; Hokkaido University	Nakase, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto, Japan.	hiropy_n@kuhp.kyoto-u.ac.jp	Nakase, Hiroshi/AAZ-4425-2020		Japan Society for the Promotion of Science KAKENHI [24590941, 23590940, 26460967, 25860532, 26893122, 23591017]; Ministry of Health, Labor, and Welfare of Japan; Japan Foundation for Applied Enzymology; Morinaga Milk Industry Co., Ltd.	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Foundation for Applied Enzymology; Morinaga Milk Industry Co., Ltd.	This work was supported by Japan Society for the Promotion of Science KAKENHI (Grant Number 24590941, 23590940, 26460967, 25860532, 26893122, 23591017), by Health and Labor Sciences Research Grants for Research on Rare and Intractable Diseases from Ministry of Health, Labor, and Welfare of Japan, and by Japan Foundation for Applied Enzymology. Morinaga Milk Industry Co., Ltd., provided support in the form of salaries for authors AI & KN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; BROWN LF, 1992, MOL BIOL CELL, V3, P1169, DOI 10.1091/mbc.3.10.1169; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Cader MZ, 2013, GUT, V62, P1653, DOI 10.1136/gutjnl-2012-303955; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Gao CJ, 2007, J IMMUNOL, V178, P1870, DOI 10.4049/jimmunol.178.3.1870; Heilmann K, 2009, J CELL MOL MED, V13, P1162, DOI 10.1111/j.1582-4934.2008.00428.x; Ichimura S, 2007, J CLIN MICROBIOL, V45, P3316, DOI 10.1128/JCM.02289-06; Masuda H, 2005, J GASTROENTEROL, V40, P409, DOI 10.1007/s00535-005-1567-2; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Mishima R, 2007, J CLIN GASTROENTEROL, V41, P167, DOI 10.1097/MCG.0b013e31802d6268; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagashima K., 2006, Bioscience and Microflora, V25, P99; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Naldini A, 2006, J IMMUNOL, V177, P4267, DOI 10.4049/jimmunol.177.7.4267; Nau GJ, 1999, INFECT IMMUN, V67, P4223, DOI 10.1128/IAI.67.8.4223-4230.1999; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Oz HS, 2012, DIGEST DIS SCI, V57, P1554, DOI 10.1007/s10620-011-2009-z; Pedraza CE, 2008, BONE, V43, P708, DOI 10.1016/j.bone.2008.06.010; Rittling SR, 2011, EXPERT REV MOL MED, V26, P13; Rollo EE, 2005, J VIROL, V79, P3509, DOI 10.1128/JVI.79.6.3509-3516.2005; Rollo EE, 1996, J LEUKOCYTE BIOL, V60, P397, DOI 10.1002/jlb.60.3.397; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; Scheinin T, 2003, CLIN EXP IMMUNOL, V133, P38, DOI 10.1046/j.1365-2249.2003.02193.x; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shimizu S, 2010, ARTHRITIS RHEUM-US, V62, P1329, DOI 10.1002/art.27400; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Zhong J, 2006, INFLAMM BOWEL DIS, V12, P790, DOI 10.1097/00054725-200608000-00015; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	40	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135552	10.1371/journal.pone.0135552	http://dx.doi.org/10.1371/journal.pone.0135552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274807	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600076
J	Wang, YN; Wang, H; Hay, AJ; Zhong, ZT; Zhu, J; Kan, BA				Wang, Yuning; Wang, Hui; Hay, Amanda J.; Zhong, Zengtao; Zhu, Jun; Kan, Biao			Functional RelBE-Family Toxin-Antitoxin Pairs Affect Biofilm Maturation and Intestine Colonization in Vibrio cholerae	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; F-PLASMID; SYSTEMS; MUTAGENESIS; CLONING; RESISTANCE; SEQUENCE; LOCUS; PHD	Toxin-antitoxin (TA) systems are small genetic elements that typically encode a stable toxin and its labile antitoxin. These cognate pairs are abundant in prokaryotes and have been shown to regulate various cellular functions. Vibrio cholerae, a human pathogen that is the causative agent of cholera, harbors at least thirteen TA loci. While functional HigBA, ParDE have been shown to stabilize plasmids and Phd/Doc to mediate cell death in V. cholerae, the function of seven RelBE-family TA systems is not understood. In this study we investigated the function of the RelBE TA systems in V. cholerae physiology and found that six of the seven relBE loci encoded functional toxins in E. coli. Deletion analyses of each relBE locus indicate that RelBE systems are involved in biofilm formation and reactive oxygen species (ROS) resistance. Interestingly, all seven relBE loci are induced under the standard virulence induction conditions and two of the relBE mutants displayed a colonization defect, which was not due to an effect on virulence gene expression. Although further studies are needed to characterize the mechanism of action, our study reveals that RelBE systems are important for V. cholerae physiology.	[Wang, Yuning; Wang, Hui; Zhong, Zengtao; Zhu, Jun] Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China; [Wang, Yuning; Kan, Biao] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Wang, Yuning; Hay, Amanda J.; Zhu, Jun] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Pennsylvania; Pennsylvania Medicine; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhu, J (corresponding author), Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China.	jun_zhu@njau.edu.cn; kanbiao@icdc.cn	Zhong, Zengtao/E-2533-2016; Zhu, Jun/A-1324-2007		NIH/NIAID R01 grant [AI080654]; Priority Project of State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID101]; 973 project [2015CB5542000]; NSFC [81371763]; China Scholarship Council; NSF GRFP fellowship [DGE-1321851]	NIH/NIAID R01 grant; Priority Project of State Key Laboratory for Infectious Disease Prevention and Control; 973 project(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NSF GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study is supported by an NIH/NIAID R01 grant (AI080654), the Priority Project of State Key Laboratory for Infectious Disease Prevention and Control (2014SKLID101), a 973 project (2015CB5542000), and an NSFC grant (81371763). Y.W. is also supported by a fellowship from China Scholarship Council, and A.J.H. is supported by an NSF GRFP fellowship (DGE-1321851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Clark CA, 1997, MOL MICROBIOL, V26, P1137; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gronlund H, 1999, J MOL BIOL, V285, P1401, DOI 10.1006/jmbi.1998.2416; Guerout AM, 2013, J BACTERIOL, V195, P2270, DOI 10.1128/JB.01389-12; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HIGGINS DE, 1994, MOL MICROBIOL, V14, P17, DOI 10.1111/j.1365-2958.1994.tb01263.x; Iqbal N, 2015, J BACTERIOL, V197, P2150, DOI 10.1128/JB.00108-15; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; JAFFE A, 1985, J BACTERIOL, V163, P841; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; MENARD R, 1993, J BACTERIOL, V175, P5899; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; PULLINGER GD, 1992, MOL MICROBIOL, V6, P1631, DOI 10.1111/j.1365-2958.1992.tb00888.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; RHINE JA, 1994, MOL MICROBIOL, V13, P1013, DOI 10.1111/j.1365-2958.1994.tb00492.x; ROBERTS RC, 1992, J BACTERIOL, V174, P8119, DOI 10.1128/JB.174.24.8119-8132.1992; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Slattery A, 2013, J BACTERIOL, V195, P647, DOI 10.1128/JB.01397-12; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Yuan J, 2011, J BACTERIOL, V193, P611, DOI 10.1128/JB.01185-10; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	50	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135696	10.1371/journal.pone.0135696	http://dx.doi.org/10.1371/journal.pone.0135696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275048	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600098
J	Spillane, DR; Wang, DY; Newbigging, S; Wang, YD; Shi, CX; Cho, HR; Shimizu, H; Gramolini, A; Liu, MY; Wen, XY				Spillane, David R.; Wang, Ding Yan; Newbigging, Susan; Wang, Youdong; Shi, Chang-Xin; Cho, Hae-Ra; Shimizu, Hiroki; Gramolini, Anthony; Liu, Mingyao; Wen, Xiao-Yan			Chromosome Condensation 1-Like (Chc1L) Is a Novel Tumor Suppressor Involved in Development of Histiocyte-Rich Neoplasms	PLOS ONE			English	Article							HISTIOCYTIC/DENDRITIC CELL SARCOMAS; CHRONIC LYMPHOCYTIC-LEUKEMIA; FOLLICULAR LYMPHOMA; GENE REARRANGEMENTS; CLONAL RELATIONSHIP; MULTIPLE-MYELOMA; PROSTATE-CANCER; MICE; TRANSDIFFERENTIATION; EXPRESSION	Human chromosomal region 13q14 is a deletion hotspot in prostate cancer, multiple myeloma, and chronic lymphocytic leukemia. This region is believed to host multiple tumor suppressors. Chromosome Condensation 1-like (CHC1L) is located at 13q14, and found within the smallest common region of loss of heterozygosity in prostate cancer. Decreased expression of CHC1L is linked to pathogenesis and progression of both prostate cancer and multiple myeloma. However, there is no direct evidence for CHC1L's putative tumor suppressing role in current literature. Presently, we describe the generation and characterization of Chc1L knockout mice. Chc1L(-/-) mice do not develop cancer at a young age, but bone marrow and spleen cells from 8-12 week-old mice display an exaggerated proliferative response. By approximately two years of age, knockout and heterozygote mice have a markedly increased incidence of tumorigenesis compared to wild-type controls, with tumors occurring mainly in the spleen, mesenteric lymph nodes, liver and intestinal tract. Histopathological analysis found that most heterozygote and knockout mice succumb to either Histiocytic Sarcoma or Histiocyte-Associated Lymphoma. Our study suggests that Chc1L is involved in suppression of these two histiocyte-rich neoplasms in mice and supports clinical data suggesting that CHC1L loss of function is an important step in the pathogenesis of cancers containing 13q14 deletion.	[Spillane, David R.; Wang, Youdong; Wen, Xiao-Yan] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Spillane, David R.; Shi, Chang-Xin; Liu, Mingyao; Wen, Xiao-Yan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Spillane, David R.; Shi, Chang-Xin; Liu, Mingyao; Wen, Xiao-Yan] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Wang, Ding Yan; Gramolini, Anthony; Liu, Mingyao; Wen, Xiao-Yan] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Newbigging, Susan] Univ Toronto, Mt Sinai Hosp, Toronto Ctr Phenogen, Ctr Modeling Human Dis,Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Cho, Hae-Ra; Shimizu, Hiroki; Liu, Mingyao] Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Wen, XY (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.	x.wen@utoronto.ca		Liu, Mingyao/0000-0002-9188-8417; Wen, Xiao-Yan/0000-0001-6728-0025	Multiple Myeloma Research Foundation (MMRF)	Multiple Myeloma Research Foundation (MMRF)	This work is funded by a grant from the Multiple Myeloma Research Foundation (MMRF) to XYW (http://www.themmrf.org/).	BAUER SR, 1986, J IMMUNOL, V136, P4695; Been RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097280; Carrasco DR, 2006, CANCER CELL, V9, P379, DOI 10.1016/j.ccr.2006.03.028; Chen W, 2009, AM J SURG PATHOL, V33, P863, DOI 10.1097/PAS.0b013e31819287b8; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Cooney KA, 1996, CANCER RES, V56, P1142; Della Porta M, 2003, EUR J HAEMATOL, V70, P315; Devilder MC, 1998, GENOMICS, V54, P99, DOI 10.1006/geno.1998.5498; Dewald GW, 2003, BRIT J HAEMATOL, V121, P287, DOI 10.1046/j.1365-2141.2003.04265.x; Elnenaei MO, 2003, GENE CHROMOSOME CANC, V36, P99, DOI 10.1002/gcc.10140; Feldman AL, 2008, BLOOD, V111, P5433, DOI 10.1182/blood-2007-11-124792; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Gertz MA, 2004, HEMATOLOGIC MALIGNAN; Hao X, 2010, VET PATHOL, V47, P434, DOI 10.1177/0300985810363705; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; JaffeES HN, 2001, PATHOLOGY GENETICS T, P273; Lacroix-Triki M, 2003, TOXICOL PATHOL, V31, P304, DOI 10.1080/01926230390204342; Latil A, 2002, INT J CANCER, V99, P689, DOI 10.1002/ijc.10393; Legartova S, 2010, NEOPLASMA, V57, P482, DOI 10.4149/neo_2010_05_482; Leroux D, 2002, BLOOD, V99, P4154, DOI 10.1182/blood.V99.11.4154; Li ZX, 2007, ANN NY ACAD SCI, V1106, P95, DOI 10.1196/annals.1392.003; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Mashima R, 2010, LAB INVEST, V90, P1357, DOI 10.1038/labinvest.2010.121; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohnishi K, 2012, J CLIN EXP HEMATOP, V52, P171, DOI 10.3960/jslrt.52.171; Ouillette P, 2008, CANCER RES, V68, P1012, DOI 10.1158/0008-5472.CAN-07-3105; Plafker KS, 2009, BIOCHEMISTRY-US, V48, P3527, DOI 10.1021/bi801971m; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wang ED, 2011, AM J SURG PATHOL, V35, P457, DOI 10.1097/PAS.0b013e3182098799; Wang ED, 2010, LEUKEMIA LYMPHOMA, V51, P802, DOI 10.3109/10428191003699845; Wang JK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037647, 10.1371/journal.pone.0030209, 10.1371/journal.pone.0047127, 10.1371/journal.pone.0051808]; Zeng WF, 2011, J CUTAN PATHOL, V38, P999, DOI 10.1111/j.1600-0560.2011.01769.x; Zhang D, 2009, INT J HEMATOL, V89, P529, DOI 10.1007/s12185-009-0300-y	35	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135755	10.1371/journal.pone.0135755	http://dx.doi.org/10.1371/journal.pone.0135755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291700	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900030
J	Oktem-Okullu, S; Tiftikci, A; Saruc, M; Cicek, B; Vardareli, E; Tozun, N; Kocagoz, T; Sezerman, U; Yavuz, AS; Sayi-Yazgan, A				Oktem-Okullu, Sinem; Tiftikci, Arzu; Saruc, Murat; Cicek, Bahattin; Vardareli, Eser; Tozun, Nurdan; Kocagoz, Tanil; Sezerman, Ugur; Yavuz, Ahmet Sinan; Sayi-Yazgan, Ayca			Multiplex-PCR-Based Screening and Computational Modeling of Virulence Factors and T-Cell Mediated Immunity in Helicobacter pylori Infections for Accurate Clinical Diagnosis	PLOS ONE			English	Article							VACUOLATING CYTOTOXIN ALLELES; GASTRITIS; ASSOCIATION; LYMPHOCYTES; PHENOTYPE; SEQUENCE; MUCOSA; ANTRUM; GENES; GAMMA	The outcome of H. pylori infection is closely related with bacteria's virulence factors and host immune response. The association between T cells and H. pylori infection has been identified, but the effects of the nine major H. pylori specific virulence factors; cagA, vacA, oipA, babA, hpaA, napA, dupA, ureA, ureB on T cell response in H. pylori infected patients have not been fully elucidated. We developed a multiplex-PCR assay to detect nine H. pylori virulence genes with in a three PCR reactions. Also, the expression levels of Th1, Th17 and Treg cell specific cytokines and transcription factors were detected by using qRT-PCR assays. Furthermore, a novel expert derived model is developed to identify set of factors and rules that can distinguish the ulcer patients from gastritis patients. Within all virulence factors that we tested, we identified a correlation between the presence of napA virulence gene and ulcer disease as a first data. Additionally, a positive correlation between the H. pylori dupA virulence factor and IFN-gamma, and H. pylori babA virulence factor and IL-17 was detected in gastritis and ulcer patients respectively. By using computer-based models, clinical outcomes of a patients infected with H. pylori can be predicted by screening the patient's H. pylori vacA m1/m2, ureA and cagA status and IFN-gamma (Th1), IL-17 (Th17), and FOXP3 (Treg) expression levels. Herein, we report, for the first time, the relationship between H. pylori virulence factors and host immune responses for diagnostic prediction of gastric diseases using computer-based models.	[Oktem-Okullu, Sinem; Sayi-Yazgan, Ayca] Istanbul Tech Univ, Dept Mol Biol & Genet, TR-80626 Istanbul, Turkey; [Oktem-Okullu, Sinem; Kocagoz, Tanil] Acibadem Univ, Sch Med, Dept Med Microbiol, Istanbul, Turkey; [Tiftikci, Arzu; Saruc, Murat; Cicek, Bahattin; Vardareli, Eser; Tozun, Nurdan] Acibadem Univ, Sch Med, Dept Internal Med, Istanbul, Turkey; [Tiftikci, Arzu; Saruc, Murat; Cicek, Bahattin; Vardareli, Eser; Tozun, Nurdan] Acibadem Hosp Grp, Dept Gastroenterol, Istanbul, Turkey; [Sezerman, Ugur] Acibadem Univ, Sch Med, Dept Biostat & Med Informat, Istanbul, Turkey; [Yavuz, Ahmet Sinan] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, Istanbul, Turkey	Istanbul Technical University; Acibadem University; Acibadem University; Acibadem Hospitals Group; Acibadem University; Sabanci University	Sayi-Yazgan, A (corresponding author), Istanbul Tech Univ, Dept Mol Biol & Genet, TR-80626 Istanbul, Turkey.	sayi@itu.edu.tr	oktem-okullu, sinem/D-2480-2015; SEZERMAN, OSMAN U/X-6441-2018; Saruc, Murat/W-9868-2018; Yazgan, Ayca Sayi/C-4733-2016; Tozun, Nurdan/D-6984-2015	oktem-okullu, sinem/0000-0002-2255-0930; Saruc, Murat/0000-0002-9541-0381; Yazgan, Ayca Sayi/0000-0002-9015-8244; Yavuz, Ahmet Sinan/0000-0003-4069-6105; Sezerman, Osman Ugur/0000-0003-0905-6783	Istanbul Technical University [36243]	Istanbul Technical University(Istanbul Technical University)	The financial support of this work was provided by Istanbul Technical University through Scientific Research Project Funds with the grant number 36243.	Abdollahi H, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812/jjm.4739; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 1999, J CLIN MICROBIOL, V37, P2979, DOI 10.1128/JCM.37.9.2979-2982.1999; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Correa Pelayo, 2004, Gastric Cancer, V7, P9, DOI 10.1007/s10120-003-0265-0; Dundon WG, 2001, INT J MED MICROBIOL, V290, P647, DOI 10.1016/S1438-4221(01)80002-3; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Hussein NR, 2010, J INFECT DIS, V202, P261, DOI 10.1086/653587; Kaebisch R, 2014, J IMMUNOL, V192, P316, DOI 10.4049/jimmunol.1302476; KARTTUNEN R, 1995, GUT, V36, P341, DOI 10.1136/gut.36.3.341; Lima VP, 2010, INT J INFECT DIS, V14, pE613, DOI 10.1016/j.ijid.2009.09.006; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Pavithran Keechilat, 2002, Gastric Cancer, V5, P240, DOI 10.1007/s101200200042; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823	23	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136212	10.1371/journal.pone.0136212	http://dx.doi.org/10.1371/journal.pone.0136212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287606	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600123
J	Zhao, ZJ; Hou, XD; Yin, XX; Li, YY; Duan, R; Boyce, BF; Yao, ZQ				Zhao, Zhijun; Hou, Xiaodong; Yin, Xiaoxiang; Li, Yanyun; Duan, Rong; Boyce, Brendan F.; Yao, Zhenqiang			TNF Induction of NF-kappa B RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MEDIATED JOINT DESTRUCTION; RHEUMATOID-ARTHRITIS; STROMAL CELLS; UP-REGULATION; BONE-MARROW; RECEPTOR; TRANSCRIPTION; DISEASE; MICE	TNF induces bone loss in common bone diseases by promoting osteoclast formation directly and indirectly, but it also limits osteoclast formation by inducing expression of NF-kappa B p100. Osteoclast precursors (OCPs) are derived from M1 (inflammatory) and M2 (resident) macrophages. However, it is not known if TNF stimulates or limits osteoclast formation through regulation of M1 or M2 differentiation or if RelB, a partner of p100, is involved. To investigate these questions, we treated bone marrow cells (BMCs) with M-CSF alone or in combination with TNF to enrich for OCPs, which we called M-OCPs and T-OCPs, respectively. We found that TNF switched CD11b(+)F4/80(+)M(-)OCPs from Ly6C-Gr1-M2 to Ly6C(+)Gr1-CD11c(+) and Ly6C-Gr1-CD11c(+)M1 cells. RANKL induced osteoclast formation from both Ly6C(+)Gr1(-) and Ly6C-Gr1-T-OCPs, but only from Ly6C(+)Gr1(-)M-OCPs, which formed significantly fewer osteoclasts than T-OCPs. Importantly, Ly6C(+)Gr1-cells from both M-and T-OCPs have increased expression of the M1 marker genes, iNOS, TNF, IL-1 beta and TGF beta 1, compared to Ly6C(-)Gr1(-) cells, and Ly6C(-)Gr1(-) cells from T-OCPs also have increased expression of iNOS and TGF beta 1 compared to cells from M-OCPs. Both RANKL and TNF increased RelB mRNA expression. TNF significantly increased RelB protein levels, but RANKL did not because it also induced RelB proteasomal degradation. TNF inhibited RANKL-induced NFATc1 mRNA expression and osteoclast formation from M-OCPs, but not from T-OCPs, and it did not induce Ly6C(+)Gr1(-)CD11c(+) or Ly6C(-)Gr1(-)CD11c(+)M1 macrophages from RelB-/- MCs. Furthermore, overexpression of RelB in M-OCPs reduced RANKL-induced osteoclast formation and NFATc1 mRNA expression, but it increased TNF-induced OC formation without affecting NFATc1 levels. Thus, TNF induction of RelB directly mediates terminal osteoclast differentiation independent of NFATc1 and limits RANKL-induced osteoclastogenesis by inhibiting NFATc1 activation. However, the dominant role of TNF is to expand the OCP pool by switching the differentiation of M-CSF-induced M2 to M1 macrophages with enhanced osteoclast forming potential. Strategies to degrade RelB could prevent TNF-induced M2/M1 switching and reduce osteoclast formation.	[Zhao, Zhijun; Hou, Xiaodong; Yin, Xiaoxiang] Henan Univ, Affiliated Hosp 1, Dept Med Imaging, Kaifeng 475001, Henan, Peoples R China; [Hou, Xiaodong; Yin, Xiaoxiang; Li, Yanyun; Duan, Rong; Boyce, Brendan F.; Yao, Zhenqiang] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Hou, Xiaodong; Yin, Xiaoxiang; Li, Yanyun; Duan, Rong; Boyce, Brendan F.; Yao, Zhenqiang] Ctr Musculoskeletal Res, Rochester, NY 14642 USA	Henan University; University of Rochester	Yao, ZQ (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Box 626,Room 1-2105,601 Elmwood Ave, Rochester, NY 14642 USA.	zhenqiang_yao@urmc.rochester.edu			National Natural Science Foundation of China [81373191]; National Institute for Arthritis, Musculoskeletal and Skin Diseases [AR43510, P30AR061307]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, P30AR061307] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute for Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding: This work was funded by National Natural Science Foundation of China 81373191 to ZY, National Institute for Arthritis, Musculoskeletal and Skin Diseases AR43510 to BFB, and P30AR061307 pilot grant (from Edward M. Schwarz) to ZY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2004, J CELL BIOCHEM, V93, P980, DOI 10.1002/jcb.20197; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Comstock KL, 1998, J MOL CELL CARDIOL, V30, P2761, DOI 10.1006/jmcc.1998.0851; Elewaut D, 2003, J EXP MED, V197, P1623, DOI 10.1084/jem.20030141; Ferrari-Lacraz S, 2011, OSTEOPOROSIS INT, V22, P435, DOI 10.1007/s00198-010-1326-y; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hah YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087733; Hodge JM, 2007, J CELL BIOCHEM, V102, P759, DOI 10.1002/jcb.21331; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Jackson SH, 2002, EXP HEMATOL, V30, P430, DOI 10.1016/S0301-472X(02)00792-0; Jeganathan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104498; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kono Y, 2014, BIOL PHARM BULL, V37, P137, DOI 10.1248/bpb.b13-00659; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Li J, 2012, ARTHRITIS RHEUM-US, V64, P1098, DOI 10.1002/art.33423; Madge LA, 2011, CELL CYCLE, V10, P6, DOI 10.4161/cc.10.1.14291; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; MARKS SC, 1985, BONE, V6, P451, DOI 10.1016/8756-3282(85)90223-6; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Redlich K, 2002, ARTHRITIS RHEUM, V46, P785, DOI 10.1002/art.10097; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Storheim K, 2014, ANN RHEUM DIS, V73, P949, DOI 10.1136/annrheumdis-2014-205327; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Symmons DPM, 2006, LUPUS, V15, P122, DOI 10.1191/0961203306lu2278rr; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Tang Simon Y, 2013, Bonekey Rep, V2, P255, DOI 10.1038/bonekey.2012.255; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Yao ZQ, 2014, J BONE MINER RES, V29, P866, DOI 10.1002/jbmr.2108; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhang YH, 2001, J BIOL CHEM, V276, P563, DOI 10.1074/jbc.M008198200; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	62	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135728	10.1371/journal.pone.0135728	http://dx.doi.org/10.1371/journal.pone.0135728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287732	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600065
J	Albuquerque, RV; Malcher, NS; Amado, LL; Coleman, MD; dos Santos, DC; Borges, RS; Valente, SAS; Valente, VC; Monteiro, MC				Albuquerque, Rosyana V.; Malcher, Nivea S.; Amado, Lilian L.; Coleman, Michael D.; dos Santos, Danielle C.; Borges, Rosivaldo Sa; Valente, Sebastiao Aldo S.; Valente, Vera C.; Monteiro, Marta Chagas			In Vitro Protective Effect and Antioxidant Mechanism of Resveratrol Induced by Dapsone Hydroxylamine in Human Cells	PLOS ONE			English	Article							INDUCED HEMOLYTIC-ANEMIA; ALPHA-LIPOIC ACID; OXIDATIVE STRESS; HUMAN ERYTHROCYTES; METHYLENE-BLUE; DNA-DAMAGE; INDUCED METHEMOGLOBINEMIA; TRANS-RESVERATROL; SODIUM ARSENITE; LEPROSY	Dapsone (DDS) hydroxylamine metabolites cause oxidative stress-linked adverse effects in patients, such as methemoglobin formation and DNA damage. This study evaluated the ameliorating effect of the antioxidant resveratrol (RSV) on DDS hydroxylamine (DDS-NHOH) mediated toxicity in vitro using human erythrocytes and lymphocytes. The antioxidant mechanism was also studied using in-silico methods. In addition, RSV provided intracellular protection by inhibiting DNA damage in human lymphocytes induced by DDS-NHOH. However, whilst pretreatment with RSV (10-1000 mu M significantly attenuated DDS-NHOH-induced methemoglobinemia, but it was not only significantly less effective than methylene blue (MET), but also post-treatment with RSV did not reverse methemoglobin formation, contrarily to that observed with MET. DDS-NHOH inhibited catalase (CAT) activity and reactive oxygen species (ROS) generation, but did not alter superoxide dismutase (SOD) activity in erythrocytes. Pretreatment with RSV did not alter these antioxidant enzymes activities in erythrocytes treated with DDS-NHOH. Theoretical calculations using density functional theory methods showed that DDS-NHOH has a pro-oxidant effect, whereas RSV and MET have antioxidant effect on ROS. The effect on methemoglobinemia reversion for MET was significantly higher than that of RSV. These data suggest that the pretreatment with resveratrol may decrease heme-iron oxidation and DNA damage through reduction of ROS generated in cells during DDS therapy.	[Albuquerque, Rosyana V.; Borges, Rosivaldo Sa; Monteiro, Marta Chagas] Univ Fed Para UFPA, Fac Farm, Programa Posgrad Ciencias Farmaceut, BR-66075110 Belem, PA, Brazil; [Malcher, Nivea S.; dos Santos, Danielle C.] Univ Fed Para UFPA, Fac Farm, BR-66075110 Belem, PA, Brazil; [Amado, Lilian L.] Univ Fed Para UFPA, Inst Ciencias Biol, BR-66075110 Belem, PA, Brazil; [Coleman, Michael D.] Aston Univ, Sch Life & Hlth Sci, Mech Drug Tox Grp, Birmingham B4 7ET, W Midlands, England; [Valente, Sebastiao Aldo S.; Valente, Vera C.] Inst Evandro Chagas, Secao Parasitol, SVS, MS, Ananindeua, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Aston University; Instituto Evandro Chagas	Monteiro, MC (corresponding author), Univ Fed Para UFPA, Fac Farm, Programa Posgrad Ciencias Farmaceut, Rua Augusto Correa 01, BR-66075110 Belem, PA, Brazil.	martachagas2@yahoo.com.br	Borges, Rosivaldo/U-3039-2019; Monteiro, Marta C./F-6575-2010; Borges, Rosivaldo RSB/K-4807-2016; Coleman, Michael Damian/AAD-5503-2019; Amado, Lílian Lund/I-1320-2012	Borges, Rosivaldo/0000-0003-4072-7573; Monteiro, Marta C./0000-0002-3328-5650; Amado, Lilian Lund/0000-0001-7693-8191; Coleman, MIchael D/0000-0002-5510-6852	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES; FAPESPA; Federal University of Para/PA; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Federal University of Para/PA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), CAPES, FAPESPA and Federal University of Para/PA. MCM was the recipient of fellowships from CNPq.	Adrian M, 2012, FITOTERAPIA, V83, P1345, DOI 10.1016/j.fitote.2012.04.004; Aebi H, 1984, Methods Enzymol, V105, P121; Aeschlimann C, 1996, DRUG METAB DISPOS, V24, P1336; Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Aly FAE, 2002, MUTAT RES-GEN TOX EN, V518, P1, DOI 10.1016/S1383-5718(02)00037-2; ANDERSON D, 1994, MUTAT RES, V307, P261, DOI 10.1016/0027-5107(94)90300-X; Banerjee T, 2004, BRIT J HAEMATOL, V124, P391, DOI 10.1046/j.1365-2141.2003.04781.x; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BEIGUELMAN B, 1975, INT J LEPROSY, V43, P41; Bergamaschi MM, 2011, FOOD CHEM TOXICOL, V49, P1638, DOI 10.1016/j.fct.2011.03.025; Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3; Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012; Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379; Bordin L, 2010, BRIT J PHARMACOL, V161, P1186, DOI 10.1111/j.1476-5381.2010.00962.x; Borges RS, 2013, J COMPUT THEOR NANOS, V10, P2029, DOI 10.1166/jctn.2013.3165; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Bukowska B, 2000, CELL BIOL INT, V24, P705, DOI 10.1006/cbir.2000.0553; Cao J, 2013, INT J MOL SCI, V14, P17525, DOI 10.3390/ijms140917525; Chen B, 2015, CHEM SOC REV, V44, P5246, DOI 10.1039/c4cs00373j; Chen CZ, 2013, BIOL TRACE ELEM RES, V155, P119, DOI 10.1007/s12011-013-9757-x; Chen CZ, 2013, FOOD CHEM TOXICOL, V59, P8, DOI 10.1016/j.fct.2013.05.030; Coleman MD, 2003, ENVIRON TOXICOL PHAR, V14, P121, DOI 10.1016/S1382-6689(03)00048-6; Coleman MD, 1996, DRUG SAFETY, V14, P394, DOI 10.2165/00002018-199614060-00005; COLEMAN MD, 1993, BRIT J DERMATOL, V129, P507, DOI 10.1111/j.1365-2133.1993.tb00476.x; DeFedericis HC, 2006, RADIAT RES, V165, P445, DOI 10.1667/RR3533.1; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Evelo C T, 1998, Blood Cells Mol Dis, V24, P280, DOI 10.1006/bcmd.1998.0194; Fernandez-Mar MI, 2012, FOOD CHEM, V130, P797, DOI 10.1016/j.foodchem.2011.08.023; Freitas LRS, 2014, TROP MED INT HEALTH, V19, P1216, DOI 10.1111/tmi.12362; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Furian AF, 2007, NEUROCHEM INT, V50, P164, DOI 10.1016/j.neuint.2006.07.012; Gandhi G, 2004, MUTAGENESIS, V19, P483, DOI 10.1093/mutage/geh061; Ganesan S, 2010, J APPL TOXICOL, V30, P271, DOI 10.1002/jat.1493; Gitika B, 2006, FREE RADICAL RES, V40, P95, DOI 10.1080/10715760500335447; GOLLAPUDI BB, 1995, MUTAT RES LETT, V347, P97; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; GROSSMAN S, 1995, J PHARMACOL EXP THER, V273, P870; HACKEL C, 1985, INT J LEPROSY, V53, P533; Hare GMT, 2013, REDOX BIOL, V1, P65, DOI 10.1016/j.redox.2012.12.003; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; HEGESH E, 1970, CLIN CHIM ACTA, V30, P679, DOI 10.1016/0009-8981(70)90260-3; ISRAILI ZH, 1973, J PHARMACOL EXP THER, V187, P138; JOENJE H, 1989, MUTAT RES, V219, P193, DOI 10.1016/0921-8734(89)90001-5; Jung U, 2001, FREE RADICAL BIO MED, V31, P479, DOI 10.1016/S0891-5849(01)00604-9; Kalaiselvi K, 2002, MUTAGENESIS, V17, P309, DOI 10.1093/mutage/17.4.309; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Kluger N, 2011, MED MALADIES INFECT, V41, P115, DOI 10.1016/j.medmal.2010.09.013; Kovacic P, 2014, J APPL TOXICOL, V34, P825, DOI 10.1002/jat.3005; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Lastoria JC, 2014, AN BRAS DERMATOL, V89, P205, DOI 10.1590/abd1806-4841.20142450; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li HG, 2012, NITRIC OXIDE-BIOL CH, V26, P102, DOI 10.1016/j.niox.2011.12.006; Lisovskaya IL, 2009, CHEM-BIOL INTERACT, V180, P433, DOI 10.1016/j.cbi.2009.04.003; Lu Z, 2007, J FLUORESC, V17, P580, DOI 10.1007/s10895-007-0220-2; Mahal HS, 2006, RES CHEM INTERMEDIAT, V32, P59, DOI 10.1163/156856706775012941; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCMILLAN DC, 1995, J PHARMACOL EXP THER, V274, P540; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Miyazaki R, 2008, ARTERIOSCL THROM VAS, V28, P1263, DOI 10.1161/ATVBAHA.108.166991; Mukherjee S, 2010, DOSE-RESPONSE, V8, P478, DOI 10.2203/dose-response.09-015.Mukherjee; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nakagawa H, 2001, J CANCER RES CLIN, V127, P258, DOI 10.1007/s004320000190; Ng BKW, 2010, PSYCHOSOMATICS, V51, P194, DOI 10.1176/appi.psy.51.3.194; Oliveira FR, 2014, J BRAZIL CHEM SOC, V25, P1770, DOI 10.5935/0103-5053.20140168; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Pandey KB, 2010, PHYTOTHER RES, V24, pS11, DOI 10.1002/ptr.2853; Pandey KB, 2009, APPL PHYSIOL NUTR ME, V34, P1093, DOI 10.1139/H09-115; Poulsen MM, 2015, BBA-MOL BASIS DIS, V1852, P1124, DOI 10.1016/j.bbadis.2014.12.024; Pritchard SM, 2011, J CELL MOL MED, V15, P1621, DOI 10.1111/j.1582-4934.2011.01273.x; Qadri SM, 2009, LIFE SCI, V85, P33, DOI 10.1016/j.lfs.2009.04.015; Queiroz AN, 2009, EUR J MED CHEM, V44, P1644, DOI 10.1016/j.ejmech.2008.09.023; Ramis MR, 2015, MECH AGEING DEV, V146, P28, DOI 10.1016/j.mad.2015.03.008; Rashid K, 2013, FOOD CHEM TOXICOL, V62, P584, DOI 10.1016/j.fct.2013.09.026; Reilly TP, 1998, BIOCHEM PHARMACOL, V55, P803, DOI 10.1016/S0006-2952(97)00547-9; REIMER DL, 1994, GENOMICS, V21, P325, DOI 10.1006/geno.1994.1273; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Riedel W, 2003, MOL CELL BIOCHEM, V247, P83, DOI 10.1023/A:1024142400835; Rifkind JM, 2004, ANTIOXID REDOX SIGN, V6, P657, DOI 10.1089/152308604773934422; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Sanches LAT, 2007, REV SOC BRAS MED TRO, V40, P541, DOI 10.1590/S0037-86822007000500010; Schalcher TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085712; Schiff DE, 2006, J PEDIAT HEMATOL ONC, V28, P395, DOI 10.1097/00043426-200606000-00015; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Singh CK, 2015, BBA-MOL BASIS DIS, V1852, P1178, DOI 10.1016/j.bbadis.2014.11.004; Tedesco I, 2000, J NUTR BIOCHEM, V11, P114, DOI 10.1016/S0955-2863(99)00080-7; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Vidavalur Ramesh, 2006, Exp Clin Cardiol, V11, P217; Vijayaraghavan R, 2005, EUR J CLIN NUTR, V59, P1121, DOI 10.1038/sj.ejcn.1602221; Vyas PA, 2005, BIOCHEM PHARMACOL, V70, P275, DOI 10.1016/j.bcp.2005.04.023; Walker JG, 2009, J NEURO-ONCOL, V94, P149, DOI 10.1007/s11060-009-9813-8; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P317; Zhu YI, 2001, J AM ACAD DERMATOL, V45, P420, DOI 10.1067/mjd.2001.114733; ZUIDEMA J, 1986, CLIN PHARMACOKINET, V11, P299, DOI 10.2165/00003088-198611040-00003	96	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134768	10.1371/journal.pone.0134768	http://dx.doi.org/10.1371/journal.pone.0134768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284371	gold, Green Accepted, Green Published			2022-12-27	WOS:000359666100016
J	Dabo, AJ; Cummins, N; Eden, E; Geraghty, P				Dabo, Abdoulaye J.; Cummins, Neville; Eden, Edward; Geraghty, Patrick			Matrix Metalloproteinase 9 Exerts Antiviral Activity against Respiratory Syncytial Virus	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; AIRWAY INFLAMMATION; LUNG; NEUTROPHIL; INFECTION; MMP-9; CELLS; GELATINASE; ACTIVATION; EXPRESSION	Increased lung levels of matrix metalloproteinase 9 (MMP9) are frequently observed during respiratory syncytial virus (RSV) infection and elevated MMP9 concentrations are associated with severe disease. However little is known of the functional role of MMP9 during lung infection with RSV. To determine whether MMP9 exerted direct antiviral potential, active MMP9 was incubated with RSV, which showed that MMP9 directly prevented RSV infectivity to airway epithelial cells. Using knockout mice the effect of the loss of Mmp9 expression was examined during RSV infection to demonstrate MMP9's role in viral clearance and disease progression. Seven days following RSV infection, Mmp9(-/-) mice displayed substantial weight loss, increased RSV-induced airway hyperresponsiveness (AHR) and reduced clearance of RSV from the lungs compared to wild type mice. Although total bronchoalveolar lavage fluid (BALF) cell counts were similar in both groups, neutrophil recruitment to the lungs during RSV infection was significantly reduced in Mmp9(-/-) mice. Reduced neutrophil recruitment coincided with diminished RANTES, IL-1 beta, SCF, G-CSF expression and p38 phosphorylation. Induction of p38 signaling was required for RANTES and G-CSF expression during RSV infection in airway epithelial cells. Therefore, MMP9 in RSV lung infection significantly enhances neutrophil recruitment, cytokine production and viral clearance while reducing AHR.	[Dabo, Abdoulaye J.; Cummins, Neville; Eden, Edward; Geraghty, Patrick] Mt Sinai Hlth Syst, Mt Sinai St Lukes Med Ctr, Div Pulm Crit Care & Sleep Med, New York, NY 10019 USA	Icahn School of Medicine at Mount Sinai; Mount Sinai St. Luke's	Geraghty, P (corresponding author), Mt Sinai Hlth Syst, Mt Sinai St Lukes Med Ctr, Div Pulm Crit Care & Sleep Med, New York, NY 10019 USA.	pgeraghty@chpnet.org		Geraghty, Patrick/0000-0003-1647-5505	Flight Attendant Medical Research Institute [YCSA 113380]	Flight Attendant Medical Research Institute	This work was supported by a grant made available to P.G. (Flight Attendant Medical Research Institute (famri.org/); YCSA 113380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; BORREGAARD N, 1995, BLOOD, V85, P812, DOI 10.1182/blood.V85.3.812.bloodjournal853812; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Cataldo DD, 2002, AM J PATHOL, V161, P491, DOI 10.1016/S0002-9440(10)64205-8; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Foronjy RF, 2015, MUCOSAL IMMUNOL, V8, P161, DOI 10.1038/mi.2014.54; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Foronjy RF, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0041-4; Foronjy RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090567; Fricke J, 2013, J VIROL, V87, P1333, DOI 10.1128/JVI.02263-12; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Geraghty P, 2014, AM J RESP CELL MOL, V50, P559, DOI 10.1165/rcmb.2013-0258OC; Geraghty P, 2013, AM J RESP CELL MOL, V49, P721, DOI 10.1165/rcmb.2013-0026OC; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; ICHIHARA M, 1994, INT J HEMATOL, V59, P81; Julovi SM, 2011, J ORTHOP RES, V29, P258, DOI 10.1002/jor.21216; Kanbe N, 1999, EUR J IMMUNOL, V29, P2645; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kinyanjui MW, 2013, J IMMUNOL, V190, P3859, DOI 10.4049/jimmunol.1200506; Kong MYF, 2014, EUR RESPIR J, V43, P1086, DOI 10.1183/09031936.00105613; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lee YH, 2013, VIRUS RES, V178, P411, DOI 10.1016/j.virusres.2013.09.011; Leigh R, 2004, AM J RESP CRIT CARE, V170, P851, DOI 10.1164/rccm.200311-1488OC; Lemjabbar H, 1999, AM J RESP CELL MOL, V20, P903, DOI 10.1165/ajrcmb.20.5.3260; Lepidi S, 2001, J VASC SURG, V34, P1111, DOI 10.1067/mva.2001.119401; Li W, 2007, CHINESE MED J-PEKING, V120, P5, DOI 10.1097/00029330-200701010-00002; Lin M, 2008, AM J PATHOL, V173, P144, DOI 10.2353/ajpath.2008.080081; Long XR, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0176-8; Louhelainen N, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-13; Luplertlop N, 2008, JPN J INFECT DIS, V61, P298; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; McCurdy LH, 2003, J VIROL, V77, P1747, DOI 10.1128/JVI.77.3.1747-1756.2003; McGovern TK, 2015, AM J RESP CELL MOL, V52, P513, DOI 10.1165/rcmb.2013-0430OC; McMillan SJ, 2004, J IMMUNOL, V172, P2586, DOI 10.4049/jimmunol.172.4.2586; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mehra D, 2010, AM J PHYSIOL-LUNG C, V298, pL189, DOI 10.1152/ajplung.00042.2009; Ng HH, 2012, EXP MOL PATHOL, V92, P287, DOI 10.1016/j.yexmp.2012.03.003; Olson MW, 1998, J BIOL CHEM, V273, P10672, DOI 10.1074/jbc.273.17.10672; Oshita Y, 2003, THORAX, V58, P757, DOI 10.1136/thorax.58.9.757; Overbeek SA, 2011, EUR J PHARMACOL, V668, P428, DOI 10.1016/j.ejphar.2011.03.022; Page K, 2009, J IMMUNOL, V183, P3400, DOI 10.4049/jimmunol.0900838; Pan ZZ, 2000, AM J PHYSIOL-LUNG C, V279, pL658, DOI 10.1152/ajplung.2000.279.4.L658; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Ringshausen I, 2004, LEUKEMIA, V18, P1964, DOI 10.1038/sj.leu.2403544; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Ventura I, 2014, ALLERGY, V69, P898, DOI 10.1111/all.12414; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Yasui K, 2005, PEDIATR INT, V47, P190, DOI 10.1111/j.1442-200x.2005.02039.x; Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	63	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135970	10.1371/journal.pone.0135970	http://dx.doi.org/10.1371/journal.pone.0135970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284919	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100092
J	Marino, M; Scuderi, F; Samengo, D; Saltelli, G; Maiuri, MT; Shen, CY; Mei, L; Sabatelli, M; Pani, G; Antonini, G; Evoli, A; Bartoccioni, E				Marino, Mariapaola; Scuderi, Flavia; Samengo, Daniela; Saltelli, Giorgia; Maiuri, Maria Teresa; Shen, Chengyong; Mei, Lin; Sabatelli, Mario; Pani, Giovambattista; Antonini, Giovanni; Evoli, Amelia; Bartoccioni, Emanuela			Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis	PLOS ONE			English	Article							TYROSINE KINASE MUSK; ACETYLCHOLINE-RECEPTOR; ANTIBODIES; LRP4; MUSCLE; BINDING; DOMAIN; SERUM	Background Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while autoantibodies to muscle-specific tyrosine kinase (MuSK) have been detected in half (5%) of the remaining 10%. Recently, the low-density lipoprotein receptor-related protein 4 (LRP4), identified as the agrin receptor, has been recognized as a third autoimmune target in a significant portion of the double sero-negative (dSN) myasthenic individuals, with variable frequency depending on different methods and origin countries of the tested population. There is also convincing experimental evidence that anti-LRP4 autoantibodies may cause MG. Methods The aim of this study was to test the presence and diagnostic significance of anti-LRP4 autoantibodies in an Italian population of 101 myasthenic patients (55 dSN, 23 AChR positive and 23 MuSK positive), 45 healthy blood donors and 40 patients with other neurological diseases as controls. All sera were analyzed by a cell-based antigen assay employing LRP4-transfected HEK293T cells, along with a flow cytofluorimetric detection system. Results We found a 14.5%(8/55) frequency of positivity in the dSN-MG group and a 13% frequency of co-occurrence (3/23) in both AChR and MuSK positive patients; moreover, we report a younger female prevalence with a mild form of disease in LRP4-positive dSN-MG individuals. Conclusion Our data confirm LRP4 as a new autoimmune target, supporting the value of including anti-LRP4 antibodies in further studies on Myasthenia gravis.	[Marino, Mariapaola; Samengo, Daniela; Maiuri, Maria Teresa; Pani, Giovambattista; Bartoccioni, Emanuela] Univ Cattolica Sacro Cuore, Sch Med, Inst Gen Pathol, Rome, Italy; [Scuderi, Flavia] Univ Cattolica Sacro Cuore, Sch Med, Dept Lab Med, Rome, Italy; [Saltelli, Giorgia; Antonini, Giovanni] Univ Roma La Sapienza, Fac Med & Psychol, Dept Neurol Mental Hlth & Sensory Organs NESMOS, I-00185 Rome, Italy; [Shen, Chengyong; Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA; [Shen, Chengyong; Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Sabatelli, Mario] Policlin A Gemelli, Ctr Clin NEMO Roma, Rome, Italy; [Evoli, Amelia] Univ Cattolica Sacro Cuore, Sch Med, Dept Neurosci, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bartoccioni, E (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Gen Pathol, Rome, Italy.	ebartoc@rm.unicatt.it	Antonini, Giovanni/AAC-6698-2022; Evoli, Amelia/AAD-6807-2022; Pani, Giovambattista/AAB-1446-2019	ANTONINI, Giovanni/0000-0002-7519-7739; Pani, Giovambattista/0000-0001-7133-8728; MARINO, Mariapaola/0000-0001-9155-6378; Sabatelli, Mario/0000-0001-6635-4985	Universita Cattolica S. Cuore as a part of its programs on promotion and dissemination of scientific research [Linea D1]	Universita Cattolica S. Cuore as a part of its programs on promotion and dissemination of scientific research	This research and its publication has been funded from Universita Cattolica S. Cuore as a part of its programs on promotion and dissemination of scientific research (Linea D1 to EB).	Barik A, 2014, J NEUROSCI, V34, P13892, DOI 10.1523/JNEUROSCI.1733-14.2014; Berrih-Aknin S, 2014, J AUTOIMMUN, V48-49, P143, DOI 10.1016/j.jaut.2014.01.003; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Cossins J, 2012, ANN NY ACAD SCI, V1275, P123, DOI 10.1111/j.1749-6632.2012.06833.x; Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223; Gallardo E, 2014, AUTOIMMUN REV, V13, P1003, DOI 10.1016/j.autrev.2014.08.039; Gasperi C, 2014, NEUROLOGY, V82, P1976, DOI 10.1212/WNL.0000000000000478; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Kawakami Y, 2011, NEUROLOGY, V77, P1819, DOI 10.1212/WNL.0b013e318237f660; Klein R, 2013, HUM IMMUNOL, V74, P1184, DOI 10.1016/j.humimm.2013.06.020; Koneczny I, 2014, J ANAT, V224, P29, DOI 10.1111/joa.12034; Koneczny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080695; Lauriola L, 2005, NEUROLOGY, V64, P536, DOI 10.1212/01.WNL.0000150587.71497.B6; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; LINDSTROM J, 1977, CLIN IMMUNOL IMMUNOP, V7, P36, DOI 10.1016/0090-1229(77)90027-7; Marino M, 2001, J NEUROIMMUNOL, V116, P94, DOI 10.1016/S0165-5728(01)00287-9; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; Provenzano C, 2010, J NEUROIMMUNOL, V218, P102, DOI 10.1016/j.jneuroim.2009.11.004; Punga AR, 2012, CURR OPIN PHARMACOL, V12, P340, DOI 10.1016/j.coph.2012.02.002; Richman DP, 2012, ARCH NEUROL-CHICAGO, V69, P434, DOI 10.1001/archneurol.2011.2855; Shen CY, 2013, J CLIN INVEST, V123, P5190, DOI 10.1172/JCI66039; Tian QB, 2006, EUR J NEUROSCI, V23, P2864, DOI 10.1111/j.1460-9568.2006.04846.x; Tzartos JS, 2014, ANN CLIN TRANSL NEUR, V1, P80, DOI 10.1002/acn3.26; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091816; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393; Zhang W, 2011, J BIOL CHEM, V286, P40624, DOI 10.1074/jbc.M111.279307; Zisimopoulou P, 2014, J AUTOIMMUN, V52, P139, DOI 10.1016/j.jaut.2013.12.004; Zong YN, 2013, CELL MOL LIFE SCI, V70, P3077, DOI 10.1007/s00018-012-1209-9	35	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135378	10.1371/journal.pone.0135378	http://dx.doi.org/10.1371/journal.pone.0135378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284792	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100035
J	Zazzo, A; Lebon, M; Quiles, A; Reiche, I; Vigne, JD				Zazzo, Antoine; Lebon, Matthieu; Quiles, Anita; Reiche, Ina; Vigne, Jean-Denis			Direct Dating and Physico-Chemical Analyses Cast Doubts on the Coexistence of Humans and Dwarf Hippos in Cyprus	PLOS ONE			English	Article							BONE APATITE; CALCINED BONES; MASTODON IVORY; ORIGIN; TRANSFORMATION; LIGHT	In the Mediterranean, the island dwarf megafaunas became extinct around the end of the Pleistocene, during a period of rapid and global climate change. In Cyprus, this coincided with the first human presence on the island, as attested by the rock shelter of Akrotiri-Aetok-remnos where an Epipaleolithic anthropogenic layer (stratum 2) was found overlying a massive accumulation of pygmy hippopotamus (Phanourios minor (Desmarest, 1822)) [Boekschoten and Sondaar, 1972] bones (stratum 4). The relationship between the two layers is highly controversial and the role played by humans in hippo extinction remains fiercely debated. Here, we provide new, direct radiocarbon and physico-chemical analyses on calcined bones which elucidates the complex depositional history of the assemblage. Bone turquoise was identified using micro-PIXE analysis and depth-profiling together with Vis spectroscopy, demonstrating that these bones were not freshly burned. Bayesian modeling of the radiocarbon dates indicates that stratum 4 accumulated during the first half of the 13th mill cal BP and that calcination occurred several hundred years later. We conclude that accumulation occurred naturally during the beginning of the Younger Dryas and that Epipalaeolithic visitors subsequently used the bones as fuel, starting from the mid-13th mill cal BP. At that time, dwarf hippos were probably already extinct or at least highly endangered. Our results shed new light on the possible causes of hippo extinction, on the subsequent introduction of the wild boar and on the earliest occupation of the island by humans.	[Zazzo, Antoine; Vigne, Jean-Denis] Museum Natl Hist Nat, CNRS, Unite Mixte Rech Archeozool Archeobot Soc Prat &, F-75005 Paris, France; [Lebon, Matthieu] Museum Natl Hist Nat, CNRS, Unite Mixte Rech Hist Nat Homme Prehist 7194, F-75005 Paris, France; [Quiles, Anita] Inst Francais Archeol Orientale, Pole Archeometrie, Cairo 11441, Egypt; [Reiche, Ina] Sorbonne Univ, Univ Paris 06, Unite Mixte Rech 8220, Lab Archeol Mol & Struct,CNRS, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Zazzo, A (corresponding author), Museum Natl Hist Nat, CNRS, Unite Mixte Rech Archeozool Archeobot Soc Prat &, CP 56,55 Rue Buffon, F-75005 Paris, France.	zazzo@mnhn.fr	zazzo, Antoine/H-1697-2011; Reiche, Ina/AAQ-3897-2020	zazzo, Antoine/0000-0001-7608-2207; Quiles, Anita/0000-0002-2933-4472	MNHN (ATM Biodiversite actuelle et passee); Ministry of higher education (PNRCC OsiRis); SEEG "Limassol" of the CNRS	MNHN (ATM Biodiversite actuelle et passee); Ministry of higher education (PNRCC OsiRis); SEEG "Limassol" of the CNRS	This work was funded by the MNHN (ATM Biodiversite actuelle et passee), grant to AZ; the Ministry of higher education (PNRCC OsiRis) grant to IR; the SEEG "Limassol" of the CNRS, grant to JDV. These grants have no specific number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman AJ, 2005, WORLD ARCHAEOL, V37, P533, DOI 10.1080/00438240500404359; Athanassiou A., 2007, P 11 INT C ATH GREEC, V40, P201, DOI DOI 10.12681/BGSG.16514; Bennett JL, 1999, J ARCHAEOL SCI, V26, P1, DOI 10.1006/jasc.1998.0283; Binford L, 2000, AM ANTIQUITY, V65, P771, DOI 10.2307/2694435; Blondel Jacques, 1993, P135; BOEKSCHOTEN G. J., 1972, P KONINKLIJKE NEDE B, V75, P306; Bromage Timothy G., 2002, BAR International Series, V1095, P420; Brook BW, 2004, J BIOGEOGR, V31, P517, DOI 10.1046/j.1365-2699.2003.01028.x; Bunimovitz S., 1996, J MEDITERR ARCHAEOL, V9, P85; Calligaro T, 2004, NUCL INSTRUM METH B, V226, P29, DOI 10.1016/j.nimb.2004.04.176; Carvalho ML, 2008, X-RAY SPECTROM, V37, P32, DOI 10.1002/xrs.1006; Castel Jean-Christophe, 2010, Revue de Paleobiologie, V29, P411; Castro W, 2010, FORENSIC SCI INT, V195, P17, DOI 10.1016/j.forsciint.2009.10.029; Coumont M-P, 2006, AVENS PIEGES FAIBLE, P181; Cucchi T, 2006, ZOOTAXA, P1; Habelitz S, 2001, J MATER SCI, V36, P4131, DOI 10.1023/A:1017996217452; Hadjisterkotis E, 2008, EUR J WILDLIFE RES, V54, P122, DOI 10.1007/s10344-007-0121-3; Held SO, 1989, COLONIZATION CYCLES, V1, P1; Huls CM, 2010, RADIOCARBON, V52, P587; Knapp AB, 2010, J WORLD PREHIST, V23, P79, DOI 10.1007/s10963-010-9034-2; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lanting JN, 2001, RADIOCARBON, V43, P249; Lebon M, 2010, J ARCHAEOL SCI, V37, P2265, DOI 10.1016/j.jas.2010.03.024; Martin P.S., 1984, P354; MAXWELL JA, 1989, NUCL INSTRUM METH B, V43, P218, DOI 10.1016/0168-583X(89)90042-6; Olsen Sandra L., 1999, FAUNAL EXTINCTION IS, P230; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reese, 1995, PLEISTOCENE VERTEBRA; Reese D., 1999, FAUNAL EXTINCTION IS, P161; Reiche I, 2000, SOLID STATE SCI, V2, P625, DOI 10.1016/S1293-2558(00)01067-0; Reiche I, 2001, AM MINERAL, V86, P1519; Reiche I, 2008, HETEROGENEITES COMPO; Reiche I, 2008, J ANAL ATOM SPECTROM, V23, P799, DOI 10.1039/b717442j; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Simmons AH, 2013, EURASIAN PREHISTORY, V10, P139; Simmons AH, 1997, GEOARCHAEOLOGY, V12, P567; Simmons AH, 1999, FAUNAL EXTINCTION IS, p[i, 1]; Simmons AH, 1999, FAUNAL EXTINCTION IS, P283; Simmons A, 2007, WORLD ARCHAEOL, V39, P475, DOI 10.1080/00438240701676169; Snoeck C, 2014, RADIOCARBON, V56, P591, DOI 10.2458/56.17454; Van Strydonck M, 2010, RADIOCARBON, V52, P578; Vigne J-D, 2013, EURASIAN PREHISTORY, V10, P157; Vigne JD, 2009, P NATL ACAD SCI USA, V106, P16135, DOI 10.1073/pnas.0905015106; Wasse A, 2007, MARGINS SW ASIA CYPR, P43; WEINER S, 1990, J ARCHAEOL SCI, V17, P187, DOI 10.1016/0305-4403(90)90058-D; Wigand P., 1999, FAUNAL EXTINCTION IS, P193; Zazzo A, 2011, PALAEOGEOGR PALAEOCL, V310, P52, DOI 10.1016/j.palaeo.2010.12.004; Zazzo A, 2013, RADIOCARBON, V55, P1409, DOI 10.1017/S0033822200048347; Zazzo A, 2012, RADIOCARBON, V54, P855, DOI 10.1017/S0033822200047500	49	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134429	10.1371/journal.pone.0134429	http://dx.doi.org/10.1371/journal.pone.0134429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284623	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100010
J	Lee, SSJ; Lin, HH; Tsai, HC; Su, IJ; Yang, CH; Sun, HY; Hung, CC; Sy, CL; Wu, KS; Chen, JK; Chen, YS; Fang, CT				Lee, Susan Shin-Jung; Lin, Hsi-Hsun; Tsai, Hung-Chin; Su, Ih-Jen; Yang, Chin-Hui; Sun, Hsin-Yun; Hung, Chien-Chin; Sy, Cheng-Len; Wu, Kuan-Sheng; Chen, Jui-Kuang; Chen, Yao-Shen; Fang, Chi-Tai			A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; GAMMA RELEASE ASSAYS; QUANTIFERON-TB GOLD; RIO-DE-JANEIRO; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; SKIN-TEST; DOUBLE-BLIND; PREVALENCE; DIAGNOSIS	Background Predicting the risk of tuberculosis (TB) in people living with HIV (PLHIV) using a single test is currently not possible. We aimed to develop and validate a clinical algorithm, using baseline CD4 cell counts, HIV viral load (pVL), and interferon-gamma release assay (IGRA), to identify PLHIV who are at high risk for incident active TB in low-to-moderate TB burden settings where highly active antiretroviral therapy (HAART) is routinely provided. Materials and Methods A prospective, 5-year, cohort study of adult PLHIV was conducted from 2006 to 2012 in two hospitals in Taiwan. HAART was initiated based on contemporary guidelines (CD4 count < = 350/mu L). Cox regression was used to identify the predictors of active TB and to construct the algorithm. The validation cohorts included 1455 HIV-infected individuals from previous published studies. Area under the receiver operating characteristic (ROC) curve was calculated. Results Seventeen of 772 participants developed active TB during a median follow-up period of 5.21 years. Baseline CD4 < 350/mu L or pVL >= 100,000/mL was a predictor of active TB (adjusted HR 4.87, 95% CI 1.49-15.90, P = 0.009). A positive baseline IGRA predicted TB in patients with baseline CD4 >= 350/mu L and pVL < 100,000/mL (adjusted HR 6.09, 95% CI 1.52-24.40, P = 0.01). Compared with an IGRA-alone strategy, the algorithm improved the sensitivity from 37.5% to 76.5%, the negative predictive value from 98.5% to 99.2%. Compared with an untargeted strategy, the algorithm spared 468 (60.6%) from unnecessary TB preventive treatment. Area under the ROC curve was 0.692 (95% CI: 0.587-0.798) for the study cohort and 0.792 (95% CI: 0.776-0.808) and 0.766 in the 2 validation cohorts. Conclusions A validated algorithm incorporating the baseline CD4 cell count, HIV viral load, and IGRA status can be used to guide targeted TB preventive treatment in PLHIV in low-to-moderate TB burden settings where HAART is routinely provided to all PLHIV. The implementation of this algorithm will avoid unnecessary exposure of low-risk patients to drug toxicity and simultaneously, reduce the burden of universal treatment on the healthcare system.	[Lee, Susan Shin-Jung; Tsai, Hung-Chin; Sy, Cheng-Len; Wu, Kuan-Sheng; Chen, Jui-Kuang; Chen, Yao-Shen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Lee, Susan Shin-Jung; Tsai, Hung-Chin; Sy, Cheng-Len; Wu, Kuan-Sheng; Chen, Jui-Kuang; Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Internal Med, Infect Dis Sect, Kaohsiung 813, Taiwan; [Lee, Susan Shin-Jung; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 100, Taiwan; [Lin, Hsi-Hsun] I Shou Univ, E Da Hosp, Dept Infect Control & Internal Med, Kaohsiung, Taiwan; [Lin, Hsi-Hsun] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Su, Ih-Jen] Natl Hlth Res Inst, Zhu Nan, Taiwan; [Yang, Chin-Hui] Minist Hlth & Welf, Ctr Dis Control, Taipei, Taiwan; [Yang, Chin-Hui] Taipei Med Univ, Taipei Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Sun, Hsin-Yun; Hung, Chien-Chin; Fang, Chi-Tai] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei 100, Taiwan; [Sun, Hsin-Yun; Hung, Chien-Chin; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; National Taiwan University; E-Da Hospital; I Shou University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Centers For Disease Control - Taiwan; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Fang, CT (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Room 535,17 Xu Zhou Rd, Taipei 100, Taiwan.	fangct@ntu.edu.tw	Fang, Chi-Tai/P-2908-2016	Fang, Chi-Tai/0000-0002-7380-1699; SUN, HSIN-YUN/0000-0003-0074-7721	Kaohsiung Veterans General Hospital [VGHKS101-032, VGHKS97-066]; National Science Council of Taiwan [NSC100-2314-B-010-039, NSC102-2314-B-010-017]; National Health Research Institute, Taiwan [NHRI-99A1-PDCO-0710101]	Kaohsiung Veterans General Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from Kaohsiung Veterans General Hospital [VGHKS101-032 and VGHKS97-066], the National Science Council of Taiwan [NSC100-2314-B-010-039 and NSC102-2314-B-010-017] and the National Health Research Institute, Taiwan [NHRI-99A1-PDCO-0710101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2002, J Microbiol Immunol Infect, V35, P207; [Anonymous], 2011, GUID INT TUB CAS FIN; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Centers for Disease Control R. O. C. (Taiwan), 2014, TAIW TUB CONTR REP 2; Chan PC, 2012, INT J TUBERC LUNG D, V16, P633, DOI 10.5588/ijtld.11.0504; Chan PC, 2014, AM J RESP CRIT CARE, V189, P203, DOI 10.1164/rccm.201305-0863OC; Chan PC, 2013, THORAX, V68, P263, DOI 10.1136/thoraxjnl-2012-202208; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P1446, DOI 10.1097/QAD.0b013e32832d53fc; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Janis EM, 1996, AM J MED, V100, P186, DOI 10.1016/S0002-9343(97)89457-0; Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984; McMullen SE, 2014, CLIN INFECT DIS, V58, P1260, DOI 10.1093/cid/ciu119; Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2013, LANCET INFECT DIS, V13, P825, DOI 10.1016/S1473-3099(13)70218-4; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Sultan B, 2013, INT J STD AIDS, V24, P775, DOI 10.1177/0956462413486459; Sun HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125260; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Tedla Z, 2014, CHEST, DOI [10.1378/chest.1314-0215, DOI 10.1378/CHEST.1314-0215]; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073069	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135801	10.1371/journal.pone.0135801	http://dx.doi.org/10.1371/journal.pone.0135801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280669	Green Submitted, gold, Green Published			2022-12-27	WOS:000359664300024
J	Pringproa, K; Rungsiwiwut, R; Tantilertcharoen, R; Praphet, R; Pruksananonda, K; Baumgartner, W; Thanawongnuwech, R				Pringproa, Kidsadagon; Rungsiwiwut, Ruttachuk; Tantilertcharoen, Rachod; Praphet, Reunkeaw; Pruksananonda, Kamthorn; Baumgaertner, Wolfgang; Thanawongnuwech, Roongroje			Tropism and Induction of Cytokines in Human Embryonic-Stem Cells-Derived Neural Progenitors upon Inoculation with Highly-Pathogenic Avian H5N1 Influenza Virus	PLOS ONE			English	Article							A SUBTYPE H5N1; HUMAN-DISEASE; INFECTION; PATHOLOGY; PROLIFERATION; BRAIN; DIFFERENTIATION; REMYELINATION	Central nervous system (CNS) dysfunction caused by neurovirulent influenza viruses is a dreaded complication of infection, and may play a role in some neurodegenerative conditions, such as Parkinson-like diseases and encephalitis lethargica. Although CNS infection by highly pathogenic H5N1 virus has been demonstrated, it is unknown whether H5N1 infects neural progenitor cells, nor whether such infection plays a role in the neuroinflammation and neurodegeneration. To pursue this question, we infected human neural progenitor cells (hNPCs) differentiated from human embryonic stem cells in vitro with H5N1 virus, and studied the resulting cytopathology, cytokine expression, and genes involved in the differentiation. Human embryonic stem cells (BG01) were maintained and differentiated into the neural progenitors, and then infected by H5N1 virus (A/Chicken/Thailand/CUK2/04) at a multiplicity of infection of 1. At 6, 24, 48, and 72 hours post-infection (hpi), cytopathic effects were observed. Then cells were characterized by immunofluorescence and electron microscopy, supernatants quantified for virus titers, and sampled cells studied for candidate genes. The hNPCs were susceptible to H5N1 virus infection as determined by morphological observation and immunofluorescence. The infection was characterized by a significant up-regulation of TNF-alpha gene expression, while expressions of IFN-alpha 2, IFN-alpha 1, IFN-gamma and IL-6 remained unchanged compared to mock-infected controls. Moreover, H5N1 infection did not appear to alter expression of neuronal and astrocytic markers of hNPCs, such as beta-III tubulin and GFAP, respectively. The results indicate that hNPCs support H5N1 virus infection and may play a role in the neuroinflammation during acute viral encephalitis.	[Pringproa, Kidsadagon] Chiang Mai Univ, Dept Vet Biosci & Vet Publ Hlth, Fac Vet Med, Chiang Mai 50000, Thailand; [Rungsiwiwut, Ruttachuk; Pruksananonda, Kamthorn] Chulalongkorn Univ, Fac Med, Human Embryon Stem Cell Res Ctr, Reprod Med Unit,Dept Obstet & Gynecol, Bangkok 10330, Thailand; [Rungsiwiwut, Ruttachuk; Pruksananonda, Kamthorn] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Tantilertcharoen, Rachod] Chulalongkorn Univ, Fac Vet Sci, Vet Diagnost Lab, Bangkok, Thailand; [Praphet, Reunkeaw] Maejo Univ, Inst Prod Qual & Standardizat, Chiang Mai, Thailand; [Baumgaertner, Wolfgang] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Thanawongnuwech, Roongroje] Chulalongkorn Univ, Dept Pathol, Fac Vet Sci, Bangkok, Thailand	Chiang Mai University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Maejo University; University of Veterinary Medicine Hannover, Foundation; Chulalongkorn University	Pringproa, K (corresponding author), Chiang Mai Univ, Dept Vet Biosci & Vet Publ Hlth, Fac Vet Med, Chiang Mai 50000, Thailand.	kidsadagon.p@cmu.ac.th	Pringproa, Kidsadagon/GPC-6171-2022; Rungsiwiwut, Ruttachuk/Q-2224-2019	Rungsiwiwut, Ruttachuk/0000-0002-1448-2309; Tantilertcharoen, Rachod/0000-0002-5465-8735	Thailand Research Fund (TRF); Higher Commission of Education; Chiang Mai University, Thailand [MRG5480252]	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Higher Commission of Education; Chiang Mai University, Thailand	This study was supported by the Thailand Research Fund (TRF), the Higher Commission of Education, and Chiang Mai University, Thailand, grant number MRG5480252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aponso PM, 2008, NEUROSCIENCE, V151, P1142, DOI 10.1016/j.neuroscience.2007.11.036; Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Dale RC, 2004, BRAIN, V127, P21, DOI 10.1093/brain/awh008; Das S, 2011, NEUROCHEM INT, V59, P357, DOI 10.1016/j.neuint.2011.02.020; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Dickman MS, 2001, ARCH NEUROL-CHICAGO, V58, P1696, DOI 10.1001/archneur.58.10.1696; Dukhovny A, 2012, J VIROL, V86, P3211, DOI 10.1128/JVI.06810-11; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hardy J, 2006, J NEUROCHEM, V97, P1690, DOI 10.1111/j.1471-4159.2006.03979.x; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Khatri M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029567; Kitcharoen S, 2010, EMERG INFECT DIS, V16, P569, DOI 10.3201/eid1603.091699; Kitic Maja, 2013, Acta Neuropathol Commun, V1, P5, DOI 10.1186/2051-5960-1-5; Klopfleisch R, 2006, VET PATHOL, V43, P463, DOI 10.1354/vp.43-4-463; Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lan XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050783; Lee D C W, 2012, Hong Kong Med J, V18 Suppl 2, P12; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Matthaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056659; Morris M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029257; Ng WF, 2007, LANCET, V370, P1106, DOI 10.1016/S0140-6736(07)61490-1; Ng WF, 2006, HUM PATHOL, V37, P381, DOI 10.1016/j.humpath.2006.01.015; Ng YP, 2010, NEUROSCIENCE, V168, P613, DOI 10.1016/j.neuroscience.2010.04.013; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Penderis J, 2003, BRAIN, V126, P1382, DOI 10.1093/brain/awg126; Pringproa K, 2010, BRAIN RES, V1327, P24, DOI 10.1016/j.brainres.2010.02.068; Rungsiwiwut R, 2013, CELLS TISSUES ORGANS, V198, P127, DOI 10.1159/000354031; Thanunchai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081805; Vascellari M, 2007, VET PATHOL, V44, P635, DOI 10.1354/vp.44-5-635; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Viseshakul N, 2004, VIROLOGY, V328, P169, DOI 10.1016/j.virol.2004.06.045; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Wang GF, 2008, CELL MOL IMMUNOL, V5, P113, DOI 10.1038/cmi.2008.14; World Health Organization, 2014, CUM NUMB CONF HUM CA; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015	49	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135850	10.1371/journal.pone.0135850	http://dx.doi.org/10.1371/journal.pone.0135850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274828	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600126
J	Meng, JR; Liu, PP; Zhu, LL; Zou, CW; Li, JQ; Chen, BS				Meng, Jiaorong; Liu, Pingping; Zhu, Liling; Zou, Chengwu; Li, Jieqiu; Chen, Baoshan			Complete Genome Sequence of Mulberry Vein Banding Associated Virus, a New Tospovirus Infecting Mulberry	PLOS ONE			English	Article							CHLOROTIC-SPOT-VIRUS; RINGSPOT-VIRUS; MOLECULAR CHARACTERIZATION; TOMATO; PROTEIN; RNA; ISOLATE; IDENTIFICATION; MOVEMENT; CHINA	Mulberry vein banding associated virus (MVBaV) that infects mulberry plants with typical vein banding symptoms had been identified as a tentative species of the genus Tospovirus based on the homology of N gene sequence to those of tospoviruses. In this study, the complete sequence of the tripartite RNA genome of MVBaV was determined and analyzed. The L RNA has 8905 nucleotides (nt) and encodes the putative RNA-dependent RNA polymerase (RdRp) of 2877 aa amino acids (aa) in the viral complementary (vc) strand. The RdRp of MVBaV shares the highest aa sequence identity (85.9%) with that of Watermelon silver mottle virus (WSMoV), and contains conserved motifs shared with those of the species of the genus Tospovirus. The M RNA contains 4731 nt and codes in ambisense arrangement for the NSm protein of 309 aa in the sense strand and the Gn/Gc glycoprotein precursor (GP) of 1,124 aa in the vc strand. The NSm and GP of MVBaV share the highest aa sequence identities with those of Capsicum chlorosis virus (CaCV) and Groundnut bud necrosis virus (GBNV) (83.2% and 84.3%, respectively). The S RNA is 3294 nt in length and contains two open reading frames (ORFs) in an ambisense coding strategy, encoding a 439-aa non-structural protein (NSs) and the 277-aa nucleocapsid protein (N), respectively. The NSs and N also share the highest aa sequence identity (71.1% and 74.4%, respectively) with those of CaCV. Phylogenetic analysis of the RdRp, NSm, GP, NSs, and N proteins showed that MVBaV is most closely related to CaCV and GBNV and that these proteins cluster with those of the WSMoV serogroup, and that MVBaV seems to be a species bridging the two subgroups within the WSMoV serogroup of tospoviruses in evolutionary aspect, suggesting that MVBaV represents a distinct tospovirus. Analysis of S RNA sequence uncovered the highly conserved 5'-/3'-ends and the coding regions, and the variable region of IGR with divergent patterns among MVBaV isolates.	[Meng, Jiaorong; Liu, Pingping; Zhu, Liling; Zou, Chengwu; Li, Jieqiu] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Meng, Jiaorong; Chen, Baoshan] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China; [Meng, Jiaorong; Chen, Baoshan] Minist Educ China Microbial & Plant Genet Engn, Key Lab, Nanning, Peoples R China	Guangxi University; Guangxi University	Chen, BS (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.	chenyaoj@gxu.edu.cn	Zou, Chengwu/GXW-2438-2022		Natural Science Foundation of Guangxi Province [2011GXNSFD018019, 2014GXNSFAA118085]; Key Laboratory of Ministry of Education of China [JB1301]	Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province); Key Laboratory of Ministry of Education of China(Ministry of Education, China)	This work was partially supported by grants from the Natural Science Foundation of Guangxi Province (2011GXNSFD018019, 2014GXNSFAA118085), and the Key Laboratory of Ministry of Education of China for Microbial and Plant Genetic Engineering (JB1301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen TC, 2012, PLANT PATHOL, V61, P183, DOI 10.1111/j.1365-3059.2011.02484.x; Chen TC, 2013, VIRUS GENES, V46, P487, DOI 10.1007/s11262-013-0880-8; Chen TC, 2010, ARCH VIROL, V155, P1085, DOI 10.1007/s00705-010-0688-y; de Oliveira AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038634; de Oliveira AS, 2011, VIRUS GENES, V43, P385, DOI 10.1007/s11262-011-0639-z; de Ronde D, 2014, MOL PLANT PATHOL, V15, P185, DOI 10.1111/mpp.12082; De Ronde D, 2013, MOL PLANT PATHOL, V14, P405, DOI 10.1111/mpp.12016; Dong JH, 2013, VIRUS GENES, V46, P567, DOI 10.1007/s11262-012-0873-z; Dong JH, 2008, ARCH VIROL, V153, P855, DOI 10.1007/s00705-008-0054-5; Dullemans AM, 2015, ARCH VIROL, V160, P605, DOI 10.1007/s00705-014-2282-1; Hedil M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106027; Hu ZZ, 2011, ARCH VIROL, V156, P1905, DOI 10.1007/s00705-011-1078-9; Jones DR, 2005, EUR J PLANT PATHOL, V113, P119, DOI 10.1007/s10658-005-2334-1; Kang YC, 2014, EUR J PLANT PATHOL, V140, P815, DOI 10.1007/s10658-014-0511-9; Kayvan Etebari, 2004, Entomologia Sinica, V11, P243, DOI 10.1111/j.1744-7917.2004.tb00421.x; Khatabi B, 2012, EUR J PLANT PATHOL, V133, P783, DOI 10.1007/s10658-012-9969-5; Kikkert M, 1997, J GEN VIROL, V78, P1755, DOI 10.1099/0022-1317-78-7-1755; King AMQ, 2011, VIRUS TAXONOMY, P725; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Lian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063380; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; Margaria P, 2014, ARCH VIROL, V159, P3149, DOI 10.1007/s00705-014-2166-4; Meng JR, 2013, PLANT DIS, V97, P1001, DOI 10.1094/PDIS-08-12-0792-PDN; Montero-Astua M, 2014, MOL PLANT MICROBE IN, V27, P296, DOI 10.1094/MPMI-09-13-0287-FI; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Quito-Avila DF, 2014, EUR J PLANT PATHOL, V140, P193, DOI 10.1007/s10658-014-0454-1; Rao XQ, 2013, VIRUS GENES, V46, P576, DOI 10.1007/s11262-013-0885-3; Reitz SR, 2011, AGR SCI CHINA, V10, P867, DOI 10.1016/S1671-2927(11)60073-4; Seepiban C, 2011, ARCH VIROL, V156, P263, DOI 10.1007/s00705-010-0856-0; Shimomoto Y, 2014, J GEN PLANT PATHOL, V80, P169, DOI 10.1007/s10327-014-0503-9; Silva MS, 2001, ARCH VIROL, V146, P1267, DOI 10.1007/s007050170090; Singh P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099370; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres R, 2012, ARCH VIROL, V157, P609, DOI 10.1007/s00705-011-1217-3; TSUCHIZAKI T, 1971, Annals of the Phytopathological Society of Japan, V37, P266; TSUCHIZAKI T, 1976, Annals of the Phytopathological Society of Japan, V42, P304, DOI 10.3186/jjphytopath.42.304; Webster CG, 2015, PHYTOPATHOLOGY, V105, P388, DOI 10.1094/PHYTO-06-14-0172-R; Webster CG, 2011, VIROLOGY, V413, P216, DOI 10.1016/j.virol.2011.02.011; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Whitfield AE, 2004, J VIROL, V78, P13197, DOI 10.1128/JVI.78.23.13197-13206.2004; Xu Y, 2014, ARCH VIROL, V159, P2805, DOI 10.1007/s00705-014-2100-9; Xu Y, 2013, ARCH VIROL, V158, P2597, DOI 10.1007/s00705-013-1756-x; Yin YQ, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/201421; Zhai Y, 2014, ARCH VIROL, V159, P1499, DOI 10.1007/s00705-013-1928-8; Zhou J, 2011, VIRUS GENES, V43, P289, DOI 10.1007/s11262-011-0621-9	45	15	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136196	10.1371/journal.pone.0136196	http://dx.doi.org/10.1371/journal.pone.0136196			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291718	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900063
J	Zhang, SY; Shi, CH; Mao, CY; Song, B; Hou, HM; Wu, J; Liu, XJ; Luo, HY; Sun, SL; Xu, YM				Zhang, Shuyu; Shi, Changhe; Mao, Chengyuan; Song, Bo; Hou, Haiman; Wu, Jun; Liu, Xinjing; Luo, Haiyang; Sun, Shilei; Xu, Yuming			Plasma Homocysteine, Vitamin B12 and Folate Levels in Multiple System Atrophy: A Case-Control Study	PLOS ONE			English	Article							PARKINSONS-DISEASE; DNA-DAMAGE; EXCITOTOXICITY; NEUROTOXICITY; METAANALYSIS; DEFICIENCY; SURVIVAL; NEURONS; RISK	Background Multiple system atrophy (MSA) is a neurodegenerative disease, and its pathological hallmark is the accumulation of alpha-synuclein proteins. Homocysteine (Hcy) is an intermediate amino acid generated during the metabolism of methionine. Hcy may contribute to the pathogenesis of neurodegenerative disorders. Vitamin B12 and folate are cofactors necessary for the methylation of homocysteine. Methods This study compared the levels of serum Hcy, vitamin B12 and folate in patients with MSA with those in healthy people to reveal the possible association between MSA and plasma levels of Hcy, vitamin B12 and folate. We enrolled 161 patients with MSA and 161 healthy people in this study. The association between MSA and the levels of Hcy, vitamin B12 and folate were analyzed using binary logistic regression. Results The mean level of Hcy in patients with MSA was significantly higher than that in healthy controls (16.23 +/- 8.09 umol/l vs 14.04 +/- 4.25 umol/l, p < 0.05). After adjusting for age, sex and medical history, the odds ratio for Hcy was 1.07 (95% CI = 1.01-1.13, p < 0.05) for patients with MSA. Vitamin B12 and folate levels were not significantly different between patients with MSA and controls. Conclusion Our data suggest that higher levels of Hcy may be associated with an increased risk for MSA.	[Zhang, Shuyu; Shi, Changhe; Mao, Chengyuan; Song, Bo; Hou, Haiman; Wu, Jun; Liu, Xinjing; Luo, Haiyang; Sun, Shilei; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University	Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.	xuyuming@zzu.edu.cn			National Natural Science Foundation of China [81471158, U1404311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 81471158 from the National Natural Science Foundation of China (to Dr. Yu-ming Xu) and grant U1404311 from the National Natural Science Foundation of China (to Dr. Chang-he Shi).	BenShlomo Y, 1997, NEUROLOGY, V48, P384, DOI 10.1212/WNL.48.2.384; Chen H, 2015, CURR ALZHEIMER RES, V12, P88, DOI 10.2174/1567205012666141218144035; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Geser F, 2006, MOVEMENT DISORD, V21, P179, DOI 10.1002/mds.20678; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Ho PI, 2002, J NEUROSCI RES, V70, P694, DOI 10.1002/jnr.10416; Jellinger KA, 2014, MOVEMENT DISORD, V29, P1720, DOI 10.1002/mds.26052; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim WK, 1999, NEUROSCI LETT, V265, P99, DOI 10.1016/S0304-3940(99)00212-8; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lendinez AM, 2014, CLIN LAB, V60, P1579, DOI 10.7754/Clin.Lab.2013.130914; Liu YY, 2011, J MOL CELL BIOL, V3, P239, DOI 10.1093/jmcb/mjr011; Macedo D, 2015, HUM MOL GENET, V24, P1717, DOI 10.1093/hmg/ddu585; Madenci G, 2012, NEUROCHEM RES, V37, P1436, DOI 10.1007/s11064-012-0729-x; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; McCann H, 2014, PARKINSONISM RELAT D, V20, P62, DOI DOI 10.1016/S1353-8020(13)70017-8; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Sakuta H, 2005, CLIN NUTR, V24, P244, DOI 10.1016/j.clnu.2004.10.006; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Schrag A, 2008, MOVEMENT DISORD, V23, P294, DOI 10.1002/mds.21839; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Vaes BLT, 2009, CALCIFIED TISSUE INT, V84, P413, DOI 10.1007/s00223-009-9244-8; Voutilainen S, 1999, ARTERIOSCL THROM VAS, V19, P1263, DOI 10.1161/01.ATV.19.5.1263; Zhang DF, 2014, MOVEMENT DISORD, V29, P819, DOI 10.1002/mds.25863	26	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136468	10.1371/journal.pone.0136468	http://dx.doi.org/10.1371/journal.pone.0136468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291976	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900087
J	Gilda, JE; Ghosh, R; Cheah, JX; West, TM; Bodine, SC; Gomes, AV				Gilda, Jennifer E.; Ghosh, Rajeshwary; Cheah, Jenice X.; West, Toni M.; Bodine, Sue C.; Gomes, Aldrin V.			Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS)	PLOS ONE			English	Article							UBIQUITIN-BINDING ENTITIES; SUPERIOR LOADING CONTROL; BETA-ACTIN; SPECIFICITY; PROTEIN; EXPRESSION; MUSCLE; BLOTS	Western blotting is a commonly used technique in biological research. A major problem with Western blotting is not the method itself, but the use of poor quality antibodies as well as the use of different experimental conditions that affect the linearity and sensitivity of the Western blot. Investigation of some conditions that are commonly used and often modified in Western blotting, as well as some commercial antibodies, showed that published articles often fail to report critical parameters needed to reproduce the results. These parameters include the amount of protein loaded, the blocking solution and conditions used, the amount of primary and secondary antibodies used, the antibody incubation solutions, the detection method and the quantification method utilized. In the present study, comparison of ubiquitinated proteins in rat heart and liver samples showed different results depending on the antibody utilized. Validation of five commercial ubiquitin antibodies using purified ubiquitinated proteins, ubiquitin chains and free ubiquitin showed that these antibodies differ in their ability to detect free ubiquitin or ubiquitinated proteins. Investigating proteins modified with interferon-stimulated gene 15 (ISG15) in young and old rat hearts using six commercially available antibodies showed that most antibodies gave different semi-quantitative results, suggesting large variability among antibodies. Evidence showing the importance of the Western blot buffer and the concentration of antibody used is presented. Hence there is a critical need for comprehensive reporting of experimental conditions to improve the accuracy and reproducibility of Western blot analysis. A Western blotting minimal reporting standard (WBMRS) is suggested to improve the reproducibility of Western blot analysis.	[Gilda, Jennifer E.; Ghosh, Rajeshwary; Cheah, Jenice X.; Bodine, Sue C.; Gomes, Aldrin V.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [West, Toni M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Bodine, Sue C.; Gomes, Aldrin V.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Gomes, AV (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	avgomes@ucdavis.edu	Gomes, Aldrin V/I-6529-2018	Gomes, Aldrin V/0000-0002-9819-3036; Ghosh, Rajeshwary/0000-0001-6528-2940; Bodine, Sue/0000-0002-5742-9145; Cheah, Jenice/0000-0002-0453-7433	National Institutes of Health [HL080101, HL096819]; UC Davis funds; VA RRD Merit [1I01RX000673]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101, R01HL096819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis funds; VA RRD Merit; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by National Institutes of Health Grants HL080101 and HL096819 (AVG), UC Davis funds (AVG), and a VA RR&D Merit 1I01RX000673 (SCB). The funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Bederman IR, 2015, J APPL PHYSIOL, V119, P16, DOI 10.1152/japplphysiol.00004.2014; Beermann S, 2012, N-S ARCH PHARMACOL, V385, P125, DOI 10.1007/s00210-011-0700-4; Benicky J, 2012, CELL MOL NEUROBIOL, V32, P1353, DOI 10.1007/s10571-012-9862-y; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bernstone L, 2012, HYBRIDOMA, V31, P7, DOI 10.1089/hyb.2010.0092; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Cernecka H, 2012, N-S ARCH PHARMACOL, V385, P875, DOI 10.1007/s00210-012-0767-6; Dewey S, 2013, J PROTEOME RES, V12, P3920, DOI 10.1021/pr4004739; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Ferrara F, 2015, MABS-AUSTIN, V7, P32, DOI 10.4161/19420862.2015.989047; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Ghosh R, 2014, EXPERT REV PROTEOMIC, P1, DOI DOI 10.1586/14789450.2014.939635; Gibson JA, 2011, AM J SURG PATHOL, V35, P742, DOI 10.1097/PAS.0b013e31821537a2; Gilda JE, 2015, METHODS MOL BIOL, V1295, P381, DOI 10.1007/978-1-4939-2550-6_27; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Herrera M, 2013, HYPERTENSION, V61, P253, DOI 10.1161/HYPERTENSIONAHA.112.203679; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; KRUCHININA NG, 1994, BIOTECHNIQUES, V17, P280; Le Grand JN, 2011, AUTOPHAGY, V7, P1302, DOI 10.4161/auto.7.11.16723; Liu Z, 2012, ANGEW CHEM INT EDIT, V51, P469, DOI 10.1002/anie.201106190; Lopitz-Otsoa F, 2012, J PROTEOMICS, V75, P2998, DOI 10.1016/j.jprot.2011.12.001; Manning CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038313; Marchalant Y, 2014, J HISTOCHEM CYTOCHEM, V62, P395, DOI 10.1369/0022155414530995; Marx V, 2013, NAT METHODS, V10, P703, DOI 10.1038/nmeth.2570; Moffitt JA, 2013, AM J PHYSIOL-REG I, V304, pR362, DOI 10.1152/ajpregu.00391.2012; Mollica JP, 2009, ANAL BIOCHEM, V386, P270, DOI 10.1016/j.ab.2008.12.029; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vigelso A, 2015, J APPL PHYSIOL, V118, P386, DOI 10.1152/japplphysiol.00840.2014; Yu WQ, 2013, N-S ARCH PHARMACOL, V386, P885, DOI 10.1007/s00210-013-0894-8; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	37	52	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135392	10.1371/journal.pone.0135392	http://dx.doi.org/10.1371/journal.pone.0135392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287535	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600047
J	Hermans, S; Horsburgh, CR; Wood, R				Hermans, Sabine; Horsburgh, C. Robert, Jr.; Wood, Robin			A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control Interventions	PLOS ONE			English	Article							NEW-YORK-CITY; HISTORICAL DECLINES; ENGLAND; AFRICA; WALES; INFECTION; LONDON	Background Cape Town has one of the highest TB burdens of any city in the world. In 1900 the City of Cape Town, New York City and London had high mortality of tuberculosis (TB). Throughout the 20th century contemporaneous public health measures including screening, diagnosis and treatment were implemented in all three settings. Mandatory notification of TB and vital status enabled comparison of disease burden trajectories. Methods TB mortality, notification and case fatality rates were calculated from 1912 to 2012 using annual TB notifications, TB death certifications and population estimates. Notification rates were stratified by age and in Cape Town by HIV status (from 2009 onwards). Results Pre-chemotherapy, TB mortality and notification rates declined steadily in New York and London but remained high in Cape Town. Following introduction of combination chemotherapy, mean annual case fatality dropped from 45-60% to below 10% in all three settings. Mortality and notification rates subsequently declined, although Cape Town notifications did not decline as far as those in New York or London and returned to pre-chemotherapy levels by 1980. The proportional contribution of childhood TB diminished in New York and London but remained high in Cape Town. The advent of the Cape Town HIV-epidemic in the 1990s was associated with a further two-fold increase in incidence. In 2012, notification rates among HIV-negatives remained at pre-chemotherapy levels. Conclusions TB control was achieved in New York and London but failed in Cape Town. The TB disease burden trajectories started diverging before the availability of combination chemotherapy in 1952 and further diverged following the HIV epidemic in 1990. Chemotherapy impacted case fatality but not transmission, evidenced by on-going high childhood TB rates. Currently endemic TB results from high on-going transmission, which has been exacerbated by the HIV epidemic. TB control will require reducing transmission, which is inexorably linked to prevailing socio-economic factors.	[Hermans, Sabine; Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Hermans, Sabine] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Hermans, Sabine] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Kampala, Uganda; [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wood, Robin] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Wood, Robin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England	University of Cape Town; University of Amsterdam; Academic Medical Center Amsterdam; Makerere University; Boston University; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Hermans, S (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	sabine.hermans@hiv-research.org.za		Hermans, Sabine/0000-0001-5146-2932; Horsburgh, C./0000-0001-6838-7895	European Union [PIOF-GA-2012-332311]; Swiss National Science Foundation [PBSKP3_145774]; National Institutes of Health [R01AI058736-02, R01AI093269-02, U01AI069924-02, U01A1069519, U01AI100805]; South African Medical Research Council [MRC-RFA-UFSP-01-2013/CCAMP]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100805, R37AI093269, R01AI058736, R01AI093269, U01AI069924] Funding Source: NIH RePORTER	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the European Union [Marie Curie International Outgoing Fellowship for Career Development PIOF-GA-2012-332311 to SH], the Swiss National Science Foundation [PBSKP3_145774 to SH], the National Institutes of Health [R01AI058736-02, R01AI093269-02, U01AI069924-02 and U01A1069519 to RW, U01AI100805 to CRH], and the South African Medical Research Council [MRC-RFA-UFSP-01-2013/CCAMP to RW]. The funding bodies had no role in study design, data analysis, or write-up.	Actuarial Society of South Africa, 2008, AIDS DEM MOD 2008; Albertyn AA, 1965, J S AFR VET ASSOC, V36, P33; Anderson SR, 2007, THORAX, V62, P162, DOI 10.1136/thx.2006.058313; [Anonymous], 1982, PUBL HLTH ENGL; Atkins P., 2000, FOOD SCI POLICY REGU; [Bureau of Tuberculosis Control New York City Department of Health and Mental Hygiene], 1900, BUR TUB CONTR ANN SU; [City of Cape Town Medical Officer of Health], 2012, ANN REP 1904 1994; Compendium of population health indicators, 1993, MORT TUB IND STAND R; Davies RPO, 1999, INT J TUBERC LUNG D, V3, P1051; Department for Environment Food and Rural Affairs, 2011, BOV TB DIS ITS EP HI; Drolet G, 1952, HALF CENTURY PROGR T; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Grange JM, 2001, INT J TUBERC LUNG D, V5, P208; Gurney Champion S, 1936, BRIT MED J, V2, P740; Hayward AC, 2000, EMERG INFECT DIS, V6, P12; LERNER BH, 1993, AM J PUBLIC HEALTH, V83, P758, DOI 10.2105/AJPH.83.5.758; Macaraig M, 2014, NEW ENGL J MED, V370, P2362, DOI 10.1056/NEJMp1402147; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Medical Officer of Health London, 1848, ANN REP; [Ministry of Health England & Wales Chief Medical Officer], 1950, ANN REP; National Department of Health, 2011, NAT ANT SENT HIV SYP; New York City Department of Health and Mental Hygiene, 2014, EPIQUERY NYC INT HLT; New York Department of Health, 2005, BRIEF HIST CAMP TUB; Office for National Statistics, 2012, 2011 CENS POP HOUS E; Office for Population Censuses and Surveys, 1974, OPCS MON DH5 MORT ST; Office for Population Censuses and Surveys, 1974, OPCS MON MB2 COMM DI; Provincial Administration of the Western Cape Provincial Region City of Cape Town, 2004, CAP TOWN TB CONTR PR; Provincial Government of the Western Cape, 2002, MIGR STUD W CAP 2001; Public Health England, 2013, TURB LOND ANN REV 20; Registrar-General, 1965, STAT REV ENGL WAL; Roy Sukhendu, 2012, J Indian Med Assoc, V110, P728; Statistics South Africa, 2014, MORT CAUS DEATH S AF; Statistics South Africa, 2002, MID POP EST 2002 201; Strategic Development Information and GIS Department City of Cape Town, 2011, CAP TOWN OV CENS 201; United Nations Department of Economic and Social Affairs Population Division, 1952, MAN 1 METH EST TOT P; United Nations Human Settlements Programme, 2012, STAT WORLDS CIT 2012; United States Census Bureau, 2002, DEM TRENDS 20 CENT; United States Census Bureau, 2005, NEW YORK RAC HOSP OR; [University of Portsmouth Great Britain Historical GIS Project], 2014, VIS BRIT TIM 2014; US Census Bureau, 2010, 2010 CENS; vanHarmelen J, 1997, AIDS, V11, P81, DOI 10.1097/00002030-199701000-00012; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; Walker ARP, 2001, J R SOC PROMO HEALTH, V121, P85, DOI 10.1177/146642400112100208; WILSON LG, 1990, J HIST MED ALL SCI, V45, P366, DOI 10.1093/jhmas/45.3.366; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, 2014, REP GLOB TUB CONTR; World Health Organization, 1987, WEEKLY EPIDEMIOLOGIC	51	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135179	10.1371/journal.pone.0135179	http://dx.doi.org/10.1371/journal.pone.0135179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288079	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600039
J	Petit, C; Le Ru, B; Dupas, S; Frerot, B; Ahuya, P; Kaiser-Arnauld, L; Harry, M; Calatayud, PA				Petit, Christophe; Le Ru, Bruno; Dupas, Stephane; Frerot, Brigitte; Ahuya, Peter; Kaiser-Arnauld, Laure; Harry, Myriam; Calatayud, Paul-Andre			Influence of Dietary Experience on the Induction of Preference of Adult Moths and Larvae for a New Olfactory Cue	PLOS ONE			English	Article							LEPIDOPTERAN STEM BORERS; TRICHOPLUSIA-NI; HOST-SELECTION; BUSSEOLA-FUSCA; OVIPOSITION; NOCTUIDAE; RESPONSES; PLANTS; MAIZE; SPECIALIST	In Lepidoptera, host plant selection is first conditioned by oviposition site preference of adult females followed by feeding site preference of larvae. Dietary experience to plant volatile cues can induce larval and adult host plant preference. We investigated how the parent's and self-experience induce host preference in adult females and larvae of three lepidopteran stem borer species with different host plant ranges, namely the polyphagous Sesamia nonagrioides, the oligophagous Busseola fusca and the monophagous Busseola nairobica, and whether this induction can be linked to a neurophysiological phenotypic plasticity. The three species were conditioned to artificial diet enriched with vanillin from the neonate larvae to the adult stage during two generations. Thereafter, two-choice tests on both larvae and adults using a Y-tube olfactometer and electrophysiological (electroantennography [EAG] recordings) experiments on adults were carried out. In the polyphagous species, the induction of preference for a new olfactory cue (vanillin) by females and 3rd instar larvae was determined by parents' and self-experiences, without any modification of the sensitivity of the females antennae. No preference induction was found in the oligophagous and monophagous species. Our results suggest that lepidopteran stem borers may acquire preferences for new olfactory cues from the larval to the adult stage as described by Hopkins' host selection principle (HHSP), neo-Hopkins' principle, and the concept of 'chemical legacy.'	[Petit, Christophe; Le Ru, Bruno; Ahuya, Peter; Calatayud, Paul-Andre] African Insect Sci Food & Hlth, ICIPE, Inst Rech Dev, Noctuid Stem Borer Biodivers Team, Nairobi, Kenya; [Petit, Christophe; Le Ru, Bruno; Dupas, Stephane; Kaiser-Arnauld, Laure; Harry, Myriam; Calatayud, Paul-Andre] CNRS, Inst Rech Dev, Evolut Genomes Comportement & Ecol, UMR 247, Gif Sur Yvette, France; [Petit, Christophe; Le Ru, Bruno; Dupas, Stephane; Kaiser-Arnauld, Laure; Harry, Myriam; Calatayud, Paul-Andre] Univ Paris 11, Orsay, France; [Frerot, Brigitte] INRA, Inst Ecol & Sci Environm Paris, UMR 1392, Versailles, France	Institut de Recherche pour le Developpement (IRD); International Centre of Insect Physiology & Ecology (ICIPE); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Petit, C (corresponding author), African Insect Sci Food & Hlth, ICIPE, Inst Rech Dev, Noctuid Stem Borer Biodivers Team, Nairobi, Kenya.	christophepetit86@gmail.com	HARRY, Myriam/AAF-1530-2019; Calatayud, Paul-andre/AAG-8117-2020; LE RU, BRUNO/C-5862-2011; Le Ru, bruno/K-3480-2016; Paul-André, Calatayud/K-3282-2019	Calatayud, Paul-andre/0000-0002-9482-4646; Le Ru, bruno/0000-0002-4208-3727; 				Akhtar Y, 2003, J CHEM ECOL, V29, P1853, DOI 10.1023/A:1024802328458; Anderson P, 2014, PLANT CELL ENVIRON, V37, P1826, DOI 10.1111/pce.12342; Anderson P, 2013, ANIM BEHAV, V85, P1169, DOI 10.1016/j.anbehav.2013.03.002; ATKINSON PR, 1980, J ENTOMOL SOC S AFR, V43, P171; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; Berdegue M, 1998, ENTOMOL EXP APPL, V89, P57, DOI 10.1023/A:1003464102518; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Calatayud PA, 2014, ENTOMOL EXP APPL, V152, P72, DOI 10.1111/eea.12201; Chakraborty TS, 2009, J NEUROGENET, V23, P210, DOI 10.1080/01677060802491559; Chow JK, 2005, CHEMOECOLOGY, V15, P129, DOI 10.1007/s00049-005-0304-x; CORBET SA, 1985, ECOL ENTOMOL, V10, P143, DOI 10.1111/j.1365-2311.1985.tb00543.x; Cunningham JP, 1998, ANIM BEHAV, V55, P227, DOI 10.1006/anbe.1997.0600; DICKENS JC, 1984, J CHEM ECOL, V10, P1759, DOI 10.1007/BF00987360; Felix AE, 2013, ANN SOC ENTOMOL FR, V49, P345, DOI 10.1080/00379271.2013.863040; Hopkins AD, 1916, USDA PROGRAM WORK 19, P353; Hora KH, 2005, ENTOMOL EXP APPL, V115, P271, DOI 10.1111/j.1570-7458.2005.00287.x; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; Le Ru BP, 2006, B ENTOMOL RES, V96, P555, DOI [10.1079/BER2006457, 10.1017/BER2006457]; Le Ru BP, 2006, ANN SOC ENTOMOL FR, V42, P353, DOI 10.1080/00379271.2006.10697467; Ledon-Rettig CC, 2013, BEHAV ECOL, V24, P311, DOI 10.1093/beheco/ars145; Moolman J, 2014, J APPL ENTOMOL, V138, P52, DOI 10.1111/jen.12085; Ndemah R, 2007, J APPL ENTOMOL, V131, P658, DOI 10.1111/j.1439-0418.2007.01219.x; NgiSong AJ, 1996, J CHEM ECOL, V22, P307, DOI 10.1007/BF02055101; Ong'amo G. O, 2009, DIVERSITY ECOLOGY PO; Ong'amo GO, 2006, ANN SOC ENTOMOL FR, V42, P171, DOI 10.1080/00379271.2006.10700620; ONYANGO FO, 1994, ENTOMOL EXP APPL, V73, P139, DOI 10.1007/BF02383419; Roessingh P, 2007, J COMP PHYSIOL A, V193, P635, DOI 10.1007/s00359-007-0218-x; Schoonhoven L. M., 2005, Insect-plant biology; TRAYNIER RMM, 1984, PHYSIOL ENTOMOL, V9, P465, DOI 10.1111/j.1365-3032.1984.tb00789.x; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhang PJ, 2007, J CHEM ECOL, V33, P1528, DOI 10.1007/s10886-007-9325-y	32	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136169	10.1371/journal.pone.0136169	http://dx.doi.org/10.1371/journal.pone.0136169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288070	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600114
J	Pockett, RD; Watkins, J; McEwan, P; Meier, G				Pockett, Rhys D.; Watkins, John; McEwan, Phil; Meier, Genevieve			Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study	PLOS ONE			English	Article							SEASONAL INFLUENZA; COST-EFFECTIVENESS; UNITED-KINGDOM; ENGLAND; COMMUNITY; OUTBREAK; HEALTH; IMPACT	Objective Detailed data are lacking on influenza burden in the United Kingdom (UK). The objective of this study was to estimate the disease burden associated with influenza-like illness (ILI) in the United Kingdom stratified by age, risk and influenza vaccination status. Methods This retrospective, cross-sectional, exploratory, observational study used linked data from the General Practice Research Database and the Hospital Episode Statistics databases to estimate resource use and cost associated with ILI in the UK. Results Data were included from 156,193 patients with >= 1 general practitioner visit with ILI. There were 21,518 high-risk patients, of whom 12,514 (58.2%) were vaccinated and 9,004 (41.8%) were not vaccinated, and 134,675 low-risk patients, of whom 17,482 (13.0%) were vaccinated and 117,193 (87.0%) were not vaccinated. High-risk vaccinated patients were older (p<0.001) and had more risk conditions (p<0.001). High-risk (odds ratio [OR] 2.16) or vaccinated (OR 1.19) patients had a higher probability of > 1 general practitioner visit compared with low-risk and unvaccinated patients. Patients who were high-risk and vaccinated had a reduced risk of > 1 general practitioner visit (OR 0.82; p<0.001). High-risk individuals who were also vaccinated had a lower probability of ILI-related hospitalisation than individuals who were high-risk or vaccinated alone (OR 0.59). In people aged >= 65 years, the mortality rate was lower in vaccinated than unvaccinated individuals (OR 0.75). The cost of ILI-related GP visits and hospital admissions in the UK over the study period in low-risk vaccinated patients was 27,391,142 pound and 141,932,471 pound, respectively. In low-risk unvaccinated patients the corresponding values were 168,318,709 pound and 112,534,130 pound, respectively. Conclusions Although vaccination rates in target groups have increased, many people are still not receiving influenza vaccination, and the burden of ILI in the United Kingdom remains substantial. Improving influenza vaccination uptake may have the potential to reduce this burden.	[Pockett, Rhys D.; McEwan, Phil] Swansea Univ, Swansea Ctr Hlth Econ, Swansea SA2 8PP, W Glam, Wales; [Watkins, John] Cardiff Univ, Coll Biomed & Life Sci, Cardiff CF14 4YS, S Glam, Wales; [Meier, Genevieve] GSK Vaccines, Hlth Econ, B-1300 Wavre, Belgium	Swansea University; Cardiff University; GlaxoSmithKline	Meier, G (corresponding author), GSK Vaccines, Hlth Econ, B-1300 Wavre, Belgium.	genevieve.c.meier@gsk.com	Pockett, Rhys/F-1703-2018	Pockett, Rhys/0000-0003-4135-7383	GlaxoSmithKline Biologicals SA., Wavre, Belgium	GlaxoSmithKline Biologicals SA., Wavre, Belgium	This work was supported by GlaxoSmithKline Biologicals SA., Wavre, Belgium, which was involved in all stages of the study conduct and analysis and also funded preparation of the manuscript and page charges. All authors had full access to the data and agreed with the submission of the publication.	Ahmed AH, 1997, EPIDEMIOL INFECT, V118, P27, DOI 10.1017/S0950268896007121; Baguelin M, 2012, VACCINE, V30, P3459, DOI 10.1016/j.vaccine.2012.03.019; Belshe RB, 2010, VACCINE, V28, pD45, DOI 10.1016/j.vaccine.2010.08.028; Centers for Disease Control and Prevention, 2014, TYP INFL VIR; Clements KM, 2011, VALUE HEALTH, V14, P800, DOI 10.1016/j.jval.2011.03.005; Cromer D, 2014, J INFECTION, V68, P363, DOI 10.1016/j.jinf.2013.11.013; Department of Health, 2010, INFLUENZA; Dexter LJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000851; Gallagher AM, 2011, INT SOC PHARM 27 ANN; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Jick H, 2010, PHARMACOTHERAPY, V30, P1199, DOI 10.1592/phco.30.12.1199; Joint Committee on Vaccination and Immunisation, 2012, JCVI STAT ANN INFL V; Keenan H, 2007, BRIT J GEN PRACT, V57, P359; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Lone NI, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001019; Mayor S, 2004, INT CONGR SER, V1263, P577, DOI 10.1016/j.ics.2004.02.143; Mayor S, 2004, INT CONGR SER, V1263, P267, DOI 10.1016/j.ics.2004.02.056; Meier CR, 2000, EUR J CLIN MICROBIOL, V19, P834, DOI 10.1007/s100960000376; National Institute for Health and Care Excellence, 2011, AM OS ZAN TREATM INF; NHS Choices, 2013, WHO SHOULD HAV FLU J; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Office for National Statistics (ONS), 2013, POP EST UK ENGL WAL; Peasah SK, 2013, VACCINE, V31, P5339, DOI 10.1016/j.vaccine.2013.09.013; Personal Social Services Research Unit, 2011, UN COSTS HLTH SOC CA; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Public Health England, 2013, INFL GREEN BOOK; Public Health England, 2013, HLTH PROTECTION REPO; RYAN MJ, 1996, J INFECT DIS S1, V174, P12; Sampson R, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583155; WHO, 2014, INFL SEAS	30	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134928	10.1371/journal.pone.0134928	http://dx.doi.org/10.1371/journal.pone.0134928			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287532	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600032
J	Raina, HS; Singh, A; Popli, S; Pandey, N; Rajagopal, R				Raina, Harpreet Singh; Singh, Ambika; Popli, Sonam; Pandey, Neeti; Rajagopal, Raman			Infection of Bacterial Endosymbionts in Insects: A Comparative Study of Two Techniques viz PCR and FISH for Detection and Localization of Symbionts in Whitefly, Bemisia tabaci	PLOS ONE			English	Article							RICKETTSIA-SP; DIVERSITY; IDENTIFICATION; EFFICIENCY; WOLBACHIA; BIOLOGY; PROBES; TISSUE	Bacterial endosymbionts have been associated with arthropods and large number of the insect species show interaction with such bacteria. Different approaches have been used to understand such symbiont-host interactions. The whitefly, Bemisia tabaci, a highly invasive agricultural pest, harbors as many as seven different bacterial endosymbionts. These bacterial endosymbionts are known to provide various nutritional, physiological, environmental and evolutionary benefits to its insect host. In this study, we have tried to compare two techniques, Polymerase chain reaction (PCR) and Flourescence in situ Hybridisation (FISH) commonly used for identification and localization of bacterial endosymbionts in B. tabaci as it harbors one of the highest numbers of endosymbionts which have helped it in becoming a successful global invasive agricultural pest. The amplified PCR products were observed as bands on agarose gel by electrophoresis while the FISH samples were mounted on slides and observed under confocal microscope. Analysis of results obtained by these two techniques revealed the advantages of FISH over PCR. On a short note, performing FISH, using LNA probes proved to be more sensitive and informative for identification as well as localization of bacterial endosymbionts in B. tabaci than relying on PCR. This study would help in designing more efficient experiments based on much reliable detection procedure and studying the role of endosymbionts in insects.	[Raina, Harpreet Singh; Singh, Ambika; Popli, Sonam; Pandey, Neeti; Rajagopal, Raman] Univ Delhi, Dept Zool, Gut Biol Lab, Delhi 110007, India	University of Delhi	Rajagopal, R (corresponding author), Univ Delhi, Dept Zool, Gut Biol Lab, Delhi 110007, India.	zoorajagopal@gmail.com	Popli, Sonam/AAR-1900-2021	Popli, Sonam/0000-0001-7450-6862	National Funds for Basic Strategic and Frontier Application Research in Agriculture (NFBSFARA) of the Indian council for Agricultural Research (ICAR), Government of India	National Funds for Basic Strategic and Frontier Application Research in Agriculture (NFBSFARA) of the Indian council for Agricultural Research (ICAR), Government of India	This work was supported by National Funds for Basic Strategic and Frontier Application Research in Agriculture (NFBSFARA) of the Indian council for Agricultural Research (ICAR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bing XL, 2013, APPL ENVIRON MICROB, V79, P569, DOI 10.1128/AEM.03030-12; Bridge RS, 2006, MODERN PATHOL, V19, P1, DOI 10.1038/modpathol.3800486; Brown Judith K., 1995, Ceiba, V36, P73; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Clark EL, 2010, PROTOPLASMA, V244, P25, DOI 10.1007/s00709-010-0156-2; Costa HS, 1995, PROTOPLASMA, V189, P194, DOI 10.1007/BF01280174; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Einerson RR, 2005, AM J CLIN PATHOL, V124, P421, DOI 10.1309/BLH8MMK85UBQ4K6R; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Frieden M, 2003, NUCLEOS NUCLEOT NUCL, V22, P1041, DOI 10.1081/NCN-120022731; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Gosalbes MJ, 2010, INT J MED MICROBIOL, V300, P271, DOI 10.1016/j.ijmm.2009.12.001; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Guo HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084538; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Kaiser W, 2010, P ROY SOC B-BIOL SCI, V277, P2311, DOI 10.1098/rspb.2010.0214; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Kubota K, 2006, APPL ENVIRON MICROB, V72, P5311, DOI 10.1128/AEM.03039-05; Li ZX, 2007, CURR MICROBIOL, V54, P467, DOI 10.1007/s00284-007-0011-7; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Muyzer G., 1996, MOL MICROBIAL ECOLOG, V34, P1; Nordkamp LO, 2009, J PEDIAT HEMATOL ONC, V31, P930, DOI 10.1097/MPH.0b013e3181bc9c85; Oakeson KF, 2014, GENOME BIOL EVOL, V6, P76, DOI 10.1093/gbe/evt210; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Olsen KN, 2008, ANTON LEEUW INT J G, V94, P423, DOI 10.1007/s10482-008-9260-0; ONeill SL, 1997, INFLUENTIAL PASSENGE; Pandey N, 2016, INSECT SCI, V23, P704, DOI 10.1111/1744-7917.12220; Pandey N, 2013, ENVIRON ENTOMOL, V42, P1257, DOI 10.1603/EN13110; Priya NG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-81; Raina HS, 2015, INFECT GENET EVOL, V32, P224, DOI 10.1016/j.meegid.2015.03.022; Rana VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042168; Sato T, 2003, PRENATAL DIAG, V23, P678, DOI 10.1002/pd.660; Singh ST, 2013, ENVIRON ENTOMOL, V42, P711, DOI 10.1603/EN13032; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Szklarzewicz T, 2001, PROTOPLASMA, V218, P45, DOI 10.1007/BF01288359; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Weeks AR, 2003, CONT T ENT, P165; Wellinghausen N, 2005, J CLIN MICROBIOL, V43, P4070, DOI 10.1128/JCM.43.8.4070-4075.2005; West NJ, 2001, MICROBIOL-SGM, V147, P1731, DOI 10.1099/00221287-147-7-1731; Xue X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048148; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	52	6	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136159	10.1371/journal.pone.0136159	http://dx.doi.org/10.1371/journal.pone.0136159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287997	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600113
J	Pandey, P; Sui, M; Li, MY; Zhang, QZ; Kim, ES; Lee, J				Pandey, Puran; Sui, Mao; Li, Ming-Yu; Zhang, Quanzhen; Kim, Eun-Soo; Lee, Jihoon			Systematic Study on the Self-Assembled Hexagonal Au Voids, Nano-Clusters and Nanoparticles on GaN (0001)	PLOS ONE			English	Article							AGGLOMERATION BEHAVIOR; FABRICATION; FILMS; TEMPERATURE; MORPHOLOGY; NANOWIRES; EVOLUTION; DROPLETS; GROWTH	Au nano-clusters and nanoparticles (NPs) have been widely utilized in various electronic, optoelectronic, and bio-medical applications due to their great potentials. The size, density and configuration of Au NPs play a vital role in the performance of these devices. In this paper, we present a systematic study on the self-assembled hexagonal Au voids, nano-clusters and NPs fabricated on GaN (0001) by the variation of annealing temperature and deposition amount. At relatively low annealing temperatures between 400 and 600 degrees C, the fabrication of hexagonal shaped Au voids and Au nano-clusters are observed and discussed based on the diffusion limited aggregation model. The size and density of voids and nano-clusters can systematically be controlled. The self-assembled Au NPs are fabricated at comparatively high temperatures from 650 to 800 degrees C based on the Volmer-Weber growth model and also the size and density can be tuned accordingly. The results are symmetrically analyzed and discussed in conjunction with the diffusion theory and thermodynamics by utilizing AFM and SEM images, EDS maps and spectra, FFT power spectra, cross-sectional line-profiles and size and density plots.	[Pandey, Puran; Sui, Mao; Li, Ming-Yu; Zhang, Quanzhen; Kim, Eun-Soo; Lee, Jihoon] Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea; [Lee, Jihoon] Univ Arkansas, Inst Nanoscale Sci & Engn, Fayetteville, AR 72701 USA	Kwangwoon University; University of Arkansas System; University of Arkansas Fayetteville	Lee, J (corresponding author), Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea.	jihoonleenano@gmail.com	/B-7688-2019; Li, Ming-Yu/AAH-6879-2020; Pandey, Puran/AFR-7802-2022	/0000-0002-8768-8586; Li, Ming-Yu/0000-0003-4812-8604; Pandey, Puran/0000-0002-4993-2066; Lee, Jihoon/0000-0002-0508-486X	National Research Foundation (NRF) of Korea [2011-0030821, 2013R1A1A1007118]; Kwangwoon University	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Kwangwoon University	Financial support from the National Research Foundation (NRF) of Korea (no. 2011-0030821 and 2013R1A1A1007118), and in part by the research grant of Kwangwoon University in 2015 is gratefully acknowledged.	Abraham DB, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/16002; AbuWaar ZY, 2006, NANOTECHNOLOGY, V17, P4037, DOI 10.1088/0957-4484/17/16/007; Baker CO, 2011, ACS NANO, V5, P3469, DOI 10.1021/nn200992w; Chen XQ, 2013, SOL ENERG MAT SOL C, V111, P1, DOI 10.1016/j.solmat.2012.12.016; Dahiya AS, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-379; Dong YJ, 2009, NANO LETT, V9, P2183, DOI 10.1021/nl900858v; Dowdy R, 2012, IEEE ELECTR DEVICE L, V33, P522, DOI 10.1109/LED.2012.2186115; Gholampour M, 2014, MATER LETT, V120, P136, DOI 10.1016/j.matlet.2014.01.062; Glasner K, 2009, EUR J APPL MATH, V20, P1, DOI 10.1017/S0956792508007559; Huang XH, 2010, J ADV RES, V1, P13, DOI 10.1016/j.jare.2010.02.002; Jacopin G, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.014101; Jensen MCR, 2008, J PHYS CHEM C, V112, P16953, DOI 10.1021/jp804492h; Jessen GH, 2003, IEEE ELECTR DEVICE L, V24, P677, DOI 10.1109/LED.2003.818816; Kawamura M, 2005, MICROELECTRON ENG, V82, P277, DOI 10.1016/j.mee.2005.07.035; Kim BJ, 2014, NANO LETT, V14, P4554, DOI 10.1021/nl501582q; Kuznetsov AI, 2011, ACS NANO, V5, P4843, DOI 10.1021/nn2009112; Kwon JY, 2003, J APPL PHYS, V93, P3270, DOI 10.1063/1.1556178; Lee JM, 2007, MAT SCI ENG A-STRUCT, V449, P769, DOI 10.1016/j.msea.2006.02.403; Li MY, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-407; Li MY, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-113; Liu CY, 2011, SCRIPTA MATER, V64, P533, DOI 10.1016/j.scriptamat.2010.11.036; Mishra UK, 2008, P IEEE, V96, P287, DOI 10.1109/JPROC.2007.911060; Obi D, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/44/445008; Petrov I, 2003, J VAC SCI TECHNOL A, V21, pS117, DOI 10.1116/1.1601610; Qiao LF, 2011, APPL ENERG, V88, P848, DOI 10.1016/j.apenergy.2010.09.021; Ruffino F, 2014, J APPL PHYS, V115, DOI 10.1063/1.4866876; Sahoo P, 2013, J MATER CHEM C, V1, P7237, DOI 10.1039/c3tc31494d; Salomon D, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-61; Strobel S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/50/505301; Sugawara K, 2008, VACUUM, V83, P610, DOI 10.1016/j.vacuum.2008.04.029; Sui M, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-436; Sui M, 2014, CRYSTENGCOMM, V16, P4390, DOI 10.1039/c4ce00210e; Sui M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-525; Sun W, 2013, J PHYS CHEM C, V117, P19234, DOI 10.1021/jp406294t; Takahashi K, 2007, WIDE BANDGAP SEMICON, P393; Wang CM, 2005, J APPL PHYS, V98, DOI 10.1063/1.2130890; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; YAO JH, 1993, PHYS REV B, V47, P14110, DOI 10.1103/PhysRevB.47.14110; Yu HZ, 2014, ACTA MATER, V67, P189, DOI 10.1016/j.actamat.2013.12.031; Zhou HQ, 2010, J AM CHEM SOC, V132, P944, DOI 10.1021/ja909228n; Zhu HW, 2014, BIOMED MICRODEVICES, V16, P479, DOI 10.1007/s10544-014-9850-8	41	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134637	10.1371/journal.pone.0134637	http://dx.doi.org/10.1371/journal.pone.0134637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285135	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100014
J	Nygaard, GO; Celius, EG; Benavent, SAD; Sowa, P; Gustavsen, MW; Fjell, AM; Landro, NI; Walhovd, KB; Harbo, HF				Nygaard, Gro O.; Celius, Elisabeth G.; Benavent, Sigrid A. de Rodez; Sowa, Piotr; Gustavsen, Marte W.; Fjell, Anders M.; Landro, Nils I.; Walhovd, Kristine B.; Harbo, Hanne F.			A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity	PLOS ONE			English	Article							NATALIZUMAB; PROGRESSION; THERAPY; RESERVE	New treatment options may make "no evidence of disease activity" (NEDA: no relapses or disability progression and no new/enlarging MRI lesions, as opposed to "evidence of disease activity" (EDA) with at least one of the former), an achievable goal in relapsing-remitting multiple sclerosis (RRMS). The objective of the present study was to determine whether early RRMS patients with EDA at one-year follow-up had different disability, cognition, treatment and gray matter (GM) atrophy rates from NEDA patients and healthy controls (HC). RRMS patients (mean age 34 years, mean disease duration 2.2 years) were examined at baseline and one-year follow-up with neurological (n = 72), neuropsychological (n = 56) and structural MRI (n = 57) examinations. Matched HC (n = 61) were retested after three years. EDA was found in 46% of RRMS patients at follow-up. EDA patients used more first line and less second line disease modifying treatment than NEDA (p = 0.004). While the patients groups had similar disability levels at baseline, they differed in disability at follow-up (p = 0.010); EDA patients progressed (EDSS: 1.8-2.2, p = 0.010), while NEDA patients improved (EDSS: 2.0-1.7, p<0.001). Cognitive function was stable in both patient groups. Subcortical GM atrophy rates were higher in EDA patients than HC (p<0.001). These results support the relevance of NEDA as outcome in RRMS and indicate that pathological neuro-degeneration in RRMS mainly occur in patients with evidence of disease activity.	[Nygaard, Gro O.; Celius, Elisabeth G.; Gustavsen, Marte W.; Harbo, Hanne F.] Univ Oslo, Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Nygaard, Gro O.; Celius, Elisabeth G.; Benavent, Sigrid A. de Rodez; Sowa, Piotr; Gustavsen, Marte W.; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Benavent, Sigrid A. de Rodez] Univ Oslo, Dept Ophthalmol, Oslo Univ Hosp, Oslo, Norway; [Sowa, Piotr] Univ Oslo, Dept Radiol, Oslo Univ Hosp, Oslo, Norway; [Fjell, Anders M.; Landro, Nils I.; Walhovd, Kristine B.] Univ Oslo, Dept Psychol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Nygaard, GO (corresponding author), Univ Oslo, Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	g.o.nygaard@medisin.uio.no	Celius, Elisabeth Gulowsen/S-1387-2019	Celius, Elisabeth Gulowsen/0000-0002-9127-6488	South-Eastern Health Authorities of Norway [2011059]; Odd Fellows Foundation for Multiple Sclerosis Research	South-Eastern Health Authorities of Norway; Odd Fellows Foundation for Multiple Sclerosis Research	This work was funded by the South-Eastern Health Authorities of Norway (grant number 2011059, entitled 'Genetic risk factors and MRI and clinical outcome in MS') and a research grant from the Odd Fellows Foundation for Multiple Sclerosis Research. This funding was external to our organization. The first author received a PhD scholarship from the former, and the research assistants who performed neuropsychological testing of the patients were supported by the latter grant, both of which were administered by Oslo University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2013, NEUROLOGY, V80, P1728, DOI 10.1212/WNL.0b013e3182918c6f; Bakshi R, 2008, ARCH NEUROL-CHICAGO, V65, P1449, DOI 10.1001/archneur.65.11.1449; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Beck AT, 1996, MANUAL FOR THE BECK; Benedict RH, 1997, BVMT R BRIEF VISUOSP; Bevan CJ, 2014, JAMA NEUROL, V71, P269, DOI 10.1001/jamaneurol.2013.5486; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; De Stefano N, 2014, CNS DRUGS, V28, P147, DOI 10.1007/s40263-014-0140-z; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Geurts JJG, 2012, LANCET NEUROL, V11, P1082, DOI 10.1016/S1474-4422(12)70230-2; Giovannoni G, 2011, LANCET NEUROL, V10, P329, DOI 10.1016/S1474-4422(11)70023-0; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Karussis D, 2006, EUR J NEUROL, V13, P61, DOI 10.1111/j.1468-1331.2006.01147.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lublin FD, 2013, ANN NEUROL, V73, P327, DOI 10.1002/ana.23863; Myhr K-M, 2011, NASJONALE FAGLIGE RE; Nash RA, 2015, JAMA NEUROL, V72, P159, DOI 10.1001/jamaneurol.2014.3780; Nygaard GO, 2015, MULT SCLER J, V21, P402, DOI 10.1177/1352458514543811; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rotstein DL, 2015, JAMA NEUROL, V72, P152, DOI 10.1001/jamaneurol.2014.3537; Sastre-Garriga J, 2015, MULT SCLER J, V21, P749, DOI 10.1177/1352458514556300; Shirani A, 2012, JAMA; Smith A., 1982, SYMBOL DIGIT MODALIT; Sormani MP, 2013, MULT SCLER J, V19, P605, DOI 10.1177/1352458512460605; Sumowski JF, 2014, NEUROLOGY, V82, P1776, DOI 10.1212/WNL.0000000000000433; Tedeholm H, 2013, MULT SCLER J, V19, P765, DOI 10.1177/1352458512463764; Tremlett H, 2012, MULT SCLER J, V18, P1412, DOI 10.1177/1352458512439119; Van Schependom J, 2015, MULT SCLER J, V21, P83, DOI 10.1177/1352458514537012; Vidal-Jordana A, 2013, MULT SCLER J, V19, P1175, DOI 10.1177/1352458512473190; Vrenken H, 2013, J NEUROL, V260, P2458, DOI 10.1007/s00415-012-6762-5; Walhovd KB, 2013, NEUROBIOLOGY OF AGIN; Wegner C, 2006, NEUROLOGY, V67, P960, DOI 10.1212/01.wnl.0000237551.26858.39; Zivadinov R, 2008, NEUROLOGY, V71, P136, DOI 10.1212/01.wnl.0000316810.01120.05	40	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135974	10.1371/journal.pone.0135974	http://dx.doi.org/10.1371/journal.pone.0135974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280173	Green Published, gold			2022-12-27	WOS:000359664300029
J	Chien, MY; Chen, LC; Chen, YC; Sheu, MT; Tsai, YC; Ho, HO; Su, CH; Liu, DZ				Chien, Mei-Yin; Chen, Ling-Chun; Chen, Ying-Chen; Sheu, Ming-Thau; Tsai, Ya-Chi; Ho, Hsiu-O; Su, Ching-Hua; Liu, Der-Zen			Mycelial Mattress from a Sporangia Formation-Delayed Mutant of Rhizopus stolonifer as Wound Healing-Enhancing Biomaterial	PLOS ONE			English	Article							FUNGAL MYCELIA; KERATINOCYTE PROLIFERATION; SKIN SUBSTITUTES; CHITOSAN; CHITIN; METALLOPROTEINASES; INHIBITORS	A mycelial mattress of Rhizopus stolonifer obtained from a liquid static culture was utilized for wound dressing and biomedical use. Following screening of mutants induced by UV radiation, F6, exhibiting delayed sporangium formation was selected because its sporangium maturation exhibited a 5-day delay without significant loss of mycelial weight compared to the wild type. The sporangium-free mycelial mattress from the sporangiospore culture of F6 was treated with 1N sodium hydroxide NaOH at 85 degrees C for 2 h to produce a sponge-like membrane named Rhizochitin. The trifluoroacetic acid hydrolysate of Rhizochitin contained 36% N-acetylglucosamine and 53% hexose respectively detected by the Elson-Morgen and phenol-sulfuric acid methods. Results indicated the wound area in rats covered with Rhizochitin was 40% less than that of the uncovered group. Rhizochitin decreased the expression of PDGF in the proliferation stage, increased the expression of TGF-beta in the inflammation and proliferation stages, and increased the expression of VEGF in the inflammation and proliferation stages. Rhizochitin inhibited secretion of matrix metalloproteinase-9 on days 1, 7, 9, and 12 and matrix metalloproteinase-2 on days 3, 7, 9, and 12. It was concluded that Rhizochitin has beneficial properties of biocompatible, biodegradable, and wound healing.	[Chien, Mei-Yin] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Chen, Ling-Chun; Chen, Ying-Chen; Sheu, Ming-Thau; Ho, Hsiu-O] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Clin Res Ctr, Taipei, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei, Taiwan; [Tsai, Ya-Chi; Liu, Der-Zen] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan; [Su, Ching-Hua] Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan; [Liu, Der-Zen] Hsuan Chuang Univ, Ctr Gen Educ, Hsinchu, Taiwan; [Chien, Mei-Yin] Ko Da Pharmaceut Co, Taoyuan, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Hsuan Chuang University	Liu, DZ (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan.	tonyliu@tmu.edu.tw			Center of Excellence for Clinical Trials and Research in Neuroscience [DOH 100-TD-B-111-003]; Ministry of Science and Technology of ROC [NSC 100-2320-B-038-004-MY3]; Ko Da Pharmaceutical Co., Taoyuan, Taiwan	Center of Excellence for Clinical Trials and Research in Neuroscience; Ministry of Science and Technology of ROC; Ko Da Pharmaceutical Co., Taoyuan, Taiwan	Financial funding from the Center of Excellence for Clinical Trials and Research in Neuroscience (DOH 100-TD-B-111-003) and Ministry of Science and Technology of ROC (NSC 100-2320-B-038-004-MY3) is highly appreciated. Ko Da Pharmaceutical Co., Taoyuan, Taiwan provided support in the form of salaries for author MYC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik WY, 2002, BIORESOURCE TECHNOL, V81, P167, DOI 10.1016/S0960-8524(01)00148-1; Chen C, 1999, WOUND REPAIR REGEN, V7, P486, DOI 10.1046/j.1524-475X.1999.00486.x; Chittoria R. K., 2012, J SOC WOUND CARE RES, V5, P2; Ferreira JA, 2012, BIORESOURCE TECHNOLO; Francesko A, 2011, ADV BIOCHEM ENG BIOT, V125, P1, DOI [10.10007/10_2010_93, 10.1007/10_2010_93]; Franco RA, 2013, J BIOMATER APPL, V27, P605, DOI 10.1177/0885328211416527; Gibson D., 2009, WOUNDS INT, V1, P1; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Hung WS, 2004, J BIOMED MATER RES B, V70B, P122, DOI 10.1002/jbm.b.30028; Jayakumar R, 2011, INT J MOL SCI, V12, P1876, DOI 10.3390/ijms12031876; Kennedy JF, 1994, CARBOHYDRATE ANALYSI; Moussa S, 2011, INT J BIOL MACROMOL, V48, P736, DOI 10.1016/j.ijbiomac.2011.02.022; Rodriguez X, 2004, BIOINORGANIC CHEMIST, P1, DOI [10.1155/S1565363304000019, DOI 10.1155/S1565363304000019]; Senevirathne M, 2012, ADV FOOD NUTR RES, V65, P495, DOI 10.1016/B978-0-12-416003-3.00032-9; Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Srinivasan A, 2010, BIORESOURCE TECHNOL, V101, P6594, DOI 10.1016/j.biortech.2010.03.079; Su CH, 2005, J BIOMED MATER RES A, V72A, P220, DOI 10.1002/jbm.a.30235; Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3; Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2; Tayel AA, 2010, INT J BIOL MACROMOL, V47, P454, DOI 10.1016/j.ijbiomac.2010.06.011; Tayel AA, 2010, INT J BIOL MACROMOL, V47, P10, DOI 10.1016/j.ijbiomac.2010.04.005; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s; Zamani A, 2013, BIOTECHNOLOGY ADVANC; Zamani A, 2010, INT J MOL SCI, V11, P2976, DOI 10.3390/ijms11082976; Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962	27	4	4	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134090	10.1371/journal.pone.0134090	http://dx.doi.org/10.1371/journal.pone.0134090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275241	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600020
J	Fan, YF; Geren, IN; Dong, JB; Lou, JL; Wen, WH; Conrad, F; Smith, TJ; Smith, LA; Ho, MF; Pires-Alves, M; Wilson, BA; Marks, JD				Fan, Yongfeng; Geren, Isin N.; Dong, Jianbo; Lou, Jianlong; Wen, Weihua; Conrad, Fraser; Smith, Theresa J.; Smith, Leonard A.; Ho, Mengfei; Pires-Alves, Melissa; Wilson, Brenda A.; Marks, James D.			Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity	PLOS ONE			English	Article							MOTOR-NERVE TERMINALS; TOXIN TYPE-A; LIGHT-CHAIN; HEAVY-CHAIN; CLOSTRIDIAL NEUROTOXINS; MOLECULAR EVOLUTION; STRUCTURAL INSIGHT; CRYSTAL-STRUCTURE; PROTEIN-RECEPTOR; IMMUNE GLOBULIN	The paralytic disease botulism is caused by botulinum neurotoxins (BoNT), multi-domain proteins containing a zinc endopeptidase that cleaves the cognate SNARE protein, thereby blocking acetylcholine neurotransmitter release. Antitoxins currently used to treat botulism neutralize circulating BoNT but cannot enter, bind to or neutralize BoNT that has already entered the neuron. The light chain endopeptidase domain (LC) of BoNT serotype A (BoNT/A) was targeted for generation of monoclonal antibodies (mAbs) that could reverse paralysis resulting from intoxication by BoNT/A. Single-chain variable fragment (scFv) libraries from immunized humans and mice were displayed on the surface of yeast, and 19 BoNT/A LC-specific mAbs were isolated by using fluorescence-activated cell sorting (FACS). Affinities of the mAbs for BoNT/A LC ranged from a K-D value of 9.0x10(-11) M to 3.53x10(-8) M(mean K-D 5.38x10(-9) M and median K-D 1.53x10(-9) M), as determined by flow cytometry analysis. Eleven mAbs inhibited BoNT/A LC catalytic activity with IC50 values ranging from 8.3 similar to 73x10(-9) M. The fine epitopes of selected mAbs were also mapped by alanine-scanning mutagenesis, revealing that the inhibitory mAbs bound the alpha-exosite region remote from the BoNT/A LC catalytic center. The results provide mAbs that could prove useful for intracellular reversal of paralysis post-intoxication and further define epitopes that could be targeted by small molecule inhibitors.	[Fan, Yongfeng; Geren, Isin N.; Dong, Jianbo; Lou, Jianlong; Wen, Weihua; Conrad, Fraser; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; [Smith, Theresa J.] US Army Med Inst Infect Dis, Mol & Translat Sci Div, Ft Detrick, MD USA; [Smith, Leonard A.] US Army Med Inst Infect Dis, Med Countermeasures Technol, US Army Med Res & Mat Command, Ft Detrick, MD USA; [Ho, Mengfei; Pires-Alves, Melissa; Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of California System; University of California San Francisco; United States Department of Defense; United States Army; University of Illinois System; University of Illinois Urbana-Champaign	Marks, JD (corresponding author), Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA.	jim.marks@ucsf.edu	Ho, Mengfei/Q-6844-2019; Geren, Isin/AAG-7281-2019	Ho, Mengfei/0000-0002-8315-8158; Geren, Isin/0000-0001-7777-1450	NIH/NIAID [U01 AI056493, R21/R33 AI101504, U01 AI075502, U54 AI0571530]; DTRA [HDTRA1-07-C-0030]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101504, U01AI056493, R33AI101504, U01AI075502] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DTRA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by NIH/NIAID under Cooperative Agreement U01 AI056493 (to JDM), DTRA contract HDTRA1-07-C-0030 (to JDM), NIH/NIAID R21/R33 AI101504 (to BAW), NIH/NIAID U01 AI075502 (to BAW), and NIH/NIAID subcontract under U54 AI0571530 (to BAW). Opinions, interpretations, conclusions, and recommendations are those of the authors and not necessarily endorsed by the U.S. Army, the National Institute of Allergy and Infectious Diseases, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLAUSTEIN RO, 1987, FEBS LETT, V226, P115, DOI 10.1016/0014-5793(87)80562-8; Bradbury A, 2004, PHAGE ANTIBODY LIB; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dickerson TJ, 2006, ACS CHEM BIOL, V1, P359, DOI 10.1021/cb600179d; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Edupuganti OP, 2012, FEBS J, V279, P2555, DOI 10.1111/j.1742-4658.2012.08638.x; Farrow B, 2015, ANGEW CHEM INT ED EN; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fischer A, 2009, P NATL ACAD SCI USA, V106, P1330, DOI 10.1073/pnas.0812839106; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Hall YHJ, 2004, J IMMUNOL METHODS, V288, P55, DOI 10.1016/j.jim.2004.02.011; Hayes ME, 2006, GENE THER, V13, P646, DOI 10.1038/sj.gt.3302699; Hibbs RG, 1996, CLIN INFECT DIS, V23, P337, DOI 10.1093/clinids/23.2.337; Ho MF, 2012, PROTEIN SCI, V21, P318, DOI 10.1002/pro.2017; Ho MF, 2011, PROTEIN ENG DES SEL, V24, P247, DOI 10.1093/protein/gzq093; Hu X, 2014, J COMPUT AID MOL DES, V28, P765, DOI 10.1007/s10822-014-9758-7; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Kalb SR, 2015, ANAL CHEM, V87, P3911, DOI 10.1021/ac504716v; KRIEGLSTEIN KG, 1994, J PROTEIN CHEM, V13, P49, DOI 10.1007/BF01891992; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Marks James D, 2004, Anesthesiol Clin North Am, V22, P509, DOI 10.1016/j.atc.2004.05.010; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; Muller J, 2009, CHEM BIOL, V16, P442, DOI 10.1016/j.chembiol.2009.03.007; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Park JG, 2006, BIOORGAN MED CHEM, V14, P395, DOI 10.1016/j.bmc.2005.08.018; Pires-Alves M, 2009, TOXICON, V53, P392, DOI 10.1016/j.toxicon.2008.12.016; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Schechter R, 2000, LANCET, V355, P237, DOI 10.1016/S0140-6736(05)72119-X; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; SIMPSON LL, 1980, J PHARMACOL EXP THER, V212, P16; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Takahashi T, 2009, VACCINE, V27, P2616, DOI 10.1016/j.vaccine.2009.02.051; Wilson BA, 2014, CURR TOP MED CHEM, V14, P2081, DOI 10.2174/1568026614666141022094517; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104	58	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135306	10.1371/journal.pone.0135306	http://dx.doi.org/10.1371/journal.pone.0135306			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275214	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600060
J	Maeda, T; Babazono, A; Nishi, T; Yasui, M; Matsuda, S; Fushimi, K; Fujimori, K				Maeda, Toshiki; Babazono, Akira; Nishi, Takumi; Yasui, Midori; Matsuda, Shinya; Fushimi, Kiyohide; Fujimori, Kenji			The Impact of Opportunistic Infections on Clinical Outcome and Healthcare Resource Uses for Adult T Cell Leukaemia	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; FUNGAL-INFECTION; LYMPHOMA; COMPLICATIONS; GUIDELINES; ASSOCIATION; MANAGEMENT; MORTALITY; THERAPY; SOCIETY	We examined the impact of opportunistic infections on in-hospital mortality, hospital length of stay (LOS), and the total cost (TC) among adult T-cell leukaemia (ATL) patients. In this retrospective cohort study, we identified 3712 patients with ATL using national hospital administrative data. Analysed opportunistic infections included Aspergillus spp., Candida spp., cytomegalovirus (CMV), herpes simplex virus (HSV), pneumocystis pneumonia (PCP), tuberculosis, varicella zoster virus (VZV), Cryptococcus spp., nontuberculous mycobacteria, and Strongyloides spp. Multilevel logistic regression analysis for in-hospital mortality and a multilevel linear regression analysis for LOS and TC were employed to determine the impact of opportunistic infections on clinical outcomes and healthcare resources. We found ATL patients infected with CMV had significantly higher in-hospital mortality (adjusted odds ratio (AOR) 2.29 [1.50-3.49] p < 0.001), longer LOS (coefficient (B): 0.13 [0.06-0.20] p < 0.001) and higher TC (B: 0.25 [0.17-0.32] p < 0.001) than those without CMV. Those with CAN and PCP were associated with a lower in-hospital mortality rate (AOR 0.72 [0.53-0.98] p = 0.035 and 0.54[0.41-0.73] p < 0.001, respectively) than their infections. VZV was associated with longer LOS (B: 0.13 [0.06-0.19] p < 0.001), while aspergillosis, HSV, or VZV infections were associated with higher TC (B: 0.16 [0.07-0.24] p < 0.001, 0.12 [0.02-0.23] p = 0.025, and 0.17 [0.10-0.24] p < 0.001, respectively). Our findings reveal that CMV infection is a major determinant of poor prognosis in patients affected by ATL.	[Maeda, Toshiki; Babazono, Akira; Nishi, Takumi; Yasui, Midori] Kyushu Univ, Dept Healthcare Adm & Management, Grad Sch Healthcare Sci, Fukuoka 812, Japan; [Matsuda, Shinya] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Fukuoka, Japan; Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Tokyo, Japan; [Fujimori, Kenji] Tohoku Univ, Dept Hlth Adm & Policy, Sendai, Miyagi 980, Japan	Kyushu University; University of Occupational & Environmental Health - Japan; Tokyo Medical & Dental University (TMDU)	Maeda, T (corresponding author), Kyushu Univ, Dept Healthcare Adm & Management, Grad Sch Healthcare Sci, Fukuoka 812, Japan.	toshikimaeda1216@gmail.com		Matsuda, Shinya/0000-0002-8472-8909; Nishi, Takumi/0000-0003-2560-6765				Abbott K C, 2001, Transpl Infect Dis, V3, P203, DOI 10.1034/j.1399-3062.2001.30404.x; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Fujiwara H, 2000, J MED VIROL, V62, P140, DOI 10.1002/1096-9071(200010)62:2&lt;140::AID-JMV3&gt;3.0.CO;2-X; FUNAI N, 1995, ACTA HAEMATOL-BASEL, V93, P25; GILL PS, 1995, NEW ENGL J MED, V332, P1744, DOI 10.1056/NEJM199506293322603; Gourishankar S, 2004, AM J TRANSPLANT, V4, P108, DOI 10.1046/j.1600-6143.2003.00287.x; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Itonaga H, 2013, BIOL BLOOD MARROW TR, V19, P607, DOI 10.1016/j.bbmt.2013.01.011; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; Khera N, 2012, BLOOD, V120, P1545, DOI 10.1182/blood-2012-05-426783; Kuwabara K, 2008, HEALTH POLICY, V85, P196, DOI 10.1016/j.healthpol.2007.07.015; Lee SJ, 2000, J CLIN ONCOL, V18, P64, DOI 10.1200/JCO.2000.18.1.64; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Maeda T, 2014, BRIT J HAEMATOL, P1; Masaki A, 2013, J IMMUNOL, V191, P135, DOI 10.4049/jimmunol.1202692; Matsuda S., 2008, Eurohealth, V14, P25; Matsuda S., 2007, JPN J SOC SEC POLICY, V6, P43; Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Ministerio de Sanidad, 2014, PLAN DESC ATM ESTR 2, P1; Nichols WG, 2002, J INFECT DIS, V185, P273, DOI 10.1086/338624; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Penack O, 2011, ANN ONCOL, V22, P1019, DOI 10.1093/annonc/mdq442; Pergam SA, 2009, AM J TRANSPLANT, V9, pS108, DOI 10.1111/j.1600-6143.2009.02901.x; Rabkin JM, 2000, AM J SURG, V179, P426, DOI 10.1016/S0002-9610(00)00366-4; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; SHIMOYAMA M, 1991, LEUKEMIA RES, V15, P81; Stocchi R, 1999, HAEMATOLOGICA, V84, P71; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; SUZUMIYA J, 1993, LEUKEMIA LYMPHOMA, V11, P281, DOI 10.3109/10428199309087005; Svahn BM, 2012, BONE MARROW TRANSPL, V47, P706, DOI 10.1038/bmt.2011.162; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang EHZ, 2012, TRANSPL INFECT DIS, V14, P519, DOI 10.1111/j.1399-3062.2012.00740.x	37	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135042	10.1371/journal.pone.0135042	http://dx.doi.org/10.1371/journal.pone.0135042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274925	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600047
J	Tasiou, V; Hiber, M; Steenpass, L				Tasiou, Vasiliki; Hiber, Michaela; Steenpass, Laura			A Mouse Model for Imprinting of the Human Retinoblastoma Gene	PLOS ONE			English	Article							DE-NOVO METHYLATION; CPG ISLANDS; EVOLUTION; IDENTIFICATION; ORIGIN; TRANSCRIPTION; ACQUISITION; EXPRESSION; REVEALS; DEFENSE	The human RB1 gene is imprinted due to integration of the PPP1R26P1 pseudogene into intron 2. PPP1R26P1 harbors the gametic differentially methylated region of the RB1 gene, CpG85, which is methylated in the female germ line. The paternally unmethylated CpG85 acts as promoter for the alternative transcript 2B of RB1, which interferes with expression of full-length RB1 in cis. In mice, PPP1R26P1 is not present in the Rb1 gene and Rb1 is not imprinted. Assuming that the mechanisms responsible for genomic imprinting are conserved, we investigated if imprinting of mouse Rb1 can be induced by transferring human PPP1R26P1 into mouse Rb1. We generated humanized Rb1_PPP1R26P1 knock-in mice that pass human PPP1R26P1 through the mouse germ line. We found that the function of unmethylated CpG85 as promoter for an alternative Rb1 transcript and as cis-repressor of the main Rb1 transcript is maintained in mouse tissues. However, CpG85 is not recognized as a gametic differentially methylated region in the mouse germ line. DNA methylation at CpG85 is acquired only in tissues of neuroectodermal origin, independent of parental transmission of PPP1R26P1. Absence of CpG85 methylation in oocytes and sperm implies a failure of imprint methylation establishment in the germ line. Our results indicate that site-specific integration of a proven human gametic differentially methylated region is not sufficient for acquisition of DNA methylation in the mouse germ line, even if promoter function of the element is maintained. This suggests a considerable dependency of DNA methylation induction on the surrounding sequence. However, our model is suited to determine the cellular function of the alternative Rb1 transcript.	[Tasiou, Vasiliki; Hiber, Michaela; Steenpass, Laura] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany	University of Duisburg Essen	Steenpass, L (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany.	laura.steenpass@uni-due.de			Deutsche Forschungsgemeinschaft [STE1987/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	LS received funding for this study from the Deutsche Forschungsgemeinschaft, grant number STE1987/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar SL, 2014, J PATHOL, V233, P392, DOI 10.1002/path.4376; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Benavente CA, 2015, ANNU REV PATHOL-MECH, V10, P547, DOI 10.1146/annurev-pathol-012414-040259; Beygo J, 2011, MOL SYNDROMOL, V2, P53, DOI 10.1159/000335545; CHAILLET JR, 1994, MUTAT RES, V307, P441, DOI 10.1016/0027-5107(94)90255-0; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Cowley M, 2010, BRIEF FUNCT GENOMICS, V9, P340, DOI 10.1093/bfgp/elq015; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Edwards CA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-157; Hanna CW, 2014, HEREDITY, V113, P176, DOI 10.1038/hdy.2014.54; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kanber D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081502; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; KELSEY G, 2013, BIOL SCI, V368, P10336, DOI DOI 10.1098/RSTB.2011.0336; Kuehnen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002543; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lewis MW, 2015, P NATL ACAD SCI USA, V112, P6871, DOI 10.1073/pnas.1411261111; Lonfat N, 2013, P NATL ACAD SCI USA, V110, P11946, DOI 10.1073/pnas.1310704110; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; McCole RB, 2008, EPIGENETICS-US, V3, P258, DOI 10.4161/epi.3.5.7052; McDonald JF, 2005, CYTOGENET GENOME RES, V110, P242, DOI 10.1159/000084958; Nabetani A, 1997, MOL CELL BIOL, V17, P789, DOI 10.1128/MCB.17.2.789; Ohshima K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r74; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Rademacher K, 2014, GENOME BIOL EVOL, V6, P1579, DOI 10.1093/gbe/evu125; Rahmann S, 2013, PEER J PREPRINTS, DOI [10.7287/peerj.preprints.122v2, DOI 10.7287/PEERJ.PREPRINTS.122V2]; Regha K, 2006, CYTOGENET GENOME RES, V113, P165, DOI 10.1159/000090829; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schulz R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl461; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Steenpass L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074159; Suzuki S, 2011, GENOME BIOL EVOL, V3, P1276, DOI 10.1093/gbe/evr104; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhang JK, 2004, CELL CYCLE, V3, P952; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	57	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134672	10.1371/journal.pone.0134672	http://dx.doi.org/10.1371/journal.pone.0134672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275142	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600039
J	Thoompumkal, IJ; Rao, MRKS; Kumaraswamy, A; Krishnan, R; Mahalingam, S				Thoompumkal, Indu Jose; Rao, Malireddi Rama Krishna Subba; Kumaraswamy, Anbarasu; Krishnan, Rehna; Mahalingam, Sundarasamy			GNL3L Is a Nucleo-Cytoplasmic Shuttling Protein: Role in Cell Cycle Regulation	PLOS ONE			English	Article							RETINOBLASTOMA SUSCEPTIBILITY GENE; NUCLEAR EXPORT; RICH DOMAIN; BINDING; GTPASES; SIGNAL; DNA; LOCALIZATION; REPLICATION; ACTIVATION	GNL3L is an evolutionarily conserved high molecular weight GTP binding nucleolar protein belonging to HSR1-MMR1 subfamily of GTPases. The present investigation reveals that GNL3L is a nucleo-cytoplasmic shuttling protein and its export from the nucleus is sensitive to Leptomycin B. Deletion mutagenesis reveals that the C-terminal domain (amino acids 501-582) is necessary and sufficient for the export of GNL3L from the nucleus and the exchange of hydrophobic residues (M567, L570 and 572) within the C-terminal domain impairs this process. Results from the protein-protein interaction analysis indicate that GNL3L interaction with CRM1 is critical for its export from the nucleus. Ectopic expression of GNL3L leads to lesser accumulation of cells in the 'G2/M' phase of cell cycle whereas depletion of endogenous GNL3L results in 'G2/M' arrest. Interestingly, cell cycle analysis followed by BrdU labeling assay indicates that significantly increased DNA synthesis occurs in cells expressing nuclear export defective mutant (GNL3L(Delta NES)) compared to the wild type or nuclear import defective GNL3L. Furthermore, increased hyperphosphorylation of Rb at Serine 780 and the upregulation of E2F1, cyclins A2 and E1 upon ectopic expression of GNL3L(Delta NES) results in faster 'S' phase progression. Collectively, the present study provides evidence that GNL3L is exported from the nucleus in CRM1 dependent manner and the nuclear localization of GNL3L is important to promote 'S' phase progression during cell proliferation.	[Thoompumkal, Indu Jose; Rao, Malireddi Rama Krishna Subba; Kumaraswamy, Anbarasu; Krishnan, Rehna; Mahalingam, Sundarasamy] Indian Inst Technol, Lab Mol Virol & Cell Biol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India; [Kumaraswamy, Anbarasu; Mahalingam, Sundarasamy] Indian Inst Technol, Natl Canc Tissue Biobank, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Mahalingam, S (corresponding author), Indian Inst Technol, Lab Mol Virol & Cell Biol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in	Kumaraswamy, Anbarasu/Q-2208-2019; , rehna/AAQ-5044-2021; Malireddi, RKSubbarao/C-5804-2013	Kumaraswamy, Anbarasu/0000-0002-9997-7430; Malireddi, RKSubbarao/0000-0001-8855-9447; JOSE T., INDU/0000-0001-9463-663X; Mahalingam, Sundarasamy/0000-0003-4460-3949	Department of Science and Technology, Govt. of India [VI-D&P/411/2012-2013/TDT(G)]; Council of Scientific and Industrial Research (CSIR) [09/084(05000/2009-EMR-I)]	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grant VI-D&P/411/2012-2013/TDT(G) from the Department of Science and Technology, Govt. of India (http://www.dst.gov.in/) to SM, and a graduate fellowship (09/084(05000/2009-EMR-I) from the Council of Scientific and Industrial Research (CSIR) (http://www.csirhrdg.res.in/) to IJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Boddapati N, 2012, J MOL BIOL, V416, P346, DOI 10.1016/j.jmb.2011.12.066; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Du XM, 2006, MOL BIOL CELL, V17, P460, DOI 10.1091/mbc.E05-09-0848; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; JAKESZ R, 1984, CANCER RES, V44, P619; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kumar PR, 2003, J MOL BIOL, V331, P1141, DOI 10.1016/s0022-2836(03)00853-3; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Meng L, 2010, ONCOGENE, P1; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Mundle SD, 2003, FASEB J, V17, P569, DOI 10.1096/fj.02-0431rev; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; Rao MRKS, 2006, J MOL BIOL, V364, P637, DOI 10.1016/j.jmb.2006.09.007; Reynaud EG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-21; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHMIDTZACHMANN MS, 1993, CELL, V74, P493, DOI 10.1016/0092-8674(93)80051-F; Sherr CJ, 2000, CANCER RES, V60, P3689; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Trotta CR, 2003, EMBO J, V22, P2841, DOI 10.1093/emboj/cdg249; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yasumoto H, 2007, J CELL SCI, V120, P2532, DOI 10.1242/jcs.009878; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	42	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135845	10.1371/journal.pone.0135845	http://dx.doi.org/10.1371/journal.pone.0135845			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274615	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600125
J	Manley, R; Harrup, LE; Veronesi, E; Stubbins, F; Stoner, J; Gubbins, S; Wilson, A; Batten, C; Koenraadt, CJM; Henstock, M; Barber, J; Carpenter, S				Manley, Robyn; Harrup, Lara E.; Veronesi, Eva; Stubbins, Francesca; Stoner, Jo; Gubbins, Simon; Wilson, Anthony; Batten, Carrie; Koenraadt, Constantianus J. M.; Henstock, Mark; Barber, James; Carpenter, Simon			Testing of UK Populations of Culex pipiens L. for Schmallenberg Virus Vector Competence and Their Colonization	PLOS ONE			English	Article							WEST-NILE-VIRUS; COMPLEX; TRANSMISSION; MOSQUITOS; DIPTERA; IDENTIFICATION; ARBOVIRUSES; CULICIDAE; OUTBREAK; EUROPE	Background Schmallenberg virus (SBV), an arboviral pathogen of ruminants, emerged in northern Europe during 2011 and has subsequently spread across a vast geographic area. While Culicoides biting midges (Diptera: Ceratopogonidae) have been identified as a biological transmission agent of SBV, the role of mosquitoes (Diptera: Culicidae) as potential vectors has not been defined beyond small-scale field collections in affected areas. Culex pipiens L. are one of the most widespread mosquitoes in northern Europe; they are present on farms across the region and have previously been implicated as vectors of several other arboviruses. We assessed the ability of three colony lines of Cx. pipiens, originating from geographically diverse field populations, to become fully infected by SBV using semi-quantitative real-time RT-PCR (sqPCR). Findings Two colony lines of Cx. pipiens were created in the UK ('Brookwood' and 'Caldbeck') from field collections of larvae and pupae and characterised using genetic markers. A third strain of Cx. pipiens from CVI Wageningen, The Netherlands, was also screened during experiments. Intrathoracic inoculation of the Brookwood line resulted in infections after 14 days that were characterised by high levels of RNA throughout individuals, but which demonstrated indirect evidence of salivary gland barriers. Feeding of 322 individuals across the three colony lines on a membrane based infection system resulted in no evidence of full dissemination of SBV, although infections did occur in a small proportion of Cx. pipiens from each line. Conclusions/Significance This study established two novel lines of Cx. pipiens mosquitoes of UK origin in the laboratory and subsequently tested their competence for SBV. Schmallenberg virus replication and dissemination was restricted, demonstrating that Cx. pipiens is unlikely to be an epidemiologically important vector of the virus in northern Europe.	[Manley, Robyn; Harrup, Lara E.; Veronesi, Eva; Stubbins, Francesca; Stoner, Jo; Gubbins, Simon; Wilson, Anthony; Batten, Carrie; Henstock, Mark; Barber, James; Carpenter, Simon] Pirbright Inst, Vector Borne Viral Dis Programme, Pirbright, Surrey, England; [Koenraadt, Constantianus J. M.] WUR, Entomol Lab, Wageningen, Netherlands	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Wageningen University & Research	Carpenter, S (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Pirbright, Surrey, England.	simon.carpenter@pirbright.ac.uk	Carpenter, Simon T/C-2718-2013	Carpenter, Simon T/0000-0001-5775-045X; Batten, Carrie/0000-0003-4274-7375; Gubbins, Simon/0000-0003-0538-4173; Harrup, Lara/0000-0001-8828-7349; Wilson, Anthony/0000-0002-2000-2914; Veronesi, Eva/0000-0003-3411-7891; Koenraadt, Constantianus/0000-0001-7861-8781	Defra grant [SE: 0542]; BBSRC grant [BBS/E/I/00001445]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001701, BBS/E/I/00001445] Funding Source: researchfish; BBSRC [BBS/E/I/00001445, BBS/E/I/00001701] Funding Source: UKRI	Defra grant; BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Studies were financially supported by Defra grant SE: 0542 and BBSRC grant: BBS/E/I/00001445.	Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Balenghien T, 2014, PREV VET MED, V116, P360, DOI 10.1016/j.prevetmed.2014.03.007; Becker N, 2010, MOSQUITOES THEIR CON, P43, DOI DOI 10.1007/978-3-540-92874-4_4; Becker N, 2012, J AM MOSQUITO CONTR, V28, P53, DOI 10.2987/8756-971X-28.4s.53; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Ciota AT, 2013, PARASITE VECTOR, V6, P4; Danabalan R, 2012, J AM MOSQUITO CONTR, V28, P68, DOI 10.2987/8756-971X-28.0.68; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fritz ML, 2015, MED VET ENTOMOL, V29, P115, DOI 10.1111/mve.12096; Gomes B, 2013, INFECT GENET EVOL, V16, P218, DOI 10.1016/j.meegid.2013.02.006; Gomes B, 2012, J AM MOSQUITO CONTR, V28, P75, DOI 10.2987/8756-971X-28.4s.75; Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hesson JC, 2011, VECTOR-BORNE ZOONOT, V11, P1383, DOI 10.1089/vbz.2011.0630; Hoch A.L., 1987, Bulletin of the Pan American Health Organization, V21, P55; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoffmann B, 2009, EMERG INFECT DIS, V15, P1481, DOI 10.3201/eid1509.090562; Koenraadt CJM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-77; Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005; Mackenzie-Impoinvil L, 2015, MED VET ENTOMOL, V29, P1, DOI 10.1111/mve.12083; Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Medlock Jolyon M., 2011, European Mosquito Bulletin, V29, P38; MELLOR PS, 1980, ANN TROP MED PARASIT, V74, P463, DOI 10.1080/00034983.1980.11687368; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; PINHEIRO FP, 1982, SCIENCE, V215, P1251, DOI 10.1126/science.6800036; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Richards SL, 2010, AM J TROP MED HYG, V83, P126, DOI 10.4269/ajtmh.2010.09-0776; Scholte EJ, 2014, MED VET ENTOMOL, V28, P110, DOI 10.1111/mve.12010; Shaikevich E. V., 2007, European Mosquito Bulletin, P25; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TURELL MJ, 1984, SCIENCE, V225, P1039, DOI 10.1126/science.6474165; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Wernike K, 2014, PARASITE VECTOR, V7, P6	41	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134453	10.1371/journal.pone.0134453	http://dx.doi.org/10.1371/journal.pone.0134453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291533	Green Published, gold, Green Accepted			2022-12-27	WOS:000359919900006
J	Zhi, HY; Dai, J; Liu, JL; Zhu, JQ; Newman, DK; Gao, CJ; Newman, PJ				Zhi, Huiying; Dai, Jing; Liu, Junling; Zhu, Jieqing; Newman, Debra K.; Gao, Cunji; Newman, Peter J.			Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin alpha IIb beta 3 and Lyn Kinase	PLOS ONE			English	Article							FC-GAMMA-RIIA; SRC FAMILY KINASES; TYROSINE PHOSPHORYLATION; RHEUMATOID-ARTHRITIS; SEQUENTIAL PHOSPHORYLATION; ADHESION; RECEPTOR; PROTEIN; IDENTIFICATION; ROLES	IgG immune complexes contribute to the etiology and pathogenesis of numerous autoimmune disorders, including heparin-induced thrombocytopenia, systemic lupus erythematosus, rheumatoid-and collagen-induced arthritis, and chronic glomerulonephritis. Patients suffering from immune complex-related disorders are known to be susceptible to plateletmediated thrombotic events. Though the role of the Fc receptor, Fc gamma RIIa, in initiating platelet activation is well understood, the role of the major platelet adhesion receptor, integrin alpha IIb beta 3, in amplifying platelet activation and mediating adhesion and aggregation downstream of encountering IgG immune complexes is poorly understood. The goal of this investigation was to gain a better understanding of the relative roles of these two receptor systems in immune complex-mediated thrombotic complications. Human platelets, and mouse platelets genetically engineered to differentially express Fc gamma RIIa and alpha IIb beta 3, were allowed to interact with IgG-coated surfaces under both static and flow conditions, and their ability to spread and form thrombi evaluated in the presence and absence of clinically-used fibrinogen receptor antagonists. Although binding of IgG immune complexes to Fc gamma RIIa was sufficient for platelet adhesion and initial signal transduction events, platelet spreading and thrombus formation over IgG-coated surfaces showed an absolute requirement for alpha IIb beta 3 and its ligands. Tyrosine kinases Lyn and Syk were found to play key roles in IgGinduced platelet activation events. Taken together, our data suggest a complex functional interplay between Fc gamma RIIa, Lyn, and alpha IIb beta 3 in immune complex-induced platelet activation. Future studies may be warranted to determine whether patients suffering from immune complex disorders might benefit from treatment with anti-alpha IIb beta 3-directed therapeutics.	[Zhi, Huiying; Zhu, Jieqing; Newman, Debra K.; Gao, Cunji; Newman, Peter J.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA; [Dai, Jing] Shanghai Jiao Tong Univ, Sch Med, Ruijing Hosp, Shanghai 200030, Peoples R China; [Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China; [Zhu, Jieqing] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Newman, Debra K.] Med Coll Wisconsin, Dept Microbiol, Milwaukee, WI 53226 USA; [Newman, Debra K.; Newman, Peter J.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Gao, Cunji] Zhejiang Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Chron Dis Res Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Newman, Peter J.] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Zhejiang University; Medical College of Wisconsin	Newman, PJ (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA.	peter.newman@bcw.edu			National Natural Science Foundation of China [81270586]; Heart, Lung, and Blood Institute of the National Institutes of Health [HL-44612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, R56HL122985] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China #81270586 (to CG) and by the Heart, Lung, and Blood Institute of the National Institutes of Health #HL-44612 (to DKN and PJN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Aringer M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4126; Arman M, 2014, BLOOD; Bisoendial RJ, 2010, SEMIN THROMB HEMOST, V36, P452, DOI 10.1055/s-0030-1254054; Bodin S, 2003, THROMB HAEMOSTASIS, V89, P318, DOI 10.1055/s-0037-1613449; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; CHACKO GW, 1994, J BIOL CHEM, V269, P32435; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Fernandez M, 2007, ARTHRITIS RHEUM, V56, P614, DOI 10.1002/art.22376; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Gomez-Puerta JA, 2011, NAT REV RHEUMATOL, V7, P134, DOI 10.1038/nrrheum.2011.8; Gratacap MP, 1998, J BIOL CHEM, V273, P24314, DOI 10.1074/jbc.273.38.24314; Greinacher A, 2009, J THROMB HAEMOST, V7, P9, DOI 10.1111/j.1538-7836.2009.03385.x; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; HUANG MM, 1992, J BIOL CHEM, V267, P5467; Ibarrola I, 1997, BBA-MOL CELL RES, V1357, P348, DOI 10.1016/S0167-4889(97)00034-7; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; KARAS SP, 1982, BLOOD, V60, P1277; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; LEGRAND C, 1989, BLOOD, V73, P1226; Lewis JE, 2013, DISCOV MED, V15, P85; Li ZY, 2010, J BIOL CHEM, V285, P12559, DOI 10.1074/jbc.M109.098756; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mameli A, 2009, CLIN EXP RHEUMATOL, V27, P846; McKenzie SE, 1999, J IMMUNOL, V162, P4311; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Michel M, 2002, BRIT J HAEMATOL, V119, P354, DOI 10.1046/j.1365-2141.2002.03817.x; Ming ZY, 2011, BLOOD, V117, P3903, DOI 10.1182/blood-2010-09-304816; Mitrugno A, 2014, BLOOD, V123, P249, DOI 10.1182/blood-2013-03-492447; MOVAT HZ, 1965, P SOC EXP BIOL MED, V120, P232; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Paddock C, 2011, BLOOD, V117, P6012, DOI 10.1182/blood-2010-11-317867; Palatinus A, 2009, SEMIN THROMB HEMOST, V35, P621, DOI 10.1055/s-0029-1242716; PELLETIER AJ, 1995, J BIOL CHEM, V270, P18133, DOI 10.1074/jbc.270.30.18133; Ragab A, 2007, BLOOD, V110, P2466, DOI 10.1182/blood-2007-02-075432; Reddy KB, 2008, J CELL SCI, V121, P1641, DOI 10.1242/jcs.014076; Reilly MP, 2011, BLOOD, V117, P2241, DOI 10.1182/blood-2010-03-274969; ROSENFELD SI, 1985, J CLIN INVEST, V76, P2317, DOI 10.1172/JCI112242; Ruzzene M, 1996, BIOCHEMISTRY-US, V35, P5327, DOI 10.1021/bi9528614; Severin S, 2012, J THROMB HAEMOST, V10, P1631, DOI 10.1111/j.1538-7836.2012.04814.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Su XY, 2008, BLOOD, V112, P592, DOI 10.1182/blood-2007-09-110437; Tourdot BE, 2013, BIOCHEMISTRY-US, V52, P2597, DOI 10.1021/bi301461t; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202; Xiong Y, 2006, BIOCHEMISTRY-US, V45, P8721, DOI 10.1021/bi060529u; Zhi HY, 2013, BLOOD, V121, P1858, DOI 10.1182/blood-2012-07-443325; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	49	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135738	10.1371/journal.pone.0135738	http://dx.doi.org/10.1371/journal.pone.0135738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291522	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900028
J	Ambreen, H; Kumar, S; Variath, MT; Joshi, G; Bali, S; Agarwal, M; Kumar, A; Jagannath, A; Goel, S				Ambreen, Heena; Kumar, Shivendra; Variath, Murali Tottekkad; Joshi, Gopal; Bali, Sapinder; Agarwal, Manu; Kumar, Amar; Jagannath, Arun; Goel, Shailendra			Development of Genomic Microsatellite Markers in Carthamus tinctorius L. (Safflower) Using Next Generation Sequencing and Assessment of Their Cross-Species Transferability and Utility for Diversity Analysis	PLOS ONE			English	Article							GENETIC DIVERSITY; SSR MARKERS; TRANSCRIPTOME; REPEATS; LOCI; DNA; IDENTIFICATION; AMPLIFICATION; POLYMORPHISM; GERMPLASM	Background Safflower (Carthamus tinctorius L.), an Asteraceae member, yields high quality edible oil rich in unsaturated fatty acids and is resilient to dry conditions. The crop holds tremendous potential for improvement through concerted molecular breeding programs due to the availability of significant genetic and phenotypic diversity. Genomic resources that could facilitate such breeding programs remain largely underdeveloped in the crop. The present study was initiated to develop a large set of novel microsatellite markers for safflower using next generation sequencing. Principal Findings Low throughput genome sequencing of safflower was performed using Illumina paired end technology providing similar to 3.5X coverage of the genome. Analysis of sequencing data allowed identification of 23,067 regions harboring perfect microsatellite loci. The safflower genome was found to be rich in dinucleotide repeats followed by tri-, tetra-, penta- and hexa-nucleotides. Primer pairs were designed for 5,716 novel microsatellite sequences with repeat length >= 20 bases and optimal flanking regions. A subset of 325 microsatellite loci was tested for amplification, of which 294 loci produced robust amplification. The validated primers were used for assessment of 23 safflower accessions belonging to diverse agro-climatic zones of the world leading to identification of 93 polymorphic primers (31.6%). The numbers of observed alleles at each locus ranged from two to four and mean polymorphism information content was found to be 0.3075. The polymorphic primers were tested for cross-species transferability on nine wild relatives of cultivated safflower. All primers except one showed amplification in at least two wild species while 25 primers amplified across all the nine species. The UPGMA dendrogram clustered C. tinctorius accessions and wild species separately into two major groups. The proposed progenitor species of safflower, C. oxyacantha and C. palaestinus were genetically closer to cultivated safflower and formed a distinct cluster. The cluster analysis also distinguished diploid and tetraploid wild species of safflower. Conclusion Next generation sequencing of safflower genome generated a large set of microsatellite markers. The novel markers developed in this study will add to the existing repertoire of markers and can be used for diversity analysis, synteny studies, construction of linkage maps and marker-assisted selection.	[Ambreen, Heena; Kumar, Shivendra; Variath, Murali Tottekkad; Joshi, Gopal; Bali, Sapinder; Agarwal, Manu; Kumar, Amar; Jagannath, Arun; Goel, Shailendra] Univ Delhi, Dept Bot, Delhi 110007, India	University of Delhi	Jagannath, A (corresponding author), Univ Delhi, Dept Bot, Delhi 110007, India.	jagannatharun@yahoo.co.in; shailendragoel@gmail.com	Bali, Sapinder/AAR-7019-2021	Goel, Shailendra/0000-0002-8731-8892; AGARWAL, MANU/0000-0003-4241-5055	Delhi University-Department of Science and Technology, Government of India [Dean(R)/2009/868]; University Grants Commission, India [/JRF/AA/208/2010-11]	Delhi University-Department of Science and Technology, Government of India; University Grants Commission, India(University Grants Commission, India)	Funding: This work was supported by Delhi University-Department of Science and Technology grant, Government of India to SG, AJ, AK and MA, and grant no. Dean(R)/2009/868. HA was supported by a research fellowship from University Grants Commission, India, grant no. Sch.No./JRF/AA/208/2010-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; [Anonymous], 1991, MOL TECHNIQUES TAXON; ASHRI A, 1960, AGRON J, V52, P11, DOI 10.2134/agronj1960.00021962005200010004x; ASHRI A, 1971, EUPHYTICA, V20, P410, DOI 10.1007/BF00035666; Bali S, 2013, MOL BREEDING, V32, P735, DOI 10.1007/s11032-013-9902-4; Cardle L, 2000, GENETICS, V156, P847; Carlsson AS, 2014, BIOCATAL AGRIC BIOTE, V3, P58, DOI 10.1016/j.bcab.2013.12.007; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Dajue L, 1996, SAFFLOWER CARTHAMUS, V7; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Flider FJ, 2013, LIPID TECHNOL, V25, P27; Garcia-Moreno MJ, 2010, EUPHYTICA, V175, P145, DOI 10.1007/s10681-010-0139-6; Garnatje T, 2006, ANN BOT-LONDON, V97, P461, DOI 10.1093/aob/mcj050; Golkar P., 2014, Australian Journal of Crop Science, V8, P1079; Hamdan YAS, 2011, PLANT BREEDING, V130, P237, DOI 10.1111/j.1439-0523.2010.01826.x; Heesacker A, 2008, THEOR APPL GENET, V117, P1021, DOI 10.1007/s00122-008-0841-0; Huang DN, 2014, MOL ECOL RESOUR, V14, P569, DOI 10.1111/1755-0998.12197; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Ilkilic C, 2011, FUEL PROCESS TECHNOL, V92, P356, DOI 10.1016/j.fuproc.2010.09.028; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jin L, 1996, P NATL ACAD SCI USA, V93, P15285, DOI 10.1073/pnas.93.26.15285; Johnson RC, 2007, CROP SCI, V47, P1728, DOI 10.2135/cropsci2006.12.0757; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kumar S, 2015, PLANT MOL BIOL REP, V33, P1299, DOI 10.1007/s11105-014-0828-8; Lee GA, 2014, MOL ECOL RESOUR, V14, P69, DOI 10.1111/1755-0998.12146; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Majidi MM, 2011, AUST J CROP SCI, V5, P1055; McPherson MA, 2009, TRANSGENIC RES, V18, P281, DOI 10.1007/s11248-008-9217-0; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Naresh V, 2009, EUPHYTICA, V170, P347, DOI 10.1007/s10681-009-9995-3; Nimbkar N, 2008, P 7 INT SAFFL C WAGG; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peakall R, 1998, MOL BIOL EVOL, V15, P1275, DOI 10.1093/oxfordjournals.molbev.a025856; Pearl SA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-43; Peng S, 2008, BIOCHEM SYST ECOL, V36, P531, DOI 10.1016/j.bse.2008.03.010; Perrier X., 2006, DARWIN SOFTWARE; Perry DJ, 2004, THEOR APPL GENET, V109, P55, DOI 10.1007/s00122-004-1597-9; Pootakham W, 2012, PLANT BREEDING, V131, P555, DOI 10.1111/j.1439-0523.2012.01982.x; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sabzalian MR, 2010, CROP PROT, V29, P550, DOI 10.1016/j.cropro.2009.12.013; Sehgal D, 2008, GENOME, V51, P638, DOI 10.1139/G08-049; Sehgal D, 2009, GENETICA, V135, P457, DOI 10.1007/s10709-008-9292-4; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney Rajeev K., 2007, P207, DOI 10.1007/978-1-4020-6297-1_10; Velasco L, 2005, PLANT BREEDING, V124, P459, DOI 10.1111/j.1439-0523.2005.01150.x; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang HX, 2012, PLANT CELL REP, V31, P2047, DOI 10.1007/s00299-012-1315-z; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Weiss E.A., 1983, OILSEED CROPS, P216; Whitton J, 1997, MOL BIOL EVOL, V14, P204, DOI 10.1093/oxfordjournals.molbev.a025755; Yang T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-65; Yang YX, 2007, GENET RESOUR CROP EV, V54, P1043, DOI 10.1007/s10722-006-9192-3; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhu W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-286	68	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135443	10.1371/journal.pone.0135443	http://dx.doi.org/10.1371/journal.pone.0135443			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287743	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600050
J	Bunaciu, RP; Jensen, HA; MacDonald, RJ; LaTocha, DH; Varner, JD; Yen, A				Bunaciu, Rodica P.; Jensen, Holly A.; MacDonald, Robert J.; LaTocha, Dorian H.; Varner, Jeffrey D.; Yen, Andrew			6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; JUVENILE MYELOMONOCYTIC LEUKEMIA; ACID-INDUCED DIFFERENTIATION; INDUCED BLR1 EXPRESSION; TRANS-RETINOIC ACID; ACUTE MYELOID-LEUKEMIA; C-CBL; GRANULOCYTIC DIFFERENTIATION; CD38 EXPRESSION; SURFACE ANTIGEN	6-Formylindolo(3,2-b) carbazole (FICZ) is a photoproduct of tryptophan and an endogenous high affinity ligand for aryl hydrocarbon receptor (AhR). It was previously reported that, in patient-derived HL-60 myeloblastic leukemia cells, retinoic acid (RA)-induced differentiation is driven by a signalsome containing c-Cbl and AhR. FICZ enhances RA-induced differentiation, assessed by expression of the membrane differentiation markers CD38 and CD11b, cell cycle arrest and the functional differentiation marker, inducible oxidative metabolism. Moreover, FICZ augments the expression of a number of the members of the RA-induced signalsome, such as c-Cbl, Vav1, Slp76, PI3K, and the Src family kinases Fgr and Lyn. Pursuing the molecular signaling responsible for RA-induced differentiation, we characterized, using FRET and clustering analysis, associations of key molecules thought to drive differentiation. Here we report that, assayed by FRET, AhR interacts with c-Cbl upon FICZ plus RA-induced differentiation, whereas AhR constitutively interacts with Cbl-b. Moreover, correlation analysis based on the flow cytometric assessment of differentiation markers and western blot detection of signaling factors reveal that Cbl-b, p-p38a and pT390-GSK3 beta, are not correlated with other known RA-induced signaling components or with a phenotypic outcome. We note that FICZ plus RA elicited signaling responses that were not typical of RA alone, but may represent alternative differentiation-driving pathways. In clusters of signaling molecules seminal to cell differentiation, FICZ co-administered with RA augments type and intensity of the dynamic changes induced by RA. Our data suggest relevance for FICZ in differentiation-induction therapy. The mechanism of action includes modulation of a SFK and MAPK centered signalsome and c-Cbl-AhR association.	[Bunaciu, Rodica P.; Jensen, Holly A.; MacDonald, Robert J.; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Jensen, Holly A.; Varner, Jeffrey D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [LaTocha, Dorian H.; Yen, Andrew] Cornell Univ, Flow Cytometry Core Facil, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Yen, A (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	ay13@cornell.edu		Bunaciu, Rodica/0000-0002-3101-0928	NIH [R01 CA033505, R01 CA152870]; NIH/PS-OC [3U54CA143876]; NYSTEM NY Dept. Health [C026718]; Cornell Vertebrate Genomics (VERGE); National Science Foundation [CBET-0846876]; NATIONAL CANCER INSTITUTE [R01CA033505, R01CA152870, U54CA143876] Funding Source: NIH RePORTER; Directorate For Engineering [0846876] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/PS-OC; NYSTEM NY Dept. Health; Cornell Vertebrate Genomics (VERGE); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding: R01 CA033505, R01 CA152870 from NIH (AY) and 3U54CA143876 NIH/PS-OC (Shuler/AY/RPB), C026718 NYSTEM NY Dept. Health (AY), Cornell Vertebrate Genomics (VERGE) (RPB) and CBET-0846876 from National Science Foundation (JDV/HAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BD, 1989, TOXICOL APPL PHARM, V99, P287, DOI 10.1016/0041-008X(89)90011-2; ABBOTT BD, 1989, TERATOLOGY, V40, P533, DOI 10.1002/tera.1420400602; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Battle TE, 2000, EXP CELL RES, V254, P287, DOI 10.1006/excr.1999.4766; Battle TE, 2001, EUR J CELL BIOL, V80, P59, DOI 10.1078/0171-9335-00141; Brooks SC, 1996, BLOOD, V87, P227; Bunaciu RP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-39; Bunaciu RP, 2011, CANCER RES, V71, P2371, DOI 10.1158/0008-5472.CAN-10-2299; Bunaciu RP, 2015, CURRENT PHARM REPORT, DOI [10.1007/s40495-015-0036-8, DOI 10.1007/S40495-015-0036-8]; BUSQUE L, 1995, BLOOD, V85, P21, DOI 10.1182/blood.V85.1.21.bloodjournal85121; Cambier N, 2001, Hematol J, V2, P97, DOI 10.1038/sj.thj.6200099; Chen GQ, 1996, LEUKEMIA, V10, P825; Chen WL, 2014, BLOOD, V124, P1645, DOI 10.1182/blood-2014-02-554204; Cheng J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8209; CLEGHON V, 1994, J BIOL CHEM, V269, P17749; COMIC M, 1994, LEUKEMIA, V8, P914; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Congleton J, 2014, CELL SIGNAL, V26, P1589, DOI 10.1016/j.cellsig.2014.03.021; COURTNEY KD, 1971, TOXICOL APPL PHARM, V20, P396, DOI 10.1016/0041-008X(71)90282-1; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Daver N, 2015, BRIT J HAEMATOL, V168, P646, DOI 10.1111/bjh.13189; Douer D, 2013, LEUKEMIA RES, V37, P795, DOI 10.1016/j.leukres.2013.03.001; Efficace F, 2014, J CLIN ONCOL, V32, P3406, DOI 10.1200/JCO.2014.55.3453; Fernandes MS, 2010, J BIOL CHEM, V285, P32596, DOI 10.1074/jbc.M110.106161; Finsinger P, 2015, ANN HEMATOL, V94, P195, DOI 10.1007/s00277-014-2197-7; Fritz H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021107; Geil WM, 2013, FEBS J; Gilbert S.F., 2010, DEV BIOL; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; GRATAS C, 1993, LEUKEMIA, V7, P1156; Hong HY, 2001, DIFFERENTIATION, V68, P55, DOI 10.1046/j.1432-0436.2001.068001055.x; Huang BT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0233-z; Jacobs H, 2011, ENVIRON HEALTH PERSP, V119, P1590, DOI 10.1289/ehp.1003075; Kishimoto H, 1998, J BIOL CHEM, V273, P15429, DOI 10.1074/jbc.273.25.15429; Kontani K, 1996, J BIOL CHEM, V271, P1534; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; Lo-Coco F, 2014, CURR HEMATOL MALIG R, V9, P138, DOI 10.1007/s11899-014-0206-5; Loh ML, 2011, BRIT J HAEMATOL, V152, P677, DOI 10.1111/j.1365-2141.2010.08525.x; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Marchisio M, 1998, BIOCHEM BIOPH RES CO, V253, P346, DOI 10.1006/bbrc.1998.9787; Maschan M, 2014, PEDIATR BLOOD CANCER, V61, P1871, DOI 10.1002/pbc.25013; Mehta K, 1997, BLOOD, V89, P3607, DOI 10.1182/blood.V89.10.3607.3607_3607_3614; Melander F, 2003, BIOCHEM J, V370, P687, DOI 10.1042/BJ20021201; Moro M, 2015, J THORACIC ONCOLOGY; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; NILSSON B, 1984, BRIT J HAEMATOL, V57, P365, DOI 10.1111/j.1365-2141.1984.tb02910.x; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Shen MQ, 2008, CANCER RES, V68, P8761, DOI 10.1158/0008-5472.CAN-08-1058; Shen MQ, 2011, LEUKEMIA LYMPHOMA, V52, P2372, DOI 10.3109/10428194.2011.603449; Shen MQ, 2009, J BIOL CHEM, V284, P25664, DOI 10.1074/jbc.M109.014241; Shiba N, 2010, LEUKEMIA, V24, P1090, DOI 10.1038/leu.2010.49; Smith J, 2009, EXP CELL RES, V315, P2241, DOI 10.1016/j.yexcr.2009.03.004; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Veselits M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089792; Visani G, 2001, LEUKEMIA, V15, P1696, DOI 10.1038/sj.leu.2402266; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang JR, 2004, MOL CELL BIOL, V24, P2423, DOI 10.1128/MCB.24.6.2423-2443.2004; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Welch H, 1997, ONCOGENE, V15, P2021, DOI 10.1038/sj.onc.1201356; Werner B, 2014, CANCER RES, V74, P5386, DOI 10.1158/0008-5472.CAN-14-1210; Werner S, 2015, CANCER DISCOV, V5, P506, DOI 10.1158/2159-8290.CD-14-1042; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Yamada T, 2014, J CRANIO MAXILL SURG, V42, P1, DOI 10.1016/j.jcms.2013.01.024; Yang CM, 2013, BIOCHEM PHARMACOL, V85, P1115, DOI 10.1016/j.bcp.2013.01.013; Yen A, 2006, EUR J CELL BIOL, V85, P117, DOI 10.1016/j.ejcb.2005.09.020; Yen A, 2000, IN VITRO CELL DEV-AN, V36, P249; YEN A, 1994, EUR J CELL BIOL, V65, P103; Yen A, 1998, CANCER RES, V58, P3163	72	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135668	10.1371/journal.pone.0135668	http://dx.doi.org/10.1371/journal.pone.0135668			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287494	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600061
J	Feng, YF; Guo, H; Yuan, F; Shen, MQ				Feng, Yi-fan; Guo, Hua; Yuan, Fei; Shen, Min-qian			Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; CHLAMYDIA-PNEUMONIAE; TUBE FORMATION; FACTOR-I; MIGRATION; TLR4; PROLIFERATION; PATHOGENESIS; INFLAMMATION	Stromal cell-derived factor-1 (SDF-1) has been confirmed to participate in the formation of choroidal neovascularization (CNV) via its two receptors: CXC chemokine receptors 4 (CXCR4) and CXCR7. Previous studies have indicated that the activation of Toll-like receptors (TLRs) by lipopolysaccharide (LPS) might elevate CXCR4 and/or CXCR7 expression in tumor cells, enhancing the response to SDF-1 to promote invasion and cell dissemination. However, the impact of LPS on the CXCR4 and CXCR7 expression in endothelial cells and subsequent pathological angiogenesis formation remains to be elucidated. The present study shows that LPS enhanced the CXCR4 and CXCR7 expression via activation of the TLR4 pathway in choroid-retinal endothelial (RF/6A) cells. In addition, the transcriptional regulation of CXCR4 and CXCR7 by LPS was found to be mediated by phosphorylation of the extracellular signal-related kinase (ERK) 1/2 and activation of nuclear factor kappa B (NF-kappa B) signaling pathways, which were blocked by ERK-or NF-kappa B-specific inhibitors. Furthermore, the increased CXCR4 and CXCR7 expression resulted in increased SDF-1induced RF/6A cells proliferation, migration and tube formation. In vivo, LPS-treated rat had significantly higher mRNA levels of CXCR4 and CXCR7 expression and lager laser-induced CNV area than vehicle-treated rat. SDF-1 blockade with a neutralizing antibody attenuated the progression of CNV in LPS-treated rat after a single intravitreal injection. Altogether, these results demonstrated that LPS might influence CNV formation by enhancing CXCR7 and CXCR7 expression in endothelial cells, possibly providing a new perspective for the treatment of CNV-associated diseases.	[Feng, Yi-fan; Guo, Hua; Yuan, Fei; Shen, Min-qian] Fudan Univ, Dept Ophthalmol, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University	Yuan, F (corresponding author), Fudan Univ, Dept Ophthalmol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	yuanfeiyk@163.com			National Nature Science Foundation of China [81470637]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Nature Science Foundation of China (no. 81470637, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin AJ, 2009, EXPERT OPIN THER TAR, V13, P641, DOI 10.1517/14728220902942322; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Dai XZ, 2011, J CELL MOL MED, V15, P1299, DOI 10.1111/j.1582-4934.2011.01301.x; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edelman JL, 2000, EXP EYE RES, V71, P523, DOI 10.1006/exer.2000.0907; Elner SG, 2005, INVEST OPHTH VIS SCI, V46, P4627, DOI 10.1167/iovs.05-0658; Feng YF, 2014, MOL CELL BIOCH; Franitza S, 2002, EUR J IMMUNOL, V32, P193, DOI 10.1002/1521-4141(200201)32:1<193::AID-IMMU193>3.0.CO;2-H; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Fujimoto T, 2010, INVEST OPHTH VIS SCI, V51, P4694, DOI 10.1167/iovs.09-4464; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Jin J, 2013, MOL CELL BIOCHEM, V381, P267, DOI 10.1007/s11010-013-1710-y; Jin J, 2013, OPHTHALMIC RES, V50, P6, DOI 10.1159/000348532; Kindzelskii AL, 2004, J GEN PHYSIOL, V124, P139, DOI 10.1085/jgp.200409062; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Li DM, 2014, J DENT, V42, P1327, DOI 10.1016/j.jdent.2014.07.007; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; LOU DA, 1987, IN VITRO CELL DEV B, V23, P75, DOI 10.1007/BF02623586; Matsumura N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039890; Miao H, 2012, MOL VIS, V18, P574; Miller DM, 2004, AM J OPHTHALMOL, V138, P323, DOI 10.1016/j.ajo.2004.03.018; Niu N, 2013, INVEST OPHTH VIS SCI, V54, P7045, DOI 10.1167/iovs.13-12531; Otsuka H, 2010, AM J PATHOL, V177, P2268, DOI 10.2353/ajpath.2010.100134; Robman L, 2005, AM J EPIDEMIOL, V161, P1013, DOI 10.1093/aje/kwi130; Sabroe I, 2003, J IMMUNOL, V171, P1630, DOI 10.4049/jimmunol.171.4.1630; Suzuki M, 2014, BRIT J OPHTHALMOL, V98, P1186, DOI 10.1136/bjophthalmol-2013-304670; Takabayashi T, 2009, ORAL ONCOL, V45, P968, DOI 10.1016/j.oraloncology.2009.06.006; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Wang XB, 2008, BIOCHEM BIOPH RES CO, V371, P283, DOI 10.1016/j.bbrc.2008.04.055; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027399; Zhang ZX, 2011, CURR EYE RES, V36, P838, DOI 10.3109/02713683.2011.593107	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136175	10.1371/journal.pone.0136175	http://dx.doi.org/10.1371/journal.pone.0136175			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288180	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600116
J	Fritz, HK; Gustafsson, A; Ljungberg, B; Ceder, Y; Axelson, H; Dahlback, B				Fritz, Helena K.; Gustafsson, Anna; Ljungberg, Borje; Ceder, Yvonne; Axelson, Hakan; Dahlback, Bjorn			The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; GENE-EXPRESSION; CANCER; MICRORNAS; OVEREXPRESSION; PROLIFERATION; THERAPY; TARGETS; UPDATE; FAMILY	High expression of the receptor tyrosine kinase Axl is associated with poor prognosis in patients with Renal Cell Carcinoma (RCC), the most common malignancy of the kidney. The miR-34a has been shown to directly regulate Axl in cancer cells. The miR-34a is a mediator of p53-dependent tumor suppression, and low expression of miR-34a has been associated with worse prognosis in several cancers. Our aim was to elucidate whether miR-34a or the other members of the miR-34 family (miR-34b/c) regulate Axl in RCC.	[Fritz, Helena K.; Gustafsson, Anna; Dahlback, Bjorn] Lund Univ, Dept Translat Med, Sect Clin Chem, Univ Hosp Malmo, Malmo, Sweden; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Ljungberg, Borje] Umea Univ, Dept Urol, Umea, Sweden; [Ljungberg, Borje] Umea Univ, Dept Androl, Umea, Sweden; [Ceder, Yvonne; Axelson, Hakan] Lund Univ, Dept Lab Med, Div Translat Canc Res, Lund, Sweden	Lund University; Skane University Hospital; Umea University; Umea University; Umea University; Lund University	Dahlback, B (corresponding author), Lund Univ, Dept Translat Med, Sect Clin Chem, Univ Hosp Malmo, Malmo, Sweden.			Ljungberg, Borje/0000-0002-4121-3753; Ceder, Yvonne/0000-0002-8705-8293; Dahlback, Bjorn/0000-0003-1546-0328	Swedish Cancer Foundation; Swedish Research Council; University Hospital Malmo Cancer Research Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); University Hospital Malmo Cancer Research Foundation	The work was supported by Swedish Cancer Foundation, Swedish Research Council grant, and University Hospital Malmo Cancer Research Foundation.	Abe H, 2013, INT J UROL, V20, P944, DOI 10.1111/iju.12187; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Axelrod H, 2014, ONCOTARGET, V5, P1, DOI 10.18632/oncotarget.2422; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boysen J, 2014, LEUKEMIA, V28, P451, DOI 10.1038/leu.2013.298; Brand TM, 2014, CANCER RES, V74, P5152, DOI 10.1158/0008-5472.CAN-14-0294; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Dutta KK, 2007, CANCER SCI, V98, P1845, DOI 10.1111/j.1349-7006.2007.00619.x; Escudier B, 2012, NAT REV CLIN ONCOL, V9, P327, DOI 10.1038/nrclinonc.2012.59; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritz HKM, 2014, EUR J CANCER, V50, P1758, DOI 10.1016/j.ejca.2014.03.281; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Jain AK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002859; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Lopez-Beltran A, 2009, INT J UROL, V16, P432, DOI 10.1111/j.1442-2042.2009.02302.x; Mackiewicz M, 2011, BREAST CANCER RES TR, V130, P663, DOI 10.1007/s10549-011-1690-0; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Paccez JD, 2014, INT J CANCER, V134, P1024, DOI 10.1002/ijc.28246; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; Thorstenson A, 2014, SCAND J UROL, V48, P231, DOI 10.3109/21681805.2013.864698; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Wang ZY, 2013, BBA-GENE REGUL MECH, V1829, P436, DOI 10.1016/j.bbagrm.2012.12.009; Weikert S, 2010, WORLD J UROL, V28, P247, DOI 10.1007/s00345-010-0555-1; Wirsing A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027438; Yu G, 2014, J UROLOGY, V192, P1229, DOI 10.1016/j.juro.2014.05.094	42	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135991	10.1371/journal.pone.0135991	http://dx.doi.org/10.1371/journal.pone.0135991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287733	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600095
J	Zheng, Y; Godar, SP; Litovsky, RY				Zheng, Yi; Godar, Shelly P.; Litovsky, Ruth Y.			Development of Sound Localization Strategies in Children with Bilateral Cochlear Implants	PLOS ONE			English	Article							MINIMUM AUDIBLE ANGLE; AUDITORY SPACE; BARN OWL; SPEECH-INTELLIGIBILITY; SENSITIVE PERIOD; TIME DIFFERENCES; SPATIAL RELEASE; NEURAL CIRCUITS; HEARING; CORTEX	Localizing sounds in our environment is one of the fundamental perceptual abilities that enable humans to communicate, and to remain safe. Because the acoustic cues necessary for computing source locations consist of differences between the two ears in signal intensity and arrival time, sound localization is fairly poor when a single ear is available. In adults who become deaf and are fitted with cochlear implants (CIs) sound localization is known to improve when bilateral CIs (BiCIs) are used compared to when a single CI is used. The aim of the present study was to investigate the emergence of spatial hearing sensitivity in children who use BiCIs, with a particular focus on the development of behavioral localization patterns when stimuli are presented in free-field horizontal acoustic space. A new analysis was implemented to quantify patterns observed in children for mapping acoustic space to a spatially relevant perceptual representation. Children with normal hearing were found to distribute their responses in a manner that demonstrated high spatial sensitivity. In contrast, children with BiCIs tended to classify sound source locations to the left and right; with increased bilateral hearing experience, they developed a perceptual map of space that was better aligned with the acoustic space. The results indicate experience-dependent refinement of spatial hearing skills in children with CIs. Localization strategies appear to undergo transitions from sound source categorization strategies to more fine-grained location identification strategies. This may provide evidence for neural plasticity, with implications for training of spatial hearing ability in CI users.	[Zheng, Yi; Godar, Shelly P.; Litovsky, Ruth Y.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Litovsky, RY (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	Litovsky@waisman.wisc.edu			National Institutes of Health [5R01-DC008365, 2P30-HD003352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: This work was supported by National Institutes of Health, Grant 5R01-DC008365, 2P30-HD003352 http://www.nih.gov.	Brown CA, 2014, EAR HEARING, V35, P580, DOI 10.1097/AUD.0000000000000044; Dahmen JC, 2010, NEURON, V66, P937, DOI 10.1016/j.neuron.2010.05.018; Gordon KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00719; Gordon KA, 2013, BRAIN, V136, P1609, DOI 10.1093/brain/awt052; Grieco-Calub TM, 2012, EAR HEARING, V33, P561, DOI 10.1097/AUD.0b013e31824c7801; Grieco-Calub TM, 2010, EAR HEARING, V31, P645, DOI 10.1097/AUD.0b013e3181e50a1d; Hartmann WM, 1998, J ACOUST SOC AM, V104, P3546, DOI 10.1121/1.423936; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Johnstone PM, 2006, J ACOUST SOC AM, V120, P2177, DOI 10.1121/1.2225416; Jones H, 2014, TRENDS HEAR IN PRESS; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kacelnik O, 2006, PLOS BIOL, V4, P627, DOI 10.1371/journal.pbio.0040071; Kan A, 2015, HEARING RES, V322, P127, DOI 10.1016/j.heares.2014.08.005; Keating P, 2014, EUR J NEUROSCI, V39, P197, DOI 10.1111/ejn.12402; King AJ, 2000, P NATL ACAD SCI USA, V97, P11821, DOI 10.1073/pnas.97.22.11821; King AJ, 2011, NEUROSCI BIOBEHAV R, V35, P2129, DOI 10.1016/j.neubiorev.2011.03.008; KNUDSEN EI, 1984, J NEUROSCI, V4, P1001; Knudsen EI, 1996, NATURE, V383, P428, DOI 10.1038/383428a0; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; Kral Andrej, 2006, Adv Otorhinolaryngol, V64, P89, DOI 10.1159/000094647; Kral A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00093; Kral A, 2013, BRAIN, V136, P180, DOI 10.1093/brain/aws305; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Kumpik DP, 2010, J NEUROSCI, V30, P4883, DOI 10.1523/JNEUROSCI.5488-09.2010; Laback B, 2004, EAR HEARING, V25, P488, DOI 10.1097/01.aud.0000145124.85517.e8; Litovsky RY, 2012, J AM ACAD AUDIOL, V23, P476, DOI 10.3766/jaaa.23.6.9; Litovsky RY, 2009, EAR HEARING, V30, P419, DOI 10.1097/AUD.0b013e3181a165be; Litovsky RY, 2006, EAR HEARING, V27, P43, DOI 10.1097/01.aud.0000194515.28023.4b; Litovsky RY, 2004, ARCH OTOLARYNGOL, V130, P648, DOI 10.1001/archotol.130.5.648; Litovsky RY, 1997, J ACOUST SOC AM, V102, P1739, DOI 10.1121/1.420106; Litovsky RY, 2011, COCHLEAR IMPLANTS IN; Lomber SG, 2001, J COMP NEUROL, V441, P44, DOI 10.1002/cne.1396; Majdak P, 2006, J ACOUST SOC AM, V120, P2190, DOI 10.1121/1.2258390; MASINO T, 1990, NATURE, V345, P434, DOI 10.1038/345434a0; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Misurelli SM, 2012, J ACOUST SOC AM, V132, P380, DOI 10.1121/1.4725760; Nakamoto KT, 2008, J NEUROPHYSIOL, V99, P2347, DOI 10.1152/jn.01326.2007; Salminen NH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007600; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; Van Deun L, 2010, AUDIOL NEURO-OTOL, V15, P7, DOI 10.1159/000218358; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; WHITFIELD IC, 1972, J NEUROPHYSIOL, V35, P718, DOI 10.1152/jn.1972.35.5.718; Wright BA, 2006, INT J AUDIOL, V45, pS92, DOI 10.1080/14992020600783004	46	29	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135790	10.1371/journal.pone.0135790	http://dx.doi.org/10.1371/journal.pone.0135790			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288142	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600070
J	Zoratti, L; Jaakola, L; Haggman, H; Giongo, L				Zoratti, Laura; Jaakola, Laura; Haeggman, Hely; Giongo, Lara			Modification of Sunlight Radiation through Colored Photo-Selective Nets Affects Anthocyanin Profile in Vaccinium spp. Berries	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; ANTIOXIDANT CAPACITY; WILD POPULATIONS; FRUIT-QUALITY; MYRTILLUS L.; BIOSYNTHESIS; BLUEBERRY; TEMPERATURE; BILBERRY; PHOTORECEPTORS	Objectives In recent years, the interest on the effects of the specific wavelengths of the light spectrum on growth and metabolism of plants has been increasing markedly. The present study covers the effect of modified sunlight conditions on the accumulation of anthocyanin pigments in two Vaccinium species: the European wild bilberry (V. myrtillus L.) and the cultivated high-bush blueberry (V. corymbosum L.). Methods The two Vaccinium species were grown in the same test field in the Alps of Trentino (Northern Italy) under modified light environment. The modification of sunlight radiation was carried out in field, through the use of colored photo-selective nets throughout the berry ripening during two consecutive growing seasons. The anthocyanin profile was then assessed in berries at ripeness. Results The results indicated that the light responses of the two Vaccinium species studied were different. Although both studied species are shade-adapted plants, 90% shading of sunlight radiation was beneficial only for bilberry plants, which accumulated the highest content of anthocyanins in both seasons. The same condition, instead, was not favorable for blueberries, whose maturation was delayed for at least two weeks, and anthocyanin accumulation was significantly decreased compared to berries grown under sunlight conditions. Moreover, the growing season had strong influence on the anthocyanin accumulation in both species, in relation to temperature flow and sunlight spectra composition during the berry ripening period. Conclusions Our results suggest that the use of colored photo-selective nets may be a complementary agricultural practice for cultivation of Vaccinium species. However, further studies are needed to analyze the effect of the light spectra modifications to other nutritional properties, and to elucidate the molecular mechanisms behind the detected differences between the two relative Vaccinium species.	[Zoratti, Laura; Haeggman, Hely] Univ Oulu, Genet & Physiol Unit, Oulu, Finland; [Jaakola, Laura] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Climate Lab, Tromso, Norway; [Jaakola, Laura] NIBIO Holt, Norwegian Inst Bioecon Res, Tromso, Norway; [Zoratti, Laura; Giongo, Lara] Edmund Mach Fdn, Genom & Biol Fruit Crop Dept, Res & Innovat Ctr, Trento, Italy	University of Oulu; UiT The Arctic University of Tromso; Norwegian Institute of Bioeconomy Research; Fondazione Edmund Mach	Zoratti, L (corresponding author), Univ Oulu, Genet & Physiol Unit, Oulu, Finland.	laura.zoratti@oulu.fi	Jaakola, Laura/AAA-4437-2021		Fondazione Edmund Mach, Applied Rosaceous Genomics research group (Italy)	Fondazione Edmund Mach, Applied Rosaceous Genomics research group (Italy)	This work was supported by funding granted to LG from the Fondazione Edmund Mach, Applied Rosaceous Genomics research group (Italy) (http://www.fmach.it/eng/CRI/general-info/organisation/Genomics-and-Biology-of-Fruit-Crop/Applied-Rosaceous-Genomics).	Aung T, 2014, J JPN SOC HORTIC SCI, V83, P273, DOI 10.2503/jjshs1.CH-110; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Cheng JH, 2015, J AGR SCI TECH-IRAN, V17, P157; Ehlenfeldt MK, 2001, J AGR FOOD CHEM, V49, P2222, DOI 10.1021/jf0013656; Eichholz I., 2015, PROCESSING IMPACT AC, P173; Giacalone M, 2015, BIOACTIVE NUTRACEUTICALS AND DIETARY SUPPLEMENTS IN NEUROLOGICAL AND BRAIN DISEASE: PREVENTION AND THERAPY, P17, DOI 10.1016/B978-0-12-411462-3.00002-3; Giongo L, 2013, POSTHARVEST BIOL TEC, V76, P34, DOI 10.1016/j.postharvbio.2012.09.004; Giovanelli G, 2009, FOOD CHEM, V112, P903, DOI 10.1016/j.foodchem.2008.06.066; Gough E. R., 1993, HIGHBUSH BLUEBERRY I, P288; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jovancevic M, 2011, J MED PLANTS RES, V5, P910; Kadomura-Ishikawa Y, 2013, J PLANT RES, V126, P847, DOI 10.1007/s10265-013-0582-2; Kondo S, 2014, J PLANT PHYSIOL, V171, P823, DOI 10.1016/j.jplph.2014.01.001; Koyama K, 2012, PHYTOCHEMISTRY, V78, P54, DOI 10.1016/j.phytochem.2012.02.026; Kuhn N, 2014, J EXP BOT, V65, P4543, DOI 10.1093/jxb/ert395; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Lobos GA, 2013, SCI HORTIC-AMSTERDAM, V153, P143, DOI 10.1016/j.scienta.2013.02.012; Moze S, 2011, J AGR FOOD CHEM, V59, P6998, DOI 10.1021/jf200765n; Nestby R, 2009, ACTA HORTIC, V838, P67; Norberto S, 2013, J FUNCT FOODS, V5, P1518, DOI 10.1016/j.jff.2013.08.015; Ordidge M, 2010, FOOD CHEM, V119, P1224, DOI 10.1016/j.foodchem.2009.08.039; Parlane S, 2006, FOREST ECOL MANAG, V222, P272, DOI 10.1016/j.foreco.2005.10.032; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; Retamales JB, 2008, ACTA HORTIC, V770, P193; Rieger G, 2008, J AGR FOOD CHEM, V56, P9080, DOI 10.1021/jf801104e; Riihinen K, 2008, FOOD CHEM, V110, P156, DOI 10.1016/j.foodchem.2008.01.057; Rodriguez-Mateos A, 2012, J AGR FOOD CHEM, V60, P5772, DOI 10.1021/jf203812w; Routray W, 2011, COMPR REV FOOD SCI F, V10, P303, DOI 10.1111/j.1541-4337.2011.00164.x; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Shahak Y, 2008, ACTA HORTIC, V770, P161; Stagnari F, 2014, J SCI FOOD AGR, V94, P713, DOI 10.1002/jsfa.6312; Steyn W. J., 2009, P85, DOI 10.1007/978-0-387-77335-3_4; Tarara JM, 2008, AM J ENOL VITICULT, V59, P235; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Uleberg E, 2012, J AGR FOOD CHEM, V60, P10406, DOI 10.1021/jf302924m; Gonzalez CV, 2015, PHYTOCHEMISTRY, V110, P46, DOI 10.1016/j.phytochem.2014.11.018; Wang CY, 2009, FOOD CHEM, V117, P426, DOI 10.1016/j.foodchem.2009.04.037; Yamane T, 2006, AM J ENOL VITICULT, V57, P54; Zoratti L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0377-1; Zoratti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00534	42	32	32	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135935	10.1371/journal.pone.0135935	http://dx.doi.org/10.1371/journal.pone.0135935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288240	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600087
J	Baracz, SJ; Everett, NA; Cornish, JL				Baracz, Sarah Jane; Everett, Nicholas Adams; Cornish, Jennifer Louise			The Involvement of Oxytocin in the Subthalamic Nucleus on Relapse to Methamphetamine-Seeking Behaviour	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; MEDIAL PREFRONTAL CORTEX; ADMINISTERED OXYTOCIN; ACCUMBENS CORE; BINDING-SITES; DOPAMINE; VASOPRESSIN; REWARD; COCAINE; BRAIN	The psychostimulant methamphetamine (METH) is an addictive drug of abuse. The neuropeptide oxytocin has been shown to modulate METH-related reward and METH-seeking behaviour. Recent findings implicated the subthalamic nucleus (STh) as a key brain region in oxytocin modulation of METH-induced reward. However, it is unclear if oxytocin acts in this region to attenuate relapse to METH-seeking behaviour, and if this action is through the oxytocin receptor. We aimed to determine whether oxytocin pretreatment administered into the STh would reduce reinstatement to METH use in rats experienced at METH self-administration, and if this could be reversed by the co-administration of the oxytocin receptor antagonist desGly-NH2,d(CH2)5[D-Tyr2,Thr4]OVT. Male Sprague Dawley rats underwent surgery to implant an intravenous jugular vein catheter and bilateral microinjection cannulae into the STh under isoflourane anaesthesia. Rats were then trained to self-administer intravenous METH (0.1 mg/kg/infusion) by lever press during 2-hour sessions under a fixed ratio 1 schedule for 20 days. Following extinction of lever press activity, the effect of microinjecting saline, oxytocin (0.2 pmol, 0.6 pmol, 1.8 pmol, 3.6 pmol) or co-administration of oxytocin (3.6 pmol) and desGly-NH2,d(CH2)5[D-Tyr(2),Thr(4)]OVT (3 nmol) into the STh (200 nl/side) was examined on METH-primed reinstatement (1 mg/kg; i.p.). We found that local administration of the highest oxytocin dose (3.6 pmol) into the STh decreased METH-induced reinstatement and desGly-NH2,d(CH2)5[ D-Tyr2,Thr4]OVT had a non-specific effect on lever press activity. These findings highlight that oxytocin modulation of the STh is an important modulator of relapse to METH abuse.	[Baracz, Sarah Jane; Everett, Nicholas Adams; Cornish, Jennifer Louise] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	Macquarie University	Cornish, JL (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	Jennifer.cornish@mq.edu.au	Baracz, Sarah Jane/K-4860-2019	Everett, Nicholas/0000-0001-9226-6153; Baracz, Sarah/0000-0002-9938-1936; Cornish, Jennifer/0000-0002-9754-8069	Macquarie University; Australian Postgraduate Award	Macquarie University; Australian Postgraduate Award(Australian Government)	Research was supported by internal funding from Macquarie University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miss Sarah Baracz is the recipient of an Australian Postgraduate Award.	ADAN RAH, 1995, ENDOCRINOLOGY, V136, P4022, DOI 10.1210/en.136.9.4022; Baracz SJ, 2013, HORM BEHAV, V63, P370, DOI 10.1016/j.yhbeh.2012.12.003; Baracz SJ, 2012, BEHAV BRAIN RES, V228, P185, DOI 10.1016/j.bbr.2011.11.038; Baracz SJ, ADDICTION BIOL; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Baunez C, 2005, NAT NEUROSCI, V8, P484, DOI 10.1038/nn1429; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Carson DS, 2010, ADDICT BIOL, V15, P448, DOI 10.1111/j.1369-1600.2010.00247.x; Carson DS, 2010, NEUROPHARMACOLOGY, V58, P38, DOI 10.1016/j.neuropharm.2009.06.018; Chan W.Y., 2003, EXP PHYSL S, V85S, P7; Chudasama Y, 2003, J NEUROSCI, V23, P5477; Ciketic S, 2012, J SUBST USE, V17, P363, DOI 10.3109/14659891.2011.592900; Cox BM, 2013, PSYCHONEUROENDOCRINO, V38, P2343, DOI 10.1016/j.psyneuen.2013.05.005; Cui SS, 2001, J NEUROSCI, V21, P9867, DOI 10.1523/JNEUROSCI.21-24-09867.2001; Darbaky Y, 2005, NEUROREPORT, V16, P1241, DOI 10.1097/00001756-200508010-00022; Dyer KR, 2005, AUST PSYCHOL, V40, P96, DOI 10.1080/00050060500094647; Field A, 2009, DISCOVERING STATISTI; Figueira RJ, 2008, BEHAV NEUROSCI, V122, P618, DOI 10.1037/0735-7044.122.3.618; FREUNDMERCIER MJ, 1988, NEUROSCIENCE, V26, P261, DOI 10.1016/0306-4522(88)90143-1; Gong WH, 1997, PROG NEURO-PSYCHOPH, V21, P839, DOI 10.1016/S0278-5846(97)00084-5; Harris D, 2000, AM J ADDICTION, V9, P28; Hicks C, 2014, BRIT J PHARMACOL, V171, P2868, DOI 10.1111/bph.12613; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KOVACS GL, 1985, NEUROPHARMACOLOGY, V24, P413, DOI 10.1016/0028-3908(85)90026-7; KOVACS GL, 1990, NEUROPHARMACOLOGY, V29, P365, DOI 10.1016/0028-3908(90)90095-9; Lardeux S, 2008, NEUROPSYCHOPHARMACOL, V33, P634, DOI 10.1038/sj.npp.1301432; Lardeux S, 2013, J NEUROPHYSIOL, V110, P1497, DOI 10.1152/jn.00160.2013; Lardeux S, 2009, J NEUROPHYSIOL, V102, P2526, DOI 10.1152/jn.91009.2008; Lintas A, 2012, BRAIN RES, V1434, P142, DOI 10.1016/j.brainres.2011.09.005; Manning M, 2008, PROG BRAIN RES, V170, P473, DOI 10.1016/S0079-6123(08)00437-8; McCann UD, 1998, J NEUROSCI, V18, P8417; McGregor IS, 2008, BRIT J PHARMACOL, V154, P358, DOI 10.1038/bjp.2008.132; McGregor IS, 2012, HORM BEHAV, V61, P331, DOI 10.1016/j.yhbeh.2011.12.001; Meredith CW, 2005, HARVARD REV PSYCHIAT, V13, P141, DOI 10.1080/10673220591003605; Motbey CP, 2013, J PSYCHOPHARMACOL, V27, P823, DOI 10.1177/0269881113490325; Ornstein TJ, 2000, NEUROPSYCHOPHARMACOL, V23, P113, DOI 10.1016/S0893-133X(00)00097-X; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; PHILLIPS AG, 1984, BRAIN RES BULL, V12, P195, DOI 10.1016/0361-9230(84)90189-8; PONTIERI FE, 1990, PSYCHOPHARMACOLOGY, V102, P175, DOI 10.1007/BF02245919; Qi J, 2008, N-S ARCH PHARMACOL, V376, P441, DOI 10.1007/s00210-007-0245-8; Qi J, 2009, NEUROPHARMACOLOGY, V56, P856, DOI 10.1016/j.neuropharm.2009.01.010; Ramos L, 2013, NEUROPSYCHOPHARMACOL, V38, P2249, DOI 10.1038/npp.2013.125; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rouaud T, 2010, P NATL ACAD SCI USA, V107, P1196, DOI 10.1073/pnas.0908189107; SARNYAI Z, 1992, NEUROPEPTIDES, V23, P27, DOI 10.1016/0143-4179(92)90006-I; Shen KZ, 2000, J PHYSIOL-LONDON, V525, P331, DOI 10.1111/j.1469-7793.2000.00331.x; Shirley DG, 2011, NEPHRON PHYSIOL, V117, pP21, DOI 10.1159/000320290; Smith Y, 1998, NEUROSCIENCE, V86, P353; Song ZM, 2014, PSYCHONEUROENDOCRINO, V50, P14, DOI 10.1016/j.psyneuen.2014.08.005; TRIBOLLET E, 1988, BRAIN RES, V442, P105, DOI 10.1016/0006-8993(88)91437-0; Turnipseed SD, 2003, J EMERG MED, V24, P369, DOI 10.1016/S0736-4679(03)00031-3; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REPORT; UVNASMOBERG K, 1994, PHARMACOL BIOCHEM BE, V49, P101, DOI 10.1016/0091-3057(94)90462-6; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Watson C, 1997, THE RAT BRAIN ATLAS; Westover AN, 2007, ARCHIVES OF GENERAL, P64; Yang J, 2011, PEPTIDES, V32, P2104, DOI 10.1016/j.peptides.2011.08.021; You ZD, 2000, NEUROREPORT, V11, P3113, DOI 10.1097/00001756-200009280-00015; Zanos P, 2014, PHARMACOL BIOCHEM BE, V119, P72, DOI 10.1016/j.pbb.2013.05.009	59	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136132	10.1371/journal.pone.0136132	http://dx.doi.org/10.1371/journal.pone.0136132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284529	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100105
J	Bowman, JS; Ducklow, HW				Bowman, Jeff S.; Ducklow, Hugh W.			Microbial Communities Can Be Described by Metabolic Structure: A General Framework and Application to a Seasonally Variable, Depth-Stratified Microbial Community from the Coastal West Antarctic Peninsula	PLOS ONE			English	Article							SEA-ICE; BACTERIAL; BACTERIOPLANKTON; PHYLOGENY; DIVERSITY; ALIGNMENT; GENOMICS; DATABASE; SUMMER; WINTER	Taxonomic marker gene studies, such as the 16S rRNA gene, have been used to successfully explore microbial diversity in a variety of marine, terrestrial, and host environments. For some of these environments long term sampling programs are beginning to build a historical record of microbial community structure. Although these 16S rRNA gene datasets do not intrinsically provide information on microbial metabolism or ecosystem function, this information can be developed by identifying metabolisms associated with related, phenotyped strains. Here we introduce the concept of metabolic inference; the systematic prediction of metabolism from phylogeny, and describe a complete pipeline for predicting the metabolic pathways likely to be found in a collection of 16S rRNA gene phylotypes. This framework includes a mechanism for assigning confidence to each metabolic inference that is based on a novel method for evaluating genomic plasticity. We applied this framework to 16S rRNA gene libraries from the West Antarctic Peninsula marine environment, including surface and deep summer samples and surface winter samples. Using statistical methods commonly applied to community ecology data we found that metabolic structure differed between summer surface and winter and deep samples, comparable to an analysis of community structure by 16S rRNA gene phylotypes. While taxonomic variance between samples was primarily driven by low abundance taxa, metabolic variance was attributable to both high and low abundance pathways. This suggests that clades with a high degree of functional redundancy can occupy distinct adjacent niches. Overall our findings demonstrate that inferred metabolism can be used in place of taxonomy to describe the structure of microbial communities. Coupling metabolic inference with targeted metagenomics and an improved collection of completed genomes could be a powerful way to analyze microbial communities in a high-throughput manner that provides direct access to metabolic and ecosystem function.	[Bowman, Jeff S.; Ducklow, Hugh W.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Bowman, Jeff S.] Blue Marble Space Inst Sci, Seattle, WA USA	Columbia University	Bowman, JS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	bowmanjs@ldeo.columbia.edu		Bowman, Jeff/0000-0002-8811-6280	National Science Foundation Division of Polar Programs [1440435, 1340886]; Directorate For Geosciences [1440435] Funding Source: National Science Foundation	National Science Foundation Division of Polar Programs(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding provided by National Science Foundation Division of Polar Programs, http://www.nsf.gov/div/index.jsp?div=PLR, grant number 1440435 to HWD and National Science Foundation Division of Polar Programs, http://www.nsf.gov/div/index.jsp?div=PLR, grant number 1340886 to HWD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bowman JS, 2014, FEMS MICROBIOL ECOL, V89, P376, DOI 10.1111/1574-6941.12331; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caro-Quintero A, 2012, ENVIRON MICROBIOL, V14, P347, DOI 10.1111/j.1462-2920.2011.02668.x; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; CHAO A, 1984, SCAND J STAT, V11, P265; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ducklow HW, 2013, OCEANOGRAPHY, V26, P190, DOI 10.5670/oceanog.2013.62; Ghiglione JF, 2012, ENVIRON MICROBIOL, V14, P617, DOI 10.1111/j.1462-2920.2011.02601.x; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grzymski JJ, 2012, ISME J, V6, P1901, DOI 10.1038/ismej.2012.31; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Luria CM, 2014, AQUAT MICROB ECOL, V73, P107, DOI 10.3354/ame01703; Martens K, 2005, HYDROBIOLOGIA, V542, P27, DOI 10.1007/s10750-005-0892-z; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Michotey V, 1997, MAR ECOL PROG SER, V160, P47, DOI 10.3354/meps160047; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Okuda S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2203; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Roling WFM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00125; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Shemesh Y, 2004, ENVIRON MICROBIOL, V6, P12, DOI 10.1046/j.1462-2920.2003.00530.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Steinle L, 2015, NAT GEOSCI, V8, P378, DOI [10.1038/NGEO2420, 10.1038/ngeo2420]; Team RC, 2014, R LANG ENV STAT COMP; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Vollmers J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063422; Wietz M, 2015, ENVIRON MICROBIOL, V17, P3822, DOI 10.1111/1462-2920.12842	43	88	92	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135868	10.1371/journal.pone.0135868	http://dx.doi.org/10.1371/journal.pone.0135868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285202	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100079
J	Li, TJ; Yu, T; Hawkins, BS; Dickersin, K				Li, Tianjing; Yu, Tsung; Hawkins, Barbara S.; Dickersin, Kay			Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis	PLOS ONE			English	Article							OVER TRIALS; CLINICAL-TRIALS; LATANOPROST	Randomized crossover trials are clinical experiments in which participants are assigned randomly to a sequence of treatments and each participant serves as his/her own control in estimating treatment effect. We need a better understanding of the validity of their results to enable recommendations as to which crossover trials can be included in meta-analysis and for development of reporting guidelines. Objective To evaluate the characteristics of the design, analysis, and reporting of crossover trials for inclusion in a meta-analysis of treatment for primary open-angle glaucoma and to provide empirical evidence to inform the development of tools to assess the validity of the results from crossover trials and reporting guidelines. Methods We searched MEDLINE, EMBASE, and Cochrane's CENTRAL register for randomized crossover trials for a systematic review and network meta-analysis we are conducting. Two individuals independently screened the search results for eligibility and abstracted data from each included report. Results We identified 83 crossover trials eligible for inclusion. Issues affecting the risk of bias in crossover trials, such as carryover, period effects and missing data, were often ignored. Some trials failed to accommodate the within-individual differences in the analysis. For a large proportion of the trials, the authors tabulated the results as if they arose from a parallel design. Precision estimates properly accounting for the paired nature of the design were often unavailable from the study reports; consequently, to include trial findings in a meta-analysis would require further manipulation and assumptions. Conclusions The high proportion of poorly reported analyses and results has the potential to affect whether crossover data should or can be included in a meta-analysis. There is pressing need for reporting guidelines for crossover trials.	[Li, Tianjing; Yu, Tsung; Hawkins, Barbara S.; Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Clin Trials & Evidence Synth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Li, TJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Clin Trials & Evidence Synth, Baltimore, MD 21205 USA.	tli19@jhu.edu		Li, Tianjing/0000-0001-5371-4558	National Eye Institute, National Institutes of Health, United States [1 RC1 EY020140, U01-EY020522]; NATIONAL EYE INSTITUTE [RC1EY020140, U01EY020522] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, United States; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The project was funded by Grant 1 RC1 EY020140 and Grant U01-EY020522, National Eye Institute, National Institutes of Health, United States.	BECKER MP, 1993, BIOMETRICS, V49, P997, DOI 10.2307/2532242; CLEOPHAS TJM, 1995, J CLIN PHARMACOL, V35, P594, DOI 10.1002/j.1552-4604.1995.tb05016.x; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Feingold M, 1996, STAT MED, V15, P953, DOI 10.1002/(SICI)1097-0258(19960530)15:10<953::AID-SIM213>3.0.CO;2-M; FREEMAN PR, 1989, STAT MED, V8, P1421, DOI 10.1002/sim.4780081202; Harasymowycz P, 2007, CAN J OPHTHALMOL, V42, P75, DOI 10.3129/canjophthalmol.06-096; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; JONES B, 1987, STAT MED, V6, P555, DOI 10.1002/sim.4780060504; Kenward M G, 1994, Stat Methods Med Res, V3, P325, DOI 10.1177/096228029400300403; KENWARD MG, 1991, STAT MED, V10, P1607, DOI 10.1002/sim.4780101012; Konstas AGP, 2006, ARCH OPHTHALMOL-CHIC, V124, P1553, DOI 10.1001/archopht.124.11.1553; Lathyris DN, 2007, INT J EPIDEMIOL, V36, P422, DOI 10.1093/ije/dym001; Mills EJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-27; Piantadosi S, 2005, WILEY SER PROBAB ST, P515; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Senn S, 2002, CROSS OVER TRIALS CL; Vass C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003167.pub3; Wellek S, 2012, DTSCH ARZTEBL INT, V109, P276, DOI 10.3238/arztebl.2012.0276; WILLAN AR, 1986, CONTROL CLIN TRIALS, V7, P282, DOI 10.1016/0197-2456(86)90036-X	19	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0133023	10.1371/journal.pone.0133023	http://dx.doi.org/10.1371/journal.pone.0133023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284684	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100002
J	Alos, J; Puiggros, A; Diaz-Gil, C; Palmer, M; Rossello, R; Arlinghaus, R				Alos, Josep; Puiggros, Antoni; Diaz-Gil, Carlos; Palmer, Miquel; Rossello, Rosario; Arlinghaus, Robert			Empirical Evidence for Species-Specific Export of Fish Naivete from a No-Take Marine Protected Area in a Coastal Recreational Hook and Line Fishery	PLOS ONE			English	Article							ANGLING CATCH RATES; RESERVES; VULNERABILITY; SPILLOVER; BEHAVIOR; TROUT; POPULATIONS; IMPACTS; EXPLOITATION; CONSERVATION	No-take marine protected areas (MPAs) are assumed to enhance fisheries catch via the "spillover" effect, where biomass is exported to adjacent exploited areas. Recent studies in spearfishing fisheries suggest that the spillover of gear-naive individuals from protected to unprotected sites increases catch rates outside the boundaries of MPAs. Whether this is a widespread phenomenon that also holds for other gear types and species is unknown. In this study, we tested if the distance to a Mediterranean MPA predicted the degree of vulnerability to hook and line in four small-bodied coastal fish species. With the assistance of underwater video recording, we investigated the interaction effect of the distance to the boundary of an MPA and species type relative to the latency time to ingest a natural bait, which was considered as a surrogate of fish naivete or vulnerability to fishing. Vulnerability to angling increased (i.e., latency time decreased) within and near the boundary of an MPA for an intrinsically highly catchable species (Serranus scriba), while it remained constant for an intrinsically uncatchable control species (Chromis chromis). While all of the individuals of S. scriba observed within the MPA and surrounding areas were in essence captured by angling gear, only one fifth of individuals in the far locations were captured. This supports the potential for the spillover of gear-naive and consequently more vulnerable fish from no-take MPAs. Two other species initially characterized as intermediately catchable (Coris julis and Diplodus annularis) also had a shorter latency time in the vicinity of an MPA, but for these two cases the trend was not statistically significant. Overall, our results suggest that an MPA-induced naivete effect may not be universal and may be confined to only intrinsically highly catchable fish species. This fact emphasizes the importance of considering the behavioural dimension when predicting the outcomes of MPAs, otherwise the effective contribution may be smaller than predicted for certain highly catchable species such as S. scriba.	[Alos, Josep; Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Muggelseedamm 310, D-12587 Berlin, Germany; [Puiggros, Antoni; Diaz-Gil, Carlos; Palmer, Miquel; Rossello, Rosario] IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Illes Balears, Spain; [Diaz-Gil, Carlos] LIMIA Balear Govt, Lab Invest Marines & Aqicultura, Port Dandratx, Illes Balears, Spain; [Arlinghaus, Robert] Humboldt Univ, Div Integrat Fisheries Management, Fac Life Sci, D-10155 Berlin, Germany; [Arlinghaus, Robert] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10155 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Humboldt University of Berlin; Humboldt University of Berlin	Alos, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Muggelseedamm 310, Muggelseedamm 310, D-12587 Berlin, Germany.	alos@igb-berlin.de	Arlinghaus, Robert/E-3340-2010; Díaz Gil, Carlos/H-2454-2017; Arlinghaus, Robert/J-6171-2019; Palmer, Miquel/E-3561-2013	Arlinghaus, Robert/0000-0003-2861-527X; Díaz Gil, Carlos/0000-0003-4095-1559; Alos, Josep/0000-0003-4385-9539; Miquel, Palmer/0000-0002-7875-3673	Marie Curie Post-Doc grant (Project Fish&Fishers, FP7-PEOPLE-IEF) [327160]; B-Types project through Leibniz Competition [SAW-2013-IGB-2]; FPI-INIA grant; REC2 [CTM2011-23835]	Marie Curie Post-Doc grant (Project Fish&Fishers, FP7-PEOPLE-IEF); B-Types project through Leibniz Competition; FPI-INIA grant; REC2	This study was funded through a Marie Curie Post-Doc grant (Project Fish&Fishers, FP7-PEOPLE-2012-IEF, grant #327160, https://www.facebook.com/pages/FishFishers-Research-Project/985161008176055). JA and RA received additional funding from the B-Types project funded through Leibniz Competition (grant #SAW-2013-IGB-2, http://www.b-types.igb-berlin.de/). CDG was funded by FPI-INIA-2012 grant and MP and CDG by the research project REC2 (grant#CTM2011-23835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2014, REV FISH BIOL FISHER, V24, P1033, DOI 10.1007/s11160-014-9362-x; Alos J, 2009, J APPL ICHTHYOL, V25, P565, DOI 10.1111/j.1439-0426.2009.01272.x; Alos J, 2015, CAN J FISH AQUAT SCI, V72, P217, DOI 10.1139/cjfas-2014-0183; Alos J, 2014, MAR ECOL PROG SER, V503, P219, DOI 10.3354/meps10745; Alos J, 2013, FISH RES, V137, P88, DOI 10.1016/j.fishres.2012.09.007; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Ariyomo TO, 2013, BEHAV GENET, V43, P161, DOI 10.1007/s10519-013-9585-y; Arlinghaus R, 2008, FISH RES, V92, P53, DOI 10.1016/j.fishres.2007.12.012; Arlinghaus R, 2006, N AM J FISH MANAGE, V26, P592, DOI 10.1577/M04-220.1; Askey PJ, 2006, N AM J FISH MANAGE, V26, P1020, DOI 10.1577/M06-035.1; Bellier E, 2013, ECOL INFORM, V18, P188, DOI 10.1016/j.ecoinf.2013.09.004; BEUKEMA JJ, 1970, J FISH BIOL, V2, P155, DOI 10.1111/j.1095-8649.1970.tb03268.x; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2283; Bohnsack JA, 2011, B MAR SCI, V87, P939, DOI 10.5343/bms.2010.1072; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Botsford LW, 2003, ECOL APPL, V13, pS25; Cardona L, 2007, SCI MAR, V71, P811, DOI 10.3989/scimar.2007.71n4811; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; Cerda M, 2010, FISH RES, V101, P146, DOI 10.1016/j.fishres.2009.09.016; COBLE DW, 1985, CAN J FISH AQUAT SCI, V42, P791, DOI 10.1139/f85-101; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cote IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094248; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cox SP, 2002, N AM J FISH MANAGE, V22, P21, DOI 10.1577/1548-8675(2002)022&lt;0021:MEIRFA&gt;2.0.CO;2; Crawley M.J., 2007, R BOOK; Deudero S, 2004, MAR BIOL, V145, P971, DOI 10.1007/s00227-004-1374-y; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dochtermann NA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2201; Donaldson MR, 2011, FISHERIES, V36, P385, DOI 10.1080/03632415.2011.597672; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Font T, 2014, REV FISH SCI AQUAC, V22, P73, DOI 10.1080/10641262.2013.823907; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Francour P, 2001, AQUAT CONSERV, V11, P155, DOI 10.1002/aqc.442; Fujitani ML, 2012, ECOL APPL, V22, P597, DOI 10.1890/11-0603.1; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Godo OR, 1997, ICES J MAR SCI, V54, P273, DOI 10.1006/jmsc.1996.0167; Guidetti P, 2008, J MAR BIOL ASSOC UK, V88, P625, DOI 10.1017/S0025315408000933; Halpern BS, 2014, NATURE, V506, P167, DOI 10.1038/nature13053; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Harkonen L, 2014, CAN J FISH AQUAT SCI, V71, P1900, DOI 10.1139/cjfas-2014-0221; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2003, ECOL APPL, V13, pS65; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; HILBORN R, 1992; Hougaard P, 1999, BIOMETRICS, V55, P13, DOI 10.1111/j.0006-341X.1999.00013.x; Januchowski-Hartley FA, 2015, BIOL CONSERV, V182, P8, DOI 10.1016/j.biocon.2014.11.024; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Karpouzi VS, 2003, J FISH BIOL, V62, P1353, DOI 10.1046/j.1095-8649.2003.00118.x; Klefoth T, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011072; Klefoth T, 2013, FISHERIES MANAGEMENT, V20, P12; Klefoth T, 2012, BEHAV ECOL SOCIOBIOL, V66, P547, DOI 10.1007/s00265-011-1303-2; Kuparinen A, 2010, FISH RES, V105, P111, DOI 10.1016/j.fishres.2010.03.011; Letessier TB, 2015, J EXP MAR BIOL ECOL, V466, P120, DOI 10.1016/j.jembe.2015.02.013; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOKKEBORG S, 1989, CAN J FISH AQUAT SCI, V46, P1478, DOI 10.1139/f89-189; March D, 2014, FISH RES, V154, P63, DOI 10.1016/j.fishres.2014.01.020; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Moland E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2679; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Olsen EM, 2012, ECOLOGY EVOLUTION, V2, P13; Paukert CP, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026&lt;0006:AOONPR&gt;2.0.CO;2; Perez-Ruzafa A, 2008, J NAT CONSERV, V16, P234, DOI 10.1016/j.jnc.2008.09.003; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Pine WE, 2009, FISHERIES, V34, P165, DOI 10.1577/1548-8446-34.4.165; Pinnegar JK, 2000, OECOLOGIA, V122, P399, DOI 10.1007/s004420050046; Pitcher T, 1993, PREDATION RISK FEEDI, P716; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAAT A J P, 1985, Aquaculture and Fisheries Management, V16, P171, DOI 10.1111/j.1365-2109.1985.tb00305.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Seytre C, 2014, MAR FRESHWATER RES, V65, P244, DOI 10.1071/MF13080; Stelzenmuller V, 2008, MAR POLLUT BULL, V56, P2018, DOI 10.1016/j.marpolbul.2008.08.006; Sutter DAH, 2012, P NATL ACAD SCI USA, V109, P20960, DOI 10.1073/pnas.1212536109; van Poorten BT, 2005, N AM J FISH MANAGE, V25, P329, DOI 10.1577/M03-225.1; Villegas-Rios D, 2014, MAR ECOL PROG SER, V515, P239, DOI 10.3354/meps11018; Ward HGM, 2013, CAN J FISH AQUAT SCI, V70, P1542, DOI 10.1139/cjfas-2013-0264; Watson JR, 2011, ECOLOGY, V92, P1193, DOI 10.1890/10-1436.1	84	22	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135348	10.1371/journal.pone.0135348	http://dx.doi.org/10.1371/journal.pone.0135348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275290	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600061
J	Bessi, A; Zollo, F; Del Vicario, M; Scala, A; Caldarelli, G; Quattrociocchi, W				Bessi, Alessandro; Zollo, Fabiana; Del Vicario, Michela; Scala, Antonio; Caldarelli, Guido; Quattrociocchi, Walter			Trend of Narratives in the Age of Misinformation	PLOS ONE			English	Article							SOCIAL-INFLUENCE; MEDIA; COMMUNITIES	Social media enabled a direct path from producer to consumer of contents changing the way users get informed, debate, and shape their worldviews. Such a disintermediation might weaken consensus on social relevant issues in favor of rumors, mistrust, or conspiracy thinking-e.g., chem-trails inducing global warming, the link between vaccines and autism, or the New World Order conspiracy. Previous studies pointed out that consumers of conspiracy-like content are likely to aggregate in homophile clusters-i.e., echo-chambers. Along this path we study, by means of a thorough quantitative analysis, how different topics are consumed inside the conspiracy echo-chamber in the Italian Facebook. Through a semi-automatic topic extraction strategy, we show that the most consumed contents semantically refer to four specific categories: environment, diet, health, and geopolitics. We find similar consumption patterns by comparing users activity (likes and comments) on posts belonging to these different semantic categories. Finally, we model users mobility across the distinct topics finding that the more a user is active, the more he is likely to span on all categories. Once inside a conspiracy narrative users tend to embrace the overall corpus.	[Bessi, Alessandro] IUSS Inst Adv Study, Pavia, Italy; [Bessi, Alessandro; Zollo, Fabiana; Del Vicario, Michela; Scala, Antonio; Caldarelli, Guido; Quattrociocchi, Walter] IMT Inst Adv Studies, Lab Computat Social Sci, Lucca, Italy; [Scala, Antonio; Caldarelli, Guido] ISC CNR UoS Sapienza, Rome, Italy; [Caldarelli, Guido] London Inst Math Sci, London, England	IUSS PAVIA; IMT School for Advanced Studies Lucca; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Quattrociocchi, W (corresponding author), IMT Inst Adv Studies, Lab Computat Social Sci, Lucca, Italy.	walterquattrociocchi@gmail.com	Scala, Antonio/H-9153-2019; Zollo, Fabiana/Z-1506-2019; Scala, Antonio/GRS-5823-2022; Scala, Antonio/A-2098-2012; Caldarelli, Guido/AAB-8206-2022; Quattrociocchi, Walter/L-4550-2016; Caldarelli, Guido/A-5274-2010	Zollo, Fabiana/0000-0002-0833-5388; Scala, Antonio/0000-0002-3414-2686; Scala, Antonio/0000-0002-3414-2686; Bessi, Alessandro/0000-0001-6260-4422; Del Vicario, Michela/0000-0002-8561-4364; Quattrociocchi, Walter/0000-0002-4374-9324; Caldarelli, Guido/0000-0001-9377-3616	EU FET project MULTIPLEX [317532]; EU FET project SIMPOL [610704]; EU FET project DOLFINS [640772]; EU FET project SOBIGDATA [654024]	EU FET project MULTIPLEX; EU FET project SIMPOL; EU FET project DOLFINS; EU FET project SOBIGDATA	Funding for this work was provided by EU FET project MULTIPLEX nr. 317532, SIMPOL nr. 610704, DOLFINS nr. 640772, SOBIGDATA 654024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LM, 2012, ACM T WEB, V6, DOI 10.1145/2180861.2180866; Anagnostopoulos A., 2014, ARXIV14112893; [Anonymous], 2014, EBOLA CONSPIRACY THE; [Anonymous], 2014, INEVITABLE RISE EBOL; [Anonymous], 2014, EBOLA LESSONS SOCIAL; [Anonymous], 2011, GOAL IS POW GLOB WAR; Ayers MS, 1998, PSYCHON B REV, V5, P1, DOI 10.3758/BF03209454; Bessi A., 2014, J TRUST MANAG, V1, P12, DOI [10.1186/s40493-014-0012-y, DOI 10.1186/S40493-014-0012-Y]; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Bessi A, 2014, LECT NOTES COMPUT SC, V8851, P259, DOI 10.1007/978-3-319-13734-6_18; Blaylock DL, 2011, EXTREMISM PSYCHOL UN, V8; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Brown J, 2007, J INTERACT MARK, V21, P2, DOI 10.1002/dir.20082; Bruland K., 1997, RESISTANCE NEW TECHN, P125; Byford J, 2011, CONSPIRACY THEORIES: A CRITICAL INTRODUCTION, P1, DOI 10.1057/9780230349216; Campion-Vincent V., 2005, RUMOR MILLSOCIAL I; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Facebook, 2013, US GRAPH API; Frenda SJ, 2011, CURR DIR PSYCHOL SCI, V20, P20, DOI 10.1177/0963721410396620; Furedi Frank, 2006, CULTURE FEAR REVISIT; Garrett R.K., 2013, P ACM 2013 C COMPUTE, P1047, DOI [10.1145/2441776.2441895, DOI 10.1145/2441776.2441895]; Gu B, 2014, INFORM SYST RES, V25, P604, DOI 10.1287/isre.2014.0531; Howell L, 2013, WEF REPORT 2013; Kahn R, 2004, NEW MEDIA SOC, V6, P87, DOI 10.1177/1461444804039908; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kleinberg J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0378; Koriat A, 2000, ANNU REV PSYCHOL, V51, P481, DOI 10.1146/annurev.psych.51.1.481; Kuklinski JH, 2000, J POLIT, V62, P790, DOI 10.1111/0022-3816.00033; Kumar R., 2010, P 16 ACM SIGKDD INT, P553, DOI DOI 10.1145/1835804.1835875; Locke S, 2009, SOCIOL REV, V57, P567, DOI 10.1111/j.1467-954X.2009.01862.x; Meade ML, 2002, MEM COGNITION, V30, P995, DOI 10.3758/BF03194318; Mocanu D, 2015, COMPUT HUM BEHAV, V51, P1198, DOI 10.1016/j.chb.2015.01.024; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Paolucci M., 2009, SOCIAL KNOWLEDGE E G; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Quattrociocchi W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04938; Quattrociocchi W, 2011, ADV COMPLEX SYST, V14, P567, DOI 10.1142/S0219525911003165; Quattrociocchi W, 2009, INT J KNOWL LEARN, V5, P457, DOI 10.1504/IJKL.2009.031509; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Sunstein CR, 2009, J POLIT PHILOS, V17, P202, DOI 10.1111/j.1467-9760.2008.00325.x; Suriowecki J, 2004, WISDOM CROWDS MANY A; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Welinder P., 2010, ADV NEURAL INFORM PR, V23, P2424; Zhu B, 2010, PERS INDIV DIFFER, V48, P889, DOI 10.1016/j.paid.2010.02.016	49	47	47	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134641	10.1371/journal.pone.0134641	http://dx.doi.org/10.1371/journal.pone.0134641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275043	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000359493600038
J	Jabaudon, M; Blondonnet, R; Roszyk, L; Pereira, B; Guerin, R; Perbet, S; Cayot, S; Bouvier, D; Blanchon, L; Sapin, V; Constantin, JM				Jabaudon, Matthieu; Blondonnet, Raiko; Roszyk, Laurence; Pereira, Bruno; Guerin, Renaud; Perbet, Sebastien; Cayot, Sophie; Bouvier, Damien; Blanchon, Loic; Sapin, Vincent; Constantin, Jean-Michel			Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study	PLOS ONE			English	Article							ENDOGENOUS SECRETORY RECEPTOR; ALVEOLAR FLUID CLEARANCE; ACUTE LUNG INJURY; RAGE; OUTCOMES; MARKER; RECRUITMENT; TISSUE	Background The main soluble form of the receptor for advanced glycation end-products (sRAGE) is elevated during acute respiratory distress syndrome (ARDS). However other RAGE isoforms and multiple ligands have been poorly reported in the clinical setting, and their respective contribution to RAGE activation during ARDS remains unclear. Our goal was therefore to describe main RAGE isoforms and ligands levels during ARDS. Methods 30 ARDS patients and 30 mechanically ventilated controls were prospectively included in this monocenter observational study. Arterial, superior vena cava and alveolar fluid levels of sRAGE, endogenous-secretory RAGE (esRAGE), high mobility group box-1 protein (HMGB1), S100A12 and advanced glycation end-products (AGEs) were measured in duplicate ELISA on day 0, day 3 and day 6. In patients with ARDS, baseline lung morphology was assessed with computed tomography. Results ARDS patients had higher arterial, central venous and alveolar levels of sRAGE, HMGB1 and S100A12, but lower levels of esRAGE and AGEs, than controls. Baseline arterial sRAGE, HMGB1 and S100A12 were correlated with nonfocal ARDS (AUC 0.79, 0.65 and 0.63, respectively). Baseline arterial sRAGE, esRAGE, S100A12 and AGEs were associated with severity as assessed by PaO2/FiO(2). Conclusions This is the first kinetics study of levels of RAGE main isoforms and ligands during ARDS. Elevated sRAGE, HMGB1 and S100A12, with decreased esRAGE and AGEs, were found to distinguish patients with ARDS from those without. Our findings should prompt future studies aimed at elucidating RAGE/HMGB1/S100A12 axis involvement in ARDS.	[Jabaudon, Matthieu; Blondonnet, Raiko; Guerin, Renaud; Perbet, Sebastien; Cayot, Sophie; Constantin, Jean-Michel] Estaing Hosp, CHU Clermont Ferrand, Intens Care Unit, Dept Anesthesiol Crit Care & Perioperat Med, Clermont Ferrand, France; [Jabaudon, Matthieu; Blondonnet, Raiko; Roszyk, Laurence; Perbet, Sebastien; Bouvier, Damien; Blanchon, Loic; Sapin, Vincent; Constantin, Jean-Michel] Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Roszyk, Laurence; Bouvier, Damien; Sapin, Vincent] Estaing Univ Hosp, CHU Clermont Ferrand, Dept Med Biochem & Mol Biol, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Dept Clin Res & Innovat DRCI, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand	Jabaudon, M (corresponding author), Estaing Hosp, CHU Clermont Ferrand, Intens Care Unit, Dept Anesthesiol Crit Care & Perioperat Med, Clermont Ferrand, France.	mjabaudon@chu-clermontferrand.fr	Jabaudon, Matthieu/GLQ-8455-2022	Jabaudon, Matthieu/0000-0002-8121-1680; Bouvier, Damien/0000-0002-2707-4320; BLANCHON, LOIC/0000-0001-8842-0162; Pereira, Bruno/0000-0003-3778-7161	Clermont-Ferrand University Hospital ("Appel d'Offre Interne", CHU Clermont-Ferrand); Auvergne Regional Council ("Programme Nouveau Chercheur de la Region Auvergne"); Direction Generale de l'Offre de Soins ("Programme de Recherche Translationnelle en Sante") [ANR-13-PRTS-0010]; Agence Nationale de la Recherche	Clermont-Ferrand University Hospital ("Appel d'Offre Interne", CHU Clermont-Ferrand); Auvergne Regional Council ("Programme Nouveau Chercheur de la Region Auvergne")(Region Auvergne-Rhone-Alpes); Direction Generale de l'Offre de Soins ("Programme de Recherche Translationnelle en Sante"); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from Clermont-Ferrand University Hospital ("Appel d'Offre Interne" 2010, CHU Clermont-Ferrand) (Dr Jabaudon), the Auvergne Regional Council ("Programme Nouveau Chercheur de la Region Auvergne" 2013) (Pr Constantin), the Agence Nationale de la Recherche and the Direction Generale de l'Offre de Soins ("Programme de Recherche Translationnelle en Sante" ANR-13-PRTS-0010) (Dr Jabaudon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Cohen J., 1988, STATISTICAL POWER AN, pxxi; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Constantin JM, 2007, ANESTHESIOLOGY, V106, P944, DOI 10.1097/01.anes.0000265153.17062.64; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Geroldi D, 2006, CURR MED CHEM, V13, P1971, DOI 10.2174/092986706777585013; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Jabaudon M, 2011, CRIT CARE MED, V39, P480, DOI 10.1097/CCM.0b013e318206b3ca; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Malbouisson LM, 2001, AM J RESP CRIT CARE, V163, P1444, DOI 10.1164/ajrccm.163.6.2005001; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; Nakamura T, 2011, CLIN BIOCHEM, V44, P601, DOI 10.1016/j.clinbiochem.2010.12.014; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Pietzsch J, 2009, AMINO ACIDS, V36, P381, DOI 10.1007/s00726-008-0097-7; Puybasset L, 2000, INTENS CARE MED, V26, P857, DOI 10.1007/s001340051274; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Santilli F, 2009, CURR MED CHEM, V16, P940, DOI 10.2174/092986709787581888; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Yan Shi Fang, 2007, Curr Diab Rep, V7, P146, DOI 10.1007/s11892-007-0024-4	34	37	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135857	10.1371/journal.pone.0135857	http://dx.doi.org/10.1371/journal.pone.0135857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274928	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600127
J	Kirov, JV; Adkisson, M; Nava, AJ; Cipollone, A; Willis, B; Engelhard, EK; Lloyd, KCK; de Jong, P; West, DB				Kirov, Julia V.; Adkisson, Michael; Nava, A. J.; Cipollone, Andreana; Willis, Brandon; Engelhard, Eric K.; Lloyd, K. C. Kent; de Jong, Pieter; West, David B.			Reporter Gene Silencing in Targeted Mouse Mutants Is Associated with Promoter CpG Island Methylation	PLOS ONE			English	Article							BODY-SPECIFIC METHYLATION; DNA METHYLATION; TRANSGENE EXPRESSION; X-CHROMOSOME; IN-VIVO; GENOME; TRANSCRIPTION; RESOURCE; INACTIVATION; LANDSCAPE	Targeted mutations in mouse disrupt local chromatin structure and may lead to unanticipated local effects. We evaluated targeted gene promoter silencing in a group of six mutants carrying the tm1a Knockout Mouse Project allele containing both a LacZ reporter gene driven by the native promoter and a neo selection cassette. Messenger RNA levels of the reporter gene and targeted gene were assessed by qRT-PCR, and methylation of the promoter CpG islands and LacZ coding sequence were evaluated by sequencing of bisulfite-treated DNA. Mutants were stratified by LacZ staining into presumed Silenced and Expressed reporter genes. Silenced mutants had reduced relative quantities LacZ mRNA and greater CpG Island methylation compared with the Expressed mutant group. Within the silenced group, LacZ coding sequence methylation was significantly and positively correlated with CpG Island methylation, while promoter CpG methylation was only weakly correlated with LacZ gene mRNA. The results support the conclusion that there is promoter silencing in a subset of mutants carrying the tm1a allele. The features of targeted genes which promote local silencing when targeted remain unknown.	[Kirov, Julia V.; Adkisson, Michael; Nava, A. J.; de Jong, Pieter; West, David B.] CHORI, Oakland, CA 94609 USA; [Cipollone, Andreana; Willis, Brandon; Engelhard, Eric K.; Lloyd, K. C. Kent] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA	Children's Hospital Oakland Research Institute; University of California System; University of California Davis	West, DB (corresponding author), CHORI, Oakland, CA 94609 USA.	dwest@chori.org			National Health Institutes [U42OD011175, U54HG006364, U01HG004080]; Children's Hospital Oakland Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006364, U01HG004080] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011175] Funding Source: NIH RePORTER	National Health Institutes(National Health Research Institutes - Taiwan); Children's Hospital Oakland Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by U42OD011175 National Health Institutes DBW KCKL; U54HG006364 National Health Institutes DBW KCKL; U01HG004080 National Health Institutes PdJ; grant from the Children's Hospital Oakland Research Foundation DBW.	Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birling Marie-Christine, 2009, Methods Mol Biol, V561, P245, DOI 10.1007/978-1-60327-019-9_16; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Ciavatta D, 2006, P NATL ACAD SCI USA, V103, P9958, DOI 10.1073/pnas.0603754103; Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Furst RW, 2012, J STEROID BIOCHEM, V130, P96, DOI 10.1016/j.jsbmb.2012.01.009; Galy B, 2004, RNA, V10, P1019, DOI 10.1261/rna.7220704; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gates H, 2011, METHODS, V53, P394, DOI 10.1016/j.ymeth.2010.12.017; Hadjantonakis Anna-Katerina, 2008, V461, P111, DOI 10.1007/978-1-60327-483-8_8; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; MacDonald WA, 2014, MOL REPROD DEV, V81, P126, DOI 10.1002/mrd.22220; Maguire S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091807; Masser DR, 2013, EPIGENET CHROMATIN, V6, P33, DOI DOI 10.1186/1756-8935-6-33; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Rosser JM, 2010, GENE, V456, P15, DOI 10.1016/j.gene.2010.02.005; Ryder E, 2013, MAMM GENOME, V24, P286, DOI 10.1007/s00335-013-9467-x; Scacheri PC, 2001, GENESIS, V30, P259, DOI 10.1002/gene.1072; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tajima S, 2006, J BIOCHEM, V139, P705, DOI 10.1093/jb/mvj075; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Voss AK, 1998, DEV DYNAM, V212, P258; West DB, 2015, GENOME IN PRESS 0115; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	47	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134155	10.1371/journal.pone.0134155	http://dx.doi.org/10.1371/journal.pone.0134155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275310	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600021
J	Scruggs, AK; Cioffi, EA; Cioffi, DL; King, JAC; Bauer, NN				Scruggs, April K.; Cioffi, Eugene A.; Cioffi, Donna L.; King, Judy A. C.; Bauer, Natalie N.			Lectin-Based Characterization of Vascular Cell Microparticle Glycocalyx	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; MEMBRANE MICROPARTICLES; CIRCULATING MICROPARTICLES; INTRAPULMONARY ARTERIES; PLATELET MICROPARTICLES; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; HUMAN PLASMA; IN-VITRO	Microparticles (MPs) are released constitutively and from activated cells. MPs play significant roles in vascular homeostasis, injury, and as biomarkers. The unique glycocalyx on the membrane of cells has frequently been exploited to identify specific cell types, however the glycocalyx of the MPs has yet to be defined. Thus, we sought to determine whether MPs, released both constitutively and during injury, from vascular cells have a glycocalyx matching those of the parental cell type to provide information on MP origin. For these studies we used rat pulmonary microvascular and artery endothelium, pulmonary smooth muscle, and aortic endothelial cells. MPs were collected from healthy or cigarette smoke injured cells and analyzed with a panel of lectins for specific glycocalyx linkages. Intriguingly, we determined that the MPs released either constitutively or stimulated by CSE injury did not express the same glycocalyx of the parent cells. Further, the glycocalyx was not unique to any of the specific cell types studied. These data suggest that MPs from both normal and healthy vascular cells do not share the parental cell glycocalyx makeup.	[Scruggs, April K.; Cioffi, Eugene A.; Bauer, Natalie N.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Cioffi, Donna L.] Univ S Alabama, Coll Med, Dept Biochem, Mobile, AL 36688 USA; [King, Judy A. C.] W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA; [Scruggs, April K.; Cioffi, Eugene A.; Cioffi, Donna L.; Bauer, Natalie N.] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL USA	University of South Alabama; University of South Alabama; West Virginia University; University of South Alabama	Bauer, NN (corresponding author), Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA.	nbauer@southalabama.edu		Scruggs, April/0000-0003-3943-4212	American Heart Association [SDG7390037]; National Institutes of Health, National Heart Lung and Blood Institute [HL076125]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076125] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association SDG7390037 to NNB (http://www.heart.org); and National Institutes of Health, National Heart Lung and Blood Institute HL076125 to AKS.	Amabile N, 2008, AM J RESP CRIT CARE, V177, P1268, DOI 10.1164/rccm.200710-1458OC; Amabile N, 2009, J HEART LUNG TRANSPL, V28, P1081, DOI 10.1016/j.healun.2009.06.005; Bakouboula B, 2008, AM J RESP CRIT CARE, V177, P536, DOI 10.1164/rccm.200706-840OC; Baron M, 2012, J CELL MOL MED, V16, P1365, DOI 10.1111/j.1582-4934.2011.01486.x; Bastarache JA, 2009, AM J PHYSIOL-LUNG C, V297, pL1035, DOI 10.1152/ajplung.00214.2009; Batista BS, 2011, J PROTEOME RES, V10, P4624, DOI 10.1021/pr200434y; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Bruno S., 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033115; Camaioni C, 2013, INTERN EMERG MED, V8, P291, DOI 10.1007/s11739-011-0705-5; Cioffi DL, 2012, AM J PHYSIOL-LUNG C, V302, pL1067, DOI 10.1152/ajplung.00190.2011; Collins SR, 2013, ANESTH ANALG, V117, P664, DOI 10.1213/ANE.0b013e3182975b85; Dodla MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023266; FOETS BJJ, 1991, GRAEF ARCH CLIN EXP, V229, P498, DOI 10.1007/BF00166319; Garcia S, 2005, J HEART LUNG TRANSPL, V24, P2184, DOI 10.1016/j.healun.2005.07.006; Gebb S, 2004, MICROVASC RES, V68, P1, DOI 10.1016/j.mvr.2004.02.002; Giannopoulos G, 2014, INT J CARDIOL, V176, P145, DOI 10.1016/j.ijcard.2014.07.022; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Hagedorn M, 2004, DEV DYNAM, V230, P23, DOI 10.1002/dvdy.20020; Hallberg EC, 1998, XENOTRANSPLANTATION, V5, P246, DOI 10.1111/j.1399-3089.1998.tb00035.x; Hargett LA, 2013, PULM CIRC, V3, P329, DOI 10.4103/2045-8932.114760; HJELLE JT, 1991, PERITON DIALYSIS INT, V11, P307; HOLDEN WE, 1989, J APPL PHYSIOL, V66, P443, DOI 10.1152/jappl.1989.66.1.443; HOLDEN WE, 1990, TOXICOL APPL PHARM, V104, P191, DOI 10.1016/0041-008X(90)90294-5; Horstman Lawrence L., 2004, Keio Journal of Medicine, V53, P210, DOI 10.2302/kjm.53.210; Janczyk P, 2010, J ELECTRON MICROSC, V59, P291, DOI 10.1093/jmicro/dfq007; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Kurz H, 2008, HISTOCHEM CELL BIOL, V130, P1027, DOI 10.1007/s00418-008-0478-8; Loesch A, 1997, J ANAT, V190, P93, DOI 10.1046/j.1469-7580.1997.19010093.x; Low B, 2007, J PHARMACOL SCI, V104, P225, DOI 10.1254/jphs.FP0070385; Lu Q, 2011, AM J PHYSIOL-LUNG C, V301, pL847, DOI 10.1152/ajplung.00178.2011; Markiewicz Margaret, 2013, J Aging Res, V2013, P734509, DOI 10.1155/2013/734509; Midura EF, 2015, THE JOURNAL OF SURGI; Natalie JR Bauer, 2009, MICROSCOPY TODAY, V17, P42; Nomura S, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-014-0066-z; Novelli F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095013; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pirro M, 2006, ARTERIOSCL THROM VAS, V26, P2530, DOI 10.1161/01.ATV.0000243941.72375.15; Press JZ, 2012, INT J GYNECOL CANCER, V22, P546, DOI 10.1097/IGC.0b013e318241d9b9; SCHNITZER JE, 1990, EUR J CELL BIOL, V52, P241; SCHUMACHER U, 1993, CELL BIOCHEM FUNCT, V11, P225, DOI 10.1002/cbf.290110311; Shantsila E, 2010, J THROMB HAEMOST, V8, P2358, DOI 10.1111/j.1538-7836.2010.04007.x; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Sossdorf M, 2011, MED SCI SPORT EXER, V43, P1169, DOI 10.1249/MSS.0b013e3182068645; Souza ACP, 2015, KIDNEY INT, V87, P1100, DOI 10.1038/ki.2015.26; Stepien E, 2012, ARCH MED RES, V43, P31, DOI 10.1016/j.arcmed.2012.01.006; Tamagawa-Mineoka R, 2010, J AM ACAD DERMATOL, V62, P621, DOI 10.1016/j.jaad.2009.06.053; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Wright JL, 2008, J APPL PHYSIOL, V104, P1462, DOI 10.1152/japplphysiol.00520.2007; Wu ZH, 2013, EUR REV MED PHARMACO, V17, P2420; Xiao HY, 2002, CRYOBIOLOGY, V44, P179, DOI 10.1016/S0011-2240(02)00024-X; Yeager ME, 2012, AM J RESP CELL MOL, V46, P14, DOI 10.1165/rcmb.2010-0506OC	52	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135533	10.1371/journal.pone.0135533	http://dx.doi.org/10.1371/journal.pone.0135533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274589	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600075
J	Liu, XC; Lian, W; Zhang, LJ; Feng, XC; Gao, Y; Li, SX; Liu, C; Cheng, Y; Yang, L; Wang, XJ; Chen, L; Wang, RQ; Chai, J; Chen, WS				Liu, Xiao-cong; Lian, Wei; Zhang, Liang-jun; Feng, Xin-chan; Gao, Yu; Li, Shao-xue; Liu, Chang; Cheng, Ying; Yang, Long; Wang, Xiao-Juan; Chen, Lei; Wang, Rong-quan; Chai, Jin; Chen, Wen-sheng			Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; BILE-ACID TRANSPORTERS; NECROSIS-FACTOR-ALPHA; OBSTRUCTIVE CHOLESTASIS; LIVER-INJURY; RAT-LIVER; MRP2; MECHANISMS; PATHWAY; GENES	Multidrug resistance-associated protein 2 (MRP2) plays an important role in bile acid metabolism by transporting toxic organic anion conjugates, including conjugated bilirubin, glutathione, sulfate, and multifarious drugs. MRP2 expression is reduced in cholestatic patients and rodents. However, the molecular mechanism of MRP2 down-regulation remains elusive. In this report, we treated human hepatoma HepG2 cells with interleukin-18 (IL-18) and measured the expression of MRP2, nuclear factor kappa B (NF-kappa B), farnesoid X receptor (FXR), and the transcription factor Yin Yang 1 (YY1) by quantitative real-time quantitative polymerase chain reaction (PCR) and western blotting. We found that expression of MRP2 was repressed by IL-18 at both the mRNA and protein levels in a dose-and time-dependent manner. Furthermore, the activated NF-kappa B pathway increased YY1 and reduced FXR. These changes were all attenuated in HepG2 cells with knockdown of the NF-kappa B subunit, p65. The reduced expression of FXR and MRP2 in HepG2 cells that had been caused by IL-18 treatment was also attenuated by YY1 knockdown. We further observed significantly elevated IL-18, NF-kappa B, and YY1 expression and decreased FXR and MRP2 expression in bile duct-ligated Sprague Dawley rat livers. Chromatin immunoprecipitation assays also showed that FXR bound to the promoter region in MRP2 was less abundant in liver extracts from bile duct-ligated rats than sham-operated rats. Our findings indicate that IL-18 down-regulates MRP2 expression through the nuclear receptor FXR in HepG2 cells, and may be mediated by NF-kappa B and YY1.	[Liu, Xiao-cong; Lian, Wei; Zhang, Liang-jun; Feng, Xin-chan; Gao, Yu; Li, Shao-xue; Liu, Chang; Cheng, Ying; Yang, Long; Chen, Lei; Wang, Rong-quan; Chai, Jin; Chen, Wen-sheng] Third Mil Med Univ, Dept Gastroenterol, Southwest Hosp, Chongqing, Peoples R China; [Liu, Xiao-cong] Chengdu Mil Gen Hosp, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China; [Wang, Xiao-Juan] Chengdu Mil Gen Hosp, Dept Burn & Plast Surg, Chengdu, Sichuan, Peoples R China	Army Medical University	Chen, WS (corresponding author), Third Mil Med Univ, Dept Gastroenterol, Southwest Hosp, Chongqing, Peoples R China.	wenshengchen@hotmail.com	Zhang, Liang/GWM-6088-2022	Wang, Rongquan/0000-0001-5307-0086; Chai, Jin/0000-0002-8543-4566	National Natural Science Foundation of China [81170430, 81370560, 81470850, 81470880, 81101427]; Chongqing Natural Science Foundation of China [CSTC 2012jjB0079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation of China	This work was supported by National Natural Science Foundation of China (81170430 to W.S. Chen, 81370560 to W.S. Chen, 81470850 to L Chen, 81470880 to J Chai and 81101427 to X.J. Wang) and Chongqing Natural Science Foundation of China (CSTC 2012jjB0079 to W.S. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai J, 2012, HEPATOLOGY, V55, P1485, DOI 10.1002/hep.24801; Chen HL, 2008, PEDIATR RES, V63, P667, DOI 10.1203/PDR.0b013e318170a6b5; Cherrington NJ, 2013, AM J PHYSIOL-GASTR L, V304, pG48, DOI 10.1152/ajpgi.00317.2012; Dawiskiba Janusz, 2002, HPB (Oxford), V4, P11, DOI 10.1080/136518202753598681; Denson LA, 2000, J BIOL CHEM, V275, P8835, DOI 10.1074/jbc.275.12.8835; El-Sayed IH, 2003, CLIN CHIM ACTA, V336, P123, DOI 10.1016/S0009-8981(03)00336-X; Geier A, 2003, HEPATOLOGY, V38, P345, DOI 10.1053/jhep.2003.50317; Grube M, 2005, DRUG METAB DISPOS, V33, P31, DOI 10.1124/dmd.104.001560; Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Jin Ping, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P329; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Keppler D, 1996, Prog Liver Dis, V14, P55; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Kullak-Ublick GA, 2002, HEPATOL RES, V23, P78, DOI 10.1016/S1386-6346(01)00159-0; Lickteig AJ, 2007, DRUG METAB DISPOS, V35, P402, DOI 10.1124/dmd.106.012138; Lu Y, 2014, GUT, V63, P170, DOI 10.1136/gutjnl-2012-303150; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Martinez-Paniagua MA, 2012, MOL CANCER THER, V11, P572, DOI 10.1158/1535-7163.MCT-11-0635; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Shoda J, 2001, AM J GASTROENTEROL, V96, P3368; Siewert E, 2004, BIOCHEM BIOPH RES CO, V322, P232, DOI 10.1016/j.bbrc.2004.07.102; Sun PY, 2014, PHARMACOL REP, V66, P311, DOI 10.1016/j.pharep.2014.02.013; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Trauner M, 1997, GASTROENTEROLOGY, V113, P255, DOI 10.1016/S0016-5085(97)70103-3; Trauner M, 2005, J CLIN GASTROENTEROL, V39, pS111, DOI 10.1097/01.mcg.0000155551.37266.26; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wen X, 2014, AM J PATHOL, V184, P1299, DOI 10.1016/j.ajpath.2014.01.025; Yamada T, 2005, LANGENBECK ARCH SURG, V390, P421, DOI 10.1007/s00423-005-0564-5; Yamamoto N, 2008, INT J MOL MED, V22, P43; Yamano T, 2000, CLIN EXP IMMUNOL, V122, P227, DOI 10.1046/j.1365-2249.2000.01356.x; Zhang JH, 2014, GENE, V537, P230, DOI 10.1016/j.gene.2013.12.062; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646	38	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136215	10.1371/journal.pone.0136215	http://dx.doi.org/10.1371/journal.pone.0136215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292095	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900066
J	Ma, LB; Liu, XY; Wang, FM; He, XY; Chen, S; Li, WD				Ma, LiBing; Liu, Xiyu; Wang, FengMei; He, XiaoYing; Chen, Shan; Li, Wenda			Different Donor Cell Culture Methods Can Influence the Developmental Ability of Cloned Sheep Embryos	PLOS ONE			English	Article							SERUM STARVATION; NUCLEAR TRANSFER; CONTACT INHIBITION; CYCLE SYNCHRONIZATION; IN-VITRO; DEPENDENT INHIBITION; FIBROBLAST CELLS; BOVINE EMBRYOS; GRANULOSA; OOCYTES	It was proposed that arresting nuclear donor cells in G0/G1 phase facilitates the development of embryos that are derived from somatic cell nuclear transfer (SCNT). Full confluency or serum starvation is commonly used to arrest in vitro cultured somatic cells in G0/G1 phase. However, it is controversial as to whether these two methods have the same efficiency in arresting somatic cells in G0/G1 phase. Moreover, it is unclear whether the cloned embryos have comparable developmental ability after somatic cells are subjected to one of these methods and then used as nuclear donors in SCNT. In the present study, in vitro cultured sheep skin fibroblasts were divided into four groups: (1) cultured to 70-80% confluency (control group), (2) cultured to full confluency, (3) starved in low serum medium for 4 d, or (4) cultured to full confluency and then further starved for 4 d. Flow cytometry was used to assay the percentage of fibroblasts in G0/G1 phase, and cell counting was used to assay the viability of the fibroblasts. Then, real-time reverse transcription PCR was used to determine the levels of expression of several cell cycle-related genes. Subsequently, the four groups of fibroblasts were separately used as nuclear donors in SCNT, and the developmental ability and the quality of the cloned embryos were compared. The results showed that the percentage of fibroblasts in G0/G1 phase, the viability of fibroblasts, and the expression levels of cell cycle-related genes was different among the four groups of fibroblasts. Moreover, the quality of the cloned embryos was comparable after these four groups of fibroblasts were separately used as nuclear donors in SCNT. However, cloned embryos derived from fibroblasts that were cultured to full confluency combined with serum starvation had the highest developmental ability. The results of the present study indicate that there are synergistic effects of full confluency and serum starvation on arresting fibroblasts in G0/G1 phase, and the short-term treatment of nuclear donor cells with these two methods could improve the efficiency of SCNT.	[Ma, LiBing; Liu, Xiyu; He, XiaoYing; Chen, Shan; Li, Wenda] Inner Mongolia Univ Sci & Technol, Sch Math Phys & Biol Engn, Baotou, Inner Mongolia, Peoples R China; [Wang, FengMei] Baotou Light Ind Vocat Tech Coll, Baotou, Inner Mongolia, Peoples R China	Inner Mongolia University of Science & Technology	Ma, LB (corresponding author), Inner Mongolia Univ Sci & Technol, Sch Math Phys & Biol Engn, Baotou, Inner Mongolia, Peoples R China.	mlb-xn2004@163.com			National Natural Science Foundation of China [31160245]; Natural Science Foundation of Inner Mongolia Autonomous Region of China [2012MS0503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia Autonomous Region of China	This work was funded by National Natural Science Foundation of China, grant number 31160245; National Natural Science Foundation of China (http://www.nsfc.gov.cn/), to Ma LiBing; and Natural Science Foundation of Inner Mongolia Autonomous Region of China, grant number 2012MS0503 (http://www.nmkjt.gov.cn/), to He XiaoYing.	Arat S, 2001, MOL REPROD DEV, V60, P20, DOI 10.1002/mrd.1057; Bhojwani S, 2007, THERIOGENOLOGY, V67, P341, DOI 10.1016/j.theriogenology.2006.08.006; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Chiu A, 2007, BLOOD, V109, P729, DOI 10.1182/blood-2006-04-015958; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Cooper S, 2003, FASEB J, V17, P333, DOI 10.1096/fj.02-0352rev; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Dalman A, 2010, REPROD DOMEST ANIM, V45, pE46, DOI 10.1111/j.1439-0531.2009.01520.x; de Barros FRO, 2010, REPROD DOMEST ANIM, V45, P38, DOI 10.1111/j.1439-0531.2008.01201.x; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Golpour M, 2014, INT J MOL CELL MED, V3, P74; Gos M, 2005, CELL PROLIFERAT, V38, P107, DOI 10.1111/j.1365-2184.2005.00334.x; GUSTINCICH S, 1993, CELL GROWTH DIFFER, V4, P753; Hayes O, 2005, ANIM REPROD SCI, V87, P181, DOI 10.1016/j.anireprosci.2004.11.011; Hua S, 2007, CLONING STEM CELLS, V9, P237, DOI 10.1089/clo.2006.0020; Iuso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051317; Khammanit R, 2008, THERIOGENOLOGY, V70, P27, DOI 10.1016/j.theriogenology.2008.02.015; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Kim MK, 2007, CLONING STEM CELLS, V9, P130, DOI 10.1089/clo.2006.0034; LEVINE EM, 1965, P NATL ACAD SCI USA, V53, P350, DOI 10.1073/pnas.53.2.350; Ma LB, 2014, INDIAN J ANIM RES, V48, P221, DOI 10.5958/j.0976-0555.48.3.047; Ma LB, 2008, MOL REPROD DEV, V75, P33, DOI 10.1002/mrd.20736; Ma LB, 2014, ZYGOTE, V22, P540, DOI 10.1017/S0967199413000129; Ma LB, 2014, ANIM CELLS SYST, V18, P161, DOI 10.1080/19768354.2014.927397; Moulavi F, 2013, REPRODUCTION, V145, P345, DOI 10.1530/REP-12-0318; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Sanchez E, 2012, BRIT J HAEMATOL, V158, P727, DOI 10.1111/j.1365-2141.2012.09241.x; Shin JS, 2008, INT J ONCOL, V32, P435; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Wani NA, 2010, BIOL REPROD, V82, P373, DOI 10.1095/biolreprod.109.081083; Wells DN, 2003, THERIOGENOLOGY, V59, P45, DOI 10.1016/S0093-691X(02)01273-6; Wen BQ, 2014, THERIOGENOLOGY, V81, P332, DOI 10.1016/j.theriogenology.2013.09.032; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wittayarat M, 2013, REPROD DOMEST ANIM, V48, P305, DOI 10.1111/j.1439-0531.2012.02149.x; Zimmermann O, 2006, J VASC RES, V43, P157, DOI 10.1159/000090945	36	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135344	10.1371/journal.pone.0135344	http://dx.doi.org/10.1371/journal.pone.0135344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291536	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900017
J	Damman, CJ; Brittnacher, MJ; Westerhoff, M; Hayden, HS; Radey, M; Hager, KR; Marquis, SR; Miller, SI; Zisman, TL				Damman, Christopher J.; Brittnacher, Mitchell J.; Westerhoff, Maria; Hayden, Hillary S.; Radey, Matthew; Hager, Kyle R.; Marquis, Sara R.; Miller, Samuel I.; Zisman, Timothy L.			Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CLINICAL-RESPONSE; CROHNS-DISEASE; SP NOV.; TRANSPLANTATION; REMISSION; THERAPY	Objective Fecal microbiota transplantation (FMT) is an investigational treatment for diseases thought to involve alterations in the intestinal microbiota including ulcerative colitis (UC). Case reports have described therapeutic benefit of FMT in patients with UC, possibly due to changes in the microbiota. We measured the degree to which the transplanted microbiota engraft following FMT in patients with UC using a donor similarity index (DSI). Methods Seven patients with mild to moderate UC (UC disease activity index scores 3-10) received a single colonoscopic administration of FMT. Metagenomic sequence data from stool were analyzed using an alignment-free comparison tool, to measure the DSI, and a phylogenetic analysis tool, to characterize taxonomic changes. Clinical, endoscopic, histologic, and fecal calprotectin outcome measures were also collected. Results One of 5 patients from whom sequencing data were available achieved the primary end-point of 50% donor similarity at week 4; an additional 2 patients achieved 40% donor similarity. One patient with 40% donor similarity achieved clinical and histologic remission 1 month after FMT. However, these were lost by 2-3 months, and loss correlated with a decrease in DSI. The remaining patients did not demonstrate clinical response or remission. Histology scores improved in all but 1 patient. No patients remained in remission at 3 months after FMT. Conclusions Following a single colonoscopic fecal transplant, a DSI of 40-50% is achieved in about two-thirds of recipients. This level of engraftment correlated with a temporary clinical improvement in only 1/5 patients. Larger sample sizes could further validate this method for measuring engraftment, and changes in transplant frequency or method might improve microbiota engraftment and efficacy.	[Damman, Christopher J.; Marquis, Sara R.; Zisman, Timothy L.] Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA 98195 USA; [Brittnacher, Mitchell J.; Hayden, Hillary S.; Radey, Matthew; Hager, Kyle R.; Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Westerhoff, Maria] Univ Washington, Dept Anat Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Damman, CJ (corresponding author), Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA 98195 USA.	cjdamman@uw.edu			Broad Foundation [IBD-0038]; Kenneth Rainin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	Broad Foundation; Kenneth Rainin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was financially supported by the Broad Foundation (IBD-0038, http://www.ccfa.org/science-and-professionals/broad/) and the Kenneth Rainin Foundation (http://krfoundation.org/health/innovator-awards/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert C, 2008, CURR ISSUES MOL BIOL, V10, P17; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; BENNET JD, 1989, LANCET, V1, P164; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; BORODY TJ, 1989, MED J AUSTRALIA, V150, P604, DOI 10.5694/j.1326-5377.1989.tb136704.x; Borody TJ, 2003, J CLIN GASTROENTEROL, V37, P42, DOI 10.1097/00004836-200307000-00012; Cima RR, 2010, DIGEST DIS, V28, P501, DOI 10.1159/000320409; Damman CJ, 2012, AM J GASTROENTEROL, V107, P1452, DOI 10.1038/ajg.2012.93; Feces H, 1986, BACTEROIDES CACCAE, P499; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Khan KJ, 2011, AM J GASTROENTEROL, V106, P661, DOI 10.1038/ajg.2011.72; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Kunde S, 2013, J PEDIATR GASTR NUTR, V56, P597, DOI 10.1097/MPG.0b013e318292fa0d; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Maillet N, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S10; Meijer BJ, 2011, J CLIN GASTROENTEROL, V45, pS139, DOI 10.1097/MCG.0b013e31822103f7; Michail S, 2012, INFLAMM BOWEL DIS, V18, P1799, DOI 10.1002/ibd.22860; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Nagalingam NA, 2012, INFLAMM BOWEL DIS, V18, P968, DOI 10.1002/ibd.21866; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Rotmistrovsky KAR, 2011, BMTAGGER BEST UNPUB; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Song YL, 2006, INT J SYST EVOL MICR, V56, P1985, DOI 10.1099/ijs.0.64318-0; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Talley NJ, 2011, AM J GASTROENTEROL, V106, pS2, DOI 10.1038/ajg.2011.58; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Woo PCY, 2010, J CLIN MICROBIOL, V48, P319, DOI 10.1128/JCM.01459-09; Wurdemann D, 2009, INT J SYST EVOL MICR, V59, P1405, DOI 10.1099/ijs.0.005900-0	34	46	49	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133925	10.1371/journal.pone.0133925	http://dx.doi.org/10.1371/journal.pone.0133925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288277	gold, Green Submitted, Green Published			2022-12-27	WOS:000360018600013
J	Gu, LJ; Han, Y; Li, YJ; Zhu, T; Song, XJ; Huang, Y; Yang, FF; Guan, S; Xie, J; Gohda, J; Hosoya, N; Kawana-Tachikawa, A; Liu, WJ; Gao, GF; Iwamoto, A; Li, TS; Ishida, T				Gu, Lijun; Han, Yang; Li, Yijia; Zhu, Ting; Song, Xiaojing; Huang, Ying; Yang, Feifei; Guan, Shuo; Xie, Jing; Gohda, Jin; Hosoya, Noriaki; Kawana-Tachikawa, Ai; Liu, Wenjun; Gao, George Fu; Iwamoto, Aikichi; Li, Taisheng; Ishida, Takaomi			Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; TENOFOVIR; EPIDEMIOLOGY; INDIVIDUALS; MUTATIONS; GENOTYPES; EFFICACY; HAART	In China, HIV-1-infected patients typically receive antiretroviral therapy (ART) that includes lamivudine (3TC) as a reverse-transcriptase inhibitor (RTI) (ART-3TC). Previous studies from certain developed countries have shown that, in ART-3TC, 3TC-resistant HBV progressively emerges at an annual rate of 15-20% in patients coinfected with HIV-1 and HBV. This scenario in China warrants investigation because >10% of all HIV-infected patients in China are HBV carriers. We measured the occurrence of 3TC-resistant HBV during ART3TC for HIV-HBV coinfection and also tested the effect of tenofovir disoproxil fumarate (TDF) used as an additional RTI (ART-3TC/TDF) in a cohort study in China. We obtained 200 plasma samples collected from 50 Chinese patients coinfected with HIV-1 and HBV (positive for hepatitis B surface antigen) and examined them for the prevalence of 3TC-resistant HBV by directly sequencing PCR products that covered the HBV reverse-transcriptase gene. We divided the patients into ART-3TC and ART-3TC/TDF groups and compared the efficacy of treatment and incidence of drug-resistance mutation between the groups. HIV RNA and HBV DNA loads drastically decreased in both ART-3TC and ART-3TC/TDF groups. In the ART-3TC group, HBV breakthrough or insufficient suppression of HBV DNA loads was observed in 20% (10/50) of the patients after 96-week treatment, and 8 of these patients harbored 3TC-resistant mutants. By contrast, neither HBV breakthrough nor treatment failure was recorded in the ART-3TC/TDF group. All of the 3TC-resistant HBV mutants emerged from the cases in which HBV DNA loads were high at baseline. Our results clearly demonstrated that ART-3TC is associated with the emergence of 3TC-resistant HBV in patients coinfected with HIV-1 and HBV and that ART-3TC/TDF reduces HBV DNA loads to an undetectable level. These findings support the use of TDF-based treatment regimens for patients coinfected with HIV-1 and HBV.	[Gu, Lijun; Huang, Ying; Yang, Feifei; Guan, Shuo; Gohda, Jin; Liu, Wenjun; Ishida, Takaomi] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China; [Gu, Lijun; Gohda, Jin; Hosoya, Noriaki; Iwamoto, Aikichi; Ishida, Takaomi] Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo, Japan; [Han, Yang; Li, Yijia; Zhu, Ting; Song, Xiaojing; Xie, Jing; Li, Taisheng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China; [Kawana-Tachikawa, Ai; Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Infect Dis, Tokyo, Japan; [Liu, Wenjun; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Tokyo; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Tokyo; Chinese Academy of Sciences; Institute of Microbiology, CAS	Li, TS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China.	litsh@263.net; imoakat@ims.u-tokyo.ac.jp	han, yang/GRS-2388-2022; Li, Yijia/AAD-6744-2022; Gao, George Fu/ABD-5229-2021	Li, Yijia/0000-0001-5300-0571; Li, Yijia/0000-0003-0513-1950	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [10005010]; Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine-For personalized medicine and the control of worldwide infectious diseases) of MEXT [F06]; JSPS KAKENHI [25293226, 26860300]; Ministry of Health, Labor, and Welfare of Japan [H24-AIDS-IPPAN-008, H25-AIDS-IPPAN-006]; Research on International Cooperation in Medical Science, Research on Global Health Issues, Health and Labour Science Research Grants, the Ministry of Health, Labor, and Welfare of Japan [H25-KOKUI-SITEI-001]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine-For personalized medicine and the control of worldwide infectious diseases) of MEXT; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research on International Cooperation in Medical Science, Research on Global Health Issues, Health and Labour Science Research Grants, the Ministry of Health, Labor, and Welfare of Japan	This work was supported in part by a contract research fund from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (10005010) (AI); Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine-For personalized medicine and the control of worldwide infectious diseases) of MEXT (F06) (AI); JSPS KAKENHI (25293226) (AK-T); JSPS KAKENHI (26860300) (NH); Grants for AIDS Research from the Ministry of Health, Labor, and Welfare of Japan (H24-AIDS-IPPAN-008, AK-T; and H25-AIDS-IPPAN-006, NH); and Research on International Cooperation in Medical Science, Research on Global Health Issues, Health and Labour Science Research Grants, the Ministry of Health, Labor, and Welfare of Japan (H25-KOKUI-SITEI-001) (AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, J ANTIMICROB CHEMOTH, V55, P139, DOI 10.1093/jac/dkh533; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; BENHAMOU Y, 1995, LANCET, V345, P396, DOI 10.1016/S0140-6736(95)90388-7; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; Burns GS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a024935; Chien RN, 2003, HEPATOLOGY, V38, P1267, DOI 10.1053/jhep.2003.50458; Childs K, 2013, AIDS, V27, P1443, DOI 10.1097/QAD.0b013e32836011c2; Chu CM, 2005, J HEPATOL, V43, P411, DOI 10.1016/j.jhep.2005.03.018; Croagh CMN, 2015, WORLD J HEPATOL, V7, P289, DOI 10.4254/wjh.v7.i3.289; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Hoffmann CJ, 2009, AIDS, V23, P1881, DOI 10.1097/QAD.0b013e32832e463a; Hsiang JC, 2014, ALIMENT PHARM THER, V40, P716, DOI 10.1111/apt.12874; Hua WH, 2015, BRAZ J INFECT DIS, V19, P291, DOI 10.1016/j.bjid.2015.03.012; Iser DM, 2008, J GASTROEN HEPATOL, V23, P699, DOI 10.1111/j.1440-1746.2008.05382.x; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kosi L, 2012, J VIRAL HEPATITIS, V19, P801, DOI 10.1111/j.1365-2893.2012.01601.x; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Lacombe K, 2013, HEPATOLOGY, V58, P912, DOI 10.1002/hep.26374; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Matthews GV, 2013, CLIN INFECT DIS, V56, pE87, DOI 10.1093/cid/cit002; Matthews GV, 2006, AIDS, V20, P863, DOI 10.1097/01.aids.0000218550.85081.59; Price H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068152; Sun HY, 2014, WORLD J GASTROENTERO, V20, P14598, DOI 10.3748/wjg.v20.i40.14598; Thio CL, 2013, AIDS, V27, P191, DOI 10.1097/QAD.0b013e32835a9984; Wang HL, 2012, AIDS, V26, P1755, DOI 10.1097/QAD.0b013e328355ced2; WHO Library Cataloguing-in-Publication Data, GLOB POL REP PREV CO; WHO Library Cataloguing-in-Publication Data, GLOB REP UNAIDS REP; WHO Library Cataloguing-in-Publication Data, 2006, ANT THER HIV INF INF; Zhang FJ, 2012, HDB NATL FREE ANTIRE, P41; Zhu Yuao, 2009, Antivir Chem Chemother, V19, P165	33	15	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134539	10.1371/journal.pone.0134539	http://dx.doi.org/10.1371/journal.pone.0134539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288093	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600024
J	Horng, JL; Chao, PL; Chen, PY; Shih, TH; Lin, LY				Horng, Jiun-Lin; Chao, Pei-Lin; Chen, Po-Yen; Shih, Tin-Han; Lin, Li-Yih			Aquaporin 1 Is Involved in Acid Secretion by Ionocytes of Zebrafish Embryos through Facilitating CO2 Transport	PLOS ONE			English	Article							ATPASE-RICH CELLS; KILLIFISH FUNDULUS-HETEROCLITUS; RELATIVE CO2/NH3 SELECTIVITIES; DEPENDENT SODIUM UPTAKE; AMMONIA EXCRETION; MOLECULAR-MECHANISMS; SEAWATER ACCLIMATION; CARBONIC-ANHYDRASE; XENOPUS OOCYTES; BASE REGULATION	Mammalian aquaporin 1 (AQP1) is well known to function as a membrane channel for H2O and CO2 transport. Zebrafish AQP1a.1 (the homologue of mammalian AQP1) was recently identified in ionocytes of embryos; however its role in ionocytes is still unclear. In this study, we hypothesized that zebrafish AQP1a.1 is involved in the acid secretion by ionocytes through facilitating H2O and CO2 diffusion. A real-time PCR showed that mRNA levels of AQP1a.1 in embryos were induced by exposure to 1% CO2 hypercapnia for 3 days. In situ hybridization and immunohistochemistry showed that the AQP1a. 1 transcript was highly expressed by acid-secreting ionocytes, i.e., H+-ATPase-rich (HR) cells. A scanning ion-selective electrode technique (SIET) was applied to analyze CO2-induced H+ secretion by individual ionocytes in embryos. H+ secretion by HR cells remarkably increased after a transient loading of CO2 (1% for 10 min). AQP1a.1 knockdown with morpholino oligonucleotides decreased the H+ secretion of HR cells by about half and limited the CO2 stimulated increase. In addition, exposure to an AQP inhibitor (PCMB) for 10 min also suppressed CO2-induced H+ secretion. Results from this study support our hypothesis and provide in vivo evidence of the physiological role of AQP1 in CO2 transport.	[Horng, Jiun-Lin] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Chao, Pei-Lin; Chen, Po-Yen; Shih, Tin-Han; Lin, Li-Yih] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Taipei Medical University; National Taiwan Normal University	Lin, LY (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	linly@ntnu.edu.tw			Ministry of Science and Technology of Taiwan [101-2311-B-003 -004 -MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grant (101-2311-B-003 -004 -MY3) of the Ministry of Science and Technology of Taiwan.	Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Chen LM, 2010, AM J PHYSIOL-REG I, V299, pR1163, DOI 10.1152/ajpregu.00319.2010; Choi YJ, 2013, COMP BIOCHEM PHYS A, V165, P228, DOI 10.1016/j.cbpa.2013.03.013; Cutler CP, 2007, COMP BIOCHEM PHYS A, V148, P82, DOI 10.1016/j.cbpa.2006.09.022; Dymowska AK, 2012, RESP PHYSIOL NEUROBI, V184, P282, DOI 10.1016/j.resp.2012.08.025; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Geyer RR, 2013, AM J PHYSIOL-CELL PH, V304, pC985, DOI 10.1152/ajpcell.00033.2013; Giffard-Mena I, 2007, COMP BIOCHEM PHYS A, V148, P430, DOI 10.1016/j.cbpa.2007.06.002; Gilmour KM, 2009, J EXP BIOL, V212, P1647, DOI 10.1242/jeb.029181; Hamm LL, 2008, SELDIN GIEBSCHS KIDN; Herrera M, 2007, AM J PHYSIOL-RENAL, V292, pF1443, DOI 10.1152/ajprenal.00353.2006; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Herrera M, 2011, PFLUG ARCH EUR J PHY, V462, P623, DOI 10.1007/s00424-011-1002-x; Hirano Y, 2010, BIOPHYS J, V98, P1512, DOI 10.1016/j.bpj.2009.12.4310; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Horng JL, 2007, AM J PHYSIOL-REG I, V292, pR2068, DOI 10.1152/ajpregu.00578.2006; Horng JL, 2009, AM J PHYSIOL-CELL PH, V296, pC682, DOI 10.1152/ajpcell.00576.2008; Hwang P.P., 2013, PHYSL FISHES; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Ip YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061163; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Jung D, 2012, TOXICOL SCI, V127, P101, DOI 10.1093/toxsci/kfs078; Katoh F, 2003, J EXP BIOL, V206, P793, DOI 10.1242/jeb.00159; Kim YK, 2014, COMP BIOCHEM PHYS A, V171, P1, DOI 10.1016/j.cbpa.2014.01.012; Kwong RWM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070764; Lee YC, 2011, AM J PHYSIOL-CELL PH, V300, pC295, DOI 10.1152/ajpcell.00263.2010; Lignot JH, 2002, J EXP BIOL, V205, P2653; Lin LY, 2013, AM J PHYSIOL-CELL PH, V305, pC1060, DOI 10.1152/ajpcell.00077.2013; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Lin TY, 2008, AM J PHYSIOL-CELL PH, V294, pC1250, DOI 10.1152/ajpcell.00021.2008; Liu ST, 2013, AM J PHYSIOL-REG I, V305, pR242, DOI 10.1152/ajpregu.00047.2013; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; Shih TH, 2013, AM J PHYSIOL-REG I, V304, pR1130, DOI 10.1152/ajpregu.00550.2012; Shih TH, 2012, AM J PHYSIOL-REG I, V302, pR84, DOI 10.1152/ajpregu.00318.2011; Shih TH, 2008, AM J PHYSIOL-CELL PH, V295, pC1625, DOI 10.1152/ajpcell.00255.2008; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Tse WKF, 2006, BIOCHEM BIOPH RES CO, V346, P1181, DOI 10.1016/j.bbrc.2006.06.028; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Weihrauch D, 2009, J EXP BIOL, V212, P1716, DOI 10.1242/jeb.024851; Wu SC, 2010, AM J PHYSIOL-CELL PH, V298, pC237, DOI 10.1152/ajpcell.00373.2009	43	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136440	10.1371/journal.pone.0136440	http://dx.doi.org/10.1371/journal.pone.0136440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287615	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600138
J	Ustav, M; Castaneda, FR; Reinson, T; Mannik, A; Ustav, M				Ustav, Mart, Jr.; Castaneda, Fernando Rodriguez; Reinson, Tormi; Maennik, Andres; Ustav, Mart			Human Papillomavirus Type 18 cis-Elements Crucial for Segregation and Latency	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; E2 BINDING-SITES; BOVINE PAPILLOMAVIRUS; EPISOMAL MAINTENANCE; VIRAL-GENOME; TRANSCRIPTIONAL ACTIVATION; MUTATIONAL ANALYSIS; TERMINAL DOMAIN; REPLICATION; PROTEIN	Stable maintenance replication is characteristic of the latency phase of HPV infection, during which the viral genomes are actively maintained as extrachromosomal genetic elements in infected proliferating basal keratinocytes. Active replication in the S-phase and segregation of the genome into daughter cells in mitosis are required for stable maintenance replication. Most of our knowledge about papillomavirus genome segregation has come from studies of bovine papillomavirus type 1 (BPV-1), which have demonstrated that the E2 protein cooperates with cellular trans-factors and that E2 binding sites act as cis-regulatory elements in the viral genome that are essential for the segregation process. However, the genomic organization of the regulatory region in HPVs, and the properties of the viral proteins are different from those of their BPV-1 counterparts. We have designed a segregation assay for HPV-18 and used it to demonstrate that the E2 protein performs segregation in combination with at least two E2 binding sites. The cooperative binding of the E2 protein to two E2 binding sites is a major determinant of HPV-18 genome segregation, as demonstrated by the change in spacing between adjacent binding sites #1 and #2 in the HPV-18 Upstream Regulatory Region (URR). Duplication or triplication of the natural 4 bp 5'-CGGG-3' spacer between the E2 binding sites increased the cooperative binding of the E2 molecules as well as E2-dependent segregation. Removal of any spacing between these sites eliminated cooperative binding of the E2 protein and disabled segregation of the URR and HPV-18 genome. Transfer of these configurations of the E2 binding sites into viral genomes confirmed the role of the E2 protein and binding sites #1 and #2 in the segregation process. Additional analysis demonstrated that these sites also play an important role in the transcriptional regulation of viral gene expression from different HPV-18 promoters.	[Ustav, Mart, Jr.; Castaneda, Fernando Rodriguez; Reinson, Tormi; Ustav, Mart] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Maennik, Andres; Ustav, Mart] Icosagen Cell Factory OU, Tartu, Estonia; [Ustav, Mart] Estonian Acad Sci, EE-200103 Tallinn, Estonia	University of Tartu; Estonian Academy of Sciences	Ustav, M (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	mart.ustav@ut.ee	Ustav, Mart/G-6484-2017		Estonian Research Council [SF0180175A, SF0180175B]; Center of Excellence in Chemical Biology - European Regional Development Fund [3.2.0101.08-0017]; Estonian Science Foundation [9385, 9467]; Enterprise Estonia (EAS) Project [EU42266]; IUT of the Estonian Ministry of Education and Research [20-27]	Estonian Research Council(Estonian Research Council); Center of Excellence in Chemical Biology - European Regional Development Fund; Estonian Science Foundation; Enterprise Estonia (EAS) Project; IUT of the Estonian Ministry of Education and Research	Funding: This work was supported by targeted financing to projects SF0180175A and SF0180175B by the Estonian Research Council; by the Center of Excellence in Chemical Biology (3.2.0101.08-0017) financed by the European Regional Development Fund; by research grants 9385 and 9467 from the Estonian Science Foundation; by Enterprise Estonia (EAS) Project EU42266; and by institutional research funding IUT(20-27) of the Estonian Ministry of Education and Research. The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Abroi A, 2004, J VIROL, V78, P2100, DOI 10.1128/JVI.78.4.2100-2113.2004; Ballestas ME, 2001, J VIROL, V75, P3250, DOI 10.1128/JVI.75.7.3250-3258.2001; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; CESARMAN E, 1995, BLOOD, V86, P2708, DOI 10.1182/blood.V86.7.2708.bloodjournal8672708; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Chang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110882; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; Collins CM, 2002, ADV CANCER RES, V84, P155, DOI 10.1016/S0065-230X(02)84005-2; Cotter MA, 2001, VIROLOGY, V291, P241, DOI 10.1006/viro.2001.1202; Dao LD, 2006, J VIROL, V80, P4792, DOI 10.1128/JVI.80.10.4792-4800.2006; Donaldson MM, 2007, J VIROL, V81, P4338, DOI 10.1128/JVI.02353-06; Fradet-Turcotte A, 2011, J VIROL, V85, P8996, DOI 10.1128/JVI.00542-11; Geimanen J, 2011, J VIROL, V85, P3315, DOI 10.1128/JVI.01985-10; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Grm HS, 2005, ONCOGENE, V24, P5149, DOI 10.1038/sj.onc.1208701; Helfer CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077994; Ilves I, 2006, J VIROL, V80, P3660, DOI 10.1128/JVI.80.7.3660-3665.2006; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; Johannsen E, 2013, VIROLOGY, V445, P205, DOI 10.1016/j.virol.2013.07.016; Kadaja M, 2007, EMBO J, V26, P2180, DOI 10.1038/sj.emboj.7601665; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; Klueevsek K, 2007, VIROLOGY, V360, P191, DOI 10.1016/j.virol.2006.10.018; Kurg R, 2010, VIROLOGY, V408, P159, DOI 10.1016/j.virol.2010.09.010; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; MCBRIDE AA, 1988, EMBO J, V7, P533, DOI 10.1002/j.1460-2075.1988.tb02842.x; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Oliveira JG, 2006, P NATL ACAD SCI USA, V103, P1047, DOI 10.1073/pnas.0507624103; Orav M, 2013, J VIROL, V87, P12051, DOI 10.1128/JVI.01798-13; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Piirsoo M, 1996, EMBO J, V15, P1; Poddar A, 2009, J VIROL, V83, P640, DOI 10.1128/JVI.01936-08; Reinson T, 2013, J VIROL, V87, P951, DOI 10.1128/JVI.01943-12; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003777; Sakakibara N, 2011, J VIROL, V85, P8981, DOI 10.1128/JVI.00541-11; Sanchez IE, 2008, NUCLEIC ACIDS RES, V36, P756, DOI 10.1093/nar/gkm1104; Sankovski E, 2014, J VIROL, V88, P961, DOI 10.1128/JVI.01841-13; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Schmiedeskamp MR, 2006, ANN PHARMACOTHER, V40, P1344, DOI 10.1345/aph.1G723; Sears J, 2003, J VIROL, V77, P11767, DOI 10.1128/JVI.77.21.11767-11780.2003; Sekhar V, 2010, J VIROL, V84, P543, DOI 10.1128/JVI.01908-09; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; Siddiqui MAA, 2006, DRUGS, V66, P1263, DOI 10.2165/00003495-200666090-00008; Silla T, 2010, J VIROL, V84, P11175, DOI 10.1128/JVI.01366-10; SPALHOLZ BA, 1988, J VIROL, V62, P3143, DOI 10.1128/JVI.62.9.3143-3150.1988; TAN SH, 1994, J VIROL, V68, P6411, DOI 10.1128/JVI.68.10.6411-6420.1994; Toots M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116151; USTAV M, 1991, EMBO J, V10, P4321, DOI 10.1002/j.1460-2075.1991.tb05010.x; Vinokurova S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024451; Voitenleitner C, 2002, J VIROL, V76, P3440, DOI 10.1128/JVI.76.7.3440-3451.2002; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Wang X, 2013, J VIROL, V87, P3871, DOI 10.1128/JVI.03068-12; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2010, BBA-GENE REGUL MECH, V1799, P192, DOI 10.1016/j.bbagrm.2009.09.009; Yu T, 2007, J VIROL, V81, P1736, DOI 10.1128/JVI.01638-06	65	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135770	10.1371/journal.pone.0135770	http://dx.doi.org/10.1371/journal.pone.0135770			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288015	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600068
J	Adler, C; Haelterman, E; Barlow, P; Marchant, A; Levy, J; Goetghebuer, T				Adler, Catherine; Haelterman, Edwige; Barlow, Patricia; Marchant, Arnaud; Levy, Jack; Goetghebuer, Tessa			Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INCREASED RISK; 1ST YEAR; CHILDREN; DISEASE; MORBIDITY; MORTALITY; SURVEILLANCE; TRANSMISSION; PNEUMONIA	Background Several studies indicate that HIV-exposed uninfected (HEU) children have a high infectious morbidity. We previously reported an increased incidence of group B streptococcus (GBS) infections in HEU infants born in Belgium. Methods This study was undertaken to evaluate the incidence and risk factors of all cause severe infections in HEU infants born in Belgium between 1985 and 2006, including the pre-antiretroviral (ARV) prophylaxis era (1985 to 1994). The medical charts of 537 HEU infants followed in a single center were reviewed. Results The incidence rate of severe infections during the first year of life was 16.8/100 HEU infant-years. The rates of invasive S. pneumoniae (0.62/100 infant-years) and GBS infections (1.05/100 infant-years) were, respectively, 4 and 13-fold higher in HEU infants than in the general infant population. Preterm birth was a risk factor for severe infections in the neonatal period (aOR = 21.34, 95% CI: 7.12-63.93) and post-neonatal period (aHR = 3.00, 95% CI: 1.53-5.88). As compared to the pre-ARV prophylaxis era, infants born in the ARV prophylaxis era (i.e., after April 1994) had a greater risk of severe infections (aHR = 2.93; 95% CI: 1.07-8.05). This risk excess was present in those who received ARV prophylaxis (aHR 2.01, 95% CI 0.72-5.65) and also in those born in the ARV prophylaxis era who did not benefit from ARV prophylaxis as a result of poor access to antenatal care or lack of compliance (aHR 3.06, 95% CI 0.88-10.66). Conclusions In HEU infants born in an industrialized country, preterm birth and being born during the ARV prophylaxis era were risk factors of severe infections throughout the first year of life. These observations have important implications for the clinical management of HIV-infected mothers and their infants.	[Adler, Catherine; Levy, Jack; Goetghebuer, Tessa] St Pierre Univ Hosp, Dept Pediat, Brussels, Belgium; [Haelterman, Edwige] ImmuneHealth, Clin Invest Unit, Gosselies, Belgium; [Barlow, Patricia] St Pierre Univ Hosp, Dept Obstet, Brussels, Belgium; [Marchant, Arnaud] Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles	Levy, J (corresponding author), St Pierre Univ Hosp, Dept Pediat, Brussels, Belgium.	jack_levy@stpierre-bru.be			Kids Foundation, Belgium; Smiles Foundation, Belgium	Kids Foundation, Belgium; Smiles Foundation, Belgium	Dr C. Adler benefited from research grants from the Kids Foundation, Belgium. Dr. A. Marchant is a senior associate at the Fonds National de la Recherche Scientifique (FNRS), Belgium. This study was supported by the Smiles Foundation, Belgium.	[Anonymous], 2002, JAMA, V287, P1106; Casimir GJA, 2010, SHOCK, V33, P258, DOI 10.1097/SHK.0b013e3181b2b36b; Chougnet C, 2000, J INFECT DIS, V181, P1590, DOI 10.1086/315458; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; CSS, 2003, RECOMMANDATIONS DU C, P7721; Cutland CL, 2015, EMERG INFECT DIS, V21, P638, DOI 10.3201/eid2104.141562; Cutland CL, 2012, PEDIATRICS, V130, pE581, DOI 10.1542/peds.2011-1548; Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Giaquinto C, 2004, AIDS, V18, P2009, DOI 10.1097/00002030-200410210-00005; Goetghebuer T, 2009, EUR J PEDIATR, V168, P79, DOI 10.1007/s00431-008-0717-y; Hainaut M, 2009, J PEDIAT BELGE, V11, P70; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Heresi GP, 1997, CLIN INFECT DIS, V25, P739, DOI 10.1086/516938; Houweling LMA, 2013, J PEDIATR-US, V163, P61, DOI 10.1016/j.jpeds.2012.12.014; Hviid A, 2007, AM J EPIDEMIOL, V165, P756, DOI 10.1093/aje/kwk064; Knapp KM, 2012, PEDIATR INFECT DIS J, V31, P164, DOI 10.1097/INF.0b013e318235c7aa; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kuhn L, 2002, CLIN INFECT DIS, V34, P267, DOI 10.1086/338153; Le Chenadec J, 2003, AIDS, V17, P2053, DOI 10.1097/00002030-200309260-00006; Leroy Ch. VLV, 2013, DONNEES PERINATATLES; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Minsart AF, 2013, EUR J PUBLIC HEALTH, V23, P269, DOI 10.1093/eurpub/cks032; Mussi-Pinhata MM, 2007, PEDIATRICS, V119, pE694, DOI 10.1542/peds.2006-1856; Mussi-Pinhata MM, 2010, INT J INFECT DIS, V14, pE176, DOI 10.1016/j.ijid.2010.01.006; Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398; Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645; Paul ME, 2005, PEDIATR INFECT DIS J, V24, P46, DOI 10.1097/01.inf.0000148879.83854.7e; Slogrove AL, 2010, J TROP PEDIATRICS, V56, P75, DOI 10.1093/tropej/fmp057; Slogrove A, 2012, J TROP PEDIATRICS, V58, P505, DOI 10.1093/tropej/fms019; Taron-Brocard C, 2014, CLIN INFECT DIS; THEA DM, 1993, NEW ENGL J MED, V329, P1696, DOI 10.1056/NEJM199312023292304; Vergison A, 2006, PEDIATRICS, V118, pE801, DOI 10.1542/peds.2005-3195; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; von Mollendorf C, 2015, CLIN INFECT DIS; WEINHOLD KJ, 1989, J IMMUNOL, V142, P3091	39	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135375	10.1371/journal.pone.0135375	http://dx.doi.org/10.1371/journal.pone.0135375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284528	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100033
J	Tang, YT; Ji, YH; Ye, XF; Wang, XF; Cai, L; Xu, JM; Lu, Y				Tang, Yating; Ji, Yinghong; Ye, Xiaofang; Wang, Xiaofeng; Cai, Lei; Xu, Jianming; Lu, Yi			The Association of Outdoor Activity and Age-Related Cataract in a Rural Population of Taizhou Eye Study: Phase 1 Report	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; BEAVER DAM EYE; HORMONE REPLACEMENT THERAPY; MIXED LENS OPACITIES; ANGELES-LATINO-EYE; RISK-FACTORS; CORTICAL CATARACT; 10-YEAR INCIDENCE; NUCLEAR CATARACT; LIGHT EXPOSURE	Purpose To study the relationship between outdoor activity and risk of age-related cataract (ARC) in a rural population of Taizhou Eye Study (phrase 1 report). Method A population-based, cross-sectional study of 2006 eligible rural adults (>= 45 years old) from Taizhou Eye Study was conducted from Jul. to Sep. 2012. Participants underwent detailed ophthalmologic examinations including uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), intraocular pressure (IOP), slit lamp and fundus examinations as well as questionnaires about previous outdoor activity and sunlight protection methods. ARC was recorded by LOCS. classification system. The prevalence of cortical, nuclear and posterior subcapsular cataract were assessed separately for the risk factors and its association with outdoor activity. Results Of all 2006 eligible participants, 883 (44.0%) adults were diagnosed with ARC. The prevalence rates of cortical, nuclear and posterior subcapsular cataract per person were 41.4%, 30.4% and 1.5%, respectively. Women had a higher tendency of nuclear and cortical cataract than men (OR = 1.559, 95% CI 1.204-2.019 and OR = 1.862, 95% CI 1.456-2.380, respectively). Adults with high myopia had a higher prevalence of nuclear cataract than adults without that (OR = 2.528, 95% CI 1.055-6.062). Multivariable logistic regression revealed that age was risk factor of nuclear (OR = 1.190, 95% CI 1.167-1.213) and cortical (OR = 1.203, 95% CI 1.181-1.226) cataract; eyes with fundus diseases was risk factor of posterior subcapsular cataract (OR = 6.529, 95% CI 2.512-16.970). Outdoor activity was an independent risk factor of cortical cataract (OR = 1.043, 95% CI 1.004-1.083). The risk of cortical cataract increased 4.3% (95% CI 0.4%-8.3%) when outdoor activity time increased every one hour. Furthermore, the risk of cortical cataract increased 1.1% (95% CI 0.1%-2.0%) when cumulative UV-B exposure time increased every one year. Conclusion Outdoor activity was an independent risk factor for cortical cataract, but was not risk factor for nuclear and posterior subcapsular cataract. The risk of cortical cataract increased 4.3% when outdoor activity time increased every one hour. In addition, the risk of cortical cataract increased 1.1% (95% CI 0.1%-2.0%) when cumulative UV-B exposure time increased every one year.	[Tang, Yating; Ji, Yinghong; Cai, Lei; Lu, Yi] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Tang, Yating; Ji, Yinghong; Cai, Lei; Lu, Yi] Minist Hlth, Myopia Key Lab, Shanghai, Peoples R China; [Tang, Yating; Ji, Yinghong; Cai, Lei; Lu, Yi] Visual Impairment & Reconstruct Key Lab Shanghai, Shanghai, Peoples R China; [Ye, Xiaofang] Fudan Univ, Shanghai 200433, Peoples R China; [Ye, Xiaofang; Xu, Jianming] Pudong Meteorol Serv, Shanghai Key Lab Meteorol & Hlth, Shanghai, Peoples R China; [Wang, Xiaofeng] Fudan Univ, State Key Lab Genet Engn, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Xiaofeng] Fudan Univ, MOE Key Lab Contemporary Anthropol, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Xiaofeng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Xiaofeng] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Lu, Y (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, 83 Fenyang Rd, Shanghai 200433, Peoples R China.	luyieent@126.com			Shanghai Science and Technology Commission [11231200602]; Key Projects in the National Science & Technology Pillar Program [2011BAI09B00]; New One Hundred People's Plan of Shanghai Health Bureau [XBR2011056]; Visual Impairment and Reconstruction Key Laboratory of Shanghai [12DZ2260500];  [NSFC81270989];  [81300745]	Shanghai Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)Shanghai Science & Technology Committee); Key Projects in the National Science & Technology Pillar Program; New One Hundred People's Plan of Shanghai Health Bureau; Visual Impairment and Reconstruction Key Laboratory of Shanghai; ; 	The work was supported by grants for Natural Science Foundation of China (NSFC81270989 and 81300745), Shanghai Science and Technology Commission (11231200602), Key Projects in the National Science & Technology Pillar Program (2011BAI09B00), New One Hundred People's Plan of Shanghai Health Bureau (XBR2011056) and Visual Impairment and Reconstruction Key Laboratory of Shanghai (12DZ2260500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LANCET, V372, P1273, DOI [10.1016/S0140-6736(08)61348-3, 10.1016/S0140-6736(08)61527-5]; Brian G, 2001, B WORLD HEALTH ORGAN, V79, P249; Cheng C Y, 2000, Zhonghua Yi Xue Za Zhi (Taipei), V63, P641; China national committee on aging office, 2014, PROSP CHIN ELD NEXT; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Congdon NG, 2001, BRIT J OPHTHALMOL, V85, P516, DOI 10.1136/bjo.85.5.516; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Delcourt C, 2000, ARCH OPHTHALMOL-CHIC, V118, P385, DOI 10.1001/archopht.118.3.385; Delcourt C, 2003, OPHTHALMOLOGY, V110, P2318, DOI 10.1016/S0161-6420(03)00713-9; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Freeman EE, 2001, ARCH OPHTHALMOL-CHIC, V119, P1687; HIRVELA H, 1995, OPHTHALMOLOGY, V102, P108; Holekamp NM, 2005, AM J OPHTHALMOL, V139, P302, DOI 10.1016/j.ajo.2004.09.046; HU TS, 1989, ARCH OPHTHALMOL-CHIC, V107, P666, DOI 10.1001/archopht.1989.01070010684027; Huang WY, 2012, INVEST OPHTH VIS SCI, V53, P7936, DOI 10.1167/iovs.12-10903; JAVITT JC, 1994, DOC OPHTHALMOL, V88, P307, DOI 10.1007/BF01203684; Ji Y, 2014, MOL CELL BIOCH; Kanthan GL, 2008, OPHTHALMOLOGY, V115, P808, DOI 10.1016/j.ophtha.2007.07.008; Kanthan GL, 2014, CLIN EXP OPHTHALMOL, V42, P347, DOI 10.1111/ceo.12206; Klein B E, 1999, Ophthalmic Epidemiol, V6, P247; Klein BEK, 2008, OPHTHALMOLOGY, V115, P477, DOI 10.1016/j.ophtha.2007.11.024; Klein BEK, 2000, AM J OPHTHALMOL, V130, P322, DOI 10.1016/S0002-9394(00)00474-8; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Koo E, 2013, OPHTHAL EPIDEMIOL, V20, P71, DOI 10.3109/09286586.2012.759598; Lai KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078647; Li EY, 2013, OPHTHALMOLOGY, V120, P2176, DOI 10.1016/j.ophtha.2013.04.003; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; Lindblad BE, 2010, OPHTHALMOLOGY, V117, P424, DOI 10.1016/j.ophtha.2009.07.046; Mahdi AM, 2014, INVEST OPHTH VIS SCI, V55, P2642, DOI 10.1167/iovs.12-10303; McCarty CA, 1996, B WORLD HEALTH ORGAN, V74, P353; Na KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096461; Navarro EJ, 2007, EUR J OPHTHALMOL, V17, P29; PALMQUIST BM, 1984, BRIT J OPHTHALMOL, V68, P113, DOI 10.1136/bjo.68.2.113; Prokofyeva E, 2013, ACTA OPHTHALMOL, V91, P395, DOI 10.1111/j.1755-3768.2012.02444.x; Richter GM, 2012, OPHTHALMOLOGY, V119, P2040, DOI 10.1016/j.ophtha.2012.05.001; Richter GM, 2012, OPHTHALMOLOGY, V119, P547, DOI 10.1016/j.ophtha.2011.09.005; Richter GM, 2009, OPHTHALMOLOGY, V116, P2327, DOI 10.1016/j.ophtha.2009.05.040; Sasaki H, 2003, INVEST OPHTH VIS SCI, V44, P4210, DOI 10.1167/iovs.01-1221; Sperduto RD, 2001, OPHTHALMOLOGY, V108, P1400; Tang Y, 2015, OPHTHALMOLOGY; Tsai SY, 2003, OPHTHALMOLOGY, V110, P1089, DOI 10.1016/S0161-6420(03)00243-4; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1449; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Xu L, 2006, OPHTHALMOLOGY, V113, P747, DOI 10.1016/j.ophtha.2006.01.026; Younan C, 2002, AM J EPIDEMIOL, V155, P997, DOI 10.1093/aje/155.11.997; Zhang JS, 2011, OPHTHALMOLOGY, V118, P711, DOI 10.1016/j.ophtha.2010.08.021; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zhou Q, 2007, OPHTHAL EPIDEMIOL, V14, P399, DOI 10.1080/09286580701331974	49	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135870	10.1371/journal.pone.0135870	http://dx.doi.org/10.1371/journal.pone.0135870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284359	gold, Green Published, Green Submitted			2022-12-27	WOS:000359666100080
J	Todor, H; Gooding, J; Ilkayeva, OR; Schmid, AK				Todor, Horia; Gooding, Jessica; Ilkayeva, Olga R.; Schmid, Amy K.			Dynamic Metabolite Profiling in an Archaeon Connects Transcriptional Regulation to Metabolic Consequences	PLOS ONE			English	Article							HALOBACTERIUM-SALINARUM; HALOFERAX-VOLCANII; PATHWAYS; PURIFICATION; PHOSPHATE; GROWTH; TRMB	Previous work demonstrated that the TrmB transcription factor is responsible for regulating the expression of many enzyme-coding genes in the hypersaline-adapted archaeon Halobacterium salinarum via a direct interaction with a cis-regulatory sequence in their promoters. This interaction is abolished in the presence of glucose. Although much is known about the effects of TrmB at the transcriptional level, it remains unclear whether and to what extent changes in mRNA levels directly affect metabolite levels. In order to address this question, here we performed a high-resolution metabolite profiling time course during a change in nutrients using a combination of targeted and untargeted methods in wild-type and Delta trmB strain backgrounds. We found that TrmB-mediated transcriptional changes resulted in widespread and significant changes to metabolite levels across the metabolic network. Additionally, the pattern of growth complementation using various purines suggests that the mis-regulation of gluconeogenesis in the Delta trmB mutant strain in the absence of glucose results in low phosphoribosylpyrophosphate (PRPP) levels. We confirmed these low PRPP levels using a quantitative mass spectrometric technique and found that they are associated with a metabolic block in de novo purine synthesis, which is partially responsible for the growth defect of the Delta trmB mutant strain in the absence of glucose. In conclusion, we show how transcriptional regulation of metabolism affects metabolite levels and ultimately, phenotypes.	[Todor, Horia; Schmid, Amy K.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Gooding, Jessica; Ilkayeva, Olga R.] Duke Univ, Med Ctr, Dept Pharmacol, Sarah W Stedman Nutr & Metab Ctr,Duke Mol Physiol, Durham, NC 27710 USA; [Gooding, Jessica; Ilkayeva, Olga R.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Sarah W Stedman Nutr & Metab Ctr,Duke Mol Physiol, Durham, NC USA; [Schmid, Amy K.] Duke Univ, Univ Program Genet & Genom, Durham, NC USA; [Schmid, Amy K.] Duke Univ, Ctr Syst Biol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Schmid, AK (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	amy.schmid@duke.edu			National Science Foundation [MCB-1052290, MCB-1417750]; Duke University; National Institutes of Health [K01-GM109320-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K01GM109320] Funding Source: NIH RePORTER; Direct For Biological Sciences [1417750] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Duke University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation (nsf.gov) under grant numbers MCB-1052290 and MCB-1417750 to AKS, by Duke University (duke.edu) startup funds to AKS, and by the National Institutes of Health (nih.gov) under grant number K01-GM109320-02 to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2014, METABOLOMICS, V10, P141, DOI 10.1007/s11306-013-0565-2; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cunchillos C, 2005, MOL BIOL EVOL, V22, P1, DOI 10.1093/molbev/msh253; DEMEDICIS E, 1982, BIOCHIM BIOPHYS ACTA, V708, P57, DOI 10.1016/0167-4838(82)90203-5; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; GOCHNAUER MB, 1969, CAN J MICROBIOL, V15, P1157, DOI 10.1139/m69-211; Gonzalez O, 2008, MOL BIOSYST, V4, P148, DOI 10.1039/b715203e; Gonzalez O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000332; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kanai T, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703424200; Krug M, 2013, PROTEIN SCI, V22, P800, DOI 10.1002/pro.2263; Lee SJ, 2003, J BIOL CHEM, V278, P983, DOI 10.1074/jbc.M210236200; LEICHT W, 1978, BIOCHEMISTRY-US, V17, P4004, DOI 10.1021/bi00612a020; Malki L, 2009, J BACTERIOL, V191, P5196, DOI 10.1128/JB.00297-09; NEWTON GL, 1985, J BACTERIOL, V161, P438, DOI 10.1128/JB.161.1.438-441.1985; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; Pickl A, 2015, FEBS LETT, V589, P1105, DOI 10.1016/j.febslet.2015.03.026; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Schmid AK, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.40; Severina L. O., 1990, ARCH MICROBIOL, V155, P131, DOI DOI 10.1007/BF00248606; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; SONAWAT HM, 1990, BIOCHEM BIOPH RES CO, V173, P358, DOI 10.1016/S0006-291X(05)81065-4; Stuer-Lauridsen B, 1998, J BACTERIOL, V180, P457, DOI 10.1128/JB.180.3.457-463.1998; Todor H, 2014, MOL MICROBIOL, V93, P1172, DOI 10.1111/mmi.12726; Todor H, 2013, NUCLEIC ACIDS RES, V41, P8546, DOI 10.1093/nar/gkt659; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135693	10.1371/journal.pone.0135693	http://dx.doi.org/10.1371/journal.pone.0135693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284786	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100059
J	Ahn, SH; Kim, J; Min, HJ; Chung, HJ; Hong, JM; Lee, JG; Kim, CH; Cho, HJ				Ahn, Sang Hyeon; Kim, Jinna; Min, Hyun Jin; Chung, Hyo Jin; Hong, Jae Min; Lee, Jeung-Gweon; Kim, Chang-Hoon; Cho, Hyung-Ju			Tongue Volume Influences Lowest Oxygen Saturation but Not Apnea-Hypopnea Index in Obstructive Sleep Apnea	PLOS ONE			English	Article							UPPER AIRWAY; CEPHALOMETRIC ANALYSIS; OBESE; FAT; HYPERTENSION; MORPHOLOGY; DISORDERS; NONOBESE; ADULTS; RATIO	Objectives The aim of this study was to identify correlations between sleep apnea severity and tongue volume or posterior airway space measured via three-dimensional reconstruction of volumetric computerized tomography (CT) images in patients with obstructive sleep apnea (OSA) for use in predicting OSA severity and in surgical treatment. We also assessed associations between tongue volume and Mallampati score. Methods Snoring/OSA male patients (n = 64) who underwent polysomnography, cephalometry, and CT scans were enrolled in this retrospective study. OSA was diagnosed when the apneahypopnea index (AHI) was greater than 5 (mild 5-14; moderate 15-29; severe>30). The patients were also categorized into the normal-mild group (n = 22) and the moderate-severe group (n = 42). Using volumetric CT images with the three-dimensional reconstruction technique, the volume of the tongue, posterior airway space volume, and intra-mandibular space were measured. The volumes, polysomnographic parameters, and physical examination findings were compared, and independent factors that are related to OSA were analysed. Results No associations between tongue volume or posterior airway space and the AHI were observed. However, multivariate linear analyses showed that tongue volume had significantly negative association with lowest O-2 saturation (r = 0.365, p = 0.027). High BMI was related to an increase in tongue volume. Modified Mallampati scores showed borderline significant positive correlations with absolute tongue volume (r = 0.251, p = 0.046) and standardized tongue volume (absolute tongue volume / intramandibular area; r = 0.266, p = 0.034). Between the normal-mild and moderate-severe groups, absolute tongue volumes were not different, although the standardized tongue volume in the moderate-severe group was significantly higher. Conclusion Absolute tongue volume showed stronger associations with lowest O-2 saturation during sleep than with the severity of AHI. We also found that high BMI was a relevant factor for an increase in absolute tongue volume and modified Mallampati grading was a useful physical examination to predict tongue size.	[Ahn, Sang Hyeon; Chung, Hyo Jin; Hong, Jae Min; Lee, Jeung-Gweon; Kim, Chang-Hoon; Cho, Hyung-Ju] Yonsei Univ, Coll Med, Severance Hosp, Dept Otorhinolaryngol, Seoul, South Korea; [Kim, Jinna] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea; [Min, Hyun Jin] Chung Ang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 156756, South Korea; [Kim, Chang-Hoon; Cho, Hyung-Ju] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chung Ang University; Chung Ang University Hospital; Yonsei University; Yonsei University Health System	Kim, CH (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Otorhinolaryngol, Seoul, South Korea.	entman@yuhs.ac; hyungjucho@yuhs.ac	Chung-ang, HyunJin/AAO-9395-2020; Kim, Chang-Hoon/D-7205-2016	Kim, Chang-Hoon/0000-0003-1238-6396; Cho, Hyung-Ju/0000-0002-2851-3225; Kim, Jinna/0000-0002-9978-4356; Ahn, Sang Hyeon/0000-0002-2389-0005	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education [2012R1A1A2042476]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2013M3A9D5072551]; Yonsei University Future-leading Research Initiative [2014-22-0131]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2013R1A1A1010151]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; Yonsei University Future-leading Research Initiative; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education(2012R1A1A2042476) to C.H. Kim. This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2013M3A9D5072551) to C.H. Kim. This research was supported (in part) by the Yonsei University Future-leading Research Initiative of 2014 (2014-22-0131) to C.H. Kim. This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (NRF-2013R1A1A1010151) to H.J. Cho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennick MJ, 2014, SLEEP, V37, P1095, DOI 10.5665/sleep.3768; Brennick MJ, 2009, AM J RESP CRIT CARE, V179, P158, DOI 10.1164/rccm.200809-1435OC; Chi L, 2011, EUR RESPIR J, V38, P348, DOI 10.1183/09031936.00119210; Faria AC, 2013, SLEEP BREATH, V17, P395, DOI 10.1007/s11325-012-0707-1; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Friedman M, 1999, LARYNGOSCOPE, V109, P1901, DOI 10.1097/00005537-199912000-00002; Friedman M, 2002, OTOLARYNG HEAD NECK, V127, P13, DOI 10.1067/mhn.2002.126477; Ha JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081590; Iida-Kondo Chisato, 2006, Journal of Medical and Dental Sciences, V53, P119; KALES A, 1985, J CHRON DIS, V38, P427, DOI 10.1016/0021-9681(85)90138-9; Kim AM, 2014, SLEEP, V37, P1639, DOI 10.5665/sleep.4072; Lee RWW, 2010, SLEEP, V33, P1249, DOI 10.1093/sleep/33.9.1249; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; LOWE AA, 1986, AM J ORTHOD DENTOFAC, V90, P484, DOI 10.1016/0889-5406(86)90108-3; LOWE AA, 1986, AM J ORTHOD DENTOFAC, V90, P364, DOI 10.1016/0889-5406(86)90002-8; LYBERG T, 1989, J LARYNGOL OTOL, V103, P287, DOI 10.1017/S0022215100108734; Min HJ, 2014, YONSEI MED J, V55, P1310, DOI 10.3349/ymj.2014.55.5.1310; Nashi N, 2007, LARYNGOSCOPE, V117, P1467, DOI 10.1097/MLG.0b013e318068b566; Ogawa T, 2005, ST HEAL T, V111, P365; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; Sakakibara H, 1999, EUR RESPIR J, V13, P403, DOI 10.1183/09031936.99.13240399; Schwab RJ, 2003, AM J RESP CRIT CARE, V168, P522, DOI 10.1164/rccm.200208-866OC; Shigeta Y, 2011, ORAL SURG ORAL MED O, V111, P239, DOI 10.1016/j.tripleo.2010.10.013; Tsuiki S, 2008, ANESTHESIOLOGY, V108, P1009, DOI 10.1097/ALN.0b013e318173f103; Vicini C, 2014, HEAD NECK-J SCI SPEC, V36, P77, DOI 10.1002/hed.23271; Welch KC, 2002, SLEEP, V25, P532, DOI 10.1093/sleep/25.5.530; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2008, SLEEP, V31, P1071; Yu XJ, 2003, CHEST, V124, P212, DOI 10.1378/chest.124.1.212	30	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135796	10.1371/journal.pone.0135796	http://dx.doi.org/10.1371/journal.pone.0135796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280546	gold, Green Published, Green Submitted			2022-12-27	WOS:000359664300023
J	Janjigian, YY; Vakiani, E; Ku, GY; Herrera, JM; Tang, LH; Bouvier, N; Viale, A; Socci, ND; Capanu, M; Berger, M; Ilson, DH				Janjigian, Yelena Y.; Vakiani, Efsevia; Ku, Geoffrey Y.; Herrera, Jessica M.; Tang, Laura H.; Bouvier, Nancy; Viale, Agnes; Socci, Nicholas D.; Capanu, Marinela; Berger, Michael; Ilson, David H.			Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer	PLOS ONE			English	Article							ADVANCED GASTRIC-CANCER; DOUBLE-BLIND; 1ST-LINE THERAPY; ADENOCARCINOMA; COMBINATION; MULTICENTER; CISPLATIN; FAILURE; REGORAFENIB; BEVACIZUMAB	Purpose Vascular endothelial growth factor receptor (VEGFR2) directed therapies result in a modest survival benefit for patients with advanced esophageal and gastroesophageal (GE) junction cancer. Platelet-derived growth factor receptor (PDGFR) may contribute to escape from VEGFR2 inhibition. We evaluated the efficacy of sorafenib, a broad spectrum tyrosine kinase inhibitor targeting VEGFR2 and PDGFR as well as RET and RAF1, in patients with metastatic chemotherapy refractory esophageal and GE junction cancer. Patients and Methods This phase II trial of sorafenib 400 mg twice daily enrolled chemotherapy refractory patients with metastatic esophageal and GE junction cancer with primary endpoint of progression-free survival (PFS) rate at two months. Secondary endpoints included overall survival, objective response rate and toxicity. Results Among 34 patients, 8 week Kaplan-Meier estimated PFS was 61% (90% CI 45 to 73%). Median PFS is 3.6 months (95% CI 1.8 to 3.9 months), with median overall survival OS 9.7 months (95% CI 5.9 to 11.6 months). Grade 3 toxicities were uncommon and included hand foot skin reaction, rash, dehydration and fatigue. One patient (3%) with ongoing complete response and remains on trial for over 5 years. Whole exome sequencing of this tumor revealed mutations in many cancer-associated genes including ARID1A, PIK3CA, and TP53, and focal amplifications of HMGA2 and MET. Conclusion Sorafenib therapy results in disease stabilization and encouraging PFS in patients with refractory esophageal and GE junction cancer.	[Janjigian, Yelena Y.; Ku, Geoffrey Y.; Herrera, Jessica M.; Ilson, David H.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Gastrointestinal Oncol Serv, New York, NY 10021 USA; [Janjigian, Yelena Y.; Ku, Geoffrey Y.; Herrera, Jessica M.; Ilson, David H.] Weill Cornell Med Coll, New York, NY USA; [Vakiani, Efsevia; Tang, Laura H.; Berger, Michael] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Bouvier, Nancy; Viale, Agnes; Socci, Nicholas D.; Berger, Michael] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, New York, NY 10021 USA; [Socci, Nicholas D.] Sloan Kettering Inst, Dept Bioinformat, New York, NY USA; [Capanu, Marinela] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Janjigian, YY (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Gastrointestinal Oncol Serv, New York, NY 10021 USA.	janjigiy@mskcc.org		Ku, Geoffrey/0000-0002-0448-1038	Bayer	Bayer(Bayer AG)	Financial support and sorafenib was provided by Bayer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Connell C, 2014, ICORG 06 41 PHASE 2; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Erber R, 2003, FASEB J; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hironaka S, 2013, J CLIN ONCOL, V31, P4438, DOI 10.1200/JCO.2012.48.5805; Imielinski M, 2014, J CLIN INVEST, V124, P1582, DOI 10.1172/JCI72763; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Martin-Richard M, 2013, INVEST NEW DRUG, V31, P1573, DOI 10.1007/s10637-013-0020-2; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Qin SK, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.4003; Sinicrope FA, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.3525; Sun WJ, 2010, J CLIN ONCOL, V28, P2947, DOI 10.1200/JCO.2009.27.7988; TEW W, 2005, P GI ASCO 2005, V5; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2119, DOI 10.1200/JCO.2011.39.9824; van Zandwijk N, 2015, ANN ONCOL, V26, P16, DOI 10.1093/annonc/mdv090.2; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	29	35	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134731	10.1371/journal.pone.0134731	http://dx.doi.org/10.1371/journal.pone.0134731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275293	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600041
J	Lee, KN; Chirwa, S				Lee, Kiera-Nicole; Chirwa, Sanika			Blocking Dopaminergic Signaling Soon after Learning Impairs Memory Consolidation in Guinea Pigs	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIME-DEPENDENT REORGANIZATION; SPATIAL WORKING-MEMORY; HIPPOCAMPAL-FORMATION; PREFRONTAL CORTEX; LOCUS-COERULEUS; NORADRENERGIC NEURONS; RECOGNITION MEMORY; D-1/D-5 RECEPTORS; CA1 REGION	Formation of episodic memories (i.e. remembered experiences) requires a process called consolidation which involves communication between the neocortex and hippocampus. However, the neuromodulatory mechanisms underlying this neocortico-hippocampal communication are poorly understood. Here, we examined the involvement of dopamine D1 receptors (D1R) and D2 receptors (D2R) mediated signaling on memory consolidation using the Novel Object Recognition (NOR) test. We conducted the tests in male Hartley guinea pigs and cognitive behaviors were assessed in customized Phenotyper home cages utilizing Ethovision XT software from Noldus enabled for the 3-point detection system (nose, center of the body, and rear). We found that acute intraperitoneal injections of either 0.25 mg/kg SCH23390 to block D1Rs or 1.0 mg/kg sulpiride to block D2Rs soon after acquisition (which involved familiarization to two similar objects) attenuated subsequent discrimination for novel objects when tested after 5-hours in the NOR test. By contrast guinea pigs treated with saline showed robust discrimination for novel objects indicating normal operational processes undergirding memory consolidation. The data suggests that involvement of dopaminergic signaling is a key post-acquisition factor in modulating memory consolidation in guinea pigs.	[Lee, Kiera-Nicole; Chirwa, Sanika] Meharry Med Coll, Dept Neurosci & Pharmacol, Nashville, TN 37208 USA; [Chirwa, Sanika] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA	Meharry Medical College; Vanderbilt University	Chirwa, S (corresponding author), Meharry Med Coll, Dept Neurosci & Pharmacol, 1005 DB Todd Blvd, Nashville, TN 37208 USA.	schirwa@mmc.edu			National Institutes of Health [R24 DA021471, R25 GM059994, T32 NS061201]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA021471] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health research grant R24 DA021471, and training grants R25 GM059994, T32 NS061201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2013, P NATL ACAD SCI USA, V110, P10379, DOI 10.1073/pnas.1301199110; ANCILL RJ, 1956, J PHYSIOL-LONDON, V132, P469, DOI 10.1113/jphysiol.1956.sp005539; Balderas I, 2013, HIPPOCAMPUS, V23, P873, DOI 10.1002/hipo.22143; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; Bouret S, 2002, EUR J NEUROSCI, V16, P2371, DOI 10.1046/j.1460-9568.2002.02413.x; Bourne JA, 2001, CNS DRUG REV, V7, P399; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Chen ZX, 1996, RECEPTOR CHANNEL, V4, P1; Chirwa S, 2005, BRAIN RES BULL, V64, P433, DOI 10.1016/j.brainresbull.2004.09.012; Ciliax BJ, 2000, SYNAPSE, V37, P125, DOI 10.1002/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7; Clark RE, 2000, J NEUROSCI, V20, P8853; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; Depue BE, 2012, NEUROSCI BIOBEHAV R, V36, P1382, DOI 10.1016/j.neubiorev.2012.02.012; Dere E, 2006, NEUROSCI BIOBEHAV R, V30, P1206, DOI 10.1016/j.neubiorev.2006.09.005; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Eichenbaum H, 2012, COGNITIVE NEUROSCIEN; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Eschenko O, 2008, CEREB CORTEX, V18, P2596, DOI 10.1093/cercor/bhn020; Eschenko O, 2012, CEREB CORTEX, V22, P426, DOI 10.1093/cercor/bhr121; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Furini CRG, 2014, BEHAV BRAIN RES, V271, P212, DOI 10.1016/j.bbr.2014.06.027; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Harley CW, 2007, PROG BRAIN RES, V163, P299, DOI 10.1016/S0079-6123(07)63018-0; Hars B, 2014, LEARN MEMORY, V13, P515; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hollnagel JO, 2014, NEUROSCI LETT, V574, P15, DOI 10.1016/j.neulet.2014.04.045; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jenkins TA, 2004, NEUROSCIENCE, V124, P43, DOI 10.1016/j.neuroscience.2003.11.024; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Khan ZU, 2000, NEUROSCIENCE, V100, P689, DOI 10.1016/S0306-4522(00)00274-8; Komorowski RW, 2013, J NEUROSCI, V33, P8079, DOI 10.1523/JNEUROSCI.5458-12.2013; Lai ECC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089795; Lai ECC, 2013, SCHIZOPHRENIA BULL, V39, P673, DOI 10.1093/schbul/sbs002; Lee KN, 2014, SYNAPSE, V68, P221, DOI 10.1002/syn.21731; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810548; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Manago F, 2009, LEARN MEMORY, V16, P46, DOI 10.1101/lm.1177509; Marzo A, 2009, CURR NEUROPHARMACOL, V7, P286, DOI 10.2174/157015909790031193; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCCORMICK DA, 1991, PROG BRAIN RES, V88, P293; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Mehta MA, 2003, NEUROIMAGE, V20, P1982, DOI 10.1016/j.neuroimage.2003.08.007; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Mehta MA, 2008, PSYCHOPHARMACOLOGY, V196, P157, DOI 10.1007/s00213-007-0947-0; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV, V3; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Robinson Susan W., 1997, P137; Rossato JI, 2013, NEUROBIOL LEARN MEM, V106, P66, DOI 10.1016/j.nlm.2013.07.012; Roullet P, 1998, NEURAL PLAST, V6, P63, DOI 10.1155/NP.1998.63; Rowland DC, 2011, P NATL ACAD SCI USA, V108, P14654, DOI 10.1073/pnas.1105445108; Sara SJ, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00185; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; STEINFELS GF, 1983, BRAIN RES, V277, P150, DOI 10.1016/0006-8993(83)90917-4; Swanson-Park JL, 1996, NEUROSCIENCE, V92, P485; Szpunar KK, 2009, SCHOLARPEDIA, V4, P3332, DOI DOI 10.4249/SCH0LARPEDIA.3332; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Takehara K, 2003, J NEUROSCI, V23, P9897; TOBLER I, 1993, AM J PHYSIOL, V264, pR1125, DOI 10.1152/ajpregu.1993.264.6.R1125; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; Ul Haq R, 2012, HIPPOCAMPUS, V22, P516, DOI 10.1002/hipo.20918; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Williams S, 2006, NEUROSCI LETT, V402, P46, DOI 10.1016/j.neulet.2006.03.075; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	80	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135578	10.1371/journal.pone.0135578	http://dx.doi.org/10.1371/journal.pone.0135578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275140	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600079
J	Lanza, FC; Santos, MLD; Selman, JPR; Silva, JC; Marcolin, N; Santos, J; Oliveira, CMG; Dal Lago, P; Dal Corso, S				Lanza, Fernanda Cordoba; de Moraes Santos, Mara Lisiane; Selman, Jessyca Pachi Rodrigues; Silva, Jaksoel Cunha; Marcolin, Natalia; Santos, Jeniffer; Oliveira, Cilmery M. G.; Dal Lago, Pedro; Dal Corso, Simone			Reference Equation for Respiratory Pressures in Pediatric Population: A Multicenter Study	PLOS ONE			English	Article							NORMAL VALUES; HEALTHY-CHILDREN; EXPIRATORY PRESSURES; MUSCLE STRENGTH; CYSTIC-FIBROSIS; ADOLESCENTS; PREDICTION	Previous studies have proposed only one prediction equation for respiratory muscle strength without taking into consideration differences between ages in pediatric population. In addition, those researches were single-center studies. The objective of this study was to establish reference equations for maximal inspiratory pressure (PImax) and maximal expiratory pressure (PEmax) in children and teenagers. In a multicenter study, 450 healthy volunteers were evaluated (aged 6-18yrs). There were included volunteers with normal lung function. We excluded volunteers who could not perform the tests; participated in physical activity more than twice a week; were born prematurely; smokers; chronic respiratory, cardiologic, and/or neurologic diseases; had acute respiratory disease during the prior three weeks. The volunteers were divided into two groups: Group 6-11 (6-11yrs) and Group 12-18 (12-18yrs). PImax and PEmax were measured according to statement. The mean PImax value was 85.6 (95% IC 83.6-87.6 cmH(2)O), and PEmax 84.6 (95% IC 85.5-86.2 cmH(2)O). The prediction equations for PImax and PEmax for Group 6-11 were 37.458-0.559 + (age * 3.253) + (BMI * 0.843) + (age * gender * 0.985); and 38.556 + 15.892 + (age * 3.023) + (BMI * 0.579) + (age * gender * 0.881), respectively (R-2 = 0.34 and 0.31, P < 0.001). The equations for Group 12-18 were 92.472 + (gender * 9.894) + 7.103, (R-2 = 0.27, P = 0.006) for PImax; and 68.113 + (gender * 17.022) + 6.46 + (BMI * 0.927), (R-2 = 0.34, P < 0.0001) for PEmax. This multicenter study determined the respiratory muscle strength prediction equations for children and teenagers.	[Lanza, Fernanda Cordoba; Dal Corso, Simone] Univ Nove de Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil; [de Moraes Santos, Mara Lisiane] Univ Fed Mato Grosso do Sul, Sch Phys Therapy, Campo Grande, MS, Brazil; [Selman, Jessyca Pachi Rodrigues; Silva, Jaksoel Cunha; Santos, Jeniffer] Univ Nove de Julho UNINOVE, Dept Hlth, Sch Physiotherapy, Sao Paulo, SP, Brazil; [Marcolin, Natalia; Dal Lago, Pedro] UFCSPA, Physiol Lab, Porto Alegre, RS, Brazil; [Oliveira, Cilmery M. G.] State Univ Hlth Sci Alagoas, UNCISAL, Maceio, AL, Brazil	Universidade Nove de Julho; Universidade Federal de Mato Grosso do Sul; Universidade Nove de Julho; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Estadual de Ciencias da Saude de Alagoas	Lanza, FC (corresponding author), Univ Nove de Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil.	lanzafe@gmail.com	Dal Corso, Simone/C-3135-2012; Lanza, Fernanda C/N-8414-2013; Dal Lago, Pedro/AAM-9136-2020; Selman, Jessyca/AAG-2743-2019	Dal Corso, Simone/0000-0001-9190-6796; Lanza, Fernanda C/0000-0002-4748-6947; Dal Lago, Pedro/0000-0001-9907-7689; 	Sao Paulo Research Foundation (FAPESP) [2011/23221-7, 2012/17875-7]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Sao Paulo Research Foundation (FAPESP), grant: 2011/23221-7. Jenifer Santos was supported by Sao Paulo Research Foundation (FAPESP), grant: 2012/17875-7.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Arnall DA, 2013, PEDIATR PULM, V48, P804, DOI 10.1002/ppul.22645; Cox DW, 2012, RESPIRATION, V84, P485, DOI 10.1159/000342298; Dassios T, 2013, RESP MED, V107, P684, DOI 10.1016/j.rmed.2013.01.016; De Jong W, 2001, RESP MED, V95, P31, DOI 10.1053/rmed.2000.0966; Domenech-Clar R, 2003, PEDIATR PULM, V35, P126, DOI 10.1002/ppul.10217; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; de Oliveira CMG, 2012, J BRAS PNEUMOL, V38, P308, DOI 10.1590/S1806-37132012000300005; GAULTIER C, 1983, RESP PHYSIOL, V51, P45, DOI 10.1016/0034-5687(83)90101-9; Heinzmann JP, 2012, RESP MED, V106, P1639, DOI 10.1016/j.rmed.2012.08.015; Inal-Ince D, 2009, SPINE J, V9, P981, DOI 10.1016/j.spinee.2009.08.451; Jalayondeja Wattana, 2014, Journal of the Medical Association of Thailand, V97, pS16; Lima Elisângela Veruska Nóbrega Crispim Leite, 2008, J. bras. pneumol., V34, P552, DOI 10.1590/S1806-37132008000800003; Matecki S, 2003, PEDIATR PULM, V35, P368, DOI 10.1002/ppul.10274; Mendes REF, 2013, BRAZ J PHYS THER, V17, P218, DOI 10.1590/S1413-35552012005000086; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Noizet O, 2005, CRIT CARE, V9, pR798, DOI 10.1186/cc3898; Ong BA, 2013, BRIT J HAEMATOL, V163, P112, DOI 10.1111/bjh.12481; Pereira CAC, 2002, J BRAS PNEUMOL S3, V28, P207; Rogol AD, 2010, ENDOCRIN DEV, V17, P77, DOI 10.1159/000262530; SMYTH RJ, 1984, CHEST, V86, P568, DOI 10.1378/chest.86.4.568; Tomalak W, 2002, PEDIATR PULM, V34, P42, DOI 10.1002/ppul.10130; WAGENER JS, 1984, AM REV RESPIR DIS, V129, P873, DOI 10.1164/arrd.1984.129.5.873; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535; Yeldan I, 2008, CLIN REHABIL, V22, P741, DOI 10.1177/0269215508091203	25	14	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135662	10.1371/journal.pone.0135662	http://dx.doi.org/10.1371/journal.pone.0135662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291318	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900026
J	Shen, LY; Luo, J; Du, JJ; Liu, CD; Wu, XQ; Pu, Q; Fu, YH; Tang, QZ; Liu, YR; Li, Q; Yang, RL; Li, XW; Tang, GQ; Jiang, YZ; Li, MZ; Zhang, SH; Zhu, L				Shen, Linyuan; Luo, Jia; Du, Jingjing; Liu, Chendong; Wu, Xiaoqian; Pu, Qiang; Fu, Yuhua; Tang, Qianzi; Liu, Yuanrui; Li, Qiang; Yang, Runlin; Li, Xuewei; Tang, Guoqing; Jiang, Yanzhi; Li, Mingzhou; Zhang, Shunhua; Zhu, Li			Transcriptome Analysis of Liangshan Pig Muscle Development at the Growth Curve Inflection Point and Asymptotic Stages Using Digital Gene Expression Profiling	PLOS ONE			English	Article							FATTY-ACID; SKELETAL-MUSCLE; MEAT QUALITY; CARCASS CHARACTERISTICS; INITIATION-FACTORS; INTRAMUSCULAR FAT; FEED-INTAKE; PERFORMANCE; WEIGHT; VCAM-1	Animal growth curves can provide essential information for animal breeders to optimize feeding and management strategies. However, the genetic mechanism underlying the phenotypic differentiation between the inflection point and asymptotic stages of the growth curve is not well characterized. Here, we employed Liangshan pigs in stages of growth at the inflection point (under inflection point: UIP) and the two asymptotic stages (before the inflection point: BIP, after the inflection point: AIP) as models to survey global gene expression in the longissimus dorsi muscle using digital gene expression (DGE) tag profiling. We found Liangshan pigs reached maximum growth rate (UIP) at 163.6 days of age and a weight of 134.6 kg. The DGE libraries generated 117 million reads of 5.89 gigabases in length. 21,331, 20,996 and 20,139 expressed transcripts were identified BIP, UIP and AIP, respectively. Among them, we identified 757 differentially expressed genes (DEGs) between BIP and UIP, and 271 DEGs between AIP and UIP. An enrichment analysis of DEGs proved the immune system was strengthened in the AIP stage. Energy metabolism rate, global transcriptional activity and bone development intensity were highest UIP. Meat from Liangshan pigs had the highest intramuscular fat content and most favorable fatty acid composition in the AIP. Three hundred eighty (27.70%) specific expression genes were highly enriched in QTL regions for growth and meat quality traits. This study completed a comprehensive analysis of diverse genetic mechanisms underlying the inflection point and asymptotic stages of growth. Our findings will serve as an important resource in the understanding of animal growth and development in indigenous pig breeds.	[Shen, Linyuan; Luo, Jia; Du, Jingjing; Liu, Chendong; Wu, Xiaoqian; Pu, Qiang; Tang, Qianzi; Yang, Runlin; Li, Xuewei; Tang, Guoqing; Li, Mingzhou; Zhang, Shunhua; Zhu, Li] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China; [Fu, Yuhua] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; [Fu, Yuhua] Huazhong Agr Univ, Key Lab Swine Genet, Wuhan, Peoples R China; [Yang, Runlin] Mabian Gold Liangshan Agr Dev Co Ltd, Chengdu, Sichuan, Peoples R China; [Jiang, Yanzhi] Sichuan Agr Univ, Dept Biol, Coll Life & Sci, Chengdu, Sichuan, Peoples R China; [Li, Qiang] Sichuan Prov Gen Stn Anim Husb, Chengdu, Sichuan, Peoples R China; [Liu, Yuanrui] LC Sci, Hangzhou, Zhejiang, Peoples R China	Sichuan Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Sichuan Agricultural University	Zhang, SH (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China.	zhangsh1919@163.com; zhuli7508@163.com	Du, Jingjing/X-4006-2019	Shen, Linyuan/0000-0001-6072-3268; Li, Mingzhou/0000-0001-8681-7684	Sichuan Sci & Tech Support Program [2013NZ0041]; earmarked fund for China Agriculture Research System [CARS-36-485 05B]; Chinese National Sci & Tech Support Program [2013BAD20B07]; International Science & Technology Cooperation Program of China [2014DFA31260]; Mabian Gold Liangshan Agricultural Development Co., Ltd.; LC Sciences	Sichuan Sci & Tech Support Program; earmarked fund for China Agriculture Research System; Chinese National Sci & Tech Support Program; International Science & Technology Cooperation Program of China; Mabian Gold Liangshan Agricultural Development Co., Ltd.; LC Sciences	The study was supported by the Sichuan Sci & Tech Support Program (No. 2013NZ0041), the earmarked fund for China Agriculture Research System (No. CARS-36-485 05B), the Chinese National Sci & Tech Support Program (No. 2013BAD20B07), and International Science & Technology Cooperation Program of China (2014DFA31260). Mabian Gold Liangshan Agricultural Development Co., Ltd. provided support in the form of a salary for author RY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. LC Sciences provided support in the form of a salary for author YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ai HS, 2015, NAT GENET, V47, P217, DOI 10.1038/ng.3199; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bermejo JL, 2003, LIVEST PROD SCI, V82, P15, DOI 10.1016/S0301-6226(03)00005-8; Brossard L, 2009, ANIMAL, V3, P1114, DOI 10.1017/S1751731109004546; Cao Y, 1998, GENOMICS, V49, P327, DOI 10.1006/geno.1998.5268; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Cook-Mills JM, 2002, MOL IMMUNOL, V39, P499, DOI 10.1016/S0161-5890(02)00206-7; de Lange CFM, 2001, CAN J ANIM SCI, V81, P1, DOI 10.4141/A00-006; Edelson BT, 2006, BLOOD, V107, P143, DOI 10.1182/blood-2005-06-2218; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Enser M, 2001, OILS FATS ANIMAL CAR, V2, P77; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; Gerbens F, 2001, J ANIM SCI, V79, P347; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Green DM, 2003, J SCI FOOD AGR, V83, P1150, DOI 10.1002/jsfa.1519; Guantes R, 2015, GENOME RES, V25, P633, DOI 10.1101/gr.178426.114; Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L; Jiang YZ, 2011, ANIMAL, V5, P1485, DOI 10.1017/S1751731111000425; Kebreab E, 2007, J ANIM SCI, V85, P2498, DOI 10.2527/jas.2006-738; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; KINGSLEY MCS, 1979, CAN J ZOOL, V57, P1020, DOI 10.1139/z79-130; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kohn F, 2007, J ANIM SCI, V85, P84, DOI 10.2527/jas.2006-271; Kourtidis A, 2010, CANCER RES, V70, P1783, DOI 10.1158/0008-5472.CAN-09-1550; KRIETER J, 1989, J ANIM BREED GENET, V106, P300, DOI 10.1111/j.1439-0388.1989.tb00244.x; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Langelier MF, 2001, J BIOL CHEM, V276, P38652, DOI 10.1074/jbc.M106422200; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li X, 2010, MOL BIOL REP, V37, P3931, DOI 10.1007/s11033-010-0050-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU PW, 1994, J BONE MINER RES, V9, P1451; Mandal A, 2011, COMPUT STAT DATA AN, V55, P1086, DOI 10.1016/j.csda.2010.09.003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Mottram DS, 1998, FOOD CHEM, V62, P415, DOI 10.1016/S0308-8146(98)00076-4; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Nesetrilova H, 2005, CZECH J ANIM SCI, V50, P347, DOI 10.17221/4176-CJAS; Pas M. F. W. te, 2005, Archiv fur Tierzucht, V48, P141; Pas MFWT, 2005, J MUSCLE RES CELL M, V26, P157, DOI 10.1007/s10974-005-7004-6; Qiao Yong, 2007, Journal of Genetics and Genomics, V34, P909, DOI 10.1016/S1673-8527(07)60102-7; Richard D, 2009, CELL MOL LIFE SCI, V66, P3277, DOI 10.1007/s00018-009-0085-4; Shen LY, 2014, ANIM SCI J, V85, P770, DOI 10.1111/asj.12207; Sonck E, 2009, VET IMMUNOL IMMUNOP, V130, P131, DOI 10.1016/j.vetimm.2009.01.010; Strathe AB, 2010, J ANIM SCI, V88, P638, DOI 10.2527/jas.2009-1822; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang T, 2013, INT J BIOL SCI, V9, P550, DOI 10.7150/ijbs.6257; Watanabe Akira, 2004, Animal Science Journal, V75, P361, DOI 10.1111/j.1740-0929.2004.00198.x; Weatherup RN, 1998, ANIM SCI, V67, P591, DOI 10.1017/S1357729800033038; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Xiao RJ, 1999, ANIM FEED SCI TECH, V79, P119, DOI 10.1016/S0377-8401(98)00282-X; Xu YJ, 2012, J PROTEOMICS, V75, P2093, DOI 10.1016/j.jprot.2012.01.013; Yang HJ, 2005, MEAT SCI, V71, P670, DOI 10.1016/j.meatsci.2005.05.019; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhou HT, 2010, DEV COMP IMMUNOL, V34, P246, DOI 10.1016/j.dci.2009.11.002	60	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135978	10.1371/journal.pone.0135978	http://dx.doi.org/10.1371/journal.pone.0135978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292092	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900044
J	Tillack, K; Aboutalebi, H; Kramer, ER				Tillack, Karsten; Aboutalebi, Helia; Kramer, Edgar R.			An Efficient and Versatile System for Visualization and Genetic Modification of Dopaminergic Neurons in Transgenic Mice	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; HYDROXYLASE MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; TYROSINE-HYDROXYLASE; CRE RECOMBINASE; CATECHOLAMINERGIC NEURONS; CONDITIONAL EXPRESSION; PARKINSONS-DISEASE; LATERAL HABENULA	Background & Aims The brain dopaminergic (DA) system is involved in fine tuning many behaviors and several human diseases are associated with pathological alterations of the DA system such as Parkinson's disease (PD) and drug addiction. Because of its complex network integration, detailed analyses of physiological and pathophysiological conditions are only possible in a whole organism with a sophisticated tool box for visualization and functional modification. Methods & Results Here, we have generated transgenic mice expressing the tetracycline-regulated transactivator (tTA) or the reverse tetracycline-regulated transactivator (rtTA) under control of the tyrosine hydroxylase (TH) promoter, TH-tTA (tet-OFF) and TH-rtTA (tet-ON) mice, to visualize and genetically modify DA neurons. We show their tight regulation and efficient use to overexpress proteins under the control of tet-responsive elements or to delete genes of interest with tet-responsive Cre. In combination with mice encoding tet-responsive luciferase, we visualized the DA system in living mice progressively over time. Conclusion These experiments establish TH-tTA and TH-rtTA mice as a powerful tool to generate and monitor mouse models for DA system diseases.	[Tillack, Karsten; Aboutalebi, Helia; Kramer, Edgar R.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Dev & Maintenance Nervous Syst, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kramer, ER (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Dev & Maintenance Nervous Syst, Hamburg, Germany.	kramer@zmnh.uni-hamburg.de	Kramer, Edgar/A-9288-2012	Kramer, Edgar/0000-0002-4882-4143	German Research Foundation (DFG) [KR 3529/4-1]; town of Hamburg (Lexi)	German Research Foundation (DFG)(German Research Foundation (DFG)); town of Hamburg (Lexi)	This study was supported by grants from the German Research Foundation (DFG KR 3529/4-1 to ERK) and the town of Hamburg (Lexi to ERK).	Asmus SE, 2008, BRAIN RES, V1222, P95, DOI 10.1016/j.brainres.2008.05.053; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Baker H, 2003, CELL MOL NEUROBIOL, V23, P507, DOI 10.1023/A:1025015928129; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Cagniard B, 2006, NEURON, V51, P541, DOI 10.1016/j.neuron.2006.07.026; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; DIPORZIO U, 1990, INT J DEV NEUROSCI, V8, P523; Donaldson AE, 2005, MOL CELL NEUROSCI, V30, P108, DOI 10.1016/j.mcn.2005.06.004; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Evans MS, 2014, NAT METHODS, V11, P393, DOI [10.1038/NMETH.2839, 10.1038/nmeth.2839]; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; FUJII T, 1994, NEUROSCI LETT, V165, P161, DOI 10.1016/0304-3940(94)90734-X; Gardaneh M, 2004, MOL BRAIN RES, V126, P173, DOI 10.1016/j.molbrainres.2004.04.008; Gelman DM, 2003, GENESIS, V36, P196, DOI 10.1002/gene.10217; Gingrich JR, 1998, ANNU REV NEUROSCI, V21, P377, DOI 10.1146/annurev.neuro.21.1.377; Golden JP, 2013, J NEUROSCI, V 33, P17095, DOI 10.1523/JNEUROSCI.0890-13.2013; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masuda M, 2011, EUR J NEUROSCI, V34, P1355, DOI 10.1111/j.1460-9568.2011.07873.x; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; MIN N, 1994, MOL BRAIN RES, V27, P281, DOI 10.1016/0169-328X(94)90011-6; Oyer JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004832; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Qiu HY, 2008, GENESIS, V46, P324, DOI 10.1002/dvg.20399; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Root DH, 2014, J NEUROSCI, V34, P13906, DOI 10.1523/JNEUROSCI.2029-14.2014; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; SATOH J, 1990, DEV BRAIN RES, V53, P1, DOI 10.1016/0165-3806(90)90119-J; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schonig K, 2013, TRANSGENIC RES, V22, P251, DOI 10.1007/s11248-012-9660-9; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Smedemark-Margulies N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00018; Smidt MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042641; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Stuber GD, 2015, NEURON, V85, P439, DOI 10.1016/j.neuron.2014.12.034; Takebayashi H, 2008, GENESIS, V46, P775, DOI 10.1002/dvg.20461; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Wurst W, 2010, DOPAMINE HDB, P141; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zhou WB, 2009, STEM CELLS, V27, P2952, DOI 10.1002/stem.216; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	64	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136203	10.1371/journal.pone.0136203	http://dx.doi.org/10.1371/journal.pone.0136203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291828	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900064
J	Xu, JQ; Hu, HX; Chen, B; Yue, RC; Zhou, Z; Liu, Y; Zhang, S; Xu, L; Wang, H; Yu, ZP				Xu, Jiqian; Hu, Houxiang; Chen, Bin; Yue, Rongchuan; Zhou, Zhou; Liu, Yin; Zhang, Shuang; Xu, Lei; Wang, Huan; Yu, Zhengping			Lycopene Protects against Hypoxia/Reoxygenation Injury by Alleviating ER Stress Induced Apoptosis in Neonatal Mouse Cardiomyocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION-INJURY; CARDIOVASCULAR-DISEASE; BETA-CAROTENE; CELL-CYCLE; HEART; INHIBITION	Endoplasmic reticulum (ER) stress induced apoptosis plays a pivotal role in myocardial ischemia/reperfusion (I/R)-injury. Inhibiting ER stress is a major therapeutic target/strategy in treating cardiovascular diseases. Our previous studies revealed that lycopene exhibits great pharmacological potential in protecting against the I/R-injury in vitro and vivo, but whether attenuation of ER stress (and) or ER stress-induced apoptosis contributes to the effects remains unclear. In the present study, using neonatal mouse cardiomyocytes to establish an in vitro model of hypoxia/reoxygenation (H/R) to mimic myocardium I/R in vivo, we aimed to explore the hypothesis that lycopene could alleviate the ER stress and ER stress-induced apoptosis in H/R-injury. We observed that lycopene alleviated the H/R injury as revealed by improving cell viability and reducing apoptosis, suppressed reactive oxygen species (ROS) generation and improved the phosphorylated AMPK expression, attenuated ER stress as evidenced by decreasing the expression of GRP78, ATF6 mRNA, sXbp-1 mRNA, eIF2 alpha mRNA and eIF2 alpha phosphorylation, alleviated ER stress-induced apoptosis as manifested by reducing CHOP/GADD153 expression, the ratio of Bax/Bcl-2, caspase-12 and caspase-3 activity in H/R-treated cardiomyocytes. Thapsigargin (TG) is a potent ER stress inducer and used to elicit ER stress of cardiomyocytes. Our results showed that lycopene was able to prevent TG-induced ER stress as reflected by attenuating the protein expression of GRP78 and CHOP/GADD153 compared to TG group, significantly improve TG-caused a loss of cell viability and decrease apoptosis in TG-treated cardiomyocytes. These results suggest that the protective effects of lycopene on H/R-injury are, at least in part, through alleviating ER stress and ER stress-induced apoptosis in neonatal mouse cardiomyocytes.	[Xu, Jiqian; Hu, Houxiang; Yue, Rongchuan; Zhang, Shuang; Xu, Lei; Wang, Huan] Affiliated Hosp, North Sichuan Med Coll, Dept Cardiol, Nanchong 637000, Sichuan, Peoples R China; [Xu, Jiqian; Chen, Bin] Affiliated Hosp, North Sichuan Med Coll, Dept Anesthesiol, Nanchong 637000, Sichuan, Peoples R China; [Zhou, Zhou; Yu, Zhengping] Third Mil Med Univ, Dept Occupat Hlth, Chongqing 400038, Peoples R China; [Liu, Yin] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	North Sichuan Medical University; North Sichuan Medical University; Army Medical University; Western University (University of Western Ontario)	Hu, HX (corresponding author), Affiliated Hosp, North Sichuan Med Coll, Dept Cardiol, Nanchong 637000, Sichuan, Peoples R China.	hhxiang17@163.com; chenbin8703@163.com			National Natural Science Foundation of China [NSFC 81070101]; Applied Basic Research Programs of Sichuan Provincial Science and Education Department [12ZA060, 15ZB0200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Programs of Sichuan Provincial Science and Education Department	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81070101) and the Applied Basic Research Programs of Sichuan Provincial Science and Education Department (12ZA060 and 15ZB0200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca CA, 2012, PHARM BIOL, V50, P1513, DOI 10.3109/13880209.2012.688057; Bansal P, 2006, MOL CELL BIOCHEM, V289, P1, DOI 10.1007/s11010-006-9141-7; Bian YF, 2011, J INVEST MED, V59, P921, DOI 10.2310/JIM.0b013e318216ad04; Cao HP, 2013, IN VITRO CELL DEV-AN, V49, P759, DOI 10.1007/s11626-013-9671-8; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091793; Crnkovic S, 2012, FREE RADICAL BIO MED, V52, P1786, DOI 10.1016/j.freeradbiomed.2012.02.036; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Das S, 2005, FREE RADICAL RES, V39, P449, DOI 10.1080/10715760500053685; Ekelof S, 2014, CARDIOVASC DRUG THER, V28, P173, DOI 10.1007/s10557-014-6511-3; Fonseca ACRG, 2013, BBA-MOL BASIS DIS, V1832, P2191, DOI 10.1016/j.bbadis.2013.08.007; Fujita K, 2013, NEUROCHEM RES, V38, P461, DOI 10.1007/s11064-012-0952-5; Gao X, 2012, BASIC CLIN PHARMACOL, V111, P14, DOI 10.1111/j.1742-7843.2011.00854.x; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; Gupta P, 2013, BIOCHEM BIOPH RES CO, V434, P479, DOI 10.1016/j.bbrc.2013.03.099; Hardy B, 2010, J MOL MED, V88, P1157, DOI 10.1007/s00109-010-0657-7; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Karppi J, 2013, ATHEROSCLEROSIS, V226, P172, DOI 10.1016/j.atherosclerosis.2012.10.077; Karppi J, 2012, EUR J PUBLIC HEALTH, V22, P835, DOI 10.1093/eurpub/ckr174; Kim Y, 2010, BRAIN RES, V1317, P13, DOI 10.1016/j.brainres.2009.12.062; Levitsky S, 2006, CIRCULATION, V114, pI339, DOI 10.1161/CIRCULATIONAHA.105.001685; Levonen AL, 2008, CIRCULATION, V117, P2142, DOI 10.1161/CIRCULATIONAHA.107.718585; Liu BM, 2012, FREE RADICAL BIO MED, V53, P183, DOI 10.1016/j.freeradbiomed.2012.04.015; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Neuber C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098893; Oerlemans MIFJ, 2013, INT J CARDIOL, V165, P410, DOI 10.1016/j.ijcard.2012.03.055; Soares NDP, 2013, NUTR CANCER, V65, P1076, DOI 10.1080/01635581.2013.812225; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Qiu B, 2013, BIOCHEM BIOPH RES CO, V436, P655, DOI 10.1016/j.bbrc.2013.05.142; Qiu X, 2013, CANCER PREV RES, V6, P419, DOI 10.1158/1940-6207.CAPR-12-0364; Song P, 2012, FREE RADICAL BIO MED, V52, P1607, DOI 10.1016/j.freeradbiomed.2012.01.025; Takeshima M, 2014, CANCER SCI, V105, P252, DOI 10.1111/cas.12349; Tao JP, 2011, AM J PHYSIOL-HEART C, V301, pH1471, DOI 10.1152/ajpheart.00097.2011; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Upaganlawar Aman, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P345, DOI 10.1016/S2221-1691(12)60054-9; Wu CX, 2013, NEUROSCI LETT, V546, P57, DOI 10.1016/j.neulet.2013.04.060; Wu XD, 2013, APOPTOSIS, V18, P85, DOI 10.1007/s10495-012-0766-6; Yadavilli S, 2007, TOXICOL IN VITRO, V21, P1429, DOI 10.1016/j.tiv.2007.06.007; Yeh CH, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/130636; Yi F, 2013, NEUROCHEM RES, V38, P1747, DOI 10.1007/s11064-013-1079-z; Yue RC, 2015, J CELL PHYSIOL, V230, P2128, DOI 10.1002/jcp.24941; Yue RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050778; Zhang GG, 2013, PEPTIDES, V48, P156, DOI 10.1016/j.peptides.2013.08.015; Zhu XY, 2013, J ETHNOPHARMACOL, V150, P672, DOI 10.1016/j.jep.2013.09.044	48	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136443	10.1371/journal.pone.0136443	http://dx.doi.org/10.1371/journal.pone.0136443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291709	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900085
J	Yap, TWC; Leow, AHR; Azmi, AN; Francois, F; Perez-Perez, GI; Blaser, MJ; Poh, BH; Loke, MF; Goh, KL; Vadivelu, J				Yap, Theresa Wan-Chen; Leow, Alex Hwong-Ruey; Azmi, Ahmad Najib; Francois, Fritz; Perez-Perez, Guillermo I.; Blaser, Martin J.; Poh, Bee-Hoon; Loke, Mun-Fai; Goh, Khean-Lee; Vadivelu, Jamuna			Changes in Metabolic Hormones in Malaysian Young Adults following Helicobacter pylori Eradication	PLOS ONE			English	Article							PLASMA GHRELIN LEVELS; BODY-MASS INDEX; CIRCULATING GHRELIN; GASTRIC GHRELIN; PANCREATIC-POLYPEPTIDE; GUT MICROBIOTA; FOOD-INTAKE; PEPTIDE YY; INFECTION; LEPTIN	Background More than half of the world's adults carry Helicobacter pylori. The eradication of H. pylori may affect the regulation of human metabolic hormones. The aim of this study was to evaluate the effect of H. pylori eradication on meal-associated changes in appetite-controlled insulinotropic and digestive hormones, and to assess post-eradication changes in body mass index as part of a currently on-going multicentre ESSAY (Eradication Study in Stable Adults/Youths) study. Methods We enrolled 29 H. pylori-positive young adult (18-30 year-old) volunteer subjects to evaluate the effect of H. pylori eradication on meal-associated changes on eight gastrointestinal hormones, using a multiplex bead assay. Changes in body mass index and anthropometric measurements were recorded, pre- and post-eradication therapy. Results Pre-prandial active amylin, total peptide YY (PYY) and pancreatic polypeptide (PP) levels were significantly elevated 12 months post-eradication compared with baseline (n = 18; Wilcoxon's signed rank test, p<0.05). Four of the post-prandial gut metabolic hormones levels (GLP-1, total PYY, active amylin, PP) were significantly higher 12 months post-eradication compared to baseline (n = 18; p<0.05). Following H. pylori eradication, the BMI and anthropometric values did not significantly change. Conclusions Our study indicates that H. pylori eradication was associated with long-term disturbance in three hormones (active amylin, PP and total PYY) both pre- and post-prandially and one hormone (GLP-1) post-prandially. Longer post-eradication monitoring is needed to investigate the long-term impact of the observed hormonal changes on metabolic homeostasis.	[Yap, Theresa Wan-Chen; Loke, Mun-Fai; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Leow, Alex Hwong-Ruey; Azmi, Ahmad Najib; Goh, Khean-Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia; [Francois, Fritz] NYU, Sch Med, Inst Canc, New York, NY USA; [Francois, Fritz; Perez-Perez, Guillermo I.; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY USA; [Perez-Perez, Guillermo I.; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Poh, Bee-Hoon] BP Healthcare, Ipoh 30250, Perak, Malaysia	Universiti Malaya; Universiti Malaya; New York University; New York University; New York University	Loke, MF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	lokemunfai@um.edu.my	Goh, Khean-Lee/B-6404-2009; Perez, Guillermo Perez/AAJ-3761-2020; Loke, Mun Fai/B-1060-2011; Leow, Alex HR/B-1626-2017; VADIVELU, JAMUNARANI S/B-8696-2010	Goh, Khean-Lee/0000-0002-9965-1561; Loke, Mun Fai/0000-0002-3554-5313; Leow, Alex HR/0000-0003-1752-0435; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Perez Perez, Guillermo/0000-0002-0131-5798; Francois, Fritz/0000-0003-4491-2637	University of Malaya-Ministry of Education (UM-MOE) High Impact Research (HIR) [UM.C/HIR/MOE/13/4, H-50001-00-A000029]; Diane Belfer Program for Human Microbial Ecology; C and D fund; Knapp Family Fund	University of Malaya-Ministry of Education (UM-MOE) High Impact Research (HIR); Diane Belfer Program for Human Microbial Ecology; C and D fund; Knapp Family Fund	This study was supported by the University of Malaya-Ministry of Education (UM-MOE) High Impact Research (HIR) Grant UM.C/HIR/MOE/13/4 (HIR Account No: H-50001-00-A000029), by the Diane Belfer Program for Human Microbial Ecology, the C and D fund (philanthropic (non-commercial) anonymous donors), and the Knapp Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to also declare that one of the authors is employed by a commercial company called BP Healthcare. This commercial affiliation provided support in the form of salaries for author BHP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the "Author contributions" section.	Anini Y, 1999, PFLUG ARCH EUR J PHY, V438, P299, DOI 10.1007/s004240050913; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Azuma T, 2001, GUT, V49, P324, DOI 10.1136/gut.49.3.324; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Boey CCM, 1999, J PAEDIATR CHILD H, V35, P151, DOI 10.1046/j.1440-1754.1999.00306.x; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chan JL, 2004, J CLIN ENDOCR METAB, V89, P335, DOI 10.1210/jc.2003-031412; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Choe YH, 2007, GUT LIVER, V1, P132, DOI 10.5009/gnl.2007.1.2.132; Clyne M, 2007, FEMS MICROBIOL LETT, V268, P135, DOI 10.1111/j.1574-6968.2007.00648.x; Corry J.E., 2003, PROGR IND MICROBIOLO, VVol. 37., P271; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Francois F, 2008, GUT, V57, P16, DOI 10.1136/gut.2007.131672; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; Goh K L, 2009, Med J Malaysia, V64, P187; Goh KL, 1997, J GASTROEN HEPATOL, V12, pS29, DOI 10.1111/j.1440-1746.1997.tb00455.x; Goh KL, 2001, EUR J GASTROEN HEPAT, V13, P177, DOI 10.1097/00042737-200102000-00014; GRANBERG C, 1993, J CLIN MICROBIOL, V31, P1450, DOI 10.1128/JCM.31.6.1450-1453.1993; Ho GY, 2001, AM J GASTROENTEROL, V96, P3288, DOI 10.1111/j.1572-0241.2001.05327.x; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x; Ikezaki A, 2002, DIABETES, V51, P3408, DOI 10.2337/diabetes.51.12.3408; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Jang EJ, 2008, J GASTROEN HEPATOL, V23, pS278, DOI 10.1111/j.1440-1746.2008.05415.x; Kaneko H, 2002, J GASTROENTEROL, V37, P77, DOI 10.1007/s005350200000; Kaur Gurjeet, 2003, Malays J Med Sci, V10, P66; Kawashima J, 2009, J GASTROENTEROL, V44, P1046, DOI 10.1007/s00535-009-0120-0; KIRCHNER H, 2012, HDB EXP PHARM, V209, P161, DOI DOI 10.1007/978-3-642-24716-3_7; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; KODA JE, 1992, LANCET, V339, P1179, DOI 10.1016/0140-6736(92)90785-2; Liew PL, 2006, OBES SURG, V16, P612, DOI 10.1381/096089206776945002; Lutz TA, 2006, PHYSIOL BEHAV, V89, P465, DOI 10.1016/j.physbeh.2006.04.001; MAZZAFERRI EL, 1984, J CLIN ENDOCR METAB, V58, P640, DOI 10.1210/jcem-58-4-640; Mearin F, 1999, AM J GASTROENTEROL, V94, P116; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Muller A, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-25; Musial F, 2007, WORLD J GASTROENTERO, V13, P3425, DOI 10.3748/wjg.v13.i25.3425; Nwokolo CU, 2003, GUT, V52, P637, DOI 10.1136/gut.52.5.637; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Osawa H, 2008, WORLD J GASTROENTERO, V14, P6327, DOI 10.3748/wjg.14.6327; Osawa H, 2006, J GASTROENTEROL, V41, P954, DOI 10.1007/s00535-006-1880-4; Pacifico L, 2008, EUR J ENDOCRINOL, V158, P323, DOI 10.1530/EJE-07-0438; Robinson K, 2010, ADV M C M, P94, DOI 10.1079/9781845935948.0094; Rushdan AA, 2005, MED J MALAYSIA, V60, P27; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shimzu T, 2002, GUT, V51, P142, DOI 10.1136/gut.51.1.142; Sreenivasan Sasidharan, 2012, Asian Pacific Journal of Tropical Disease, V2, P502; Sun J, 2014, GENES DIS, V1, P132, DOI 10.1016/j.gendis.2014.08.001; Cadamuro ACT, 2014, WORLD J GASTROENTERO, V20, P1424, DOI 10.3748/wjg.v20.i6.1424; Tay CY, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-126; Thorens B, 2011, DIABETES OBES METAB, V13, P82, DOI 10.1111/j.1463-1326.2011.01453.x; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; TYTGAT GNJ, 1991, J GASTROEN HEPATOL, V6, P223, DOI 10.1111/j.1440-1746.1991.tb01469.x; Ulasoglu C, 2013, WORLD J GASTROENTERO, V19, P2388, DOI 10.3748/wjg.v19.i15.2388; vandeWouw BAM, 1995, NETH J MED, V47, P272, DOI 10.1016/0300-2977(95)00104-2; Wynne K, 2004, J CLIN ENDOCR METAB, V89, P2576, DOI 10.1210/jc.2004-0189; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yamada Y, 2006, DIABETES, V55, pS86, DOI 10.2337/db06-S011	67	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135771	10.1371/journal.pone.0135771	http://dx.doi.org/10.1371/journal.pone.0135771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291794	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900031
J	Medlock, AE; Shiferaw, MT; Marcero, JR; Vashisht, AA; Wohlschlegel, JA; Phillips, JD; Dailey, HA				Medlock, Amy E.; Shiferaw, Mesafint T.; Marcero, Jason R.; Vashisht, Ajay A.; Wohlschlegel, James A.; Phillips, John D.; Dailey, Harry A.			Identification of the Mitochondrial Heme Metabolism Complex	PLOS ONE			English	Article							LINKED SIDEROBLASTIC ANEMIA; ERYTHROID CELL-DIFFERENTIATION; SUCCINYL-COA SYNTHETASE; SYNTHASE MESSENGER-RNA; PORPHOBILINOGEN DEAMINASE; ERYTHROLEUKEMIA-CELLS; IN-SITU; ABC-ME; IRON; ENZYME	Heme is an essential cofactor for most organisms and all metazoans. While the individual enzymes involved in synthesis and utilization of heme are fairly well known, less is known about the intracellular trafficking of porphyrins and heme, or regulation of heme biosynthesis via protein complexes. To better understand this process we have undertaken a study of macromolecular assemblies associated with heme synthesis. Herein we have utilized mass spectrometry with coimmunoprecipitation of tagged enzymes of the heme biosynthetic pathway in a developing erythroid cell culture model to identify putative protein partners. The validity of these data obtained in the tagged protein system is confirmed by normal porphyrin/heme production by the engineered cells. Data obtained are consistent with the presence of a mitochondrial heme metabolism complex which minimally consists of ferrochelatase, protoporphyrinogen oxidase and aminolevulinic acid synthase-2. Additional proteins involved in iron and intermediary metabolism as well as mitochondrial transporters were identified as potential partners in this complex. The data are consistent with the known location of protein components and support a model of transient protein-protein interactions within a dynamic protein complex.	[Medlock, Amy E.; Shiferaw, Mesafint T.; Marcero, Jason R.; Dailey, Harry A.] Univ Georgia, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Medlock, Amy E.; Shiferaw, Mesafint T.; Marcero, Jason R.; Dailey, Harry A.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Dailey, Harry A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Medlock, Amy E.; Shiferaw, Mesafint T.] Univ Georgia, GRU UGA Med Partnership, Athens, GA 30602 USA; [Phillips, John D.] Univ Utah, Sch Med, Dept Med, Div Hematol, Salt Lake City, UT USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Medlock, AE (corresponding author), Univ Georgia, Biomed & Hlth Sci Inst, Athens, GA 30602 USA.	medlock@uga.edu		Medlock, Amy/0000-0001-9402-3593	American Heart Association [12GRNT12080123]; National Institutes of Health [DK096051, GM089778, DK020503, DK083909]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096051, R56DK020503, R01DK020503, U54DK083909, R37DK020503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The research was supported by an American Heart Association (http://www.heart.org) grant 12GRNT12080123 (to A.E.M.) and National Institutes of Health (http://www.nih.gov) grants DK096051 (to H.A.D.), GM089778 (to J.A.W.), DK020503 and DK083909 (to J.D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070; Barman-Aksozen J, 2013, BLOOD CELL MOL DIS, V51, P151, DOI 10.1016/j.bcmd.2013.05.008; Bayeva M, 2013, CIRC RES, V113, P279, DOI 10.1161/CIRCRESAHA.113.301552; Bekri S, 2000, BLOOD, V96, P3256; Besur S, 2014, METABOLITES, V4, P977, DOI 10.3390/metabo4040977; BHASKER CR, 1993, J BIOL CHEM, V268, P12699; Bishop DF, 2012, J BIOL CHEM, V287, P28943, DOI 10.1074/jbc.M111.306423; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; Burden AE, 1999, BBA-PROTEIN STRUCT M, V1435, P191, DOI 10.1016/S0167-4838(99)00196-X; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Cardalda CA, 1997, ARCH BIOCHEM BIOPHYS, V347, P69, DOI 10.1006/abbi.1997.0310; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; CHEUNG CW, 1989, J BIOL CHEM, V264, P4038; CONDER LH, 1991, BIOCHEM J, V275, P321, DOI 10.1042/bj2750321; De March M, 2014, J INORG BIOCHEM, V135, P58, DOI 10.1016/j.jinorgbio.2014.02.015; Deery E, 2012, NAT CHEM BIOL, V8, P933, DOI [10.1038/NCHEMBIO.1086, 10.1038/nchembio.1086]; DEYBACH JC, 1985, EUR J BIOCHEM, V149, P431, DOI 10.1111/j.1432-1033.1985.tb08943.x; ELDER GH, 1978, BIOCHEM J, V172, P345, DOI 10.1042/bj1720345; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Furuyama K, 2000, J CLIN INVEST, V105, P757, DOI 10.1172/JCI6816; Gill R, 2009, BIOCHEM J, V420, P17, DOI 10.1042/BJ20082077; GRANDCHAMP B, 1978, BIOCHEM J, V176, P97, DOI 10.1042/bj1760097; Hamdi A, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4023.4023; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HRADILEK A, 1992, J CELL PHYSIOL, V150, P327, DOI 10.1002/jcp.1041500216; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Kabe Y, 2006, J BIOL CHEM, V281, P31729, DOI 10.1074/jbc.M604729200; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; LAKEBULLOCK H, 1993, MOL CELL BIOL, V13, P7122, DOI 10.1128/MCB.13.11.7122; Leighton J, 1998, METHOD ENZYMOL, V292, P776; Liesa M, 2012, BBA-MOL CELL RES, V1823, P1945, DOI 10.1016/j.bbamcr.2012.07.013; Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Medlock Amy E., 2009, P116, DOI 10.1007/978-0-387-78518-9_7; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; OHTA Y, 1976, P NATL ACAD SCI USA, V73, P1232, DOI 10.1073/pnas.73.4.1232; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; ROBINSON JB, 1985, J BIOL CHEM, V260, P800; RUTHERFORD T, 1979, P NATL ACAD SCI USA, V76, P833, DOI 10.1073/pnas.76.2.833; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; SINGER D, 1974, P NATL ACAD SCI USA, V71, P2668, DOI 10.1073/pnas.71.7.2668; Spector DL, 1999, INSTITUTE OF EXPERIM, V1, P411; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; SRERE PA, 1994, BIOCHEM SOC T, V22, P446, DOI 10.1042/bst0220446; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212; Tang LL, 2012, BRIT J HAEMATOL, V157, P151, DOI 10.1111/j.1365-2141.2011.08936.x; TSAI SF, 1987, J BIOL CHEM, V262, P1268; WARD JH, 1982, J BIOL CHEM, V257, P317; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Woodard SI, 2000, ARCH BIOCHEM BIOPHYS, V384, P375, DOI 10.1006/abbi.2000.2069; Yamamoto M, 2014, MOL CELL BIOL, V34, P1077, DOI 10.1128/MCB.00865-13; Yien YY, 2014, J CLIN INVEST, V124, P4294, DOI 10.1172/JCI76979; YOUNG SP, 1990, BIOCHEM J, V265, P587, DOI 10.1042/bj2650587; Zhang AS, 2005, BLOOD, V105, P368, DOI 10.1182/blood-2004-06-2226	67	64	64	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135896	10.1371/journal.pone.0135896	http://dx.doi.org/10.1371/journal.pone.0135896			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287972	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600082
J	Senanayake, U; Piraveenan, M; Zomaya, A				Senanayake, Upul; Piraveenan, Mahendra; Zomaya, Albert			The Pagerank-Index: Going beyond Citation Counts in Quantifying Scientific Impact of Researchers	PLOS ONE			English	Article							H-INDEX; BIBLIOMETRIC INDICATORS	Quantifying and comparing the scientific output of researchers has become critical for governments, funding agencies and universities. Comparison by reputation and direct assessment of contributions to the field is no longer possible, as the number of scientists increases and traditional definitions about scientific fields become blurred. The h-index is often used for comparing scientists, but has several well-documented shortcomings. In this paper, we introduce a new index for measuring and comparing the publication records of scientists: the pagerank-index (symbolised as pi). The index uses a version of pagerank algorithm and the citation networks of papers in its computation, and is fundamentally different from the existing variants of h-index because it considers not only the number of citations but also the actual impact of each citation. We adapt two approaches to demonstrate the utility of the new index. Firstly, we use a simulation model of a community of authors, whereby we create various 'groups' of authors which are different from each other in inherent publication habits, to show that the pagerank-index is fairer than the existing indices in three distinct scenarios: (i) when authors try to 'massage' their index by publishing papers in low-quality outlets primarily to self-cite other papers (ii) when authors collaborate in large groups in order to obtain more authorships (iii) when authors spend most of their time in producing genuine but low quality publications that would massage their index. Secondly, we undertake two real world case studies: (i) the evolving author community of quantum game theory, as defined by Google Scholar (ii) a snapshot of the high energy physics (HEP) theory research community in arXiv. In both case studies, we find that the list of top authors vary very significantly when h-index and pagerank-index are used for comparison. We show that in both cases, authors who have collaborated in large groups and/or published less impactful papers tend to be comparatively favoured by the h-index, whereas the pagerank-index highlights authors who have made a relatively small number of definitive contributions, or written papers which served to highlight the link between diverse disciplines, or typically worked in smaller groups. Thus, we argue that the pagerank-index is an inherently fairer and more nuanced metric to quantify the publication records of scientists compared to existing measures.	[Senanayake, Upul; Piraveenan, Mahendra] Univ Sydney, Fac Engn & IT, Ctr Complex Syst Res, Sydney, NSW 2006, Australia; [Zomaya, Albert] Univ Sydney, Sch Informat Technol, Ctr Distributed & High Performance Comp, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Piraveenan, M (corresponding author), Univ Sydney, Fac Engn & IT, Ctr Complex Syst Res, Sydney, NSW 2006, Australia.	mahendrarajah.piraveenan@sydney.edu.au	Zomaya, Albert Y./G-9697-2017	Zomaya, Albert Y./0000-0002-3090-1059				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2008, QUANTUM GAME THEORY; [Anonymous], 1998, TECHNICAL REPORT; ArXivData, 2003, KDD CUP 2003; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1381, DOI 10.1002/asi.20609; Chai JC., 2008, P WIS; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Costas R, 2007, J INFORMETR, V1, P193, DOI 10.1016/j.joi.2007.02.001; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hu XJ, 2010, J INF SCI, V36, P73, DOI 10.1177/0165551509348133; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Konstantin K, 2008, SCIENTOMETRICS, V77, P373, DOI [10.1007/s11192-006-1716-2, DOI 10.1007/S11192-006-1716-2]; Kozak M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047679; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Ma N, 2008, INFORM PROCESS MANAG, V44, P800, DOI 10.1016/j.ipm.2007.06.006; PINSKI G, 1976, INFORM PROCESS MANAG, V12, P297, DOI 10.1016/0306-4573(76)90048-0; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; SIMON HA, 1955, BIOMETRIKA, V42, P425; Tscharntke T, 2007, PLOS BIOL, V5, P13, DOI 10.1371/journal.pbio.0050018; van Nierop E, 2009, STAT NEERL, V63, P52, DOI 10.1111/j.1467-9574.2008.00408.x; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Walker D, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/06/P06010; Waltman L, 2012, CORR ABS 1206 4863; Waltman L, 2012, MEAS-INTERDISCIP RES, V10, P172, DOI 10.1080/15366367.2012.716260; Zhang H, 2004, LECT NOTES COMPUT SC, V3243, P92	27	45	46	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134794	10.1371/journal.pone.0134794	http://dx.doi.org/10.1371/journal.pone.0134794			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26288312	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600028
J	Tung-Thompson, G; Libera, DA; Koch, KL; de los Reyes, FL; Jaykus, LA				Tung-Thompson, Grace; Libera, Dominic A.; Koch, Kenneth L.; de los Reyes, Francis L., III; Jaykus, Lee-Ann			Aerosolization of a Human Norovirus Surrogate, Bacteriophage MS2, during Simulated Vomiting	PLOS ONE			English	Article							NORWALK VIRUS; AIRBORNE TRANSMISSION; ARTIFICIAL SALIVA; ENTERIC VIRUSES; UNITED-STATES; GASTROENTERITIS; CONTAMINATION; ENVIRONMENT; INFECTION; OUTBREAKS	Human noroviruses (NoV) are the leading cause of acute gastroenteritis worldwide. Epidemiological studies of outbreaks have suggested that vomiting facilitates transmission of human NoV, but there have been no laboratory-based studies characterizing the degree of NoV release during a vomiting event. The purpose of this work was to demonstrate that virus aerosolization occurs in a simulated vomiting event, and to estimate the amount of virus that is released in those aerosols. A simulated vomiting device was constructed at one-quarter scale of the human body following similitude principles. Simulated vomitus matrices at low (6.24 mPa*s) and high (177.5 mPa*s) viscosities were inoculated with low (10(8) PFU/mL) and high (10(10) PFU/mL) concentrations of bacteriophage MS2 and placed in the artificial "stomach" of the device, which was then subjected to scaled physiologically relevant pressures associated with vomiting. Bio aerosols were captured using an SKC Biosampler. In low viscosity artificial vomitus, there were notable differences between recovered aerosolized MS2 as a function of pressure (i.e., greater aerosolization with increased pressure), although this was not always statistically significant. This relationship disappeared when using high viscosity simulated vomitus. The amount of MS2 aerosolized as a percent of total virus "vomited" ranged from 7.2 x 10(-5) to 2.67 x 10(-2) (which corresponded to a range of 36 to 13,350 PFU total). To our knowledge, this is the first study to document and measure aerosolization of a NoV surrogate in a similitude-based physical model. This has implications for better understanding the transmission dynamics of human NoV and for risk modeling purposes, both of which can help in designing effective infection control measures.	[Tung-Thompson, Grace; Jaykus, Lee-Ann] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Libera, Dominic A.; de los Reyes, Francis L., III] N Carolina State Univ, Dept Civil Construct & Environm Engn, Raleigh, NC 27695 USA; [Koch, Kenneth L.] Wake Forest Univ, Bowman Gray Sch Med, Gastroenterol Sect, Winston Salem, NC 27157 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Wake Forest University; Wake Forest Baptist Medical Center	de los Reyes, FL (corresponding author), N Carolina State Univ, Dept Civil Construct & Environm Engn, Raleigh, NC 27695 USA.	fldelosr@ncsu.edu	de los Reyes, Francis/AAL-7909-2020; de los Reyes, Francis/E-6780-2011	de los Reyes, Francis/0000-0002-3593-0932; de los Reyes, Francis/0000-0002-3593-0932	USDA-CSREES National Integrated Food Safety Initiative (NIFSI) project [2011-51110-31020]; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-68003-30395]	USDA-CSREES National Integrated Food Safety Initiative (NIFSI) project; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported by the USDA-CSREES National Integrated Food Safety Initiative (NIFSI) project #2011-51110-31020 (http://www.nifa.usda.gov/nea/food/in_focus/safety_if_national.html). Partial support was also provided by Agriculture and Food Research Initiative Competitive Grant no. 2011-68003-30395 from the USDA National Institute of Food and Agriculture (http://www.nifa.usda.gov/funding/rfas/afri.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Badman L, 2001, WATER MATTERS PROPOS, P43; Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/1420326X03012001002; Beggs CB, 2000, INDOOR BUILT ENVIRON, V9, P241, DOI 10.1159/000057517; Bonifait L, 2015, CLIN INFECT DIS, V61, P299, DOI 10.1093/cid/civ321; CAUL EO, 1994, LANCET, V343, P1240, DOI 10.1016/S0140-6736(94)92146-6; Cheesbrough JS, 2000, EPIDEMIOL INFECT, V125, P93, DOI 10.1017/S095026889900432X; Dawson DJ, 2005, J APPL MICROBIOL, V98, P203, DOI 10.1111/j.1365-2672.2004.02439.x; Dijkstra PU, 1999, J ORAL REHABILITATIO; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Fox R.W., 2004, INTRO FLUID MECH; Gallimore CI, 2008, J CLIN MICROBIOL, V46, P3112, DOI 10.1128/JCM.00400-08; Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010; GREENBERG HB, 1979, LANCET, V1, P55; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Harris JP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003060; Hogan CJ, 2005, J APPL MICROBIOL, V99, P1422, DOI 10.1111/j.1365-2672.2005.02720.x; Iqbal A, 2008, SURG ENDOSC, V22, P2571, DOI 10.1007/s00464-008-0080-0; Isakbaeva ET, 2005, EMERG INFECT DIS, V11, P154, DOI 10.3201/eid1101.040434; Koch KL, 2006, THERAPY DIGESTIVE DI, P1003; Kotwal G, 2014, CURR OPIN VIROL, V4, P37, DOI 10.1016/j.coviro.2013.12.003; Kuo Braden, 2006, GI MOTILITY ONLINE, DOI DOI 10.1038/GIMO6; Leith DE, 1986, INDOOR AIR, DOI [10.1002/cphy.cp030320.31, DOI 10.1002/CPHY.CP030320.31]; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; MAILLARD JY, 1994, APPL ENVIRON MICROB, V60, P2205, DOI 10.1128/AEM.60.6.2205-2206.1994; Makison Booth Catherine, 2014, J Infect Prev, V15, P176, DOI 10.1177/1757177414545390; Marks PJ, 2000, EPIDEMIOL INFECT, V124, P481, DOI 10.1017/S0950268899003805; Nazaroff WW, 2011, INDOOR AIR, V21, P353, DOI 10.1111/j.1600-0668.2011.00735.x; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Sarkar A, 2009, FOOD HYDROCOLLOID, V23, P1270, DOI 10.1016/j.foodhyd.2008.09.008; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Su XW, 2011, APPL ENVIRON MICROB, V77, P3982, DOI 10.1128/AEM.00193-11; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Todd ECD, 2008, J FOOD PROTECT, V71, P2582, DOI 10.4315/0362-028X-71.12.2582; Tseng CC, 2005, J AEROSOL SCI, V36, P593, DOI 10.1016/j.jaerosci.2004.12.004; Turgeon N, 2014, APPL ENVIRON MICROB, V80, P4242, DOI 10.1128/AEM.00767-14; Utrup LJ, 2004, EXP BIOL MED, V229, P345, DOI 10.1177/153537020422900409; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Zuo ZL, 2014, APPL ENVIRON MICROB, V80, P2796, DOI 10.1128/AEM.00056-14	42	33	33	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134277	10.1371/journal.pone.0134277	http://dx.doi.org/10.1371/journal.pone.0134277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287612	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600018
J	Amber-Vitos, O; Kucherenko, N; Nachliel, E; Gutman, M; Tsfadia, Y				Amber-Vitos, Ortal; Kucherenko, Nataly; Nachliel, Esther; Gutman, Menachem; Tsfadia, Yossi			The Interaction of FABP with Kap alpha	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; FATTY-ACID-BINDING; IMPORTIN-ALPHA; STRUCTURAL BASIS; PROTEIN-BINDING; PPAR-GAMMA; RECEPTOR; NLS; SIMULATIONS; ACTIVATION	Gene-activating lipophilic compounds are carried into the nucleus when loaded on fatty-acid-binding proteins (FABP). Some of these proteins are recognized by the alpha-Karyopherin (Kap alpha) through its nuclear localization signal (NLS) consisting of three positive residues that are not in a continuous sequence. The Importin system can distinguish between FABP loaded with activating and non-activating compounds. In the present study, we introduced molecular dynamics as a tool for clarifying the mechanism by which FABP4, loaded with activating ligand (linoleate) is recognized by Kapa. In the first phase, we simulated the complex between Kap alpha(Delta IBB) (termed "Armadillo") that was crystallized with two NLS hepta-peptides. The trajectory revealed that the crystal-structure orientation of the peptides is rapidly lost and new interactions dominate. Though, the NLS sequence of FABP4 is cryptic, since the functional residues are not in direct sequence, implicating more than one possible conformation. Therefore, four possible docked conformations were generated, in which the NLS of FABP4 is interacting with either the major or the minor sites of Kap alpha, and the N -> C vectors are parallel or anti-parallel. Out of these four basic starting positions, only the FABP4-minor site complex exhibited a large number of contact points. In this complex, the FABP interacts with the minor and the major sites, suppressing the self-inhibitory interaction of the Kap alpha, rendering it free to react with Kap beta. Finally, we propose that the transportable conformation generated an extended hydrophobic domain which expanded out of the boundary of the FABP4, allowing the loaded linoleate to partially migrate out of the FABP into a joint complex in which the Kapa contributes part of a combined binding pocket.	[Amber-Vitos, Ortal; Kucherenko, Nataly; Nachliel, Esther; Gutman, Menachem; Tsfadia, Yossi] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Tsfadia, Y (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	YossiT@tauex.tau.ac.il						Armstrong EH, 2014, J BIOL CHEM; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Castelein H, 1997, BIOCHEM BIOPH RES CO, V233, P91, DOI 10.1006/bbrc.1997.6395; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Darnell SJ, 2008, NUCLEIC ACIDS RES, V36, pW265, DOI 10.1093/nar/gkn346; Daura X, 1999, PROTEINS, V36, P542, DOI 10.1002/(SICI)1097-0134(19990901)36:4<542::AID-PROT17>3.0.CO;2-M; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Fontes MRM, 2005, BBA-PROTEINS PROTEOM, V1750, P9, DOI 10.1016/j.bbapap.2005.03.014; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Glatz J.F.C., 2014, PROSTAGLANDINS LEUKO; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang H, 2014, FEBS J, V281, P2266, DOI 10.1111/febs.12780; Konecny R, 2012, COMPUTATIONAL SCIENC, V5; Kruger DM, 2013, NUCLEIC ACIDS RES, V41, pW340, DOI 10.1093/nar/gkt292; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; Morgan E, 2010, INVOLVEMENT FATTY AC, V2010; Motojima K, 1997, BIOCHEM BIOPH RES CO, V230, P155, DOI 10.1006/bbrc.1996.5906; Noy N, 2007, BIOCHEMISTRY-US, V46, P13461, DOI 10.1021/bi7018699; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pedraza L, 1997, NEURON, V18, P579, DOI 10.1016/S0896-6273(00)80299-8; Pfleger C, 2013, J COMPUT CHEM, V34, P220, DOI 10.1002/jcc.23122; Plutzky J, 2011, CIRC RES, V108, P1002, DOI 10.1161/CIRCRESAHA.110.226860; RICHIERI GV, 1995, J BIOL CHEM, V270, P15076, DOI 10.1074/jbc.270.25.15076; Roman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082038; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0132138	10.1371/journal.pone.0132138	http://dx.doi.org/10.1371/journal.pone.0132138			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284534	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100001
J	Juan-Mateu, J; Gonzalez-Quereda, L; Rodriguez, MJ; Baena, M; Verdura, E; Nascimento, A; Ortez, C; Baiget, M; Gallano, P				Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Rodriguez, Maria Jose; Baena, Manel; Verdura, Edgard; Nascimento, Andres; Ortez, Carlos; Baiget, Montserrat; Gallano, Pia			DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SPECTRIN-LIKE REPEATS; ACTIN-BINDING DOMAIN; BETA-DYSTROGLYCAN; MISSENSE MUTATIONS; POINT MUTATIONS; ZZ DOMAIN; GENOMIC DISORDERS; REFERRAL CENTER; GENE	Recent advances in molecular therapies for Duchenne muscular dystrophy (DMD) require precise genetic diagnosis because most therapeutic strategies are mutation-specific. To understand more about the genotype-phenotype correlations of the DMD gene we performed a comprehensive analysis of the DMD mutational spectrum in a large series of families. Here we provide the clinical, pathological and genetic features of 576 dystrophinopathy patients. DMD gene analysis was performed using the MLPA technique and whole gene sequencing in blood DNA and muscle cDNA. The impact of the DNA variants on mRNA splicing and protein functionality was evaluated by in silico analysis using computational algorithms. DMD mutations were detected in 576 unrelated dystrophinopathy families by combining the analysis of exonic copies and the analysis of small mutations. We found that 471 of these mutations were large intragenic rearrangements. Of these, 406 (70.5%) were exonic deletions, 64 (11.1%) were exonic duplications, and one was a deletion/duplication complex rearrangement (0.2%). Small mutations were identified in 105 cases (18.2%), most being nonsense/frameshift types (75.2%). Mutations in splice sites, however, were relatively frequent (20%). In total, 276 mutations were identified, 85 of which have not been previously described. The diagnostic algorithm used proved to be accurate for the molecular diagnosis of dystrophinopathies. The reading frame rule was fulfilled in 90.4% of DMD patients and in 82.4% of Becker muscular dystrophy patients (BMD), with significant differences between the mutation types. We found that 58% of DMD patients would be included in single exon-exon skipping trials, 63% from strategies directed against multiexon-skipping exons 45 to 55, and 14% from PTC therapy. A detailed analysis of missense mutations provided valuable information about their impact on the protein structure.	[Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Baiget, Montserrat; Gallano, Pia] Hosp Santa Creu & Sant Pau, Dept Genet, CIBERER U705, Barcelona, Spain; [Rodriguez, Maria Jose; Baena, Manel; Verdura, Edgard] Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona, Spain; [Nascimento, Andres; Ortez, Carlos] Hosp St Joan de Deu, Neuromuscular Unit, Esplugas de Llobregat, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau	Gallano, P (corresponding author), Hosp Santa Creu & Sant Pau, Dept Genet, CIBERER U705, Barcelona, Spain.	pgallano@santpau.cat	Gonzalez, Lidia/E-7669-2013	Gonzalez, Lidia/0000-0003-0715-6414; Juan-Mateu, Jonas/0000-0001-9749-6441; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Verdura, Edgard/0000-0003-3856-2060	Instituto de Salud Carlos III [PI 11/02586]; FEDER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER(European Commission)	The study is sponsored through a governmental grant of the Instituto de Salud Carlos III (PI 11/02586) which is co-funded by FEDER.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Acsadi G, 2012, J BIOL CHEM, V287, P18153, DOI 10.1074/jbc.M111.284521; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Becker Kristin, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9143; BEGGS AH, 1990, HUM GENET, V86, P45; Bennett RR, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-17; Bhasin N, 2005, J MOL BIOL, V352, P795, DOI 10.1016/j.jmb.2005.07.064; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; DeWolf C, 1997, BIOPHYS J, V72, P2599, DOI 10.1016/S0006-3495(97)78903-3; Dolinsky Luciana C B, 2003, Methods Mol Biol, V217, P165; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Ferlini A, 1998, AM J HUM GENET, V63, P436, DOI 10.1086/301952; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Flanigan KM, 2003, AM J HUM GENET, V72, P931, DOI 10.1086/374176; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; Gualandi F, 2006, GENE, V370, P26, DOI 10.1016/j.gene.2005.11.002; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; Hamed SA, 2006, AM J MED GENET B, V141B, P44, DOI 10.1002/ajmg.b.30234; Harper SQ, 2002, HUM MOL GENET, V11, P1807, DOI 10.1093/hmg/11.16.1807; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Hnia K, 2007, BIOCHEM J, V401, P667, DOI 10.1042/BJ20061051; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hofstra RMW, 2004, HUM MUTAT, V23, P57, DOI 10.1002/humu.10283; HU XY, 1991, EMBO J, V10, P2471, DOI 10.1002/j.1460-2075.1991.tb07786.x; HU XY, 1990, AM J HUM GENET, V46, P682; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Juan-Mateu J, 2012, CLIN GENET, V82, P574, DOI 10.1111/j.1399-0004.2011.01814.x; Juan-Mateu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059916; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Legrand B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023819; Mendell JR, 2001, NEUROLOGY, V57, P645, DOI 10.1212/WNL.57.4.645; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miller LA, 2006, BIRTH DEFECTS RES A, V76, P793, DOI 10.1002/bdra.20279; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Sakamoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1265, DOI 10.1016/S0006-291X(02)00362-5; Schwartz M, 2004, GENET TEST, V8, P361, DOI 10.1089/gte.2004.8.361; Sedlackova J, 2009, NEUROMUSCULAR DISORD, V19, P749, DOI 10.1016/j.nmd.2009.08.011; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; SOMMER SS, 1995, TRENDS GENET, V11, P141, DOI 10.1016/S0168-9525(00)89028-9; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Tokarz SA, 1998, MOL GENET METAB, V65, P272, DOI 10.1006/mgme.1998.2763; Tuffery-Giraud S, 2004, NEUROMUSCULAR DISORD, V14, P650, DOI 10.1016/j.nmd.2004.05.002; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Yamashita K, 2010, BIOCHEM BIOPH RES CO, V391, P812, DOI 10.1016/j.bbrc.2009.11.144; Zhong Min, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P757	78	70	80	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135189	10.1371/journal.pone.0135189	http://dx.doi.org/10.1371/journal.pone.0135189			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284620	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100026
J	Missbach, B; Hinterbuchinger, B; Dreiseitl, V; Zellhofer, S; Kurz, C; Konig, J				Missbach, Benjamin; Hinterbuchinger, Barbara; Dreiseitl, Verena; Zellhofer, Silvia; Kurz, Carina; Koenig, Juergen			When Eating Right, Is Measured Wrong! A Validation and Critical Examination of the ORTO-15 Questionnaire in German	PLOS ONE			English	Article							ORTHOREXIA NERVOSA; ADAPTATION; BEHAVIOR; HEALTHY	The characteristic trait of individuals developing a pathological obsession and preoccupation with healthy foods and a restrictive and avoidant eating behavior is described as orthorexia nervosa (ON). For ON, neither universal diagnosis criteria nor valid tools for large-scale epidemiologic assessment are available in the literature. The aim of the current study is to analyze the psychometric properties of a translated German version of the ORTO-15 questionnaire. The German version of the ORTO-15, a eating behavior and dieting habits questionnaire were completed by 1029 German-speaking participants (74.6% female) aged between 19 and 70 years (M = 31.21 +/- 10.43 years). Our results showed that after confirmatory factor analysis, the best fitting model of the original version is a single-factor structure (9-item shortened version: ORTO-9-GE). The final model showed only moderate internal consistency (Cronbach's alpha = .67), even after omitting 40% of the original question. A total of 69.1% participants showed orthorectic tendencies. Orthorectic tendencies are associated with special eating behavior features (dieting frequency, vegetarian and vegan diet). Education level did not influence ON tendency and nutritional students did not show higher ON tendency compared to students from other disciplines. This study is the first attempt to translate and to evaluate the psychometric properties of a German version of the ORTO-15 questionnaire. The ORTO-9-GE questionnaire, however, is only a mediocre tool for assessing orthorectic tendencies in individuals and shows moderate reliability and internal consistency. Our research suggests, that future studies are needed to provide more reliable and valid assessment tools to investigate orthorexia nervosa.	[Missbach, Benjamin; Dreiseitl, Verena; Zellhofer, Silvia; Kurz, Carina; Koenig, Juergen] Univ Vienna, Dept Nutr Sci, Vienna, Austria; [Hinterbuchinger, Barbara] Med Univ Vienna, Div Social Psychiat, Dept Psychiat & Psychotherapy, Vienna, Austria	University of Vienna; Medical University of Vienna	Missbach, B (corresponding author), Univ Vienna, Dept Nutr Sci, Vienna, Austria.	benjamin.missbach@univie.ac.at	Koenig, juergen/I-8130-2014; Missbach, Benjamin/B-3363-2017	Koenig, juergen/0000-0003-2184-9372; Hinterbuchinger, Barbara/0000-0003-0634-6398; Missbach, Benjamin/0000-0002-8513-6382	University of Vienna	University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna.	Aksoydan E, 2009, EAT WEIGHT DISORD-ST, V14, P33, DOI 10.1007/BF03327792; Alvarenga MS, 2012, EAT WEIGHT DISORD-ST, V17, pE29, DOI 10.1007/BF03325325; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Arusoglu G, 2008, TURK PSIKIYATR DERG, V19, P283; Bosi ATB, 2007, APPETITE, V49, P661, DOI 10.1016/j.appet.2007.04.007; Bratman S., 2001, HLTH FOOD JUNKIES OR; Brytek-Matera A., 2014, NEW DEV ANOREXIA NER, P39; Brytek-Matera A, 2015, J EAT DISORD, V3, DOI [10.1186/s40337-016-0105-3, 10.1186/s40337-015-0038-2]; Brytek-Matera A, 2014, EAT WEIGHT DISORD-ST, V19, P69, DOI 10.1007/s40519-014-0100-0; BURKERT NT, 2014, PLOS ONE, V9, DOI DOI 10.1371/J0URNAL.P0NE.0088278; Butcher JN, 1989, ENCY PSYCHOL; Cartwright Martina M, 2004, Crit Care Nurs Clin North Am, V16, P515, DOI 10.1016/j.ccell.2004.07.002; Donini L M, 2005, Eat Weight Disord, V10, pe28; Donini L M, 2004, Eat Weight Disord, V9, P151; Elgar FJ, 2005, J ADOLESCENT HEALTH, V37, P371, DOI 10.1016/j.jadohealth.2004.07.014; Eriksson L, 2008, SCAND J MED SCI SPOR, V18, P389, DOI 10.1111/j.1600-0838.2007.00723.x; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fidan T, 2010, COMPR PSYCHIAT, V51, P49, DOI 10.1016/j.comppsych.2009.03.001; Fox N, 2008, APPETITE, V50, P422, DOI 10.1016/j.appet.2007.09.007; Hair J., 2010, MULTIVARIATE DATA AN, V7; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Kinzl JF, 2006, PSYCHOTHER PSYCHOSOM, V75, P395, DOI 10.1159/000095447; Koven N.S., 2013, OJPSYCH, V3, P214, DOI [10.4236/ojpsych.2013.32019, DOI 10.4236/OJPSYCH.2013.32019]; Koven NS, 2015, NEUROPSYCH DIS TREAT, V11, P385, DOI 10.2147/NDT.S61665; Miles J, 2007, PERS INDIV DIFFER, V42, P869, DOI 10.1016/j.paid.2006.09.022; Moroze RM, 2014, PSYCHOSOMATICS, P19; Poinhos R, 2015, APPETITE, V84, P28, DOI 10.1016/j.appet.2014.09.011; Ramacciotti CE, 2011, EAT WEIGHT DISORD-ST, V16, pE127, DOI 10.1007/BF03325318; Segura-Garcia C, 2012, EAT WEIGHT DISORD-ST, V17, pE226, DOI 10.3275/8272; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; Vandereycken Walter, 2011, Eat Disord, V19, P145, DOI 10.1080/10640266.2011.551634; Varga M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-59; Varga M, 2013, EAT WEIGHT DISORD-ST, V18, P103, DOI 10.1007/s40519-013-0026-y; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zamora MLC, 2005, ACTAS ESP PSIQUIATRI, V33, P66	37	125	127	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135772	10.1371/journal.pone.0135772	http://dx.doi.org/10.1371/journal.pone.0135772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VK	26280449	Green Published, Green Submitted, gold			2022-12-27	WOS:000359664300022
J	Quisenberry, AJ; Eddy, CR; Patterson, DL; Franck, CT; Bickel, WK				Quisenberry, Amanda J.; Eddy, Celia R.; Patterson, David L.; Franck, Christopher T.; Bickel, Warren K.			Regret Expression and Social Learning Increases Delay to Sexual Gratification	PLOS ONE			English	Article							DECISION-MAKING; DEPENDENT OUTPATIENTS; HYPOTHETICAL REWARDS; ANTICIPATED REGRET; EXPECTED FEEDBACK; MONETARY REWARDS; TIME PERSPECTIVE; BEHAVIOR; DRUG; AVERSION	Objective Modification and prevention of risky sexual behavior is important to individuals' health and public health policy. This study employed a novel sexual discounting task to elucidate the effects of social learning and regret expression on delay to sexual gratification in a behavioral task. Methods Amazon Mechanical Turk Workers were assigned to hear one of three scenarios about a friend who engages in similar sexual behavior. The scenarios included a positive health consequence, a negative health consequence or a negative health consequence with the expression of regret. After reading one scenario, participants were asked to select from 60 images, those with whom they would have casual sex. Of the selected images, participants chose one image each for the person they most and least want to have sex with and person most and least likely to have a sexually transmitted infection. They then answered questions about engaging in unprotected sex now or waiting some delay for condom-protected sex in each partner condition. Results Results indicate that the negative health outcome scenario with regret expression resulted in delayed sexual gratification in the most attractive and least STI partner conditions, whereas in the least attractive and most STI partner conditions the negative health outcome with and without regret resulted in delayed sexual gratification. Conclusions Results suggest that the sexual discounting task is a relevant laboratory measure and the framing of information to include regret expression may be relevant for prevention of risky sexual behavior.	[Quisenberry, Amanda J.; Eddy, Celia R.; Patterson, David L.; Franck, Christopher T.; Bickel, Warren K.] Virginia Tech Caril, Res Inst, Roanoke, VA 24030 USA; [Eddy, Celia R.; Franck, Christopher T.] Virginia Tech, Dept Stat, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Bickel, WK (corresponding author), Virginia Tech Caril, Res Inst, Roanoke, VA 24030 USA.	wkbickel@vtc.vt.edu	Bickel, Warren/D-8898-2011; Quisenberry, Amanda/GNP-5578-2022; Bickel, Warren/M-5413-2019	Bickel, Warren/0000-0002-1048-7372; 	National Institute on Drug Abuse [R01DA034755, R01DA030241]; National Institute on Alcohol Abuse and Alcoholism [R01AA021529]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034755, R01DA030241] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the following: National Institute on Drug Abuse, www.drugabuse.gov, R01DA034755 - WKB, R01DA030241 - WKB; and National Institute on Alcohol Abuse and Alcoholism, www.niaaa.nih.gov, R01AA021529 - WKB. All funds were used for participant compensation and to partially support the authors' research activities.	Ashare RL, 2010, PSYCHOPHYSIOLOGY, V47, P838, DOI 10.1111/j.1469-8986.2010.01001.x; Bandura Albert, 1977, SOCIAL LEARNING THEO; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Bickel WK, 2011, BIOL PSYCHIAT, V69, P260, DOI 10.1016/j.biopsych.2010.08.017; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Callan MJ, 2011, J PERS SOC PSYCHOL, V101, P955, DOI 10.1037/a0024778; Callan MJ, 2009, J EXP SOC PSYCHOL, V45, P246, DOI 10.1016/j.jesp.2008.08.013; Cho SS, 2010, BRAIN STIMUL, V3, P170, DOI 10.1016/j.brs.2009.10.002; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; D'Alessio M, 2003, TIME SOC, V12, P333, DOI 10.1177/0961463X030122010; Ebert JEJ, 2001, ACTA PSYCHOL, V108, P155, DOI 10.1016/S0001-6918(01)00033-6; Fletcher PJ, 2013, PSYCHOPHARMACOLOGY, V226, P561, DOI 10.1007/s00213-012-2929-0; Gilman JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101570; Giordano LA, 2002, PSYCHOPHARMACOLOGY, V163, P174, DOI 10.1007/s00213-002-1159-2; Heil SH, 2006, ADDICT BEHAV, V31, P1290, DOI 10.1016/j.addbeh.2005.09.005; Herrmann ES, 2014, DRUG ALCOHOL DEPEN, V144, P53, DOI 10.1016/j.drugalcdep.2014.07.026; Janis IL, 1977, DECISION MAKING A PS; Jarmolowicz DP, 2014, ADDICT BEHAV, V39, P1652, DOI 10.1016/j.addbeh.2014.04.026; JEMMOTT JB, 1992, AM J PUBLIC HEALTH, V82, P372, DOI 10.2105/AJPH.82.3.372; Johnson MW, 2012, DRUG ALCOHOL DEPEN, V123, P15, DOI 10.1016/j.drugalcdep.2011.09.032; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Johnson MW, 2013, EXP CLIN PSYCHOPHARM, V21, P997; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Koffarnus MN, 2013, J EXP ANAL BEHAV, V99, P32, DOI 10.1002/jeab.2; Koffarnus MN, 2014, COCAINE DEPENDENT AD; Kotov RI, 2004, MULTIDIMENSIONAL IOW, P7; Madden GJ, 2004, EXP CLIN PSYCHOPHARM, V12, P251, DOI 10.1037/1064-1297.12.4.251; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Magen E, 2008, PSYCHOL SCI, V19, P648, DOI 10.1111/j.1467-9280.2008.02137.x; Mitchell JM, 2005, ALCOHOL CLIN EXP RES, V29, P2158, DOI 10.1097/01.alc.0000191755.63639.4a; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Parker D, 1996, J APPL SOC PSYCHOL, V26, P1, DOI 10.1111/j.1559-1816.1996.tb01835.x; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Reb J, 2008, ORGAN BEHAV HUM DEC, V105, P169, DOI 10.1016/j.obhdp.2007.08.006; Reynolds B, 2006, PHARMACOL BIOCHEM BE, V83, P194, DOI 10.1016/j.pbb.2006.01.007; Richard R, 1996, J BEHAV DECIS MAKING, V9, P185, DOI 10.1002/(SICI)1099-0771(199609)9:3<185::AID-BDM228>3.0.CO;2-5; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; Senecal N, 2012, JUDGM DECIS MAK, V7, P568; SIMONSON I, 1992, J CONSUM RES, V19, P105, DOI 10.1086/209290; STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742; Ward J, 1990, THE HIV RISK TAKING; Yi R, 2008, PSYCHOL REC, V58, P163, DOI 10.1007/BF03395609; Zeelenberg M, 1996, ORGAN BEHAV HUM DEC, V65, P148, DOI 10.1006/obhd.1996.0013; Zeelenberg M, 1999, J BEHAV DECIS MAKING, V12, P93, DOI 10.1002/(SICI)1099-0771(199906)12:2<93::AID-BDM311>3.0.CO;2-S; Zeelenberg M, 1997, ORGAN BEHAV HUM DEC, V72, P63, DOI 10.1006/obhd.1997.2730	47	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135977	10.1371/journal.pone.0135977	http://dx.doi.org/10.1371/journal.pone.0135977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VK	26280349	Green Submitted, gold, Green Published			2022-12-27	WOS:000359664300030
J	Sakata, R; Kabutomori, R; Okano, K; Mitsui, H; Takemura, A; Miwa, T; Yamamoto, H; Okano, T				Sakata, Rie; Kabutomori, Ryo; Okano, Keiko; Mitsui, Hiromasa; Takemura, Akihiro; Miwa, Tetsuya; Yamamoto, Hiroyuki; Okano, Toshiyuki			Rhodopsin in the Dark Hot Sea: Molecular Analysis of Rhodopsin in a Snailfish, Careproctus rhodomelas, Living near the Deep-Sea Hydrothermal Vent	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; PHOTOSENSITIVE PIGMENTS; BOVINE RHODOPSIN; COTTOID FISH; LAKE BAIKAL; ROD; SHRIMP; OPSIN; BIOLUMINESCENCE; EXPRESSION	Visual systems in deep-sea fishes have been previously studied from a photobiological aspect; however, those of deep-sea fish inhabiting the hydrothermal vents are far less understood due to sampling difficulties. In this study, we analyzed the visual pigment of a deep-sea snailfish, Careproctus rhodomelas, discovered and collected only near the hydrothermal vents of oceans around Japan. Proteins were solubilized from the C. rhodomelas eyeball and subjected to spectroscopic analysis, which revealed the presence of a pigment characterized by an absorption maximum (lambda(max)) at 480 nm. Immunoblot analysis of the ocular protein showed a rhodopsin-like immunoreactivity. We also isolated a retinal cDNA encoding the entire coding sequence of putative C. rhodomelas rhodopsin (CrRh). HEK293EBNA cells were transfected with the CrRh cDNA and the proteins extracted from the cells were subjected to spectroscopic analysis. The recombinant CrRh showed the absorption maximum at 480 nm in the presence of 11-cis retinal. Comparison of the results from the eyeball extract and the recombinant CrRh strongly suggests that CrRh has an A(1)-based 11-cis-retinal chromophore and works as a photoreceptor in the C. rhodomelas retina, and hence that C. rhodomelas responds to dim blue light much the same as other deep-sea fishes. Because hydrothermal vent is a huge supply of viable food, C. rhodomelas likely do not need to participate diel vertical migration and may recognize the bioluminescence produced by aquatic animals living near the hydrothermal vents.	[Sakata, Rie; Kabutomori, Ryo; Okano, Keiko; Mitsui, Hiromasa; Okano, Toshiyuki] Waseda Univ TWIns, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan; [Takemura, Akihiro] Univ Ryukyus, Dept Chem Biol & Marine Sci, Fac Sci, Nishihara, Okinawa 90301, Japan; [Miwa, Tetsuya] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Marine Technol Dev Dept, Marine Technol & Engn Ctr, Yokosuka, Kanagawa, Japan; [Yamamoto, Hiroyuki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Environm Impact Assessment Res Grp, Res & Dev Ctr Submarine Resources, Yokosuka, Kanagawa, Japan	Waseda University; University of the Ryukyus; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Okano, T (corresponding author), Waseda Univ TWIns, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan.	okano@waseda.jp		Okano, Toshiyuki/0000-0001-6740-6265	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Research Foundation for Opto-Science and Technology; Japanese Society for the Promotion of Science (JSPS) of Japan [23248033, 24657109, 26650024]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Opto-Science and Technology; Japanese Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Research Foundation for Opto-Science and Technology, and the Japanese Society for the Promotion of Science (JSPS, No. 23248033, 24657109, 26650024, Core-to-Core Program, A. Advanced Research Networks) of Japan awarded to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWMAKER JK, 1994, VISION RES, V34, P591, DOI 10.1016/0042-6989(94)90015-9; BOWMAKER JK, 1988, J COMP PHYSIOL A, V163, P685, DOI 10.1007/BF00603853; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; CRESCITELLI F, 1985, J COMP PHYSIOL A, V157, P323, DOI 10.1007/BF00618122; DENTON EJ, 1957, J MAR BIOL ASSOC UK, V36, P651, DOI 10.1017/S0025315400025911; Douglas RH, 1999, VISION RES, V39, P2817, DOI 10.1016/S0042-6989(98)00332-0; Douglas RH, 1997, J FISH BIOL, V50, P68; DOUGLAS RH, 1995, J COMP PHYSIOL A, V177, P111; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; DUNTLEY SQ, 1963, J OPT SOC AM, V53, P214, DOI 10.1364/JOSA.53.000214; FITE KV, 1973, VISION RES, V13, P219, DOI 10.1016/0042-6989(73)90101-6; Gilbert C. H., 1912, P US NAT MUS, V42, P351; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; GRASSLE JF, 1985, SCIENCE, V229, P713, DOI 10.1126/science.229.4715.713; Hasegawa EI, 2008, J FISH BIOL, V72, P937, DOI 10.1111/j.1095-8649.2007.01772.x; HERRING PJ, 1983, PROC R SOC SER B-BIO, V220, P183, DOI 10.1098/rspb.1983.0095; Hisatomi O, 1997, PHOTOCHEM PHOTOBIOL, V66, P792, DOI 10.1111/j.1751-1097.1997.tb03226.x; Hope AJ, 1997, P ROY SOC B-BIOL SCI, V264, P155, DOI 10.1098/rspb.1997.0023; Hunt DM, 2001, J EXP BIOL, V204, P3333; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; Jinks RN, 2002, NATURE, V420, P68, DOI 10.1038/nature01144; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; Morel A, 2007, LIMNOL OCEANOGR, V52, P217, DOI 10.4319/lo.2007.52.1.0217; MUNZ FW, 1958, J PHYSIOL-LONDON, V140, P220, DOI 10.1113/jphysiol.1958.sp005929; Okano K, 2000, J EXP ZOOL, V286, P136, DOI 10.1002/(SICI)1097-010X(20000201)286:2<136::AID-JEZ5>3.0.CO;2-X; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; PARTRIDGE JC, 1988, J COMP PHYSIOL A, V162, P543, DOI 10.1007/BF00612519; PELLI DG, 1989, NATURE, V337, P460, DOI 10.1038/337460a0; Robison BH, 2004, J EXP MAR BIOL ECOL, V300, P253, DOI 10.1016/j.jembe.2004.01.012; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Takemura A, 2010, J FISH BIOL, V77, P1709, DOI 10.1111/j.1095-8649.2010.02789.x; Takemura A, 2008, CRUISE REPORT NATSUS; Tokuda G, 2008, MAR ECOL-EVOL PERSP, V29, P106, DOI 10.1111/j.1439-0485.2007.00211.x; VanDover CL, 1996, GEOPHYS RES LETT, V23, P2049, DOI 10.1029/96GL02151; VANDOVER CL, 1989, NATURE, V337, P458, DOI 10.1038/337458a0; Wada Y, 1998, FEBS LETT, V424, P53, DOI 10.1016/S0014-5793(98)00138-0; WIDDER EA, 1983, BIOL BULL, V165, P791, DOI 10.2307/1541479; Yokoyama S, 2007, PHOTOCHEM PHOTOBIOL, V83, P236, DOI 10.1562/2006-06-19-RA-939	47	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135888	10.1371/journal.pone.0135888	http://dx.doi.org/10.1371/journal.pone.0135888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275172	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600129
J	Wilson, AM; Likens, GE				Wilson, Adam M.; Likens, Gene E.			Content Volatility of Scientific Topics in Wikipedia: A Cautionary Tale	PLOS ONE			English	Article								Wikipedia has quickly become one of the most frequently accessed encyclopedic references, despite the ease with which content can be changed and the potential for 'edit wars' surrounding controversial topics. Little is known about how this potential for controversy affects the accuracy and stability of information on scientific topics, especially those with associated political controversy. Here we present an analysis of the Wikipedia edit histories for seven scientific articles and show that topics we consider politically but not scientifically "controversial" (such as evolution and global warming) experience more frequent edits with more words changed per day than pages we consider "noncontroversial" (such as the standard model in physics or heliocentrism). For example, over the period we analyzed, the global warming page was edited on average (geometric mean +/- SD) 1.9 +/- 2.7 times resulting in 110.9 +/- 10.3 words changed per day, while the standard model in physics was only edited 0.2 +/- 1.4 times resulting in 9.4 +/- 5.0 words changed per day. The high rate of change observed in these pages makes it difficult for experts to monitor accuracy and contribute time-consuming corrections, to the possible detriment of scientific accuracy. As our society turns to Wikipedia as a primary source of scientific information, it is vital we read it critically and with the understanding that the content is dynamic and vulnerable to vandalism and other shenanigans.	[Wilson, Adam M.] SUNY Buffalo, Dept Geog, Buffalo, NY 14260 USA; [Wilson, Adam M.; Likens, Gene E.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Likens, Gene E.] Cary Inst Ecosyst Studies, Millbrook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Connecticut; Cary Institute of Ecosystem Studies	Wilson, AM (corresponding author), SUNY Buffalo, Dept Geog, Buffalo, NY 14260 USA.	adamw@buffalo.edu	Wilson, Adam/C-6731-2009	Wilson, Adam/0000-0003-3362-7806	Direct For Biological Sciences [1114804] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Acid Rain Protection log, 2013, AC RAIN PROT LOG; Adler BT, 2011, LECT NOTES COMPUT SC, V6609, P277, DOI 10.1007/978-3-642-19437-5_23; Alexa, 2013, AL TOP 500 GLOB SIT; Apic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020902; Bateman A, 2010, NATURE, V468, P765, DOI 10.1038/468765c; Bond AL, 2011, IBIS, V153, P640, DOI 10.1111/j.1474-919X.2011.01135.x; Borra E., 2014, OPENSYM, P1, DOI [DOI 10.1145/2641580.2641622, 10.1145/2641580.2641622]; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Kittur A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P453; Konietschke F, 2012, ELECTRON J STAT, V6, P738, DOI 10.1214/12-EJS691; LIKENS GE, 1972, ENVIRONMENT, V14, P33, DOI 10.1080/00139157.1972.9933001; Nielsen FA, 2007, SCI CITATIONS WIKIPE, P12; Oreskes Naomi, MERCHANTS DOUBT HAND; Samoilenko A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds20; Sumi R., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P724, DOI 10.1109/PASSAT/SocialCom.2011.47; Voss J, 2005, ISSI 2005: Proceedings of the 10th International Conference of the International Society for Scientometrics and Informetrics, Vols 1 and 2, P221; Waters NL, 2007, COMMUN ACM, V50, P15, DOI 10.1145/1284621.1284635; West K, 2009, REF SERV REV, V37, P260, DOI 10.1108/00907320910982758; Wikipedia, 2013, WIK BOLD REV DISC CY; Wikipedia, 2011, AC RAIN DIFF REV; Wikipedia, 2013, WIK 10 THINGS YOU MA; Wikipedia, 2013, AC RAIN; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038869	23	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134454	10.1371/journal.pone.0134454	http://dx.doi.org/10.1371/journal.pone.0134454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275058	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600028
J	Bi, K; Yang, J; Wang, L; Gu, Y; Zhan, B; Zhu, XP				Bi, Kuo; Yang, Jing; Wang, Lei; Gu, Yuan; Zhan, Bin; Zhu, Xinping			Partially Protective Immunity Induced by a 20 kDa Protein Secreted by Trichinella spiralis Stichocytes	PLOS ONE			English	Article							SERINE-PROTEASE; HUMAN TRICHINOSIS; RAPID EXPULSION; MICE; IDENTIFICATION; INFECTIONS; EXPRESSION; ANTIGENS; VACCINES; CLONING	Background Trichinella spiralis infection induces protective immunity against re-infection in animal models. Identification of the antigens eliciting acquired immunity during infection is important for vaccine development against Trichinella infection and immunodiagnosis. Methods and Findings The T. spiralis adult cDNA library was immunoscreened with sera from pigs experimentally infected with 20,000 infective T. spiralis larvae. Total 43 positive clones encoding for 28 proteins were identified; one of the immunodominant proteins was 20 kDa Ts-ES-1 secreted by Trichinella stichocytes and existing in the excretory/secretory (ES) products of T. spiralis adult and muscle larval worms. Ts-ES-1 contains 172 amino acids with a typical signal peptide in the first 20 amino acids. The expression of Ts-ES-1 was detected in both the adult and muscle larval stages at the mRNA and protein expression levels. Mice immunized with recombinant Ts-ES-1 (rTs-ES-1) formulated with ISA50v2 adjuvant exhibited a significant worm reduction in both the adult worm (27%) and muscle larvae burden (42.1%) after a challenge with T. spiralis compared to the adjuvant control group (p<0.01). The rTs-ES-1-induced protection was associated with a high level of specific anti-Ts-ES-1 IgG antibodies and a Th1/Th2 mixed immune response. Conclusion The newly identified rTs-ES-1 is an immunodominant protein secreted by Trichinella stichocytes during natural infection and enables to the induction of partial protective immunity in vaccinated mice against Trichinella infection. Therefore, rTs-ES-1 is a potential candidate for vaccine development against trichinellosis.	[Bi, Kuo; Yang, Jing; Wang, Lei; Gu, Yuan; Zhu, Xinping] Capital Med Univ, Dept Parasitol, Sch Basic Med Sci, Beijing, Peoples R China; [Wang, Lei] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China; [Zhan, Bin] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA	Capital Medical University; Capital Medical University; Baylor College of Medicine	Zhu, XP (corresponding author), Capital Med Univ, Dept Parasitol, Sch Basic Med Sci, Beijing, Peoples R China.	zhuxping@ccmu.edu.cn		Wolf, Nathaniel/0000-0001-6567-2447	National Natural Science Foundation of China [81171598, 81371837, 81201313]; National Science and Technology Major Project [2012ZX10004220-012]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [IDHT20140212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This study was supported by grants from the National Natural Science Foundation of China (81171598, 81371837, 81201313), the National Science and Technology Major Project (2012ZX10004220-012), and the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (IDHT20140212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIZADEH H, 1982, INT J PARASITOL, V12, P65, DOI 10.1016/0020-7519(82)90097-2; APPLETON JA, 1988, IMMUNOLOGY, V65, P487; Bai X, 2012, PARASITOL RES, V110, P2481, DOI 10.1007/s00436-011-2789-2; Bell RG, 1998, ADV PARASIT, V41, P149, DOI 10.1016/S0065-308X(08)60424-8; Blum LK, 2009, J IMMUNOL, V183, P5816, DOI 10.4049/jimmunol.0900944; Bruschi F., 2002, ENDOCRINE METABOLIC, V2, P269; Cao XD, 2014, EXP PARASITOL, V146, P43, DOI 10.1016/j.exppara.2014.09.004; Chen XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049913; Cui J, 2011, ACTA TROP, V118, P1, DOI 10.1016/j.actatropica.2011.02.005; Cui J, 2015, ACTA TROP, V142, P57, DOI 10.1016/j.actatropica.2014.10.017; Dea-Ayuela MA, 2000, FOLIA PARASIT, V47, P172, DOI 10.14411/fp.2000.034; Dea-Ayuela MA, 2006, VACCINE, V24, P2772, DOI 10.1016/j.vaccine.2006.01.006; DESPOMMIER DD, 1976, J PARASITOL, V62, P775, DOI 10.2307/3278960; Deville S, 2005, VET PARASITOL, V132, P75, DOI 10.1016/j.vetpar.2005.05.029; Dixon H, 2008, PARASITE IMMUNOL, V30, P454, DOI 10.1111/j.1365-3024.2008.01035.x; Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; Dupouy-Camet J, 2009, VET PARASITOL, V159, P194, DOI 10.1016/j.vetpar.2008.10.064; El Ridi R, 2013, J PARASITOL, V99, P194, DOI 10.1645/GE-3186.1; Fang L, 2014, VACCINE, V32, P4412, DOI 10.1016/j.vaccine.2014.06.055; Feng S, 2013, J PARASITOL, V99, P426, DOI 10.1645/12-46.1; Gajadhar AA, 2009, VET PARASITOL, V159, P197, DOI 10.1016/j.vetpar.2008.10.063; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Gour JK, 2012, EXP PARASITOL, V132, P355, DOI 10.1016/j.exppara.2012.04.022; Gu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077238; Haffner A, 1998, EXP PARASITOL, V90, P26, DOI 10.1006/expr.1998.4313; Harnett W, 2014, MOL BIOCHEM PARASIT, V195, P130, DOI 10.1016/j.molbiopara.2014.03.007; Hussaarts L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00499; KARANU FN, 1993, EXP PARASITOL, V77, P362, DOI 10.1006/expr.1993.1093; Kolodziej-Sobocinska M, 2006, EXP PARASITOL, V112, P52, DOI 10.1016/j.exppara.2005.09.004; Li LG, 2015, ACTA TROP, V146, P25, DOI 10.1016/j.actatropica.2015.02.020; Li X, 2013, PARASITOL RES, V112, P3229, DOI 10.1007/s00436-013-3500-6; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; McVay C, 2000, INFECT IMMUN, V68, P1912, DOI 10.1128/IAI.68.4.1912-1918.2000; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; MURRELL KD, 1985, EXP PARASITOL, V59, P347, DOI 10.1016/0014-4894(85)90090-6; Nagano I, 2001, J HELMINTHOL, V75, P273; Oeser K, 2015, MUCOSAL IMMUNOL, V8, P672, DOI 10.1038/mi.2014.101; Onah Denis Nnabuike, 2000, Korean Journal of Parasitology, V38, P209, DOI 10.3347/kjp.2000.38.4.209; Ortega-Pierres G, 2015, J HELMINTHOL, P1; Pecaut MJ, 2000, COMPARATIVE MED, V50, P595; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; REASON AJ, 1994, GLYCOBIOLOGY, V4, P593, DOI 10.1093/glycob/4.5.593; RUSSELL DA, 1984, J PARASITOL, V70, P593, DOI 10.2307/3281412; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Singh PK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/590281; TAKAHASHI Y, 1992, J PARASITOL, V78, P518, DOI 10.2307/3283656; Wang B, 2013, EXP PARASITOL, V134, P148, DOI 10.1016/j.exppara.2013.03.004; WATANABE N, 1988, P NATL ACAD SCI USA, V85, P4460, DOI 10.1073/pnas.85.12.4460; Wei JF, 2011, VACCINE, V29, P3162, DOI 10.1016/j.vaccine.2011.02.072; White RR, 2012, VIRULENCE, V3, P668, DOI 10.4161/viru.22832; Williamson AL, 2006, INFECT IMMUN, V74, P961, DOI 10.1128/IAI.74.2.961-967.2006; Yang J, 2008, BIOCHEM BIOPH RES CO, V365, P528, DOI 10.1016/j.bbrc.2007.11.012; Yang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096454; Yang YP, 2010, VACCINE, V28, P2735, DOI 10.1016/j.vaccine.2010.01.026; Zhang YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-246; Zocevic A, 2011, PARASITOLOGY, V138, P463, DOI 10.1017/S0031182010001526	59	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136189	10.1371/journal.pone.0136189	http://dx.doi.org/10.1371/journal.pone.0136189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288365	Green Submitted, gold, Green Published			2022-12-27	WOS:000360018600119
J	Hollenbach, JA; Saperstein, A; Albrecht, M; Vierra-Green, C; Parham, P; Norman, PJ; Maiers, M				Hollenbach, Jill A.; Saperstein, Aliya; Albrecht, Mark; Vierra-Green, Cynthia; Parham, Peter; Norman, Paul J.; Maiers, Martin			Race, Ethnicity and Ancestry in Unrelated Transplant Matching for the National Marrow Donor Program: A Comparison of Multiple Forms of Self-Identification with Genetics	PLOS ONE			English	Article							POPULATION STRATIFICATION; UNITED-STATES; CLASSIFICATION; RACE/ETHNICITY; AMERICANS	We conducted a nationwide study comparing self-identification to genetic ancestry classifications in a large cohort (n = 1752) from the National Marrow Donor Program. We sought to determine how various measures of self-identification intersect with genetic ancestry, with the aim of improving matching algorithms for unrelated bone marrow transplant. Multiple dimensions of self-identification, including race/ethnicity and geographic ancestry were compared to classifications based on ancestry informative markers (AIMs), and the human leukocyte antigen (HLA) genes, which are required for transplant matching. Nearly 20% of responses were inconsistent between reporting race/ethnicity versus geographic ancestry. Despite strong concordance between AIMs and HLA, no measure of self-identification shows complete correspondence with genetic ancestry. In certain cases geographic ancestry reporting matches genetic ancestry not reflected in race/ethnicity identification, but in other cases geographic ancestries show little correspondence to genetic measures, with important differences by gender. However, when respondents assign ancestry to grandparents, we observe sub-groups of individuals with well-defined genetic ancestries, including important differences in HLA frequencies, with implications for transplant matching. While we advocate for tailored questioning to improve accuracy of ancestry ascertainment, collection of donor grandparents' information will improve the chances of finding matches for many patients, particularly for mixed-ancestry individuals.	[Hollenbach, Jill A.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Saperstein, Aliya] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Albrecht, Mark; Maiers, Martin] Natl Marrow Donor Program, Bioinformat Res, Minneapolis, MN USA; [Vierra-Green, Cynthia] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Parham, Peter; Norman, Paul J.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Parham, Peter; Norman, Paul J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; National Marrow Donor Program; Center for International Blood & Marrow Transplant Research; Stanford University; Stanford University	Hollenbach, JA (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA.	jill.hollenbach@ucsf.edu	Saperstein, Aliya/E-8403-2013	Saperstein, Aliya/0000-0002-6429-1172; Maiers, Martin/0000-0002-0198-2064; Norman, Paul/0000-0001-8370-7703	Office of Naval Research [N00014-12-1-0142]	Office of Naval Research(Office of Naval Research)	This work was funded by the Office of Naval Research N00014-12-1-0142 (MA, CVG, MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Khan Sarah E, 2011, Hugo J, V5, P47, DOI 10.1007/s11568-011-9154-5; Barnholtz-Sloan JS, 2005, CANCER EPIDEM BIOMAR, V14, P1545, DOI 10.1158/1055-9965.EPI-04-0832; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Bloche MG, 2004, NEW ENGL J MED, V351, P2035, DOI 10.1056/NEJMp048271; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Burnett MS, 2006, AM J EPIDEMIOL, V163, P486, DOI 10.1093/aje/kwj057; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Compton E, 2012, 2010 CENSUS RACE ETH; Comstock RD, 2004, AM J EPIDEMIOL, V159, P611, DOI 10.1093/aje/kwh084; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Davis F. James, 2001, WHO IS BLACK ONE NAT; Divers J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-28; Dorsey R, 2011, JAMA-J AM MED ASSOC, V306, P2378, DOI 10.1001/jama.2011.1789; Duster T, 2005, SCIENCE, V307, P1050, DOI 10.1126/science.1110303; Epstein Steve, 2007, INCLUSION POLITICS D; Gragert L, 2014, NEW ENGLAND IN PRESS; Gravlee CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006821; Gravlee CC, 2009, AM J PHYS ANTHROPOL, V139, P47, DOI 10.1002/ajpa.20983; Gullickson A, 2011, SOC SCI RES, V40, P498, DOI 10.1016/j.ssresearch.2010.12.010; Hall JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099161; HOLM S, 1979, SCAND J STAT, V6, P65; HOUT M, 1994, AM SOCIOL REV, V59, P64, DOI 10.2307/2096133; Kaplan JB, 2003, JAMA-J AM MED ASSOC, V289, P2709, DOI 10.1001/jama.289.20.2709; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Kristie N, 2009, SOC POLICY J N Z, V36, P32; Lee S S, 2001, Yale J Health Policy Law Ethics, V1, P33; Lee YL, 2010, J GENET, V89, P417, DOI 10.1007/s12041-010-0060-8; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mays VM, 2003, ANNU REV PUBL HEALTH, V24, P83, DOI 10.1146/annurev.publhealth.24.100901.140927; Mora GC, 2014, MAKING HISPANICS ACT; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Obama Barack, 2007, DREAMS MY FATHER STO; Pew Research Center, 2015, MULT AM PROUD DIV GR; Phillips EM, 2007, SOC FORCES, V86, P795, DOI 10.1093/sf/86.2.795; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Roberts S, 2010, NY TIMES; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Saperstein A, 2012, ETHNIC RACIAL STUD, V35, P1484, DOI 10.1080/01419870.2011.607504; Saperstein A, 2009, RES SOCIOL HEALTH CA, V27, P21, DOI 10.1108/S0275-4959(2009)0000027004; Sinha M, 2006, NEW ENGL J MED, V354, P421, DOI 10.1056/NEJMc052515; Smith T, 1995, REV ETHNO RACIAL MEA; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; U. S. Commission on Civil Rights, 2010, RAC CAT 2010 CENS BR; United States Census Bureau, 2014, FACTS FEAT HISP HER; US Office of Management and Budget, 1997, FED REGISTER, V62, P58781; Vina MAF, 2012, PHILOS T R SOC B, V367, P820, DOI 10.1098/rstb.2011.0320; Walker Tim, 2011, Clin Transpl, P55; Winker MA, 2004, JAMA-J AM MED ASSOC, V292, P1612, DOI 10.1001/jama.292.13.1612; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Zuniga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074442	55	28	28	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135960	10.1371/journal.pone.0135960	http://dx.doi.org/10.1371/journal.pone.0135960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287376	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600090
J	McBurney, MI; Yu, EA; Ciappio, ED; Bird, JK; Eggersdorfer, M; Mehta, S				McBurney, Michael I.; Yu, Elaine A.; Ciappio, Eric D.; Bird, Julia K.; Eggersdorfer, Manfred; Mehta, Saurabh			Suboptimal Serum alpha-Tocopherol Concentrations Observed among Younger Adults and Those Depending Exclusively upon Food Sources, NHANES 2003-2006(1-3)	PLOS ONE			English	Article							VITAMIN-E; OXIDATIVE STRESS; GAMMA-TOCOPHEROL; MAJOR DEPRESSION; BETA-CAROTENE; DISEASE; SUPPLEMENTATION; METAANALYSIS; WOMEN; ANTIOXIDANTS	Vitamin E is an essential nutrient for human health, with an established function as a lipidsoluble antioxidant that protects cell membranes from free radical damage. Low vitamin E status has been linked to multiple health outcomes, including total mortality. With vitamin E being identified as a 'shortfall nutrient' because >90% of American adults are not consuming recommended amounts of vitamin E, we aimed to determine the prevalence of both clinical vitamin E deficiency (serum alpha-tocopherol concentration < 12 mu mol/L) and failure to meet a criterion of vitamin E adequacy, serum alpha-tocopherol concentration of 30 mu mol/L, based on the Estimated Average Requirement (EAR) and lowest mortality rate in the Alpha-Tocopherol Beta-Carotene (ATBC) study. The most recent nationally-representative cross-sectional data (2003-2006) among non-institutionalized US citizens with available serum concentrations of alpha-tocopherol from the National Health and Nutrition Examination Survey (NHANES); Centers for Disease Control and Prevention were analyzed. Serum alpha-tocopherol distributions were compared between those reporting consumption of food without supplement use (FOOD) and food and supplement use (FOOD+DS) by sex, age, and race/ethnicity. Only 1% of the US population is clinically deficient. FOOD consumers have lower average alpha-tocopherol levels (24.9 +/- 0.2 mu mol/L) than FOOD+DS users (33.7 +/- 0.3 mu mol/L), even when adjusted for total cholesterol. Using a criterion of adequacy of 30 mu mol/L, 87% of persons 20-30y and 43% of those 51+y had inadequate vitamin E status (p<0.01). A significant greater prevalence of FOOD compared to FOOD+DS users did not meet the criterion of adequacy which was based on the EAR and low ATBC mortality rate consistently across age, sex, and race/ethnic groups. The prevalence of inadequate vitamin E levels is significantly higher among non-users of dietary supplements. With declining usage of vitamin E supplements, the population should be monitored for changes in vitamin E status and related health outcomes.	[McBurney, Michael I.; Ciappio, Eric D.] DSM Nutr Prod, Parsippany, NJ 07054 USA; [Yu, Elaine A.; Mehta, Saurabh] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Bird, Julia K.] DSM Nutr Prod, Delft, Netherlands; [Eggersdorfer, Manfred] DSM Nutr Prod, Kaiseraugst, Switzerland	DSM NV; Cornell University; DSM NV; DSM NV	McBurney, MI (corresponding author), DSM Nutr Prod, Parsippany, NJ 07054 USA.	Michael.McBurney@dsm.com	McBurney, Michael I./AAB-6850-2019; Mehta, Saurabh/L-8490-2017; Bird, Julia K./I-3044-2019	McBurney, Michael I./0000-0003-4511-6034; Mehta, Saurabh/0000-0003-3788-0665; Bird, Julia K./0000-0001-6015-3576; Yu, Elaine A./0000-0003-2433-9562	DSM Nutritional Products	DSM Nutritional Products	Funding: This statistical analysis of data collected by the Centers for Disease Control (CDC) (http://www.cdc.gov/nutritionreport/faq.html) was supported by DSM Nutritional Products, a manufacturer of vitamin E. MM, EC, JB and ME are employees of DSM Nutritional Products. DSM Nutritional Products provided support in the form of salaries for authors MM, EC, JB, and ME and as an unencumbered gift to Cornell University that was used to support EY as a graduate research assistant, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abner Erin L, 2011, Curr Aging Sci, V4, P158; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Almbro M, 2011, ECOL LETT, V14, P891, DOI 10.1111/j.1461-0248.2011.01653.x; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; [Anonymous], NCHS LAB PROC MAN; Bailey RL, 2012, J PEDIATR-US, V161, P837, DOI 10.1016/j.jpeds.2012.05.009; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Benedetti S, 2012, REPROD BIOMED ONLINE, V25, P300, DOI 10.1016/j.rbmo.2012.05.011; Beydoun MA, 2013, BRIT J NUTR, V109, P1714, DOI 10.1017/S0007114512003467; Biesalski HK, 2010, NUTRIENTS, V2, P929, DOI 10.3390/nu2090929; Biesalski HK, 1997, CLIN NUTR, V16, P151, DOI 10.1016/S0261-5614(97)80245-2; Center for Disease Control, 2012, 2 NAT REP BIOCH IND; Chai WW, 2014, J AM COLL NUTR, V33, P192, DOI 10.1080/07315724.2013.862490; Cicek N, 2012, J ASSIST REPROD GEN, V29, P325, DOI 10.1007/s10815-012-9714-1; Dysken MW, 2014, ALZHEIMERS DEMENT, V10, P36, DOI 10.1016/j.jalz.2013.01.014; Ford ES, 2006, AM J CLIN NUTR, V84, P375; Fulgoni VL, 2011, J NUTR, V141, P1847, DOI 10.3945/jn.111.142257; Gahche Jamie, 2011, NCHS Data Brief, P1; Geva E, 1996, FERTIL STERIL, V66, P430, DOI 10.1016/S0015-0282(16)58514-8; Han Sung Nim, 2006, Expert Rev Clin Immunol, V2, P561, DOI 10.1586/1744666X.2.4.561; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; HHS/USDA, 2015, SCI REP 2015 DIET GU; Khalil A, 2011, EXP GERONTOL, V46, P475, DOI 10.1016/j.exger.2011.02.002; Kim HJ, 2014, J ACAD NUTR DIET; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Lebold KM, 2012, AM J CLIN NUTR, V96, P801, DOI 10.3945/ajcn.112.038620; Levy AP, 2004, DIABETES CARE, V27, P925, DOI 10.2337/diacare.27.4.925; Maes M, 2000, J AFFECT DISORDERS, V58, P241, DOI 10.1016/S0165-0327(99)00121-4; Mangialasche F, 2013, J INTERN MED, V273, P602, DOI 10.1111/joim.12037; Menezo Y, 2014, ADV EXP MED BIOL, V791, P173, DOI 10.1007/978-1-4614-7783-9_11; Michaelsson K, 2014, AM J CLIN NUTR, V99, P107, DOI 10.3945/ajcn.113.064691; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; National Academies Press, 2000, DIETARY REFERENCE IN; NHLBI N, 2005, NIH PUBLICATION, V05-3290; Niki E, 2012, ANN NUTR METAB, V61, P207, DOI 10.1159/000343106; Owen AJ, 2005, EUR J CLIN NUTR, V59, P304, DOI 10.1038/sj.ejcn.1602072; Ozkaya MO, 2010, FERTIL STERIL, V94, P2465, DOI 10.1016/j.fertnstert.2010.01.066; Pae M, 2012, AGING DIS, V3, P91; Peter S, 2013, INT J VITAM NUTR RES, V83, P129, DOI 10.1024/0300-9831/a000153; Pfeiffer CM, 2013, J NUTR, V143, p938S, DOI 10.3945/jn.112.172858; Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011; Schleicher RL, 2013, J NUTR, V143, p966S, DOI 10.3945/jn.112.172965; Schmid TE, 2012, FERTIL STERIL, V98, P1130, DOI 10.1016/j.fertnstert.2012.07.1126; Siddiqui IA, 2013, BIOMARK MED, V7, P229, DOI [10.2217/BMM.12.109, 10.2217/bmm.12.109]; THURNHAM DI, 1986, ANN CLIN BIOCHEM, V23, P514, DOI 10.1177/000456328602300505; Traber MG, 2008, CURR OPIN LIPIDOL, V19, P30, DOI 10.1097/MOL.0b013e3282f2dab6; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Vardi M, 2012, EUR J INTERN MED, V23, P628, DOI 10.1016/j.ejim.2012.04.009; Weinstein SJ, 2007, CANCER EPIDEM BIOMAR, V16, P1253, DOI 10.1158/1055-9965.EPI-06-1084; Wright ME, 2006, AM J CLIN NUTR, V84, P1200, DOI 10.1093/ajcn/84.5.1200; Zhao Y, 2014, BRIT J NUTR, V112, P1575, DOI 10.1017/S0007114514002438	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135510	10.1371/journal.pone.0135510	http://dx.doi.org/10.1371/journal.pone.0135510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287975	gold, Green Submitted, Green Published			2022-12-27	WOS:000360018600052
J	Schuler, E; Larsson, M; Parris, TZ; Johansson, ME; Helou, K; Forssell-Aronsson, E				Schuler, Emil; Larsson, Maria; Parris, Toshima Z.; Johansson, Martin E.; Helou, Khalil; Forssell-Aronsson, Eva			Potential Biomarkers for Radiation-Induced Renal Toxicity following Lu-177-Octreotate Administration in Mice	PLOS ONE			English	Article							RECEPTOR RADIONUCLIDE THERAPY; GENE-EXPRESSION; RADIOLABELED SOMATOSTATIN; TRANSCRIPTIONAL RESPONSE; NEUROENDOCRINE TUMORS; PROTEIN BIOMARKERS; MOUSE-TISSUES; DOSE-RATE; EXPOSURE; RENOGRAPHY	The kidneys are one of the main dose-limiting organs in peptide receptor radionuclide therapy and due to large inter-individual variations in renal toxicity, biomarkers are urgently needed in order to optimize therapy and reduce renal tissue damage. The aim of this study was to investigate the transcriptional, functional, and morphological effects on renal tissue after Lu-177-octreotate administration in normal mice, and to identify biomarkers for radiation induced renal toxicity. Methods C57BL/6N mice were i.v. injected with 0, 30, 60, 90, 120, or 150 MBq Lu-177-octreotate (0, 16, 29, 40, 48, and 54 Gy to the kidneys). At 4, 8, and 12 months after administration, radiation-induced effects were evaluated in relation to (a) global transcriptional variations in kidney tissues, (b) morphological changes in the kidneys, (c) changes in white and red blood cell count as well as blood levels of urea, and (d) changes in renal function using Tc-99m-DTPA/Tc-99m-DMSA scintigraphy. Results In general, the highest number of differentially regulated transcripts was observed at 12 months after administration. The Cdkn1a, C3, Dbp, Lcn2, and Per2 genes displayed a distinct dose-dependent regulation, with increased expression level with increasing absorbed dose. Ifng, Tnf, and Il1B were identified as primary up-stream regulators of the recurrently regulated transcripts. Furthermore, previously proposed biomarkers for kidney injury and radiation damage were also observed. The functional investigation revealed reduced excretion of Tc-99m-DTPA after 150 MBq, an increased uptake of Tc-99m-DMSA at all dose levels compared with the controls, and markedly increased urea level in blood after 150 MBq at 12 months. Conclusion Distinct dose-response relationships were found for several of the regulated transcripts. The Cdkn1a, Dbp, Lcn2, and Per2 genes are proposed as biomarkers for Lu-177-octreotate exposure of kidney. Correlations to functional and morphological effects further confirm applicability of these genes as markers of radiation damage in kidney tissue.	[Schuler, Emil; Larsson, Maria; Forssell-Aronsson, Eva] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Acad, Gothenburg, Sweden; [Parris, Toshima Z.; Helou, Khalil] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Canc Ctr, Dept Oncol,Inst Clin Sci,Sahlgrenska Acad, Gothenburg, Sweden; [Johansson, Martin E.] Lund Univ, Dept Lab Med, SUS Malmo, Malmo, Sweden; [Forssell-Aronsson, Eva] Sahlgrens Univ Hosp, Dept Med Phys & Med Bioengn, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Lund University; Sahlgrenska University Hospital	Schuler, E (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Acad, Gothenburg, Sweden.	emil.schuler@gu.se	Parris, Toshima/Q-5427-2018	Parris, Toshima/0000-0003-0834-5540; Forssell-Aronsson, Eva/0000-0002-7558-4368	Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital; Assar Gabrielsson Cancer Research Foundation; Lions Cancerfond Vast; Adlerbertska Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital; Assar Gabrielsson Cancer Research Foundation; Lions Cancerfond Vast; Adlerbertska Research Foundation	This study was supported by grants from the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE - a National Strategic Research Program at the University of Gothenburg, the Swedish Radiation Safety Authority, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Assar Gabrielsson Cancer Research Foundation, the Lions Cancerfond Vast, and the Adlerbertska Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiyanti Sri S, 2012, Acta Med Indones, V44, P246; Assadi M, 2008, INT UROL NEPHROL, V40, P1059, DOI 10.1007/s11255-008-9446-4; Barone R, 2005, J NUCL MED, V46, p99S; Bodei L, 2014, EUR J NUCL MED MOL I; Bodei L, 2008, EUR J NUCL MED MOL I, V35, P1847, DOI 10.1007/s00259-008-0778-1; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Cruz Dinna N, 2010, Congest Heart Fail, V16 Suppl 1, pS25, DOI 10.1111/j.1751-7133.2010.00163.x; Daniel GB, 1999, VET RADIOL ULTRASOUN, V40, P572, DOI 10.1111/j.1740-8261.1999.tb00883.x; Filiano AN, 2011, RADIAT RES, V176, P49, DOI 10.1667/RR2419.1; Forrer F, 2007, CANCER BIOTHER RADIO, V22, P40, DOI 10.1089/cbr.2006.353; Forssell-Aronsson E, 2004, ACTA ONCOL, V43, P436, DOI 10.1080/02841860410030670; Forssell-Aronsson EB, 2000, J NUCL MED, V41, P636; Forssell-Aronsson E, 2013, NEUROENDOCRINOLOGY, V97, P86, DOI 10.1159/000336086; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hecht S, 2010, CAN VET J, V51, P1360; Hewitt SM, 2004, J AM SOC NEPHROL, V15, P1677, DOI 10.1097/01.ASN.0000129114.92265.32; Hoffmann D, 2010, TOXICOL SCI, V116, P8, DOI 10.1093/toxsci/kfq029; Khan S, 2011, J NUCL MED, V52, P1361, DOI 10.2967/jnumed.111.087932; Langen B, 2015, EJNMMI RES, V5, P1, DOI 10.1186/s13550-014-0078-7; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Marchetti F, 2006, INT J RADIAT BIOL, V82, P605, DOI 10.1080/09553000600930103; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Melis M, 2005, EUR J NUCL MED MOL I, V32, P1136, DOI 10.1007/s00259-005-1793-0; Melis M, 2007, NUCL MED BIOL, V34, P633, DOI 10.1016/j.nucmedbio.2007.05.002; Melis M, 2010, J NUCL MED, V51, P1962, DOI 10.2967/jnumed.110.080143; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Narvaez-Sanchez R, 2008, CLIN BIOCHEM, V41, P498, DOI 10.1016/j.clinbiochem.2008.01.022; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; Pajonk F, 2001, RADIOTHER ONCOL, V59, P203, DOI 10.1016/S0167-8140(01)00311-5; Perco P, 2006, EUR J CLIN INVEST, V36, P753, DOI 10.1111/j.1365-2362.2006.01729.x; Medeiros FSR, 2009, TRANSPL INT, V22, P323, DOI 10.1111/j.1432-2277.2008.00799.x; Ritchie G, 2008, PEDIATR RADIOL, V38, P857, DOI 10.1007/s00247-008-0908-8; Rudqvist N, 2015, NUCL MED BIOL, V42, P263, DOI 10.1016/j.nucmedbio.2014.11.006; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuler E, 2015, ACTA ONCOL, P1; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Svensson J, 2012, NUCL MED BIOL, V39, P756, DOI 10.1016/j.nucmedbio.2012.02.003; Sward C, 2010, WORLD J SURG, V34, P1368, DOI 10.1007/s00268-009-0387-6; Thomas C, 2009, DTSCH ARZTEBL INT, V106, P849, DOI 10.3238/arztebl.2009.0849; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Weyer K, 2013, J NUCL MED, V54, P159, DOI 10.2967/jnumed.112.110528	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136204	10.1371/journal.pone.0136204	http://dx.doi.org/10.1371/journal.pone.0136204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287527	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600122
J	Scott, A; Rucklidge, JJ; Mulder, RT				Scott, Amelia; Rucklidge, Julia J.; Mulder, Roger T.			Is Mandatory Prospective Trial Registration Working to Prevent Publication of Unregistered Trials and Selective Outcome Reporting? An Observational Study of Five Psychiatry Journals That Mandate Prospective Clinical Trial Registration	PLOS ONE			English	Article							PUBLISHED PRIMARY OUTCOMES; RANDOMIZED-TRIALS; INTERNATIONAL COMMITTEE; PROTOCOLS; POLICY; BIAS	Objective To address the bias occurring in the medical literature associated with selective outcome reporting, in 2005, the International Committee of Medical Journal Editors (ICMJE) introduced mandatory trial registration guidelines and member journals required prospective registration of trials prior to patient enrolment as a condition of publication. No research has examined whether these guidelines are impacting psychiatry publications. Our objectives were to determine the extent to which articles published in psychiatry journals adhering to ICMJE guidelines were correctly prospectively registered, whether there was evidence of selective outcome reporting and changes to participant numbers, and whether there was a relationship between registration status and source of funding. Materials and Methods Any clinical trial (as defined by ICMJE) published between 1 January 2009 and 31 July 2013 in the top five psychiatry journals adhering to ICMJE guidelines (The American Journal of Psychiatry, Archives of General Psychiatry/JAMA Psychiatry, Biological Psychiatry, Journal of the American Academy of Child and Adolescent Psychiatry, and The Journal of Clinical Psychiatry) and conducted after July 2005 (or 2007 for two journals) was included. For each identified trial, where possible we extracted trial registration information, changes to POMs between publication and registry to assess selective outcome reporting, changes to participant numbers, and funding type. Results Out of 3305 articles, 181 studies were identified as clinical trials requiring registration: 21 (11.6%) were deemed unregistered, 61 (33.7%) were retrospectively registered, 37 (20.4%) had unclear POMs either in the article or the registry and 2 (1.1%) were registered in an inaccessible trial registry. Only 60 (33.1%) studies were prospectively registered with clearly defined POMs; 17 of these 60 (28.3%) showed evidence of selective outcome reporting and 16 (26.7%) demonstrated a change in participant numbers of 20% or more; only 26 (14.4%) of the 181 the trials were prospectively registered and did not alter their POMs or the time frames at which they were measured. Prospective registration with no changes in POMs occurred more frequently with pharmaceutical funding. Discussion Although standards are in place to improve prospective registration and transparency in clinical trials, less than 15% of psychiatry trials were prospectively registered with no changes in POMs. Most trials were either not prospectively registered, changed POMs or the time-frames at some point after registration or changed participant numbers. Authors, journal editors and reviewers need to further efforts to highlight the value of prospective trial registration.	[Scott, Amelia; Rucklidge, Julia J.] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [Mulder, Roger T.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand	University of Canterbury; University of Otago	Rucklidge, JJ (corresponding author), Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand.	julia.rucklidge@canterbury.ac.nz		Rucklidge, Julia/0000-0003-3793-7342				Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; BALLENGER JC, 1988, ARCH GEN PSYCHIAT, V45, P413; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Chalmers I, 2006, J ROY SOC MED, V99, P337, DOI 10.1258/jrsm.99.7.337; Chan A-W, 2013, BMJ-BRIT MED J, V2013, P346, DOI DOI 10.1136/BMJ.E7586; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Hannink G, 2013, ANN SURG, V257, P818, DOI 10.1097/SLA.0b013e3182864fa3; Hooft L, 2014, NETH J MED, V72, P349; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; Huser V, 2013, J AM MED INFORM ASSN, V20, pE169, DOI 10.1136/amiajnl-2012-001501; Killeen S, 2014, ANN SURG, V259, P193, DOI 10.1097/SLA.0b013e318299d00b; Knuppel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075995; Kunath F, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000430; Mathieu S, 2013, PLOS ONE, V10, P8, DOI DOI 10.1371/J0URNAL.P0NE.0059910; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; McGee RG, 2011, TRANSPLANTATION, V92, P1094, DOI 10.1097/TP.0b013e318232baf2; Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Sune P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054583; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Viergever RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084727; Walker KF, 2014, JRSM OPEN, V5, DOI [10.1177/2042533313517688, DOI 10.1177/2042533313517688]; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	27	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133718	10.1371/journal.pone.0133718	http://dx.doi.org/10.1371/journal.pone.0133718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287998	gold, Green Submitted, Green Published			2022-12-27	WOS:000360018600008
J	Zhou, SH; Shi, ZY; Cui, M; Li, JL; Ma, Z; Shi, YY; Zheng, ZJ; Zhang, FC; Jin, TB; Geng, TT; Chen, C; Guo, YL; Zhou, JP; Huang, S; Guo, XL; Gao, L; Gong, PY; Gao, XC; Zhang, KJ				Zhou, Shaohe; Shi, Zhangyan; Cui, Meng; Li, Junlin; Ma, Zhe; Shi, Yuanyu; Zheng, Zijian; Zhang, Fuchang; Jin, Tianbo; Geng, Tingting; Chen, Chao; Guo, Yale; Zhou, Jianping; Huang, Shaoping; Guo, Xingli; Gao, Lin; Gong, Pingyuan; Gao, Xiaocai; Zhang, Kejin			A New Role for LOC101928437 in Non-Syndromic Intellectual Disability: Findings from a Family-Based Association Test	PLOS ONE			English	Article							MENTAL-RETARDATION; UNIFIED APPROACH; POPULATION; BINDING; GENES	Non-syndromic intellectual disability (NSID) is mental retardation in persons of normal physical appearance who have no recognisable features apart from obvious deficits in intellectual functioning and adaptive ability; however, its genetic etiology of most patients has remained unknown. The main purpose of this study was to fine map and identify specific causal gene(s) by genotyping a NSID family cohort using a panel of markers encompassing a target region reported in a previous work. A total of 139 families including probands, parents and relatives were included in the household survey, clinical examinations and intelligence tests, recruited from the Qinba mountain region of Shannxi province, western China. A collection of 34 tagged single nucleotide polymorphisms (tSNPs) spanning five microsatellite marker (STR) loci were genotyped using an iPLEX Gold assay. The association between tSNPs and patients was analyzed by family-based association testing (FBAT) and haplotype analysis (HBAT). Four markers (rs5974392, rs12164331, rs5929554 and rs3116911) in a block that showed strong linkage disequilibrium within the first three introns of the LOC101928437 locus were found to be significantly associated with NSID (all P<0.01) by the FBAT method for a single marker in additive, dominant and recessive models. The results of haplotype tests of this block also revealed a significant association with NSID (all P<0.05) using 2-window and larger HBAT analyses. These results suggest that LOC101928437 is a novel candidate gene for NSID in Han Chinese individuals of the Qinba region of China. Although the biological function of the gene has not been well studied, knowledge about this gene will provide insights that will increase our understanding of NSID development.	[Zhou, Shaohe; Shi, Zhangyan; Li, Junlin; Ma, Zhe; Shi, Yuanyu; Zhang, Fuchang; Gao, Xiaocai; Zhang, Kejin] NW Univ Xian, Inst Populat & Hlth, Coll Life Sci, Minist Educ,Key Lab Resource Biol & Biotechnol We, Xian 710069, Peoples R China; [Cui, Meng] Xian Inst Mental Hlth, Xian, Peoples R China; [Zheng, Zijian; Zhang, Fuchang; Gao, Xiaocai] NW Univ Xian, Inst Applicat Psychol, Coll Publ Management, Xian 710069, Peoples R China; [Jin, Tianbo; Geng, Tingting; Chen, Chao] NW Univ Xian, Sch Life Sci, Xian 710069, Shaanxi, Peoples R China; [Jin, Tianbo; Geng, Tingting; Chen, Chao] Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shaanxi, Peoples R China; [Guo, Yale; Zhou, Jianping; Huang, Shaoping] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China; [Guo, Xingli; Gao, Lin] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Gong, Pingyuan] Henan Univ Sci & Technol, Lab Med Mol Biol, Luoyang, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; Northwest University Xi'an; Xi'an Jiaotong University; Xidian University; Henan University of Science & Technology	Gao, XC (corresponding author), NW Univ Xian, Inst Populat & Hlth, Coll Life Sci, Minist Educ,Key Lab Resource Biol & Biotechnol We, Xian 710069, Peoples R China.	gaoxc@nwu.edu.cn; zhangkj@nwu.edu.cn	Zhang, Kejin/A-4205-2015	Zhang, Kejin/0000-0002-4980-1736; Li, Junlin/0000-0002-3204-6420; Geng, Tingting/0000-0003-2309-7637	Natural Science Foundation of China [31340028, 31371327, 31100899]; NWU Graduate Innovation and Creativity Funds [201410697124]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NWU Graduate Innovation and Creativity Funds	Funding: This study was supported by grants from the Natural Science Foundation of China (No. 31340028) to Kejin Zhang, (No. 31371327) to Junlin Li and (No. 31100899) to Zhangyan Shi, and NWU Graduate Innovation and Creativity Funds (No. 201410697124) to Shaohe Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Delbridge ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-65; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gong Y., 1993, WECHSLER INTELLIGENC; Gong Y, 1989, ADULT MENTAL HANDICA; Gong YX., 1992, CHINESE WECHSLER YOU; Gong YX, 1992, MANUAL CHINESE REVIS; Gremer L, 2010, HUM MOL GENET, V19, P790, DOI 10.1093/hmg/ddp548; He Y, 2008, ANN HUM GENET, V72, P801, DOI 10.1111/j.1469-1809.2008.00465.x; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kelly SM, 2014, RNA, V20, P681, DOI 10.1261/rna.043984.113; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Longo-Guess CM, 2005, P NATL ACAD SCI USA, V102, P7894, DOI 10.1073/pnas.0500760102; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vink JM, 2002, BIOL PSYCHOL, V61, P53, DOI 10.1016/S0301-0511(02)00052-2; Visser R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049229; Wang D, 2007, CHINESE J CLIN PSYCH, V15, P6; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zhang KJ, 2009, PSYCHIAT GENET, V19, P27, DOI 10.1097/YPG.0b013e3283121d05; ZUO Q, 1988, ADAPTIVE SCALE INFAN	31	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135669	10.1371/journal.pone.0135669	http://dx.doi.org/10.1371/journal.pone.0135669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287547	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600062
J	Gimblet, C; Loesche, MA; Carvalho, L; Carvalho, EM; Grice, EA; Artis, D; Scott, P				Gimblet, Ciara; Loesche, Michael A.; Carvalho, Lucas; Carvalho, Edgar M.; Grice, Elizabeth A.; Artis, David; Scott, Phillip			IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis	PLOS ONE			English	Article							HOST-DEFENSE; KERATINOCYTE MIGRATION; CELLS; INFLAMMATION; INNATE; DIFFERENTIATION; INTERLEUKIN-22; EXPRESSION; IMMUNITY; SEVERITY	Cutaneous leishmaniasis is a disease characterized by ulcerating skin lesions, the resolution of which requires an effective, but regulated, immune response that limits parasite growth without causing permanent tissue damage. While mechanisms that control the parasites have been well studied, the factors regulating immunopathologic responses are less well understood. IL-22, a member of the IL-10 family of cytokines, can contribute to wound healing, but in other instances promotes pathology. Here we investigated the role of IL-22 during leishmania infection, and found that IL-22 limits leishmania-induced pathology when a certain threshold of damage is induced by a high dose of parasites. Il22(-/-) mice developed more severe disease than wild-type mice, with significantly more pathology at the site of infection, and in some cases permanent loss of tissue. The increased inflammation was not due to an increased parasite burden, but rather was associated with the loss of a wound healing phenotype in keratinocytes. Taken together, these studies demonstrate that during cutaneous leishmaniasis, IL-22 can play a previously unappreciated role in controlling leishmania-induced immunopathology.	[Gimblet, Ciara; Scott, Phillip] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Loesche, Michael A.; Grice, Elizabeth A.] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Carvalho, Lucas; Carvalho, Edgar M.] Univ Fed Bahia, Serv Imunol, Salvador, BA, Brazil; [Carvalho, Lucas; Carvalho, Edgar M.] Inst Nacl Ciencias & Tecnol Doencas Trop, Salvador, BA, Brazil; [Carvalho, Lucas; Carvalho, Edgar M.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil; [Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Universidade Federal da Bahia; Universidade Federal da Bahia; University of Pennsylvania; Pennsylvania Medicine	Scott, P (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	pscott@vet.upenn.edu	Carvalho, Lucas/AAP-1844-2020	Loesche, Michael/0000-0003-0737-0138; Grice, Elizabeth/0000-0003-3939-2200; Artis, David/0000-0002-1753-4100; Gimblet-Ochineg, Ciara/0000-0002-7699-9645	National Institutes of Health [RO1AI106842 (PS), AR060873 (EAG)]; Tropical Medicine Research Center [AI30639, T32AI753216]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106842, F31AI114227, P50AI030639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007465, R00AR060873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tropical Medicine Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health, RO1AI106842 (PS), AR060873 (EAG), Tropical Medicine Research Centers AI30639 (EMC), and T32AI753216 (CG). All funders played a role in the study design, data collection and analysis, decision to publish, and/or preparation of the manuscript.	Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Bafica A, 2003, INT J DERMATOL, V42, P203, DOI 10.1046/j.1365-4362.2003.01868.x; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brosch S, 2014, J INVEST DERMATOL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsen ED, 2015, J INNATE IMMUN; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Crosby EJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003970; da Silva Santos C, 2014, J INVEST DERMATOL; de Moura TR, 2005, INFECT IMMUN, V73, P5827, DOI 10.1128/IAI.73.9.5827-5834.2005; de Oliveira CI, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00145; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elso C, 2004, GENES IMMUN, V5, P188, DOI 10.1038/sj.gene.6364056; Elso CM, GENES; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Fernandez-Figueroa EA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001533; Gaze ST, 2006, SCAND J IMMUNOL, V63, P70, DOI 10.1111/j.1365-3083.2005.01707.x; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Guilloteau K, 2010, J IMMUNOL; Hannigan GD, 2014, J ORTHOP RES, V32, P597, DOI 10.1002/jor.22578; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mcgee HM, 2013, J INVEST DERMATOL, V133, P1321, DOI 10.1038/jid.2012.463; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Novais FO, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003504; Novais FO, 2014, J INVEST DERMATOL; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sertorio M, 2015, HEPATOLOGY, V61, P1321, DOI 10.1002/hep.27629; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Sun DP, 2013, CYTOKINE, V62, P360, DOI 10.1016/j.cyto.2013.03.017; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Taube C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021799; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Usui ML, 2005, WOUND REPAIR REGEN, V13, P468, DOI 10.1111/j.1067-1927.2005.00067.x; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Voronov E, 2010, INT IMMUNOL, V22, P245, DOI 10.1093/intimm/dxq006; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Xu X, 2014, J IMMUNOL, V192, P1778, DOI 10.4049/jimmunol.1300039; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	68	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134698	10.1371/journal.pone.0134698	http://dx.doi.org/10.1371/journal.pone.0134698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285207	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100015
J	Okoche, D; Asiimwe, BB; Katabazi, FA; Kato, L; Najjuka, CF				Okoche, Deogratius; Asiimwe, Benon B.; Katabazi, Fred Ashaba; Kato, Laban; Najjuka, Christine F.			Prevalence and Characterization of Carbapenem-Resistant Enterobacteriaceae Isolated from Mulago National Referral Hospital, Uganda	PLOS ONE			English	Article							MODIFIED HODGE TEST; KLEBSIELLA-PNEUMONIAE; SPREAD	Introduction Carbapenemases have increasingly been reported in enterobacteriaceae worldwide. Most carbapenemases are plasmid encoded hence resistance can easily spread. Carbapenem-resistant enterobacteriaceae are reported to cause mortality in up to 50% of patients who acquire bloodstream infections. We set out to determine the burden of carbapenem resistance as well as establish genes encoding for carbapenemases in enterobacteriaceae clinical isolates obtained from Mulago National Referral Hospital, Uganda. Methods This was a cross-sectional study with a total of 196 clinical isolates previously collected from pus swabs, urine, blood, sputum, tracheal aspirates, cervical swabs, endomentrial aspirates, rectal swabs, Vaginal swabs, ear swabs, products of conception, wound biopsy and amniotic fluid. All isolates were subjected to phenotypic carbapenemase screening using Boronic acid-based inhibition, Modified Hodge and EDTA double combined disk test. In addition, all the isolates were subjected to PCR assay to confirm presence of carbapenemase encoding genes. Results The study found carbapenemase prevalence of 22.4%(44/196) in the isolates using phenotypic tests, with the genotypic prevalence slightly higher at 28.6% (56/196). Over all, the most prevalent gene was blaVIM (21,10.7%), followed by blaOXA-48 (19, 9.7%), blaIMP (12, 6.1%), blaKPC (10, 5.1%) and blaNDM-1 (5, 2.6%). Among 56 isolates positive for 67 carbapenemase encoding genes, Klebsiella pneumonia was the species with the highest number (52.2%). Most 32/67(47.7%) of these resistance genes were in bacteria isolated from pus swabs. Conclusion There is a high prevalence of carbapenemases and carbapenem-resistance encoding genes among third generation cephalosporins resistant Enterobacteriaceae in Uganda, indicating a danger of limited treatment options in this setting in the near future.	[Okoche, Deogratius; Asiimwe, Benon B.; Katabazi, Fred Ashaba; Kato, Laban; Najjuka, Christine F.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda	Makerere University	Najjuka, CF (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.	najjukafc@gmail.com			BBA	BBA	DO was a student supported by BBA. The authors received no specific funding for this work.	Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Brink AJ, 2012, J CLIN MICROBIOL, V50, P525, DOI 10.1128/JCM.05956-11; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Cockerill FR, 2011, CLSI PERFORMANCE STA; Coetzee J., 2011, Southern African Journal of Epidemiology & Infection, V26, P239; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Ehrhard I, 2014, BUNDESGESUNDHEITSBLA, V57, P406, DOI 10.1007/s00103-013-1914-z; El Wartiti MA, 2012, INT ARAB J ANTIMICRO, V2, P1, DOI [10.3823/718, DOI 10.3823/718]; Girlich D, 2012, J CLIN MICROBIOL, V50, P477, DOI 10.1128/JCM.05247-11; Gwimile JJ, 2012, PAN AFR MED J, V12; Hu L, 2014, EPIDEMIOL INFECT, V142, P1972, DOI 10.1017/S0950268813002975; Huang TD, 2014, J ANTIMICROB CHEMOTH, V69, P445, DOI 10.1093/jac/dkt367; Karuniawati Anis, 2013, Acta Med Indones, V45, P101; Khosravi Y, 2012, SCI WORLD J, DOI 10.1100/2012/654939; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Miriagou V, 2010, CLIN MICROBIOL INFEC, V16, P112, DOI 10.1111/j.1469-0691.2009.03116.x; Miro E, 2013, EUR J CLIN MICROBIOL, V32, P253, DOI 10.1007/s10096-012-1737-0; Moquet O, 2011, EMERG INFECT DIS, V17, P143, DOI [10.3201/eid1701.100224, 10.3201/eid1701.100244]; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Nagdeo Neena V., 2012, CHRONICLES OF YOUNG, V3, P292; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Pasteran F, 2009, J CLIN MICROBIOL, V47, P1631, DOI 10.1128/JCM.00130-09; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Spyros Pournaras, 2010, J ANTIMICROB CHEMOTH, P1; Tian BY, 2012, MBIO, V3, DOI 10.1128/mBio.00377-12; Tsakris A, 2008, J ANTIMICROB CHEMOTH, V62, P1257, DOI 10.1093/jac/dkn364; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Yusuf I., 2012, BAJOPAS, V5, P84	33	63	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135745	10.1371/journal.pone.0135745	http://dx.doi.org/10.1371/journal.pone.0135745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284519	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100065
J	Palma, G; Tedeschi, E; Borrelli, P; Cocozza, S; Russo, C; Liu, SF; Ye, YQ; Comerci, M; Alfano, B; Salvatore, M; Haacke, EM; Mancini, M				Palma, Giuseppe; Tedeschi, Enrico; Borrelli, Pasquale; Cocozza, Sirio; Russo, Carmela; Liu, Saifeng; Ye, Yongquan; Comerci, Marco; Alfano, Bruno; Salvatore, Marco; Haacke, E. Mark; Mancini, Marcello			A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain	PLOS ONE			English	Article							T-1; TISSUE; QUANTIFICATION; RELAXOMETRY; RELAXATION; TIME	Magnetic Resonance properties of tissues can be quantified in several respects: relaxation processes, density of imaged nuclei, magnetism of environmental molecules, etc. In this paper, we propose a new comprehensive approach to obtain 3D high resolution quantitative maps of arbitrary body districts, mainly focusing on the brain. The theory presented makes it possible to map longitudinal (R-1), pure transverse (R-2) and free induction decay (R-2*) rates, along with proton density (PD) and magnetic susceptibility (chi), from a set of fast acquisition sequences in steady-state that are highly insensitive to flow phenomena. A novel denoising scheme is described and applied to the acquired datasets to enhance the signal to noise ratio of the derived maps and an information theory approach compensates for biases from radio frequency (RF) inhomogeneities, if no direct measure of the RF field is available. Finally, the results obtained on sample brain scans of healthy controls and multiple sclerosis patients are presented and discussed.	[Palma, Giuseppe; Comerci, Marco; Alfano, Bruno; Mancini, Marcello] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Tedeschi, Enrico; Cocozza, Sirio; Russo, Carmela] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Borrelli, Pasquale; Salvatore, Marco] IRCCS SDN, Naples, Italy; [Liu, Saifeng] MRI Inst Biomed Res, Waterloo, ON, Canada; [Ye, Yongquan; Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Haacke, E. Mark] MRI Inst Biomed Res, Detroit, MI USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Wayne State University	Palma, G (corresponding author), CNR, Inst Biostruct & Bioimaging, Naples, Italy.	giuseppe.palma@ibb.cnr.it	Russo, Carmela/AAA-3193-2022; Borrelli, Pasquale/H-7493-2016; Palma, Giuseppe/GXV-0228-2022; Palma, Giuseppe/AAX-1413-2020; Tedeschi, Enrico/AAN-7112-2020; Cocozza, Sirio/ABD-1161-2020; Borrelli, Pasquale/N-4880-2019; Liu, Saifeng/I-1242-2019; Salvatore, Marco/K-8083-2016	Borrelli, Pasquale/0000-0002-9299-9661; Palma, Giuseppe/0000-0002-0210-268X; Tedeschi, Enrico/0000-0002-0511-0132; Cocozza, Sirio/0000-0002-0300-5160; Borrelli, Pasquale/0000-0002-9299-9661; Salvatore, Marco/0000-0001-9734-7702; Alfano, Bruno/0000-0002-7315-3628; Russo, Carmela/0000-0003-1855-7571; Liu, Saifeng/0000-0002-3642-8282	Italian Ministry of Education, University and Research (MIUR), within the PRIN framework [2010XE5L2R]; Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant [CIF 99472]	Italian Ministry of Education, University and Research (MIUR), within the PRIN framework(Ministry of Education, Universities and Research (MIUR)); Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant(Canadian Institutes of Health Research (CIHR))	This study has been supported by the Italian Ministry of Education, University and Research (MIUR), within the PRIN framework (2010XE5L2R) and by the Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant #CIF 99472.	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Bjork M, 2011, EUR SIGNAL PR CONF, P1000; Bjork M, 2014, MAGN RESON MED, V72, P880, DOI 10.1002/mrm.24986; Bonnier G, 2014, ANN CLIN TRANSL NEUR, V1, P423, DOI 10.1002/acn3.68; Borrelli Pasquale, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1230, DOI 10.1109/ICASSP.2014.6853793; Borrelli P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126835; Brown RW, 2014, MAGNETIC RESONANCE I, DOI 10.1002/9781118633953.ch18; Chavhan GB, 2008, RADIOGRAPHICS, V28, P1147, DOI 10.1148/rg.284075031; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deoni Sean C L, 2010, Top Magn Reson Imaging, V21, P101, DOI 10.1097/RMR.0b013e31821e56d8; Deoni SCL, 2009, J MAGN RESON IMAGING, V30, P411, DOI 10.1002/jmri.21849; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2011, SUSCEPTIBILITY WEIGH; Hanicke W, 2003, MAGN RESON MED, V49, P771, DOI 10.1002/mrm.10410; Heule R, 2014, NMR BIOMED, V27, P1037, DOI 10.1002/nbm.3152; Heule R, 2014, MAGN RESON MED, V71, P230, DOI 10.1002/mrm.24659; Li L, 2001, J MAGN RESON, V148, P442, DOI 10.1006/jmre.2000.2267; Neeb H, 2012, NEUROIMAGE-CLIN, V1, P121, DOI 10.1016/j.nicl.2012.09.013; Neema M, 2009, NEUROIMAGE, V46, P633, DOI 10.1016/j.neuroimage.2009.03.001; Palma G, 2012, US Patent App, Patent No. [13/409,953, 13409953]; Palma G, 2013, FED CONF COMPUT SCI, P495; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Sirignano C, 2012, EUR C RADIOLOGY; Soscia E, 2011, EUR C RADIOLOGY; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Tofts P, 2005, QUANTITATIVE MRI BRA; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Warntjes JBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070864; Weiskopf N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00095; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8; ZUR Y, 1990, MAGNET RESON MED, V16, P444, DOI 10.1002/mrm.1910160311	35	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134963	10.1371/journal.pone.0134963	http://dx.doi.org/10.1371/journal.pone.0134963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284778	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100019
J	Xiao, YD; Lao, SY; Hou, LL; Small, M; Bai, L				Xiao, Yandong; Lao, Songyang; Hou, Lvlin; Small, Michael; Bai, Liang			Effects of Edge Directions on the Structural Controllability of Complex Networks	PLOS ONE			English	Article							INDEPENDENT SETS; EMERGENCE; DYNAMICS	Recent advances indicate that assigning or reversing edge direction can significantly improve the structural controllability of complex networks. For directed networks, approaching the optimal structural controllability can be achieved by detecting and reversing certain "inappropriate" edge directions. However, the existence of multiple sets of "inappropriate" edge directions suggests that different edges have different effects on optimal controllability-that is, different combinations of edges can be reversed to achieve the same structural controllability. Therefore, we classify edges into three categories based on their direction: critical, redundant and intermittent. We then investigate the effects of changing these edge directions on network controllability, and demonstrate that the existence of more critical edge directions implies not only a lower cost of modifying inappropriate edges but also better controllability. Motivated by this finding, we present a simple edge orientation method aimed at producing more critical edge directions-utilizing only local information-which achieves near optimal controllability. Furthermore, we explore the effects of edge direction on the controllability of several real networks.	[Xiao, Yandong; Lao, Songyang; Hou, Lvlin; Bai, Liang] Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China; [Hou, Lvlin; Small, Michael] Univ Western Australia, Sch Math & Stat, Crawley, WA, Australia	National University of Defense Technology - China; University of Western Australia	Xiao, YD (corresponding author), Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China.	ydxiao@nudt.edu.cn	Small, Michael/C-9807-2010	Small, Michael/0000-0001-5378-1582	Fundamental Funds for Open Cooperation Research [2014021]; Graduate Innovation Fund [B150501]	Fundamental Funds for Open Cooperation Research; Graduate Innovation Fund	This work was supported by Fundamental Funds for Open Cooperation Research under grant number 2014021 and the Graduate Innovation Fund under grant number B150501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Balaji S., 2010, ADV MODEL OPTIM, V12, P107; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Delpini D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01626; Donetti L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.188701; ERDOS P, 1960, B INT STATIST INST, V38, P343; Gao JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6415; Gazmuri PG, NETWORKS, V14, P367, DOI [10.1002/net, DOI 10.1002/NET]; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Hou LL, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/10/108901; Hou L, 2015, PHYS LETT A, V379, P1321, DOI 10.1016/j.physleta.2015.03.018; Hou LL, 2014, PHYS LETT A, V378, P3426, DOI 10.1016/j.physleta.2014.09.057; Hou LL, 2013, 2013 THIRD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM DESIGN AND ENGINEERING APPLICATIONS (ISDEA), P709, DOI 10.1109/ISDEA.2012.168; Jia T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02354; Jia T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3002; Kalman R. E., 1963, J SOC IND APPL MATH, V1, P152, DOI [10.1137/0301010, DOI 10.1137/0301010]; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lombardi A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056110; Menichetti G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.078701; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066130; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; ROBSON JM, 1986, J ALGORITHM, V7, P425, DOI 10.1016/0196-6774(86)90032-5; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rugh W.J., 1996, LINEAR SYSTEM THEORY; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; Wang WX, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026115; Wuchty S, 2014, P NATL ACAD SCI USA, V111, P7156, DOI 10.1073/pnas.1311231111; Xiao YD, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042804; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447	40	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135282	10.1371/journal.pone.0135282	http://dx.doi.org/10.1371/journal.pone.0135282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281042	gold, Green Submitted, Green Published			2022-12-27	WOS:000359664300010
J	Chieffo, D; Brogna, C; Berardinelli, A; D'Angelo, G; Mallardi, M; D'Amico, A; Alfieri, P; Mercuri, E; Pane, M				Chieffo, Daniela; Brogna, Claudia; Berardinelli, Angela; D'Angelo, Grazia; Mallardi, Maria; D'Amico, Adele; Alfieri, Paolo; Mercuri, Eugenio; Pane, Marika			Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study	PLOS ONE			English	Article							MENTAL RETARDATION; BOYS; INTELLIGENCE; ASSOCIATION; DISORDER	Objective Neurodevelopmental and cognitive difficulties are known to occur frequently in boys with Duchenne muscular dystrophy but so far none of the published studies have reported both early neurodevelopmental assessments and cognitive tests in the same cohort. The aim of the present longitudinal study was to establish the correlation between early neurodevelopmental assessments performed in preschool boys and the cognitive scales performed at school age or later. Methods We performed cognitive tests at school age (mean age 5.7 year +/- 1.7 SD) (69 months+ 19 SD) in a cohort of Duchenne boys, previously assessed using the Griffiths scales before the age of 4 years (mean age when the Griffiths scales were performed 30 months +/- 8.9 SD). Results The range of total Developmental quotients on the Griffiths ranged between 56 and 116 (mean 89 +/- 15.6 SD). The total Intelligence Quotients on the Wechsler scales ranged between 35 and 119 (mean 87 +/- 17.2 SD). There was a significant correlation between the findings on the two scales. P = <0.0001. When we subdivided the cohort according to site of mutations, there was a difference between boys with mutations upstream exon 44 and those with mutations in exon 44-45 affecting Dp140 on both Developmental and Intelligence Quotient (p 0.01 and p 0,003 respectively). Conclusions Our results confirm that Duchenne boys tend to slightly underperform on both neurodevelopmental and cognitive assessments. Early neurodevelopmental findings correlated with the cognitive results obtained at school age with a clear concordance between subscales exploring similar domains on the two scales.	[Chieffo, Daniela; Brogna, Claudia; Mallardi, Maria; Mercuri, Eugenio; Pane, Marika] Univ Cattolica Sacro Cuore, Dept Paediat Neurol, Rome, Italy; [Berardinelli, Angela] C Mondino Fdn, Child Neurol & Psychiat Unit, Pavia, Italy; [D'Angelo, Grazia] IRCCS Eugenio Medea, Bosisio Parini, Italy; [D'Amico, Adele] Bambino Gesu Pediat Hosp, Unit Neuromuscular & Neurodegenerat Disorders, Dept Neurosci, Rome, Italy; [Alfieri, Paolo] Bambino Gesu Pediat Hosp, Child & Adolescence Neuropsychiat Unit, Dept Neurosci, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Casimiro Mondino; IRCCS Eugenio Medea; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Dept Paediat Neurol, Rome, Italy.	mercuri@rm.unicatt.it	Berardinelli, angela/AAA-9496-2019; d'amico, adele/J-9203-2016; Mercuri, Eugenio/G-1351-2015; D'Angelo, Maria Grazia/K-4685-2016; BROGNA, Claudia/K-9759-2016	d'amico, adele/0000-0003-2438-2624; Mercuri, Eugenio/0000-0002-9851-5365; berardinelli, angela/0000-0002-4645-8055; Pane, Marika/0000-0002-4851-6124; D'Angelo, Maria Grazia/0000-0003-1241-4350; BROGNA, Claudia/0000-0002-9526-6367	Telethon UILDM grant [GUP 11002]	Telethon UILDM grant(Fondazione Telethon)	The study is supported by Telethon UILDM grant (GUP 11002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JE, 1960, AM J DIS CHILD, V100, P208, DOI 10.1001/archpedi.1960.04020040210008; COHEN HJ, 1968, DEV MED CHILD NEUROL, V10, P754; Connolly AM, 2014, PEDIATR NEUROL, V50, P557, DOI 10.1016/j.pediatrneurol.2014.02.006; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Cotton SM, 2005, DEV MED CHILD NEUROL, V47, P257, DOI 10.1017/S0012162205000496; Cyrulnik SE, 2007, J PEDIAT, V150, P456; Cyrulnik SE, 2008, NEUROSCI BIOBEHAV R, V32, P486, DOI 10.1016/j.neubiorev.2007.09.001; DORMAN C, 1988, DEV MED CHILD NEUROL, V30, P316, DOI 10.1111/j.1469-8749.1988.tb14556.x; DUBOWITZ V, 1965, ARCH DIS CHILD, V40, P296, DOI 10.1136/adc.40.211.296; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Griffiths R., 1996, GRIFFITHS MENTAL DEV; Griffiths R, 1984, ABILITIES YOUNG CHIL, P21; Hinton VJ, 2007, J AUTISM DEV DISORD, V37, P1925, DOI 10.1007/s10803-006-0325-5; Hinton V J, 2004, Learn Disabil Res Pract, V19, P146, DOI 10.1111/j.1540-5826.2004.00098.x; Hinton VJ, 2000, NEUROLOGY, V54, P2127, DOI 10.1212/WNL.54.11.2127; LEIBOWITZ D, 1981, DEV MED CHILD NEUROL, V23, P577; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; MILLER G, 1993, PEDIATR NEUROL, V9, P3, DOI 10.1016/0887-8994(93)90002-T; Muntoni F, 2003, DUCHENNE MUSCULAR DY; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P451, DOI 10.1016/j.nmd.2013.02.012; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; Picone L, 2006, WISC 3 WECHSL INT SC; [Primary Scale of Intelligence Wechsler Preschool], 1989, WECHSL PRESCH PRIM S; PROSSER EJ, 1969, ARCH DIS CHILD, V44, P221, DOI 10.1136/adc.44.234.221; Ricotti V, 2011, DEV MED CHILD NEUROL, V53, P12, DOI 10.1111/j.1469-8749.2010.03836.x; Sivo S, 2014, NEUROMUSCUL DISORD; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Wechsler D, 1991, WISC 3 WECHSL INT SC; WORDEN DK, 1962, PEDIATRICS, V29, P968	29	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133214	10.1371/journal.pone.0133214	http://dx.doi.org/10.1371/journal.pone.0133214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275215	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600010
J	Ring, A; Strom, BO; Turner, SR; Timperley, CM; Bird, M; Green, AC; Chad, JE; Worek, F; Tattersall, JEH				Ring, Avi; Strom, Bjorn Oddvar; Turner, Simon R.; Timperley, Christopher M.; Bird, Michael; Green, A. Christopher; Chad, John E.; Worek, Franz; Tattersall, John E. H.			Bispyridinium Compounds Inhibit Both Muscle and Neuronal Nicotinic Acetylcholine Receptors in Human Cell Lines	PLOS ONE			English	Article							ADULT SUBTYPE; SH-SY5Y CELLS; ION CHANNEL; NERVE; DESENSITIZATION; BLOOD; INTOXICATION; REACTIVATORS; QUATERNARY; TRANSPORT	Standard treatment of poisoning by organophosphorus anticholinesterases uses atropine to reduce the muscarinic effects of acetylcholine accumulation and oximes to reactivate acetylcholinesterase (the effectiveness of which depends on the specific anticholinesterase), but does not directly address the nicotinic effects of poisoning. Bispyridinium molecules which act as noncompetitive antagonists at nicotinic acetylcholine receptors have been identified as promising compounds and one has been shown to improve survival following organophosphorus poisoning in guinea-pigs. Here, we have investigated the structural requirements for antagonism and compared inhibitory potency of these compounds at muscle and neuronal nicotinic receptors and acetylcholinesterase. A series of compounds was synthesised, in which the length of the polymethylene linker between the two pyridinium moieties was increased sequentially from one to ten carbon atoms. Their effects on nicotinic receptor-mediated calcium responses were tested in muscle-derived (CN21) and neuronal (SH-SY5Y) cells. Their ability to inhibit acetylcholinesterase activity was tested using human erythrocyte ghosts. In both cell lines, the nicotinic response was inhibited in a dose-dependent manner and the inhibitory potency of the compounds increased with greater linker length between the two pyridinium moieties, as did their inhibitory potency for human acetylcholinesterase activity in vitro. These results demonstrate that bispyridinium compounds inhibit both neuronal and muscle nicotinic receptors and that their potency depends on the length of the hydrocarbon chain linking the two pyridinium moieties. Knowledge of structure-activity relationships will aid the optimisation of molecular structures for therapeutic use against the nicotinic effects of organophosphorus poisoning.	[Ring, Avi; Strom, Bjorn Oddvar] Norwegian Def Res Estab, N-2007 Kjeller, Norway; [Turner, Simon R.; Timperley, Christopher M.; Bird, Michael; Green, A. Christopher; Tattersall, John E. H.] Dstl Porton Down, Salisbury, Wilts, England; [Turner, Simon R.; Chad, John E.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Worek, Franz] Bundeswehr Inst Pharmacol & Toxicol, Munich, Germany	Norwegian Defence Research Establishment; Defence Science & Technology Laboratory; University of Southampton	Tattersall, JEH (corresponding author), Dstl Porton Down, Salisbury, Wilts, England.	JTattersall@dstl.gov.uk			Ministry of Defence UK; Ministry of Defence Germany	Ministry of Defence UK; Ministry of Defence Germany	This work was supported by the Ministry of Defence UK, and the Ministry of Defence Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKONDON M, 1989, J PHARMACOL EXP THER, V250, P842; Bajgar J, 2007, MINI-REV MED CHEM, V7, P461, DOI 10.2174/138955707780619581; Beeson D, 1996, NEUROSCI LETT, V207, P57, DOI 10.1016/0304-3940(96)12488-5; BLABER LC, 1963, BRIT J PHARM CHEMOTH, V20, P326, DOI 10.1111/j.1476-5381.1963.tb01472.x; Bowman WC, 2006, BRIT J PHARMACOL, V147, pS277, DOI 10.1038/sj.bjp.0706404; CAVALLITO CJ, 1959, BIOCHEM PHARMACOL, V2, P233, DOI 10.1016/0006-2952(59)90036-X; Christopoulos A, 1999, J PHARMACOL EXP THER, V289, P1220; Dadparvar M, 2011, TOXICOL LETT, V206, P60, DOI 10.1016/j.toxlet.2011.06.027; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Elenes S, 2002, J PHYSIOL-LONDON, V541, P367, DOI 10.1113/jphysiol.2001.016022; Fucile S, 2006, J PHYSIOL-LONDON, V573, P35, DOI 10.1113/jphysiol.2006.108092; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; HAZARD R, 1952, ARCH INT PHARMACOD T, V90, P271; Hobbiger F., 1976, NEUROMUSCULAR JUNCTI, P487; Joosen MJA, 2011, TOXICOL LETT, V206, P67, DOI 10.1016/j.toxlet.2011.05.231; KENNEDY C, 1992, NEUROSCIENCE, V49, P937, DOI 10.1016/0306-4522(92)90369-D; LUKAS RJ, 1993, MOL CELL NEUROSCI, V4, P1, DOI 10.1006/mcne.1993.1001; MARRS TC, 1991, ADVERSE DRUG REACT T, V10, P61; MASELLI RA, 1993, MUSCLE NERVE, V16, P548, DOI 10.1002/mus.880160518; MEETER E, 1969, ACTA PHYSIOL PHARM N, V15, P243; Michelmore S, 2002, N-S ARCH PHARMACOL, V366, P235, DOI 10.1007/s00210-002-0589-z; OGUROOKANO M, 1992, MAYO CLIN PROC, V67, P1150, DOI 10.1016/S0025-6196(12)61144-6; PATON WDM, 1949, BRIT J PHARM CHEMOTH, V4, P381, DOI 10.1111/j.1476-5381.1949.tb00565.x; Sheridan RD, 2005, J ROY SOC MED, V98, P114, DOI 10.1258/jrsm.98.3.114; Sit RK, 2011, J BIOL CHEM, V286, P19422, DOI 10.1074/jbc.M111.230656; Smythies J, 2004, J ROY SOC MED, V97, P32, DOI 10.1258/jrsm.97.1.32; STRATTON MR, 1989, CARCINOGENESIS, V10, P899, DOI 10.1093/carcin/10.5.899; TATTERSALL JEH, 1993, BRIT J PHARMACOL, V108, P1006, DOI 10.1111/j.1476-5381.1993.tb13498.x; Timperley CM, 2012, MEDCHEMCOMM, V3, P352, DOI 10.1039/c2md00258b; Timperley CM, 2005, J FLUORINE CHEM, V126, P1160, DOI 10.1016/j.jfluchem.2005.05.004; Turner SR, 2011, TOXICOL LETT, V206, P105, DOI 10.1016/j.toxlet.2011.05.1035; Wille T, 2010, TOXICOL IN VITRO, V24, P1026, DOI 10.1016/j.tiv.2009.11.023; Worek F, 1999, CLIN CHIM ACTA, V288, P73, DOI 10.1016/S0009-8981(99)00144-8; Worek F, 2002, ARCH TOXICOL, V76, P523, DOI 10.1007/s00204-002-0375-1	35	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135811	10.1371/journal.pone.0135811	http://dx.doi.org/10.1371/journal.pone.0135811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274808	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000359493600116
J	Virard, F; Cousty, S; Cambus, JP; Valentin, A; Kemoun, P; Clement, F				Virard, Francois; Cousty, Sarah; Cambus, Jean-Pierre; Valentin, Alexis; Kemoun, Philippe; Clement, Franck			Cold Atmospheric Plasma Induces a Predominantly Necrotic Cell Death via the Microenvironment	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; REACTIVE OXYGEN; APOPTOSIS; DNA	Introduction Cold plasma is a partially ionized gas generated by an electric field at atmospheric pressure that was initially used in medicine for decontamination and sterilization of inert surfaces. There is currently growing interest in using cold plasma for more direct medical applications, mainly due to the possibility of tuning it to obtain selective biological effects in absence of toxicity for surrounding normal tissues,. While the therapeutic potential of cold plasma in chronic wound, blood coagulation, and cancer treatment is beginning to be documented, information on plasma/cell interaction is so far limited and controversial. Methods and Results Using normal primary human fibroblast cultures isolated from oral tissue, we sought to decipher the effects on cell behavior of a proprietary cold plasma device generating guided ionization waves carried by helium. In this model, cold plasma treatment induces a predominantly necrotic cell death. Interestingly, death is not triggered by a direct interaction of the cold plasma with cells, but rather via a transient modification in the microenvironment. We show that modification of the microenvironment redox status suppresses treatment toxicity and protects cells from death. Moreover, necrosis is not accidental and seems to be an active response to an environmental cue, as its execution can be inhibited to rescue cells. Conclusion These observations will need to be taken into account when studying in vitro plasma/cell interaction and may have implications for the design and future evaluation of the efficacy and safety of this new treatment strategy.	[Virard, Francois] Univ Lyon 1, Ctr Rech Cancerol Lyon, UCBL, UMR5286,CNRS,INSERM, F-69365 Lyon, France; [Virard, Francois] Univ Lyon 1, Fac Odontol Lyon, F-69365 Lyon, France; [Cousty, Sarah; Kemoun, Philippe] Univ Toulouse 3, Fac Chirurg Dentaire Toulouse, F-31062 Toulouse, France; [Cousty, Sarah; Cambus, Jean-Pierre; Valentin, Alexis; Kemoun, Philippe] CHU Toulouse, Toulouse, France; [Cambus, Jean-Pierre] Hop Rangueil, Lab Hematol, TSA 50032, Toulouse, France; [Valentin, Alexis] Univ Toulouse 3, Fac Pharm, UMR IRD UPS PHARMA DEV 152, F-31062 Toulouse, France; [Clement, Franck] Univ Pau & Pays Adour, LCABIE IPREM, UMR 5254, Pau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour	Kemoun, P (corresponding author), Univ Toulouse 3, Fac Chirurg Dentaire Toulouse, F-31062 Toulouse, France.	philippe.kemoun@univ-tlse3.fr	VIRARD, francois/Y-1839-2019; Cousty, Sarah/AGZ-6395-2022; Valentin, Alexis/I-6821-2015	VIRARD, francois/0000-0001-7570-1088; Cousty, Sarah/0000-0003-4077-2796; Valentin, Alexis/0000-0002-2133-112X; KEMOUN, PHILIPPE/0000-0001-7373-2657	French National Research Agency [ANR-10-BLAN-0950, ANR-12-BSV5-0006]; ANR	French National Research Agency(French National Research Agency (ANR)); ANR(French National Research Agency (ANR))	The French National Research Agency 1 - PLASMAVIV ANR-10-BLAN-0950 http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-10-BLAN-0950 Understanding of the interaction mechanisms between plasma produced atomic nitrogen and living matter FC UPPA-IPREM : LCABIE UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR 2- PLASMINF ANR-12-BSV5-0006 http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-12-BSV5-0006 Plasma gas for infectious diseases and inflammation FC; AV ANR funded project Calls for proposals Bookmark & Share Blanc - SVSE 5 - Physique, chimie du vivant et innovations biotechnologiques (Blanc SVSE 5) Edition 2012 PlasmInf Plasma gas for infectious diseases and inflammation Use of a physic process, plasma gas, for the treatment of infectious diseases The use of plasma gas (physical process without toxic chemical inputs) for the treatment of inflammatory or infectious diseases is here studied to understand its mechanisms of action on infectious targets. Understanding its mechanisms should allow for this very new process in medicine, a controlled tool. plasma gas as a treatment without chemical inputs PLASMINF aims to analyze the interactions and modes of action of bio-compatible plasma models on living targets. Understanding how plasma at the cellular level is expected in order to extend their applications to various diseases and, in some cases, opening the possibility to get rid of expensive chemical treatments, potentially toxic, or low effective because the development of resistance of some bacteria or cells. The potential gains in terms of savings are difficult to quantify so far, but it seems reasonable to assume that physical technique, potentially minimally invasive will greatly reduce some adverse effects of chemotherapy currently used in medicine Activity of plasma on cellular targets The purpose, here is to understand, through the use of techniques of cellular biology (imaging) and molecular biology (amplification of some mesengers) cellular and nuclear changes induced in the cells by the plasma gas. This understanding should guide the response of the body, depending on the desired effects (inflammation or repair) with a non-intrusive process, the plasma gas Resultats Undeveloped, the project was initiated six months ago. Perspectives Undeveloped Productions scientifiques et brevets undeveloped PARTENAIRES Pharma-DEV UMR 152 IRD-UPS Pharmacochimie et pharmacologie pour le developpement IPREM / UMR 5254 / LCABIE Universite de Pau et des Pays de l'Adour The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Aichelmann-Reidy ME, 2008, J PERIODONTOL, V79, P387, DOI 10.1902/jop.2008.060521 ; Bedner E, 2001, CYTOMETRY, V43, P38, DOI 10.1002/1097-0320(20010101)43:1<38::AID-CYTO1017>3.0.CO;2-S; Boeuf JP, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/1/015201; Chang JW, 2014, ARCH BIOCHEM BIOPHYS, V545, P133, DOI 10.1016/j.abb.2014.01.022; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Dudek D, 2007, J PHYS D APPL PHYS, V40, P7367, DOI 10.1088/0022-3727/40/23/017; Foster B L, 2005, Orthod Craniofac Res, V8, P285, DOI 10.1111/j.1601-6343.2005.00351.x; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gazeli K, 2015, J APPL PHYS, V117, DOI 10.1063/1.4914035; Gazeli K, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/2/025020; Gazeli K., 2012, 19 INT C GAS DISCH T, V38; Hong YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2400078; Jarrige J, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/6/065005; Joh HM, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4742742; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kang SU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.33; Kemoun P, 2011, BIOMATERIALS, V32, P7375, DOI 10.1016/j.biomaterials.2011.06.043; Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511; Kim SJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462293; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Laroussi M, 2004, J APPL PHYS, V96, P3028, DOI 10.1063/1.1777392; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Lu X, 2014, PHYS REP, V540, P123, DOI 10.1016/j.physrep.2014.02.006; Lu XP, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912524; Lunov O, 2014, SCI REP-UK, V4, DOI 10.1038/srep07129; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Mericam-Bourdet N, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/055207; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Reuter S, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034015; Robert E, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034017; Ryu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066231; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Srivastava N, 2011, IEEE T PLASMA SCI, V39, P918, DOI 10.1109/TPS.2010.2101618; Stoffels E, 2003, J PHYS D APPL PHYS, V36, P2908, DOI 10.1088/0022-3727/36/23/007; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; van Gils CAJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175203; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Walsh JL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2817965; Weltmann KD, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/194008; Xiong Q, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/1/015011; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	49	38	38	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133120	10.1371/journal.pone.0133120	http://dx.doi.org/10.1371/journal.pone.0133120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275141	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600009
J	Adams, AJ; LaBonte, JP; Ball, ML; Richards-Hrdlicka, KL; Toothman, MH; Briggs, CJ				Adams, Andrea J.; LaBonte, John P.; Ball, Morgan L.; Richards-Hrdlicka, Kathryn L.; Toothman, Mary H.; Briggs, Cheryl J.			DNA Extraction Method Affects the Detection of a Fungal Pathogen in Formalin-Fixed Specimens Using qPCR	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; AMPHIBIAN CHYTRID FUNGUS; BATRACHOCHYTRIUM-DENDROBATIDIS; KILLING FUNGUS; CHYTRIDIOMYCOSIS; DYNAMICS; BIODIVERSITY; EXTINCTION; DECLINES; ENDEMISM	Museum collections provide indispensable repositories for obtaining information about the historical presence of disease in wildlife populations. The pathogenic amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) has played a significant role in global amphibian declines, and examining preserved specimens for Bd can improve our understanding of its emergence and spread. Quantitative PCR (qPCR) enables Bd detection with minimal disturbance to amphibian skin and is significantly more sensitive to detecting Bd than histology; therefore, developing effective qPCR methodologies for detecting Bd DNA in formalin-fixed specimens can provide an efficient and effective approach to examining historical Bd emergence and prevalence. Techniques for detecting Bd in museum specimens have not been evaluated for their effectiveness in control specimens that mimic the conditions of animals most likely to be encountered in museums, including those with low pathogen loads. We used American bullfrogs (Lithobates catesbeianus) of known infection status to evaluate the success of qPCR to detect Bd in formalin-fixed specimens after three years of ethanol storage. Our objectives were to compare the most commonly used DNA extraction method for Bd (PrepMan, PM) to Macherey-Nagel DNA FFPE (MN), test optimizations for Bd detection with PM, and provide recommendations for maximizing Bd detection. We found that successful detection is relatively high (80-90%) when Bd loads before formalin fixation are high, regardless of the extraction method used; however, at lower infection levels, detection probabilities were significantly reduced. The MN DNA extraction method increased Bd detection by as much as 50% at moderate infection levels. Our results indicate that, for animals characterized by lower pathogen loads (i.e., those most commonly encountered in museum collections), current methods may underestimate the proportion of Bd-infected amphibians. Those extracting DNA from archived museum specimens should ensure that the techniques they are using are known to provide high-quality throughput DNA for later analysis.	[Adams, Andrea J.; LaBonte, John P.; Toothman, Mary H.; Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Ball, Morgan L.] Wildlands Conservat Sci, Lompoc, CA USA; [Richards-Hrdlicka, Kathryn L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	University of California System; University of California Santa Barbara; Yale University	Adams, AJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	andrea.adams@lifesci.ucsb.edu	Adams, Andrea/C-4092-2015; Adams, Andrea/AAH-3580-2021	Adams, Andrea/0000-0001-5609-6150; Adams, Andrea/0000-0001-5609-6150	National Science Foundation Ecology of Infectious Disease [EF-0723563]; Robert and Patricia Switzer Foundation; Vandenberg Air Force Base	National Science Foundation Ecology of Infectious Disease(National Science Foundation (NSF)); Robert and Patricia Switzer Foundation; Vandenberg Air Force Base	Funding was provided by the National Science Foundation Ecology of Infectious Disease grant #EF-0723563 (awarded to CJB, http://www.nsf.gov/), the Robert and Patricia Switzer Foundation (fellowship awarded to AJA, http://www.switzernetwork.org/), and Vandenberg Air Force Base (awarded to JPL, http://www.vandenberg.af.mil/). None of the funders played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Avila-Arcos MC, 2013, MOL BIOL EVOL, V30, P299, DOI 10.1093/molbev/mss223; Barta JL, 2014, J ARCHAEOL SCI, V46, P281, DOI 10.1016/j.jas.2014.03.030; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Bucklin A, 2004, MOL PHYLOGENET EVOL, V30, P879, DOI 10.1016/j.ympev.2003.11.002; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Daszak P, 2004, HERPETOL J, V14, P201; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fong JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115656; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Heard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023150; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Huss M, 2013, ECOHEALTH, V10, P339, DOI 10.1007/s10393-013-0895-6; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kosch TA, 2013, MOL ECOL RESOUR, V13, P230, DOI 10.1111/1755-0998.12041; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P141, DOI 10.3354/dao071141; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2011, P NATL ACAD SCI USA, V108, P9323, DOI 10.1073/pnas.1107246108; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; McDiarmid R.W., 1994, MEASURING MONITORING, P289; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Mendelson JR, 2014, S AM J HERPETOL, V9, P151, DOI 10.2994/SAJH-D-14-00021.1; Morehouse EA, 2003, MOL ECOL, V12, P395, DOI 10.1046/j.1365-294X.2003.01732.x; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Muletz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103728; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Carnaval ACOD, 2006, ECOHEALTH, V3, P41, DOI 10.1007/s10393-005-0008-2; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Padgett-Flohr GE., 2009, THESIS; Padgett-Flohr GE, 2009, DIS AQUAT ORGAN, V83, P1, DOI 10.3354/dao02003; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Piovia-Scott J, 2015, ISME J, V9, P1570, DOI 10.1038/ismej.2014.241; Popa Oana Paula, 2007, Travaux du Museum National d'Histoire Naturelle Grigore Antipa, V50, P527; PORTER RD, 1969, SCIENCE, V165, P199, DOI 10.1126/science.165.3889.199; R Core Team, 2012, R A LANGUAGE AND ENV; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Richards-Hrdlicka KL, 2012, METHODS ECOL EVOL, V3, P842, DOI 10.1111/j.2041-210X.2012.00228.x; Rocha LA, 2014, SCIENCE, V344, P814, DOI 10.1126/science.344.6186.814; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Simmons JE, 2002, HERPETOLOGICAL CIRCU, P153; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soto-Azat C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079862; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; Vredenburg VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063791; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Weinstein SB, 2009, COPEIA, P653, DOI 10.1643/CH-08-180; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Zhu W, 2014, ECOHEALTH, V11, P241, DOI 10.1007/s10393-013-0894-7	64	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135389	10.1371/journal.pone.0135389	http://dx.doi.org/10.1371/journal.pone.0135389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291624	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900018
J	Butovskaya, ML; Lazebny, OE; Vasilyev, VA; Dronova, DA; Karelin, DV; Mabulla, AZP; Shibalev, DV; Shackelford, TK; Fink, B; Ryskov, AP				Butovskaya, Marina L.; Lazebny, Oleg E.; Vasilyev, Vasiliy A.; Dronova, Daria A.; Karelin, Dmitri V.; Mabulla, Audax Z. P.; Shibalev, Dmitri V.; Shackelford, Todd K.; Fink, Bernhard; Ryskov, Alexey P.			Androgen Receptor Gene Polymorphism, Aggression, and Reproduction in Tanzanian Foragers and Pastoralists	PLOS ONE			English	Article							HUNTER-GATHERERS; PERSONALITY-TRAITS; DATOGA PASTORALISTS; REPEAT POLYMORPHISM; TESTOSTERONE LEVELS; AFRICAN FORAGERS; MATE PREFERENCES; MEN; HADZA; CAG	The androgen receptor (AR) gene polymorphism in humans is linked to aggression and may also be linked to reproduction. Here we report associations between AR gene polymorphism and aggression and reproduction in two small-scale societies in northern Tanzania (Africa)-the Hadza (monogamous foragers) and the Datoga (polygynous pastoralists). We secured self-reports of aggression and assessed genetic polymorphism of the number of CAG repeats for the AR gene for 210 Hadza men and 229 Datoga men (aged 17-70 years). We conducted structural equation modeling to identify links between AR gene polymorphism, aggression, and number of children born, and included age and ethnicity as covariates. Fewer AR CAG repeats predicted greater aggression, and Datoga men reported more aggression than did Hadza men. In addition, aggression mediated the identified negative relationship between CAG repeats and number of children born.	[Butovskaya, Marina L.; Dronova, Daria A.] Russian Acad Sci, Inst Ethnol & Anthropol, Dept Cross Cultural Psychol & Human Ethol, Moscow, Russia; [Lazebny, Oleg E.] Russian Acad Sci, Dept Evolutionary & Dev Genet, Koltzov Inst Dev Biol, Moscow, Russia; [Vasilyev, Vasiliy A.; Shibalev, Dmitri V.; Ryskov, Alexey P.] Russian Acad Sci, Inst Gene Biol, Dept Genome Org, Moscow, Russia; [Karelin, Dmitri V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Mabulla, Audax Z. P.] Univ Dar Es Salaam, Coll Arts & Social Sci, Dept Archaeol, Dar Es Salaam, Tanzania; [Shackelford, Todd K.] Oakland Univ, Dept Psychol, Rochester, MI 48063 USA; [Fink, Bernhard] Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany	Russian Academy of Sciences; N.N. Miklukho-Maklai Institute of Ethnology & Anthropology; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; University of Dar es Salaam; Oakland University; University of Gottingen	Lazebny, OE (corresponding author), Russian Acad Sci, Dept Evolutionary & Dev Genet, Koltzov Inst Dev Biol, Moscow, Russia.	oelazebny@gmail.com	Fink, Bernhard/G-7312-2011; Vasilyev, Vasily/AAO-5336-2021; Mabulla, Audax ZP/ABE-2455-2020; Shackelford, Todd K./T-6243-2017; Butovskaya, Marina/E-2368-2016; Karelin, Dmitriy/AAE-5169-2019; Karelin, Dmitry/AAK-9470-2020; Lazebny, Oleg/R-9208-2016; Dronova, Daria/V-2150-2019; Ryskov, Alexey/F-1179-2016	Fink, Bernhard/0000-0003-2739-5236; Shackelford, Todd K./0000-0001-8101-4292; Butovskaya, Marina/0000-0002-5528-0519; Karelin, Dmitry/0000-0001-5778-3163; Lazebny, Oleg/0000-0003-3136-0415; Dronova, Daria/0000-0002-2735-6248; Ryskov, Alexey/0000-0002-4159-0671	Russian Foundation for Humanities [12-01-00032-MLB]; Russian Foundation for Basic Research [13-06-00393-MLB, 12-04-31869-APR, 13-04-00858-APR]; Research Program of Russian Academy of Sciences 'Molecular and Cell Biology'-APR; President RF Program [5233.2012.4-APR, 2501.2014.4-APR]	Russian Foundation for Humanities; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Research Program of Russian Academy of Sciences 'Molecular and Cell Biology'-APR; President RF Program	This work was supported by the Russian Foundation for Humanities-12-01-00032-MLB, the Russian Foundation for Basic Research-13-06-00393-MLB, the Russian Foundation for Basic Research-12-04-31869-APR, the Russian Foundation for Basic Research-13-04-00858-APR, the Research Program of Russian Academy of Sciences 'Molecular and Cell Biology'-APR, the President RF Program-5233.2012.4-APR, and the President RF Program-2501.2014.4-APR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluja A, 2011, PSYCHIAT GENET, V21, P229, DOI 10.1097/YPG.0b013e328345465e; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Archer J, 2007, PERS INDIV DIFFER, V43, P627, DOI 10.1016/j.paid.2007.01.005; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Bachu A., 1996, WORKING PAPER SERIES; Boehm C, 1999, HUM NATURE-INT BIOS, V10, P205, DOI 10.1007/s12110-999-1003-z; Bogaert V, 2009, EUR J ENDOCRINOL, V161, P171, DOI 10.1530/EJE-09-0123; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Buss D.M., 2006, EVOLUTION SOCIAL PSY, P263; Butovskaia M. L., 2011, ANTHROPOLOGY SOCIAL, P365; [Бутовская Марина Львовна Butovskaya M.L.], 2011, [Этнографическое обозрение, Ethnographic Review, Etnograficheskoe obozrenie], P85; Butovskaya M.L., 2013, WAR PEACE HUMAN NATU, P278, DOI [DOI 10.1093/ACPROF:OSO/9780199858996.003.0014, 10.1093/acprof:oso/9780199858996.003.0014]; Butovskaya ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep03148; Butovskaya ML, 2012, J AGGRESS CONFL PEAC, V4, P28, DOI 10.1108/17596591211192975; Butovskaya ML, 2012, BEHAV GENET, V42, P647, DOI 10.1007/s10519-012-9533-2; Butovskaya ML, 2010, J AGGRESS CONFL PEAC, V2, P17, DOI 10.5042/jacpr.2010.0002; Campbell BC, 2009, INT J ANDROL, V32, P140, DOI 10.1111/j.1365-2605.2007.00825.x; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chapman D.W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI [10.3102/01623737001003071, DOI 10.3102/01623737001003071]; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; Daly M, 2001, Nebr Symp Motiv, V47, P1; Daly M, 1990, Hum Nat, V1, P81, DOI 10.1007/BF02692147; Daly M, 1988, HOMICIDE HAWTHORNE; Fouts HN, 2008, CROSS-CULT RES, V42, P290, DOI 10.1177/1069397108317484; Fry D. P, 2004, WAR HUMAN POTENTIAL; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; Gray PB, 2006, P ROY SOC B-BIOL SCI, V273, P333, DOI 10.1098/rspb.2005.3311; Gray Peter B., 2010, FATHERHOOD EVOLUTION; Grundy E, 2008, AM J EPIDEMIOL, V167, P271, DOI 10.1093/aje/kwm295; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hewlett BS, 1993, INTIMATE FATHERS NAT; Holmberg AR, 1969, NOMADS LONG BOW SIRI; Irons W, 1979, EVOLUTIONARY BIOL HU, P256; Jonsson EG, 2001, PSYCHIAT GENET, V11, P19, DOI 10.1097/00041444-200103000-00004; KNAUFT BM, 1991, CURR ANTHROPOL, V32, P391, DOI 10.1086/203975; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; LANE C., 1996, PASTURES LOST BARABA; Loehlin JC, 2005, PERS INDIV DIFFER, V39, P661, DOI 10.1016/j.paid.2005.02.016; Low B., 2000, WHY SEX MATTRES DARW; Manning JT, 2008, FINGER BOOK; Marlowe F., 2002, ETHNICITY HUNTER GAT, P247; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Marlowe FW, 2012, J HUM EVOL, V63, P834, DOI 10.1016/j.jhevol.2012.09.004; Marlowe FW, 2004, HUM NATURE-INT BIOS, V15, P365, DOI 10.1007/s12110-004-1014-8; Marlowe FW, 2003, EVOL HUM BEHAV, V24, P217, DOI 10.1016/S1090-5138(03)00014-X; Marlowe FW, 2003, CROSS-CULT RES, V37, P282, DOI 10.1177/1069397103254008; Mulder MB, 2007, EVOL HUM BEHAV, V28, P299, DOI 10.1016/j.evolhumbehav.2007.05.009; Muller MN, 2009, P ROY SOC B-BIOL SCI, V276, P347, DOI 10.1098/rspb.2008.1028; Pisanski K, 2013, CROSS-CULT RES, V47, P162, DOI 10.1177/1069397112471806; Rajender S, 2008, INT J LEGAL MED, V122, P367, DOI 10.1007/s00414-008-0225-7; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sear R, 2009, BIOL LETTERS, V5, P606, DOI 10.1098/rsbl.2009.0342; Shibalev DV, 2013, RUSS J GENET+, V49, P1258, DOI 10.1134/S1022795413120119; Sorokowski P, 2012, BODY IMAGE, V9, P510, DOI 10.1016/j.bodyim.2012.07.002; Tomikawa M., 1978, SENRI ETHOLOGICAL ST, V1, P1; TURKE PW, 1985, ETHOL SOCIOBIOL, V6, P79, DOI 10.1016/0162-3095(85)90001-9; Westberg L, 2009, J PSYCHIATR NEUROSCI, V34, P205; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WOODBURN J, 1982, MAN, V17, P431, DOI 10.2307/2801707; Woodburn J, 1988, HUNTERS GATHERERS, V1, P43	63	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136208	10.1371/journal.pone.0136208	http://dx.doi.org/10.1371/journal.pone.0136208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291982	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900065
J	Groten, K; Pahari, NT; Xu, SQ; van Doorn, MM; Baldwin, IT				Groten, Karin; Pahari, Nabin T.; Xu, Shuqing; van Doorn, Maja Miloradovic; Baldwin, Ian T.			Virus-Induced Gene Silencing Using Tobacco Rattle Virus as a Tool to Study the Interaction between Nicotiana attenuata and Rhizophagus irregularis	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; PHOSPHATE TRANSPORTER GENES; GERMIN-LIKE PROTEINS; MEDICAGO-TRUNCATULA; GLOMUS-INTRARADICES; TRANSCRIPTION FACTOR; EXPRESSION PATTERNS; CORTICAL-CELLS; PLANT; SYMBIOSIS	Most land plants live in a symbiotic association with arbuscular mycorrhizal fungi (AMF) that belong to the phylum Glomeromycota. Although a number of plant genes involved in the plant-AMF interactions have been identified by analyzing mutants, the ability to rapidly manipulate gene expression to study the potential functions of new candidate genes remains unrealized. We analyzed changes in gene expression of wild tobacco roots (Nicotiana attenuata) after infection with mycorrhizal fungi (Rhizophagus irregularis) by serial analysis of gene expression (SuperSAGE) combined with next generation sequencing, and established a virus-induced gene-silencing protocol to study the function of candidate genes in the interaction. From 92,434 SuperSAGE Tag sequences, 32,808 (35%) matched with our in-house Nicotiana attenuata transcriptome database and 3,698 (4%) matched to Rhizophagus genes. In total, 11,194 Tags showed a significant change in expression (p<0.05, >2-fold change) after infection. When comparing the functions of highly up-regulated annotated Tags in this study with those of two previous large-scale gene expression studies, 18 gene functions were found to be up-regulated in all three studies mainly playing roles related to phytohormone metabolism, catabolism and defense. To validate the function of identified candidate genes, we used the technique of virus-induced gene silencing (VIGS) to silence the expression of three putative N. attenuata genes: germin-like protein, indole-3-acetic acid-amido synthetase GH3.9 and, as a proof-of-principle, calcium and calmodulin- dependent protein kinase (CCaMK). The silencing of the three plant genes in roots was successful, but only CCaMK silencing had a significant effect on the interaction with R. irregularis. Interestingly, when a highly activated inoculum was used for plant inoculation, the effect of CCaMK silencing on fungal colonization was masked, probably due to transcomplementation. This study demonstrates that large-scale gene expression studies across different species induce of a core set of genes of similar functions. However, additional factors seem to influence the overall pattern of gene expression, resulting in high variability among independent studies with different hosts. We conclude that VIGS is a powerful tool with which to investigate the function of genes involved in plant-AMF interactions but that inoculum strength can strongly influence the outcome of the interaction.	[Groten, Karin; Pahari, Nabin T.; Xu, Shuqing; van Doorn, Maja Miloradovic; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany	Max Planck Society	Groten, K (corresponding author), Max Planck Inst Sci Human Hist, Kahlaische Str 10, D-07745 Jena, Germany.	groten@shh.mpg.de	Groten, Karin/B-2883-2018; Xu, Shuqing/AAL-6634-2021; Baldwin, Ian T/K-1809-2013; Groten, Karin/H-9652-2015	Groten, Karin/0000-0003-0177-8810; Xu, Shuqing/0000-0001-7010-4604; Groten, Karin/0000-0003-0177-8810; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society; Global Research Lab Program from the National Research Foundation of Korea [2012055546]; Swiss National Science Foundation [PEBZP3-142886]; Marie Curie Intra-European Fellowships (IEF) [328935]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Global Research Lab Program from the National Research Foundation of Korea(National Research Foundation of Korea); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Intra-European Fellowships (IEF)(European Commission)	Funding by the Max Planck Society, the Global Research Lab Program (2012055546) from the National Research Foundation of Korea, the Swiss National Science Foundation (Project number PEBZP3-142886 to SX), and the Marie Curie Intra-European Fellowships (IEF) (Project Number 328935 to SX) is gratefully acknowledged.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Allen JW, 2009, PLANT PHYSIOL, V149, P549, DOI 10.1104/pp.108.129866; Allen MF, 2009, NEW PHYTOL, V182, P290, DOI 10.1111/j.1469-8137.2009.02815.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Balestrini R, 2007, MOL PLANT MICROBE IN, V20, P1055, DOI 10.1094/MPMI-20-9-1055; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Bapaume L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00223; Belmondo S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00436; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Brechenmacher L, 2004, MYCORRHIZA, V14, P253, DOI 10.1007/s00572-003-0263-4; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Campanella JJ, 2008, J PLANT GROWTH REGUL, V27, P26, DOI 10.1007/s00344-007-9027-2; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Doll J, 2003, PLANT CELL PHYSIOL, V44, P1208, DOI 10.1093/pcp/pcg153; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Etemadi M, 2014, PLANT PHYSIOL, V166, P281, DOI 10.1104/pp.114.246595; Feddermann N, 2008, PLANTA, V227, P671, DOI 10.1007/s00425-007-0649-1; Fiorilli V, 2013, PLANTA, V237, P1267, DOI 10.1007/s00425-013-1842-z; Fiorilli V, 2009, NEW PHYTOL, V184, P975, DOI 10.1111/j.1469-8137.2009.03031.x; Fitze D, 2005, J PLANT PHYSIOL, V162, P1210, DOI 10.1016/j.jplph.2005.01.014; Floss DS, 2013, P NATL ACAD SCI USA, V110, pE5025, DOI 10.1073/pnas.1308973110; Foo E, 2013, J PLANT PHYSIOL, V170, P523, DOI 10.1016/j.jplph.2012.11.002; Galis I, 2012, VIRUS INDUCED GENE S, P109; Gase K, 2012, PLANT ECOL DIVERS, V5, P485, DOI 10.1080/17550874.2012.754797; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Genre A, 2005, PLANT CELL, V17, P3489, DOI 10.1105/tpc.105.035410; Genre A, 2008, PLANT CELL, V20, P1407, DOI 10.1105/tpc.108.059014; Gerlach N, 2015, PLANT CELL IN PRESS; Gilardoni PA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-66; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Gronlund M, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-28; Groten K, 2015, PLANT CELL IN PRESS; Groth M, 2010, PLANT CELL, V22, P2509, DOI 10.1105/tpc.109.069807; Grunwald U, 2009, PLANTA, V229, P1023, DOI 10.1007/s00425-008-0877-z; Guether M, 2009, NEW PHYTOL, V182, P200, DOI 10.1111/j.1469-8137.2008.02725.x; Guimil S, 2005, P NATL ACAD SCI USA, V102, P8066, DOI 10.1073/pnas.0502999102; Gutjahr C, 2014, CURR OPIN PLANT BIOL, V20, P26, DOI 10.1016/j.pbi.2014.04.003; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; Hogekamp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-306; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Ivanov S, 2012, P NATL ACAD SCI USA, V109, P8316, DOI 10.1073/pnas.1200407109; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Kistner C, 2005, LOTUS JAPONICUS HANDBOOK, P123, DOI 10.1007/1-4020-3735-X_9; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Kumar P, 2014, P NATL ACAD SCI USA, V111, P1245, DOI 10.1073/pnas.1314848111; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Lanfranco L, 1999, NEW PHYTOL, V142, P347, DOI 10.1046/j.1469-8137.1999.00393.x; Laparre J, 2014, MOL PLANT, V7, P554, DOI 10.1093/mp/sst136; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liao D, 2014, PLANT CELL PHYSL, P1; Liu JY, 2007, PLANT J, V50, P529, DOI 10.1111/j.1365-313X.2007.03069.x; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Meldau S, 2012, ANN BOT-LONDON, V110, P1503, DOI 10.1093/aob/mcs212; Middleton PH, 2007, PLANT CELL, V19, P1221, DOI 10.1105/tpc.106.048264; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Perez-Sancho J, 2015, PLANT PHYSIOL, V168, P132, DOI 10.1104/pp.15.00260; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Riedel T, 2008, PLANT CELL ENVIRON, V31, P1203, DOI 10.1111/j.1365-3040.2008.01827.x; Ruzicka D, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.06.0007; Saedler R, 2004, J EXP BOT, V55, P151, DOI 10.1093/jxb/erh004; Santhanam R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094710; Schmitz AM, 2014, J INTEGR PLANT BIOL, V56, P250, DOI 10.1111/jipb.12155; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schweiger R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4886; Seddas PMA, 2009, MOL PLANT MICROBE IN, V22, P341, DOI 10.1094/MPMI-22-3-0341; Seo PJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-101; Singh S, 2012, CURR OPIN PLANT BIOL, V15, P444, DOI 10.1016/j.pbi.2012.04.002; Smith FA, 2013, PLANT SOIL, V363, P7, DOI 10.1007/s11104-012-1583-y; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; Tamayo E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00547; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Veiga RSL, 2013, PLANT CELL ENVIRON, V36, P1926, DOI 10.1111/pce.12102; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Veresoglou SD, 2012, TRENDS ECOL EVOL, V27, P588, DOI 10.1016/j.tree.2012.08.002; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Willmann M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00533; Wulf A, 2003, MOL PLANT MICROBE IN, V16, P306, DOI 10.1094/MPMI.2003.16.4.306; Yang DH, 2012, PLANT PHYSIOL, V159, P1591, DOI 10.1104/pp.112.199018; Zhang Q, 2010, PLANT CELL, V22, P1483, DOI 10.1105/tpc.110.074955	102	8	10	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136234	10.1371/journal.pone.0136234	http://dx.doi.org/10.1371/journal.pone.0136234			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291081	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900069
J	Tanno, LK; Kerr, DS; dos Santos, B; Talib, LL; Yamaguti, C; Rodrigues, H; Gattaz, WF; Kalil, J				Tanno, Luciana Kase; Kerr, Daniel Shikanai; dos Santos, Bernardo; Talib, Leda Leme; Yamaguti, Celia; Rodrigues, Helcio; Gattaz, Wagner Farid; Kalil, Jorge			The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects	PLOS ONE			English	Article							STEVENS-JOHNSON-SYNDROME; MICROSOMAL EPOXIDE HYDROLASE; CARBAMAZEPINE; PHENOTYPE; EXPRESSION; VARIANTS; EPILEPSY	Although aromatic anticonvulsants are usually well tolerated, they can cause cutaneous adverse drug reactions in up to 10% of patients. The clinical manifestations of the antiepileptics-induced hypersensitivity reactions (AHR) vary from mild skin rashes to severe cutaneous drug adverse reactions which are related to high mortality and significant morbidity. Genetic polymorphisms in cytochrome P450 genes are associated with altered enzymatic activity and may contribute to the risk of AHR. Here we present a case-control study in which we genotyped SNPs of CYP2C19, 2C9 and 3A5 of 55 individuals with varying severities of AHR, 83 tolerant, and 366 healthy control subjects from Sao Paulo, Brazil. Clinical characterization was based on standardized scoring systems and drug patch test. All in vivo investigation followed the ENDA (European Network of Drug Allergy) recommendations. Genotype was determined by real time PCR using peripheral blood DNA as a template. Of all 504 subjects, 65% were females, 45% self-identified as Afro-American, 38% as Caucasian and 17% as having non-African mixed ascendancy. Amongst 55 subjects with AHR, 44 had severe cutaneous drug adverse reactions. Of the 46 drug patch tests performed, 29 (63%) were positive. We found a strong association between the absence of CYP3A5*3 and tolerant subjects when compared to AHR (p = 0.0002, OR = 5.28 [CI95% 2.09-14.84]). None of our groups presented positive association with CYP2C19 and 2C9 polymorphisms, however, both SNPs contributed to separation of cases and tolerants in a Classification and Regression Tree. Our findings indicate that drug metabolism genes can contribute in the tolerability of antiepileptics. CYP3A5*3 is the most prevalent CYP3A5 allele associated with reduced enzymatic function. The current study provides evidence that normal CYP3A5 activity might be a protective factor to aromatic antiepileptics-induced hypersensitivity reactions in Brazilian subjects.	[Tanno, Luciana Kase; Kalil, Jorge] Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil; [Kerr, Daniel Shikanai; Talib, Leda Leme; Gattaz, Wagner Farid] Univ Sao Paulo, Inst Psychiat, Lab Neurosci LIM 27, Sao Paulo, Brazil; [Yamaguti, Celia; Rodrigues, Helcio; Kalil, Jorge] Univ Sao Paulo, Clin Immunol & Allergy Div, Lab Immunol LIM 19, Sao Paulo, Brazil; [dos Santos, Bernardo] Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil; [Kerr, Daniel Shikanai; Talib, Leda Leme; Gattaz, Wagner Farid] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Tanno, LK (corresponding author), Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil.	luciana.tanno@gmail.com	Tanno, Luciana Kase/J-9981-2014; Talib, Leda/AAJ-4669-2021; KALIL, JORGE/C-8029-2012	Tanno, Luciana Kase/0000-0003-3236-1225; Talib, Leda/0000-0001-5866-1993; KALIL, JORGE/0000-0001-8415-4274	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/22748-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work received funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - http://fapesp.br/) under the grant number 2011/22748-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auquier-Dunant A, 2002, ARCH DERMATOL, V138, P1019, DOI 10.1001/archderm.138.8.1019; Barbaud A, 2013, BRIT J DERMATOL, V168, P555, DOI 10.1111/bjd.12125; Baron JM, 2008, CURR MED CHEM, V15, P2258, DOI 10.2174/092986708785747535; Brockow K, 2013, ALLERGY, V68, P702, DOI 10.1111/all.12142; Demoly P, 2014, ALLERGY, V69, P420, DOI 10.1111/all.12350; Edwards SGM, 1999, POSTGRAD MED J, V75, P680, DOI 10.1136/pgmj.75.889.680; GAEDIGK A, 1994, PHARMACOGENETICS, V4, P142, DOI 10.1097/00008571-199406000-00005; Goldstein JA, 1997, PHARMACOGENETICS, V7, P59, DOI 10.1097/00008571-199702000-00008; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; GREEN VJ, 1995, BIOCHEM PHARMACOL, V50, P1353, DOI 10.1016/0006-2952(95)02009-8; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; LAITINEN J, 1994, BIOTECHNIQUES, V17, P316; Lee AY, 2003, CONTACT DERMATITIS, V48, P137, DOI 10.1034/j.1600-0536.2003.00065.x; LERTRATANANGKOON K, 1982, DRUG METAB DISPOS, V10, P1; Lonjou C, 2006, PHARMACOGENOMICS J, V6, P265, DOI 10.1038/sj.tpj.6500356; Madden S, 1996, DRUG METAB DISPOS, V24, P469; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mockenhaupt M, 2014, INCLUSION CRITERIA; Naisbitt DJ, 2003, MOL PHARMACOL, V63, P732, DOI 10.1124/mol.63.3.732; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; Ozawa Shogo, 2004, Drug Metab Pharmacokinet, V19, P83, DOI 10.2133/dmpk.19.83; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pirmohamed M, 2011, CLIN PHARMACOL THER, V89, P896, DOI 10.1038/clpt.2011.79; Posadas SJ, 2007, CLIN EXP ALLERGY, V37, P989, DOI 10.1111/j.1365-2222.2007.02742.x; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Santiago F, 2010, CONTACT DERMATITIS, V62, P47, DOI 10.1111/j.1600-0536.2009.01659.x; Sim Sarah C., 2010, Human Genomics, V4, P278; SPIELBERG SP, 1981, J PHARMACOL EXP THER, V217, P386; Suarez-Kurtz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083472; Thorn CF, 2012, PHARMACOGENET GENOM, V22, P466, DOI 10.1097/FPC.0b013e32834aeedb; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Wiffen PJ, 2011, COCHRANE DATABASE SY; Wu Y, 2006, J ALLERGY CLIN IMMUN, V118, P233, DOI 10.1016/j.jaci.2006.03.005; Xie HG, 2002, ADV DRUG DELIVER REV, V54, P1257, DOI 10.1016/S0169-409X(02)00076-5	37	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136141	10.1371/journal.pone.0136141	http://dx.doi.org/10.1371/journal.pone.0136141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291084	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900058
J	Al-Asmari, AK; Albalawi, SM; Athar, MT; Khan, AQ; Al-Shahrani, H; Islam, M				Al-Asmari, Abdulrahman Khazim; Albalawi, Sulaiman Mansour; Athar, Md Tanwir; Khan, Abdul Quaiyoom; Al-Shahrani, Hamoud; Islam, Mozaffarul			Moringa oleifera as an Anti-Cancer Agent against Breast and Colorectal Cancer Cell Lines	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; SAUDI-ARABIA; D-ALLOSE; EUGENOL; APOPTOSIS; CURCUMIN; HEALTH; PHYTOCHEMICALS; ISOTHIOCYANATE	In this study we investigated the anti-cancer effect of Moringa oleifera leaves, bark and seed extracts. When tested against MDA-MB-231 and HCT-8 cancer cell lines, the extracts of leaves and bark showed remarkable anti-cancer properties while surprisingly, seed extracts exhibited hardly any such properties. Cell survival was significantly low in both cells lines when treated with leaves and bark extracts. Furthermore, a striking reduction (about 70-90%) in colony formation as well as cell motility was observed upon treatment with leaves and bark. Additionally, apoptosis assay performed on these treated breast and colorectal cancer lines showed a remarkable increase in the number of apoptotic cells; with a 7 fold increase in MD-MB-231 to an increase of several fold in colorectal cancer cell lines. However, no significant apoptotic cells were detected upon seeds extract treatment. Moreover, the cell cycle distribution showed a G2/M enrichment (about 2-3 fold) indicating that these extracts effectively arrest the cell progression at the G2/M phase. The GC-MS analyses of these extracts revealed numerous known anti-cancer compounds, namely eugenol, isopropyl isothiocynate, D-allose, and hexadeconoic acid ethyl ester, all of which possess long chain hydrocarbons, sugar moiety and an aromatic ring. This suggests that the anticancer properties of Moringa oleifera could be attributed to the bioactive compounds present in the extracts from this plant. This is a novel study because no report has yet been cited on the effectiveness of Moringa extracts obtained in the locally grown environment as an anti-cancer agent against breast and colorectal cancers. Our study is the first of its kind to evaluate the anti-malignant properties of Moringa not only in leaves but also in bark. These findings suggest that both the leaf and bark extracts of Moringa collected from the Saudi Arabian region possess anti-cancer activity that can be used to develop new drugs for treatment of breast and colorectal cancers.	[Al-Asmari, Abdulrahman Khazim; Albalawi, Sulaiman Mansour; Athar, Md Tanwir; Khan, Abdul Quaiyoom; Al-Shahrani, Hamoud; Islam, Mozaffarul] Prince Sultan Mil Med City, Res Ctr, Riyadh 11159, Saudi Arabia	Prince Sultan Military Medical City	Al-Asmari, AK (corresponding author), Prince Sultan Mil Med City, Res Ctr, Riyadh 11159, Saudi Arabia.	abdulrahman.alasmari@gmail.com			Prince Sultan Military Medical City	Prince Sultan Military Medical City	Funding: This work was funded by Prince Sultan Military Medical City. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2013, BREAST CANC FACTS FI, P1; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Aja P, 2014, ADV LIFE SCI TECHNOL, V24, P73; Al-Sharif I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-600; Alaklabi A, 2014, SAUDI J BIOL SCI; Alghamdi IG, 2013, BREAST CANCER-TARGET, V5, P103, DOI 10.2147/BCTT.S50750; American Cancer Society (ACS), 2014, COL CANC FACTS FIG, P1; Berkovich L, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-212; Bhuvaneswari V., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P627, DOI 10.2174/156801105774574667; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Craig W, 1999, CAN J DIET PRACT RES, V60, P78; Craig WJ, 1997, J AM DIET ASSOC, V97, pS199, DOI 10.1016/S0002-8223(97)00765-7; Emmanuel S.A., 2014, AM J ETHNOMED, V1, P346; Ferreira Paulo Michel Pinheiro, 2014, PHARM THERAPEUTICS; FOLKMAN J, 1982, ANN NY ACAD SCI, V401, P212, DOI 10.1111/j.1749-6632.1982.tb25720.x; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Garg AK, 2005, ANTIOXID REDOX SIGN, V7, P1630, DOI 10.1089/ars.2005.7.1630; Gaurisankar Sa, 2010, Al Ameen Journal of Medical Sciences, V3, P21; Ghosh R, 2005, J BIOL CHEM, V280, P5812, DOI 10.1074/jbc.M411429200; Ghosh R, 2009, J STEROID BIOCHEM, V113, P25, DOI 10.1016/j.jsbmb.2008.11.002; Harada H, 2002, ANTICANCER RES, V22, P2587; Islam M, 2000, EXP EYE RES, V70, P261, DOI 10.1006/exer.1999.0783; Islam M, 2013, ORAL ONCOL, V49, P778, DOI 10.1016/j.oraloncology.2013.04.003; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Jung IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095492; Kalkunte S, 2006, J EXP THER ONCOL, V5, P287; Kaur G, 2010, MOL CARCINOGEN, V49, P290, DOI 10.1002/mc.20601; Kong KW, 2010, MOLECULES, V15, P959, DOI 10.3390/molecules15020959; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Leone A, 2015, INT J MOL SCI, V16, P12791, DOI 10.3390/ijms160612791; MANIGAUHA, 2010, DRUG INVENTION TODAY, V2; Manikandan P, 2011, INVEST NEW DRUG, V29, P110, DOI 10.1007/s10637-009-9345-2; Manikandan P, 2010, LIFE SCI, V86, P936, DOI 10.1016/j.lfs.2010.04.010; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; Matsuda H, 2007, EUR J PHARMACOL, V561, P172, DOI 10.1016/j.ejphar.2006.12.040; Mbikay M., 2012, FRONT PHARMACOL, P3; Mosli MH, 2012, ASIAN PAC J CANCER P, V13, P3809, DOI 10.7314/APJCP.2012.13.8.3809; Olson ME, 2002, SYST BOT, V27, P55; Pal D, 2010, J DERMATOL SCI, V59, P31, DOI 10.1016/j.jdermsci.2010.04.013; Park BS, 2005, APOPTOSIS, V10, P193, DOI 10.1007/s10495-005-6074-7; Pisano M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-8; Rao AVR, 2000, J AM COLL NUTR, V19, P563, DOI 10.1080/07315724.2000.10718953; Razis AFA, 2014, ASIAN PAC J CANCER P, V15, P8571, DOI 10.7314/APJCP.2014.15.20.8571; Shanmugam MK, 2015, MOLECULES, V20, P2728, DOI 10.3390/molecules20022728; Shehzad A, 2013, BIOFACTORS, V39, P27, DOI 10.1002/biof.1065; Shin SH, 2007, J KOR ASSOC ORAL MAX, V32, P20; Shishodia S, 2013, BIOFACTORS, V39, P37, DOI 10.1002/biof.1041; Sui L, 2005, INT J ONCOL, V27, P907; Tiloke C, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-226; Trejo-Solis C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705121; Vermeulen SJ, 1998, CANCER GENET CYTOGEN, V107, P76, DOI 10.1016/S0165-4608(98)00081-8; Yamaguchi F, 2008, INT J ONCOL, V32, P377; Yoo CB, 2005, CANCER LETT, V225, P41, DOI 10.1016/j.canlet.2004.11.018; Yuan Peng, 2008, Chinese Journal of Natural Medicines, V6, P325, DOI 10.3724/SP.J.1009.2008.00325; 김규천, 2006, Anatomy and Cell Biology, V39, P245	55	143	150	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135814	10.1371/journal.pone.0135814	http://dx.doi.org/10.1371/journal.pone.0135814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288313	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600073
J	Lee, SH; Kim, JS; Ravichandran, K; Gil, HW; Song, HY; Hong, SY				Lee, Sun-hyo; Kim, Jin-sun; Ravichandran, Kameswaran; Gil, Hyo-Wook; Song, Ho-yeon; Hong, Sae-yong			P-Glycoprotein Induction Ameliorates Colistin Induced Nephrotoxicity in Cultured Human Proximal Tubular Cells	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; AUTOPHAGY; APOPTOSIS; EXPRESSION; DEATH; TRANSPORTER; POLYMYXINS; PROTEINS; MODEL	The pathogenesis of colistin induced nephrotoxicity is poorly understood. Currently there are no effective therapeutic or prophylactic agents available. This study was aimed to determine the mechanism of colistin induced nephrotoxicity and to determine whether P-glycoprotein (P-gp) induction could prevent colistin induced nephrotoxicity. Colistin induced cell toxicity in cultured human proximal tubular cells in both dose and time dependent manner. Colistin provoked ROS in a dose dependent manner as measured by DCF-DA. To investigate apoptosis, caspase 3/7 activity was determined. Caspase 3/7 activity was increased dose dependently (25, 50, 100 mu g/ml) at 6 h. Autophagosome formation was assessed by measuring LC3-II/LC3-I ratio. The ratio of LC3-II to LC3-I was increased at 2 h (25 mu g/ml). Suppression of autophagosome formation increased colistin induced nephrotoxicity. The expression of P-gp and the cell toxicity was determined in colistin with or without dexamethasone (P-gp inducer) and verapamil (selective P-gp inhibitor). Colistin itself suppressed the expression of P-gp. P-gp expression and activity decreased colistin induced nephrotoxicity with dexamethasone treatment. In addition induced P-gp transporter was shown to improve the efflux effect on colistin treated HK2 cell line, which was demonstrated by calcein-AM fluorescence accumulation assay. The increased activity could be blocked by N-acetylcysteine. In conclusion, colistin induces nephrotoxicity by suppressing P-gp. Induction of P-gp could ameliorate colistin induced nephrotoxicity by decreasing apoptosis.	[Lee, Sun-hyo; Kim, Jin-sun; Gil, Hyo-Wook; Hong, Sae-yong] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Ravichandran, Kameswaran] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO USA; [Song, Ho-yeon] Soonchunhyang Univ, Dept Microbiol, Coll Med, Cheonan, South Korea	Soonchunhyang University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Soonchunhyang University	Gil, HW (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	hwgil@schmc.ac.kr	RAVICHANDRAN, KAMESWARAN/Y-6920-2019; Song, Ho-Yeon/G-7168-2016	RAVICHANDRAN, KAMESWARAN/0000-0002-0596-2044; hong, saeyong/0000-0001-7854-3871	Soonchunghyang University [20130622]	Soonchunghyang University	Soonchunghyang University Research fund (No. 20130622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergen PJ, 2006, ANTIMICROB AGENTS CH, V50, P1953, DOI 10.1128/AAC.00035-06; Dai CS, 2014, ANTIMICROB AGENTS CH, V58, P4075, DOI 10.1128/AAC.00070-14; del Moral RG, 1998, EXP NEPHROL, V6, P89; Demeule M, 1999, FEBS LETT, V442, P208, DOI 10.1016/S0014-5793(98)01663-9; Eadon MT, 2013, PHYSIOL GENOMICS, V45, P877, DOI 10.1152/physiolgenomics.00076.2013; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Ghlissi Z, 2013, RENAL FAILURE, V35, P1130, DOI 10.3109/0886022X.2013.815091; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Kim YH, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-60; Ko HJ, 2011, NEPHRON CLIN PRACT, V117, pC284, DOI 10.1159/000320746; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Livingston MJ, 2014, SEMIN NEPHROL, V34, P17, DOI 10.1016/j.semnephrol.2013.11.004; Ma Z, 2009, ANTIMICROB AGENTS CH, V53, P2857, DOI 10.1128/AAC.00030-09; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Ozyilmaz E, 2011, INTENS CARE MED, V37, P141, DOI 10.1007/s00134-010-2038-7; Paglin S, 2001, CANCER RES, V61, P439; Phe K, 2014, ANTIMICROB AGENTS CH, V58, P2740, DOI 10.1128/AAC.02476-13; Romiti N, 2002, TOXICOL APPL PHARM, V183, P83, DOI 10.1006/taap.2002.9461; Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164; Wang LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079814; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yousef JM, 2012, J ANTIMICROB CHEMOTH, V67, P452, DOI 10.1093/jac/dkr483; Yousef JM, 2011, ANTIMICROB AGENTS CH, V55, P4044, DOI 10.1128/AAC.00328-11; Yun B, 2015, J ANTIMICROB CHEMOTH, V70, P827, DOI 10.1093/jac/dku441; Zhang XH, 2014, J IMMUNOL, V193, P2405, DOI 10.4049/jimmunol.1302798	30	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136075	10.1371/journal.pone.0136075	http://dx.doi.org/10.1371/journal.pone.0136075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287374	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600105
J	Perogamvros, L; Aberg, K; Gex-Fabry, M; Perrig, S; Cloninger, CR; Schwartz, S				Perogamvros, Lampros; Aberg, Kristoffer; Gex-Fabry, Marianne; Perrig, Stephen; Cloninger, C. Robert; Schwartz, Sophie			Increased Reward-Related Behaviors during Sleep and Wakefulness in Sleepwalking and Idiopathic Nightmares	PLOS ONE			English	Article							CYCLIC ALTERNATING PATTERN; NOVELTY-SEEKING; DREAM CONTENT; REM-SLEEP; PERSONALITY PROFILES; BAD DREAMS; WAKE-LIKE; DISORDER; FREQUENCY; TEMPERAMENT	Background We previously suggested that abnormal sleep behaviors, i.e., as found in parasomnias, may often be the expression of increased activity of the reward system during sleep. Because nightmares and sleepwalking predominate during REM and NREM sleep respectively, we tested here whether exploratory excitability, a waking personality trait reflecting high activity within the mesolimbic dopaminergic (ML-DA) system, may be associated with specific changes in REM and NREM sleep patterns in these two sleep disorders. Methods Twenty-four unmedicated patients with parasomnia (12 with chronic sleepwalking and 12 with idiopathic nightmares) and no psychiatric comorbidities were studied. Each patient spent one night of sleep monitored by polysomnography. The Temperament and Character Inventory (TCI) was administered to all patients and healthy controls from the Geneva population (n = 293). Results Sleepwalkers were more anxious than patients with idiopathic nightmares (Spielberger Trait anxiety/STAI-T), but the patient groups did not differ on any personality dimension as estimated by the TCI. Compared to controls, parasomnia patients (sleepwalkers together with patients with idiopathic nightmares) scored higher on the Novelty Seeking (NS) TCI scale and in particular on the exploratory excitability/curiosity (NS1) subscale, and lower on the Self-directedness (SD) TCI scale, suggesting a general increase in reward sensitivity and impulsivity. Furthermore, parasomnia patients tended to worry about social separation persistently, as indicated by greater anticipatory worry (HA1) and dependence on social attachment (RD3). Moreover, exploratory excitability (NS1) correlated positively with the severity of parasomnia (i.e., the frequency of self-reported occurrences of nightmares and sleepwalking), and with time spent in REM sleep in patients with nightmares. Conclusions These results suggest that patients with parasomnia might share common waking personality traits associated to reward-related brain functions. They also provide further support to the notion that reward-seeking networks are active during human sleep.	[Perogamvros, Lampros; Gex-Fabry, Marianne; Perrig, Stephen] Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland; [Perogamvros, Lampros; Aberg, Kristoffer; Schwartz, Sophie] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Perogamvros, Lampros] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Aberg, Kristoffer; Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Cloninger, C. Robert] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	University of Geneva; University of Geneva; University of Wisconsin System; University of Wisconsin Madison; University of Geneva; Washington University (WUSTL)	Perogamvros, L (corresponding author), Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland.	lambros.pero@gmail.com	Aberg, Kristoffer/F-1040-2018; Perogamvros, Lampros/AAC-4931-2019; Cloninger, Claude/F-5357-2012	Aberg, Kristoffer/0000-0002-0970-400X; Cloninger, Claude/0000-0003-3096-4807; Schwartz, Sophie/0000-0001-7718-4053	Swiss National Science Foundation [320030_135653]; National Center of Competence in Research (NCCR) Affective Sciences - Swiss National Science Foundation [51NF40-104897]; BIAL Foundation [225/12]; Boninchi Foundation; Swiss Branch of the Anthropedia Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) Affective Sciences - Swiss National Science Foundation; BIAL Foundation(Bial Foundation); Boninchi Foundation; Swiss Branch of the Anthropedia Foundation	This work was supported by the Swiss National Science Foundation (No 320030_135653) to SS, the National Center of Competence in Research (NCCR) Affective Sciences financed by the Swiss National Science Foundation (No 51NF40-104897) to SS, the BIAL Foundation (No 225/12) to SS, and a grant from the Boninchi Foundation to SS. CC is supported by the Swiss Branch of the Anthropedia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; American Academy of Sleep Medicine, 2005, DIAGN COD MAN; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Blagrove M, 2004, J SLEEP RES, V13, P129, DOI 10.1111/j.1365-2869.2004.00394.x; BONKALO A, 1974, PSYCHIAT QUART, V48, P400, DOI 10.1007/BF01562162; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P271; Bravo-Ortiz M, 2013, SLEEP MED S1, V14, P297; Brion A, 2012, SLEEP MED, V13, P1094, DOI 10.1016/j.sleep.2012.06.012; Cartwright R, 2005, SLEEPWALKING HOBOKEN; Chivers L, 1999, PERS INDIV DIFFER, V27, P843, DOI 10.1016/S0191-8869(99)00033-1; Cloninger C Robert, 2011, Int J Pers Cent Med, V1, P43; Cloninger CR, 2012, J AFFECT DISORDERS, V136, P758, DOI 10.1016/j.jad.2011.09.046; Cloninger CR, 2009, AUST NZ J PSYCHIAT, V43, P994, DOI 10.3109/00048670903270506; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Ebstein RP, 1997, MOL PSYCHIATR, V2, P381, DOI 10.1038/sj.mp.4000315; Fantini ML, 2005, NEUROLOGY, V65, P1010, DOI 10.1212/01.wnl.0000179346.39655.e0; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Feld GB, 2014, J COGNITIVE NEUROSCI, V26, P2310, DOI 10.1162/jocn_a_00629; Giesbrecht T, 2004, PERS INDIV DIFFER, V37, P1341, DOI 10.1016/j.paid.2004.01.004; Guilleminault C, 2006, SLEEP MED, V7, P163, DOI 10.1016/j.sleep.2005.12.006; Guilleminault C, 2005, BRAIN, V128, P1062, DOI 10.1093/brain/awh481; Guilleminault C, 2001, J PSYCHOSOM RES, V51, P411, DOI 10.1016/S0022-3999(01)00187-8; Guilleminault C, 2006, SLEEP, V29, P14; HARTMANN E, 1989, PSYCHIAT J U OTTAWA, V14, P557; Howell D. C., 2013, STAT METHODS PSYCHOL; Hublin C, 1997, NEUROLOGY, V48, P177, DOI 10.1212/WNL.48.1.177; Hublin C, 1999, AM J MED GENET, V88, P329, DOI 10.1002/(SICI)1096-8628(19990820)88:4<329::AID-AJMG8>3.0.CO;2-E; Iber C., 2007, AASM MANUAL SCORING; Krebs RM, 2009, BIOL PSYCHIAT, V65, P103, DOI 10.1016/j.biopsych.2008.08.019; Kryger MH., 2011, PRINCIPLES PRACTICE; Labelle MA, 2013, SLEEP MED, V14, P1348, DOI 10.1016/j.sleep.2013.05.023; Lancee J, 2010, SLEEP BIOL RHYTHMS, V8, P187, DOI 10.1111/j.1479-8425.2010.00447.x; Lansink CS, 2008, J NEUROSCI, V28, P6372, DOI 10.1523/JNEUROSCI.1054-08.2008; Levin R, 2002, SLEEP, V25, P205; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Licis AK, 2011, NEUROLOGY, V76, P49, DOI 10.1212/WNL.0b013e318203e964; Lopez R, 2013, SLEEP, V36, P345, DOI 10.5665/sleep.2446; Mahowald MW, 2011, CURR TOP MED CHEM, V11, P2392; McNamara P, 2001, J SLEEP RES, V10, P117, DOI 10.1046/j.1365-2869.2001.00244.x; McNamara P, 2011, ATTACH HUM DEV, V13, P141, DOI 10.1080/14616734.2011.553999; Mwenge B, 2013, SLEEP MED, V14, P1226, DOI 10.1016/j.sleep.2013.04.027; Nielsen T, 2007, SLEEP MED REV, V11, P295, DOI 10.1016/j.smrv.2007.03.004; Nobili L, 2011, NEUROIMAGE, V58, P612, DOI 10.1016/j.neuroimage.2011.06.032; Ohayon MM, 1999, J CLIN PSYCHIAT, V60, P268, DOI 10.4088/JCP.v60n0413; Oudiette D, 2009, SLEEP, V32, P1621, DOI 10.1093/sleep/32.12.1621; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Park JH, 2012, PSYCHIAT RES, V197, P275, DOI 10.1016/j.psychres.2011.09.018; Perogamvros L, 2012, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00168; Perogamvros L, 2012, NEUROSCI BIOBEHAV R, V36, P1934, DOI 10.1016/j.neubiorev.2012.05.010; Perroud N, 2013, J AFFECT DISORDERS, V146, P246, DOI 10.1016/j.jad.2012.09.012; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Revonsuo A, 2000, BEHAV BRAIN SCI, V23, P877, DOI 10.1017/S0140525X00004015; Robert G, 2014, SLEEP, V37, P409, DOI 10.5665/sleep.3426; Saurat MT, 2011, CONSCIOUS COGN, V20, P1425, DOI 10.1016/j.concog.2011.05.015; Schmidt RE, 2008, BEHAV SLEEP MED, V6, P178, DOI 10.1080/15402000802162570; Schredl M, 2003, EUR ARCH PSY CLIN N, V253, P241, DOI 10.1007/s00406-003-0438-1; Schredl M, 2003, CONSCIOUS COGN, V12, P298, DOI 10.1016/S1053-8100(02)00072-7; Schredl M, 1999, DREAMING, V9, P257, DOI 10.1023/A:1021336103535; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simor P, 2014, J SLEEP RES, V23, P70; Simor P, 2013, BIOL PSYCHOL, V94, P592, DOI 10.1016/j.biopsycho.2013.05.022; Simor P, 2013, SLEEP, V36, P413, DOI 10.5665/sleep.2462; Simor P, 2011, SCAND J PSYCHOL, V52, P369, DOI 10.1111/j.1467-9450.2011.00888.x; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Smith MJ, 2008, SCHIZOPHR RES, V104, P198, DOI 10.1016/j.schres.2008.06.025; Solms M, 2000, BEHAV BRAIN SCI, V23, P843, DOI 10.1017/S0140525X00003988; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spoormaker VI, 2006, SLEEP MED REV, V10, P19, DOI 10.1016/j.smrv.2005.06.001; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Voss U, 2011, CONSCIOUS COGN, V20, P673, DOI 10.1016/j.concog.2010.10.020; Winkelman John W, 2011, Handb Clin Neurol, V98, P577, DOI 10.1016/B978-0-444-52006-7.00037-X; Zadra A, 2006, SLEEP, V29, pA269; Zadra A, 2000, J ABNORM PSYCHOL, V109, P273, DOI 10.1037/0021-843X.109.2.273; Zadra A, 2013, LANCET NEUROL, V12, P285, DOI 10.1016/S1474-4422(12)70322-8; Zald DH, 2008, J NEUROSCI, V28, P14372, DOI 10.1523/JNEUROSCI.2423-08.2008	79	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134504	10.1371/journal.pone.0134504	http://dx.doi.org/10.1371/journal.pone.0134504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287974	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600022
J	Xiang, JJ; Hansen, A; Pisaniello, D; Bi, P				Xiang, Jianjun; Hansen, Alana; Pisaniello, Dino; Bi, Peng			Perceptions of Workplace Heat Exposure and Controls among Occupational Hygienists and Relevant Specialists in Australia	PLOS ONE			English	Article							FARM-WORKERS; ILLNESS; HEALTH; MIGRANT; PREVENTION; EXHAUSTION; SAFETY; ISSUES; IMPACT; INDEX	With warmer weather projections, workplace heat exposure is presenting a growing challenge to workers' health and safety. Occupational hygienists are the specialist group conducting measurements and providing advice on heat stress management to industry. In order to provide insights into hygienists perceptions on workplace heat exposure, current and future preparedness for extreme heat, and barriers to possible heat adaptation strategies, a self-administered questionnaire survey was conducted during a national conference of the Australian Institute of Occupational Hygienists. Nearly 90% of the 180 respondents were at least moderately concerned about extreme heat and 19% were dissatisfied with current heat stress prevention measures. Barriers recognized by the participants were lack of awareness (68%), insufficient training (56%), unsatisfactory management commitment (52%), and low compliance with prevention policies (40%). The findings suggest a need to refine occupational heat management and prevention strategies.	[Xiang, Jianjun; Hansen, Alana; Pisaniello, Dino; Bi, Peng] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Xiang, Jianjun] Fujian Prov Ctr Dis Control & Prevent, Dept Publ Hlth Preparedness & Response, Fuzhou, Fujian, Peoples R China	University of Adelaide	Bi, P (corresponding author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.	peng.bi@adelaide.edu.au		Xiang, Jianjun/0000-0002-6862-2696; Pisaniello, Dino/0000-0002-4156-0608; Bi, Peng/0000-0002-3238-3427				Balakrishnan K, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5635; Commonwealth Scientific and Industrial Research Organisation (CSIRO) & Bureau of Meteorology, 2014, STAT CLIM 2014; Corleto RD, 2013, GUIDE MANAGING HEAT; Crowe J, 2009, GLOBAL HEALTH ACTION, V2, P71, DOI 10.3402/gha.v2i0.2062; Crowe J, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5619; Cutforth P, 2013, WORKERS DEATH LINKED; Donoghue AM, 2000, OCCUP MED-OXFORD, V50, P259, DOI 10.1093/occmed/50.4.259; Donoghue AM, 2000, OCCUP ENVIRON MED, V57, P165, DOI 10.1136/oem.57.3.165; Fleischer NL, 2013, AM J PREV MED, V44, P199, DOI 10.1016/j.amepre.2012.10.020; Forbes CF, 2010, INT J BIOMETEOROL, V52, P1; [Forestry Mining and Energy Union (CFMEU) Australian Construction], 2012, INCL WEATH HEAT POL; Government of Western Australia, 2009, DEATH QUEENSL WORK P; Gubernot DM, 2014, INT J BIOMETEOROL, V58, P1779, DOI 10.1007/s00484-013-0752-x; Gun RT, 1987, STUDIES HEAT STRESS; Hanna EG, 2011, ASIA-PAC J PUBLIC HE, V23, p14S, DOI 10.1177/1010539510391457; Hansen E, 2003, J HEALTH CARE POOR U, V14, P153, DOI 10.1177/1049208903014002001; Hyatt OM, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5715; Kjellstrom T, 2011, HOTHAPS PROGRAM CLIM; Kjellstrom T, 2013, IND HEALTH, V51, P56, DOI 10.2486/indhealth.2012-0174; Kjellstrom T, 2009, GLOBAL HEALTH ACTION, V2, P81, DOI 10.3402/gha.v2i0.2082; Lam M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1004; Maeda T, 2006, J OCCUP HEALTH, V48, P223, DOI 10.1539/joh.48.223; Mares P, 2005, 2 FUT AUSTR COUNTR T; Mathee A, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5612; Mckean B, 2010, BRICKLAYER DIES HEAT; Miller V, 2007, J OCCUP HLTH SAF AUS, V23, P79; Mirabelli MC, 2010, AM J PREV MED, V39, P468, DOI 10.1016/j.amepre.2010.07.008; MOBED K, 1992, WESTERN J MED, V157, P367; Nevarez J, 2013, J OCCUP ENVIRON HYG, V10, pD67, DOI 10.1080/15459624.2013.784177; Oosthuizen J, 2012, GLOBAL WARMING HEAT, P289, DOI [10.5772/34794, DOI 10.5772/34794]; Quandt SA, 2013, AM J PUBLIC HEALTH, V103, pE24, DOI 10.2105/AJPH.2012.301135; Riley K, 2012, NEW SOLUT, V22, P297, DOI 10.2190/NS.22.3.e; Safe Work Australia, 2011, MOD COD PRACT MAN WO; Schulte PA, 2009, J OCCUP ENVIRON HYG, V6, P542, DOI 10.1080/15459620903066008; Singh S, 2015, HEALTH PROMOT INT, V30, P239, DOI 10.1093/heapro/dat027; Stoecklin-Marois M, 2013, IND HEALTH, V51, P47, DOI 10.2486/indhealth.2012-0128; Storey K, 2001, AUST GEOGR, V32, P133, DOI 10.1080/00049180120066616; The US Department of Labor, 2011, CAMPAIGN TO PREVENT; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; Xiang J, 2013, IND HLTH, V52, P91; Xiang JJ, 2014, ENVIRON RES, V133, P90, DOI 10.1016/j.envres.2014.04.042; Xiang JJ, 2014, OCCUP ENVIRON MED, V71, P246, DOI 10.1136/oemed-2013-101584	42	28	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135040	10.1371/journal.pone.0135040	http://dx.doi.org/10.1371/journal.pone.0135040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287608	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600033
J	Mia, S; Federico, G; Feger, M; Pakladok, T; Meissner, A; Voelkl, J; Groene, HJ; Alesutan, I; Lang, F				Mia, Sobuj; Federico, Giuseppina; Feger, Martina; Pakladok, Tatsiana; Meissner, Adrian; Voelkl, Jakob; Groene, Hermann-Josef; Alesutan, Ioana; Lang, Florian			Impact of AMP-Activated Protein Kinase alpha 1 Deficiency on Tissue Injury following Unilateral Ureteral Obstruction	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; TGF-BETA; RENAL FIBROSIS; MYOCARDIAL-INFARCTION; SKELETAL-MUSCLE; ANGIOTENSIN-II; TAK1; PATHWAY	Background AMP-activated protein kinase (Ampk) is a sensor of the cellular energy status and a powerful regulator of metabolism. Activation of Ampk was previously shown to participate in monocyte-to-fibroblast transition and matrix protein production in renal tissue. Thus, the present study explored whether the catalytic Ampk alpha 1 isoform participates in the regulation of the renal fibrotic response following unilateral ureteral obstruction (UUO). Methods UUO was induced in gene-targeted mice lacking functional Ampk alpha 1 (Ampk alpha 1(-/-)) and in corresponding wild-type mice (Ampk alpha 1(+/+)). In the obstructed kidney and, for comparison, in the non-obstructed control kidney, quantitative RT-PCR, Western blotting and immunostaining were employed to determine transcript levels and protein abundance, respectively. Results In Ampk alpha 1(+/+) mice, UUO significantly up-regulated the protein abundance of the Ampka1 isoform, but significantly down-regulated the Ampk alpha 2 isoform in renal tissue. Phosphorylated Ampka protein levels were significantly increased in obstructed kidney tissue of Ampk alpha 1(+/+) mice but not of Ampk alpha 1(-/-) mice. Renal expression of a-smooth muscle actin was increased following UUO, an effect again less pronounced in Ampk alpha 1(-/-) mice than in Ampk alpha 1(+/+) mice. Histological analysis did not reveal a profound effect of Ampk alpha 1 deficiency on collagen 1 protein deposition. UUO significantly increased phosphorylated and total Tgf-beta-activated kinase 1 (Tak1) protein, as well as transcript levels of Tak1-downstream targets c-Fos, Il6, Pai1 and Snai1 in Ampk alpha 1(+/+) mice, effects again significantly ameliorated in Ampk alpha 1(-/-) mice. Moreover, Ampk alpha 1 deficiency inhibited the UUO-induced mRNA expression of Cd206, a marker of M2 macrophages and of Cxcl16, a pro-fibrotic chemokine associated with myeloid fibroblast formation. The effects of Ampk alpha 1 deficiency during UUO were, however, paralleled by increased tubular injury and apoptosis. Conclusions Renal obstruction induces an isoform shift from Ampk alpha 2 towards Ampk alpha 1, which contributes to the signaling involved in cell survival and fibrosis.	[Mia, Sobuj; Feger, Martina; Pakladok, Tatsiana; Meissner, Adrian; Voelkl, Jakob; Alesutan, Ioana; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; [Federico, Giuseppina; Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ)	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Voelkl, Jakob/T-4298-2019; Mia, Sobuj/P-5425-2017		Deutsche Forschungsgemeinschaft [GK 1302]; IZKF-Nachwuchsgruppe of the Medical Faculty of the University of Tubingen [1889-0-0]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF-Nachwuchsgruppe of the Medical Faculty of the University of Tubingen	The funders, Deutsche Forschungsgemeinschaft (GK 1302 / URL: http://www.dfg.de/) and IZKF-Nachwuchsgruppe of the Medical Faculty of the University of Tubingen (No. 1889-0-0/ URL: http://www.acrc-gu.de/izkf_tuebingen.php?first = izkf) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Carling David, 2007, Novartis Found Symp, V286, P72; Chen G, 2011, J AM SOC NEPHROL, V22, P1876, DOI 10.1681/ASN.2010080881; Chen KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106554; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Cieslik KA, 2013, J MOL CELL CARDIOL, V63, P26, DOI 10.1016/j.yjmcc.2013.07.005; Cieslik KA, 2011, AM J PATHOL, V179, P1792, DOI 10.1016/j.ajpath.2011.06.022; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Guo F, 2013, J INVEST DERMATOL, V133, P1646, DOI 10.1038/jid.2013.28; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hattori Y, 2006, HYPERTENSION, V47, P265, DOI 10.1161/01.HYP.0000198425.21604.aa; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Horman Sandrine, 2012, Curr Heart Fail Rep, V9, P164, DOI 10.1007/s11897-012-0102-z; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kim M, 2012, J MOL CELL CARDIOL, V52, P1066, DOI 10.1016/j.yjmcc.2012.01.016; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Liang Y, 2014, BRIT J PHARMACOL, V171, P498, DOI 10.1111/bph.12482; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Ma FY, 2011, AM J PHYSIOL-RENAL, V300, pF1410, DOI 10.1152/ajprenal.00018.2011; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Noppe G, 2014, J MOL CELL CARDIOL, V74, P32, DOI 10.1016/j.yjmcc.2014.04.018; Pan BX, 2015, CELL PHYSIOL BIOCHEM, V35, P1062, DOI 10.1159/000373932; Qin SF, 2008, J BIOL CHEM, V283, P6744, DOI 10.1074/jbc.M708848200; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Sasaki Y, 2001, J BIOL CHEM, V276, P29943, DOI 10.1074/jbc.M104230200; Shen YY, 2007, NEPHROL DIAL TRANSPL, V22, P171, DOI 10.1093/ndt/gfl552; Silverstein DM, 2003, KIDNEY INT, V64, P25, DOI 10.1046/j.1523-1755.2003.00067.x; Steinberg GR, 2009, APPL PHYSIOL NUTR ME, V34, P315, DOI 10.1139/H09-009; Strippoli R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031492; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Voelkl J, 2013, KIDNEY BLOOD PRESS R, V38, P156, DOI 10.1159/000355763; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xiong M, 2012, AM J PHYSIOL-RENAL, V303, pF1107, DOI 10.1152/ajprenal.00151.2012; Xu X, 2014, HYPERTENSION, V63, P723, DOI 10.1161/HYPERTENSIONAHA.113.02619; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yang J, 2013, J AM SOC NEPHROL, V24, P1644, DOI 10.1681/ASN.2013030217; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505; Zhang F, 2009, AM J PHYSIOL-CELL PH, V296, pC346, DOI 10.1152/ajpcell.00444.2008	63	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135235	10.1371/journal.pone.0135235	http://dx.doi.org/10.1371/journal.pone.0135235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285014	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100029
J	Rajkumar, H; Ramagoni, RK; Anchoju, VC; Vankudavath, RN; Syed, AUZ				Rajkumar, Hemalatha; Ramagoni, Ramesh Kumar; Anchoju, Vijayendra Chary; Vankudavath, Raju Naik; Syed, Arshi Uz Zaman			De Novo Transcriptome Analysis of Allium cepa L. (Onion) Bulb to Identify Allergens and Epitopes	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; CONTACT-DERMATITIS; IGE	Allium cepa (onion) is a diploid plant with one of the largest nuclear genomes among all diploids. Onion is an example of an under-researched crop which has a complex heterozygous genome. There are no allergenic proteins and genomic data available for onions. This study was conducted to establish a transcriptome catalogue of onion bulb that will enable us to study onion related genes involved in medicinal use and allergies. Transcriptome dataset generated from onion bulb using the Illumina HiSeq 2000 technology showed a total of 99,074,309 high quality raw reads (similar to 20 Gb). Based on sequence homology onion genes were categorized into 49 different functional groups. Most of the genes however, were classified under 'unknown' in all three gene ontology categories. Of the categorized genes, 61.2% showed metabolic functions followed by cellular components such as binding, cellular processes; catalytic activity and cell part. With BLASTx top hit analysis, a total of 2,511 homologous allergenic sequences were found, which had 37-100% similarity with 46 different types of allergens existing in the database. From the 46 contigs or allergens, 521 B-cell linear epitopes were identified using BepiPred linear epitope prediction tool. This is the first comprehensive insight into the transcriptome of onion bulb tissue using the NGS technology, which can be used to map IgE epitopes and prediction of structures and functions of various proteins.	[Rajkumar, Hemalatha; Ramagoni, Ramesh Kumar; Anchoju, Vijayendra Chary] Indian Council Med Res, Natl Inst Nutr, Dept Microbiol & Immunol, Hyderabad 500007, Telangana State, India; [Vankudavath, Raju Naik] Indian Council Med Res, Natl Inst Nutr, Biomed Informat Ctr, Hyderabad 500007, Telangana State, India; [Syed, Arshi Uz Zaman] Nucleome Informat Pvt Ltd, Hyderabad 500049, Telangana State, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Rajkumar, H (corresponding author), Indian Council Med Res, Natl Inst Nutr, Dept Microbiol & Immunol, Jamai Osmania Po, Hyderabad 500007, Telangana State, India.	rhemalathanin@gmail.com	Rajunaik, Vankudavath/GPX-0362-2022; Naik Raju, Vankudavath/Q-7148-2017	Rajunaik, Vankudavath/0000-0002-5601-0633; Naik Raju, Vankudavath/0000-0001-8514-1889	Department of Biotechnology, Ministry of science and technology [BT/PR-11489/FNS/20/391/2008]; National Institute of Nutrition, ICMR; Nucleome Informatics Pvt. Ltd.	Department of Biotechnology, Ministry of science and technology; National Institute of Nutrition, ICMR(Indian Council of Medical Research (ICMR)); Nucleome Informatics Pvt. Ltd.	The authors acknowledge the Department of Biotechnology, Ministry of science and technology for funding the study (Grant no. BT/PR-11489/FNS/20/391/2008). The authors thank the National Institute of Nutrition, ICMR for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Nucleome Informatics Pvt. Ltd., provided support in the form of a salary for author Syed Arshi Uz Zaman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contribution section.	Accelrys Software Inc, 2013, DISCOVERY STUDIO MOD; [Anonymous], ALL AB ON; Arena A, 2000, Allergol Immunopathol (Madr), V28, P287; Arochena L, 2012, J INVEST ALLERG CLIN, V22, P441; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Asero R, 2001, J ALLERGY CLIN IMMUN, V108, P309, DOI 10.1067/mai.2001.116983; Asero R, 2007, MOL NUTR FOOD RES, V51, P135, DOI 10.1002/mnfr.200600132; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BLEUMINK E, 1972, BRIT J DERMATOL, V87, P6, DOI 10.1111/j.1365-2133.1972.tb05089.x; Block E., 2010, GARLIC OTHER ALLIUMS; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRUIJNZEELKOOMEN C, 1995, ALLERGY, V50, P623, DOI 10.1111/j.1398-9995.1995.tb02579.x; Chinnappareddy LRD, 2013, CZECH J GENET PLANT, V49, P131, DOI 10.17221/111/2013-CJGPB; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Enrique E, 2007, ANN ALLERG ASTHMA IM, V98, P202, DOI 10.1016/S1081-1206(10)60700-4; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gonzalez CA, 2006, INT J CANCER, V118, P2559, DOI 10.1002/ijc.21678; Hamilton RG, 2010, IMMUNOL RES, V47, P273, DOI 10.1007/s12026-009-8160-3; HOST A, 1990, ALLERGY, V45, P587, DOI 10.1111/j.1398-9995.1990.tb00944.x; Ivanciuc O, 2003, NUCLEIC ACIDS RES, V31, P359, DOI 10.1093/nar/gkg010; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088339; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mari A, 2002, INT ARCH ALLERGY IMM, V129, P286, DOI 10.1159/000067591; Mari A, 2009, CURR ALLERGY ASTHM R, V9, P376, DOI 10.1007/s11882-009-0055-9; McCallum J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-168; Moneret-Vautrin D A, 2002, Allerg Immunol (Paris), V34, P135; Moyle Mignon, 2004, Australas J Dermatol, V45, P223, DOI 10.1111/j.1440-0960.2004.00102.x; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; Ricroch A, 2005, GENOME, V48, P511, DOI 10.1139/G05-017; Rowan BA, 2011, DEV CELL, V21, P65, DOI 10.1016/j.devcel.2011.05.021; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shek LPC, 2005, ALLERGY, V60, P912, DOI 10.1111/j.1398-9995.2005.00705.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Smarda P, 2014, P NATL ACAD SCI USA, V111, pE4096, DOI 10.1073/pnas.1321152111; Toledo-Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070781; Turktas M, 2015, TURK J AGRIC FOR, V39, P361, DOI 10.3906/tar-1409-93; VALDIVIESO R, 1994, J ALLERGY CLIN IMMUN, V94, P928, DOI 10.1016/0091-6749(94)90161-9; Vijayendra CA, 2012, INT J PHARM PHARM SC, V4, P175; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	50	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135387	10.1371/journal.pone.0135387	http://dx.doi.org/10.1371/journal.pone.0135387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284934	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100036
J	Romay-Barja, M; Jarrin, I; Ncogo, P; Nseng, G; Sagrado, MJ; Santana-Morales, MA; Aparcio, P; Valladares, B; Riloha, M; Benito, A				Romay-Barja, Maria; Jarrin, Inma; Ncogo, Policarpo; Nseng, Gloria; Jose Sagrado, Maria; Santana-Morales, Maria A.; Aparcio, Pilar; Valladares, Basilio; Riloha, Matilde; Benito, Agustin			Rural-Urban Differences in Household Treatment-Seeking Behaviour for Suspected Malaria in Children at Bata District, Equatorial Guinea	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; GHANA IMPLICATIONS; FEBRILE ILLNESS; PERCEPTIONS; TRANSMISSION; COMMUNITY; KNOWLEDGE; REGION; AREA; CARE	Background Malaria remains a major cause of morbidity and mortality among children under five years old in Equatorial Guinea. However, little is known about the community management of malaria and treatment-seeking patterns. We aimed to assess symptoms of children with reported malaria and treatment-seeking behaviour of their caretakers in rural and urban areas in the Bata District. Methodology A cross-sectional study was conducted in the district of Bata and 440 houses were selected from 18 rural villages and 26 urban neighbourhoods. Differences between rural and urban caregivers and children with reported malaria were assessed through the chi-squared test for independence of categorical variables and the t-Student or the non-parametric Mann-Whitney test for normally or not-normally distributed continuous variables, respectively. Results Differences between rural and urban households were observed in caregiver treatment-seeking patterns. Fever was the main symptom associated with malaria in both areas. Malaria was treated first at home, particularly in rural areas. The second step was to seek treatment outside the home, mainly at hospital and Health Centre for rural households and at hospital and private clinic for urban ones. Artemether monotherapy was the antimalarial treatment prescribed most often. Households waited for more than 24 hours before seeking treatment outside and delays were longest in rural areas. The total cost of treatment was higher in urban than in rural areas in Bata. Conclusions The delays in seeking treatment, the type of malaria therapy received and the cost of treatment are the principal problems found in Bata District. Important steps for reducing malaria morbidity and mortality in this area are to provide sufficient supplies of effective antimalarial drugs and to improve malaria treatment skills in households and in both public and private sectors.	[Romay-Barja, Maria; Aparcio, Pilar; Benito, Agustin] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Romay-Barja, Maria; Santana-Morales, Maria A.; Aparcio, Pilar; Valladares, Basilio; Benito, Agustin] RICET, Madrid, Spain; [Jarrin, Inma; Jose Sagrado, Maria] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain; [Ncogo, Policarpo] Ctr Referencia Control Endemias, Malabo, Guinea; [Nseng, Gloria; Riloha, Matilde] Minist Salud & Bienestar Social, Malabo, Guinea; [Santana-Morales, Maria A.; Valladares, Basilio] Inst Univ Enfermedades Trop & Salud Publ Canaria, Tenerife, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Romay-Barja, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain.	mromay@isciii.es		JARRIN, INMA/0000-0002-7485-2252; Romay-Barja, Maria/0000-0002-0177-6885; Benito, Agustin/0000-0001-8229-5540	Agencia Espanola de Cooperacion Internacional AECID [TREG1415/11]; Tropical Diseases Research Network [RD06/0021/0000]; RICET	Agencia Espanola de Cooperacion Internacional AECID; Tropical Diseases Research Network; RICET	This study was funding by the Agencia Espanola de Cooperacion Internacional AECID http://www.aecid.es/ES TREG1415/11 and the Tropical Diseases Research Network RD06/0021/0000; RICET http://www.ricet.es/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBAJE EO, 1991, ANN TROP MED PARASIT, V85, P585, DOI 10.1080/00034983.1991.11812613; AGYEPONG IA, 1992, SOC SCI MED, V35, P131, DOI 10.1016/0277-9536(92)90160-R; Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; AKENDENGUE B, 1992, J ETHNOPHARMACOL, V37, P165, DOI 10.1016/0378-8741(92)90075-3; Akenji TKN, 2005, T ROY SOC TROP MED H, V99, P325, DOI 10.1016/j.trstmh.2003.12.016; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Baiden F, 2014, Ghana Med J, V48, P112; Baume C, 2000, SOC SCI MED, V51, P1491, DOI 10.1016/S0277-9536(00)00049-6; Custodio E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-225; Deressa W, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-259; Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-49; Dike N, 2006, SOC SCI MED, V63, P103, DOI 10.1016/j.socscimed.2005.11.061; Guerra-Neira Ana, 2006, Int J Health Geogr, V5, P27, DOI 10.1186/1476-072X-5-27; Hausmann-Muela S, 14 DCPP; Holtz TH, 2003, T ROY SOC TROP MED H, V97, P491, DOI 10.1016/S0035-9203(03)80003-2; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P865, DOI 10.1046/j.1365-3156.2000.00651.x; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; Molyneux CS, 1999, TROP MED INT HEALTH, V4, P836, DOI 10.1046/j.1365-3156.1999.00489.x; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; Odu BP, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/2049-9957-4-1; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; Olanlokun J O, 2012, Afr J Med Med Sci, V41 Suppl, P27; Onwujekwe O, 2004, ACTA TROP, V91, P101, DOI 10.1016/j.actatropica.2004.03.005; Orem JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-175; Rehman AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-154; The DHS Program, 2011, EQ GUIN DHS 2011 FIN; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; WHO, 2015, EM SPREAD ART RES CA; WHO, WORLD HLTH STAT 9789; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010	34	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135887	10.1371/journal.pone.0135887	http://dx.doi.org/10.1371/journal.pone.0135887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26284683	Green Published, gold			2022-12-27	WOS:000359666100082
J	Ward, BA				Ward, Ben A.			Temperature-Correlated Changes in Phytoplankton Community Structure Are Restricted to Polar Waters	PLOS ONE			English	Article							SOUTHERN-OCEAN; SIZE STRUCTURE; CHLOROPHYLL; ECOSYSTEMS; PRODUCTIVITY; LIMITATION; ATLANTIC; PIGMENTS; MARINE; GROWTH	Globally distributed observations of size-fractionated chlorophyll a and temperature were used to incorporate temperature dependence into an existing semi-empirical model of phytoplankton community size structure. The additional temperature-dependent term significantly increased the model's ability to both reproduce and predict observations of chlorophyll a size-fractionation at temperatures below 2 degrees C. The most notable improvements were in the smallest (picoplankton) size-class, for which overall model fit was more than doubled, and predictive skill was increased by approximately 40%. The model was subsequently applied to generate global maps for three phytoplankton size classes, on the basis of satellite-derived estimates of surface chlorophyll a and sea surface temperature. Polar waters were associated with marked decline in the chlorophyll a biomass of the smallest cells, relative to lower latitude waters of equivalent total chlorophyll a. In the same regions a complementary increase was seen in the chlorophyll a biomass of larger size classes. These findings suggest that a warming and stratifying ocean will see a poleward expansion of the habitat range of the smallest phytoplankton, with the possible displacement of some larger groups that currently dominate. There was no evidence of a strong temperature dependence in tropical or sub-tropical regions, suggesting that future direct temperature effects on community structure at lower latitudes may be small.	[Ward, Ben A.] Inst Univ Europeen Mer, Lab Sci Environm Marin, Plouzane, France; [Ward, Ben A.] Univ Bristol, Sch Geog Sci, Bristol, Avon, England	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Bristol	Ward, BA (corresponding author), Inst Univ Europeen Mer, Lab Sci Environm Marin, Pl Nicolas Copernic, Plouzane, France.	b.a.ward@bristol.ac.uk	Ward, Ben/I-4776-2012	Ward, Ben/0000-0003-1290-8270	"Laboratoire d'Excellence" LabexMER [ANR-10-LABX-19]; French government under the program "Investissements d'Avenir"; Regional Council of Brittany (SAD programme); European Research Council "PALEOGENiE" project [ERC-2013-CoG-617313]	"Laboratoire d'Excellence" LabexMER; French government under the program "Investissements d'Avenir"(French National Research Agency (ANR)); Regional Council of Brittany (SAD programme)(Region Bretagne); European Research Council "PALEOGENiE" project	This work was supported by the "Laboratoire d'Excellence" LabexMER (ANR-10-LABX-19), co-funded by a grant from the French government under the program "Investissements d'Avenir", and by a grant from the Regional Council of Brittany (SAD programme). Support through the European Research Council "PALEOGENiE" project (ERC-2013-CoG-617313) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Brewin RJW, 2014, J GEOPHYS RES-OCEANS, V119; Brewin RJW, 2010, ECOL MODEL, V221, P1472, DOI 10.1016/j.ecolmodel.2010.02.014; Cermeno P, 2006, ESTUAR COAST SHELF S, V67, P251, DOI 10.1016/j.ecss.2005.11.027; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; CUSHING DH, 1989, J PLANKTON RES, V11, P1, DOI 10.1093/plankt/11.1.1; Devred E, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002880; Dierssen HM, 2010, P NATL ACAD SCI USA, V107, P17073, DOI 10.1073/pnas.0913800107; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Fiala M, 1998, J MARINE SYST, V17, P179, DOI 10.1016/S0924-7963(98)00037-2; Flombaum P., 2013, P NATL ACAD SCI US, DOI 10.1073/pnas.1307701110; Froneman PW, 2004, DEEP-SEA RES PT II, V51, P2715, DOI 10.1016/j.dsr2.2002.09.001; Froneman PW, 2001, J PLANKTON RES, V23, P611, DOI 10.1093/plankt/23.6.611; Henson SA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046735; Hirata T, 2011, BIOGEOSCIENCES, V8, P311, DOI 10.5194/bg-8-311-2011; Imai K, 2002, DEEP-SEA RES PT II, V49, P5395, DOI 10.1016/S0967-0645(02)00198-4; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kostadinov TS, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005303; Lara-Lara JR, 2005, CIENC MAR, V31, P11, DOI 10.7773/cm.v31i11.82; Latasa M, 1998, DEEP-SEA RES PT II, V45, P2133, DOI 10.1016/S0967-0645(98)00066-6; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Litchman E, 2009, P NATL ACAD SCI USA, V106, P2665, DOI 10.1073/pnas.0810891106; Maranon E, 2001, MAR ECOL PROG SER, V216, P43, DOI 10.3354/meps216043; Maranon E, 2015, LIMNOLOGY OCEANOGRAP; Maranon E, 2015, MAR SCI, V7; Maranon E, 2012, LIMNOL OCEANOGR, V57, P1266, DOI 10.4319/lo.2012.57.5.1266; Moran XAG, 2015, LIMNOLOGY OCEANOGRAP; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Mouw CB, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006337; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Roy S, 2013, REMOTE SENS ENVIRON, V139, P185, DOI 10.1016/j.rse.2013.08.004; Sathyendranath S, 2001, INT J REMOTE SENS, V22, P249, DOI 10.1080/014311601449925; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Smith RC, 2000, J GEOPHYS RES, V105, P26, DOI [10.1029/, DOI 10.1029/1999JC000296]; Sosik HM, 2002, DEEP-SEA RES PT I, V49, P1195, DOI 10.1016/S0967-0637(02)00015-8; THINGSTAD TF, 1990, MAR ECOL PROG SER, V63, P261, DOI 10.3354/meps063261; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Uitz J, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003207	39	38	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135581	10.1371/journal.pone.0135581	http://dx.doi.org/10.1371/journal.pone.0135581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285028	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000359666100045
J	Zheng, J; Wu, WL; Liu, YP; Xiang, Z; Liu, M; Chan, KH; Lau, SY; Lam, KT; To, KKW; Chan, JFW; Li, LJ; Chen, HL; Lau, L; Yuen, KY; Tu, WW				Zheng, Jian; Wu, Wai-Lan; Liu, Yinping; Xiang, Zheng; Liu, Ming; Chan, Kwok-Hung; Lau, Siu-Ying; Lam, Kwok-Tai; To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Li, Lanjuan; Chen, Honglin; Lau, Lung; Yuen, Kwok-Yung; Tu, Wenwei			The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice	PLOS ONE			English	Article							DELTA-T-CELLS; MOUSE MODELS; ORIGIN	A novel avian influenza virus H7N9 infection occurred among human populations since 2013. Although the lack of sustained human-to-human transmission limited the epidemics caused by H7N9, the late presentation of most patients and the emergence of neuraminidase-resistant strains made the development of novel antiviral strategy against H7N9 in urgent demands. In this study, we evaluated the potential of pamidronate, a pharmacological phosphoantigen that can specifically boost human V delta 2-T-cell, on treating H7N9 virus-infected humanized mice. Our results showed that intraperitoneal injection of pamidronate could potently decrease the morbidity and mortality of H7N9-infected mice through controlling both viral replication and inflammation in affected lungs. More importantly, pamidronate treatment starting from 3 days after infection could still significantly ameliorate the severity of diseases in infected mice and improve their survival chance, whereas orally oseltamivir treatment starting at the same time showed no therapeutic effects. As for the mechanisms underlying pamidronate-based therapy, our in vitro data demonstrated that its antiviral effects were partly mediated by IFN-gamma secreted from human V delta 2-T cells. Meanwhile, human V delta 2-T cells could directly kill virus-infected host cells in a perforin-, granzyme B- and CD137-dependent manner. As pamidronate has been used for osteoporosis treatment for more than 20 years, pamidronate-based therapy represents for a safe and readily available option for clinical trials to treat H7N9 infection.	[Zheng, Jian; Liu, Yinping; Xiang, Zheng; Lam, Kwok-Tai; Lau, Lung; Tu, Wenwei] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Wu, Wai-Lan; Chan, Kwok-Hung; Lau, Siu-Ying; To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Liu, Ming] Guangzhou Med Univ, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	University of Hong Kong; University of Hong Kong; Guangzhou Medical University; Zhejiang University	Tu, WW (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	wwtu@hku.hk	To, Kelvin/AAV-7007-2020; Chen, Honglin/C-4224-2009; Chan, Kwok Hung/ABD-5399-2021; Chan, Jasper F. W./D-8007-2013; Lau, Yu Lung/C-4322-2009	To, Kelvin/0000-0002-1921-5824; Chen, Honglin/0000-0001-5108-8338; Chan, Jasper F. W./0000-0001-6336-6657; Yuen, Kwok-yung/0000-0002-2083-1552; Lau, Yu Lung/0000-0002-4780-0289	General Research Fund, Research Grants Council of Hong Kong [HKU 780113M]; Area of Excellence program on Influenza of Hong Kong SAR, China [AoE/M-12/06]	General Research Fund, Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Area of Excellence program on Influenza of Hong Kong SAR, China	This work was supported in part by General Research Fund, Research Grants Council of Hong Kong (HKU 780113M), Area of Excellence program on Influenza (AoE/M-12/06) of Hong Kong SAR, China, and Dr. Richard YH Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantia S, 2011, ANTIVIR RES, V90, P17, DOI 10.1016/j.antiviral.2011.02.001; Beck BH, 2010, BREAST CANCER RES TR, V122, P135, DOI 10.1007/s10549-009-0527-6; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Chan-Tack KM, 2009, NEW ENGL J MED, V361, P1713, DOI 10.1056/NEJMc0905290; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Ebell Mark H, 2014, Evid Based Med, V19, P211, DOI 10.1136/ebmed-2014-110033; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Mao Huawei, 2014, Virologica Sinica, V29, P170, DOI 10.1007/s12250-014-3473-3; Mok CKP, 2013, MBIO, V4, DOI 10.1128/mBio.00362-13; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Peiris JSM, 2009, EUR J IMMUNOL, V39, P2946, DOI 10.1002/eji.200939911; Poccia F, 2005, IMMUNOL LETT, V100, P14, DOI 10.1016/j.imlet.2005.06.025; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Viasus D, 2011, J INFECTION, V62, P193, DOI 10.1016/j.jinf.2011.01.014; Wang LS, 2001, J CLIN INVEST, V108, P1349, DOI 10.1172/JCI13584; WHO, MAP EP CURV CONF HUM; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; Zheng J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004943; Zheng J, 2013, CELL MOL IMMUNOL, V10, P50, DOI 10.1038/cmi.2012.43; Zhirnov OP, 2011, ANTIVIR RES, V92, P27, DOI 10.1016/j.antiviral.2011.07.014; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	36	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135999	10.1371/journal.pone.0135999	http://dx.doi.org/10.1371/journal.pone.0135999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285203	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100095
J	Cong, XJ; Campomanes, P; Kless, A; Schapitz, I; Wagener, M; Koch, T; Carloni, P				Cong, Xiaojing; Campomanes, Pablo; Kless, Achim; Schapitz, Inga; Wagener, Markus; Koch, Thomas; Carloni, Paolo			Structural Determinants for the Binding of Morphinan Agonists to the mu-Opioid Receptor	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; FREE-ENERGY; FUNCTIONAL SELECTIVITY; CRYSTAL-STRUCTURE; LIGAND-BINDING; FORCE-FIELD; VALIDATION; ACTIVATION; PROTEINS; RECOGNITION	Atomistic descriptions of the mu-opioid receptor (mu OR) noncovalently binding with two of its prototypical morphinan agonists, morphine (MOP) and hydromorphone (HMP), are investigated using molecular dynamics (MD) simulations. Subtle differences between the binding modes and hydration properties of MOP and HMP emerge from the calculations. Alchemical free energy perturbation calculations show qualitative agreement with in vitro experiments performed in this work: indeed, the binding free energy difference between MOP and HMP computed by forward and backward alchemical transformation is 1.2 +/- 1.1 and 0.8 +/- 0.8 kcal/mol, respectively, to be compared with 0.4 +/- 0.3 kcal/mol from experiment. Comparison with an MD simulation of mu OR covalently bound with the antagonist beta-funaltrexamine hints to agonist-induced conformational changes associated with an early event of the receptor's activation: a shift of the transmembrane helix 6 relative to the transmembrane helix 3 and a consequent loss of the key R165-T279 interhelical hydrogen bond. This finding is consistent with a previous proposal suggesting that the R165-T279 hydrogen bond between these two helices indicates an inactive receptor conformation.	[Cong, Xiaojing; Campomanes, Pablo; Carloni, Paolo] German Res Sch Simulat Sci GmbH, Lab Computat Biophys, D-52425 Julich, Germany; [Cong, Xiaojing; Campomanes, Pablo; Carloni, Paolo] Forschungszentrum Julich, IAS, Computat Biomed Sect IAS 5, D-52425 Julich, Germany; [Cong, Xiaojing; Campomanes, Pablo; Carloni, Paolo] Forschungszentrum Julich, INM, Computat Biomed Sect INM 9, D-52425 Julich, Germany; [Kless, Achim; Schapitz, Inga; Wagener, Markus; Koch, Thomas] Grunenthal GmbH, Grunenthal Innovat, D-52078 Aachen, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Grunenthal Group	Carloni, P (corresponding author), German Res Sch Simulat Sci GmbH, Lab Computat Biophys, D-52425 Julich, Germany.	p.carloni@fz-juelich.de	Campomanes, Pablo/E-1068-2014; Kless, Achim/B-8341-2014	Campomanes, Pablo/0000-0001-9229-8323; Kless, Achim/0000-0001-8301-5934; Carloni, Paolo/0000-0002-9010-0149	European Union [604102]; Grunenthal GmbH	European Union(European Commission); Grunenthal GmbH	This work has been funded by the European Union Seventh Framework Programme (FP7/2007-2013, http://ec.europa.eu/research/fp7) under Grant Agreement N. 604102 (the Human Brain Project) to P. Carloni. The in vitro data were provided by Grunenthal GmbH through research collaboration without additional financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grunenthal GmbH provided support in the form of salaries for authors [AK, IS, MW and TK] but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; BROWNSTEIN MJ, 1993, P NATL ACAD SCI USA, V90, P5391, DOI 10.1073/pnas.90.12.5391; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Frisch G. W., 2013, GAUSSIAN 09; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Huang P, 2001, BIOCHEMISTRY-US, V40, P13501, DOI 10.1021/bi010917q; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P1306, DOI 10.1001/jama.297.12.1306; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Lamberts JT, 2013, CURR PHARM DESIGN, V19, P7333; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Law PY, 2013, TRENDS BIOCHEM SCI, V38, P275, DOI 10.1016/j.tibs.2013.03.003; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; LORD JAH, 1977, NATURE, V267, P495, DOI 10.1038/267495a0; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mansour A, 1997, J NEUROCHEM, V68, P344, DOI 10.1046/j.1471-4159.1997.68010344.x; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rominger DH, 2014, CURR OPIN PHARMACOL, V16, P108, DOI 10.1016/j.coph.2014.04.002; Ross S, 2009, CLIN NEUROPHARMACOL, V32, P269, DOI 10.1097/WNF.0b013e3181a9163c; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serohijos AWR, 2011, STRUCTURE, V19, P1683, DOI 10.1016/j.str.2011.08.003; Spetea M, 2013, CURR PHARM DESIGN, V19, P7415; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; SURRATT CK, 1994, J BIOL CHEM, V269, P20548; Suwa M, 2011, PHARMACEUTICALS, V4, P652, DOI 10.3390/ph4040652; TATTRIE NH, 1968, CAN J BIOCHEM CELL B, V46, P819, DOI 10.1139/o68-124; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Yuan SG, 2013, ANGEW CHEM INT EDIT, V52, P10112, DOI 10.1002/anie.201302244; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; Zhou L, 2014, CURR OPIN CELL BIOL, V27, P102, DOI 10.1016/j.ceb.2013.11.010	57	16	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135998	10.1371/journal.pone.0135998	http://dx.doi.org/10.1371/journal.pone.0135998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280453	gold, Green Published, Green Submitted			2022-12-27	WOS:000359664300031
J	Witt, F; Guhrs, J; Morlock, MM; Bishop, NE				Witt, Florian; Guehrs, Julian; Morlock, Michael M.; Bishop, Nicholas E.			Quantification of the Contact Area at the Head-Stem Taper Interface of Modular Hip Prostheses	PLOS ONE			English	Article							LARGE-DIAMETER METAL; NATIONAL JOINT REGISTRY; WEAR; REPLACEMENTS; CORROSION; FAILURE; BEARINGS; ARTHROPLASTY; JUNCTION; CONNECTIONS	Corrosion of modular taper junctions of hip implants may be associated with clinical failure. Taper design parameters, as well as the intraoperatively applied assembly forces, have been proposed to affect corrosion. Fretting corrosion is related to relative interface shear motion and fluid ingress, which may vary with contact force and area. It was hypothesised in this study that assembly forces modify the extent and distribution of the surface contact area at the taper interface between a cobalt chrome head and titanium stem taper with a standard threaded surface profile. Local abrasion of a thin gold coating applied to the stem taper prior to assembly was used to determine the contact area after disassembly. Profilometry was then used to assess permanent deformation of the stem taper surface profile. With increasing assembly force (500 N, 2000 N, 4000 N and 8000 N) the number of stem taper surface profile ridges in contact with the head taper was found to increase (9.2 +/- 9.3%, 65.4 +/- 10.8%, 92.8 +/- 6.0% and 100%) and the overall taper area in contact was also found to increase (0.6 +/- 0.7%, 5.5 +/- 1.0%, 9.9 +/- 1.1% and 16.1 +/- 0.9%). Contact was inconsistently distributed over the length of the taper. An increase in plastic radial deformation of the surface ridges (-0.05 +/- 0.14 mu m, 0.1 +/- 0.14 mu m, 0.21 +/- 0.22 mu m and 0.96 +/- 0.25 mu m) was also observed with increasing assembly force. The limited contact of the taper surface ridges at lower assembly forces may influence corrosion rates, suggesting that the magnitude of the assembly force may affect clinical outcome. The method presented provides a simple and practical assessment of the contact area at the taper interface.	[Witt, Florian; Guehrs, Julian; Morlock, Michael M.; Bishop, Nicholas E.] TUHH Hamburg Univ Technol, Inst Biomech, D-21073 Hamburg, Germany; [Bishop, Nicholas E.] HAW Hamburg Univ Appl Sci, Fac Life Sci, D-21033 Hamburg, Germany	Hamburg University of Technology; Hochschule Angewandte Wissenschaft Hamburg	Witt, F (corresponding author), TUHH Hamburg Univ Technol, Inst Biomech, D-21073 Hamburg, Germany.	witt@tuhh.de		Morlock, Michael/0000-0002-5330-2454	German Research Foundation (DFG); Hamburg University of Technology (TUHH)	German Research Foundation (DFG)(German Research Foundation (DFG)); Hamburg University of Technology (TUHH)	This publication was supported by the German Research Foundation (DFG) and the Hamburg University of Technology (TUHH) in the funding program Open Access Publishing. The authors are grateful for material support by DePuy-Synthes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxmann M, 2013, MED ENG PHYS, V35, P676, DOI 10.1016/j.medengphy.2012.07.013; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bishop N, 2013, J ORTHOP RES, V31, P1116, DOI 10.1002/jor.22326; Bishop NE, 2013, J ORTHOP RES, V31, P807, DOI 10.1002/jor.22255; Campbell P, 2008, J ARTHROPLASTY, V23, P1080, DOI 10.1016/j.arth.2007.09.024; Cook RB, 2013, J ARTHROPLASTY, V28, P1430, DOI 10.1016/j.arth.2013.02.009; Damm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078373; GILBERT JL, 1993, J BIOMED MATER RES, V27, P1533, DOI 10.1002/jbm.820271210; Glyn-Jones S, 2011, J BONE JOINT SURG AM, V93A, P2180, DOI 10.2106/JBJS.J.01206; Hart AJ, 2013, J BONE JOINT SURG AM, V95A, P678, DOI 10.2106/JBJS.J.01447; Higgs GB, 2013, J ARTHROPLASTY, V28, P2, DOI 10.1016/j.arth.2013.05.040; Higuchi F, 1995, J ARTHROPLASTY, V10, P851, DOI 10.1016/S0883-5403(05)80086-5; Jameson SS, 2013, BONE JOINT J, V95B, P747, DOI 10.1302/0301-620X.95B6.31378; Jauch SY, 2011, J BIOMECH, V44, P1747, DOI 10.1016/j.jbiomech.2011.04.007; Kocagoz Sevi B, 2013, Semin Arthroplasty, V24, P246; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; Langton DJ, 2012, BONE JOINT RES, V1, P56, DOI 10.1302/2046-3758.14.2000047; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Matthies AK, 2013, J ORTHOP RES, V31, P1677, DOI 10.1002/jor.22431; Morlock MM, 2008, J BONE JOINT SURG AM, V90A, P89, DOI 10.2106/JBJS.H.00621; Mroczkowski ML, 2006, J ORTHOP RES, V24, P271, DOI 10.1002/jor.20048; Nassutt R, 2006, BIOMED TECH, V51, P103, DOI 10.1515/BMT.2006.018; Panagiotidou A, 2013, J ORTHOP RES, V31, P2032, DOI 10.1002/jor.22461; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Pandorf T, 2009, P 13 INT BIOLOX S BI; Pennock AT, 2002, J ARTHROPLASTY, V17, P773, DOI 10.1054/arth.2002.33565; Porter M, 2013, NATL JOINT REGISTRY; Prieto HA, 2014, J ARTHROPLASTY, V29, P1808, DOI 10.1016/j.arth.2014.04.008; Rehmer A, 2012, CLIN BIOMECH, V27, P77, DOI 10.1016/j.clinbiomech.2011.08.002; Samelko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067127; Scully CWF, 2013, ORTHOPEDICS, V36, pE666, DOI 10.3928/01477447-20130426-33; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Tateiwa T, 2008, AM J ORTHOP, V37, P26; Tuke M, 2010, PRECIS ENG, V34, P777, DOI 10.1016/j.precisioneng.2010.06.001; Vundelinckx BJ, 2013, J ARTHROPLASTY, V28, P1218, DOI 10.1016/j.arth.2013.01.018; Weisse B, 2008, P I MECH ENG H, V222, P829, DOI 10.1243/09544119JEIM374; Whitehouse MR, 2013, CLIN ORTHOP RELAT R, V471, P4082, DOI 10.1007/s11999-013-3133-1; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; WILLMANN G, 1993, MATERIALWISS WERKST, V24, P315, DOI 10.1002/mawe.19930240908; Witt F, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01199; Zippel H., 2003, BIOCERAMICS JOINT AR, P193, DOI [10.1007/978-3-642-85763-830, DOI 10.1007/978-3-642-85763-830]	41	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135517	10.1371/journal.pone.0135517	http://dx.doi.org/10.1371/journal.pone.0135517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280914	Green Published, gold, Green Submitted			2022-12-27	WOS:000359664300017
J	Escobar-Camacho, D; Barriga, R; Ron, SR				Escobar-Camacho, Daniel; Barriga, Ramiro; Ron, Santiago R.			Discovering Hidden Diversity of Characins (Teleostei: Characiformes) in Ecuador's Yasuni National Park	PLOS ONE			English	Article							ASTYANAX-FASCIATUS TELEOSTEI; 6TH MASS EXTINCTION; CRYPTIC DIVERSITY; OSTARIOPHYSI CHARACIFORMES; MOLECULAR-IDENTIFICATION; SPECIES-COMPLEX; FISH; PHYLOGENY; GYMNOTIFORMES; CONSERVATION	Background Management and conservation of biodiversity requires adequate species inventories. The Yasuni National Park is one of the most diverse regions on Earth and recent studies of terrestrial vertebrates, based on genetic evidence, have shown high levels of cryptic and undescribed diversity. Few genetic studies have been carried out in freshwater fishes from western Amazonia. Thus, in contrast with terrestrial vertebrates, their content of cryptic diversity remains unknown. In this study, we carried out genetic and morphological analyses on characin fishes at Yasuni National Park, in eastern Ecuador. Our goal was to identify cryptic diversity among one of the most speciose fish families in the Amazon region. This is the first time that genetic evidence has been used to assess the species content of the Napo Basin, one of the richest regions in vertebrate diversity. Results Phylogenetic analyses of partial mitochondrial 16S ribosomal RNA gene (similar to 600 pb) DNA sequences from 232 specimens of the family Characidae and its closest groups revealed eight candidate new species among 33 species sampled, representing a 24% increase in species number. Analyses of external morphology allowed us to confirm the species status of six of the candidate species. Conclusions Our results show high levels of cryptic diversity in Amazonian characins. If this group is representative of other Amazonian fish, our results would imply that the species richness of the Amazonian ichthyofauna is highly underestimated. Molecular methods are a necessary tool to obtain more realistic inventories of Neotropical freshwater fishes.	[Escobar-Camacho, Daniel; Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Pichincha, Ecuador; [Escobar-Camacho, Daniel; Barriga, Ramiro] Escuela Politec Nacl, Museo Ictiol, Museo Hist Nat Gustavo Orces, Inst Ciencias Biol, Quito, Pichincha, Ecuador	Pontificia Universidad Catolica del Ecuador; Escuela Politecnica Nacional Ecuador	Ron, SR (corresponding author), Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Pichincha, Ecuador.	santiago.r.ron@gmail.com	Ron, Santiago/J-4203-2019	Ron, Santiago/0000-0001-6300-9350	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT [PI-C08-0000470]; Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA) department	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT; Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA) department	This study was supported by grants from the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (PI-C08-0000470) http://www.educacionsuperior.gob.ec/, for SRR; and a grant from Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA) department for SRR, http://www.puce.edu.ec/portal/content/Cont%C3%A1ctenos/1?link = oln30.redirect. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe KT, 2013, MOL PHYLOGENET EVOL, V69, P1209, DOI 10.1016/j.ympev.2013.07.005; Albert JS, 2011, ANIMALS-BASEL, V1, P205, DOI 10.3390/ani1020205; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Ardura A, 2010, BIOL CONSERV, V143, P1438, DOI 10.1016/j.biocon.2010.03.019; Balian EV, 2008, HYDROBIOLOGIA, V595, P627, DOI 10.1007/s10750-007-9246-3; Barletta M, 2010, J FISH BIOL, V76, P2118, DOI 10.1111/j.1095-8649.2010.02684.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barriga R. S., 2012, REV POLITECNICA, V30, P83, DOI DOI 10.5962/BHL.TITLE.67474; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Bergmann PJ, 2007, ZOOL J LINN SOC-LOND, V149, P339; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Casciotta J, 2012, ZOOTAXA, P39; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Cooke GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048800; Cooke GM, 2012, J BIOGEOGR, V39, P724, DOI 10.1111/j.1365-2699.2011.02635.x; Craig M. T., 2009, Endangered Species Research, V7, P167, DOI 10.3354/esr00117; Di Finizio A, 2007, EUR FOOD RES TECHNOL, V225, P337, DOI 10.1007/s00217-006-0420-z; Elmer KR, 2008, ZOOTAXA, P11, DOI 10.11646/zootaxa.1784.1.2; Eschmeyer WN, 2014, FAMILY SUBFAMILY CHA, P1; Ferreira-Neto M, 2012, COMP CYTOGENET, V6, P29, DOI 10.3897/CompCytogen.v6i1.2151; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Fink WL, 1983, B MUSEUM COMP ZOOL, V150, P386; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Garcia-Davilla C, 2013, GENETICA, V141, P347, DOI 10.1007/s10709-013-9734-5; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kavalco KF, 2009, GENET MOL BIOL, V32, P477, DOI 10.1590/S1415-47572009005000055; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Kon T, 2007, MOL PHYLOGENET EVOL, V44, P53, DOI 10.1016/j.ympev.2006.12.007; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lakra WS, 2009, MOL BIOL REP, V36, P831, DOI 10.1007/s11033-008-9252-1; Leary S, 2013, EUTHANASIA ANIMALS; Littmann MW, 2001, P ACAD NAT SCI PHILA, V151, P87, DOI 10.1635/0097-3157(2001)151[0087:ANCSOS]2.0.CO;2; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Maddison WP., 2008, EVOLUTION, V62, P1103; Marcos Mirande J, 2009, Cladistics, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Mariguela TC, 2013, J ZOOL SYST EVOL RES, V51, P327, DOI 10.1111/jzs.12025; Medrado AS, 2008, GENET MOL BIOL, V31, P208, DOI 10.1590/S1415-47572008000200007; Milhomem SSR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-75; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Murray SW, 2012, MOL PHYLOGENET EVOL, V62, P597, DOI 10.1016/j.ympev.2011.10.021; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagamachi CY, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-28; Nakayama C, 2001, COPEIA, P866; Nelson JS, 2006, FISHES WORLD; Oberdorff Thierry, 2011, International Journal of Ecology, V2011, DOI 10.1155/2011/967631; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pazza Rubens, 2003, Cytologia (Tokyo), V68, P159, DOI 10.1508/cytologia.68.159; Peces Barriga R., 2011, PECES FAUNA GUIYERO, P145; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Piggott MP, 2011, BIOL J LINN SOC, V102, P391, DOI 10.1111/j.1095-8312.2010.01571.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, MOL EVOLUTION PHYLOG; Rheindt FE, 2013, BIOL J LINN SOC, V108, P889, DOI 10.1111/j.1095-8312.2012.02036.x; Schneider CH, 2012, J FISH BIOL, V81, P1210, DOI 10.1111/j.1095-8649.2012.03403.x; Silva DD, 2008, MICRON, V39, P1251, DOI 10.1016/j.micron.2008.04.001; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Tisseuil C, 2013, J ANIM ECOL, V82, P365, DOI 10.1111/1365-2656.12018; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Zhang J, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-405; Zwickl D. J, 2006, GENETIC ALGORITHM AP	79	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135569	10.1371/journal.pone.0135569	http://dx.doi.org/10.1371/journal.pone.0135569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275041	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600078
J	Linhart, P; Ratcliffe, VF; Reby, D; Spinka, M				Linhart, Pavel; Ratcliffe, Victoria F.; Reby, David; Spinka, Marek			Expression of Emotional Arousal in Two Different Piglet Call Types	PLOS ONE			English	Article							INFANT DISTRESS VOCALIZATIONS; MOTIVATION-STRUCTURAL RULES; PHYSIOLOGICAL-RESPONSES; DOMESTIC PIGLETS; VOCAL QUALITY; MAMMAL SOUNDS; SUS-SCROFA; STRESS; PIGS; ANIMALS	Humans as well as many animal species reveal their emotional state in their voice. Vocal features show strikingly similar correlation patterns with emotional states across mammalian species, suggesting that the vocal expression of emotion follows highly conserved signalling rules. To fully understand the principles of emotional signalling in mammals it is, however, necessary to also account for any inconsistencies in the way that they are acoustically encoded. Here we investigate whether the expression of emotions differs between call types produced by the same species. We compare the acoustic structure of two common piglet calls-the scream (a distress call) and the grunt (a contact call)-across three levels of arousal in a negative situation. We find that while the central frequency of calls increases with arousal in both call types, the amplitude and tonal quality (harmonic-to-noise ratio) show contrasting patterns: as arousal increased, the intensity also increased in screams, but not in grunts, while the harmonicity increased in screams but decreased in grunts. Our results suggest that the expression of arousal depends on the function and acoustic specificity of the call type. The fact that more vocal features varied with arousal in scream calls than in grunts is consistent with the idea that distress calls have evolved to convey information about emotional arousal.	[Linhart, Pavel; Spinka, Marek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Ratcliffe, Victoria F.; Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	Czech Research Institute of Animal Science; University of Sussex	Linhart, P (corresponding author), Inst Anim Sci, Dept Ethol, Prague, Czech Republic.	linhart.pavel@vuzv.cz	Spinka, Marek/E-2395-2011; Linhart, Pavel/AAZ-7474-2021	Spinka, Marek/0000-0002-2506-9552; Linhart, Pavel/0000-0002-6097-5892; Reby, David/0000-0001-9261-1711	Czech Science Foundation [GA14-27925S]; Ministry of Agriculture of Czech Republic [MZERO0714]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Czech Science Foundation (GA14-27925S) and Ministry of Agriculture of Czech Republic (MZERO0714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenmuller E, 2013, EVOLUTION EMOTIONAL; AUGUST PV, 1987, J MAMMAL, V68, P1, DOI 10.2307/1381039; Bates D., 2013, MIXED EFFECTS MODELS; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; Blumstein DT, 2012, BIOL LETTERS, V8, P189, DOI 10.1098/rsbl.2011.0832; Boersma P., 1993, P I PHONETIC SCI, V17, P97; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Briefer EF, 2015, ANIM BEHAV, V99, P131, DOI 10.1016/j.anbehav.2014.11.002; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Esch HC, 2009, J MAMMAL, V90, P638, DOI 10.1644/08-MAMM-A-069R.1; Farago T, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0926; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; Fitch WT, 2000, PHONETICA, V57, P205; Geverink NA, 2002, PHYSIOL BEHAV, V77, P451, DOI 10.1016/S0031-9384(02)00877-6; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Hollen LI, 2007, AM NAT, V169, P758, DOI 10.1086/516719; Illmann G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083529; Lingle S, 2014, AM NAT, V184, P510, DOI 10.1086/677677; Lingle S, 2012, CURR ZOOL, V58, P698, DOI 10.1093/czoolo/58.5.698; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Maruscakova IL, 2015, J COMP PSYCHOL, V129, P121, DOI 10.1037/a0038870; Mateo JM, 2010, BIOL LETTERS, V6, P623, DOI 10.1098/rsbl.2010.0118; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Owings DH, 2006, ANIMAL VOCAL COMMUNI; Panksepp J, 2011, NEUROSCI BIOBEHAV R, V35, P1791, DOI 10.1016/j.neubiorev.2011.08.003; Puppe B, 2005, APPL ANIM BEHAV SCI, V95, P67, DOI 10.1016/j.applanim.2005.05.001; Reimert I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108700; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sauter DA, 2010, Q J EXP PSYCHOL, V63, P2251, DOI 10.1080/17470211003721642; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Schrader L, 1998, ETHOLOGY, V104, P859, DOI 10.1111/j.1439-0310.1998.tb00036.x; Specht R, 2013, AVISOFT SASLAB PRO V; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Tallet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071841; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Titze I. R., 2000, PRINCIPLES VOICE PRO; Tokuda IT, 2008, CHAOS, V18, DOI 10.1063/1.2825295; Weary DM, 1998, APPL ANIM BEHAV SCI, V56, P161, DOI 10.1016/S0168-1591(97)00092-0; WEARY DM, 1995, ANIM BEHAV, V50, P1047, DOI 10.1016/0003-3472(95)80105-7; Weenink D, 2013, PRAAT DOING PHONETCI; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; Zimmermann E, 2013, EVOLUTION EMOTIONAL	46	42	42	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135414	10.1371/journal.pone.0135414	http://dx.doi.org/10.1371/journal.pone.0135414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274816	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000359493600066
J	Nadrah, K; Beck, TC; Pereira, JP				Nadrah, Kristina; Beck, Thomas C.; Pereira, Joao P.			Immature B Cell Egress from Bone Marrow Is SOCS3 Independent	PLOS ONE			English	Article							WHIM-SYNDROME; UP-REGULATION; RECEPTOR INTERNALIZATION; BETA-ARRESTIN; CXCR4; CHEMOKINE; MIGRATION; RESPONSES; PHOSPHORYLATION; RESPONSIVENESS	Suppressor of cytokine signaling (SOCS)-3 has been suggested to regulate CXCR4 signaling in a variety of human cell lines. In mice, conditional SOCS3 inactivation in hematopoietic cells including B-lineage lymphocytes has been reported to exacerbate CXCR4-signaling and focal adhesion kinase phosphorylation, which resulted in altered immature B cell distribution in bone marrow (BM) due to sustained alpha 4 beta 1 integrin-mediated adhesion to the extracellular matrix. However, a recent study examining conditional SOCS3 deletion specifically in B-lineage cells failed to detect significant roles in B-lineage cell retention in BM. In this study we carefully examined the role played by SOCS3 in CXCR4 signaling in developing B cell subsets. We show that in mice conditionally deficient in SOCS3 exclusively in B cells (Socs3(fl/fl) Mb1(cre/+)) there was no detectable difference in B cell development in BM and in periphery. We show that SOCS3 deficient and sufficient immature B cell subsets are similarly distributed between BM parenchyma and sinusoids, and are equally competent at exiting BM into peripheral blood. Furthermore, we found no significant differences in CXCR4 desensitization upon ligand exposure in developing B lymphocyte subsets. Consequently, SOCS3-deficient and sufficient B-lineage cell migration towards CXCL12 in vitro was undistinguishable, and B-lineage cell amoeboid motility within BM parenchyma was also unaffected by SOCS3-deficiency. Thus we conclude that SOCS3 has no detectable influence on biological processes known to be controlled by CXCR4 signaling.	[Nadrah, Kristina; Beck, Thomas C.; Pereira, Joao P.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Pereira, JP (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	joao.pereira@yale.edu	Nadrah, Kristina/L-9779-2016	Beck, Thomas/0000-0002-8860-5850; Pereira, Joao/0000-0002-5694-4938	National Institutes of Health [R56AI098996, RO1AI113040]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113040, R56AI098996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were funded by the National Institutes of Health (grants no. R56AI098996 and RO1AI113040). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; BATTEN SJ, 1984, J IMMUNOL METHODS, V72, P381, DOI 10.1016/0022-1759(84)90007-3; Beck TC, 2014, J EXP MED, V211, P2567, DOI 10.1084/jem.20140457; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Cronshaw DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015397; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Donovan EE, 2010, EUR J IMMUNOL, V40, P688, DOI 10.1002/eji.200939858; Fedyk ER, 1999, J LEUKOCYTE BIOL, V66, P667, DOI 10.1002/jlb.66.4.667; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Garzon R, 2004, J BIOL CHEM, V279, P44460, DOI 10.1074/jbc.M408010200; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Honczarenko M, 1999, BLOOD, V94, P2990, DOI 10.1182/blood.V94.9.2990.421k36_2990_2998; Jones SA, 2011, J IMMUNOL, V187, P6318, DOI 10.4049/jimmunol.1102057; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011; Liu Q, 2012, BLOOD, V120, P181, DOI 10.1182/blood-2011-12-395608; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; McDermott DH, 2014, BLOOD, V123, P2308, DOI 10.1182/blood-2013-09-527226; Moriguchi M, 2005, J BIOL CHEM, V280, P17408, DOI 10.1074/jbc.M414219200; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pello OM, 2006, BLOOD, V108, P3928, DOI 10.1182/blood-2006-02-006353; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Pereira JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009277; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0136061	10.1371/journal.pone.0136061	http://dx.doi.org/10.1371/journal.pone.0136061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274929	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600147
J	Sagarra, O; Szell, M; Santi, P; Diaz-Guilera, A; Ratti, C				Sagarra, Oleguer; Szell, Michael; Santi, Paolo; Diaz-Guilera, Albert; Ratti, Carlo			Supersampling and Network Reconstruction of Urban Mobility	PLOS ONE			English	Article							PREDICTABILITY	Understanding human mobility is of vital importance for urban planning, epidemiology, and many other fields that draw policies from the activities of humans in space. Despite the recent availability of large-scale data sets of GPS traces or mobile phone records capturing human mobility, typically only a subsample of the population of interest is represented, giving a possibly incomplete picture of the entire system under study. Methods to reliably extract mobility information from such reduced data and to assess their sampling biases are lacking. To that end, we analyzed a data set of millions of taxi movements in New York City. We first show that, once they are appropriately transformed, mobility patterns are highly stable over long time scales. Based on this observation, we develop a supersampling methodology to reliably extrapolate mobility records from a reduced sample based on an entropy maximization procedure, and we propose a number of network-based metrics to assess the accuracy of the predicted vehicle flows. Our approach provides a well founded way to exploit temporal patterns to save effort in recording mobility data, and opens the possibility to scale up data from limited records when information on the full system is required.	[Sagarra, Oleguer; Diaz-Guilera, Albert] Univ Barcelona, Dept Fis Fonamental, Barcelona, Spain; [Sagarra, Oleguer; Szell, Michael; Santi, Paolo; Ratti, Carlo] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Szell, Michael] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Santi, Paolo] CNR, Ist Informat & Telemat, I-56100 Pisa, Italy	University of Barcelona; Massachusetts Institute of Technology (MIT); Northeastern University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR)	Sagarra, O (corresponding author), Univ Barcelona, Dept Fis Fonamental, Barcelona, Spain.	osagarra@ub.edu	Diaz-Guilera, Albert/A-5218-2009	Diaz-Guilera, Albert/0000-0002-3114-0984; Szell, Michael/0000-0003-3022-2483	EU-LASAGNE Project [318132]; Spanish MINECO [FIS2012-38266-C02-02]; Generalitat de Catalunya through the FI Program [2014-SGR-00608]; Enel Foundation; Audi Volkswagen	EU-LASAGNE Project; Spanish MINECO(Spanish Government); Generalitat de Catalunya through the FI Program; Enel Foundation; Audi Volkswagen	The work of O.S. has been partially supported by the EU-LASAGNE Project, Contract No. 318132 (STREP), the Spanish MINECO Grant FIS2012-38266-C02-02 and by the Generalitat de Catalunya through the FI Program and 2014-SGR-00608. P.S. and C.R. thank the Enel Foundation, Audi Volkswagen, and all the members of the MIT Senseable City Lab Consortium for supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M., 2013, NEW SCI CITIES; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Bianconi G, 2009, P NATL ACAD SCI USA, V106, P11433, DOI 10.1073/pnas.0811511106; Blondel VD, 2015, ARXIV150203406; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Lenormand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105184; Lenormand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045985; Peng CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034487; Piorkowski M., 2009, P 1 INT C COMM SYST, P1, DOI [DOI 10.1109/COMSNETS.2009.4808865, 10.1109/COMSNETS.2009.4808865]; ROBILLARD P, 1975, TRANSPORT RES, V9, P123, DOI 10.1016/0041-1647(75)90049-0; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Sagarra O, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/38002; Sagarra O, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062806; Sagarra O, 2014, ODME ORIGIN DESTINAT; Sagarra O, 2011, THESIS U POLITECNICA; Santi P, 2014, P NATL ACAD SCI USA, V111, P13290, DOI 10.1073/pnas.1403657111; Scellato S, 2011, ICWSM, V11; Scellato S, 2011, LECT NOTES COMPUT SC, V6696, P152, DOI 10.1007/978-3-642-21726-5_10; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Spieser K, 2014, LECT N MOBIL, P229, DOI 10.1007/978-3-319-05990-7_20; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; WILSON AG, 1967, TRANSPORT RES, V1, P253, DOI 10.1016/0041-1647(67)90035-4; Yang YX, 2014, SCI REP-UK, V4, DOI 10.1038/srep05662; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	37	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134508	10.1371/journal.pone.0134508	http://dx.doi.org/10.1371/journal.pone.0134508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275237	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600030
J	Feigin, VL; Krishnamurthi, RV; Barker-Collo, S; McPherson, KM; Barber, PA; Parag, V; Arroll, B; Bennett, DA; Tobias, M; Jones, A; Witt, E; Brown, P; Abbott, M; Bhattacharjee, R; Rush, E; Suh, FM; Theadom, A; Rathnasabapathy, Y; Ao, BT; Parmar, PG; Anderson, C; Bonita, R				Feigin, Valery L.; Krishnamurthi, Rita V.; Barker-Collo, Suzanne; McPherson, Kathryn M.; Barber, P. Alan; Parag, Varsha; Arroll, Bruce; Bennett, Derrick A.; Tobias, Martin; Jones, Amy; Witt, Emma; Brown, Paul; Abbott, Max; Bhattacharjee, Rohit; Rush, Elaine; Suh, Flora Minsun; Theadom, Alice; Rathnasabapathy, Yogini; Ao, Braden Te; Parmar, Priya G.; Anderson, Craig; Bonita, Ruth		ARCOS IV Grp	30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies	PLOS ONE			English	Article							CASE-FATALITY RATES; REGIONAL COMMUNITY STROKE; RISK-FACTORS; SUBARACHNOID HEMORRHAGE; ETHNIC DISPARITIES; GLOBAL BURDEN; ATRIAL-FIBRILLATION; CEREBROVASCULAR-DISEASE; CARDIOVASCULAR-DISEASE; HEALTH DISPARITIES	Background Insufficient data exist on population-based trends in morbidity and mortality to determine the success of prevention strategies and improvements in health care delivery in stroke. The aim of this study was to determine trends in incidence and outcome (1-year mortality, 28-day case-fatality) in relation to management and risk factors for stroke in the multi-ethnic population of Auckland, New Zealand (NZ) over 30-years. Methods Four stroke incidence population-based register studies were undertaken in adult residents (aged >= 15 years) of Auckland NZ in 1981-1982, 1991-1992, 2002-2003 and 2011-2012. All used standard World Health Organization (WHO) diagnostic criteria and multiple overlapping sources of case-ascertainment for hospitalised and non-hospitalised, fatal and non-fatal, new stroke events. Ethnicity was consistently self-identified into four major groups. Crude and age-adjusted (WHO world population standard) annual incidence and mortality with corresponding 95% confidence intervals (CI) were calculated per 100,000 people, assuming a Poisson distribution. Results 5400 new stroke patients were registered in four 12 month recruitment phases over the 30-year study period; 79% were NZ/European, 6% Maori, 8% Pacific people, and 7% were of Asian or other origin. Overall stroke incidence and 1-year mortality decreased by 23% (95% CI 5%-31%) and 62% (95% CI 36%-86%), respectively, from 1981 to 2012. Whilst stroke incidence and mortality declined across all groups in NZ from 1991, Maori and Pacific groups had the slowest rate of decline and continue to experience stroke at a significantly younger age (mean ages 60 and 62 years, respectively) compared with NZ/Europeans (mean age 75 years). There was also a decline in 28-day stroke case fatality (overall by 14%, 95% CI 11%-17%) across all ethnic groups from 1981 to 2012. However, there were significant increases in the frequencies of pre-morbid hypertension, myocardial infarction, and diabetes mellitus, but a reduction in frequency of current smoking among stroke patients. Conclusions In this unique temporal series of studies spanning 30 years, stroke incidence, early case-fatality and 1-year mortality have declined, but ethnic disparities in risk and outcome for stroke persisted suggesting that primary stroke prevention remains crucial to reducing the burden of this disease.	[Feigin, Valery L.; Krishnamurthi, Rita V.; Jones, Amy; Witt, Emma; Brown, Paul; Abbott, Max; Bhattacharjee, Rohit; Rush, Elaine; Theadom, Alice; Ao, Braden Te; Parmar, Priya G.] Auckland Univ Technol, Auckland, New Zealand; [Barker-Collo, Suzanne; Barber, P. Alan; Parag, Varsha; Arroll, Bruce; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [McPherson, Kathryn M.] Hlth Res Council New Zealand, Auckland, New Zealand; [Bennett, Derrick A.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Tobias, Martin] Minist Hlth, Publ Hlth Intelligence, Wellington, New Zealand; [Brown, Paul] Univ Calif Merced, Merced, CA USA; [Suh, Flora Minsun] Univ Queensland, Brisbane, Qld, Australia; [Rathnasabapathy, Yogini] North Shore Hosp, Waitemata Dist Hlth Board, Auckland, New Zealand; [Anderson, Craig] Univ Sydney, Camperdown, NSW, Australia	Auckland University of Technology; University of Auckland; University of Oxford; University of California System; University of California Merced; University of Queensland; University of Sydney	Feigin, VL (corresponding author), Auckland Univ Technol, Auckland, New Zealand.	valery.feigin@aut.ac.nz	Krishnamurthi, Rita/AAU-7841-2021; , Bennett/O-7998-2019; Rush, Elaine/AAQ-9992-2021; Feigin, Valery/AAF-2313-2019; Bennett, Derrick/AAH-1220-2022; Bennett, Derrick/AFL-9254-2022	Krishnamurthi, Rita/0000-0003-0869-2083; Rush, Elaine/0000-0001-7713-6203; Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Parmar, Priya/0000-0001-6001-9326; Anderson, Craig/0000-0002-7248-4863; Barber, P Alan/0000-0003-2469-9023; McPherson, Kathryn/0000-0003-1240-8882; Te Ao, Braden/0000-0002-1050-200X; Feigin, Valery L./0000-0002-6372-1740; McPherson, Kath/0000-0003-0487-8497	Health Research Council of New Zealand [10/458]	Health Research Council of New Zealand(Health Research Council of New Zealand)	Support was provided by grant number 10/458 from the Health Research Council of New Zealand [http://www.hrc.govt.nz]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad O. B., 2000, GPE DISCUSSION PAPER, V31; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; Alberti KGMM, 2013, NAT REV ENDOCRINOL, V9, P258, DOI 10.1038/nrendo.2013.54; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; [Anonymous], 2004, ETHN DAT PROT HLTH D; [Anonymous], 2007, LANCET, V369, P247; Bell C, 1996, NEW ZEAL MED J, V109, P66; Benatru I, 2006, STROKE, V37, P1674, DOI 10.1161/01.STR.0000226979.56456.a8; Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; BONITA R, 1983, STROKE, V14, P342, DOI 10.1161/01.STR.14.3.342; Bonita R, 1997, STROKE, V28, P758, DOI 10.1161/01.STR.28.4.758; BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; BONITA R, 1995, INT J EPIDEMIOL, V24, P535, DOI 10.1093/ije/24.3.535; BONITA R, 1984, AM J EPIDEMIOL, V120, P236, DOI 10.1093/oxfordjournals.aje.a113885; BONITA R, 1995, STROKE, V26, P541, DOI 10.1161/01.STR.26.4.541; Briggs ADM, 2013, BMJ-BRIT MED J, P347; Carter K, 2006, STROKE, V37, P56, DOI 10.1161/01.STR.0000195131.23077.85; CASPER M, 1992, AM J PUBLIC HEALTH, V82, P1600, DOI 10.2105/AJPH.82.12.1600; Chroinin DN, 2011, STROKE, V42, P1021, DOI 10.1161/STROKEAHA.110.596734; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Corbin DOC, 2004, STROKE, V35, P1254, DOI 10.1161/01.STR.0000127371.24658.df; Corso G, 2009, NEUROEPIDEMIOLOGY, V32, P186, DOI 10.1159/000195688; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Diaz KM, 2014, HYPERTENSION, V64, P465, DOI 10.1161/HYPERTENSIONAHA.114.03565; Dundas R, 2001, ETHNIC HEALTH, V6, P95, DOI 10.1080/13557850120068423; Dyall L, 2006, N Z MED J, V119; Dyall L, 2008, SOC POLICY J NZ, P178; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2; Feigin V, 2005, STROKE, V36, P1360, DOI 10.1161/01.STR.0000170710.95689.41; Feigin VL, 2007, INT J STROKE, V2, P208, DOI 10.1111/j.1747-4949.2007.00140.x; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2014, INT J STROKE, V9, P61, DOI 10.1111/ijs.12117; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fink J, 2006, N Z MED J, V119, P1; Fisher A, 2014, J STROKE CEREBROVASC, V23, P759, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.035; FRASER GE, 1978, INT J EPIDEMIOL, V7, P277, DOI 10.1093/ije/7.3.277; Friberg L, 2014, STROKE; Gulliford MC, 2010, J NEUROL NEUROSUR PS, V81, P416, DOI 10.1136/jnnp.2009.193136; Gunarathne A, 2008, J HUM HYPERTENS, V22, P18, DOI 10.1038/sj.jhh.1002265; Hajat C, 2001, STROKE, V32, P37, DOI 10.1161/01.STR.32.1.37; Hallstrom B, 2008, STROKE, V39, P10, DOI 10.1161/STROKEAHA.107.491779; Hannon N, 2011, STROKE, V42, P2503, DOI 10.1161/STROKEAHA.110.602235; Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9; Harwood M, 2000, STROKE, V31, P2517, DOI 10.1161/01.STR.31.10.2517; Health. Mo, 2012, HLTH NZ AD 2011 12 K; Health Mo, 2013, MORTALITY DEMOGRAPHI; Health Mo, 2013, HLTH LOSS NZ REP NZ; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Howard G, 2013, STROKE, V44, P1282, DOI 10.1161/STROKEAHA.111.000529; Howard G, 2011, STROKE, V42, P3369, DOI 10.1161/STROKEAHA.111.625277; Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Kita Y, 2009, INT J STROKE, V4, P241, DOI 10.1111/j.1747-4949.2009.00293.x; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Krishnamurthi R, 2014, INT J STROKE, V9, P140, DOI 10.1111/ijs.12108; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kwon JW, 2013, WORLD NEUROSURG, V79, P499, DOI 10.1016/j.wneu.2012.07.032; Leyden JM, 2013, STROKE, V44, P1226, DOI 10.1161/STROKEAHA.113.675140; Macpherson KJ, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-38; Manobianca G, 2010, EUR J NEUROL, V17, P1148, DOI 10.1111/j.1468-1331.2010.02983.x; McGruder HF, 2004, STROKE, V35, P1557, DOI 10.1161/01.STR.0000130427.84114.50; McLean RM, 2013, NZ MED J, V126; McPherson KM, 2003, BRIT MED J, V327, P443, DOI 10.1136/bmj.327.7412.443; Mo Health, 2010, TAT KAH MAOR HLTH CH; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Palm F, 2010, STROKE, V41, P1865, DOI 10.1161/STROKEAHA.110.592642; Rastenyte D, 2006, SCAND J PUBLIC HEALT, V34, P488, DOI 10.1080/14034940600551640; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; SACCO RL, 1995, NEUROLOGY, V45, P659, DOI 10.1212/WNL.45.4.659; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; SAKURAI Y, 1995, TOHOKU J EXP MED, V177, P89, DOI 10.1620/tjem.177.89; SPRAFKA JM, 1994, DIABETIC MED, V11, P678, DOI 10.1111/j.1464-5491.1994.tb00332.x; Statistics New Zealand, 2014, NZ CENS 2013; Stroke Foundation of New Zealand and New Zealand Guidelines Group, 2010, NZ CLIN GUID STROK M; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c; Talelli Penelope, 2008, Ther Adv Cardiovasc Dis, V2, P387, DOI 10.1177/1753944708093411; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Tobias M, 2007, AUST NZ J PUBL HEAL, V31, P520, DOI 10.1111/j.1753-6405.2007.00136.x; Vaartjes IP, STROKE; Vibo R, 2005, STROKE, V36, P2544, DOI 10.1161/01.STR.0000189633.33623.69; Waxman A., 2004, Development (London), V47, P75, DOI 10.1057/palgrave.development.1100032; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; Ziegler PD, 2012, AM J CARDIOL, V110, P1309, DOI 10.1016/j.amjcard.2012.06.034	99	67	68	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134609	10.1371/journal.pone.0134609	http://dx.doi.org/10.1371/journal.pone.0134609			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291829	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900009
J	Schulz, K; Frahm, J; Kersten, S; Meyer, U; Rehage, J; Piechotta, M; Meyerholz, M; Breves, G; Reiche, D; Sauerwein, H; Danicke, S				Schulz, Kirsten; Frahm, Jana; Kersten, Susanne; Meyer, Ulrich; Rehage, Juergen; Piechotta, Marion; Meyerholz, Maria; Breves, Gerhard; Reiche, Dania; Sauerwein, Helga; Daenicke, Sven			Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; LACTATING DAIRY-COWS; FATTY LIVER; PLASMA-CONCENTRATIONS; INSULIN-RESISTANCE; GUT PEPTIDES; EXPRESSION; ACIDS; PERFORMANCE; HAPTOGLOBIN	The inhibition of dipeptidyl peptidase-4 (DPP4) via specific inhibitors is known to result in improved glucose tolerance and insulin sensitivity and decreased accumulation of hepatic fat in type II diabetic human patients. The metabolic situation of dairy cows can easily be compared to the status of human diabetes and non-alcoholic fatty liver. For both, insulin sensitivity is reduced, while hepatic fat accumulation increases, characterized by high levels of non-esterified fatty acids (NEFA) and ketone bodies. Therefore, in the present study, a DPP4 inhibitor was employed (BI 14332) for the first time in cows. In a first investigation BI 14332 treatment (intravenous injection at dosages of up to 3 mg/kg body weight) was well tolerated in healthy lactating pluriparous cows (n = 6) with a significant inhibition of DPP4 in plasma and liver. Further testing included primi- and pluriparous lactating cows suffering from subclinical ketosis (beta-hydroxybutyrate concentrations in serum > 1.2 mM; n = 12). The intension was to offer effects of DPP4 inhibition during comprehensive lipomobilisation and hepatosteatosis. The cows of subclinical ketosis were evenly allocated to either the treatment group (daily injections, 0.3 mg BI 14332/kg body weight, 7 days) or the control group. Under condition of subclinical ketosis, the impact of DPP4 inhibition via BI 14332 was less, as in particular beta-hydroxybutyrate and the hepatic lipid content remained unaffected, but NEFA and triglyceride concentrations were decreased after treatment. Owing to lower NEFA, the revised quantitative insulin sensitivity check index (surrogate marker for insulin sensitivity) increased. Therefore, a positive influence on energy metabolism might be quite possible. Minor impacts on immune-modulating variables were limited to the lymphocyte CD4(+)/CD8(+) ratio for which a trend to decreased values in treated versus control animals was noted. In sum, the DPP4 inhibition in cows did not affect glycaemic control like it is shown in humans, but was able to impact hyperlipemia, as NEFA and TG decreased.	[Schulz, Kirsten; Frahm, Jana; Kersten, Susanne; Meyer, Ulrich; Daenicke, Sven] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Germany; [Rehage, Juergen; Piechotta, Marion; Meyerholz, Maria] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany; [Breves, Gerhard] Univ Vet Med Hannover, Dept Physiol, Hannover, Germany; [Reiche, Dania] Boehringer Ingelheim Vetmed, Ingelheim, Germany; [Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany	Friedrich Loeffler Institute; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Boehringer Ingelheim; University of Bonn	Frahm, J (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Germany.	jana.frahm@fli.bund.de	Sauerwein, Helga/R-8242-2019; Breves, Gerhard/ABI-1315-2020		Boehringer Ingelheim Vetmedica GmbH	Boehringer Ingelheim Vetmedica GmbH(Boehringer Ingelheim)	Boehringer Ingelheim Vetmedica GmbH (www.vetmedica.de) funded the present study. Represented by Dr. Dania Reiche, Boehringer Ingelheim Vetmedica GmbH was involved in study design and data Analysis. Furthermore, Boehringer Ingelheim Vetmedica GmbH granted the decision to publish the present manuscript.	Anz D, 2014, DIABETES OBES METAB, V16, P569, DOI 10.1111/dom.12246; Asai K, 1998, VET IMMUNOL IMMUNOP, V65, P51, DOI 10.1016/S0165-2427(98)00176-7; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Bradford BJ, 2008, J DAIRY SCI, V91, P1443, DOI 10.3168/jds.2007-0670; Connor EE, 2010, J DAIRY SCI, V93, P5167, DOI 10.3168/jds.2010-3205; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Dirksen G., 2012, BOVINE INTERNAL DIS; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duffield T, 2000, VET CLIN N AM-FOOD A, V16, P231, DOI 10.1016/S0749-0720(15)30103-1; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Fathi E, 2013, INT J RECENT SCI RES, V4, P842; Flatt PR, 2008, FRONT BIOSCI-LANDMRK, V13, P3648, DOI 10.2741/2956; Frey H, 2009, LEHRBUCH PHARMAKOLOG; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Hachenberg S, 2007, J ANIM SCI, V85, P1923, DOI 10.2527/jas.2006-480; Hiss S, 2004, J DAIRY SCI, V87, P3778, DOI 10.3168/jds.S0022-0302(04)73516-X; Holtenius P, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-29; HOVE K, 1978, J DAIRY SCI, V61, P1407, DOI 10.3168/jds.S0022-0302(78)83742-4; Huttner S, 2008, J CLIN PHARMACOL, V48, P1171, DOI 10.1177/0091270008323753; Larsen M, 2010, J DAIRY SCI, V93, P5729, DOI 10.3168/jds.2010-3258; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; Mehrzad J, 2008, J DAIRY RES, V75, P457, DOI 10.1017/S0022029908003439; MUNOZ E, 1992, IMMUNOLOGY, V77, P43; Ohtsuka H, 2001, J VET MED SCI, V63, P1021, DOI 10.1292/jvms.63.1021; Pezeshki A, 2012, J DAIRY SCI, V95, P5089, DOI 10.3168/jds.2011-5311; Relling AE, 2008, DOMEST ANIM ENDOCRIN, V35, P35, DOI 10.1016/j.domaniend.2008.01.005; Saremi B, 2012, VET IMMUNOL IMMUNOP, V146, P201, DOI 10.1016/j.vetimm.2012.03.011; Saremi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086211; *SAS I, 2004, SAS STAT 9 1 US GUID, V1; Schulz K, 2015, ARCH ANIM NUTR, V69, P113, DOI 10.1080/1745039X.2015.1013666; Schulz K, 2014, J DAIRY RES, V81, P257, DOI 10.1017/S0022029914000107; Starke A, 2010, J ANIM SCI, V88, P2741, DOI 10.2527/jas.2009-2599; StatSoft I., 2011, STATISTICA WIND OP S; Stelter K, 2013, ARCH ANIM NUTR, V67, P461, DOI 10.1080/1745039X.2013.858897; Taylor-Edwards CC, 2010, DOMEST ANIM ENDOCRIN, V39, P181, DOI 10.1016/j.domaniend.2010.05.002; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Toutain PL, 2004, J VET PHARMACOL THER, V27, P415, DOI 10.1111/j.1365-2885.2004.00605.x; Toutain PL, 2004, J VET PHARMACOL THER, V27, P427, DOI 10.1111/j.1365-2885.2004.00600.x; White JR., 2008, CLIN DIABETES, V26, P53, DOI [DOI 10.2337/DIACLIN.26.2.53, 10.2337/diaclin.26.2.53]	41	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136078	10.1371/journal.pone.0136078	http://dx.doi.org/10.1371/journal.pone.0136078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291537	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900050
J	Talundzic, E; Chenet, SM; Goldman, IF; Patel, DS; Nelson, JA; Plucinski, MM; Barnwell, JW; Udhayakumar, V				Talundzic, Eldin; Chenet, Stella M.; Goldman, Ira F.; Patel, Dhruviben S.; Nelson, Julia A.; Plucinski, Mateusz M.; Barnwell, John W.; Udhayakumar, Venkatachalam			Genetic Analysis and Species Specific Amplification of the Artemisinin Resistance-Associated Kelch Propeller Domain in P. falciparum and P-vivax	PLOS ONE			English	Article							REAL-TIME PCR; WESTERN CAMBODIA; SOUTHEAST-ASIA; MALARIA; CLEARANCE; PROVINCE	Plasmodium falciparum resistance to artemisinin has emerged in the Greater Mekong Sub-region and now poses a threat to malaria control and prevention. Recent work has identified mutations in the kelch propeller domain of the P. falciparum K13 gene to be associated artemisinin resistance as defined by delayed parasite clearance and ex vivo ring stage survival assays. Species specific primers for the two most prevalent human malaria species, P. falciparum and P. vivax, were designed and tested on multiple parasite isolates including human, rodent, and non-humans primate Plasmodium species. The new protocol described here using the species specific primers only amplified their respective species, P. falciparum and P. vivax, and did not cross react with any of the other human malaria Plasmodium species. We provide an improved species specific PCR and sequencing protocol that could be effectively used in areas where both P. falciparum and P. vivax are circulating. To design this improved protocol, the kelch gene was analyzed and compared among different species of Plasmodium. The kelch propeller domain was found to be highly conserved across the mammalian Plasmodium species.	[Talundzic, Eldin; Chenet, Stella M.; Goldman, Ira F.; Patel, Dhruviben S.; Plucinski, Mateusz M.; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Atlanta, GA 30329 USA; [Talundzic, Eldin; Nelson, Julia A.] Atlanta Res & Educ Fdn, VA Med Ctr, Decatur, GA USA; [Plucinski, Mateusz M.] Presidents Malaria Initiat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Talundzic, E (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, 1600 Clifton Rd,Mail Stop D-67, Atlanta, GA 30329 USA.	etalundzic@cdc.gov	Chenet, Stella M/H-6001-2018	Chenet, Stella M/0000-0002-5305-0664; Plucinski, Mateusz/0000-0002-7322-4625	CDC Advanced Molecular Detection Initiative; Atlanta Research and Education Foundation; American Society of Microbiology postdoctoral fellowship	CDC Advanced Molecular Detection Initiative; Atlanta Research and Education Foundation; American Society of Microbiology postdoctoral fellowship	The authors acknowledge funding support from the CDC Advanced Molecular Detection Initiative. ET is supported by the Atlanta Research and Education Foundation and SMC by the American Society of Microbiology postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], J INFECT DIS; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Collins W.E, 1971, PRIMATE MALARIAS, P366; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Gogtay N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008492.pub3; Kamau E., 2014, J INFECT DIS; Khim N, 2014, EMERG INFECT DIS, V20, P1637, DOI 10.3201/eid2010.140411; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Mohon A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-431; Na-Bangchang K, 2007, TOHOKU J EXP MED, V211, P99, DOI 10.1620/tjem.211.99; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Plucinski M.M., 2014, ANTIMICROB AGENTS CH; Popovici J, 2015, ANTIMICROB AGENTS CH, V59, P730, DOI 10.1128/AAC.03908-14; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789; Talundzic E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-31; Taylor SM, 2014, J INFECT DIS; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2020, REP ANT DRUG EFF RES; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006	31	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136099	10.1371/journal.pone.0136099	http://dx.doi.org/10.1371/journal.pone.0136099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292024	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900054
J	Hussein, MA; Shrestha, E; Ouimet, M; Barrett, TJ; Leone, S; Moore, KJ; Herault, Y; Fisher, EA; Garabedian, MJ				Hussein, Maryem A.; Shrestha, Elina; Ouimet, Mireille; Barrett, Tessa J.; Leone, Sarah; Moore, Kathryn J.; Herault, Yann; Fisher, Edward A.; Garabedian, Michael J.			LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; CHOLESTEROL EFFLUX; NUCLEAR RECEPTOR; ARGININE METHYLTRANSFERASE; GENE-EXPRESSION; RISK-FACTORS; X RECEPTOR; PROTEIN; ATHEROSCLEROSIS; METHYLATION	High cholesterol and diabetes are major risk factors for atherosclerosis. Regression of atherosclerosis is mediated in part by the Liver X Receptor (LXR) through the induction of genes involved in cholesterol transport and efflux. In the context of diabetes, regression of atherosclerosis is impaired. We proposed that changes in glucose levels modulate LXR-dependent gene expression. Using a mouse macrophage cell line (RAW 264.7) and primary bone marrow derived macrophages (BMDMs) cultured in normal or diabetes relevant high glucose conditions we found that high glucose inhibits the LXR-dependent expression of ATP-binding cassette transporter A1 (ABCA1), but not ABCG1. To probe for this mechanism, we surveyed the expression of a host of chromatin-modifying enzymes and found that Protein Arginine Methyltransferase 2 (PRMT2) was reduced in high compared to normal glucose conditions. Importantly, ABCA1 expression and ABCA1-mediated cholesterol efflux were reduced in Prmt2(-/-) compared to wild type BMDMs. Monocytes from diabetic mice also showed decreased expression of Prmt2 compared to non-diabetic counterparts. Thus, PRMT2 represents a glucose-sensitive factor that plays a role in LXR-mediated ABCA1-dependent cholesterol efflux and lends insight to the presence of increased atherosclerosis in diabetic patients.	[Hussein, Maryem A.; Shrestha, Elina; Leone, Sarah; Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ouimet, Mireille; Barrett, Tessa J.; Moore, Kathryn J.; Fisher, Edward A.] NYU, Sch Med, Dept Med, New York, NY USA; [Herault, Yann] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Herault, Yann] CNRS, UMR7104, Illkirch Graffenstaden, France; [Herault, Yann] INSERM, U964, Illkirch Graffenstaden, France; [Herault, Yann] Univ Strasbourg, Illkirch Graffenstaden, France; [Herault, Yann] ICS, F-67404 Illkirch Graffenstaden, France	New York University; New York University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Garabedian, MJ (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	michael.garabedian@nyumc.org	Herault, Yann/B-5500-2012; Moore, Kathryn/ABE-6416-2020; Fisher, Edward/ABE-7469-2020	Herault, Yann/0000-0001-7049-6900; Moore, Kathryn/0000-0003-2505-2547; Fisher, Edward/0000-0001-9802-143X; Barrett, Tessa/0000-0003-0751-1578	National Institutes of Health [T32AI07180, T32GM007238, R01DK095684, R01HL117226, T32 GM007308]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007238, T32GM007308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (www.NIH.gov) grants T32AI07180 (MAH), T32GM007238 (ES), R01DK095684 (TB and EAF), R01HL117226 (MJG and EAF). T32 GM007308 (MAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Chait A, 2009, J LIPID RES, V50, pS335, DOI 10.1194/jlr.R800059-JLR200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Costet P, 2000, J BIOL CHEM, V275, P28240; DORMAN JS, 1985, DIABETES CARE, V8, P54, DOI 10.2337/diacare.8.1.S54; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Gabbi C, 2014, BIOCHEM BIOPH RES CO, V446, P647, DOI 10.1016/j.bbrc.2013.11.077; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Iwasaki H, 2010, CIRC RES, V107, P992, DOI 10.1161/CIRCRESAHA.110.225326; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Le DD, 2012, CURR OPIN CHEM BIOL, V16, P507, DOI 10.1016/j.cbpa.2012.09.014; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Meyer R, 2007, J STEROID BIOCHEM, V107, P1, DOI 10.1016/j.jsbmb.2007.05.006; Miao F, 2013, PHYSIOL GENOMICS, V45, P287, DOI 10.1152/physiolgenomics.00001.2013; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moreno PR, 2000, CIRCULATION, V102, P2180; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; SMITHIES O, 1995, P NATL ACAD SCI USA, V92, P5266, DOI 10.1073/pnas.92.12.5266; Sparrow CP, 2002, J BIOL CHEM, V277, P10021, DOI 10.1074/jbc.M108225200; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Torra IP, 2008, MOL CELL BIOL, V28, P2626, DOI 10.1128/MCB.01575-07; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoshimoto T, 2006, EXP CELL RES, V312, P2040, DOI 10.1016/j.yexcr.2006.03.001; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	48	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135218	10.1371/journal.pone.0135218	http://dx.doi.org/10.1371/journal.pone.0135218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288135	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600040
J	Lakestani, N; Donaldson, ML				Lakestani, Nelly; Donaldson, Morag L.			Dog Bite Prevention: Effect of a Short Educational Intervention for Preschool Children	PLOS ONE			English	Article							BEHAVIOR; PERCEPTION; OWNERSHIP; INJURIES; PROGRAM	This study aimed to investigate whether preschool children can learn how to interpret dogs' behaviours, with the purpose of helping avoid dog bites. Three-to five-year-old children (N = 70) were tested on their ability to answer questions about dogs' emotional states before and after participating in either an educational intervention about dog behaviour (intervention group) or an activity about wild animals (control group). Children who had received training about dog behaviour (intervention group) were significantly better at judging the dogs' emotional states after the intervention compared to before. The frequency with which they referred to relevant behaviours in justifying their judgements also increased significantly. In contrast, the control group's performance did not differ significantly between the two testing times. These results indicate that preschool children can be taught how to correctly interpret dogs' behaviours. This implies that incorporating such training into prevention programmes may contribute to reducing dog bite incidents.	[Lakestani, Nelly] Univ Andres Bello, Escuela Med Vet, Fac Ecol & Recursos Nat, Santiago, Chile; [Donaldson, Morag L.] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland	Universidad Andres Bello; University of Edinburgh	Lakestani, N (corresponding author), Univ Andres Bello, Escuela Med Vet, Fac Ecol & Recursos Nat, Santiago, Chile.	nelly.lakestani@unab.cl						AMPOFOBOATENG K, 1991, BRIT J PSYCHOL, V82, P487, DOI 10.1111/j.2044-8295.1991.tb02415.x; AVMA, 2012, US PET OWN STAT DEM; Beard R.M., 2013, OUTLINE PIAGETS DEV, DOI [10.4324/9780203715765, DOI 10.4324/9780203715765]; BECK AM, 1985, PUBLIC HEALTH REP, V100, P315; Bernardo LM, 2002, PEDIATR EMERG CARE, V18, P247, DOI 10.1097/00006565-200206000-00024; Chapman S, 2000, BRIT MED J, V320, P1512, DOI 10.1136/bmj.320.7248.1512; De Keuster T, 2006, VET J, V172, P482, DOI 10.1016/j.tvjl.2005.04.024; Gilchrist J, 2008, INJURY PREV, V14, P296, DOI 10.1136/ip.2007.016220; GRIEVE R, 1985, BRIT J DEV PSYCHOL, V3, P385, DOI 10.1111/j.2044-835X.1985.tb00990.x; Guy NC, 2001, APPL ANIM BEHAV SCI, V74, P43, DOI 10.1016/S0168-1591(01)00155-1; Hill R, 2000, BRIT J DEV PSYCHOL, V18, P103, DOI 10.1348/026151000165607; Kahn A, 2004, EUR J PEDIATR, V163, P424, DOI 10.1007/s00431-004-1456-3; Kahn A, 2003, EUR J PEDIATR, V162, P254, DOI 10.1007/s00431-002-1130-6; Lakestani N.N., 2007, THESIS U EDINBURGH E; Lakestani NN, 2014, ANTHROZOOS, V27, P65, DOI 10.2752/175303714X13837396326413; Love M, 2001, J AM VET MED ASSOC, V219, P446, DOI 10.2460/javma.2001.219.446; Meints K, 2009, J PEDIATR PSYCHOL, V34, P1084, DOI 10.1093/jpepsy/jsp053; Mendez Gallart R, 2002, An Esp Pediatr, V56, P425; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Ozanne-Smith J, 2001, Inj Prev, V7, P321, DOI 10.1136/ip.7.4.321; Peak Karen, 2002, J Emerg Nurs, V28, P450, DOI 10.1067/men.2002.128404; Poresky RH, 1996, ANTHROZOOS, V9, P159, DOI 10.2752/089279396787001437; Reisner IR, 2011, INJURY PREV, V17, P348, DOI 10.1136/ip.2010.029868; Sacks J J, 1996, Inj Prev, V2, P52, DOI 10.1136/ip.2.1.52; Savino F, 2002, Minerva Pediatr, V54, P237; Schwebel DC, 2012, J PEDIATR PSYCHOL, V37, P272, DOI 10.1093/jpepsy/jsr102; Shen JB, 2013, INT J ENV RES PUB HE, V10, P950, DOI 10.3390/ijerph10030950; Spiegel IB, 2000, ANTHROZOOS, V13, P164, DOI 10.2752/089279300786999789; Thompson B, 2005, COMP CONT EDUC PRACT, V27, P328; VANHOUTTE BA, 1995, J APPL DEV PSYCHOL, V16, P463, DOI 10.1016/0193-3973(95)90030-6; Westgarth C, 2010, INT J ENV RES PUB HE, V7, P3704, DOI 10.3390/ijerph7103704; Wilson F, 2003, J COMMUNITY PSYCHOL, V31, P75, DOI 10.1002/jcop.10038	32	27	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134319	10.1371/journal.pone.0134319	http://dx.doi.org/10.1371/journal.pone.0134319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287686	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600019
J	Linsuwanon, P; Poovorawan, Y; Li, LL; Deng, XT; Vongpunsawad, S; Delwart, E				Linsuwanon, Piyada; Poovorawan, Yong; Li, Linlin; Deng, Xutao; Vongpunsawad, Sompong; Delwart, Eric			The Fecal Virome of Children with Hand, Foot, and Mouth Disease that Tested PCR Negative for Pathogenic Enteroviruses	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; HUMAN RHINOVIRUS C; COXSACKIEVIRUS A6; GENETIC DIVERSITY; ENTERIC VIRUSES; HUMAN BOCAVIRUS; SAFFOLD VIRUS; STOOL SAMPLES; 71 INFECTION; ASTROVIRUS	Hand, foot, and mouth disease (HFMD) affects infant and young children. A viral metagenomic approach was used to identify the eukaryotic viruses in fecal samples from 29 Thai children with clinical diagnosis of HFMD collected during the 2012 outbreak. These children had previously tested negative by PCR for enterovirus 71 and coxsackievirus A16 and A6. Deep sequencing revealed nine virus families: Picornaviridae, Astroviridae, Parvoviridae, Caliciviridae, Paramyxoviridae, Adenoviridae, Reoviridae, Picobirnaviridae, and Polyomaviridae. The highest number of viral sequences belonged to human rhinovirus C, astrovirus-MLB2, and coxsackievirus A21. Our study provides an overview of virus community and highlights a broad diversity of viruses found in feces from children with HFMD.	[Linsuwanon, Piyada; Poovorawan, Yong; Vongpunsawad, Sompong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Bangkok, Thailand; [Li, Linlin; Deng, Xutao; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Li, Linlin; Deng, Xutao; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Chulalongkorn University; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Ibrahim, Essam Hassan/G-1960-2018; Linsuwanon, Piyada/AAS-7642-2020	Ibrahim, Essam Hassan/0000-0003-0130-2257; vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807	Ratchadaphiseksomphot Endowment Fund; Blood Systems Research Institute (BSRI), NIH [R01 HL083254, R01HL105770]; Research Chair Grant National Science and Technology Development Agency (NSTDA); National Research University Project, Office of Higher Education Commission [HR1155A, WCU-001, 007-HR-57]; Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; MK Restaurant Company Limited; Siam Cement Pcl; King Chulalongkorn Memorial Hospital Thai Red Cross Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770, R01HL083254] Funding Source: NIH RePORTER	Ratchadaphiseksomphot Endowment Fund; Blood Systems Research Institute (BSRI), NIH; Research Chair Grant National Science and Technology Development Agency (NSTDA); National Research University Project, Office of Higher Education Commission; Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project; Outstanding Professor of the Thailand Research Fund; MK Restaurant Company Limited; Siam Cement Pcl; King Chulalongkorn Memorial Hospital Thai Red Cross Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This project described was supported by the Ratchadaphiseksomphot Endowment Fund to Dr. Piyada Linsuwanon; The Blood Systems Research Institute (BSRI), NIH R01 HL083254 and NIH R01HL105770 to Dr. Eric Delwart; The Research Chair Grant National Science and Technology Development Agency (NSTDA); the National Research University Project, Office of Higher Education Commission (HR1155A, WCU-001, 007-HR-57); the Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project (CU56-HR01); the Outstanding Professor of the Thailand Research Fund (DPG5480002); MK Restaurant Company Limited and The Siam Cement Pcl; and King Chulalongkorn Memorial Hospital Thai Red Cross Society to Professor Yong Poovorawan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Berciaud S, 2012, J CLIN VIROL, V54, P302, DOI 10.1016/j.jcv.2012.04.009; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Bouzalas IG, 2014, J CLIN MICROBIOL, V52, P3318, DOI 10.1128/JCM.01195-14; Cardosa MJ, 1999, LANCET, V354, P987, DOI 10.1016/S0140-6736(98)11032-2; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chen SY, 2013, PEDIATR INFECT DIS J, V32, P1335, DOI 10.1097/INF.0b013e3182a5f5b6; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; De Gascun CF, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/373579; Delwart E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003146; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Downing C, 2014, J CLIN VIROL, V60, P381, DOI 10.1016/j.jcv.2014.04.023; Drexler JF, 2010, J GEN VIROL, V91, P1418, DOI 10.1099/vir.0.018887-0; Dropulic LK, 2008, BONE MARROW TRANSPL, V41, P11, DOI 10.1038/sj.bmt.1705886; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Hall AJ, 2014, MMWR-MORBID MORTAL W, V63, P491; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harvala H, 2012, J MED VIROL, V84, P536, DOI 10.1002/jmv.23203; He B, 2013, PLOS ONE, V8, DOI [10.1371/annotation/68f77773-a2a0-4bfe-b5e6-950dc30b79f9, DOI 10.1371/ANNOTATION/68F77773-A2A0-4BFE-B5E6-950DC30B79F9]; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Holtz LR, 2014, CLIN VACCINE IMMUNOL, V21, P908, DOI 10.1128/CVI.00100-14; Holtz LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028647; Honkanen H, 2013, J CLIN VIROL, V56, P250, DOI 10.1016/j.jcv.2012.11.020; Hu YF, 2012, J VIROL, V86, P10901, DOI 10.1128/JVI.01808-12; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kim GY, 2004, CLIN GASTROENTEROL H, V2, P175, DOI 10.1016/S1542-3565(03)00316-1; King D, 2013, MMWR-MORBID MORTAL W, V62, P637; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Kung YA, 2014, EXPERT OPIN BIOL TH, V14, P1455, DOI 10.1517/14712598.2014.935330; Lau SKP, 2012, J CLIN VIROL, V53, P290, DOI 10.1016/j.jcv.2012.01.008; Lau SKP, 2009, J INFECT DIS, V200, P1096, DOI 10.1086/605697; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee HF, 2014, J CHILD NEUROL, V29, P1283, DOI 10.1177/0883073813516193; Li LL, 2013, EMERG INFECT DIS, V19, P1385, DOI 10.3201/eid1909.130682; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Lukashev AN, 2014, J GEN VIROL, V95, P868, DOI 10.1099/vir.0.060004-0; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Martinez M, 2014, INFECT GENET EVOL, V27, P402, DOI 10.1016/j.meegid.2014.08.015; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; McIntyre Mary G., 2012, Morbidity and Mortality Weekly Report, V61, P213; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mori D, 2013, EMERG INFECT DIS, V19, P1859, DOI 10.3201/eid1911.121548; Naeem A, 2014, J GEN VIROL, V95, P1945, DOI 10.1099/vir.0.066498-0; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nielsen ACY, 2013, J CLIN VIROL, V57, P239, DOI 10.1016/j.jcv.2013.03.015; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Petrogiannis-Haliotis T, 2001, NEW ENGL J MED, V345, P1250, DOI 10.1056/NEJMoa010319; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Puenpa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098888; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rovida F, 2013, DIAGN MICR INFEC DIS, V77, P231, DOI 10.1016/j.diagmicrobio.2013.07.020; Samphutthanon R, 2014, INT J ENV RES PUB HE, V11, P312, DOI 10.3390/ijerph110100312; Savolainen-Kopra C, 2013, J MED VIROL, V85, P1466, DOI 10.1002/jmv.23593; Schibler M, 2012, J GEN VIROL, V93, P93, DOI 10.1099/vir.0.035808-0; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tian HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084233; Tokarz R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-288; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Vanchiere JA, 2009, J CLIN MICROBIOL, V47, P2388, DOI 10.1128/JCM.02472-08; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Wong ASY, 2009, BONE MARROW TRANSPL, V43, P43, DOI 10.1038/bmt.2008.266; Wu JM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e26; Wurzel DF, 2014, CLIN INFECT DIS, V59, P34, DOI 10.1093/cid/ciu225; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485; Zhang XA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07704; Zhang XA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-606; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	108	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135573	10.1371/journal.pone.0135573	http://dx.doi.org/10.1371/journal.pone.0135573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288145	gold, Green Submitted, Green Published			2022-12-27	WOS:000360018600055
J	Zhang, P; Guo, ZY; Wu, Y; Hu, RL; Du, J; He, XS; Jiao, XY; Zhu, XF				Zhang, Peng; Guo, Zhiyong; Wu, Ying; Hu, Ronglin; Du, Jun; He, Xiaoshun; Jiao, Xingyuan; Zhu, Xiaofeng			Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling	PLOS ONE			English	Article							CANCER-THERAPY; MTOR; PATHWAY; SAHA; TRANSLATION; RESECTION; GROWTH; PTEN	Gallbladder carcinoma is an aggressive malignancy with high mortality mainly due to the limited potential for curative resection and its resistance to chemotherapeutic agents. Here, we show that the histone deacetylase inhibitors (HDACIs) trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA) reduce the proliferation and induce apoptosis of gallbladder carcinoma cells by suppressing the AKT/mammalian target of rapamycin (mTOR) signaling. Gallbladder carcinoma SGC-996 cells were treated with different concentrations of TSA and SAHA for different lengths of time. Cell proliferation and morphology were assessed with MTT assay and microscopy, respectively. Cell cycle distribution and cell apoptosis were analyzed with flow cytometry. Western blotting was used to detect the proteins related to apoptosis, cell cycle, and the AKT/mTOR signaling pathway. Our data showed that TSA and SAHA reduced SGC-996 cell viability and arrested cell cycle at the G1 phase in a dose-and time-dependent manner. TSA and SAHA promoted apoptosis of SGC-996 cells, down-regulated the expression of cyclin D1, c-Myc and Bmi1, and decreased the phosphorylation of AKT, mTOR p70S6K1, S6 and 4E-BP1. Additionally, the mTOR inhibitor rapamycin further reduced the cell viability of TSA-and SAHA-treated SGC-996 cells and the phosphorylation of mTOR, whereas the mTOR activator 1,2-dioctanoyl-sn-glycero-3-phosphate (C8-PA) exerted the opposite influence. Our results demonstrate that histone deacetylase inhibitors (HDACIs) suppress the proliferation of gallbladder carcinoma cell via inhibition of AKT/mTOR signaling. These findings offer a mechanistic rationale for the application of HDACIs in gallbladder carcinoma treatment.	[Zhang, Peng; Guo, Zhiyong; Hu, Ronglin; He, Xiaoshun; Jiao, Xingyuan; Zhu, Xiaofeng] Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Ying] Sun Yat Sen Univ, Dept Biostat, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Du, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Jiao, XY (corresponding author), Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	jiaoxingyuan@hotmail.com; 740803277@qq.com			National Natural Science Foundation of China [81270531, 81071984]; Natural Science Foundation of Guangdong Province of China [2009B030801371]; Specialized Research Fund for the Doctoral Thesis Program of Higher Education in China [20120171110073]; Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology [2013A061401007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Thesis Program of Higher Education in China; Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology	This study was supported by grants from the National Natural Science Foundation of China (No. 81270531 and 81071984), the Natural Science Foundation of Guangdong Province of China (No. 2009B030801371), the Specialized Research Fund for the Doctoral Thesis Program of Higher Education in China (No. 20120171110073) and the Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology (No. 2013A061401007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren-Sandberg A, 2014, CURR OPIN GASTROEN, V30, P326, DOI 10.1097/MOG.0000000000000068; Bajbouj K, 2012, J NEURO-ONCOL, V107, P503, DOI 10.1007/s11060-011-0791-2; Bartlett DL, 1996, ANN SURG, V224, P639, DOI 10.1097/00000658-199611000-00008; Batra Y, 2005, J GASTROEN HEPATOL, V20, P309, DOI 10.1111/j.1440-1746.2005.03576.x; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; Burgess A, 2004, ONCOGENE, V23, P6693, DOI 10.1038/sj.onc.1207893; Butte JM, 2011, J AM COLL SURGEONS, V212, P50, DOI 10.1016/j.jamcollsurg.2010.09.009; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chao OS, 2014, MOL CANC RES; Coburn NG, 2008, J AM COLL SURGEONS, V207, P371, DOI 10.1016/j.jamcollsurg.2008.02.031; Czito BG, 2005, INT J RADIAT ONCOL, V62, P1030, DOI 10.1016/j.ijrobp.2004.12.059; Duvic M, 2007, BIOL-TARGETS THER, V1, P377; Ellis L, 2013, ONCOTARGET, V4, P2225, DOI 10.18632/oncotarget.1314; Erlich RB, 2012, BRIT J CANCER, V106, P107, DOI 10.1038/bjc.2011.495; Gupta M, 2009, BLOOD, V114, P2926, DOI 10.1182/blood-2009-05-220889; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Huang WJ, 2011, J ETHNOPHARMACOL, V136, P156, DOI 10.1016/j.jep.2011.04.034; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kitamura T, 2012, J HEPATOL, V57, P84, DOI 10.1016/j.jhep.2012.01.018; Lin W, 2012, CANCER LETT, V314, P127, DOI 10.1016/j.canlet.2011.09.004; Monneret C, 2007, ANTI-CANCER DRUG, V18, P363, DOI 10.1097/CAD.0b013e328012a5db; Mwakwari SC, 2010, CURR TOP MED CHEM, V10, P1423; Nishioka C, 2008, LEUKEMIA, V22, P2159, DOI 10.1038/leu.2008.243; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi J, 2010, CANCER SCI, V101, P355, DOI 10.1111/j.1349-7006.2009.01387.x; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhang P, 2013, ONCOL REP, V29, P269, DOI 10.3892/or.2012.2073	32	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136193	10.1371/journal.pone.0136193	http://dx.doi.org/10.1371/journal.pone.0136193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287365	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600120
J	Cai, YP; Chen, L; Liu, XJ; Sun, S; Wu, CX; Jiang, BJ; Han, TF; Hou, WS				Cai, Yupeng; Chen, Li; Liu, Xiujie; Sun, Shi; Wu, Cunxiang; Jiang, Bingjun; Han, Tianfu; Hou, Wensheng			CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots	PLOS ONE			English	Article							CRISPR-CAS SYSTEM; TARGETED MUTAGENESIS; AGROBACTERIUM-RHIZOGENES; HOMOLOGOUS RECOMBINATION; MEDIATED TRANSFORMATION; GLYCINE-MAX; GUIDE RNA; PLANTS; GENE; RICE	As a new technology for gene editing, the CRISPR (clustered regularly interspaced short palindromic repeat)/Cas (CRISPR-associated) system has been rapidly and widely used for genome engineering in various organisms. In the present study, we successfully applied type II CRISPR/Cas9 system to generate and estimate genome editing in the desired target genes in soybean (Glycine max (L.) Merrill.). The single-guide RNA (sgRNA) and Cas9 cassettes were assembled on one vector to improve transformation efficiency, and we designed a sgRNA that targeted a transgene (bar) and six sgRNAs that targeted different sites of two endogenous soybean genes (GmFEI2 and GmSHR). The targeted DNA mutations were detected in soybean hairy roots. The results demonstrated that this customized CRISPR/Cas9 system shared the same efficiency for both endogenous and exogenous genes in soybean hairy roots. We also performed experiments to detect the potential of CRISPR/Cas9 system to simultaneously edit two endogenous soybean genes using only one customized sgRNA. Overall, generating and detecting the CRISPR/Cas9-mediated genome modifications in target genes of soybean hairy roots could rapidly assess the efficiency of each target loci. The target sites with higher efficiencies can be used for regular soybean transformation. Furthermore, this method provides a powerful tool for root-specific functional genomics studies in soybean.	[Cai, Yupeng; Chen, Li; Liu, Xiujie; Sun, Shi; Wu, Cunxiang; Jiang, Bingjun; Han, Tianfu; Hou, Wensheng] Chinese Acad Agr Sci, Key Lab Soybean Biol Beijing, Inst Crop Sci, Minist Agr, Beijing 100081, Peoples R China; [Cai, Yupeng; Chen, Li; Liu, Xiujie; Hou, Wensheng] Chinese Acad Agr Sci, Inst Crop Sci, Natl Ctr Transgen Res Plants, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Hou, WS (corresponding author), Chinese Acad Agr Sci, Key Lab Soybean Biol Beijing, Inst Crop Sci, Minist Agr, Beijing 100081, Peoples R China.	houwensheng@caas.cn	Jiang, Bingjun/GWQ-4354-2022		Major Science and Technology Projects of China [2014ZX08010-004]; CAAS (Chinese Academy of Agriculture Sciences) Innovation Project	Major Science and Technology Projects of China; CAAS (Chinese Academy of Agriculture Sciences) Innovation Project	This work was supported by Major Science and Technology Projects of China (2014ZX08010-004) and the CAAS (Chinese Academy of Agriculture Sciences) Innovation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVAN MW, 1982, ANNU REV GENET, V16, P357, DOI 10.1146/annurev.ge.16.120182.002041; Cao D, 2011, PLANT CELL TISS ORG, V107, P541, DOI 10.1007/s11240-011-0005-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jian B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-78; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Meyer JDF, 2009, PLANT PHYSIOL, V150, P295, DOI 10.1104/pp.108.134551; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nakano M, 2014, PLANT CELL PHYSIOL, V55, P1763, DOI 10.1093/pcp/pcu107; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Olhoft PM, 2006, METH MOL B, V343, P385; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Taylor CG, 2006, METH MOL B, V343, P155; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Wang GL, 2008, PLANT CELL REP, V27, P1177, DOI 10.1007/s00299-008-0535-8; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	32	120	140	4	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136064	10.1371/journal.pone.0136064	http://dx.doi.org/10.1371/journal.pone.0136064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284791	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100099
J	Khan, W; Aguilar, C; Kiddle, SJ; Doyle, O; Thambisetty, M; Muehlboeck, S; Sattlecker, M; Newhouse, S; Lovestone, S; Dobson, R; Giampietro, V; Westman, E; Simmons, A				Khan, Wasim; Aguilar, Carlos; Kiddle, Steven J.; Doyle, Orla; Thambisetty, Madhav; Muehlboeck, Sebastian; Sattlecker, Martina; Newhouse, Stephen; Lovestone, Simon; Dobson, Richard; Giampietro, Vincent; Westman, Eric; Simmons, Andrew		Alzheimer's Dis Neuroimaging Initi	A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ACID-BINDING PROTEIN; CHROMOGRANIN-A; CSF BIOMARKERS; MCI PATIENTS; MRI MEASURES; PATTERNS; NEURODEGENERATION; ADNI	In this exploratory neuroimaging-proteomic study, we aimed to identify CSF proteins associated with AD and test their prognostic ability for disease classification and MCI to AD conversion prediction. Our study sample consisted of 295 subjects with CSF multi-analyte panel data and MRI at baseline downloaded from ADNI. Firstly, we tested the statistical effects of CSF proteins (n = 83) to measures of brain atrophy, CSF biomarkers, ApoE genotype and cognitive decline. We found that several proteins (primarily CgA and FABP) were related to either brain atrophy or CSF biomarkers. In relation to ApoE genotype, a unique biochemical profile characterised by low CSF levels of Apo E was evident in epsilon 4 carriers compared to epsilon 3 carriers. In an exploratory analysis, 3/83 proteins (SGOT, MCP-1, IL6r) were also found to be mildly associated with cognitive decline in MCI subjects over a 4-year period. Future studies are warranted to establish the validity of these proteins as prognostic factors for cognitive decline. For disease classification, a subset of proteins (n = 24) combined with MRI measurements and CSF biomarkers achieved an accuracy of 95.1% (Sensitivity 87.7%; Specificity 94.3%; AUC 0.95) and accurately detected 94.1% of MCI subjects progressing to AD at 12 months. The subset of proteins included FABP, CgA, MMP-2, and PPP as strong predictors in the model. Our findings suggest that the marker of panel of proteins identified here may be important candidates for improving the earlier detection of AD. Further targeted proteomic and longitudinal studies would be required to validate these findings with more generalisability.	[Khan, Wasim; Kiddle, Steven J.; Doyle, Orla; Muehlboeck, Sebastian; Sattlecker, Martina; Newhouse, Stephen; Dobson, Richard; Giampietro, Vincent; Westman, Eric; Simmons, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Khan, Wasim; Kiddle, Steven J.; Muehlboeck, Sebastian; Sattlecker, Martina; Newhouse, Stephen; Dobson, Richard; Simmons, Andrew] NIHR Biomed Res Ctr Mental Hlth, London, England; [Khan, Wasim; Muehlboeck, Sebastian; Dobson, Richard; Simmons, Andrew] NIHR Biomed Res Unit Dementia, London, England; [Aguilar, Carlos; Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Thambisetty, Madhav] NIA, Lab Behav Neurosci, NIH, Baltimore, MD 21224 USA; [Lovestone, Simon] Univ Oxford, Dept Psychiat, Oxford, England	University of London; King's College London; University of London; King's College London; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oxford	Khan, W (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.	wasim.khan@kcl.ac.uk	Aguilar, Carlos/AAQ-9837-2021; Simmons, Andrew/B-8848-2008; Westman, Eric/H-5771-2011; Giampietro, Vincent P/D-1279-2011; dobson, richard/C-9269-2011	Aguilar, Carlos/0000-0003-4321-2516; Simmons, Andrew/0000-0003-2306-5811; Westman, Eric/0000-0002-3115-2977; Giampietro, Vincent P/0000-0002-9381-8201; Lovestone, Simon/0000-0003-0473-4565; Doyle, Orla/0000-0002-6964-0140; Kiddle, Steven/0000-0003-4350-7437; dobson, richard/0000-0003-4224-9245; Newhouse, Stephen/0000-0002-1843-9842; Khan, Wasim/0000-0002-4489-4945	ADNI from National Institutes of Health [U01 393 AG024904]; NIHR Biomedical Research Centre for Mental Health; NIHR Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Alzheimer's Research UK; National Institutes of Health [P30 AG010129, K01 AG030514]; Dana Foundation; MRC [MR/L011859/1] Funding Source: UKRI; Alzheimers Research UK [ART-PG2010-4] Funding Source: researchfish; Medical Research Council [MR/L011859/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10053] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000200, P30AG010129, P50AG005146, K01AG030514] Funding Source: NIH RePORTER	ADNI from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London(General Electric); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project were funded by the ADNI (grant U01 393 AG024904 from the National Institutes of Health). This study was supported by funds from the NIHR Biomedical Research Centre for Mental Health and NIHR Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, and Alzheimer's Research UK. This research was also supported by grants P30 AG010129 and K01 AG030514 from the National Institutes of Health and by the Dana Foundation.	Aguilar C, 2013, PSYCHIAT RES-NEUROIM, V212, P89, DOI 10.1016/j.pscychresns.2012.11.005; Apostolova LG, 2010, NEUROBIOL AGING, V31, P1284, DOI 10.1016/j.neurobiolaging.2010.05.003; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; BLENNOW K, 1995, DEMENTIA, V6, P306, DOI 10.1159/000106963; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chiasserini D, 2010, J ALZHEIMERS DIS, V22, P1281, DOI 10.3233/JAD-2010-101293; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Davatzikos C, 2010, NEUROBIOL AGING; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Fagan AM, 2012, BIOMARK MED, V6, P455, DOI [10.2217/bmm.12.42, 10.2217/BMM.12.42]; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2014, LANCET NEUROL, V13, P997, DOI 10.1016/S1474-4422(14)70194-2; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012; Mattsson N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.69; Mattsson N, 2014, NEUROBIOL AGING, V35, P614, DOI 10.1016/j.neurobiolaging.2013.08.027; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Olsson B, 2013, J ALZHEIMERS DIS, V34, P673, DOI 10.3233/JAD-121384; Paterson RW, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.58; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Scholkopf B., 2002, LEARNING KERNELS; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Taylor DL, 2002, J NEUROCHEM, V82, P1179, DOI 10.1046/j.1471-4159.2002.01062.x; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westman E, 2011, NEUROIMAGE, V58, P818, DOI 10.1016/j.neuroimage.2011.06.065; Westman E, 2011, NEUROIMAGE, V54, P1178, DOI 10.1016/j.neuroimage.2010.08.044; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	47	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134368	10.1371/journal.pone.0134368	http://dx.doi.org/10.1371/journal.pone.0134368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284520	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100009
J	McDonald, LM; Griffin, HJ; Angeli, A; Torkamani, M; Georgiev, D; Jahanshahi, M				McDonald, Louise M.; Griffin, Harry J.; Angeli, Aikaterini; Torkamani, Mariam; Georgiev, Dejan; Jahanshahi, Marjan			Motivational Modulation of Self-Initiated and Externally Triggered Movement Speed Induced by Threat of Shock: Experimental Evidence for Paradoxical Kinesis in Parkinson's Disease	PLOS ONE			English	Article							MOTOR URGENCY; TIME; INVENTORY; BRAIN; DEPRESSION; DOPAMINE; ANXIETY	Background Paradoxical kinesis has been observed in bradykinetic people with Parkinson's disease. Paradoxical kinesis occurs in situations where an individual is strongly motivated or influenced by relevant external cues. Our aim was to induce paradoxical kinesis in the laboratory. We tested whether the motivation of avoiding a mild electric shock was sufficient to induce paradoxical kinesis in externally-triggered and self-initiated conditions in people with Parkinson's disease tested on medication and in age-matched controls. Methods Participants completed a shock avoidance behavioural paradigm in which half of the trials could result in a mild electric shock if the participant did not move fast enough. Half of the trials of each type were self-initiated and half were externally-triggered. The criterion for avoiding shock was a maximum movement time, adjusted according to each participant's performance on previous trials using a staircase tracking procedure. Results On trials with threat of shock, both patients with Parkinson's disease and controls had faster movement times compared to no potential shock trials, in both self-initiated and externally-triggered conditions. The magnitude of improvement of movement time from no potential shock to potential shock trials was positively correlated with anxiety ratings. Conclusions When motivated to avoid mild electric shock, patients with Parkinson's disease, similar to healthy controls, showed significant speeding of movement execution. This was observed in both self-initiated and externally-triggered versions of the task. Nevertheless, in the ET condition the improvement of reaction times induced by motivation to avoid shocks was greater for the PD patients than controls, highlighting the value of external cues for movement initiation in PD patients. The magnitude of improvement from the no potential shock to the potential shock trials was associated with the threat-induced anxiety. This demonstration of paradoxical kinesis in the laboratory under both self-initiated and externally-triggered conditions has implications for motivational and attentional enhancement of movement speed in Parkinson's disease.	[McDonald, Louise M.; Griffin, Harry J.; Angeli, Aikaterini; Torkamani, Mariam; Georgiev, Dejan; Jahanshahi, Marjan] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England	University of London; University College London	Jahanshahi, M (corresponding author), UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	m.jahanshah@ucl.ac.uk		Georgiev, Dejan/0000-0003-1832-3441	European Commission Ambient Assisted Living Programme; Parkinson's UK; Medical Research Council (MRC) grant	European Commission Ambient Assisted Living Programme; Parkinson's UK(Parkinson's UK); Medical Research Council (MRC) grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LMM and MT were funded by a grant from the European Commission Ambient Assisted Living Programme. HJG was funded by a project grant from Parkinson's UK, and DG was funded by a Medical Research Council (MRC) grant.	AUERBACH SM, 1974, J GENET PSYCHOL, V124, P187, DOI 10.1080/00221325.1974.10532280; Ballanger B, 2008, J NEUROL NEUROSUR PS, V79, P1110, DOI 10.1136/jnnp.2007.141689; Ballanger B, 2006, MOVEMENT DISORD, V21, P1490, DOI 10.1002/mds.20987; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bonanni L, 2010, NEUROL SCI, V31, P751, DOI 10.1007/s10072-010-0403-5; Chase HW, 2011, J COGNITIVE NEUROSCI, V23, P936, DOI 10.1162/jocn.2010.21456; Clark J, 2006, CAN ADRENALINE HELP; Crucian GP, 2001, NEUROLOGY, V56, P159, DOI 10.1212/WNL.56.2.159; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; FitzGerald M.J.T., 2011, CLIN NEUROANATOMY NE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLICKSTEIN M, 1991, TRENDS NEUROSCI, V14, P480, DOI 10.1016/0166-2236(91)90055-Y; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hall AJ, 1927, LANCET NEUROL, V12, P1009; Hanakawa T, 1999, ANN NEUROL, V45, P329, DOI 10.1002/1531-8249(199903)45:3<329::AID-ANA8>3.0.CO;2-S; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; JAHANSHAHI M, 1992, BRAIN, V115, P539, DOI 10.1093/brain/115.2.539; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kojovic M, 2014, J NEUROL, V261, P1080, DOI 10.1007/s00415-014-7315-x; LEVIN BE, 1988, J NEUROL NEUROSUR PS, V51, P1401, DOI 10.1136/jnnp.51.11.1401; LINDMAN R, 1975, SCAND J PSYCHOL, V16, P65, DOI 10.1111/j.1467-9450.1975.tb00165.x; Luria A.R, 1932, NATURE HUMAN CONFLIC; Majsak MJ, 2008, EXP NEUROL, V210, P479, DOI 10.1016/j.expneurol.2007.11.023; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mir P, 2011, EXP BRAIN RES, V209, P551, DOI 10.1007/s00221-011-2583-5; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Purdon-Martin J, 1967, BASAL GANGLIA POSTUR; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Robinson OJ, 2011, COGN AFFECT BEHAV NE, V11, P217, DOI 10.3758/s13415-011-0030-5; Sacks O, 1991, AWAKENINGS; Schmidt L, 2009, J NEUROSCI, V29, P9450, DOI 10.1523/JNEUROSCI.1951-09.2009; Shiner T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047138; Siegert RJ, 2002, J CLIN EXP NEUROPSYC, V24, P146, DOI 10.1076/jcen.24.2.146.991; Souques A, 1921, REV NEUROL, V37, P559, DOI DOI 10.1002/MDS.20281; Thobois S, 2007, NEUROIMAGE, V37, P243, DOI 10.1016/j.neuroimage.2007.04.049	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135149	10.1371/journal.pone.0135149	http://dx.doi.org/10.1371/journal.pone.0135149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26284366	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100024
J	Reijnierse, EM; Trappenburg, MC; Leter, MJ; Blauw, GJ; de van der Schueren, MAE; Meskers, CGM; Maier, AB				Reijnierse, Esmee M.; Trappenburg, Marijke C.; Leter, Morena J.; Blauw, Gerard Jan; de van der Schueren, Marian A. E.; Meskers, Carel G. M.; Maier, Andrea B.			The Association between Parameters of Malnutrition and Diagnostic Measures of Sarcopenia in Geriatric Outpatients	PLOS ONE			English	Article							LOWER-EXTREMITY PERFORMANCE; BODY-COMPOSITION; MUSCLE MASS; PHYSICAL PERFORMANCE; FUNCTIONAL IMPAIRMENT; OLDER PERSONS; LEAN MASS; WOMEN; CONSENSUS; STRENGTH	Objectives Diagnostic criteria for sarcopenia include measures of muscle mass, muscle strength and physical performance. Consensus on the definition of sarcopenia has not been reached yet. To improve insight into the most clinically valid definition of sarcopenia, this study aimed to compare the association between parameters of malnutrition, as a risk factor in sarcopenia, and diagnostic measures of sarcopenia in geriatric outpatients. Material and Methods This study is based on data from a cross-sectional study conducted in a geriatric outpatient clinic including 185 geriatric outpatients (mean age 82 years). Parameters of malnutrition included risk of malnutrition (assessed by the Short Nutritional Assessment Questionnaire), loss of appetite, unintentional weight loss and underweight (body mass index <22 kg/m(2)). Diagnostic measures of sarcopenia included relative musclemass (lean mass and appendicular lean mass [ALM] as percentages), absolute muscle mass (total lean mass and ALM/height(2)), handgrip strength and walking speed. All diagnostic measures of sarcopenia were standardized. Associations between parameters of malnutrition (independent variables) and diagnostic measures of sarcopenia (dependent variables) were analysed using multivariate linear regression models adjusted for age, body mass, fat mass and height in separate models. Results None of the parameters of malnutrition was consistently associated with diagnostic measures of sarcopenia. The strongest associations were found for both relative and absolute muscle mass; less stronger associations were found for muscle strength and physical performance. Underweight (p = < 0.001) and unintentional weight loss (p = 0.031) were most strongly associated with higher lean mass percentage after adjusting for age. Loss of appetite (p = 0.003) and underweight (p = 0.021) were most strongly associated with lower total lean mass after adjusting for age and fat mass. Conclusion Parameters of malnutrition relate differently to diagnostic measures of sarcopenia in geriatric outpatients. The association between parameters of malnutrition and diagnostic measures of sarcopenia was strongest for both relative and absolute muscle mass, while less strong associations were found with muscle strength and physical performance.	[Reijnierse, Esmee M.; Trappenburg, Marijke C.; Leter, Morena J.; Maier, Andrea B.] Vrije Univ Amsterdam Med Ctr, Sect Gerontol & Geriatr, Dept Internal Med, Amsterdam, Netherlands; [Trappenburg, Marijke C.] Amstelland Hosp, Dept Internal Med, Amstelveen, Netherlands; [Blauw, Gerard Jan] Leiden Univ Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Blauw, Gerard Jan] Bronovo Hosp, Dept Geriatr, The Hague, Netherlands; [de van der Schueren, Marian A. E.] Vrije Univ Amsterdam Med Ctr, Sect Nutr & Dietet, Dept Internal Med, Amsterdam, Netherlands; [de van der Schueren, Marian A. E.] HAN Univ Appl Sci, Fac Hlth & Social Studies, Dept Nutr Sports & Hlth, Nijmegen, Netherlands; [Meskers, Carel G. M.] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Haaglanden Medical Center; Bronovo Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Maier, AB (corresponding author), Vrije Univ Amsterdam Med Ctr, Sect Gerontol & Geriatr, Dept Internal Med, Amsterdam, Netherlands.	a.maier@vumc.nl	Blauw, Gerard/GWD-1079-2022; Maier, Andrea B./Q-5548-2019; Blauw, Gerard/AAW-7904-2021; Maier, Andrea/W-7060-2019; de van der Schueren, Marian A.E./AAM-5713-2021	Maier, Andrea/0000-0001-7206-1724; de van der Schueren, Marian A.E./0000-0001-5693-0811; Reijnierse, Esmee M./0000-0002-4197-4800; Meskers, Carel/0000-0002-5056-5611	MYOAGE [HEALTH-2007-2.4.5-10]; Dutch Technology Foundation STW, Netherlands Organization for Scientific Research; Ministry of Economic Affairs, Agriculture, and Innovation	MYOAGE; Dutch Technology Foundation STW, Netherlands Organization for Scientific Research; Ministry of Economic Affairs, Agriculture, and Innovation	This study was supported by the seventh framework program MYOAGE (HEALTH-2007-2.4.5-10), and by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research, and partly funded by the Ministry of Economic Affairs, Agriculture, and Innovation.	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Baumgartner RN, 1995, J GERONTOL A-BIOL, V50, P307; Bijlsma AY, 2014, AGE, V36, P275, DOI 10.1007/s11357-013-9556-5; Bijlsma AY, 2013, AGE, V35, P2367, DOI 10.1007/s11357-013-9516-0; Bijlsma AY, 2013, OSTEOPOROSIS INT, V24, P2681, DOI 10.1007/s00198-013-2376-8; Bijlsma AY, 2013, AGE, V35, P871, DOI 10.1007/s11357-012-9384-z; Bijlsma AY, 2013, J AM MED DIR ASSOC, V14, P493, DOI 10.1016/j.jamda.2013.02.001; Boirie Y, 2014, MECH AGEING DEV, V136, P76, DOI 10.1016/j.mad.2014.01.008; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Estrada M, 2007, J AM GERIATR SOC, V55, P1712, DOI 10.1111/j.1532-5415.2007.01436.x; Ferreira RS, 2013, GERIATR NURS, V34, P465, DOI 10.1016/j.gerinurse.2013.07.013; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guerra RS, 2015, JPEN-PARENTER ENTER, V39, P322, DOI 10.1177/0148607113514113; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Houston DK, 2008, AM J CLIN NUTR, V87, P150, DOI 10.1093/ajcn/87.1.150; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kruizenga HM, 2005, CLIN NUTR, V24, P75, DOI 10.1016/j.clnu.2004.07.015; Landi F, 2010, J AM MED DIR ASSOC, V11, P268, DOI 10.1016/j.jamda.2009.12.088; Lebrun CEI, 2006, MENOPAUSE, V13, P474, DOI 10.1097/01.gme.0000222331.23478.ec; Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001; Martone AM, 2013, NUTRIENTS, V5, P4126, DOI 10.3390/nu5104126; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Rosenberg IH, 1997, J NUTR, V127, P990, DOI DOI 10.1016/J.CGER.2011.03.003; Schilp J, 2011, NED TIJDSCHR EVID BA, V9, P18; Sergi G, 2002, J GERONTOL A-BIOL, V57, pM302, DOI 10.1093/gerona/57.5.M302; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Tolea MI, 2010, J GERONTOL B-PSYCHOL, V65, P174, DOI 10.1093/geronb/gbp130; van Bokhorst-de van der Schueren MAE, 2013, CLIN NUTR, V32, P1007, DOI 10.1016/j.clnu.2013.05.007; Vasunilashorn S, 2009, J GERONTOL A-BIOL, V64, P223, DOI 10.1093/gerona/gln022; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Welch AA, 2014, P NUTR SOC, V73, P16, DOI 10.1017/S0029665113003698; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	39	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135933	10.1371/journal.pone.0135933	http://dx.doi.org/10.1371/journal.pone.0135933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284368	Green Published, gold			2022-12-27	WOS:000359666100088
J	Zheng, R; Yao, CW; Jin, H; Zhu, L; Zhang, Q; Deng, W				Zheng, Ran; Yao, Chuanwei; Jin, Hai; Zhu, Lei; Zhang, Qin; Deng, Wei			Parallel Key Frame Extraction for Surveillance Video Service in a Smart City	PLOS ONE			English	Article								Surveillance video service (SVS) is one of the most important services provided in a smart city. It is very important for the utilization of SVS to provide design efficient surveillance video analysis techniques. Key frame extraction is a simple yet effective technique to achieve this goal. In surveillance video applications, key frames are typically used to summarize important video content. It is very important and essential to extract key frames accurately and efficiently. A novel approach is proposed to extract key frames from traffic surveillance videos based on GPU (graphics processing units) to ensure high efficiency and accuracy. For the determination of key frames, motion is a more salient feature in presenting actions or events, especially in surveillance videos. The motion feature is extracted in GPU to reduce running time. It is also smoothed to reduce noise, and the frames with local maxima of motion information are selected as the final key frames. The experimental results show that this approach can extract key frames more accurately and efficiently compared with several other methods.	[Zheng, Ran; Yao, Chuanwei; Jin, Hai; Zhu, Lei; Zhang, Qin; Deng, Wei] Huazhong Univ Sci & Technol, Serv Comp Technol & Syst Lab, Cluster & Grid Comp Lab, Sch Comp Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Jin, H (corresponding author), Huazhong Univ Sci & Technol, Serv Comp Technol & Syst Lab, Cluster & Grid Comp Lab, Sch Comp Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	hjin@hust.edu.cn		Zhu, Lei/0000-0002-2993-7142	National 863 Basic Research Program of China [2012AA01A306]; National Natural Science Foundation of China [61133008]	National 863 Basic Research Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National 863 Basic Research Program of China under grant No. 2012AA01A306, and the National Natural Science Foundation of China, under grant No. 61133008.	Bhatt HS, 2014, IEEE T INF FOREN SEC, V9, P1056, DOI 10.1109/TIFS.2014.2318433; Chang J, 2009, INT C METH MOD COMP, P1; Chen WN, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-4, P697; Gao XB, 2009, PATTERN RECOGN LETT, V30, P140, DOI 10.1016/j.patrec.2008.02.009; Goyette N., 2012, 2012 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), DOI 10.1109/CVPRW.2012.6238919; Hu WM, 2011, IEEE T SYST MAN CY C, V41, P797, DOI 10.1109/TSMCC.2011.2109710; Kehoe P, 2007, P 8 INT WORKSH IM AN, P15; Kuanar SK, 2013, J VIS COMMUN IMAGE R, V24, P1212, DOI 10.1016/j.jvcir.2013.08.003; Liu YX, 2009, INT PARALL DISTRIB P, P74; Merrill DG, 2010, PACT 2010: PROCEEDINGS OF THE NINETEENTH INTERNATIONAL CONFERENCE ON PARALLEL ARCHITECTURES AND COMPILATION TECHNIQUES, P545, DOI 10.1145/1854273.1854344; Omidyeganeh M., 2010, Proceedings of the 2010 IEEE Workshop on Signal Processing Systems (SiPS 2010), P128, DOI 10.1109/SIPS.2010.5624775; Patel BV., 2012, INT J UBICOMP, V3, P13, DOI [10.5121/iju.2012.3202, DOI 10.5121/IJU.2012.3202]; Quast K, 2010, VISAPP 2010: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 1, P413; Ran Zheng, 2015, CAMPUS ROAD SURVEILL, DOI [http://dx.doi.org/10.6084/m9.figshare.1500802, DOI 10.6084/M9.FIGSHARE.1500802]; Sun ZH, 2008, 2008 FOURTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, PROCEEDINGS, P196, DOI 10.1109/IIH-MSP.2008.245; Truong BT, 2007, ACM T MULTIM COMPUT, V3, DOI 10.1145/1198302.1198305; Yang Y, 2011, P AM MATH SOC, V139, P3171, DOI 10.1090/S0002-9939-2011-10735-4; Zhang H. J., 1993, MULTIMEDIA SYSTEMS, V1, P10, DOI DOI 10.1007/BF01210504; Zhang HJ, 1977, PATTERN RECOGN, V30, P643	19	7	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135694	10.1371/journal.pone.0135694	http://dx.doi.org/10.1371/journal.pone.0135694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284923	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100060
J	Matthews, Q; Isabelle, M; Harder, SJ; Smazynski, J; Beckham, W; Brolo, AG; Jirasek, A; Lum, JJ				Matthews, Quinn; Isabelle, Martin; Harder, Samantha J.; Smazynski, Julian; Beckham, Wayne; Brolo, Alexandre G.; Jirasek, Andrew; Lum, Julian J.			Radiation-Induced Glycogen Accumulation Detected by Single Cell Raman Spectroscopy Is Associated with Radioresistance that Can Be Reversed by Metformin	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACTIVATED PROTEIN-KINASE; CANCER-CELLS; IONIZING-RADIATION; IN-VITRO; AMPK; INHIBITION; CYCLE; LINES; METABOLISM	Altered cellular metabolism is a hallmark of tumor cells and contributes to a host of properties associated with resistance to radiotherapy. Detection of radiation-induced biochemical changes can reveal unique metabolic pathways affecting radiosensitivity that may serve as attractive therapeutic targets. Using clinically relevant doses of radiation, we performed label-free single cell Raman spectroscopy on a series of human cancer cell lines and detected radiation-induced accumulation of intracellular glycogen. The increase in glycogen post-irradiation was highest in lung (H460) and breast (MCF7) tumor cells compared to prostate (LNCaP) tumor cells. In response to radiation, the appearance of this glycogen signature correlated with radiation resistance. Moreover, the buildup of glycogen was linked to the phosphorylation of GSK-3 beta, a canonical modulator of cell survival following radiation exposure and a key regulator of glycogen metabolism. When MCF7 cells were irradiated in the presence of the anti-diabetic drug metformin, there was a significant decrease in the amount of radiation-induced glycogen. The suppression of glycogen by metformin following radiation was associated with increased radiosensitivity. In contrast to MCF7 cells, metformin had minimal effects on both the level of glycogen in H460 cells following radiation and radiosensitivity. Our data demonstrate a novel approach of spectral monitoring by Raman spectroscopy to assess changes in the levels of intracellular glycogen as a potential marker and resistance mechanism to radiation therapy.	[Matthews, Quinn; Isabelle, Martin; Lum, Julian J.] BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Isabelle, Martin; Harder, Samantha J.; Beckham, Wayne] Univ Victoria, Dept Phys & Astron, Victoria, BC, Canada; [Smazynski, Julian; Lum, Julian J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Matthews, Quinn; Beckham, Wayne] BC Canc Agcy, Dept Med Phys, Victoria, BC, Canada; [Brolo, Alexandre G.] Univ Victoria, Dept Chem, Victoria, BC, Canada; [Jirasek, Andrew] Univ British Columbia Okanagan, Math Stat Phys & Comp Sci, Kelowna, BC, Canada	British Columbia Cancer Agency; University of Victoria; University of Victoria; British Columbia Cancer Agency; University of Victoria; University of British Columbia; University of British Columbia Okanagan	Jirasek, A (corresponding author), Univ British Columbia Okanagan, Math Stat Phys & Comp Sci, Kelowna, BC, Canada.	andrew.jirasek@ubc.ca; jjlum@bccancer.bc.ca	Matthews, Quinn/A-2568-2013	Matthews, Quinn/0000-0001-6512-7000; Multhoff, Gabriele/0000-0002-2616-3137; Lum, Julian/0000-0002-5624-3541; Jirasek, Andrew/0000-0003-0844-2092	Canadian Institutes for Health Research [258926]; Cancer Research Society; Western Economic Diversification Fund; Canada Foundation for Innovations; British Columbia Knowledge Development Fund; Michael Smith Foundation for Health Research & Provincial Health Services Authority Post-doctoral Fellowship Award [STPDF03250(11-1)B]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Western Economic Diversification Fund; Canada Foundation for Innovations(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Michael Smith Foundation for Health Research & Provincial Health Services Authority Post-doctoral Fellowship Award	The authors are grateful for funding from Canadian Institutes for Health Research (258926, JJL, AGB, AJ), Cancer Research Society (JJL), Western Economic Diversification Fund (AGB), Canada Foundation for Innovations and British Columbia Knowledge Development Fund (AGB), Michael Smith Foundation for Health Research & Provincial Health Services Authority Post-doctoral Fellowship Award (STPDF03250(11-1) B, QM),	Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Chan JW, 2009, ANAL CHEM, V81, P1324, DOI 10.1021/ac801665m; Cheng KW, 2012, EMBO MOL MED, V4, P125, DOI 10.1002/emmm.201100193; Crow P, 2005, BRIT J CANCER, V92, P2166, DOI 10.1038/sj.bjc.6602638; Fasih A, 2014, RADIAT RES, V182, P50, DOI 10.1667/RR13568.1; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gartel AL, 2003, ONCOL RES, V13, P405; Harder SJ, 2015, APPL SPECTROSC, V69, P193, DOI 10.1366/14-07561; Jiang XY, 2014, INT J RADIAT ONCOL, V89, P714, DOI 10.1016/j.ijrobp.2014.04.018; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Konorov SO, 2011, ANAL CHEM, V83, P6254, DOI 10.1021/ac201581e; Lai SL, 2007, J BIOMEDICAL SCI, P64; Li HW, 2014, ONCOL REP, V32, P2596, DOI 10.3892/or.2014.3485; Liu JF, 2012, ONCOL REP, V28, P1406, DOI 10.3892/or.2012.1932; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matthews Q, 2011, PHYS MED BIOL, V56, P6839, DOI 10.1088/0031-9155/56/21/006; Matthews Q, 2011, PHYS MED BIOL, V56, P19, DOI 10.1088/0031-9155/56/1/002; Matthews Q, 2010, APPL SPECTROSC, V64, P871, DOI 10.1366/000370210792080966; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Neugebauer U, 2010, J BIOPHOTONICS, V3, P579, DOI 10.1002/jbio.201000020; Oshima Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316296; Pascut FC, 2013, BBA-GEN SUBJECTS, V1830, P3517, DOI 10.1016/j.bbagen.2013.01.030; Pelletier J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00018; ROUSSET M, 1980, JNCI-J NATL CANCER I, V65, P885; Sanli T, 2014, CANCER BIOL THER, V15, P156, DOI 10.4161/cbt.26726; Sanli T, 2012, RADIOTHER ONCOL, V102, P459, DOI 10.1016/j.radonc.2011.11.014; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Shimura T, 2011, J RADIAT RES, V52, P539, DOI 10.1269/jrr.11098; Skinner HD, 2013, ACTA ONCOL, V52, P1002, DOI 10.3109/0284186X.2012.718096; Skjoth IHE, 2006, INT J ONCOL, V28, P217; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Spalding AC, 2010, NEOPLASIA, V12, P357, DOI 10.1593/neo.92112; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Takahashi S, 1999, J GASTROENTEROL, V34, P474, DOI 10.1007/s005350050299; Thotala DK, 2012, CELL DEATH DIFFER, V19, P387, DOI 10.1038/cdd.2011.94; Townsend KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082406; Wang J, 2015, CELL BIOCH BIOPHYSIC; Witney TH, 2014, CANCER RES, V74, P1319, DOI 10.1158/0008-5472.CAN-13-2768; Zannella VE, 2011, RADIOTHER ONCOL, V99, P293, DOI 10.1016/j.radonc.2011.05.049	43	24	26	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135356	10.1371/journal.pone.0135356	http://dx.doi.org/10.1371/journal.pone.0135356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280348	Green Published, gold, Green Submitted			2022-12-27	WOS:000359664300012
J	Gao, F; Mei, JY; Sun, JP; Wang, J; Yang, EF; Hussain, A				Gao, Fei; Mei, Jingyuan; Sun, Jinping; Wang, Jun; Yang, Erfu; Hussain, Amir			A Novel Classification Algorithm Based on Incremental Semi-Supervised Support Vector Machine	PLOS ONE			English	Article							ENSEMBLE; SVM	For current computational intelligence techniques, a major challenge is how to learn new concepts in changing environment. Traditional learning schemes could not adequately address this problem due to a lack of dynamic data selection mechanism. In this paper, inspired by human learning process, a novel classification algorithm based on incremental semi-supervised support vector machine (SVM) is proposed. Through the analysis of prediction confidence of samples and data distribution in a changing environment, a "softstart" approach, a data selection mechanism and a data cleaning mechanism are designed, which complete the construction of our incremental semi-supervised learning system. Noticeably, with the ingenious design procedure of our proposed algorithm, the computation complexity is reduced effectively. In addition, for the possible appearance of some new labeled samples in the learning process, a detailed analysis is also carried out. The results show that our algorithm does not rely on the model of sample distribution, has an extremely low rate of introducing wrong semi-labeled samples and can effectively make use of the unlabeled samples to enrich the knowledge system of classifier and improve the accuracy rate. Moreover, our method also has outstanding generalization performance and the ability to overcome the concept drift in a changing environment.	[Gao, Fei; Mei, Jingyuan; Sun, Jinping; Wang, Jun] Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China; [Yang, Erfu] Univ Strathclyde, Dept Design Manufacture & Engn Management, Space Mechatron Syst Technol Lab, Glasgow G1 1XJ, Lanark, Scotland; [Hussain, Amir] Univ Stirling, Sch Nat Sci, Cognit Signal Image & Control Proc Res Lab, Stirling FK9 4LA, Scotland	Beihang University; University of Strathclyde; University of Stirling	Mei, JY (corresponding author), Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China.	347068642@qq.com	Yang, Erfu/N-2673-2016; SUN, JIN/GPX-9641-2022; Hussain, Amir/AAG-6299-2020	Yang, Erfu/0000-0003-1813-5950; Hussain, Amir/0000-0002-8080-082X	National Natural Science Foundation of China [61071139, 61471019, 61171122]; Royal Society of Edinburgh (RSE); National Natural Science Foundation of China (NNSFC) [61211130210]; Beihang University; RSE-NNSFC joint project [61211130309]; Anhui University, China; Engineering and Physical Sciences Research Council [EP/I009310/1] Funding Source: researchfish; EPSRC [EP/I009310/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society of Edinburgh (RSE); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); Beihang University; RSE-NNSFC joint project; Anhui University, China(Anhui University); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research is supported by the National Natural Science Foundation of China, No. 61071139, No. 61471019 and No. 61171122, the Royal Society of Edinburgh (RSE), and The National Natural Science Foundation of China (NNSFC) under the RSE-NNSFC joint project (2012-2014) [grant number 61211130210] with Beihang University. This research is also funded, in part, by the RSE-NNSFC joint project (2012-2014) [grant number 61211130309] with Anhui University, China; URL: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	[Anonymous], GEOSC REM SENS S IGA; Baluja S., 1998, PROBABILISTIC MODELI; Bruzzone L, 2009, IEEE T GEOSCI REMOTE, V47, P2142, DOI 10.1109/TGRS.2008.2011983; Cauwenberghs G, 2001, ADV NEUR IN, V13, P409; Cheng SX, 2007, PATTERN RECOGN, V40, P964, DOI 10.1016/j.patcog.2006.06.016; Chia-Feng J, 2014, FUZZY SYSTEMS IEEE T, V22, P324; COPPOCK HW, 1962, SCIENCE, V135, P318, DOI 10.1126/science.135.3500.318; Diehl CP, 2003, NEUR NETW 2003 P INT; Domeniconi Carlotta, 2001, DAT MIN 2001 ICDM 20; Emara W, 2007, DAT MIN WORKSH 2007; Erdem Z, 2005, LECT NOTES COMPUT SC, V3541, P246; Erdem Z, 2005, LECT NOTES COMPUT SC, V3697, P607; Fujino A, 1999, P NAT C ART INT 2005; Jianzhao Q, 2006, PATT REC 2006 ICPR 2; Jin-Long A, 2003, MACH LEARN CYB 2003; Jun J, 2008, ED TECHN TRAIN 2008; Laskov P, 2006, J MACH LEARN RES, V7, P1909; Maulik U, 2013, IEEE T BIO-MED ENG, V60, P1111, DOI 10.1109/TBME.2012.2225622; Minku LL, 2010, IEEE T KNOWL DATA EN, V22, P730, DOI 10.1109/TKDE.2009.156; Mitra P, 2000, PATT REC 2000 P 15 I; Nigam K, 2000, MACH LEARN, V39, P103, DOI 10.1023/A:1007692713085; Rong X, 2000, TOOLS ART INT 2000 I; Srinivas U, 2014, IEEE T AERO ELEC SYS, V50, P591, DOI 10.1109/TAES.2013.120340; Syed N, 1999, P 5 ACM SIGKDD INT C; Syed N.A., 1999, INCREMENTAL LEARNING; Vapnik V.N., 1995, NATURE STAT LEARNING; Widmer G., 1993, MACHINE LEARNING ECM; Zhu X, 2008, COMPUTER SCI, V2, P3	28	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135709	10.1371/journal.pone.0135709	http://dx.doi.org/10.1371/journal.pone.0135709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275294	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000359493600101
J	Higashide, T; Ohkubo, S; Sugiyama, K				Higashide, Tomomi; Ohkubo, Shinji; Sugiyama, Kazuhisa			Long-Term Outcomes and Prognostic Factors of Trabeculectomy following Intraocular Bevacizumab Injection for Neovascular Glaucoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AHMED VALVE IMPLANTATION; INTRAVITREAL BEVACIZUMAB; MITOMYCIN-C; INTRACAMERAL BEVACIZUMAB; IRIS NEOVASCULARIZATION; MOLTENO IMPLANT; EFFICACY; TUBE	Purpose To evaluate long-term outcomes and identify prognostic factors of trabeculectomy following intraocular bevacizumab injection for neovascular glaucoma. Methods Sixty-one eyes of 54 patients with neovascular glaucoma treated by trabeculectomy following intraocular bevacizumab injection were consecutively enrolled. Surgical success criteria were sufficient intraocular pressure (IOP) reduction (IOP <= 21 mmHg, >= 20% IOP reduction, no additional medications or glaucoma surgeries) without devastating complications (loss of light perception, phthisis bulbi, and endophthalmitis) or significant hypotony (IOP <= 5 mmHg continued >= 6 months and until the last follow-up visit or hypotony requiring intervention). Kaplan-Meier survival curves and Cox regression analysis were used to examine success rates and risk factors for surgical outcomes. Results The follow-up period after trabeculectomy was 45.0 +/- 22.2 months (mean +/- standard deviation). Surgical success rate was 86.9 +/- 4.3% (+/- standard error), 74.0 +/- 6.1%, and 51.3 +/- 8.6% at 1, 3, and 5 years. Multivariate Cox regression analysis identified two risk factors; lower preoperative IOP (<= 30 mmHg) for surgical failure and hypotony [hazard ratio (HR), 2.92, 6.64; 95% confidence interval (CI), 1.22 to 7.03, 1.47 to 30.0; P = 0.018, 0.014, respectively], and vitrectomy after trabeculectomy for surgical failure with or without hypotony criteria (HR, 2.32, 4.06; 95% CI, 1.02 to 5.28, 1.30 to 12.7; P = 0.045, 0.016, respectively). Conclusions The long-term outcomes of trabeculectomy following intraocular bevacizumab injection for neovascular glaucoma were favorable. Lower baseline IOP was associated with development of significant hypotony, while additional vitrectomy was related to insufficient IOP reduction.	[Higashide, Tomomi; Ohkubo, Shinji; Sugiyama, Kazuhisa] Kanazawa Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Kanazawa University	Higashide, T (corresponding author), Kanazawa Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	eyetomo@med.kanazawa-u.ac.jp		Shukla, Deepak/0000-0002-3039-6953				AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Al Obeidan SA, 2008, EUR J OPHTHALMOL, V18, P758, DOI 10.1177/112067210801800516; BENSON MT, 1990, BRIT J OPHTHALMOL, V74, P103, DOI 10.1136/bjo.74.2.103; Bindlish R, 2002, OPHTHALMOLOGY, V109, P1336, DOI 10.1016/S0161-6420(02)01069-2; Chen CH, 2010, J OCUL PHARMACOL TH, V26, P111, DOI 10.1089/jop.2009.0055; Davidorf FH, 2006, RETINA-J RET VIT DIS, V26, P354, DOI 10.1097/00006982-200603000-00017; Every SG, 2006, ARCH OPHTHALMOL-CHIC, V124, P355, DOI 10.1001/archopht.124.3.355; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Gedde SJ, 2009, AM J OPHTHALMOL, V148, P670, DOI 10.1016/j.ajo.2009.06.018; Grisanti S, 2006, AM J OPHTHALMOL, V142, P158, DOI 10.1016/j.ajo.2006.02.045; Gupta V, 2009, EUR J OPHTHALMOL, V19, P435, DOI 10.1177/112067210901900318; Hyung S M, 2001, Korean J Ophthalmol, V15, P98; Iliev ME, 2006, AM J OPHTHALMOL, V142, P1054, DOI 10.1016/j.ajo.2006.06.066; Jamil AL, 2007, AM J OPHTHALMOL, V143, P141, DOI 10.1016/j.ajo.2006.10.024; Kang JY, 2014, INT OPHTHALMOL, V34, P793, DOI 10.1007/s10792-013-9875-7; Kim YG, 2009, J GLAUCOMA, V18, P443, DOI 10.1097/IJG.0b013e3181895e5c; Kirwan JF, 2013, OPHTHALMOLOGY, V120, P2532, DOI 10.1016/j.ophtha.2013.07.049; Kiuchi Y, 2006, OPHTHALMOLOGICA, V220, P383, DOI 10.1159/000095865; Kobayashi S, 2015, J GLAUCOMA; Kunikata H, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/306814; Mahdy RA, 2013, J GLAUCOMA, V22, P768, DOI 10.1097/IJG.0b013e318259aec4; Mandal Anil K., 2002, Indian Journal of Ophthalmology, V50, P287; Miki A, 2011, EYE, V25, P658, DOI 10.1038/eye.2011.58; Nakatake S, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-55; Netland PA, 2010, J GLAUCOMA, V19, P581, DOI 10.1097/IJG.0b013e3181ca7f7f; Saito Y, 2010, AM J OPHTHALMOL, V149, P964, DOI 10.1016/j.ajo.2010.01.008; Saito Y, 2010, ACTA OPHTHALMOL, V88, P96, DOI 10.1111/j.1755-3768.2009.01648.x; Sevim MS, 2013, OPHTHALMOLOGICA, V229, P94, DOI 10.1159/000345490; Shaarawy TM, 2009, GUIDELINES DESIGN RE, P15; Simha A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007920.pub2; Sivak-Callcott JA, 2001, OPHTHALMOLOGY, V108, P1767, DOI 10.1016/S0161-6420(01)00775-8; Takihara Y, 2011, J GLAUCOMA, V20, P196, DOI 10.1097/IJG.0b013e3181d9ce12; Takihara Y, 2009, AM J OPHTHALMOL, V147, P912, DOI 10.1016/j.ajo.2008.11.015; Teixeira SH, 2012, J GLAUCOMA, V21, P342, DOI 10.1097/IJG.0b013e31820d7e4e; Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010; TSAI JC, 1995, OPHTHALMOLOGY, V102, P887, DOI 10.1016/S0161-6420(95)30938-4; Wakabayashi T, 2008, OPHTHALMOLOGY, V115, P1571, DOI 10.1016/j.ophtha.2008.02.026; Yalvac IS, 2007, EYE, V21, P65, DOI 10.1038/sj.eye.6702125; Yildirim N, 2009, J GLAUCOMA, V18, P192, DOI 10.1097/IJG.0b013e31817d235c; Zhang HT, 2014, INT J OPHTHALMOL-CHI, V7, P837, DOI 10.3980/j.issn.2222-3959.2014.05.18; Zhou MW, 2013, CHINESE MED J-PEKING, V126, P1412, DOI 10.3760/cma.j.issn.0366-6999.20130011	41	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135766	10.1371/journal.pone.0135766	http://dx.doi.org/10.1371/journal.pone.0135766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275060	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600108
J	Kaplovitch, E; Gomes, T; Camacho, X; Dhalla, IA; Mamdani, MM; Juurlink, DN				Kaplovitch, Eric; Gomes, Tara; Camacho, Ximena; Dhalla, Irfan A.; Mamdani, Muhammad M.; Juurlink, David N.			Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; UNITED-STATES; PRESCRIPTION OPIOIDS; NONMALIGNANT PAIN; TRENDS; GENDER; RISK; METAANALYSIS; ANALGESICS; MORTALITY	Background The use of opioids for noncancer pain is widespread, and more than 16,000 die of opioid-related causes in the United States annually. The patients at greatest risk of death are those receiving high doses of opioids. Whether sex influences the risk of dose escalation or opioid-related mortality is unknown. Methods and Findings We conducted a cohort study using healthcare records of 32,499 individuals aged 15 to 64 who commenced chronic opioid therapy for noncancer pain between April 1, 1997 and December 31, 2010 in Ontario, Canada. Patients were followed from their first opioid prescription until discontinuation of therapy, death from any cause or the end of the study period. Among patients receiving chronic opioid therapy, 589 (1.8%) escalated to high dose therapy and n = 59 (0.2%) died of opioid-related causes while on treatment. After multivariable adjustment, men were more likely than women to escalate to high-dose opioid therapy ( adjusted hazard ratio 1.44; 95% confidence interval 1.21 to 1.70) and twice as likely to die of opioid-related causes (adjusted hazard ratio 2.04; 95% confidence interval 1.18 to 3.53). These associations were maintained in a secondary analysis of 285,520 individuals receiving any opioid regardless of the duration of therapy. Conclusions Men are at higher risk than women for escalation to high-dose opioid therapy and death from opioid-related causes. Both outcomes were more common than anticipated.	[Kaplovitch, Eric; Dhalla, Irfan A.; Juurlink, David N.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Gomes, Tara; Camacho, Ximena; Dhalla, Irfan A.; Mamdani, Muhammad M.; Juurlink, David N.] Inst Clin Evaluat Sci, Chron Dis & Pharmacotherapy Res Program, Toronto, ON, Canada; [Gomes, Tara; Mamdani, Muhammad M.] Univ Toronto, Dept Pharm, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Juurlink, DN (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	david.juurlink@ices.on.ca		Gomes, Tara/0000-0002-1468-1965	Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC	Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC	This study was supported by a grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund and the Institute for Clinical Evaluative Sciences (ICES), a non-profit research institute sponsored by the Ontario MOHLTC. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US MED US REV 2011; Back SE, 2010, ADDICT BEHAV, V35, P1001, DOI 10.1016/j.addbeh.2010.06.018; Back SE, 2009, CLIN J PAIN, V25, P477, DOI 10.1097/AJP.0b013e31819c2c2f; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Campbell CI, 2010, AM J PUBLIC HEALTH, V100, P2541, DOI 10.2105/AJPH.2009.180646; Caudill-Slosberg MA, 2004, PAIN, V109, P514, DOI 10.1016/j.pain.2004.03.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gomes T, 2013, JAMA INTERN MED, V173, P196, DOI 10.1001/2013.jamainternmed.733; Gomes Tara, 2011, Open Med, V5, pe13; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Green CR, 2003, J PAIN, V4, P29, DOI 10.1054/jpai.2003.5; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Han Huijun, 2013, J Opioid Manag, V9, P129, DOI 10.5055/jom.2012.0154; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jamison RN, 2010, J PAIN, V11, P312, DOI 10.1016/j.jpain.2009.07.016; Joynt M, 2013, J GEN INTERN MED; Kissin I, 2013, J PAIN RES, V6, P513, DOI [10.2147/JPR.S47182, 10.2147/JPR.S47162]; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; National Opioid Use Guideline Group (NOUGG), 2010, CAN GUID SAF EFF US; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; Noble M, 2008, J PAIN SYMPTOM MANAG, V35, P214, DOI 10.1016/j.jpainsymman.2007.03.015; Paulozzi Leonard J., 2012, Morbidity and Mortality Weekly Report, V61, P493; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; PORTENOY RK, 1986, PAIN, V25, P171, DOI 10.1016/0304-3959(86)90091-6; Sadowski CA, 2009, J POPUL THER CLIN PH, V16, pE322; Spiller H, 2009, J ADDICT DIS, V28, P130, DOI 10.1080/10550880902772431; Sullivan MD, 2008, PAIN, V138, P440, DOI 10.1016/j.pain.2008.04.027; Von Korff M, 2011, ANN INTERN MED, V155, P325, DOI 10.7326/0003-4819-155-5-201109060-00011; Warner Margaret, 2011, NCHS Data Brief, P1; Wisniewski AM, 2008, J ADDICT DIS, V27, P1, DOI 10.1300/J069v27n01_01; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8	40	97	98	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134550	10.1371/journal.pone.0134550	http://dx.doi.org/10.1371/journal.pone.0134550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291716	Green Published, gold			2022-12-27	WOS:000359919900008
J	Li, GC; Wang, JZ; Hu, WG; Zhang, Z				Li, Guichao; Wang, Jiazhou; Hu, Weigang; Zhang, Zhen			Radiation-Induced Liver Injury in Three-Dimensional Conformal Radiation Therapy (3D-CRT) for Postoperative or Locoregional Recurrent Gastric Cancer: Risk Factors and Dose Limitations	PLOS ONE			English	Article							COMPLICATION PROBABILITY MODEL; HEPATOCELLULAR-CARCINOMA; PARALLEL-ARCHITECTURE; NORMAL-TISSUES; DISEASE; RADIOTHERAPY; IRRADIATION; TOLERANCE; PREDICTION	Purpose This study examined the status of radiation-induced liver injury in adjuvant or palliative gastric cancer radiation therapy (RT), identified risk factors of radiation-induced liver injury in gastric cancer RT, analysed the dose-volume effects of liver injury, and developed a liver dose limitation reference for gastric cancer RT. Methods and Materials Data for 56 post-operative gastric cancer patients and 6 locoregional recurrent gastric cancer patients treated with three-dimensional conformal radiation therapy (3D-CRT) or intensity-modulated radiation therapy (IMRT) from Sep 2007 to Sep 2009 were analysed. Forty patients (65%) were administered concurrent chemotherapy. Pre- and post-radiation chemotherapy were given to 61 patients and 43 patients, respectively. The radiation dose was 45-50.4 Gy in 25-28 fractions. Clinical parameters, including gender, age, hepatic B virus status, concurrent chemotherapy, and the total number of chemotherapy cycles, were included in the analysis. Univariate analyses with a non-parametric rank test (Mann-Whitney test) and logistic regression test and a multivariate analysis using a logistic regression test were completed. We also analysed the correlation between RT and the changes in serum chemistry parameters [including total bilirubin, (TB), direct bilirubin (D-TB), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and serum albumin (ALB)] after RT. Results The Child-Pugh grade progressed from grade A to grade B after radiotherapy in 10 patients. A total of 16 cases of classic radiation-induced liver disease (RILD) were observed, and 2 patients had both Child-Pugh grade progression and classic RILD. No cases of non-classic radiation liver injury occurred in the study population. Among the tested clinical parameters, the total number of chemotherapy cycles correlated with liver function injury. V35 and ALP levels were significant predictive factors for radiation liver injury. Conclusions In 3D-CRT for gastric cancer patients, radiation-induced liver injury may occur and affect the overall treatment plan. The total number of chemotherapy cycles correlated with liver function injury, and V35 and ALP are significant predictive factors for radiation-induced liver injury. Our dose limitation reference for liver protection is feasible.	[Zhang, Zhen] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhang, Z (corresponding author), Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	zhenzhang6@163.com						Bockbrader M, 2009, EXPERT REV ANTICANC, V9, P637, DOI 10.1586/ERA.09.16; Cheng JCH, 2005, INT J RADIAT ONCOL, V62, P1150, DOI 10.1016/j.ijrobp.2004.12.031; Cheng JCH, 2002, INT J RADIAT ONCOL, V54, P156, DOI 10.1016/S0360-3016(02)02915-2; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dawson LA, 2005, SEMIN RADIAT ONCOL, V15, P279, DOI 10.1016/j.semradonc.2005.04.005; Dawson LA, 2001, INT J RADIAT ONCOL, V51, P1410, DOI 10.1016/S0360-3016(01)02653-0; Dawson LA, 2001, SEMIN RADIAT ONCOL, V11, P240, DOI 10.1053/srao.2001.23485; Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8; JACKSON A, 1993, MED PHYS, V20, P613, DOI 10.1118/1.597056; Kang Y., 2006, ASCO, V24, DOI [10.1200/jco.2006.24.18_suppl.lba4018, DOI 10.1200/JCO.2006.24.18_SUPPL.LBA4018]; Kim TH, 2007, INT J RADIAT ONCOL, V67, P225, DOI 10.1016/j.ijrobp.2006.08.015; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Liang SX, 2006, INT J RADIAT ONCOL, V65, P426, DOI 10.1016/j.ijrobp.2005.12.031; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Ohara K, 1997, INT J RADIAT ONCOL, V38, P367, DOI 10.1016/S0360-3016(96)00587-1; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Tai A, 2009, INT J RADIAT ONCOL, V74, P283, DOI 10.1016/j.ijrobp.2008.11.029; Xu ZY, 2006, INT J RADIAT ONCOL, V65, P189, DOI 10.1016/j.ijrobp.2005.11.034; Yorke ED, 2001, SEMIN RADIAT ONCOL, V11, P197, DOI 10.1053/srao.2001.23478; YORKE ED, 1993, RADIOTHER ONCOL, V26, P226, DOI 10.1016/0167-8140(93)90264-9; Zhu J, 2006, JPN J CLIN ONCOL, V36, P783, DOI 10.1093/jjco/hyl117	21	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136288	10.1371/journal.pone.0136288	http://dx.doi.org/10.1371/journal.pone.0136288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291715	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900074
J	Rohde, RA; Muller, RA				Rohde, Robert A.; Muller, Richard A.			Air Pollution in China: Mapping of Concentrations and Sources	PLOS ONE			English	Article							PARTICULATE MATTER; GLOBAL BURDEN; NO X; MORTALITY; AEROSOL; EMISSIONS; EXPOSURE; DISEASE	China has recently made available hourly air pollution data from over 1500 sites, including airborne particulate matter (PM), SO2, NO2, and O-3. We apply Kriging interpolation to four months of data to derive pollution maps for eastern China. Consistent with prior findings, the greatest pollution occurs in the east, but significant levels are widespread across northern and central China and are not limited to major cities or geologic basins. Sources of pollution are widespread, but are particularly intense in a northeast corridor that extends from near Shanghai to north of Beijing. During our analysis period, 92% of the population of China experienced > 120 hours of unhealthy air (US EPA standard), and 38% experienced average concentrations that were unhealthy. China's population-weighted average exposure to PM2.5 was 52 mu g/m(3). The observed air pollution is calculated to contribute to 1.6 million deaths/year in China [0.7-2.2 million deaths/year at 95% confidence], roughly 17% of all deaths in China.	[Rohde, Robert A.; Muller, Richard A.] Berkeley Earth, Berkeley, CA 94720 USA; [Muller, Richard A.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rohde, RA (corresponding author), Berkeley Earth, Berkeley, CA 94720 USA.	robert@berkeleyearth.org; rich@berkeleyearth.org			Berkeley Earth	Berkeley Earth	The authors received support from Berkeley Earth, a 501c3 non-profit, whose website is http://www.berkeleyearth.org. There was no directed funding for this project, and no funders were involved in the design, execution, or reporting of this study.	Battelle Memorial Institute Center for International Earth Science Information Network-CIESIN-Columbia University, 2013, GLOB ANN AV PM2 5 GR, DOI [10.7927/H4H41PB4, DOI 10.7927/H4H41PB4]; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Boys BL, 2014, ENVIRON SCI TECHNOL, V48, P11109, DOI 10.1021/es502113p; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Cai H, 2012, ANLESD122; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Davidson CI, 2005, AEROSOL SCI TECH, V39, P737, DOI 10.1080/02786820500191348; de Sherbinin A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084013; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Environmental Protection Agency, 2014, AIR QUAL IND GUID AI; Government of China, 2012, 30952012 GB GOV CHIN; Hoek G, 2012, ENV HLTH, V12, P43; Huffman G J, 2011, REAL TIME TRMM MULTI; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Lei Y, 2011, ATMOS CHEM PHYS, V11, P931, DOI 10.5194/acp-11-931-2011; Liu XH, 2010, ATMOS ENVIRON, V44, P2415, DOI 10.1016/j.atmosenv.2010.03.035; Lu Z, 2011, ATMOS CHEM PHYS, V11, P9839, DOI 10.5194/acp-11-9839-2011; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NOAA/NCEP, 2012, GLOB FOR SYST GFS AT; O'Keefe B., 2013, HEI ANN C 2012; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rohde R., 2013, GEOINF GEOSTAL OVERV, V1, P1, DOI [10.4172/2327-4581.1000103, DOI 10.4172/2327-4581.1000103]; Schabenberger O., 2004, STAT METHODS SPATIAL; Shi Y, 2014, J ZHEJIANG UNIV-SC A, V15, P454, DOI 10.1631/jzus.A1300379; Song WZ, 2014, REMOTE SENS ENVIRON, V154, P1, DOI 10.1016/j.rse.2014.08.008; US Energy Information Agency, 1998, DOEEIA056098; van Donkelaar A, 2015, ENV HLTH PERSPECT, DOI [10.1289/ehp.1408646, DOI 10.1289/EHP.1408646]; Wang J, 2010, REMOTE SENS ENVIRON, V114, P2575, DOI 10.1016/j.rse.2010.05.034; World Health Organization, 2012, BURD DIS JOINT EFF H; World Health Organization (WHO), 2014, WHOHISHSIGHE20147; Yang A, 2012, GLOBAL COAL RISK ASS; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang Q, 2012, CHINESE SCI BULL, V57, P2857, DOI 10.1007/s11434-012-5015-4; Zhang WJ, 2006, BIOMED ENVIRON SCI, V19, P461	35	470	485	28	339	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135749	10.1371/journal.pone.0135749	http://dx.doi.org/10.1371/journal.pone.0135749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291610	Green Submitted, gold, Green Published			2022-12-27	WOS:000359919900029
J	Yazaki, K; Kuroda, K; Nakano, T; Kitao, M; Tobita, H; Ogasa, MY; Ishida, A				Yazaki, Kenichi; Kuroda, Katsushi; Nakano, Takashi; Kitao, Mitsutoshi; Tobita, Hiroyuki; Ogasa, Mayumi Y.; Ishida, Atsushi			Recovery of Physiological Traits in Saplings of Invasive Bischofia Tree Compared with Three Species Native to the Bonin Islands under Successive Drought and Irrigation Cycles	PLOS ONE			English	Article							CRYOSCANNING ELECTRON-MICROSCOPY; WOOD DENSITY; HYDRAULIC EFFICIENCY; ECOLOGICAL SIGNIFICANCE; XYLEM CAVITATION; WATER TRANSPORT; EMBOLISM REPAIR; LEAF; SAFETY; FOREST	Partial leaf shedding induced by hydraulic failure under prolonged drought can prevent excess water consumption, resulting in delayed recovery of carbon productivity following rainfall. To understand the manner of water use of invasive species in oceanic island forests under a fluctuating water regime, leaf shedding, multiple physiological traits, and the progress of embolism in the stem xylem under repeated drought-irrigation cycles were examined in the potted saplings of an invasive species, Bischofia javanica Blume, and three endemic native species, Schima mertensiana (Sieb. Et Zucc,) Koitz., Hibiscus glaber Matsum, and Distylium lepidotum Nakai, from the Bonin Islands, Japan. The progress of xylem embolism was observed by cryo-scanning electron microscopy. The samples exhibited different processes of water saving and drought tolerance based on the different combinations of partial leaf shedding involved in embolized conduits following repeated de-rehydration. Predawn leaf water potential largely decreased with each successive drought-irrigation cycle for all tree species, except for B. javanica. B. javanica shed leaves conspicuously under drought and showed responsive stomatal conductance to VPD, which contributed to recover leaf gas exchange in the remaining leaves, following a restored water supply. In contrast, native tree species did not completely recover photosynthetic rates during the repeated drought-irrigation cycles. H. glaber and D. lepidotum preserved water in vessels and adjusted leaf osmotic rates but did not actively shed leaves. S. mertensiana exhibited partial leaf shedding during the first cycle with an osmotic adjustment, but they showed less responsive stomatal conductance to VPD. Our data indicate that invasive B. javanica saplings can effectively use water supplied suddenly under drought conditions. We predict that fluctuating precipitation in the future may change tree distributions even in mesic or moist sites in the Bonin Islands.	[Yazaki, Kenichi; Kitao, Mitsutoshi; Tobita, Hiroyuki; Ogasa, Mayumi Y.] FFPRI, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan; [Kuroda, Katsushi] FFPRI, Dept Wood Properties, Tsukuba, Ibaraki 3058687, Japan; [Nakano, Takashi] Mt Fuji Res Inst, Div Nat Environm Sci, Fujiyoshida, Yamanashi 4030005, Japan; [Ishida, Atsushi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Kyoto University	Yazaki, K (corresponding author), FFPRI, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan.	kyazaki@ffpri.affrc.go.jp		Y. Ogasa, Mayumi/0000-0002-3814-4937; Ishida, Atsushi/0000-0003-0620-5819	Japan's Ministry of Education, Culture, Sports, Science and Technology [19780129, 23780190, 14360091, 24370009, 26660125]	Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid (19780129, 23780190 to KY, 14360091, 24370009, 26660125 to AT) from Japan's Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman CJ, 2009, PLANT CELL ENVIRON, V32, P1584, DOI 10.1111/j.1365-3040.2009.02023.x; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Charra-Vaskou K, 2012, TREE PHYSIOL, V32, P1161, DOI 10.1093/treephys/tps071; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Cochard H, 2000, PLANT PHYSIOL, V124, P1191, DOI 10.1104/pp.124.3.1191; Cochard H, 2013, ANN FOREST SCI, V70, P659, DOI 10.1007/s13595-013-0317-5; Delzon S, 2014, NEW PHYTOL, V203, P355, DOI 10.1111/nph.12798; Engelbrecht BMJ, 2005, TREES-STRUCT FUNCT, V19, P312, DOI 10.1007/s00468-004-0393-0; Field C.B., 2012, MANAGING RISKS EXTRE; Fukuda K, 2007, TREE PHYSIOL, V27, P969, DOI 10.1093/treephys/27.7.969; Hacke UG, 2003, PLANT CELL ENVIRON, V26, P303, DOI 10.1046/j.1365-3040.2003.00962.x; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Hacke UG, 2006, TREE PHYSIOL, V26, P689, DOI 10.1093/treephys/26.6.689; Holbrook NM, 1999, PLANT PHYSIOL, V120, P7, DOI 10.1104/pp.120.1.7; Hukin D, 2005, J EXP BOT, V56, P2003, DOI 10.1093/jxb/eri198; Ishida A, 2009, OGASAWARA RES, V34, P1; Ishida A, 2008, OECOLOGIA, V156, P193, DOI 10.1007/s00442-008-0965-6; Ishida A, 2010, TREE PHYSIOL, V30, P935, DOI 10.1093/treephys/tpq025; Johnson DM, 2012, PLANT SCI, V195, P48, DOI 10.1016/j.plantsci.2012.06.010; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Markesteijn L, 2011, PLANT CELL ENVIRON, V34, P137, DOI 10.1111/j.1365-3040.2010.02231.x; Martinez-Cabrera HI, 2009, AM J BOT, V96, P1388, DOI 10.3732/ajb.0800237; Mayr S, 2014, PLANT PHYSIOL, V164, P1731, DOI 10.1104/pp.114.236646; McCulloh KA, 2011, OECOLOGIA, V167, P27, DOI 10.1007/s00442-011-1973-5; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2013, NEW PHYTOL, V200, P304, DOI 10.1111/nph.12465; Meinzer FC, 2008, TREE PHYSIOL, V28, P1609, DOI 10.1093/treephys/28.11.1609; Meinzer FC, 2013, TREE PHYSIOL, V33, P331, DOI 10.1093/treephys/tpt022; Mencuccini M, 2003, PLANT CELL ENVIRON, V26, P163, DOI 10.1046/j.1365-3040.2003.00991.x; Mishio M., 1992, FUNCTIONAL PLANT BIO, V19, P539; Nardini A, 2011, PLANT SCI, V180, P604, DOI 10.1016/j.plantsci.2010.12.011; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Osone Y, 2014, J PLANT RES, V127, P315, DOI 10.1007/s10265-013-0609-8; Pittermann J, 2006, PLANT CELL ENVIRON, V29, P1618, DOI 10.1111/j.1365-3040.2006.01539.x; Pittermann J, 2010, PLANT PHYSIOL, V153, P1919, DOI 10.1104/pp.110.158824; Preston KA, 2006, NEW PHYTOL, V170, P807, DOI 10.1111/j.1469-8137.2006.01712.x; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; SHIMIZU Y, 1991, Pacific Science, V45, P28; SOBRADO MA, 1993, OECOLOGIA, V96, P19, DOI 10.1007/BF00318025; Torres-Ruiz JM, 2015, PLANT PHYSIOL, V167, P40, DOI 10.1104/pp.114.249706; TYREE MT, 1993, PLANT CELL ENVIRON, V16, P879, DOI 10.1111/j.1365-3040.1993.tb00511.x; Tyree MT, 1999, PLANT PHYSIOL, V120, P11, DOI 10.1104/pp.120.1.11; Utsumi Y, 1998, PLANT PHYSIOL, V117, P1463, DOI 10.1104/pp.117.4.1463; Wheeler JK, 2013, PLANT CELL ENVIRON, V36, P1938, DOI 10.1111/pce.12139; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yamashita N, 2000, OECOLOGIA, V125, P412, DOI 10.1007/s004420000475; Yamashita N, 2002, ANN BOT-LONDON, V90, P599, DOI 10.1093/aob/mcf231; Yamashita N, 2002, PLANT CELL ENVIRON, V25, P1341, DOI 10.1046/j.1365-3040.2002.00907.x; Yazaki K, 2010, TREE PHYSIOL, V30, P597, DOI 10.1093/treephys/tpq010; Zanne AE, 2006, FUNCT ECOL, V20, P200, DOI 10.1111/j.1365-2435.2006.01101.x	52	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135117	10.1371/journal.pone.0135117	http://dx.doi.org/10.1371/journal.pone.0135117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291326	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900015
J	Bracis, C; Gurarie, E; Van Moorter, B; Goodwin, RA				Bracis, Chloe; Gurarie, Eliezer; Van Moorter, Bram; Goodwin, R. Andrew			Memory Effects on Movement Behavior in Animal Foraging	PLOS ONE			English	Article							SPATIAL MEMORY; HOME RANGES; MODELS; SEAGRASS; MECHANISMS; SELECTION; HABITATS; ECOLOGY; MAP	An individual's choices are shaped by its experience, a fundamental property of behavior important to understanding complex processes. Learning and memory are observed across many taxa and can drive behaviors, including foraging behavior. To explore the conditions under which memory provides an advantage, we present a continuous-space, continuous-time model of animal movement that incorporates learning and memory. Using simulation models, we evaluate the benefit memory provides across several types of landscapes with variable-quality resources and compare the memory model within a nested hierarchy of simpler models (behavioral switching and random walk). We find that memory almost always leads to improved foraging success, but that this effect is most marked in landscapes containing sparse, contiguous patches of high-value resources that regenerate relatively fast and are located in an otherwise devoid landscape. In these cases, there is a large payoff for finding a resource patch, due to size, value, or locational difficulty. While memory-informed search is difficult to differentiate from other factors using solely movement data, our results suggest that disproportionate spatial use of higher value areas, higher consumption rates, and consumption variability all point to memory influencing the movement direction of animals in certain ecosystems.	[Bracis, Chloe] Univ Washington, Quantitat Ecol & Resource Management, Seattle, WA 98195 USA; [Bracis, Chloe] Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr BiK F, Frankfurt, Main, Germany; [Bracis, Chloe] Goethe Univ Frankfurt, D-60054 Frankfurt, Main, Germany; [Gurarie, Eliezer] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Van Moorter, Bram] Norwegian Univ Sci & Technol, Ctr Conservat Biol, N-7034 Trondheim, Norway; [Van Moorter, Bram] Norwegian Inst Nat Res NINA, Trondheim, Norway; [Goodwin, R. Andrew] US Army Engineer Res & Dev Ctr, Environm Lab, Portland, OR USA	University of Washington; University of Washington Seattle; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; University System of Maryland; University of Maryland College Park; Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Bracis, C (corresponding author), Univ Washington, Quantitat Ecol & Resource Management, Seattle, WA 98195 USA.	cbracis@uw.edu	Gurarie, Eliezer/AGI-0958-2022; Goodwin, R. Andrew/ABG-5799-2020	Gurarie, Eliezer/0000-0002-8666-9674; Goodwin, R. Andrew/0000-0002-6846-0287; Van Moorter, Bram/0000-0002-3196-1993	U.S. Army Engineer Research and Development Center (ERDC); Cold Regions Research and Engineering Laboratory; AT24 Program; Geospatial Research and Engineering Program; ERDC BAA; ERDC Construction Engineering Research Laboratory; National Science Foundation [ABI-1062411]; Norwegian Research Council	U.S. Army Engineer Research and Development Center (ERDC)(United States Department of DefenseUnited States Army); Cold Regions Research and Engineering Laboratory; AT24 Program; Geospatial Research and Engineering Program; ERDC BAA; ERDC Construction Engineering Research Laboratory; National Science Foundation(National Science Foundation (NSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	Research was conducted under sponsorship of the U.S. Army Engineer Research and Development Center (ERDC, http://www.erdc.usace.army.mil), Cold Regions Research and Engineering Laboratory, AT24 and Geospatial Research and Engineering Programs (Bert Davis, Randy Hill). C.B. was partially funded through an ERDC BAA awarded to James Anderson, University of Washington. R.G. was partially funded through the ERDC Construction Engineering Research Laboratory, Military Ranges and Lands Program (Alan Anderson). E.G. was partially funded by National Science Foundation (http://www.nsf.gov) grant ABI-1062411. B.M. was funded by Norwegian Research Council's (http://www.forskningsradet.no) PredClim grant to B.-E. Saether. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson James J., 2002, Natural Resource Modeling, V15, P55; Anderson JJ, 2010, P 32 ANN C COGN SCI; Aragones LV, 2006, OECOLOGIA, V149, P635, DOI 10.1007/s00442-006-0477-1; Avgar T, 2015, J ANIM ECOL, V84, P1059, DOI 10.1111/1365-2656.12357; Avgar T, 2013, ECOL MODEL, V251, P158, DOI 10.1016/j.ecolmodel.2012.12.002; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DA, 2006, INT J GEOGR INF SCI, V20, P1039, DOI 10.1080/13658810600830806; Boyer D, 2012, J R SOC INTERFACE, V9, P842, DOI 10.1098/rsif.2011.0582; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Butcher J.C., 2008, NUMERICAL METHODS OR, DOI DOI 10.1002/9780470753767; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Codling EA, 2005, J THEOR BIOL, V233, P573, DOI 10.1016/j.jtbi.2004.11.008; COURANT R, 1967, IBM J RES DEV, V11, P215, DOI 10.1147/rd.112.0215; Cruse H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002009; Eliassen S, 2009, AM NAT, V174, P478, DOI 10.1086/605370; Esposito S, 2010, ECOL MODEL, V221, P1283, DOI 10.1016/j.ecolmodel.2010.01.009; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Gautestad AO, 2011, J THEOR BIOL, V287, P26, DOI 10.1016/j.jtbi.2011.07.010; Gautestad AO, 2010, ECOL MODEL, V221, P2741, DOI 10.1016/j.ecolmodel.2010.08.014; Gil M, 2009, J EXP BIOL, V212, P2830, DOI 10.1242/jeb.032623; Goodwin RA, 2014, P NATL ACAD SCI USA, V111, P5277, DOI 10.1073/pnas.1311874111; GORDON IJ, 1989, OECOLOGIA, V79, P383, DOI 10.1007/BF00384318; Grove M, 2013, MATH BIOSCI, V242, P25, DOI 10.1016/j.mbs.2012.11.011; Gurarie E, 2013, THEOR ECOL-NETH, V6, P189, DOI 10.1007/s12080-012-0170-4; Gurarie E, 2011, AM NAT, V178, P113, DOI 10.1086/660285; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Humston R, 2004, T AM FISH SOC, V133, P1304, DOI 10.1577/T03-040.1; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Kacelnik A., 1987, Quantitative Analyses of Behavior, V6, P63; KAMIL AC, 1985, ANNU REV PSYCHOL, V36, P141, DOI 10.1146/annurev.ps.36.020185.001041; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; McClintock BT, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0021-6; McNamara JM, 2013, SCIENCE, V340, P1084, DOI 10.1126/science.1230599; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Mueller T, 2011, THEOR ECOL-NETH, V4, P341, DOI 10.1007/s12080-010-0081-1; Nabe-Nielsen J, 2013, OIKOS, V122, P1307, DOI 10.1111/j.1600-0706.2013.00069.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Oom SP, 2004, ECOL COMPLEX, V1, P299, DOI 10.1016/j.ecocom.2004.06.003; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; R Core Team, 2021, R LANGUAGE ENV STAT; REESE ES, 1989, ENVIRON BIOL FISH, V25, P79, DOI 10.1007/BF00002202; Regular PM, 2013, ANIM BEHAV, V86, P545, DOI 10.1016/j.anbehav.2013.06.008; Schlather M, 2014, R PACKAGE VERSION 3; Sheppard JK, 2007, ESTUAR COAST SHELF S, V71, P117, DOI 10.1016/j.ecss.2006.07.006; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Spencer WD, 2012, J MAMMAL, V93, P929, DOI 10.1644/12-MAMM-S-061.1; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Turchin Peter, 1998; TURNER MG, 1993, ECOL MODEL, V69, P163, DOI 10.1016/0304-3800(93)90026-O; Van Moorter B, 2013, ECOGRAPHY, V36, P323, DOI 10.1111/j.1600-0587.2012.07291.x; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; Vincenot CE, 2015, ECOL COMPLEX, V22, P139, DOI 10.1016/j.ecocom.2015.03.004; Watkins KS, 2013, ECOL MODEL, V250, P214, DOI 10.1016/j.ecolmodel.2012.11.011	67	53	53	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136057	10.1371/journal.pone.0136057	http://dx.doi.org/10.1371/journal.pone.0136057			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288228	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000360018600102
J	Kornblatt, JA; Quiros, V; Kornblatt, MJ				Kornblatt, Jack A.; Quiros, Veronica; Kornblatt, M. Judith			The Energetics of Streptococcal Enolase Octamer Formation: The Quantitative Contributions of the Last Eight Amino Acids at the Carboxy-Terminus	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; SIZE-DISTRIBUTION ANALYSIS; GROUP-A STREPTOCOCCI; CRYSTAL-STRUCTURE; YEAST ENOLASE; ANALYTICAL ULTRACENTRIFUGATION; PLASMINOGEN-BINDING; AQUEOUS-SOLUTION; SURFACE ENOLASE; DIMERIC ENZYME	The enolase produced by Streptococcus pyogenes is a homo-octamer whose overall shape resembles that of a donut. The octamer is best described as a tetramer of dimers. As such, it contains two types of interfaces. The first is common to almost all enolases as most enolases that have been studied are dimers. The second is unique to the octamers and includes residues near the carboxy-terminus. The primary sequence of the enolase contains 435 residues with an added 19 as an N-terminal hexahistine tag. We have systematically truncated the carboxy-terminus, individually removing the first 8 residues. This gave rise to a series of eight structures containing respectively, 435, 434, 433, 432, 431, 430, 429 and 427 residues. The truncations cause the protein to gradually dissociate from octamers to enzymatically inactive monomers with very small amounts of intermediate tetramers and dimers. We have evaluated the contributions of the missing residues to the monomer/octamer equilibrium using a combination of analytical ultracentrifugation and activity assays. For the dissociation reaction, octramer double left arrow double right arrow 8 monomer truncation of all eight C-terminal residues resulted in a diminution in the standard Gibbs energy of dissociation of about 59 kJ/mole of octamer relative to the full length protein. Considering that this change is spread over eight subunits, this translates to a change in standard Gibbs interaction energy of less than 8 kJ/mole of monomer distributed over the eight monomers. The resulting proteins, containing 434, 433, 432, 431, 430, 429 and 427 residues per monomer, showed intermediate free energies of dissociation. Finally, three other mutations were introduced into our reference protein to establish how they influenced the equilibrium. The main importance of this work is it shows that for homo-multimeric proteins a small change in the standard Gibbs interaction energy between subunits can have major physiological effects.	[Kornblatt, Jack A.] Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, Montreal, PQ H3G 1M8, Canada; [Quiros, Veronica] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Kornblatt, M. Judith] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada; Concordia University - Canada; Concordia University - Canada	Kornblatt, JA (corresponding author), Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	jack.kornblatt@concordia.ca		kornblatt, jack/0000-0002-9802-8321	Natural Sciences and Engineering Research Council (Canada) [9988]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: Funding was provided by Natural Sciences and Engineering Research Council (Canada) Grant Number 9988 jak, http://www.nserc-crsng.gc.ca/.	Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Chaussee MA, 2008, ARCH MICROBIOL, V189, P27, DOI 10.1007/s00203-007-0290-1; Cork AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121764; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gerstein M, 1996, P NATL ACAD SCI USA, V93, P10167, DOI 10.1073/pnas.93.19.10167; Gerstein M, 1999, SCIENCE, V285, P1682, DOI 10.1126/science.285.5434.1682; GUTTE B, 1971, J BIOL CHEM, V246, P1922; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; HAYASHI R, 1973, J BIOL CHEM, V248, P3889; HEATH WF, 1986, P NATL ACAD SCI USA, V83, P6367, DOI 10.1073/pnas.83.17.6367; HODGES RS, 1975, J BIOL CHEM, V250, P1231; Karbassi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008810; KORNBLATT J, 1982, EUR J BIOCHEM, V128, P577; Kornblatt JA, 2005, BIOCHEMISTRY-US, V44, P13122, DOI 10.1021/bi050895y; Kornblatt MJ, 2004, EUR J BIOCHEM, V271, P3897, DOI 10.1111/j.1432-1033.2004.04326.x; KORNBLATT MJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P277, DOI 10.1016/0003-9861(87)90032-4; Kornblatt MJ, 1996, EUR J BIOCHEM, V236, P78, DOI 10.1111/j.1432-1033.1996.00078.x; Kornblatt MJ, 1998, EUR J BIOCHEM, V251, P775, DOI 10.1046/j.1432-1327.1998.2510775.x; KORNBLATT MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P495, DOI 10.1006/abbi.1993.1542; LIN MC, 1972, J BIOL CHEM, V247, P4768; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Martin TW, 1999, NAT STRUCT BIOL, V6, P403, DOI 10.1038/8195; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Perica T, 2014, SCIENCE, V346, DOI 10.1126/science.1254346; Perica T, 2012, P NATL ACAD SCI USA, V109, P8127, DOI 10.1073/pnas.1120028109; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Roche J, 2013, J AM CHEM SOC, V135, P14610, DOI 10.1021/ja406682e; Schottel BL, 2008, CHEM SOC REV, V37, P68, DOI 10.1039/b614208g; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Sims PA, 2005, J MOL CATAL B-ENZYM, V32, P77, DOI 10.1016/j.molcatb.2004.10.002; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TIMASHEFF SN, 1992, BIOCHEMISTRY-US, V31, P9857, DOI 10.1021/bi00156a001; Tsatsaronis JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004266; UNSON CG, 1995, J BIOL CHEM, V270, P27720, DOI 10.1074/jbc.270.46.27720; van Holde K.E., 1998, PRINCIPLES PHYS BIOC, Vsecond; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WUTHRICH K, 1992, FARADAY DISCUSS, V93, P35, DOI 10.1039/fd9929300035; Zhao SP, 2008, FEBS J, V275, P97, DOI 10.1111/j.1742-4658.2007.06177.x	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135754	10.1371/journal.pone.0135754	http://dx.doi.org/10.1371/journal.pone.0135754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287818	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600066
J	Navanesan, S; Wahab, NA; Manickam, S; Sim, KS				Navanesan, Suerialoasan; Wahab, Norhanom Abdul; Manickam, Sugumaran; Sim, Kae Shin			Leptospermum flavescens Constituent-LF1 Causes Cell Death through the Induction of Cell Cycle Arrest and Apoptosis in Human Lung Carcinoma Cells	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; CANCER; PROLIFERATION; CASPASE-3; SMOKING; ASSAY	Leptospermum flavescens Sm. (Myrtaceae), locally known as 'Senna makki' is a smallish tree that is widespread and recorded to naturally occur in the montane regions above 900 m a.s.l from Burma to Australia. Although the species is recorded to be used traditionally to treat various ailments, there is limited data on biological and chemical investigations of L. flavescens. The aim of the present study was to investigate and understand the ability of L. flavescens in inducing cell death in lung cancer cells. The cytotoxic potentials of the extraction yields (methanol, hexane, ethyl acetate and water extracts as wells as a semi pure fraction, LF1) were evaluated against two human non-small cell lung carcinoma cell lines (A549 and NCI-H1299) using the MTT assay. LF1 showed the greatest cytotoxic effect against both cell lines with IC50 values of 7.12 +/- 0.07 and 9.62 +/- 0.50 mu g/ml respectively. LF1 treated cells showed a sub-G1 region in the cell cycle analysis and also caused the presence of apoptotic morphologies in cells stained with acridine orange and ethidium bromide. Treatment with LF1 manifested an apoptotic population in cells that were evaluated using the Annexin V/propidium iodide assay. Increasing dosage of LF1 caused a rise in the presence of activated caspase-3 enzymes in treated cells. Blockage of cell cycle progression was also observed in LF1-treated cells. These findings suggest that LF1 induces apoptosis and cell cycle arrest in treated lung cancer cells. Further studies are being conducted to isolate and identify the active compound as well to better understand the mechanism involved in inducing cell death.	[Navanesan, Suerialoasan; Sim, Kae Shin] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Wahab, Norhanom Abdul] Univ Malaya, Div Biol, Ctr Fdn Studies Sci, Kuala Lumpur, Malaysia; [Manickam, Sugumaran] Univ Malaya, Fac Sci, Inst Biol Sci, Rimba Ilmu Bot Garden, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Sim, KS (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	simkaeshin@um.edu.my	SIM, KAE SHIN/B-9780-2010; NAVANESAN, SUERIALOASAN/AAK-5297-2020; Manickam, Sugumaran/B-5268-2010	Manickam, Sugumaran/0000-0003-3125-767X	University of Malaya [RG082-13BIO, FP006-2013A]	University of Malaya(Universiti Malaya)	This work was supported by research funding from University of Malaya Research Grant (UMRG), RG082-13BIO and Fundamental Research Grant Scheme (FRGS), FP006-2013A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS MJ, 1990, AM J PATHOL, V136, P593; Ariffin SHZ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-6; Bartucci M, 2012, CELL DEATH DIFFER, V19, P768, DOI 10.1038/cdd.2011.170; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Batugal PA, 2004, MED PLANTS RES ASIA, VI; Bi XL, 2014, EUR J PHARMACOL, V742, P145, DOI 10.1016/j.ejphar.2014.08.032; Catelinois O, 2006, ENVIRON HEALTH PERSP, V114, P1361, DOI 10.1289/ehp.9070; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Demuner AJ, 2011, MOLECULES, V16, P1181, DOI 10.3390/molecules16021181; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gorlova OY, 2007, INT J CANCER, V121, P111, DOI 10.1002/ijc.22615; HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8; Hseu YC, 2014, J ETHNOPHARMACOL, V153, P499, DOI 10.1016/j.jep.2014.03.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; Kabir Z, 2007, Ir Med J, V100, P367; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Khazir J, 2013, J ASIAN NAT PROD RES, V15, P764, DOI 10.1080/10286020.2013.798314; King RJB, 2006, CANC BIOL; Li L, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-49; Mahavorasirikul W, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-55; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PARKIN DM, 1994, INT J CANCER, V59, P494, DOI 10.1002/ijc.2910590411; Parrish Amanda B, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a008672; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Sachithanandan A, 2012, Med J Malaysia, V67, P3; Sancho-Martinez SM, 2011, TOXICOL SCI, V122, P73, DOI 10.1093/toxsci/kfr098; Song GB, 2006, COLLOID SURFACE B, V48, P1, DOI 10.1016/j.colsurfb.2005.12.012; Stark R, 1981, BOOK APHRODISIACS; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135995	10.1371/journal.pone.0135995	http://dx.doi.org/10.1371/journal.pone.0135995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287817	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600096
J	Rubiano-Labrador, C; Bland, C; Miotello, G; Armengaud, J; Baena, S				Rubiano-Labrador, Carolina; Bland, Celine; Miotello, Guylaine; Armengaud, Jean; Baena, Sandra			Salt Stress Induced Changes in the Exoproteome of the Halotolerant Bacterium Tistlia consotensis Deciphered by Proteogenomics	PLOS ONE			English	Article							MODERATELY HALOPHILIC BACTERIUM; PROTEIN SECRETION; MASS-SPECTROMETRY; LIGAND-BINDING; PROTEOMICS; TOLERANCE; BIOSYNTHESIS; TRANSDUCTION; PEPTIDES; GENOMICS	The ability of bacteria to adapt to external osmotic changes is fundamental for their survival. Halotolerant microorganisms, such as Tistlia consotensis, have to cope with continuous fluctuations in the salinity of their natural environments which require effective adaptation strategies against salt stress. Changes of extracellular protein profiles from Tistlia consotensis in conditions of low and high salinities were monitored by proteogenomics using a bacterial draft genome. At low salinity, we detected greater amounts of the HpnM protein which is involved in the biosynthesis of hopanoids. This may represent a novel, and previously unreported, strategy by halotolerant microorganisms to prevent the entry of water into the cell under conditions of low salinity. At high salinity, proteins associated with osmosensing, exclusion of Na+ and transport of compatible solutes, such as glycine betaine or proline are abundant. We also found that, probably in response to the high salt concentration, T. consotensis activated the synthesis of flagella and triggered a chemotactic response neither of which were observed at the salt concentration which is optimal for growth. Our study demonstrates that the exoproteome is an appropriate indicator of adaptive response of T. consotensis to changes in salinity because it allowed the identification of key proteins within its osmoadaptive mechanism that had not previously been detected in its cell proteome.	[Rubiano-Labrador, Carolina; Baena, Sandra] Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento Biotecnol Ambiental, Bogota, DC, Colombia; [Rubiano-Labrador, Carolina; Baena, Sandra] GeBiX, Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, DC, Colombia; [Bland, Celine; Miotello, Guylaine; Armengaud, Jean] CEA, DSV, IBEB, SBTN,Lab Biochim Syst Perturb, F-30207 Bagnols Sur Ceze, France	Pontificia Universidad Javeriana; CEA	Baena, S (corresponding author), Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento Biotecnol Ambiental, POB 56710, Bogota, DC, Colombia.	baena@javeriana.edu.co	Baena, Sandra/AAF-8165-2019	ARMENGAUD, Jean/0000-0003-1589-445X; Rubiano Labrador, Carolina/0000-0001-9064-3680; Baena, Sandra/0000-0001-5377-9079; Miotello, Guylaine/0000-0002-2398-1249	Commissariat al'Energie Atomique et aux Energies Alternatives (C. E.A. Lab Biochim SystemPerturb, France); Pontificia Universidad Javeriana (Colombia); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS, Colombia); Colombian Center for Genomics and Bioinformatics of Extreme Environments (GeBiX, Colombia); ECOS-NORD bilateralprogram; MAVDT [56]	Commissariat al'Energie Atomique et aux Energies Alternatives (C. E.A. Lab Biochim SystemPerturb, France); Pontificia Universidad Javeriana (Colombia); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS, Colombia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Colombian Center for Genomics and Bioinformatics of Extreme Environments (GeBiX, Colombia); ECOS-NORD bilateralprogram; MAVDT	The authors thank the Commissariat al'Energie Atomique et aux Energies Alternatives (C. E.A. Lab Biochim SystemPerturb, France), Pontificia Universidad Javeriana (Colombia), Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS, Colombia), Colombian Center for Genomics and Bioinformatics of Extreme Environments (GeBiX, Colombia), and the ECOS-NORD bilateralprogram for financial support. This work was carried out under MAVDT Research Permit Resolution No. 0168, 2009 and MAVDT Contract No. 56, 2013 for Access to Genetic Resources.	Armengaud J, 2013, ENVIRON MICROBIOL, V15, P12, DOI 10.1111/j.1462-2920.2012.02811.x; Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Ashby MK, 2004, FEMS MICROBIOL LETT, V231, P277, DOI 10.1016/S0378-1097(04)00004-7; Averhoff B, 2010, RES MICROBIOL, V161, P506, DOI 10.1016/j.resmic.2010.05.006; Bagos PG, 2008, J PROTEOME RES, V7, P5082, DOI 10.1021/pr800162c; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; BERRY AM, 1993, P NATL ACAD SCI USA, V90, P6091, DOI 10.1073/pnas.90.13.6091; Breed J, 2001, ACTA CRYSTALLOGR D, V57, P448, DOI 10.1107/S0907444901000397; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Christie-Oleza JA, 2012, ISME J, V6, P124, DOI 10.1038/ismej.2011.86; Christie-Oleza JA, 2010, MAR DRUGS, V8, P2223, DOI 10.3390/md8082223; Clair G, 2010, MOL CELLULAR PROTEOM; Dalbey RE, 2012, FEMS MICROBIOL REV, V36, P1023, DOI 10.1111/j.1574-6976.2012.00327.x; de Carvalho CCCR, 2010, MAR DRUGS, V8, P705, DOI 10.3390/md8030705; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Dedieu A, 2011, J BIOL CHEM, V286, P259, DOI 10.1074/jbc.M110.159483; Derr P, 2006, J MOL BIOL, V355, P923, DOI 10.1016/j.jmb.2005.11.025; Diaz-Cardenas C, 2010, INT J SYST EVOL MICR, V60, P1437, DOI 10.1099/ijs.0.010926-0; Diaz-Cardenas C, 2011, THESIS PONTIFICIA U; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Gul N, 2013, MOL MEMBR BIOL, V30, P138, DOI 10.3109/09687688.2012.754060; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Harrison JP, 2013, TRENDS MICROBIOL, V21, P204, DOI 10.1016/j.tim.2013.01.006; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HORBACH S, 1991, FEMS MICROBIOL LETT, V79, P347, DOI 10.1016/0378-1097(91)90110-V; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kim K, 1998, J BACTERIOL, V180, P3692, DOI 10.1128/JB.180.14.3692-3696.1998; Kokoeva MV, 2002, EMBO J, V21, P2312, DOI 10.1093/emboj/21.10.2312; Koster M, 2000, INT J MED MICROBIOL, V290, P325; Kramer R, 2010, CHEM REC, V10, P217, DOI 10.1002/tcr.201000005; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Lacal J, 2010, ENVIRON MICROBIOL, V12, P2873, DOI 10.1111/j.1462-2920.2010.02325.x; Lopes MS, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-92; Magnus M, 2012, BBA-PROTEINS PROTEOM, V1824, P1425, DOI 10.1016/j.bbapap.2012.05.018; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Muddiman D, 2010, ANAL BIOANAL CHEM, V398, P377, DOI 10.1007/s00216-010-3955-6; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Penn K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-86; PORALLA K, 1984, FEMS MICROBIOL LETT, V23, P253; Poralla K, 2000, FEMS MICROBIOL LETT, V189, P93, DOI 10.1111/j.1574-6968.2000.tb09212.x; Pumirat P, 2009, BBA-PROTEINS PROTEOM, V1794, P898, DOI 10.1016/j.bbapap.2009.01.011; Roessler M, 2002, J BACTERIOL, V184, P6207, DOI 10.1128/JB.184.22.6207-6215.2002; Rubiano-Labrador C, 2014, J PROTEOMICS, V97, P36, DOI 10.1016/j.jprot.2013.05.020; Saum SH, 2007, J BACTERIOL, V189, P6968, DOI 10.1128/JB.00775-07; Schmerk CL, 2011, J BACTERIOL, V193, P6712, DOI 10.1128/JB.05979-11; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Tsuzuki M, 2011, APPL ENVIRON MICROB, V77, P7551, DOI 10.1128/AEM.05463-11; WALMSLEY AR, 1992, J BIOL CHEM, V267, P8064; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Zhang WJ, 2012, J MOL BIOL, V416, P558, DOI 10.1016/j.jmb.2011.12.065; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	56	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135065	10.1371/journal.pone.0135065	http://dx.doi.org/10.1371/journal.pone.0135065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287734	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600035
J	Traver, S; Scalici, E; Mullet, T; Molinari, N; Vincens, C; Anahory, T; Hamamah, S				Traver, Sabine; Scalici, Elodie; Mullet, Tiffany; Molinari, Nicolas; Vincens, Claire; Anahory, Tal; Hamamah, Samir			Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes	PLOS ONE			English	Article							HUMAN CUMULUS CELLS; FREE NUCLEIC-ACIDS; CONTROLLED OVARIAN STIMULATION; ANTI-MULLERIAN HORMONE; EMBRYO CULTURE-MEDIUM; ANTIMULLERIAN HORMONE; MITOCHONDRIAL-DNA; GENE-EXPRESSION; GNRH ANTAGONIST; PREGNANCY	Cell-free DNA (cfDNA) fragments, detected in blood and in other biological fluids, are released from apoptotic and/or necrotic cells. CfDNA is currently used as biomarker for the detection of many diseases such as some cancers and gynecological and obstetrics disorders. In this study, we investigated if cfDNA levels in follicular fluid (FF) samples from in vitro fertilization (IVF) patients, could be related to their ovarian reserve status, controlled ovarian stimulation (COS) protocols and IVF outcomes. Therefore, 117 FF samples were collected from women (n = 117) undergoing IVF/Intra-cytoplasmic sperm injection (ICSI) procedure and cfDNA concentration was quantified by ALU-quantitative PCR. We found that cfDNA level was significantly higher in FF samples from patients with ovarian reserve disorders (low functional ovarian reserve or polycystic ovary syndrome) than from patients with normal ovarian reserve (2.7 +/- 2.7 ng/mu l versus 1.7 +/- 2.3 ng/mu l, respectively, p = 0.03). Likewise, FF cfDNA levels were significant more elevated in women who received long ovarian stimulation (>10 days) or high total dose of gonadotropins (>= 3000 IU/l) than in women who received short stimulation duration (7-10 days) or total dose of gonadotropins < 3000 IU/l (2.4 +/- 2.8 ng/mu l versus 1.5 +/- 1.9 ng/mu l, p = 0.008; 2.2 +/- 2.3 ng/mu l versus 1.5 +/- 2.1 ng/mu l, p = 0.01, respectively). Finally, FF cfDNA level was an independent and significant predictive factor for pregnancy outcome (adjusted odds ratio = 0.69 [0.5; 0.96], p = 0.03). In multivariate analysis, the Receiving Operator Curve (ROC) analysis showed that the performance of FF cfDNA in predicting clinical pregnancy reached 0.73 [0.66-0.87] with 88% specificity and 60% sensitivity. CfDNA might constitute a promising biomarker of follicular micro-environment quality which could be used to predict IVF prognosis and to enhance female infertility management.	[Traver, Sabine; Scalici, Elodie; Hamamah, Samir] St Eloi Hosp, CHU Montpellier, Inst Regenerat Med & Biotherapy, INSERM,U1203, Montpellier, France; [Scalici, Elodie; Mullet, Tiffany; Hamamah, Samir] Univ Montpellier I, UFR Med, Montpellier, France; [Scalici, Elodie; Mullet, Tiffany; Vincens, Claire; Anahory, Tal; Hamamah, Samir] CHU Montpellier, Arnaud de Villeneuve Hosp, ART PGD Dept, Montpellier, France; [Molinari, Nicolas] CHRU, DIM, UMR 1049, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Hamamah, S (corresponding author), St Eloi Hosp, CHU Montpellier, Inst Regenerat Med & Biotherapy, INSERM,U1203, Montpellier, France.	s-hamamah@chu-montpellier.fr	HAMAMAH, Samir/AAC-4156-2019; molinari, nicolas/Y-9681-2019		University Hospital of Montpellier; Ferring Pharmaceuticals	University Hospital of Montpellier; Ferring Pharmaceuticals(Ferring Pharmaceuticals)	This study was funded with partial financial support from the University Hospital of Montpellier and Ferring Pharmaceuticals. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Baka S, 2006, REPROD BIOMED ONLINE, V12, P500, DOI 10.1016/S1472-6483(10)62005-6; Broekmans FJ, 2014, HUM REPROD, V29, P1688, DOI 10.1093/humrep/deu090; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Carpintero Nayara Lopez, 2014, J Hum Reprod Sci, V7, P187, DOI 10.4103/0974-1208.142479; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chiba H, 1997, GYNECOL OBSTET INVES, V43, P171, DOI 10.1159/000291848; Czamanski-Cohen J, 2014, ARCH WOMEN MENT HLTH, V17, P251, DOI 10.1007/s00737-013-0407-2; Czamanski-Cohen J, 2013, REPROD BIOMED ONLINE, V26, P36, DOI 10.1016/j.rbmo.2012.09.018; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Ficicioglu C, 2014, GYNECOL ENDOCRINOL, V30, P372, DOI 10.3109/09513590.2014.887064; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gebhardt KM, 2011, FERTIL STERIL, V96, P47, DOI 10.1016/j.fertnstert.2011.04.033; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Iager AE, 2013, FERTIL STERIL, V99, P745, DOI 10.1016/j.fertnstert.2012.10.041; Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; La Marca A, 2014, HUM REPROD UPDATE, V20, P124, DOI 10.1093/humupd/dmt037; La Marca A, 2012, CURR PHARM BIOTECHNO, V13, P398, DOI 10.2174/138920112799361972; Lavorato HL, 2012, EUR J OBSTET GYN R B, V165, P61, DOI 10.1016/j.ejogrb.2012.07.014; Ledee N, 2013, HUM REPROD, V28, P406, DOI 10.1093/humrep/des354; Liu S, 2011, REPROD FERT DEVELOP, V23, P990, DOI 10.1071/RD11079; Lynch CD, 2014, HUM REPROD, V29, P1067, DOI 10.1093/humrep/deu032; Mendoza C, 2002, HUM REPROD, V17, P1017, DOI 10.1093/humrep/17.4.1017; Nardo LG, 2009, FERTIL STERIL, V92, P1586, DOI 10.1016/j.fertnstert.2008.08.127; Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051; Ni XR, 2015, REPROD SCI, V22, P271, DOI 10.1177/1933719114549852; Ralla B, 2014, CRIT REV CL LAB SCI, V51, pA2, DOI 10.3109/10408363.2014.914888; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Scalici E, 2014, HUM REPROD, V29, P2661, DOI 10.1093/humrep/deu238; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Seifer DB, 1996, FERTIL STERIL, V66, P593, DOI 10.1016/S0015-0282(16)58573-2; Spencer S J, 1996, Obstet Gynecol Surv, V51, P314, DOI 10.1097/00006254-199605000-00023; Stigliani S, 2014, MOL HUM REPROD, V20, P1238, DOI 10.1093/molehr/gau086; Stigliani S, 2013, HUM REPROD, V28, P2652, DOI 10.1093/humrep/det314; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Tal R, 2015, FERTIL STERIL, V103, P119, DOI 10.1016/j.fertnstert.2014.09.041; Traver S, 2014, HUM REPROD UPDATE, V20, P905, DOI 10.1093/humupd/dmu031; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; Uyar A, 2013, FERTIL STERIL, V99, P979, DOI 10.1016/j.fertnstert.2013.01.129; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Vital Reyes V S, 2001, Ginecol Obstet Mex, V69, P101; Lan VTN, 2013, REPROD BIOMED ONLINE, V27, P390, DOI 10.1016/j.rbmo.2013.07.008; Wathlet S, 2012, FERTIL STERIL, V98, P432, DOI 10.1016/j.fertnstert.2012.05.007; Xu XF, 2015, REPROD SCI, V22, P173, DOI 10.1177/1933719114536471; Yanaihara A, 2007, FERTIL STERIL, V87, P279, DOI 10.1016/j.fertnstert.2006.06.025; Younis JS, 2005, FERTIL STERIL, V83, P504, DOI 10.1016/j.fertnstert.2004.09.021	51	19	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136172	10.1371/journal.pone.0136172	http://dx.doi.org/10.1371/journal.pone.0136172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288130	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600115
J	Mei, SY; Xin, JX; Liu, Y; Zhang, Y; Liang, X; Su, XM; Yan, H; Huang, YG; Yang, RC				Mei, Shiyue; Xin, Jiaxuan; Liu, Yu; Zhang, Yuan; Liang, Xue; Su, Xiaomin; Yan, Hui; Huang, Yugang; Yang, Rongcun			MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; T-CELL; DENDRITIC CELLS; GM-CSF; CANCER; DIFFERENTIATION; ACCUMULATION; INFLAMMATION; MECHANISMS; INTERLEUKIN-10	Myeloid-derived suppressor cells (MDSCs) constitute one of the major populations that potently suppress anti-tumor immune responses and favor tumor growth in tumor microenvironment. However, the mechanism(s) regulating the differentiation and suppressive function of tumor-associated MDSCs remain(s) unclear. Here, we identified a microRNA-200c (miR-200c), whose expression was dramatically induced by tumor-derived factors. Meanwhile, we also demonstrated that GM-CSF was a main inducer of miR-200c in tumor environment, and miR-200c in turn promoted the expansion and immune suppressive activity of MDSCs via targeting phosphatase and tensin homolog (PTEN) and friend of Gata 2 (FOG2), which can lead to STAT3 and PI3K/Akt activation. Finally, we examined in vivo suppressive function of miR-200c transfected MDSCs and found that miR-200c could remarkably promote tumor growth via modifying MDSCs. Thus, GM-CSF induced miR200c in tumor environment plays a critical role in governing the expansion and functions of tumor-associated MDSCs and serves as a potential target in immunotherapy against tumor.	[Mei, Shiyue; Xin, Jiaxuan; Liu, Yu; Zhang, Yuan; Liang, Xue; Su, Xiaomin; Yan, Hui; Huang, Yugang; Yang, Rongcun] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China; [Yang, Rongcun] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Yang, Rongcun] Nankai Univ, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Yang, RC (corresponding author), Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China.	ryang@nankai.edu.cn			NSFC [31470876, 91029736, 91442111]; ISF-NSFC program [31461143010]; Ministry of Science and Technology grant (863 program) [2008AA02Z129]; National Key Scientific Program [2011CB964902]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13023]; State Key Laboratory of Medicinal Chemical Biology	NSFC(National Natural Science Foundation of China (NSFC)); ISF-NSFC program; Ministry of Science and Technology grant (863 program); National Key Scientific Program; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State Key Laboratory of Medicinal Chemical Biology	This research was supported by NSFC grants 31470876, 91029736, 91442111 and ISF-NSFC program 31461143010, a Ministry of Science and Technology grant (863 program, 2008AA02Z129), the National Key Scientific Program (2011CB964902) the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13023) and State Key Laboratory of Medicinal Chemical Biology.	Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goddard S, 2004, AM J PATHOL, V164, P511, DOI 10.1016/S0002-9440(10)63141-0; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Kusmartsev S, 2006, CANCER METAST REV, V25, P323, DOI 10.1007/s10555-006-9002-6; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li LM, 2014, J IMMUNOL, V192, P1034, DOI 10.4049/jimmunol.1301309; Liu QF, 2011, INT J CANCER, V129, P2662, DOI 10.1002/ijc.25921; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Min SP, 2013, J IMMUNOL, V190, P2437, DOI 10.4049/jimmunol.1202282; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; PAK AS, 1995, CLIN CANCER RES, V1, P95; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Petriv OI, 2010, P NATL ACAD SCI USA, V107, P15443, DOI 10.1073/pnas.1009320107; PISA P, 1992, P NATL ACAD SCI USA, V89, P7708, DOI 10.1073/pnas.89.16.7708; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Sonda N, 2013, IMMUNITY, V38, P1236, DOI 10.1016/j.immuni.2013.06.004; Yang RC, 2004, J VIROL, V78, P11152, DOI 10.1128/JVI.78.20.11152-11160.2004; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang MM, 2011, J IMMUNOL, V186, P4716, DOI 10.4049/jimmunol.1002989; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	43	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135867	10.1371/journal.pone.0135867	http://dx.doi.org/10.1371/journal.pone.0135867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285119	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100078
J	Oi, M; Yoshikawa, S; Maruyama, S; Nogami, S				Oi, Masaaki; Yoshikawa, Souichi; Maruyama, Soichi; Nogami, Sadao			Comparison of Toxoplasma gondii Seroprevalence in Shelter Cats and Dogs during 1999-2001 and 2009-2011 in Tokyo, Japan	PLOS ONE			English	Article							DOMESTIC CATS; BARTONELLA-HENSELAE; RISK-FACTORS; INFECTION; TRANSMISSION; PREVALENCE; ANTIBODIES; CHILDREN	Toxoplasma gondii is an important human health concern with respect to abortion, congenital hydrocephalus, and encephalitis in immunocompromised people. Cats and dogs both are potential sources of T. gondii because they have close contact with humans. However, no epidemiological surveys have been conducted in Tokyo over the past decade. Therefore, the present study investigated and compared the seroprevalence of T. gondii infection in shelter cats and dogs during 1999-2001 and 2009-2011 in Tokyo, Japan. Serum samples were collected from 337 shelter cats and 325 shelter dogs in urban and suburban areas of Tokyo, during 1999-2001 (233 cats and 219 dogs) and 2009-2011 (104 cats and 106 dogs). T. gondii antibodies were measured in the serum samples using a commercial latex agglutination test. Data were compared using the Fisher's exact test, and significance was indicated at P < 0.05. The overall seroprevalence of T. gondii infection in cats was 5.6% (13 of 233) in 1999-2001 and 6.7% (7 of 104) in 2009-2011, and that in dogs was 1.8% (4 of 219) and 1.9% (2 of 106), respectively. Significantly higher seroprevalence was observed in cats from suburban areas compared with cats in urban areas during both periods (P < 0.05). These results reveal that there has been little change in the feline and canine seroprevalence over the past decade, indicating that the risk of T. gondii exposure for cats and dogs in Tokyo is considerably low as the seroprevalence has reached a steady state.	[Oi, Masaaki; Maruyama, Soichi; Nogami, Sadao] Nihon Univ, Dept Vet Med, Fujisawa, Kanagawa, Japan; [Yoshikawa, Souichi] Tokyo Metropolitan Inst Publ Hlth, Dept Food Safety, Shinjuku Ku, Tokyo 1690073, Japan	Nihon University	Oi, M (corresponding author), Nihon Univ, Dept Vet Med, Fujisawa, Kanagawa, Japan.	brma12501@g.nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [S1491007]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was financially supported in part by a Grant-in-Aid for the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (S1491007, Soichi Maruyama, http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso E, 2010, EPIDEMIOL INFECT, V138, P1105, DOI 10.1017/S0950268809991270; Day MJ., 2012, EMERG INFECT DIS, V18, DOI [10.3201/eid1812.120664, DOI 10.3201/EID1812.120664]; de Brito AF, 2002, MEM I OSWALDO CRUZ, V97, P31, DOI 10.1590/S0074-02762002000100003; Deksne G, 2013, J PARASITOL, V99, P48, DOI 10.1645/GE-3254.1; Dubey JP, 2010, TOXOPLASMOSIS IN ANI; Etheredge GD, 2004, REV PANAM SALUD PUBL, V16, P176, DOI 10.1590/S1020-49892004000900004; Frenkel Jacob Karl, 2003, Int J Infect Dis, V7, P292, DOI 10.1016/S1201-9712(03)90112-3; FRENKEL JK, 1970, SCIENCE, V167, P893, DOI 10.1126/science.167.3919.893; FRENKEL JK, 1995, AM J TROP MED HYG, V53, P458, DOI 10.4269/ajtmh.1995.53.458; Hornok S, 2008, ACTA VET HUNG, V56, P81, DOI 10.1556/AVet.56.2008.1.8; Jittapalapong S, 2007, VET PARASITOL, V145, P138, DOI 10.1016/j.vetpar.2006.10.021; Lindsay DS, 1997, VET PARASITOL, V73, P27, DOI 10.1016/S0304-4017(97)00048-4; Lopes AP, 2011, J PARASITOL, V97, P418, DOI 10.1645/GE-2691.1; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Maruyama S, 1998, J VET MED SCI, V60, P997, DOI 10.1292/jvms.60.997; Maruyama S, 2003, MICROBIOL IMMUNOL, V47, P147, DOI 10.1111/j.1348-0421.2003.tb02798.x; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nogami S, 1998, J VET MED SCI, V60, P1001, DOI 10.1292/jvms.60.1001; Opsteegh M, 2012, PREV VET MED, V104, P317, DOI 10.1016/j.prevetmed.2012.01.003; Saito N, 2008, J ENVIRON DIS, V17, P1; Saito N, 2005, J ENVIRON, V14, P5; Sakikawa M, 2012, CLIN VACCINE IMMUNOL, V19, P365, DOI 10.1128/CVI.05486-11; [Tokyo Metropolitan Government Bureau of Environment], 2014, TOKYO METROPOLITAN G; YILMAZ SM, 1972, J PARASITOL, V58, P938, DOI 10.2307/3286589	25	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135956	10.1371/journal.pone.0135956	http://dx.doi.org/10.1371/journal.pone.0135956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284780	Green Submitted, gold, Green Published			2022-12-27	WOS:000359666100091
J	Shang, XF; Luo, ZL; Wang, XD; Jaeblon, T; Marymont, JV; Dong, YF				Shang, Xifu; Luo, Zhengliang; Wang, Xudong; Jaeblon, Todd; Marymont, John V.; Dong, Yufeng			Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling	PLOS ONE			English	Article							BONE-MARROW; STROMAL CELLS; GROWTH-FACTOR; DIFFERENTIATION	Recently we have demonstrated the importance of RBPjk-dependent Notch signaling in the regulation of mesenchymal stem cell (MSC) differentiation during skeletogenesis both in vivo and in vitro. Here we further performed RBPJK loss-of-function experiments to demonstrate for the first time that RBPJK deficient MSC shows enhanced differentiation and osteogenesis acts via up-regulation of the BMP signaling. In the present study, we first compared the spontaneous and osteogenic differentiation in normal and recombination signal binding protein for immunoglobulin kappa J region (RBPJK) deficient human bone marrow-derived mesenchymal stem cells (MSCs). It was found that RBPJK highly expressed in fresh isolated MSCs and its expression was progressing down-regulated during spontaneous differentiation and even greater in osteogenic media inducted differentiation. Deletion of RBPJK in MSCs not only enhances cell spontaneous differentiation, but also significantly accelerates condition media inducted osteogenic differentiation by showing enhanced alkaline phosphatase (ALP) activity, Alizarin red staining, gene expression of Runx2, Osteopontin (OPN), Type I collagen (COL1a1) in culture. Additionally, BMP signaling responsive reporter activity and phosphor-smad1/5/8 expression were also significantly increased upon removal of RBPJK in MSCs. These data proved that inhibition of Notch signaling in MSCs promotes cell osteogenic differentiation by up-regulation of BMP signaling, and RBPJK deficient MSC maybe a better cell population for cell-based bone tissue engineering.	[Shang, Xifu; Luo, Zhengliang] Anhui Prov Hosp, Dept Orthopaed Surg, Hefei, Anhui, Peoples R China; [Wang, Xudong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Craniomaxillofacial Surg, Shanghai 200030, Peoples R China; [Jaeblon, Todd; Marymont, John V.; Dong, Yufeng] Louisiana State Univ, Hlth Sci Ctr, Dept Orthopaed Surg, Shreveport, LA 71105 USA	Shanghai Jiao Tong University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Dong, YF (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Orthopaed Surg, Shreveport, LA 71105 USA.	ydong@lsuhsc.edu			NIH/NIAMS [AR063803]; Department of Orthopedic Surgery at LSUHSC-Shreveport; China Anhui Province [1503062022]; Natural Science Foundation of China [81271122]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063803] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Orthopedic Surgery at LSUHSC-Shreveport; China Anhui Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the following grants: NIH/NIAMS R21 grant (AR063803) to YD, Start-up funds from Department of Orthopedic Surgery at LSUHSC-Shreveport to YD, Foreign scientific cooperation grant from China Anhui Province (Grant No. 1503062022) to XS, the Natural Science Foundation of China (Grant No. 81271122) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Bai Y, 2013, BIOTECHNOL LETT, V35, P301, DOI 10.1007/s10529-012-1084-3; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105705; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; D'Alimonte I, 2013, STEM CELL RES, V11, P611, DOI 10.1016/j.scr.2013.04.002; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dong Y, 2014, STEM CELLS TRANSLATI; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; FRIEDENSTEIN A, 1971, TRANSPLANTATION, V12, P99, DOI 10.1097/00007890-197108000-00001; Giuliani N, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/312501; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Horn P, 2008, CYTOTHERAPY, V10, P676, DOI 10.1080/14653240802398845; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; La Noce M, 2014, J DENT, V42, P761, DOI 10.1016/j.jdent.2014.02.018; Lee MW, 2004, BIOCHEM BIOPH RES CO, V320, P273, DOI 10.1016/j.bbrc.2004.04.206; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Oliveira MS, 2015, WORLD J STEM CELLS, V7, P769, DOI 10.4252/wjsc.v7.i4.769; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Rodriguez IA, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/159484; Ulrich H, 2015, STEM CELL REV REP, V11, P474, DOI 10.1007/s12015-014-9556-6; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074255; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC	30	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135971	10.1371/journal.pone.0135971	http://dx.doi.org/10.1371/journal.pone.0135971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285013	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100093
J	Al-Mubarak, BR; Bohlega, SA; Alkhairallah, TS; Magrashi, AI; AlTurki, MI; Khalil, DS; AlAbdulaziz, BS; Abou Al-Shaar, H; Mustafa, AE; Alyemni, EA; Alsaffar, BA; Tahir, AI; Al Tassan, NA				Al-Mubarak, Bashayer R.; Bohlega, Saeed A.; Alkhairallah, Thamer S.; Magrashi, Amna I.; AlTurki, Maha I.; Khalil, Dania S.; AlAbdulaziz, Basma S.; Abou Al-Shaar, Hussam; Mustafa, Abeer E.; Alyemni, Eman A.; Alsaffar, Bashayer A.; Tahir, Asma I.; Al Tassan, Nada A.			Parkinson's Disease in Saudi Patients: A Genetic Study	PLOS ONE			English	Article							UBIQUITIN-PROTEIN LIGASE; EARLY-ONSET PARKINSONISM; PINK1 MUTATIONS; DJ-1 MUTATIONS; LRRK2 G2019S; POLYMORPHISM; DOMAIN; ASSOCIATION; STABILITY; VARIANTS	Parkinson's disease (PD) is one of the major causes of parkinsonism syndrome. Its characteristic motor symptoms are attributable to dopaminergic neurons loss in the midbrain. Genetic advances have highlighted underlying molecular mechanisms and provided clues to potential therapies. However, most of the studies focusing on the genetic component of PD have been performed on American, European and Asian populations, whereas Arab populations (excluding North African Arabs), particularly Saudis remain to be explored. Here we investigated the genetic causes of PD in Saudis by recruiting 98 PD-cases (sporadic and familial) and screening them for potential pathogenic mutations in PD-established genes; SNCA, PARKIN, PINK1, PARK7/DJ1, LRRK2 and other PD-associated genes using direct sequencing. To our surprise, the screening revealed only three pathogenic point mutations; two in PINK1 and one in PARKIN. In addition to mutational analysis, CNV and cDNA analysis was performed on a subset of patients. Exon/intron dosage alterations in PARKIN were detected and confirmed in 2 cases. Our study suggests that mutations in the ORF of the screened genes are not a common cause of PD in Saudi population; however, these findings by no means exclude the possibility that other genetic events such as gene expression/dosage alteration may be more common nor does it eliminate the possibility of the involvement of novel genes.	[Al-Mubarak, Bashayer R.; Magrashi, Amna I.; AlTurki, Maha I.; Khalil, Dania S.; AlAbdulaziz, Basma S.; Abou Al-Shaar, Hussam; Mustafa, Abeer E.; Alyemni, Eman A.; Tahir, Asma I.; Al Tassan, Nada A.] King Faisal Specialist Hosp & Res Ctr, Behav Genet Unit, Dept Genet, Riyadh 11211, Saudi Arabia; [Bohlega, Saeed A.; Alkhairallah, Thamer S.] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia; [Alsaffar, Bashayer A.] King Abdulaziz City Sci & Technol, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Abdulaziz City for Science & Technology	Al-Mubarak, BR (corresponding author), King Faisal Specialist Hosp & Res Ctr, Behav Genet Unit, Dept Genet, Riyadh 11211, Saudi Arabia.	BAl-Mubarak@kfshrc.edu.sa	Al-Mubarak, Bashayer/ABI-5117-2020; Tassan, Nada Al/K-5605-2019	Al-Mubarak, Bashayer/0000-0001-9716-3241; Tassan, Nada Al/0000-0001-9076-0334	King Abdulaziz City for Science and Technology (KACST) [11-BIO1440-20]	King Abdulaziz City for Science and Technology (KACST)	This project was funded by King Abdulaziz City for Science and Technology (KACST; http://www.kacst.edu.sa/en/Pages/default.aspx) grant number (11-BIO1440-20). Fund recipient authors are NAT, BRA, SAB and TSA. The authors can confirm that KACST had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, ANN NEUROL, V60, P414, DOI 10.1002/ana.20960; Alvarez-Castelao B, 2012, BBA-MOL CELL RES, V1823, P524, DOI 10.1016/j.bbamcr.2011.11.010; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Biswas A, 2006, PARKINSONISM RELAT D, V12, P420, DOI 10.1016/j.parkreldis.2006.04.005; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chaudhary S, 2006, PARKINSONISM RELAT D, V12, P239, DOI 10.1016/j.parkreldis.2005.12.004; Chishti MA, 2006, ARCH NEUROL-CHICAGO, V63, P1483, DOI 10.1001/archneur.63.10.1483; Clarimon J, 2005, AM J MED GENET B, V133B, P120, DOI 10.1002/ajmg.b.30119; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Deng H, 2006, ARCH NEUROL-CHICAGO, V63, P273, DOI 10.1001/archneur.63.2.273; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Hedrich K, 2004, ANN NEUROL, V55, P145, DOI 10.1002/ana.10816; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Ibanez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesage S, 2005, ANN NEUROL, V58, P784, DOI 10.1002/ana.20636; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marongiu R, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20719; Matenia D, 2012, J BIOL CHEM, V287, P8174, DOI 10.1074/jbc.M111.262287; Miyake Y, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-62; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Myhre R, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-47; Nakaso K, 2006, NEUROSCI LETT, V400, P44, DOI 10.1016/j.neulet.2006.02.035; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Sadhukhan T, 2012, DIS MARKERS, V33, P127, DOI 10.1155/2012/467085; Safadi SS, 2011, BIOCHEMISTRY-US, V50, P2603, DOI 10.1021/bi200065g; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Sim CH, 2012, HUM MUTAT, V33, P1408, DOI 10.1002/humu.22127; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Spatola M., 2014, PARKINSONISM RELA S1, V20, pS35, DOI DOI 10.1016/S1353-8020(13)70011-7; Stoessl AJ, 2011, LANCET NEUROL, V10, P987, DOI 10.1016/S1474-4422(11)70214-9; Sun S, 2014, NEUROL SCI, V35, P1867, DOI 10.1007/s10072-014-1973-4; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wang M, 1999, ANN NEUROL, V45, P655, DOI 10.1002/1531-8249(199905)45:5<655::AID-ANA15>3.0.CO;2-G; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2013, AM J MED GENET B, V162B, P235, DOI 10.1002/ajmg.b.32138; Zhang Yu-hu, 2005, Zhonghua Yi Xue Za Zhi, V85, P1538	57	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135950	10.1371/journal.pone.0135950	http://dx.doi.org/10.1371/journal.pone.0135950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274610	Green Submitted, gold, Green Published			2022-12-27	WOS:000359493600135
J	Badoud, F; Lam, KP; Perreault, M; Zulyniak, MA; Britz-McKibbin, P; Mutch, DM				Badoud, Flavia; Lam, Karen P.; Perreault, Maude; Zulyniak, Michael A.; Britz-McKibbin, Philip; Mutch, David M.			Metabolomics Reveals Metabolically Healthy and Unhealthy Obese Individuals Differ in their Response to a Caloric Challenge	PLOS ONE			English	Article							INSULIN-RESISTANCE; BRANCHED-CHAIN; FATTY-ACIDS; YOUNG-ADULTS; AMINO-ACIDS; PLASMA; PREDICTORS; PROFILES; MARKERS; WEIGHT	Objective To determine if metabolically healthy obese (MHO) individuals have a different metabolic response to a standardized diet compared to lean healthy (LH) and metabolically unhealthy obese (MUO) individuals. Methods Thirty adults (35-70 yrs) were classified as LH, MHO, and MUO according to anthropometric and clinical measurements. Participants consumed a standardized high calorie meal (similar to 1330 kcal). Blood glucose and insulin were measured at fasting, and 15, 30, 60, 90 and 120 min postprandially. Additional blood samples were collected for the targeted analysis of amino acids (AAs) and derivatives, and fatty acids (FAs). Results The postprandial response (i.e., area under the curve, AUC) for serum glucose and insulin were similar between MHO and LH individuals, and significantly lower than MUO individuals (p < 0.05). Minor differences were found in postprandial responses for AAs between MHO and MUO individuals, while three polyunsaturated FAs (linoleic acid,gamma-linolenic acid, arachidonic acid) showed smaller changes in serum after the meal in MHO individuals compared to MUO. Fasting levels for various AAs (notably branched-chain AA) and FAs (e.g., saturated myristic and palmitic acids) were found to correlate with glucose and insulin AUC. Conclusion MHO individuals show preserved insulin sensitivity and a greater ability to adapt to a caloric challenge compared to MUO individuals.	[Badoud, Flavia; Perreault, Maude; Zulyniak, Michael A.; Mutch, David M.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Lam, Karen P.; Britz-McKibbin, Philip] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada	University of Guelph; McMaster University	Mutch, DM (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	dmutch@uoguelph.ca		Mutch, David/0000-0002-0908-7259; Zulyniak, Michael/0000-0003-4944-5521	Public Health Agency of Canada; Canadian Institutes of Health Research; Swiss National Scientific Foundation; Natural Sciences and Engineering Research Council of Canada	Public Health Agency of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by the Public Health Agency of Canada and Canadian Institutes of Health Research (DMM). FB was a recipient of a fellowship supported by the Swiss National Scientific Foundation. PBM also acknowledges support from the Natural Sciences and Engineering Research Council of Canada.	Alcala-Diaz JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096297; Badoud F, 2015, FASEB J, V29, P748, DOI 10.1096/fj.14-263913; Badoud F, 2014, J PROTEOME RES, V13, P3455, DOI 10.1021/pr500416v; Bondia-Pons I., 2014, FASEB J; Bos C, 2003, J NUTR, V133, P1308; Elshorbagy AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044166; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Heymsfield SB, 2011, AM J CLIN NUTR, V94, P1650, DOI 10.3945/ajcn.111.026476; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Hruby A, 2014, PHARMACOECONOMICS, P1, DOI DOI 10.1007/S40273-013-0118-6; Kantartzis K, 2011, DIABETOLOGIA, V54, P864, DOI 10.1007/s00125-010-2006-3; Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8; Komatsu M, 1998, DIABETES, V47, P352, DOI 10.2337/diabetes.47.3.352; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Kuehnbaum NL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06166; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Marini M., 2013, ACTA DIABETOL, V51, P1; McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x; Moazzami AA, 2014, J NUTR, V144, P807, DOI 10.3945/jn.113.188912; Nakamura H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.32; Naukkarinen J, 2014, DIABETOLOGIA, V57, P167, DOI 10.1007/s00125-013-3066-y; Palmer ND, 2014, J CLIN ENDOCRINOL ME, V0, P2014; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Pellis L, 2012, METABOLOMICS, V8, P347, DOI 10.1007/s11306-011-0320-5; Perez-Martinez P, 2014, EUR J CLIN INVEST, V44, P1053, DOI 10.1111/eci.12339; Perreault M, 2014, LIPIDS, V49, P255, DOI 10.1007/s11745-013-3874-3; Perreault M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088539; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Ralston JC, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-42; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Samocha-Bonet D, 2014, OBES REV, V15, P697, DOI 10.1111/obr.12199; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Succurro E, 2008, OBESITY, V16, P1881, DOI 10.1038/oby.2008.308; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Winnike JH, 2009, AM J CLIN NUTR, V90, P1496, DOI 10.3945/ajcn.2009.28234; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895	38	35	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134613	10.1371/journal.pone.0134613	http://dx.doi.org/10.1371/journal.pone.0134613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274804	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600036
J	Bhandaru, M; Martinka, M; McElwee, KJ; Rotte, A				Bhandaru, Madhuri; Martinka, Magdalena; McElwee, Kevin J.; Rotte, Anand			Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA GENE; DNA-DAMAGE RESPONSE; KINASE-ACTIVITY; IONIZING-RADIATION; REPAIR PATHWAY; BREAST-CANCER; CELLS; PROTEIN; P53; INHIBITION	UV radiation induced genomic instability is one of the leading causes for melanoma. Phosphorylation of Ataxia Telangiectasia Mutated (ATM) is one of the initial events that follow DNA damage. Phospho-ATM (p-ATM) plays a key role in the activation of DNA repair and several oncogenic pathways as well as in the maintenance of genomic integrity. The present study was therefore performed to understand the significance of p-ATM in melanoma progression and to correlate it with patient prognosis. Tissue microarray and immunohistochemical analysis were employed to study the expression of p-ATM in melanoma patients. A total of 366 melanoma patients (230 primary melanoma and 136 metastatic melanoma) were used for the study. Chi-square test, Kaplan-Meier, univariate and multivariate Cox regression analysis were used to elucidate the prognostic significance of p-ATM expression. Results revealed that both loss of, and gain in, p-ATM expression were associated with progression of melanoma from normal nevi to metastatic melanoma. Patients whose samples showed negative or strong p-ATM staining had significantly worse 5-year survival compared to patients who had weak to moderate expression. Loss of p-ATM expression was associated with relatively better 5-year survival, but the corresponding 10-year survival curve almost overlapped with that of strong p-ATM expression. p-ATM expression was found to be an independent prognostic factor for 5-year but not for 10-year patient survival. In conclusion our findings show that loss of p-ATM expression and gain-in p-ATM expression are indicators of worse melanoma patient survival.	[Bhandaru, Madhuri; McElwee, Kevin J.; Rotte, Anand] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Martinka, Magdalena] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [McElwee, Kevin J.] Replicel Inc, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Bhandaru, M (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	madhuribhandaru@gmail.com; anand.rotte@gmail.com	Rotte, Anand/H-4774-2019	Rotte, Anand/0000-0002-3452-7068; McElwee, Kevin/0000-0003-1020-3832	grants from Canadian Institutes of Health Research (CIHR) [CCI-117958, MOP-93810, MOP-110974]; Canadian Dermatology Foundation (CDF); Replicel Life Sciences Inc.	grants from Canadian Institutes of Health Research (CIHR); Canadian Dermatology Foundation (CDF); Replicel Life Sciences Inc.	MB & AR were supported by grants from Canadian Institutes of Health Research (CIHR; CCI-117958, MOP-93810, MOP-110974) and KJM was supported by the Canadian Dermatology Foundation (CDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KJM is affiliated to Replicel Life Sciences Inc. Replicel Life Sciences Inc. provided support in the form of consulting fees for author KJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Batey MA, 2013, MOL CANCER THER, V12, P959, DOI 10.1158/1535-7163.MCT-12-0707; Battu A, 2011, NUCLEIC ACIDS RES, V39, P7931, DOI 10.1093/nar/gkr523; Bhandaru M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-398; Bhandaru M, 2014, PIGM CELL MELANOMA R, V27, P366, DOI 10.1111/pcmr.12212; Biddlestone-Thorpe L, 2013, CLIN CANCER RES, V19, P3189, DOI 10.1158/1078-0432.CCR-12-3408; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; Chen GD, 2012, J INVEST DERMATOL, V132, P2632, DOI 10.1038/jid.2012.193; Cheng YB, 2013, CANCER METAST REV, V32, P567, DOI 10.1007/s10555-013-9433-9; Chou WC, 2015, CARCINOGENESIS, V36, P832, DOI 10.1093/carcin/bgv079; Dianov GL, 2015, REF MISMAT, V112, P3997, DOI 10.1073/pnas.141SG31112; Eich M, 2013, MOL CANCER THER, V12, P2529, DOI 10.1158/1535-7163.MCT-13-0136; Gao Y, 2011, CARCINOGENESIS, V32, P882, DOI 10.1093/carcin/bgr071; Gonzaga Evelyn R, 2009, Am J Clin Dermatol, V10 Suppl 1, P19, DOI 10.2165/0128071-200910001-00004; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Ivanov VN, 2009, CANCER RES, V69, P3510, DOI 10.1158/0008-5472.CAN-08-3883; Bin K, 2008, MUTAT RES-FUND MOL M, V638, P17, DOI 10.1016/j.mrfmmm.2007.08.013; Khalil HS, 2012, EXP BIOL MED, V237, P622, DOI 10.1258/ebm.2012.011378; Kim H, 2014, CLIN CANCER RES, V20, P1865, DOI 10.1158/1078-0432.CCR-13-1239; Kim HS, 2013, PATHOBIOLOGY, V80, P127, DOI 10.1159/000346034; Lee HE, 2013, PATHOBIOLOGY, V81, P25, DOI 10.1159/000351072; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lin H, 2009, CLIN CANCER RES, V15, P6404, DOI 10.1158/1078-0432.CCR-09-1135; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Mhawech- Fauceglia P, 2014, GYNECOL ONCOL, V132, P593, DOI [10. 1016/ j. ygyno. 2014. 02. 002, DOI 10.1016/J.YGYN0.2014.02.002]; Moschos SJ, 2009, CANCER BIOL THER, V8, P1815, DOI 10.4161/cbt.8.19.9435; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Perlman Susan, 2003, Semin Pediatr Neurol, V10, P173, DOI 10.1016/S1071-9091(03)00026-3; Prokopcova J, 2007, BREAST CANCER RES TR, V104, P121, DOI 10.1007/s10549-006-9406-6; Ray A, 2013, DNA REPAIR, V12, P273, DOI 10.1016/j.dnarep.2013.01.003; REMMELE W, 1987, PATHOLOGE, V8, P138; Roesch A, 2007, CANCER EPIDEM BIOMAR, V16, P2486, DOI 10.1158/1055-9965.EPI-07-0224; Rondeau S, 2015, BRIT J CANCER, V112, P1059, DOI 10.1038/bjc.2015.60; Roossink F, 2012, INT J CANCER, V131, P2056, DOI 10.1002/ijc.27488; Rotte A, 2015, CANCER METAST REV, V34, P115, DOI 10.1007/s10555-014-9542-0; Rotte A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075405; Rustgi AK, 2014, REF MISMAT, V28, P1, DOI 10.1101/gad.228452.113; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shen L, 2014, REF MISMAT, V9, DOI 10.1371/]ournal.pone.0096911; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shin JU, 2012, TUMOR BIOL, V33, P1645, DOI 10.1007/s13277-012-0420-5; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stagni V, 2014, INT J MOL SCI, V15, P5388, DOI 10.3390/ijms15045388; Stankovic T, 1998, REF MISMAT, V62, P334, DOI 10.1086/301706; Thorstenson YR, 2003, CANCER RES, V63, P3325; Wakasugi M, 2014, J BIOL CHEM, V289, P28730, DOI 10.1074/jbc.M114.589747; Wang JZ, 2006, AM J PHYSIOL-RENAL, V291, pF1300, DOI 10.1152/ajprenal.00509.2005; Wong RPC, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00948.x; Yu GZ, 2004, PANCREAS, V28, P421, DOI 10.1097/00006676-200405000-00011; Zhang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045037; Zhang ZZ, 2011, CANCER-AM CANCER SOC, V117, P2719, DOI 10.1002/cncr.25838	54	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134678	10.1371/journal.pone.0134678	http://dx.doi.org/10.1371/journal.pone.0134678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275218	gold, Green Submitted, Green Published			2022-12-27	WOS:000359493600040
J	Chen, BJ; Litvin, O; Ungar, L; Pe'er, D				Chen, Bo-Juen; Litvin, Oren; Ungar, Lyle; Pe'er, Dana			Context Sensitive Modeling of Cancer Drug Sensitivity	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; INDUCED APOPTOSIS; STEM-CELLS; KAPPA-B; INSULIN; INHIBITION; PACLITAXEL; SELECTION; PATHWAYS	Recent screening of drug sensitivity in large panels of cancer cell lines provides a valuable resource towards developing algorithms that predict drug response. Since more samples provide increased statistical power, most approaches to prediction of drug sensitivity pool multiple cancer types together without distinction. However, pan-cancer results can be misleading due to the confounding effects of tissues or cancer subtypes. On the other hand, independent analysis for each cancer-type is hampered by small sample size. To balance this trade-off, we present CHER (Contextual Heterogeneity Enabled Regression), an algorithm that builds predictive models for drug sensitivity by selecting predictive genomic features and deciding which ones should-and should not-be shared across different cancers, tissues and drugs. CHER provides significantly more accurate models of drug sensitivity than comparable elastic-net-based models. Moreover, CHER provides better insight into the underlying biological processes by finding a sparse set of shared and type-specific genomic features.	[Chen, Bo-Juen] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Chen, Bo-Juen; Litvin, Oren; Pe'er, Dana] Columbia Univ, Dept Biol Sci, Dept Syst Biol, New York, NY 10027 USA; [Ungar, Lyle] Univ Penn, Comp & Informat Sci, Philadelphia, PA 19104 USA	Columbia University; Columbia University; University of Pennsylvania	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, Dept Syst Biol, New York, NY 10027 USA.	dpeer@biology.columbia.edu			Stand Up To Cancer Innovative Research Grant [IRG08]; National Institutes of Health [R01CA164729]; National Centers for Biomedical Computing Grant [1U54CA121852-01A1]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA164729] Funding Source: NIH RePORTER	Stand Up To Cancer Innovative Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Stand Up To Cancer Innovative Research Grant (IRG08), National Institutes of Health (R01CA164729) and National Centers for Biomedical Computing Grant 1U54CA121852-01A1. D.P. holds a Packard Fellowship for Science and Engineering.	Ahmad S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04483; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bava SV, 2011, INT J BIOCHEM CELL B, V43, P331, DOI 10.1016/j.biocel.2010.09.011; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Bickel P.J., 1977, MATH STAT; Bielen A, 2012, P NATL ACAD SCI USA, V109, pE1267, DOI 10.1073/pnas.1105034109; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Calzone FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055135; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chi DDJ, 1997, AM J PATHOL, V150, P2143; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Dhillon PS, 2011, J MACH LEARN RES, V12, P525; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Flanigan SA, 2010, CLIN CANCER RES, V16, P5436, DOI 10.1158/1078-0432.CCR-10-2054; Frankild S, DISEASES DIS GENE AS; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goto Y, 2012, INVEST NEW DRUG, V30, P1548, DOI 10.1007/s10637-011-9715-4; Gu L, 2008, LEUKEMIA, V22, P730, DOI 10.1038/leu.2008.11; Gualberto A, 2011, BRIT J CANCER, V104, P68, DOI 10.1038/sj.bjc.6605972; Hamilton A, 2006, LEUKEMIA, V20, P1035, DOI 10.1038/sj.leu.2404189; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Kopetz S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3534; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Lee SY, 2011, J PATHOL, V223, P15, DOI 10.1002/path.2766; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Nguyen DM, 2004, J THORAC CARDIOV SUR, V127, P365, DOI 10.1016/j.jtcvs.2003.09.033; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Patel NM, 2000, ONCOGENE, V19, P4159, DOI 10.1038/sj.onc.1203768; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Raina R, 2006, P 23 INT C MACH LEAR; Rissanen J, 1999, COMPUT J, V42, P260, DOI 10.1093/comjnl/42.4.260; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Spiliotaki M, 2011, LUNG CANCER, V73, P158, DOI 10.1016/j.lungcan.2010.11.010; Tang J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003226; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yin D, 2005, NEUROL RES, V27, P27, DOI 10.1179/016164105X18151; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	59	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133850	10.1371/journal.pone.0133850	http://dx.doi.org/10.1371/journal.pone.0133850			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274927	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600017
J	Godefroid, M; Cruaud, A; Rossi, JP; Rasplus, JY				Godefroid, Martin; Cruaud, Astrid; Rossi, Jean-Pierre; Rasplus, Jean-Yves			Assessing the Risk of Invasion by Tephritid Fruit Flies: Intraspecific Divergence Matters	PLOS ONE			English	Article							ANASTREPHA-FRATERCULUS DIPTERA; COMPLEX DIPTERA; CERATITIS-ROSA; BACTROCERA-CUCURBITAE; FLY DIPTERA; OLIVE FLY; AMERICAN POPULATIONS; DISTRIBUTION MODELS; GENETIC DIVERSITY; DNA BARCODES	Widely distributed species often show strong phylogeographic structure, with lineages potentially adapted to different biotic and abiotic conditions. The success of an invasion process may thus depend on the intraspecific identity of the introduced propagules. However, pest risk analyses are usually performed without accounting for intraspecific diversity. In this study, we developed bioclimatic models using MaxEnt and boosted regression trees approaches, to predict the potential distribution in Europe of six economically important Tephritid pests (Ceratitis fasciventris (Bezzi), Bactrocera oleae (Rossi), Anastrepha obliqua (Macquart), Anastrepha fraterculus (Wiedemann), Rhagoletis pomonella (Walsh) and Bactrocera cucurbitae (Coquillet)). We considered intraspecific diversity in our risk analyses by independently modeling the distributions of conspecific lineages. The six species displayed different potential distributions in Europe. A strong signal of intraspecific climate envelope divergence was observed in most species. In some cases, conspecific lineages differed strongly in potential distributions suggesting that taxonomic resolution should be accounted for in pest risk analyses. No models (lineage- and species-based approaches) predicted high climatic suitability in the entire invaded range of B. oleae-the only species whose intraspecific identity of invading populations has been elucidated-in California. Host availability appears to play the most important role in shaping the geographic range of this specialist pest. However, climatic suitability values predicted by species-based models are correlated with population densities of B. oleae globally reported in California. Our study highlights how classical taxonomic boundaries may lead to under- or overestimation of the potential pest distributions and encourages accounting for intraspecific diversity when assessing the risk of biological invasion.	[Godefroid, Martin; Cruaud, Astrid; Rossi, Jean-Pierre; Rasplus, Jean-Yves] INRA, Ctr Biol Gest Populat, Montferriez Sur Lez, France	INRAE; Institut de Recherche pour le Developpement (IRD)	Godefroid, M (corresponding author), INRA, Ctr Biol Gest Populat, Montferriez Sur Lez, France.	martin.godefroid@gmail.com	Rasplus, Jean-Yves/O-2873-2017	Rasplus, Jean-Yves/0000-0001-8614-6665; Rossi, Jean-Pierre/0000-0002-8139-1116	Metaprogram SMACH (Sustainable Management of Crop Health) of the French National Agronomic Institute (INRA); BIOFIS (Bioagressors and invasive species: From individual to population to species) project [1001-001]	Metaprogram SMACH (Sustainable Management of Crop Health) of the French National Agronomic Institute (INRA); BIOFIS (Bioagressors and invasive species: From individual to population to species) project	This work was financially supported by the Metaprogram SMACH (Sustainable Management of Crop Health; http://www.smach.inra.fr/) of the French National Agronomic Institute (INRA). This work was also based on financial support received from the BIOFIS (Bioagressors and invasive species: From individual to population to species) project (number 1001-001) allocated by Agropolis Fondation to JYR (Montpellier, France; http://www.agropolis-fondation.fr/fr/accueil.html).	Alberti AC, 2002, ANN ENTOMOL SOC AM, V95, P505, DOI 10.1603/0013-8746(2002)095[0505:EITAPO]2.0.CO;2; Alberti AC, 2008, GENETICA, V132, P1, DOI 10.1007/s10709-007-9143-8; Aluja M, 2000, P ENTOMOL SOC WASH, V102, P802; Aluja M, 2003, J ECON ENTOMOL, V96, P1693, DOI 10.1603/0022-0493-96.6.1693; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beaumont LJ, 2014, DIVERS DISTRIB, V20, P613, DOI 10.1111/ddi.12190; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Brooks CP, 2012, ECOLOGY, V93, P402, DOI 10.1890/11-0541.1; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Coeur d'acier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097620; Copeland R, 2006, ANN ENTOMOL SOC AM, V99, P261, DOI 10.1603/0013-8746(2006)099[0261:GDHFAP]2.0.CO;2; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; De Meyer Marc, 2001, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V71, P55; de Villiers M, 2013, B ENTOMOL RES, V103, P60, DOI 10.1017/S0007485312000454; Diamantidis AD, 2011, BIOL J LINN SOC, V102, P334, DOI 10.1111/j.1095-8312.2010.01579.x; Diamantidis AD, 2009, BIOL J LINN SOC, V97, P106, DOI 10.1111/j.1095-8312.2009.01178.x; DOLEDEC S, 1987, ACTA OECOL-OEC GEN, V8, P403; Drew RAI, 2005, AFR ENTOMOL, V13, P149; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Feder JL, 2005, P NATL ACAD SCI USA, V102, P6573, DOI 10.1073/pnas.0502099102; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Godsoe W, 2015, METHODS ECOL EVOL, V6, P59, DOI 10.1111/2041-210X.12307; Grout TG, 2007, ENVIRON ENTOMOL, V36, P1310, DOI 10.1603/0046-225X(2007)36[1310:DRACTO]2.0.CO;2; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Gutierrez AP, 2009, CLIMATIC CHANGE, V95, P195, DOI 10.1007/s10584-008-9528-4; Hamilton JA, 2015, MOL ECOL, V24, P2253, DOI 10.1111/mec.13099; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hernandez-Ortiz V, 2004, B ENTOMOL RES, V94, P487, DOI 10.1079/BER2004325; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2013, SPECIES DISTRIBUTION; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Johnson MW, 2011, CALIF AGR, V65, P29, DOI 10.3733/ca.v065n01p29; Katiyar KP, 2000, FLA ENTOMOL, V83, P480, DOI 10.2307/3496724; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Koyama J, 2004, ANNU REV ENTOMOL, V49, P331, DOI 10.1146/annurev.ento.49.061802.123224; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Larson ER, 2014, DIVERS DISTRIB, V20, P1296, DOI 10.1111/ddi.12233; Larson ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1114, DOI 10.1111/j.1466-8238.2012.00758.x; Legendre P., 1998, NUMERICAL ECOLOGY; Ludena B, 2010, ANN SOC ENTOMOL FR, V46, P344, DOI 10.1080/00379271.2010.10697673; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Michalak P, 2001, P NATL ACAD SCI USA, V98, P13195, DOI 10.1073/pnas.231478298; Michel AP, 2007, MOL ECOL, V16, P2867, DOI 10.1111/j.1365-294X.2007.03263.x; Muller HG, 2009, P ROY SOC B-BIOL SCI, V276, P4409, DOI 10.1098/rspb.2009.1461; Mun J, 2003, MOL ECOL, V12, P2941, DOI 10.1046/j.1365-294X.2003.01978.x; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Papadopoulos NT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1466; Papadopoulos NT, 1996, ANN ENTOMOL SOC AM, V89, P526, DOI 10.1093/aesa/89.4.526; Papanastasiou SA, 2011, J INSECT PHYSIOL, V57, P83, DOI 10.1016/j.jinsphys.2010.09.008; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2003, ECOL LETT, V6, P774, DOI 10.1046/j.1461-0248.2003.00502.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Rafter MA, 2013, EVOL APPL, V6, P1195, DOI 10.1111/eva.12096; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; Rey O, 2012, ECOL LETT, V15, P1266, DOI 10.1111/j.1461-0248.2012.01849.x; Rice R. E., 2003, California Agriculture, V57, P122, DOI 10.3733/ca.v057n04p122; Ridgeway G, 2004, THE GBM PACKAGE; Rossi JP, 2005, SOIL BIOL BIOCHEM, V37, P1093, DOI 10.1016/j.soilbio.2004.11.008; Ruiz-Arce R, 2012, J ECON ENTOMOL, V105, P2147, DOI 10.1603/EC12211; Rull J, 2010, BIOL J LINN SOC, V100, P213, DOI 10.1111/j.1095-8312.2010.01403.x; Santos H, 2011, J EVOLUTION BIOL, V24, P146, DOI 10.1111/j.1420-9101.2010.02147.x; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Schulte U, 2012, GLOBAL ECOL BIOGEOGR, V21, P198, DOI 10.1111/j.1466-8238.2011.00665.x; Selivon D, 2005, ANN ENTOMOL SOC AM, V98, P367, DOI 10.1603/0013-8746(2005)098[0367:AGCOTC]2.0.CO;2; Sivinski J, 2004, ANN ENTOMOL SOC AM, V97, P504, DOI 10.1603/0013-8746(2004)097[0504:NAOSAT]2.0.CO;2; Smith-Caldas Martha R. B., 2001, Neotropical Entomology, V30, P565, DOI 10.1590/S1519-566X2001000400009; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Thompson GD, 2011, DIVERS DISTRIB, V17, P1001, DOI 10.1111/j.1472-4642.2011.00820.x; van Asch B, 2012, GENETICA, V140, P181, DOI 10.1007/s10709-012-9669-2; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vera MT, 2006, ANN ENTOMOL SOC AM, V99, P387, DOI 10.1603/0013-8746(2006)099[0387:MIAPOT]2.0.CO;2; Vera MT, 2002, ENVIRON ENTOMOL, V31, P1009, DOI 10.1603/0046-225X-31.6.1009; Virgilio M, 2008, MOL PHYLOGENET EVOL, V48, P270, DOI 10.1016/j.ympev.2008.04.018; Virgilio M, 2013, MOL ECOL, V22, P2526, DOI 10.1111/mec.12278; Virgilio M, 2010, MOL ECOL, V19, P2713, DOI 10.1111/j.1365-294X.2010.04662.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; White I, 2000, PROCEEDINGS OF THE I; White IM, 1992, FRUIT FLIES OF ECONO; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wu Y, 2012, INSECT SCI, V19, P195, DOI 10.1111/j.1744-7917.2011.01443.x; Yokoyama VY, 2008, ENVIRON ENTOMOL, V37, P764, DOI 10.1603/0046-225X(2008)37[764:PCCHBF]2.0.CO;2; Zygouridis NE, 2009, HEREDITY, V102, P402, DOI 10.1038/hdy.2008.125	103	25	26	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135209	10.1371/journal.pone.0135209	http://dx.doi.org/10.1371/journal.pone.0135209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274582	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600055
J	Cody, EM; Reagan, AJ; Mitchell, L; Dodds, PS; Danforth, CM				Cody, Emily M.; Reagan, Andrew J.; Mitchell, Lewis; Dodds, Peter Sheridan; Danforth, Christopher M.			Climate Change Sentiment on Twitter: An Unsolicited Public Opinion Poll	PLOS ONE			English	Article							SOCIAL MEDIA; MASS-MEDIA; BELIEF; WEATHER	The consequences of anthropogenic climate change are extensively debated through scientific papers, newspaper articles, and blogs. Newspaper articles may lack accuracy, while the severity of findings in scientific papers may be too opaque for the public to understand. Social media, however, is a forum where individuals of diverse backgrounds can share their thoughts and opinions. As consumption shifts from old media to new, Twitter has become a valuable resource for analyzing current events and headline news. In this research, we analyze tweets containing the word "climate" collected between September 2008 and July 2014. Through use of a previously developed sentiment measurement tool called the Hedonometer, we determine how collective sentiment varies in response to climate change news, events, and natural disasters. We find that natural disasters, climate bills, and oil-drilling can contribute to a decrease in happiness while climate rallies, a book release, and a green ideas contest can contribute to an increase in happiness. Words uncovered by our analysis suggest that responses to climate change news are predominately from climate change activists rather than climate change deniers, indicating that Twitter is a valuable resource for the spread of climate change awareness.	[Cody, Emily M.; Reagan, Andrew J.; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Computat Story Lab, Burlington, VT 05401 USA; [Cody, Emily M.; Reagan, Andrew J.; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT 05401 USA; [Cody, Emily M.; Reagan, Andrew J.; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA; [Mitchell, Lewis] Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia	University of Vermont; University of Vermont; University of Vermont; University of Adelaide	Cody, EM (corresponding author), 16 Colchester Ave, Burlington, VT 05401 USA.	Emily.Cody@uvm.edu	Mitchell, Lewis/U-8250-2019; Mitchell, Lewis/W-1312-2018; Dodds, Peter/C-9119-2014	Mitchell, Lewis/0000-0001-8191-1997; Mitchell, Lewis/0000-0001-8191-1997; Dodds, Peter/0000-0003-1973-8614	National Science Foundation (NSF) grant [DMS-0940271]; NSF CAREER Award [0846668]; Direct For Mathematical & Physical Scien [0940271] Funding Source: National Science Foundation	National Science Foundation (NSF) grant(National Science Foundation (NSF)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors are grateful for the computational resources provided by the Vermont Advanced Computing Core which is supported by the Vermont Complex Systems Center. CMD, AJR, EMC, and LM were supported by National Science Foundation (NSF) grant DMS-0940271 to the Mathematics & Climate Research Network. PSD was supported by NSF CAREER Award #0846668.	An X., 2014, KDD; Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Boykoff M. T., 2011, MAKING SENSE MEDIA R; Boykoff MT, 2007, GEOFORUM, V38, P1190, DOI 10.1016/j.geoforum.2007.01.008; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Everett, 1996, AGENDA SETTING, V6; Field C.B., 2012, MANAGING RISKS EXTRE; Fischer EM, 2015, NAT CLIM CHANGE, V5, P560, DOI 10.1038/nclimate2617; Hamilton LC, 2013, WEATHER CLIM SOC, V5, P112, DOI 10.1175/WCAS-D-12-00048.1; Howe PD, 2015, NAT CLIM CHANGE, V5, P596, DOI 10.1038/nclimate2583; Huber D.G., 2011, EXTREME WEATHER CLIM; Kirilenko AP, 2015, GLOBAL ENVIRON CHANG, V30, P92, DOI 10.1016/j.gloenvcha.2014.11.003; Kloumann IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029484; Kryvasheyeu Y, 2015, NOWCASTING DIS UNPUB; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Leiserowitz A., 2013, CLIMATE CHANGE AM MI; Li Y, 2011, PSYCHOL SCI, V22, P454, DOI 10.1177/0956797611400913; Lin Y.R., 2013, P 22 INT C WORLD WID, P737, DOI DOI 10.1145/2488388.2488453; Lin YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094093; MacKay D., 2008, SUSTAINABLE ENERGY H; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Phan TQ, 2015, P NATL ACAD SCI USA, V112, P6595, DOI 10.1073/pnas.1404770112; Ripberger JT, 2014, WEATHER CLIM SOC, V6, P520, DOI 10.1175/WCAS-D-13-00028.1; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Schuldt J. P., 2011, PUBLIC OPIN QUART; Twain M, 1980, M TWAINS NOTEBOOKS J, V8; Williams HTP, 2015, GLOBAL ENVIRON CHANG, V32, P126, DOI 10.1016/j.gloenvcha.2015.03.006; Wilson KM., 1995, MASS COMMUNICATION R, V22, P75; Zaval L, 2014, NAT CLIM CHANGE, V4, P143, DOI 10.1038/NCLIMATE2093; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	36	115	117	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136092	10.1371/journal.pone.0136092	http://dx.doi.org/10.1371/journal.pone.0136092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291877	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900053
J	Karita, E; Price, MA; Lakhi, S; Kilembe, W; Kamali, A; Ruzagira, E; Hunter, E; Farmer, P; Allen, S; Stevens, G; Chetty, P; Welsh, S; Yang, A; Gilmour, J; Fast, P				Karita, Etienne; Price, Matt A.; Lakhi, Shabir; Kilembe, William; Kamali, Anatoli; Ruzagira, Eugene; Hunter, Eric; Farmer, Paul; Allen, Susan; Stevens, Gwynn; Chetty, Paramesh; Welsh, Sabrina; Yang, Annie; Gilmour, Jill; Fast, Pat		IAVI Africa HIV Prevention	High Transmitter CD4+T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; PREVENT TRANSMISSION; VIRAL LOAD; HIV; DECLINE; ZAMBIA; INITIATION; INFECTION	Background 2013 WHO guidelines recommend starting ART at CD4+ T-cell counts <= 500 cells/mu L. We present the T-cell counts from adult Africans with HIV shortly following transmission to their sexual partners. Methods HIV-discordant couples in Zambia, Uganda and Rwanda were followed prospectively and received couples counseling and condoms. HIV uninfected partners were tested for HIV at least quarterly and HIV-infected partners received HIV care and referral for ART per national guidelines. Upon diagnosis of incident HIV infection in the previously HIV-uninfected partner, a blood sample was collected from both partners to measure CD4+ T-cells and perform viral linkage. The estimated date of infection (EDI) of the incident case was calculated based on testing history. EDI was unknown for suspected transmitting partners. Results From 2006-2011, 4,705 HIV-discordant couples were enrolled in this cohort, and 443 cases of incident HIV infection were documented. Virus linkage analysis was performed in 374 transmission pairs, and 273 (73%) transmissions were linked genetically. CD4 counts in the transmitting partner were measured a median of 56 days after EDI (mean:90.5, min:10, max:396). The median CD4 count was 339 cells/mu l (mean:386.4, min:15,max:1,434), and the proportion of partners with a CD4+ T-cell count above 500/mu l was 25% (95% CI:21, 31). Conclusions In our cohort of discordant couples, 73% of HIV transmissions occurred within the relationship, and the transmitter CD4+ T-cell count shortly after the transmission event was frequently higher than the WHO 2013 ART-initiation guidelines.	[Karita, Etienne; Hunter, Eric] Projet San Francisco, Kigali, Rwanda; [Price, Matt A.; Welsh, Sabrina; Yang, Annie; Fast, Pat] IAVI, New York, NY 10004 USA; [Lakhi, Shabir; Kilembe, William; Hunter, Eric] Zambia Emory HIV Res Project, Lusaka, Ndola & Kitwe, Zambia; [Kamali, Anatoli; Ruzagira, Eugene] Uganda Virus Res Inst, MRC, Masaka, Uganda; [Kamali, Anatoli; Ruzagira, Eugene] Uganda Virus Res Inst, MRC, Entebbe, Uganda; [Hunter, Eric; Farmer, Paul] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Allen, Susan] Emory Univ, Sch Med, Atlanta, GA USA; [Stevens, Gwynn; Chetty, Paramesh; Gilmour, Jill] IAVI, Human Immunol Lab, London, England; [Price, Matt A.] UCSF Dept Epidemiol & Biostat, San Francisco, CA USA	International AIDS Vaccine Initiative; Uganda Virus Research Institute; Emory University; Emory University; International AIDS Vaccine Initiative	Price, MA (corresponding author), IAVI, New York, NY 10004 USA.	mprice@iavi.org	Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Ruzagira, Eugene/0000-0002-7291-1693	Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); American people through USAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064060, R37AI051231] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); American people through USAID(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. This study is made possible by the generous support of the American people through USAID. None of the funders had a role in study design, data collection, decision to publish, or preparation of the manuscript.	Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Czaicki N, 2012, PROGR CHALLENGES INT; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Fabiani M, 1998, J ACQ IMMUN DEF SYND, V18, P514, DOI 10.1097/00042560-199808150-00015; Fast PE, 2013, LANCET, V382, P1778, DOI 10.1016/S0140-6736(13)62539-8; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kamali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116100; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; UNAIDS, 2012, GLOB AIDS EP FACTS F; Urassa W, 2004, AIDS, V18, P433, DOI 10.1097/00002030-200402200-00009; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; WHO UNICEF UNAIDS, 2013, PROGR CHALL INT CVCT; World Health Organization, 2013, CREAT AFR HIV CLIN R; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134438	10.1371/journal.pone.0134438	http://dx.doi.org/10.1371/journal.pone.0134438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291456	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900005
J	Toth, Z				Toth, Zoltan			Context-Dependent Plastic Response during Egg-Laying in a Widespread Newt Species	PLOS ONE			English	Article							PREDATOR-INDUCED PLASTICITY; PHENOTYPIC PLASTICITY; BEHAVIORAL PLASTICITY; MATERNAL INVESTMENT; WRAPPING BEHAVIOR; NATURAL-SELECTION; FITNESS COSTS; SMOOTH NEWTS; T-HELVETICUS; SIZE	Previous research on predator-induced phenotypic plasticity mostly focused on responses in morphology, developmental time and/or behaviour during early life stages, but the potential significance of anticipatory parental responses has been investigated less often. In this study I examined behavioural and maternal responses of gravid female smooth newts, Lissotriton vulgaris, in the presence of chemical cues originating from invertebrate predators, Acilius sulcatus water beetles and Aeshna cyanea dragonfly larvae. More specifically, I tested the extent of oviposition preference, plasticity in egg-wrapping behaviour and plasticity in egg size when females had the possibility to lay eggs at oviposition sites with and without predator cues during overnight trials. I found that individuals did not avoid laying eggs in the environment with predator cues; however, individuals that deposited eggs into both environments adjusted the size of the laid eggs to the perceived environment. Females deposited larger eggs earlier in the season but egg size decreased with time in the absence of predator cues, whereas individuals laid eggs of average size throughout the investigated reproductive period when such cues were present. Also, egg size was found to be positively related to hatching success. Individuals did not adjust their wrapping behaviour to the presence of predator cues, but females differed in the extent of egg-wrapping between ponds. Females' body mass and tail depth were also different between ponds, whereas their body size was positively associated with egg size. According to these results, female smooth newts have the potential to exhibit activational plasticity and invest differently into eggs depending on temporal and environmental factors. Such an anticipatory response may contribute to the success of this caudate species under a wide range of predator regimes at its natural breeding habitats.	Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Lendulet Evolutionary Ecol Res Grp, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Toth, Z (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Lendulet Evolutionary Ecol Res Grp, Budapest, Hungary.	toth.zoltan@agrar.mta.hu		Toth, Zoltan/0000-0002-2634-8393	Hungarian Scientific Research Fund [PD108938]; Postdoctoral Research Programme of the Hungarian Academy of Sciences [SZ-029/2013]; "Lendulet" Programme of the Hungarian Academy of Sciences [LP2012-24/2012]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Postdoctoral Research Programme of the Hungarian Academy of Sciences; "Lendulet" Programme of the Hungarian Academy of Sciences	This study was financially supported by a grant of the Hungarian Scientific Research Fund to ZT (www.otka.hu, PD108938). During the study, ZT was also supported by the Postdoctoral Research Programme of the Hungarian Academy of Sciences (www.mta.hu, SZ-029/2013) and the "Lendulet" Programme of the Hungarian Academy of Sciences (LP2012-24/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abjornsson K, 2004, ECOLOGY, V85, P1859, DOI 10.1890/03-0074; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Alekseev V, 2001, NATURE, V414, P899, DOI 10.1038/414899a; Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; American Public Health Association, 1985, WATER WASTEWATER STA; Arntzen JW, 2009, IUCN 2012 IUCN RED L; BELL G, 1977, ECOL MONOGR, V47, P279, DOI 10.2307/1942518; Berrigan D., 2004, PHENOTYPIC PLASTICIT, P82; Bestion E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0701; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bronmark C, 2000, OIKOS, V88, P103, DOI 10.1034/j.1600-0706.2000.880112.x; Bronmark C, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P203; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Burgess SC, 2014, OIKOS, V123, P769, DOI 10.1111/oik.01235; Coslovsky M, 2012, GEN COMP ENDOCR, V176, P211, DOI 10.1016/j.ygcen.2012.01.013; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Ezard THG, 2014, FUNCT ECOL, V28, P693, DOI 10.1111/1365-2435.12207; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Gasc J. P., 1997, COLLECTION PATRIMOIN; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; GOULDEN CE, 1987, OECOLOGIA, V72, P28, DOI 10.1007/BF00385040; Hettyey A, 2011, J EVOLUTION BIOL, V24, P1007, DOI 10.1111/j.1420-9101.2011.02233.x; Hettyey A, 2010, OIKOS, V119, P1814, DOI 10.1111/j.1600-0706.2010.18563.x; Huizinga M, 2009, J EVOLUTION BIOL, V22, P1860, DOI 10.1111/j.1420-9101.2009.01799.x; Jehle R, 2007, BIOLOGY LETT, V3, P526, DOI 10.1098/rsbl.2007.0311; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Kaplan RH, 2006, EVOLUTION, V60, P142; Kaplan RH, 1997, HERPETOLOGICA, V53, P149; Kasumovic MM, 2013, ANIM BEHAV, V85, P1049, DOI 10.1016/j.anbehav.2013.02.009; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kurdikova V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023842; Laurila A, 2004, OIKOS, V107, P90, DOI 10.1111/j.0030-1299.2004.13126.x; Lind MI, 2011, EVOLUTION, V65, P684, DOI 10.1111/j.1558-5646.2010.01122.x; Loman J, 2002, J ZOOL, V257, P93, DOI 10.1017/S0952836902000687; Manenti R, 2013, J ZOOL, V289, P182, DOI 10.1111/j.1469-7998.2012.00976.x; Marco A, 2001, ANIM BEHAV, V61, P639, DOI 10.1006/anbe.2000.1632; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Martin RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009117; MCGINLEY MA, 1987, AM NAT, V130, P370, DOI 10.1086/284716; MIAUD C, 1994, COPEIA, P535; MIAUD C, 1993, J ZOOL, V231, P575, DOI 10.1111/j.1469-7998.1993.tb01939.x; Michimae H, 2012, J EVOLUTION BIOL, V25, P1331, DOI 10.1111/j.1420-9101.2012.02523.x; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nollert A., 1992, AMPHIBIEN EUROPAS BE; Norris KM, 2005, ETHOLOGY, V111, P357, DOI 10.1111/j.1439-0310.2005.01071.x; Orizaola G, 2003, HERPETOL J, V13, P189; Orizaola G, 2003, HERPETOL J, V13, P121; Ortiz-Santaliestra ME, 2007, AQUAT TOXICOL, V85, P251, DOI 10.1016/j.aquatox.2007.09.008; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pigliucci M., 2001, SYN ECO EVO; R Core Team, R LANG ENV STAT COMP; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Rieger JF, 2004, ECOLOGY, V85, P2094, DOI 10.1890/04-0156; Schmidt BR, 2005, J EVOLUTION BIOL, V18, P415, DOI 10.1111/j.1420-9101.2004.00822.x; Schmidt Peter, 2006, P139; Segers FHID, 2012, P ROY SOC B-BIOL SCI, V279, P1241, DOI 10.1098/rspb.2011.1290; Segers FHID, 2011, FUNCT ECOL, V25, P166, DOI 10.1111/j.1365-2435.2010.01790.x; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Sih Andrew, 2004, P112; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; TEMPLETON AR, 1978, THEOR POPUL BIOL, V13, P340, DOI 10.1016/0040-5809(78)90050-3; Tollrian Ralph, 1999, P177; Toth Z, 2011, J ZOOL, V284, P46, DOI 10.1111/j.1469-7998.2010.00781.x; Toth Z, 2011, AMPHIBIA-REPTILIA, V32, P77, DOI 10.1163/017353710X543001; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Van Buskirk J, 1999, OIKOS, V85, P31, DOI 10.2307/3546789; Van Buskirk J, 2002, EVOLUTION, V56, P361; Van Buskirk J, 2001, J EVOLUTION BIOL, V14, P482, DOI 10.1046/j.1420-9101.2001.00282.x; Van Buskirk J, 1997, EVOLUTION, V51, P1983, DOI 10.1111/j.1558-5646.1997.tb05119.x; Van Buskirk J, 2000, ECOLOGY, V81, P3009, DOI 10.1890/0012-9658(2000)081[3009:PIPPIL]2.0.CO;2; VERRELL PA, 1986, J HERPETOL, V20, P416, DOI 10.2307/1564504; Walsh MR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2205; WARD D, 1981, COPEIA, P724; Weddeling K, 2004, HERPETOL J, V14, P1; Weitere M, 2004, MOL ECOL, V13, P1665, DOI 10.1111/j.1365-294X.2004.02155.x; Wells KD, 2007, ECOLOGY BEHAV AMPHIB, P499; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Wilson RS, 2005, FUNCT ECOL, V19, P238, DOI 10.1111/j.1365-2435.2005.00958.x	85	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136044	10.1371/journal.pone.0136044	http://dx.doi.org/10.1371/journal.pone.0136044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291328	Green Published, gold, Green Accepted			2022-12-27	WOS:000359919900048
J	Cincotta, A; Yans, J; Godefroit, P; Garcia, G; Dejax, J; Benammi, M; Amico, S; Valentin, X				Cincotta, Aude; Yans, Johan; Godefroit, Pascal; Garcia, Geraldine; Dejax, Jean; Benammi, Mouloud; Amico, Sauveur; Valentin, Xavier			Integrated Paleoenvironmental Reconstruction and Taphonomy of a Unique Upper Cretaceous Vertebrate-Bearing Locality (Velaux, Southeastern France)	PLOS ONE			English	Article							PROVENCE BASIN; LATE EOCENE; FACIES; LACUSTRINE; REASSESSMENT; DINOSAURS; EGGSHELLS; LIMESTONE; PATTERNS; DEPOSITS	The Velaux-La Bastide Neuve fossil-bearing site (Bouches-du-Rhone, France) has yielded a diverse vertebrate assemblage dominated by dinosaurs, including the titanosaur Atsinganosaurus velauciensis. We here provide a complete inventory of vertebrate fossils collected during two large-scale field campaigns. Numerous crocodilian teeth occur together with complete skulls. Pterosaur, hybodont shark and fish elements are also represented but uncommon. Magnetostratigraphic analyses associated with biostratigraphic data from dinosaur eggshell and charophytes suggest a Late Campanian age for the locality. Lithologic and taphonomic studies, associated with microfacies and palynofacies analyses, indicate a fluvial setting of moderate energy with broad floodplain. Palynomorphs are quite rare; only three taxa of pollen grains occur: a bisaccate taxon, a second form probably belonging to the Normapolles complex, and another tricolporate taxon. Despite the good state of preservation, these taxa are generally difficult to identify, since they are scarce and have a very minute size. Most of the vertebrate remains are well preserved and suggest transport of the carcasses over short distances before accumulation in channel and overbank facies, together with reworked Aptian grains of glauconite, followed by a rapid burial. The bones accumulated in three thin layers that differ by their depositional modes and their taphonomic histories. Numerous calcareous and iron oxides-rich paleosols developed on the floodplain, suggesting an alternating dry and humid climate in the region during the Late Campanian.	[Cincotta, Aude; Yans, Johan] Univ Namur, Dept Geol, NaGRIDD, Namur, Belgium; [Cincotta, Aude; Godefroit, Pascal] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium; [Garcia, Geraldine; Benammi, Mouloud; Valentin, Xavier] Univ Poitiers, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, UMR 7262, TSA 51106, Poitiers, France; [Dejax, Jean] Univ Paris 06, CNRS, Sorbonne Univ, CR2P,UMR 7207,MNHN, Paris, France; [Amico, Sauveur] Conseil Gen Bouches du Rhone, Hotel Dept, Direct Environm, Marseille, France; [Valentin, Xavier] Palaios Assoc, Valdivienne, France	University of Namur; Royal Belgian Institute of Natural Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Cincotta, A (corresponding author), Univ Namur, Dept Geol, NaGRIDD, Namur, Belgium.	aude.cincotta@unamur.be			'Fond National pour la Recherche Scientifique' (FNRS)	'Fond National pour la Recherche Scientifique' (FNRS)(Fonds de la Recherche Scientifique - FNRS)	AC disposes of a FRIA grant provided by the 'Fond National pour la Recherche Scientifique' (FNRS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2003, CR PALEVOL, V2, P27, DOI 10.1016/S1631-0683(03)00002-2; Armenteros I, 1997, PALAEOGEOGR PALAEOCL, V128, P111, DOI 10.1016/S0031-0182(96)00108-3; Behrensmeyer A. K., 2007, BONEBEDS GENESIS ANA; Blasco R, 2008, J ARCHAEOL SCI, V35, P1605, DOI 10.1016/j.jas.2007.11.007; Brierley GJ, 1997, SEDIMENT GEOL, V114, P1, DOI 10.1016/S0037-0738(97)00114-0; Brown SAE, 2012, CRETACEOUS RES, V36, P162, DOI 10.1016/j.cretres.2012.02.008; CLARK J, 1967, Fieldiana Geology Memoirs, V5, P1; Cojan I, 2003, PALAEOGEOGR PALAEOCL, V191, P111, DOI 10.1016/S0031-0182(02)00655-7; Csiki Z, 2010, PALAEOGEOGR PALAEOCL, V293, P375, DOI 10.1016/j.palaeo.2009.10.013; Cuny G, 2012, BERNISSART DINOSAURS, P629; deBroin FD, 1996, CR ACAD SCI II A, V323, P729; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; do Nascimento DR, 2015, SEDIMENT GEOL, V316, P1, DOI 10.1016/j.sedgeo.2014.11.002; Dominguez-Rodrigo M, 2014, J ARCHAEOL SCI, V41, P44, DOI 10.1016/j.jas.2013.07.025; Eberth DA, 2005, LIFE O PAST, P501; Eberth DA, 2005, LIFE O PAST, P453; Faith JT, 2006, J ARCHAEOL SCI, V33, P1718, DOI 10.1016/j.jas.2006.03.004; Fiorillo A.R., 1988, ROCKY MT GEOL, V26, P57; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V88, P157, DOI 10.1016/0031-0182(91)90062-V; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V81, P281, DOI 10.1016/0031-0182(91)90151-G; Garcia G, 2001, PALAEOGEOGR PALAEOCL, V169, P153, DOI 10.1016/S0031-0182(01)00215-2; Garcia G, 2010, B SOC GEOL FR, V181, P269, DOI 10.2113/gssgfbull.181.3.269; Ghosh P, 2006, SEDIMENT GEOL, V191, P3, DOI 10.1016/j.sedgeo.2006.01.002; Gradstein F, 2012, GEOLOGIC TIME SCALE, P435; Guyonnet-Benaize C, 2010, J GEODYN, V50, P81, DOI 10.1016/j.jog.2010.03.003; Kabanov P, 2008, SEDIMENT GEOL, V205, P81; Kos AM, 2003, J ARCHAEOL SCI, V30, P781, DOI 10.1016/S0305-4403(02)00252-2; Marmi J, 2012, CRETACEOUS RES, V35, P133, DOI 10.1016/j.cretres.2011.12.004; Marmi J, 2009, CRETACEOUS RES, V30, P1307, DOI 10.1016/j.cretres.2009.07.008; Murru M, 2003, CR GEOSCI, V335, P227, DOI 10.1016/S1631-0713(03)00029-4; Nichols GJ, 2007, SEDIMENT GEOL, V195, P75, DOI 10.1016/j.sedgeo.2006.07.004; Pimentel NL, 1996, SEDIMENT GEOL, V105, P1, DOI 10.1016/0037-0738(96)00034-6; PLAZIAT JC, 1981, PALAEOGEOGR PALAEOCL, V36, P263, DOI 10.1016/0031-0182(81)90110-3; Schnyder J, 2009, PALAEOGEOGR PALAEOCL, V281, P79, DOI 10.1016/j.palaeo.2009.07.014; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P1, DOI 10.1016/S0031-0182(00)00168-1; SMOOT JP, 1991, PALAEOGEOGR PALAEOCL, V84, P369, DOI 10.1016/0031-0182(91)90055-V; Srivastava P, 2006, PALAEOGEOGR PALAEOCL, V239, P241, DOI 10.1016/j.palaeo.2006.01.012; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; STEWART DJ, 1981, SEDIMENTOLOGY, V28, P1, DOI 10.1111/j.1365-3091.1981.tb01658.x; Tabuce R, 2013, ZOOL J LINN SOC-LOND, V169, P653, DOI 10.1111/zoj.12074; Thouand E, 2004, THESIS U POITIERS; Tofalo OR, 2010, J S AM EARTH SCI, V29, P665, DOI 10.1016/j.jsames.2009.09.002; Turkmen I, 2007, J ASIAN EARTH SCI, V30, P181, DOI 10.1016/j.jseaes.2006.08.006; Valentin Xavier, 2012, P582; Vedrine S, 2007, FACIES, V53, P535, DOI 10.1007/s10347-007-0114-4; Vila B, 2012, PALAEOGEOGR PALAEOCL, V350, P19, DOI 10.1016/j.palaeo.2012.06.008; Viseras C, 2006, PALAEOGEOGR PALAEOCL, V242, P139, DOI 10.1016/j.palaeo.2006.05.013; WESTPHAL M, 1989, EARTH PLANET SC LETT, V94, P143, DOI 10.1016/0012-821X(89)90090-3; Wright VP, 1997, SEDIMENT GEOL, V114, P81, DOI 10.1016/S0037-0738(97)00059-6; Wright VP, 1992, DEV SEDIMENTOL, V47, P591, DOI DOI 10.1016/S0070-4571(08)70574-0	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134231	10.1371/journal.pone.0134231	http://dx.doi.org/10.1371/journal.pone.0134231			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287486	Green Published, gold			2022-12-27	WOS:000360018600016
J	Morand-Ferron, J; Hamblin, S; Cole, EF; Aplin, LM; Quinn, JL				Morand-Ferron, Julie; Hamblin, Steven; Cole, Ella F.; Aplin, Lucy M.; Quinn, John L.			Taking the Operant Paradigm into the Field: Associative Learning in Wild Great Tits	PLOS ONE			English	Article							PROBLEM-SOLVING PERFORMANCE; MIXED-SPECIES FLOCKS; INDIVIDUAL VARIATION; BEHAVIORAL FLEXIBILITY; COGNITIVE PERFORMANCE; PERSONALITY; EVOLUTION; MONKEYS; MEMORY; BLUE	Associative learning is essential for resource acquisition, predator avoidance and reproduction in a wide diversity of species, and is therefore a key target for evolutionary and comparative cognition research. Automated operant devices can greatly enhance the study of associative learning and yet their use has been mainly restricted to laboratory conditions. We developed a portable, weatherproof, battery-operated operant device and conducted the first fully automated colour-associative learning experiment using free-ranging individuals in the wild. We used the device to run a colour discrimination task in a monitored population of tits (Paridae). Over two winter months, 80 individuals from four species recorded a total of 5,128 trials. Great tits (Parus major) were more likely than other species to visit the devices and engage in trials, but there were no sex or personality biases in the sample of great tits landing at the devices and registering key pecks. Juveniles were more likely than adults to visit the devices and to register trials. Individuals that were successful at solving a novel technical problem in captivity (lever-pulling) learned faster than non-solvers when at the operant devices in the wild, suggesting cross-contextual consistency in learning performance in very different tasks. There was no significant effect of personality or sex on learning rate, but juveniles' choice accuracy tended to improve at a faster rate than adults. We discuss how customisable automated operant devices, such as the one described here, could prove to be a powerful tool in evolutionary ecology studies of cognitive traits, especially among inquisitive species such as great tits.	[Morand-Ferron, Julie] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Morand-Ferron, Julie; Cole, Ella F.; Aplin, Lucy M.; Quinn, John L.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Hamblin, Steven] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Quinn, John L.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland	University of Ottawa; University of Oxford; University of New South Wales Sydney; University College Cork	Morand-Ferron, J (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	jmf@uottawa.ca; j.quinn@ucc.ie	Morand-Ferron, Julie/AAW-7022-2021	Morand-Ferron, Julie/0000-0001-5186-7710	Natural Environment Research Council [NE/I017208/1]; Leverhulme grant [RPG-265]; NERC grant [NE/I017208/1]; Natural Sciences and Engineering Research Council Discovery grant [435596-2013]; BBSRC [BB/L006081/1] Funding Source: UKRI; NERC [NE/K006274/1, NE/I017208/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L006081/1] Funding Source: researchfish; Natural Environment Research Council [NE/K006274/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme grant; NERC grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Sciences and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council grant (NE/I017208/1) to JLQ, and EFC was funded by a Leverhulme grant (RPG-265) (http://www.leverhulme.ac.uk/) to JLQ. JMF was funded by a NERC grant (NE/I017208/1) and a Natural Sciences and Engineering Research Council Discovery grant (435596-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Aplin LM, 2015, NATURE, V518, P538, DOI 10.1038/nature13998; Aplin LM, 2013, ANIM BEHAV, V85, P1225, DOI 10.1016/j.anbehav.2013.03.009; Auguie B, 2017, GRIDEXTRA MISCELLANE; BAUM WM, 1974, SCIENCE, V185, P78, DOI 10.1126/science.185.4145.78; Benson-Amram S, 2013, ANIM BEHAV, V85, P349, DOI 10.1016/j.anbehav.2012.11.003; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Boisvert MJ, 2000, PHYSIOL BEHAV, V71, P147, DOI 10.1016/S0031-9384(00)00317-6; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bond AB, 2007, J COMP PSYCHOL, V121, P372, DOI 10.1037/0735-7036.121.4.372; Bonte E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00188; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Boogert NJ, 2010, BEHAV PROCESS, V85, P135, DOI 10.1016/j.beproc.2010.06.020; Cole EF, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0178; Cole EF, 2012, CURR BIOL, V22, P1808, DOI 10.1016/j.cub.2012.07.051; Cole EF, 2012, P ROY SOC B-BIOL SCI, V279, P1168, DOI 10.1098/rspb.2011.1539; Cole EF, 2011, ANIM BEHAV, V81, P491, DOI 10.1016/j.anbehav.2010.11.025; Dickinson A, 2012, PHILOS T R SOC B, V367, P2733, DOI 10.1098/rstb.2012.0220; Drea CM, 1999, P NATL ACAD SCI USA, V96, P12965, DOI 10.1073/pnas.96.22.12965; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Farine DR, 2012, ANIM BEHAV, V84, P1271, DOI 10.1016/j.anbehav.2012.08.008; Ferrari MCO, 2011, ANIM COGN, V14, P309, DOI 10.1007/s10071-010-0363-4; Galef BG, 2004, LEARN BEHAV, V32, P53; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Ginsburg S, 2010, J THEOR BIOL, V266, P11, DOI 10.1016/j.jtbi.2010.06.017; Gosler A, 1993, GREAT TIT; Greenlees MJ, 2010, BEHAV ECOL, V21, P966, DOI 10.1093/beheco/arq095; Griffin AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084907; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Guenther A, 2014, J COMP PSYCHOL, V128, P74, DOI 10.1037/a0033678; Guillette LM, 2009, BEHAV PROCESS, V82, P265, DOI 10.1016/j.beproc.2009.07.005; Ham AD, 2006, BEHAV ECOL SOCIOBIOL, V60, P482, DOI 10.1007/s00265-006-0190-4; HEALY SD, 1995, Q J EXP PSYCHOL-B, V48, P179; Heyes C, 2012, PHILOS T R SOC B, V367, P2695, DOI 10.1098/rstb.2012.0217; Hoffman AM, 2007, BEHAV RES METHODS, V39, P776, DOI 10.3758/BF03192968; HOLLIS KL, 1989, J COMP PSYCHOL, V103, P115, DOI 10.1037/0735-7036.103.2.115; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Hurly TA, 1996, ANIM BEHAV, V51, P1149; Ings TC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1207, DOI 10.1007/s00265-009-0731-8; Isden J, 2013, ANIM BEHAV, V86, P829, DOI 10.1016/j.anbehav.2013.07.024; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Lihoreau Mathieu, 2013, Commun Integr Biol, V6, pe22701, DOI 10.4161/cib.22701; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Lipp HP, 2001, NEUROSCI BIOBEHAV R, V25, P83, DOI 10.1016/S0149-7634(00)00050-6; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Biondi LM, 2010, ANIM COGN, V13, P701, DOI 10.1007/s10071-010-0319-8; Marshall RES, 2012, ANIM BEHAV, V83, P1163, DOI 10.1016/j.anbehav.2012.02.003; Marzluff JM, 2010, ANIM BEHAV, V79, P699, DOI 10.1016/j.anbehav.2009.12.022; Matechou E, 2015, ECOLOGY, V96, P1641, DOI 10.1890/14-0886.1; Morand-Ferron J, 1967, ANIM BEHAV, V200468, P1267; Morand-Ferron J, 2016, BIOL REV, V91, P367, DOI 10.1111/brv.12174; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Morand-Ferron J, 2011, P NATL ACAD SCI USA, V108, P15898, DOI 10.1073/pnas.1111560108; MORGAN MJ, 1976, PERCEPTION, V5, P57, DOI 10.1068/p050057; Nachev V, 2012, ANIM COGN, V15, P393, DOI 10.1007/s10071-011-0465-7; Overington SE, 2011, BEHAV PROCESS, V87, P274, DOI 10.1016/j.beproc.2011.06.002; Papini MR, 2002, PSYCHOL REV, V109, P186, DOI 10.1037//0033-295X.109.1.186; Patrick SC, 2012, P ROY SOC B-BIOL SCI, V279, P1724, DOI 10.1098/rspb.2011.1820; Paur J, 2011, ANIM BEHAV, V82, P825, DOI 10.1016/j.anbehav.2011.07.017; Perrins C.M., 1979, BRIT TITS; Pinheiro J, 2001, MIXED EFFECTS MODELS; Psorakis I, 2012, J R SOC INTERFACE, V9, P3055, DOI 10.1098/rsif.2012.0223; Quinn JL, 2012, P ROY SOC B-BIOL SCI, V279, P1919, DOI 10.1098/rspb.2011.2227; Quinn JL, 2014, BEHAV ECOL, V25, P1297, DOI 10.1093/beheco/aru141; Quinn JL, 2011, J ANIM ECOL, V80, P918, DOI 10.1111/j.1365-2656.2011.01835.x; Quinn JL, 2009, J ANIM ECOL, V78, P1203, DOI 10.1111/j.1365-2656.2009.01585.x; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Roth TC, 2010, P ROY SOC B-BIOL SCI, V277, P3187, DOI 10.1098/rspb.2010.0630; Rowe C, 2014, BEHAV ECOL, V25, P1287, DOI 10.1093/beheco/aru090; SASVARI L, 1979, ANIM BEHAV, V27, P767, DOI 10.1016/0003-3472(79)90012-5; SASVARI L, 1992, ANIM BEHAV, V43, P289, DOI 10.1016/S0003-3472(05)80224-6; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; SCHULER W, 1992, ADV STUD BEHAV, V21, P111, DOI 10.1016/S0065-3454(08)60143-6; Schwarz S, 2010, BEHAV ECOL SOCIOBIOL, V64, P2033, DOI 10.1007/s00265-010-1016-y; Shettleworth S.J., 2009, COGNITION EVOLUTION; Skinner BF, 1932, J GEN PSYCHOL, V6, P38, DOI 10.1080/00221309.1932.9711853; Steurer MM, 2012, BEHAV RES METHODS, V44, P909, DOI 10.3758/s13428-012-0198-9; Stuber EF, 2013, BEHAV ECOL, V24, P1092, DOI 10.1093/beheco/art035; Svadova K, 2009, ANIM BEHAV, V77, P327, DOI 10.1016/j.anbehav.2008.09.034; Svensson L., 1992, IDENTIFICATION GUIDE; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214; Titulaer M, 2012, ANIM BEHAV, V83, P723, DOI 10.1016/j.anbehav.2011.12.020; Toxopeus IB, 2005, BEHAVIOUR, V142, P1269, DOI 10.1163/156853905774539373; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Webster SJ, 2001, ANIM BEHAV, V62, P23, DOI 10.1006/anbe.2000.1725; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250	91	46	46	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133821	10.1371/journal.pone.0133821	http://dx.doi.org/10.1371/journal.pone.0133821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288131	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600010
J	Konar, M; Beernink, PT; Granoff, DM				Konar, Monica; Beernink, Peter T.; Granoff, Dan M.			A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbp	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; PROTEIN; IMMUNOGENICITY	Background Two meningococcal serogroup B vaccines contain Factor H binding protein (FHbp). Binding of Factor H (FH) to FHbp was thought to be specific for human or chimpanzee FH. However, in a previous study an amino acid polymorphism in rhesus macaque FH domain 6, tyrosine at position 352 (Y352) was associated with high binding to FHbp, whereas histidine at position 352 (H352) was associated with low binding. Methods and Results Here we report that a second FH polymorphism at position 360 also affects macaque FH binding. Of 43 macaques, 11 had high FH binding and 32 had low binding. As in our previous study, all 11 animals with high binding had Y352, and 24 with low binding had H352. However the remaining eight with low FH binding had Y352, which was predicted to yield high binding. All eight had S360 instead of P360. Thus, three allelic variants at positions 352 and 360 affect macaque FH binding to FHbp: HP (low), YS (low), and YP (high). We measured binding affinity of each FH sequence type to FHbp by surface plasmon resonance. Two animals with high binding types (YS/YP and HP/YP) had dissociation constants (K-D) of 10.4 and 18.2 nM, respectively, which were similar to human FH (19.8 nM). Two macaques with low binding (HP/HP and HP/YS) had K-D values approximately five-fold higher (100.3 and 99.5 nM, respectively). A third macaque with low binding (YS/YS) had a K-D value too high to be measured. Conclusions Macaques have at least three allelic variants encoding FH with different affinities for FHbp (five genotypic combinations of these variants). Since in previous studies binding of FH to FHbp vaccines decreased protective antibody responses, our data will aid in selection of macaques with FH binding that is similar to humans for further investigation of FHbp vaccine immunogenicity.	[Konar, Monica; Beernink, Peter T.; Granoff, Dan M.] UCSF Benioff Childrens Hosp Oakland, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Granoff, DM (corresponding author), UCSF Benioff Childrens Hosp Oakland, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA.	dgranoff@chori.org		Konar, Monica/0000-0002-8312-9699	Public Health Service grants from the National Institute of Allergy and Infectious Diseases, NIH [R01 AI 046464, AI 099125, AI 114701]; California National Primate Research Center [OD011107]; National Institute of Heart, Lung and Blood, NIH [R25 HL125451]; Research Facilities Improvement Program from the National Center for Research Resources, NIH [C06 RR016226]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016226] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL125451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046464, R01AI099125, R01AI114701] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	Public Health Service grants from the National Institute of Allergy and Infectious Diseases, NIH; California National Primate Research Center; National Institute of Heart, Lung and Blood, NIH; Research Facilities Improvement Program from the National Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Public Health Service grants R01 AI 046464 (to D.M.G.), AI 099125 (to P.T.B.), and AI 114701 (D.M.G. and P.T.B.) from the National Institute of Allergy and Infectious Diseases, NIH, and OD011107 from the California National Primate Research Center (P.T.B. and D.M.G.). Additional support came from the National Institute of Heart, Lung and Blood, NIH grant R25 HL125451. The work at Children's Hospital Oakland Research Institute (CHORI) was performed in a facility funded by Research Facilities Improvement Program grant number C06 RR016226 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Beernink PT, 2014, CLIN VACCINE IMMUNOL, V21, P1505, DOI 10.1128/CVI.00517-14; Beernink PT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002688; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research Division on Earth and Life Studies National Research Council of the National Academies, 2011, GUIDE FOR THE CARE A; Costa I, 2014, MBIO, V5, DOI 10.1128/mBio.01625-14; Granoff DM, 2015, J INFECT DIS, V212, P784, DOI 10.1093/infdis/jiv081; Granoff DM, 2013, CLIN VACCINE IMMUNOL, V20, P1099, DOI 10.1128/CVI.00260-13; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Granoff DM, 2014, MICROBE, V9, P321; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Rossi R, 2013, VACCINE, V31, P5451, DOI 10.1016/j.vaccine.2013.08.099; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; van der Veen S, 2014, INFECT IMMUN, V82, P1157, DOI 10.1128/IAI.01183-13	16	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135996	10.1371/journal.pone.0135996	http://dx.doi.org/10.1371/journal.pone.0135996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285122	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100094
J	Pfalzer, AC; Nesbeth, PDC; Parnell, LD; Iyer, LK; Liu, ZH; Kane, AV; Chen, CYO; Tai, AK; Bowman, TA; Obin, MS; Mason, JB; Greenberg, AS; Choi, SW; Selhub, J; Paul, L; Crott, JW				Pfalzer, Anna C.; Nesbeth, Paula-Dene C.; Parnell, Laurence D.; Iyer, Lakshmanan K.; Liu, Zhenhua; Kane, Anne V.; Chen, C-Y. Oliver; Tai, Albert K.; Bowman, Thomas A.; Obin, Martin S.; Mason, Joel B.; Greenberg, Andrew S.; Choi, Sang-Woon; Selhub, Jacob; Paul, Ligi; Crott, Jimmy W.			Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc(1638N) Mice	PLOS ONE			English	Article							EXPERIMENTAL MURINE COLITIS; GUT MICROBIOME; ADENOSINE; CANCER; INFLAMMATION; TUMORIGENESIS; MECHANISMS; PATTERNS; INCREASE; MUTATION	Obesity is a risk factor for colorectal cancer (CRC), and alterations in the colonic microbiome and metabolome may be mechanistically involved in this relationship. The relative contribution of diet and obesity per se are unclear. We compared the effect of diet-and genetically-induced obesity on the intestinal microbiome and metabolome in a mouse model of CRC. Apc(1638N) mice were made obese by either high fat (HF) feeding or the presence of the Lepr(db/db) (DbDb) mutation. Intestinal tumors were quantified and stool microbiome and metabolome were profiled. Genetic obesity, and to a lesser extent HF feeding, promoted intestinal tumorigenesis. Each induced distinct microbial patterns: taxa enriched in HF were mostly Firmicutes (6 of 8) while those enriched in DbDb were split between Firmicutes (7 of 12) and Proteobacteria (5 of 12). Parabecteroides distasonis was lower in tumor-bearing mice and its abundance was inversely associated with colonic Il1b production (p<0.05). HF and genetic obesity altered the abundance of 49 and 40 fecal metabolites respectively, with 5 in common. Of these 5, adenosine was also lower in obese and in tumor-bearing mice (p<0.05) and its concentration was inversely associated with colonic Il1b and Tnf production (p<0.05). HF and genetic obesity differentially alter the intestinal microbiome and metabolome. A depletion of adenosine and P. distasonis in tumor-bearing mice could play a mechanistic role in tumor formation. Adenosine and P. distasonis have previously been shown to be anti-inflammatory in the colon and we postulate their reduction could promote tumorigenesis by de-repressing inflammation.	[Pfalzer, Anna C.; Nesbeth, Paula-Dene C.; Parnell, Laurence D.; Liu, Zhenhua; Kane, Anne V.; Chen, C-Y. Oliver; Bowman, Thomas A.; Obin, Martin S.; Mason, Joel B.; Greenberg, Andrew S.; Choi, Sang-Woon; Selhub, Jacob; Paul, Ligi; Crott, Jimmy W.] Tufts Univ, Canc Cluster, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Pfalzer, Anna C.; Nesbeth, Paula-Dene C.; Liu, Zhenhua; Chen, C-Y. Oliver; Obin, Martin S.; Mason, Joel B.; Greenberg, Andrew S.; Selhub, Jacob; Paul, Ligi; Crott, Jimmy W.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Parnell, Laurence D.] Tufts Univ, ARS, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Iyer, Lakshmanan K.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Liu, Zhenhua] Univ Massachusetts, Dept Nutr, Amherst, MA 01003 USA; [Kane, Anne V.] Tufts Med Ctr, Phoenix Lab, Boston, MA USA; [Tai, Albert K.] Tufts Univ, Sch Med, Genom Core, Boston, MA 02111 USA; [Choi, Sang-Woon] CHA Univ, Sch Med, Seoul, South Korea	Tufts University; United States Department of Agriculture (USDA); Tufts University; Tufts University; United States Department of Agriculture (USDA); Tufts University; University of Massachusetts System; University of Massachusetts Amherst; Tufts Medical Center; Tufts University; Pochon Cha University	Crott, JW (corresponding author), Tufts Univ, Canc Cluster, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA.	jimmy.crott@tufts.edu	Bowman, Thomas/I-4649-2013	Bowman, Thomas/0000-0002-9591-7561	Agricultural Research Service of the United States Department of Agriculture [58-1950-0-014, 58-1950-4-003]; National Institutes of Health [RO1 DK098606, RO1 DKO98606 02S1, 5UO1 ES020958, RO3 ES022710, P30 DK046200]; Prevent Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK098606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES022710, U01ES020958] Funding Source: NIH RePORTER	Agricultural Research Service of the United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prevent Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the Agricultural Research Service of the United States Department of Agriculture, Cooperative Agreements #58-1950-0-014 and #58-1950-4-003, the National Institutes of Health RO1 DK098606, RO1 DKO98606 02S1, 5UO1 ES020958, RO3 ES022710, P30 DK046200 (ASG), and the Prevent Cancer Foundation (JBM).	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Aleman JO, 2014, GASTROENTEROLOGY, V146, P357, DOI 10.1053/j.gastro.2013.11.051; Antonioli L, 2007, J PHARMACOL EXP THER, V322, P435, DOI 10.1124/jpet.107.122762; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2010, J PHARMACOL EXP THER, V335, P434, DOI 10.1124/jpet.110.171223; Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20; Brown JB, 2008, INFLAMM BOWEL DIS, V14, P880, DOI 10.1002/ibd.20410; Burghoff S, 2013, ARCH PHYSIOL BIOCHEM, V119, P39, DOI 10.3109/13813455.2012.755547; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Gravaghi C, 2008, INT J OBESITY, V32, P1716, DOI 10.1038/ijo.2008.149; Hausler SFM, 2014, AM J TRANSL RES, V6, P129; Huffman DM, 2013, CANCER PREV RES, V6, P177, DOI 10.1158/1940-6207.CAPR-12-0414; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Liu ZH, 2011, FASEB J, V25, P3136, DOI 10.1096/fj.11-184143; Mabley J, 2003, EUR J PHARMACOL, V466, P323, DOI 10.1016/S0014-2999(03)01570-X; Mane J, 2009, J NUTR, V139, P603, DOI 10.3945/jn.108.101170; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; Muller-Haegele S, 2014, EXPERT REV CLIN IMMU, V10, P897, DOI 10.1586/1744666X.2014.915739; Odashima M, 2005, GASTROENTEROLOGY, V129, P26, DOI 10.1053/j.gastro.2005.05.032; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; R Core Team, 2021, R LANGUAGE ENV STAT; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zitomersky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063686	49	34	37	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135758	10.1371/journal.pone.0135758	http://dx.doi.org/10.1371/journal.pone.0135758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284788	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100067
J	Qu, DF; Weygant, N; May, R; Chandrakesan, P; Madhoun, M; Ali, N; Sureban, SM; An, GY; Schlosser, MJ; Houchen, CW				Qu, Dongfeng; Weygant, Nathaniel; May, Randal; Chandrakesan, Parthasarathy; Madhoun, Mohammad; Ali, Naushad; Sureban, Sripathi M.; An, Guangyu; Schlosser, Michael J.; Houchen, Courtney W.			Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RADIATION-INJURY; PATHOGENESIS; INFILTRATION; BARRIER; REPAIR; CRYPT	Doublecortin-like kinase 1 (Dclk1), a microtubule-associated kinase, marks the fifth lineage of intestinal epithelial cells called tuft cells that function as tumor stem cells in Apc mutant models of colon cancer. In order to determine the role of Dclk1 in dextran sulfate sodium (DSS) induced colonic inflammation both intestinal epithelial specific Dclk1 deficient (Villin(Cre);Dclk1(f/f)) and control (Dclk1f/f) mice were fed 3% DSS in drinking water for 9 days, allowed to recover for 2 days, and killed. The clinical and histological features of DSS-induced colitis were scored and immunohistochemical, gene expression, pro-inflammatory cytokines/chemokines, and immunoblotting analyses were used to examine epithelial barrier integrity, inflammation, and stem and tuft cell features. In DSS-induced colitis, Villin(Cre);Dclk1(f/f) mice demonstrated exacerbated injury including higher clinical colitis scores, increased epithelial barrier permeability, higher levels of pro-inflammatory cytokines and chemokines, decreased levels of Lgr5, and dysregulated Wnt/b-Catenin pathway genes. These results suggest that Dclk1 plays an important role in regulating colonic inflammatory response and colonic epithelial integrity.	[Qu, Dongfeng; Weygant, Nathaniel; May, Randal; Chandrakesan, Parthasarathy; Madhoun, Mohammad; Ali, Naushad; Sureban, Sripathi M.; An, Guangyu; Houchen, Courtney W.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Qu, Dongfeng; May, Randal; Sureban, Sripathi M.; Houchen, Courtney W.] Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Qu, Dongfeng; Chandrakesan, Parthasarathy; Ali, Naushad; Sureban, Sripathi M.; Houchen, Courtney W.] Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK 73104 USA; [An, Guangyu] Capitol Med Univ, Beijing Chaoyang Hosp, Dept Oncol, Beijing 100020, Peoples R China; [Schlosser, Michael J.; Houchen, Courtney W.] COARE Biotechnol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Capital Medical University	Houchen, CW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA.	Courtney-houchen@ouhsc.edu	Sureban, Sripathi/Q-8232-2019; Chandrakesan, Parthasarathy/AAB-9136-2020	Sureban, Sripathi/0000-0001-5476-9593; Weygant, Nathaniel/0000-0001-7861-6532; Chandrakesan, Parthasarathy/0000-0002-7587-9553; Ali, Naushad/0000-0002-0058-7396	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases [NIH U01 DK-085508]; Veterans Affairs Merit Award [1I01BX001952]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085508] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001952] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This research was performed as a project of the Intestinal Stem Cell Consortium; a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases (NIH U01 DK-085508 to CWH) and also funded by a Veterans Affairs Merit Award (1I01BX001952) to CWH. COARE Biotechnology provided support in the form of salaries for MJS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim ER, 2014, WORLD J GASTROENTERO, V20, P9872, DOI 10.3748/wjg.v20.i29.9872; Koch S, 2012, ANNU REV PATHOL-MECH, V7, P35, DOI 10.1146/annurev-pathol-011811-120905; Koelink PJ, 2014, GUT, V63, P578, DOI 10.1136/gutjnl-2012-303252; Koo BK, 2014, GASTROENTEROLOGY, V147, P289, DOI 10.1053/j.gastro.2014.05.007; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2014, STEM CELLS, V32, P822, DOI 10.1002/stem.1566; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Qu DF, 2014, AM J PHYSIOL-GASTR L, V306, pG404, DOI 10.1152/ajpgi.00088.2013; Wallace JL, 2006, THESCIENTIFICWORLDJO, V6, P577, DOI 10.1100/tsw.2006.122; Westphalen CB, 2014, J CLIN INVEST; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	22	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134212	10.1371/journal.pone.0134212	http://dx.doi.org/10.1371/journal.pone.0134212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285154	Green Submitted, Green Published, gold			2022-12-27	WOS:000359666100006
J	Versypt, ANF; Arendt, PD; Pack, DW; Braatz, RD				Versypt, Ashlee N. Ford; Arendt, Paul D.; Pack, Daniel W.; Braatz, Richard D.			Derivation of an Analytical Solution to a Reaction-Diffusion Model for Autocatalytic Degradation and Erosion in Polymer Microspheres	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; HYDROLYTIC DEGRADATION; ALIPHATIC POLYESTERS; PLGA MICROSPHERES; RELEASE; ACID); MATRICES	A mathematical reaction-diffusion model is defined to describe the gradual decomposition of polymer microspheres composed of poly(D, L-lactic-co-glycolic acid) (PLGA) that are used for pharmaceutical drug delivery over extended periods of time. The partial differential equation (PDE) model treats simultaneous first-order generation due to chemical reaction and diffusion of reaction products in spherical geometry to capture the microsphere-size-dependent effects of autocatalysis on PLGA erosion that occurs when the microspheres are exposed to aqueous media such as biological fluids. The model is solved analytically for the concentration of the autocatalytic carboxylic acid end groups of the polymer chains that comprise the microspheres as a function of radial position and time. The analytical solution for the reaction and transport of the autocatalytic chemical species is useful for predicting the conditions under which drug release from PLGA microspheres transitions from diffusion-controlled to erosion-controlled release, for understanding the dynamic coupling between the PLGA degradation and erosion mechanisms, and for designing drug release particles. The model is the first to provide an analytical prediction for the dynamics and spatial heterogeneities of PLGA degradation and erosion within a spherical particle. The analytical solution is applicable to other spherical systems with simultaneous diffusive transport and first-order generation by reaction.	[Versypt, Ashlee N. Ford; Arendt, Paul D.; Pack, Daniel W.; Braatz, Richard D.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Versypt, Ashlee N. Ford; Braatz, Richard D.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Pack, Daniel W.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY USA; [Pack, Daniel W.] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA	University of Illinois System; University of Illinois Urbana-Champaign; Massachusetts Institute of Technology (MIT); University of Kentucky; University of Kentucky	Braatz, RD (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	braatz@mit.edu	Versypt, Ashlee Ford/H-1274-2012; Braatz, Richard D/I-6725-2015; Ford Versypt, Ashlee/AAY-8953-2020	Versypt, Ashlee Ford/0000-0001-9059-5703; Braatz, Richard D/0000-0003-4304-3484; Ford Versypt, Ashlee/0000-0001-9059-5703	National Institutes of Health [NIBIB 5RO1EB005181]; National Science Foundation [0426328]; U.S. Department of Energy Computational Science Graduate Fellowship Program of the Office of Science; National Nuclear Security Administration in the Department of Energy [DE-FG02-97ER25308]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy Computational Science Graduate Fellowship Program of the Office of Science; National Nuclear Security Administration in the Department of Energy(National Nuclear Security Administration); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge the support of the National Institutes of Health (NIBIB 5RO1EB005181) and the National Science Foundation (Grant #0426328). A. N. Ford Versypt acknowledges the support of the U.S. Department of Energy Computational Science Graduate Fellowship Program of the Office of Science and National Nuclear Security Administration in the Department of Energy under contract DE-FG02-97ER25308.	Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b; Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117; Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0; Berkland C, 2007, J PHARM SCI-US, V96, P1176, DOI 10.1002/jps.20948; Crank J., 1975, MATH DIFFUSION; Deen, 1998, ANAL TRANSPORT PHENO; Edlund U, 2002, ADV POLYM SCI, V157, P67; Edwards CH., 2004, DIFF EQUAT+; Estey T, 2006, J PHARM SCI-US, V95, P1626, DOI 10.1002/jps.20625; Ford Versypt AN, 2012, THESIS U ILLINOIS UR; Freiberg S, 2004, INT J PHARMACEUT, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013; Fu K, 2000, PHARM RES-DORDR, V17, P100, DOI 10.1023/A:1007582911958; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F; Haberman R, 2004, APPL PARTIAL DIFFERE; Klose D, 2008, INT J PHARMACEUT, V354, P95, DOI 10.1016/j.ijpharm.2007.10.030; Kulkarni A, 2007, SURF INTERFACE ANAL, V39, P740, DOI 10.1002/sia.2580; Lao LL, 2011, INT J PHARMACEUT, V418, P28, DOI 10.1016/j.ijpharm.2010.12.020; Lyu S, 2005, J POLYM SCI POL PHYS, V43, P383, DOI 10.1002/polb.20340; PITT CG, 1995, J CONTROL RELEASE, V33, P391, DOI 10.1016/0168-3659(94)00113-9; Raman C, 2005, J CONTROL RELEASE, V103, P149, DOI 10.1016/j.jconrel.2004.11.012; Sackett CK, 2011, INT J PHARMACEUT, V418, P104, DOI 10.1016/j.ijpharm.2010.11.048; Schiesser W. E., 1991, NUMERICAL METHOD LIN; Schiesser W. E., 2013, PARTIAL DIFFERENTIAL; Scott Fogler H., 2006, ELEMENTS CHEM REACTI; Siepmann J, 2005, BIOMACROMOLECULES, V6, P2312, DOI 10.1021/bm050228k; Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P229, DOI 10.1016/S0169-409X(01)00116-8; Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9; Tzafriri AR, 2000, J CONTROL RELEASE, V63, P69, DOI 10.1016/S0168-3659(99)00174-1; van Nostrum CF, 2004, POLYMER, V45, P6779, DOI 10.1016/j.polymer.2004.08.001; Varde NK, 2004, EXPERT OPIN BIOL TH, V4, P35, DOI 10.1517/eobt.4.1.35.25256; Versypt ANF, 2013, J CONTROL RELEASE, V165, P29, DOI 10.1016/j.jconrel.2012.10.015; Vert M, 1997, ANGEW MAKROMOL CHEM, V247, P239, DOI 10.1002/apmc.1997.052470116; Wang Y, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.042	34	12	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135506	10.1371/journal.pone.0135506	http://dx.doi.org/10.1371/journal.pone.0135506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284787	gold, Green Published, Green Submitted			2022-12-27	WOS:000359666100043
J	Abubakari, A; Kynast-Wolf, G; Jahn, A				Abubakari, Abdulai; Kynast-Wolf, Gisela; Jahn, Albrecht			Maternal Determinants of Birth Weight in Northern Ghana	PLOS ONE			English	Article							PREPREGNANCY WEIGHT; FETAL ORIGINS; UNITED-STATES; PREGNANCY; GAIN; OBESITY; OUTCOMES; RISK; MACROSOMIA; MANAGEMENT	Objectives Weight at birth is usually considered as an indicator of the health status of a given society. As a result this study was designed to investigate the association between birth weight and maternal factors such as gestational weight gain, pre-pregnancy BMI and socio-economic status in Northern Ghana. Methods The study was a facility-based cross-sectional survey conducted in two districts in the Northern region of Ghana. These districts were purposively sampled to represent a mix of urban, peri-urban and rural population. The current study included 419 mother-infant pairs who delivered at term (37-42 weeks). Mother's height, pre-pregnancy weight and weight changes were generated from the antenatal records. Questionnaires were administered to establish socio-economic and demographic information of respondents. Maternal factors associated with birth weight were examined using multiple and univariate regressions. Results The mothers were generally well nourished before conception (Underweight 3.82%, Normal 57.76%, Overweight 25.06% and Obesity 13.37%) but approximately half of them could not gain adequate weight according to Institute of Medicine recommendations (Low weight gain 49.64%, Adequate weight gain 42.96% and Excessive weight gain 7.40%). Infants whose mothers had excess weight gain were 431g (95% CI 18-444) heavier compared to those whose mothers gained normal weight, while those whose mothers gained less were 479g (95% CI -682-(-276) lighter. Infants of mothers who were overweight and obese before conception were 246g (95% CI 87-405) and 595g (95% CI 375-815) respectively heavier than those of normal mothers, whereas those whose mothers were underweight were 305g (95% CI -565 -(-44) lighter. The mean birth weight observed was 2.98 +/- 0.68 kg. Conclusion Our findings show that pre-pregnancy body mass index and weight gain during pregnancy influence birth weight. Therefore, emphasis should be placed on counseling and assisting pregnant women to stay within the recommended weight gain ranges.	[Abubakari, Abdulai; Kynast-Wolf, Gisela; Jahn, Albrecht] Univ Dev Studies, Sch Allied Hlth Sci, Community Nutr Dept, Tamale, Ghana; [Abubakari, Abdulai] Heidelberg Univ, Fac Med, Inst Publ Hlth, D-69115 Heidelberg, Germany	University for Development Studies; Ruprecht Karls University Heidelberg	Abubakari, A (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Community Nutr Dept, Tamale, Ghana.	abubakariabdulai@yahoo.com						Abrams B, 2000, AM J CLIN NUTR, V71, p1233S, DOI 10.1093/ajcn/71.5.1233s; Addo V, 2011, GHANA MED J, V44, P64; Allen LH, 2004, WHAT WORKS REV EFFIC; Amin Nurul, 1993, Indian Journal of Pediatrics, V60, P269, DOI 10.1007/BF02822189; ANDERSON GD, 1984, AM J OBSTET GYNECOL, V150, P236, DOI 10.1016/S0002-9378(84)90358-2; Appiah CA., 2014, INT J CLIN NUTR, V2, P60, DOI [10.12691/ijcn-2-3-3, DOI 10.12691/IJCN-2-3-3, https://doi.org/10.12691/ijcn-2-3-3]; Arendas K, 2008, J OBSTET GYNAECOL CA, V30, P477, DOI 10.1016/S1701-2163(16)32863-8; Bailey BA, 2009, J RURAL HEALTH, V25, P141, DOI 10.1111/j.1748-0361.2009.00210.x; Bale JR, 2003, IMPROVING BIRTH OUTC; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bish CL, 2009, MATERN CHILD HLTH J, V13, P286, DOI 10.1007/s10995-008-0349-x; Boerma JT, 1996, B WORLD HEALTH ORGAN, V74, P209; Boulet S L, 2004, J Obstet Gynaecol, V24, P622; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; Bracero LA, 1998, GYNECOL OBSTET INVES, V46, P9, DOI 10.1159/000009988; Clausen T, 2005, EUR J ENDOCRINOL, V153, P887, DOI 10.1530/eje.1.02034; Dake Fidelia AA, 2012, J PUBLIC HLTH, V3; De-Graft Aikins A., 2011, FATNESS MATERNAL BOD; DeVader SR, 2007, OBSTET GYNECOL, V110, P745, DOI 10.1097/01.AOG.0000284451.37882.85; Dietz P., 2009, AM J OBSTET GYNECOL, V53, pe1; Dubois L, 2006, PEDIATR INT, V48, P470, DOI 10.1111/j.1442-200X.2006.02256.x; EKBLAD U, 1992, INT J GYNECOL OBSTET, V39, P277, DOI 10.1016/0020-7292(92)90258-K; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fosu M. O., 2013, Journal of Biology, Agriculture and Healthcare, V3, P205; Gluckman PD, 1993, PERINATAL PEDIATRIC; Godfrey K M, 2001, Public Health Nutr, V4, P611; Grange A., 2006, PAED ASS NIG C JOS N; Guoyao W, 2004, J NUTR, P2169; Hedderson MM, 2006, OBSTET GYNECOL, V108, P1153, DOI 10.1097/01.AOG.0000242568.75785.68; Institute of Medicine Nutrition During Pregnancy, 1990, WEIGHT GAIN 1; Institute of Medicine Nutrition During Pregnancy, 1990, NUTR SUPPL 2; Johansson K, 2007, OBES RES CLIN PRACT, V1, P243, DOI 10.1016/j.orcp.2007.09.001; Kac Gilberto, 2005, J. Pediatr. (Rio J.), V81, P47, DOI [10.2223/JPED.1282, 10.1590/S0021-75572005000100010]; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Konan ER, 2010, EPIDEMIOLOGY ADIPOSI; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; KRAMER MS, 1990, PEDIATRICS, V86, P18; Kramer MS, 1987, OFFICIAL J AM ACAD P; Kumar R, 1987, 10 WHO, V10; Kumari AS, 2001, INT J GYNECOL OBSTET; LAWOYIN TO, 1991, J TROP PEDIATRICS, V37, P166, DOI 10.1093/tropej/37.4.166; Marsoosi V, 2004, INT J GYNECOL OBSTET, V87, P36, DOI 10.1016/j.ijgo.2004.06.002; May R, 2007, AM J HUM BIOL, V19, P305, DOI 10.1002/ajhb.20572; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Muller O, 2009, MATERNAL AND CHILD HEALTH: GLOBAL CHALLENGES, PROGRAMS AND POLICIES, P287, DOI 10.1007/b106524_16; Munim S, 2012, JCPSP-J COLL PHYSICI, V22, P694, DOI 11.2012/JCPSP.694698; Obed Sa, 2006, Ghana Med J, V40, P8; OHLIN A, 1990, INT J OBESITY, V14, P159; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Orskou J, 2003, OBSTET GYNECOL, V102, P115, DOI 10.1016/S0029-7844(03)00402-2; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Popkin BM, 2005, PUBLIC HEALTH NUTR, V8, P724, DOI 10.1079/PHN2005776; Popkin BM, 1998, PUBLIC HEALTH NUTR, P1; RANSOMEKUTI O, 1985, ACTA PAEDIATR SCAND, P95; Rasmussen KM, 2009, I MED WEIGHT GAIN DU; Saaka M, 2012, INT J CHILD HEALTH N, V1, P148, DOI 10.6000/1929-4247.2012.01.02.6; Sacks DA, 2000, OBSTET GYNECOL SURV, V55, P229, DOI 10.1097/00006254-200004000-00022; Samaras TT, 2003, J NATL MED ASSOC, V95, P1170; Shin D, 2014, MATERN CHILD HLTH J, V18, P1667, DOI 10.1007/s10995-013-1407-6; Simas TAM, 2012, J WOMENS HEALTH, V21, P410, DOI 10.1089/jwh.2011.2810; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Suitor CW, 1997, MATERNAL WEIGHT GAIN; Sukalich S, 2006, AM J OBSTET GYNECOL, V195, P851, DOI 10.1016/j.ajog.2006.06.070; Tayie F., 2004, AFR J FOOD AGR NUTR, V4; The Vanuatu National Statistics Office, 2009, NAT POP HOUS CENS AN, V2; United Nations Administrative Committee on Coordination Subcommittee on Nutrition, 2000, NUTR THROUGH LIF CYC; VARMA TR, 1984, INT J GYNECOL OBSTET, V22, P161, DOI 10.1016/0020-7292(84)90031-6; Voigt M, 2007, Z Geburtshilfe Neonatol, V211, P191, DOI 10.1055/s-2007-981327; Wax JR, 2009, CURR OPIN OBSTET GYN, V21, P117, DOI 10.1097/GCO.0b013e328328d3c7; WHO/UNICEF, 2004, LOW BIRTH WEIGHT COU	71	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135641	10.1371/journal.pone.0135641	http://dx.doi.org/10.1371/journal.pone.0135641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281013	gold, Green Published, Green Submitted			2022-12-27	WOS:000359664300018
J	Deng, YP; Yang, M; Xu, F; Zhang, Q; Zhao, Q; Yu, HT; Li, DF; Zhang, G; Lu, AP; Cho, K; Teng, FK; Wu, P; Wang, LL; Wu, WY; Liu, X; Guo, DA; Jiang, BH				Deng, Yanping; Yang, Min; Xu, Feng; Zhang, Qian; Zhao, Qun; Yu, Haitao; Li, Defang; Zhang, Ge; Lu, Aiping; Cho, Kenka; Teng, Fukang; Wu, Peng; Wang, Linlin; Wu, Wanying; Liu, Xuan; Guo, De-an; Jiang, Baohong			Combined Salvianolic Acid B and Ginsenoside Rg1 Exerts Cardioprotection against Ischemia/Reperfusion Injury in Rats	PLOS ONE			English	Article							HEART; COMBINATION; ACTIVATION; MECHANISMS; CELLS	Lack of pharmacological strategies in clinics restricts the patient prognosis with myocardial ischemia/reperfusion (I/R) injury. The aim of this study was to evaluate the cardioprotection of combined salvianolic acid B (SalB) and ginsenoside Rg1 (Rg1) against myocardial I/R injury and further investigate the underlying mechanism. I/R injury was induced by coronary artery ligation for Wistar male rats and hypoxia/reoxygenation injury was induced on H9c2 cells. Firstly, the best ratio between SalB and Rg1 was set as 2: 5 based on their effects on heart function detected by hemodynamic measurement. Then SalB-Rg1 (2: 5) was found to maintain mitochondrial membrane potential and resist apoptosis and necrosis in H9c2 cell with hypoxia/reoxygenation injury. Companying with same dose of SalB or Rg1 only, SalB-Rg1 showed more significant effects on down-regulation of myocardial infarct size, maintenance of myocardium structure, improvement on cardiac function, decrease of cytokine secretion including TNF-alpha, IL-1 beta, RANTES and sVCAM-1. Finally, the SalB-Rg1 improved the viability of cardiac myocytes other than cardiac fibroblasts in rats with I/R injury using flow cytometry. Our results revealed that SalB-Rg1 was a promising strategy to prevent myocardial I/R injury.	[Deng, Yanping; Yang, Min; Zhao, Qun; Yu, Haitao; Teng, Fukang; Wu, Peng; Wang, Linlin; Wu, Wanying; Liu, Xuan; Guo, De-an; Jiang, Baohong] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Xu, Feng; Zhao, Qun; Teng, Fukang; Wu, Peng] Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R China; [Zhang, Qian] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 200237, Peoples R China; [Li, Defang; Zhang, Ge; Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China; [Cho, Kenka] Takarazuka Univ Med & Hlth Care, Takarazuka, Hyogo 6660162, Japan	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shenyang Pharmaceutical University; Fudan University; Hong Kong Baptist University	Jiang, BH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Haike Rd 501, Shanghai 201203, Peoples R China.	jiangbh@simm.ac.cn	zhou, ju/M-3255-2017; Zhang, Ge/K-9118-2019	Zhang, Ge/0000-0002-7807-7695; Li, Defang/0000-0003-4151-9151	National Science & Technology Major Project for "Key New Drug Creation and Manufacturing Program" [2013ZX09103002-024]; National Natural Science Foundation of China [81173587]; Shanghai Science and Technology Development Foundation [14401900900]; Croucher Foundation [CAS14201]; State Key Laboratory of Drug Research [SIMM1501KF-01]	National Science & Technology Major Project for "Key New Drug Creation and Manufacturing Program"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Foundation; Croucher Foundation; State Key Laboratory of Drug Research	This work was supported by National Science & Technology Major Project for "Key New Drug Creation and Manufacturing Program" (2013ZX09103002-024), National Natural Science Foundation of China Grants (81173587), and Shanghai Science and Technology Development Foundation (14401900900). This work was also partially supported by the Croucher Foundation (CAS14201) and the State Key Laboratory of Drug Research (SIMM1501KF-01).	Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Betgem RP, 2015, NAT REV CARDIOL, V12, P156, DOI 10.1038/nrcardio.2014.188; Crea F, 2015, ATHEROSCLEROSIS, V241, P157, DOI 10.1016/j.atherosclerosis.2015.04.802; Deng YP, 2015, J CHIN MED ASSOC, V78, P114, DOI 10.1016/j.jcma.2014.10.001; Diaz RJ, 2013, CARDIOVASC RES, V98, P411, DOI 10.1093/cvr/cvt056; Feng GM, 2012, EUR J NUTR, V51, P987, DOI 10.1007/s00394-011-0278-0; Guo J, 2013, ATHEROSCLEROSIS, V231, P384, DOI 10.1016/j.atherosclerosis.2013.10.003; Homma T, 2013, J MOL CELL CARDIOL, V62, P179, DOI 10.1016/j.yjmcc.2013.06.004; Kassiri Z, 2009, J BIOL CHEM, V284, P29893, DOI 10.1074/jbc.M109.028449; Poh KK, 2014, EUR J CLIN PHARMACOL, V70, P527, DOI 10.1007/s00228-014-1650-9; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Morrison A, 2011, BIOCHEM PHARMACOL, V82, P195, DOI 10.1016/j.bcp.2011.04.004; Rodrigues SF, 2010, CARDIOVASC RES, V87, P291, DOI 10.1093/cvr/cvq090; Seif AA, 2013, J PHYSIOL BIOCHEM, V69, P937, DOI 10.1007/s13105-013-0272-5; Suzuki YJ, 2003, ANTIOXID REDOX SIGN, V5, P741, DOI 10.1089/152308603770380043; Wang YH, 2011, PHYTOMEDICINE, V19, P13, DOI 10.1016/j.phymed.2011.06.024; Wei YH, 2007, J PHARMACEUT BIOMED, V45, P775, DOI 10.1016/j.jpba.2007.07.013; Wu B, 2014, CLIN EXP IMMUNOL, V176, P438, DOI 10.1111/cei.12284; Xu H, 2014, DRUG METAB DISPOS, V42, P274, DOI 10.1124/dmd.113.053694; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024036; Yue QX, 2012, J ETHNOPHARMACOL, V141, P659, DOI 10.1016/j.jep.2011.08.044; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zhou Q, 2014, THROMB RES, V133, P57, DOI 10.1016/j.thromres.2013.10.032	24	46	52	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135435	10.1371/journal.pone.0135435	http://dx.doi.org/10.1371/journal.pone.0135435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280455	Green Submitted, Green Published, gold			2022-12-27	WOS:000359664300013
J	Kim, SY; Sim, S; Kim, SG; Choi, HG				Kim, So Young; Sim, Songyong; Kim, Sung-Gyun; Choi, Hyo Geun			Sleep Deprivation Is Associated with Bicycle Accidents and Slip and Fall Injuries in Korean Adolescents	PLOS ONE			English	Article							TRAUMATIC DENTAL INJURIES; DURATION; RISK; RECOMMENDATIONS; PREVALENCE; CHILDREN; SAFETY; AGE	Objective This study sought to evaluate associations between sleep time and bicycle accidents, falls under various circumstances, and dental injuries in adolescents. Methods A total of 61,696 participants ranging from 12 to 18 years of age who completed the Korea Youth Risk Behavior Web-based Survey (KYRBWS) in 2013 were enrolled in this study. Bicycle riding accidents were analyzed for 17,232 bicycle-riding participants. Data were collected regarding the weekday sleep duration for the most recent 7 days, which was categorized as < 5.5 h, 5.5-6.5 h, 6.5-7.5 h, or >= 7.5 h per day, and the incidence of bicycle accidents, slips and falls under various circumstances, and dental injuries in the most recent 12 months. Adjusted odds ratios (aORs) were calculated among sleep groups for bicycle accidents, slips and falls, and dental injuries using simple and multiple logistic regression analyses with complex sampling. Results Bicycle riding accidents and slips and falls in classrooms, corridors, the ground, toilets, stairs, and other unspecified situations showed positive correlations with sleep deprivation. Comparisons of groups with >= 7.5 h sleep, < 5.5 h, 5.5-6.5 h sleep, and 6.5-7.5 h sleep revealed increased associations with slips and falls under various circumstances. In particular, the aORs were higher in the groups with less sleep (aOR of the 5.5 h group > the 5.5-6.5 h group > the 6.5-7.5 h group). There was no significant relationship between sleep deprivation and dental injury. Conclusions This study demonstrated that sleep deprivation among Korean adolescents was associated with bicycle accidents and falls at home and school. Thus, adequate sleep may be needed to prevent accidents and falls.	[Kim, So Young] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, So Young] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Kim, Sung-Gyun] Hallym Univ, Coll Med, Dept Internal Med, Anyang, South Korea; [Choi, Hyo Geun] Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hallym University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	Hallym University Sacred Heart Hospital [HURF-2014-58, HURF-2015-3]	Hallym University Sacred Heart Hospital	This study was supported by a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2014-58 and HURF-2015-3).	Adams SK, 2013, HEALTH SERV INSIGHTS, V6, P99, DOI 10.4137/HSI.S11083; Arora T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072406; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Chen MC, 2012, J SLEEP RES, V21, P68, DOI 10.1111/j.1365-2869.2011.00934.x; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; Daniel LC, 2012, ANN ALLERG ASTHMA IM, V109, P41, DOI 10.1016/j.anai.2012.05.015; Davis AL, 2013, J ADOLESCENT HEALTH, V53, P785, DOI 10.1016/j.jadohealth.2013.07.008; Garbarino S, 2001, SLEEP, V24, P203; Gillberg M, 1996, SLEEP, V19, P570, DOI 10.1093/sleep/19.7.570; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hoffrage U, 2003, J EXP PSYCHOL-APPL, V9, P249, DOI 10.1037/1076-898X.9.4.249; Howland RH, 2011, J PSYCHOSOC NURS MEN, V49, P17, DOI 10.3928/02793695-20101208-01; Killgore WDS, 2006, J SLEEP RES, V15, P7, DOI 10.1111/j.1365-2869.2006.00487.x; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Matricciani LA, 2012, PEDIATRICS, V129, P548, DOI 10.1542/peds.2011-2039; Matthews KA, 2012, SLEEP, V35, P1353, DOI 10.5665/sleep.2112; Mercer PW, 1998, J ADOLESCENT HEALTH, V23, P259, DOI 10.1016/S1054-139X(98)00037-8; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; O'Brien Erin M, 2005, Behav Sleep Med, V3, P113, DOI 10.1207/s15402010bsm0303_1; Owens Judith A, 2005, Behav Sleep Med, V3, P18, DOI 10.1207/s15402010bsm0301_4; Owens JA, 2012, PEDIATRICS, V129, P987, DOI 10.1542/peds.2012-0755A; Paavonen EJ, 2009, PEDIATRICS, V123, pE857, DOI 10.1542/peds.2008-2164; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; Philip P, 2006, SLEEP MED REV, V10, P347, DOI 10.1016/j.smrv.2006.04.002; Philip P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114102; Ravishankar TL, 2010, CHIN J DENT RES, V13, P57; Rowe R, 2007, J CHILD PSYCHOL PSYC, V48, P71, DOI 10.1111/j.1469-7610.2006.01674.x; Soriano EP, 2007, DENT TRAUMATOL, V23, P232, DOI 10.1111/j.1600-9657.2005.00426.x; Thornley S, 2014, NEW ZEAL MED J, V127, P32; Valent F, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.2.e23; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135753	10.1371/journal.pone.0135753	http://dx.doi.org/10.1371/journal.pone.0135753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VK	26280345	Green Submitted, Green Published, gold			2022-12-27	WOS:000359664300021
J	Noiret, L; Baigent, S; Jalan, R; Thomas, SR				Noiret, Lorette; Baigent, Stephen; Jalan, Rajiv; Thomas, S. Randall			Mathematical Model of Ammonia Handling in the Rat Renal Medulla	PLOS ONE			English	Article							THICK ASCENDING LIMB; RH C GLYCOPROTEIN; NA+-K+-ATPASE; COLLECTING DUCT; METABOLIC-ACIDOSIS; NA+-K+-2CL(-) COTRANSPORTER; JUXTAMEDULLARY NEPHRON; BICARBONATE TRANSPORT; CHRONIC HYPERKALEMIA; POTASSIUM SECRETION	The kidney is one of the main organs that produces ammonia and release it into the circulation. Under normal conditions, between 30 and 50% of the ammonia produced in the kidney is excreted in the urine, the rest being absorbed into the systemic circulation via the renal vein. In acidosis and in some pathological conditions, the proportion of urinary excretion can increase to 70% of the ammonia produced in the kidney. Mechanisms regulating the balance between urinary excretion and renal vein release are not fully understood. We developed a mathematical model that reflects current thinking about renal ammonia handling in order to investigate the role of each tubular segment and identify some of the components which might control this balance. The model treats the movements of water, sodium chloride, urea, NH3 and NH4+, and non-reabsorbable solute in an idealized renal medulla of the rat at steady state. A parameter study was performed to identify the transport parameters and microenvironmental conditions that most affect the rate of urinary ammonia excretion. Our results suggest that urinary ammonia excretion is mainly determined by those parameters that affect ammonia recycling in the loops of Henle. In particular, our results suggest a critical role for interstitial pH in the outer medulla and for luminal pH along the inner medullary collecting ducts.	[Noiret, Lorette; Baigent, Stephen] UCL, CoMPLEX, London, England; [Baigent, Stephen] UCL, Math, London, England; [Jalan, Rajiv] UCL, Sch Med, Inst Hepatol, London W1N 8AA, England; [Thomas, S. Randall] Univ Paris 11, CNRS, IR4M UMR8081, F-91405 Orsay, France	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay	Noiret, L (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02138 USA.	noiret.lorette@mgh.harvard.edu			Engineering and Physical Sciences Research Council through the UCL CoMPLEX doctoral training centre; Virtual Physiological Human - Network of Excellence (EU) [23920]	Engineering and Physical Sciences Research Council through the UCL CoMPLEX doctoral training centre; Virtual Physiological Human - Network of Excellence (EU)	This work was supported by the Engineering and Physical Sciences Research Council through the UCL CoMPLEX doctoral training centre and by the following grant: The Virtual Physiological Human - Network of Excellence (EU FP7, grant 23920, http://cordis.europa.eu/fp7/ict/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hossain S, 2011, AM J PHYSIOL-RENAL, V301, pF969, DOI 10.1152/ajprenal.00010.2011; Attmane-Elakeb A, 1998, J BIOL CHEM, V273, P33681, DOI 10.1074/jbc.273.50.33681; Attmane-Elakeb A, 2001, AMERICAN JOURNAL OF, V280; BATTILANA CA, 1978, J CLIN INVEST, V62, P1093, DOI 10.1172/JCI109215; Bishop JM, 2013, AM J PHYSIOL-RENAL, V304, pF422, DOI 10.1152/ajprenal.00301.2012; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; BUERKERT J, 1983, AM J PHYSIOL, V244, pF442, DOI 10.1152/ajprenal.1983.244.4.F442; BUERKERT J, 1982, J CLIN INVEST, V70, P1, DOI 10.1172/JCI110581; DEJONG CHC, 1993, J CLIN INVEST, V92, P2834, DOI 10.1172/JCI116903; DEJONG CHC, 1993, GUT, V34, P1112, DOI 10.1136/gut.34.8.1112; DUBOSE TD, 1992, J CLIN INVEST, V90, P1443, DOI 10.1172/JCI116011; DUBOSE TD, 1991, J AM SOC NEPHROL, V1, P1193; DUBOSE TD, 1983, AM J PHYSIOL, V244, pF497, DOI 10.1152/ajprenal.1983.244.5.F497; DUBOSE TD, 1991, AM J PHYSIOL, V260, pF680, DOI 10.1152/ajprenal.1991.260.5.F680; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; FERGUSON EB, 1951, J PHYSIOL-LONDON, V112, P420, DOI 10.1113/jphysiol.1951.sp004539; FLESSNER MF, 1991, AM J PHYSIOL, V260, pF264, DOI 10.1152/ajprenal.1991.260.2.F264; FLESSNER MF, 1993, AM J PHYSIOL, V264, pF837, DOI 10.1152/ajprenal.1993.264.5.F837; FLESSNER MF, 1992, AM J PHYSIOL, V262, pF1, DOI 10.1152/ajprenal.1992.262.1.F1; Garibotto G, 2009, METAB BRAIN DIS, V24, P159, DOI 10.1007/s11011-008-9121-6; GARVIN JL, 1988, AM J PHYSIOL, V255, pF56; Garvin JL, 1987, THE AMERICAN JOURNAL, V252; GOOD DW, 1985, AM J PHYSIOL, V248, pF459, DOI 10.1152/ajprenal.1985.248.4.F459; GOOD DW, 1984, J CLIN INVEST, V73, P602, DOI 10.1172/JCI111250; GOOD DW, 1987, J CLIN INVEST, V80, P1358, DOI 10.1172/JCI113213; GOOD DW, 1988, AM J PHYSIOL, V255, pF78, DOI 10.1152/ajprenal.1988.255.1.F78; GRABER ML, 1981, AM J PHYSIOL, V241, pF669, DOI 10.1152/ajprenal.1981.241.6.F669; Han KH, 2011, AM J PHYSIOL-RENAL, V301, pF823, DOI 10.1152/ajprenal.00266.2011; Hervy S, 2003, AMERICAN JOURNAL OF, V284; Houillier P, 2012, AM J PHYSIOL-RENAL, V302, pF293, DOI 10.1152/ajprenal.00307.2011; JAMISON RL, 1976, KIDNEY INT, V9, P323, DOI 10.1038/ki.1976.38; JAMISON RL, 1982, URINARY CONCENTRATIN; JEN JF, 1994, B MATH BIOL, V56, P491, DOI 10.1007/BF02460468; KERSTING U, 1994, PFLUG ARCH EUR J PHY, V426, P354, DOI 10.1007/BF00374794; KINNE R, 1986, J MEMBRANE BIOL, V94, P279, DOI 10.1007/BF01869723; KNEPPER MA, 1977, KIDNEY INT, V12, P313, DOI 10.1038/ki.1977.118; KRIZ W, 1967, Z ZELLFORSCH MIK ANA, V82, P495, DOI 10.1007/BF00337120; Kuramochi G, 1996, PFLUG ARCH EUR J PHY, V432, P1062, DOI 10.1007/s004240050235; Kuramochi G, 1997, PFLUG ARCH EUR J PHY, V434, P392, DOI 10.1007/s004240050412; KURTZ I, 1986, AM J PHYSIOL, V250, pF497, DOI 10.1152/ajprenal.1986.250.3.F497; Lee HW, 2013, AM J PHYSIOL-RENAL, V304, pF410, DOI 10.1152/ajprenal.00300.2012; Lee HW, 2009, AM J PHYSIOL-RENAL, V296, pF1364, DOI 10.1152/ajprenal.90667.2008; LEONARD E, 1955, AM J PHYSIOL, V182, P131, DOI 10.1152/ajplegacy.1955.182.1.131; LEVINE DZ, 1991, J CLIN INVEST, V87, P1513, DOI 10.1172/JCI115161; MALNIC G, 1966, AM J PHYSIOL, V211, P529, DOI 10.1152/ajplegacy.1966.211.3.529; Mejia Raymond, 1993, American Journal of Physiology, V264, pF397; OWEN EE, 1962, J CLIN INVEST, V41, P1139, DOI 10.1172/JCI104566; Pannabecker TL, 2004, AMERICAN JOURNAL OF, V286; Paredes A, 2006, AM J PHYSIOL-RENAL, V290, pF1094, DOI 10.1152/ajprenal.00071.2005; SAJO IM, 1981, KIDNEY INT, V20, P353, DOI 10.1038/ki.1981.146; SIMON E, 1985, J CLIN INVEST, V76, P855, DOI 10.1172/JCI112043; Stephenson JL, 1974, PROCEEDINGS OF THE N, V71, P1618, DOI [10.1073/pnas.71.5.1618, DOI 10.1073/PNAS.71.5.1618]; Stephenson JL, 1992, HANDBOOK OF PHYSIOLO, V2; STERN L, 1985, KIDNEY INT, V27, P652, DOI 10.1038/ki.1985.60; Stettner P, 2013, P NATL ACAD SCI USA, V110, P9998, DOI 10.1073/pnas.1217775110; Sufit CR, 1983, THE AMERICAN JOURNAL, V245; Tannehill-Gregg SH, 2009, TOXICOL PATHOL, V37, P293, DOI 10.1177/0192623309332990; TANNEN RL, 1977, KIDNEY INT, V11, P453, DOI 10.1038/ki.1977.63; Thomas SR, 1995, THE AMERICAN JOURNAL, V269; TIZIANELLO A, 1980, J CLIN INVEST, V65, P1162, DOI 10.1172/JCI109771; TIZIANELLO A, 1982, CONTRIB NEPHROL, V31, P40; TIZIANELLO A, 1991, KIDNEY INT, V40, P772, DOI 10.1038/ki.1991.274; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wall SM, 1999, AM J PHYSIOL-RENAL, V277, pF866, DOI 10.1152/ajprenal.1999.277.6.F866; Wall SM, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134827; WALL SM, 1994, AM J PHYSIOL-RENAL, V267, pF660, DOI 10.1152/ajprenal.1994.267.4.F660; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Weinstein AM, 2015, AM J PHYSIOL-RENAL, V308, pF1076, DOI 10.1152/ajprenal.00504.2014; Weinstein AM, 2010, AM J PHYSIOL-RENAL, V298, pF543, DOI 10.1152/ajprenal.00232.2009; Weinstein AM, 2002, AM J PHYSIOL-RENAL, V283, pF1237, DOI 10.1152/ajprenal.00162.2002; WILCOX CS, 1984, AM J PHYSIOL, V247, pF506, DOI 10.1152/ajprenal.1984.247.3.F506; Zhai XY, 2007, J AM SOC NEPHROL, V18, P2937, DOI 10.1681/ASN.2007010056	73	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134477	10.1371/journal.pone.0134477	http://dx.doi.org/10.1371/journal.pone.0134477			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280830	Green Published, gold			2022-12-27	WOS:000359664300007
J	Pan, T; Wang, H; Hu, CC; Sun, ZL; Zhu, XX; Meng, T; Meng, XX; Zhang, BW				Pan, Tao; Wang, Hui; Hu, Chaochao; Sun, Zhonglou; Zhu, Xiaoxue; Meng, Tao; Meng, Xiuxiang; Zhang, Baowei			Species Delimitation in the Genus Moschus (Ruminantia: Moschidae) and Its High-Plateau Origin	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; EAST-ASIAN MONSOON; MUSK DEER; TIBETAN PLATEAU; COMPREHENSIVE ANALYSIS; PHYLOGENETIC ANALYSIS; GENETIC CONSEQUENCES; CYTOCHROME-B; UPLIFT; DNA	The authenticity of controversial species is a significant challenge for systematic biologists. Moschidae is a small family of musk deer in the Artiodactyla, composing only one genus, Moschus. Historically, the number of species in the Moschidae family has been debated. Presently, most musk deer species were restricted in the Tibetan Plateau and surrounding/adjacent areas, which implied that the evolution of Moschus might have been punctuated by the uplift of the Tibetan Plateau. In this study, we aimed to determine the evolutionary history and delimit the species in Moschus by exploring the complete mitochondrial genome (mtDNA) and other mitochondrial gene. Our study demonstrated that six species, M. leucogaster, M. fuscus, M. moschiferus, M. berezovskii, M. chrysogaster and M. anhuiensis, were authentic species in the genus Moschus. Phylogenetic analysis and molecular dating showed that the ancestor of the present Moschidae originates from Tibetan Plateau which suggested that the evolution of Moschus was prompted by the most intense orogenic movement of the Tibetan Plateau during the Pliocene age, and alternating glacial-interglacial geological eras.	[Pan, Tao; Wang, Hui; Sun, Zhonglou; Zhu, Xiaoxue; Zhang, Baowei] Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei 230601, Anhui, Peoples R China; [Hu, Chaochao] Nanjing Normal Univ, Sch Life Sci, Nanjing 230039, Jiangsu, Peoples R China; [Meng, Tao] Guangxi Forest Inventory & Planning Inst, Nanning 530011, Guangxi, Peoples R China; [Meng, Xiuxiang] Renmin Univ China, Sch Environm & Nat Resources, Beijing 100872, Peoples R China	Anhui University; Nanjing Normal University; Renmin University of China	Zhang, BW (corresponding author), Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei 230601, Anhui, Peoples R China.	zhangbw@ahu.edu.cn			The wild populations investigation and habitat assessment project of Moschus anhuiensis; The field patrol and habitat protected project of Moschus anhuiensis, (Anhui Nature Reserve Management Station) [20132014]; Foundation for Young and Key Teachers Project of Anhui University [02203104/04]; Endangerment mechanism and habitat assessment project of forest musk deer (Guangxi) [2014GXNSFAA118122]	The wild populations investigation and habitat assessment project of Moschus anhuiensis; The field patrol and habitat protected project of Moschus anhuiensis, (Anhui Nature Reserve Management Station); Foundation for Young and Key Teachers Project of Anhui University; Endangerment mechanism and habitat assessment project of forest musk deer (Guangxi)	This project was funded by The wild populations investigation and habitat assessment project of Moschus anhuiensis (The second land survey of wild animal resources investigation project, 2014-2015, Baowei ZHANG), The field patrol and habitat protected project of Moschus anhuiensis, (Anhui Nature Reserve Management Station, 20132014, Baowei ZHANG) and Foundation for Young and Key Teachers Project of Anhui University (02203104/04, Baowei ZHANG), Endangerment mechanism and habitat assessment project of forest musk deer (Guangxi, 2014GXNSFAA118122, Tao MENG). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. All projects came from Baowei ZHANG support the study design, data collection and analysis and decision to publish. The project came from Tao MENG support the preparation of the manuscript and data collection and analysis.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Anderson S, 1981, SEQUENCE AND ORGANIZ; [Anonymous], 2001, PRIMER V5; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Burland T G, 2000, Methods Mol Biol, V132, P71; Cao MM, 2012, MOL PHYLOGENET EVOL, V65, P823, DOI 10.1016/j.ympev.2012.08.004; Chung SL, 1998, NATURE, V394, P769, DOI 10.1038/29511; Davies TJ, 2011, PHILOS T R SOC B, V366, P2526, DOI 10.1098/rstb.2011.0018; DEGIORGI C, 1989, CELL BIOPHYS, V14, P67, DOI 10.1007/BF02797392; Deng T, 2011, SCIENCE, V333, P1285, DOI 10.1126/science.1206594; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Feng H, 2012, ACTA AGRICULTURAE BO, V8, P3; Flerov C, 1929, YEARBOOK OF THE ZOOL, V31, P1; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; GROVES C P, 1986, Acta Theriologica Sinica, V6, P101; Groves Colin P., 1995, Acta Theriologica Sinica, V15, P181; GRUBB P, 1982, Saeugetierkundliche Mitteilungen, V30, P127; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hodgson BH, 1839, J ASIATIC SOC BENGAL, V7, P202; Hua X, 2013, AM NAT, V182, P1, DOI 10.1086/670690; HUELSENBECK J, 2005, MRBAYES VERSION 3 1; Jang KH, 2010, MITOCHONDR DNA, V21, P65, DOI 10.3109/19401736.2010.490834; Jin YT, 2014, MOL PHYLOGENET EVOL, V71, P288, DOI 10.1016/j.ympev.2013.11.004; Li M, 1999, CHINESE SCI BULL, V44, P719, DOI 10.1007/BF02909711; Li ZX, 1981, ZOOL RES, V2, P7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin YH, 2002, GENE, V294, P119, DOI 10.1016/S0378-1119(02)00695-9; Linnaeus C., 1758, SYSTEMA NATURAE, V1; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu XD, 2002, PALAEOGEOGR PALAEOCL, V183, P223, DOI 10.1016/S0031-0182(01)00488-6; Lu B, 2014, MOL PHYLOGENET EVOL, V73, P40, DOI 10.1016/j.ympev.2014.01.008; Nylander J, 2003, MRMODELTEST 1 0 B A; Pan GT, 2012, J ASIAN EARTH SCI, V53, P3, DOI 10.1016/j.jseaes.2011.12.018; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peng HY, 2009, J NAT HIST, V43, P1219, DOI 10.1080/00222930902767458; Qiang XK, 2001, EARTH PLANET SC LETT, V187, P83, DOI 10.1016/S0012-821X(01)00281-3; Rambaut A., 2010, TREEANNOTATOR VERSIO; Rambaut A., 2009, FIGTREE VERSION 1 3; Rannala B, 2003, GENETICS, V164, P1645; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Sambrook J, 1989, MOLECULAR CLONING CO; Sanchez IM, 2011, J VERTEBR PALEONTOL, V31, P1397, DOI 10.1080/02724634.2011.618155; Sheng H.L., 1992, THE DEER IN CHINA; Sheng HL, 2007, THE MUSK DEER IN CHI; Sokolov VE, 1997, IZV AKAD NAUK BIOL+, P677; Sowerby A. de C., 1925, China Journal of Science and Arts, V3, P651; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Su B, 1999, MOL PHYLOGENET EVOL, V12, P241, DOI 10.1006/mpev.1999.0616; Su Bing, 2001, Zoological Research, V22, P169; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vislobokova IA, 2009, PALEONTOL J+, V43, P326, DOI 10.1134/S0031030109030125; Wang H, 2013, MITOCHONDR DNA, V24, P487, DOI 10.3109/19401736.2013.770499; Wang Q., 1982, Acta Theriologica Sinica, V2, P133; Wang XM, 2013, PALAEOGEOGR PALAEOCL, V374, P81, DOI 10.1016/j.palaeo.2013.01.007; Wang XM, 2003, AM MUS NOVIT, P1; Wang Y. X., 2003, COMPLETE CHECKLIST M; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yang CZ, 2015, MITOCHONDR DNA, V26, P605, DOI 10.3109/19401736.2014.880887; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang JQ, 2004, JOURNAL OF CHINA WES, V25, P251; Zhang PZ, 2004, GEOLOGY, V32, P809, DOI 10.1130/G20554.1; Zhou YJ, 2004, FOLIA ZOOL, V53, P129; Zhu XX, 2013, MITOCHONDR DNA, V24, P205, DOI 10.3109/19401736.2012.744985	83	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134183	10.1371/journal.pone.0134183	http://dx.doi.org/10.1371/journal.pone.0134183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280166	gold, Green Published, Green Submitted			2022-12-27	WOS:000359664300002
J	Hoeflinger, JL; Kashtanov, DO; Cox, SB; Dowd, SE; Jouni, ZE; Donovan, SM; Miller, MJ				Hoeflinger, Jennifer L.; Kashtanov, Dimitri O.; Cox, Stephen B.; Dowd, Scot E.; Jouni, Zeina E.; Donovan, Sharon M.; Miller, Michael J.			Characterization of the Intestinal Lactobacilli Community following Galactooligosaccharides and Polydextrose Supplementation in the Neonatal Piglet	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; INULIN-TYPE PREBIOTICS; BOVINE-MILK; INFANT FORMULA; MICROBIOTA; IDENTIFICATION; DIVERSITY; NUTRITION; SEQUENCES; DIGESTION	Recently, prebiotic supplementation of infant formula has become common practice; however the impact on the intestinal microbiota has not been completely elucidated. In this study, neonatal piglets were randomized to: formula (FORM, n = 8), formula supplemented with 2 g/L each galactooligosaccharides (GOS) and polydextrose (PDX, F+GP, n = 9) or a sow-reared (SOW, n = 12) reference group for 19 days. The ileal (IL) and ascending colon (AC) microbiota were characterized using culture-dependent and -independent methods. 16S amplicon sequencing identified no differences at the genera level in the IL. Interestingly, six genera in the AC were significantly different between FORM and F+GP (P<0.05): Lactobacillus, Ruminococcus, Parabacteroides, Oscillospira, Hydrogenoanaerobacterium and Catabacter. In particular, the relative abundance of AC Lactobacillus was higher (P = 0.04) in F+GP as compared to FORM. Culture-dependent analysis of the IL and AC lactobacilli communities of FORM and F+GP revealed a Lactobacillus spp. composition similar to 16S amplicon sequencing. Additional analysis demonstrated individual Lactobacillus isolates were unable to ferment PDX. Conversely, a majority of lactobacilli isolates could ferment GOS, regardless of piglet diet. In addition, the ability of lactobacilli isolates to ferment the longer chain GOS fragments (DP 3 or greater), which are expected to be present in the distal intestine, was not different between FORM and F+GP. In conclusion, prebiotic supplementation of formula impacted the AC microbiota; however, direct utilization of GOS or PDX does not lead to an increase in Lactobacillus spp.	[Hoeflinger, Jennifer L.; Donovan, Sharon M.; Miller, Michael J.] Univ Illinois, Dept Food Sci & Human Nutr Sci, Urbana, IL 61801 USA; [Kashtanov, Dimitri O.; Donovan, Sharon M.; Miller, Michael J.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Dowd, Scot E.; Jouni, Zeina E.] Res & Testing Lab, Lubbock, TX 79407 USA; [Jouni, Zeina E.] Mead Johnson Nutr, Evansville, IN 47712 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Miller, MJ (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr Sci, 905 S Goodwin Ave, Urbana, IL 61801 USA.	mille216@illinois.edu	Dowd, Scot E/M-5386-2017; Donovan, Sharon/AAY-6787-2020	Dowd, Scot E/0000-0002-6296-1427; Hoeflinger, Jennifer/0000-0002-3342-3611; Miller, Michael/0000-0001-8579-1080	Mead Johnson Nutrition; Research and Testing Laboratory; Molecular Research LP	Mead Johnson Nutrition; Research and Testing Laboratory; Molecular Research LP	This study was funded by Mead Johnson Nutrition who had a role in the study design. They had a limited role in the decision to publish and preparation of the manuscript but had no role in the collection and analysis of data. Mead Johnson Nutrition provided support in the form of a salary for author ZEJ, but did not have any additional role in the data collection and analysis. The specific role of this author is articulated in the 'author contributions' section. Research and Testing Laboratory and Molecular Research LP provided support in the form of salaries for authors SBC and SED, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Aufreiter S, 2011, J NUTR, V141, P366, DOI 10.3945/jn.110.135343; Barry KA, 2009, J ANIM SCI, V87, P3244, DOI 10.2527/jas.2008-1659; BETTELHEIM KA, 1974, J HYG-CAMBRIDGE, V72, P67, DOI 10.1017/S0022172400023226; Blaiotta G, 2008, APPL ENVIRON MICROB, V74, P208, DOI 10.1128/AEM.01711-07; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; Boehm G, 2002, ARCH DIS CHILD-FETAL, V86, P178, DOI 10.1136/fn.86.3.F178; BROOK I, 1979, PEDIATRICS, V63, P451; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Coppa G V, 2006, Dig Liver Dis, V38 Suppl 2, pS291; Cummings JH, 2002, BRIT J NUTR, V87, pS145, DOI 10.1079/BJN/2002530; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; Domeneghini C, 2006, HISTOL HISTOPATHOL, V21, P273, DOI 10.14670/HH-21.273; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Eshach Adiv Orly, 2004, Pediatr Endocrinol Rev, V2, P216; Fava F, 2007, BRIT J NUTR, V98, P123, DOI 10.1017/S0007114507691818; Garrido D, 2013, FOOD MICROBIOL, V33, P262, DOI 10.1016/j.fm.2012.10.003; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gopal Pramod K., 2000, British Journal of Nutrition, V84, pS69; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Herfel TM, 2009, FOOD CHEM TOXICOL, V47, P1530, DOI 10.1016/j.fct.2009.03.039; Herfel TM, 2011, J NUTR, V141, P2139, DOI 10.3945/jn.111.143727; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; KARLSSON FH, 2011, MICROB ECOL, V61, P473, DOI DOI 10.1007/s00248-010-9796-1; Kelly G, 2009, ALTERN MED REV, V14, P36; Kelly G, 2008, ALTERN MED REV, V13, P315; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Konstantinov SR, 2004, APPL ENVIRON MICROB, V70, P3821, DOI 10.1128/AEM.70.7.3821-3830.2004; Konstantinov SR, 2003, FEMS MICROBIOL ECOL, V43, P225, DOI 10.1111/j.1574-6941.2003.tb01062.x; Korhonen JM, 2007, J APPL MICROBIOL, V103, P2496, DOI 10.1111/j.1365-2672.2007.03483.x; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lau K, 2011, J IMMUNOL, V186, P3538, DOI 10.4049/jimmunol.1001864; Li M, 2012, J NUTR, V142, P681, DOI 10.3945/jn.111.154427; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; Martin-Sosa S, 2003, J DAIRY SCI, V86, P52, DOI 10.3168/jds.S0022-0302(03)73583-8; Monaco MH, 2011, J PEDIATR GASTR NUTR, V52, P210, DOI 10.1097/MPG.0b013e3181ffcaee; Mountzouris KC, 2002, BRIT J NUTR, V87, P405, DOI 10.1079/BJN2002563; Muir HE, 1996, J ANIM SCI, V74, P1641; Nakamura N, 2009, APPL ENVIRON MICROB, V75, P1121, DOI 10.1128/AEM.02359-07; Odle J, 2014, ANNU REV ANIM BIOSCI, V2, P419, DOI 10.1146/annurev-animal-022513-114158; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rao S, 2009, ARCH PEDIAT ADOL MED, V163, P755, DOI 10.1001/archpediatrics.2009.94; Ribeiro TC, 2011, J PEDIATR GASTROENTE; Roberfroid MB, 2007, J NUTR, V137, p2493S, DOI 10.1093/jn/137.11.2493S; Roberts DW, 2010, LABDSV ORDINATION AN, V1, P4; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Salvini F, 2011, J NUTR, V141, P1335, DOI 10.3945/jn.110.136747; Sanders ME, 2010, GUT MICROBES, V1, P164, DOI 10.4161/gmic.1.3.12127; Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Scalabrin DMF, 2012, J PEDIATR GASTR NUTR, V54, P343, DOI 10.1097/MPG.0b013e318237ed95; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Smiricky-Tjardes MR, 2003, J ANIM SCI, V81, P2535; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Valladares R, 2013, FASEB J, V27, P1711, DOI 10.1096/fj.12-223339; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Veereman-Wauters G, 2011, J PEDIATR GASTR NUTR, V52, P763, DOI 10.1097/MPG.0b013e3182139f39; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wang M, 2013, J NUTR, V143, P795, DOI 10.3945/jn.112.173096; Warnes GR, 2015, GPLOTS VARIOUS R PRO; Yang JL, 2011, CLIN INVEST MED, V34, pE254; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Ziegler E, 2007, J PEDIATR GASTR NUTR, V44, P359, DOI 10.1097/MPG.0b013e31802fca8c	77	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135494	10.1371/journal.pone.0135494	http://dx.doi.org/10.1371/journal.pone.0135494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275147	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600069
J	Li, S; Hao, L; Wang, L; Lu, Y; Li, Q; Zhu, Z; Shao, JZ; Chen, W				Li, Sheng; Hao, Liang; Wang, Lin; Lu, Yun; Li, Qian; Zhu, Zheng; Shao, Jian-Zhong; Chen, Wei			Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; GENE-THERAPY; CATHEPSIN-K; PARKINSONS-DISEASE; PROTON PUMP; IN-VITRO; V-ATPASE; MOUSE; EXPRESSION; DIFFERENTIATION	Periodontal disease (Periodontitis) is a serious disease that affects a majority of adult Americans and is associated with other systemic diseases, including diabetes, rheumatoid arthritis, and other inflammatory diseases. While great efforts have been devoted toward understanding the pathogenesis of periodontitis, there remains a pressing need for developing potent therapeutic strategies for targeting this pervasive and destructive disease. In this study, we utilized novel adeno-associated virus (AAV)-mediated Atp6v1c1 knockdown gene therapy to treat bone erosion and inflammatory caused by periodontitis in mouse model. Atp6v1c1 is a subunit of the V-ATPase complex and regulator of the assembly of the V0 and V1 domains of the V-ATPase complex. We demonstrated previously that Atp6v1c1 has an essential function in osteoclast mediated bone resorption. We hypothesized that Atp6v1c1 may be an ideal target to prevent the bone erosion and inflammation caused by periodontitis. To test the hypothesis, we employed AAV RNAi knockdown of Atp6v1c1 gene expression to prevent bone erosion and gingival inflammation simultaneously. We found that lesion-specific injection of AAV-shRNA-Atp6v1c1 into the periodontal disease lesions protected against bone erosion (>85%) and gingival inflammation caused by P. gingivalis W50 infection. AAV-mediated Atp6v1c1 knockdown dramatically reduced osteoclast numbers and inhibited the infiltration of dendritic cells and macrophages in the bacteria-induced inflammatory lesions in periodontitis. Silencing of Atp6v1c1 expression also prevented the expressions of osteoclast-related genes and pro-inflammatory cytokine genes. Our data suggests that AAV-shRNA-Atp6v1c1 treatment can significantly attenuate the bone erosion and inflammation caused by periodontitis, indicating the dual function of AAV-shRNA-Atp6v1c1 as an inhibitor of bone erosion mediated by osteoclasts, and as an inhibitor of inflammation through down-regulation of pro-inflammatory cytokine expression. This study demonstrated that Atp6v1c1 RNAi knockdown gene therapy mediated by AAV-shRNA-Atp6v1c1 is a promising novel therapeutic approach for the treatment of bone erosion and inflammatory related diseases, such as periodontitis and rheumatoid arthritis.	[Li, Sheng; Hao, Liang; Lu, Yun; Zhu, Zheng; Chen, Wei] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Li, Sheng; Wang, Lin; Zhu, Zheng] Nanjing Med Univ, Coll Stomatol, Nanjing 210029, Jiangsu, Peoples R China; [Li, Qian; Shao, Jian-Zhong] Zhejiang Univ, Life Sci Coll, Hangzhou 310058, Zhejiang, Peoples R China	University of Alabama System; University of Alabama Birmingham; Nanjing Medical University; Zhejiang University	Chen, W (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	wechen@uab.edu		Hao, Liang/0000-0003-2071-7044	NIH [R01DE023813]; UAB Department of Pathology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044741, P30AR046031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Department of Pathology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIH grant R01DE023813 (YPL), and the UAB Department of Pathology Start-Up funding (WC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter BJ, 2005, HUM GENE THER, V16, P541, DOI 10.1089/hum.2005.16.541; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Chen W, 2014, P NATL ACAD SCI USA, V111, P8482, DOI 10.1073/pnas.1310617111; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cirelli JA, 2009, GENE THER, V16, P426, DOI 10.1038/gt.2008.174; Collins Sara A, 2010, Genet Vaccines Ther, V8, P8, DOI 10.1186/1479-0556-8-8; Cottard V, 2000, GENE THER, V7, P1930, DOI 10.1038/sj.gt.3301324; Evans C, 2010, J RHEUMATOL, V37, P683, DOI 10.3899/jrheum.100055; Feng SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084833; Feng SM, 2013, INT J BIOL SCI, V9, P853, DOI 10.7150/ijbs.6030; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Fischer CL, 2013, INT J ORAL SCI, V5, P130, DOI 10.1038/ijos.2013.28; Gao B, 2013, J DENT RES, V92, P180, DOI 10.1177/0022034512468757; Gasmi M, 2007, MOL THER, V15, P62, DOI 10.1038/sj.mt.6300010; Hao L, 2015, J PERIODONTOL, V16, P1, DOI DOI 10.1902/J0P.2015.140643; Hao L, 2015, INFECT IMMUN, V83, P1235, DOI 10.1128/IAI.01713-14; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jiang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058599; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Li YP, 1999, J BONE MINER RES, V14, P487, DOI 10.1359/jbmr.1999.14.4.487; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; LI YP, 1995, J BONE MINER RES, V10, P1197; Lourbakos A, 2001, INFECT IMMUN, V69, P5121, DOI 10.1128/IAI.69.8.5121-5130.2001; Mabbott NA, 2011, IMMUNOLOGY, V133, P482, DOI 10.1111/j.1365-2567.2011.03461.x; Miyajima S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05171; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Perez-Sayans M, 2010, CANCER BIOL THER, V9, P1057, DOI 10.4161/cbt.9.12.11880; Qi J, 2007, J BIOENERG BIOMEMBR, V39, P423, DOI 10.1007/s10863-007-9116-8; Qin A, 2012, INT J BIOCHEM CELL B, V44, P1422, DOI 10.1016/j.biocel.2012.05.014; Sasaki H, 2004, J PERIODONTAL RES, V39, P432, DOI 10.1111/j.1600-0765.2004.00760.x; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Sood S, 2012, MED ORAL PATOL ORAL, V17, pE301, DOI 10.4317/medoral.17472; Ulrich-Vinther M, 2007, ACTA ORTHOP, V78, P5; Wilensky A, 2009, J CLIN PERIODONTOL, V36, P915, DOI 10.1111/j.1600-051X.2009.01464.x; Yang S, 2013, BONE RES, V1, P260, DOI 10.4248/BR201303005; Yang SY, 2007, J CELL SCI, V120, P3362, DOI 10.1242/jcs.008300; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yu H, 2011, GENE THER, V18, P344, DOI 10.1038/gt.2010.139; Zhou Q, 2011, ARTHRITIS RHEUM-US, V63, P2318, DOI 10.1002/art.30421	46	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134903	10.1371/journal.pone.0134903	http://dx.doi.org/10.1371/journal.pone.0134903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274612	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600045
J	Hachicho, N; Reithel, S; Miltner, A; Heipieper, HJ; Kuster, E; Luckenbach, T				Hachicho, Nancy; Reithel, Sarah; Miltner, Anja; Heipieper, Hermann J.; Kuester, Eberhard; Luckenbach, Till			Body Mass Parameters, Lipid Profiles and Protein Contents of Zebrafish Embryos and Effects of 2,4-Dinitrophenol Exposure	PLOS ONE			English	Article							COD GADUS-MACROCEPHALUS; FATTY-ACID COMPOSITION; DANIO-RERIO; SUBSTITUTED PHENOLS; CARASSIUS-AURATUS; DEVELOPING EGGS; RISK-ASSESSMENT; UNFED LARVAE; MARINE FISH; NEW-MODEL	Morphology and physiology of fish embryos undergo dramatic changes during their development until the onset of feeding, supplied only by endogenous yolk reserves. For obtaining an insight how these restructuring processes are reflected by body mass related parameters, dry weights (dw), contents of the elements carbon and nitrogen and lipid and protein levels were quantified in different stages within the first four days of embryo development of the zebrafish (Danio rerio). The data show age dependent changes in tissue composition. Dry weights decreased significantly from 79 mu gdw/egg at 0hours post fertilization (hpf) to 61 mu gdw/egg after 96 hpf. The amounts of total carbon fluctuated between 460 mg g(-1) and 540 mg g(-1) dw, nitrogen was at about 100 mg g(-1) dw and total fatty acids were between 48-73 mg g(-1) dw. In contrast to these parameters that remained relatively constant, the protein content, which was 240 mg g(-1) at 0 hpf, showed an overall increase of about 40%. Comparisons of intact eggs and dechorionated embryos at stages prior to hatching (24, 30, 48 hpf) showed that the differences seen for dry weight and for carbon and nitrogen contents became smaller at more advanced stages, consistent with transition of material from the chorion to embryo tissue. Further, we determined the effect of 2,4-dinitrophenol at a subacutely toxic concentration (14 mu M, LC10) as a model chemical challenge on the examined body mass related parameters. The compound caused significant decreases in phospholipid and glycolipid fatty acid contents along with a decrease in the phospholipid fatty acid unsaturation index. No major changes were observed for the other examined parameters. Lipidomic studies as performed here may thus be useful for determining subacute effects of lipophilic organic compounds on lipid metabolism and on cellular membranes of zebrafish embryos.	[Hachicho, Nancy; Miltner, Anja; Heipieper, Hermann J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, D-04318 Leipzig, Germany; [Reithel, Sarah; Kuester, Eberhard; Luckenbach, Till] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, D-04318 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Luckenbach, T (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Permoserstr 15, D-04318 Leipzig, Germany.	till.luckenbach@ufz.de	Heipieper, Hermann/D-1864-2010; Luckenbach, Till/G-6482-2015	Heipieper, Hermann/0000-0002-3723-9600; Luckenbach, Till/0000-0001-6204-1033; Miltner, Anja/0000-0001-9317-0487; Kuster, Eberhard/0000-0002-6062-2755	UFZ - Helmholtz Centre of Environmental Research [POF II-U45]	UFZ - Helmholtz Centre of Environmental Research	This work was supported by UFZ - Helmholtz Centre of Environmental Research (POF II-U45) to NH, SR, AM, HJH, EK, and TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonsignorio D, 1996, ZYGOTE, V4, P101, DOI 10.1017/S0967199400002975; Braasch I, 2015, J EXP ZOOL PART B, V324, P316, DOI 10.1002/jez.b.22589; Braun MH, 2009, AM J PHYSIOL-RENAL, V296, pF994, DOI 10.1152/ajprenal.90656.2008; COSSINS AR, 1978, P NATL ACAD SCI USA, V75, P2040, DOI 10.1073/pnas.75.4.2040; COTELLI F, 1988, J ULTRA MOL STRUCT R, V99, P70, DOI 10.1016/0889-1605(88)90034-1; COUTURE P, 1995, J MEMBRANE BIOL, V148, P27; Czamanski M, 2011, MAR BIOL, V158, P2847, DOI 10.1007/s00227-011-1783-7; Dantas MC, 2007, J FISH BIOL, V70, P100, DOI 10.1111/j.1095-8649.2006.01277.x; DEY I, 1993, P NATL ACAD SCI USA, V90, P7498, DOI 10.1073/pnas.90.16.7498; EHRLICH KF, 1975, COMP BIOCHEM PHYS B, V51, P25, DOI 10.1016/0305-0491(75)90354-5; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Escher BI, 1996, ENVIRON SCI TECHNOL, V30, P260, DOI 10.1021/es9503084; Farkas T, 2001, AQUAC RES, V32, P645, DOI 10.1046/j.1365-2109.2001.00600.x; Finn RN, 2007, BIOL REPROD, V76, P926, DOI 10.1095/biolreprod.106.059766; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; FRASER AJ, 1988, MAR BIOL, V99, P307, DOI 10.1007/BF02112122; Frazer JK, 2009, LEUKEMIA, V23, P1825, DOI 10.1038/leu.2009.116; Goldsmith P, 2004, CURR OPIN PHARMACOL, V4, P504, DOI 10.1016/j.coph.2004.04.005; GREEN DE, 1966, J LIPID RES, V7, P587; Haque S, 2014, ZEBRAFISH, V11, P499, DOI 10.1089/zeb.2014.0994; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; JONES D. B., 1931, U.S. Dept. Agric., Circular; Kamler E, 2008, REV FISH BIOL FISHER, V18, P143, DOI 10.1007/s11160-007-9070-x; Kaszycki P, 2013, APPL MICROBIOL BIOT, V97, P5555, DOI 10.1007/s00253-013-4796-y; Kim DH, 2006, IEEE T NANOBIOSCI, V5, P89, DOI 10.1109/TNB.2006.875054; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kluver N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029063; Krishnan Kannan, 2009, ECOTOXICOLOGY MODELI, P145, DOI [10.1007/978-1-4419-0197-2_6, DOI 10.1007/978-1-4419-0197-2_6]; KROES J, 1972, BIOCHIM BIOPHYS ACTA, V274, P71, DOI 10.1016/0005-2736(72)90281-7; Kuster E, 2005, AQUAT TOXICOL, V75, P76, DOI 10.1016/j.aquatox.2005.07.005; Ladam F, 2014, METHODS MOL BIOL, V1196, P133, DOI 10.1007/978-1-4939-1242-1_9; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Laurel BJ, 2012, MAR BIOL, V159, P2025, DOI 10.1007/s00227-012-1989-3; Laurel BJ, 2010, MAR BIOL, V157, P1713, DOI 10.1007/s00227-010-1445-1; MACFARLANE RB, 1995, J EXP BIOL, V198, P1197; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Miyares RL, 2014, DIS MODEL MECH, V7, P915, DOI 10.1242/dmm.015800; Mommsen T.P., 1988, P347; MORRISON WR, 1964, J LIPID RES, V5, P600; Mukhopadhyay Tapas, 2007, J Oleo Sci, V56, P399; Mushtaq MY, 2014, PLANTA MED, V80, P1227, DOI 10.1055/s-0034-1382878; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; Nunes C, 2008, J ENVIRON BIOL, V29, P733; Oberemm A, 2000, LAB ANIMAL, V29, P32; OECD, 2013, OECD TEST 236 FISH E; PALMEIRA CM, 1994, TOXICOL APPL PHARM, V127, P50, DOI 10.1006/taap.1994.1138; Pelster Bernd, 2008, P91; Petersen GI, 1998, ENVIRON TOXICOL CHEM, V17, P1385, DOI 10.1002/etc.5620170724; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Pilati A, 2007, OIKOS, V116, P1663, DOI 10.1111/j.2007.0030-1299.15970.x; RAINUZZO JR, 1992, COMP BIOCHEM PHYS B, V103, P21, DOI 10.1016/0305-0491(92)90407-I; Rao P. G. P., 2013, International Food Research Journal, V20, P275; Ronnestad I, 1999, AQUACULTURE, V177, P201, DOI 10.1016/S0044-8486(99)00082-4; Rossmeisl M, 2000, FASEB J, V14, P1793, DOI 10.1096/fj.99-0965com; Sarasquete C, 2002, HISTOL HISTOPATHOL, V17, P775, DOI 10.14670/HH-17.775; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; Sterner RW, 2000, ECOLOGY, V81, P127, DOI 10.1890/0012-9658(2000)081[0127:CNAPSO]2.0.CO;2; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; TOCHER DR, 1985, LIPIDS, V20, P84, DOI 10.1007/BF02534213; TOCHER DR, 1984, LIPIDS, V19, P492, DOI 10.1007/BF02534481; WATANABE T, 1994, AQUACULTURE, V124, P223, DOI 10.1016/0044-8486(94)90386-7; Webb KJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r81; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WIEGAND MD, 1991, FISH PHYSIOL BIOCHEM, V9, P199, DOI 10.1007/BF02265141	73	37	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134755	10.1371/journal.pone.0134755	http://dx.doi.org/10.1371/journal.pone.0134755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292096	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900011
J	Momen, B; Behling, SJ; Lawrence, GB; Sullivan, JH				Momen, Bahram; Behling, Shawna J.; Lawrence, Greg B.; Sullivan, Joseph H.			Photosynthetic and Growth Response of Sugar Maple (Acer saccharum Marsh.) Mature Trees and Seedlings to Calcium, Magnesium, and Nitrogen Additions in the Catskill Mountains, NY, USA	PLOS ONE			English	Article							ACIDIC DEPOSITION; EXPERIMENTAL FOREST; SOIL ACIDIFICATION; ALLEGHENY PLATEAU; CROWN VIGOR; NUTRITION; DECLINE; STRESS; SATURATION; ECOSYSTEM	Decline of sugar maple in North American forests has been attributed to changes in soil calcium (Ca) and nitrogen (N) by acidic precipitation. Although N is an essential and usually a limiting factor in forests, atmospheric N deposition may cause N-saturation leading to loss of soil Ca. Such changes can affect carbon gain and growth of sugar maple trees and seedlings. We applied a 2(2) factorial arrangement of N and dolomitic limestone containing Ca and Magnesium (Mg) to 12 forest plots in the Catskill Mountain region of NY, USA. To quantify the short-term effects, we measured photosynthetic-light responses of sugar maple mature trees and seedlings two or three times during two summers. We estimated maximum net photosynthesis (An-max) and its related light intensity (PAR at An-max), apparent quantum efficiency (A(qe)), and light compensation point (LCP). To quantify the long-term effects, we measured basal area of living mature trees before and 4 and 8 years after treatment applications. Soil and foliar chemistry variables were also measured. Dolomitic limestone increased Ca, Mg, and pH in the soil Oe horizon. Mg was increased in the B horizon when comparing the plots receiving N with those receiving CaMg. In mature trees, foliar Ca and Mg concentrations were higher in the CaMg and N+CaMg plots than in the reference or N plots; foliar Ca concentration was higher in the N+CaMg plots compared with the CaMg plots, foliar Mg was higher in the CaMg plots than the N+CaMg plots; An-max was maximized due to N+CaMg treatment; A(qe) decreased by N addition; and PAR at An-max increased by N or CaMg treatments alone, but the increase was maximized by their combination. No treatment effect was detected on basal areas of living mature trees four or eight years after treatment applications. In seedlings, An-max was increased by N+CaMg addition. The reference plots had an open herbaceous layer, but the plots receiving N had a dense monoculture of common woodfern in the forest floor, which can impede seedling survival.	[Momen, Bahram] Univ Maryland, Environm Sci & Technol Dept, College Pk, MD 20742 USA; [Behling, Shawna J.; Sullivan, Joseph H.] Univ Maryland, Plant Sci & Landscape Architecture Dept, College Pk, MD 20742 USA; [Lawrence, Greg B.] US Geol Survey, New York Water Sci Ctr, Troy, NY USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of the Interior; United States Geological Survey	Momen, B (corresponding author), Univ Maryland, Environm Sci & Technol Dept, College Pk, MD 20742 USA.	bmomen@umd.edu	Sullivan, Joe H./AAC-2195-2020	Sullivan, Joe H./0000-0002-2082-0343; Behling, Shawn/0000-0001-5537-3603	GBL through USGS	GBL through USGS	SJB received Research Assistantship from the University of Maryland, College Park when working on this project. Travel and treatment applications expenses were provided by GBL through USGS internal funds.	ADAMS CM, 1992, CAN J FOREST RES, V22, P1489, DOI 10.1139/x92-199; Bailey SW, 2005, SOIL SCI SOC AM J, V69, P681, DOI 10.2136/sssaj2004.0057; Bernacchi CJ, 2003, NEW PHYTOL, V159, P609, DOI 10.1046/j.1469-8137.2003.00850.x; Catovsky S, 2002, ECOL APPL, V12, P1056, DOI 10.1890/1051-0761(2002)012[1056:NAIROT]2.0.CO;2; Clark RB, 2000, J PLANT NUTR, V23, P867, DOI 10.1080/01904160009382068; Dijkstra FA, 2002, ECOSYSTEMS, V5, P385, DOI 10.1007/s10021-001-0082-4; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Duchesne L, 2005, FOREST ECOL MANAG, V208, P223, DOI 10.1016/j.foreco.2004.12.003; Duchesne L, 2002, J ENVIRON QUAL, V31, P1676, DOI 10.2134/jeq2002.1676; Eallonardo AS, 2006, THESIS STATE U NEW Y; Elvir JA, 2010, ENVIRON MONIT ASSESS, V171, P129, DOI 10.1007/s10661-010-1523-3; FAHEY TJ, 1994, J ECOL, V82, P533, DOI 10.2307/2261262; Hallett RA, 2006, CAN J FOREST RES, V36, P2235, DOI 10.1139/X06-120; Heijne B, 1996, PLANT SOIL, V179, P197, DOI 10.1007/BF00009329; Horsley SB, 2000, CAN J FOREST RES, V30, P1365, DOI 10.1139/cjfr-30-9-1365; Hotopp KP, 2002, SOUTHEAST NAT, V1, P27, DOI 10.1656/1528-7092(2002)001[0027:LSASCI]2.0.CO;2; Huggett BA, 2007, CAN J FOREST RES, V37, P1692, DOI 10.1139/X07-042; Hurd TM, 1998, CAN J FOREST RES, V28, P799, DOI 10.1139/cjfr-28-6-799; Johnson AH, 2008, SOIL SCI SOC AM J, V72, P1824, DOI 10.2136/sssaj2006.0407; Jones ME, 2011, ARTHROPOD-PLANT INTE, V5, P163, DOI 10.1007/s11829-011-9125-8; Juice SM, 2006, ECOLOGY, V87, P1267, DOI 10.1890/0012-9658(2006)87[1267:ROSMTC]2.0.CO;2; KOLB TE, 1993, CAN J FOREST RES, V23, P2395, DOI 10.1139/x93-296; Lange OL, 1986, TREES-STRUCT FUNCT, V1, P70, DOI 10.1007/BF00197027; Lawrence GB, 1999, ECOL APPL, V9, P1059, DOI 10.1890/1051-0761(1999)009[1059:SCSATR]2.0.CO;2; Lawrence GB, 2000, BIOGEOCHEMISTRY, V50, P21, DOI 10.1023/A:1006332230890; LIU G, 1994, PLANT SOIL, V160, P79, DOI 10.1007/BF00150348; Long RP, 2009, ECOL APPL, V19, P1454, DOI 10.1890/08-1535.1; Long RP, 1997, CAN J FOREST RES, V27, P1560, DOI 10.1139/cjfr-27-10-1560; Lovett GM, 2000, ECOL APPL, V10, P73, DOI 10.1890/1051-0761(2000)010[0073:NSARIF]2.0.CO;2; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; Markewitz D, 1998, SOIL SCI SOC AM J, V62, P1428, DOI 10.2136/sssaj1998.03615995006200050040x; McLaughlin S, 1999, WATER AIR SOIL POLL, V116, P151, DOI 10.1023/A:1005215112743; Monson RK, 2007, PHILOS T R SOC A, V365, P1677, DOI 10.1098/rsta.2007.2038; Moore JD, 2006, CAN J FOREST RES, V36, P1834, DOI 10.1139/X06-081; Murdoch PS, 1993, AIR SOIL POLLUT, V67, P365; OUIMET R, 1995, CAN J SOIL SCI, V75, P169, DOI 10.4141/cjss95-024; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; Schabenberger O., 2002, CONT STAT MODELS PLA; Shaffer, 1990, HDB METHODS ACID DEP; Siemion J, 2014, HYDROL PROCESS, V28, P3615, DOI 10.1002/hyp.9903; Sullivan TJ, 2013, ENVIRON SCI TECHNOL, V47, P12687, DOI 10.1021/es401864w; Talhelm AF, 2011, ECOL APPL, V21, P2413, DOI 10.1890/10-2076.1; Thomas G. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P159; Tissue DT, 2002, TREE PHYSIOL, V22, P1157, DOI 10.1093/treephys/22.15-16.1157; Warby RAF, 2009, SOIL SCI SOC AM J, V73, P274, DOI 10.2136/sssaj2007.0016; Wargo PM, 2002, CAN J FOREST RES, V32, P629, DOI [10.1139/x02-008, 10.1139/X02-008]; Warren JM, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu074; Wilmot TR, 1996, FOREST ECOL MANAG, V84, P123, DOI 10.1016/0378-1127(96)03743-7	48	5	6	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136148	10.1371/journal.pone.0136148	http://dx.doi.org/10.1371/journal.pone.0136148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291323	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900059
J	Renz, PB; Cavagnolli, G; Weinert, LS; Silveiro, SP; Camargo, JL				Renz, Paula Breitenbach; Cavagnolli, Gabriela; Weinert, Leticia Schwerz; Silveiro, Sandra Pinho; Camargo, Joiza Lins			HbA1c Test as a Tool in the Diagnosis of Gestational Diabetes Mellitus	PLOS ONE			English	Article							REFERENCE INTERVALS; PREGNANCY; WOMEN; A1C; HYPERGLYCEMIA; GLUCOSE; HBA(1C)	Aims Gestational diabetes mellitus (GDM) is a prevalent and potentially serious condition which may put both mothers and neonates at risk. The current recommendation for diagnosis is the oral glucose tolerance test (OGTT). This study aimed to determine the usefulness of HbA1c test as a diagnostic tool for GDM as compared to the traditional criteria based on the OGTT. Methods This was a diagnostic test accuracy study. We performed OGTT and HbA1c test in women attending prenatal visits at a tertiary hospital. GDM was defined according to WHO1999 or ADA/WHO 2013 criteria. ROC curve was used to evaluate the diagnostic performance of HbA1c. Sensitivity, specificity and likelihood ratios for different HbA1c cut-off points were calculated. Results Of the 262 women in the third trimester of gestation enrolled in the study, 86 (33%) were diagnosed with GDM. Only five of these women presented HbA1c >= 48 mmol/mol (6.5%). This cut-off point presented 100% specificity but very low sensitivity (7%). Based on ROC curve, and considering OGTT as the reference criterion, HbA1c >= 40 mmol/mol (5.8%) showed adequate specificity in diagnosing GDM (94.9%) but low sensitivity (26.4%). Unlike, HbA1c values of 31 mmol/mol (5.0%) presented adequate sensitivity (89.7%) but low specificity (32.6%) to detect GDM. For women with HbA1c >= 40 mmol/mol (5.8%), the positive and negative likelihood ratios were 5.14 (95%CI 2.49-10.63) and 0.78 (0.68-0.88), respectively. The post-test probability of GDM was about 40%, representing a 4.0-fold increase in the mean pre-test probability. This cut-off point could eliminate the need for the unpleasant and laborious OGTT tests in almost one third of cases, as 38% of patients with GDM may be diagnosable by HbA1c test alone. Conclusions Our results show that combined HbA1c and OGTT measurements may be useful in diagnosing GDM.	[Renz, Paula Breitenbach; Cavagnolli, Gabriela; Weinert, Leticia Schwerz; Silveiro, Sandra Pinho; Camargo, Joiza Lins] Univ Fed Rio Grande Sul UFRGS, Grad Program Endocrinol, Porto Alegre, RS, Brazil; [Weinert, Leticia Schwerz] Univ Catolica Pelotas UCPEL, Sch Med, Pelotas, Brazil; [Silveiro, Sandra Pinho; Camargo, Joiza Lins] Hosp Clin Porto Alegre HCPA, Dept Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Catolica de Pelotas	Camargo, JL (corresponding author), Univ Fed Rio Grande Sul UFRGS, Grad Program Endocrinol, Porto Alegre, RS, Brazil.	jcamargo@hcpa.ufrgs.br	Camargo, Joiza Lins/G-9301-2011; Silveiro, Sandra Pinho/V-7922-2019	Camargo, Joiza Lins/0000-0001-8834-4075; Silveiro, Sandra Pinho/0000-0003-4891-4074	Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA); Coordination for the Enhancement of Higher Level Personnel (CAPES); National Council for Scientific and Technological Development (CNPq)	Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA); Coordination for the Enhancement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA). PBR and GC received scholarships from the Coordination for the Enhancement of Higher Level Personnel (CAPES) and the National Council for Scientific and Technological Development (CNPq), respectively.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Balaji V, 2007, DIABETES CARE, V30, P1865, DOI 10.2337/dc06-2329; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Cavagnolli G, 2011, DIABETIC MED, V28, P31, DOI 10.1111/j.1464-5491.2010.03159.x; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Donovan L, 2013, ANN INTERN MED, V159, P115, DOI 10.7326/0003-4819-159-2-201307160-00657; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Falavigna M, 2012, DIABETES RES CLIN PR, V98, P396, DOI 10.1016/j.diabres.2012.09.002; Farrar D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007122.pub3; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Hiramatsu Y, 2012, ENDOCR J, V59, P145, DOI 10.1507/endocrj.K10E-410; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Lowe LP, 2012, DIABETES CARE, V35, P574, DOI 10.2337/dc11-1687; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mosca A, 2006, CLIN CHEM, V52, P1138, DOI 10.1373/clinchem.2005.064899; O'Connor C, 2012, CLIN CHEM LAB MED, V50, P905, DOI 10.1515/CCLM.2011.397; Rajput R, 2012, DIABETES RES CLIN PR, V98, P104, DOI 10.1016/j.diabres.2012.02.018; Rowan JA, 2014, AUST NZ J OBSTET GYN, V54, P177, DOI 10.1111/ajo.12166; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Suhonen L, 2000, DIABETOLOGIA, V43, P79, DOI 10.1007/s001250050010; Waugh N, 2010, BEST PRACT RES CL EN, V24, P553, DOI 10.1016/j.beem.2010.06.004; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; World Health Organization, US GLYC HAEM HBA1C D; World Health Organization, 1999, WHONCDNCS99	29	41	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135989	10.1371/journal.pone.0135989	http://dx.doi.org/10.1371/journal.pone.0135989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292213	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900045
J	Chiang, SH; Harrington, WW; Luo, GZ; Milliken, NO; Ulrich, JC; Chen, J; Rajpal, DK; Qian, Y; Carpenter, T; Murray, R; Geske, RS; Stimpson, SA; Kramer, HF; Haffner, CD; Becherer, JD; Preugschat, F; Billin, AN				Chiang, Shian-Huey; Harrington, W. Wallace; Luo, Guizhen; Milliken, Naphtali O.; Ulrich, John C.; Chen, Jing; Rajpal, Deepak K.; Qian, Ying; Carpenter, Tiffany; Murray, Rusty; Geske, Robert S.; Stimpson, Stephen A.; Kramer, Henning F.; Haffner, Curt D.; Becherer, J. David; Preugschat, Frank; Billin, Andrew N.			Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility	PLOS ONE			English	Article							SKELETAL-MUSCLE; INDUCED OBESITY; HIGH-FAT; NAD(+); MICE; FLEXIBILITY; ACETYLATION; LIPOLYSIS; DISEASE; SIRT1	Nicotinamide adenine dinucleotide (NAD(+)) is a key cofactor required for essential metabolic oxidation-reduction reactions. It also regulates various cellular activities, including gene expression, signaling, DNA repair and calcium homeostasis. Intracellular NAD(+) levels are tightly regulated and often respond rapidly to nutritional and environmental changes. Numerous studies indicate that elevating NAD(+) may be therapeutically beneficial in the context of numerous diseases. However, the role of NAD(+) on skeletal muscle exercise performance is poorly understood. CD38, a multi-functional membrane receptor and enzyme, consumes NAD(+) to generate products such as cyclic-ADP-ribose. CD38 knockout mice show elevated tissue and blood NAD(+) level. Chronic feeding of high-fat, high-sucrose diet to wild type mice leads to exercise intolerance and reduced metabolic flexibility. Loss of CD38 by genetic mutation protects mice from diet-induced metabolic deficit. These animal model results suggest that elevation of tissue NAD(+) through genetic ablation of CD38 can profoundly alter energy homeostasis in animals that are maintained on a calorically-excessive Western diet.	[Chiang, Shian-Huey; Harrington, W. Wallace; Luo, Guizhen; Milliken, Naphtali O.; Ulrich, John C.; Qian, Ying; Carpenter, Tiffany; Stimpson, Stephen A.; Kramer, Henning F.; Haffner, Curt D.; Becherer, J. David; Preugschat, Frank; Billin, Andrew N.] GlaxoSmithKline, Muscle Metab Discovery Performance Unit, Res Triangle Pk, NC 27709 USA; [Chen, Jing; Rajpal, Deepak K.] GlaxoSmithKline, QSCI Computat Biol, Res Triangle Pk, NC 27709 USA; [Murray, Rusty] GlaxoSmithKline, Lab Anim Sci, Res Triangle Pk, NC 27709 USA; [Geske, Robert S.] GlaxoSmithKline, Target & Pathway Validat, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Chiang, SH (corresponding author), GlaxoSmithKline, Muscle Metab Discovery Performance Unit, Res Triangle Pk, NC 27709 USA.	shianhuey.chiang@gmail.com		Billin, Andrew/0000-0001-7752-0934	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The author(s) received no specific funding for this work. GlaxoSmithKline provided support in the form of salaries for all the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139; Grahnert A, 2011, INNATE IMMUN-LONDON, V17, P212, DOI 10.1177/1753425910361989; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hipkiss AR, 2009, BIOGERONTOLOGY, V10, P523, DOI 10.1007/s10522-008-9188-9; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Vieira DCL, 2013, CLIN INTERV AGING, V8, P1377, DOI 10.2147/CIA.S50333; Li M, 2006, ENDOCRINOLOGY, V147, P2163, DOI 10.1210/en.2005-1313; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Wagner Gregory R, 2011, J Aging Res, V2011, P234875, DOI 10.4061/2011/234875; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	35	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134927	10.1371/journal.pone.0134927	http://dx.doi.org/10.1371/journal.pone.0134927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287487	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600031
J	Koyama, S; Omura, T; Yonezawa, A; Imai, S; Nakagawa, S; Nakagawa, T; Yano, I; Matsubara, K				Koyama, Satoshi; Omura, Tomohiro; Yonezawa, Atsushi; Imai, Satoshi; Nakagawa, Shunsaku; Nakagawa, Takayuki; Yano, Ikuko; Matsubara, Kazuo			Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INTERSTITIAL LUNG-DISEASE; INDUCED APOPTOSIS; HUMAN HRD1; EIF2-ALPHA KINASE; CARCINOMA-CELLS; ER STRESS; CYCLIN D1; DEATH	Gefitinib and erlotinib are anticancer agents, which inhibit epidermal growth factor receptor (EGFR) tyrosine kinase. Interstitial lung disease (ILD) occurs in patients with non-small cell lung cancer receiving EGFR inhibitors. In the present study, we examined whether gefitinib- and erlotinib-induced lung injury related to ILD through endoplasmic reticulum (ER) stress, which is a causative intracellular mechanism in cytotoxicity caused by various chemicals in adenocarcinomic human alveolar basal epithelial cells. These two EGFR inhibitors increased Parkinson juvenile disease protein 2 and C/EBP homologous protein mRNA expressions, and activated the eukaryotic initiation factor (eIF) 2 alpha/activating transcription factor 4 pathway without protein kinase R-like ER kinase activation in A549 cells. Gefitinib and erlotinib caused neither ER stress nor cell death; however, these agents inhibited cell growth via the reduction of cyclin-D1 expression. Tauroursodeoxycholic acid, which is known to suppress eIF2 alpha phosphorylation, cancelled the effects of EGFR inhibitors on cyclin-D1 expression and cell proliferation in a concentration-dependent manner. The results of an EGFR-silencing study using siRNA showed that gefitinib and erlotinib affected eIF2 alpha phosphorylation and cyclin-D1 expression independent of EGFR inhibition. Therefore, the inhibition of cell growth by these EGFR inhibitors might equate to impairment of the alveolar epithelial cell repair system via eIF2 alpha phosphorylation and reduced cyclin-D1 expression.	[Koyama, Satoshi; Omura, Tomohiro; Yonezawa, Atsushi; Imai, Satoshi; Nakagawa, Shunsaku; Nakagawa, Takayuki; Yano, Ikuko; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 606, Japan	Kyoto University	Omura, T (corresponding author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 606, Japan.	omurat@kuhp.kyoto-u.ac.jp	Tomohiro, Omura/AAR-8420-2021; Yonezawa, Atsushi/AAS-8423-2020	Yonezawa, Atsushi/0000-0002-8057-6768; Imai, Satoshi/0000-0003-4737-8695; Nakagawa, Shunsaku/0000-0002-1285-122X; Nakagawa, Takayuki/0000-0003-1890-0843	MEXT/JSPS KAKENHI [25136710, 24590176, 25860112]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by MEXT/JSPS KAKENHI (https://kaken.nii.ac.jp/en/) Grant Numbers 25136710, 24590176 and 25860112.	Barber GN, 2005, CELL DEATH DIFFER, V12, P563, DOI 10.1038/sj.cdd.4401643; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Cersosimo RJ, 2006, EXPERT OPIN DRUG SAF, V5, P469, DOI 10.1517/14740338.5.3.469; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cybulsky AV, 2005, J BIOL CHEM, V280, P24396, DOI 10.1074/jbc.M500729200; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Henkel AS, 2012, AM J PHYSIOL-GASTR L, V303, pG54, DOI 10.1152/ajpgi.00052.2012; Higenbottam T, 2004, BRIT J CANCER, V91, pS31, DOI 10.1038/sj.bjc.6602065; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lin YC, 2014, ONCOTARGET, V5, P298, DOI 10.18632/oncotarget.1628; Macedo B, 2008, BBA-MOL BASIS DIS, V1782, P517, DOI 10.1016/j.bbadis.2008.05.005; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Moriuchi A, 2001, BIOCHEM BIOPH RES CO, V280, P368, DOI 10.1006/bbrc.2000.4063; Namba T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027296; Omura T, 2013, BIOCHEM BIOPH RES CO, V432, P689, DOI 10.1016/j.bbrc.2013.01.131; Orzaez M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.155; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Petty WJ, 2004, CLIN CANCER RES, V10, P7547, DOI 10.1158/1078-0432.CCR-04-1169; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	48	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136176	10.1371/journal.pone.0136176	http://dx.doi.org/10.1371/journal.pone.0136176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288223	Green Submitted, Green Published, gold			2022-12-27	WOS:000360018600117
J	Lebenberg, J; Lalande, A; Clarysse, P; Buvat, I; Casta, C; Cochet, A; ConstantinidSs, C; Cousty, J; de Cesare, A; Jehan-Besson, S; Lefort, M; Najman, L; Roullot, E; Sarry, L; Tilmant, C; Frouin, F; Garreau, M				Lebenberg, Jessica; Lalande, Alain; Clarysse, Patrick; Buvat, Irene; Casta, Christopher; Cochet, Alexandre; ConstantinidSs, Constantin; Cousty, Jean; de Cesare, Alain; Jehan-Besson, Stephanie; Lefort, Muriel; Najman, Laurent; Roullot, Elodie; Sarry, Laurent; Tilmant, Christophe; Frouin, Frederique; Garreau, Mireille			Improved Estimation of Cardiac Function Parameters Using a Combination of Independent Automated Segmentation Results in Cardiovascular Magnetic Resonance Imaging	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; ALGORITHMS; HEART	This work aimed at combining different segmentation approaches to produce a robust and accurate segmentation result. Three to five segmentation results of the left ventricle were combined using the STAPLE algorithm and the reliability of the resulting segmentation was evaluated in comparison with the result of each individual segmentation method. This comparison was performed using a supervised approach based on a reference method. Then, we used an unsupervised statistical evaluation, the extended Regression Without Truth (eRWT) that ranks different methods according to their accuracy in estimating a specific biomarker in a population. The segmentation accuracy was evaluated by estimating six cardiac function parameters resulting from the left ventricle contour delineation using a public cardiac cine MRI database. Eight different segmentation methods, including three expert delineations and five automated methods, were considered, and sixteen combinations of the automated methods using STAPLE were investigated. The supervised and unsupervised evaluations demonstrated that in most cases, STAPLE results provided better estimates than individual automated segmentation methods. Overall, combining different automated segmentation methods improved the reliability of the segmentation result compared to that obtained using an individual method and could achieve the accuracy of an expert.	[Lebenberg, Jessica; ConstantinidSs, Constantin; de Cesare, Alain; Lefort, Muriel] Univ Paris 06, CNRS, INSERM, Lab Imagerie Biomed, Paris, France; [Lebenberg, Jessica; ConstantinidSs, Constantin; Roullot, Elodie] Ecole Speciale Mecan & Elect Sudria, Ivry, France; [Lalande, Alain; Cochet, Alexandre] Univ Bourgogne, CNRS, Lab Elect Informat & Image, Dijon, France; [Clarysse, Patrick; Casta, Christopher] Univ Lyon 1, CNRS, INSERM, Inst Natl Sci Appl Lyon,Ctr Rech Acquisit & Trait, F-69622 Villeurbanne, France; [Buvat, Irene; Frouin, Frederique] Univ Paris 11, CNRS, Commissariat Energie Atom,Inst Natl Sante & Rech, Unite Imagerie Mol Vivo,Serv Hosp Frederic Joliot, F-91405 Orsay, France; [Cousty, Jean; Najman, Laurent] Univ Paris Est Marne la Vallee, Ecole Super Ingenieurs Electrotech & Elect, CNRS, Lab Informat Gaspard Monge, Marne La Vallee, France; [Jehan-Besson, Stephanie] CNRS, Grp Rech Informat Image Automat & Instrumentat Ca, Caen, France; [Sarry, Laurent] Univ Auvergne, CNRS, Image Sci Intervent Tech, Clermont Ferrand, France; [Tilmant, Christophe] Univ Blaise Pascal, CNRS, Inst Pascal, Clermont Ferrand, France; [Garreau, Mireille] Univ Rennes, INSERM, Lab Traitement Signal & Images, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Lebenberg, J (corresponding author), CEA, Inst Imagerie Biomed, Neurospin, Gif Sur Yvette, France.	jessica.lebenberg@gmail.com	Clarysse, Patrick/G-6371-2014; Najman, Laurent/AAB-4212-2020; Garreau, Mireille/ABC-4360-2020; Frouin, Frédérique/N-7709-2015; Lalande, Alain/T-1050-2017; Sarry, Laurent/K-5708-2018; Jehan-Besson, Stéphanie/ABF-3965-2020; lebenberg, jessica/AAQ-7790-2021; Buvat, Irene/U-8447-2018	Clarysse, Patrick/0000-0002-5495-7655; Najman, Laurent/0000-0002-6190-0235; Garreau, Mireille/0000-0001-5728-1403; Frouin, Frédérique/0000-0002-7288-1543; Sarry, Laurent/0000-0002-2237-0497; lebenberg, jessica/0000-0002-5403-8288; Buvat, Irene/0000-0002-7053-6471; Lalande, Alain/0000-0002-7970-366X; Jehan-Besson, Stephanie/0000-0002-1850-3445	Stic-Sante [GdR 2647]; NIH from National Center for Research Resources [R01 RR021885]; Neuroscience Blueprint I/C from National Institute of Biomedical Imaging and Bioengineering [R01 EB008015]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR021885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008015] Funding Source: NIH RePORTER	Stic-Sante; NIH from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Neuroscience Blueprint I/C from National Institute of Biomedical Imaging and Bioengineering; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding: This work was performed in the framework of the French MedIEval (Medical Image segmentation Evaluation) working group. The authors gratefully acknowledge the GdR 2647 Stic-Sante for its support to the MedIEval action. The research concerning the STAPLE algorithm was supported in part by NIH R01 RR021885 from the National Center for Research Resources, and by an award from the Neuroscience Blueprint I/C through R01 EB008015 from the National Institute of Biomedical Imaging and Bioengineering.	Chalana V, 1997, IEEE T MED IMAGING, V16, P642, DOI 10.1109/42.640755; Chen A, 2012, PHYS MED BIOL, V57, P93, DOI 10.1088/0031-9155/57/1/93; Constantinides C, 2010, COMPUT CARDIOL CONF, V37, P911; Constantinides C., 2009, MIDAS J CARDIAC MR L; Constantinides C, 2012, IEEE ENG MED BIO, P3207, DOI 10.1109/EMBC.2012.6346647; Cousty J, 2010, IMAGE VISION COMPUT, V28, P1229, DOI 10.1016/j.imavis.2010.01.001; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Hoppin JW, 2002, IEEE T MED IMAGING, V21, P441, DOI 10.1109/TMI.2002.1009380; Jehan-Besson S, 2014, IEEE IMAGE PROC, P887, DOI 10.1109/ICIP.2014.7025178; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kupinski MA, 2006, ACAD RADIOL, V13, P329, DOI 10.1016/j.acra.2005.12.005; Kupinski MA, 2002, ACAD RADIOL, V9, P290, DOI 10.1016/S1076-6332(03)80372-0; Lalande A, 2004, J CARDIOVASC MAGN R, V6, P817, DOI 10.1081/JCMR-200036143; Lebenberg J, 2012, IEEE T MED IMAGING, V31, P1651, DOI 10.1109/TMI.2012.2201737; McLachlan GJ., 1996, WILEY SERIES PROBABI; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; Radau P., 2009, MIDAS JCARDIAC MR LE, DOI [DOI 10.54294/G80RUO, 10.54294/g80ruo]; Robitaille N, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/431095; Schaerer J, 2010, MED IMAGE ANAL, V14, P738, DOI 10.1016/j.media.2010.05.009; Soret M, 2007, NUCL INSTRUM METH A, V571, P173, DOI 10.1016/j.nima.2006.10.236; Suinesiaputra A, 2014, MED IMAGE ANAL, V18, P50, DOI 10.1016/j.media.2013.09.001; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354	25	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135715	10.1371/journal.pone.0135715	http://dx.doi.org/10.1371/journal.pone.0135715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287691	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600064
J	Li, L; Yang, L; Zhu, HH; Dai, RR				Li, Lin; Yang, Lei; Zhu, Haihong; Dai, Rongrong			Explorative Analysis of Wuhan Intra-Urban Human Mobility Using Social Media Check-In Data	PLOS ONE			English	Article							SURFACE MODELS; URBAN FORM; NETWORK	Social media check-in data as a geo-tagged information source have been used for revealing spatio-temporal patterns in the field of social and urban study, such as human behavior or public issues. This paper investigates a case study and presents a new method of representing the mobility of people within a city from check-in data. By dividing the data in a temporal sequence, this study examines the overall mobility in the case study city through the gradient/difference of population density with a series of time after computing the population density from the check-in data using an incorporated Thiessen polygon method. By classifying check-in data with their geo-tags into several groups according to travel purposes, and partitioning the data according to administrative district boundaries, various moving patterns for those travel purposes in those administrative districts are identified by scrutinizing a series of spatial geometries of a weighted standard deviational ellipse (WSDE). Through deep analyses of those data by the adopted approaches, the general pattern of mobility in the case city, such as people moving to the central urban area from the suburb from 4 am to 8 am, is ascertained, and different characteristics of movement in those districts are also depicted. Furthermore, it can tell that in which district less movement is likely for a certain purpose (e.g., for dinner or entertainment). This study has demonstrated the availability of the proposed methodology and check-in data for investigating intra-urban human mobility.	[Li, Lin; Yang, Lei; Zhu, Haihong; Dai, Rongrong] Wuhan Univ, Sch Resources & Environm Sci, Wuhan 430072, Peoples R China	Wuhan University	Yang, L (corresponding author), Wuhan Univ, Sch Resources & Environm Sci, Wuhan 430072, Peoples R China.	yangleigis@whu.edu.cn; hhzhu@whu.edu.cn			National Natural Science Fund of China [41271458]; National 863 Plan of China [2013AA12A202]; National Key Technology Support Program of China [2012BAH35F03-06]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National 863 Plan of China(National High Technology Research and Development Program of China); National Key Technology Support Program of China(National Key Technology R&D Program)	This study is funded by the National Natural Science Fund of China (41271458), the National 863 Plan of China (2013AA12A202), and the National Key Technology Support Program of China (2012BAH35F03-06). HZ received the first funding, and LL received the last two funding. And the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahas R, 2005, FUTURES, V37, P547, DOI 10.1016/j.futures.2004.10.012; Alvares L.O., 2007, P 15 ANN ACM INT S A, P22, DOI DOI 10.1145/1341012.1341041; Anderson TR, 1956, PAPERS REGIONAL SCI, V2, P175, DOI DOI 10.1111/J.1435-5597.1956.TB01563.X; AXHAUSEN KW, 1992, TRANSPORT REV, V12, P323, DOI 10.1080/01441649208716826; Baert AE, 2004, ISPDC 2004: THIRD INTERNATIONAL SYMPOSIUM ON PARALLEL AND DISTRIBUTED COMPUTING/HETEROPAR '04: THIRD INTERNATIONAL WORKSHOP ON ALGORITHMS, MODELS AND TOOLS FOR PARALLEL COMPUTING ON HETEROGENEOUS NETWORKS, PROCEEDINGS, P29; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Ben-Akiva M., 1998, TRANSPORTATION MODEL, P4; Bettini C, 2014, PERVASIVE MOB COMPUT; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Crane R., 2000, J PLAN LIT, V15, P3, DOI DOI 10.1177/08854120022092890; Dieleman FM, 2002, URBAN STUD, V39, P507, DOI 10.1080/00420980220112801; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Fujita H, 2013, CARTOGR GEOGR INFORM, V40; Furletti B., 2013, P 2 ACM SIGKDD INT W, P1; Goodman MK, 2011, GEOGR J, V177, P102, DOI 10.1111/j.1475-4959.2011.00401.x; [胡庆武 Hu Qingwu], 2014, [测绘学报, Acta Geodetica et Cartographica Sinica], V43, P314; KITAMURA R, 1988, TRANSPORTATION, V15, P9; Kwan MP, 2000, AREA, V32, P145, DOI 10.1111/j.1475-4762.2000.tb00125.x; LAM NSN, 1983, AM CARTOGRAPHER, V10, P129, DOI 10.1559/152304083783914958; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086026; Liu Y, 2015, ANN ASSOC AM GEOGR, V105, P512, DOI 10.1080/00045608.2015.1018773; Liu Y, 2012, LANDSCAPE URBAN PLAN, V106, P73, DOI 10.1016/j.landurbplan.2012.02.012; Lloyd CD, 2014, COMPUT ENVIRON URBAN, V48, P64, DOI 10.1016/j.compenvurbsys.2014.07.001; Loo BPY, 2013, TRANSPORTMETRICA A, V9, P629, DOI 10.1080/18128602.2011.643509; Mennis J, 2003, PROF GEOGR, V55, P31; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Otieno H, 2014, J HYDROL ENG, V19; Phithakkitnukoon S, 2010, LECT NOTES COMPUT SC, V6219, P14, DOI 10.1007/978-3-642-14715-9_3; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Schaller Richard, 2014, Advances in Information Retrieval. 36th European Conference on IR Research, ECIR 2014. Proceedings: LNCS 8416, P681, DOI 10.1007/978-3-319-06028-6_76; Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Snellen D, 2002, ENVIRON PLANN A, V34, P1207, DOI 10.1068/a349; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Wang BJ, 2008, SOIL SEDIMENT CONTAM, V17, P437, DOI 10.1080/15320380802146784; Wang SW, 2014, SUSTAINABILITY-BASEL, V6, P1821, DOI 10.3390/su6041821; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097010; Wu S., 2005, GISCI REMOTE SENS, V42, P80, DOI [10.2747/1548-1603.42.1.80, DOI 10.2747/1548-1603.42.1.80]; [闫庆武 YAN Qingwu], 2011, [武汉大学学报. 信息科学版, Geomatics and Information Science of Wuhan University], V36, P987; Yue TX, 2003, POPUL ENVIRON, V25, P141, DOI 10.1023/B:POEN.0000015562.88915.01; Yue Y., 2010, P 2 ACM SIGSPATIAL I, P27, DOI DOI 10.1145/1867699.1867704; Zhang WS, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P943; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063; Zuo XQ, 2012, J COMPUT, V7, P1753, DOI 10.4304/jcp.7.7.1753-1760	50	23	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135286	10.1371/journal.pone.0135286	http://dx.doi.org/10.1371/journal.pone.0135286			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26288273	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600043
J	Moreau, JD; Neraudeau, D; Tafforeau, P; Depre, E				Moreau, Jean-David; Neraudeau, Didier; Tafforeau, Paul; Depre, Eric			Study of the Histology of Leafy Axes and Male Cones of Glenrosa carentonensis sp nov (Cenomanian Flints of Charente-Maritime, France) Using Synchrotron Microtomography Linked with Palaeoecology	PLOS ONE			English	Article							RAY TOMOGRAPHIC MICROSCOPY; SOUTHWESTERN FRANCE; CONIFER GLENROSA; NORTH-AMERICA; AMBER; PLANT; PORTUGAL; FLOWER; PHASE; GEN.	We report exceptionally well-preserved plant remains ascribed to the extinct conifer Glenrosa J. Watson et H.L. Fisher emend. V. Srinivasan inside silica-rich nodules from the Cenomanian of the Font-de-Benon quarry, Charente-Maritime, western France. Remains are preserved in three dimensions and mainly consist of fragmented leafy axes. Pollen cones of this conifer are for the first time reported and in some cases remain connected to leafy stems. Histology of Glenrosa has not previously been observed; here, most of internal tissues and cells are well-preserved and allow us to describe a new species, Glenrosa carentonensis sp. nov., using propagation phase-contrast X-ray synchrotron microtomography, a non-destructive technique. Leafy axes consist of characteristic helically arranged leaves bearing stomatal crypts. Glenrosa carentonensis sp. nov. differs from the other described species in developing a phyllotaxy 8/21, claw-shaped leaves, a thicker cuticle, a higher number of papillae and stomata per crypt. Pollen cones consist of peltate, helically arranged microsporophylls, each of them bearing 6-7 pollen sacs. The new high resolution tomographic approach tested here allows virtual palaeohistology on plants included inside a dense rock to be made. Most tissues of Glenrosa carentonensis sp. nov. are described. Lithological and palaeontological data combined with xerophytic features of Glenrosa carentonensis sp. nov. suggest that this conifer has been adapted to survive in harsh and instable environments such as coastal area exposed to hot, dry conditions.	[Moreau, Jean-David; Neraudeau, Didier] Univ Rennes 1, CNRS UMR 6118, Geosci Rennes, Rennes, France; [Moreau, Jean-David; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Depre, Eric] GIP GEVES Grp Etud & Controle Varietes & Semences, Surgeres, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; European Synchrotron Radiation Facility (ESRF)	Moreau, JD (corresponding author), Univ Rennes 1, CNRS UMR 6118, Geosci Rennes, Rennes, France.	jean.david.moreau@gmail.com	MOREAU, Jean-David/AAH-4652-2019	MOREAU, Jean-David/0000-0003-2978-5983; Tafforeau, Paul/0000-0002-5962-1683	Geosciences Rennes [CNRS-UMR6118]; European Synchrotron Radiation Facility	Geosciences Rennes; European Synchrotron Radiation Facility	This work was supported by funding from Geosciences Rennes, CNRS-UMR6118, to J-DM, DN; and the European Synchrotron Radiation Facility, to J-DM, PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARALE G, 1997, GEOBIOS, V21, P17; BREWER CA, 1995, AM J BOT, V82, P1271, DOI 10.2307/2446250; Coiffard C, 2009, PALAEONTOLOGY, V52, P323, DOI 10.1111/j.1475-4983.2009.00845.x; DARLING MS, 1989, AM J BOT, V76, P1698, DOI 10.2307/2444408; Feist M, 2005, AM J BOT, V92, P1152, DOI 10.3732/ajb.92.7.1152; Fontaine W.M., 1893, P NATL MUSEUM, V16, P261; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Friis EM, 2014, J PALEONTOL, V88, P684, DOI 10.1666/13-099; Friis EM, 2013, INT J PLANT SCI, V174, P647, DOI 10.1086/669908; Friis EM, 2011, GRANA, V50, P3, DOI 10.1080/00173134.2011.559728; Friis EM, 2010, REV PALAEOBOT PALYNO, V162, P341, DOI 10.1016/j.revpalbo.2009.11.009; Friis EM, 2009, INT J PLANT SCI, V170, P1086, DOI 10.1086/605120; Gomez B, 2001, PALAEOGEOGR PALAEOCL, V170, P133, DOI 10.1016/S0031-0182(01)00232-2; Gomez B, 2008, CR PALEVOL, V7, P135, DOI 10.1016/j.crpv.2007.12.006; Gomez Bernard, 2004, Annales de Paleontologie, V90, P147, DOI 10.1016/j.annpal.2004.03.003; Gomez B, 2012, REV PALAEOBOT PALYNO, V172, P21, DOI 10.1016/j.revpalbo.2012.01.009; Hassiotou F, 2009, J EXP BOT, V60, P2303, DOI 10.1093/jxb/erp021; Hermanova Z, 2011, INT J PLANT SCI, V172, P285, DOI 10.1086/657278; Jordan GJ, 2008, AM J BOT, V95, P521, DOI 10.3732/ajb.2007333; Kunzmann L, 2010, REV PALAEOBOT PALYNO, V159, P123, DOI 10.1016/j.revpalbo.2009.11.006; Lak M, 2008, MICROSC MICROANAL, V14, P251, DOI 10.1017/S1431927608080264; Larcher W, 2003, PHYSL PLANT ECOLOGY; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; LOSCH R, 1982, FLORA, V172, P138; Moreau JD, 2014, CR PALEVOL, V13, P455, DOI 10.1016/j.crpv.2014.03.007; Moreau JD, 2014, LETHAIA, V47, P313, DOI 10.1111/let.12049; Moreau JD, 2014, MICROSC MICROANAL, V20, P305, DOI 10.1017/S1431927613014025; Nel A., 2004, Geologica Acta, V2, P23; Neraudeau D, 2005, CR PALEVOL, V4, P79, DOI 10.1016/j.crpv.2004.11.008; Neraudeau D, 2002, GEOBIOS-LYON, V35, P233, DOI 10.1016/S0016-6995(02)00024-4; Neraudeau D, 2008, CRETACEOUS RES, V29, P925, DOI 10.1016/j.cretres.2008.05.009; Neraudeau D, 2013, ANN PALEONTOL, V99, P361, DOI 10.1016/j.annpal.2013.10.001; Neraudeau D, 2009, GEODIVERSITAS, V31, P13, DOI 10.5252/g2009n1a2; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Perrichot Vincent, 2010, P192; Roth-Nebelsick A, 2007, ANN BOT-LONDON, V100, P23, DOI 10.1093/aob/mcm075; Roth-Nebelsick A, 2009, PLANT PHYSIOL, V151, P2018, DOI 10.1104/pp.109.146969; Saint Martin JP, 2013, ANN PALEONTOL, V99, P289; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Schonenberger J, 2012, ANN BOT-LONDON, V109, P921, DOI 10.1093/aob/mcs009; Scott AC, 2009, MICROSC MICROANAL, V15, P166, DOI 10.1017/S1431927609090126; SRINIVASAN V, 1992, REV PALAEOBOT PALYNO, V72, P245, DOI 10.1016/0034-6667(92)90029-G; Steart DC, 2014, PEERJ, V2, DOI 10.7717/peerj.624; Strullu-Derrien C, 2014, BOT J LINN SOC, V175, P423, DOI 10.1111/boj.12175; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Thevenard F, 2005, CR PALEVOL, V4, P67, DOI 10.1016/j.crpv.2004.11.012; von Balthazar M, 2007, AM J BOT, V94, P2041, DOI 10.3732/ajb.94.12.2041; Vullo Romain, 2003, Annales de Paleontologie, V89, P171, DOI 10.1016/S0753-3969(03)00025-9; Watson J., 1984, PALAEONTOLOGY, V77, P719; Zhou ZY, 2000, PALAEONTOLOGY, V43, P561	51	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134515	10.1371/journal.pone.0134515	http://dx.doi.org/10.1371/journal.pone.0134515			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288019	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600023
J	Szamado, S				Szamado, Szabolcs			Attention-Seeking Displays	PLOS ONE			English	Article							FEMALE CHOICE; ANIMAL COMMUNICATION; FIELD CRICKET; SIGNALS; COURTSHIP; ATTRACTION; RELATIVES; HONEST; COST	Animal communication abounds with extravagant displays. These signals are usually interpreted as costly signals of quality. However, there is another important function for these signals: to call the attention of the receiver to the signaller. While there is abundant empirical evidence to show the importance of this stage, it is not yet incorporated into standard signalling theory. Here I investigate a general model of signalling - based on a basic action-response game - that incorporates this searching stage. I show that giving attention-seeking displays and searching for them can be an ESS. This is a very general result and holds regardless whether only the high quality signallers or both high and low types give them. These signals need not be costly at the equilibrium and they need not be honest signals of any quality, as their function is not to signal quality but simply to call the attention of the potential receivers. These kind of displays are probably more common than their current weight in the literature would suggest.	Eotvos Lorand Univ, MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Dept Plant Taxon & Ecol, Budapest, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Eotvos Lorand University	Szamado, S (corresponding author), Eotvos Lorand Univ, MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Dept Plant Taxon & Ecol, Budapest, Hungary.	szamszab@ludens.elte.hu	Számadó, Szabolcs/A-9804-2013	Számadó, Szabolcs/0000-0003-2204-9705	Orszagos Kutatasi Alapprogramok (OTKA Hungary) [108974]	Orszagos Kutatasi Alapprogramok (OTKA Hungary)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	Funding: This work was supported by Orszagos Kutatasi Alapprogramok (OTKA Hungary) Grant number: 108974, http://www.otka.hu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1995, J THEOR BIOL, V175, P405, DOI 10.1006/jtbi.1995.0151; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; Bergstrom CT, 2002, PHILOS T R SOC B, V357, P1595, DOI 10.1098/rstb.2002.1068; Bergstrom CT, 1997, PHILOS T ROY SOC B, V352, P609, DOI 10.1098/rstb.1997.0041; Bertram SM, 2012, ETHOLOGY, V118, P360, DOI 10.1111/j.1439-0310.2011.02019.x; BORGIA G, 1995, ANIM BEHAV, V49, P1291, DOI 10.1006/anbe.1995.0161; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; Cressman R, 2003, ECON LEARN SOC EVOL, P1; Fitzsimmons LP, 2013, BEHAV ECOL SOCIOBIOL, V67, P885, DOI 10.1007/s00265-013-1511-z; Fitzsimmons LP, 2013, BEHAV ECOL SOCIOBIOL, V67, P213, DOI 10.1007/s00265-012-1441-1; Gibson RM, 1996, BEHAV ECOL SOCIOBIOL, V39, P55, DOI 10.1007/s002650050266; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Heeb P, 2003, ANIM BEHAV, V66, P637, DOI 10.1006/anbe.2003.2238; Hurd PL, 2005, ANIM BEHAV, V70, P1155, DOI 10.1016/j.anbehav.2005.02.014; HURD PL, 1995, J THEOR BIOL, V174, P217, DOI 10.1006/jtbi.1995.0093; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Kilner R, 1998, ANIM BEHAV, V56, P705, DOI 10.1006/anbe.1998.0785; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Lehtonen TK, 2012, ANIM BEHAV, V83, P1153, DOI 10.1016/j.anbehav.2012.01.040; LLOYD JE, 1965, SCIENCE, V149, P653, DOI 10.1126/science.149.3684.653; Loyau A, 2007, BEHAV ECOL, V18, P1123, DOI 10.1093/beheco/arm088; Mateos C, 1999, BEHAV ECOL SOCIOBIOL, V45, P235, DOI 10.1007/s002650050558; Maynard Smith J., 1982, pi; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Ord TJ, 2008, P NATL ACAD SCI USA, V105, P18830, DOI 10.1073/pnas.0807657105; Peters RA, 2003, J EXP BIOL, V206, P4293, DOI 10.1242/jeb.00664; Polnaszek TJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2457; RICHARDS DG, 1981, BEHAVIOUR, V76, P223, DOI 10.1163/156853981X00095; Rivero A, 2000, ANIM BEHAV, V60, P187, DOI 10.1006/anbe.2000.1452; Robson TE, 2005, BIOL LETTERS, V1, P264, DOI 10.1098/rsbl.2005.0325; Scheuber H, 2003, ANIM BEHAV, V65, P721, DOI 10.1006/anbe.2003.2083; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Selten R., 1975, International Journal of Game Theory, V4, P25, DOI 10.1007/BF01766400; Selten R., 1965, J INST THEOR ECON, V121, P301; SMITH JM, 1991, ANIM BEHAV, V42, P1034, DOI 10.1016/S0003-3472(05)80161-7; Szamado S, 2000, ANIM BEHAV, V59, P221, DOI 10.1006/anbe.1999.1293; Szamado S, 1999, J THEOR BIOL, V198, P593, DOI 10.1006/jtbi.1999.0935; Wiebe KL, 2009, ANIM BEHAV, V78, P1413, DOI 10.1016/j.anbehav.2009.09.013; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6; Zahavi A., 1997, HANDICAP PRINCIPLE	44	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135379	10.1371/journal.pone.0135379	http://dx.doi.org/10.1371/journal.pone.0135379			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287489	gold, Green Submitted, Green Published			2022-12-27	WOS:000360018600046
J	Wang, SS; Hu, SW; Zhang, QH; Xia, AX; Jiang, ZX; Chen, XM				Wang, Shuang-shuang; Hu, Si-wang; Zhang, Qing-hua; Xia, Ai-xiang; Jiang, Zhi-xin; Chen, Xiao-min			Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASES; STROMAL CELLS; LUNG INJURY; IN-VIVO; TSG-6; INFLAMMATION	Background and objectives Formation and progression of atherosclerotic vulnerable plaque (VP) is the primary cause of many cardio-cerebrovascular diseases such as acute coronary syndrome and stroke. It has been reported that bone marrow mesenchymal stem cells (MSC) exhibit protective effects against many kinds of diseases including myocardial infarction. Here, we examined the effects of intravenous MSC infusion on a VP model and provide novel evidence of its influence as a therapy in this animal disease model. Subjects and methods Thirty healthy male New Zealand white rabbits were randomly divided into a MSC, VP or stable plaque (SP) group (n = 10/group) and received high fat diet and cold-induced common carotid artery intimal injury with liquid nitrogen to form atherosclerotic plaques. Serum hs-CRP, TNF-alpha, IL-6 and IL-10 levels were measured by ELISA at 1, 2, 3, 7, 14, 21 and 28 days after MSC transplantation. The animals were sacrificed at 4 weeks after MSC transplantation. Lesions in the right common carotid were observed using H&E and Masson staining, and the fibrous cap/lipid core ratio of atherosclerotic plaques were calculated. The expression of nuclear factor kappa B (NF-kappa B) and matrix metalloproteinase 1, 2, 9 (MMP-1,2,9) in the plaque were detected using immunohistochemistry, and apoptotic cells in the plaques were detected by TUNEL. In addition, the level of TNF-alpha stimulated gene/protein 6 (TSG-6) mRNA and protein were measured by quantitative Real-Time PCR and Western blotting, respectively. Results Two rabbits in the VP group died of lung infection and cerebral infarction respectively at 1 week after plaque injury by liquid nitrogen. Both H&E and Masson staining revealed that the plaques from the SP and MSC groups had more stable morphological structure and a larger fibrous cap/lipid core ratio than the VP group. Serum hs-CRP, TNF-alpha and IL-6 were significantly down-regulated, whereas IL-10 was significantly up-regulated in the MSC group compared with the VP group.. Immunohistochemistry analysis revealed that NF-kappa B and MMP expression was reduced in the MSC and SP groups compared to the VP group. Cell apoptosis decreased significantly in both the MSC and SP groups in comparison to the VP group. TSG-6 mRNA and protein expression were higher in the plaques of the MSC group compared to the VP and SP groups. Conclusions Our study results suggest that MSC transplantation can effectively stabilize vulnerable plaques in atherosclerotic rabbits. This may potentially offer a new clinical application of MSC in atherosclerosis.	[Wang, Shuang-shuang] Zhejiang Univ, Coll Med, Hangzhou 310009, Zhejiang, Peoples R China; [Wang, Shuang-shuang; Chen, Xiao-min] Ningbo First Hosp, Dept Cardiol, Ningbo 315000, Zhejiang, Peoples R China; [Hu, Si-wang] Ningbo Univ, Coll Med, Affiliated Hosp, Dept Spine Surg, Ningbo 315000, Zhejiang, Peoples R China; [Zhang, Qing-hua; Xia, Ai-xiang; Jiang, Zhi-xin] Chinese PLA 305 Hosp, Beijing 100017, Peoples R China	Zhejiang University; Ningbo University	Jiang, ZX (corresponding author), Chinese PLA 305 Hosp, Beijing 100017, Peoples R China.	658jzx@163.com; chenxm_nfh@126.com	chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; Wang, Shuangshuang/ABE-9819-2020; chen, xia/GXM-5435-2022		Natural Science Foundation of China [30971235]; Post-doctoral scientific research station Foundation of Ningbo	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Post-doctoral scientific research station Foundation of Ningbo	This study was supported by the Natural Science Foundation of China (No. 30971235) and Post-doctoral scientific research station Foundation of Ningbo.	[Anonymous], 2005, PHYSL REV, V85, P1; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Christodoulidis G, 2014, CARDIOL REV, V22, P279, DOI 10.1097/CRD.0000000000000006; Comite P, 2010, TRANSPL P, V42, P1341, DOI 10.1016/j.transproceed.2010.03.080; Dixon JA, 2009, CIRCULATION, V120, pS220, DOI 10.1161/CIRCULATIONAHA.108.842302; Du YY, 2008, CYTOTHERAPY, V10, P469, DOI 10.1080/14653240802129893; Fang SM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-39; Guo J, 2007, INFLAMMATION, V30, P97, DOI 10.1007/s10753-007-9025-3; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; Igarashi A, 2007, TISSUE ENG, V13, P2405, DOI 10.1089/ten.2006.0340; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Jungebluth P, 2011, CELL TRANSPLANT, V20, P1561, DOI 10.3727/096368910X557254; Kablak-Ziembicka A, 2011, KARDIOL POL, V69, P1024; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Koukkunen H, 2001, ANN MED, V33, P37, DOI 10.3109/07853890109002058; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li YK, 2006, J BIOL CHEM, V281, P6707, DOI 10.1074/jbc.M510579200; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; Shah Svati H, 2003, Cardiol Rev, V11, P169, DOI 10.1097/01.CRD.0000077906.74217.6E; Sheikh AM, 2011, NEUROBIOL DIS, V41, P717, DOI 10.1016/j.nbd.2010.12.009; Spagnoli LG, 2004, JAMA-J AM MED ASSOC, V292, P1845, DOI 10.1001/jama.292.15.1845; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Su J, 2014, CELL DEATH DIFFER, V21, P388, DOI 10.1038/cdd.2013.149; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; van Buul GM, 2012, OSTEOARTHR CARTILAGE, V20, P1186, DOI 10.1016/j.joca.2012.06.003; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Wang SP, 2012, MOL MED REP, V6, P848, DOI 10.3892/mmr.2012.997; Wang XH, 2014, GENET MOL RES, V13, P4260, DOI 10.4238/2014.June.9.11; Williams MS, 2014, PSYCHOSOMATICS, V55, P252, DOI 10.1016/j.psym.2013.09.004; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Wu X, 2014, HEART VESSELS; Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842; Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189; You Q, 2008, INT J GYNECOL OBSTET, V103, P149, DOI 10.1016/j.ijgo.2008.06.012	53	36	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136026	10.1371/journal.pone.0136026	http://dx.doi.org/10.1371/journal.pone.0136026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288013	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600098
J	Aberese-Ako, M; Agyepong, IA; Gerrits, T; Van Dijk, H				Aberese-Ako, Matilda; Agyepong, Irene Akua; Gerrits, Trudie; Van Dijk, Han			'I Used to Fight with Them but Now I Have Stopped!': Conflict and Doctor-Nurse-Anaesthetists' Motivation in Maternal and Neonatal Care Provision in a Specialist Referral Hospital	PLOS ONE			English	Article							HEALTH WORKER MOTIVATION; PUBLIC-SECTOR; TRUST; SATISFACTION; PERFORMANCE; MANAGEMENT; CONSEQUENCES	Background and Objectives This paper analyses why and how conflicts occur and their influence on doctors and nurse-anaesthetists' motivation in the provision of maternal and neonatal health care in a specialist hospital. Methodology The study used ethnographic methods including participant observation, conversation and in-depth interviews over eleven months in a specialist referral hospital in Ghana. Qualitative analysis software Nvivo 8 was used for coding and analysis of data. Main themes identified in the analysis form the basis for interpreting and reporting study findings. Ethics Statement Ethical clearance was obtained from the Ghana Health Service Ethics Review board (approval number GHS-ERC: 06/01/12) and from the University of Wageningen. Written consent was obtained from interview participants, while verbal consent was obtained for conversations. To protect the identity of the hospital and research participants pseudonyms are used in the article and the part of Ghana in which the study was conducted is not mentioned. Results Individual characteristics, interpersonal and organisational factors contributed to conflicts. Unequal power relations and distrust relations among doctors and nurse-anaesthetists affected how they responded to conflicts. Responses to conflicts including forcing, avoiding, accommodating and compromising contributed to persistent conflicts, which frustrated and demotivated doctors and nurse-anaesthetists. Demotivated workers exhibited poor attitudes in collaborating with co-workers in the provision of maternal and neonatal care, which sometimes led to poor health worker response to client care, consequently compromising the hospital's goal of providing quality health care to clients. Conclusion To improve health care delivery in health facilities in Ghana, health managers and supervisors need to identify conflicts as an important phenomenon that should be addressed whenever they occur. Effective mechanisms including training managers and health workers on conflict management should be put in place. Additionally promoting communication and interaction among health workers can foster team spirit. Also resolving conflicts using the collaborating response may help to create a conducive work environment that will promote healthy work relations, which can facilitate the delivery of quality maternal and neonatal health care. However, such an approach requires that unequal power relations, which is a root cause of the conflicts is addressed.	[Aberese-Ako, Matilda; Van Dijk, Han] Wageningen Univ, Sociol Dev & Change SDC Grp, NL-6700 AP Wageningen, Netherlands; [Aberese-Ako, Matilda; Agyepong, Irene Akua] Ghana Hlth Serv, Accra, Ghana; [Agyepong, Irene Akua] Univ Ghana, Sch Publ Hlth, Legon, Ghana; [Gerrits, Trudie] Univ Amsterdam, Amsterdam Sch Social Sci Res, Amsterdam, Netherlands	Wageningen University & Research; Ghana Health Service; University of Ghana; University of Amsterdam	Aberese-Ako, M (corresponding author), Wageningen Univ, Sociol Dev & Change SDC Grp, NL-6700 AP Wageningen, Netherlands.	matilda.aberese-ako@wur.nl	van Dijk, Han/L-6710-2016	van Dijk, Han/0000-0002-4406-4909; Agyepong, Irene Akua/0000-0002-0193-5882	Netherlands Organization for Scientific Research (NWO/WOTRO) [WOTRO-IP W 07.45.102.00]	Netherlands Organization for Scientific Research (NWO/WOTRO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Netherlands Organization for Scientific Research (NWO/WOTRO) on the project "Accelerating progress towards attainment of MDG 4 and 5 in Ghana through basic health systems function strengthening," grant number [WOTRO-IP W 07.45.102.00]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong I A, 2001, Qual Manag Health Care, V9, P1; Agyepong IA, 2004, INT J HEALTH PLAN M, V19, P319, DOI 10.1002/hpm.770; Almost J, 2006, J ADV NURS, V53, P444, DOI 10.1111/j.1365-2648.2006.03738.x; Almost J, 2010, J NURS MANAGE, V18, P981, DOI 10.1111/j.1365-2834.2010.01154.x; Ansong-Tornui Janet, 2007, Ghana Med J, V41, P125; Bazin JE, 2014, ANN FR ANESTH, V33, P335, DOI 10.1016/j.annfar.2014.04.006; Bercovitch J, 1983, ASIAN J PUBLIC ADM, V5, P104; Board E, 1994, ANAESTHETISTS DISCUO; Bonenberger M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-43; Booij LHDJ, 2007, CURR OPIN ANESTHESIO, V20, P152, DOI 10.1097/ACO.0b013e32809f9506; Bosu Wk, 2007, Ghana Med J, V41, P118; Bousari M. P., 2009, Research Journal of Biological Sciences, V4, P236; Brinkert R, 2010, J NURS MANAGE, V18, P145, DOI 10.1111/j.1365-2834.2010.01061.x; Capitulo KL, 2009, NURSE LEAD, V7, P38, DOI 10.1016/j.mnl.2009.01.009; Cinar F, 2012, PROCD SOC BEHV, V58, P197, DOI 10.1016/j.sbspro.2012.09.993; Coe R, 2008, J ADV NURS, V61, P609, DOI 10.1111/j.1365-2648.2007.04544.x; Coombs Maureen, 2003, Intensive Crit Care Nurs, V19, P125, DOI 10.1016/S0964-3397(03)00040-5; DAHL RA, 1957, BEHAV SCI, V2, P201, DOI 10.1002/bs.3830020303; De Dreu CKW, 2003, J APPL PSYCHOL, V88, P741, DOI 10.1037/0021-9010.88.4.741; Dieleman M, 2006, HUMAN RESOURCES HLTH, V4, P1; Dieleman Marjolein, 2003, Hum Resour Health, V1, P10, DOI 10.1186/1478-4491-1-10; DISCOMBE G, 1954, BRIT MED J, V1, P326, DOI 10.1136/bmj.1.4857.326; Emerson M.R., 2005, WRITING ETHNOGRAPHIC, P353; Encyclopedia Wikipedia, 2014, UT MYOM; Ferres N., 2004, J MANAGE PSYCHOL, V19, P608, DOI [10.1108/02683940410551516, DOI 10.1108/02683940410551516]; Fox A., 1974, CONTRACT WORK POWER; Franco LM, 2004, SOC SCI MED, V58, P343, DOI 10.1016/S0277-9536(03)00203-X; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Gilson L, 2005, SOC SCI MED, V61, P1418, DOI 10.1016/j.socscimed.2004.11.062; Gilson Lucy, 2006, J Health Organ Manag, V20, P359, DOI 10.1108/14777260610701768; Guerra ST, 2011, REV LAT-AM ENFERM, V19, P362, DOI 10.1590/S0104-11692011000200019; Jack H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057940; Jehn KA, 2006, INT J CONFL MANAGE, V17, P96, DOI 10.1108/10444060610736594; Johns JL, 1996, J ADV NURS, V24, P76, DOI 10.1046/j.1365-2648.1996.16310.x; Katiliute E, 2007, BALT J MANAG, V2, P213, DOI DOI 10.1108/17465260710751008; Katz JD, 2007, J CLIN ANESTH, V19, P152, DOI 10.1016/j.jclinane.2006.07.007; Laschinger HKS, 2000, J NURS ADMIN, V30, P413, DOI 10.1097/00005110-200009000-00008; Lipsky M., 1980, STREET LEVEL BUREAUC, DOI DOI 10.1007/s13178-012-0092-3; Mansour JB, 2005, MANAGERS WHO LEAD HD; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Mintzberg H., 1983, POWER ORG, DOI DOI 10.1177/017084068400500419; Mohammed A, 2012, INT FEDERATION GYNEC; National Development Planning Commission Government of Ghana United Nations Development Programme (UNDP) Ghana, 2010, 2008 GHAN MILL DEV G; Pavlakis A, 2011, INT NURS REV, V58, P242, DOI 10.1111/j.1466-7657.2011.00880.x; PONDY LR, 1967, ADMIN SCI QUART, V12, P296, DOI 10.2307/2391553; Purohit B, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-12; Rosenstein AH, 2011, AM J OBSTET GYNECOL, V204, P187, DOI 10.1016/j.ajog.2010.10.899; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Slack T., 2006, UNDERSTANDING SPORT, V2nd ed.; Thom DH, 2004, HEALTH AFFAIR, V23, P124, DOI 10.1377/hlthaff.23.4.124; Van der Geest S, 1998, SOC SCI MED, V47, P1373, DOI 10.1016/S0277-9536(98)00179-8; Vivar Cristina Garcia, 2006, J Nurs Manag, V14, P201; Whetten DA, 1996, EFFECTIVE CONFLICT M; ZAND DE, 1972, ADMIN SCI QUART, V17, P229, DOI 10.2307/2393957	55	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135129	10.1371/journal.pone.0135129	http://dx.doi.org/10.1371/journal.pone.0135129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26285108	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100022
J	Escudero, L; Al-Refai, M; Nieto, C; Laatsch, H; Malpartida, F; Seco, EM				Escudero, Leticia; Al-Refai, Mahmoud; Nieto, Cristina; Laatsch, Hartmut; Malpartida, Francisco; Seco, Elena M.			New Rimocidin/CE-108 Derivatives Obtained by a Crotonyl-CoA Carboxylase/Reductase Gene Disruption in Streptomyces diastaticus var. 108: Substrates for the Polyene Carboxamide Synthase PcsA	PLOS ONE			English	Article							POLYKETIDE SYNTHASE; AMPHOTERICIN-B; ENGINEERED BIOSYNTHESIS; ANTIFUNGAL ACTIVITY; AMIDE DERIVATIVES; CLONING VECTORS; MACROLIDES; NYSTATIN; ANTIBIOTICS; GLUTAMINE	The rimJ gene, which codes for a crotonyl-CoA carboxylase/reductase, lies within the bio-synthetic gene cluster for two polyketides belonging to the polyene macrolide group (CE-108 and rimocidin) produced by Streptomyces diastaticus var. 108. Disruption of rimJ by insertional inactivation gave rise to a recombinant strain overproducing new polyene derivatives besides the parental CE-108 (2a) and rimocidin (4a). The structure elucidation of one of them, CE-108D (3a), confirmed the incorporation of an alternative extender unit for elongation step 13. Other compounds were also overproduced in the fermentation broth of rimJ disruptant. The new compounds are in vivo substrates for the previously described polyene carboxamide synthase PcsA. The rimJ disruptant strain, constitutively expressing the pcsA gene, allowed the overproduction of CE-108E (3b), the corresponding carboxamide derivative of CE-108D (3a), with improved pharmacological properties.	[Escudero, Leticia; Nieto, Cristina; Malpartida, Francisco; Seco, Elena M.] CSIC, CNB, Madrid 28049, Spain; [Al-Refai, Mahmoud; Laatsch, Hartmut] Univ Gottingen, Dept Organ & Biomol Chem, D-37077 Gottingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Gottingen	Seco, EM (corresponding author), CSIC, CNB, Campus Univ Autonoma Madrid, Madrid 28049, Spain.	eseco@cnb.csic.es	Al-Refai, Mahmoud/GOH-0260-2022	Seco, Elena M./0000-0003-1431-4441	Spanish Ministerio de Ciencia e Innovacion [BIO2005-02785, BIO2008-03683]; Spanish Ministerio de Economia y Competitividad [BFU2012-39879-C02-01]; German Academic Exchange Service (DAAD)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants to F.M. from the Spanish Ministerio de Ciencia e Innovacion BIO2005-02785 and BIO2008-03683, and to J.C.A. from Spanish Ministerio de Economia y Competitividad BFU2012-39879-C02-01. The German Academic Exchange Service (DAAD) supported M.A.R. with a Ph.D. grant.	[Anonymous], 1997, M27A NCFCLS; Aparicio JF, 2003, APPL MICROBIOL BIOT, V61, P179, DOI 10.1007/s00253-002-1183-5; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Atlas RM, 1993, MICROBIOLOGICAL MEDI; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Borgos SEF, 2006, J MED CHEM, V49, P2431, DOI 10.1021/jm050895w; Brautaset T, 2000, CHEM BIOL, V7, P395, DOI 10.1016/S1074-5521(00)00120-4; Brautaset T, 2002, CHEM BIOL, V9, P367, DOI 10.1016/S1074-5521(02)00108-4; Brautaset T, 2008, CHEM BIOL, V15, P1198, DOI 10.1016/j.chembiol.2008.08.009; Bruzzese T, 1996, EUR J MED CHEM, V31, P965, DOI 10.1016/S0223-5234(97)86175-2; Caffrey P, 2001, CHEM BIOL, V8, P713, DOI 10.1016/S1074-5521(01)00046-1; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Carmody M, 2005, J BIOL CHEM, V280, P34420, DOI 10.1074/jbc.M506689200; Cybulska B, 1995, BBA-BIOMEMBRANES, V1240, P167, DOI 10.1016/0005-2736(95)00170-0; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Goldman RD, 2007, J CLIN PHARMACOL, V47, P1049, DOI 10.1177/0091270007301799; Heia S, 2011, APPL ENVIRON MICROB, V77, P6982, DOI 10.1128/AEM.05781-11; Jung WS, 2011, APPL MICROBIOL BIOT, V91, P1389, DOI 10.1007/s00253-011-3348-6; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kosec G, 2012, METAB ENG, V14, P39, DOI 10.1016/j.ymben.2011.11.003; LARSON JL, 1986, PLASMID, V15, P199, DOI 10.1016/0147-619X(86)90038-7; Liu Y, 2009, J AM CHEM SOC, V131, P10376, DOI 10.1021/ja9042824; LYDIATE DJ, 1985, GENE, V35, P223, DOI 10.1016/0378-1119(85)90001-0; MALPARTIDA F, 1986, MOL GEN GENET, V205, P66, DOI 10.1007/BF02428033; Maniatis T., 1982, MOL CLONING; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Mendes MV, 2001, CHEM BIOL, V8, P635, DOI 10.1016/S1074-5521(01)00033-3; Miranzo D, 2010, APPL MICROBIOL BIOT, V85, P1809, DOI 10.1007/s00253-009-2195-1; Paquet V, 2008, CHEM-EUR J, V14, P2465, DOI 10.1002/chem.200701237; Perez-Zuniga FJ, 2004, J ANTIBIOT, V57, P197, DOI 10.7164/antibiotics.57.197; Power P, 2008, CHEM BIOL, V15, P78, DOI 10.1016/j.chembiol.2007.11.008; Preobrazhenskaya MN, 2009, J MED CHEM, V52, P189, DOI 10.1021/jm800695k; Seco EM, 2010, APPL MICROBIOL BIOT, V85, P1797, DOI 10.1007/s00253-009-2193-3; Seco EM, 2005, CHEM BIOL, V12, P1093, DOI 10.1016/j.chembiol.2005.08.007; Seco EM, 2005, CHEM BIOL, V12, P535, DOI 10.1016/j.chembiol.2005.02.015; Seco EM, 2004, CHEM BIOL, V11, P357, DOI 10.1016/j.chembiol.2004.02.017; Standards NCfCL, 1998, M38P NCFCL, V18; Szlinder-Richert J, 2001, BBA-GEN SUBJECTS, V1528, P15, DOI 10.1016/S0304-4165(01)00166-0; Tevyashova AN, 2013, ANTIMICROB AGENTS CH, V57, P3815, DOI 10.1128/AAC.00270-13; WALLACE KK, 1995, FEMS MICROBIOL LETT, V131, P227, DOI 10.1016/0378-1097(95)00263-5; WALLACE KK, 1995, EUR J BIOCHEM, V233, P954, DOI 10.1111/j.1432-1033.1995.954_3.x; Witkowski A, 1999, BIOCHEMISTRY-US, V38, P11643, DOI 10.1021/bi990993h; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	47	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135891	10.1371/journal.pone.0135891	http://dx.doi.org/10.1371/journal.pone.0135891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284936	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100084
J	Streit, S; Baumann, P; Barth, J; Mattle, HP; Arnold, M; Bassetti, CL; Meli, DN; Fischer, U				Streit, Sven; Baumann, Philippe; Barth, Juergen; Mattle, Heinrich P.; Arnold, Marcel; Bassetti, Claudio L.; Meli, Damian N.; Fischer, Urs			Awareness of Stroke Risk after TIA in Swiss General Practitioners and Hospital Physicians	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; PRIMARY-CARE-PHYSICIANS; MINOR STROKE; QUESTIONNAIRE SURVEY; MANAGEMENT	Background Transient ischemic attacks (TIA) are stroke warning signs and emergency situations, and, if immediately investigated, doctors can intervene to prevent strokes. Nevertheless, many patients delay going to the doctor, and doctors might delay urgently needed investigations and preventative treatments. We set out to determine how much general practitioners (GPs) and hospital physicians (HPs) knew about stroke risk after TIA, and to measure their referral rates. Methods We used a structured questionnaire to ask GPs and HPs in the catchment area of the University Hospital of Bern to estimate a patient's risk of stroke after TIA. We also assessed their referral behavior. We then statistically analysed their reasons for deciding not to immediately refer patients. Results Of the 1545 physicians, 40% (614) returned the survey. Of these, 75%(457) overestimated stroke risk within 24 hours, and 40% (245) overestimated risk within 3 months after TIA. Only 9% (53) underestimated stroke risk within 24 hours and 26%(158) underestimated risk within 3 months; 78% (473) of physicians overestimated the amount that carotid endarterectomy reduces stroke risk; 93%(543) would rigorously investigate the cause of a TIA, but only 38%(229) would refer TIA patients for urgent investigations "very often". Physicians most commonly gave these reasons for not making emergency referrals: patient's advanced age; patient's preference; patient was multimorbid; and, patient needed long-term care. Conclusions Although physicians overestimate stroke risk after TIA, their rate of emergency referral is modest, mainly because they tend not to refer multimorbid and elderly patients at the appropriate rate. Since old and frail patients benefit from urgent investigations and treatment after TIA as much as younger patients, future educational campaigns should focus on the importance of emergency evaluations for all TIA patients.	[Streit, Sven; Baumann, Philippe; Meli, Damian N.] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Barth, Juergen] Univ Zurich Hosp, Inst Complementary & Integrat Med, CH-8091 Zurich, Switzerland; [Mattle, Heinrich P.; Arnold, Marcel; Bassetti, Claudio L.; Fischer, Urs] Univ Bern, Dept Neurol, Univ Hosp Bern, Bern, Switzerland	University of Bern; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Fischer, U (corresponding author), Univ Bern, Dept Neurol, Univ Hosp Bern, Bern, Switzerland.	urs.fischer@insel.ch	Streit, Sven/I-3788-2019	Streit, Sven/0000-0002-3813-4616; Fischer, Urs/0000-0003-0521-4051; Bassetti, Claudio/0000-0002-4535-0245	Swiss University Conference; State Secretariat for Education, Research and Innovation (SUC project) [P-10]	Swiss University Conference; State Secretariat for Education, Research and Innovation (SUC project)	Sven Streit who was funded in part by the Swiss University Conference and the State Secretariat for Education, Research and Innovation (SUC project P-10). No other funding was needed to conduct this study.	Chandratheva A, 2010, STROKE, V41, P1108, DOI 10.1161/STROKEAHA.109.576611; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Del Mar C, 2014, JAMA INTERNAL MED; Engelter S, 2006, SCHW MED FORUM, V6, P479; Goldstein LB, 2000, ARCH INTERN MED, V160, P2941, DOI 10.1001/archinte.160.19.2941; Heldner M R, 2012, Praxis (Bern 1994), V101, P389, DOI 10.1024/1661-8157/a000866; Johnston SC, 1999, EUR NEUROL, V42, P105, DOI 10.1159/000069419; Lasserson DS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1569; Leung Elaine Stephanie, 2012, BMC Res Notes, V5, P278, DOI 10.1186/1756-0500-5-278; Massengo SA, 2013, CLIN NEUROL NEUROSUR, V115, P1457, DOI 10.1016/j.clineuro.2013.01.026; Nedeltchev K, 2007, J NEUROL, V254, P179, DOI 10.1007/s00415-006-0313-x; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Slezak A, 2014, SCHW MED FORUM, V14, P333; Suzuki R, 2014, INT J STROKE, V9, pE16, DOI 10.1111/ijs.12266; Tomasik T, 2003, FAM PRACT, V20, P464, DOI 10.1093/fampra/cmg423	15	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135885	10.1371/journal.pone.0135885	http://dx.doi.org/10.1371/journal.pone.0135885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284533	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000359666100081
J	van Kerkhof, LWM; Van Dycke, KCG; Jansen, EHJM; Beekhof, PK; van Oostrom, CTM; Ruskovska, T; Velickova, N; Kamcev, N; Pennings, JLA; van Steeg, H; Rodenburg, W				van Kerkhof, Linda W. M.; Van Dycke, Kirsten C. G.; Jansen, Eugene H. J. M.; Beekhof, Piet K.; van Oostrom, Conny T. M.; Ruskovska, Tatjana; Velickova, Nevenka; Kamcev, Nikola; Pennings, Jeroen L. A.; van Steeg, Harry; Rodenburg, Wendy			Diurnal Variation of Hormonal and Lipid Biomarkers in a Molecular Epidemiology-Like Setting	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CLOCK GENES; CIRCADIAN-RHYTHM; LUTEINIZING-HORMONE; SERUM TESTOSTERONE; GROWTH-HORMONE; BREAST-CANCER; NORMAL-WEIGHT; BRIGHT LIGHT; NORMAL WOMEN	Introduction Many molecular epidemiology studies focusing on high prevalent diseases, such as metabolic disorders and cancer, investigate metabolic and hormonal markers. In general, sampling for these markers can occur at any time-point during the day or after an overnight fast. However, environmental factors, such as light exposure and food intake might affect the levels of these markers, since they provide input for the internal time-keeping system. When diurnal variation is larger than the inter-individual variation, time of day should be taken into account. Importantly, heterogeneity in diurnal variation and disturbance of circadian rhythms among a study population might increasingly occur as a result of our increasing 24/7 economy and related variation in exposure to environmental factors (such as light and food). Aim The aim of the present study was to determine whether a set of often used biomarkers shows diurnal variation in a setting resembling large molecular epidemiology studies, i.e., non-fasted and limited control possibilities for other environmental influences. Results We show that markers for which diurnal variation is not an issue are adrenocorticotropic hormone, follicle stimulating hormone, estradiol and high-density lipoprotein. For all other tested markers diurnal variation was observed in at least one gender (cholesterol, cortisol, dehydroepiandrosterone sulfate, free fatty acids, low-density lipoprotein, luteinizing hormone, prolactin, progesterone, testosterone, triglycerides, total triiodothyronine and thyroid-stimulating hormone) or could not reliably be detected (human growth hormone). Discussion Thus, studies investigating these markers should take diurnal variation into account, for which we provide some options. Furthermore, our study indicates the need for investigating diurnal variation (in literature or experimentally) before setting up studies measuring markers in routine and controlled settings, especially since time-of-day likely matters for many more markers than the ones investigated in the present study.	[van Kerkhof, Linda W. M.; Van Dycke, Kirsten C. G.; Jansen, Eugene H. J. M.; Beekhof, Piet K.; van Oostrom, Conny T. M.; Pennings, Jeroen L. A.; van Steeg, Harry; Rodenburg, Wendy] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands; [Van Dycke, Kirsten C. G.] Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands; [Ruskovska, Tatjana; Velickova, Nevenka; Kamcev, Nikola] Goce Delcev Univ, Fac Med Sci, Stip, Macedonia; [van Steeg, Harry] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Goce Delcev University of Stip; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rodenburg, W (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands.	wendy.rodenburg@rivm.nl	Ruskovska, Tatjana/V-4885-2019	Ruskovska, Tatjana/0000-0002-4300-4891; Pennings, Jeroen L.A./0000-0002-9188-6358				Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Birketvedt GS, 2012, APPETITE, V59, P688, DOI 10.1016/j.appet.2012.07.015; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Carneiro BTS, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00083; Chua ECP, 2013, P NATL ACAD SCI USA, V110, P14468, DOI 10.1073/pnas.1222647110; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Davies SK, 2014, P NATL ACAD SCI USA, V111, P10761, DOI 10.1073/pnas.1402663111; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Diver MJ, 2003, CLIN ENDOCRINOL, V58, P710, DOI 10.1046/j.1365-2265.2003.01772.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FUJIMOTO VY, 1990, OBSTET GYNECOL, V76, P71; Gamble KL, 2014, NAT REV ENDOCRINOL, V10, P466, DOI 10.1038/nrendo.2014.78; Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001; Hadji P, 2014, BREAST CANCER RES TR, V144, P343, DOI 10.1007/s10549-014-2860-7; Hastings MH, 1998, CHRONOBIOL INT, V15, P425, DOI 10.3109/07420529808998700; Hirschfeld U, 1996, J CLIN ENDOCR METAB, V81, P3270, DOI 10.1210/jc.81.9.3270; James FO, 2007, CHRONOBIOL INT, V24, P1009, DOI 10.1080/07420520701800736; Jiang J, 2014, METABOLISM, V63, P1398, DOI 10.1016/j.metabol.2014.07.011; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Klingman KM, 2011, J CLIN ENDOCR METAB, V96, P1456, DOI 10.1210/jc.2010-2739; Kusanagi H, 2008, NEUROSCI RES, V61, P136, DOI 10.1016/j.neures.2008.01.012; Li SX, 2013, PSYCHONEUROENDOCRINO, V38, P2789, DOI 10.1016/j.psyneuen.2013.07.009; Mazzoccoli G, 2011, BIOMED PHARMACOTHER, V65, P275, DOI 10.1016/j.biopha.2011.02.002; Mester B, 2010, INT J OCCUP ENV MED, V1, P160; Miida T, 2002, ANN CLIN BIOCHEM, V39, P241, DOI 10.1258/0004563021901946; MIYATAKE A, 1980, J CLIN ENDOCR METAB, V51, P1365, DOI 10.1210/jcem-51-6-1365; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; MORTOLA JF, 1992, J CLIN ENDOCR METAB, V75, P861, DOI 10.1210/jc.75.3.861; Nicolau G Y, 1989, Endocrinologie, V27, P153; Niklowitz P, 2006, BIOFACTORS, V28, P47, DOI 10.1002/biof.5520280105; Ollila HM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.20; Ostrowska, 1998, Endocr Regul, V32, P169; PLYMATE SR, 1989, J ANDROL, V10, P366; RIEDEL M, 1995, METABOLISM, V44, P605, DOI 10.1016/0026-0495(95)90117-5; SPRATT DI, 1988, AM J PHYSIOL, V254, pE658, DOI 10.1152/ajpendo.1988.254.5.E658; Stevens RG, 2005, EPIDEMIOLOGY, V16, P254, DOI 10.1097/01.ede.0000152525.21924.54; Takimoto M, 2005, AM J PHYSIOL-REG I, V289, pR1273, DOI 10.1152/ajpregu.00126.2005; Teboul M, 2005, J MOL MED, V83, P693, DOI 10.1007/s00109-005-0697-6; VELDHUIS JD, 1988, J CLIN ENDOCR METAB, V66, P414, DOI 10.1210/jcem-66-2-414; WHO, 2013, FACT SH DIAB 2013; Yoshino J, 2014, J CLIN ENDOCR METAB, V99, pE1666, DOI 10.1210/jc.2014-1579; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	45	35	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135652	10.1371/journal.pone.0135652	http://dx.doi.org/10.1371/journal.pone.0135652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285127	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100054
J	Winklewski, PJ; Barak, O; Madden, D; Gruszecka, A; Gruszecki, M; Guminski, W; Kot, J; Frydrychowski, AF; Drvis, I; Dujic, Z				Winklewski, Pawel J.; Barak, Otto; Madden, Dennis; Gruszecka, Agnieszka; Gruszecki, Marcin; Guminski, Wojciech; Kot, Jacek; Frydrychowski, Andrzej F.; Drvis, Ivan; Dujic, Zeljko			Effect of Maximal Apnoea Easy-Going and Struggle Phases on Subarachnoid Width and Pial Artery Pulsation in Elite Breath-Hold Divers	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SYMPATHETIC-NERVE ACTIVITY; CEREBROVASCULAR PULSATION; SPONTANEOUS OSCILLATIONS; INTRACRANIAL-PRESSURE; NONINVASIVE METHOD; VALSALVA MANEUVER; WAVELET TRANSFORM; ACUTE HYPERCAPNIA; ACUTE HYPOTENSION	Purpose The aim of the study was to assess changes in subarachnoid space width (sas-TQ), the marker of intracranial pressure (ICP), pial artery pulsation (cc-TQ) and cardiac contribution to blood pressure (BP), cerebral blood flow velocity (CBFV) and cc-TQ oscillations throughout the maximal breath hold in elite apnoea divers. Non-invasive assessment of sas-TQ and cc-TQ became possible due to recently developed method based on infrared radiation, called near-infrared transillumination/backscattering sounding (NIR-T/BSS). Methods The experimental group consisted of seven breath-hold divers (six men). During testing, each participant performed a single maximal end-inspiratory breath hold. Apnoea consisted of the easy-going and struggle phases (characterised by involuntary breathing movements (IBMs)). Heart rate (HR) was determined using a standard ECG. BP was assessed using the photoplethysmography method. SaO(2) was monitored continuously with pulse oximetry. A pneumatic chest belt was used to register thoracic and abdominal movements. Cerebral blood flow velocity (CBFV) was estimated by a 2-MHz transcranial Doppler ultrasonic probe. sas-TQ and cc-TQ were measured using NIR-T/BSS. Wavelet transform analysis was performed to assess cardiac contribution to BP, CBFV and cc-TQ oscillations. Results Mean BP and CBFV increased compared to baseline at the end of the easy phase and were further augmented by IBMs. cc-TQ increased compared to baseline at the end of the easy phase and remained stable during the IBMs. HR did not change significantly throughout the apnoea, although a trend toward a decrease during the easy phase and recovery during the IBMs was visible. Amplitudes of BP, CBFV and cc-TQ were augmented. sas-TQ and SaO(2) decreased at the easy phase of apnoea and further decreased during the IBMs. Conclusions Apnoea increases intracranial pressure and pial artery pulsation. Pial artery pulsation seems to be stabilised by the IBMs. Cardiac contribution to BP, CBFV and cc-TQ oscillations does not change throughout the apnoea.	[Winklewski, Pawel J.; Frydrychowski, Andrzej F.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Barak, Otto] Univ Novi Sad, Fac Med, Novi Sad 21000, Serbia; [Madden, Dennis; Dujic, Zeljko] Univ Split, Dept Integrat Physiol, Sch Med, Split, Croatia; [Gruszecka, Agnieszka; Gruszecki, Marcin] Med Univ Gdansk, Dept Radiol Informat & Stat, Gdansk, Poland; [Guminski, Wojciech] Gdansk Univ Technol, Fac Elect Telecommun & Informat, Dept Comp Commun, Gdansk, Poland; [Kot, Jacek] Med Univ Gdansk, Inst Maritime & Trop Med, Natl Ctr Hyperbar Med, Gdynia, Poland; [Drvis, Ivan] Univ Zagreb, Sch Kinesiol, Zagreb 41000, Croatia	Fahrenheit Universities; Medical University Gdansk; University of Novi Sad; University of Split; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; University of Zagreb; University of Zagreb, Faculty of Kinesiology	Winklewski, PJ (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	pawelwinklewski@wp.pl	Kot, Jacek/I-5284-2012; Gumiński, Wojciech/B-5004-2013; Barak, Otto F/E-3771-2016; dujic, zeljko/D-5549-2017	Kot, Jacek/0000-0001-5604-8407; Gumiński, Wojciech/0000-0002-3113-3450; Barak, Otto F/0000-0001-6727-8304; Winklewski, Pawel/0000-0002-1671-2163; Dujic, Zeljko/0000-0002-6450-0130; Gruszecki, Marcin/0000-0003-1709-3939; Gruszecka, Agnieszka/0000-0003-4382-9540	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FRP/under the Research Executive Agency [264816]; University of Split; Medical University of Gdansk; NIRT sp. z o. o., Wierzbice, Poland; Croatian Science Foundation	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FRP/under the Research Executive Agency; University of Split; Medical University of Gdansk(Medical University Gdansk); NIRT sp. z o. o., Wierzbice, Poland; Croatian Science Foundation	The study was conducted as a part of the PHYPODE Marie Curie Initial Training Networks (FP7-PEOPLE-2010-ITN) and received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FRP/2007-2013/under the Research Executive Agency grant agreement [grant number 264816]. Funding came also from the University of Split, Medical University of Gdansk and NIRT sp. z o. o., Wierzbice, Poland. The Croatian Science Foundation supported Zeljko Dujic, Otto Barak and Ivan Drvis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVEZAAT CJJ, 1980, J NEUROL NEUROSUR PS, V43, P222, DOI 10.1136/jnnp.43.3.222; Bateman GA, 2008, NEURORADIOLOGY, V50, P491, DOI 10.1007/s00234-008-0374-x; Battisti-Charbonney A, 2011, J PHYSIOL-LONDON, V589, P3039, DOI 10.1113/jphysiol.2011.206052; Cassaglia PA, 2008, AM J PHYSIOL-REG I, V294, pR1255, DOI 10.1152/ajpregu.00332.2007; Cassaglia PA, 2009, J APPL PHYSIOL, V106, P1050, DOI 10.1152/japplphysiol.91349.2008; Cassaglia PA, 2008, SLEEP, V31, P1729, DOI 10.1093/sleep/31.12.1729; Cross TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066950; Cross TJ, 2013, MED SCI SPORT EXER, V45, P93, DOI 10.1249/MSS.0b013e3182690e6a; Cui RF, 2014, MICROVASC RES, V93, P14, DOI 10.1016/j.mvr.2014.02.008; Domoki F, 2008, ACTA PAEDIATR, V97, P280, DOI 10.1111/j.1651-2227.2007.00615.x; Dujic Z, 2009, J APPL PHYSIOL, V107, P1840, DOI 10.1152/japplphysiol.00334.2009; FITZGERALD RS, 1981, AM J PHYSIOL, V240, pH721, DOI 10.1152/ajpheart.1981.240.5.H721; Frydrychowski AE, 2002, IEEE T BIO-MED ENG, V49, P887, DOI 10.1109/TBME.2002.800786; Frydrychowski AF, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753756; Frydrychowski AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061936; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Frydrychowski AF, 2012, MICROVASC RES, V83, P229, DOI 10.1016/j.mvr.2011.08.005; Frydrychowski AF, 2011, ACTA NEUROBIOL EXP, V71, P313; Frydrychowski AF, 2011, MICROVASC RES, V82, P156, DOI 10.1016/j.mvr.2011.05.005; Georgiadis D, 2000, EUR HEART J, V21, P407, DOI 10.1053/euhj.1999.1742; GREENFIELD JC, 1984, STROKE, V15, P76, DOI 10.1161/01.STR.15.1.76; Heusser K, 2009, HYPERTENSION, V53, P719, DOI 10.1161/HYPERTENSIONAHA.108.127530; Jellema WT, 1999, ANESTHESIOLOGY, V90, P1317, DOI 10.1097/00000542-199905000-00016; JENNUM P, 1989, CHEST, V95, P279, DOI 10.1378/chest.95.2.279; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Li ZY, 2013, J CEREBR BLOOD F MET, V33, P692, DOI 10.1038/jcbfm.2013.4; Li ZY, 2011, MICROVASC RES, V82, P304, DOI 10.1016/j.mvr.2011.08.004; Mardimae A, 2012, PFLUG ARCH EUR J PHY, V464, P345, DOI 10.1007/s00424-012-1148-1; Narayanan N, 2008, J APPL PHYSIOL, V105, P152, DOI 10.1152/japplphysiol.00988.2007; Ogoh S, 2010, J PHYSIOL-LONDON, V588, P365, DOI 10.1113/jphysiol.2009.180844; Palada I, 2008, RESP PHYSIOL NEUROBI, V161, P174, DOI 10.1016/j.resp.2008.01.008; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Tzeng YC, 2014, J APPL PHYSIOL, V117, P1037, DOI 10.1152/japplphysiol.00366.2014; VORSTRUP S, 1984, J CLIN INVEST, V74, P1634, DOI 10.1172/JCI111579; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Willie CK, 2015, J CEREBR BLOOD F MET, V35, P66, DOI 10.1038/jcbfm.2014.170; Winklewski PJ, 2015, MICROVASC RES, V99, P86, DOI 10.1016/j.mvr.2015.03.003; Wszedybyl-Winklewska M, 2015, J HYPERTENS, V33, P1811, DOI 10.1097/HJH.0000000000000613; Wszedybyl-Winklewska M, 2012, ACTA NEUROBIOL EXP, V72, P80; Wszedybyl-Winklewska M, 2011, MICROVASC RES, V82, P369, DOI 10.1016/j.mvr.2011.08.003	41	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135429	10.1371/journal.pone.0135429	http://dx.doi.org/10.1371/journal.pone.0135429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285143	gold, Green Submitted, Green Published			2022-12-27	WOS:000359666100038
J	Engel, N; Ganesh, G; Patil, M; Yellappa, V; Pai, NP; Vadnais, C; Pai, M				Engel, Nora; Ganesh, Gayatri; Patil, Mamata; Yellappa, Vijayashree; Pai, Nitika Pant; Vadnais, Caroline; Pai, Madhukar			Barriers to Point-of-Care Testing in India: Results from Qualitative Research across Different Settings, Users and Major Diseases	PLOS ONE			English	Article							SOUTH-AFRICA; HIV DIAGNOSIS; PULMONARY TUBERCULOSIS; PRIVATE PRACTITIONERS; PATIENT-CENTEREDNESS; XPERT MTB/RIF; PUBLIC-HEALTH; HIV/AIDS; TB; OPPORTUNITIES	Background Successful point-of-care testing, namely ensuring the completion of the test and treat cycle in the same encounter, has immense potential to reduce diagnostic and treatment delays, and impact patient outcomes. However, having rapid tests is not enough, as many barriers may prevent their successful implementation in point-of-care testing programs. Qualitative research on diagnostic practices may help identify such barriers across different points of care in health systems. Methods In this exploratory qualitative study, we conducted 78 semi-structured interviews and 13 focus group discussions in an urban and rural area of Karnataka, India, with healthcare providers (doctors, nurses, specialists, traditional healers, and informal providers), patients, community health workers, test manufacturers, laboratory technicians, program managers and policy-makers. Participants were purposively sampled to represent settings of hospitals, peripheral labs, clinics, communities and homes, in both the public and private sectors. Results In the Indian context, the onus is on the patient to ensure successful point-of-care testing across homes, clinics, labs and hospitals, amidst uncoordinated providers with divergent and often competing practices, in settings lacking material, money and human resources. We identified three overarching themes affecting point-of-care testing: the main theme is 'relationships' among providers and between providers and patients, influenced by the cross-cutting theme of 'infrastructure'. Challenges with both result in 'modified practices' often favouring empirical (symptomatic) treatment over treatment guided by testing. Conclusions Even if tests can be conducted on the spot and infrastructure challenges have been resolved, relationships among providers and between patients and providers are crucial for successful point-of-care testing. Furthermore, these barriers do not act in isolation, but are interlinked and need to be examined as such. Also, a test alone has only limited power to overcome those difficulties. Test developers, policy-makers, healthcare providers and funders need to use these insights in overcoming barriers to point-of-care testing programs.	[Engel, Nora] Maastricht Univ, Res Sch Publ Hlth & Primary Care, Dept Hlth Eth & Soc, Maastricht, Netherlands; [Ganesh, Gayatri; Patil, Mamata; Yellappa, Vijayashree] Inst Publ Hlth, Bangalore, Karnataka, India; [Pai, Nitika Pant] McGill Univ, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada; [Pai, Nitika Pant] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Vadnais, Caroline; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, McGill Int TB Ctr, Montreal, PQ, Canada	Maastricht University; McGill University; McGill University; McGill University	Engel, N (corresponding author), Maastricht Univ, Res Sch Publ Hlth & Primary Care, Dept Hlth Eth & Soc, Maastricht, Netherlands.	n.engel@maastrichtuniversity.nl	Pai, Madhukar/AAX-9901-2021; Yellappa, vijayashree/AAQ-8532-2020; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; Yellappa, vijayashree/0000-0003-0390-7874; PAL, MRINAL/0000-0002-1032-272X; Engel, Nora/0000-0002-1823-3908	Bill & Melinda Gates Foundation [BMGF OPP1061487]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research is funded by a grant from the Bill & Melinda Gates Foundation (BMGF OPP1061487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti C, 2013, AIDS CARE, V25, P544, DOI 10.1080/09540121.2012.726339; Angotti N, 2010, SOC SCI MED, V71, P986, DOI 10.1016/j.socscimed.2010.05.020; [Anonymous], 2005, QUALITATIVE INTERVIE; Atre S, 2011, GLOB PUBLIC HEALTH, V6, P56, DOI 10.1080/17441690903334240; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Bhojani U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106522; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cain R, 2013, QUAL HEALTH RES, V23, P815, DOI 10.1177/1049732313482525; Chandler CI, 2008, MALARIA J, V7, P1475; Chandler CIR, 2012, SOC SCI MED, V74, P1528, DOI 10.1016/j.socscimed.2012.01.025; Chandler CIR, 2011, SOC SCI MED, V72, P937, DOI 10.1016/j.socscimed.2011.01.009; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Coast E, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2012-002399, DOI 10.1136/BMJ0PEN-2012-002399]; Cohen GM, 2014, JAIDS-J ACQ IMM DEF, V67, pE88, DOI 10.1097/QAI.0000000000000309; Daftary A, 2007, AIDS CARE, V19, P572, DOI 10.1080/09540120701203931; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Datye V, 2006, HEALTH POLICY PLANN, V21, P343, DOI 10.1093/heapol/czl021; De Costa A, 2008, QUAL HEALTH RES, V18, P756, DOI 10.1177/1049732308318504; de Vries G, 2007, HEALTH TECHNOL SOC, P1; Denkinger CM, 2012, LANCET INFECT DIS, V12, P169, DOI 10.1016/S1473-3099(11)70257-2; Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888; Engel N, BMC HLTH SERV UNPUB; Engel N, 2015, TROP MED INT HEALTH, V20, P493, DOI 10.1111/tmi.12450; Engel N, 2013, J EPIDEMIOL GLOB HEA, V3, P119, DOI 10.1016/j.jegh.2013.04.002; Engel N, 2012, BIOSOCIETIES, V7, P50, DOI 10.1057/biosoc.2011.23; Epstein RM, 2005, ANN FAM MED, V3, P415, DOI 10.1370/afm.348; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Hardon A, 2011, MED ANTHROPOL, V30, P183, DOI 10.1080/01459740.2011.552455; Hawkes M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-308; Hsieh YH, 2011, SEX TRANSM INFECT, V87, pA82, DOI 10.1136/sextrans-2011-050109.137; Hult JR, 2009, AIDS CARE, V21, P185, DOI 10.1080/09540120802017602; Hutchinson E, 2015, CRIT PUBLIC HEALTH, V25, P48, DOI 10.1080/09581596.2014.886762; Ishikawa H, 2013, SOC SCI MED, V96, P147, DOI 10.1016/j.socscimed.2013.07.026; Jones CHD, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-117; Jutel A, 2011, SOC SCI MED, V73, P793, DOI 10.1016/j.socscimed.2011.07.014; Jutel A, 2009, SOCIOL HEALTH ILL, V31, P278, DOI 10.1111/j.1467-9566.2008.01152.x; Kielmann K, 2005, SOC SCI MED, V61, P1540, DOI 10.1016/j.socscimed.2005.02.008; Kik SV, 2014, EUR RESPIR J, V2, P2; Law John, 2002, COMPLEXITIES SOCIAL; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Miller R, 2012, INT J HEALTH PLAN M, V27, P180, DOI 10.1002/hpm.2105; Mol A, 2002, BODY MULTIPLE ONTOLO; Mueller-Rockstroh B, 2007, THESIS U MAASTRICHT; Ngamvithayapong-Yanai J, 2005, QUAL HEALTH RES, V15, P1164, DOI 10.1177/1049732305281616; Nichter M, 1994, Soc Sci Med, V38, P649, DOI 10.1016/0277-9536(94)90456-1; Nyanzi-Wakholi B, 2009, AIDS CARE, V21, P903, DOI 10.1080/09540120802657498; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Palamountain KM, 2012, J INFECT DIS, V15, P7; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Phakathi Z, 2011, AJAR-AFR J AIDS RES, V10, P173, DOI 10.2989/16085906.2011.593381; Rintiswati N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-158; Satyanarayana S, 2014, PUBLIC HEALTH ACTION, V4, P249, DOI 10.5588/pha.14.0061; Sengupta A, 2005, BMJ-BRIT MED J, V331, P1157, DOI 10.1136/bmj.331.7526.1157; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Theron G, 2014, LANCET INFECT DIS; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Vernooij E, 2013, CULT HEALTH SEX, V15, pS553, DOI 10.1080/13691058.2012.758314; Watkins RE, 2004, QUAL HEALTH RES, V14, P691, DOI 10.1177/1049732304263628; Zar HJ, 2012, CLIN INFECT DIS, V55, P1088, DOI 10.1093/cid/cis598	66	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135112	10.1371/journal.pone.0135112	http://dx.doi.org/10.1371/journal.pone.0135112			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275231	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600050
J	Flores-Paez, LA; Zenteno, JC; Alcantar-Curiel, MD; Vargas-Mendoza, CF; Rodriguez-Martinez, S; Cancino-Diaz, ME; Jan-Roblero, J; Cancino-Diaz, JC				Flores-Paez, Luis A.; Zenteno, Juan C.; Alcantar-Curiel, Maria D.; Vargas-Mendoza, Carlos F.; Rodriguez-Martinez, Sandra; Cancino-Diaz, Mario E.; Jan-Roblero, Janet; Cancino-Diaz, Juan C.			Molecular and Phenotypic Characterization of Staphylococcus epidermidis Isolates from Healthy Conjunctiva and a Comparative Analysis with Isolates from Ocular Infection	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; BIOFILM FORMATION; BLOOD-STREAM; ENDOPHTHALMITIS; RESISTANCE; EXPRESSION; STRAINS; SUSCEPTIBILITY; EPIDEMIOLOGY; ASSOCIATION	Staphylococcus epidermidis is a common commensal of healthy conjunctiva and it can cause endophthalmitis, however its presence in conjunctivitis, keratitis and blepharitis is unknown. Molecular genotyping of S. epidermidis from healthy conjunctiva could provide information about the origin of the strains that infect the eye. In this paper two collections of S. epidermidis were used: one from ocular infection (n = 62), and another from healthy conjunctiva (n = 45). All isolates were genotyped by pulsed field gel electrophoresis (PFGE), multilocus sequence typing (MLST), staphylococcal cassette chromosome mec (SCCmec), detection of the genes icaA, icaD, IS256 and polymorphism type of agr locus. The phenotypic data included biofilm production and antibiotic resistance. The results displayed 61 PFGE types from 107 isolates and they were highly discriminatory. MLST analysis generated a total of 25 STs, of which 11 STs were distributed among the ocular infection isolates and lineage ST2 was the most frequent (48.4%), while 14 STs were present in the healthy conjunctiva isolates and lineage ST5 was the most abundant (24.4%). By means of a principal coordinates analysis (PCoA) and a discriminant analysis (DA) it was found that ocular infection isolates had as discriminant markers agr III or agr II, SCCmec V or SCCmec I, mecA gene, resistance to tobramycin, positive biofilm, and IS256(+). In contrast to the healthy conjunctiva isolates, the discriminating markers were agr I, and resistance to chloramphenicol, ciprofloxacin, gatifloxacin and oxacillin. The discriminant biomarkers of ocular infection were examined in healthy conjunctiva isolates, and it was found that 3 healthy conjunctiva isolates [two with ST2 and another with ST9] (3/45, 6.66%) had similar genotypic and phenotypic characteristics to ocular infection isolates, therefore a small population from healthy conjunctiva could cause an ocular infection. These data suggest that the healthy conjunctiva isolates do not, in almost all cases, infect the eye due to their large genotypic and phenotypic difference with the ocular infection isolates.	[Flores-Paez, Luis A.; Jan-Roblero, Janet; Cancino-Diaz, Juan C.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Mexico City, DF, Mexico; [Zenteno, Juan C.] Fdn Conde Valenciana, Inst Oftalmol, Mexico City, DF, Mexico; [Alcantar-Curiel, Maria D.] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Vargas-Mendoza, Carlos F.] Inst Politecn Nacl, Dept Zool, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Rodriguez-Martinez, Sandra; Cancino-Diaz, Mario E.] Inst Politecn Nacl, Dept Immunol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Cancino-Diaz, JC (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Mexico City, DF, Mexico.	jccancinodiaz@hotmail.com	; Jan-Roblero, Janet/U-3839-2018	Cancino-Diaz, Mario Eugenio/0000-0003-0271-7892; Vargas-Mendoza, Carlos F./0000-0002-3904-9093; Jan-Roblero, Janet/0000-0001-6177-0189; Cancino-Diaz, Juan C./0000-0002-3708-7010; RODRIGUEZ, SANDRA/0000-0001-5063-3525	COFAA-IPN fellowship; EDI-IPN fellowship; SNI-CONACyT fellowship; Consejo Nacional de Ciencia y Tecnologia, Mexico [153268]	COFAA-IPN fellowship; EDI-IPN fellowship; SNI-CONACyT fellowship; Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CFVM, SRM, JJR, MECD, and JCCD were supported by the COFAA-IPN, EDI-IPN and SNI-CONACyT fellowships. JCCD also received support from Consejo Nacional de Ciencia y Tecnologia, Mexico, 153268.	Ahlstrand E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099045; Bannerman TL, 1997, ARCH OPHTHALMOL-CHIC, V115, P357, DOI 10.1001/archopht.1997.01100150359008; Betanzos-Cabrera G, 2009, OPHTHALMIC RES, V42, P43, DOI 10.1159/000219684; Bhoomibunchoo C, 2013, CLIN OPHTHALMOL, V7, P247, DOI 10.2147/OPTH.S39934; Bispo PJM, 2014, J CLIN MICROBIOL, V52, P1412, DOI 10.1128/JCM.03098-13; Bispo PJM, 2013, J CLIN MICROBIOL, V51, P2959, DOI 10.1128/JCM.00846-13; Catalanotti P, 2005, NEW MICROBIOL, V28, P345; Cherifi S, 2013, J CLIN MICROBIOL, V51, P1541, DOI 10.1128/JCM.03378-12; Cherifi S, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-20; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Cremniter J, 2013, J CLIN MICROBIOL, V51, P1014, DOI 10.1128/JCM.02608-12; Dave SB, 2013, OPHTHALMOLOGY, V120, P937, DOI 10.1016/j.ophtha.2012.11.005; Du X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062742; Duggirala A, 2007, INVEST OPHTH VIS SCI, V48, P3239, DOI 10.1167/iovs.06-1365; Ghaznavi-Rad E, 2010, J MED MICROBIOL, V59, P1135, DOI 10.1099/jmm.0.021956-0; Giormezis N, 2014, J MED MICROBIOL, V63, P1500, DOI 10.1099/jmm.0.075259-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hellmark B, 2013, INT J MED MICROBIOL, V303, P32, DOI 10.1016/j.ijmm.2012.11.001; Kenchappa Prashanth, 2006, BMC Ophthalmol, V6, P1, DOI 10.1186/1471-2415-6-1; Leshem R, 2011, INVEST OPHTH VIS SCI, V52, P4929, DOI 10.1167/iovs.10-5335; Li M, 2004, J MED MICROBIOL, V53, P545, DOI 10.1099/jmm.0.05406-0; McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001; Mendes RE, 2012, ANTIMICROB AGENTS CH, V56, P4656, DOI 10.1128/AAC.00279-12; Mertens A, 2013, EUR J MICROBIOL IMMU, V3, P111, DOI 10.1556/EuJMI.3.2013.2.4; Miragaia M, 2008, J CLIN MICROBIOL, V46, P118, DOI 10.1128/JCM.01685-07; Moloney TP, 2014, BRIT J OPHTHALMOL, V98, P1492, DOI 10.1136/bjophthalmol-2014-305030; Park YM, 2015, EYE CONTACT LENS, V41, P84, DOI 10.1097/ICL.0000000000000068; Rodriguez-Martinez S, 2006, BRIT J OPHTHALMOL, V90, P378, DOI 10.1136/bjo.2005.082289; Rodriguez-Martinez S, 2005, BRIT J OPHTHALMOL, V89, P904, DOI 10.1136/bjo.2004.056218; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Suzuki T, 2005, AM J OPHTHALMOL, V140, P844, DOI 10.1016/j.ajo.2005.05.050; Talreja D, 2015, INVEST OPHTH VIS SCI, V56, P1719, DOI 10.1167/iovs.14-16087; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Ubels JL, 2012, INVEST OPHTH VIS SCI, V53, P6738, DOI 10.1167/iovs.12-10750; Ueta M, 2007, J MED MICROBIOL, V56, P77, DOI 10.1099/jmm.0.46810-0; Widerstrom Micael, 2009, Scand J Infect Dis, V41, P642, DOI 10.1080/00365540903146987; Yamada M, 2008, BRIT J OPHTHALMOL, V92, P848, DOI 10.1136/bjo.2007.129858; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang Y, 2013, INT J OPHTHALMOL-CHI, V6, P452, DOI 10.3980/j.issn.2222-3959.2013.04.08	41	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135964	10.1371/journal.pone.0135964	http://dx.doi.org/10.1371/journal.pone.0135964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275056	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600138
J	Chen, BL; Guo, JB; Liu, MS; Li, X; Zou, J; Chen, X; Zhang, LL; Yue, YS; Wang, XQ				Chen, Bing-Lin; Guo, Jia-Bao; Liu, Ming-Shuo; Li, Xin; Zou, Jun; Chen, Xi; Zhang, Ling-Li; Yue, Yu-Shan; Wang, Xue-Qiang			Effect of Traditional Chinese Exercise on Gait and Balance for Stroke: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TAI CHI EXERCISE; QUALITY-OF-LIFE; KNEE OSTEOARTHRITIS; MOVEMENT THERAPY; JI-QUAN; PHYSICAL FUNCTION; RISK-FACTORS; PEOPLE; WOMEN	Objective A systematic review is conducted to determine the effect of traditional Chinese exercise for patients with stroke. Methods Studies are obtained from PubMed, Embase, Cochrane Library, EBSCO, Web of Science, and CNKI. Only randomized controlled trials were left to evaluate the effects of traditional Chinese exercise for patients with stroke, and with no limits on study data or language. The primary outcome was the Berg balance score (BBS), Functional walking scale. And a random-effects model was used to calculate the pooled mean difference (MD) with 95% confidence interval (CI). Results A total of 9 studies on 820 participants conform to the inclusion criteria, whereas eight studies on 704 participants are used as data sources for the meta-analysis, all trials were published between 2004 and 2013. The BBS indicates that the efficacy of traditional Chinese exercise on balance of patients with stroke is better than that of other training or no training in short term [MD (95%CI) = 11.85 [5.41, 18.30], P < 0.00001]. And the short physical performance battery, Functional walking scale, limit of stability were observed significant differences on balance (p<0.05) and gait (p<0.05) between traditional Chinese exercise and other exercises or no exercise. In addition, there is an article showed that some other form (physiotherapy exercises focused on balance) significantly improved balance ability for stroke patients compared to tai chi chuan practice (Berg test = 0.01, Romberg, and standing on one leg). Conclusion In our meta analysis, the positive findings of this study suggest traditional Chinese exercise has beneficial effects on the balance ability in short term. However, we drew the conclusion according to the extreme heterogeneity, and evidence of better quality and from a larger sample size is required. Because of the inconsistent outcomes, there are short of enough good evidence for patients with stroke to prove the effects of traditional Chinese exercise on gait.	[Chen, Bing-Lin; Li, Xin; Wang, Xue-Qiang] Shanghai Univ Sport, Dept Sport Rehabil, Shanghai, Peoples R China; [Guo, Jia-Bao; Yue, Yu-Shan] Nanjing Univ Chinese Med, Sch Clin Med 2, Nanjing, Jiangsu, Peoples R China; [Liu, Ming-Shuo] Bulloch Acad, Statesboro, GA USA; [Zou, Jun] Shanghai Univ Sport, Minist Educ, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China; [Chen, Xi; Zhang, Ling-Li] Shanghai Univ Sport, Kinesiol & Exercise Sci, Shanghai, Peoples R China; [Wang, Xue-Qiang] Shanghai Shangti Orthopaed Hosp, Dept Rehabil Med, Shanghai, Peoples R China	Shanghai University of Sport; Nanjing University of Chinese Medicine; Shanghai University of Sport; Shanghai University of Sport	Wang, XQ (corresponding author), Shanghai Univ Sport, Dept Sport Rehabil, Shanghai, Peoples R China.	qiang897@163.com	Chen, Xi/AGS-6702-2022; Wang, Xueqiang/GPW-9671-2022		Innovation Program of Shanghai Municipal Education Commission [15ZZ084]; Shanghai Committee of Science and Technology [14490503800]; Shanghai Youth Science and Technology Sail Project [15YF1411400]; Innovation Program of Shanghai University of Sport [yjscx2014008]; Shanghai Key Lab of Human Performance (SUS), Ministry of Education	Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Youth Science and Technology Sail Project; Innovation Program of Shanghai University of Sport; Shanghai Key Lab of Human Performance (SUS), Ministry of Education	This work was supported by Innovation Program of Shanghai Municipal Education Commission (15ZZ084); Shanghai Committee of Science and Technology (14490503800); Shanghai Youth Science and Technology Sail Project (15YF1411400); Innovation Program of Shanghai University of Sport (yjscx2014008); and Shanghai Key Lab of Human Performance (SUS), Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yeung SSY, 2009, NEUROREHAB NEURAL RE, V23, P515, DOI 10.1177/1545968308326425; Bai Y., 2011, CHINA J CHINESE MED, V26, P1231; Brismee JM, 2007, CLIN REHABIL, V21, P99, DOI 10.1177/0269215506070505; Chyu MC, 2010, CLIN REHABIL, V24, P1080, DOI 10.1177/0269215510375902; Ejupi A, 2014, CURR OPIN CLIN NUTR, V17, P407, DOI 10.1097/MCO.0000000000000081; Feigin VL, 2015, NEUROL RES, V37, P378, DOI 10.1179/1743132815Y.0000000025; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Hall AM, 2011, ARTHRIT CARE RES, V63, P1576, DOI 10.1002/acr.20594; Hart J, 2004, INT J REHABIL RES, V27, P303, DOI 10.1097/00004356-200412000-00008; He Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092763; Hempel S., 2014, EVIDENCE MAP TAI CHI; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jia WZ, 2008, EFFECT YI JINJING TR; Kim JS, 2014, INT J STROKE, V9, P856, DOI 10.1111/ijs.12317; Kosse NM, 2015, INT PSYCHOGERIATR, V27, P803, DOI 10.1017/S104161021400249X; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Li FZ, 2014, J SPORT HEALTH SCI, V3, P9, DOI 10.1016/j.jshs.2013.11.002; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Liu J, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/265486; Ministry of Health of the People's Republic of China, 2010, CHIN HLTH STAT YB 20; Morris SL, 2004, CLIN REHABIL, V18, P27, DOI 10.1191/0269215504cr699oa; National Bureau of Statistics of China, 2016, NAT EC SOC DEV STAT; Shi YX, 2011, ARCH PHYS MED REHAB, V92, P972, DOI 10.1016/j.apmr.2010.12.036; Stevens JA, 2014, J SPORT HEALTH SCI, V3, P21, DOI 10.1016/j.jshs.2013.10.002; Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109; Taylor-Piliae RE, 2014, J SPORT HEALTH SCI, V3, P43, DOI 10.1016/j.jshs.2013.09.002; Taylor-Piliae RE, 2014, ARCH PHYS MED REHAB, V95, P816, DOI 10.1016/j.apmr.2014.01.001; Tsang TW, 2010, J OBES, V2010, DOI 10.1155/2010/672751; Wang CC, 2009, ARTHRIT RHEUM-ARTHR, V61, P1545, DOI 10.1002/art.24832; Wang X, 2014, NEUROSCIENCE, V271, P99, DOI 10.1016/j.neuroscience.2014.04.030; Wang XQ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-375; Wayne PM, 2014, ARCH PHYS MED REHAB, V95, P2470, DOI 10.1016/j.apmr.2014.05.005; Wayne PM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-7; Wolfson L, 1996, J AM GERIATR SOC, V44, P498, DOI 10.1111/j.1532-5415.1996.tb01433.x; Xie F, 2008, RES SHADOWBOXING REC; Yang Z., 2013, CONT MED, V24, P5; Yeh GY, 2004, AM J MED, V117, P541, DOI 10.1016/j.amjmed.2004.04.016; Yu DH, 2012, J SPORT HEALTH SCI, V1, P57, DOI 10.1016/j.jshs.2012.03.001; Yue JH, 2008, MODERN PREVENTIVE ME, V1, P71; Zhang M, 2013, LISHIZHEN MED MAT ME, V10, P2438; Zhang T, 2012, CHINESE J REHABILITA, V4, P301; Zheng GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117360; Zheng GH, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/742152; Zhou ZG, 2013, EFFECT INTENSIVE TRA; Zhuang J, 2014, CLIN INTERV AGING, V9, P131, DOI 10.2147/CIA.S56682	47	35	40	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135932	10.1371/journal.pone.0135932	http://dx.doi.org/10.1371/journal.pone.0135932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291978	gold, Green Submitted, Green Published			2022-12-27	WOS:000359919900043
J	Gonzalez-Martin, A; Gorostiza, A; Regalado-Liu, L; Arroyo-Pena, S; Tirado, S; Nuno-Arana, I; Rubi-Castellanos, R; Sandoval, K; Coble, MD; Rangel-Villalobos, H				Gonzalez-Martin, Antonio; Gorostiza, Amaya; Regalado-Liu, Lucia; Arroyo-Pena, Sergio; Tirado, Sergio; Nuno-Arana, Ismael; Rubi-Castellanos, Rodrigo; Sandoval, Karla; Coble, Michael D.; Rangel-Villalobos, Hector			Demographic History of Indigenous Populations in Mesoamerica Based on mtDNA Sequence Data	PLOS ONE			English	Article							CONTROL REGION SEQUENCES; LATE PLEISTOCENE HUMAN; BAYESIAN-INFERENCE; AMERICA; GENOME; ORIGIN; DIVERSITY; COLONIZATION; SELECTION; GENETICS	The genetic characterization of Native American groups provides insights into their history and demographic events. We sequenced the mitochondrial D-loop region (control region) of 520 samples from eight Mexican indigenous groups. In addition to an analysis of the genetic diversity, structure and genetic relationship between 28 Native American populations, we applied Bayesian skyline methodology for a deeper insight into the history of Mesoamerica. AMOVA tests applying cultural, linguistic and geographic criteria were performed. MDS plots showed a central cluster of Oaxaca and Maya populations, whereas those from the North and West were located on the periphery. Demographic reconstruction indicates higher values of the effective number of breeding females (Nef) in Central Mesoamerica during the Preclassic period, whereas this pattern moves toward the Classic period for groups in the North and West. Conversely, Nef minimum values are distributed either in the Lithic period (i.e. founder effects) or in recent periods (i.e. population declines). The Mesomerican regions showed differences in population fluctuation as indicated by the maximum Inter-Generational Rate (IGRmax): i) Center-South from the lithic period until the Preclassic; ii) West from the beginning of the Preclassic period until early Classic; iii) North characterized by a wide range of temporal variation from the Lithic to the Preclassic. Our findings are consistent with the genetic variations observed between central, South and Southeast Mesoamerica and the North-West region that are related to differences in genetic drift, structure, and temporal survival strategies (agriculture versus hunter-gathering, respectively). Interestingly, although the European contact had a major negative	[Gonzalez-Martin, Antonio; Gorostiza, Amaya; Regalado-Liu, Lucia; Arroyo-Pena, Sergio; Tirado, Sergio] Univ Complutense Madrid, Fac Biol, Dept Zool & Antropol Fis, Madrid, Spain; [Gorostiza, Amaya] GENOM SAU, Grp Zeltia, Lab Identificac Genet, Madrid 28033, Spain; [Nuno-Arana, Ismael; Rangel-Villalobos, Hector] Univ Guadalajara, Inst Invest Genet Mol, Ctr Univ Cienega, Ocotlan, Jalisco, Mexico; [Rubi-Castellanos, Rodrigo] Univ Autonoma Yucatan UADY, Ctr Invest Reg Hideyo Noguchi, Lab Genet, Merida, Yucatan, Mexico; [Sandoval, Karla] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Coble, Michael D.] Armed Forces DNA Identificat Lab, Amer Registry Pathol, Dover, DE USA	Complutense University of Madrid; PharmaMar; Universidad de Guadalajara; Universidad Autonoma de Yucatan; Stanford University	Rangel-Villalobos, H (corresponding author), Univ Guadalajara, Inst Invest Genet Mol, Ctr Univ Cienega, Ocotlan, Jalisco, Mexico.	hrangel13@hotmail.com	Gonzalez-Martin, Antonio/A-5489-2015; RANGEL-VILLALOBOS, HECTOR/C-5081-2018	Gonzalez-Martin, Antonio/0000-0003-0276-0778; RANGEL-VILLALOBOS, HECTOR/0000-0003-2641-8782; Rubi Castellanos, Rodrigo/0000-0002-5990-8326; Sandoval, Karla/0000-0002-6175-2463; Coble, Michael/0000-0003-3687-0342	CONACyT-Mexico [129693]; National Institute of Justice [2005-DN-R-086]; Ministerio de Economia y Competitividad, Espana [Project HAR2010-21063]	CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Justice(US National Institute of Justice); Ministerio de Economia y Competitividad, Espana(Spanish Government)	This work was supported by CONACyT-Mexico, grant 129693 to HRV (http://www.conacyt.mx/) for anthropological study design; National Institute of Justice (http://www.nij.gov/), InterAgency agreement 2005-DN-R-086 to MDC for Global mtDNA Databasing Project; and Ministerio de Economia y Competitividad, Espana (http://www.mineco.gob.es/), Project HAR2010-21063 to AGM for study design and analysis.	Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; Adams Richard E. W, 1996, PREHISTORIC MESOAMER; Aguilar-Moreno M, 2004, HDB LIFE AZTEC WORLD; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Blake Michael, 2006, HIST MAIZE MULTIDISC, P55; Blanto RE, 1981, COMP CHANGE 3 REGION; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Brandstatter A, 2004, INT J LEGAL MED, V118, P294, DOI 10.1007/s00414-004-0466-z; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; CAMPBELL L, 1986, LANGUAGE, V62, P530, DOI 10.2307/415477; Campos PF, 2010, P NATL ACAD SCI USA, V107, P5675, DOI 10.1073/pnas.0907189107; Carmack RM, 1996, LEGACY MESOAMERICA H; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Clark John E., 2000, HIST ANTIGUA MEXICO, V1, P437; Coe MD, 1996, MEXICO OLMECS AZTECS; CREAMER W, 1987, LAT AM RES REV, V22, P35; de St Pierre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051311; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duverger C, 2007, PRIMER MESTIZAJE CLA; Edson S. M., 2004, FORENSIC SCI REV, V16, P64; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Evans S.T., 2001, ARCHAEOLOGY ANCIENT; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; FAMSI-LACMA, FDN ADV MES STUD LOS; Finlay EK, 2007, BIOLOGY LETT, V3, P449, DOI 10.1098/rsbl.2007.0146; FU YX, 1993, GENETICS, V133, P693; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez-Jose R, 2007, P ROY SOC B-BIOL SCI, V274, P681, DOI 10.1098/rspb.2006.0151; Gorostiza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044666; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Guillot EG, 2013, HUM BIOL, V85, P135; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Irwin JA, 2007, FORENSIC SCI INT-GEN, V1, P154, DOI 10.1016/j.fsigen.2007.01.019; Kelly IT, 1980, CERAMIC SEQUENCE COL; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Kirchhoff P, 1952, MESOAMERICA ITS GEOG; Kirchoff Paul, 1943, ACTA AM, V1, P92; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kroeber Alfred Louis, 1947, CULTURAL NATURAL ARE; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Lopez-Austin A., 2001, MEXICOS INDIGENOUS; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Malhi RS, 2002, AM J HUM GENET, V70, P905, DOI 10.1086/339690; Malhi RS, 2001, HUM BIOL, V73, P17, DOI 10.1353/hub.2001.0008; Manzanilla L, 1989, ATLAS HIST MESOAMERI; Martinez-Cortes G, 2013, AM J PHYS ANTHROPOL, V151, P526, DOI 10.1002/ajpa.22293; McGuire RH., 2012, OXFORD HDB MESOAMERI, P513; Melgar Tisoc ER, 2010, RELECTURA COMERCIO T; Miller HC, 2009, TRENDS GENET, V25, P13, DOI 10.1016/j.tig.2008.09.007; Mizuno F, 2014, J HUM GENET, V59, P359, DOI 10.1038/jhg.2014.35; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Navascues M, 2009, MOL ECOL, V18, P4390, DOI 10.1111/j.1365-294X.2009.04333.x; Neurath J, 2003, PUEBLOS INDIGENAS ME; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Paez-Riberos L. A., 2006, Legal Medicine, V8, P220, DOI 10.1016/j.legalmed.2006.02.003; Pannell JR, 2003, EVOLUTION, V57, P949; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Raff JA, 2014, NATURE, V506, P162, DOI 10.1038/506162a; Ragsdale CS, 2015, AM J PHYS ANTHROPOL, V157, P121, DOI 10.1002/ajpa.22701; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sanders William T., 1968, MESOAMERICA EVOLUTIO; Sandoval K, 2009, HUM GENET, V126, P521, DOI 10.1007/s00439-009-0693-y; Schaefer S., 1996, PEOPLE PEYOTE HUICHO; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Smith M. E., 2003, POSTCLASSIC MESOAMER; Smith ME, 2000, CURR ANTHROPOL, V41, P283, DOI 10.1086/300134; Smith MichaelE., 2001, EMPIRES COMP PERSPEC, P128; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Solanes Carraro MC, 2005, ATLAS MEXICO PREHISP; Stiller M, 2010, MOL BIOL EVOL, V27, P975, DOI 10.1093/molbev/msq083; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Subramanian S, 2009, TRENDS GENET, V25, P16, DOI 10.1016/j.tig.2008.11.001; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tillmar AO, 2010, INT J LEGAL MED, V124, P91, DOI 10.1007/s00414-009-0354-7; Townsend R., 1998, ANCIENT W MEXICO ART; TRIGGER BG, 1980, AM ANTIQUITY, V45, P662, DOI 10.2307/280140; Voorhies B, 2007, CLIMATE CHANGE CULTU, P157; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wauchope R, 1964, HDB MIDDLE AM INDIAN; Weaver Muriel Porter, 1993, AZTECS MAYA THEIR PR; West CR, 1989, MIDDLE AM ITS LANDS; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199	104	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0131791	10.1371/journal.pone.0131791	http://dx.doi.org/10.1371/journal.pone.0131791			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292226	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900001
J	Hashimoto, Y; Saito, W; Fujiya, A; Yoshizawa, C; Hirooka, K; Mori, S; Noda, K; Ishida, S				Hashimoto, Yuki; Saito, Wataru; Fujiya, Akio; Yoshizawa, Chikako; Hirooka, Kiriko; Mori, Shohei; Noda, Kousuke; Ishida, Susumu			Changes in Inner and Outer Retinal Layer Thicknesses after Vitrectomy for Idiopathic Macular Hole: Implications for Visual Prognosis	PLOS ONE			English	Article							BRILLIANT-BLUE-G; SPECTRAL-DOMAIN OCT; LIMITING MEMBRANE; SEGMENT LENGTH; FOVEAL MICROSTRUCTURE; EPIRETINAL MEMBRANE; SURGERY; ACUITY; INCREASES; DEFECT	Purpose To investigate sequential post-operative thickness changes in inner and outer retinal layers in eyes with an idiopathic macular hole (MH). Methods Retrospective case series. Twenty-four eyes of 23 patients who had received pars plana vitrectomy (PPV) for the closure of MH were included in the study. Spectral domain optical coherence tomography C-scan was used to automatically measure the mean thickness of the inner and outer retinal layers pre-operatively and up to 6 months following surgery. The photoreceptor outer segment (PROS) length was measured manually and was used to assess its relationship with best-corrected visual acuity (BCVA). Results Compared with the pre-operative thickness, the inner layers significantly thinned during follow-up (P = 0.02), particularly in the parafoveal (P = 0.01), but not perifoveal, area. The post-operative inner layer thinning ranged from the ganglion cell layer to the inner plexiform layer (P = 0.002), whereas the nerve fiber layer was unaltered. Outer layer thickness was significantly greater post-operatively (P = 0.002), and especially the PROS lengthened not only in the fovea but also in the parafovea (P < 0.001). Six months after surgery, BCVA was significantly correlated exclusively with the elongated foveal PROS (R = 0.42, P = 0.03), but not with any of the other thickness parameters examined. Conclusions Following PPV for MH, retinal inner layers other than the nerve fiber layer thinned, suggestive of subclinical thickening in the inner layers where no cyst was evident pre-operatively. In contrast, retinal outer layer thickness significantly increased, potentially as a result of PROS elongation linking tightly with favorable visual prognosis in MH eyes.	[Hashimoto, Yuki; Saito, Wataru; Fujiya, Akio; Yoshizawa, Chikako; Hirooka, Kiriko; Mori, Shohei; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Saito, Wataru; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Saito, W (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan.	wsaito@med.hokudai.ac.jp		Saito, Wataru/0000-0001-8181-6252				Arias L, 2015, RETINA-J RET VIT DIS, V35, P423, DOI 10.1097/IAE.0000000000000335; Baba T, 2012, EYE, V26, P1173, DOI 10.1038/eye.2012.170; Baba T, 2012, OPHTHALMOLOGY, V119, P2609, DOI 10.1016/j.ophtha.2012.06.048; Barak Y, 2011, INVEST OPHTH VIS SCI, V52, P8266, DOI 10.1167/iovs.11-8191; Chan G, 2012, INVEST OPHTH VIS SCI, V53, P5502, DOI 10.1167/iovs.12-10265; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Forooghian F, 2010, RETINA-J RET VIT DIS, V30, P63, DOI 10.1097/IAE.0b013e3181bd2c5a; GUYER DR, 1990, OPHTHALMOLOGY, V97, P1045; Hashimoto Y, 2014, ACTA OPHTHALMOL, V92, pe591, DOI 10.1111/aos.12413; Hashimoto Y, 2014, GRAEF ARCH CLIN EXP, V252, P219, DOI 10.1007/s00417-013-2432-2; Iriyama A, 2012, RETINA-J RET VIT DIS, V32, P613, DOI 10.1097/IAE.0b013e31822091df; Itoh Y, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.023; Landa G, 2012, EYE, V26, P61, DOI 10.1038/eye.2011.237; Mester V, 2000, AM J OPHTHALMOL, V129, P769, DOI 10.1016/S0002-9394(00)00358-5; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Notomi S, 2011, AM J PATHOL, V179, P2798, DOI 10.1016/j.ajpath.2011.08.035; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ohta K, 2013, GRAEF ARCH CLIN EXP, V251, P1273, DOI 10.1007/s00417-012-2173-7; Ooka E, 2011, AM J OPHTHALMOL, V152, P283, DOI 10.1016/j.ajo.2011.02.001; Park DW, 1999, OPHTHALMOLOGY, V106, P1392, DOI 10.1016/S0161-6420(99)00730-7; Remy M, 2008, BRIT J OPHTHALMOL, V92, P1142, DOI 10.1136/bjo.2008.138164; Shiono A, 2013, OPHTHALMOLOGY, V120, P788, DOI 10.1016/j.ophtha.2012.09.044; Si YJ, 1999, BRIT J OPHTHALMOL, V83, P420, DOI 10.1136/bjo.83.4.420; Toba Y, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/187308; Wakabayashi T, 2010, OPHTHALMOLOGY, V117, P1815, DOI 10.1016/j.ophtha.2010.01.017; Yuksel K, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000182	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135925	10.1371/journal.pone.0135925	http://dx.doi.org/10.1371/journal.pone.0135925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291526	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900039
J	Jeon, YJ; Jung, N; Park, JW; Park, HY; Jung, SC				Jeon, Yeo Jin; Jung, Namhee; Park, Joo-Won; Park, Hae-Young; Jung, Sung-Chul			Epithelial-Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide	PLOS ONE			English	Article							FABRY-DISEASE; RENAL PATHOLOGY; BIOPSY FINDINGS; FIBROSIS; NEPHROPATHY; FIBROBLASTS; MECHANISMS; DIAGNOSIS; CHILDREN	Fabry disease is a lysosomal storage disorder caused by deficiency of alpha-galactosidase A (alpha-gal A), which results in the deposition of globotriaosylceramide (Gb3) in the vascular endothelium. Globotriaosylsphingosine (lyso-Gb3), a deacylated Gb3, is also increased in the plasma of patients with Fabry disease. Renal fibrosis is a key feature of advanced Fabry disease patients. Therefore, we evaluated the association of Gb3 and lyso-Gb3 accumulation and the epithelial-mesenchymal transition (EMT) on tubular epithelial cells of the kidney. In HK2 cells, exogenous treatments of Gb3 and lyso-Gb3 increased the expression of TGF-beta, EMT markers (N-cadherin and alpha-SMA), and phosphorylation of PI3K/AKT, and decreased the expression of E-cadherin. Lyso-Gb3, rather than Gb3, strongly induced EMT in HK2 cells. In the mouse renal mesangial cell line, SV40 MES 13 cells, Gb3 strongly induced phenotype changes. The EMT induced by Gb3 was inhibited by enzyme a-gal A treatment, but EMT induced by lyso-Gb3 was not abrogated by enzyme treatment. However, TGF-beta receptor inhibitor (TRI, SB525334) inhibited the activation of TGF-beta and EMT markers in HK2 cells with Gb3 and lyso-Gb3 treatments. This study suggested that increased plasma lyso-Gb3 has a crucial role in the development of renal fibrosis through the cell-specific induction of the EMT in Fabry disease, and that TRI treatment, alongside enzyme replacement therapy, could be a potential therapeutic option for patients with Fabry disease.	[Jeon, Yeo Jin; Jung, Namhee; Park, Joo-Won; Park, Hae-Young; Jung, Sung-Chul] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea	Ewha Womans University	Jung, SC (corresponding author), Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.	jungsc@ewha.ac.kr	Jung, Sung-Chul/I-3277-2019	Jung, Sung-Chul/0000-0002-3174-8965	Ministry of Health and Welfare, Republic of Korea [HI12C0598]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Health Technology R&D project (HI12C0598) of the Ministry of Health and Welfare, Republic of Korea (SCJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Barbey F, 2006, ARTERIOSCL THROM VAS, V26, P839, DOI 10.1161/01.ATV.0000209649.60409.38; Boutin M, 2012, CLIN CHIM ACTA, V414, P273, DOI 10.1016/j.cca.2012.09.026; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Campanholle G, 2013, AM J PHYSIOL-CELL PH, V304, pC591, DOI 10.1152/ajpcell.00414.2012; Du R, 2014, MOL BIOL CELL, V25, P2650, DOI 10.1091/mbc.E14-01-0044; Fogo AB, 2010, NEPHROL DIAL TRANSPL, V25, P2168, DOI 10.1093/ndt/gfp528; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; ITO M, 1995, J BIOL CHEM, V270, P24370, DOI 10.1074/jbc.270.41.24370; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Lee MH, 2012, INT J MOL MED, V30, P1275, DOI 10.3892/ijmm.2012.1139; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Najafian B, 2013, PEDIATR NEPHROL, V28, P679, DOI 10.1007/s00467-012-2222-9; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; Ortiz A, 2008, NAT CLIN PRACT NEPHR, V4, P327, DOI 10.1038/ncpneph0806; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Terryn W, 2013, NEPHROL DIAL TRANSPL, V28, P505, DOI 10.1093/ndt/gfs526; Thomaidis T, 2009, KIDNEY INT, V75, P399, DOI 10.1038/ki.2008.576; Tondel C, 2008, AM J KIDNEY DIS, V51, P767, DOI 10.1053/j.ajkd.2007.12.032; Valbuena C, 2008, VIRCHOWS ARCH, V453, P329, DOI 10.1007/s00428-008-0653-2; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; Weidemann F, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-116; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeng R, 2008, J AM SOC NEPHROL, V19, P380, DOI 10.1681/ASN.2006111194	31	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136442	10.1371/journal.pone.0136442	http://dx.doi.org/10.1371/journal.pone.0136442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291612	gold, Green Published, Green Submitted			2022-12-27	WOS:000359919900084
J	Billings, E; Sanders-Buell, E; Bose, M; Bradfield, A; Lei, E; Kijak, GH; Arroyo, MA; Kibaya, RM; Scott, PT; Wasunna, MK; Sawe, FK; Shaffer, DN; Birx, DL; McCutchan, FE; Michael, NL; Robb, ML; Kim, JH; Tovanabutra, S				Billings, Erik; Sanders-Buell, Eric; Bose, Meera; Bradfield, Andrea; Lei, Esther; Kijak, Gustavo H.; Arroyo, Miguel A.; Kibaya, Rukia M.; Scott, Paul T.; Wasunna, Monique K.; Sawe, Frederick K.; Shaffer, Douglas N.; Birx, Deborah L.; McCutchan, Francine E.; Michael, Nelson L.; Robb, Merlin L.; Kim, Jerome H.; Tovanabutra, Sodsai			The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006	PLOS ONE			English	Article							FEMALE SEX WORKERS; TYPE-1 SUBTYPES; DISEASE PROGRESSION; GENOME SEQUENCES; RAKAI DISTRICT; FOLLOW-UP; CHALLENGES; VACCINE; DIVERSITY; UGANDA	Characterization of HIV-1 subtype diversity in regions where vaccine trials are conducted is critical for vaccine development and testing. This study describes the molecular epidemiology of HIV-1 within a tea-plantation community cohort in Kericho, Kenya. Sixty-three incident infections were ascertained in the HIV and Malaria Cohort Study conducted in Kericho from 2003 to 2006. HIV-1 strains from 58 of those individuals were full genome characterized and compared to two previous Kenyan studies describing 41 prevalent infections from a blood bank survey (1999-2000) and 21 infections from a higher-risk cohort containing a mix of incident and prevalent infections (2006). Among the 58 strains from the community cohort, 43.1% were pure subtypes (36.2% A1, 5.2% C, and 1.7% G) and 56.9% were intersubtype recombinants (29.3% A1D, 8.6% A1CD, 6.9% A1A2D, 5.2% A1C, 3.4% A1A2CD, and 3.4% A2D). This diversity and the resulting genetic distance between the observed strains will need to be addressed when vaccine immunogens are chosen. In consideration of current vaccine development efforts, the strains from these three studies were compared to five candidate vaccines (each of which are viral vectored, carrying inserts corresponding to parts of gag, pol, and envelope), which have been developed for possible use in sub-Saharan Africa. The sequence comparison between the observed strains and the candidate vaccines indicates that in the presence of diverse recombinants, a bivalent vaccine is more likely to provide T-cell epitope coverage than monovalent vaccines even when the inserts of the bivalent vaccine are not subtype-matched to the local epidemic.	[Billings, Erik; Sanders-Buell, Eric; Bose, Meera; Bradfield, Andrea; Lei, Esther; Kijak, Gustavo H.; Scott, Paul T.; McCutchan, Francine E.; Robb, Merlin L.; Tovanabutra, Sodsai] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD 20817 USA; [Arroyo, Miguel A.; Birx, Deborah L.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Kibaya, Rukia M.] Kenya Govt Med Res Ctr, Walter Reed Project Clin Res Ctr, Kericho, Kenya; [Wasunna, Monique K.] Kenya Govt Med Res Ctr, Kericho, Kenya; [Wasunna, Monique K.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Sawe, Frederick K.] Kenya Govt Med Res Ctr, Walter Reed Project HIV Program, Kericho, Kenya; [Shaffer, Douglas N.] Kenya Walter Reed Project HIV Program, US Army Med Res Unit, Kericho, Kenya; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Kenya Medical Research Institute; Kenya Medical Research Institute; Kenya Medical Research Institute; Kenya Medical Research Institute; International Vaccine Institute	Tovanabutra, S (corresponding author), Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD 20817 USA.	stovanabutra@hivresearch.org		Arroyo, Miguel/0000-0001-7416-8867	United States Military HIV Research Program (the Walter Reed Army Institute of Research); United States Military HIV Research Program (Henry M. Jackson Foundation for the Advancement of Military Medicine); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [DAMD17-98-2-7007, W81XWH-04-2-0005, W81XWH-07-2-0067, W81XWH-11-2-0174]; U.S. Department of Defense (DOD) [DAMD17-98-2-7007, W81XWH-04-2-0005, W81XWH-07-2-0067, W81XWH-11-2-0174]	United States Military HIV Research Program (the Walter Reed Army Institute of Research); United States Military HIV Research Program (Henry M. Jackson Foundation for the Advancement of Military Medicine); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense)	The Walter Reed Army Institute of Research Institutional Research Board human use protocol #855 (RV142), "HIV and Malaria Cohort Study Among Plantation Workers and Adult Dependents in Kericho, Kenya," is funded through the United States Military HIV Research Program (the Walter Reed Army Institute of Research and the Henry M. Jackson Foundation for the Advancement of Military Medicine). This work was supported by cooperative agreements (DAMD17-98-2-7007, W81XWH-04-2-0005, W81XWH-07-2-0067, W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD).	Arroyo MA, 2004, AIDS RES HUM RETROV, V20, P895, DOI 10.1089/0889222041725235; Arroyo MA, 2009, AIDS RES HUM RETROV, V25, P1061, DOI 10.1089/aid.2009.0092; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Conroy SA, 2010, AIDS RES HUM RETROV, V26, P1087, DOI 10.1089/aid.2010.0054; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Foglia G, 2008, EPIDEMIOL INFECT, V136, P694, DOI 10.1017/S0950268807009028; Foglia G, 2004, J CLIN MICROBIOL, V42, P3850, DOI 10.1128/JCM.42.8.3850-3852.2004; Gaschen B, 2001, BIOINFORMATICS, V17, P415, DOI 10.1093/bioinformatics/17.5.415; Gomez-Carrillo M, 2004, AIDS RES HUM RETROV, V20, P885, DOI 10.1089/0889222041725172; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Kageha S, 2012, AIDS RES HUM RETROV, V28, P228, DOI 10.1089/aid.2011.0089; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kijak Gustavo H, 2005, Curr Infect Dis Rep, V7, P480, DOI 10.1007/s11908-005-0051-8; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Merson MH, 2012, HEALTH AFFAIR, V31, P1380, DOI 10.1377/hlthaff.2012.0206; Middelkoop K, 2014, JAIDS-J ACQ IMM DEF, V65, P473, DOI 10.1097/QAI.0000000000000067; NACC, 2014, KEN AIDS RESP PROGR; NACC NASCOP, 2011, KEN AIDS EP UPD; National AIDS and STI Control Programme (NASCOP), 2012, KEN AIDS IND SURV 20; Nyamache AK, 2013, AIDS RES HUM RETROV, V29, P400, DOI [10.1089/AID.2012.0213, 10.1089/aid.2012.0213]; Osman S, 2013, AIDS RES HUM RETROV, V29, P187, DOI [10.1089/aid.2012.0182, 10.1089/AID.2012.0182]; Oyaro M, 2011, AIDS RES HUM RETROV, V27, P257, DOI 10.1089/aid.2010.0061; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Shaffer DN, 2007, JAIDS-J ACQ IMM DEF, V45, P371, DOI 10.1097/QAI.0b013e318095a3da; Shaffer DN, 2010, JAIDS-J ACQ IMM DEF, V53, P514, DOI 10.1097/QAI.0b013e3181bcdae0; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P357, DOI [10.1089/aid.2011.0024, 10.1089/AID.2011.0024]; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thurmond J, 2008, BIOINFORMATICS, V24, P1639, DOI 10.1093/bioinformatics/btn251; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2010, AIDS RES HUM RETROV, V26, P123, DOI 10.1089/aid.2009.0115; Tully DC, 2010, AIDS, V24, P1577, DOI 10.1097/QAD.0b013e32833999e1; Visawapoka U, 2006, AIDS RES HUM RETROV, V22, P695, DOI 10.1089/aid.2006.22.695	47	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135124	10.1371/journal.pone.0135124	http://dx.doi.org/10.1371/journal.pone.0135124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287814	Green Published, Green Submitted, gold			2022-12-27	WOS:000360018600036
J	Indira, P; Kumar, PM; Shalini, S; Vaman, K				Indira, Poojary; Kumar, Papanna Mohan; Shalini, Shenoy; Vaman, Kulkarni			Opportunistic Infections among People Living with HIV (PLHIV) with Diabetes Mellitus (DM) Attending a Tertiary Care Hospital in Coastal City of South India	PLOS ONE			English	Article							CLINICAL-DISEASE; PREVALENCE; RESISTANCE; FLUCONAZOLE; ALBICANS	Background HIV/AIDS and Diabetes Mellitus are the diseases' known to supress cell mediated immunity and predispose patients for opportunistic infections. Hence, we conducted a study to compare the common opportunistic infections (OIs) between People Living with HIV with DM (PLHIV-DM) and PLHIV without DM (PLHIV). Methodology PLHIV with DM and without DM (1: 1) were prospectively included in the study from January 2011 to January 2012 at a tertiary care hospital in Mangalore city. Patients were classified as Diabetic if their fasting plasma glucose was >= 7.0mmol/l (126mg/dl) or 2-h plasma glucose was >= 11.1mmol/l (200mg/dl). Standard procedures and techniques were followed for diagnosis of OIs as per WHO guidelines. The data was entered and analyzed using Statistical Package for Social Sciences (SPSS) version 11.5. Findings The study included 37 PLHIV with DM and 37 PLHIV without DM and both groups were treated with Anti-Retroviral Therapy (ART). The median age was 47 years (IQR: 41-55years) for PLHIV-DM as compared to 40 years (IQR: 35-45.5 years) for PLHIV (p<0.0001). PLHIV-DM had median CD4 counts of 245 (IQR: 148-348) cells/mu l compared to 150(IQR: 70-278) cells/mu l for PLHIV (p = 0.02). Common OIs included oral candidiasis (49% of PLHIV-DM and 35% of PLHIV); Cryptococcal meningitis (19% of PLHIV-DMand 16% of PLHIV); Pneumocystis jiroveci pneumonia (5% of PLHIV-DM and 18% of PLHIV); extra pulmonary tuberculosis (22% of PLHIV-DM and 34.5% of PLHIV); and Cerebral toxoplasmosis (11% of PLHIV-DM and 13.5% of PLHIV). Microbiological testing of samples from PLHIV-DM, C krusei was the most common Candida species isolated from 9 out of 18 samples. Out of six pulmonary TB samples cultured, four grew Non-tuberculosis mycobacteria (NTM) and two Mycobacterium tuberculosis complexes. Conclusions Study did not identify any significant difference in profile of opportunistic infections (OIs) between PLHIV with and without Diabetes.	[Indira, Poojary] Apollo Hosp, Dept Microbiol, Madras, Tamil Nadu, India; [Kumar, Papanna Mohan; Vaman, Kulkarni] Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, Karnataka, India; [Shalini, Shenoy] Manipal Univ, Kasturba Med Coll, Dept Microbiol, Mangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Indira, P (corresponding author), Apollo Hosp, Dept Microbiol, Madras, Tamil Nadu, India.	poojaryindira02@gmail.com		Kulkarni, Vaman/0000-0002-6518-2277				[Anonymous], 2013, HIV IND PAC UNAIDS R; [Anonymous], DEFINITION DIAGNOSIS; Ayyagari A, 1999, IJMM, V17, P78; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Cartledge JD, 1999, J ANTIMICROB CHEMOTH, V43, P419, DOI 10.1093/jac/43.3.419; Census of India, 2011, PROV POP TOT; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0; Ministry of Health and Family Welfare New Delhi Department of AIDS Control, 2007, ANT THER GUID HIV IN; Monoharan G, 2001, INDIAN J MED MICROBI, V19, P157; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; MURRAY JF, 1990, AM REV RESPIR DIS, V141, P1356, DOI 10.1164/ajrccm/141.5_Pt_1.1356; REX JH, 1995, ANTIMICROB AGENTS CH, V39, P1, DOI 10.1128/AAC.39.1.1; Ryan JG., 2010, INSULIN, V5, P37, DOI DOI 10.1016/S1557-0843(10)80008-9; Saldanha D, 2008, TROP DOCT, V38, P172, DOI 10.1258/td.2007.070171; Sharma SK, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-52; Sicree R., 2006, DIABETES ATLAS, P15; SRIYABHAYA N, 1981, REV INFECT DIS, V3, P1085; TAN JS, 1975, J LAB CLIN MED, V85, P26; Udwadia Z F, 2005, J Assoc Physicians India, V53, P437; Vigouroux C, 1999, DIABETES METAB, V25, P383; WHO, TUBERCULOSIS; Yoon C, 2004, J ACQUIR IMMUNE DEFI, V37, P4	25	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136280	10.1371/journal.pone.0136280	http://dx.doi.org/10.1371/journal.pone.0136280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287949	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600127
J	Schiop, ST; Al Hassan, M; Sestras, AF; Boscaiu, M; Sestras, RE; Vicente, O				Schiop, Sorin T.; Al Hassan, Mohamad; Sestras, Adriana F.; Boscaiu, Monica; Sestras, Radu E.; Vicente, Oscar			Identification of Salt Stress Biomarkers in Romanian Carpathian Populations of Picea abies (L.) Karst.	PLOS ONE			English	Article							SALICORNIA-EUROPAEA; SALINITY; TOLERANCE; SODIUM; CAROTENOIDS; POTASSIUM; PLANTS; ACCUMULATION; TRANSPORTERS; MECHANISMS	The Norway spruce (Picea abies), the most important tree species in European forests, is relatively sensitive to salt and does not grow in natural saline environments. Yet many trees are actually exposed to salt stress due to the common practice of de-icing of mountain roads in winter, using large amounts of NaCl. To help develop strategies for an appropriate use of reproductive seed material on reforestation sites, ensuring better chances of seedling survival in salt-affected areas, we have studied the responses of young spruce seedlings to salt treatments. The specific aim of the work was to identify the optimal salt stress biomarkers in Picea abies, using as experimental material seedlings obtained by germination of seeds with origin in seven populations from the Romanian Carpathian Mountains. These responses included general, conserved reactions such as the accumulation of ions and different osmolytes in the seedlings needles, reduction in photosynthetic pigments levels, or activation of antioxidant systems. Although changes in the contents of different compounds involved in these reactions can be associated to the degree of stress affecting the plants, we propose that the (decreasing) levels of total phenolics or total carotenoids and the (increasing) levels of Na+ or K+ ions in Picea abies needles, should be considered as the most reliable and useful biomarkers for salt stress in this species. They all show very high correlation with the intensity of salt stress, independently of the genetic background of the seeds parental population, and relatively easy, quantitative assays are available to determine their concentrations, requiring simple equipment and little amount of plant material.	[Schiop, Sorin T.; Sestras, Adriana F.] Univ Agr Sci & Vet Med, Fac Hort, Dept Forestry, Cluj Napoca, Cluj, Romania; [Al Hassan, Mohamad; Vicente, Oscar] Univ Politecn Valencia, CSIC, IBMCP, Valencia, Spain; [Boscaiu, Monica] Univ Politecn Valencia, Mediterranean Agroforestal Inst IAM, Valencia, Spain; [Sestras, Radu E.] Univ Agr Sci & Vet Med, Fac Hort, Dept Hort & Landscaping, Cluj Napoca, Cluj, Romania	University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universitat Politecnica de Valencia; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Schiop, ST (corresponding author), Univ Agr Sci & Vet Med, Fac Hort, Dept Forestry, Cluj Napoca, Cluj, Romania.	sorinschiop@yahoo.com	Al Hassan, Mohamad/E-3097-2017; Sestras, Adriana F./C-1647-2012; SESTRAS, Radu E./C-1563-2012; Boscaiu, Monica/H-7878-2015; Vicente, Oscar/A-3858-2009	Al Hassan, Mohamad/0000-0002-2297-3394; Sestras, Adriana F./0000-0001-5768-4296; SESTRAS, Radu E./0000-0003-3073-1616; Boscaiu, Monica/0000-0002-9691-4223; Vicente, Oscar/0000-0001-5076-3784	European Social Found, Human Resources Development Operational Programme [POSDRU/159/1.5/S/132765]; Erasmus Mundus pre-doctoral scholarship by European Commission (Welcome Consortium)	European Social Found, Human Resources Development Operational Programme; Erasmus Mundus pre-doctoral scholarship by European Commission (Welcome Consortium)	Funding: Sorin Schiop is a PhD student at the University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. This paper was published under the frame of European Social Found, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/132765. Mohamad Al Hassan is a recipient of an Erasmus Mundus pre-doctoral scholarship financed by the European Commission (Welcome Consortium).	Adams E, 2014, J INTEGR PLANT BIOL, V56, P231, DOI 10.1111/jipb.12159; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Babu Merlene Ann, 2011, [Журнал стресс-физиологии и биохимии, Zhurnal stress-fiziologii i biokhimii], V7, P87; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Blainski A, 2013, MOLECULES, V18, P6852, DOI 10.3390/molecules18066852; Blomqvist G., 2001, THESIS ROYAL I TECHN; BOGEMANS J, 1989, PLANT SOIL, V113, P3, DOI 10.1007/BF02181915; Budeanu M, 2013, NOT BOT HORTI AGROBO, V41, P593; Cazzonelli CI, 2011, FUNCT PLANT BIOL, V38, P833, DOI 10.1071/FP11192; Chandna R., 2013, SALT STRESS PLANTS, P1; Chen XY, 2011, PLANT CELL PHYSIOL, V52, P909, DOI 10.1093/pcp/pcr043; COGDELL RJ, 1978, PHILOS T ROY SOC B, V284, P569, DOI 10.1098/rstb.1978.0090; DellaPenna D, 1999, PURE APPL CHEM, V71, P2205, DOI 10.1351/pac199971122205; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; European Task Force TG3, 2002, SNOW IC CONTR EUR RO; Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003; FLUCKIGER W, 1981, PLANT SOIL, V63, P527, DOI 10.1007/BF02370056; Forczek ST, 2011, PLANT SOIL ENVIRON, V57, P344, DOI 10.17221/356/2010-PSE; Ghassemi F., 1995, SALINISATION LAND WA; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Han HP, 2008, BIOTECHNOL LETT, V30, P1501, DOI 10.1007/s10529-008-9705-6; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Hussain M, 2013, INT J AGRIC BIOL, V15, P113; Hussain T. M., 2008, Biotechnology and Molecular Biology Reviews, V3, P008; Jansson G., 2013, FOREST TREE BREEDING, P123; Jesus J, 2014, CLIM 2014 4 C NAC AL; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jouyban Z., 2012, Technical Journal of Engineering and Applied Sciences, V2, P7; Kim SH, 2012, PHYTOCHEMISTRY, V74, P69, DOI 10.1016/j.phytochem.2011.11.003; Konijnendijk C. C., 2005, URBAN FORESTS TREES, DOI DOI 10.1007/3-540-27684-X_9; Kotuby-Amacher J, 2000, PUBLICATION UTAH STA; Larcher W., 2001, PHYSL PLANT ECOLOGY; Lauchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Maynard DG, 1997, CAN J SOIL SCI, V77, P99, DOI 10.4141/S96-048; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Parida AK, 2004, AQUAT BOT, V80, P77, DOI 10.1016/j.aquabot.2004.07.005; Parvaiz A, 2008, PLANT SOIL ENVIRON, V54, P89, DOI 10.17221/2774-PSE; Raherison E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-434; Renault S, 2005, CAN J FOREST RES, V35, P2806, DOI 10.1139/X05-194; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Sabbagh E, 2014, INT J FARM ALLI SCI, V3, P988; Saha P, 2010, INDIAN J EXP BIOL, V48, P593; Sai Kachout S, 2013, NOT BOT HORTI AGROBO, V41, P115; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Schofield RV, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001935; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Sudhir P, 2004, PHOTOSYNTHETICA, V42, P481, DOI 10.1007/S11099-005-0001-6; Varallyay G, 2010, AGRON RES, V8, P385; Volkov V, 2004, PLANT CELL ENVIRON, V27, P1, DOI 10.1046/j.0016-8025.2003.01116.x; Wakiewicz A., 2013, ECOPHYSIOLOGY RESPON, P283, DOI DOI 10.1007/978-1-4614-4747-4_11; Webber J, 2011, PATHOLOGY ADVISORY N, V11, P1; WEIMBERG R, 1987, PHYSIOL PLANTARUM, V70, P381, DOI 10.1111/j.1399-3054.1987.tb02832.x; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	62	24	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135419	10.1371/journal.pone.0135419	http://dx.doi.org/10.1371/journal.pone.0135419			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287687	Green Published, gold			2022-12-27	WOS:000360018600049
J	Alcaraz, A; Mrowiec, A; Insausti, CL; Bernabe-Garcia, A; Garcia-Vizcaino, EM; Lopez-Martinez, MC; Monfort, A; Izeta, A; Moraleda, JM; Castellanos, G; Nicolas, FJ				Alcaraz, Antonia; Mrowiec, Anna; Luisa Insausti, Carmen; Bernabe-Garcia, Angel; Maria Garcia-Vizcaino, Eva; Concepcion Lopez-Martinez, Maria; Monfort, Asuncion; Izeta, Ander; Maria Moraleda, Jose; Castellanos, Gregorio; Jose Nicolas, Francisco			Amniotic Membrane Modifies the Genetic Program Induced by TGF beta, Stimulating Keratinocyte Proliferation and Migration in Chronic Wounds	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-CELL MIGRATION; N-TERMINAL KINASE; TRANSFORMING GROWTH-FACTOR-BETA-1; DOWN-REGULATION; C-JUN; MESENCHYMAL TRANSITION; CONDITIONED MEDIUM; CANCER CELLS; MAP KINASE	Background Post-traumatic large-surface or deep wounds often cannot progress to reepithelialisation because they become irresponsive in the inflammatory stage, so intervention is necessary to provide the final sealing epidermis. Previously we have shown that Amniotic Membrane (AM) induced a robust epithelialisation in deep traumatic wounds. Methods and Findings To better understand this phenomenon, we used keratinocytes to investigate the effect of AM on chronic wounds. Using keratinocytes, we saw that AM treatment is able to exert an attenuating effect upon Smad2 and Smad3 TGF beta-induced phosphorylation while triggering the activation of several MAPK signalling pathways, including ERK and JNK1, 2. This also has a consequence for TGF beta-induced regulation on cell cycle control key players CDK1A (p21) and CDK2B (p15). The study of a wider set of TGF beta regulated genes showed that the effect of AM was not wide but very concrete for some genes. TGF beta exerted a powerful cell cycle arrest; the presence of AM however prevented TGF beta-induced cell cycle arrest. Moreover, AM induced a powerful cell migration response that correlates well with the expression of c-Jun protein at the border of the healing assay. Consistently, the treatment with AM of human chronic wounds induced a robust expression of c-Jun at the wound border. Conclusions The effect of AM on the modulation of TGF beta responses in keratinocytes that favours proliferation together with AM-induced keratinocyte migration is the perfect match that allows chronic wounds to move on from their non-healing state and progress into epithelialization. Our results may explain why the application of AM on chronic wounds is able to promote epithelialisation.	[Alcaraz, Antonia; Mrowiec, Anna; Bernabe-Garcia, Angel; Maria Garcia-Vizcaino, Eva; Concepcion Lopez-Martinez, Maria; Jose Nicolas, Francisco] Hosp Univ Virgen de la Arrixaca, Oncol Mol, Murcia, Spain; [Alcaraz, Antonia; Mrowiec, Anna; Bernabe-Garcia, Angel; Maria Garcia-Vizcaino, Eva; Concepcion Lopez-Martinez, Maria; Jose Nicolas, Francisco] Hosp Univ Virgen de la Arrixaca, TGFSS, Unidad Invest, Murcia, Spain; [Luisa Insausti, Carmen; Maria Moraleda, Jose] Hosp Clin Univ Virgen de la Arrixaca, Unidad Terapia Celular, Murcia, Spain; [Monfort, Asuncion; Izeta, Ander] Hosp Univ Donostia, Inst Biodonostia, San Sebastian, Spain; [Castellanos, Gregorio] Hosp Univ Virgen de la Arrixaca, Serv Cirugia, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; Instituto de Investigacion Sanitaria Biodonostia; Hospital Clinico Universitario Virgen de la Arrixaca	Nicolas, FJ (corresponding author), Hosp Univ Virgen de la Arrixaca, Oncol Mol, Murcia, Spain.	franciscoj.nicolas2@carm.es	Bernabé-García, Ángel/AAB-2934-2020; Moraleda, José María/AAB-4119-2020; Izeta, Ander/H-6376-2011; Nicolás, Francisco José/H-9422-2019; Izeta, Ander/ABG-8973-2020	Bernabé-García, Ángel/0000-0002-2266-5949; Nicolás, Francisco José/0000-0002-3969-1430; Izeta, Ander/0000-0003-1879-7401; Mrowiec, Anna/0000-0001-8745-5494	Fundacion Seneca de la Region de Murcia; Instituto de Salud Carlos III/Fondo de Investigaciones Sanitarias; Ministerio de Competitividad e Innovacion; Hospital Clinico Universitario Virgen de la Arrixaca; Spanish Ministry of Science and Innovation; Ramon y Cajal program of the Spanish Ministry for Education and Science; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia	Fundacion Seneca de la Region de Murcia(Fundacion Seneca); Instituto de Salud Carlos III/Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Competitividad e Innovacion; Hospital Clinico Universitario Virgen de la Arrixaca; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal program of the Spanish Ministry for Education and Science(German Research Foundation (DFG)); Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia	Fundacion Seneca de la Region de Murcia: http://fseneca.es/, Instituto de Salud Carlos III/Fondo de Investigaciones Sanitarias http://www.isciii.es/, Ministerio de Competitividad e Innovacion: http://www.mineco.gob.es, Hospital Clinico Universitario Virgen de la Arrixaca: http://arrinet.carm.es/index.htm. EMGV was the recipient of a fellowship from Fundacion Seneca de la Region de Murcia. AA was the recipient of a fellowship of the Spanish Ministry of Science and Innovation. FJN was supported by the Ramon y Cajal program of the Spanish Ministry for Education and Science and the Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2005, EXPERT REV MED DEVIC, V2, P153, DOI 10.1586/17434440.2.2.153; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Ashcroft GS, 2000, CYTOKINE GROWTH F R, V11, P125, DOI 10.1016/S1359-6101(99)00036-2; Baskovich B, 2008, INT WOUND J, V5, P543, DOI 10.1111/j.1742-481X.2007.00422.x; Bello YM, 2000, JAMA-J AM MED ASSOC, V283, P716, DOI 10.1001/jama.283.6.716; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cargnoni A, 2014, CYTOTHERAPY, V16, P17, DOI 10.1016/j.jcyt.2013.07.002; Cargnoni A, 2012, CYTOTHERAPY, V14, P153, DOI 10.3109/14653249.2011.613930; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Chan T, 2002, WOUND REPAIR REGEN, V10, P177, DOI 10.1046/j.1524-475X.2002.11101.x; COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fernandes M, 2005, CORNEA, V24, P643, DOI 10.1097/01.ico.0000151501.80952.c5; Finnson KW, 2013, ADV WOUND CARE, V2, P195, DOI 10.1089/wound.2013.0429; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Gangnuss S, 2004, J INVEST DERMATOL, V122, P791, DOI 10.1111/j.0022-202X.2004.22319.x; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hodge A, 2014, CYTOTHERAPY, V16, P1132, DOI 10.1016/j.jcyt.2014.01.005; Hong HJ, 2008, BIOMATERIALS, V29, P4831, DOI 10.1016/j.biomaterials.2008.08.023; Hu Y, 2013, CARCINOGENESIS, V34, P1764, DOI 10.1093/carcin/bgt132; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Insausti CL, 2010, WOUND REPAIR REGEN, V18, P368, DOI 10.1111/j.1524-475X.2010.00604.x; Insausti CL, 2010, HISTOL HISTOPATHOL, V25, P91, DOI 10.14670/HH-25.91; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Maas-Szabowski N, 2003, J CELL SCI, V116, P2937, DOI 10.1242/jcs.00474; Martinez-Mora C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042271; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Philipp K, 2004, INT J MOL MED, V14, P589; Pontillo CA, 2011, TOXICOL SCI, V120, P284, DOI 10.1093/toxsci/kfq390; Providence KM, 2004, J CELL PHYSIOL, V200, P297, DOI 10.1002/jcp.20016; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Ridgway PF, 2005, WOUND REPAIR REGEN, V13, P158, DOI 10.1111/j.1067-1927.2005.130206.x; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Ronai Z, 2004, MOL CELL, V15, P843, DOI 10.1016/j.molcel.2004.09.011; Ruiz-Canada C, AMNIOTIC MEMBR UNPUB; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Sant'Anna LB, 2011, CELL TRANSPLANT, V20, P441, DOI 10.3727/096368910X522252; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Singh Rita, 2004, Cell and Tissue Banking, V5, P129, DOI 10.1023/B:CATB.0000034077.05000.29; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; Soncini M, 2006, J REPRODUKTIONSMED E, V3; Stupack DG, 2000, IMMUNOL RES, V21, P83, DOI 10.1385/IR:21:2-3:83; Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb Donna J., 2004, V294, P3; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang LJ, 2001, AM J PATHOL, V159, P2147, DOI 10.1016/S0002-9440(10)63066-0; Yates S, 2002, WOUND REPAIR REGEN, V10, P5, DOI 10.1046/j.1524-475X.2002.10902.x; Yoneda N, 2013, J DENT RES, V92, P716, DOI 10.1177/0022034513491575; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	81	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135324	10.1371/journal.pone.0135324	http://dx.doi.org/10.1371/journal.pone.0135324			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284363	Green Published, gold			2022-12-27	WOS:000359666100032
J	Ganapathi, L; Van Haren, S; Dowling, DJ; Bergelson, I; Shukla, NM; Malladi, SS; Balakrishna, R; Tanji, H; Ohto, U; Shimizu, T; David, SA; Levy, O				Ganapathi, Lakshmi; Van Haren, Simon; Dowling, David J.; Bergelson, Ilana; Shukla, Nikunj M.; Malladi, Subbalakshmi S.; Balakrishna, Rajalakshmi; Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki; David, Sunil A.; Levy, Ofer			The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes	PLOS ONE			English	Article							INNATE IMMUNITY; EARLY-LIFE; VACCINE ADJUVANTS; RESPONSES; INFECTION; IMMUNIZATION; MECHANISMS; CHALLENGES; SURVIVAL; DISTINCT	Background Newborns and young infants are at higher risk for infections than adults, and manifest sub-optimal vaccine responses, motivating a search for novel immunomodulators and/or vaccine adjuvants effective in early life. In contrast to most TLR agonists (TLRA), TLR8 agonists such as imidazoquinolines (IMQs) induce adult-level Th1-polarizing cytokine production from human neonatal cord blood monocytes and are candidate early life adjuvants. We assessed whether TLR8-activating IMQ congeners may differ in potency and efficacy in inducing neonatal cytokine production in vitro, comparing the novel TLR7/8-activating IMQ analogues Hybrid-2, Meta-amine, and Para-amine to the benchmark IMQ resiquimod (R848). Methods TLRA-induced NF-kappa B activation was measured in TLR-transfected HEK cells. Cytokine production in human newborn cord and adult peripheral blood and in monocyte-derived dendritic cell cultures were measured by ELISA and multiplex assays. X-ray crystallography characterized the interaction of human TLR8 with Hybrid-2. Results Hybrid-2 selectively activated both TLR7 and 8 and was more potent than R848 in inducing adult-like levels of TNF-alpha, and IL-1 beta. Consistent with its relatively high in vitro activity, crystallographic studies suggest that absence in Hybrid-2 of an ether oxygen of the C2-ethoxy-methyl substituent, which can engage in unfavorable electrostatic and/or dipolar interactions with the carbonyl oxygen of Gly572 in human TLR8, may confer greater efficacy and potency compared to R848. Conclusions Hybrid-2 is a selective and potent TLR7/8 agonist that is a candidate adjuvant for early life immunization.	[Ganapathi, Lakshmi; Van Haren, Simon; Dowling, David J.; Bergelson, Ilana; Levy, Ofer] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Ganapathi, Lakshmi; Van Haren, Simon; Dowling, David J.; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Shukla, Nikunj M.; Malladi, Subbalakshmi S.; Balakrishna, Rajalakshmi; David, Sunil A.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Kansas; University of Tokyo	Levy, O (corresponding author), Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.	ofer.levy@childrens.harvard.edu	van Haren, Simon/K-7066-2019	van Haren, Simon/0000-0002-1791-0161; Dowling, David/0000-0003-1095-6156; Levy, Ofer/0000-0002-5859-1945	U.S. National Institutes of Health (NIH) grant [1R01AI100135-01]; NIH Adjuvant Discovery Contract [HHSN272201400052C]; Bill & Melinda Gates Foundation [OPPGH5284, OPP1035192]; VentiRx Pharmaceuticals; 3M Drug Delivery Systems; Shire; MedImmune; Crucell (Johnson Johnson); Grants-in-Aid for Scientific Research [15K14471, 26711002] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100135] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Adjuvant Discovery Contract; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); VentiRx Pharmaceuticals; 3M Drug Delivery Systems(3M); Shire; MedImmune(AstraZenecaMedimmune); Crucell (Johnson Johnson); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	OL's laboratory is supported by U.S. National Institutes of Health (NIH) grant 1R01AI100135-01, Administrative Supplement (PA14-027), and an NIH Adjuvant Discovery Contract (HHSN272201400052C), as well as Global Health (OPPGH5284) and Grand Challenges Explorations (OPP1035192) awards from the Bill & Melinda Gates Foundation. The Levy Laboratory has received sponsored research support from VentiRx Pharmaceuticals, 3M Drug Delivery Systems, MedImmune, Crucell (Johnson & Johnson) and Shire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, funding that the authors' laboratory receives from commercial sources is not directly related to this study.	Aryan Z, 2014, INT ARCH ALLERGY IMM, V164, P46, DOI 10.1159/000362553; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coombs MRP, 2011, EXPERT REV ANTI-INFE, V9, P261, DOI [10.1586/eri.10.158, 10.1586/ERI.10.158]; Cuenca AG, 2013, AM J PERINAT, V30, P105, DOI 10.1055/s-0032-1333412; Dasari P, 2011, PEDIAT ALLERG IMM-UK, V22, P221, DOI 10.1111/j.1399-3038.2010.01091.x; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Dowling DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058164; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Kaczanowska S, 2013, J LEUKOCYTE BIOL, V93, P847, DOI 10.1189/jlb.1012501; Kokatla HP, 2013, J MED CHEM, V56, P6871, DOI 10.1021/jm400694d; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Levy O, 2013, VACCINE, V31, P2500, DOI 10.1016/j.vaccine.2012.10.016; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Mifsud EJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00079; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettengill MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00457; Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Shukla NM, 2010, BIOORG MED CHEM LETT, V20, P6384, DOI 10.1016/j.bmcl.2010.09.093; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Spruance SL, 2001, J INFECT DIS, V184, P196, DOI 10.1086/322007; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Biggelaar AHJ, 2013, VACCINE, V31, P2525, DOI 10.1016/j.vaccine.2012.06.019; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Yoo E, 2014, J MED CHEM, V57, P7955, DOI 10.1021/jm500744f	45	32	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134640	10.1371/journal.pone.0134640	http://dx.doi.org/10.1371/journal.pone.0134640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274907	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600037
J	Getz, WM; Salter, R; Lyons, AJ; Sippl-Swezey, N				Getz, Wayne M.; Salter, Richard; Lyons, Andrew J.; Sippl-Swezey, Nicolas			Panmictic and Clonal Evolution on a Single Patchy Resource Produces Polymorphic Foraging Guilds	PLOS ONE			English	Article							GENETIC ALGORITHMS; NATURAL-SELECTION; SIMULATION; BEHAVIOR; ECOLOGY; SYSTEMS; MODELS; DISPERSAL; MOVEMENTS; DYNAMICS	We develop a stochastic, agent-based model to study how genetic traits and experiential changes in the state of agents and available resources influence individuals' foraging and movement behaviors. These behaviors are manifest as decisions on when to stay and exploit a current resource patch or move to a particular neighboring patch, based on information of the resource qualities of the patches and the anticipated level of intraspecific competition within patches. We use a genetic algorithm approach and an individual's biomass as a fitness surrogate to explore the foraging strategy diversity of evolving guilds under clonal versus hermaphroditic sexual reproduction. We first present the resource exploitation processes, movement on cellular arrays, and genetic algorithm components of the model. We then discuss their implementation on the Nova software platform. This platform seamlessly combines the dynamical systems modeling of consumer-resource interactions with agent-based modeling of individuals moving over a landscapes, using an architecture that lays transparent the following four hierarchical simulation levels: 1.) within-patch consumer-resource dynamics, 2.) within-generation movement and competition mitigation processes, 3.) across-generation evolutionary processes, and 4.) multiple runs to generate the statistics needed for comparative analyses. The focus of our analysis is on the question of how the biomass production efficiency and the diversity of guilds of foraging strategy types, exploiting resources over a patchy landscape, evolve under clonal versus random hermaphroditic sexual reproduction. Our results indicate greater biomass production efficiency under clonal reproduction only at higher population densities, and demonstrate that polymorphisms evolve and are maintained under random mating systems. The latter result questions the notion that some type of associative mating structure is needed to maintain genetic polymorphisms among individuals exploiting a common patchy resource on an otherwise spatially homogeneous landscape.	[Getz, Wayne M.] Univ Calif Berkeley, Dept ESPM, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, ZA-4000 Durban, South Africa; [Salter, Richard] Oberlin Coll, Dept Comp Sci, Oberlin, OH 44074 USA; [Lyons, Andrew J.] Stanford Univ, Vice Provost Off Undergrad Educ, Stanford, CA 94305 USA; [Sippl-Swezey, Nicolas] Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of Kwazulu Natal; Oberlin College; Stanford University; University of California System; University of California San Francisco	Getz, WM (corresponding author), Univ Calif Berkeley, Dept ESPM, Berkeley, CA 94720 USA.	wgetz@berkeley.edu	Lyons, Andrew/AAF-7067-2020; Getz, Wayne/I-4521-2013	Getz, Wayne/0000-0001-8784-9354	National Science Foundation [CNS-0939153]; Direct For Computer & Info Scie & Enginr [0939153] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The development of Nova has been supported by the National Science Foundation grant CNS-0939153 to Oberlin College with Richard Salter as PI.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Abrams PA, 2009, AM NAT, V174, P321, DOI 10.1086/603627; Beck CW, 2002, EVOL ECOL RES, V4, P275; Bond AB, 2002, NATURE, V415, P609, DOI 10.1038/415609a; Bond JE, 2006, ANIM CONSERV, V9, P145, DOI 10.1111/j.1469-1795.2006.00024.x; Borshchev A, 2002, FUTURE GENER COMP SY, V18, P829, DOI 10.1016/S0167-739X(02)00055-9; Corl A, 2010, P NATL ACAD SCI USA, V107, P4254, DOI 10.1073/pnas.0909480107; Cortes-Avizanda A, 2014, ECOLOGY, V95, P1799, DOI 10.1890/13-0574.1; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Drew MGB, 1999, QUANT STRUCT-ACT REL, V18, P573, DOI 10.1002/(SICI)1521-3838(199912)18:6&lt;573::AID-QSAR573&gt;3.0.CO;2-J; Edelsparre AH, 2014, ECOL LETT, V17, P333, DOI 10.1111/ele.12234; Ezoe H, 1997, RES POPUL ECOL, V39, P127, DOI 10.1007/BF02765258; FOLSE LJ, 1989, ECOL MODEL, V46, P57, DOI 10.1016/0304-3800(89)90069-0; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; Fortmann-Roe S, 2014, SIMUL MODEL PRACT TH, V47, P28, DOI 10.1016/j.simpat.2014.03.013; Getz WM, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/736507; Getz WM, 2013, ISR J ECOL EVOL, V59, P2, DOI 10.1080/15659801.2013.797676; Getz WM, 2011, ECOL LETT, V14, P113, DOI 10.1111/j.1461-0248.2010.01566.x; GETZ WM, 1989, THEOR POPUL BIOL, V36, P34, DOI 10.1016/0040-5809(89)90022-1; Giuggioli L, 2009, PLOS COMPUTATIONAL B, V7, DOI [10.1371/journal.pcbi.1002008, DOI 10.1371/J0URNAL.PCBI.1002008]; Gosme M, 2009, PHYTOPATHOLOGY, V99, P823, DOI 10.1094/PHYTO-99-7-0823; Grimm V, 1996, SCI TOTAL ENVIRON, V183, P151, DOI 10.1016/0048-9697(95)04966-5; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hamblin S, 2013, METHODS ECOL EVOL, V4, P184, DOI 10.1111/2041-210X.12000; Holland J.H., 1992, ADAPTATION IN NATURA; HOLLAND JH, 1991, AM ECON REV, V81, P365; Holmgren NMA, 2000, EVOL ECOL RES, V2, P81; Holzkamper A, 2006, ECOL MODEL, V198, P277, DOI 10.1016/j.ecolmodel.2006.05.001; Krause A, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.13; Krause J, 2002, LIVING GROUPS; Leardi R, 2001, J CHEMOMETR, V15, P559, DOI 10.1002/cem.651; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Mueller T, 2011, THEOR ECOL-NETH, V4, P341, DOI 10.1007/s12080-010-0081-1; Muetzelfeldt R, 2003, EUR J AGRON, V18, P345, DOI 10.1016/S1161-0301(02)00112-0; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Norrstrom N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029487; Norrstrom N, 2006, EVOL BIOINFORM, V2, P35; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Phelps SM, 2007, PHILOS T R SOC B, V362, P355, DOI 10.1098/rstb.2006.1963; POETHKE HJ, 1985, BEHAV ECOL SOCIOBIOL, V18, P155, DOI 10.1007/BF00299044; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Ryan JG, 2007, ECOL COMPLEX, V4, P113, DOI 10.1016/j.ecocom.2007.03.004; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; Salter RM, 2013, PROCEDIA COMPUT SCI, V18, P1784, DOI 10.1016/j.procs.2013.05.347; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Saupe EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017731; Smith FP, 2005, AGR SYST, V83, P135, DOI 10.1016/j.agsy.2004.03.004; SMITH M, 1991, ECOL MODEL, V58, P347, DOI 10.1016/0304-3800(91)90045-3; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Tracey JA, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00376.1; Valentine DT, 2013, ESSENTIAL MATLAB FOR; Vinatier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021115	58	11	11	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133732	10.1371/journal.pone.0133732	http://dx.doi.org/10.1371/journal.pone.0133732			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274613	gold, Green Published, Green Submitted			2022-12-27	WOS:000359493600015
J	Gusatti, CS; Costi, C; Halon, ML; Grandi, T; Medeiros, AFR; Silva, CMD; Gomes, SA; Silva, MSN; Niel, C; Rossetti, MLR				Gusatti, Carolina Souza; Costi, Cintia; Halon, Maria Laura; Grandi, Tarciana; Rech Medeiros, Arlete Ferrari; Dornelles Silva, Claudia Maria; Gomes, Selma Andrade; Nunes Silva, Marcia Susana; Niel, Christian; Rosa Rossetti, Maria Lucia			Hepatitis B Virus Genotype D Isolates Circulating in Chapeco, Southern Brazil, Originate from Italy	PLOS ONE			English	Article							HBV GENOTYPES; CORE PROMOTER; BLOOD-DONORS; MOLECULAR EPIDEMIOLOGY; PREVALENCE; GENOTYPES/SUBGENOTYPES; INFECTION; MARKERS; STATE; RISK	Hepatitis B virus genotype A1 (HBV/A1), of African origin, is the most prevalent genotype in Brazil, while HBV/F predominates in the other South American countries. However, HBV/D is the most common in the three states of southern Brazil, where 'islands' of elevated prevalence, as Chapeco and other cities, have been described. In this study, 202 HBV chronic carriers attending in 2013 the viral hepatitis ambulatory of Chapeco, were investigated. In comparison with previous studies performed in the same ambulatory, a rapid aging of the HBV infected population was observed (mean age of the newly diagnosed patients increasing from 29.9 +/- 10.3 years in 1996 to 44.4 +/- 13.3 years in 2013), probably due to a singular vaccination schedule at Chapeco that included not only children but also adolescents. Phylogenetic and BLAST analyses (S region) classified 91 HBV isolates into genotypes A (n = 3) and D (n = 88). The majority of HBV/D isolates were closely related to D3 sequences. To understand the reasons for the absence or near absence of genotypes A and F, and how HBV/D was introduced in the south of Brazil, HBV/D infected patients were inquired about their genealogical and geographical origins. Forty-three (52%) patients have their four grandparents of Italian origin, vs. seven (8%) who have their four grandparents of Brazilian origin. At all, 65 out of 83 (78%) patients had at least one grandparent originating from Italy. Taking into consideration the fact that Italy is one of the few countries where subgenotype D3 is predominant, the results strongly suggested that HBV/D was introduced in Brazil through Italian immigration which culminated between 1870 and 1920.	[Gusatti, Carolina Souza; Rosa Rossetti, Maria Lucia] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Gusatti, Carolina Souza; Costi, Cintia; Halon, Maria Laura; Grandi, Tarciana; Dornelles Silva, Claudia Maria; Rosa Rossetti, Maria Lucia] Fundacao Estadual Prod Pesquisa Saude, Ctr Desenvolvimento Cient & Tecnol, Porto Alegre, RS, Brazil; [Rech Medeiros, Arlete Ferrari] Secretaria Municipal Saude, Setor Hepatites Virais, Chapeco, Brazil; [Gomes, Selma Andrade; Niel, Christian] Fiocruz MS, Fundacao Oswaldo Cruz, Lab Virol Mol, BR-21045900 Rio De Janeiro, Brazil; [Nunes Silva, Marcia Susana; Rosa Rossetti, Maria Lucia] Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicada Saud, Canoas, Brazil	Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; Universidade Luterana do Brasil	Niel, C (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Lab Virol Mol, BR-21045900 Rio De Janeiro, Brazil.	niel@ioc.fiocruz.br	Costi, Cintia/S-9813-2017; Niel, Christian/G-3712-2013; Rossetti, Maria Lucia/ABH-1935-2020	Costi, Cintia/0000-0003-1531-0012; Rossetti, Maria Lucia/0000-0002-9672-9394; Gomes, Selma/0000-0003-0233-3370	CAPES; FAPERGS; FEPPS; CNPq; Brazilian Ministry of Health; Post-Graduate Program in Cellular and Molecular Biology of the Federal University of Rio Grande do Sul [PPSUS-FAPERGS/MS/CNPq/SESRS 002/2013, 1257-2551/13-8, PADCT-FEPPS-05/2010, PNPDS- 1959/2009]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FEPPS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health; Post-Graduate Program in Cellular and Molecular Biology of the Federal University of Rio Grande do Sul	This work was supported by the research funding agencies CAPES, FAPERGS, FEPPS and CNPq, the Brazilian Ministry of Health, and the Post-Graduate Program in Cellular and Molecular Biology of the Federal University of Rio Grande do Sul (PPSUS-FAPERGS/MS/CNPq/SESRS 002/2013, process no 1257-2551/13-8; PADCT-FEPPS-05/2010; PNPDS- 1959/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599; Araujo NM, 2004, ARCH VIROL, V149, P1383, DOI 10.1007/s00705-003-0269-4; Becker Carlos Eduardo, 2010, Arq. Gastroenterol., V47, P13, DOI 10.1590/S0004-28032010000100003; Bertolini DA, 2006, BRAZ J MED BIOL RES, V39, P1083, DOI 10.1590/S0100-879X2006000800011; Bertolini DA, 2012, INFECT GENET EVOL, V12, P1295, DOI 10.1016/j.meegid.2012.04.009; Brazilian Ministry of Health, 2010, EST PREV BAS POP INF; Carrilho FJ, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-13; Dal Molin G, 2006, J MED VIROL, V78, P734, DOI 10.1002/jmv.20616; De Maddalena C, 2007, VIROLOGY, V365, P113, DOI 10.1016/j.virol.2007.03.015; Deterding K, 2008, J MED VIROL, V80, P1707, DOI 10.1002/jmv.21294; Erhardt A, 2005, GUT, V54, P1009, DOI 10.1136/gut.2004.060327; Barros LMF, 2014, INFECT GENET EVOL, V24, P68, DOI 10.1016/j.meegid.2014.03.007; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; IBGE, 2012, BRAS 500 AN POV; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kupek EJ, 2001, J VIRAL HEPATITIS, V8, P78, DOI 10.1046/j.1365-2893.2001.00272.x; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105317; Levy M., 1974, REV SAUDE PUBL, V8, P49, DOI DOI 10.1590/S0034-89101974000500003; de Mello FMMA, 2014, REV SOC BRAS MED TRO, V47, P701, DOI 10.1590/0037-8682-0158-2014; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Menegol D, 2013, BRAZ J MICROBIOL, V44, P1237, DOI 10.1590/S1517-83822014005000013; Mohebbi SR, 2012, J MED VIROL, V84, P414, DOI 10.1002/jmv.23200; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; Nova ML, 2010, THESIS SAO PAULO U S; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Reis LMW, 2011, J MED VIROL, V83, P2103, DOI 10.1002/jmv.22246; Rosini Nilton, 2003, Braz J Infect Dis, V7, P262, DOI 10.1590/S1413-86702003000400006; Sagnelli C, 2014, J MED VIROL, V86, P1683, DOI 10.1002/jmv.24005; Sagnelli E, 2014, WORLD J GASTROENTERO, V20, P7635, DOI 10.3748/wjg.v20.i24.7635; Scaraveli NG, 2009, THESIS FEDERAL U SAN; Servant-Delmas A, 2010, TRANSFUSION, V50, P2607, DOI 10.1111/j.1537-2995.2010.02725.x; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Silva CMD, 2005, J INFECTION, V51, P24, DOI 10.1016/j.jinf.2004.07.007; Tallo T, 2004, J MED VIROL, V74, P221, DOI 10.1002/jmv.20169; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Trento A., 1989, OUTRO LADO ATLANTICO; Wiegand J, 2008, ANTIVIR THER, V13, P211; Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x; Zehender G, 2014, WORLD J GASTROENTERO, V20, P7622, DOI 10.3748/wjg.v20.i24.7622; Zhang YH, 2013, VIRUS RES, V171, P65, DOI 10.1016/j.virusres.2012.10.027	44	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135816	10.1371/journal.pone.0135816	http://dx.doi.org/10.1371/journal.pone.0135816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275046	Green Published, gold, Green Submitted			2022-12-27	WOS:000359493600118
J	Ortiz, MA; Nunez, C; Ordonez, D; Alvarez-Cermeno, JC; Martinez-Rodriguez, JE; Sanchez, AJ; Arroyo, R; Izquierdo, G; Malhotra, S; Montalban, X; Garcia-Merino, A; Munteis, E; Alcina, A; Comabella, M; Matesanz, F; Villar, LM; Urcelay, E				Ortiz, Miguel A.; Nunez, Concepcion; Ordonez, David; Alvarez-Cermeno, Jose C.; Martinez-Rodriguez, Jose E.; Sanchez, Antonio J.; Arroyo, Rafael; Izquierdo, Guillermo; Malhotra, Sunny; Montalban, Xavier; Garcia-Merino, Antonio; Munteis, Elvira; Alcina, Antonio; Comabella, Manuel; Matesanz, Fuencisla; Villar, Luisa M.; Urcelay, Elena			Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; ILT6 GENE; ASSOCIATION; SUSCEPTIBILITY; ORGANIZATION; PROTEIN	Background Multiple sclerosis (MS) is a neurodegenerative, autoimmune disease of the central nervous system. Genome-wide association studies (GWAS) have identified over hundred polymorphisms with modest individual effects in MS susceptibility and they have confirmed the main individual effect of the Major Histocompatibility Complex. Additional risk loci with immunologically relevant genes were found significantly overrepresented. Nonetheless, it is accepted that most of the genetic architecture underlying susceptibility to the disease remains to be defined. Candidate association studies of the leukocyte immunoglobulin-like receptor LILRA3 gene in MS have been repeatedly reported with inconsistent results. Objectives In an attempt to shed some light on these controversial findings, a combined analysis was performed including the previously published datasets and three newly genotyped cohorts. Both wild-type and deleted LILRA3 alleles were discriminated in a single-tube PCR amplification and the resulting products were visualized by their different electrophoretic mobilities. Results and Conclusion Overall, this meta-analysis involved 3200 MS patients and 3069 matched healthy controls and it did not evidence significant association of the LILRA3 deletion [carriers of LILRA3 deletion: p = 0.25, OR (95% CI) = 1.07 (0.95-1.19)], even after stratification by gender and the HLA-DRB1*15:01 risk allele.	[Ortiz, Miguel A.; Nunez, Concepcion; Urcelay, Elena] Hosp Clin San Carlos, Dept Immunol, Inst Invest Sanitaria San Carlos IdISSC, Madrid, Spain; [Ordonez, David] Inst Invest Sanitaria Puerta de Hierro, Immunogenet & Histocompatibil, Madrid, Spain; [Alvarez-Cermeno, Jose C.; Villar, Luisa M.] Hosp Ramon & Cajal, IRYCIS, Multiple Sclerosis Unit, Dept Immunol, E-28034 Madrid, Spain; [Alvarez-Cermeno, Jose C.; Villar, Luisa M.] Hosp Ramon & Cajal, IRYCIS, Multiple Sclerosis Unit, Dept Neurol, E-28034 Madrid, Spain; [Martinez-Rodriguez, Jose E.; Munteis, Elvira] Hosp del Mar Med Res Inst IMIM, Neurol, Barcelona, Spain; [Sanchez, Antonio J.; Garcia-Merino, Antonio] Hosp Univ Puerta de Hierro, Neuroimmunol, Madrid, Spain; [Arroyo, Rafael] Hosp Clin S Carlos, Dept Neurol, Inst Invest Sanitaria S Carlos IdISSC, Multiple Sclerosis Unit, Madrid, Spain; [Izquierdo, Guillermo] Hosp Virgen Macarena, Multiple Sclerosis Unit, Seville, Spain; [Malhotra, Sunny; Montalban, Xavier; Comabella, Manuel] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca Vall dHebron VHIR, Serv Neurol Neuroimmunol,Ctr Esclerosi Multiple C, E-08193 Barcelona, Spain; [Alcina, Antonio; Matesanz, Fuencisla] CSIC, IPBLN, Dept Cell Biol & Immunol, Granada, Spain	Hospital Clinico San Carlos; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario Virgen Macarena; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Urcelay, E (corresponding author), Hosp Clin San Carlos, Dept Immunol, Inst Invest Sanitaria San Carlos IdISSC, Madrid, Spain.	elena.urcelay@salud.madrid.org	Montalban, Xavier/J-5938-2016; Matesanz, Fuencisla/F-3715-2016; Sánchez-López, Antonio J./AAF-3383-2021; del Valle, David Ordonez/K-2240-2017; Alcina, Antonio/T-1893-2017; Malhotra, Sunny/ABI-1270-2020; Sánchez-López, Antonio J/E-3037-2018	Montalban, Xavier/0000-0002-0098-9918; Matesanz, Fuencisla/0000-0002-9429-1819; Sánchez-López, Antonio J./0000-0001-7168-6175; del Valle, David Ordonez/0000-0003-0738-8653; Alcina, Antonio/0000-0001-7294-0948; Sánchez-López, Antonio J/0000-0001-7168-6175; Martinez Rodriguez, Jose Enrique/0000-0001-6765-5587; Comabella Lopez, Manuel/0000-0002-2373-6657; Nunez, Concepcion/0000-0002-9489-1603; Malhotra Sareen, Sunny/0000-0003-1112-7739; Urcelay, Elena/0000-0001-8470-8396; Villar, Luisa M/0000-0002-9067-3668	Fondo de Investigacion Sanitaria (FIS)-Instituto de Salud Carlos III (ISCIII)-Fondos Europeos de Desarrollo Regional (FEDER) [PI12/00555, PI13/01527, PI13/01466, PI13/0879, RETICS-REEM RD12/0032/]; Junta de Andalucia (JA)- Fondos Europeos de Desarrollo Regional (FEDER) [CTS2704]	Fondo de Investigacion Sanitaria (FIS)-Instituto de Salud Carlos III (ISCIII)-Fondos Europeos de Desarrollo Regional (FEDER); Junta de Andalucia (JA)- Fondos Europeos de Desarrollo Regional (FEDER)	Financial support for the study was provided by: Fondo de Investigacion Sanitaria (FIS)-Instituto de Salud Carlos III (ISCIII)-Fondos Europeos de Desarrollo Regional (FEDER) (grant numbers PI12/00555 to FM; PI13/01527 to AA; PI13/01466 to GI; PI13/0879 to EU and RETICS-REEM RD12/0032/) and Junta de Andalucia (JA)- Fondos Europeos de Desarrollo Regional (FEDER) (grant number CTS2704 to FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HY, 2010, J RHEUMATOL, V37, P1596, DOI 10.3899/jrheum.091119; Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bonetti A, 2009, J NEUROIMMUNOL, V208, P119, DOI 10.1016/j.jneuroim.2009.01.003; Du Y, 2014, ANN RHEUM DIS; Du Y, 2014, ARTHRITIS RHEUMATOL, V66, P822, DOI 10.1002/art.38308; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Lill CM, 2012, J MED GENET, V49, P558, DOI 10.1136/jmedgenet-2012-101175; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Norman PJ, 2003, IMMUNOGENETICS, V55, P165, DOI 10.1007/s00251-003-0561-1; Ordonez D, 2009, GENES IMMUN, V10, P579, DOI 10.1038/gene.2009.34; Ryu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019245; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Thomas R, 2010, CLIN REV ALLERG IMMU, V38, P159, DOI 10.1007/s12016-009-8148-8; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Wisniewski A, 2003, HUM IMMUNOL, V64, P458, DOI 10.1016/S0198-8859(03)00025-9; Wisniewski A, 2013, HUM IMMUNOL, V74, P353, DOI 10.1016/j.humimm.2012.12.006; Young NT, 2001, IMMUNOGENETICS, V53, P270, DOI 10.1007/s002510100332	25	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134414	10.1371/journal.pone.0134414	http://dx.doi.org/10.1371/journal.pone.0134414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274821	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600026
J	Choudhury, AR; Sikorska, E; van den Boom, J; Bayer, P; Popenda, L; Szutkowski, K; Jurga, S; Bonomi, M; Sali, A; Zhukov, I; Passamonti, S; Novic, M				Choudhury, Amrita Roy; Sikorska, Emilia; van den Boom, Johannes; Bayer, Peter; Popenda, Lukasz; Szutkowski, Kosma; Jurga, Stefan; Bonomi, Massimiliano; Sali, Andrej; Zhukov, Igor; Passamonti, Sabina; Novic, Marjana			Structural Model of the Bilitranslocase Transmembrane Domain Supported by NMR and FRET Data	PLOS ONE			English	Article							HELIX-PACKING; PREDICTION; TRANSPORT; INHIBITION; BILIRUBIN; PROTEINS; RESIDUES; DYNAMICS; BINDING; MOTIFS	We present a 3D model of the four transmembrane (TM) helical regions of bilitranslocase (BTL), a structurally uncharacterized protein that transports organic anions across the cell membrane. The model was computed by considering helix-helix interactions as primary constraints, using Monte Carlo simulations. The interactions between the TM2 and TM3 segments have been confirmed by Forster resonance energy transfer (FRET) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy, increasing our confidence in the model. Several insights into the BTL transport mechanism were obtained by analyzing the model. For example, the observed cis-trans Leu-Pro peptide bond isomerization in the TM3 fragment may indicate a key conformational change during anion transport by BTL. Our structural model of BTL may facilitate further studies, including drug discovery.	[Choudhury, Amrita Roy; Novic, Marjana] Natl Inst Chem, Ljubljana, Slovenia; [Sikorska, Emilia] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [van den Boom, Johannes; Bayer, Peter] Univ Duisburg Essen, Ctr Med Biotechnol, Inst Struct & Med Biochem, Essen, Germany; [Popenda, Lukasz; Szutkowski, Kosma; Jurga, Stefan; Zhukov, Igor] Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland; [Szutkowski, Kosma; Jurga, Stefan] Adam Mickiewicz Univ, Fac Phys, Poznan, Poland; [Bonomi, Massimiliano] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Bonomi, Massimiliano; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Bonomi, Massimiliano; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Zhukov, Igor] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Passamonti, Sabina] Univ Trieste, Dept Life Sci, Trieste, Italy	National Institute of Chemistry - Slovenia; Fahrenheit Universities; University of Gdansk; University of Duisburg Essen; Adam Mickiewicz University; Adam Mickiewicz University; University of Cambridge; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Trieste	Zhukov, I (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland.	igor@ibb.waw.pl; spassamonti@units.it; marjana.novic@ki.si	Szutkowski, Kosma/M-1541-2019; Jurga, Stefan/E-8862-2017; Popenda, Lukasz/J-7386-2015; Bayer, Peter/B-8803-2009; Sabina Passamonti, Medical degree/G-4299-2012; Zhukov, Igor/J-4069-2015	Szutkowski, Kosma/0000-0002-6091-9049; Jurga, Stefan/0000-0002-1665-6077; Popenda, Lukasz/0000-0003-1117-3081; Bayer, Peter/0000-0003-0435-7202; Sabina Passamonti, Medical degree/0000-0001-7876-4666; Sikorska, Emilia/0000-0001-7851-6371; Bonomi, Massimiliano/0000-0002-7321-0004; Zhukov, Igor/0000-0002-9912-1018	Ministry of Higher Education, Science and Technology of Republic of Slovenia [P1-017, J1-2151]; European Regional Development Fund (Cross-border Cooperation Programme Italy-Slovenia, TRANS2CARE strategic project); Polish National Centre for Research and Development [PBS1/A9/13/2012]; NIH [R01 GM083960]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083960] Funding Source: NIH RePORTER	Ministry of Higher Education, Science and Technology of Republic of Slovenia; European Regional Development Fund (Cross-border Cooperation Programme Italy-Slovenia, TRANS2CARE strategic project); Polish National Centre for Research and Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia, grants P1-017 and J1-2151 (ARC, MN), European Regional Development Fund (Cross-border Cooperation Programme Italy-Slovenia 2007-2013, TRANS2CARE strategic project) (SP), Polish National Centre for Research and Development under research grant "Nanomaterials and their application to biomedicine", contract number PBS1/A9/13/2012, (SJ, KS and IZ), NIH R01 GM083960 grant (AS, MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Baker M, 2010, NAT METHODS, V7, P429, DOI 10.1038/nmeth0610-429; Battiston L, 1998, BIOCHEM BIOPH RES CO, V247, P687, DOI 10.1006/bbrc.1998.8868; Buxhofer-Ausch V, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/863539; Carpenter EP, 2008, CURR OPIN STRUC BIOL, V18, P581, DOI 10.1016/j.sbi.2008.07.001; Case D, 2006, AMBER 9; Choudhury AR, 2009, SAR QSAR ENVIRON RES, V20, P741, DOI 10.1080/10629360903438602; Choudhury AR, 2013, BBA-BIOMEMBRANES, V1828, P2609, DOI 10.1016/j.bbamem.2013.06.006; Gront D, 2007, J COMPUT CHEM, V28, P1593, DOI 10.1002/jcc.20624; Hicks RP, 2003, BIOPOLYMERS, V68, P459, DOI 10.1002/bip.10325; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Karawajczyk A, 2007, BIOCHEM PHARMACOL, V73, P308, DOI 10.1016/j.bcp.2006.09.024; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; LIPARI G, 1981, BIOCHEMISTRY-US, V20, P6250, DOI 10.1021/bi00524a053; Lo A, 2009, BIOINFORMATICS, V25, P996, DOI 10.1093/bioinformatics/btp114; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Maestro A, 2010, CARDIOVASC RES, V85, P175, DOI 10.1093/cvr/cvp290; Montanic S, 2013, RADIOL ONCOL, V47, P128, DOI 10.2478/raon-2013-0026; Nugent T, 2012, J STRUCT BIOL, V179, P327, DOI 10.1016/j.jsb.2011.10.008; Passamonti S, 2005, FEBS J, V272, P5522, DOI 10.1111/j.1742-4658.2005.04949.x; Passamonti S, 2005, FEBS J, V272, P3282, DOI 10.1111/j.1742-4658.2005.04751.x; Passamonti S, 1998, EUR J BIOCHEM, V253, P84, DOI 10.1046/j.1432-1327.1998.2530084.x; Passamonti S, 2009, CURR DRUG METAB, V10, P369, DOI 10.2174/138920009788498950; Perdih A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038967; Pieper U, 2013, NAT STRUCT MOL BIOL, V20, P135, DOI 10.1038/nsmb.2508; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Schmidpeter PAM, 2014, ACS CHEM BIOL, V9, P1145, DOI 10.1021/cb500001n; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Terdoslavich Michela, 2012, Drug Metab Lett, V6, P165; Tzakos AG, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/918304; Vashisth H, 2013, ACS CHEM BIOL, V8, P2778, DOI 10.1021/cb400568g; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Ziberna L, 2012, FREE RADICAL BIO MED, V52, P1750, DOI 10.1016/j.freeradbiomed.2012.02.027; Zuperl S, 2011, ANAL CHIM ACTA, V705, P322, DOI 10.1016/j.aca.2011.07.004	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135455	10.1371/journal.pone.0135455	http://dx.doi.org/10.1371/journal.pone.0135455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291722	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900019
J	Lu, JH; Ma, D				Lu, Jianhua; Ma, Dan			Repellent and Contact Toxicity of Alpinia officinarum Rhizome Extract against Lasioderma serricorne Adults	PLOS ONE			English	Article							TRIBOLIUM-CASTANEUM HERBST; SITOPHILUS-ZEAMAIS MOTSCHULSKY; STORED-PRODUCT INSECTS; ESSENTIAL OILS; FUMIGANT TOXICITY; BOTANICAL INSECTICIDES; PHOSPHINE RESISTANCE; PACKAGING MATERIALS; STORAGE INSECTS; GRANARY WEEVIL	The repellent and contact toxicities of Alpinia officinarum rhizome extract on Lasioderma serricorne adults, and its ability to protect stored wheat flour from L. serricorne adults infestation were investigated. The A. officinarum extract exhibited strong repellent and contact toxicities against L. serricorne adults. The toxicities enhanced significantly with the increasing treatment time and treatment dose. The mean percentage repellency value reached 91.3% at class V at the dose of 0.20 mu L/cm(2) after 48 h of exposure. The corrected mortality reached over 80.0% at the dose of 0.16 mu L/cm(2) after 48 h of exposure. The A. officinarum extract could significantly reduce L. serricorne infestation level against stored wheat flour. Particularly, the insect infestation was nil in wheat flour packaged with kraft paper bags coated with the A. officinarum extract at the dose of above 0.05 mu L/cm(2). The naturally occurring A. officinarum extract could be useful for integrated management of L. serricorne.	[Lu, Jianhua; Ma, Dan] Henan Univ Technol, Sch Food Sci & Technol, Zhengzhou 450001, Henan, Peoples R China	Henan University of Technology	Lu, JH (corresponding author), Henan Univ Technol, Sch Food Sci & Technol, Lianhua St, Zhengzhou 450001, Henan, Peoples R China.	jianhlv@163.com			National Research Plan for the High-tech R & D Program during the Twelfth Five-year Plan Period (National 863 plan) [2012AA101705-2]; Plan of Nature Science Fundamental Research in Henan University of Technology [11JCYJ01]; Key Technologies R & D Program of the Education Department of Henan Province [12A210003]; Basic and Cutting-edge Technology Research Projects of Henan Province	National Research Plan for the High-tech R & D Program during the Twelfth Five-year Plan Period (National 863 plan); Plan of Nature Science Fundamental Research in Henan University of Technology; Key Technologies R & D Program of the Education Department of Henan Province; Basic and Cutting-edge Technology Research Projects of Henan Province	This research was supported by the National Research Plan for the High-tech R & D Program during the Twelfth Five-year Plan Period (National 863 plan, No. 2012AA101705-2), Plan of Nature Science Fundamental Research in Henan University of Technology (No. 11JCYJ01), Key Technologies R & D Program of the Education Department of Henan Province (No. 12A210003) and the Basic and Cutting-edge Technology Research Projects of Henan Province (No. 2015).	Abdelghany AY, 2010, J STORED PROD RES, V46, P93, DOI 10.1016/j.jspr.2009.11.001; Allahvaisi S, 2010, NOT BOT HORTI AGROBO, V38, P21; [Anonymous], 1925, J ECON ENTOMOL; BARRER PM, 1980, J STORED PROD RES, V16, P1, DOI 10.1016/0022-474X(80)90028-4; BELL CH, 1995, J STORED PROD RES, V31, P199, DOI 10.1016/0022-474X(95)00012-V; BLOSZYK E, 1990, J APPL ENTOMOL, V110, P96, DOI 10.1111/j.1439-0418.1990.tb00100.x; BUTLER JH, 1996, METHYL BROMIDE ISSUE, V1, P27; Cosimi S, 2009, J STORED PROD RES, V45, P125, DOI 10.1016/j.jspr.2008.10.002; Daglish GJ, 1998, STORED PRODUCT PROTE, P584; Fan GJ, 2007, BIOORG MED CHEM LETT, V17, P6720, DOI 10.1016/j.bmcl.2007.10.054; Fardisi M, 2013, J STORED PROD RES, V52, P93, DOI 10.1016/j.jspr.2012.12.006; Germinara GS, 2012, J FOOD PROTECT, V75, P366, DOI 10.4315/0362-028X.JFP-11-142; Highland H.A., 1984, P311; Highland HA, 1991, ECOLOGY MANAGEMENT F, P345; Hill J.M., 1981, RECENT ADV FOOD SCI, V1, P473; Hou XW, 2004, J STORED PROD RES, V40, P47, DOI 10.1016/S0022-474X(02)00063-2; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470; Jovanovic Z, 2007, IND CROP PROD, V26, P100, DOI 10.1016/j.indcrop.2007.01.010; JULIANA G, 1983, J ECON ENTOMOL, V76, P154; Kim SI, 2003, J STORED PROD RES, V39, P11, DOI 10.1016/S0022-474X(02)00013-9; Kljajic P, 2006, J STORED PROD RES, V42, P149, DOI 10.1016/j.jspr.2005.01.002; Lee BH, 2004, J STORED PROD RES, V40, P553, DOI 10.1016/j.jspr.2003.09.001; Lee BH, 2001, CROP PROT, V20, P317, DOI 10.1016/S0261-2194(00)00158-7; Lee SE, 2003, LIFE SCI, V73, P167, DOI 10.1016/S0024-3205(03)00259-5; Lee SE, 2001, PEST MANAG SCI, V57, P548, DOI 10.1002/ps.322; Liu ZL, 2007, J STORED PROD RES, V43, P290, DOI 10.1016/j.jspr.2006.06.010; Liu ZL, 1999, J STORED PROD RES, V35, P317, DOI 10.1016/S0022-474X(99)00015-6; MBTOC, 1998, METHYL BROMIDE TECHN, P374; Mikhaiel AA, 2011, J STORED PROD RES, V47, P357, DOI 10.1016/j.jspr.2011.06.002; Mowery SV, 2002, J ECON ENTOMOL, V95, P1333, DOI 10.1603/0022-0493-95.6.1333; Mullen M. A., 2000, International Food Hygiene, V11, P13; MULLEN MA, 1994, J STORED PROD RES, V30, P95, DOI 10.1016/0022-474X(94)90278-X; Papadopoulou SC, 2004, J PEST SCI, V77, P183, DOI 10.1007/s10340-004-0052-7; Paul UV, 2009, J STORED PROD RES, V45, P97, DOI 10.1016/j.jspr.2008.09.006; Radwan R. N., 1997, U. S. Patent, Patent No. [5,688,509, 5688509]; RAJENDRAN S, 1994, INT J PEST MANAGE, V40, P207, DOI 10.1080/09670879409371883; Shaaya E, 1997, J STORED PROD RES, V33, P7, DOI 10.1016/S0022-474X(96)00032-X; Tapondjou AL, 2005, J STORED PROD RES, V41, P91, DOI 10.1016/j.jspr.2004.01.004; Wang J, 2006, J STORED PROD RES, V42, P339, DOI 10.1016/j.jspr.2005.06.001; White N.D.G., 1995, INTREGATED PEST MANA; Wong KKY, 2005, J AGR FOOD CHEM, V53, P4633, DOI 10.1021/jf050096m; YANG RZ, 1988, ECON BOT, V42, P376, DOI 10.1007/BF02860162; ZETTLER JL, 1994, J ECON ENTOMOL, V87, P546, DOI 10.1093/jee/87.3.546; Zhang BB, 2010, FITOTERAPIA, V81, P948, DOI 10.1016/j.fitote.2010.06.015	45	9	10	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135631	10.1371/journal.pone.0135631	http://dx.doi.org/10.1371/journal.pone.0135631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292097	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900022
J	Ying, BW; Honda, T; Tsuru, S; Seno, S; Matsuda, H; Kazuta, Y; Yomo, T				Ying, Bei-Wen; Honda, Tomoya; Tsuru, Saburo; Seno, Shigeto; Matsuda, Hideo; Kazuta, Yasuaki; Yomo, Tetsuya			Evolutionary Consequence of a Trade-Off between Growth and Maintenance along with Ribosomal Damages	PLOS ONE			English	Article							ESCHERICHIA-COLI; STATIONARY-PHASE; GENE-EXPRESSION; TRANSLATION; SELECTION; SURVIVAL; ADAPTATION; STARVATION; MUTATIONS; BACTERIA	Microorganisms in nature are constantly subjected to a limited availability of resources and experience repeated starvation and nutrition. Therefore, microbial life may evolve for both growth fitness and sustainability. By contrast, experimental evolution, as a powerful approach to investigate microbial evolutionary strategies, often targets the increased growth fitness in controlled, steady-state conditions. Here, we address evolutionary changes balanced between growth and maintenance while taking nutritional fluctuations into account. We performed a 290-day-long evolution experiment with a histidine-requiring Escherichia coli strain that encountered repeated histidine-rich and histidine-starved conditions. The cells that experienced seven rounds of starvation and re-feed grew more sustainably under prolonged starvation but dramatically lost growth fitness under rich conditions. The improved sustainability arose from the evolved capability to use a trace amount of histidine for cell propagation. The reduced growth rate was attributed to mutations genetically disturbing the translation machinery, that is, the ribosome, ultimately slowing protein translation. This study provides the experimental demonstration of slow growth accompanied by an enhanced affinity to resources as an evolutionary adaptation to oscillated environments and verifies that it is possible to evolve for reduced growth fitness. Growth economics favored for population increase under extreme resource limitations is most likely a common survival strategy adopted by natural microbes.	[Ying, Bei-Wen] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Honda, Tomoya] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Tsuru, Saburo; Seno, Shigeto; Matsuda, Hideo; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Kazuta, Yasuaki; Yomo, Tetsuya] JST, ERATO, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	University of Tsukuba; University of California System; University of California San Diego; Osaka University; Japan Science & Technology Agency (JST); Osaka University	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp	Tsuru, Saburo/M-5069-2017; Seno, Shigeto/W-1426-2019; Ying, Bei-Wen/Q-9750-2019	Tsuru, Saburo/0000-0002-7182-1637; Seno, Shigeto/0000-0003-3861-6444; Ying, Bei-Wen/0000-0003-2517-5686; Matsuda, Hideo/0000-0002-4701-3779; Honda, Tomoya/0000-0003-2391-4799	Ministry of Education, Culture, Sports, Science and Technology, Japan [26506003, 26119702]; Grants-in-Aid for Scientific Research [26506003, 26119702] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Grant-in-Aid for Scientific Research (C) no. 26506003 (to BWY) and Grant-in-Aid for Scientific Research on Innovative Areas no. 26119702 (to BWY) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Blokpoel MCJ, 2005, J BACTERIOL, V187, P6691, DOI 10.1128/JB.187.19.6691-6700.2005; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Bremer H, 1996, ESCHERICHIA COLI SAL, V1, P1553; BROCK TD, 1971, BACTERIOL REV, V35, P39, DOI 10.1128/MMBR.35.1.39-58.1971; Carroll SM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-2; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11; Dethlefsen L, 2007, J BACTERIOL, V189, P3237, DOI 10.1128/JB.01686-06; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Duval M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001731; Egli T, 2010, WATER RES, V44, P4826, DOI 10.1016/j.watres.2010.07.023; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Faure D, 2004, J BACTERIOL, V186, P6437, DOI 10.1128/JB.186.19.6437-6442.2004; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Fujii S, 2014, NAT PROTOC, V9, P1578, DOI 10.1038/nprot.2014.107; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kaczanowska M, 2004, J BACTERIOL, V186, P3046, DOI 10.1128/JB.186.10.3046-3055.2004; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Kazuta Y, 2008, MOL CELL PROTEOMICS, V7, P1530, DOI 10.1074/mcp.M800051-MCP200; Kazuta Y, 2014, J BIOSCI BIOENG, V118, P554, DOI 10.1016/j.jbiosc.2014.04.019; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Kishimoto T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001164; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; LAPPINSCOTT HM, 1988, APPL ENVIRON MICROB, V54, P1373, DOI 10.1128/AEM.54.6.1373-1382.1988; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Liu XQ, 2001, MICROBIOL-SGM, V147, P2981, DOI 10.1099/00221287-147-11-2981; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; LUCKINBILL LS, 1978, SCIENCE, V202, P1201, DOI 10.1126/science.202.4373.1201; Madrid RE, 2005, CRIT REV BIOTECHNOL, V25, P97, DOI 10.1080/07388550500248563; Matsumoto Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-808; MIKKOLA R, 1992, MOL BIOL EVOL, V9, P394; MUKAMOLOVA GV, 1995, ARCH MICROBIOL, V163, P373, DOI 10.1007/BF00404211; Nystrom T, 1996, EMBO J, V15, P3219, DOI 10.1002/j.1460-2075.1996.tb00686.x; Nystrom T, 2003, BIOESSAYS, V25, P204, DOI 10.1002/bies.10233; Nystrom T, 1998, FEMS MICROBIOL REV, V21, P283, DOI 10.1111/j.1574-6976.1998.tb00354.x; Nystrom T, 1998, BBA-BIOENERGETICS, V1365, P225, DOI 10.1016/S0005-2728(98)00072-3; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Phan K, 2013, ISME J, V7, P2034, DOI 10.1038/ismej.2013.82; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Ryall B, 2012, MICROBIOL MOL BIOL R, V76, P597, DOI 10.1128/MMBR.05028-11; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stevens MHH, 2007, GENETICS, V177, P2243, DOI 10.1534/genetics.107.076869; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Szekely P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003163; Tsuru S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.24; Usui K, 2014, FEBS LETT, V588, P117, DOI 10.1016/j.febslet.2013.11.018; Vulic M, 2001, GENETICS, V158, P519; Watson SP, 1998, J BACTERIOL, V180, P1750, DOI 10.1128/JB.180.7.1750-1758.1998; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; Ying BW, 2014, MOL BIOSYST, V10, P375, DOI 10.1039/c3mb70254e; Ying BW, 2010, J BIOSCI BIOENG, V110, P529, DOI 10.1016/j.jbiosc.2010.05.014; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zinser ER, 2004, RES MICROBIOL, V155, P328, DOI 10.1016/j.resmic.2004.01.014; Zinser ER, 1999, J BACTERIOL, V181, P5800, DOI 10.1128/JB.181.18.5800-5807.1999; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	80	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135639	10.1371/journal.pone.0135639	http://dx.doi.org/10.1371/journal.pone.0135639			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292224	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900023
J	Hoshiba, T; Nemoto, E; Sato, K; Orui, T; Otaki, T; Yoshihiro, A; Tanaka, M				Hoshiba, Takashi; Nemoto, Eri; Sato, Kazuhiro; Orui, Toshihiko; Otaki, Takayuki; Yoshihiro, Ayano; Tanaka, Masaru			Regulation of the Contribution of Integrin to Cell Attachment on Poly(2-Methoxyethyl Acrylate) (PMEA) Analogous Polymers for Attachment-Based Cell Enrichment	PLOS ONE			English	Article							FIBRONECTIN ADSORPTION; BLOOD COMPATIBILITY; PROTEIN ADSORPTION; WATER-STRUCTURE; ADHESION; EXPRESSION; CADHERIN; BINDING; SURFACE	Cell enrichment is currently in high demand in medical engineering. We have reported that non-blood cells can attach to a blood-compatible poly(2-methoxyethyl acrylate) (PMEA) substrate through integrin-dependent and integrin-independent mechanisms because the PMEA substrate suppresses protein adsorption. Therefore, we assumed that PMEA analogous polymers can change the contribution of integrin to cell attachment through the regulation of protein adsorption. In the present study, we investigated protein adsorption, cell attachment profiles, and attachment mechanisms on PMEA analogous polymer substrates. Additionally, we demonstrated the possibility of attachment-based cell enrichment on PMEA analogous polymer substrates. HT-1080 and MDA-MB-231 cells started to attach to poly(butyl acrylate) (PBA) and poly(tetrahydrofurfuryl acrylate) (PTHFA), on which proteins could adsorb well, within 1 h. HepG2 cells started to attach after 1 h. HT-1080, MDA-MB-231, and HepG2 cells started to attach within 30 min to PMEA, poly(2-(2-methoxyethoxy) ethyl acrylate-co-butyl acrylate) (30:70 mol%, PMe2A) and poly(2-(2-methoxyethoxy) ethoxy ethyl acrylate-co-butyl acrylate) (30: 70 mol%, PMe3A), which suppress protein adsorption. Moreover, the ratio of attached cells from a cell mixture can be changed on PMEA analogous polymers. These findings suggested that PMEA analogous polymers can be used for attachment-based cell enrichment.	[Hoshiba, Takashi; Nemoto, Eri; Sato, Kazuhiro; Orui, Toshihiko; Otaki, Takayuki; Tanaka, Masaru] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan; [Hoshiba, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan; [Yoshihiro, Ayano] Yamagata Univ, Dept Biochem Engn, Yonezawa, Yamagata, Japan; [Tanaka, Masaru] Kyushu Univ, Inst Mat Chem & Engn, Nishi Ku, Fukuoka 812, Japan	Yamagata University; National Institute for Materials Science; Yamagata University; Kyushu University	Hoshiba, T (corresponding author), Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan.	thoshiba@yz.yamagata-u.ac.jp; masaru_tanaka@ms.ifoc.kyushu-u.ac.jp	Tanaka, Masaru/O-3388-2018	Tanaka, Masaru/0000-0002-1115-2080	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT, Japan [26702016]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Funding Program for the Next Generation World-Leading Researchers (NEXT Program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and a Grant-in-Aid for Young Scientists (A) (26702016) from MEXT, Japan.	Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008; Elvington ES, 2013, JOVE-J VIS EXP, DOI 10.3791/50634; Goessler UR, 2006, OTOLARYNG HEAD NECK, V134, P510, DOI 10.1016/j.otohns.2005.10.026; GRINNELL F, 1982, J BIOL CHEM, V257, P4888; Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018; Hoshiba T, 2014, ADV HEALTHC MATER, V3, P775, DOI 10.1002/adhm.201300309; Jasaitis A, 2012, BIOPHYS J, V103, P175, DOI 10.1016/j.bpj.2012.06.009; Jaye DL, 2012, J IMMUNOL, V188, P4715, DOI 10.4049/jimmunol.1290017; Kai Z, 2014, STEM CELLS DEV, V23, P1340, DOI [10.1089/scd.2013.0510, DOI 10.1089/SCD.2013.0510]; Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537; Kikkawa Y, 2009, BIOMATERIALS, V30, P6888, DOI 10.1016/j.biomaterials.2009.09.011; Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Mahara A, 2010, BIOMATERIALS, V31, P4231, DOI 10.1016/j.biomaterials.2010.01.126; Mochizuki A, 2009, J BIOMAT SCI-POLYM E, V20, P591, DOI 10.1163/156856209X426411; Sato K, MACROMOL BI IN PRESS; Sheng WA, 2012, ANAL CHEM, V84, P4199, DOI 10.1021/ac3005633; Singh A, 2013, NAT METHODS, V10, P438, DOI [10.1038/nmeth.2437, 10.1038/NMETH.2437]; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088; Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3; Tanaka M, 2013, POLYM J, V45, P701, DOI 10.1038/pj.2012.229; Tian J, RHEUMATOL I IN PRESS; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; UNDERWOOD PA, 1989, J CELL SCI, V93, P641; Wadajkar AS, 2014, BIOMATERIALS, V35, P654, DOI 10.1016/j.biomaterials.2013.10.015; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yoon DS, 2014, FASEB J, V28, P3273, DOI 10.1096/fj.13-248567; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhu BL, 2013, CURR OPIN CHEM ENG, V2, P3, DOI 10.1016/j.coche.2012.11.002	30	31	31	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136066	10.1371/journal.pone.0136066	http://dx.doi.org/10.1371/journal.pone.0136066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288362	gold, Green Published, Green Submitted			2022-12-27	WOS:000360018600104
J	Itkonen, T; Pekkanen, J; Lappi, O				Itkonen, Teemu; Pekkanen, Jami; Lappi, Otto			Driver Gaze Behavior Is Different in Normal Curve Driving and when Looking at the Tangent Point	PLOS ONE			English	Article							MODEL	Several steering models in the visual science literature attempt to capture the visual strategies in curve driving. Some of them are based on steering points on the future path (FP), others on tangent points (TP). It is, however, challenging to differentiate between the models' predictions in real-world contexts. Analysis of optokinetic nystagmus (OKN) parameters is one useful measure, as the different strategies predict measurably different OKN patterns. Here, we directly test this prediction by asking drivers to either a) "drive as they normally would" or b) to "look at the TP". The design of the experiment is similar to a previous study by Kandil et al., but uses more sophisticated methods of eye-movement analysis. We find that the eye-movement patterns in the "normal" condition are indeed markedly different from the "tp" condition, and consistent with drivers looking at waypoints on the future path. This is the case for both overall fixation distribution, as well as the more informative fixation-by-fixation analysis of OKN. We find that the horizontal gaze speed during OKN corresponds well to the quantitative prediction of the future path models. The results also definitively rule out the alternative explanation that the OKN is produced by an involuntary reflex even while the driver is "trying" to look at the TP. The results are discussed in terms of the sequential organization of curve driving.	[Itkonen, Teemu; Pekkanen, Jami; Lappi, Otto] Univ Helsinki, Inst Behav Sci, Cognit Sci Div, Traff Res Unit, Helsinki, Finland; [Itkonen, Teemu] Aalto Univ, Dept Civil & Environm Engn, Transportat Engn, Aalto, Finland	University of Helsinki; Aalto University	Lappi, O (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Sci Div, Traff Res Unit, Helsinki, Finland.	otto.lappi@helsinki.fi	Lappi, Otto/I-2295-2019	Lappi, Otto/0000-0002-7996-7665; Pekkanen, Jami/0000-0001-6974-8760	Finnish Academy [1279905]	Finnish Academy(Academy of Finland)	Funding: Mr. Jami Pekkanen was employed in MULSIMCO project funded by the Finnish Academy (www.aka.fi, project no. 1279905 PI prof. Heikki Summala). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authie CN, 2010, VISION RES, V51, P1791; Authie CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031479; Boer ER, 1996, PROCEEDINGS OF THE 1996 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P7, DOI 10.1109/IVS.1996.566341; Bradski G., 2000, DOBBS J SOFTWARE TOO; DONGES E, 1978, HUM FACTORS, V20, P691, DOI 10.1177/001872087802000607; Jackson B, 2005, IEEE SIGNAL PROC LET, V12, P105, DOI 10.1109/LSP.2001.838216; Kandil FI, 2009, J VISION, V9, DOI 10.1167/9.1.11; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Kim NG, 1999, ECOL PSYCHOL, V11, P233, DOI 10.1207/s15326969eco1103_3; Land M. F., 1998, VISION AND ACTION, P163, DOI DOI 10.1016/S0960-9822(01)0; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappi O, 2013, THESIS U HELSINKI; Lappi O, 2014, J VISION, V14, DOI 10.1167/14.12.21; Lappi O, 2013, J EYE MOVEMENT RES, V6; Lappi O, 2013, J VISION, V13, DOI 10.1167/13.13.11; Lappi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068326; Raviv D., 1991, Proceedings of the IEEE Workshop on Visual Motion (Cat. No.91TH0390-5), P217, DOI 10.1109/WVM.1991.212804; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; Wann J, 2000, TRENDS COGN SCI, V4, P319, DOI 10.1016/S1364-6613(00)01513-8; Wann J. P., 2004, OPTIC FLOW, P371; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; Wilkie RM, 2008, J EXP PSYCHOL HUMAN, V34, P1150, DOI 10.1037/0096-1523.34.5.1150	22	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135505	10.1371/journal.pone.0135505	http://dx.doi.org/10.1371/journal.pone.0135505			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287914	Green Published, gold, Green Submitted			2022-12-27	WOS:000360018600051
J	Carvalho, MAM; Saintrain, MVD; Dos Anjos, RED; Pinheiro, SS; Cardoso, LDP; Moizan, JAH; de Aguiar, ASW				Melo Carvalho Filho, Marcus Antonio; de Lima Saintrain, Maria Vieira; da Silveira Dos Anjos, Rita Edna; Pinheiro, Solange Sousa; Padua Cardoso, Luciana de Carvalho; Herve Moizan, Jean Andre; Walter de Aguiar, Andrea Silvia			Prevalence of Oral and Maxillofacial Trauma in Elders Admitted to a Reference Hospital in Northeastern Brazil	PLOS ONE			English	Article							POPULATION	Objective To know the prevalence and etiology of oral and maxillofacial trauma in elders. Methods Analytical quantitative cross-sectional study conducted at a public trauma hospital located in Fortaleza-Ceara, Brazil. The study population comprised patients with trauma who were hospitalized from April to August 2014. Of these patients, patients with oral and maxillofacial trauma were chosen to be included in the research. A questionnaire was administered in order to obtain information on socio-demographics, systemic comorbidities, use of medication, deleterious habits (smoking and alcohol consumption), etiology of oral and maxillofacial trauma and type of pre-hospital care. Results Of the 280 elderly hospitalized with trauma, 47 had oral and maxillofacial trauma, with a prevalence of 16.8%. In this group, the age ranged from 60 to 88 years, with a mean age of 72.4 years (SD +/- 8.38). The elderly were mostly women (55.3%), self-declared pardos (53.2%), who presented with cardiovascular disorders (48.9%), and who received formal pre-hospital care (70.2%). Elderly who were in the 60-69 years age group, spent 6-9 years at school and drank alcohol were 2.64, 3.75, and 1.97, respectively, more likely to suffer oral and maxillofacial trauma. The main causes of trauma were physical aggression, traffic accidents, falls and domestic accidents. All of the physical aggressions resulted in oral and maxillofacial traumas, and the elderly who suffered traffic accidents were four times more likely to have oral and maxillofacial trauma. Conclusion The prevalence of 16.8% and the lack of research on oral and maxillofacial traumas in the elderly is worrisome and should be included in the oral health indicators for the elderly population to support the importance of oral health.	[Melo Carvalho Filho, Marcus Antonio; da Silveira Dos Anjos, Rita Edna; Pinheiro, Solange Sousa; Padua Cardoso, Luciana de Carvalho] Univ Fortaleza UNIFOR, Collect Hlth Masters Degree Program, Ctr Hlth Sci, Fortaleza, Ceara, Brazil; [de Lima Saintrain, Maria Vieira] Univ Fortaleza UNIFOR, Ctr Hlth Sci, Fortaleza, Ceara, Brazil; [Herve Moizan, Jean Andre] Univ Rouen, Rouen Univ Hosp, Dept Dent, Rouen, France; [Walter de Aguiar, Andrea Silvia] Univ Fed Ceara, Dent Clin Dept, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Universidade Fortaleza; CHU de Rouen; Universite de Rouen Normandie; Universidade Federal do Ceara	Saintrain, MVD (corresponding author), Univ Fortaleza UNIFOR, Ctr Hlth Sci, Fortaleza, Ceara, Brazil.	mariavieira@yahoo.com.br			Coordination for the Improvement of Higher Education Personnel (CAPES-PRODAD)	Coordination for the Improvement of Higher Education Personnel (CAPES-PRODAD)	Funding: This study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES-PRODAD), for the scholarship provided to co-authors LCPC and SSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qamachi LH, 2012, GERODONTOLOGY, V29, pE147, DOI 10.1111/j.1741-2358.2010.00431.x; Almasri M, 2013, SAUDI DENT J, V25, P107, DOI 10.1016/j.sdentj.2013.04.001; [Anonymous], 2022, TABLES 84F0209X MORT; Brasil, 2006, DIARIO OFICIAL UNIAO; Brasil, 2012, SAUD BRAS 2011 AN SI; Brasil, 2011, SAUD BRAS 2010 AN SI; Chrcanovic BR, 2008, REV ABO NACL, V16, P39; Zaitune MPD, 2012, CAD SAUDE PUBLICA, V28, P583; dos Reis LA, 2011, TEXTO CONTEXTO ENFER, V20, P52, DOI 10.1590/S0104-07072011000500006; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Gowing R, 2007, CAN J SURG, V50, P437; Guarnizo-Herreno CC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-827; Hsia RY, 2011, ARCH SURG-CHICAGO, V146, P585, DOI 10.1001/archsurg.2010.311; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2012, CENS DEM 2010 RES GE; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2014, PESQ NAC AM DOM SINT; Iwaki-Filho L, 2010, REV ODONTOL UNESP, V39, P363; Kapoor Pranav, 2012, Int J Crit Illn Inj Sci, V2, P6, DOI 10.4103/2229-5151.94872; Kara H, 2014, CLIN INTERV AGING, V9, P17, DOI 10.2147/CIA.S56542; Lima Rogério Silva, 2011, Rev. esc. enferm. USP, V45, P659; Maliska Maximiana Cristina de Souza, 2009, Braz. oral res., V23, P268, DOI 10.1590/S1806-83242009000300008; Martinez AY, 2014, J ORAL MAXIL SURG, V72, P750, DOI 10.1016/j.joms.2013.11.018; Organisation Mondiale de la Sante (OMS), 2009, FEMM SANT REAL AUJ P; Paes Jefferson Viapiana, 2012, Indian J Dent Res, V23, P80, DOI 10.4103/0970-9290.99045; Rahman NA, 2010, GERIATR GERONTOL INT, V10, P64, DOI 10.1111/j.1447-0594.2009.00561.x; Rodrigues J, 2012, REV ESC ENFERM USP, V46, P1401; Leles JLR, 2010, J APPL ORAL SCI, V18, P23, DOI 10.1590/S1678-77572010000100006; Secretaria da Saude do Ceara (SESA), 2014, HOSP REG CAR REF CIR; Silva Andréia Lobato da, 2006, Rev. bras. epidemiol., V9, P242, DOI 10.1590/S1415-790X2006000200011; Soares MDA, 2012, SAUDE IDOSOESTUDOS P; Sociedade Brasileira de Diabetes (SBD), 2014, DIR SOC BRAS DIAB 20; Thoren H, 2010, INT J ORAL MAX SURG, V39, P774, DOI 10.1016/j.ijom.2010.03.024; United Nations Population Division, WORLD POP PROSP 2010; Velayutham L, 2013, BRIT J ORAL MAX SURG, V51, P128, DOI 10.1016/j.bjoms.2012.05.003; Veras R., 2008, TERCEIRA IDADE GESTA; Watts Hannah F, 2012, J Emerg Trauma Shock, V5, P131, DOI 10.4103/0974-2700.96481; World Health Organization, WHO GLOB BURD COR HE; Wulkan Marcelo, 2005, Rev. Assoc. Med. Bras., V51, P290, DOI 10.1590/S0104-42302005000500022; Yamamoto K, 2011, J ORAL MAXIL SURG, V69, P2204, DOI 10.1016/j.joms.2011.02.115; Yildiz M, 2012, EUR REV MED PHARMACO, V16, P62	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135813	10.1371/journal.pone.0135813	http://dx.doi.org/10.1371/journal.pone.0135813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288229	Green Published, gold			2022-12-27	WOS:000360018600072
J	Bailes, F; Dean, RT; Broughton, MC				Bailes, Freya; Dean, Roger T.; Broughton, Mary C.			How Different Are Our Perceptions of Equal-Tempered and Microtonal Intervals? A Behavioural and EEG Survey	PLOS ONE			English	Article							SENSORY CONSONANCE; MOVEMENT TIME; MUSICIANS; NONMUSICIANS; POTENTIALS; CONTEXT; ERP	For listeners familiar with Western twelve-tone equal-tempered (12-TET) music, a novel microtonal tuning system is expected to present additional processing challenges. We aimed to determine whether this was the case, focusing on the extent to which our perceptions can be considered bottom-up (psychoacoustic and primarily perceptual) and top-down (dependent on familiarity and cognitive processing). We elicited both overt response ratings, and covert event-related potentials (ERPs), so as to compare subjective impressions of sounds with the neurophysiological processing of the acoustic signal. We hypothesised that microtonal intervals are perceived differently from 12-TET intervals, and that the responses of musicians (n = 10) and non-musicians (n = 10) are distinct. Two-note chords were presented comprising 12-TET intervals (consonant and dissonant) or microtonal (quarter tone) intervals, and ERP, subjective roughness ratings, and liking ratings were recorded successively. Musical experience mediated the perception of differences between dissonant and microtone intervals, with non-musicians giving similar ratings for each, and musicians preferring dissonant over the less commonly used microtonal intervals, rating them as less rough. ERP response amplitude was greater for consonant intervals than other intervals. Musical experience interacted with interval type, suggesting that musical expertise facilitates the sensory and perceptual discrimination of microtonal intervals from 12-TET intervals, and an increased ability to categorize such intervals. Non-musicians appear to have perceived microtonal intervals as instances of neighbouring 12-TET intervals.	[Bailes, Freya] Univ Hull, Sch Drama Mus & Screen, Kingston Upon Hull HU6 7RX, N Humberside, England; [Dean, Roger T.] Univ Western Sydney, MARCS Inst, Penrith, NSW 1797, Australia; [Broughton, Mary C.] Univ Queensland, Sch Mus, Brisbane, Qld, Australia	University of Hull; Western Sydney University; University of Queensland	Bailes, F (corresponding author), Univ Hull, Sch Drama Mus & Screen, Kingston Upon Hull HU6 7RX, N Humberside, England.	F.Bailes@hull.ac.uk	Broughton, Mary/C-2861-2014	Broughton, Mary/0000-0003-3490-6073; Bailes, Freya/0000-0003-2723-3579; Dean, Roger Thornton/0000-0002-8859-8902				Bates D.M., 2010, LME4 MIXED EFFECTS M; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Brattico E, 2001, MUSIC PERCEPT, V19, P199, DOI 10.1525/mp.2001.19.2.199; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Dean RT, 2009, LEONARDO, V42, P94, DOI 10.1162/leon.2009.42.1.94; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; Hasegawa R, 2006, CONT MUSIC REV, V25, P263; HOULIHAN M, 1994, INTELLIGENCE, V18, P289, DOI 10.1016/0160-2896(94)90031-0; Itoh K, 2008, ICMPC10; Itoh K, 2010, J ACOUST SOC AM, V128, P3781, DOI 10.1121/1.3500685; Klein ME, 2011, NEUROPSYCHOLOGIA, V49, P878, DOI 10.1016/j.neuropsychologia.2011.01.008; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Kung CC, 2014, CLIN NEUROPHYSIOL, V125, P971, DOI 10.1016/j.clinph.2013.10.016; Luck S, 2005, EVENTRELATED POTENTI, P17; Minati L, 2009, NEUROREPORT, V20, P87, DOI 10.1097/WNR.0b013e32831af235; Ollen J. E., 2006, CRITERION RELATED VA; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Regnault P, 2001, J COGNITIVE NEUROSCI, V13, P241, DOI 10.1162/089892901564298; Schon D, 2005, MUSIC PERCEPT, V23, P105, DOI 10.1525/mp.2005.23.2.105; Thompson WF, 2015, MUSIC THOUGHT FEELIN; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805	23	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135082	10.1371/journal.pone.0135082	http://dx.doi.org/10.1371/journal.pone.0135082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285010	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100021
J	Minguet, EG; Segard, S; Charavay, C; Parcy, F				Minguet, Eugenio Gomez; Segard, Stephane; Charavay, Celine; Parcy, Francois			MORPHEUS, a Webtool for Transcription Factor Binding Analysis Using Position Weight Matrices with Dependency	PLOS ONE			English	Article							FLORAL HOMEOTIC GENE; WEB TOOL; DNA; EVOLUTION; SITES; ACTIVATION; IDENTIFICATION; AFFINITIES; SEQUENCES	Transcriptional networks are central to any biological process and changes affecting transcription factors or their binding sites in the genome are a key factor driving evolution. As more organisms are being sequenced, tools are needed to easily predict transcription factor binding sites (TFBS) presence and affinity from mere inspection of genomic sequences. Although many TFBS discovery algorithms exist, tools for using the DNA binding models they generate are relatively scarce and their use is limited among the biologist community by the lack of flexible and user-friendly tools. We have developed a suite of web tools (called Morpheus) based on the proven Position Weight Matrices (PWM) formalism that can be used without any programing skills and incorporates some unique features such as the presence of dependencies between nucleotides positions or the possibility to compute the predicted occupancy of a large regulatory region using a biophysical model. To illustrate the possibilities and simplicity of Morpheus tools in functional and evolutionary analysis, we have analysed the regulatory link between LEAFY, a key plant transcription factor involved in flower development, and its direct target gene APETALA1 during the divergence of Brassicales clade.	[Minguet, Eugenio Gomez; Parcy, Francois] Univ Grenoble 1, CEA, INRA, Physiol Cellulaire Vegetale Lab,CNRS,UMR 5168, F-38054 Grenoble, France; [Segard, Stephane; Charavay, Celine] Univ Grenoble 1, CEA, Lab Biol Grande Echelle, INSERM,U1038,IRTSV, F-38054 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Parcy, F (corresponding author), Univ Grenoble 1, CEA, INRA, Physiol Cellulaire Vegetale Lab,CNRS,UMR 5168, F-38054 Grenoble, France.	francois.parcy@cea.fr	Minguet, Eugenio G/L-4037-2014; Parcy, François/G-9177-2011	Minguet, Eugenio G/0000-0003-0568-4299; Parcy, François/0000-0003-2191-500X	Charmful Program from the Agence Nationale de la Recherche Program [ANR11-BSV2-005-01]; ATIP+ Program from the Centre National de la Recherche Scientifique	Charmful Program from the Agence Nationale de la Recherche Program(French National Research Agency (ANR)); ATIP+ Program from the Centre National de la Recherche Scientifique	This work was supported by the Charmful Program (ANR11-BSV2-005-01) from the Agence Nationale de la Recherche Program to FP and an ATIP+ Program from the Centre National de la Recherche Scientifique to FP and EGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020059; Benlloch R, 2011, PLANT J, V67, P1094, DOI 10.1111/j.1365-313X.2011.04660.x; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fourquin C, 2012, PLANT J, V71, P990, DOI 10.1111/j.1365-313X.2012.05046.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Hames C, 2008, EMBO J, V27, P2628, DOI 10.1038/emboj.2008.184; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Lee C, 2013, BIOTECHNIQUES, V54, P141, DOI 10.2144/000113999; Litt A, 2003, GENETICS, V165, P821; Liu C, 2009, DEVELOPMENT, V136, P3379, DOI 10.1242/dev.033076; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Mathelier A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003214; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Moyroud E, 2011, PLANT CELL, V23, P1293, DOI 10.1105/tpc.111.083329; Moyroud E, 2010, TRENDS PLANT SCI, V15, P346, DOI 10.1016/j.tplants.2010.03.007; O'Flanagan RA, 2005, BIOINFORMATICS, V21, P2254, DOI 10.1093/bioinformatics/bti361; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Purugganan MD, 1997, J MOL EVOL, V45, P392, DOI 10.1007/PL00006244; Purugganan MD, 1998, P NATL ACAD SCI USA, V95, P8130, DOI 10.1073/pnas.95.14.8130; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Sayou C, 2014, SCIENCE, V343, P645, DOI 10.1126/science.1248229; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Serwatowska J, 2014, PLOS ONE IN PRESS; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; Stormo Gary D, 2013, Quant Biol, V1, P115; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685	43	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135586	10.1371/journal.pone.0135586	http://dx.doi.org/10.1371/journal.pone.0135586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285209	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100047
J	Portis, E; Cericola, F; Barchi, L; Toppino, L; Acciarri, N; Pulcini, L; Sala, T; Lanteri, S; Rotino, GL				Portis, Ezio; Cericola, Fabio; Barchi, Lorenzo; Toppino, Laura; Acciarri, Nazzareno; Pulcini, Laura; Sala, Tea; Lanteri, Sergio; Rotino, Giuseppe Leonardo			Association Mapping for Fruit, Plant and Leaf Morphology Traits in Eggplant	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RNA-BINDING PROTEINS; QTL ANALYSIS; PECTIN METHYLESTERASES; LINKAGE DISEQUILIBRIUM; GENE-FUNCTION; TOMATO; SIZE; IDENTIFICATION; EVOLUTION	An eggplant (Solanum melongena) association panel of 191 accessions, comprising a mixture of breeding lines, old varieties and landrace selections was SNP genotyped and pheno-typed for key breeding fruit and plant traits at two locations over two seasons. A genomewide association (GWA) analysis was performed using the mixed linear model, which takes into account both a kinship matrix and the sub-population membership of the accessions. Overall, 194 phenotype/genotype associations were uncovered, relating to 30 of the 33 measured traits. These associations involved 79 SNP loci mapping to 39 distinct chromosomal regions distributed over all 12 eggplant chromosomes. A comparison of the map positions of these SNPs with those of loci derived from conventional linkage mapping showed that GWA analysis both validated many of the known controlling loci and detected a large number of new marker/trait associations. Exploiting established syntenic relationships between eggplant chromosomes and those of tomato and pepper recognized orthologous regions in ten eggplant chromosomes harbouring genes influencing breeders' traits.	[Portis, Ezio; Cericola, Fabio; Barchi, Lorenzo; Lanteri, Sergio] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari DISAF, I-10095 Turin, Italy; [Cericola, Fabio; Toppino, Laura; Sala, Tea; Rotino, Giuseppe Leonardo] Consiglio Ric Agr & Anal Econ Agr CREA, Res Unit Vegetable Crops, I-26836 Lodi, Italy; [Acciarri, Nazzareno; Pulcini, Laura] Consiglio Ric Agr & Anal Econ Agr CREA, Res Unit Vegetable Crops, I-63030 Monsampolo Del Tronto, Ascoli Piceno, Italy	University of Turin; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Rotino, GL (corresponding author), Consiglio Ric Agr & Anal Econ Agr CREA, Res Unit Vegetable Crops, I-26836 Lodi, Italy.	giuseppeleonardo.rotino@entecra.it	BARCHI, Lorenzo/ABC-4206-2020; Sala, Tea/AAA-4156-2021	BARCHI, Lorenzo/0000-0001-6414-4239; PORTIS, Ezio/0000-0002-1548-6096; Toppino, Laura/0000-0002-8664-1233; PULCINI, LAURA/0000-0002-8335-4108; Acciarri, Nazzareno/0000-0002-0892-5994	Italian Ministry of Agricultural Alimentary and Forest Politics	Italian Ministry of Agricultural Alimentary and Forest Politics	This research was partially supported by the Italian Ministry of Agricultural Alimentary and Forest Politics in the framework of the "ESPLORA" project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi N, 2011, PLANT SIGNAL BEHAV, V6, P364, DOI 10.4161/psb.6.3.14380; Ano G., 2001, TROPICAL PLANT BREED, P200; [Anonymous], 2014, R LANG ENV STAT COMP; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Barchi L, 2009, THEOR APPL GENET, V118, P1157, DOI 10.1007/s00122-009-0970-0; Barrero LS, 2004, THEOR APPL GENET, V109, P669, DOI 10.1007/s00122-004-1676-y; Ben Chaim A, 2001, THEOR APPL GENET, V102, P1016, DOI 10.1007/s001220000461; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Cagas C. C., 2008, Journal of Applied Horticulture (Lucknow), V10, P106; Cericola F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-896; Cericola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073702; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Doganlar S, 2002, GENETICS, V161, P1713; ECPGR, 2008, MIN DESCR EGGPL CAPS; Francischini CW, 2009, FEBS J, V276, P5456, DOI 10.1111/j.1742-4658.2009.07230.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Frary A, 2004, THEOR APPL GENET, V108, P485, DOI 10.1007/s00122-003-1422-x; Frary A, 2003, THEOR APPL GENET, V107, P359, DOI 10.1007/s00122-003-1257-5; Frary A, 2006, E GENOME MAPPING MOL, VV; Frary A, 2014, EUPHYTICA, V197, P211, DOI 10.1007/s10681-013-1060-6; Ge HY, 2013, SCI HORTIC-AMSTERDAM, V162, P71, DOI 10.1016/j.scienta.2013.08.004; Gramazio P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0350-z; Grandillo S, 1999, THEOR APPL GENET, V99, P978, DOI 10.1007/s001220051405; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Huang ZJ, 2011, THEOR APPL GENET, V123, P465, DOI 10.1007/s00122-011-1599-3; IBPGR, 1990, PLANT GENETIC RESOUR; Kashyap V, 2003, SCI HORTIC-AMSTERDAM, V97, P1, DOI 10.1016/S0304-4238(02)00140-1; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Ku HM, 2000, THEOR APPL GENET, V101, P873, DOI 10.1007/s001220051555; Laux T, 1996, DEVELOPMENT, V122, P87; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lippman Z, 2001, GENETICS, V158, P413; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Moussian B, 2003, DEV GENES EVOL, V213, P534, DOI 10.1007/s00427-003-0359-z; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Portis E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089499; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tam PPC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-44; TUCKER G, 2004, TEXTURE FOODS, V2, P321; Vivian-Smith A, 2001, DEVELOPMENT, V128, P2321; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang YC, 2005, PLANT GROWTH REGUL, V46, P97, DOI 10.1007/s10725-005-7358-1; Wu FN, 2009, THEOR APPL GENET, V118, P927, DOI 10.1007/s00122-008-0950-9; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Xiao H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-49; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zygier S, 2005, THEOR APPL GENET, V111, P437, DOI 10.1007/s00122-005-2015-7	59	39	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135200	10.1371/journal.pone.0135200	http://dx.doi.org/10.1371/journal.pone.0135200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284782	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100027
J	Shen, JL; Xu, LF; Zhang, BL; Hu, ZM				Shen, Jieliang; Xu, Linfei; Zhang, Baolong; Hu, Zhenming			Risk Factors for the Failure of Spinal Burst Fractures Treated Conservatively According to the Thoracolumbar Injury Classification and Severity Score (TLICS): A Retrospective Cohort Trial	PLOS ONE			English	Article							POSTERIOR LIGAMENTOUS COMPLEX; PROGRESSIVE KYPHOTIC DEFORMITY; NONOPERATIVE TREATMENT; ACHILLES-TENDON; SYSTEM; RELIABILITY; VALIDITY; MORPHOLOGY; MECHANISM; INTEGRITY	Background The management of thoracolumbar (TL) burst fractures is still controversial. The thoracolumbar injury classification and severity score (TLICS) algorithm is now widely used to guide clinical decision making, however, in clinical practice, we come to realize that TLICS also has its limitations for treating patients with total scores less than 4, for which conservative treatment may not be optimal in all cases. Purpose The aim of this study is to identify several risk factors for the failure of conservative treatment of TL burst fractures according to TLICS algorithm. Methods From June 2008 to December 2013, a cohort of 129 patients with T10-l2 TL burst fractures with a TLISC score <= 3 treated non-operatively were identified and included into this retrospective study. Age, sex, pain intensity, interpedicular distance (IPD), canal compromise, loss of vertebral body height and kyphotic angle (KA) were selected as potential risk factors and compared between the non-operative success group and the non-operative failure group. Results One hundred and four patients successfully completed non-operative treatment, the other 25 patients were converted to surgical treatment because of persistent local back pain or progressive neurological deficits during follow-up. Our results showed that age, visual analogue scale (VAS) score and IPD, KA were significantly different between the two groups. Furthermore, regression analysis indicated that VAS score and IPD could be considered as significant predictors for the failure of conservative treatment. Conclusion The recommendation of non-operative treatment for TLICS score <= 3 has limitations in some patients, and VAS score and IPD could be considered as risk factors for the failure of conservative treatment. Thus, conservative treatment should be decided with caution in patients with greater VAS scores or IPD. If non-operative management is decided, a close follow-up is necessary.	[Shen, Jieliang; Hu, Zhenming] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing 400016, Peoples R China; [Xu, Linfei; Zhang, Baolong] Peoples Hosp Zhengzhou, Dept Orthopaed Surg, Zhengzhou 450003, Henan Province, Peoples R China	Chongqing Medical University	Zhang, BL (corresponding author), Peoples Hosp Zhengzhou, Dept Orthopaed Surg, 33 Huanghe Rd, Zhengzhou 450003, Henan Province, Peoples R China.	blzhang111@163.com; spinecenter_hu@126.com						Bailey CS, 2014, SPINE J, V14, P2557, DOI 10.1016/j.spinee.2013.10.017; Bensch FV, 2006, EMERG RADIOL, V12, P124, DOI 10.1007/s0010140-005-0457-5; DENIS F, 1983, SPINE, V8, P817, DOI 10.1097/00007632-198311000-00003; Haba H, 2003, J NEUROSURG, V99, P20, DOI 10.3171/spi.2003.99.1.0020; Harrop JS, 2006, J NEUROSURG-SPINE, V4, P118, DOI 10.3171/spi.2006.4.2.118; Joaquim AF, 2013, SPINE J, V13, P1760, DOI 10.1016/j.spinee.2013.03.014; Mattei TA, 2014, EUR SPINE J, V23, P2255, DOI 10.1007/s00586-014-3312-0; MUMFORD J, 1993, SPINE, V18, P955, DOI 10.1097/00007632-199306150-00003; NAGEL DA, 1981, J BONE JOINT SURG AM, V63, P62, DOI 10.2106/00004623-198163010-00008; Patel AA, 2007, SPINE, V32, pE105, DOI 10.1097/01.brs.0000254107.57551.8a; Patel AA, 2009, J NEUROSURG-SPINE, V10, P201, DOI 10.3171/2008.12.SPINE08388; PETERSILGE CA, 1995, RADIOLOGY, V194, P49, DOI 10.1148/radiology.194.1.7997581; Pizones J, 2013, SPINE, V38, P745, DOI 10.1097/BRS.0b013e31827934e4; Radcliff K, 2012, SPINE, V37, P1142, DOI 10.1097/BRS.0b013e318240fcd3; Rampersaud YR, 2006, J SPINAL DISORD TECH, V19, P477, DOI 10.1097/01.bsd.0000211237.14211.21; Reinhold M, 2010, EUR SPINE J, V19, P1657, DOI 10.1007/s00586-010-1451-5; Schnake KJ, 2014, EUR SPINE J, V23, P2263, DOI 10.1007/s00586-014-3591-5; Schnake KJ, 2014, J NEUROSURG-SPINE, V20, P497, DOI 10.3171/2014.1.SPINE13246; Shen WJ, 2001, SPINE, V26, P1038, DOI 10.1097/00007632-200105010-00010; Siebenga J, 2006, SPINE, V31, P2881, DOI 10.1097/01.brs.0000247804.91869.1e; Caffaro MFS, 2012, SPINE, V37, pE231, DOI 10.1097/BRS.0b013e318237b0cf; Vaccaro AR, 2005, SPINE, V30, P2325, DOI 10.1097/01.brs.0000182986.43345.cb; WEINSTEIN JN, 1988, SPINE, V13, P33, DOI 10.1097/00007632-198801000-00008; Whang PG, 2007, SPINE, V32, P791, DOI 10.1097/01.brs.0000258882.96011.47; Wood K, 2003, J BONE JOINT SURG AM, V85A, P773, DOI 10.2106/00004623-200305000-00001; Wood KB, 2015, J BONE JOINT SURG AM, V97A, P3, DOI 10.2106/JBJS.N.00226	26	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135735	10.1371/journal.pone.0135735	http://dx.doi.org/10.1371/journal.pone.0135735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284373	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100064
J	van der Zwaag, W; Gruetter, R; Martuzzi, R				van der Zwaag, Wietske; Gruetter, Rolf; Martuzzi, Roberto			Stroking or Buzzing? A Comparison of Somatosensory Touch Stimuli Using 7 Tesla fMRI	PLOS ONE			English	Article							HIGH-RESOLUTION FMRI; DIGIT SOMATOTOPY; FUNCTIONAL MRI; CORTEX; FINGER; RESPONSES; AREAS; REPRESENTATIONS; S1; MOTOR	Studying body representations in the brain helps us to understand how we humans relate to our own bodies. The in vivo mapping of the somatosensory cortex, where these representations are found, is greatly facilitated by the high spatial resolution and high sensitivity to brain activation available at ultra-high field. In this study, the use of different stimulus types for somatotopic mapping of the digits at ultra-high field, specifically manual stroking and mechanical stimulation, was compared in terms of sensitivity and specificity of the brain responses. Larger positive responses in digit regions of interest were found for manual stroking than for mechanical stimulation, both in terms of average and maximum t-value and in terms of number of voxels with significant responses to the tactile stimulation. Responses to manual stroking were higher throughout the entire post-central sulcus, but the difference was especially large on its posterior wall, i.e. in Brodmann area 2. During mechanical stimulation, cross-digit responses were more negative than during manual stroking, possibly caused by a faster habituation to the stimulus. These differences indicate that manual stroking is a highly suitable stimulus for fast somatotopic mapping procedures, especially if Brodmann area 2 is of interest.	[van der Zwaag, Wietske; Gruetter, Rolf] Ecole Polytech Fed Lausanne, Ctr Imagerie Biomed CIBM, CH-1015 Lausanne, Switzerland; [van der Zwaag, Wietske] Royal Netherlands Acad Arts & Sci KNAW, Spinoza Ctr Neuroimaging, Amsterdam, Netherlands; [Gruetter, Rolf] Univ Lausanne Hosp, Dept Radiol, Lausanne, Switzerland; [Gruetter, Rolf] Univ Hosp, Dept Radiol, Geneva, Switzerland; [Martuzzi, Roberto] Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [Martuzzi, Roberto] Ecole Polytech Fed Lausanne, Lab Cognit Neurosci, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Martuzzi, Roberto] Fdn Campus Biotech Geneva, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Royal Netherlands Academy of Arts & Sciences; Spinoza Centre for Neuroimaging (KNAW); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Zwaag, W (corresponding author), Ecole Polytech Fed Lausanne, Ctr Imagerie Biomed CIBM, CH-1015 Lausanne, Switzerland.	wietske.vanderzwaag@epfl.ch	van der Zwaag, Wietske/AAU-6268-2020; Gruetter, Rolf/H-6260-2011	van der Zwaag, Wietske/0000-0003-3223-9721; Gruetter, Rolf/0000-0003-1870-4025	Centre d'Imagerie BioMedicale (CIBM) of the UNIL [Universite de Lausanne]; UNIGE [Universite de Geneve]; HUG [Hopitaux Universitaires de Geneve]; CHUV [Centre hospitalier universitaire vaudois]; EPFL[Ecole polytechnique federale de Lausanne]; Leenaards and Jeantet Foundations; Swiss National Science Foundation Project grant	Centre d'Imagerie BioMedicale (CIBM) of the UNIL [Universite de Lausanne]; UNIGE [Universite de Geneve]; HUG [Hopitaux Universitaires de Geneve]; CHUV [Centre hospitalier universitaire vaudois]; EPFL[Ecole polytechnique federale de Lausanne]; Leenaards and Jeantet Foundations; Swiss National Science Foundation Project grant	This work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the UNIL [Universite de Lausanne], UNIGE [Universite de Geneve], HUG [Hopitaux Universitaires de Geneve], CHUV [Centre hospitalier universitaire vaudois], EPFL[Ecole polytechnique federale de Lausanne], and the Leenaards and Jeantet Foundations. Additional support was received in the form of a Swiss National Science Foundation Project grant to WZ: http://p3.snf.ch/project-153070. The 7T scanner of the Centre d'Imagerie Biomedicale in Lausanne, Switzerland was used for data acquisition: www.cibm.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besle J, 2014, HUM BRAIN MAPP, V35, P2027, DOI 10.1002/hbm.22310; Besle J, 2013, J NEUROPHYSIOL, V109, P2293, DOI 10.1152/jn.00499.2012; Blankenburg F, 2003, CEREB CORTEX, V13, P987, DOI 10.1093/cercor/13.9.987; Da Costa S, 2015, BRAIN TOPOGR, V28, P66, DOI 10.1007/s10548-014-0388-0; Dieguez S, 2009, CURR BIOL, V19, pR1108, DOI 10.1016/j.cub.2009.10.055; Francis ST, 2000, NEUROIMAGE, V11, P188, DOI 10.1006/nimg.2000.0541; Francis S, 2014, PHYSIOL MEAS, V35, pR167, DOI 10.1088/0967-3334/35/9/R167; Gallasch E, 2010, NEUROIMAGE, V50, P1067, DOI 10.1016/j.neuroimage.2010.01.014; Gazzola V, 2012, P NATL ACAD SCI USA, V109, pE1657, DOI 10.1073/pnas.1113211109; Geyer S, 2000, NEUROIMAGE, V11, P684, DOI 10.1006/nimg.2000.0548; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Gotz T, 2011, PSYCHOPHYSIOLOGY, V48, P569, DOI 10.1111/j.1469-8986.2010.01116.x; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Huang RS, 2007, NEUROIMAGE, V34, P1060, DOI 10.1016/j.neuroimage.2006.10.024; IWAMURA Y, 1993, EXP BRAIN RES, V92, P360; Kuehn E, 2014, BRAIN STRUCT FUNCT, V219, P119, DOI 10.1007/s00429-012-0489-z; Kurth R, 2000, NEUROREPORT, V11, P1487, DOI 10.1097/00001756-200005150-00025; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Martuzzi R, 2014, HUM BRAIN MAPP, V35, P213, DOI 10.1002/hbm.22172; Martuzzi Roberto, SOC COGN AF IN PRESS; McGlone F, 2002, BEHAV BRAIN RES, V135, P147, DOI 10.1016/S0166-4328(02)00144-4; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Mullinger KJ, 2014, NEUROIMAGE, V94, P263, DOI 10.1016/j.neuroimage.2014.02.029; Nelson AJ, 2008, CEREB CORTEX, V18, P2341, DOI 10.1093/cercor/bhm257; Overduin SA, 2004, NEUROIMAGE, V23, P462, DOI 10.1016/j.neuroimage.2004.06.024; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Ruben J, 2006, CEREB CORTEX, V16, P819, DOI 10.1093/cercor/bhj025; Salomon R, 2014, BRAIN TOPOGR, V27, P209, DOI 10.1007/s10548-013-0298-6; Sanchez-Panchuelo RM, 2010, J NEUROPHYSIOL, V103, P2544, DOI 10.1152/jn.01017.2009; Sanchez-Panchuelo RM, 2012, J NEUROSCI, V32, P15815, DOI 10.1523/JNEUROSCI.2501-12.2012; Sanchez-Panchuelo RM, 2014, NEUROIMAGE, V93, P221, DOI 10.1016/j.neuroimage.2013.03.044; Sanganahalli BG, 2008, NMR BIOMED, V21, P410, DOI 10.1002/nbm.1259; Schweisfurth MA, 2011, NEUROIMAGE, V56, P2138, DOI 10.1016/j.neuroimage.2011.03.038; Schweizer R, 2008, NEUROIMAGE, V42, P28, DOI 10.1016/j.neuroimage.2008.04.184; Stringer EA, 2014, HUM BRAIN MAPP, V35, P4841, DOI 10.1002/hbm.22517; Stringer EA, 2011, NEUROIMAGE, V54, P1012, DOI 10.1016/j.neuroimage.2010.09.058; Trulsson M, 2001, NEUROIMAGE, V13, P613, DOI 10.1006/nimg.2000.0723; van der Zwaag W, 2016, NMR BIOMED, V29, P1274, DOI 10.1002/nbm.3275; van der Zwaag W, 2013, NEUROIMAGE, V67, P354, DOI 10.1016/j.neuroimage.2012.11.041; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; van Westen D, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-28; Vidyasagar R, 2014, NEUROIMAGE, V92, P19, DOI 10.1016/j.neuroimage.2014.01.052; Weibull A, 2008, MAGN RESON IMAGING, V26, P1342, DOI 10.1016/j.mri.2008.04.007; Wiestler T, 2011, J NEUROPHYSIOL, V105, P3042, DOI 10.1152/jn.00106.2011	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134610	10.1371/journal.pone.0134610	http://dx.doi.org/10.1371/journal.pone.0134610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285027	Green Published, gold, Green Submitted			2022-12-27	WOS:000359666100013
J	Zhi, YD; Mou, ZR; Chen, J; He, YJ; Dong, H; Fu, XL; Wu, YZ				Zhi, Yidan; Mou, Zhirong; Chen, Jun; He, Yujun; Dong, Hui; Fu, Xiaolan; Wu, Yuzhang			B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; B7-H1; CD133; EMT; METASTASIS; LIGANDS; PROMISE; EPCAM	Cancer stem cells (CSCs) can invade and metastasize by epithelial-to-mesenchymal transition (EMT). However, how they escape immune surveillance is unclear. B7H1 is crucial negative co-stimulatory molecule but little information about whether it works in CSCs. Therefore, we determined the expression of B7H1 and EMT-associated markers in colorectal cancer stem-like cells to investigate a possible immunoevasion way of CSCs. We enriched CD133(+) colorectal cancer cells which manifested the CSCs-like properties such as higher levels of other stem cell markers Oct-4 and Sox-2, tumor sphere forming ability and more tumorigenic in NOD/SCID mice. These CD133(+) cells possess EMT gene expression profile including higher level of Snail, Twist, vimentin, fibronectin and lower level of E-cadherin. Moreover, CD133(+) cells in both cell line and colorectal cancer tissues expressed high level of negative co-stimulate molecule B7H1. Furthermore, some B7H1(+) cancer cells also showed the characteristic of EMT, indicating EMT cells could escape immune attack during metastasis. B7H1 expression and EMT phenotypes on CSCs indicates a possible immunoevasion way.	[Zhi, Yidan; Mou, Zhirong; Dong, Hui; Fu, Xiaolan; Wu, Yuzhang] Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China; [Chen, Jun] Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China; [He, Yujun] Daping Hosp, Dept Gen Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Mou, ZR (corresponding author), Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China.	mouzr@yahoo.com; wuyuzhang@yahoo.com		Wu, Yuzhang/0000-0002-4049-0214	National Natural Science Foundation of China [30872466]; National Program on Key Basic Research Project (973 Program) of China [2010CB529404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project (973 Program) of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (to ZM, No. 30872466), National Program on Key Basic Research Project (973 Program) of China (to ZM, No. 2010CB529404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biddle A, 2012, CANCER METAST REV, V31, P285, DOI 10.1007/s10555-012-9345-0; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Cao YJ, 2011, CANCER RES, V71, P1235, DOI 10.1158/0008-5472.CAN-10-2217; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Darini CY, 2012, ONCOGENE, V31, P2438, DOI 10.1038/onc.2011.421; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Flies DB, 2007, J IMMUNOTHER, V30, P251, DOI 10.1097/CJI.0b013e31802e085a; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hua D, 2012, WORLD J GASTROENTERO, V18, P971, DOI 10.3748/wjg.v18.i9.971; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; LaBarge MA, 2008, J CLIN INVEST, V118, P2021, DOI 10.1172/JCI36046; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Navarro-Alvarez N, 2010, CELL TRANSPLANT, V19, P865, DOI 10.3727/096368910X508997; O'Brien CA, 2007, ANN SURG ONCOL, V14, P22; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Wen KM, 2013, CANCER LETT, V333, P56, DOI 10.1016/j.canlet.2013.01.009; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Xue ZF, 2012, J CELL BIOCHEM, V113, P302, DOI 10.1002/jcb.23356; Yao Y, 2009, NEURO-ONCOLOGY, V11, P757, DOI 10.1215/15228517-2009-014; Zhang Y, 2012, ONCOL REP, V27, P1599, DOI 10.3892/or.2012.1681; Zhang YF, 2013, HEPATO-GASTROENTEROL, V60, P1766, DOI 10.5754/hge13237; Zhu LF, 2012, LAB INVEST, V92, P744, DOI 10.1038/labinvest.2012.8	44	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135528	10.1371/journal.pone.0135528	http://dx.doi.org/10.1371/journal.pone.0135528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284927	Green Published, Green Submitted, gold			2022-12-27	WOS:000359666100044
J	Tseng, SP; Wang, SF; Kuo, CY; Huang, JW; Hung, WC; Ke, GM; Lu, PL				Tseng, Sung-Pin; Wang, Sheng-Fan; Kuo, Cheng-Yu; Huang, Jun-Wei; Hung, Wei-Chun; Ke, Guan-Ming; Lu, Po-Liang			Characterization of Fosfomycin Resistant Extended-Spectrum beta-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; GENE FOSA3; ANTIMICROBIAL SUSCEPTIBILITIES; MULTIDRUG-RESISTANT; DISODIUM-FOSFOMYCIN; DISSEMINATION; PLASMIDS; PREVALENCE; MECHANISMS; ENTEROBACTERIACEAE	To investigate the efficacy of fosfomycin against extended-spectrum beta-lactamases (ESBL) producing Escherichia coli in Taiwan and the resistance mechanisms and characterization of human and pig isolates, we analyzed 145 ESBL-producing isolates collected from two hospitals (n = 123) and five farms (n = 22) in Taiwan from February to May, 2013. Antimicrobial susceptibilities were determined. Clonal relatedness was determined by PFGE and multi-locus sequence typing. ESBLs, ampC, and fosfomycin resistant genes were detected by PCR, and their flanking regions were determined by PCR mapping and sequencing. The fosfomycin resistant mechanisms, including modification of the antibiotic target (MurA), functionless transporters (GlpT and UhpT) and their regulating genes such as uhpA, cyaA, and ptsI, and antibiotic inactivation by enzymes (FosA and FosC), were examined. The size and replicon type of plasmids carrying fosfomycin resistant genes were analyzed. Our results revealed the susceptibility rates of fosfomycin were 94% for human ESBL-producing E. coli isolates and 77% for pig isolates. The PFGE analysis revealed 79 pulsotypes. No pulsotype was found existing in both human and pig isolates. Three pulsotypes were distributed among isolates from two hospitals. ISEcp1 carrying blaCTX-M-group 9 was the predominant transposable elements of the ESBL genes. Among the thirteen fosfomycin resistant isolates, functionless transporters were identified in 9 isolates. Three isolates contained novel amino acid substitutions (Asn67Ile, Phe151Ser and Trp164Ser, Val146Ala and His159Tyr, respectively) in MurA (the target of fosfomycin). Four isolates had fosfomycin modified enzyme (fosA3) in their plasmids. The fosA3 gene was harboured in an IncN-type plasmid (101 kbp) in the three pig isolates and an IncB/O-type plasmid (113 kbp) in the human isolate. In conclusion, we identified that 6% and 23% of the ESBL-producing E. coli from human and pigs were resistant to fosfomycin, respectively, in Taiwan. No clonal spread was found between human and pig isolates. Functionless transporters were the major cause of fosfomycin resistance, and the fosA3-transferring plasmid between isolates warrants further monitoring.	[Tseng, Sung-Pin; Wang, Sheng-Fan; Huang, Jun-Wei] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Tseng, Sung-Pin] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Kuo, Cheng-Yu] Kaohsiung Med Univ, Chung Ho Mem Hosp, Div Infect Dis, Kaohsiung, Taiwan; [Kuo, Cheng-Yu] Pingtung Hosp, Minist Hlth & Welf, Dept Internal Med, Kaohsiung, Taiwan; [Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Ke, Guan-Ming] Natl Pingtung Univ Sci & Technol, Grad Inst Anim Vaccine Technol, Neipu, Pingtung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Pingtung University Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lu, PL (corresponding author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.	d830166@gmail.com	Wang, Sheng-Fan/ABA-7842-2020; Lu, Po-Liang/D-4499-2009	Wang, Sheng-Fan/0000-0002-8142-4707; Lu, Po-Liang/0000-0002-7423-6783; Wang, Sheng-Fan/0000-0002-4183-3872; Tseng, sung-pin/0000-0001-8915-5268	Ministry of Science and Technology (MOST) [103-2320-B-037-023]; NSYSU-KMU Joint Research Project [NSYSUKMU103-I005]; Kaohsiung Medical University Hospital, Taiwan	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); NSYSU-KMU Joint Research Project; Kaohsiung Medical University Hospital, Taiwan	This work was supported by Ministry of Science and Technology (MOST 103-2320-B-037-023) and NSYSU-KMU Joint Research Project (NSYSUKMU103-I005) and Kaohsiung Medical University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Castaneda-Garcia A, 2013, ANTIBIOTICS-BASEL, V2, P217, DOI 10.3390/antibiotics2020217; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Couce A, 2012, ANTIMICROB AGENTS CH, V56, P2767, DOI 10.1128/AAC.06122-11; Diestra K, 2009, J ANTIMICROB CHEMOTH, V63, P60, DOI 10.1093/jac/dkn453; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; Gutierrez L, 2010, POULTRY SCI, V89, P2106, DOI 10.3382/ps.2010-00892; Ho PL, 2013, J APPL MICROBIOL, V114, P695, DOI 10.1111/jam.12099; Ho PL, 2013, J MED MICROBIOL, V62, P1707, DOI 10.1099/jmm.0.062653-0; Hou JX, 2013, J ANTIMICROB CHEMOTH, V68, P766, DOI 10.1093/jac/dks465; Hou JX, 2012, ANTIMICROB AGENTS CH, V56, P2135, DOI 10.1128/AAC.05104-11; Keating GM, 2013, DRUGS, V73, P1951, DOI 10.1007/s40265-013-0143-y; Lartigue MF, 2004, FEMS MICROBIOL LETT, V234, P201, DOI 10.1016/j.femsle.2004.01.051; Lee SY, 2012, J ANTIMICROB CHEMOTH, V67, P2843, DOI 10.1093/jac/dks319; Liu HY, 2011, J MICROBIOL IMMUNOL, V44, P364, DOI 10.1016/j.jmii.2010.08.012; Lu CL, 2011, ANTIMICROB AGENTS CH, V55, P4295, DOI 10.1128/AAC.00349-11; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Ma L, 2011, J MED MICROBIOL, V60, P1787, DOI 10.1099/jmm.0.033910-0; Miriagou V, 2005, ANTIMICROB AGENTS CH, V49, P3541, DOI 10.1128/AAC.49.8.3541-3543.2005; MOLLET B, 1983, NUCLEIC ACIDS RES, V11, P6319, DOI 10.1093/nar/11.18.6319; Nilsson AI, 2003, ANTIMICROB AGENTS CH, V47, P2850, DOI 10.1128/AAC.47.9.2850-2858.2003; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Sato N, 2013, MICROB DRUG RESIST, V19, P477, DOI 10.1089/mdr.2013.0061; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; Soraci AL, 2011, RES VET SCI, V90, P498, DOI 10.1016/j.rvsc.2010.07.011; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; Tseng SP, 2014, ANTIMICROB AGENTS CH, V58, P593, DOI 10.1128/AAC.00231-13; Wachino J, 2010, ANTIMICROB AGENTS CH, V54, P3061, DOI 10.1128/AAC.01834-09; Yan JJ, 2000, J CLIN MICROBIOL, V38, P4320, DOI 10.1128/JCM.38.12.4320-4325.2000; Yu Wen-Liang, 2006, Journal of Microbiology Immunology and Infection, V39, P264; Zahar JR, 2009, CURR OPIN INVEST DR, V10, P172	35	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135864	10.1371/journal.pone.0135864	http://dx.doi.org/10.1371/journal.pone.0135864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280832	Green Published, gold, Green Submitted			2022-12-27	WOS:000359664300025
J	Yu, MH; Ding, GD; Gao, GL; Sun, BP; Zhao, YY; Wan, L; Wang, DY; Gui, ZY				Yu, Ming-Han; Ding, Guo-Dong; Gao, Guang-Lei; Sun, Bao-Ping; Zhao, Yuan-Yuan; Wan, Li; Wang, De-Ying; Gui, Zi-Yang			How the Plant Temperature Links to the Air Temperature in the Desert Plant Artemisia ordosica	PLOS ONE			English	Article							LEAF TEMPERATURES; STOMATAL CONDUCTANCE; HEAT-STORAGE; TRANSPIRATION; RESPONSES; DROUGHT	Plant temperature (Tp) is an important indicator of plant health. To determine the dynamics of plant temperature and self-cooling ability of the plant, we measured Tp in Artemisia ordosica in July, in the Mu Us Desert of Northwest China. Related factors were also monitored to investigate their effects on Tp, including environmental factors, such as air temperature (Ta), relative humidity, wind speed; and physiological factors, such as leaf water potential, sap flow, and water content. The results indicate that: 1) Tp generally changes in conjunction with Ta mainly, and varies with height and among the plant organs. Tp in the young branches is most constant, while it is the most sensitive in the leaves. 2) Correlations between Tp and environmental factors show that Tp is affected mainly by Ta. 3) The self-cooling ability of the plant was effective by midday, with Tp being lower than Ta. 4) Increasing sap flow and leaf water potential showed that transpiration formed part of the mechanism that supported self-cooling. Increased in water conductance and specific heat at midday may be additional factors that contribute to plant cooling ability. Therefore, our results confirmed plant self-cooling ability. The response to high temperatures is regulated by both transpiration speed and an increase in stem water conductance. This study provides quantitative data for plant management in terms of temperature control. Moreover, our findings will assist species selection with taking plant temperature as an index.	[Yu, Ming-Han; Ding, Guo-Dong; Gao, Guang-Lei; Zhao, Yuan-Yuan; Wan, Li; Wang, De-Ying; Gui, Zi-Yang] Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing 100083, Peoples R China; [Ding, Guo-Dong; Gao, Guang-Lei; Sun, Bao-Ping; Zhao, Yuan-Yuan] Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing 100083, Peoples R China	Beijing Forestry University; Beijing Forestry University	Ding, GD (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing 100083, Peoples R China.	dingguodong@bjfu.edu.cn; gaoguanglei@bjfu.edu.cn	GAO, Guang-Lei/X-7720-2019; ZHAO, YUAN/HCI-5831-2022		National Basic Research Program of China [2013CB429906]; National Technology and Science Support Program of China [2012BAD16B02]	National Basic Research Program of China(National Basic Research Program of China); National Technology and Science Support Program of China	This work was funded by one of National Basic Research Program of China (2013CB429906) (http://www.973.gov.cn/English/Index.aspx) and the National Technology and Science Support Program of China (2012BAD16B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; BARTHAKUR N, 1975, INT J BIOMETEOROL, V19, P21, DOI 10.1007/BF01459837; Crawford AJ, 2012, CURR BIOL, V22, pR396, DOI 10.1016/j.cub.2012.03.044; Dethier BE, 1965, ENERGY EXCHANGE BIOS; Green RM, 2002, REMOTE SENS ENVIRON, V79, P166, DOI 10.1016/S0034-4257(01)00270-X; Guilioni L, 2008, AGR FOREST METEOROL, V148, P1908, DOI 10.1016/j.agrformet.2008.07.009; Haverd V, 2007, AGR FOREST METEOROL, V147, P125, DOI 10.1016/j.agrformet.2007.07.006; Hegazy AK, 1998, AFR J ECOL, V36, P34, DOI 10.1046/j.1365-2028.1998.109-89109.x; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Lindroth A, 2010, BIOGEOSCIENCES, V7, P301, DOI 10.5194/bg-7-301-2010; Lu CG, 2008, RICE SCI, V15, P223, DOI 10.1016/S1672-6308(08)60046-3; MEINZER FC, 1995, OECOLOGIA, V101, P514, DOI 10.1007/BF00329432; MELLOR RS, 1964, PLANTA, V61, P56, DOI 10.1007/BF01895390; Munns R, 2010, J EXP BOT, V61, P3499, DOI 10.1093/jxb/erq199; Nobel P. S., 1991, Physicochemical and environmental plant physiology.; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; RASCHKE K, 1960, ANNU REV PLANT PHYS, V11, P111, DOI 10.1146/annurev.pp.11.060160.000551; SANDERS TH, 1984, MYCOPATHOLOGIA, V86, P51, DOI 10.1007/BF00437229; SCHULZE ED, 1972, PLANTA, V108, P259, DOI 10.1007/BF00384113; TANNER CB, 1963, AGRON J, V55, P210, DOI 10.2134/agronj1963.00021962005500020043x; Urban J, 2012, BIOLOGIA, V67, P917, DOI 10.2478/s11756-012-0080-3; Wheeler TR, 2000, AGR ECOSYST ENVIRON, V82, P159, DOI 10.1016/S0167-8809(00)00224-3; Williams LE, 2007, AM J ENOL VITICULT, V58, P173; WOODHOUSE RM, 1983, OECOLOGIA, V57, P291, DOI 10.1007/BF00377170; Yuan W, 2011, BIOGEOSCIENCES, V8, P1453, DOI 10.5194/bg-8-1453-2011	27	12	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135452	10.1371/journal.pone.0135452	http://dx.doi.org/10.1371/journal.pone.0135452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280557	Green Published, gold, Green Submitted			2022-12-27	WOS:000359664300014
J	Brauner, EV; Loft, S; Sorensen, M; Jensen, A; Andersen, CE; Ulbak, K; Hertel, O; Pedersen, C; Tjonneland, A; Kjaer, SK; Raaschou-Nielsen, O				Brauner, Elvira Vaclavik; Loft, Steffen; Sorensen, Mette; Jensen, Allan; Andersen, Claus Erik; Ulbak, Kaare; Hertel, Ole; Pedersen, Camilla; Tjonneland, Anne; Kjaer, Susanne Kruger; Raaschou-Nielsen, Ole			Residential Radon Exposure and Skin Cancer Incidence in a Prospective Danish Cohort	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; DOMESTIC RADON; LUNG-CANCER; RISK; RN-222; EPIDEMIOLOGY	Background Although exposure to UV radiation is the major risk factor for skin cancer, theoretical models suggest that radon exposure can contribute to risk, and this is supported by ecological studies. We sought to confirm or refute an association between long-term exposure to residential radon and the risk for malignant melanoma (MM) and non-melanoma skin cancer (NMSC) using a prospective cohort design and long-term residential radon exposure. Methods During 1993-1997, we recruited 57,053 Danish persons and collected baseline information. We traced and geocoded all residential addresses of the cohort members and calculated radon concentrations at each address lived in from 1 January 1971 until censor date. Cox proportional hazards models were used to estimate incidence rate-ratios (IRR) and confidence intervals (CI) for the risk associated with radon exposure for NMSC and MM, and effect modification was assessed. Results Over a mean follow-up of 13.6 years of 51,445 subjects, there were 3,243 cases of basal cell carcinoma (BCC), 317 cases of squamous cell carcinoma (SCC) and 329 cases of MM. The adjusted IRRs per 100 Bq/m(3) increase in residential radon levels for BCC, SCC and MM were 1.14 (95% CI: 1.03, 1.27), 0.90 (95% CI: 0.70, 1.37) and 1.08 (95% CI: 0.77, 1.50), respectively. The association between radon exposure and BCC was stronger among those with higher socio-economic status and those living in apartments at enrollment. Conclusion and Impact Long-term residential radon exposure may contribute to development of basal cell carcinoma of the skin. We cannot exclude confounding from sunlight and cannot conclude on causality, as the relationship was stronger amongst persons living in apartments and nonexistent amongst those living in single detached homes.	[Brauner, Elvira Vaclavik] Glostrup Cty Hosp, Capital Reg Denmark, Ctr Hlth, Res Ctr Prevent & Heath, Glostrup, Denmark; [Brauner, Elvira Vaclavik; Sorensen, Mette; Pedersen, Camilla; Tjonneland, Anne; Raaschou-Nielsen, Ole] Danish Canc Soc, Res Ctr, Diet Genes & Environm, Copenhagen, Denmark; [Loft, Steffen] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark; [Jensen, Allan; Kjaer, Susanne Kruger] Danish Canc Soc, Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark; [Andersen, Claus Erik] Tech Univ Denmark, Ctr Nucl Technol, Roskilde, Denmark; [Ulbak, Kaare] Natl Inst Radiat Protect, Herlev, Denmark; [Hertel, Ole; Kjaer, Susanne Kruger] Univ Copenhagen, Rigshosp, Dept Gynecol, DK-2100 Copenhagen, Denmark; [Raaschou-Nielsen, Ole] Aarhus Univ, Dept Environm Sci, Aarhus, Denmark	University of Copenhagen; Danish Cancer Society; University of Copenhagen; Danish Cancer Society; Technical University of Denmark; Rigshospitalet; University of Copenhagen; Aarhus University	Brauner, EV (corresponding author), Glostrup Cty Hosp, Capital Reg Denmark, Ctr Hlth, Res Ctr Prevent & Heath, Glostrup, Denmark.	elvira.vaclavik.braeuner@regionh.dk	Hertel, Ole/L-4346-2013; Raaschou-Nielsen, Ole/GOK-0338-2022; Brauner, Elvira/C-7455-2018	Hertel, Ole/0000-0003-0972-7735; Raaschou-Nielsen, Ole/0000-0002-1223-0909; Jensen, Allan/0000-0001-8124-4880; Pedersen, Camilla/0000-0003-2068-0536; Sorensen, Mette/0000-0002-7302-4789; Brauner, Elvira/0000-0001-9183-4796; Kjaer, Susanne/0000-0002-8347-1398; Tjonneland, Anne/0000-0003-4385-2097; Loft, Steffen/0000-0001-9552-8518; Andersen, Claus E./0000-0002-7356-9607	Danish Cancer Society; Aase and Ejnar Danielsens; King Christian the 10th, A.P. Moller; Hartmann Brothers; Foundation of 1870; Snedker Jacobsen and hustru Astrid Jacobsen; Architect Holger Hjortenberg and hustru Dagmar Hjortenberg; Civil Engineer Frode V. Nyegaard; Simon Spies	Danish Cancer Society(Danish Cancer Society); Aase and Ejnar Danielsens; King Christian the 10th, A.P. Moller; Hartmann Brothers; Foundation of 1870; Snedker Jacobsen and hustru Astrid Jacobsen; Architect Holger Hjortenberg and hustru Dagmar Hjortenberg; Civil Engineer Frode V. Nyegaard; Simon Spies	This work was supported by Research Grants from Danish Cancer Society, Aase and Ejnar Danielsens, King Christian the 10th, A.P. Moller, The Hartmann Brothers, The Foundation of 1870, Snedker Jacobsen and hustru Astrid Jacobsen, Architect Holger Hjortenberg and hustru Dagmar Hjortenberg, Civil Engineer Frode V. Nyegaard and Simon Spies. These foundations had no role in the design of the study, interpretation of the results, or writing of the paper.	AGIR, 2009, RCE 11, P1; Andersen CE, 2007, RADIAT PROT DOSIM, V123, P83, DOI 10.1093/rpd/ncl082; Brauner EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074435; Brauner EV, 2012, ENVIRON RES, V118, P130, DOI 10.1016/j.envres.2012.05.012; Brauner EV, 2010, CANCER CAUSE CONTROL, V21, P1961, DOI 10.1007/s10552-010-9608-4; Charles MW, 2007, J RADIOL PROT, V27, P231, DOI 10.1088/0952-4746/27/3/R01; Charles MW, 2007, J RADIOL PROT, V27, P253, DOI 10.1088/0952-4746/27/3/R02; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Darby S, 2001, ANN ONCOL, V12, P1341, DOI 10.1023/A:1012518223463; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Doherty VR, 2010, BRIT J CANCER, V102, P1661, DOI 10.1038/sj.bjc.6605678; Eatough J. P., 1995, Journal of Radiological Protection, V15, P45, DOI 10.1088/0952-4746/15/1/003; EATOUGH JP, 1991, RADIAT PROT DOSIM, V39, P33; Eatough JP, 1997, PHYS MED BIOL, V42, P1899, DOI 10.1088/0031-9155/42/10/004; Etherington DJ, 1996, EUR J CANCER, V32A, P1189, DOI 10.1016/0959-8049(96)00060-3; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hansen MR, 2014, PUBLIC HEALTH, V128, P777, DOI 10.1016/j.puhe.2014.07.002; HARLEY NH, 1991, HEALTH PHYS, V61, P737, DOI 10.1097/00004032-199112000-00004; Harrel F.E., 2001, REGRESSION MODELING; IARC, 1988, IARC MON EV CARC RIS, V43; Kendall G. M., 2002, Journal of Radiological Protection, V22, P389, DOI 10.1088/0952-4746/22/4/304; Kristbjornsdottir A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-73; Lamberg Anna L, 2010, Clin Epidemiol, V2, P123; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Lichter MD, 2000, ARCH DERMATOL, V136, P1007, DOI 10.1001/archderm.136.8.1007; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Melkonian S, 2011, AM J EPIDEMIOL, V173, P183, DOI 10.1093/aje/kwq357; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Raaschou-Nielsen O, 2008, EPIDEMIOLOGY, V19, P536, DOI 10.1097/EDE.0b013e318176bfcd; Ramirez CC, 2005, INT J DERMATOL, V44, P95, DOI 10.1111/j.1365-4632.2005.02301.x; Steding-Jessen M, 2010, CANCER EPIDEMIOL, V34, P689, DOI 10.1016/j.canep.2010.06.011; Sundhedsstyrelsen Statens Institut for Stralebeskyttelse, 2013, STRAL ION STRAL; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; van Netten C, 1998, AM IND HYG ASSOC J, V59, P622, DOI 10.1080/15428119891010794; Wheeler BW, 2013, BRIT J CANCER, V109, P235, DOI 10.1038/bjc.2013.288; Wheeler BW, 2012, EPIDEMIOLOGY, V23, P44, DOI 10.1097/EDE.0b013e31823b6139	39	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135642	10.1371/journal.pone.0135642	http://dx.doi.org/10.1371/journal.pone.0135642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274607	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600085
J	Declercq, J; Brouwers, B; Pruniau, VPEG; Stijnen, P; de Faudeur, G; Tuand, K; Meulemans, S; Serneels, L; Schraenen, A; Schuit, F; Creemers, JWM				Declercq, Jeroen; Brouwers, Bas; Pruniau, Vincent P. E. G.; Stijnen, Pieter; de Faudeur, Geoffroy; Tuand, Krizia; Meulemans, Sandra; Serneels, Lutgarde; Schraenen, Anica; Schuit, Frans; Creemers, John W. M.			Metabolic and Behavioural Phenotypes in Nestin-Cre Mice Are Caused by Hypothalamic Expression of Human Growth Hormone	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; TRANSGENIC MOUSE; PROLACTIN RECEPTOR; MEDIATED RECOMBINATION; NERVOUS-SYSTEM; BRAIN; DEFECTS; GENE; GH; DISRUPTION	The Nestin-Cre driver mouse line has mild hypopituitarism, reduced body weight, a metabolic phenotype and reduced anxiety. Although several causes have been suggested, a comprehensive explanation is still lacking. In this study we examined the molecular mechanisms leading to this compound phenotype. Upon generation of the Nestin-Cre mice, the human growth hormone (hGH) minigene was inserted downstream of the Cre recombinase to ensure efficient transgene expression. As a result, hGH is expressed in the hypothalamus. This results in the auto/paracrine activation of the GH receptor as demonstrated by the increased phosphorylation of signal transducer and activator of transcription 5 (STAT5) and reduced expression of growth hormone releasing hormone (Ghrh). Low Ghrh levels cause hypopituitarism consistent with the observed mouse growth hormone (mGH) deficiency. mGH deficiency caused reduced activation of the GH receptor and hence reduced phosphorylation of STAT5 in the liver. This led to decreased levels of hepatic Igf-1 mRNA and consequently postnatal growth retardation. Furthermore, genes involved in lipid uptake and synthesis, such as CD36 and very low-density lipoprotein receptor were upregulated, resulting in liver steatosis. In conclusion, this study demonstrates the unexpected expression of hGH in the hypothalamus of Nestin-Cre mice which is able to activate both the GH receptor and the prolactin receptor. Increased hypothalamic GH receptor signaling explains the observed hypopituitarism, reduced growth and metabolic phenotype of Nestin-Cre mice. Activation of either receptor is consistent with reduced anxiety.	[Declercq, Jeroen; Brouwers, Bas; Pruniau, Vincent P. E. G.; Stijnen, Pieter; Tuand, Krizia; Meulemans, Sandra; Creemers, John W. M.] Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, Dept Human Genet, B-3000 Leuven, Belgium; [de Faudeur, Geoffroy; Schraenen, Anica; Schuit, Frans] Katholieke Univ Leuven, Gene Express Unit, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Serneels, Lutgarde] Katholieke Univ Leuven, Lab Res Degenerat Dis, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Creemers, JWM (corresponding author), Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, Dept Human Genet, KU Leuven, B-3000 Leuven, Belgium.	john.creemers@med.kuleuven.be	Tuand, Krizia/E-1657-2015; Tuand, Krizia/AAF-7888-2019	Tuand, Krizia/0000-0003-2670-5415; Tuand, Krizia/0000-0003-2670-5415; Brouwers, Bas/0000-0001-6541-4835; Serneels, Lutgarde/0000-0002-5463-4231; stijnen, pieter/0000-0002-3047-6902	FWO Vlaanderen [G.0738.15N]; KU Leuven [GOA 12/016]	FWO Vlaanderen(FWO); KU Leuven(KU Leuven)	This work was supported by FWO Vlaanderen, grant G.0738.15N and "Geconcerteerde Onderzoeksacties" GOA 12/016 grant of the KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach AB, 2004, ACTA BIOCHIM POL, V51, P9; Augustine RA, 2003, J MOL ENDOCRINOL, V31, P221, DOI 10.1677/jme.0.0310221; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Briancon N, 2010, DIABETES, V59, P3074, DOI 10.2337/db10-0481; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; CHIU SF, 1994, J NEUROENDOCRINOL, V6, P191, DOI 10.1111/j.1365-2826.1994.tb00572.x; Delacour A, 2004, MECH DEVELOP, V121, P3, DOI 10.1016/j.mod.2003.11.004; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Galichet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011443; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Giusti SA, 2014, J PSYCHIATR RES, V55, P87, DOI 10.1016/j.jpsychires.2014.04.002; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Kineman RD, 1996, ENDOCRINOLOGY, V137, P4630, DOI 10.1210/endo.137.11.8895326; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Leone S, 2014, GROWTH HORM IGF RES, V24, P192, DOI 10.1016/j.ghir.2014.06.004; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MINAMI S, 1993, J NEUROENDOCRINOL, V5, P691, DOI 10.1111/j.1365-2826.1993.tb00541.x; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Nuytens K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109598; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pruniau VPEG, 2013, HEPATOLOGY, V58, P2209, DOI 10.1002/hep.26483; Qiu LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018778; Rosenfeld RG, 2007, TRENDS ENDOCRIN MET, V18, P134, DOI 10.1016/j.tem.2007.03.004; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; SZABO M, 1995, ENDOCRINOLOGY, V136, P4044, DOI 10.1210/en.136.9.4044; Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van den Burg EH, 2011, J MOL NEUROSCI, V43, P200, DOI 10.1007/s12031-010-9452-8; Xiao F, 2014, DIABETOLOGIA, V57, P2136, DOI 10.1007/s00125-014-3336-3; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	37	44	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135502	10.1371/journal.pone.0135502	http://dx.doi.org/10.1371/journal.pone.0135502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275221	Green Submitted, Green Published, gold			2022-12-27	WOS:000359493600070
J	Yu, N; Zhang, Z; Chen, P; Zhong, YM; Cai, XX; Hu, H; Yang, Y; Zhang, J; Li, KJ; Ge, J; Yu, KM; Liu, X; Zhuang, J				Yu, Na; Zhang, Zhang; Chen, Pei; Zhong, Yimin; Cai, Xiaoxiao; Hu, Huan; Yang, Ying; Zhang, Jing; Li, Kaijing; Ge, Jian; Yu, Keming; Liu, Xing; Zhuang, Jing			Tetramethylpyrazine (TMP), an Active Ingredient of Chinese Herb Medicine Chuanxiong, Attenuates the Degeneration of Trabecular Meshwork through SDF-1/CXCR4 Axis	PLOS ONE			English	Article							RECEPTOR CXCR4 EXPRESSION; NERVOUS-SYSTEM; CULTURED HUMAN; CELLS; GLAUCOMA; MIGRATION; MATRIX; NEOVASCULARIZATION; CHEMOKINES; INHIBITION	Background A traditional Chinese medicine, Tetramethylpyrazine (TMP), has been prescribed as a complementary treatment for glaucoma to improve patient prognosis. However, the pharmacological mechanism of action of TMP is poorly understood. In previous studies, we demonstrated that TMP exerts potent inhibitory effects on neovascularization, suppresses the tumorigenic behavior of glioma cells, and protects neural cells by regulating CXCR4 expression. Here, we further investigated whether the SDF-1/CXCR4 pathway is also involved in the TMP-mediated activity in trabecular meshwork cells. Methodology/Principal Findings CXCR4 expression was examined by quantitative real-time PCR in trabecular and iris specimens from 54 primary open-angle glaucoma (POAG) patients who required surgery and 19 non-glaucomatous donors. Our data revealed markedly elevated CXCR4 expression in the trabecular meshwork of POAG patients compared with that of controls. Consistently, CXCR4 expression was much higher in glaucomatous trabecular meshwork cells than in normal trabecular meshwork cells. Using RT-PCR and western blot assays, we determined that glaucoma-related cytokines and dexamethasone (DEX) also significantly up-regulated CXCR4 expression in primary human trabecular meshwork (PHTM) cells. Moreover, the TGF-beta 1-mediated induction of CXCR4 expression in PHTM cells was markedly down-regulated by TMP compared with control treatment (PBS) and the CXCR4 antagonist AMD3100. In addition, TMP could counteract the TGF-beta 1-induced effects on stress fiber accumulation and expansion of PHTM cells. TMP markedly suppressed the migration of PHTM cells stimulated by TGF-beta 1 in transwell and scratch wound assays. TMP also suppressed the extracellular matrix (ECM) accumulation induced by TGF-beta 2. Conclusions Our findings demonstrate that CXCR4 might be involved in the pathogenetic changes in the trabecular meshwork of patients with POAG. Additionally, TMP might exert its beneficial effects in POAG patients by down-regulating CXCR4 expression.	[Yu, Na; Zhang, Zhang; Chen, Pei; Zhong, Yimin; Cai, Xiaoxiao; Hu, Huan; Yang, Ying; Zhang, Jing; Li, Kaijing; Ge, Jian; Yu, Keming; Liu, Xing; Zhuang, Jing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yu, KM (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yukeming@mail.sysu.edu.cn; liuxing@mail.sysu.edu.cn; zhuangj@mail.sysu.edu.cn	Cai, Xiaoxiao/C-4868-2018	Cai, Xiaoxiao/0000-0002-5654-7414	National Natural Science Foundation [81370987]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	All the studies were funded by the grants from the National Natural Science Foundation (Project: 81370987) [KMY].	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Baudouin Christophe, 2012, Trans Am Ophthalmol Soc, V110, P40; Bertran E, 2013, HEPATOLOGY, V58, P2032, DOI 10.1002/hep.26597; Cai XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088176; Chen M, 2011, INVEST OPHTH VIS SCI, V52, P7027, DOI 10.1167/iovs.11-7524; Chen Z, 2013, CANCER LETT, V336, P281, DOI 10.1016/j.canlet.2013.03.015; Chu CY, 2007, ONCOGENE, V26, P2491, DOI 10.1038/sj.onc.1210040; De Groef L, 2013, INVEST OPHTH VIS SCI, V54, P7756, DOI 10.1167/iovs.13-13088; Denoyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037873; Foster Paul J, 2002, Semin Ophthalmol, V17, P50; Fu YS, 2008, NEURO-ONCOLOGY, V10, P139, DOI 10.1215/15228517-2007-051; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Guyon A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00065; Kitagawa K, 2001, JPN J OPHTHALMOL, V45, P227, DOI 10.1016/S0021-5155(01)00320-3; Kucia M, 2004, J MOL HISTOL, V35, P233; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Liang XL, 2012, INVEST OPHTH VIS SCI, V53, P2157, DOI 10.1167/iovs.11-9315; Liu M, 2004, CHIN J CLIN REHAB, V8, P1299; Liu Y, 1998, HUBEI J TRADITIONAL, V20, P54; Luo X, 2013, J LIAONING U TCM, P1673; Man D, 2011, CLIN J CHINESE MED, V14, P1674; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Pang PKT, 1996, PLANTA MED, V62, P431, DOI 10.1055/s-2006-957933; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robertson JV, 2010, INVEST OPHTH VIS SCI, V51, P308, DOI 10.1167/iovs.09-3380; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Scala S, 2007, CANCER IMMUNOL IMMUN, V56, P1589, DOI 10.1007/s00262-007-0303-6; Shifera AS, 2010, EXP EYE RES, V91, P42, DOI 10.1016/j.exer.2010.04.001; SOMMER A, 1989, AM J OPHTHALMOL, V107, P186, DOI 10.1016/0002-9394(89)90221-3; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Stumm RK, 2002, J NEUROSCI, V22, P5865; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tamm ER, 1996, EXP EYE RES, V62, P389, DOI 10.1006/exer.1996.0044; Tang Ze-yao, 2011, Zhongguo Yaolixue Yu Dulixue Zazhi, V25, P114, DOI 10.3867/j.issn.1000-3002.2011.01.023; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; Xia CL, 2009, J XIAN JIAOTONG U ME, V30, P423; Yang JN, 2005, ACTA PHARMACOL SIN, V26, P887, DOI 10.1111/j.1745-7254.2005.00141.x; Yang ZK, 2008, NEUROCHEM INT, V52, P1176, DOI 10.1016/j.neuint.2007.12.008; You JM, 2010, CHIN MED, V28, P2666; Yu KM, 2007, BIOCHEM BIOPH RES CO, V358, P990, DOI 10.1016/j.bbrc.2007.05.004; Yu KM, 2012, ONCOL REP, V28, P955, DOI 10.3892/or.2012.1866; Zhang HQ, 2011, J NEUROSCI, V31, P15894, DOI 10.1523/JNEUROSCI.3943-11.2011	48	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133055	10.1371/journal.pone.0133055	http://dx.doi.org/10.1371/journal.pone.0133055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275042	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600008
J	Yamamoto, M; Lopez, MT; Hart, LA				Yamamoto, Mariko; Lopez, Mayllynne T.; Hart, Lynette A.			Registrations of Assistance Dogs in California for Identification Tags: 1999-2012	PLOS ONE			English	Article							GUIDE DOGS; SERVICE; SUITABILITY; EVOLUTION; BEHAVIOR; FUTURE	Dogs are filling a growing number of roles supporting people with various disabilities, leading to a chaotic situation in the U.S. Although the federal laws allow public access with working dogs only for people with disabilities, no governmental enforcement or management system for such dogs exists. Furthermore, there is no substantive way to confirm whether the dog is an adequately trained assistance dog or not, as neither the handlers nor the dogs are required to carry any particular certification or identification. Therefore, unqualified assistance dogs and incidents such as dog bites by assistance dogs sometimes are problems in the U.S. A governmental oversight system could reduce problems, but no information is available about the current uses of assistance dogs in the U.S. We aimed to investigate the current demographics of registered assistance dogs and the evolving patterns in uses of dogs during 1999-2012 in California. We acquired data on assistance dogs registered by animal control facilities throughout California. We used descriptive statistics to describe the uses of these assistance dogs. The number of assistance dogs sharply increased, especially service dogs, in the past decade. Dogs with small body sizes, and new types of service dogs, such as service dogs for psychiatric and medical assistance, strongly contributed to the increase. The Assistance Dog Identification tags sometimes were mistakenly issued to dogs not fitting the definition of assistance dogs under the law, such as emotional support animals and some cats; this reveals errors in the California governmental registering system. Seemingly inappropriate dogs also were registered, such as those registered for the first time at older than 10 years of age. This study reveals a prevalence of misuse and misunderstanding of regulations and legislation on assistance dogs in California.	[Yamamoto, Mariko; Lopez, Mayllynne T.; Hart, Lynette A.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis	Yamamoto, M (corresponding author), Teikyo Univ Sci, Dept Anim Sci, Yamanashi, Japan.	yamamoto-mariko@ntu.ac.jp	Hart, Lynette/L-4833-2019; Ogura, Yasuhiro/A-2557-2016; Nagao, Miki/ABG-8561-2021	Hart, Lynette/0000-0002-7133-6535; Ogura, Yasuhiro/0000-0001-5768-6160; Nagao, Miki/0000-0002-8886-6145; Matsumura, Yasufumi/0000-0001-8595-8944; Yamamoto, Masaki/0000-0002-7822-3269				Adams B, 2000, BEHAV BRAIN RES, V108, P47, DOI 10.1016/S0166-4328(99)00132-1; American Kennel Club, 2014, DOG BREEDS; American Veterinary Medical Association, 2012, US PET OWN STAT; Assistance Dogs International, 2014, DOG BREEDS BEH; Assistance Dogs International, 2014, GUID DOGS; Assistance Dogs International, 2014, TYP ASS DOGS; Beerda B, 1997, APPL ANIM BEHAV SCI, V52, P307, DOI 10.1016/S0168-1591(96)01131-8; Bergeron R, 2002, CAN J VET RES, V66, P211; Burrows KE, 2008, J APPL ANIM WELF SCI, V11, P42, DOI 10.1080/10888700701555550; Canine Companions for Independence, 2009, WHAT HAPP RET LOSS A; Clutton-Brock Juliet, 1995, P7; Cobb M, 2015, BEHAV PROCESS, V110, P96, DOI 10.1016/j.beproc.2014.10.012; Coppinger R, 1998, J Appl Anim Welf Sci, V1, P133, DOI 10.1207/s15327604jaws0102_4; Davis BW, 2004, ANTHROZOOS, V17, P130, DOI 10.2752/089279304786991765; DogsBite.org, 2012, 2012 DOG BIT FAT STA; Ennik I, 2006, J VET BEHAV, V1, P67, DOI 10.1016/j.jveb.2006.06.004; Fairman S K, 2001, Occup Ther Health Care, V13, P41, DOI 10.1080/J003v13n02_03; Fishman GA, 2003, SURV OPHTHALMOL, V48, P452, DOI 10.1016/S0039-6257(03)00052-3; Guide Dogs for the Blind Association, 2014, REH GUID DOG; Hart BL, 1988, PERFECT PUPPY CHOOSE, P40; Hart LA, 1996, APPL ANIM BEHAV SCI, V47, P7, DOI 10.1016/0168-1591(95)01006-8; Hawks E, 1975, EVENING SUN      DEC; Hoffman CL, 2014, J APPL ANIM WELF SCI, V17, P322, DOI 10.1080/10888705.2014.895904; KNOL BW, 1988, VET QUART, V10, P198, DOI 10.1080/01652176.1988.9694171; Meyers DM, 2014, YAKIMAHERALD; Ministry of Health Labour and Welfare, 2002, ACT ASS DOGS PHYS DI; MOREY DF, 1994, AM SCI, V82, P336; Parenti L, 2013, J REHABIL RES DEV, V50, P745, DOI 10.1682/JRRD.2012.11.0216; Rintala DH, 2002, SCI PSYCHOSOC PROCES, V15, p[65, 70]; Tapp PD, 2003, LEARN MEMORY, V10, P64, DOI 10.1101/lm.54403; VALENTINE DP, 1993, SOC WORK HEALTH CARE, V19, P109, DOI 10.1300/J010v19n01_07; Weiss E, 1997, APPL ANIM BEHAV SCI, V53, P297, DOI 10.1016/S0168-1591(96)01176-8; Whitmarsh L., 2005, VISUAL IMPAIRMENT RE, V7, P27, DOI [DOI 10.1080/13882350590956439, 10.1080/13882350590956439]	33	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0132820	10.1371/journal.pone.0132820	http://dx.doi.org/10.1371/journal.pone.0132820			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26322891	Green Published, gold			2022-12-27	WOS:000360018600004
J	Yamamoto, M; Takakura, S; Iinuma, Y; Hotta, G; Matsumura, Y; Matsushima, A; Nagao, M; Ogawa, K; Fujimoto, Y; Mori, A; Ogura, Y; Kaido, T; Uemoto, S; Ichiyama, S				Yamamoto, Masaki; Takakura, Shunji; Iinuma, Yoshitsugu; Hotta, Go; Matsumura, Yasufumi; Matsushima, Aki; Nagao, Miki; Ogawa, Kohei; Fujimoto, Yasuhiro; Mori, Akira; Ogura, Yasuhiro; Kaido, Toshimi; Uemoto, Shinji; Ichiyama, Satoshi			Changes in Surgical Site Infections after Living Donor Liver Transplantation	PLOS ONE			English	Article							RISK-FACTORS; COMPLICATIONS; PREVENTION; RECIPIENTS; ASSOCIATION; PROPHYLAXIS; SPECTRUM	Surgical site infections (SSIs) are a major threat for liver transplant recipients. We prospectively studied SSIs after living donor liver transplantation (LDLT) at Kyoto University Hospital from April 2001 to March 2002 (1st period) and from January 2011 to June 2012 (2nd period). We investigated the epidemiology of SSIs after LDLT and determined the differences between the two periods. A total of 129 adult recipients (66 during the 1st period and 63 during the 2nd period) and 72 pediatric recipients (39 and 33) were included in this study. The SSI rates for each period were 30.3% (1st period) and 41.3% (2nd period) among the adult recipients and 25.6% and 30.3% among the pediatric recipients. The overall rates of 30-day mortality among adult transplant recipients with SSIs were 10.0% (1st period) and 3.9% (2nd period). No pediatric recipient died from SSIs after LDLT in either period. The incidence of Enterococcus faecium increased from 5.0% to 26.9% in the adults and from 10.0% to 40.0% in the pediatric patients. Extended-spectrum beta-lactamase-producing Enterobacteriaceae were emerging important isolates during the 2nd period. For this period, a univariate analysis showed that ABO incompatibility (P=0.02), total operation duration (P=0.01), graft-to-recipient body weight ratio (GRWR [P=0.04]), and Roux-en-Y biliary reconstruction (P<0.01) in the adults and age (P=0.01) and NHSN risk index (P=0.02) in the children were associated with SSI development. In a multivariate analysis, lower GRWR (P=0.02) and Roux-en-Y biliary reconstruction (P<0.01) in the adults and older age (P=0.01) in the children were independent risk factors for SSIs during the 2nd period. In conclusion, SSIs caused by antibiotic resistant bacteria may become a major concern. Lower GRWR and Roux-en-Y biliary reconstruction among adult LDLT recipients and older age among pediatric LDLT recipients increased the risk of developing SSIs after LDLT.	[Yamamoto, Masaki; Takakura, Shunji; Hotta, Go; Matsumura, Yasufumi; Matsushima, Aki; Nagao, Miki; Ichiyama, Satoshi] Kyoto Univ, Dept Clin Lab Med, Grad Sch Med, Kyoto, Japan; [Iinuma, Yoshitsugu] Kanazawa Med Univ, Dept Infect Dis, Kanazawa, Ishikawa, Japan; [Ogawa, Kohei; Fujimoto, Yasuhiro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan; [Ogura, Yasuhiro] Nagoya Univ Hosp, Dept Transplantat Surg, Nagoya, Aichi, Japan	Kyoto University; Kanazawa Medical University; Kyoto University; Nagoya University	Takakura, S (corresponding author), Kyoto Univ, Dept Clin Lab Med, Grad Sch Med, Kyoto, Japan.	stakakr@kuhp.kyoto-u.ac.jp	Hart, Lynette/L-4833-2019; Ogura, Yasuhiro/A-2557-2016; Nagao, Miki/ABG-8561-2021	Hart, Lynette/0000-0002-7133-6535; Ogura, Yasuhiro/0000-0001-5768-6160; Nagao, Miki/0000-0002-8886-6145; Matsumura, Yasufumi/0000-0001-8595-8944; Yamamoto, Masaki/0000-0002-7822-3269	Ministry of Health, Labor and Welfare of Japan [H21-Shinko-Ippan-009, H23-Shinko-Ippan-018]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (H21-Shinko-Ippan-009 and H23-Shinko-Ippan-018). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio A, 2008, LIVER TRANSPLANT, V14, P799, DOI 10.1002/lt.21435; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; COLONNA JO, 1988, ARCH SURG-CHICAGO, V123, P360; de Villa VH, 2003, TRANSPLANTATION, V75, pS2, DOI 10.1097/01.TP.0000046532.44975.57; Prado MEG, 2008, TRANSPLANTATION, V85, P1849, DOI 10.1097/TP.0b013e3181735407; Hashimoto M, 2009, TRANSPL INFECT DIS, V11, P11, DOI 10.1111/j.1399-3062.2008.00341.x; Hellinger WC, 2011, AM J TRANSPLANT, V11, P1877, DOI 10.1111/j.1600-6143.2011.03644.x; Hellinger WC, 2009, TRANSPLANTATION, V87, P1387, DOI 10.1097/TP.0b013e3181a25133; Iinuma Y, 2004, TRANSPLANTATION, V78, P704, DOI 10.1097/01.TP.0000130178.17216.28; Kaido T, 2012, WORLD J SURG, V36, P1666, DOI 10.1007/s00268-012-1529-9; Lee SO, 2011, LIVER TRANSPLANT, V17, P733, DOI 10.1002/lt.22296; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Matsumura Y, 2012, J ANTIMICROB CHEMOTH, V67, P2612, DOI 10.1093/jac/dks278; Matsuo K, 2004, TRANSPLANT P, V36, P2299, DOI 10.1016/j.transproceed.2004.08.043; Mrzljak A, 2010, LIVER TRANSPLANT, V16, P1217, DOI 10.1002/lt.22137; Muiesan P, 2007, J HEPATOL, V46, P340, DOI 10.1016/j.jhep.2006.11.006; Nafady-Hego H, 2011, LIVER TRANSPLANT, V17, P976, DOI 10.1002/lt.22278; OZAKI CF, 1994, SURG CLIN N AM, V74, P1155, DOI 10.1016/S0039-6109(16)46438-8; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; PAYA CV, 1989, EUR J CLIN MICROBIOL, V8, P499, DOI 10.1007/BF01967467; Pungpapong S, 2006, LIVER TRANSPLANT, V12, P1244, DOI 10.1002/lt.20801; Reid GE, 2009, TRANSPLANTATION, V87, P1706, DOI 10.1097/TP.0b013e3181a60338; Shah H, 2014, LIVER TRANSPLANT, V20, P930, DOI 10.1002/lt.23890; SINGH N, 1994, TRANSPLANTATION, V58, P774, DOI 10.1097/00007890-199410150-00004; Vandecasteele E, 2010, TRANSPL INT, V23, P182, DOI 10.1111/j.1432-2277.2009.00974.x	26	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136559	10.1371/journal.pone.0136559	http://dx.doi.org/10.1371/journal.pone.0136559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322891	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500020
